ID,Probe_Id,Definition,Ontology_Component,Ontology_Process,Ontology_Function,Chromosome,Probe_Coordinates,Cytoband,Probe_Chr_Orientation,RefSeq_ID,Entrez_Gene_ID,Symbol,logFC,AveExpr,t,P.Value,adj.P.Val,B
FABP4,ILMN_1773006,"Homo sapiens fatty acid binding protein 4, adipocyte (FABP4), mRNA.",soluble fraction [goid 5625] [pmid 2481498] [evidence TAS]; cytoplasm [goid 5737] [pmid 16130169] [evidence TAS],transport [goid 6810] [evidence IEA],fatty acid binding [goid 5504] [pmid 2481498] [evidence TAS],8,82554256-82554305,8q21.13b,-,NM_001442.1,2167,FABP4,-5.381895200326967,8.23959911949076,-41.497138361818344,1.397009412276717e-72,2.722072839821183e-68,154.5769569341039
ITLN2,ILMN_2118129,"Homo sapiens intelectin 2 (ITLN2), mRNA.",,,sugar binding [goid 5529] [evidence IEA],1,159181495-159181544,1q23.3a,-,NM_080878.2,142683,ITLN2,-5.463763054638332,8.468097764105773,-32.34600103940374,9.171944216014687e-61,8.935766652452308e-57,127.95403549048689
TCF21,ILMN_1719351,"Homo sapiens transcription factor 21 (TCF21), transcript variant 1, mRNA.",nucleus [goid 5634] [evidence IEA],"mesoderm development [goid 7498] [pmid 9507058] [evidence TAS]; regulation of transcription, DNA-dependent [goid 6355] [evidence IEA]",RNA polymerase II transcription factor activity [goid 3702] [evidence NR ]; DNA binding [goid 3677] [evidence IEA],6,134258098-134258147,6q23.2d,+,NM_198392.1,6943,TCF21,-3.6891561357753853,7.957820566357217,-30.94360208643417,1.0233372002018363e-58,6.646575115310927e-55,123.30970079839821
AGER,ILMN_1690829,"Homo sapiens advanced glycosylation end product-specific receptor (AGER), transcript variant 1, mRNA.",plasma membrane [goid 5886] [pmid 1378843] [evidence NAS]; integral to plasma membrane [goid 5887] [pmid 1378843] [evidence TAS]; plasma membrane [goid 5886] [pmid 1378843] [evidence NAS]; integral to plasma membrane [goid 5887] [pmid 1378843] [evidence TAS]; plasma membrane [goid 5886] [pmid 1378843] [evidence NAS]; integral to plasma membrane [goid 5887] [pmid 1378843] [evidence TAS],cell surface receptor linked signal transduction [goid 7166] [pmid 10835680] [evidence TAS]; cell adhesion [goid 7155] [evidence IEA]; inflammatory response [goid 6954] [pmid 10399917] [evidence TAS]; cell surface receptor linked signal transduction [goid 7166] [pmid 10835680] [evidence TAS]; cell adhesion [goid 7155] [evidence IEA]; inflammatory response [goid 6954] [pmid 10399917] [evidence TAS]; cell surface receptor linked signal transduction [goid 7166] [pmid 10835680] [evidence TAS]; cell adhesion [goid 7155] [evidence IEA]; inflammatory response [goid 6954] [pmid 10399917] [evidence TAS],receptor activity [goid 4872] [evidence IEA]; transmembrane receptor activity [goid 4888] [pmid 1378843] [evidence TAS]; protein binding [goid 5515] [evidence IEA]; receptor activity [goid 4872] [evidence IEA]; transmembrane receptor activity [goid 4888] [pmid 1378843] [evidence TAS]; protein binding [goid 5515] [evidence IEA]; receptor activity [goid 4872] [evidence IEA]; transmembrane receptor activity [goid 4888] [pmid 1378843] [evidence TAS]; protein binding [goid 5515] [evidence IEA],6,32258064-32258113,6p21.32b,-,NM_001136.3,177,AGER,-4.397809764739999,8.229257955240547,-30.03202802970216,2.4002231349953235e-57,1.1692086946345969e-53,120.19750333450234
CAV1,ILMN_1687583,"Homo sapiens caveolin 1, caveolae protein, 22kDa (CAV1), mRNA.",integral to membrane [goid 16021] [evidence IEA]; lipid raft [goid 45121] [pmid 11294831] [evidence IDA]; membrane [goid 16020] [evidence IEA]; endoplasmic reticulum [goid 5783] [pmid 11294831] [evidence IDA]; integral to plasma membrane [goid 5887] [pmid 1360410] [evidence TAS]; caveolar membrane [goid 16599] [pmid 15219854] [evidence IDA]; Golgi membrane [goid 139] [pmid 11294831] [evidence IDA],cholesterol homeostasis [goid 42632] [pmid 11294831] [evidence TAS]; cholesterol transport [goid 30301] [pmid 11294831] [evidence TAS],cholesterol binding [goid 15485] [pmid 11294831] [evidence TAS]; structural molecule activity [goid 5198] [pmid 11865038] [evidence IDA]; protein binding [goid 5515] [pmid 10212252] [evidence IPI],7,115987772-115987821,7q31.2b,+,NM_001753.3,857,CAV1,-4.079363283142293,10.617398757670454,-29.924467245868975,3.4997988434516715e-57,1.3638716092931163e-53,119.82527147613627
ADH1B,ILMN_1811598,"Homo sapiens alcohol dehydrogenase IB (class I), beta polypeptide (ADH1B), mRNA.",,ethanol oxidation [goid 6069] [pmid 2398055] [evidence TAS],"metal ion binding [goid 46872] [evidence IEA]; zinc ion binding [goid 8270] [pmid 9982] [evidence IDA]; electron carrier activity [goid 9055] [pmid 2398055] [evidence TAS]; alcohol dehydrogenase activity, zinc-dependent [goid 4024] [pmid 9982] [evidence TAS]",4,100446633-100446682,4q23b,-,NM_000668.3,125,ADH1B,-4.145154784492712,7.917020981056024,-29.566824064940946,1.23572274737827e-56,4.0130096221109317e-53,118.57984409139618
LOC401286,ILMN_1784493,"Homo sapiens hypothetical gene supported by AK127120 (LOC401286), mRNA.",,,,6,167810570-167810619,6q27d,-,NM_001023565.1,401286,LOC401286,-6.7966693868047905,8.56802250216645,-29.365642270369023,2.525463096970931e-56,7.029806920639798e-53,117.87398551321313
FMO2,ILMN_1732158,"Homo sapiens flavin containing monooxygenase 2 (FMO2), mRNA.",microsome [goid 5792] [evidence IEA]; endoplasmic reticulum [goid 5783] [evidence IEA]; integral to membrane [goid 16021] [evidence IEA],electron transport [goid 6118] [evidence IEA],dimethylaniline monooxygenase (N-oxide-forming) activity [goid 4499] [evidence IEA]; magnesium ion binding [goid 287] [evidence IEA]; monooxygenase activity [goid 4497] [pmid 9804831] [evidence TAS],1,169448029-169448078,1q24.3a,+,NM_001460.2,2327,FMO2,-3.490201343283191,9.933042278250285,-29.184296713832524,4.825499213279616e-56,1.1753106521344166e-52,117.23443377873801
FAM107A,ILMN_1743445,"Homo sapiens family with sequence similarity 107, member A (FAM107A), mRNA.",nucleus [goid 5634] [pmid 10564580] [evidence IDA],regulation of cell growth [goid 1558] [pmid 10564580] [evidence IDA],molecular function unknown [goid 5554] [evidence ND ],3,58524932-58524981,3p14.2d,-,NM_007177.1,11170,FAM107A,-4.746596942426921,9.49093698858485,-29.02132661776831,8.657273089314272e-56,1.87429962383654e-52,116.65700637736052
CLEC3B,ILMN_1682176,"Homo sapiens C-type lectin domain family 3, member B (CLEC3B), mRNA.",extracellular region [goid 5576] [pmid 14718574] [evidence NAS],skeletal development [goid 1501] [pmid 7798325] [evidence TAS],sugar binding [goid 5529] [evidence IEA],3,45052268-45052317,3p21.31k,+,NM_003278.1,7123,CLEC3B,-4.328126483554617,9.685176460244145,-28.72552138497052,2.5169891203168816e-55,4.904353300937444e-52,115.60238653159438
XLKD1,ILMN_1808114,"Homo sapiens extracellular link domain containing 1 (XLKD1), mRNA.",membrane fraction [goid 5624] [pmid 10037799] [evidence TAS]; integral to plasma membrane [goid 5887] [pmid 10037799] [evidence TAS],cell-matrix adhesion [goid 7160] [pmid 10037799] [evidence TAS]; morphogenesis [goid 9653] [pmid 10037799] [evidence TAS]; cell adhesion [goid 7155] [evidence IEA]; response to wounding [goid 9611] [pmid 10037799] [evidence TAS]; cell motility [goid 6928] [pmid 10037799] [evidence TAS],hyaluronic acid binding [goid 5540] [evidence IEA]; receptor activity [goid 4872] [pmid 10037799] [evidence TAS],11,10536730-10536779,11p15.4a,-,NM_006691.2,10894,XLKD1,-3.939404208631313,7.265088177198613,-27.985859284379988,3.7644233787465285e-54,6.668162684988737e-51,112.92782097349003
LOC653463,ILMN_1766832,"PREDICTED: Homo sapiens similar to hypothetical gene supported by AK127120 (LOC653463), mRNA.",,,,6,167810570-167810619,,-,XM_376558.2,653463,LOC653463,-6.504842762707097,8.75360134898066,-27.717177616317414,1.0189432980278499e-53,1.6545091801727212e-50,111.94279934408192
STX11,ILMN_1720771,"Homo sapiens syntaxin 11 (STX11), mRNA.",membrane [goid 16020] [evidence IEA]; Golgi stack [goid 5795] [evidence IEA],intracellular protein transport [goid 6886] [evidence IEA]; membrane fusion [goid 6944] [pmid 9553086] [evidence TAS],protein transporter activity [goid 8565] [evidence IEA]; protein binding [goid 5515] [pmid 16169070] [evidence IPI]; SNAP receptor activity [goid 5484] [pmid 9553086] [evidence TAS],6,144550749-144550798,6q24.2b,+,NM_003764.2,8676,STX11,-3.1517993758505307,8.63810090843216,-27.195212093560123,7.196683578910967e-53,1.016950428658187e-49,110.00824908821788
RGC32,ILMN_1658494,"Homo sapiens response gene to complement 32 (RGC32), mRNA.",cytoplasm [goid 5737] [pmid 9756947] [evidence TAS],,,13,40942716-40942765,13q14.11b,+,NM_014059.1,28984,RGC32,-2.7324117125216443,12.737182138016346,-27.191185659316655,7.306803182558182e-53,1.016950428658187e-49,109.9932173417356
CLEC1A,ILMN_1691339,"Homo sapiens C-type lectin domain family 1, member A (CLEC1A), mRNA.",membrane [goid 16020] [evidence IEA]; integral to membrane [goid 16021] [evidence IEA],,sugar binding [goid 5529] [evidence IEA],12,10114650-10114699,12p13.2c,-,NM_016511.2,51267,CLEC1A,-2.629547662029328,7.477394247140404,-26.88942857437935,2.290908277506083e-52,2.975889852480402e-49,108.86189392918307
ETV4,ILMN_1753830,"Homo sapiens ets variant gene 4 (E1A enhancer binding protein, E1AF) (ETV4), mRNA.",nucleus [goid 5634] [evidence NAS]; nucleus [goid 5634] [evidence NAS],"regulation of transcription, DNA-dependent [goid 6355] [evidence NAS]; transcription [goid 6350] [evidence IEA]; regulation of transcription, DNA-dependent [goid 6355] [evidence NAS]; transcription [goid 6350] [evidence IEA]",transcriptional activator activity [goid 16563] [evidence NAS]; sequence-specific DNA binding [goid 43565] [evidence IEA]; transcription factor activity [goid 3700] [evidence IEA]; transcriptional activator activity [goid 16563] [evidence NAS]; transcription factor activity [goid 3700] [evidence IEA]; sequence-specific DNA binding [goid 43565] [evidence IEA],17,38961026-38961075,17q21.31b,-,NM_001986.1,2118,ETV4,3.5275855993912764,7.008971000965266,26.578560565289,7.507314346045224e-52,9.1425012520432e-49,107.6864606213271
EDG1,ILMN_1653504,"Homo sapiens endothelial differentiation, sphingolipid G-protein-coupled receptor, 1 (EDG1), mRNA.",integral to plasma membrane [goid 5887] [evidence NR ]; plasma membrane [goid 5886] [pmid 8626678] [evidence TAS],signal transduction [goid 7165] [evidence IEA]; G-protein coupled receptor protein signaling pathway [goid 7186] [pmid 8626678] [evidence TAS]; cell adhesion [goid 7155] [pmid 10555146] [evidence TAS],lysosphingolipid and lysophosphatidic acid receptor activity [goid 1619] [evidence IEA]; receptor activity [goid 4872] [evidence IEA],1,101478843-101478892,1p21.2a,+,NM_001400.2,1901,EDG1,-2.6545478047822275,7.982363885179389,-26.060419499385343,5.550095082127867e-51,6.111846378460644e-48,105.7045326359925
RHOJ,ILMN_1678215,"Homo sapiens ras homolog gene family, member J (RHOJ), mRNA.",intracellular [goid 5622] [evidence IEA]; membrane [goid 16020] [evidence IEA]; intracellular [goid 5622] [evidence IEA]; membrane [goid 16020] [evidence IEA],small GTPase mediated signal transduction [goid 7264] [evidence IEA]; actin cytoskeleton organization and biogenesis [goid 30036] [pmid 10967094] [evidence IMP]; regulation of cell shape [goid 8360] [evidence IEA]; small GTPase mediated signal transduction [goid 7264] [evidence IEA]; actin cytoskeleton organization and biogenesis [goid 30036] [pmid 10967094] [evidence IMP]; regulation of cell shape [goid 8360] [evidence IEA],protein binding [goid 5515] [evidence ISS]; GTP binding [goid 5525] [evidence IEA]; nucleotide binding [goid 166] [evidence IEA]; GTPase activity [goid 3924] [pmid 10967094] [evidence NAS]; protein binding [goid 5515] [evidence ISS]; GTP binding [goid 5525] [evidence IEA]; nucleotide binding [goid 166] [evidence IEA]; GTPase activity [goid 3924] [pmid 10967094] [evidence NAS],14,62827799-62827848,14q23.2b,+,NM_020663.2,57381,RHOJ,-2.4508209768642057,7.232198917476279,-26.0560111833029,5.646047462781195e-51,6.111846378460644e-48,105.68754713002724
JAM2,ILMN_1672350,"Homo sapiens junctional adhesion molecule 2 (JAM2), mRNA.",integral to plasma membrane [goid 5887] [pmid 10779521] [evidence NAS]; membrane [goid 16020] [evidence IEA]; tight junction [goid 5923] [evidence IEA],cell-cell adhesion [goid 16337] [pmid 10779521] [evidence NAS],,21,26000188-26000237,21q21.3a,+,NM_021219.2,58494,JAM2,-2.8081341037011978,8.110777393626616,-25.998539506111072,7.061148357830742e-51,7.241393460649054e-48,105.46591348414685
PLAC9,ILMN_1790859,"Homo sapiens placenta-specific 9 (PLAC9), mRNA.",,,,10,81891873-81891915:81893959-81893965,10q22.3f,+,NM_001012973.1,219348,PLAC9,-3.6232965586063237,9.753504907382112,-25.93055552554894,9.203814912162621e-51,8.966816678174433e-48,105.20327942642777
PECAM1,ILMN_1689518,"Homo sapiens platelet/endothelial cell adhesion molecule (CD31 antigen) (PECAM1), mRNA.",intercellular junction [goid 5911] [evidence NR ]; integral to membrane [goid 16021] [evidence IEA]; plasma membrane [goid 5886] [pmid 1690453] [evidence TAS],signal transduction [goid 7165] [pmid 7994021] [evidence TAS]; cell adhesion [goid 7155] [evidence IEA]; cell recognition [goid 8037] [pmid 1690453] [evidence TAS]; cell motility [goid 6928] [evidence NR ],protein binding [goid 5515] [evidence IEA],17,59754528-59754577,17q23.3b,-,NM_000442.2,5175,PECAM1,-2.434314269793761,10.509744429342646,-25.890678299417257,1.0754151586292432e-50,9.978316364709906e-48,105.04899384900826
MME,ILMN_1678170,"Homo sapiens membrane metallo-endopeptidase (neutral endopeptidase, enkephalinase, CALLA, CD10) (MME), transcript variant 2a, mRNA.",integral to plasma membrane [goid 5887] [pmid 2521388] [evidence TAS]; plasma membrane [goid 5886] [pmid 1660144] [evidence TAS],cell-cell signaling [goid 7267] [pmid 2521388] [evidence TAS],neprilysin activity [goid 4245] [evidence IEA]; metal ion binding [goid 46872] [evidence IEA]; metallopeptidase activity [goid 8237] [pmid 1660144] [evidence TAS]; zinc ion binding [goid 8270] [evidence IEA],3,156383599-156383648,3q25.2c-q25.31a,+,NM_007288.1,4311,MME,-3.7620424919486553,7.769987584279517,-25.82092803243774,1.4125613762999882e-50,1.251079928054785e-47,104.77871418539053
GIMAP6,ILMN_2329429,"Homo sapiens GTPase, IMAP family member 6 (GIMAP6), transcript variant 3, mRNA.",,,GTP binding [goid 5525] [evidence IEA],7,149954104-149954153,7q36.1c,-,NM_001007224.1,474344,GIMAP6,-2.8151415240242574,8.988012714035134,-25.62791744770474,3.012289168246909e-50,2.5519328018822184e-47,104.02804379207288
LDB2,ILMN_1800697,"Homo sapiens LIM domain binding 2 (LDB2), mRNA.",nucleus [goid 5634] [evidence IEA],development [goid 7275] [evidence IEA],transcription cofactor activity [goid 3712] [pmid 9880598] [evidence TAS],4,16112426-16112475,4p15.32c,-,NM_001290.2,9079,LDB2,-2.8610160026406906,10.476511351664042,-25.215117191030703,1.5421545630417274e-49,1.2520367358695024e-46,102.4088228156946
SPOCK2,ILMN_1656287,"Homo sapiens sparc/osteonectin, cwcv and kazal-like domains proteoglycan (testican) 2 (SPOCK2), mRNA.",extracellular matrix (sensu Metazoa) [goid 5578] [pmid 10386950] [evidence NAS],extracellular matrix organization and biogenesis [goid 30198] [pmid 10386950] [evidence NAS]; synaptogenesis [goid 7416] [pmid 10386950] [evidence NAS]; regulation of cell differentiation [goid 45595] [pmid 10386950] [evidence NAS],calcium ion binding [goid 5509] [pmid 10386950] [evidence IDA],10,73488877-73488926,10q22.1e,-,NM_014767.1,9806,SPOCK2,-3.1256622816586397,11.36034762469966,-25.050150384016323,2.977123546211299e-49,2.3203700919170864e-46,101.75645484701076
CA4,ILMN_1695157,"Homo sapiens carbonic anhydrase IV (CA4), mRNA.",membrane fraction [goid 5624] [pmid 6811592] [evidence TAS]; membrane [goid 16020] [evidence IEA],visual perception [goid 7601] [evidence IEA]; one-carbon compound metabolism [goid 6730] [evidence IEA],carbonate dehydratase activity [goid 4089] [pmid 1311094] [evidence TAS]; lyase activity [goid 16829] [evidence IEA]; GPI anchor binding [goid 48503] [evidence IEA]; zinc ion binding [goid 8270] [evidence IEA]; metal ion binding [goid 46872] [evidence IEA],17,55591584-55591633,17q23.1a,+,NM_000717.2,762,CA4,-5.160738648856259,9.287912616172918,-24.591909324436724,1.8798268481843635e-48,1.4087856206489354e-45,99.92830553218425
TEK,ILMN_1751576,"Homo sapiens TEK tyrosine kinase, endothelial (venous malformations, multiple cutaneous and mucosal) (TEK), mRNA.",integral to plasma membrane [goid 5887] [pmid 8382358] [evidence TAS],cell-cell signaling [goid 7267] [pmid 8980225] [evidence TAS]; signal transduction [goid 7165] [pmid 8382358] [evidence TAS]; transmembrane receptor protein tyrosine kinase signaling pathway [goid 7169] [pmid 8980225] [evidence TAS]; protein amino acid phosphorylation [goid 6468] [evidence IEA],nucleotide binding [goid 166] [evidence IEA]; kinase activity [goid 16301] [evidence IEA]; transmembrane receptor protein tyrosine kinase activity [goid 4714] [pmid 8382358] [evidence TAS]; receptor activity [goid 4872] [pmid 10766762] [evidence TAS]; transferase activity [goid 16740] [evidence IEA]; protein serine/threonine kinase activity [goid 4674] [evidence IEA]; ATP binding [goid 5524] [evidence IEA],9,27219803-27219852,9p21.2a,+,NM_000459.1,7010,TEK,-3.5024982755506375,8.7721436431167,-24.53553274765784,2.3619787582415882e-48,1.7045613371976793e-45,99.70175166593741
MMRN1,ILMN_1660114,"Homo sapiens multimerin 1 (MMRN1), mRNA.",,blood coagulation [goid 7596] [pmid 9189649] [evidence TAS]; cell adhesion [goid 7155] [pmid 9189649] [evidence TAS],,4,91094532-91094581,4q22.1d,+,NM_007351.2,22915,MMRN1,-3.6018485496379897,7.642208724642198,-24.46076947417047,3.198972545411425e-48,2.226142144547915e-45,99.40075143033086
MFAP4,ILMN_1766914,"Homo sapiens microfibrillar-associated protein 4 (MFAP4), mRNA.",microfibril [goid 1527] [pmid 7633408] [evidence NAS]; extracellular matrix (sensu Metazoa) [goid 5578] [evidence IEA],cell adhesion [goid 7155] [evidence NAS],calcium ion binding [goid 5509] [evidence IEA]; protein binding [goid 5515] [evidence IEA],17,19227463-19227512,17p11.2e,-,NM_002404.1,4239,MFAP4,-3.3244675305469364,11.821231335298462,-24.394065651148118,4.195392781301287e-48,2.818869942884675e-45,99.1316607118284
HBB,ILMN_2100437,"Homo sapiens hemoglobin, beta (HBB), mRNA.",hemoglobin complex [goid 5833] [pmid 10588683] [evidence NAS],transport [goid 6810] [evidence IEA]; positive regulation of nitric oxide biosynthesis [goid 45429] [pmid 7965120] [evidence NAS]; oxygen transport [goid 15671] [pmid 11747442] [evidence NAS],hemoglobin binding [goid 30492] [pmid 1512262] [evidence IDA]; heme binding [goid 20037] [evidence IEA]; metal ion binding [goid 46872] [evidence IEA]; oxygen transporter activity [goid 5344] [pmid 11747442] [evidence NAS]; iron ion binding [goid 5506] [evidence IEA]; selenium binding [goid 8430] [pmid 15780970] [evidence IDA]; oxygen binding [goid 19825] [pmid 11747442] [evidence IDA],11,5203383-5203403:5203404-5203432,11p15.4c,-,NM_000518.4,3043,HBB,-4.290450655229169,12.749002634466946,-23.89520469499321,3.238686238275902e-47,2.0768292829600157e-44,97.10299316055689
C20orf160,ILMN_1748206,"Homo sapiens chromosome 20 open reading frame 160 (C20orf160), mRNA.",,,,20,30083460-30083509,20q11.21b,+,NM_080625.2,140706,C20orf160,-2.8390915640855043,8.030340895306107,-23.890352533532553,3.3041677070444186e-47,2.0768292829600157e-44,97.0831200900493
MCEMP1,ILMN_1762713,"Homo sapiens mast cell-expressed membrane protein 1 (MCEMP1), mRNA.",,,,19,7650532-7650581,19p13.2e,+,NM_174918.1,199675,MCEMP1,-4.780200624987371,10.112051867705341,-23.83483515196989,4.1553795061629607e-47,2.53023655242454e-44,96.85554181185158
CDO1,ILMN_1753931,"Homo sapiens cysteine dioxygenase, type I (CDO1), mRNA.",,L-cysteine metabolism [goid 46439] [evidence IEA],electron transporter activity [goid 5489] [evidence NR ]; cysteine dioxygenase activity [goid 17172] [evidence IEA]; oxidoreductase activity [goid 16491] [evidence IEA]; iron ion binding [goid 5506] [evidence IEA],5,115169008-115169028:115169029-115169057,5q22.3b,-,NM_001801.2,1036,CDO1,-2.878165216516182,6.779044971304823,-23.568592332769455,1.2535373352758603e-46,7.401568175106103e-44,95.75915321872051
FHL1,ILMN_1805842,"Homo sapiens four and a half LIM domains 1 (FHL1), mRNA.",nucleus [goid 5634] [evidence IEA],cell differentiation [goid 30154] [evidence IEA]; cell growth [goid 16049] [evidence NAS]; muscle development [goid 7517] [pmid 7626119] [evidence NAS],zinc ion binding [goid 8270] [evidence IEA]; metal ion binding [goid 46872] [evidence IEA],X,135120766-135120815,Xq26.3b,+,NM_001449.3,2273,FHL1,-3.2590401377129075,8.819233927162683,-23.45759269859561,1.9911355160575766e-46,1.1410963391288788e-43,95.29960167191217
C2orf32,ILMN_2182148,"Homo sapiens chromosome 2 open reading frame 32 (C2orf32), mRNA.",,,protein binding [goid 5515] [pmid 16696853] [evidence IPI],2,68374157-68374206,2p14a,-,NM_015463.1,25927,C2orf32,-2.4889784989419006,6.830443853704767,-23.34468020600334,3.1927210826546796e-46,1.7774334370150408e-43,94.83064095512636
ABCA8,ILMN_1796801,"Homo sapiens ATP-binding cassette, sub-family A (ABC1), member 8 (ABCA8), mRNA.",,,ATPase activity [goid 16887] [evidence IEA]; nucleotide binding [goid 166] [evidence IEA]; ATP binding [goid 5524] [evidence IEA],17,64375585-64375634,17q24.2c,-,NM_007168.2,10351,ABCA8,-1.7893748960790905,6.7658713059088695,-23.21652052856646,5.466237320845711e-46,2.9586009499077413e-43,94.29652690641694
GHR,ILMN_1775814,"Homo sapiens growth hormone receptor (GHR), mRNA.",integral to plasma membrane [goid 5887] [pmid 2825030] [evidence TAS]; membrane [goid 16020] [evidence IEA],skeletal development [goid 1501] [pmid 9140387] [evidence TAS]; endocytosis [goid 6897] [evidence IEA]; growth [goid 40007] [pmid 9140387] [evidence TAS],receptor activity [goid 4872] [evidence IEA]; growth hormone receptor activity [goid 4903] [pmid 9140387] [evidence TAS]; protein binding [goid 5515] [pmid 10866662] [evidence IPI],5,42757566-42757615,5p12c,+,NM_000163.2,2690,GHR,-2.593712511603207,7.0222511977682736,-23.14994620604906,7.233103343773224e-46,3.809108612254629e-43,94.01830491765155
CD36,ILMN_1665132,"Homo sapiens CD36 molecule (thrombospondin receptor) (CD36), transcript variant 2, mRNA.",membrane [goid 16020] [evidence IEA]; integral to plasma membrane [goid 5887] [pmid 2468669] [evidence TAS]; membrane fraction [goid 5624] [pmid 2468669] [evidence TAS],fatty acid metabolism [goid 6631] [evidence NR ]; lipid metabolism [goid 6629] [pmid 7518447] [evidence NAS]; cell adhesion [goid 7155] [pmid 2468670] [evidence TAS]; blood coagulation [goid 7596] [pmid 2468670] [evidence TAS]; transport [goid 6810] [evidence IEA],protein binding [goid 5515] [evidence IEA]; receptor activity [goid 4872] [evidence IEA],7,80069574-80069623,7q21.11c,+,NM_001001547.1,948,CD36,-3.228016263485543,7.534369052875791,-22.936666283725998,1.7803898457015253e-45,9.129183195656374e-43,93.12342777960411
ADH1A,ILMN_1764309,"Homo sapiens alcohol dehydrogenase 1A (class I), alpha polypeptide (ADH1A), mRNA.",cytoplasm [goid 5737] [evidence NAS],alcohol metabolism [goid 6066] [pmid 2347582] [evidence NAS],"zinc ion binding [goid 8270] [evidence IEA]; metal ion binding [goid 46872] [evidence IEA]; oxidoreductase activity [goid 16491] [evidence IEA]; alcohol dehydrogenase activity, zinc-dependent [goid 4024] [pmid 2935875] [evidence NAS]",4,100416746-100416795,4q23b,-,NM_000667.2,124,ADH1A,-4.350874857775981,10.265454949470259,-22.745566886423497,4.008577590350429e-45,2.0027470345635413e-42,92.31699144905258
ANKRD47,ILMN_1755588,"Homo sapiens ankyrin repeat domain 47 (ANKRD47), mRNA.",,,,19,8295547-8295596,19p13.2d,-,NM_198471.1,256949,ANKRD47,-2.6725431894079446,7.301868790510901,-22.729103529774726,4.299754591912696e-45,2.094517955585472e-42,92.24731105189248
GSTM5,ILMN_1750790,"Homo sapiens glutathione S-transferase M5 (GSTM5), mRNA.",,metabolism [goid 8152] [evidence IEA],transferase activity [goid 16740] [evidence IEA]; glutathione transferase activity [goid 4364] [pmid 8473333] [evidence TAS],1,110062202-110062251,1p13.3b,+,NM_000851.2,2949,GSTM5,-2.282287832511635,6.6596825566922995,-22.67642104665883,5.382541326576162e-45,2.5580199450813784e-42,92.02411547844576
CAV2,ILMN_1658835,"Homo sapiens caveolin 2 (CAV2), transcript variant 1, mRNA.",perinuclear region [goid 48471] [pmid 8552590] [evidence IDA]; integral to plasma membrane [goid 5887] [pmid 8552590] [evidence IDA]; caveolar membrane [goid 16599] [pmid 8552590] [evidence NAS]; lipid raft [goid 45121] [pmid 11294831] [evidence IDA]; perinuclear region [goid 48471] [pmid 8552590] [evidence IDA]; integral to plasma membrane [goid 5887] [pmid 8552590] [evidence IDA]; caveolar membrane [goid 16599] [pmid 8552590] [evidence NAS]; lipid raft [goid 45121] [pmid 11294831] [evidence IDA],,protein binding [goid 5515] [pmid 10212252] [evidence IPI]; protein homodimerization activity [goid 42803] [pmid 8552590] [evidence IDA]; protein binding [goid 5515] [pmid 10212252] [evidence IPI]; protein homodimerization activity [goid 42803] [pmid 8552590] [evidence IDA],7,115935309-115935358,7q31.2b,+,NM_001233.3,858,CAV2,-2.9254107069189734,8.926769268875024,-22.541600738538108,9.577713579570131e-45,4.4433749785220004e-42,91.45140788307475
PYCR1,ILMN_1715178,"Homo sapiens pyrroline-5-carboxylate reductase 1 (PYCR1), transcript variant 1, mRNA.",,proline biosynthesis [goid 6561] [pmid 1730675] [evidence TAS]; amino acid biosynthesis [goid 8652] [evidence IEA]; electron transport [goid 6118] [evidence IEA],oxidoreductase activity [goid 16491] [evidence IEA]; pyrroline-5-carboxylate reductase activity [goid 4735] [pmid 1730675] [evidence TAS],17,77484213-77484262,17q25.3g,-,NM_006907.2,5831,PYCR1,1.3483718963904758,6.244257831440324,22.527252136965508,1.0184812615711555e-44,4.6151412515613876e-42,91.39032659258154
F10,ILMN_1670708,"Homo sapiens coagulation factor X (F10), mRNA.",extracellular region [goid 5576] [pmid 14718574] [evidence NAS],blood coagulation [goid 7596] [pmid 6587384] [evidence TAS],peptidase activity [goid 8233] [evidence IEA]; calcium ion binding [goid 5509] [evidence IEA]; coagulation factor Xa activity [goid 3804] [pmid 3011603] [evidence TAS],13,112851631-112851680,13q34c,+,NM_000504.2,2159,F10,-2.1616219935398107,6.745354928503656,-22.491787991321857,1.1856836167639443e-44,5.250692107419421e-42,91.23925049072908
SH3GL3,ILMN_1760990,"Homo sapiens SH3-domain GRB2-like 3 (SH3GL3), mRNA.",cytoplasm [goid 5737] [evidence IEA],signal transduction [goid 7165] [pmid 9169142] [evidence TAS]; central nervous system development [goid 7417] [pmid 9169142] [evidence TAS],,15,82078094-82078143,15q25.2b,+,NM_003027.2,6457,SH3GL3,-2.7122629239898144,6.247650174558429,-22.405043410032174,1.720741970548686e-44,7.450812732475811e-42,90.86907863831465
EMCN,ILMN_1685917,"Homo sapiens endomucin (EMCN), mRNA.",plasma membrane [goid 5886] [pmid 11418125] [evidence IDA]; integral to membrane [goid 16021] [evidence IEA]; external side of plasma membrane [goid 9897] [pmid 15249540] [evidence IC ]; membrane [goid 16020] [evidence IEA],angiogenesis [goid 1525] [pmid 11594763] [evidence IEP]; cell-cell adhesion [goid 16337] [pmid 15249540] [evidence IDA]; regulation of cell adhesion [goid 30155] [pmid 11418125] [evidence IMP],carbohydrate binding [goid 30246] [pmid 15249540] [evidence IDA],4,101556132-101556139:101557297-101557321:101561462-101561478,4q23c,-,NM_016242.2,51705,EMCN,-3.2475999071545685,7.172959399952421,-22.325764241004322,2.4203762260967067e-44,1.0252397992498768e-41,90.52996499666592
SYT15,ILMN_1747160,"Homo sapiens synaptotagmin XV (SYT15), transcript variant b, mRNA.",membrane [goid 16020] [evidence IEA]; integral to membrane [goid 16021] [evidence IEA]; membrane [goid 16020] [evidence IEA]; integral to membrane [goid 16021] [evidence IEA],,,10,46375519-46375568,10q11.22a,-,NM_181519.2,83849,SYT15,-1.491274645756727,6.950968322440428,-22.231277532521936,3.6382919408010895e-44,1.508342946095941e-41,90.12480204366456
CYYR1,ILMN_1812902,"Homo sapiens cysteine/tyrosine-rich 1 (CYYR1), mRNA.",integral to membrane [goid 16021] [evidence NAS],biological process unknown [goid 4] [evidence ND ],molecular function unknown [goid 5554] [evidence ND ],21,26760663-26760712,21q21.3a,-,NM_052954.2,116159,CYYR1,-2.750584386297101,8.395542147701448,-22.218685976072376,3.8416873968560433e-44,1.55948497766125e-41,90.07072669926792
CRYAB,ILMN_1729216,"Homo sapiens crystallin, alpha B (CRYAB), mRNA.",nucleus [goid 5634] [evidence NR ]; cytoplasm [goid 5737] [pmid 11256614] [evidence IDA],visual perception [goid 7601] [evidence NR ]; muscle contraction [goid 6936] [pmid 9731540] [evidence TAS]; protein folding [goid 6457] [pmid 9731540] [evidence NAS]; transmembrane receptor protein tyrosine kinase signaling pathway [goid 7169] [pmid 15609325] [evidence NAS],structural constituent of eye lens [goid 5212] [evidence IEA]; unfolded protein binding [goid 51082] [evidence NR ],11,111284752-111284801,11q23.1b,-,NM_001885.1,1410,CRYAB,-2.8694053889751094,9.06161910900145,-22.12563126320082,5.746039142166888e-44,2.2849300547984047e-41,89.67049596881483
CRBN,ILMN_1668582,"Homo sapiens cereblon (CRBN), mRNA.",,ATP-dependent proteolysis [goid 6510] [evidence IEA]; ATP-dependent proteolysis [goid 6510] [evidence IEA],ATP-dependent peptidase activity [goid 4176] [evidence IEA]; ATP-dependent peptidase activity [goid 4176] [evidence IEA],3,3167694-3167729:3169140-3169153,3p26.3a,-,NM_016302.2,51185,CRBN,-1.269425707709832,9.438298283829452,-22.11881621333331,5.918226067069298e-44,2.3063326983369054e-41,89.64114264305478
RECK,ILMN_1688630,"Homo sapiens reversion-inducing-cysteine-rich protein with kazal motifs (RECK), mRNA.",membrane fraction [goid 5624] [pmid 9789069] [evidence TAS]; membrane [goid 16020] [evidence IEA]; membrane fraction [goid 5624] [pmid 9789069] [evidence TAS]; membrane [goid 16020] [evidence IEA],cell cycle [goid 7049] [evidence IEA]; cell cycle [goid 7049] [evidence IEA],metalloendopeptidase inhibitor activity [goid 8191] [pmid 9789069] [evidence TAS]; serine-type endopeptidase inhibitor activity [goid 4867] [evidence IEA]; GPI anchor binding [goid 48503] [evidence IEA]; metalloendopeptidase inhibitor activity [goid 8191] [pmid 9789069] [evidence TAS]; serine-type endopeptidase inhibitor activity [goid 4867] [evidence IEA]; GPI anchor binding [goid 48503] [evidence IEA],9,36113685-36113734,9p13.3a,+,NM_021111.1,8434,RECK,-2.1243426100605065,7.202752306553851,-22.086133282950257,6.818994332667813e-44,2.6052569523927907e-41,89.50029388836043
CDH5,ILMN_1719236,"Homo sapiens cadherin 5, type 2, VE-cadherin (vascular epithelium) (CDH5), mRNA.",membrane fraction [goid 5624] [pmid 9219219] [evidence TAS]; membrane [goid 16020] [evidence IEA]; integral to membrane [goid 16021] [evidence IEA]; plasma membrane [goid 5886] [pmid 9219219] [evidence TAS],homophilic cell adhesion [goid 7156] [pmid 9219219] [evidence TAS]; cell adhesion [goid 7155] [evidence IEA],calcium ion binding [goid 5509] [evidence IEA]; protein binding [goid 5515] [evidence IEA],16,64995823-64995872,16q21e,+,NM_001795.2,1003,CDH5,-2.7689428329880155,9.862925471364639,-22.047738210741908,8.055156699351413e-44,3.018360159362736e-41,89.33466118619975
TM6SF1,ILMN_1750961,"Homo sapiens transmembrane 6 superfamily member 1 (TM6SF1), mRNA.",integral to membrane [goid 16021] [evidence IEA]; membrane [goid 16020] [evidence NAS],,,15,81587223-81587233:81596237-81596275,15q25.2b,+,NM_023003.1,53346,TM6SF1,-2.0864606208610077,7.24373600755038,-22.022814898915424,8.975982473534087e-44,3.299943745222862e-41,89.2270476284213
PI16,ILMN_1766264,"Homo sapiens peptidase inhibitor 16 (PI16), mRNA.",extracellular region [goid 5576] [evidence IEA],,,6,37040423-37040472,6p21.2c,+,NM_153370.2,221476,PI16,-3.9638318524357983,7.284278161790692,-21.954630298123675,1.2074006131969333e-43,4.356703879285601e-41,88.93225137401663
GDF10,ILMN_1678191,"Homo sapiens growth differentiation factor 10 (GDF10), mRNA.",extracellular space [goid 5615] [evidence IEA]; extracellular region [goid 5576] [evidence IEA],skeletal development [goid 1501] [pmid 8670277] [evidence TAS]; transforming growth factor beta receptor signaling pathway [goid 7179] [pmid 8679252] [evidence TAS],cytokine activity [goid 5125] [evidence IEA]; growth factor activity [goid 8083] [pmid 8679252] [evidence TAS],10,48046174-48046223,10q11.22b,-,NM_004962.2,2662,GDF10,-3.1275587450219717,6.9701065388128525,-21.81657940197551,2.2045107357979213e-43,7.809980306731363e-41,88.33363723791462
HBA1,ILMN_1667796,"Homo sapiens hemoglobin, alpha 1 (HBA1), mRNA.",hemoglobin complex [goid 5833] [evidence IEA],transport [goid 6810] [evidence IEA]; oxygen transport [goid 15671] [evidence IEA],heme binding [goid 20037] [evidence IEA]; metal ion binding [goid 46872] [evidence IEA]; oxygen transporter activity [goid 5344] [evidence IEA]; iron ion binding [goid 5506] [evidence IEA]; oxygen binding [goid 19825] [evidence IEA],16,167363-167410:167411-167412,16p13.3f,+,NM_000558.3,3039,HBA1,-3.900423188428576,13.01669659726054,-21.799928746398223,2.3709111473607747e-43,8.249500661843695e-41,88.26127823373618
HIGD1B,ILMN_1675936,"Homo sapiens HIG1 domain family, member 1B (HIGD1B), mRNA.",membrane [goid 16020] [evidence IEA]; integral to membrane [goid 16021] [evidence IEA],,,17,40282207-40282256,17q21.31d,+,NM_016438.2,51751,HIGD1B,-3.2406535835838497,8.761646155528462,-21.785869989880965,2.5212171263039245e-43,8.618581702812627e-41,88.2001562501248
C1orf162,ILMN_1754894,"Homo sapiens chromosome 1 open reading frame 162 (C1orf162), mRNA.",,,,1,111822501-111822550,1p13.2d,+,NM_174896.2,128346,C1orf162,-2.2080239773263663,11.146276578262441,-21.77699930441068,2.620953912479637e-43,8.8050494801147805e-41,88.16157742170266
WNT3A,ILMN_1815700,"Homo sapiens wingless-type MMTV integration site family, member 3A (WNT3A), mRNA.",extracellular region [goid 5576] [evidence NAS]; extracellular matrix (sensu Metazoa) [goid 5578] [evidence IEA],morphogenesis [goid 9653] [evidence NAS]; cell-cell signaling [goid 7267] [evidence NAS]; development [goid 7275] [evidence IEA]; frizzled-2 signaling pathway [goid 7223] [evidence IEA],extracellular matrix structural constituent [goid 5201] [evidence NAS]; signal transducer activity [goid 4871] [evidence IEA],1,226315482-226315531,1q42.13b,+,NM_033131.2,89780,WNT3A,-3.719850965206481,7.123814198522731,-21.74263064727354,3.046343849982524e-43,1.006067964693381e-40,88.01201554173032
COX7A1,ILMN_1662419,"Homo sapiens cytochrome c oxidase subunit VIIa polypeptide 1 (muscle) (COX7A1), mRNA.",membrane [goid 16020] [evidence IEA]; mitochondrion [goid 5739] [pmid 9344674] [evidence TAS]; integral to membrane [goid 16021] [evidence IEA]; mitochondrial electron transport chain [goid 5746] [evidence IEA],electron transport [goid 6118] [evidence IEA],electron carrier activity [goid 9055] [evidence IEA]; cytochrome-c oxidase activity [goid 4129] [pmid 1327965] [evidence TAS],19,41334414-41334463,19q13.12b,-,NM_001864.2,1346,COX7A1,-2.4643155867754594,9.877660064091211,-21.646289912330754,4.647416540610801e-43,1.5092485215633577e-40,87.59199183419268
MFNG,ILMN_1764577,"Homo sapiens MFNG O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase (MFNG), mRNA.",membrane [goid 16020] [evidence IEA]; integral to membrane [goid 16021] [evidence IEA]; extracellular space [goid 5615] [pmid 9187150] [evidence TAS],pattern specification [goid 7389] [pmid 9207795] [evidence TAS],"transferase activity, transferring glycosyl groups [goid 16757] [evidence IEA]",22,36195146-36195195,22q13.1a,-,NM_002405.2,4242,MFNG,-1.8704120509634627,9.594311927142753,-21.586058222673174,6.055381979237236e-43,1.934247833859632e-40,87.32881161436846
CHMP4B,ILMN_1771233,"Homo sapiens chromatin modifying protein 4B (CHMP4B), mRNA.",,protein transport [goid 15031] [evidence IEA],,20,31905553-31905602,20q11.22a,+,NM_176812.3,128866,CHMP4B,1.9404560979783234,9.555884337677428,21.576581343915535,6.313092100704478e-43,1.9589661116412445e-40,87.28736178677369
HBA2,ILMN_2127842,"Homo sapiens hemoglobin, alpha 2 (HBA2), mRNA.",,,,16,163658-163707,16p13.3f,+,NM_000517.3,3040,HBA2,-4.054342322866031,12.441615419045007,-21.575835398428435,6.33383962193474e-43,1.9589661116412445e-40,87.28409870891538
ADAMTS8,ILMN_1672403,"Homo sapiens ADAM metallopeptidase with thrombospondin type 1 motif, 8 (ADAMTS8), mRNA.",extracellular matrix (sensu Metazoa) [goid 5578] [evidence IEA]; extracellular matrix [goid 31012] [evidence IEA],negative regulation of cell proliferation [goid 8285] [pmid 10438512] [evidence TAS],metal ion binding [goid 46872] [evidence IEA]; low affinity phosphate transporter activity [goid 9673] [pmid 10610729] [evidence TAS]; heparin binding [goid 8201] [evidence IEA]; metalloendopeptidase activity [goid 4222] [evidence IEA]; integrin binding [goid 5178] [pmid 10438512] [evidence TAS]; zinc ion binding [goid 8270] [evidence IEA],11,129780216-129780265,11q24.3c,-,NM_007037.3,11095,ADAMTS8,-2.7868906230521144,7.18176785290388,-21.568305538637144,6.547154256042976e-43,1.9933015731093342e-40,87.25115608493915
PTPRB,ILMN_1672102,"Homo sapiens protein tyrosine phosphatase, receptor type, B (PTPRB), mRNA.",membrane [goid 16020] [evidence IEA]; integral to plasma membrane [goid 5887] [pmid 2170109] [evidence TAS]; membrane fraction [goid 5624] [evidence NR ],protein amino acid dephosphorylation [goid 6470] [pmid 2170109] [evidence TAS]; phosphate metabolism [goid 6796] [pmid 2170109] [evidence TAS],transmembrane receptor protein tyrosine phosphatase activity [goid 5001] [pmid 2170109] [evidence TAS]; protein tyrosine phosphatase activity [goid 4725] [evidence IEA]; hydrolase activity [goid 16787] [evidence IEA],12,69204636-69204638:69212082-69212128,12q15d,-,NM_002837.2,5787,PTPRB,-2.7270935046428706,7.745399094825584,-21.438953815218174,1.1578248021475738e-42,3.47080250305315e-40,86.68415184964367
C9orf19,ILMN_1652631,"Homo sapiens chromosome 9 open reading frame 19 (C9orf19), mRNA.",membrane [goid 16020] [evidence IEA]; extracellular region [goid 5576] [evidence IEA],,,9,36153798-36153847,9p13.3a,+,NM_022343.2,152007,C9orf19,-2.0639613760896562,11.74851843722493,-21.330094993929034,1.8736815156781172e-42,5.531618838331533e-40,86.2053639610867
SCARA5,ILMN_1751062,"Homo sapiens scavenger receptor class A, member 5 (putative) (SCARA5), mRNA.",membrane [goid 16020] [evidence IEA]; cytoplasm [goid 5737] [evidence IEA],phosphate transport [goid 6817] [evidence IEA],scavenger receptor activity [goid 5044] [evidence IEA]; receptor activity [goid 4872] [evidence IEA],8,27783863-27783912,8p21.1e-p21.1d,-,NM_173833.3,286133,SCARA5,-3.4997166737451746,7.090265104577541,-21.276037382877504,2.3809066129820656e-42,6.924173933426201e-40,85.96705635453482
CFD,ILMN_1777190,"Homo sapiens complement factor D (adipsin) (CFD), mRNA.",,"complement activation, alternative pathway [goid 6957] [evidence IEA]; innate immune response [goid 45087] [evidence IEA]",complement factor D activity [goid 3817] [pmid 1374388] [evidence TAS]; peptidase activity [goid 8233] [evidence IEA],19,814271-814320,19p13.3i,+,NM_001928.2,1675,CFD,-2.991613114879531,12.182217725791922,-21.25547909033222,2.6082695406993588e-42,7.473842941253973e-40,85.87633142783743
STX1A,ILMN_1760160,"Homo sapiens syntaxin 1A (brain) (STX1A), mRNA.",integral to membrane [goid 16021] [evidence IEA]; membrane [goid 16020] [evidence IEA],neurotransmitter transport [goid 6836] [evidence IEA]; regulation of insulin secretion [goid 50796] [pmid 15537656] [evidence TAS]; intracellular protein transport [goid 6886] [evidence IEA]; exocytosis [goid 6887] [evidence NR ],protein transporter activity [goid 8565] [evidence IEA]; protein binding [goid 5515] [pmid 10321247] [evidence IPI],7,72751878-72751927,7q11.23b,-,NM_004603.1,6804,STX1A,2.5765382596330024,7.194323894646179,21.037270239057413,6.889223869702362e-42,1.9454569145094276e-39,84.91010495180632
SRPX,ILMN_1709486,"Homo sapiens sushi-repeat-containing protein, X-linked (SRPX), mRNA.",membrane [goid 16020] [pmid 8634708] [evidence TAS]; cell surface [goid 9986] [pmid 12493773] [evidence IEP],cell adhesion [goid 7155] [evidence IEA],protein binding [goid 5515] [evidence IEA],X,37893885-37893907:37893908-37893934,Xp11.4e,-,NM_006307.2,8406,SRPX,-3.06686454595632,8.934257158958577,-20.995511709733126,8.302017040938309e-42,2.3109257434668992e-39,84.72451844444241
SPARCL1,ILMN_1795251,"Homo sapiens SPARC-like 1 (mast9, hevin) (SPARCL1), mRNA.",extracellular matrix (sensu Metazoa) [goid 5578] [evidence IEA],,calcium ion binding [goid 5509] [evidence IEA],4,88619685-88619734,4q22.1a,-,NM_004684.2,8404,SPARCL1,-2.6790971362918015,11.698086371948179,-20.85910123584842,1.529245972384497e-41,4.196810953790412e-39,84.1167456609668
GRK5,ILMN_1728830,"Homo sapiens G protein-coupled receptor kinase 5 (GRK5), mRNA.",soluble fraction [goid 5625] [pmid 7685906] [evidence TAS]; cytoplasm [goid 5737] [pmid 7685906] [evidence TAS],"signal transduction [goid 7165] [evidence IEA]; G-protein signaling, coupled to cAMP nucleotide second messenger [goid 7188] [pmid 8626574] [evidence TAS]; protein amino acid phosphorylation [goid 6468] [evidence IEA]; regulation of G-protein coupled receptor protein signaling pathway [goid 8277] [pmid 8288567] [evidence TAS]",nucleotide binding [goid 166] [evidence IEA]; signal transducer activity [goid 4871] [evidence IEA]; phospholipid binding [goid 5543] [pmid 9813065] [evidence TAS]; G-protein coupled receptor kinase activity [goid 4703] [evidence IEA]; transferase activity [goid 16740] [evidence IEA]; ATP binding [goid 5524] [evidence IEA]; protein kinase C binding [goid 5080] [pmid 9813065] [evidence TAS]; protein-tyrosine kinase activity [goid 4713] [evidence IEA],10,121204611-121204660,10q26.11c-q26.11d,+,NM_005308.2,2869,GRK5,-2.124421812908647,8.326299084777311,-20.812643852919773,1.8838949458965137e-41,5.0982906973324405e-39,83.90922175535088
LIMS2,ILMN_1760493,"Homo sapiens LIM and senescent cell antigen-like domains 2 (LIMS2), mRNA.",,,metal ion binding [goid 46872] [evidence IEA]; zinc ion binding [goid 8270] [evidence IEA],2,128112587-128112636,2q14.3e,-,NM_017980.2,55679,LIMS2,-2.2959012175970903,7.881177965995542,-20.690829306199795,3.259219656351474e-41,8.699437671781982e-39,83.3637875371196
HSPB2,ILMN_1671046,"Homo sapiens heat shock 27kDa protein 2 (HSPB2), mRNA.",cytosol [goid 5829] [pmid 9490724] [evidence TAS],protein folding [goid 6457] [evidence IEA]; response to unfolded protein [goid 6986] [pmid 9344664] [evidence NAS],enzyme activator activity [goid 8047] [pmid 9490724] [evidence TAS]; protein binding [goid 5515] [pmid 14594798] [evidence IPI],11,111289806-111289829:111289830-111289855,11q23.1b,+,NM_001541.2,3316,HSPB2,-2.0722692554167095,7.7171086989625035,-20.673847988829497,3.5185439796633794e-41,9.208401178894794e-39,83.2876036484548
OLFML1,ILMN_1776151,"Homo sapiens olfactomedin-like 1 (OLFML1), mRNA.",,,,11,7489027-7489076,11p15.4b,+,NM_198474.2,283298,OLFML1,-2.084897786962836,8.508947132719907,-20.672223222486924,3.5444192374498823e-41,9.208401178894794e-39,83.28031249251377
RSPO1,ILMN_1682937,"Homo sapiens R-spondin homolog (Xenopus laevis) (RSPO1), transcript variant 2, mRNA.",,electron transport [goid 6118] [evidence IEA],electron transporter activity [goid 5489] [evidence IEA]; iron ion binding [goid 5506] [evidence IEA],1,37849704-37849753,1p34.3c-p34.3b,-,NM_173640.1,284654,RSPO1,-1.732341720226061,5.849169164695981,-20.59360452172884,5.054635373641552e-41,1.2959153980974426e-38,82.92711168419906
HEG1,ILMN_1666122,"PREDICTED: Homo sapiens HEG homolog 1 (zebrafish) (HEG1), mRNA.",,,,3,126167785-126167834,3q21.2b,-,XM_087386.8,57493,HEG1,-2.262553517456495,8.850034708785719,-20.586709218895482,5.214649360358293e-41,1.3195771790465108e-38,82.89609671335785
TGFBR3,ILMN_1784287,"Homo sapiens transforming growth factor, beta receptor III (TGFBR3), mRNA.",membrane [goid 16020] [evidence IEA]; integral to membrane [goid 16021] [pmid 1333192] [evidence TAS],development [goid 7275] [pmid 10092230] [evidence TAS]; signal transduction [goid 7165] [pmid 1333192] [evidence NAS]; transforming growth factor beta receptor signaling pathway [goid 7179] [pmid 10092230] [evidence TAS],receptor activity [goid 4872] [evidence IEA]; glycosaminoglycan binding [goid 5539] [pmid 1333192] [evidence TAS],1,91920750-91920799,1p22.2a-p22.1e,-,NM_003243.2,7049,TGFBR3,-2.529055075336874,9.53613280441507,-20.58214018529859,5.323477293451248e-41,1.329845577729456e-38,82.87554195477925
C1QR1,ILMN_1704730,"Homo sapiens complement component 1, q subcomponent, receptor 1 (C1QR1), mRNA.",membrane [goid 16020] [evidence IEA]; integral to membrane [goid 16021] [pmid 9047234] [evidence IC ],macrophage activation [goid 42116] [pmid 9047234] [evidence NAS]; phagocytosis [goid 6909] [pmid 11781389] [evidence NAS]; cell-cell adhesion [goid 16337] [pmid 11994479] [evidence IDA],calcium ion binding [goid 5509] [evidence IEA]; complement component C1q binding [goid 1849] [pmid 11781389] [evidence IDA]; protein binding [goid 5515] [pmid 15819698] [evidence IPI]; receptor activity [goid 4872] [pmid 9047234] [evidence NAS]; sugar binding [goid 5529] [evidence IEA],20,23008359-23008408,20p11.21c,-,NM_012072.2,22918,C1QR1,-2.3811334422559725,11.153709995343027,-20.5497648139521,6.16296434502686e-41,1.5200678514284604e-38,82.72981887858012
LTC4S,ILMN_1668247,"Homo sapiens leukotriene C4 synthase (LTC4S), mRNA.",integral to membrane [goid 16021] [pmid 8052639] [evidence TAS]; membrane fraction [goid 5624] [pmid 8052639] [evidence TAS]; membrane [goid 16020] [evidence IEA]; microsome [goid 5792] [pmid 1454853] [evidence TAS],leukotriene biosynthesis [goid 19370] [evidence IEA],enzyme activator activity [goid 8047] [evidence IEA]; lyase activity [goid 16829] [evidence IEA]; leukotriene-C4 synthase activity [goid 4464] [pmid 8052639] [evidence TAS]; glutathione transferase activity [goid 4364] [pmid 8052639] [evidence TAS],5,179153688-179153737,5q35.3e,+,NM_145867.1,4056,LTC4S,-1.6185253974502993,6.321469983123648,-20.484537405597433,8.281071834774735e-41,2.0169585587573213e-38,82.4358243016863
FXYD1,ILMN_1764022,"Homo sapiens FXYD domain containing ion transport regulator 1 (phospholemman) (FXYD1), transcript variant a, mRNA.",plasma membrane [goid 5886] [pmid 9169143] [evidence NAS]; integral to plasma membrane [goid 5887] [pmid 9169143] [evidence TAS]; plasma membrane [goid 5886] [pmid 9169143] [evidence NAS]; integral to plasma membrane [goid 5887] [pmid 9169143] [evidence TAS],ion transport [goid 6811] [evidence IEA]; muscle contraction [goid 6936] [pmid 9169143] [evidence TAS]; chloride transport [goid 6821] [pmid 9169143] [evidence TAS]; ion transport [goid 6811] [evidence IEA]; muscle contraction [goid 6936] [pmid 9169143] [evidence TAS]; chloride transport [goid 6821] [pmid 9169143] [evidence TAS],ion channel activity [goid 5216] [evidence IEA]; chloride channel activity [goid 5254] [pmid 9169143] [evidence TAS]; ion channel activity [goid 5216] [evidence IEA]; chloride channel activity [goid 5254] [pmid 9169143] [evidence TAS],19,40322279-40322328,19q13.12a,+,NM_005031.3,5348,FXYD1,-2.121872259372978,6.7598858287726475,-20.480248181492865,8.443668308880218e-41,2.031171320969519e-38,82.4164729238001
SNCA,ILMN_1701933,"Homo sapiens synuclein, alpha (non A4 component of amyloid precursor) (SNCA), transcript variant NACP112, mRNA.",cytoplasm [goid 5737] [pmid 8248242] [evidence TAS],anti-apoptosis [goid 6916] [pmid 10818098] [evidence TAS]; central nervous system development [goid 7417] [pmid 9197268] [evidence TAS],protein binding [goid 5515] [pmid 11956199] [evidence IPI],4,90866610-90866659,4q22.1d,-,NM_007308.1,6622,SNCA,-2.1677387971507223,6.608885843743785,-20.44213090409347,1.0037373951507348e-40,2.3851003834770814e-38,82.24439958135571
TOP2A,ILMN_1686097,"Homo sapiens topoisomerase (DNA) II alpha 170kDa (TOP2A), mRNA.",chromosome [goid 5694] [pmid 9049244] [evidence IDA]; centriole [goid 5814] [pmid 9049244] [evidence IDA]; nucleus [goid 5634] [pmid 16611985] [evidence IDA]; nucleolus [goid 5730] [pmid 9049244] [evidence IDA]; protein complex [goid 43234] [pmid 16611985] [evidence IPI]; nucleoplasm [goid 5654] [pmid 9049244] [evidence IDA],DNA ligation [goid 6266] [pmid 15491148] [evidence IDA]; DNA topological change [goid 6265] [evidence IEA]; positive regulation of apoptosis [goid 43065] [pmid 16611985] [evidence IDA]; phosphoinositide-mediated signaling [goid 48015] [pmid 15504738] [evidence NAS]; DNA repair [goid 6281] [pmid 15504738] [evidence NAS]; chromosome segregation [goid 7059] [pmid 15965487] [evidence IMP]; DNA replication [goid 6260] [pmid 15504738] [evidence NAS]; apoptotic chromosome condensation [goid 30263] [pmid 10959840] [evidence IDA],DNA topoisomerase (ATP-hydrolyzing) activity [goid 3918] [pmid 16611985] [evidence IDA]; protein homodimerization activity [goid 42803] [pmid 10473615] [evidence IPI]; histone deacetylase binding [goid 42826] [pmid 11136718] [evidence IPI]; protein heterodimerization activity [goid 46982] [pmid 10473615] [evidence IPI]; ATP binding [goid 5524] [evidence IEA]; chromatin binding [goid 3682] [pmid 9049244] [evidence IDA]; DNA-dependent ATPase activity [goid 8094] [pmid 12079377] [evidence IDA]; nucleotide binding [goid 166] [evidence IEA]; protein C-terminus binding [goid 8022] [pmid 15965487] [evidence IPI]; ubiquitin binding [goid 43130] [pmid 15965487] [evidence IMP]; protein kinase C binding [goid 5080] [pmid 16611985] [evidence IPI]; drug binding [goid 8144] [pmid 16914642] [evidence IDA],17,35798592-35798641,17q21.2a,-,NM_001067.2,7153,TOP2A,3.5272643193402233,7.980175869609929,20.418422287692795,1.1178009176191138e-40,2.6241386602178836e-38,82.13727854708301
LOC131873,ILMN_1815679,"PREDICTED: Homo sapiens hypothetical protein LOC131873 (LOC131873), mRNA.",,,,3,131878080-131878129,3q22.1a,+,XM_067585.11,131873,LOC131873,-2.918179842931302,7.209099585920871,-20.397960977933543,1.2266787704294324e-40,2.8454566478354157e-38,82.04477229126901
PEBP4,ILMN_1734472,"Homo sapiens phosphatidylethanolamine-binding protein 4 (PEBP4), mRNA.",,,,8,22833642-22833691,8p21.3a,-,NM_144962.1,157310,PEBP4,-4.117750776427675,8.575286904922965,-20.38225575633764,1.3174366584372134e-40,3.0200297987822473e-38,81.97373243968936
SVEP1,ILMN_2112638,"Homo sapiens sushi, von Willebrand factor type A, EGF and pentraxin domain containing 1 (SVEP1), mRNA.",,,calcium ion binding [goid 5509] [evidence IEA]; sugar binding [goid 5529] [evidence IEA],,,9q31.3b,,NM_153366.2,79987,SVEP1,-2.7294257003714897,9.778174880813667,-20.137745409242648,4.0185543144442584e-40,9.104829164761207e-38,80.86369111705729
GYPC,ILMN_1668039,"PREDICTED: Homo sapiens glycophorin C (Gerbich blood group) (GYPC), mRNA.",,,,,,2q14.3d,,XM_940361.1,2995,GYPC,-1.5093790126135929,8.138761966431876,-20.11667284596696,4.425513676447427e-40,9.91162459604346e-38,80.76766883364587
PCOLCE2,ILMN_1746888,"Homo sapiens procollagen C-endopeptidase enhancer 2 (PCOLCE2), mRNA.",,,heparin binding [goid 8201] [evidence IEA],3,144019624-144019673,3q23d,-,NM_013363.2,26577,PCOLCE2,-3.5350755029680405,8.593435219303831,-20.086240656736138,5.087540001002568e-40,1.1264854195401707e-37,80.62889731590519
CPA3,ILMN_1766551,"Homo sapiens carboxypeptidase A3 (mast cell) (CPA3), mRNA.",secretory granule [goid 30141] [pmid 2594780] [evidence NAS],,zinc ion binding [goid 8270] [evidence IEA]; metal ion binding [goid 46872] [evidence IEA]; metallopeptidase activity [goid 8237] [evidence IEA]; carboxypeptidase activity [goid 4180] [evidence IEA]; carboxypeptidase A activity [goid 4182] [pmid 2594780] [evidence NAS],3,150097094-150097143,3q24f,+,NM_001870.1,1359,CPA3,-3.229065312341863,9.562474718114428,-20.07910211567878,5.25674735047401e-40,1.1508732822919786e-37,80.59632831318295
LAMP3,ILMN_2170813,"Homo sapiens lysosomal-associated membrane protein 3 (LAMP3), mRNA.",lysosome [goid 5764] [evidence IEA]; membrane [goid 16020] [evidence IEA]; integral to membrane [goid 16021] [evidence IEA]; lysosome [goid 5764] [evidence IEA]; membrane [goid 16020] [evidence IEA]; integral to membrane [goid 16021] [evidence IEA],,,3,184323144-184323193,3q27.1a,-,NM_014398.2,27074,LAMP3,-2.755724276004882,10.322920113426177,-20.06796337842445,5.532154592926752e-40,1.1977114693686417e-37,80.54549577629629
ANXA8,ILMN_1778087,"Homo sapiens annexin A8-like 2 (ANXA8L2), mRNA.",,blood coagulation [goid 7596] [evidence IEA]; blood coagulation [goid 7596] [evidence IEA],calcium-dependent phospholipid binding [goid 5544] [evidence IEA]; calcium ion binding [goid 5509] [evidence IEA]; calcium-dependent phospholipid binding [goid 5544] [evidence IEA]; calcium ion binding [goid 5509] [evidence IEA],10,47232690-47232739,10q11.22b,+,NM_001630.2,244,ANXA8,-3.3080807973163733,7.346643296773254,-20.009468641807192,7.2354937787709135e-40,1.5492702887840796e-37,80.2782906924504
C10orf116,ILMN_1680110,"Homo sapiens chromosome 10 open reading frame 116 (C10orf116), mRNA.",,,,10,88720419-88720468,10q23.2a,+,NM_006829.2,10974,C10orf116,-3.0184028522607953,12.557761254974782,-20.005510592208108,7.368225149964302e-40,1.5605420331201568e-37,80.26019448789381
C14orf132,ILMN_1713744,"Homo sapiens chromosome 14 open reading frame 132 (C14orf132), mRNA.",integral to membrane [goid 16021] [evidence IEA],,,14,95629766-95629815,14q32.2a,+,NM_020215.2,56967,C14orf132,-2.5320415233126283,9.194626983956697,-19.95514298266212,9.287537386923951e-40,1.9458888815506794e-37,80.02973924860852
IGSF9,ILMN_1693941,"Homo sapiens immunoglobulin superfamily, member 9 (IGSF9), mRNA.",,,,1,158163600-158163649,1q23.2c,-,NM_020789.2,57549,IGSF9,2.350484330587121,6.3698248492919225,19.940632187886468,9.928666729402409e-40,2.0580858640681483e-37,79.96328555724934
NAP5,ILMN_1809490,"PREDICTED: Homo sapiens Nck-associated protein 5 (NAP5), mRNA.",,,,2,133146543-133146592,,-,XM_929894.1,344148,NAP5,-2.2388450965762736,6.133462584004132,-19.936261348065862,1.0130373484850656e-39,2.071661107989165e-37,79.94326357639407
AQP4,ILMN_1676649,"Homo sapiens aquaporin 4 (AQP4), transcript variant a, mRNA.",integral to membrane [goid 16021] [evidence IEA]; outer membrane [goid 19867] [evidence IEA]; integral to plasma membrane [goid 5887] [pmid 7528931] [evidence TAS]; membrane [goid 16020] [pmid 8855281] [evidence NAS],transport [goid 6810] [pmid 7559426] [evidence TAS]; excretion [goid 7588] [pmid 7528931] [evidence TAS]; water transport [goid 6833] [pmid 8855281] [evidence NAS],transporter activity [goid 5215] [evidence IEA]; porin activity [goid 15288] [evidence IEA]; water channel activity [goid 15250] [evidence NR ]; water transporter activity [goid 5372] [pmid 8855281] [evidence NAS],18,22699622-22699651:22699652-22699671,18q11.2e,-,NM_001650.4,361,AQP4,-2.883086284791224,7.6367653406154234,-19.93280845313544,1.0292629294164063e-39,2.071661107989165e-37,79.9274448015186
EDNRB,ILMN_1675100,"Homo sapiens endothelin receptor type B (EDNRB), transcript variant 1, mRNA.",plasma membrane [goid 5886] [pmid 8810293] [evidence TAS]; integral to plasma membrane [goid 5887] [pmid 8810293] [evidence TAS],"negative regulation of adenylate cyclase activity [goid 7194] [pmid 9556633] [evidence TAS]; G-protein signaling, coupled to IP3 second messenger (phospholipase C activating) [goid 7200] [pmid 9556633] [evidence TAS]",endothelin receptor activity [goid 4962] [pmid 8810293] [evidence TAS]; receptor activity [goid 4872] [evidence IEA]; rhodopsin-like receptor activity [goid 1584] [evidence IEA],13,77368878-77368927,13q22.3b,-,NM_000115.1,1910,EDNRB,-1.8150889299719521,6.606430887112639,-19.93237631549746,1.0313119192966335e-39,2.071661107989165e-37,79.92546493879816
PPP1R14B,ILMN_1659888,"Homo sapiens protein phosphatase 1, regulatory (inhibitor) subunit 14B (PPP1R14B), mRNA.",,,protein phosphatase inhibitor activity [goid 4864] [evidence IEA],11,63768736-63768785,11q13.1b,-,NM_138689.2,26472,PPP1R14B,1.6680546482080754,10.823035293532355,19.911488033341225,1.135406120493379e-39,2.2428945061085013e-37,79.82973568466623
HSPA12B,ILMN_1676897,"Homo sapiens heat shock 70kD protein 12B (HSPA12B), mRNA.",,,nucleotide binding [goid 166] [evidence IEA]; ATP binding [goid 5524] [evidence IEA],20,3681581-3681630,20p13b,+,NM_052970.3,116835,HSPA12B,-2.6131681710841335,8.095308919892398,-19.910691775688232,1.1395768853207165e-39,2.2428945061085013e-37,79.82608540021319
CUGBP2,ILMN_1664170,"Homo sapiens CUG triplet repeat, RNA binding protein 2 (CUGBP2), transcript variant 1, mRNA.",,RNA processing [goid 6396] [pmid 9887331] [evidence TAS]; neuromuscular junction development [goid 7528] [evidence NR ],nucleotide binding [goid 166] [evidence IEA]; RNA binding [goid 3723] [pmid 9887331] [evidence TAS],10,11247080-11247129,10p14b-p14a,+,NM_001025076.1,10659,CUGBP2,-1.3239084671228767,6.762494235624475,-19.880895923580123,1.3072418021720124e-39,2.547160651532166e-37,79.68943406633518
ACADL,ILMN_1660890,"Homo sapiens acyl-Coenzyme A dehydrogenase, long chain (ACADL), nuclear gene encoding mitochondrial protein, mRNA.",mitochondrion [goid 5739] [evidence IEA],metabolism [goid 8152] [evidence IEA]; lipid metabolism [goid 6629] [evidence IEA]; fatty acid metabolism [goid 6631] [evidence IEA]; electron transport [goid 6118] [evidence IEA],acyl-CoA dehydrogenase activity [goid 3995] [evidence IEA]; long-chain-acyl-CoA dehydrogenase activity [goid 4466] [pmid 1945557] [evidence TAS]; FAD binding [goid 50660] [evidence IEA],2,210761312-210761361,2q34b,-,NM_001608.2,33,ACADL,-2.6335431914510776,6.543171119440936,-19.84155988812514,1.567218094391069e-39,3.023489561307919e-37,79.50885538639335
VWF,ILMN_1752755,"Homo sapiens von Willebrand factor (VWF), mRNA.",extracellular matrix (sensu Metazoa) [goid 5578] [evidence IEA],response to wounding [goid 9611] [pmid 15029268] [evidence TAS]; cell adhesion [goid 7155] [pmid 10764791] [evidence TAS]; platelet activation [goid 30168] [pmid 12871509] [evidence NAS],serine-type endopeptidase inhibitor activity [goid 4867] [evidence IEA]; growth factor activity [goid 8083] [evidence IEA]; protein binding [goid 5515] [pmid 11943773] [evidence IPI],12,,12p13.31e,-,NM_000552.2,7450,VWF,-2.1430907850368914,13.28394045791971,-19.821205599391885,1.7215660585899262e-39,3.288697514865168e-37,79.41533799880476
LOC338328,ILMN_1726210,"Homo sapiens high density lipoprotein-binding protein (LOC338328), mRNA.",,,,8,144370348-144370397,8q24.3f,+,NM_178172.2,338328,LOC338328,-2.33891882314166,7.055239395717477,-19.73463437451262,2.5685235303132543e-39,4.858998154189686e-37,79.01699661230894
TCEAL2,ILMN_1765310,"Homo sapiens transcription elongation factor A (SII)-like 2 (TCEAL2), mRNA.",,,translation elongation factor activity [goid 3746] [evidence IEA],X,101269209-101269258,Xq22.1d,+,NM_080390.3,140597,TCEAL2,-2.9604468094214793,7.469468557341895,-19.690959188762417,3.1441334546803254e-39,5.890715419658282e-37,78.81566965999286
CLEC14A,ILMN_2142185,"Homo sapiens C-type lectin domain family 14, member A (CLEC14A), mRNA.",membrane [goid 16020] [evidence IEA]; integral to membrane [goid 16021] [evidence IEA],,sugar binding [goid 5529] [evidence IEA],14,37793276-37793325,14q21.1a,-,NM_175060.1,161198,CLEC14A,-2.6135174814315363,10.36833146870581,-19.664895580432113,3.547779694316682e-39,6.54231493590545e-37,78.6954094960779
GPM6B,ILMN_1670308,"Homo sapiens glycoprotein M6B (GPM6B), transcript variant 4, mRNA.",membrane [goid 16020] [evidence IEA]; integral to membrane [goid 16021] [evidence NAS]; membrane [goid 16020] [evidence IEA]; integral to membrane [goid 16021] [evidence NAS],cell differentiation [goid 30154] [evidence IEA]; cell differentiation [goid 30154] [evidence IEA],,X,13866617-13866666,Xp22.2,-,NM_001001994.1,2824,GPM6B,-2.4855312795557696,6.62044852986981,-19.664210022164504,3.559073046989878e-39,6.54231493590545e-37,78.69224508657103
MS4A7,ILMN_2331082,"Homo sapiens membrane-spanning 4-domains, subfamily A, member 7 (MS4A7), transcript variant 2, mRNA.",membrane [goid 16020] [evidence IEA]; integral to membrane [goid 16021] [evidence IEA]; membrane [goid 16020] [evidence IEA]; integral to membrane [goid 16021] [evidence IEA],signal transduction [goid 7165] [evidence IEA]; signal transduction [goid 7165] [evidence IEA],receptor activity [goid 4872] [evidence IEA]; receptor activity [goid 4872] [evidence IEA],11,59919442-59919491,11q12.2a,+,NM_206938.1,58475,MS4A7,-2.3733009357576815,9.345821225720456,-19.654680998699586,3.719843553889621e-39,6.773939406312081e-37,78.64825465758459
EPAS1,ILMN_1704753,"Homo sapiens endothelial PAS domain protein 1 (EPAS1), mRNA.",nucleus [goid 5634] [evidence IEA],"regulation of transcription, DNA-dependent [goid 6355] [evidence IEA]; signal transduction [goid 7165] [pmid 9079689] [evidence TAS]; transcription from RNA polymerase II promoter [goid 6366] [pmid 9079689] [evidence TAS]; response to hypoxia [goid 1666] [pmid 11782478] [evidence IDA]; angiogenesis [goid 1525] [evidence IEA]; cell differentiation [goid 30154] [evidence IEA]","RNA polymerase II transcription factor activity, enhancer binding [goid 3705] [pmid 9079689] [evidence TAS]; histone acetyltransferase binding [goid 35035] [pmid 15261140] [evidence IPI]; signal transducer activity [goid 4871] [evidence IEA]; transcription coactivator activity [goid 3713] [pmid 9079689] [evidence TAS]; protein binding [goid 5515] [pmid 15261140] [evidence IPI]",2,46466797-46466846,2p21b,+,NM_001430.3,2034,EPAS1,-2.22682384256783,12.475895390484428,-19.523200170679523,6.851474648043076e-39,1.236120217751105e-36,78.04009085738885
LOC285016,ILMN_2089752,"Homo sapiens hypothetical protein LOC285016 (LOC285016), mRNA.",,,,2,270097-270146,2p25.3g,-,NM_001002919.1,285016,LOC285016,-3.0548055937761953,7.59744986426868,-19.49067247693602,7.971757478502837e-39,1.417578720443024e-36,77.88929254900778
AP1S2,ILMN_1766411,"Homo sapiens adaptor-related protein complex 1, sigma 2 subunit (AP1S2), mRNA.",plasma membrane [goid 5886] [evidence NR ]; AP-1 adaptor complex [goid 30121] [pmid 2040623] [evidence ISS]; coated pit [goid 5905] [evidence IEA]; Golgi trans face [goid 5802] [pmid 2040623] [evidence ISS]; Golgi apparatus [goid 5794] [evidence NR ]; membrane coat adaptor complex [goid 30119] [pmid 9733768] [evidence TAS]; plasma membrane [goid 5886] [evidence NR ]; AP-1 adaptor complex [goid 30121] [pmid 2040623] [evidence ISS]; coated pit [goid 5905] [evidence IEA]; Golgi trans face [goid 5802] [pmid 2040623] [evidence ISS]; Golgi apparatus [goid 5794] [evidence NR ]; membrane coat adaptor complex [goid 30119] [pmid 9733768] [evidence TAS],intracellular protein transport [goid 6886] [evidence IEA]; transport [goid 6810] [evidence IEA]; receptor mediated endocytosis [goid 6898] [evidence ISS]; intracellular protein transport [goid 6886] [evidence IEA]; transport [goid 6810] [evidence IEA]; receptor mediated endocytosis [goid 6898] [evidence ISS],protein transporter activity [goid 8565] [pmid 2040623] [evidence ISS]; protein transporter activity [goid 8565] [pmid 2040623] [evidence ISS],X,15754397-15754446,Xp22.2,-,NM_003916.3,8905,AP1S2,-1.7084464318111792,9.863532036438313,-19.48983931899048,8.002753874710426e-39,1.417578720443024e-36,77.8854282500634
SPTBN1,ILMN_1661335,"Homo sapiens spectrin, beta, non-erythrocytic 1 (SPTBN1), transcript variant 1, mRNA.",membrane [goid 16020] [evidence IEA]; cytoskeleton [goid 5856] [evidence IEA]; spectrin [goid 8091] [pmid 1527002] [evidence TAS],barbed-end actin filament capping [goid 51016] [evidence IEA],actin binding [goid 3779] [pmid 1527002] [evidence TAS]; calmodulin binding [goid 5516] [evidence IEA]; structural constituent of cytoskeleton [goid 5200] [pmid 1527002] [evidence TAS],2,54749118-54749167,2p16.2a,+,NM_003128.1,6711,SPTBN1,-1.8362185402294546,8.671058088091268,-19.48584892944511,8.152899449045707e-39,1.4311643762581586e-36,77.8669190517773
CCL14,ILMN_1740609,"Homo sapiens chemokine (C-C motif) ligand 14 (CCL14), transcript variant 2, mRNA.",extracellular region [goid 5576] [evidence IEA]; extracellular space [goid 5615] [pmid 8551235] [evidence TAS],calcium ion homeostasis [goid 6874] [pmid 8551235] [evidence TAS]; immune response [goid 6955] [evidence IEA]; positive regulation of cell proliferation [goid 8284] [pmid 8551235] [evidence TAS],signal transducer activity [goid 4871] [pmid 8551235] [evidence TAS]; chemokine activity [goid 8009] [evidence IEA],,,17q12b,,NM_032962.2,6358,CCL14,-3.6742397904362596,9.330527300092681,-19.479551662814487,8.395630950204164e-39,1.457083368906863e-36,77.83770538237404
FXYD6,ILMN_1768812,"Homo sapiens FXYD domain containing ion transport regulator 6 (FXYD6), mRNA.",plasma membrane [goid 5886] [pmid 11256614] [evidence IDA]; integral to membrane [goid 16021] [evidence ISS]; extracellular space [goid 5615] [evidence ISS],ion transport [goid 6811] [evidence IEA],ion channel activity [goid 5216] [evidence IEA],11,117213021-117213070,11q23.3c,-,NM_022003.1,53826,FXYD6,-2.1183692676857495,9.023979818006014,-19.478163433991636,8.45011140294973e-39,1.457083368906863e-36,77.8312645620347
JARID1B,ILMN_1755727,"Homo sapiens jumonji, AT rich interactive domain 1B (JARID1B), mRNA.",nucleus [goid 5634] [pmid 12657635] [evidence TAS]; intracellular [goid 5622] [evidence IEA],"negative regulation of transcription, DNA-dependent [goid 45892] [pmid 12657635] [evidence IDA]; regulation of transcription, DNA-dependent [goid 6355] [evidence IEA]; protein amino acid phosphorylation [goid 6468] [evidence IEA]",transcriptional repressor activity [goid 16564] [pmid 12657635] [evidence IDA]; DNA binding [goid 3677] [pmid 15640446] [evidence IDA]; zinc ion binding [goid 8270] [evidence IEA]; ATP binding [goid 5524] [evidence IEA]; protein binding [goid 5515] [pmid 12657635] [evidence IPI]; protein kinase activity [goid 4672] [evidence IEA],1,200963341-200963390,1q32.1d,-,NM_006618.3,10765,JARID1B,1.2772248115694023,10.381884157866605,19.384061014335526,1.3107687783608325e-38,2.240379793540423e-36,77.39409147671137
MAMDC2,ILMN_1679391,"Homo sapiens MAM domain containing 2 (MAMDC2), mRNA.",membrane [goid 16020] [evidence IEA]; endoplasmic reticulum [goid 5783] [pmid 11256614] [evidence IDA],,receptor activity [goid 4872] [evidence IEA],9,72031386-72031435,9q21.11b-q21.11c,+,NM_153267.3,256691,MAMDC2,-3.397896740343488,9.301877851293925,-19.332893569266716,1.664952736949964e-38,2.8210090503887e-36,77.15590554084486
INMT,ILMN_1781149,"Homo sapiens indolethylamine N-methyltransferase (INMT), mRNA.",,,transferase activity [goid 16740] [evidence IEA]; methyltransferase activity [goid 8168] [evidence IEA]; amine N-methyltransferase activity [goid 30748] [evidence IEA],7,30763562-30763611,7p15.1b,+,NM_006774.4,11185,INMT,-3.407867590785587,10.801810549562811,-19.30258368140727,1.9186788110683252e-38,3.222884192557441e-36,77.01465376046755
ZFHX1B,ILMN_1688698,"Homo sapiens zinc finger homeobox 1b (ZFHX1B), mRNA.",nucleus [goid 5634] [pmid 9853615] [evidence IC ],"regulation of transcription, DNA-dependent [goid 6355] [evidence IEA]; negative regulation of transcription [goid 16481] [pmid 11592033] [evidence IC ]",metal ion binding [goid 46872] [evidence IEA]; phosphatase regulator activity [goid 19208] [pmid 11477103] [evidence NAS]; nucleic acid binding [goid 3676] [evidence IEA]; zinc ion binding [goid 8270] [evidence IEA]; SMAD binding [goid 46332] [evidence NAS]; transcriptional repressor activity [goid 16564] [pmid 11592033] [evidence ISS]; sequence-specific DNA binding [goid 43565] [evidence IEA]; transcription factor activity [goid 3700] [evidence IEA],2,144862732-144862781,2q22.3a,-,NM_014795.2,9839,ZFHX1B,-1.9536252589747862,7.361658062167659,-19.286278635512446,2.0709077227824523e-38,3.4488578614030844e-36,76.93861935124957
PMP22,ILMN_1659312,"Homo sapiens peripheral myelin protein 22 (PMP22), transcript variant 1, mRNA.",membrane fraction [goid 5624] [evidence NR ]; integral to plasma membrane [goid 5887] [evidence NR ]; membrane [goid 16020] [evidence IEA],mechanosensory behavior [goid 7638] [evidence IEA]; peripheral nervous system development [goid 7422] [pmid 8275092] [evidence TAS]; synaptic transmission [goid 7268] [pmid 8275092] [evidence TAS]; negative regulation of cell proliferation [goid 8285] [evidence NR ],,17,15109233-15109282,17p12a,-,NM_000304.2,5376,PMP22,-2.303377139125044,8.568190141725806,-19.264795190211682,2.2901950533506294e-38,3.7817331029268654e-36,76.8383847237094
MGC9712,ILMN_1815937,"Homo sapiens hypothetical protein MGC9712 (MGC9712), mRNA.",,transport [goid 6810] [evidence IEA],transporter activity [goid 5215] [evidence IEA]; binding [goid 5488] [evidence IEA],7,1550141-1550190,7p22.3b,-,NM_152689.2,202915,MGC9712,2.6759682014278567,6.611868157259563,19.24538695971432,2.5083239129303326e-38,4.1071169280208006e-36,76.74778144463279
DCN,ILMN_1683194,"Homo sapiens decorin (DCN), transcript variant A1, mRNA.",extracellular matrix (sensu Metazoa) [goid 5578] [evidence IEA],,transferase activity [goid 16740] [evidence IEA],12,90100644-90100693,12q21.33c,-,NM_001920.3,1634,DCN,-3.207643700395014,10.636196902364572,-19.22813360898048,2.719726614488329e-38,4.416156090275425e-36,76.66719718921384
SGCG,ILMN_1659649,"Homo sapiens sarcoglycan, gamma (35kDa dystrophin-associated glycoprotein) (SGCG), mRNA.",plasma membrane [goid 5886] [pmid 8641426] [evidence TAS]; integral to membrane [goid 16021] [evidence IEA]; sarcoglycan complex [goid 16012] [pmid 8641426] [evidence TAS]; cytoskeleton [goid 5856] [evidence IEA],muscle development [goid 7517] [pmid 8641426] [evidence TAS]; cytoskeleton organization and biogenesis [goid 7010] [evidence IEA],,13,22796982-22797031,13q12.12a,+,NM_000231.1,6445,SGCG,-2.234760847979243,5.944471513300064,-19.20116747418049,3.086616321718475e-38,4.9704726469987176e-36,76.54117146639324
GRRP1,ILMN_1707055,"Homo sapiens glycine/arginine rich protein 1 (GRRP1), mRNA.",,,,1,26361282-26361298:26361299-26361331,1p36.11b,+,NM_024869.2,79927,GRRP1,-2.53135393814222,7.344865540137896,-19.196071023054692,3.16135876304386e-38,5.049104549008985e-36,76.51734281241907
ABI3BP,ILMN_1673639,"Homo sapiens ABI gene family, member 3 (NESH) binding protein (ABI3BP), mRNA.",integral to membrane [goid 16021] [evidence IEA],,,3,101950986-101951035,3q12.2a-q12.2b,-,NM_015429.2,25890,ABI3BP,-2.7992455529794418,9.014893292381524,-19.158785955864445,3.766496752849352e-38,5.9666820511601315e-36,76.34291363194899
TMEM100,ILMN_1698259,"Homo sapiens transmembrane protein 100 (TMEM100), mRNA.",integral to membrane [goid 16021] [evidence IEA]; membrane [goid 16020] [evidence IEA],,,17,51152729-51152778,17q22b,-,NM_018286.1,55273,TMEM100,-4.359603276503799,8.559374259163068,-19.142880726576887,4.0589012713878057e-38,6.378039618789629e-36,76.26845056257685
SRGN,ILMN_1760347,"Homo sapiens serglycin (SRGN), mRNA.",,,,10,70533801-70533850,10q21.3e,+,NM_002727.2,5552,SRGN,-2.4918801610221646,11.524301669259444,-19.087760018613558,5.260733445968422e-38,8.200431295575576e-36,76.01014218654727
FLJ22184,ILMN_1765636,"PREDICTED: Homo sapiens hypothetical protein FLJ22184 (FLJ22184), mRNA.",,,,,,19p13.2e,,XM_940456.1,80164,FLJ22184,2.271964639894181,7.632117776319376,19.082190736901406,5.400528717990511e-38,8.35153191032104e-36,75.98402154869204
MGC3101,ILMN_1757631,"Homo sapiens dysbindin (dystrobrevin binding protein 1) domain containing 1 (DBNDD1), transcript variant 2, mRNA.",cytoplasm [goid 5737] [evidence IEA],,protein binding [goid 5515] [evidence IEA],16,88599067-88599116,16q24.3b,-,NM_024043.2,79007,MGC3101,2.1519782481686365,7.1572116165704385,19.07732479755496,5.525724423800732e-38,8.477853574626556e-36,75.96119641612982
SRPK1,ILMN_1798804,"Homo sapiens SFRS protein kinase 1 (SRPK1), mRNA.",nucleus [goid 5634] [pmid 11509566] [evidence IDA]; cytoplasm [goid 5737] [pmid 11509566] [evidence IDA],"protein kinase cascade [goid 7243] [pmid 11509566] [evidence IDA]; regulation of mRNA processing [goid 50684] [pmid 8208298] [evidence IDA]; chromosome segregation [goid 7059] [pmid 15034300] [evidence IDA]; cell differentiation [goid 30154] [evidence IEA]; protein amino acid phosphorylation [goid 6468] [pmid 11509566] [evidence IDA]; nuclear mRNA splicing, via spliceosome [goid 398] [evidence IEA]",transferase activity [goid 16740] [evidence IEA]; nucleotide binding [goid 166] [evidence IEA]; ATP binding [goid 5524] [pmid 11509566] [evidence IDA]; magnesium ion binding [goid 287] [pmid 11509566] [evidence IDA]; protein serine/threonine kinase activity [goid 4674] [pmid 11509566] [evidence IDA]; protein binding [goid 5515] [pmid 11509566] [evidence IPI],6,35908947-35908996,6p21.31b,-,NM_003137.3,6732,SRPK1,1.5021396522335557,9.172664841636456,19.065285333734412,5.848179702235189e-38,8.902482929535364e-36,75.90470867216982
DPEP2,ILMN_1689160,"Homo sapiens dipeptidase 2 (DPEP2), mRNA.",membrane [goid 16020] [evidence IEA],,dipeptidyl-peptidase activity [goid 8239] [evidence IEA]; metallopeptidase activity [goid 8237] [evidence IEA]; membrane dipeptidase activity [goid 4237] [evidence IEA]; GPI anchor binding [goid 48503] [evidence IEA]; zinc ion binding [goid 8270] [evidence IEA]; metal ion binding [goid 46872] [evidence IEA],16,66578893-66578909:66578910-66578942,16q22.1b,-,NM_022355.1,64174,DPEP2,-2.286545013478933,8.279667658302651,-19.03164845678191,6.852996325637841e-38,1.0320906481076399e-35,75.74678977837004
CRTAC1,ILMN_1658384,"Homo sapiens cartilage acidic protein 1 (CRTAC1), mRNA.",,,calcium ion binding [goid 5509] [evidence IEA],10,99614982-99615031,10q24.2a,-,NM_018058.4,55118,CRTAC1,-3.75499092609013,9.518764308427844,-19.030632743993067,6.88590116776973e-38,1.0320906481076399e-35,75.74201893568443
LGI3,ILMN_1737162,"Homo sapiens leucine-rich repeat LGI family, member 3 (LGI3), mRNA.",,,,8,22060537-22060586,8p21.3a,-,NM_139278.2,203190,LGI3,-2.602473417915549,6.4680982825215185,-19.00208875660128,7.87852765669269e-38,1.1718558121424203e-35,75.6078925393493
SLC39A11,ILMN_1742705,"Homo sapiens solute carrier family 39 (metal ion transporter), member 11 (SLC39A11), mRNA.",membrane [goid 16020] [evidence IEA],metal ion transport [goid 30001] [evidence IEA],metal ion transporter activity [goid 46873] [evidence IEA],17,68153894-68153943,17q24.3c-q25.1a,-,NM_139177.2,201266,SLC39A11,1.619578908210448,9.388301083910765,19.00027192012623,7.946376338522356e-38,1.1729935072432434e-35,75.59935179780844
GPM6A,ILMN_1711312,"Homo sapiens glycoprotein M6A (GPM6A), transcript variant 2, mRNA.",integral to plasma membrane [goid 5887] [evidence NR ]; membrane [goid 16020] [evidence IEA]; cell surface [goid 9986] [pmid 12493773] [evidence IEP],,,4,176971126-176971175,4q34.2a,-,NM_201591.1,2823,GPM6A,-1.3736135231425495,6.077290622321662,-18.989371746323872,8.365956502689316e-38,1.2256440786082807e-35,75.54810242102943
KL,ILMN_2352077,"Homo sapiens klotho (KL), transcript variant 2, mRNA.",membrane [goid 16020] [evidence IEA]; integral to membrane [goid 16021] [evidence IEA],aging [goid 7568] [pmid 11792841] [evidence IMP]; positive regulation of bone mineralization [goid 30501] [pmid 12110410] [evidence IMP]; carbohydrate metabolism [goid 5975] [evidence IEA]; metabolism [goid 8152] [evidence IEA],glucosidase activity [goid 15926] [evidence IEA]; hormone activity [goid 5179] [evidence IEA]; vitamin D binding [goid 5499] [evidence IEA]; beta-glucuronidase activity [goid 4566] [evidence IEA],13,32538076-32538125,13q13.1b,+,NM_153683.2,9365,KL,-2.3361335608433444,6.799880769673484,-18.98151266048414,8.682236036758725e-38,1.261533904221383e-35,75.51114186984668
IL33,ILMN_1809099,"Homo sapiens interleukin 33 (IL33), mRNA.",extracellular space [goid 5615] [evidence IEA]; extracellular space [goid 5615] [evidence IEA],,cytokine activity [goid 5125] [evidence IEA]; cytokine activity [goid 5125] [evidence IEA],9,6247132-6247181,9p24.1b,+,NM_033439.2,90865,IL33,-3.360727564914022,8.04673202219667,-18.980098289127838,8.740419659732445e-38,1.261533904221383e-35,75.50448937050622
FOXF1,ILMN_1680973,"Homo sapiens forkhead box F1 (FOXF1), mRNA.",transcription factor complex [goid 5667] [pmid 9722567] [evidence TAS]; nucleus [goid 5634] [pmid 9722567] [evidence TAS],transcription [goid 6350] [evidence IEA]; regulation of transcription from RNA polymerase II promoter [goid 6357] [evidence NR ],transcription coactivator activity [goid 3713] [evidence NR ]; protein binding [goid 5515] [pmid 9722567] [evidence TAS]; transcription factor activity [goid 3700] [pmid 8626802] [evidence NAS],16,85105071-85105120,16q24.1c,+,NM_001451.1,2294,FOXF1,-2.727214684802436,7.70933445508215,-18.96195773229124,9.5223914464952e-38,1.364292627462934e-35,75.41914243768159
UBE2O,ILMN_1746579,"Homo sapiens ubiquitin-conjugating enzyme E2O (UBE2O), mRNA.",,ubiquitin cycle [goid 6512] [evidence IEA],ubiquitin-like activating enzyme activity [goid 8642] [evidence IEA],17,71897622-71897671,17q25.1d,-,NM_022066.2,63893,UBE2O,1.4998619794562424,7.944811017210136,18.95964646143501,9.626949600477197e-38,1.3692052041262644e-35,75.40826543217358
TNNC1,ILMN_1809842,"Homo sapiens troponin C type 1 (slow) (TNNC1), mRNA.",,,calcium ion binding [goid 5509] [evidence IEA],3,52460296-52460330:52460331-52460345,3p21.1d,-,NM_003280.1,7134,TNNC1,-3.3145164371212195,9.139086360064082,-18.94712829670666,1.0213644871259292e-37,1.4405706111190584e-35,75.34934213657183
SLC31A2,ILMN_1758938,"Homo sapiens solute carrier family 31 (copper transporters), member 2 (SLC31A2), mRNA.",integral to plasma membrane [goid 5887] [pmid 9207117] [evidence TAS],copper ion transport [goid 6825] [pmid 9207117] [evidence TAS]; ion transport [goid 6811] [evidence IEA],copper ion transporter activity [goid 5375] [pmid 9207117] [evidence TAS]; copper ion binding [goid 5507] [evidence IEA],9,114965858-114965907,9q32b,+,NM_001860.1,1318,SLC31A2,-2.032416297358738,9.635900173822703,-18.94582849319899,1.0276587885324563e-37,1.4405706111190584e-35,75.34322277767947
GIMAP4,ILMN_1748473,"Homo sapiens GTPase, IMAP family member 4 (GIMAP4), mRNA.",,,GTP binding [goid 5525] [evidence IEA]; nucleotide binding [goid 166] [evidence IEA],7,149901875-149901924,7q36.1c,+,NM_018326.2,55303,GIMAP4,-1.966655127185149,10.769622391509253,-18.93086046304962,1.103015064041764e-37,1.5351606087752693e-35,75.27273899300324
GDDR,ILMN_1813688,"Homo sapiens gastrokine 2 (GKN2), mRNA.",,,,2,69026019-69026068,2p14a,-,NM_182536.2,200504,GDDR,-4.791167714223265,9.110759529722284,-18.921311233999905,1.1539698264417384e-37,1.5844145512480828e-35,75.22775706758131
GCNT3,ILMN_1712082,"Homo sapiens glucosaminyl (N-acetyl) transferase 3, mucin type (GCNT3), mRNA.",membrane fraction [goid 5624] [pmid 9988682] [evidence TAS]; membrane [goid 16020] [evidence IEA],carbohydrate metabolism [goid 5975] [pmid 9988682] [evidence NAS],"transferase activity, transferring glycosyl groups [goid 16757] [evidence IEA]; N-acetyllactosaminide beta-1,6-N-acetylglucosaminyltransferase activity [goid 8109] [pmid 9988682] [evidence TAS]",15,57699351-57699400,15q22.2a,+,NM_004751.1,9245,GCNT3,4.807587841339318,8.04731419070972,18.921183539664476,1.1546670068115358e-37,1.5844145512480828e-35,75.22715548030003
MMP11,ILMN_1655915,"Homo sapiens matrix metallopeptidase 11 (stromelysin 3) (MMP11), mRNA.",extracellular matrix (sensu Metazoa) [goid 5578] [pmid 1701851] [evidence TAS],morphogenesis [goid 9653] [evidence NR ]; collagen catabolism [goid 30574] [evidence IEA],zinc ion binding [goid 8270] [evidence IEA]; stromelysin 3 activity [goid 4249] [pmid 7746327] [evidence TAS]; calcium ion binding [goid 5509] [evidence IEA],22,22456201-22456250,22q11.23a,+,NM_005940.3,4320,MMP11,4.580162338076288,7.882791283772668,18.87670281798467,1.4252184491178121e-37,1.9419847189552846e-35,75.01747268184248
MS4A2,ILMN_1806721,"Homo sapiens membrane-spanning 4-domains, subfamily A, member 2 (Fc fragment of IgE, high affinity I, receptor for; beta polypeptide) (MS4A2), mRNA.",integral to plasma membrane [goid 5887] [pmid 2448768] [evidence TAS]; membrane [goid 16020] [evidence IEA],humoral immune response [goid 6959] [pmid 2448768] [evidence TAS]; cell proliferation [goid 8283] [pmid 2448768] [evidence TAS]; G-protein coupled receptor protein signaling pathway [goid 7186] [pmid 9169438] [evidence TAS]; signal transduction [goid 7165] [evidence IEA],IgE binding [goid 19863] [evidence IEA]; receptor activity [goid 4872] [evidence IEA]; calcium channel activity [goid 5262] [pmid 9169438] [evidence TAS],11,59622246-59622295,11q12.1d,+,NM_000139.2,2206,MS4A2,-2.6828973428244707,7.319817412018582,-18.833826420143353,1.7462711557328922e-37,2.3629231576010698e-35,74.81511218607142
GPC3,ILMN_2051972,"Homo sapiens glypican 3 (GPC3), mRNA.",integral to plasma membrane [goid 5887] [pmid 7657705] [evidence TAS]; membrane [goid 16020] [evidence IEA]; extracellular matrix (sensu Metazoa) [goid 5578] [evidence IEA],morphogenesis [goid 9653] [pmid 8589713] [evidence TAS],GPI anchor binding [goid 48503] [evidence IEA],X,132497888-132497937,Xq26.2b,-,NM_004484.2,2719,GPC3,-3.0596174078164955,9.00868960859776,-18.826593137339653,1.8071997894964134e-37,2.428502613678456e-35,74.78095053424083
FAM83A,ILMN_1670158,"Homo sapiens family with sequence similarity 83, member A (FAM83A), transcript variant 2, mRNA.",,,,8,124291158-124291207,8q24.13b,+,NM_207006.1,84985,FAM83A,2.5740589504939457,6.152054053406751,18.822122239113515,1.8459243645252343e-37,2.4635504275872734e-35,74.75983182835056
PTPRM,ILMN_1744937,"Homo sapiens protein tyrosine phosphatase, receptor type, M (PTPRM), mRNA.",integral to plasma membrane [goid 5887] [pmid 1655529] [evidence TAS]; membrane [goid 16020] [evidence IEA],protein amino acid dephosphorylation [goid 6470] [pmid 10809770] [evidence TAS],transmembrane receptor protein tyrosine phosphatase activity [goid 5001] [pmid 10809770] [evidence TAS]; receptor activity [goid 4872] [evidence IEA]; hydrolase activity [goid 16787] [evidence IEA]; protein tyrosine phosphatase activity [goid 4725] [evidence IEA],18,8396361-8396410,18p11.23b-p11.23a,+,NM_002845.2,5797,PTPRM,-1.813192651477868,9.356800436978908,-18.808630793574654,1.9679133009556593e-37,2.608489161164695e-35,74.69608816333188
SLC2A1,ILMN_1659027,"Homo sapiens solute carrier family 2 (facilitated glucose transporter), member 1 (SLC2A1), mRNA.",integral to membrane [goid 16021] [evidence IEA]; membrane fraction [goid 5624] [pmid 9462754] [evidence TAS]; membrane [goid 16020] [pmid 3028891] [evidence TAS],glucose transport [goid 15758] [pmid 9462754] [evidence TAS]; carbohydrate transport [goid 8643] [evidence IEA],transporter activity [goid 5215] [evidence IEA]; sugar porter activity [goid 5351] [evidence IEA]; glucose transporter activity [goid 5355] [pmid 9462754] [evidence TAS],1,43164575-43164624,1p34.2a,-,NM_006516.1,6513,SLC2A1,2.857535769998072,9.195407067632113,18.800315153615024,2.0471090250509077e-37,2.695129686021415e-35,74.65678722592364
C10orf54,ILMN_2205963,"Homo sapiens chromosome 10 open reading frame 54 (C10orf54), mRNA.",membrane [goid 16020] [evidence IEA]; integral to membrane [goid 16021] [evidence IEA],,receptor activity [goid 4872] [evidence IEA],10,73177396-73177445,10q22.1d-q22.1e,-,NM_022153.1,64115,C10orf54,-2.0399430972994477,8.724795829102217,-18.76849464482899,2.380919484946838e-37,3.113571554643566e-35,74.50631681900073
CXCL12,ILMN_1689111,"Homo sapiens chemokine (C-X-C motif) ligand 12 (stromal cell-derived factor 1) (CXCL12), transcript variant 3, mRNA.",extracellular region [goid 5576] [evidence IEA]; extracellular space [goid 5615] [evidence IEA],regulation of actin polymerization and/or depolymerization [goid 8064] [pmid 10570282] [evidence TAS]; immune response [goid 6955] [evidence IEA]; circulation [goid 8015] [pmid 10772939] [evidence TAS]; cell adhesion [goid 7155] [pmid 10198043] [evidence TAS]; cell-cell signaling [goid 7267] [evidence NR ]; response to virus [goid 9615] [pmid 10772939] [evidence TAS]; chemotaxis [goid 6935] [pmid 10620615] [evidence TAS]; calcium ion homeostasis [goid 6874] [pmid 10772939] [evidence TAS]; G-protein coupled receptor protein signaling pathway [goid 7186] [pmid 8752280] [evidence TAS]; inflammatory response [goid 6954] [evidence NR ]; signal transduction [goid 7165] [pmid 10491003] [evidence TAS],signal transducer activity [goid 4871] [pmid 10802710] [evidence TAS]; growth factor activity [goid 8083] [evidence IEA]; chemokine activity [goid 8009] [pmid 10772939] [evidence TAS],10,44196274-44196323,10q11.21c,-,NM_001033886.1,6387,CXCL12,-2.5039107155315126,7.745229793331994,-18.717398043171038,3.035331936322285e-37,3.9428961852826483e-35,74.26442306564243
FLJ13909,ILMN_1656452,"Homo sapiens hypothetical protein FLJ13909 (FLJ13909), mRNA.",,,,16,2454788-2454837,16p13.3d,+,NM_025108.1,80178,FLJ13909,2.0260836727104934,6.187393728576433,18.67617037886967,3.693204050853381e-37,4.7443012457385096e-35,74.06900496808912
GPT2,ILMN_1684158,"Homo sapiens glutamic pyruvate transaminase (alanine aminotransferase) 2 (GPT2), mRNA.",,biosynthesis [goid 9058] [evidence IEA],transaminase activity [goid 8483] [evidence IEA]; 1-aminocyclopropane-1-carboxylate synthase activity [goid 16847] [evidence IEA],16,45522597-45522646,16q11.2i-q12.1a,+,NM_133443.1,84706,GPT2,2.3483307303157037,9.056865431053987,18.675729234659297,3.70096889582886e-37,4.7443012457385096e-35,74.06691277552643
C9orf140,ILMN_1702197,"Homo sapiens chromosome 9 open reading frame 140 (C9orf140), mRNA.",,,calcium ion binding [goid 5509] [evidence IEA],9,139076854-139076903,9q34.3e,-,NM_178448.2,89958,C9orf140,2.420905081337427,6.395447932325444,18.61881532056027,4.853816267645772e-37,6.181477776148881e-35,73.79678046918848
BAIAP2L1,ILMN_1703593,"Homo sapiens BAI1-associated protein 2-like 1 (BAIAP2L1), mRNA.",,,,7,97760653-97760702,7q21.3d,-,NM_018842.3,55971,BAIAP2L1,1.9227793184713278,9.371719356255515,18.610700848908646,5.045318070552335e-37,6.383637831474821e-35,73.7582326274651
CELSR3,ILMN_1691290,"Homo sapiens cadherin, EGF LAG seven-pass G-type receptor 3 (flamingo homolog, Drosophila) (CELSR3), mRNA.",integral to membrane [goid 16021] [pmid 15203201] [evidence TAS]; membrane [goid 16020] [evidence IEA],signal transduction [goid 7165] [evidence IEA]; development [goid 7275] [evidence IEA]; neuropeptide signaling pathway [goid 7218] [evidence IEA]; homophilic cell adhesion [goid 7156] [evidence IEA],structural molecule activity [goid 5198] [evidence IEA]; receptor activity [goid 4872] [evidence IEA]; G-protein coupled receptor activity [goid 4930] [pmid 15203201] [evidence TAS]; calcium ion binding [goid 5509] [evidence IEA],3,48648930-48648979,3p21.31e,-,NM_001407.1,1951,CELSR3,2.7351440298525906,7.188013385417519,18.58422531888925,5.724598774046831e-37,7.196374652406613e-35,73.63240170366171
PPAP2B,ILMN_1672608,"Homo sapiens phosphatidic acid phosphatase type 2B (PPAP2B), transcript variant 1, mRNA.",membrane [goid 16020] [pmid 9305923] [evidence TAS]; integral to membrane [goid 16021] [evidence IEA]; membrane [goid 16020] [pmid 9305923] [evidence TAS]; integral to membrane [goid 16021] [evidence IEA],germ cell migration [goid 8354] [pmid 9305923] [evidence TAS]; lipid metabolism [goid 6629] [pmid 9705349] [evidence NAS]; germ cell migration [goid 8354] [pmid 9305923] [evidence TAS]; lipid metabolism [goid 6629] [pmid 9705349] [evidence NAS],hydrolase activity [goid 16787] [evidence IEA]; phosphoprotein phosphatase activity [goid 4721] [pmid 9705349] [evidence TAS]; phosphatidate phosphatase activity [goid 8195] [evidence IEA]; hydrolase activity [goid 16787] [evidence IEA]; phosphoprotein phosphatase activity [goid 4721] [pmid 9705349] [evidence TAS]; phosphatidate phosphatase activity [goid 8195] [evidence IEA],1,56817352-56817401,1p32.2c,-,NM_003713.3,8613,PPAP2B,-1.8493008570547067,8.410549193870766,-18.580442734364784,5.828886572299517e-37,7.267939031054325e-35,73.61441677295088
PTGER4,ILMN_1795930,"Homo sapiens prostaglandin E receptor 4 (subtype EP4) (PTGER4), mRNA.",integral to membrane [goid 16021] [pmid 8163486] [evidence TAS],"immune response [goid 6955] [pmid 8862514] [evidence TAS]; signal transduction [goid 7165] [evidence IEA]; G-protein signaling, coupled to cAMP nucleotide second messenger [goid 7188] [pmid 8163486] [evidence TAS]; G-protein coupled receptor protein signaling pathway [goid 7186] [evidence IEA]",rhodopsin-like receptor activity [goid 1584] [evidence IEA]; prostaglandin E receptor activity [goid 4957] [pmid 8163486] [evidence TAS]; receptor activity [goid 4872] [evidence IEA],5,40729369-40729418,5p13.1b,+,NM_000958.2,5734,PTGER4,-1.935173271748761,9.245323007540755,-18.579465899614043,5.856127420454344e-37,7.267939031054325e-35,73.60977195041222
EML1,ILMN_1729455,"Homo sapiens echinoderm microtubule associated protein like 1 (EML1), transcript variant 2, mRNA.",microtubule associated complex [goid 5875] [pmid 9226380] [evidence TAS]; microtubule [goid 5874] [evidence IEA]; microtubule associated complex [goid 5875] [pmid 9226380] [evidence TAS]; microtubule [goid 5874] [evidence IEA],visual perception [goid 7601] [evidence NR ]; visual perception [goid 7601] [evidence NR ],acid phosphatase activity [goid 3993] [evidence IEA]; calcium ion binding [goid 5509] [evidence IEA]; acid phosphatase activity [goid 3993] [evidence IEA]; calcium ion binding [goid 5509] [evidence IEA],14,99477179-99477228,14q32.2b,+,NM_004434.2,2009,EML1,-2.107638550497213,7.603776065712395,-18.530119492028057,7.412601829519088e-37,9.14142700304933e-35,73.37497178286488
LOC648470,ILMN_1704554,"PREDICTED: Homo sapiens similar to Caspase-4 precursor (CASP-4) (ICH-2 protease) (TX protease) (ICE(rel)-II) (LOC648470), mRNA.",,,,,,,,XM_937514.1,648470,LOC648470,-1.9237681673690155,8.552422538263723,-18.519054206642483,7.81523406008651e-37,9.577348154766392e-35,73.32227803030207
TACC1,ILMN_1770084,"Homo sapiens transforming, acidic coiled-coil containing protein 1 (TACC1), mRNA.",nucleus [goid 5634] [evidence IEA],cell cycle [goid 7049] [evidence IEA]; cell division [goid 51301] [evidence IEA],protein binding [goid 5515] [pmid 15064709] [evidence IPI],8,38829434-38829483,8p11.23c,+,NM_006283.1,6867,TACC1,-1.7486397273205796,12.266112689116119,-18.514036979929454,8.004973053359045e-37,9.748556246543811e-35,73.29838042836215
SERINC2,ILMN_2111932,"Homo sapiens serine incorporator 2 (SERINC2), mRNA.",membrane [goid 16020] [evidence IEA],positive regulation of transferase activity [goid 51347] [evidence ISS]; phosphatidylserine metabolism [goid 6658] [evidence ISS],,1,31679770-31679819,1p35.2a,+,NM_178865.3,347735,SERINC2,2.8619896417318538,8.751177755823393,18.487473886230564,9.089482821380607e-37,1.100053247047212e-34,73.17180367984751
FUT2,ILMN_1794659,"Homo sapiens fucosyltransferase 2 (secretor status included) (FUT2), mRNA.",integral to Golgi membrane [goid 30173] [evidence NAS]; integral to membrane [goid 16021] [evidence IEA]; Golgi stack [goid 5795] [evidence IEA]; membrane [goid 16020] [evidence IEA],protein amino acid glycosylation [goid 6486] [pmid 11698403] [evidence TAS]; L-fucose catabolism [goid 42355] [pmid 11698403] [evidence NAS]; carbohydrate metabolism [goid 5975] [pmid 7876235] [evidence TAS],"transferase activity, transferring glycosyl groups [goid 16757] [evidence IEA]; fucosyltransferase activity [goid 8417] [pmid 7876235] [evidence TAS]; galactoside 2-alpha-L-fucosyltransferase activity [goid 8107] [pmid 11698403] [evidence TAS]",19,53900557-53900606,19q13.33a,+,NM_000511.3,2524,FUT2,2.774525241420174,6.48613808437106,18.473289296231673,9.727933842971213e-37,1.1700542650018154e-34,73.10417510591367
KAL1,ILMN_1750373,"Homo sapiens Kallmann syndrome 1 sequence (KAL1), mRNA.",extracellular space [goid 5615] [pmid 8842728] [evidence TAS]; extracellular matrix (sensu Metazoa) [goid 5578] [pmid 8832397] [evidence TAS],chemotaxis [goid 6935] [pmid 8842728] [evidence TAS]; axon guidance [goid 7411] [pmid 1922361] [evidence TAS]; cell adhesion [goid 7155] [pmid 1922361] [evidence TAS]; cell motility [goid 6928] [pmid 1922361] [evidence TAS],serine-type endopeptidase inhibitor activity [goid 4867] [evidence IEA]; protein binding [goid 5515] [evidence IEA]; extracellular matrix structural constituent [goid 5201] [pmid 8842728] [evidence TAS],X,8457273-8457322,Xp22.31b,-,NM_000216.1,3730,KAL1,-3.1514958019615156,9.02761123247857,-18.455488224357005,1.059337265381083e-36,1.266330467236221e-34,73.01926753144072
CENPF,ILMN_1664516,"Homo sapiens centromere protein F, 350/400ka (mitosin) (CENPF), mRNA.",kinetochore [goid 776] [pmid 7542657] [evidence IDA]; nuclear matrix [goid 16363] [pmid 7542657] [evidence IDA]; chromatin [goid 785] [pmid 9891037] [evidence NAS]; cytoplasm [goid 5737] [pmid 12974617] [evidence IDA]; spindle pole [goid 922] [pmid 7542657] [evidence IDA]; outer kinetochore of condensed chromosome [goid 940] [pmid 12974617] [evidence TAS],mitotic spindle checkpoint [goid 7094] [pmid 12974617] [evidence NAS]; cell proliferation [goid 8283] [pmid 15927522] [evidence NAS]; G2 phase of mitotic cell cycle [goid 85] [pmid 12154071] [evidence IMP]; response to drug [goid 42493] [pmid 12467231] [evidence NAS]; metaphase plate congression [goid 51310] [pmid 15870278] [evidence IDA]; cell division [goid 51301] [evidence IEA]; kinetochore assembly [goid 51382] [pmid 16252009] [evidence NAS]; mitosis [goid 7067] [evidence IEA]; negative regulation of transcription [goid 16481] [pmid 15677469] [evidence IDA],protein heterodimerization activity [goid 46982] [pmid 7642639] [evidence IDA]; protein C-terminus binding [goid 8022] [pmid 7642639] [evidence IPI]; transcription factor binding [goid 8134] [pmid 15677469] [evidence IPI]; chromatin binding [goid 3682] [pmid 9891037] [evidence NAS]; dynein binding [goid 45502] [pmid 12974617] [evidence IDA]; protein homodimerization activity [goid 42803] [pmid 7642639] [evidence IPI],1,212904364-212904413,1q41a,+,NM_016343.3,1063,CENPF,2.4030908415492442,6.546159899987082,18.44927430521518,1.0913370842908578e-36,1.2966282370370344e-34,72.98961880143021
GAS6,ILMN_1768260,"Homo sapiens growth arrest-specific 6 (GAS6), mRNA.",extracellular region [goid 5576] [evidence IEA]; extracellular region [goid 5576] [evidence IEA],cell proliferation [goid 8283] [pmid 7854420] [evidence TAS]; regulation of cell growth [goid 1558] [evidence IEA]; signal transduction [goid 7165] [pmid 7854420] [evidence TAS]; cell proliferation [goid 8283] [pmid 7854420] [evidence TAS]; regulation of cell growth [goid 1558] [evidence IEA]; signal transduction [goid 7165] [pmid 7854420] [evidence TAS],calcium ion binding [goid 5509] [evidence IEA]; receptor binding [goid 5102] [pmid 7854420] [evidence TAS]; calcium ion binding [goid 5509] [evidence IEA]; receptor binding [goid 5102] [pmid 7854420] [evidence TAS],13,113547353-113547395:113562920-113562926,13q34d,+,NM_000820.1,2621,GAS6,-1.6920020105725229,9.908156312437187,-18.426523158981073,1.217021825298447e-36,1.4371921373297114e-34,72.88102305299475
VSIG4,ILMN_1669409,"Homo sapiens V-set and immunoglobulin domain containing 4 (VSIG4), mRNA.",integral to membrane [goid 16021] [evidence IEA]; membrane [goid 16020] [evidence IEA],,protein binding [goid 5515] [pmid 16530040] [evidence IPI],X,65158578-65158627,Xq12a,-,NM_007268.1,11326,VSIG4,-2.805046730348934,9.284364559513456,-18.397081407020266,1.4015273169920324e-36,1.645106010336732e-34,72.74039317745587
CD52,ILMN_2208903,"Homo sapiens CD52 molecule (CD52), mRNA.",membrane fraction [goid 5624] [pmid 1711975] [evidence TAS]; integral to plasma membrane [goid 5887] [pmid 1711975] [evidence TAS]; membrane [goid 16020] [evidence IEA],,GPI anchor binding [goid 48503] [evidence IEA],1,26519273-26519322,1p36.11b,+,NM_001803.2,1043,CD52,-2.6513893335197363,11.399816076344045,-18.38900926711863,1.4568592351734152e-36,1.6998145028355685e-34,72.70181681671617
P4HB,ILMN_1719303,"Homo sapiens procollagen-proline, 2-oxoglutarate 4-dioxygenase (proline 4-hydroxylase), beta polypeptide (P4HB), mRNA.",extracellular region [goid 5576] [pmid 14718574] [evidence NAS]; endoplasmic reticulum [goid 5783] [pmid 3034602] [evidence TAS]; cell surface [goid 9986] [pmid 12493773] [evidence IEP]; ER-Golgi intermediate compartment [goid 5793] [pmid 15308636] [evidence IDA],peptidyl-proline hydroxylation to 4-hydroxy-L-proline [goid 18401] [pmid 7753822] [evidence IDA]; electron transport [goid 6118] [evidence IEA],isomerase activity [goid 16853] [evidence IEA]; electron transporter activity [goid 5489] [evidence IEA]; procollagen-proline 4-dioxygenase activity [goid 4656] [pmid 7753822] [evidence IDA]; protein disulfide isomerase activity [goid 3756] [pmid 2846539] [evidence TAS],17,77394447-77394496,17q25.3g,-,NM_000918.2,5034,P4HB,1.1608590146300255,13.077042683334573,18.381259602107917,1.5120466923417928e-36,1.7537041547785614e-34,72.66477368707166
STIL,ILMN_2413650,"Homo sapiens SCL/TAL1 interrupting locus (STIL), transcript variant 2, mRNA.",,cell proliferation [goid 8283] [pmid 8825637] [evidence TAS],,,,1p33d,,NM_003035.2,6491,STIL,2.037401848280033,7.303084353388448,18.280362701762424,2.455278373346387e-36,2.8308342665475945e-34,72.18178743382121
SOX17,ILMN_1671092,"Homo sapiens SRY (sex determining region Y)-box 17 (SOX17), mRNA.",nucleus [goid 5634] [evidence IEA],"transcription [goid 6350] [evidence IEA]; regulation of transcription, DNA-dependent [goid 6355] [evidence IEA]",DNA binding [goid 3677] [evidence IEA],8,55535063-55535108:55535109-55535112,8q11.23d,+,NM_022454.2,64321,SOX17,-2.435686838178694,6.620945324110338,-18.26526581807431,2.6402840109350507e-36,3.0262314090040863e-34,72.10940753218257
SASH1,ILMN_1712673,"Homo sapiens SAM and SH3 domain containing 1 (SASH1), mRNA.",,cell cycle [goid 7049] [evidence IEA],,6,148914326-148914375,6q24.3c,+,NM_015278.3,23328,SASH1,-2.1597529541775717,9.02963364306756,-18.259792133868874,2.7107708394523777e-36,3.0888520354812617e-34,72.08315750538564
ACVRL1,ILMN_1807493,"Homo sapiens activin A receptor type II-like 1 (ACVRL1), mRNA.",membrane [goid 16020] [evidence IEA]; integral to plasma membrane [goid 5887] [pmid 8397373] [evidence TAS],protein amino acid phosphorylation [goid 6468] [evidence IEA]; transforming growth factor beta receptor signaling pathway [goid 7179] [pmid 8928814] [evidence TAS]; circulation [goid 8015] [pmid 9245985] [evidence TAS],manganese ion binding [goid 30145] [evidence IEA]; nucleotide binding [goid 166] [evidence IEA]; magnesium ion binding [goid 287] [evidence IEA]; receptor activity [goid 4872] [evidence IEA]; transferase activity [goid 16740] [evidence IEA]; transforming growth factor beta receptor activity [goid 5024] [evidence IEA]; ATP binding [goid 5524] [evidence IEA],12,50600813-50600862,12q13.13c,+,NM_000020.1,94,ACVRL1,-2.3496794047504865,8.14516846583195,-18.25785576389425,2.7361567683226487e-36,3.098160728579963e-34,72.07387037956556
CLEC12A,ILMN_1663142,"Homo sapiens C-type lectin domain family 12, member A (CLEC12A), transcript variant 3, mRNA.",,,receptor activity [goid 4872] [evidence IEA]; sugar binding [goid 5529] [evidence IEA]; receptor activity [goid 4872] [evidence IEA]; sugar binding [goid 5529] [evidence IEA],12,10029269-10029318,12p13.2c,+,NM_201625.1,160364,CLEC12A,-2.1856746395663214,6.676670831786739,-18.2567515016346,2.7507406006894203e-36,3.098160728579963e-34,72.06857395425607
SDPR,ILMN_1715991,"Homo sapiens serum deprivation response (phosphatidylserine binding protein) (SDPR), mRNA.",membrane fraction [goid 5624] [evidence NR ]; caveola [goid 5901] [evidence NR ]; cytosol [goid 5829] [pmid 2390065] [evidence IDA],,phosphatidylserine binding [goid 1786] [pmid 10191091] [evidence IDA]; protein binding [goid 5515] [evidence ISS],2,192407481-192407530,2q32.3a,-,NM_004657.4,8436,SDPR,-3.03380741870121,9.9014746655692,-18.250439709254373,2.83561244153865e-36,3.175397035826471e-34,72.03829740813184
PGM5,ILMN_1709590,"PREDICTED: Homo sapiens phosphoglucomutase 5 (PGM5), mRNA.",,,,,,9q13a-q13b,,XM_936702.1,5239,PGM5,-1.7567135189741405,7.2230590612330134,-18.2418046378078,2.9560063758858026e-36,3.2913019562362778e-34,71.99686823979552
BCHE,ILMN_1685641,"Homo sapiens butyrylcholinesterase (BCHE), mRNA.",extracellular region [goid 5576] [pmid 14718574] [evidence NAS]; extracellular region [goid 5576] [pmid 14718574] [evidence NAS],cocaine metabolism [goid 50783] [pmid 8622553] [evidence TAS]; cocaine metabolism [goid 50783] [pmid 8622553] [evidence TAS],enzyme binding [goid 19899] [pmid 11569538] [evidence NAS]; beta-amyloid binding [goid 1540] [pmid 11569538] [evidence NAS]; serine esterase activity [goid 4759] [evidence IEA]; cholinesterase activity [goid 4104] [evidence NAS]; hydrolase activity [goid 16787] [evidence IEA]; enzyme binding [goid 19899] [pmid 11569538] [evidence NAS]; beta-amyloid binding [goid 1540] [pmid 11569538] [evidence NAS]; serine esterase activity [goid 4759] [evidence IEA]; cholinesterase activity [goid 4104] [evidence NAS]; hydrolase activity [goid 16787] [evidence IEA],3,166973917-166973966,3q26.1e,-,NM_000055.1,590,BCHE,-2.8006510565356004,6.905474321984229,-18.222077100905583,3.250699825850805e-36,3.5988571651535756e-34,71.90218404022458
PPP1R14A,ILMN_1761968,"Homo sapiens protein phosphatase 1, regulatory (inhibitor) subunit 14A (PPP1R14A), mRNA.",,,protein phosphatase inhibitor activity [goid 4864] [evidence IEA],19,43433736-43433785,19q13.2a,-,NM_033256.1,94274,PPP1R14A,-2.095627091806577,10.353182034763805,-18.215724319142776,3.35175234051889e-36,3.6897680426559646e-34,71.87168264857672
RASL12,ILMN_1806403,"Homo sapiens RAS-like, family 12 (RASL12), mRNA.",membrane [goid 16020] [evidence IEA],small GTPase mediated signal transduction [goid 7264] [evidence IEA],GTP binding [goid 5525] [evidence IEA]; nucleotide binding [goid 166] [evidence IEA],15,63132850-63132899,15q22.31b,-,NM_016563.2,51285,RASL12,-2.159441503393099,9.273057126273816,-18.20032115768097,3.6100793496135113e-36,3.95182000714715e-34,71.79770652807379
CLDN18,ILMN_1662484,"Homo sapiens claudin 18 (CLDN18), transcript variant 2, mRNA.",membrane [goid 16020] [evidence IEA]; integral to membrane [goid 16021] [evidence ISS]; tight junction [goid 5923] [evidence ISS],calcium-independent cell-cell adhesion [goid 16338] [evidence ISS],structural molecule activity [goid 5198] [evidence IEA],3,139200523-139200572,3q22.3b,+,NM_001002026.2,51208,CLDN18,-3.350539916731961,8.716962184785311,-18.196048226297805,3.685224673063806e-36,3.996480454072595e-34,71.7771797169734
FLJ20701,ILMN_1671891,"Homo sapiens phosphotyrosine interaction domain containing 1 (PID1), mRNA.",,,,2,229597546-229597595,2q36.3d-q36.3e,-,NM_017933.3,55022,FLJ20701,-2.7111070131615582,7.963748907063938,-18.1956729654774,3.691898802838424e-36,3.996480454072595e-34,71.77537688319
EMP3,ILMN_1765446,"Homo sapiens epithelial membrane protein 3 (EMP3), mRNA.",membrane fraction [goid 5624] [evidence NR ]; membrane [goid 16020] [evidence IEA]; integral to membrane [goid 16021] [evidence IEA],development [goid 7275] [evidence NR ]; cell growth [goid 16049] [evidence IEA]; negative regulation of cell proliferation [goid 8285] [pmid 8996089] [evidence TAS]; cell death [goid 8219] [evidence NR ],,19,53524428-53524477,19q13.32c,+,NM_001425.1,2014,EMP3,-1.5356959576071123,11.567736493748901,-18.190897615519855,3.77789884931746e-36,4.066981164582912e-34,71.7524334994182
LEPR,ILMN_1676265,"Homo sapiens leptin receptor (LEPR), transcript variant 3, mRNA.",integral to plasma membrane [goid 5887] [evidence NR ]; membrane [goid 16020] [evidence IEA]; integral to plasma membrane [goid 5887] [evidence NR ]; membrane [goid 16020] [evidence IEA],development [goid 7275] [pmid 9537324] [evidence TAS]; cell surface receptor linked signal transduction [goid 7166] [pmid 9537324] [evidence TAS]; energy reserve metabolism [goid 6112] [pmid 9537324] [evidence TAS]; development [goid 7275] [pmid 9537324] [evidence TAS]; cell surface receptor linked signal transduction [goid 7166] [pmid 9537324] [evidence TAS]; energy reserve metabolism [goid 6112] [pmid 9537324] [evidence TAS],hematopoietin/interferon-class (D200-domain) cytokine receptor activity [goid 4896] [evidence IEA]; hematopoietin/interferon-class (D200-domain) cytokine receptor activity [goid 4896] [evidence IEA],1,65854386-65854435,1p31.3b,+,NM_001003680.1,3953,LEPR,-1.502526727147365,6.268801688038307,-18.180128411625144,3.9793101587721485e-36,4.260266947454688e-34,71.70068166014748
SLC19A3,ILMN_1716359,"Homo sapiens solute carrier family 19, member 3 (SLC19A3), mRNA.",membrane [goid 16020] [evidence IEA]; integral to membrane [goid 16021] [pmid 11136550] [evidence NAS],transport [goid 6810] [evidence NAS],folic acid binding [goid 5542] [evidence IEA]; reduced folate carrier activity [goid 8518] [evidence IEA]; carrier activity [goid 5386] [pmid 11136550] [evidence NAS],2,228258197-228258246,2q36.3c,-,NM_025243.2,80704,SLC19A3,-2.928851445341863,7.459487514618536,-18.173335304696227,4.111876789474774e-36,4.378137663547321e-34,71.66802947822643
DNASE1L3,ILMN_2049184,"Homo sapiens deoxyribonuclease I-like 3 (DNASE1L3), mRNA.",nucleus [goid 5634] [evidence IEA],DNA catabolism [goid 6308] [evidence IEA]; apoptosis [goid 6915] [evidence IEA],hydrolase activity [goid 16787] [evidence IEA]; deoxyribonuclease activity [goid 4536] [pmid 9070308] [evidence TAS]; DNA binding [goid 3677] [pmid 9070308] [evidence TAS]; endonuclease activity [goid 4519] [evidence IEA]; calcium ion binding [goid 5509] [pmid 9205125] [evidence TAS],3,58153544-58153570:58154110-58154132,3p14.3a,-,NM_004944.2,1776,DNASE1L3,-3.728502713583943,7.572838998885142,-18.16477330720775,4.28530783910211e-36,4.538001263310034e-34,71.62686642051312
FIGF,ILMN_1707612,"Homo sapiens c-fos induced growth factor (vascular endothelial growth factor D) (FIGF), mRNA.",extracellular space [goid 5615] [pmid 9479493] [evidence TAS]; membrane [goid 16020] [evidence IEA],cell proliferation [goid 8283] [evidence IEA]; angiogenesis [goid 1525] [evidence IEA]; positive regulation of cell proliferation [goid 8284] [pmid 9479493] [evidence TAS]; cell differentiation [goid 30154] [evidence IEA],platelet-derived growth factor receptor binding [goid 5161] [pmid 9479493] [evidence TAS]; growth factor activity [goid 8083] [evidence IEA],X,15273936-15273985,Xp22.2,-,NM_004469.2,2277,FIGF,-2.8582278692774974,6.768866701071587,-18.1364653948965,4.9128194456549436e-36,5.174393886410085e-34,71.49070520153141
GJA12,ILMN_1723048,"Homo sapiens gap junction protein, alpha 12, 47kDa (GJA12), mRNA.",membrane [goid 16020] [evidence IEA]; connexon complex [goid 5922] [evidence IEA]; integral to membrane [goid 16021] [evidence IEA],cell communication [goid 7154] [evidence IEA],connexon channel activity [goid 15285] [evidence IEA],1,226414049-226414098,1q42.13c,+,NM_020435.2,57165,GJA12,-2.3647533613782468,8.278062649722452,-18.119796716027544,5.3247350936350273e-36,5.563841999377901e-34,71.41048080061988
CES1,ILMN_1675386,"Homo sapiens carboxylesterase 1 (monocyte/macrophage serine esterase 1) (CES1), transcript variant 2, mRNA.",endoplasmic reticulum [goid 5783] [evidence IEA]; extracellular space [goid 5615] [evidence NR ],metabolism [goid 8152] [pmid 1918003] [evidence TAS]; response to toxin [goid 9636] [pmid 1918003] [evidence TAS],hydrolase activity [goid 16787] [evidence IEA]; serine esterase activity [goid 4759] [pmid 1918003] [evidence TAS]; carboxylesterase activity [goid 4091] [evidence IEA],16,54417574-54417623,16q12.2c,-,NM_001025194.1,1066,CES1,-3.120796033470861,9.0534935470285,-18.11921624324932,5.3396892680711694e-36,5.563841999377901e-34,71.40768641262002
PRKCH,ILMN_1780898,"Homo sapiens protein kinase C, eta (PRKCH), mRNA.",,protein amino acid phosphorylation [goid 6468] [pmid 1986216] [evidence TAS]; intracellular signaling cascade [goid 7242] [evidence IEA],zinc ion binding [goid 8270] [evidence IEA]; metal ion binding [goid 46872] [evidence IEA]; ATP binding [goid 5524] [evidence IEA]; transferase activity [goid 16740] [evidence IEA]; diacylglycerol binding [goid 19992] [evidence IEA]; nucleotide binding [goid 166] [evidence IEA]; protein kinase C activity [goid 4697] [pmid 1986216] [evidence TAS],14,61087117-61087166,14q23.1c,+,NM_006255.3,5583,PRKCH,-1.4173535894027651,10.050995483717463,-18.109274435024275,5.602466669165309e-36,5.806599098334364e-34,71.35981999348567
AGTR1,ILMN_1814327,"Homo sapiens angiotensin II receptor, type 1 (AGTR1), transcript variant 5, mRNA.",integral to plasma membrane [goid 5887] [pmid 1378723] [evidence TAS]; plasma membrane [goid 5886] [pmid 1378723] [evidence TAS],"signal transduction [goid 7165] [evidence IEA]; G-protein signaling, coupled to IP3 second messenger (phospholipase C activating) [goid 7200] [pmid 1378723] [evidence TAS]; circulation [goid 8015] [pmid 8135787] [evidence NAS]; fluid secretion [goid 7589] [evidence NR ]",receptor activity [goid 4872] [evidence IEA]; C-X-C chemokine receptor activity [goid 16494] [evidence IEA]; bradykinin receptor activity [goid 4947] [evidence IEA]; rhodopsin-like receptor activity [goid 1584] [evidence IEA]; angiotensin type II receptor activity [goid 4945] [pmid 8135787] [evidence TAS],3,149942964-149943013,3q24f,+,NM_032049.1,185,AGTR1,-1.976726038766782,6.382033098569391,-18.056802120686722,7.220786599722657e-36,7.444287137333121e-34,71.1069742671489
FLJ21986,ILMN_1677038,"Homo sapiens hypothetical protein FLJ21986 (FLJ21986), mRNA.",endoplasmic reticulum [goid 5783] [pmid 11256614] [evidence IDA],,,7,120724622-120724671,7q31.31d,+,NM_024913.3,79974,FLJ21986,-2.1692695296472246,8.704511595157378,-18.0124508060475,8.950584881115164e-36,9.179060337290999e-34,70.8929863249603
CLDN5,ILMN_1728197,"Homo sapiens claudin 5 (transmembrane protein deleted in velocardiofacial syndrome) (CLDN5), mRNA.",membrane [goid 16020] [evidence IEA]; integral to membrane [goid 16021] [evidence ISS]; tight junction [goid 5923] [evidence ISS],calcium-independent cell-cell adhesion [goid 16338] [evidence ISS],structural molecule activity [goid 5198] [evidence IEA],22,17890627-17890676,22q11.21c,-,NM_003277.2,7122,CLDN5,-2.6168451524935126,10.960894262162785,-17.97611580190326,1.067434282606876e-35,1.088950628093978e-33,70.71748850294844
ADRB2,ILMN_1695590,"Homo sapiens adrenergic, beta-2-, receptor, surface (ADRB2), mRNA.",lysosome [goid 5764] [pmid 9507004] [evidence TAS]; endosome [goid 5768] [pmid 10734107] [evidence TAS]; integral to plasma membrane [goid 5887] [pmid 9228019] [evidence TAS]; plasma membrane [goid 5886] [pmid 10734107] [evidence TAS],"G-protein coupled receptor protein signaling pathway [goid 7186] [pmid 9924018] [evidence TAS]; adenylate cyclase activation [goid 7190] [pmid 8386307] [evidence TAS]; G-protein signaling, coupled to cAMP nucleotide second messenger [goid 7188] [pmid 2823249] [evidence TAS]; protein kinase cascade [goid 7243] [pmid 10734107] [evidence TAS]; receptor mediated endocytosis [goid 6898] [pmid 10734107] [evidence TAS]; transmembrane receptor protein tyrosine kinase activation (dimerization) [goid 7171] [pmid 10734107] [evidence TAS]; endosome to lysosome transport [goid 8333] [pmid 9507004] [evidence TAS]",beta2-adrenergic receptor activity [goid 4941] [pmid 10734107] [evidence TAS]; rhodopsin-like receptor activity [goid 1584] [evidence IEA]; protein binding [goid 5515] [pmid 9560162] [evidence IPI]; receptor activity [goid 4872] [evidence IEA],5,148188246-148188295,5q33.1b,+,NM_000024.3,154,ADRB2,-2.368687755027498,9.205507873022292,-17.96485927344228,1.1273330485759476e-35,1.1440668985157469e-33,70.66308533794299
CDC20,ILMN_1663390,"Homo sapiens CDC20 cell division cycle 20 homolog (S. cerevisiae) (CDC20), mRNA.",spindle [goid 5819] [pmid 7513050] [evidence TAS],cell division [goid 51301] [evidence IEA]; mitosis [goid 7067] [evidence IEA]; ubiquitin-dependent protein catabolism [goid 6511] [pmid 9682218] [evidence TAS]; ubiquitin cycle [goid 6512] [evidence IEA],protein binding [goid 5515] [pmid 14743218] [evidence IPI],1,43601352-43601387:43601388-43601401,1p34.2a,+,NM_001255.1,991,CDC20,2.8224372283242056,8.56605130049412,17.943730193082885,1.249044562070542e-35,1.2572595222485277e-33,70.56092412819656
HOXA5,ILMN_1753613,"Homo sapiens homeobox A5 (HOXA5), mRNA.",nucleus [goid 5634] [evidence NAS],"regulation of transcription, DNA-dependent [goid 6355] [evidence NAS]; development [goid 7275] [evidence NAS]",sequence-specific DNA binding [goid 43565] [evidence IEA]; transcription factor activity [goid 3700] [evidence NAS],7,27147859-27147908,7p15.2a,-,NM_019102.2,3202,HOXA5,-2.3717181427263707,10.37359533757836,-17.943280306428477,1.2517749413200637e-35,1.2572595222485277e-33,70.55874826172025
TSRC1,ILMN_1687035,"Homo sapiens thrombospondin repeat containing 1 (TSRC1), transcript variant 2, mRNA.",extracellular matrix [goid 31012] [evidence IEA]; extracellular matrix [goid 31012] [evidence IEA],,metalloendopeptidase activity [goid 4222] [evidence IEA]; peptidase activity [goid 8233] [evidence IEA]; metalloendopeptidase activity [goid 4222] [evidence IEA]; peptidase activity [goid 8233] [evidence IEA],1,148797683-148797732,1q21.2b-q21.2c,+,NM_025008.2,54507,TSRC1,-1.4470334307100154,6.4821746689700745,-17.927241239870472,1.3531389821980858e-35,1.3520981060579334e-33,70.48115880673423
ERO1L,ILMN_1744963,"Homo sapiens ERO1-like (S. cerevisiae) (ERO1L), mRNA.",membrane [goid 16020] [evidence IEA]; endoplasmic reticulum [goid 5783] [pmid 10671517] [evidence IDA],transport [goid 6810] [evidence IEA]; electron transport [goid 6118] [evidence IEA],oxidoreductase activity [goid 16491] [pmid 11707400] [evidence IDA],14,52178370-52178419,14q22.1d,-,NM_014584.1,30001,ERO1L,1.947268658539227,8.869653464391444,17.916556624416174,1.425204760140345e-35,1.4168425893538073e-33,70.42945344622109
UBE2T,ILMN_1711470,"Homo sapiens ubiquitin-conjugating enzyme E2T (putative) (UBE2T), mRNA.",,ubiquitin cycle [goid 6512] [evidence IEA],ubiquitin-protein ligase activity [goid 4842] [evidence IEA]; ligase activity [goid 16874] [evidence IEA],1,200568771-200568820,1q32.1d,-,NM_014176.1,29089,UBE2T,2.171286138945778,7.211642866105598,17.906681284789798,1.4952397971175827e-35,1.4789211901947258e-33,70.38165140771564
ANGPT1,ILMN_1677723,"Homo sapiens angiopoietin 1 (ANGPT1), mRNA.",,angiogenesis [goid 1525] [evidence IEA]; cell differentiation [goid 30154] [evidence IEA]; signal transduction [goid 7165] [pmid 10766762] [evidence TAS]; angiogenesis [goid 1525] [evidence IEA]; cell differentiation [goid 30154] [evidence IEA]; signal transduction [goid 7165] [pmid 10766762] [evidence TAS],receptor binding [goid 5102] [pmid 10766762] [evidence TAS]; receptor binding [goid 5102] [pmid 10766762] [evidence TAS],8,108331309-108331358,8q23.1b-q23.1c,-,NM_001146.3,284,ANGPT1,-2.6111252258877693,7.891178046046997,-17.89344578074863,1.5945627253927467e-35,1.5691946820342257e-33,70.31756482584294
CDCA8,ILMN_1709294,"Homo sapiens cell division cycle associated 8 (CDCA8), mRNA.","chromosome [goid 5694] [evidence IEA]; protein complex [goid 43234] [pmid 16239925] [evidence IDA]; nucleus [goid 5634] [evidence IEA]; chromosome, pericentric region [goid 775] [evidence IEA]",mitosis [goid 7067] [evidence IEA]; cell cycle [goid 7049] [evidence IEA]; cell division [goid 51301] [evidence IEA],protein binding [goid 5515] [pmid 16291752] [evidence IPI],1,37947578-37947627,1p34.3b,+,NM_018101.2,55143,CDCA8,1.9605325901553563,6.608200594953985,17.872067058829828,1.7692010818477112e-35,1.7323056824021436e-33,70.21400142181822
PILRA,ILMN_1729915,"Homo sapiens paired immunoglobin-like type 2 receptor alpha (PILRA), transcript variant 2, mRNA.",integral to plasma membrane [goid 5887] [evidence ISS]; membrane [goid 16020] [evidence IEA]; integral to plasma membrane [goid 5887] [evidence ISS]; membrane [goid 16020] [evidence IEA],transmembrane receptor protein tyrosine kinase activation (dimerization) [goid 7171] [evidence ISS]; signal transduction [goid 7165] [pmid 10903717] [evidence IDA]; transmembrane receptor protein tyrosine kinase activation (dimerization) [goid 7171] [evidence ISS]; signal transduction [goid 7165] [pmid 10903717] [evidence IDA],receptor activity [goid 4872] [evidence IEA]; protein binding [goid 5515] [evidence ISS]; receptor activity [goid 4872] [evidence IEA]; protein binding [goid 5515] [evidence ISS],7,99835352-99835401,7q22.1c,+,NM_178272.1,29992,PILRA,-1.6041980960258915,7.708250377364477,-17.815300516660198,2.3320958886489505e-35,2.27204441951624e-33,69.93872856491835
CGNL1,ILMN_1730229,"Homo sapiens cingulin-like 1 (CGNL1), mRNA.",myosin [goid 16459] [evidence IEA],,motor activity [goid 3774] [evidence IEA],15,55630050-55630099,15q21.3d,+,NM_032866.3,84952,CGNL1,-1.8900306241594986,11.059611876059524,-17.793453046252267,2.5939726775499403e-35,2.5146048568189345e-33,69.83267617347431
SEPP1,ILMN_1785071,"Homo sapiens selenoprotein P, plasma, 1 (SEPP1), transcript variant 1, mRNA.",extracellular region [goid 5576] [pmid 14718574] [evidence NAS]; extracellular region [goid 5576] [pmid 14718574] [evidence NAS],response to oxidative stress [goid 6979] [pmid 2037562] [evidence TAS]; response to oxidative stress [goid 6979] [pmid 2037562] [evidence TAS],selenium binding [goid 8430] [pmid 8421687] [evidence TAS]; selenium binding [goid 8430] [pmid 8421687] [evidence TAS],5,42836624-42836673,5p12c,-,NM_005410.2,6414,SEPP1,-1.6986326543181702,7.8946353936244575,-17.792149779120255,2.6104977578039856e-35,2.518096475782706e-33,69.82634790872048
ADARB1,ILMN_1657442,"Homo sapiens adenosine deaminase, RNA-specific, B1 (RED1 homolog rat) (ADARB1), transcript variant 4, mRNA.",intracellular [goid 5622] [evidence IEA]; intracellular [goid 5622] [evidence IEA],mRNA processing [goid 6397] [evidence IEA]; mRNA processing [goid 6397] [evidence IEA],zinc ion binding [goid 8270] [evidence IEA]; metal ion binding [goid 46872] [evidence IEA]; adenosine deaminase activity [goid 4000] [evidence IEA]; hydrolase activity [goid 16787] [evidence IEA]; double-stranded RNA binding [goid 3725] [evidence IEA]; zinc ion binding [goid 8270] [evidence IEA]; metal ion binding [goid 46872] [evidence IEA]; adenosine deaminase activity [goid 4000] [evidence IEA]; hydrolase activity [goid 16787] [evidence IEA]; double-stranded RNA binding [goid 3725] [evidence IEA],21,45379071-45379120,21q22.3e,+,NM_001033049.1,104,ADARB1,-1.3931972666230426,7.3819463004296075,-17.782275005972302,2.739195222284462e-35,2.6292226062173768e-33,69.77839201583285
ASPM,ILMN_1815184,"Homo sapiens asp (abnormal spindle)-like, microcephaly associated (Drosophila) (ASPM), mRNA.",nucleus [goid 5634] [evidence IEA],cell division [goid 51301] [evidence IEA]; mitosis [goid 7067] [evidence IEA]; cell cycle [goid 7049] [evidence IEA],binding [goid 5488] [evidence IEA]; calmodulin binding [goid 5516] [evidence IEA],1,195320084-195320133,1q31.3c,-,NM_018136.2,259266,ASPM,2.457857313345734,6.590530323718268,17.734084160940437,3.4649262809349067e-35,3.3095141462753265e-33,69.54417965689831
C1orf186,ILMN_1690209,"Homo sapiens chromosome 1 open reading frame 186 (C1orf186), mRNA.",,,,1,204405726-204405775,1q32.1h,-,NM_001007544.1,440712,C1orf186,-2.3563544795861366,6.953386796576808,-17.723157789530777,3.654722031309184e-35,3.4708200402041654e-33,69.49103529051025
GPR146,ILMN_1684227,"Homo sapiens G protein-coupled receptor 146 (GPR146), mRNA.",membrane [goid 16020] [evidence IEA]; integral to membrane [goid 16021] [evidence IEA],G-protein coupled receptor protein signaling pathway [goid 7186] [evidence IEA]; signal transduction [goid 7165] [evidence IEA],receptor activity [goid 4872] [evidence IEA]; rhodopsin-like receptor activity [goid 1584] [evidence IEA],7,1065282-1065331,7p22.3b,+,NM_138445.2,115330,GPR146,-1.5901769019580545,6.453637437712113,-17.722334884419496,3.669432529032887e-35,3.4708200402041654e-33,69.4870321783296
PROM2,ILMN_1761946,"Homo sapiens prominin 2 (PROM2), mRNA.",integral to membrane [goid 16021] [evidence IEA],,,2,95320692-95320741,2q11.1c,+,NM_144707.1,150696,PROM2,2.810002882628705,9.264767849907367,17.7099184215138,3.898757728082414e-35,3.669917600564533e-33,69.42662047762852
TGFBR2,ILMN_1726245,"Homo sapiens transforming growth factor, beta receptor II (70/80kDa) (TGFBR2), transcript variant 1, mRNA.",membrane [goid 16020] [evidence IEA]; integral to membrane [goid 16021] [evidence TAS]; membrane [goid 16020] [evidence IEA]; integral to membrane [goid 16021] [evidence TAS]; membrane [goid 16020] [evidence IEA]; integral to membrane [goid 16021] [evidence TAS],positive regulation of cell proliferation [goid 8284] [pmid 7761852] [evidence TAS]; protein amino acid dephosphorylation [goid 6470] [evidence NAS]; protein amino acid phosphorylation [goid 6468] [evidence IEA]; transmembrane receptor protein serine/threonine kinase signaling pathway [goid 7178] [evidence IEA]; positive regulation of cell proliferation [goid 8284] [pmid 7761852] [evidence TAS]; protein amino acid dephosphorylation [goid 6470] [evidence NAS]; protein amino acid phosphorylation [goid 6468] [evidence IEA]; transmembrane receptor protein serine/threonine kinase signaling pathway [goid 7178] [evidence IEA]; positive regulation of cell proliferation [goid 8284] [pmid 7761852] [evidence TAS]; protein amino acid dephosphorylation [goid 6470] [evidence NAS]; protein amino acid phosphorylation [goid 6468] [evidence IEA]; transmembrane receptor protein serine/threonine kinase signaling pathway [goid 7178] [evidence IEA],"protein binding [goid 5515] [pmid 8242742] [evidence IPI]; magnesium ion binding [goid 287] [evidence IEA]; receptor activity [goid 4872] [evidence IEA]; ATP binding [goid 5524] [evidence NAS]; nucleotide binding [goid 166] [evidence IEA]; manganese ion binding [goid 30145] [evidence IEA]; transforming growth factor beta receptor activity, type II [goid 5026] [pmid 7761852] [evidence TAS]; transferase activity [goid 16740] [evidence IEA]; protein binding [goid 5515] [pmid 8242742] [evidence IPI]; magnesium ion binding [goid 287] [evidence IEA]; receptor activity [goid 4872] [evidence IEA]; ATP binding [goid 5524] [evidence NAS]; nucleotide binding [goid 166] [evidence IEA]; manganese ion binding [goid 30145] [evidence IEA]; transforming growth factor beta receptor activity, type II [goid 5026] [pmid 7761852] [evidence TAS]; transferase activity [goid 16740] [evidence IEA]; protein binding [goid 5515] [pmid 8242742] [evidence IPI]; magnesium ion binding [goid 287] [evidence IEA]; receptor activity [goid 4872] [evidence IEA]; ATP binding [goid 5524] [evidence NAS]; nucleotide binding [goid 166] [evidence IEA]; manganese ion binding [goid 30145] [evidence IEA]; transforming growth factor beta receptor activity, type II [goid 5026] [pmid 7761852] [evidence TAS]; transferase activity [goid 16740] [evidence IEA]",3,30710136-30710185,3p24.1a,+,NM_001024847.1,7048,TGFBR2,-1.197972178421674,9.840634948240568,-17.705595212509365,3.9819424196947474e-35,3.7301994253727e-33,69.40558151080226
ID2,ILMN_1793990,"Homo sapiens inhibitor of DNA binding 2, dominant negative helix-loop-helix protein (ID2), mRNA.",nucleus [goid 5634] [pmid 14627819] [evidence IC ]; nucleus [goid 5634] [pmid 14627819] [evidence IC ],negative regulation of transcription factor activity [goid 43433] [pmid 14627819] [evidence IDA]; development [goid 7275] [pmid 1741406] [evidence TAS]; negative regulation of transcription [goid 16481] [pmid 14627819] [evidence IDA]; negative regulation of transcription factor activity [goid 43433] [pmid 14627819] [evidence IDA]; development [goid 7275] [pmid 1741406] [evidence TAS]; negative regulation of transcription [goid 16481] [pmid 14627819] [evidence IDA],transcriptional repressor activity [goid 16564] [pmid 14627819] [evidence IDA]; protein binding [goid 5515] [pmid 15249128] [evidence IPI]; transcriptional repressor activity [goid 16564] [pmid 14627819] [evidence IDA]; protein binding [goid 5515] [pmid 15249128] [evidence IPI],2,8739817-8739866,2p25.1e,+,NM_002166.4,3398,ID2,-2.2009359005737306,9.982310157465253,-17.700566633839614,4.080946924070284e-35,3.80465314906744e-33,69.38110686088828
CALCRL,ILMN_1758281,"Homo sapiens calcitonin receptor-like (CALCRL), mRNA.",membrane [goid 16020] [evidence IEA]; integral to plasma membrane [goid 5887] [pmid 7818539] [evidence TAS],"signal transduction [goid 7165] [evidence IEA]; G-protein signaling, coupled to cyclic nucleotide second messenger [goid 7187] [pmid 7818539] [evidence TAS]",calcitonin receptor activity [goid 4948] [evidence IEA]; receptor activity [goid 4872] [evidence IEA]; G-protein coupled receptor activity [goid 4930] [pmid 7818539] [evidence TAS],2,187918362-187918411,2q32.1e,-,NM_005795.2,10203,CALCRL,-3.131593795408013,7.861495040371144,-17.69167860398109,4.2620296409546305e-35,3.9545546454286184e-33,69.33783997009182
VGLL3,ILMN_1714586,"Homo sapiens vestigial like 3 (Drosophila) (VGLL3), mRNA.",nucleus [goid 5634] [evidence IEA],regulation of transcription [goid 45449] [evidence IEA],transcription regulator activity [goid 30528] [evidence IEA],3,87070266-87070315,3p12.1a,-,NM_016206.2,389136,VGLL3,-2.3618170588312344,6.594820084344948,-17.65265827665497,5.157595064205781e-35,4.76283127137676e-33,69.14777037122366
SEMA6A,ILMN_1713529,"Homo sapiens sema domain, transmembrane domain (TM), and cytoplasmic domain, (semaphorin) 6A (SEMA6A), mRNA.",integral to membrane [goid 16021] [pmid 10993894] [evidence NAS]; axon [goid 30424] [pmid 10993894] [evidence NAS]; membrane [goid 16020] [evidence IEA],cytoskeleton organization and biogenesis [goid 7010] [pmid 10993894] [evidence NAS]; axon guidance [goid 7411] [pmid 10993894] [evidence NAS]; development [goid 7275] [evidence IEA]; cell surface receptor linked signal transduction [goid 7166] [pmid 10993894] [evidence NAS]; apoptosis [goid 6915] [pmid 10993894] [evidence NAS]; cell differentiation [goid 30154] [evidence IEA],protein binding [goid 5515] [pmid 10993894] [evidence IPI]; receptor activity [goid 4872] [evidence IEA],5,115807371-115807420,5q23.1a,-,NM_020796.2,57556,SEMA6A,-2.802490566678828,8.794679728537007,-17.633631058138082,5.660667077505021e-35,5.2027404719427044e-33,69.05501784771235
MSRB3,ILMN_1676088,"Homo sapiens methionine sulfoxide reductase B3 (MSRB3), transcript variant 1, mRNA.",mitochondrion [goid 5739] [pmid 14699060] [evidence IDA]; endoplasmic reticulum [goid 5783] [pmid 14699060] [evidence IDA]; mitochondrion [goid 5739] [pmid 14699060] [evidence IDA]; endoplasmic reticulum [goid 5783] [pmid 14699060] [evidence IDA],protein repair [goid 30091] [pmid 14699060] [evidence IDA]; protein repair [goid 30091] [pmid 14699060] [evidence IDA],zinc ion binding [goid 8270] [pmid 14699060] [evidence IDA]; protein-methionine-R-oxide reductase activity [goid 318] [pmid 14699060] [evidence IDA]; zinc ion binding [goid 8270] [pmid 14699060] [evidence IDA]; protein-methionine-R-oxide reductase activity [goid 318] [pmid 14699060] [evidence IDA],12,64146501-64146550,12q14.3a,+,NM_198080.2,253827,MSRB3,-2.134293074283198,6.96865579139742,-17.624059799448915,5.932090095827803e-35,5.426609179211491e-33,69.00834317794646
SEMA4B,ILMN_1672589,"Homo sapiens sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4B (SEMA4B), transcript variant 1, mRNA.",membrane [goid 16020] [evidence IEA]; integral to membrane [goid 16021] [evidence IEA]; membrane [goid 16020] [evidence IEA]; integral to membrane [goid 16021] [evidence IEA],cell differentiation [goid 30154] [evidence IEA]; development [goid 7275] [evidence IEA]; cell differentiation [goid 30154] [evidence IEA]; development [goid 7275] [evidence IEA],receptor activity [goid 4872] [evidence IEA]; receptor activity [goid 4872] [evidence IEA],15,88573628-88573677,15q26.1b,+,NM_020210.2,10509,SEMA4B,1.0563066000900507,7.681176476325411,17.612793689117595,6.268390483606572e-35,5.707457409956731e-33,68.95338858428975
C14orf139,ILMN_1684357,"Homo sapiens chromosome 14 open reading frame 139 (C14orf139), mRNA.",,,,14,94943542-94943591,14q32.13b,-,NM_024633.2,79686,C14orf139,-1.7601033548056515,6.492568688969902,-17.58437079432161,7.204522477581742e-35,6.529307929101406e-33,68.81467387212847
C10orf67,ILMN_1719577,"Homo sapiens chromosome 10 open reading frame 67 (C10orf67), mRNA.",,,,10,23645589-23645638,10p12.2a,-,NM_153714.1,256815,C10orf67,-2.561038294912012,6.370646884798668,-17.557416753277113,8.22188019211623e-35,7.416821089971516e-33,68.6830330413142
RRAS,ILMN_1780825,"Homo sapiens related RAS viral (r-ras) oncogene homolog (RRAS), mRNA.",intracellular [goid 5622] [evidence IEA],Ras protein signal transduction [goid 7265] [pmid 3098437] [evidence TAS],nucleotide binding [goid 166] [evidence IEA]; GTPase activity [goid 3924] [pmid 3098437] [evidence TAS]; GTP binding [goid 5525] [evidence IEA],19,54830468-54830517,19q13.33b,-,NM_006270.2,6237,RRAS,-1.7135624072394293,11.74782207696255,-17.54880015317743,8.57665816273735e-35,7.701206649812778e-33,68.64093099549781
C1orf21,ILMN_1797735,"Homo sapiens chromosome 1 open reading frame 21 (C1orf21), mRNA.",,,,1,182864519-182864568,1q25.3f,+,NM_030806.3,81563,C1orf21,-2.171198056421807,7.864410472227289,-17.541561833152937,8.886555819495974e-35,7.942868813893535e-33,68.60555616481234
VIM,ILMN_1782538,"Homo sapiens vimentin (VIM), mRNA.",cytoskeleton [goid 5856] [pmid 16130169] [evidence TAS]; intermediate filament [goid 5882] [pmid 11889032] [evidence IDA]; cytoplasm [goid 5737] [pmid 9150946] [evidence IDA]; cytoskeleton [goid 5856] [pmid 16130169] [evidence TAS]; intermediate filament [goid 5882] [pmid 11889032] [evidence IDA]; cytoplasm [goid 5737] [pmid 9150946] [evidence IDA],cell motility [goid 6928] [pmid 16130169] [evidence TAS]; cell motility [goid 6928] [pmid 16130169] [evidence TAS],structural molecule activity [goid 5198] [evidence IEA]; protein binding [goid 5515] [pmid 11889032] [evidence IDA]; structural constituent of cytoskeleton [goid 5200] [pmid 11889032] [evidence IDA]; structural molecule activity [goid 5198] [evidence IEA]; protein binding [goid 5515] [pmid 11889032] [evidence IDA]; structural constituent of cytoskeleton [goid 5200] [pmid 11889032] [evidence IDA],10,17316823-17316823:17317174-17317222,10p12.33c,+,NM_003380.2,7431,VIM,-1.4764342270081272,13.19643982153935,-17.51911239202645,9.92114891270433e-35,8.827104409317071e-33,68.49579990684458
FBLN5,ILMN_1664176,"Homo sapiens fibulin 5 (FBLN5), mRNA.",extracellular matrix (sensu Metazoa) [goid 5578] [pmid 10428823] [evidence TAS]; membrane [goid 16020] [evidence IEA]; soluble fraction [goid 5625] [pmid 10428823] [evidence TAS]; extracellular matrix (sensu Metazoa) [goid 5578] [pmid 10428823] [evidence TAS]; membrane [goid 16020] [evidence IEA]; soluble fraction [goid 5625] [pmid 10428823] [evidence TAS],blood coagulation [goid 7596] [evidence IEA]; cell adhesion [goid 7155] [evidence IEA]; cell-matrix adhesion [goid 7160] [pmid 10428823] [evidence TAS]; blood coagulation [goid 7596] [evidence IEA]; cell adhesion [goid 7155] [evidence IEA]; cell-matrix adhesion [goid 7160] [pmid 10428823] [evidence TAS],integrin binding [goid 5178] [pmid 10428823] [evidence TAS]; transmembrane receptor activity [goid 4888] [evidence IEA]; calcium ion binding [goid 5509] [evidence IEA]; protein binding [goid 5515] [evidence IEA]; integrin binding [goid 5178] [pmid 10428823] [evidence TAS]; transmembrane receptor activity [goid 4888] [evidence IEA]; calcium ion binding [goid 5509] [evidence IEA]; protein binding [goid 5515] [evidence IEA],14,91406198-91406247,14q32.12a,-,NM_006329.2,10516,FBLN5,-2.128061070126657,9.216059425424513,-17.514273285901247,1.0159568741019181e-34,8.998145314489034e-33,68.47213294724719
PC,ILMN_1671489,"Homo sapiens pyruvate carboxylase (PC), nuclear gene encoding mitochondrial protein, transcript variant A, mRNA.",mitochondrion [goid 5739] [evidence IEA]; mitochondrion [goid 5739] [evidence IEA],metabolism [goid 8152] [evidence IEA]; lipid biosynthesis [goid 8610] [evidence IEA]; gluconeogenesis [goid 6094] [evidence IEA]; metabolism [goid 8152] [evidence IEA]; lipid biosynthesis [goid 8610] [evidence IEA]; gluconeogenesis [goid 6094] [evidence IEA],manganese ion binding [goid 30145] [evidence IEA]; nucleotide binding [goid 166] [evidence IEA]; biotin binding [goid 9374] [pmid 8048912] [evidence TAS]; ATP binding [goid 5524] [pmid 8048912] [evidence TAS]; ligase activity [goid 16874] [evidence IEA]; pyruvate carboxylase activity [goid 4736] [pmid 7918683] [evidence TAS]; manganese ion binding [goid 30145] [evidence IEA]; nucleotide binding [goid 166] [evidence IEA]; biotin binding [goid 9374] [pmid 8048912] [evidence TAS]; ATP binding [goid 5524] [pmid 8048912] [evidence TAS]; ligase activity [goid 16874] [evidence IEA]; pyruvate carboxylase activity [goid 4736] [pmid 7918683] [evidence TAS],11,66372712-66372761,11q13.1e-q13.1f,-,NM_000920.2,5091,PC,1.5748927981045027,6.3712032272557915,17.502133914511067,1.078332816241934e-34,9.507382318766555e-33,68.41274900674196
ITM2A,ILMN_2076600,"Homo sapiens integral membrane protein 2A (ITM2A), mRNA.",membrane [goid 16020] [evidence IEA]; integral to membrane [goid 16021] [evidence IEA]; membrane [goid 16020] [evidence IEA]; integral to membrane [goid 16021] [evidence IEA],,,X,78503309-78503330:78503482-78503509,Xq21.1b,-,NM_004867.3,9452,ITM2A,-1.7537339032382873,8.192394071594398,-17.45968035042854,1.3283556529456825e-34,1.165901346740839e-32,68.20492594405326
FCN1,ILMN_1668063,"Homo sapiens ficolin (collagen/fibrinogen domain containing) 1 (FCN1), mRNA.",cytoplasm [goid 5737] [evidence IEA],phosphate transport [goid 6817] [evidence IEA]; opsonization [goid 8228] [pmid 8576206] [evidence TAS],antigen binding [goid 3823] [pmid 8576206] [evidence TAS]; sugar binding [goid 5529] [pmid 8576206] [evidence TAS]; calcium ion binding [goid 5509] [pmid 8576206] [evidence TAS],9,136941286-136941335,9q34.3a,-,NM_002003.2,2219,FCN1,-2.810473903066109,9.55331888795648,-17.457860973007758,1.3402864889675941e-34,1.1710978581853619e-32,68.1960144421702
RASIP1,ILMN_1755657,"Homo sapiens Ras interacting protein 1 (RASIP1), mRNA.",myosin [goid 16459] [evidence IEA],signal transduction [goid 7165] [evidence IEA],motor activity [goid 3774] [evidence IEA],19,53915773-53915822,19q13.33a,-,NM_017805.2,54922,RASIP1,-2.2961444082947686,9.517697736421916,-17.446863794035014,1.4147307916404868e-34,1.2306263158533431e-32,68.14214018652036
ID3,ILMN_1732296,"Homo sapiens inhibitor of DNA binding 3, dominant negative helix-loop-helix protein (ID3), mRNA.",nucleus [goid 5634] [pmid 14627819] [evidence IC ],negative regulation of transcription factor activity [goid 43433] [pmid 14627819] [evidence IDA]; development [goid 7275] [pmid 1628620] [evidence TAS]; negative regulation of transcription [goid 16481] [pmid 14627819] [evidence IDA],transcription corepressor activity [goid 3714] [pmid 8437843] [evidence TAS],1,23757369-23757418,1p36.12a,-,NM_002167.2,3399,ID3,-2.3947003480735756,11.136759953550795,-17.43877998729592,1.4720916987154142e-34,1.2741995018450496e-32,68.10252853980035
FEZ1,ILMN_1727992,"Homo sapiens fasciculation and elongation protein zeta 1 (zygin I) (FEZ1), transcript variant 2, mRNA.",,axon guidance [goid 7411] [pmid 9096408] [evidence TAS]; cell adhesion [goid 7155] [pmid 9096408] [evidence TAS]; axon guidance [goid 7411] [pmid 9096408] [evidence TAS]; cell adhesion [goid 7155] [pmid 9096408] [evidence TAS],protein binding [goid 5515] [pmid 16169070] [evidence IPI]; protein binding [goid 5515] [pmid 16169070] [evidence IPI],11,124864600-124864649,11q24.2b,-,NM_022549.2,9638,FEZ1,-1.2800072055905805,6.995177269984564,-17.437978960774043,1.4779013980856103e-34,1.2741995018450496e-32,68.09860296126368
LOC641700,ILMN_1705630,"PREDICTED: Homo sapiens hypothetical protein LOC641700 (LOC641700), mRNA.",,,,5,138822451-138822483:138824748-138824764,5q31.2d,-,XM_930608.1,641700,LOC641700,-2.6290939626505025,6.395765658568911,-17.430898144901285,1.5302701154569435e-34,1.313538026417557e-32,68.06389858495824
LPXN,ILMN_1742789,"Homo sapiens leupaxin (LPXN), mRNA.",cytoplasm [goid 5737] [evidence NR ],cell adhesion [goid 7155] [pmid 9565592] [evidence NAS]; signal transduction [goid 7165] [pmid 9565592] [evidence TAS]; protein complex assembly [goid 6461] [pmid 9565592] [evidence TAS],zinc ion binding [goid 8270] [evidence IEA]; metal ion binding [goid 46872] [evidence IEA],11,58051048-58051097,11q12.1c,-,NM_004811.1,9404,LPXN,-1.446355484757163,10.544361982134129,-17.425917410235446,1.5682207045463576e-34,1.340209667898499e-32,68.03948329290591
CBLC,ILMN_1811729,"Homo sapiens Cas-Br-M (murine) ecotropic retroviral transforming sequence c (CBLC), mRNA.",,,,19,49989338-49989378:49995478-49995486,19q13.31b,+,NM_012116.2,23624,CBLC,2.1484416057940194,6.51456600013638,17.382040223539516,1.946207861854754e-34,1.6495007822963254e-32,67.8242642034447
LPL,ILMN_1786444,"Homo sapiens lipoprotein lipase (LPL), mRNA.",chylomicron [goid 42627] [evidence IEA]; membrane [goid 16020] [evidence IEA]; extracellular region [goid 5576] [pmid 1969408] [evidence TAS],fatty acid metabolism [goid 6631] [evidence NR ]; lipid catabolism [goid 16042] [evidence IEA]; circulation [goid 8015] [pmid 1969408] [evidence TAS],lipoprotein lipase activity [goid 4465] [pmid 1969408] [evidence TAS]; hydrolase activity [goid 16787] [evidence IEA]; lipid transporter activity [goid 5319] [evidence IEA]; heparin binding [goid 8201] [pmid 1969408] [evidence TAS],8,19868711-19868760,8p21.3c,+,NM_000237.1,4023,LPL,-2.7518690053620807,9.022790153523905,-17.381951038202576,1.9470627658617134e-34,1.6495007822963254e-32,67.8238264986055
CDCA5,ILMN_1683450,"Homo sapiens cell division cycle associated 5 (CDCA5), mRNA.",nucleus [goid 5634] [evidence ISS]; cohesin complex [goid 8278] [pmid 15837422] [evidence IDA]; cytoplasm [goid 5737] [evidence ISS],mitotic metaphase plate congression [goid 7080] [pmid 15837422] [evidence IMP]; G1/S transition of mitotic cell cycle [goid 82] [pmid 15837422] [evidence IDA]; mitosis [goid 7067] [pmid 15837422] [evidence IDA]; mitotic chromosome condensation [goid 7076] [pmid 15837422] [evidence IMP]; cell cycle [goid 7049] [evidence IEA]; cell division [goid 51301] [evidence IEA],chromatin binding [goid 3682] [pmid 15837422] [evidence TAS]; protein binding [goid 5515] [evidence ISS],11,64601683-64601732,11q13.1c,-,NM_080668.2,113130,CDCA5,2.365123720104987,7.970649647461787,17.36597577489089,2.1064499939019835e-34,1.7768042481030367e-32,67.74540670840796
CAT,ILMN_1651705,"Homo sapiens catalase (CAT), mRNA.",peroxisome [goid 5777] [evidence IEA],response to oxidative stress [goid 6979] [evidence IEA]; hydrogen peroxide catabolism [goid 42744] [evidence IEA]; electron transport [goid 6118] [evidence IEA],metal ion binding [goid 46872] [evidence IEA]; oxidoreductase activity [goid 16491] [evidence IEA]; iron ion binding [goid 5506] [evidence IEA]; catalase activity [goid 4096] [pmid 2268310] [evidence TAS],11,34449164-34449164:34449491-34449539,11p13c,+,NM_001752.2,847,CAT,-1.804345790719438,9.917249498369506,-17.35328668611632,2.2423483613814003e-34,1.8832826647205423e-32,67.68309521419852
SH2D3C,ILMN_1674440,"Homo sapiens SH2 domain containing 3C (SH2D3C), transcript variant 1, mRNA.",intracellular [goid 5622] [evidence IEA]; intracellular [goid 5622] [evidence IEA],small GTPase mediated signal transduction [goid 7264] [evidence IEA]; intracellular signaling cascade [goid 7242] [evidence IEA]; small GTPase mediated signal transduction [goid 7264] [evidence IEA]; intracellular signaling cascade [goid 7242] [evidence IEA],guanyl-nucleotide exchange factor activity [goid 5085] [evidence IEA]; guanyl-nucleotide exchange factor activity [goid 5085] [evidence IEA],9,129573299-129573329:129573330-129573348,9q34.11a,-,NM_005489.1,10044,SH2D3C,-1.472862962378147,7.029805332473251,-17.343314361281475,2.3553088132948052e-34,1.969664902448467e-32,67.63411049535253
MGC10993,ILMN_1756402,"Homo sapiens transmembrane protein 177 (TMEM177), mRNA.",,,,2,120155837-120155886,2q14.2c,+,NM_030577.1,80775,MGC10993,1.1480076406257496,8.128225441161801,17.340549481868617,2.3876285523504698e-34,1.9881599291687568e-32,67.62052700267091
TIMP3,ILMN_1701461,"Homo sapiens TIMP metallopeptidase inhibitor 3 (Sorsby fundus dystrophy, pseudoinflammatory) (TIMP3), mRNA.",extracellular matrix (sensu Metazoa) [goid 5578] [pmid 7925969] [evidence NAS],visual perception [goid 7601] [evidence IEA]; transmembrane receptor protein tyrosine kinase signaling pathway [goid 7169] [pmid 15609325] [evidence NAS]; induction of apoptosis by extracellular signals [goid 8624] [pmid 7925969] [evidence NAS],metalloendopeptidase inhibitor activity [goid 8191] [evidence IEA]; enzyme inhibitor activity [goid 4857] [evidence IEA],22,31588368-31588417,22q12.3a,+,NM_000362.4,7078,TIMP3,-2.511584420854149,11.085588330436362,-17.337511201529235,2.423658525215449e-34,2.0095738878222562e-32,67.60559921439221
CD300LG,ILMN_2174804,"Homo sapiens CD300 molecule-like family member g (CD300LG), mRNA.",,,,17,39295859-39295908,17q21.31b,+,NM_145273.2,146894,CD300LG,-1.7034117119709506,6.66787719247886,-17.306306248288085,2.826879171072571e-34,2.3339720613707223e-32,67.45221451780556
C2orf29,ILMN_1708906,"Homo sapiens chromosome 2 open reading frame 29 (C2orf29), mRNA.",,cell proliferation [goid 8283] [pmid 10497265] [evidence NAS],,2,101253114-101253163,2q11.2e,+,NM_017546.3,55571,C2orf29,1.1783913302300366,11.545667860118085,17.26229961960015,3.512787544522271e-34,2.888044949578753e-32,67.2356958975115
SOSTDC1,ILMN_1715463,"Homo sapiens sclerostin domain containing 1 (SOSTDC1), mRNA.",,Wnt receptor signaling pathway [goid 16055] [evidence IEA],,7,16468320-16468369,7p21.1c,-,NM_015464.1,25928,SOSTDC1,-3.6959689926688384,7.474143282979221,-17.24161364332851,3.890776330222491e-34,3.1853687728733294e-32,67.13383379027088
RAI2,ILMN_1760574,"Homo sapiens retinoic acid induced 2 (RAI2), mRNA.",,embryonic development [goid 9790] [pmid 10049581] [evidence NAS],,X,17728570-17728619,Xp22.13d,-,NM_021785.2,10742,RAI2,-1.4566204444128736,6.84116662534038,-17.183365814802567,5.189659196841157e-34,4.2309836590146423e-32,66.84671996474441
RECQL4,ILMN_1703092,"Homo sapiens RecQ protein-like 4 (RECQL4), mRNA.",nucleus [goid 5634] [evidence IEA],development [goid 7275] [pmid 10319867] [evidence TAS]; DNA repair [goid 6281] [pmid 9878247] [evidence TAS],DNA helicase activity [goid 3678] [pmid 9878247] [evidence TAS]; nucleotide binding [goid 166] [evidence IEA]; nucleic acid binding [goid 3676] [evidence IEA]; hydrolase activity [goid 16787] [evidence IEA]; ATP binding [goid 5524] [evidence IEA]; ATP-dependent helicase activity [goid 8026] [evidence IEA],8,145707910-145707959,8q24.3h,-,NM_004260.1,9401,RECQL4,1.8452189284516392,5.970700317721074,17.17456829374243,5.4206303681355995e-34,4.4008742801300897e-32,66.80331835479171
LMO2,ILMN_1800078,"Homo sapiens LIM domain only 2 (rhombotin-like 1) (LMO2), mRNA.",nucleus [goid 5634] [evidence IEA],development [goid 7275] [pmid 1923511] [evidence TAS],metal ion binding [goid 46872] [evidence IEA]; zinc ion binding [goid 8270] [evidence IEA]; protein binding [goid 5515] [evidence ISS],11,33836929-33836978,11p13c,-,NM_005574.2,4005,LMO2,-2.2510461054118878,8.928125369700766,-17.153378230393653,6.020279589034704e-34,4.867433518354407e-32,66.69873958021745
UHRF1,ILMN_1786065,"Homo sapiens ubiquitin-like, containing PHD and RING finger domains, 1 (UHRF1), mRNA.",nucleus [goid 5634] [evidence IEA]; ubiquitin ligase complex [goid 151] [evidence IEA]; nucleus [goid 5634] [evidence IEA],"ubiquitin cycle [goid 6512] [evidence IEA]; transcription [goid 6350] [evidence IEA]; regulation of transcription, DNA-dependent [goid 6355] [evidence IEA]; DNA repair [goid 6281] [evidence IEA]; cell cycle [goid 7049] [evidence IEA]; regulation of transcription, DNA-dependent [goid 6355] [evidence IEA]; cell cycle [goid 7049] [evidence IEA]; protein ubiquitination [goid 16567] [evidence IEA]; transcription [goid 6350] [evidence IEA]; DNA repair [goid 6281] [evidence IEA]",ligase activity [goid 16874] [evidence IEA]; DNA binding [goid 3677] [evidence IEA]; zinc ion binding [goid 8270] [evidence IEA]; metal ion binding [goid 46872] [evidence IEA]; protein binding [goid 5515] [evidence IEA]; metal ion binding [goid 46872] [evidence IEA]; protein binding [goid 5515] [evidence IEA]; DNA binding [goid 3677] [evidence IEA]; ubiquitin-protein ligase activity [goid 4842] [evidence IEA]; zinc ion binding [goid 8270] [evidence IEA]; ligase activity [goid 16874] [evidence IEA],19,4912679-4912728,19p13.3c,+,NM_013282.2,29128,UHRF1,1.4095412420036535,6.223914493051561,17.134209672908298,6.6199911939598074e-34,5.330187124558135e-32,66.60408892614454
TK1,ILMN_1806037,"Homo sapiens thymidine kinase 1, soluble (TK1), mRNA.",cytoplasm [goid 5737] [evidence NR ],"DNA replication [goid 6260] [evidence IEA]; nucleobase, nucleoside, nucleotide and nucleic acid metabolism [goid 6139] [pmid 3335503] [evidence TAS]",thymidine kinase activity [goid 4797] [pmid 3335503] [evidence TAS]; nucleotide binding [goid 166] [evidence IEA]; transferase activity [goid 16740] [evidence IEA]; ATP binding [goid 5524] [evidence IEA]; kinase activity [goid 16301] [evidence IEA],17,73682074-73682123,17q25.3b,-,NM_003258.1,7083,TK1,2.505586470663622,8.293765786292662,17.13318861357907,6.653570400487414e-34,5.335177747057501e-32,66.59904583773152
EFEMP1,ILMN_1665250,"Homo sapiens EGF-containing fibulin-like extracellular matrix protein 1 (EFEMP1), transcript variant 2, mRNA.",extracellular matrix (sensu Metazoa) [goid 5578] [pmid 10369267] [evidence TAS],visual perception [goid 7601] [pmid 10369267] [evidence TAS],calcium ion binding [goid 5509] [evidence IEA]; protein binding [goid 5515] [pmid 12620389] [evidence IPI],2,56002639-56002688,2p16.1d,-,NM_018894.1,2202,EFEMP1,-1.8663870011224235,8.21239005624961,-17.11531073991558,7.270051771186686e-34,5.760568708697168e-32,66.5107244880023
TTK,ILMN_1788166,"Homo sapiens TTK protein kinase (TTK), mRNA.",spindle [goid 5819] [pmid 10366450] [evidence TAS],mitotic spindle organization and biogenesis [goid 7052] [pmid 7737118] [evidence TAS]; mitotic spindle checkpoint [goid 7094] [pmid 10366450] [evidence TAS]; protein amino acid phosphorylation [goid 6468] [evidence IEA]; positive regulation of cell proliferation [goid 8284] [pmid 1639825] [evidence TAS],kinase activity [goid 16301] [evidence IEA]; transferase activity [goid 16740] [evidence IEA]; protein-tyrosine kinase activity [goid 4713] [pmid 7737118] [evidence TAS]; nucleotide binding [goid 166] [evidence IEA]; binding [goid 5488] [evidence IEA]; ATP binding [goid 5524] [evidence IEA]; protein serine/threonine kinase activity [goid 4674] [pmid 7737118] [evidence TAS],6,80807086-80807135,6q14.1d,+,NM_003318.3,7272,TTK,1.9092941125707767,6.0414138182089925,17.1152352392457,7.27277342745447e-34,5.760568708697168e-32,66.5103514100273
GMFG,ILMN_1711617,"Homo sapiens glia maturation factor, gamma (GMFG), mRNA.",intracellular [goid 5622] [evidence IEA],protein amino acid phosphorylation [goid 6468] [pmid 7598724] [evidence TAS],enzyme activator activity [goid 8047] [pmid 8798479] [evidence TAS]; protein kinase inhibitor activity [goid 4860] [pmid 8639570] [evidence TAS]; growth factor activity [goid 8083] [evidence IEA]; actin binding [goid 3779] [evidence IEA],19,44510871-44510920,19q13.2a,-,NM_004877.1,9535,GMFG,-1.726168242879611,10.048151067188648,-17.103439550426135,7.710813304551031e-34,6.082801507658982e-32,66.45205557545273
C10orf128,ILMN_1674046,"PREDICTED: Homo sapiens chromosome 10 open reading frame 128, transcript variant 8 (C10orf128), mRNA.",,,,,,10q11.22d,,XM_943334.1,170371,C10orf128,-1.859684194693485,6.522593552536071,-17.05476278486561,9.817416995319377e-34,7.713402022330567e-32,66.21130419705308
COL13A1,ILMN_2311052,"Homo sapiens collagen, type XIII, alpha 1 (COL13A1), transcript variant 19, mRNA.",plasma membrane [goid 5886] [pmid 9624150] [evidence TAS]; collagen type XIII [goid 5600] [pmid 9624150] [evidence TAS]; cytoplasm [goid 5737] [evidence IEA],phosphate transport [goid 6817] [evidence IEA],,10,71388731-71388780,10q21.3e-q22.1a,+,NM_080815.2,1305,COL13A1,-2.015303057519608,7.397721317295992,-17.050344228729337,1.0035186015397724e-33,7.852835321687736e-32,66.18943568218978
DUS1L,ILMN_1653342,"Homo sapiens dihydrouridine synthase 1-like (S. cerevisiae) (DUS1L), mRNA.",,tRNA processing [goid 8033] [evidence IEA],oxidoreductase activity [goid 16491] [evidence IEA]; FAD binding [goid 50660] [evidence IEA],17,77609348-77609397,17q25.3g,-,NM_022156.3,64118,DUS1L,1.4990323968087678,8.053606874944576,17.04060524972435,1.0532471902350243e-33,8.209008600691779e-32,66.14122646522743
PLEKHK1,ILMN_1740606,"Homo sapiens pleckstrin homology domain containing, family K member 1 (PLEKHK1), mRNA.",intracellular [goid 5622] [evidence IEA],signal transduction [goid 7165] [evidence IEA],nucleotide binding [goid 166] [evidence IEA],10,63623463-63623512,10q21.2b,-,NM_145307.2,219790,PLEKHK1,-2.559905160007223,6.220883536581946,-17.033395353802597,1.0916509466460825e-33,8.474429759123074e-32,66.10552889428382
F12,ILMN_1671766,"Homo sapiens coagulation factor XII (Hageman factor) (F12), mRNA.",extracellular space [goid 5615] [evidence IEA],blood coagulation [goid 7596] [pmid 2888762] [evidence TAS]; fibrinolysis [goid 42730] [evidence IEA],calcium ion binding [goid 5509] [evidence IEA]; coagulation factor XIa activity [goid 3805] [pmid 2888762] [evidence TAS]; coagulation factor XIIa activity [goid 3806] [pmid 3162339] [evidence TAS],5,176761826-176761875,5q35.3a,-,NM_000505.2,2161,F12,2.1449160324893883,7.261020860492557,17.027421613477873,1.124534328232424e-33,8.695060073654279e-32,66.07594683959694
C1orf106,ILMN_1713952,"Homo sapiens chromosome 1 open reading frame 106 (C1orf106), mRNA.",,,,1,199151198-199151247,1q32.1b,+,NM_018265.1,55765,C1orf106,2.5433312578728406,9.075912320981903,17.01921977988252,1.1713106632444909e-33,9.020943981548975e-32,66.03532396187273
FPR1,ILMN_2092118,"Homo sapiens formyl peptide receptor 1 (FPR1), mRNA.",plasma membrane [goid 5886] [pmid 10882119] [evidence TAS]; integral to membrane [goid 16021] [pmid 2161213] [evidence TAS]; endosome [goid 5768] [pmid 10823817] [evidence TAS],"nitric oxide mediated signal transduction [goid 7263] [pmid 10861041] [evidence TAS]; cell motility [goid 6928] [pmid 10882119] [evidence TAS]; G-protein signaling, coupled to cAMP nucleotide second messenger [goid 7188] [pmid 10889468] [evidence TAS]; chemotaxis [goid 6935] [pmid 10857861] [evidence TAS]; G-protein coupled receptor protein signaling pathway [goid 7186] [pmid 10823817] [evidence TAS]; inflammatory response [goid 6954] [evidence NR ]; signal transduction [goid 7165] [pmid 10820279] [evidence TAS]",N-formyl peptide receptor activity [goid 4982] [pmid 12218158] [evidence IDA]; receptor activity [goid 4872] [pmid 10857861] [evidence TAS]; rhodopsin-like receptor activity [goid 1584] [evidence IEA],19,56941267-56941316,19q13.33e,-,NM_002029.3,2357,FPR1,-3.082230089120892,8.430305439343574,-16.989469357273475,1.3580109156213157e-33,1.0417654602709186e-31,65.88790246095891
ARHGEF16,ILMN_1669928,"Homo sapiens Rho guanine exchange factor (GEF) 16 (ARHGEF16), mRNA.",intracellular [goid 5622] [evidence IEA],regulation of Rho protein signal transduction [goid 35023] [evidence IEA],Rho guanyl-nucleotide exchange factor activity [goid 5089] [evidence IEA],1,3387466-3387515,1p36.32b,+,NM_014448.2,27237,ARHGEF16,1.8445570343176625,6.966392086802161,16.956380832263193,1.6010220855052615e-33,1.223369228865491e-31,65.72380988369486
ZFP106,ILMN_1800912,"Homo sapiens zinc finger protein 106 homolog (mouse) (ZFP106), mRNA.",intracellular [goid 5622] [evidence IEA]; intracellular [goid 5622] [evidence IEA],electron transport [goid 6118] [evidence IEA]; electron transport [goid 6118] [evidence IEA],zinc ion binding [goid 8270] [evidence IEA]; metal ion binding [goid 46872] [evidence IEA]; nucleic acid binding [goid 3676] [evidence IEA]; zinc ion binding [goid 8270] [evidence IEA]; metal ion binding [goid 46872] [evidence IEA]; nucleic acid binding [goid 3676] [evidence IEA],15,40492788-40492837,15q15.1d,-,NM_022473.1,64397,ZFP106,-1.4044014424147289,9.808936039878846,-16.909116254919514,2.02592565149983e-33,1.5419984890419606e-31,65.48917852937954
RHBDL1,ILMN_1660864,"Homo sapiens rhomboid, veinlet-like 1 (Drosophila) (RHBDL1), mRNA.",membrane fraction [goid 5624] [pmid 9662444] [evidence TAS]; integral to plasma membrane [goid 5887] [pmid 9662444] [evidence TAS]; membrane [goid 16020] [evidence IEA],signal transduction [goid 7165] [pmid 9662444] [evidence TAS],serine-type endopeptidase activity [goid 4252] [evidence IEA]; peptidase activity [goid 8233] [evidence IEA]; calcium ion binding [goid 5509] [evidence IEA],16,668114-668163,16p13.3f,+,NM_003961.1,9028,RHBDL1,2.0716487524746707,6.293564198544021,16.90220672730425,2.096900500675259e-33,1.5898095819321954e-31,65.45485484630026
ANKRD25,ILMN_1716089,"Homo sapiens ankyrin repeat domain 25 (ANKRD25), mRNA.",,,,19,11136606-11136655,19p13.2b,-,NM_015493.4,25959,ANKRD25,-2.1802477665122932,8.581270195809605,-16.89623828016599,2.160217207933776e-33,1.631466368084869e-31,65.42520127619593
PPME1,ILMN_1732772,"Homo sapiens protein phosphatase methylesterase 1 (PPME1), mRNA.",,protein amino acid demethylation [goid 6482] [pmid 10318862] [evidence IDA]; aromatic compound metabolism [goid 6725] [evidence IEA],protein phosphatase inhibitor activity [goid 4864] [pmid 10318862] [evidence TAS]; hydrolase activity [goid 16787] [evidence IEA]; serine esterase activity [goid 4759] [evidence IEA]; protein phosphatase type 2A regulator activity [goid 8601] [pmid 10318862] [evidence TAS]; protein binding [goid 5515] [pmid 10318862] [evidence IDA]; carboxylic ester hydrolase activity [goid 16789] [pmid 10318862] [evidence IDA],11,73643195-73643244,11q13.4c,+,NM_016147.1,51400,PPME1,1.0654872111910318,9.151967092765764,16.879456981445813,2.3487310895190113e-33,1.766989393022314e-31,65.34180148079695
ECRG4,ILMN_1676822,"Homo sapiens chromosome 2 open reading frame 40 (C2orf40), mRNA.",,,,2,106060761-106060810,2q12.2b,+,NM_032411.1,84417,ECRG4,-3.6122259353196062,7.697105086232419,-16.87509269092909,2.4004109261916414e-33,1.7989233421863127e-31,65.32010606117238
LILRA5,ILMN_1726545,"Homo sapiens leukocyte immunoglobulin-like receptor, subfamily A (with TM domain), member 5 (LILRA5), transcript variant 4, mRNA.",,,,19,59514620-59514669,19q13.42a,-,NM_181986.1,353514,LILRA5,-1.8522988414213426,6.938671259408293,-16.871913768218,2.438772193240843e-33,1.820669585643595e-31,65.30430175733699
C19orf48,ILMN_2383484,"Homo sapiens chromosome 19 open reading frame 48 (C19orf48), mRNA.",,,,19,55993333-55993382,19q13.33c,-,NM_199250.1,84798,C19orf48,1.7929955639842747,7.094663648118389,16.841546355538863,2.8377572293527204e-33,2.1104465501502958e-31,65.15326404602104
TLR4,ILMN_1706217,"Homo sapiens toll-like receptor 4 (TLR4), transcript variant 4, mRNA.",lipopolysaccharide receptor complex [goid 46696] [pmid 11970998] [evidence NAS]; membrane [goid 16020] [evidence IEA]; integral to plasma membrane [goid 5887] [pmid 9435236] [evidence TAS],mast cell activation [goid 45576] [pmid 11490012] [evidence ISS]; signal transduction [goid 7165] [pmid 10426995] [evidence TAS]; positive regulation of interleukin-1 biosynthesis [goid 45362] [pmid 11490012] [evidence ISS]; positive regulation of interleukin-12 biosynthesis [goid 45084] [pmid 11970998] [evidence NAS]; detection of pathogenic bacteria [goid 9598] [pmid 10835634] [evidence NAS]; innate immune response [goid 45087] [evidence IEA]; macrophage activation [goid 42116] [pmid 10835634] [evidence IMP]; T-helper 1 type immune response [goid 42088] [pmid 11970998] [evidence NAS]; positive regulation of interleukin-6 biosynthesis [goid 45410] [pmid 11490012] [evidence ISS]; positive regulation of interleukin-13 biosynthesis [goid 45368] [pmid 11490012] [evidence ISS]; negative regulation of osteoclast differentiation [goid 45671] [pmid 12133979] [evidence NAS]; activation of NF-kappaB-inducing kinase [goid 7250] [pmid 11490012] [evidence ISS],lipopolysaccharide binding [goid 1530] [pmid 10835634] [evidence NAS]; protein binding [goid 5515] [pmid 11544529] [evidence IPI]; transmembrane receptor activity [goid 4888] [pmid 11970998] [evidence NAS],9,119516825-119516874,9q33.1c,+,NM_138557.1,7099,TLR4,-1.4983883910679623,6.263045554028631,-16.83605959159598,2.916553396969338e-33,2.1608001117850783e-31,65.1259624243966
STXBP6,ILMN_1750912,"Homo sapiens syntaxin binding protein 6 (amisyn) (STXBP6), mRNA.",integral to membrane [goid 16021] [evidence IEA]; integral to membrane [goid 16021] [evidence IEA],vesicle-mediated transport [goid 16192] [evidence IEA]; vesicle-mediated transport [goid 16192] [evidence IEA],,14,24395050-24395099,14q12a,-,NM_014178.6,29091,STXBP6,-2.661404889040475,7.484947131320111,-16.82594739752333,3.0675826016182628e-33,2.2555851909774645e-31,65.07563529759898
C3orf54,ILMN_1690454,"Homo sapiens chromosome 3 open reading frame 54 (C3orf54), mRNA.",,,,3,49817311-49817360,3p21.31c,+,NM_203370.1,389119,C3orf54,-1.9971120513329295,8.160292504301951,-16.825943509048535,3.0676421637620124e-33,2.2555851909774645e-31,65.07561594270233
SOX7,ILMN_1815032,"Homo sapiens SRY (sex determining region Y)-box 7 (SOX7), mRNA.",nucleus [goid 5634] [evidence IEA],"regulation of transcription, DNA-dependent [goid 6355] [evidence IEA]; transcription [goid 6350] [evidence IEA]",DNA binding [goid 3677] [evidence IEA],8,10619203-10619252,8p23.1b,-,NM_031439.2,83595,SOX7,-2.4669737829762717,6.657039860426524,-16.818652232968823,3.181396625446959e-33,2.330432828828346e-31,65.03932028777264
FGD5,ILMN_2104141,"Homo sapiens FYVE, RhoGEF and PH domain containing 5 (FGD5), mRNA.",lamellipodium [goid 30027] [evidence ISS]; ruffle [goid 1726] [evidence ISS]; cytoskeleton [goid 5856] [evidence IEA]; Golgi apparatus [goid 5794] [evidence ISS]; cytoplasm [goid 5737] [evidence ISS]; intracellular [goid 5622] [evidence IEA],regulation of Cdc42 GTPase activity [goid 43088] [evidence ISS]; filopodium formation [goid 46847] [evidence ISS]; regulation of cell shape [goid 8360] [evidence ISS]; regulation of Rho protein signal transduction [goid 35023] [evidence IEA]; actin cytoskeleton organization and biogenesis [goid 30036] [evidence ISS]; cytoskeleton organization and biogenesis [goid 7010] [evidence ISS],protein binding [goid 5515] [evidence ISS]; small GTPase binding [goid 31267] [evidence ISS]; Rho guanyl-nucleotide exchange factor activity [goid 5089] [evidence IEA]; zinc ion binding [goid 8270] [evidence IEA]; metal ion binding [goid 46872] [evidence IEA],3,14950699-14950748,3p24.3e,+,NM_152536.2,152273,FGD5,-2.1585959606709304,8.981743948781302,-16.80707522770925,3.3707888560922386e-33,2.4599183843055157e-31,64.98167689761239
CDGAP,ILMN_1752914,"Homo sapiens Cdc42 GTPase-activating protein (CDGAP), mRNA.",intracellular [goid 5622] [evidence IEA],signal transduction [goid 7165] [evidence IEA],,3,120618869-120618918,3q13.32b-q13.33a,+,NM_020754.1,57514,CDGAP,-1.7053762182308931,7.122834441966702,-16.769805143148506,4.060966213198162e-33,2.9525345770211265e-31,64.79599142804166
GIMAP5,ILMN_1769383,"Homo sapiens GTPase, IMAP family member 5 (GIMAP5), mRNA.",membrane [goid 16020] [evidence IEA]; mitochondrion [goid 5739] [evidence IEA]; integral to membrane [goid 16021] [evidence IEA]; outer membrane [goid 19867] [evidence IEA],,GTP binding [goid 5525] [evidence IEA]; nucleotide binding [goid 166] [evidence IEA],7,150071390-150071439,7q36.1c,+,NM_018384.3,55340,GIMAP5,-2.067250650553053,9.41787599897205,-16.768811541585972,4.0811925702820485e-33,2.956209562525863e-31,64.79103879022853
PVRL4,ILMN_1749044,"Homo sapiens poliovirus receptor-related 4 (PVRL4), mRNA.",,cell adhesion [goid 7155] [evidence IEA],receptor activity [goid 4872] [evidence IEA]; protein binding [goid 5515] [evidence IEA],1,159308405-159308454,1q23.3a,-,NM_030916.1,81607,PVRL4,1.673718913684147,5.915211244960063,16.764784544841987,4.164210528007132e-33,3.005171931045147e-31,64.77096484710846
PRC1,ILMN_1728934,"Homo sapiens protein regulator of cytokinesis 1 (PRC1), transcript variant 1, mRNA.",nucleus [goid 5634] [pmid 9885575] [evidence TAS]; spindle microtubule [goid 5876] [pmid 9885575] [evidence TAS],cell cycle [goid 7049] [evidence IEA]; cytokinesis [goid 910] [pmid 9885575] [evidence TAS]; mitotic spindle elongation [goid 22] [pmid 9885575] [evidence TAS],protein binding [goid 5515] [pmid 14744859] [evidence IPI],15,89310504-89310553,15q26.1c,-,NM_003981.2,9055,PRC1,1.8928450819960236,8.06567712306649,16.757744479861124,4.3134418780749895e-33,3.101380627095615e-31,64.73586640686135
ARHGEF6,ILMN_1803423,"Homo sapiens Rac/Cdc42 guanine nucleotide exchange factor (GEF) 6 (ARHGEF6), mRNA.",intracellular [goid 5622] [pmid 11017088] [evidence IC ],regulation of Rho protein signal transduction [goid 35023] [evidence IEA]; apoptosis [goid 6915] [pmid 11564864] [evidence NAS]; JNK cascade [goid 7254] [pmid 11564864] [evidence NAS],Rho guanyl-nucleotide exchange factor activity [goid 5089] [pmid 11017088] [evidence NAS]; GTPase activator activity [goid 5096] [pmid 9582122] [evidence NAS],X,135575492-135575541,Xq26.3b-q26.3c,-,NM_004840.2,9459,ARHGEF6,-1.6507280641109396,10.269984901984929,-16.753984958818176,4.3953235369109823e-33,3.148635261643768e-31,64.71712069465742
LOC653110,ILMN_1661628,"PREDICTED: Homo sapiens similar to annexin A8, transcript variant 1 (LOC653110), mRNA.",,,,10,47898803-47898852,10q11.22b,+,XM_926584.1,653110,LOC653110,-2.662368688926306,6.63250910692673,-16.753102273640742,4.414773595888609e-33,3.150984011571046e-31,64.71271919874778
SGPP2,ILMN_1662140,"Homo sapiens sphingosine-1-phosphate phosphotase 2 (SGPP2), mRNA.",membrane [goid 16020] [evidence IEA]; integral to membrane [goid 16021] [evidence IEA]; endoplasmic reticulum [goid 5783] [evidence IEA]; membrane [goid 16020] [evidence IEA]; integral to membrane [goid 16021] [evidence IEA]; endoplasmic reticulum [goid 5783] [evidence IEA],,hydrolase activity [goid 16787] [evidence IEA]; hydrolase activity [goid 16787] [evidence IEA],2,222997707-222997756,2q36.1b-q36.1c,+,NM_152386.2,130367,SGPP2,1.3884593249408672,7.266910000380728,16.7445492720968,4.6077779556246757e-33,3.2767355279323653e-31,64.67006479163423
C6orf189,ILMN_1751326,"PREDICTED: Homo sapiens chromosome 6 open reading frame 189 (C6orf189), mRNA.",,,,6,117180135-117180184,6q22.2a,-,XM_927381.1,221303,C6orf189,-2.549398749583105,9.781491343391801,-16.740105149247277,4.711387551150053e-33,3.326137189643434e-31,64.64789806878157
C9orf61,ILMN_2179717,"Homo sapiens chromosome 9 open reading frame 61 (C9orf61), mRNA.",,,,9,71196936-71196985,9q21.11a,+,NM_004816.2,9413,C9orf61,-2.3119623581156166,8.904087508835644,-16.70243616069875,5.689153180302232e-33,4.001918762389494e-31,64.45991175667183
ALOX5,ILMN_1680996,"Homo sapiens arachidonate 5-lipoxygenase (ALOX5), mRNA.",,leukotriene biosynthesis [goid 19370] [evidence IEA]; electron transport [goid 6118] [evidence IEA]; inflammatory response [goid 6954] [evidence NR ]; leukotriene biosynthesis [goid 19370] [evidence IEA]; electron transport [goid 6118] [evidence IEA]; inflammatory response [goid 6954] [evidence NR ],iron ion binding [goid 5506] [evidence IEA]; lipoxygenase activity [goid 16165] [evidence IEA]; arachidonate 5-lipoxygenase activity [goid 4051] [pmid 2829172] [evidence TAS]; oxidoreductase activity [goid 16491] [evidence IEA]; protein binding [goid 5515] [pmid 11785969] [evidence IPI]; calcium ion binding [goid 5509] [evidence IEA]; iron ion binding [goid 5506] [evidence IEA]; lipoxygenase activity [goid 16165] [evidence IEA]; arachidonate 5-lipoxygenase activity [goid 4051] [pmid 2829172] [evidence TAS]; oxidoreductase activity [goid 16491] [evidence IEA]; protein binding [goid 5515] [pmid 11785969] [evidence IPI]; calcium ion binding [goid 5509] [evidence IEA],10,45261351-45261400,10q11.21d,+,NM_000698.2,240,ALOX5,-1.2304509672124935,8.412951296347094,-16.696459783317042,5.862032798218295e-33,4.098595435309044e-31,64.43007063830295
CDH13,ILMN_1766925,"Homo sapiens cadherin 13, H-cadherin (heart) (CDH13), mRNA.",membrane [goid 16020] [evidence IEA],homophilic cell adhesion [goid 7156] [evidence IEA]; cell adhesion [goid 7155] [pmid 8673923] [evidence TAS],GPI anchor binding [goid 48503] [evidence IEA]; calcium ion binding [goid 5509] [evidence IEA]; protein binding [goid 5515] [evidence IEA],16,82387382-82387431,16q23.3a-q23.3b,+,NM_001257.3,1012,CDH13,-2.310282589983295,6.526904100483442,-16.69623427131634,5.868658590973688e-33,4.098595435309044e-31,64.42894453021809
MGP,ILMN_1651958,"Homo sapiens matrix Gla protein (MGP), mRNA.",extracellular region [goid 5576] [evidence IEA]; extracellular matrix (sensu Metazoa) [goid 5578] [pmid 9916809] [evidence TAS]; extracellular region [goid 5576] [evidence IEA]; extracellular matrix (sensu Metazoa) [goid 5578] [pmid 9916809] [evidence TAS],ossification [goid 1503] [pmid 9916809] [evidence TAS]; cell differentiation [goid 30154] [evidence IEA]; cartilage condensation [goid 1502] [pmid 9916809] [evidence TAS]; regulation of bone mineralization [goid 30500] [evidence IEA]; ossification [goid 1503] [pmid 9916809] [evidence TAS]; cell differentiation [goid 30154] [evidence IEA]; cartilage condensation [goid 1502] [pmid 9916809] [evidence TAS]; regulation of bone mineralization [goid 30500] [evidence IEA],structural constituent of bone [goid 8147] [pmid 9916809] [evidence TAS]; extracellular matrix structural constituent [goid 5201] [pmid 9916809] [evidence TAS]; calcium ion binding [goid 5509] [evidence IEA]; structural constituent of bone [goid 8147] [pmid 9916809] [evidence TAS]; extracellular matrix structural constituent [goid 5201] [pmid 9916809] [evidence TAS]; calcium ion binding [goid 5509] [evidence IEA],12,14930002-14930051,12p12.3e,-,NM_000900.2,4256,MGP,-2.0407445351943956,12.869864824655942,-16.654580443759386,7.231080091663716e-33,5.032056985216696e-31,64.22083583185352
MTA3,ILMN_1768751,"Homo sapiens metastasis associated 1 family, member 3 (MTA3), mRNA.",nucleus [goid 5634] [evidence IEA],"regulation of transcription, DNA-dependent [goid 6355] [evidence IEA]",zinc ion binding [goid 8270] [evidence IEA]; metal ion binding [goid 46872] [evidence IEA]; sequence-specific DNA binding [goid 43565] [evidence IEA]; transcription factor activity [goid 3700] [evidence IEA],2,42789546-42789595,2p21e,+,NM_020744.2,57504,MTA3,1.3319924886201493,8.535881690089491,16.644117016758837,7.62065906753713e-33,5.284289748432775e-31,64.16852534225268
TUBB6,ILMN_1699489,"PREDICTED: Homo sapiens tubulin, beta 6 (TUBB6), mRNA.",,,,,,18p11.21e,,XM_940079.1,84617,TUBB6,-2.0991148544472127,8.035032017256755,-16.640346520750416,7.766155934201722e-33,5.366083275812786e-31,64.14967194702174
C5AR1,ILMN_1689836,"Homo sapiens complement component 5a receptor 1 (C5AR1), mRNA.",integral to plasma membrane [goid 5887] [pmid 2007135] [evidence TAS]; plasma membrane [goid 5886] [pmid 2007135] [evidence TAS],chemotaxis [goid 6935] [pmid 10352266] [evidence TAS]; phospholipase C activation [goid 7202] [pmid 7649993] [evidence TAS]; signal transduction [goid 7165] [pmid 8702752] [evidence TAS]; G-protein coupled receptor protein signaling pathway [goid 7186] [evidence IEA]; sensory perception of chemical stimulus [goid 7606] [pmid 9590258] [evidence TAS]; cellular defense response [goid 6968] [pmid 8779720] [evidence TAS],C5a anaphylatoxin receptor activity [goid 4944] [pmid 10352266] [evidence TAS]; receptor activity [goid 4872] [evidence IEA]; rhodopsin-like receptor activity [goid 1584] [evidence IEA],19,52516830-52516879,19q13.32b,+,NM_001736.2,728,C5AR1,-2.0901150575456446,7.88787392915401,-16.597654609287467,9.621837907350794e-33,6.6247883966335765e-31,63.9360797940256
CCDC48,ILMN_1751099,"Homo sapiens coiled-coil domain containing 48 (CCDC48), mRNA.",,,,3,130241920-130241969,3q21.3c,+,NM_024768.1,79825,CCDC48,-1.9769862868793933,6.295523422278505,-16.582130968103183,1.040201788268843e-32,7.136736564936059e-31,63.85835773251567
ATAD3A,ILMN_1738530,"Homo sapiens ATPase family, AAA domain containing 3A (ATAD3A), mRNA.",,,ATP binding [goid 5524] [evidence IEA]; nucleotide binding [goid 166] [evidence IEA]; nucleoside-triphosphatase activity [goid 17111] [evidence IEA],1,1459776-1459825,1p36.33a,+,NM_018188.2,55210,ATAD3A,1.5942811714690954,8.054346252930253,16.58084472203613,1.046944547579068e-32,7.157794564764259e-31,63.851916566892726
TSPAN7,ILMN_1809291,"Homo sapiens tetraspanin 7 (TSPAN7), mRNA.",plasma membrane [goid 5886] [pmid 10617319] [evidence TAS]; integral to plasma membrane [goid 5887] [pmid 8420826] [evidence TAS]; plasma membrane [goid 5886] [pmid 10617319] [evidence TAS]; integral to plasma membrane [goid 5887] [pmid 8420826] [evidence TAS],,,X,38432497-38432546,Xp11.4e,+,NM_004615.2,7102,TSPAN7,-3.154905654345429,9.084756190236021,-16.574832508402377,1.0790489109032876e-32,7.351492317814881e-31,63.82180636039948
WIF1,ILMN_1721541,"Homo sapiens WNT inhibitory factor 1 (WIF1), mRNA.",,cell-cell signaling [goid 7267] [evidence NR ]; signal transduction [goid 7165] [pmid 10201374] [evidence NAS]; Wnt receptor signaling pathway [goid 16055] [evidence IEA]; development [goid 7275] [evidence IEA],protein-tyrosine kinase activity [goid 4713] [evidence IEA],12,63736151-63736173:63742528-63742554,12q14.3a,-,NM_007191.2,11197,WIF1,-4.028794029515307,7.8711424905581495,-16.566903210920415,1.122908084472775e-32,7.623646002073876e-31,63.7820882694179
HSPB6,ILMN_1721283,"Homo sapiens heat shock protein, alpha-crystallin-related, B6 (HSPB6), mRNA.",,protein folding [goid 6457] [evidence IEA]; response to unfolded protein [goid 6986] [evidence IEA],structural constituent of eye lens [goid 5212] [evidence IEA]; protein binding [goid 5515] [pmid 16225851] [evidence IPI],19,40937371-40937420,19q13.12a,-,NM_144617.1,126393,HSPB6,-2.33632034842171,7.871596682943619,-16.558037212394705,1.1740734731562319e-32,7.943340841822631e-31,63.73766906229406
PLSCR4,ILMN_1757338,"Homo sapiens phospholipid scramblase 4 (PLSCR4), mRNA.",membrane [goid 16020] [evidence IEA]; integral to membrane [goid 16021] [evidence NAS],phospholipid scrambling [goid 17121] [pmid 10930526] [evidence NAS]; blood coagulation [goid 7596] [evidence NAS],calcium ion binding [goid 5509] [pmid 10930526] [evidence NAS]; phospholipid scramblase activity [goid 17128] [pmid 10930526] [evidence NAS],3,147393419-147393468,3q24c-q24d,-,NM_020353.1,57088,PLSCR4,-2.1867306996518696,8.919589436770522,-16.546018556347313,1.2471940641162762e-32,8.408849944396415e-31,63.67743942274218
REM1,ILMN_1719811,"Homo sapiens RAS (RAD and GEM)-like GTP-binding 1 (REM1), mRNA.",,small GTPase mediated signal transduction [goid 7264] [evidence IEA],calmodulin binding [goid 5516] [evidence IEA]; GTP binding [goid 5525] [evidence IEA]; nucleotide binding [goid 166] [evidence IEA],20,29536213-29536262,20q11.21b,+,NM_014012.4,28954,REM1,-2.109524153400769,6.941008723331326,-16.536045352973638,1.311333137623169e-32,8.810802133306016e-31,63.627446784654424
METTL7B,ILMN_2064725,"Homo sapiens methyltransferase like 7B (METTL7B), mRNA.",,,transferase activity [goid 16740] [evidence IEA]; methyltransferase activity [goid 8168] [evidence IEA],12,54364456-54364505,12q13.2b,+,NM_152637.1,196410,METTL7B,3.0210021734377346,7.05257216054392,16.516848433829562,1.444272592620254e-32,9.670670607287163e-31,63.531184095253806
FZD4,ILMN_1743367,"Homo sapiens frizzled homolog 4 (Drosophila) (FZD4), mRNA.",integral to membrane [goid 16021] [pmid 10544037] [evidence TAS]; membrane [goid 16020] [evidence IEA],frizzled signaling pathway [goid 7222] [pmid 10544037] [evidence TAS]; G-protein coupled receptor protein signaling pathway [goid 7186] [evidence IEA]; development [goid 7275] [evidence IEA],receptor activity [goid 4872] [evidence IEA]; Wnt receptor activity [goid 42813] [pmid 10544037] [evidence TAS]; G-protein coupled receptor activity [goid 4930] [evidence IEA]; non-G-protein coupled 7TM receptor activity [goid 4926] [evidence IEA],11,86334627-86334676,11q14.2a,-,NM_012193.2,8322,FZD4,-1.868067312161088,9.658467634680296,-16.51214454012115,1.478862902927929e-32,9.868371117654348e-31,63.50758958799183
ABCC3,ILMN_1677814,"Homo sapiens ATP-binding cassette, sub-family C (CFTR/MRP), member 3 (ABCC3), transcript variant MRP3A, mRNA.",membrane fraction [goid 5624] [pmid 9813153] [evidence TAS]; integral to plasma membrane [goid 5887] [pmid 9813153] [evidence TAS],transport [goid 6810] [pmid 9813153] [evidence TAS],"nucleotide binding [goid 166] [evidence IEA]; ATPase activity, coupled to transmembrane movement of substances [goid 42626] [pmid 9813153] [evidence TAS]; ATPase activity [goid 16887] [evidence IEA]; organic anion transporter activity [goid 8514] [pmid 9738950] [evidence TAS]; ATP binding [goid 5524] [pmid 9813153] [evidence TAS]",17,46123787-46123836,17q21.33b,+,NM_020037.1,8714,ABCC3,1.4624942639034746,8.082798612160737,16.49519276380561,1.6105711415830342e-32,1.0710572933018917e-30,63.42253777914378
LILRA2,ILMN_1716983,"Homo sapiens leukocyte immunoglobulin-like receptor, subfamily A (with TM domain), member 2 (LILRA2), mRNA.",membrane [goid 16020] [evidence IEA]; integral to membrane [goid 16021] [evidence IEA],immune response [goid 6955] [evidence IEA]; signal transduction [goid 7165] [pmid 9548455] [evidence TAS],receptor activity [goid 4872] [pmid 9548455] [evidence TAS]; antigen binding [goid 3823] [pmid 9548455] [evidence TAS],19,59790667-59790716,19q13.42a,+,NM_006866.1,11027,LILRA2,-2.3178572942060143,6.856898367210227,-16.493088706961302,1.6277206473657166e-32,1.078780163738809e-30,63.41197867970193
PDIA4,ILMN_1815261,"Homo sapiens protein disulfide isomerase family A, member 4 (PDIA4), mRNA.",endoplasmic reticulum lumen [goid 5788] [pmid 2295602] [evidence TAS],electron transport [goid 6118] [evidence IEA]; protein secretion [goid 9306] [pmid 2295602] [evidence TAS],electron transporter activity [goid 5489] [evidence IEA]; protein disulfide isomerase activity [goid 3756] [evidence IEA]; calcium ion binding [goid 5509] [evidence IEA]; isomerase activity [goid 16853] [evidence IEA],7,148331345-148331394,7q36.1a,-,NM_004911.3,9601,PDIA4,1.7508674476578312,8.480470983471301,16.479187955709413,1.7457258369417234e-32,1.153066709586762e-30,63.34220485820151
AOC3,ILMN_1782086,"Homo sapiens amine oxidase, copper containing 3 (vascular adhesion protein 1) (AOC3), mRNA.",plasma membrane [goid 5886] [pmid 9653080] [evidence IDA]; integral to membrane [goid 16021] [pmid 9653080] [evidence IDA]; cell surface [goid 9986] [pmid 9653080] [evidence IDA],amine metabolism [goid 9308] [pmid 9653080] [evidence IDA]; cell adhesion [goid 7155] [pmid 9653080] [evidence IDA]; inflammatory response [goid 6954] [pmid 9653080] [evidence TAS]; electron transport [goid 6118] [pmid 9653080] [evidence IDA],oxidoreductase activity [goid 16491] [evidence IEA]; protein homodimerization activity [goid 42803] [pmid 9653080] [evidence TAS]; copper ion binding [goid 5507] [pmid 8972912] [evidence TAS]; amine oxidase activity [goid 8131] [pmid 9653080] [evidence IDA]; calcium ion binding [goid 5509] [evidence IEA]; protein binding [goid 5515] [evidence IEA],17,38263530-38263579,17q21.31a,+,NM_003734.2,8639,AOC3,-2.224373213383017,6.921005918719895,-16.476991904369815,1.7651392958807097e-32,1.1619506479809336e-30,63.331179771821
ARHGAP30,ILMN_1750805,"Homo sapiens Rho GTPase activating protein 30 (ARHGAP30), transcript variant 2, mRNA.",intracellular [goid 5622] [evidence IEA]; intracellular [goid 5622] [evidence IEA],signal transduction [goid 7165] [evidence IEA]; signal transduction [goid 7165] [evidence IEA],,1,159283524-159283573,1q23.3a,-,NM_181720.2,257106,ARHGAP30,-1.3378568470945353,7.906329128283652,-16.467295622593397,1.8534829283094453e-32,1.2159971332696815e-30,63.28249336716614
FGR,ILMN_1795158,"Homo sapiens Gardner-Rasheed feline sarcoma viral (v-fgr) oncogene homolog (FGR), mRNA.",,response to virus [goid 9615] [pmid 3003578] [evidence TAS]; intracellular signaling cascade [goid 7242] [evidence IEA]; protein amino acid phosphorylation [goid 6468] [pmid 2995972] [evidence TAS],nucleotide binding [goid 166] [evidence IEA]; protein kinase activity [goid 4672] [evidence IEA]; transferase activity [goid 16740] [evidence IEA]; ATP binding [goid 5524] [evidence IEA]; protein-tyrosine kinase activity [goid 4713] [pmid 3003578] [evidence TAS],1,27811518-27811567,1p35.3b,-,NM_005248.1,2268,FGR,-1.3042665452723403,7.987851989017329,-16.4662170153899,1.8635808462583184e-32,1.2185192211189038e-30,63.27707681634685
GPR30,ILMN_1665435,"Homo sapiens G protein-coupled receptor 30 (GPR30), transcript variant 2, mRNA.",integral to membrane [goid 16021] [evidence IEA]; integral to plasma membrane [goid 5887] [pmid 8920907] [evidence TAS],signal transduction [goid 7165] [evidence IEA]; G-protein coupled receptor protein signaling pathway [goid 7186] [pmid 8920907] [evidence TAS],"rhodopsin-like receptor activity [goid 1584] [evidence IEA]; purinergic nucleotide receptor activity, G-protein coupled [goid 45028] [evidence IEA]; receptor activity [goid 4872] [evidence IEA]",7,1098987-1099018:1099019-1099036,7p22.3b,+,NM_001505.1,2852,GPR30,-2.060399949656219,7.411174697613589,-16.465467441494177,1.8706308936683664e-32,1.2190382261915759e-30,63.27331252150107
CD300C,ILMN_1701906,"Homo sapiens CD300c molecule (CD300C), mRNA.",membrane [goid 16020] [evidence IEA]; integral to plasma membrane [goid 5887] [pmid 1349532] [evidence TAS],cellular defense response [goid 6968] [pmid 1349532] [evidence TAS],transmembrane receptor activity [goid 4888] [pmid 1349532] [evidence TAS],17,70048957-70049006,17q25.1b,-,NM_006678.2,10871,CD300C,-2.41260033587226,6.838564337484118,-16.44591642943801,2.0642908603760143e-32,1.3363025719078618e-30,63.17510476456734
FABP5,ILMN_1696302,"Homo sapiens fatty acid binding protein 5 (psoriasis-associated) (FABP5), mRNA.",cytoplasm [goid 5737] [pmid 16130169] [evidence TAS]; cytoplasm [goid 5737] [pmid 16130169] [evidence TAS]; cytoplasm [goid 5737] [pmid 16130169] [evidence TAS],transport [goid 6810] [evidence IEA]; lipid metabolism [goid 6629] [pmid 8092987] [evidence TAS]; epidermis development [goid 8544] [pmid 1512466] [evidence TAS]; transport [goid 6810] [evidence IEA]; lipid metabolism [goid 6629] [pmid 8092987] [evidence TAS]; epidermis development [goid 8544] [pmid 1512466] [evidence TAS]; transport [goid 6810] [evidence IEA]; lipid metabolism [goid 6629] [pmid 8092987] [evidence TAS]; epidermis development [goid 8544] [pmid 1512466] [evidence TAS],fatty acid binding [goid 5504] [pmid 8092987] [evidence TAS]; protein binding [goid 5515] [pmid 12839573] [evidence IPI]; fatty acid binding [goid 5504] [pmid 8092987] [evidence TAS]; protein binding [goid 5515] [pmid 12839573] [evidence IPI]; fatty acid binding [goid 5504] [pmid 8092987] [evidence TAS]; protein binding [goid 5515] [pmid 12839573] [evidence IPI],8,82358292-82358328:82358663-82358675,8q21.13b,+,NM_001444.1,2171,FABP5,-2.542239883024365,8.305026498149065,-16.44210267345984,2.1043537500617105e-32,1.3577262523163055e-30,63.15594223024708
ABCA9,ILMN_1668446,"Homo sapiens ATP-binding cassette, sub-family A (ABC1), member 9 (ABCA9), transcript variant 1, mRNA.",,,ATPase activity [goid 16887] [evidence IEA]; nucleotide binding [goid 166] [evidence IEA]; ATP binding [goid 5524] [evidence IEA]; ATPase activity [goid 16887] [evidence IEA]; nucleotide binding [goid 166] [evidence IEA]; ATP binding [goid 5524] [evidence IEA],17,64483214-64483263,17q24.2c,-,NM_080283.2,10350,ABCA9,-1.3140378163351567,5.98442774896659,-16.4404017135228,2.122473100002804e-32,1.3648973053978426e-30,63.14739504216435
TNFRSF21,ILMN_1699695,"Homo sapiens tumor necrosis factor receptor superfamily, member 21 (TNFRSF21), mRNA.",membrane [goid 16020] [evidence IEA]; integral to membrane [goid 16021] [evidence IEA],apoptosis [goid 6915] [evidence IEA]; signal transduction [goid 7165] [evidence IEA],receptor activity [goid 4872] [evidence IEA]; protein binding [goid 5515] [evidence IEA],6,47307455-47307504,6p12.3d,-,NM_014452.3,27242,TNFRSF21,1.7086645773758775,11.450279989863873,16.430591629179986,2.230076228383742e-32,1.42937616151504e-30,63.09809325027376
GNG11,ILMN_1782419,"Homo sapiens guanine nucleotide binding protein (G protein), gamma 11 (GNG11), mRNA.",heterotrimeric G-protein complex [goid 5834] [evidence IEA],signal transduction [goid 7165] [evidence IEA]; G-protein coupled receptor protein signaling pathway [goid 7186] [evidence IEA],signal transducer activity [goid 4871] [evidence IEA],7,93389369-93389385:93389386-93389418,7q21.3a,+,NM_004126.2,2791,GNG11,-2.9780439676931394,10.36376230319192,-16.42017012548574,2.3503978405892342e-32,1.5015574401272535e-30,63.045705815906544
NTNG1,ILMN_1727778,"Homo sapiens netrin G1 (NTNG1), mRNA.",membrane [goid 16020] [evidence IEA]; extracellular matrix (sensu Metazoa) [goid 5578] [evidence IEA]; anchored to plasma membrane [goid 46658] [evidence ISS]; membrane [goid 16020] [evidence IEA]; extracellular matrix (sensu Metazoa) [goid 5578] [evidence IEA]; anchored to plasma membrane [goid 46658] [evidence ISS],cell differentiation [goid 30154] [evidence IEA]; axonogenesis [goid 7409] [evidence ISS]; cell differentiation [goid 30154] [evidence IEA]; axonogenesis [goid 7409] [evidence ISS],GPI anchor binding [goid 48503] [evidence IEA]; protein binding [goid 5515] [pmid 14595443] [evidence IPI]; GPI anchor binding [goid 48503] [evidence IEA]; protein binding [goid 5515] [pmid 14595443] [evidence IPI],1,107825560-107825609,1p13.3d,+,NM_014917.2,22854,NTNG1,-2.325099566857438,6.356616254438296,-16.418296712626027,2.3727091499157624e-32,1.5108574439904782e-30,63.03628702630674
EFNA4,ILMN_1665696,"Homo sapiens ephrin-A4 (EFNA4), transcript variant 1, mRNA.",integral to plasma membrane [goid 5887] [pmid 8660976] [evidence TAS]; membrane [goid 16020] [evidence IEA],cell-cell signaling [goid 7267] [pmid 8660976] [evidence TAS],transmembrane-ephrin receptor activity [goid 5005] [pmid 8660976] [evidence TAS]; GPI anchor binding [goid 48503] [evidence IEA],1,153308015-153308064,1q22a,+,NM_005227.2,1945,EFNA4,1.2828647599349603,7.5985374177184655,16.389052205386776,2.749916023449234e-32,1.7453457236777955e-30,62.88920151275613
GPR172A,ILMN_2041577,"Homo sapiens G protein-coupled receptor 172A (GPR172A), mRNA.",membrane [goid 16020] [evidence IEA]; integral to membrane [goid 16021] [evidence IEA],,receptor activity [goid 4872] [evidence IEA],8,145555566-145555615,8q24.3h,+,NM_024531.3,79581,GPR172A,1.318122292504162,10.042518724969595,16.38022433730879,2.875214180846253e-32,1.818946373824326e-30,62.844781174669635
FHL5,ILMN_1669023,"Homo sapiens four and a half LIM domains 5 (FHL5), mRNA.",nucleus [goid 5634] [evidence IEA],,zinc ion binding [goid 8270] [evidence IEA]; metal ion binding [goid 46872] [evidence IEA],6,97170923-97170972,6q16.1f,+,NM_020482.3,9457,FHL5,-1.9217776394362378,6.288048966551857,-16.37938565429246,2.887412392755215e-32,1.8207517952373906e-30,62.84056056959919
PKNOX2,ILMN_1807689,"Homo sapiens PBX/knotted 1 homeobox 2 (PKNOX2), mRNA.",nucleus [goid 5634] [evidence IEA],"regulation of transcription, DNA-dependent [goid 6355] [evidence IEA]",transcription factor activity [goid 3700] [evidence IEA],11,124808015-124808064,11q24.2b,+,NM_022062.1,63876,PKNOX2,-1.8632511847388722,6.728605230455628,-16.352842778562472,3.3015426420765854e-32,2.07517930260846e-30,62.706941408278226
C20orf46,ILMN_1751228,"Homo sapiens chromosome 20 open reading frame 46 (C20orf46), mRNA.",membrane [goid 16020] [evidence IEA]; integral to membrane [goid 16021] [evidence IEA],,,20,1109274-1109323,20p13e,-,NM_018354.1,55321,C20orf46,-2.270198663693292,8.691204318626948,-16.349116063400906,3.3642828478590187e-32,2.1078151540364303e-30,62.68817393057746
SPC24,ILMN_2181432,"Homo sapiens SPC24, NDC80 kinetochore complex component, homolog (S. cerevisiae) (SPC24), mRNA.",,,,19,11117635-11117684,19p13.2b,-,NM_182513.1,147841,SPC24,2.240822244932591,7.768906616699573,16.331075341158417,3.68536220393237e-32,2.3015795687058408e-30,62.59729822456018
ADAM8,ILMN_1708348,"Homo sapiens ADAM metallopeptidase domain 8 (ADAM8), mRNA.",integral to plasma membrane [goid 5887] [pmid 9126482] [evidence TAS],,metalloendopeptidase activity [goid 4222] [evidence IEA]; metal ion binding [goid 46872] [evidence IEA]; zinc ion binding [goid 8270] [evidence IEA],10,134926186-134926235,10q26.3f,-,NM_001109.2,101,ADAM8,2.3226334262640513,7.498518935605974,16.323993868272254,3.8196545271672234e-32,2.3778264684298193e-30,62.561616228683235
PTRF,ILMN_1757552,"Homo sapiens polymerase I and transcript release factor (PTRF), mRNA.",membrane [goid 16020] [evidence IEA]; nucleus [goid 5634] [evidence IEA],"transcription termination [goid 6353] [evidence IEA]; regulation of transcription, DNA-dependent [goid 6355] [evidence IEA]; transcription [goid 6350] [evidence IEA]",rRNA binding [goid 19843] [evidence IEA],17,37808068-37808117,17q21.31a,-,NM_012232.2,284119,PTRF,-1.6761311819590148,12.304057398602849,-16.317086892535926,3.9553735348640134e-32,2.454473035886156e-30,62.526807614893315
CD33,ILMN_1747622,"Homo sapiens CD33 molecule (CD33), mRNA.",integral to plasma membrane [goid 5887] [pmid 3139766] [evidence TAS]; plasma membrane [goid 5886] [pmid 3139766] [evidence TAS],signal transduction [goid 7165] [pmid 10611343] [evidence TAS]; negative regulation of cell proliferation [goid 8285] [pmid 10611343] [evidence TAS]; cell adhesion [goid 7155] [pmid 10611343] [evidence NAS]; cell-cell signaling [goid 7267] [pmid 10611343] [evidence TAS],protein binding [goid 5515] [evidence IEA]; sugar binding [goid 5529] [evidence IEA]; receptor activity [goid 4872] [pmid 10611343] [evidence TAS],19,56434712-56434755:56434756-56434761,19q13.33d,+,NM_001772.2,945,CD33,-2.1404360133589444,7.403532410368722,-16.316140567164073,3.974342031539821e-32,2.4584144280810605e-30,62.522038032086456
GPBAR1,ILMN_1727709,"Homo sapiens G protein-coupled bile acid receptor 1 (GPBAR1), mRNA.",integral to membrane [goid 16021] [evidence IEA],signal transduction [goid 7165] [evidence IEA]; G-protein coupled receptor protein signaling pathway [goid 7186] [evidence IEA],rhodopsin-like receptor activity [goid 1584] [evidence IEA]; receptor activity [goid 4872] [evidence IEA],2,218836680-218836684:218836685-218836729,2q35e,+,NM_170699.1,151306,GPBAR1,-1.7160043853482714,6.865968772932552,-16.314167376867204,4.0141878753649516e-32,2.4752041377052556e-30,62.51209258846052
RPESP,ILMN_1808245,"Homo sapiens RPE-spondin (RPESP), mRNA.",,,,8,74141845-74141894,8q21.11a,-,NM_153225.2,157869,RPESP,-2.8502007324130174,7.379979064622398,-16.31171014795779,4.06436983736653e-32,2.498241207605263e-30,62.49970679056375
ITPKA,ILMN_1776516,"Homo sapiens inositol 1,4,5-trisphosphate 3-kinase A (ITPKA), mRNA.",,signal transduction [goid 7165] [pmid 2176078] [evidence TAS],kinase activity [goid 16301] [evidence IEA]; calmodulin binding [goid 5516] [evidence IEA]; ATP binding [goid 5524] [evidence IEA]; transferase activity [goid 16740] [evidence IEA]; nucleotide binding [goid 166] [evidence IEA],15,39582984-39583033,15q15.1c,+,NM_002220.1,3706,ITPKA,3.8091598335975565,7.249404259680389,16.302391307468877,4.2604766127092084e-32,2.61054675467418e-30,62.452727997599666
KRT8,ILMN_1753584,"Homo sapiens keratin 8 (KRT8), mRNA.",intermediate filament [goid 5882] [evidence NAS],cytoskeleton organization and biogenesis [goid 7010] [evidence NAS],structural molecule activity [goid 5198] [evidence NAS]; protein binding [goid 5515] [pmid 15731013] [evidence IPI],12,51577384-51577433,12q13.13e,-,NM_002273.2,3856,KRT8,2.080450373978561,11.11730008422592,16.27424917222086,4.9123390237337423e-32,3.0005305917696543e-30,62.31079192092919
CHPF,ILMN_1731353,"Homo sapiens chondroitin polymerizing factor (CHPF), mRNA.",membrane [goid 16020] [evidence IEA]; integral to membrane [goid 16021] [evidence IEA],,metal ion binding [goid 46872] [evidence IEA]; transferase activity [goid 16740] [evidence IEA]; N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity [goid 50510] [evidence IEA]; protein binding [goid 5515] [pmid 15231747] [evidence IPI],2,220112075-220112124,2q35f,-,NM_024536.4,79586,CHPF,2.101077158907179,9.5382322499929,16.25777548597623,5.339509469484004e-32,3.2512606879029946e-30,62.227661615757654
FCGR1B,ILMN_2261600,"Homo sapiens Fc fragment of IgG, high affinity Ib, receptor (CD64) (FCGR1B), transcript variant 1, mRNA.",,,,1,120736083-120736132,,-,NM_001017986.1,2210,FCGR1B,-2.1985755691355786,6.836740761482166,-16.25229133824951,5.489843387946368e-32,3.3323862434309966e-30,62.19997995298537
CARD12,ILMN_1796976,"Homo sapiens NLR family, CARD domain containing 4 (NLRC4), mRNA.",intracellular [goid 5622] [pmid 15107016] [evidence NAS],positive regulation of apoptosis [goid 43065] [pmid 11374873] [evidence IMP]; caspase activation [goid 6919] [pmid 15030775] [evidence IDA],transferase activity [goid 16740] [evidence IEA]; protein homodimerization activity [goid 42803] [pmid 15107016] [evidence IDA]; nucleotide binding [goid 166] [evidence IEA]; ATP binding [goid 5524] [pmid 15882992] [evidence IDA]; magnesium ion binding [goid 287] [pmid 15882992] [evidence TAS]; protein binding [goid 5515] [pmid 15107016] [evidence IPI],2,32314083-32314132,2p22.3e,-,NM_021209.3,58484,CARD12,-1.4809802790380067,6.027480516458246,-16.25147775349245,5.512505132631903e-32,3.335750388488591e-30,62.19587301034764
GPX3,ILMN_1726666,"Homo sapiens glutathione peroxidase 3 (plasma) (GPX3), mRNA.",soluble fraction [goid 5625] [pmid 3619451] [evidence TAS]; extracellular region [goid 5576] [pmid 3619451] [evidence TAS],response to lipid hydroperoxide [goid 6982] [evidence NR ],electron transporter activity [goid 5489] [pmid 3619451] [evidence TAS]; selenium binding [goid 8430] [evidence IEA]; oxidoreductase activity [goid 16491] [evidence IEA]; glutathione peroxidase activity [goid 4602] [pmid 3619451] [evidence TAS],5,150388662-150388711,5q33.1d,+,NM_002084.2,2878,GPX3,-2.004572938426943,12.731724079216097,-16.24895390150175,5.583404748472785e-32,3.3681932360369105e-30,62.183132198643634
UBL3,ILMN_1810729,"Homo sapiens ubiquitin-like 3 (UBL3), mRNA.",membrane [goid 16020] [evidence IEA]; intracellular [goid 5622] [pmid 11256614] [evidence IDA],protein modification [goid 6464] [evidence IEA],,13,29236843-29236892,13q12.3b,-,NM_007106.2,5412,UBL3,-1.3864678812599216,10.424518948190842,-16.236426016108535,5.94913228703881e-32,3.573417572156117e-30,62.11987800203528
DDR1,ILMN_1812262,"Homo sapiens discoidin domain receptor family, member 1 (DDR1), transcript variant 2, mRNA.",integral to plasma membrane [goid 5887] [pmid 8390675] [evidence TAS]; membrane [goid 16020] [evidence IEA]; membrane [goid 16020] [evidence IEA]; integral to plasma membrane [goid 5887] [pmid 8390675] [evidence TAS],cell adhesion [goid 7155] [pmid 8302582] [evidence TAS]; transmembrane receptor protein tyrosine kinase signaling pathway [goid 7169] [evidence IEA]; protein amino acid phosphorylation [goid 6468] [evidence IEA]; cell adhesion [goid 7155] [pmid 8302582] [evidence TAS]; transmembrane receptor protein tyrosine kinase signaling pathway [goid 7169] [evidence IEA]; protein amino acid phosphorylation [goid 6468] [evidence IEA],transferase activity [goid 16740] [evidence IEA]; protein-tyrosine kinase activity [goid 4713] [evidence IEA]; nucleotide binding [goid 166] [evidence IEA]; transmembrane receptor protein tyrosine kinase activity [goid 4714] [pmid 9659899] [evidence TAS]; ATP binding [goid 5524] [evidence IEA]; receptor activity [goid 4872] [evidence IEA]; nucleotide binding [goid 166] [evidence IEA]; transmembrane receptor protein tyrosine kinase activity [goid 4714] [pmid 9659899] [evidence TAS]; receptor activity [goid 4872] [evidence IEA]; transferase activity [goid 16740] [evidence IEA]; ATP binding [goid 5524] [evidence IEA]; protein-tyrosine kinase activity [goid 4713] [evidence IEA],6,30975562-30975611,6p21.33a,+,NM_001954.3,780,DDR1,1.2779118765962947,8.200114468800827,16.2360563931908,5.96028078496658e-32,3.573417572156117e-30,62.118011460852216
MNDA,ILMN_1738992,"Homo sapiens myeloid cell nuclear differentiation antigen (MNDA), mRNA.",nucleus [goid 5634] [evidence IEA],"cellular defense response [goid 6968] [pmid 1644857] [evidence TAS]; regulation of transcription, DNA-dependent [goid 6355] [evidence IEA]; transcription [goid 6350] [evidence IEA]",DNA binding [goid 3677] [evidence IEA],1,157080517-157080536:157082001-157082030,1q23.1g,+,NM_002432.1,4332,MNDA,-2.7490746700921775,6.774170555680984,-16.199190057980253,7.184570652597795e-32,4.294213471345645e-30,61.9317589298435
CCNF,ILMN_1773119,"Homo sapiens cyclin F (CCNF), mRNA.",nucleus [goid 5634] [evidence IEA],cell division [goid 51301] [evidence IEA]; mitosis [goid 7067] [evidence IEA],,16,2448700-2448749,16p13.3d,+,NM_001761.1,899,CCNF,1.9675685607131026,7.890769349447897,16.18652251399741,7.661176445939963e-32,4.56507715746606e-30,61.86772329519053
TFAP2A,ILMN_1733135,"Homo sapiens transcription factor AP-2 alpha (activating enhancer binding protein 2 alpha) (TFAP2A), transcript variant 1, mRNA.",nucleus [goid 5634] [pmid 8321221] [evidence TAS]; nucleus [goid 5634] [pmid 12586840] [evidence IMP],"regulation of transcription, DNA-dependent [goid 6355] [evidence IEA]; signal transduction [goid 7165] [evidence NR ]; transcription [goid 6350] [evidence IEA]; regulation of transcription from RNA polymerase II promoter [goid 6357] [pmid 8321221] [evidence TAS]; ectoderm development [goid 7398] [pmid 8661133] [evidence TAS]; transcription [goid 6350] [evidence IEA]; ectoderm development [goid 7398] [pmid 8661133] [evidence TAS]; regulation of transcription from RNA polymerase II promoter [goid 6357] [pmid 8321221] [evidence TAS]; regulation of transcription, DNA-dependent [goid 6355] [evidence IEA]; signal transduction [goid 7165] [evidence NR ]","RNA polymerase II transcription factor activity, enhancer binding [goid 3705] [evidence NR ]; transcription coactivator activity [goid 3713] [pmid 8321221] [evidence TAS]; protein binding [goid 5515] [pmid 10987820] [evidence IPI]; transcription factor activity [goid 3700] [evidence IEA]; transcription coactivator activity [goid 3713] [pmid 8321221] [evidence TAS]; protein dimerization activity [goid 46983] [pmid 12072434] [evidence IDA]; transcription factor activity [goid 3700] [evidence IEA]; RNA polymerase II transcription factor activity, enhancer binding [goid 3705] [evidence NR ]",6,10523193-10523204:10523205-10523242,6p24.3a,-,NM_003220.2,7020,TFAP2A,1.3819111558102035,6.590616494388065,16.177266851143568,8.029384294759964e-32,4.769894908030424e-30,61.82092280138188
FRMD4A,ILMN_1678961,"Homo sapiens FERM domain containing 4A (FRMD4A), mRNA.",membrane [goid 16020] [evidence IEA]; cytoskeleton [goid 5856] [evidence IEA]; cytoplasm [goid 5737] [evidence IEA],,cytoskeletal protein binding [goid 8092] [evidence IEA]; binding [goid 5488] [evidence IEA],10,13726018-13726067,10p13d-p13c,-,NM_018027.2,55691,FRMD4A,-1.5808935546139873,7.61766431489264,-16.17069730756307,8.301473987786335e-32,4.916541661155524e-30,61.78769817884877
TRAP1,ILMN_1699737,"Homo sapiens TNF receptor-associated protein 1 (TRAP1), mRNA.",mitochondrion [goid 5739] [evidence IEA],protein folding [goid 6457] [evidence IEA],ATP binding [goid 5524] [evidence IEA]; unfolded protein binding [goid 51082] [evidence IEA]; nucleotide binding [goid 166] [evidence IEA]; tumor necrosis factor receptor binding [goid 5164] [pmid 7876093] [evidence NAS],16,3648842-3648867:3651989-3652012,16p13.3c,-,NM_016292.1,10131,TRAP1,1.1443329994777258,9.26974160889731,16.165514952886326,8.522631915128498e-32,5.0322267535236e-30,61.76148541516804
FLJ46072,ILMN_1751328,"Homo sapiens FLJ46072 protein (FLJ46072), mRNA.",,,,8,144878338-144878387,8q24.3g,-,NM_198488.1,286077,FLJ46072,1.665160200380825,9.755051389112097,16.15246362362904,9.106186099729942e-32,5.3605448988893635e-30,61.69545641301933
MGC7036,ILMN_1668743,"Homo sapiens hypothetical protein MGC7036 (MGC7036), mRNA.",,,,12,122466218-122466267,12q24.31d,-,NM_145058.1,196383,MGC7036,-1.397050343863965,8.871992549630773,-16.136641879008167,9.867717205795964e-32,5.79133945044983e-30,61.615383881551296
SPDEF,ILMN_2161330,"Homo sapiens SAM pointed domain containing ets transcription factor (SPDEF), mRNA.",nucleus [goid 5634] [evidence IEA],"regulation of transcription, DNA-dependent [goid 6355] [evidence IEA]; development [goid 7275] [pmid 10625666] [evidence TAS]; transcription [goid 6350] [evidence IEA]",sequence-specific DNA binding [goid 43565] [evidence IEA]; transcription factor activity [goid 3700] [evidence IEA]; protein binding [goid 5515] [pmid 10625666] [evidence TAS],6,34613689-34613738,6p21.31e,-,NM_012391.1,25803,SPDEF,3.228586119107561,7.300243222128572,16.108181106617284,1.1402321165038922e-31,6.656914116848913e-30,61.471270485569264
UBE2E2,ILMN_1707475,"Homo sapiens ubiquitin-conjugating enzyme E2E 2 (UBC4/5 homolog, yeast) (UBE2E2), mRNA.",,ubiquitin cycle [goid 6512] [evidence IEA],ubiquitin-protein ligase activity [goid 4842] [evidence IEA]; ligase activity [goid 16874] [evidence IEA],3,23606887-23606936,3p24.3a,+,NM_152653.1,7325,UBE2E2,-1.2659767619012108,10.16876099592447,-16.108033476304794,1.1410876648845457e-31,6.656914116848913e-30,61.47052269388794
LSR,ILMN_1749396,"Homo sapiens lipolysis stimulated lipoprotein receptor (LSR), transcript variant 1, mRNA.",plasma membrane [goid 5886] [evidence ISS]; integral to membrane [goid 16021] [evidence IEA]; chylomicron [goid 42627] [evidence IEA],lipoprotein transport [goid 42953] [evidence ISS]; liver development [goid 1889] [evidence ISS]; embryonic development [goid 9790] [evidence ISS],low-density lipoprotein binding [goid 30169] [evidence ISS]; triglyceride binding [goid 17129] [evidence ISS]; lipoprotein receptor activity [goid 30228] [evidence ISS]; receptor activity [goid 4872] [evidence IEA]; lipid transporter activity [goid 5319] [evidence IEA]; fatty acid binding [goid 5504] [evidence ISS],19,40450319-40450368,19q13.12a,+,NM_015925.5,51599,LSR,1.2151320930218903,6.542258295044232,16.09971424895773,1.1903561750389145e-31,6.923608976308433e-30,61.428379089831125
CCL23,ILMN_1686109,"Homo sapiens chemokine (C-C motif) ligand 23 (CCL23), transcript variant CKbeta8-1, mRNA.",extracellular region [goid 5576] [evidence IEA]; extracellular space [goid 5615] [evidence IEA]; extracellular region [goid 5576] [evidence IEA]; extracellular space [goid 5615] [evidence IEA],cell-cell signaling [goid 7267] [pmid 9104803] [evidence TAS]; negative regulation of cell proliferation [goid 8285] [pmid 9104803] [evidence TAS]; chemotaxis [goid 6935] [pmid 9104803] [evidence TAS]; calcium ion homeostasis [goid 6874] [pmid 9886417] [evidence TAS]; G-protein coupled receptor protein signaling pathway [goid 7186] [pmid 9886417] [evidence TAS]; signal transduction [goid 7165] [pmid 9886417] [evidence NAS]; inflammatory response [goid 6954] [pmid 9104803] [evidence TAS]; cell-cell signaling [goid 7267] [pmid 9104803] [evidence TAS]; negative regulation of cell proliferation [goid 8285] [pmid 9104803] [evidence TAS]; chemotaxis [goid 6935] [pmid 9104803] [evidence TAS]; calcium ion homeostasis [goid 6874] [pmid 9886417] [evidence TAS]; G-protein coupled receptor protein signaling pathway [goid 7186] [pmid 9886417] [evidence TAS]; signal transduction [goid 7165] [pmid 9886417] [evidence NAS]; inflammatory response [goid 6954] [pmid 9104803] [evidence TAS],heparin binding [goid 8201] [evidence IEA]; chemokine activity [goid 8009] [pmid 9886417] [evidence TAS]; heparin binding [goid 8201] [evidence IEA]; chemokine activity [goid 8009] [pmid 9886417] [evidence TAS],17,31364298-31364347,17q12b,-,NM_005064.3,6368,CCL23,-2.2094881576280105,7.773673195511196,-16.095761711985382,1.2145074799741745e-31,7.041547389151349e-30,61.40835338656093
TMEM45B,ILMN_1771120,"Homo sapiens transmembrane protein 45B (TMEM45B), mRNA.",,,,11,129235043-129235092,11q24.3b,+,NM_138788.2,120224,TMEM45B,2.63664673895964,7.76154338081756,16.095219193708026,1.2178606467251756e-31,7.041547389151349e-30,61.405604547363225
ANKRD22,ILMN_1799848,"Homo sapiens ankyrin repeat domain 22 (ANKRD22), mRNA.",,,,10,90572750-90572755:90573017-90573060,10q23.31b,-,NM_144590.1,118932,ANKRD22,2.614074042798963,6.9883610853374405,16.067869420071016,1.399528101031657e-31,8.067989659349656e-30,61.266982574247336
KIF20A,ILMN_1695658,"Homo sapiens kinesin family member 20A (KIF20A), mRNA.",microtubule associated complex [goid 5875] [evidence IEA]; microtubule [goid 5874] [evidence IEA]; Golgi apparatus [goid 5794] [pmid 9438855] [evidence TAS],vesicle-mediated transport [goid 16192] [pmid 9438855] [evidence TAS]; microtubule-based movement [goid 7018] [evidence IEA]; protein transport [goid 15031] [evidence IEA],microtubule motor activity [goid 3777] [evidence IEA]; transporter activity [goid 5215] [pmid 9438855] [evidence TAS]; nucleotide binding [goid 166] [evidence IEA]; ATP binding [goid 5524] [evidence IEA],5,137550940-137550989,5q31.2c,+,NM_005733.1,10112,KIF20A,2.156137778526456,6.731305671911078,16.061454721871126,1.4459387153306027e-31,8.31094863369227e-30,61.23445677677148
LOC387758,ILMN_1716247,"Homo sapiens similar to RIKEN cDNA 1110018M03 (LOC387758), mRNA.",,,,11,26974881-26974930,11p14.2a,+,NM_203371.1,387758,LOC387758,-1.9504357171904099,6.011721395174814,-16.01700363090979,1.8129604886784215e-31,1.0389863271146778e-29,61.00893171088036
ALOX5AP,ILMN_1797875,"Homo sapiens arachidonate 5-lipoxygenase-activating protein (ALOX5AP), mRNA.",membrane fraction [goid 5624] [evidence NR ]; membrane [goid 16020] [evidence IEA]; integral to membrane [goid 16021] [evidence IEA],leukotriene biosynthesis [goid 19370] [evidence IEA]; inflammatory response [goid 6954] [pmid 2300173] [evidence TAS],enzyme activator activity [goid 8047] [pmid 2300173] [evidence TAS]; binding [goid 5488] [pmid 2300173] [evidence TAS],13,30236347-30236396,13q12.3c,+,NM_001629.2,241,ALOX5AP,-2.241913412198782,12.290521118793434,-16.015325948179292,1.8285131026837956e-31,1.0448263286156527e-29,61.00041526799065
MARCO,ILMN_1731503,"Homo sapiens macrophage receptor with collagenous structure (MARCO), mRNA.",integral to plasma membrane [goid 5887] [pmid 9468508] [evidence TAS]; membrane [goid 16020] [evidence IEA]; cytoplasm [goid 5737] [evidence IEA],phosphate transport [goid 6817] [evidence IEA]; cell surface receptor linked signal transduction [goid 7166] [pmid 9468508] [evidence TAS],pattern recognition receptor activity [goid 8329] [pmid 10331948] [evidence TAS]; scavenger receptor activity [goid 5044] [evidence IEA],2,119468445-119468494,2q14.2b,+,NM_006770.3,8685,MARCO,-3.3656139019783105,9.976574094214692,-16.00972035375148,1.8814573295409258e-31,1.0719355574884485e-29,60.97195707696305
LHFP,ILMN_1767448,"Homo sapiens lipoma HMGIC fusion partner (LHFP), mRNA.",,,,13,38815518-38815567,13q13.3e,-,NM_005780.1,10186,LHFP,-2.081836429573242,9.304310292910014,-16.007425719441972,1.9035716593672536e-31,1.081372996582243e-29,60.96030671404161
KLF4,ILMN_1779857,"Homo sapiens Kruppel-like factor 4 (gut) (KLF4), mRNA.",nucleus [goid 5634] [pmid 9422764] [evidence ISS],"mesodermal cell fate determination [goid 7500] [pmid 8940147] [evidence TAS]; transcription [goid 6350] [evidence IEA]; negative regulation of cell proliferation [goid 8285] [pmid 8702718] [evidence TAS]; negative regulation of transcription, DNA-dependent [goid 45892] [pmid 9422764] [evidence IEP]",metal ion binding [goid 46872] [evidence IEA]; nucleic acid binding [goid 3676] [evidence IEA]; zinc ion binding [goid 8270] [pmid 9422764] [evidence NAS]; transcriptional activator activity [goid 16563] [pmid 9422764] [evidence NAS]; transcriptional repressor activity [goid 16564] [pmid 9422764] [evidence IEP]; transcription factor activity [goid 3700] [pmid 9422764] [evidence NAS],9,109287552-109287601,9q31.2b,-,NM_004235.3,9314,KLF4,-1.8050975996886303,7.119174723137105,-16.004854269610032,1.9286642082047262e-31,1.092442502815962e-29,60.94725015082712
PLEKHC1,ILMN_1695290,"Homo sapiens pleckstrin homology domain containing, family C (with FERM domain) member 1 (PLEKHC1), mRNA.",stress fiber [goid 1725] [evidence NAS]; cytoskeleton [goid 5856] [evidence IEA],regulation of cell shape [goid 8360] [evidence IEA]; cell adhesion [goid 7155] [evidence NAS]; actin cytoskeleton organization and biogenesis [goid 30036] [evidence NAS],protein binding [goid 5515] [evidence NAS],14,52393815-52393864,14q22.2a,-,NM_006832.1,10979,PLEKHC1,-1.3969920480716738,11.245461156903401,-15.999546900507895,1.981509897623173e-31,1.1191223291358702e-29,60.92029943322869
TMEM88,ILMN_1757129,"Homo sapiens transmembrane protein 88 (TMEM88), mRNA.",,,,17,7699966-7700015,17p13.1d,+,NM_203411.1,92162,TMEM88,-2.007895867352441,7.084499994690955,-15.994545915740154,2.032635446799774e-31,1.1446792393321847e-29,60.89490145314524
FCGR2A,ILMN_1666932,"Homo sapiens Fc fragment of IgG, low affinity IIa, receptor (CD32) (FCGR2A), mRNA.",plasma membrane [goid 5886] [pmid 2139735] [evidence NAS]; integral to membrane [goid 16021] [evidence IEA]; plasma membrane [goid 5886] [pmid 2139735] [evidence NAS]; integral to membrane [goid 16021] [evidence IEA],immune response [goid 6955] [evidence NR ]; immune response [goid 6955] [evidence NR ],receptor activity [goid 4872] [evidence IEA]; IgG binding [goid 19864] [evidence IEA]; receptor signaling protein activity [goid 5057] [evidence NR ]; receptor activity [goid 4872] [evidence IEA]; IgG binding [goid 19864] [evidence IEA]; receptor signaling protein activity [goid 5057] [evidence NR ],1,159755359-159755408,1q23.3a,+,NM_021642.2,2212,FCGR2A,-1.5737774566774956,8.415271525153354,-15.990246140976126,2.0776507676630705e-31,1.1666577869716118e-29,60.873062249581025
MARVELD3,ILMN_1710644,"Homo sapiens MARVEL domain containing 3 (MARVELD3), transcript variant 1, mRNA.",membrane [goid 16020] [evidence IEA],,,16,70233218-70233267,16q22.3a,+,NM_001017967.2,91862,MARVELD3,1.5704940724095549,6.7993948777688775,15.958528821424933,2.4421655732946372e-31,1.3653455020915428e-29,60.71189711779897
SAP18,ILMN_1752793,"Homo sapiens Sin3A-associated protein, 18kDa (SAP18), mRNA.",histone deacetylase complex [goid 118] [pmid 9150135] [evidence TAS],transcription [goid 6350] [evidence IEA]; regulation of transcription from RNA polymerase II promoter [goid 6357] [pmid 9150135] [evidence TAS],transcription corepressor activity [goid 3714] [pmid 9150135] [evidence TAS]; protein binding [goid 5515] [pmid 9150135] [evidence IPI],13,20620710-20620759,13q12.11b,+,NM_005870.3,10284,SAP18,-1.472814434614106,8.188249117940527,-15.95826124201703,2.4454995136256015e-31,1.3653455020915428e-29,60.71053695752843
WASF3,ILMN_1810797,"Homo sapiens WAS protein family, member 3 (WASF3), mRNA.",actin cytoskeleton [goid 15629] [evidence NR ],actin filament polymerization [goid 30041] [pmid 10381382] [evidence TAS]; protein complex assembly [goid 6461] [pmid 10381382] [evidence TAS],actin binding [goid 3779] [evidence IEA],13,26160641-26160690,13q12.13c,+,NM_006646.4,10810,WASF3,-2.1423335627855282,7.486687045695685,-15.943829433772152,2.632255488508331e-31,1.4654142341024237e-29,60.637164533702816
AHNAK,ILMN_1714567,"Homo sapiens AHNAK nucleoprotein (AHNAK), transcript variant 1, mRNA.",nucleus [goid 5634] [pmid 1608957] [evidence NAS],,protein binding [goid 5515] [evidence IEA],11,62040123-62040172,11q12.3a,-,NM_001620.1,79026,AHNAK,-1.5424847364540186,8.610379304212897,-15.931508596571277,2.80299325904945e-31,1.5560206168825793e-29,60.574504847849795
ST6GALNAC3,ILMN_1779061,"Homo sapiens ST6 (alpha-N-acetyl-neuraminyl-2,3-beta-galactosyl-1, 3)-N-acetylgalactosaminide alpha-2,6-sialyltransferase 3 (ST6GALNAC3), mRNA.",integral to Golgi membrane [goid 30173] [evidence IEA]; membrane [goid 16020] [evidence IEA]; integral to membrane [goid 16021] [evidence IEA]; integral to Golgi membrane [goid 30173] [evidence IEA]; membrane [goid 16020] [evidence IEA]; integral to membrane [goid 16021] [evidence IEA],protein amino acid glycosylation [goid 6486] [evidence IEA]; protein amino acid glycosylation [goid 6486] [evidence IEA],sialyltransferase activity [goid 8373] [evidence IEA]; sialyltransferase activity [goid 8373] [evidence IEA],1,76868513-76868562,1p31.1g-p31.1f,+,NM_152996.1,256435,ST6GALNAC3,-1.134036122023451,5.578965298175846,-15.89523190842548,3.373106836161042e-31,1.867187122232895e-29,60.38990896289313
PLA2G4F,ILMN_1744211,"Homo sapiens phospholipase A2, group IVF (PLA2G4F), mRNA.",membrane [goid 16020] [evidence IEA],phospholipid catabolism [goid 9395] [evidence IEA]; lipid catabolism [goid 16042] [evidence IEA],phospholipase A2 activity [goid 4623] [evidence IEA]; hydrolase activity [goid 16787] [evidence IEA]; phospholipase activity [goid 4620] [evidence IEA]; calcium ion binding [goid 5509] [evidence IEA],15,40220760-40220809,15q15.1d,-,NM_213600.2,255189,PLA2G4F,-2.615608175865412,8.194962214221057,-15.888226520375163,3.4959520522533966e-31,1.9297061115625335e-29,60.35424368254826
LOC400120,ILMN_1797526,"Homo sapiens hypothetical LOC400120 (LOC400120), mRNA.",,,,13,36169230-36169279,13q13.3b,+,NM_203451.1,400120,LOC400120,-1.7881582780968008,6.4797301996177845,-15.878599783553534,3.672130686668672e-31,2.0212278652468666e-29,60.30522331114308
HMMR,ILMN_1781942,"Homo sapiens hyaluronan-mediated motility receptor (RHAMM) (HMMR), transcript variant 2, mRNA.",,cell motility [goid 6928] [evidence NR ],hyaluronic acid binding [goid 5540] [evidence IEA],5,162851071-162851120,5q34c,+,NM_012485.1,3161,HMMR,1.8425265688464911,6.166235366840241,15.849823990578729,4.253758297661418e-31,2.334774096617823e-29,60.15862849357342
CANT1,ILMN_1664012,"Homo sapiens calcium activated nucleotidase 1 (CANT1), mRNA.",membrane [goid 16020] [evidence IEA]; integral to membrane [goid 16021] [evidence IEA]; endoplasmic reticulum [goid 5783] [evidence IEA],positive regulation of I-kappaB kinase/NF-kappaB cascade [goid 43123] [pmid 12761501] [evidence IMP],hydrolase activity [goid 16787] [evidence IEA]; signal transducer activity [goid 4871] [pmid 12761501] [evidence IMP]; nucleoside-diphosphatase activity [goid 17110] [evidence IEA]; calcium ion binding [goid 5509] [evidence IEA],17,74499665-74499714,17q25.3c,-,NM_138793.2,124583,CANT1,1.304533114085487,10.024689509149196,15.848555622255155,4.281425056821653e-31,2.3433586301171323e-29,60.15216469007501
MT1M,ILMN_1657435,"Homo sapiens metallothionein 1M (MT1M), mRNA.",,,cadmium ion binding [goid 46870] [evidence IEA]; zinc ion binding [goid 8270] [evidence IEA]; copper ion binding [goid 5507] [evidence IEA]; metal ion binding [goid 46872] [evidence IEA],16,55224074-55224123,16q13b,+,NM_176870.1,4499,MT1M,-3.8300467446639708,8.520325502797254,-15.829199740967946,4.726775079788707e-31,2.579865894388878e-29,60.05350050757711
KIAA0101,ILMN_1732150,"Homo sapiens KIAA0101 (KIAA0101), transcript variant 1, mRNA.",nucleus [goid 5634] [evidence IEA]; mitochondrion [goid 5739] [evidence IEA]; nucleus [goid 5634] [evidence IEA]; mitochondrion [goid 5739] [evidence IEA],,,15,62444630-62444679,15q22.31a,-,NM_014736.4,9768,KIAA0101,1.0462554365320003,9.300398283912713,15.816366157542932,5.0474308506252835e-31,2.747184081688091e-29,59.988058537122356
FBLN1,ILMN_1672536,"Homo sapiens fibulin 1 (FBLN1), transcript variant D, mRNA.",extracellular region [goid 5576] [pmid 14718574] [evidence NAS]; extracellular space [goid 5615] [pmid 2269669] [evidence TAS]; extracellular matrix (sensu Metazoa) [goid 5578] [pmid 2269669] [evidence TAS]; soluble fraction [goid 5625] [pmid 2269669] [evidence TAS],,extracellular matrix structural constituent [goid 5201] [pmid 2269669] [evidence TAS]; calcium ion binding [goid 5509] [evidence IEA],22,44375589-44375638,22q13.31c,+,NM_006486.2,2192,FBLN1,-1.370923238180504,8.559814058717063,-15.801621781359998,5.4429002070334305e-31,2.954175780892657e-29,59.912848932307014
KIAA1324L,ILMN_1652371,"Homo sapiens KIAA1324-like (KIAA1324L), mRNA.",,,,7,86347484-86347533,7q21.12a,-,NM_152748.2,222223,KIAA1324L,-2.396275387184808,8.302043794452223,-15.78938841423717,5.794549287889058e-31,3.1362998020699525e-29,59.8504282935922
IL17D,ILMN_1753823,"Homo sapiens interleukin 17D (IL17D), mRNA.",extracellular region [goid 5576] [evidence IEA]; extracellular space [goid 5615] [evidence IEA],inflammatory response [goid 6954] [evidence IEA],cytokine activity [goid 5125] [evidence IEA],13,20195083-20195132,13q12.11b,+,NM_138284.1,53342,IL17D,-1.786840202106923,7.523244968265075,-15.774370863618474,6.257593796698533e-31,3.377540585281743e-29,59.77377729901467
MYCT1,ILMN_1750225,"Homo sapiens myc target 1 (MYCT1), mRNA.",,,,6,153084758-153084807,6q25.2a,+,NM_025107.1,80177,MYCT1,-1.3680077549314396,5.706893329609835,-15.76989355102568,6.402708896693977e-31,3.446319968289562e-29,59.750919539885544
SESN1,ILMN_1800626,"Homo sapiens sestrin 1 (SESN1), mRNA.",nucleus [goid 5634] [pmid 9926927] [evidence TAS],response to DNA damage stimulus [goid 6974] [pmid 9926927] [evidence TAS]; cell cycle arrest [goid 7050] [pmid 9926927] [evidence TAS]; negative regulation of cell proliferation [goid 8285] [pmid 9926927] [evidence TAS],,6,109414622-109414671,6q21f,-,NM_014454.1,27244,SESN1,-1.5082133043639043,9.409411793433977,-15.769060643124769,6.4300750475373855e-31,3.4515154903930016e-29,59.74666708444833
KIF14,ILMN_1808071,"Homo sapiens kinesin family member 14 (KIF14), mRNA.",microtubule associated complex [goid 5875] [evidence IEA]; microtubule [goid 5874] [evidence IEA],microtubule-based movement [goid 7018] [evidence IEA],ATP binding [goid 5524] [evidence IEA]; microtubule motor activity [goid 3777] [evidence IEA]; nucleotide binding [goid 166] [evidence IEA],1,198788286-198788335,1q32.1b,-,NM_014875.1,9928,KIF14,1.3016910263058872,5.986481278520521,15.755791782944105,6.882228981373417e-31,3.684072299507171e-29,59.67891122076222
CASQ2,ILMN_1722329,"Homo sapiens calsequestrin 2 (cardiac muscle) (CASQ2), mRNA.",smooth endoplasmic reticulum [goid 5790] [evidence NR ],striated muscle contraction [goid 6941] [pmid 9795116] [evidence TAS]; heart development [goid 7507] [pmid 9795116] [evidence TAS]; muscle development [goid 7517] [evidence IEA],calcium ion binding [goid 5509] [evidence IEA],1,116044535-116044584,1p13.1d,-,NM_001232.1,845,CASQ2,-2.0078694022999137,6.100498625364906,-15.754328812567643,6.9339971292912555e-31,3.7016146318969895e-29,59.6714394697954
TIE1,ILMN_1815690,"Homo sapiens tyrosine kinase with immunoglobulin-like and EGF-like domains 1 (TIE1), mRNA.",integral to plasma membrane [goid 5887] [pmid 1312667] [evidence TAS],signal transduction [goid 7165] [pmid 1312667] [evidence TAS]; protein amino acid phosphorylation [goid 6468] [evidence IEA]; mesoderm development [goid 7498] [pmid 7596437] [evidence TAS],nucleotide binding [goid 166] [evidence IEA]; transmembrane receptor protein tyrosine kinase activity [goid 4714] [pmid 1312667] [evidence TAS]; receptor activity [goid 4872] [evidence IEA]; transferase activity [goid 16740] [evidence IEA]; ATP binding [goid 5524] [evidence IEA]; protein-tyrosine kinase activity [goid 4713] [evidence IEA],1,43561228-43561277,1p34.2a,+,NM_005424.2,7075,TIE1,-1.6442486376977135,7.11565920681197,-15.753091728062268,6.978077262683534e-31,3.7149681820597995e-29,59.66512117762814
DARC,ILMN_1723684,"Homo sapiens Duffy blood group, chemokine receptor (DARC), mRNA.",plasma membrane [goid 5886] [pmid 7689250] [evidence TAS]; integral to membrane [goid 16021] [evidence IEA],defense response [goid 6952] [pmid 10570183] [evidence NAS]; G-protein coupled receptor protein signaling pathway [goid 7186] [evidence IEA]; signal transduction [goid 7165] [evidence IEA],chemokine receptor activity [goid 4950] [evidence NAS]; rhodopsin-like receptor activity [goid 1584] [evidence IEA],1,157442608-157442657,1q23.2a,+,NM_002036.2,2532,DARC,-3.3493402288174856,9.470927899845478,-15.746465431219395,7.219023955731518e-31,3.832770620638382e-29,59.63127493417379
CPSF6,ILMN_1795454,"Homo sapiens cleavage and polyadenylation specific factor 6, 68kDa (CPSF6), mRNA.",nucleus [goid 5634] [evidence IEA]; mRNA cleavage factor complex [goid 5849] [pmid 9659921] [evidence IDA],mRNA processing [goid 6397] [pmid 14690600] [evidence IDA],RNA binding [goid 3723] [pmid 8626397] [evidence IDA]; nucleotide binding [goid 166] [evidence IEA]; protein binding [goid 5515] [pmid 15169763] [evidence IPI],12,67950813-67950862,12q15c,+,NM_007007.1,11052,CPSF6,1.0403794113301643,6.632932936861711,15.739461284147579,7.482802606654238e-31,3.9620219780070064e-29,59.59549307958686
LRRN3,ILMN_1773650,"Homo sapiens leucine rich repeat neuronal 3 (LRRN3), mRNA.",extracellular matrix (sensu Metazoa) [goid 5578] [evidence IEA],,,7,110552004-110552053,7q31.1b,+,NM_018334.3,54674,LRRN3,-2.2257938068370775,6.349145229537371,-15.72637683568896,8.001783742236184e-31,4.2253321468149607e-29,59.5286335755014
KCNK5,ILMN_1766918,"Homo sapiens potassium channel, subfamily K, member 5 (KCNK5), mRNA.",membrane fraction [goid 5624] [evidence NR ]; membrane [goid 16020] [evidence IEA]; integral to plasma membrane [goid 5887] [pmid 9812978] [evidence TAS],ion transport [goid 6811] [evidence IEA]; potassium ion transport [goid 6813] [pmid 9812978] [evidence TAS]; excretion [goid 7588] [pmid 9812978] [evidence TAS],potassium ion binding [goid 30955] [evidence IEA]; potassium channel activity [goid 5267] [pmid 9812978] [evidence TAS]; voltage-gated ion channel activity [goid 5244] [evidence IEA],6,39265062-39265111,6p21.2b,-,NM_003740.2,8645,KCNK5,2.0707339073942697,7.5105542378694485,15.709136599399585,8.74122459764214e-31,4.59091000768348e-29,59.44050800675633
OR7E37P,ILMN_2199926,"Homo sapiens olfactory receptor, family 7, subfamily E, member 37 pseudogene (OR7E37P) on chromosome 13.",,,,13,40915657-40915706,13q14.11b,+,NR_002163.2,26636,OR7E37P,-1.7390303781188239,6.801420645546157,-15.700734055571825,9.126117274244532e-31,4.780171910985342e-29,59.39754476696591
FUT3,ILMN_1653358,"Homo sapiens fucosyltransferase 3 (galactoside 3(4)-L-fucosyltransferase, Lewis blood group) (FUT3), mRNA.",membrane fraction [goid 5624] [pmid 1977660] [evidence TAS]; membrane [goid 16020] [evidence IEA]; integral to membrane [goid 16021] [evidence IEA]; Golgi stack [goid 5795] [evidence IEA],protein amino acid glycosylation [goid 6486] [evidence IEA]; carbohydrate metabolism [goid 5975] [pmid 1977660] [evidence TAS],"3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase activity [goid 17060] [evidence IEA]; transferase activity, transferring glycosyl groups [goid 16757] [evidence IEA]",19,5794132-5794181,19p13.3b,-,NM_000149.1,2525,FUT3,2.5264811918739714,7.670210062773586,15.69577986037924,9.360983534996679e-31,4.890047297035128e-29,59.37220948699424
TTYH3,ILMN_1692731,"Homo sapiens tweety homolog 3 (Drosophila) (TTYH3), mRNA.",,,,7,2670726-2670775,7p22.2c,+,NM_025250.2,80727,TTYH3,2.001947593324788,8.932126073964323,15.644905875438555,1.2153875356293298e-30,6.332039072657083e-29,59.11187891828253
PPARG,ILMN_1679901,"Homo sapiens peroxisome proliferative activated receptor, gamma (PPARG), transcript variant 3, mRNA.",nucleus [goid 5634] [evidence IEA],signal transduction [goid 7165] [pmid 9568716] [evidence TAS]; generation of precursor metabolites and energy [goid 6091] [pmid 10622252] [evidence TAS]; white fat cell differentiation [goid 50872] [pmid 12588810] [evidence TAS]; transcription [goid 6350] [evidence IEA]; regulation of transcription from RNA polymerase II promoter [goid 6357] [pmid 9568715] [evidence TAS]; lipid metabolism [goid 6629] [pmid 9568716] [evidence TAS]; response to nutrient [goid 7584] [pmid 10973253] [evidence TAS],metal ion binding [goid 46872] [evidence IEA]; protein binding [goid 5515] [pmid 12040021] [evidence IPI]; steroid hormone receptor activity [goid 3707] [evidence IEA]; zinc ion binding [goid 8270] [evidence IEA]; sequence-specific DNA binding [goid 43565] [evidence IEA]; transcription factor activity [goid 3700] [pmid 10622252] [evidence TAS],3,12305445-12305494,3p25.2a-p25.1d,+,NM_138711.2,5468,PPARG,-1.4317966909654771,6.764448098648073,-15.638515328157887,1.2559372648927947e-30,6.525850028382961e-29,59.07915609382373
TLR8,ILMN_1657892,"Homo sapiens toll-like receptor 8 (TLR8), transcript variant 2, mRNA.",membrane [goid 16020] [evidence IEA]; integral to membrane [goid 16021] [pmid 12032557] [evidence IC ],positive regulation of interleukin-8 biosynthesis [goid 45416] [pmid 16188996] [evidence IMP]; detection of virus [goid 9597] [pmid 12032557] [evidence NAS]; defense response to virus [goid 51607] [pmid 16188996] [evidence IMP]; positive regulation of interferon-gamma biosynthesis [goid 45078] [pmid 16286015] [evidence IDA]; positive regulation of interferon-beta biosynthesis [goid 45359] [pmid 16286015] [evidence IDA]; positive regulation of innate immune response [goid 45089] [pmid 16123302] [evidence IDA]; innate immune response [goid 45087] [pmid 12032557] [evidence NAS]; I-kappaB kinase/NF-kappaB cascade [goid 7249] [pmid 12032557] [evidence NAS]; inflammatory response [goid 6954] [evidence IEA],transferase activity [goid 16740] [evidence IEA]; transmembrane receptor activity [goid 4888] [evidence IEA]; DNA binding [goid 3677] [pmid 16123302] [evidence IDA]; double-stranded RNA binding [goid 3725] [pmid 16111635] [evidence IDA]; single-stranded RNA binding [goid 3727] [pmid 14976262] [evidence IDA]; Toll binding [goid 5121] [pmid 12032557] [evidence NAS],X,12850750-12850799,Xp22.2,+,NM_138636.2,51311,TLR8,-2.0845202738517186,6.846633726492372,-15.63473835863174,1.2805392241521925e-30,6.635985846437626e-29,59.05981386931086
MELK,ILMN_1731184,"Homo sapiens maternal embryonic leucine zipper kinase (MELK), mRNA.",,protein amino acid phosphorylation [goid 6468] [evidence IEA],protein serine/threonine kinase activity [goid 4674] [evidence IEA]; transferase activity [goid 16740] [evidence IEA]; nucleotide binding [goid 166] [evidence IEA]; ATP binding [goid 5524] [evidence IEA],9,36667223-36667272,9p13.2b,+,NM_014791.2,9833,MELK,2.0899346465285564,6.427985271675365,15.63010865693483,1.3113569367802324e-30,6.777663106939742e-29,59.03610245591577
ANLN,ILMN_1739645,"Homo sapiens anillin, actin binding protein (ANLN), mRNA.",contractile ring [goid 5826] [pmid 10931866] [evidence IDA]; nucleus [goid 5634] [evidence IEA],mitosis [goid 7067] [evidence IEA]; cell cycle [goid 7049] [evidence IEA]; cytokinesis [goid 910] [pmid 10931866] [evidence IDA],actin binding [goid 3779] [pmid 10931866] [evidence IDA],7,36459286-36459335,7p14.2a,+,NM_018685.2,54443,ANLN,1.8503097783693834,6.323230917472142,15.62489164708145,1.346977755608387e-30,6.943349621171805e-29,59.009380104564116
BIRC5,ILMN_1803124,"Homo sapiens baculoviral IAP repeat-containing 5 (survivin) (BIRC5), transcript variant 3, mRNA.","chromosome, pericentric region [goid 775] [pmid 11084331] [evidence IDA]; midbody [goid 30496] [pmid 11084331] [evidence IDA]; spindle microtubule [goid 5876] [pmid 9859993] [evidence TAS]; intracellular [goid 5622] [evidence IEA]",G2/M transition of mitotic cell cycle [goid 86] [pmid 9859993] [evidence IDA]; apoptosis [goid 6915] [evidence IEA]; anti-apoptosis [goid 6916] [pmid 9859993] [evidence IDA],metal ion binding [goid 46872] [evidence IEA]; protein binding [goid 5515] [pmid 11024045] [evidence IPI]; microtubule binding [goid 8017] [pmid 9859993] [evidence IDA]; cysteine protease inhibitor activity [goid 4869] [evidence IEA]; zinc ion binding [goid 8270] [evidence NAS]; caspase inhibitor activity [goid 43027] [pmid 9859993] [evidence IMP],17,73733114-73733163,17q25.3b,+,NM_001012271.1,332,BIRC5,1.67143818681288,6.004094638004972,15.59901172850676,1.5385816938827443e-30,7.91009612277184e-29,58.876772275635304
IGSF10,ILMN_1682100,"Homo sapiens immunoglobulin superfamily, member 10 (IGSF10), mRNA.",,protein amino acid phosphorylation [goid 6468] [evidence IEA],ATP binding [goid 5524] [evidence IEA]; transferase activity [goid 16740] [evidence IEA]; vascular endothelial growth factor receptor activity [goid 5021] [evidence IEA],3,152637696-152637745,3q25.1c,-,NM_178822.3,285313,IGSF10,-1.820524503156017,5.7046725802817715,-15.59736688927508,1.55164632541136e-30,7.956270697536934e-29,58.86834154526754
RNF43,ILMN_1700606,"Homo sapiens ring finger protein 43 (RNF43), mRNA.",,,zinc ion binding [goid 8270] [evidence IEA]; metal ion binding [goid 46872] [evidence IEA]; protein binding [goid 5515] [evidence IEA],17,53786311-53786360,17q22d,-,NM_017763.3,54894,RNF43,1.9280679887838037,6.981246401005729,15.596522792785509,1.5583940194610273e-30,7.969896973542814e-29,58.86401495191829
HHIP,ILMN_1675453,"Homo sapiens hedgehog interacting protein (HHIP), mRNA.",,,,4,145878446-145878495,4q31.22a,+,NM_022475.1,64399,HHIP,-2.3101067367482306,6.627089478695304,-15.5849027343754,1.6543368213490918e-30,8.438417006279333e-29,58.80444550535469
MSRA,ILMN_2228180,"Homo sapiens methionine sulfoxide reductase A (MSRA), mRNA.",,protein metabolism [goid 19538] [evidence IEA]; protein modification [goid 6464] [pmid 10452521] [evidence TAS]; response to oxidative stress [goid 6979] [pmid 10452521] [evidence TAS]; methionine metabolism [goid 6555] [pmid 10452521] [evidence TAS],oxidoreductase activity [goid 16491] [evidence IEA]; protein-methionine-S-oxide reductase activity [goid 8113] [pmid 10452521] [evidence TAS],8,10323581-10323630,8p23.1c,+,NM_012331.2,4482,MSRA,-1.347207814857187,9.05940858127412,-15.576281509065268,1.7293337976103644e-30,8.797929254944635e-29,58.760239255207196
Gcom1,ILMN_1660403,"Homo sapiens GRINL1A combined protein (Gcom1), transcript variant 9, mRNA.",,,,15,55788274-55788323,15q21.3d,+,NM_001018097.1,145781,Gcom1,-1.2158112223004203,5.613782606868295,-15.5714571398388,1.7727820412868165e-30,8.995483873560839e-29,58.73549802950676
LTBP4,ILMN_1665219,"Homo sapiens latent transforming growth factor beta binding protein 4 (LTBP4), mRNA.",extracellular matrix (sensu Metazoa) [goid 5578] [pmid 9660815] [evidence NAS],regulation of cell differentiation [goid 45595] [evidence ISS]; development [goid 7275] [evidence ISS]; regulation of proteolysis [goid 30162] [evidence ISS]; growth hormone secretion [goid 30252] [evidence ISS]; regulation of transforming growth factor beta receptor signaling pathway [goid 17015] [evidence ISS]; protein folding [goid 6457] [evidence ISS]; regulation of cell growth [goid 1558] [evidence ISS]; cell growth [goid 16049] [pmid 9660815] [evidence TAS],growth factor activity [goid 8083] [pmid 9660815] [evidence TAS]; growth factor binding [goid 19838] [evidence IEA]; glycosaminoglycan binding [goid 5539] [evidence ISS]; integrin binding [goid 5178] [evidence ISS]; calcium ion binding [goid 5509] [evidence NAS]; transforming growth factor beta receptor activity [goid 5024] [pmid 9660815] [evidence NAS],19,45827396-45827445,19q13.2b,+,NM_003573.1,8425,LTBP4,-1.7231934501713777,8.195522107186136,-15.54968436551066,1.98291988171676e-30,1.003563477798729e-28,58.62380531815985
SFTPA1,ILMN_1689114,"Homo sapiens surfactant, pulmonary-associated protein A1B (SFTPA1B), mRNA.",cytoplasm [goid 5737] [evidence IEA]; cytoplasm [goid 5737] [evidence IEA],phosphate transport [goid 6817] [evidence IEA]; respiratory gaseous exchange [goid 7585] [evidence IEA]; regulation of liquid surface tension [goid 50828] [evidence IEA]; phosphate transport [goid 6817] [evidence IEA]; respiratory gaseous exchange [goid 7585] [evidence IEA]; regulation of liquid surface tension [goid 50828] [evidence IEA],sugar binding [goid 5529] [evidence IEA]; calcium ion binding [goid 5509] [evidence IEA]; sugar binding [goid 5529] [evidence IEA]; calcium ion binding [goid 5509] [evidence IEA],10,81361590-81361639,10q22.3f,+,NM_005411.3,6435,SFTPA1,-4.812567666971846,10.240155328177448,-15.547032407934756,2.0101682773714335e-30,1.012096549258166e-28,58.610197225791254
KIF2C,ILMN_1685916,"Homo sapiens kinesin family member 2C (KIF2C), mRNA.","microtubule associated complex [goid 5875] [evidence IEA]; microtubule [goid 5874] [evidence IEA]; nucleus [goid 5634] [evidence IEA]; chromosome, pericentric region [goid 775] [evidence IEA]; kinesin complex [goid 5871] [pmid 9434124] [evidence TAS]",microtubule-based movement [goid 7018] [evidence IEA]; cell proliferation [goid 8283] [pmid 9434124] [evidence TAS]; mitosis [goid 7067] [pmid 9434124] [evidence TAS],centromeric DNA binding [goid 19237] [pmid 9434124] [evidence TAS]; microtubule motor activity [goid 3777] [pmid 9434124] [evidence TAS]; nucleotide binding [goid 166] [evidence IEA]; ATP binding [goid 5524] [evidence IEA]; protein binding [goid 5515] [pmid 11092768] [evidence IPI],1,45005776-45005825,1p34.1d,+,NM_006845.2,11004,KIF2C,1.8809175628673804,6.3771882348870506,15.547032370372996,2.0101686659631015e-30,1.012096549258166e-28,58.61019703304338
TNFSF13,ILMN_1784264,"Homo sapiens tumor necrosis factor (ligand) superfamily, member 13 (TNFSF13), transcript variant gamma, mRNA.",membrane [goid 16020] [evidence IEA]; extracellular space [goid 5615] [evidence IEA],immune response [goid 6955] [evidence IEA]; signal transduction [goid 7165] [pmid 9743536] [evidence TAS]; positive regulation of cell proliferation [goid 8284] [pmid 9743536] [evidence TAS]; positive regulation of isotype switching to IgA isotypes [goid 48298] [pmid 14988498] [evidence IDA],tumor necrosis factor receptor binding [goid 5164] [evidence IEA],17,7404833-7404858:7405040-7405046:7405047-7405063,17p13.1d,+,NM_172088.1,8741,TNFSF13,-1.718218535219087,6.4526915113525956,-15.544544485401424,2.036073058898772e-30,1.0224969987794477e-28,58.59743011347321
C20orf100,ILMN_2082209,"Homo sapiens chromosome 20 open reading frame 100 (C20orf100), mRNA.",nucleus [goid 5634] [evidence IEA],"transcription [goid 6350] [evidence IEA]; regulation of transcription, DNA-dependent [goid 6355] [evidence IEA]",DNA binding [goid 3677] [evidence IEA],20,42131524-42131573,20q13.12a,+,NM_032883.1,84969,C20orf100,-1.7184806509251214,10.500168694758575,-15.543663177876685,2.0453296229637496e-30,1.0245050823508653e-28,58.592907392595265
ADAMTSL3,ILMN_1798690,"Homo sapiens ADAMTS-like 3 (ADAMTSL3), mRNA.",,integrin-mediated signaling pathway [goid 7229] [evidence IEA],metallopeptidase activity [goid 8237] [evidence IEA],15,82499175-82499224,15q25.2b,+,NM_207517.1,57188,ADAMTSL3,-2.0481940625314214,6.335015045829511,-15.543031529353696,2.051989955871168e-30,1.0252057510294797e-28,58.589665824173636
NME1,ILMN_1713875,"Homo sapiens non-metastatic cells 1, protein (NM23A) expressed in (NME1), transcript variant 1, mRNA.",nucleus [goid 5634] [pmid 16130169] [evidence TAS]; cytoplasm [goid 5737] [pmid 16130169] [evidence TAS]; nucleus [goid 5634] [pmid 16130169] [evidence TAS]; cytoplasm [goid 5737] [pmid 16130169] [evidence TAS],UTP biosynthesis [goid 6228] [evidence IEA]; GTP biosynthesis [goid 6183] [evidence IEA]; regulation of apoptosis [goid 42981] [pmid 16130169] [evidence TAS]; cell cycle [goid 7049] [evidence IEA]; nucleoside triphosphate biosynthesis [goid 9142] [evidence NAS]; nucleotide metabolism [goid 9117] [evidence IEA]; negative regulation of cell proliferation [goid 8285] [pmid 1851158] [evidence TAS]; CTP biosynthesis [goid 6241] [evidence IEA]; UTP biosynthesis [goid 6228] [evidence IEA]; GTP biosynthesis [goid 6183] [evidence IEA]; regulation of apoptosis [goid 42981] [pmid 16130169] [evidence TAS]; cell cycle [goid 7049] [evidence IEA]; nucleoside triphosphate biosynthesis [goid 9142] [evidence NAS]; nucleotide metabolism [goid 9117] [evidence IEA]; negative regulation of cell proliferation [goid 8285] [pmid 1851158] [evidence TAS]; CTP biosynthesis [goid 6241] [evidence IEA],kinase activity [goid 16301] [evidence IEA]; transferase activity [goid 16740] [evidence IEA]; DNA binding [goid 3677] [pmid 11555662] [evidence IC ]; ATP binding [goid 5524] [evidence NAS]; deoxyribonuclease activity [goid 4536] [pmid 11555662] [evidence IDA]; nucleotide binding [goid 166] [evidence IEA]; magnesium ion binding [goid 287] [pmid 11555662] [evidence IDA]; kinase activity [goid 16301] [evidence IEA]; transferase activity [goid 16740] [evidence IEA]; DNA binding [goid 3677] [pmid 11555662] [evidence IC ]; ATP binding [goid 5524] [evidence NAS]; deoxyribonuclease activity [goid 4536] [pmid 11555662] [evidence IDA]; nucleotide binding [goid 166] [evidence IEA]; magnesium ion binding [goid 287] [pmid 11555662] [evidence IDA],17,46586724-46586733:46586734-46586773,17q21.33b,+,NM_198175.1,4830,NME1,1.269616174808899,8.179131423442145,15.540822166851829,2.0754580994594187e-30,1.0342787996922448e-28,58.57832719423746
SDCBP,ILMN_2363586,"Homo sapiens syndecan binding protein (syntenin) (SDCBP), transcript variant 2, mRNA.",interleukin-5 receptor complex [goid 5895] [pmid 11498591] [evidence ISS]; nucleus [goid 5634] [pmid 11179419] [evidence NAS]; membrane [goid 16020] [pmid 9391086] [evidence NAS]; cytoskeleton [goid 5856] [pmid 9391086] [evidence NAS]; adherens junction [goid 5912] [pmid 11179419] [evidence NAS]; endoplasmic reticulum [goid 5783] [evidence IEA]; interleukin-5 receptor complex [goid 5895] [pmid 11498591] [evidence ISS]; nucleus [goid 5634] [pmid 11179419] [evidence NAS]; membrane [goid 16020] [pmid 9391086] [evidence NAS]; cytoskeleton [goid 5856] [pmid 9391086] [evidence NAS]; adherens junction [goid 5912] [pmid 11179419] [evidence NAS]; endoplasmic reticulum [goid 5783] [evidence IEA],"synaptic transmission [goid 7268] [pmid 9883737] [evidence NAS]; substrate-bound cell migration, cell extension [goid 6930] [pmid 12037664] [evidence NAS]; metabolism [goid 8152] [evidence IEA]; protein targeting to membrane [goid 6612] [pmid 10230395] [evidence NAS]; intracellular signaling cascade [goid 7242] [pmid 9391086] [evidence NAS]; actin cytoskeleton organization and biogenesis [goid 30036] [pmid 12037664] [evidence NAS]; synaptic transmission [goid 7268] [pmid 9883737] [evidence NAS]; substrate-bound cell migration, cell extension [goid 6930] [pmid 12037664] [evidence NAS]; metabolism [goid 8152] [evidence IEA]; protein targeting to membrane [goid 6612] [pmid 10230395] [evidence NAS]; intracellular signaling cascade [goid 7242] [pmid 9391086] [evidence NAS]; actin cytoskeleton organization and biogenesis [goid 30036] [pmid 12037664] [evidence NAS]",protein heterodimerization activity [goid 46982] [pmid 11152476] [evidence IPI]; neurexin binding [goid 42043] [pmid 11152476] [evidence ISS]; protein binding [goid 5515] [evidence IEA]; oxidoreductase activity [goid 16491] [evidence IEA]; cytoskeletal adaptor activity [goid 8093] [pmid 9391086] [evidence NAS]; interleukin-5 receptor binding [goid 5137] [pmid 11498591] [evidence ISS]; syndecan binding [goid 45545] [pmid 9391086] [evidence NAS]; protein heterodimerization activity [goid 46982] [pmid 11152476] [evidence IPI]; neurexin binding [goid 42043] [pmid 11152476] [evidence ISS]; protein binding [goid 5515] [evidence IEA]; oxidoreductase activity [goid 16491] [evidence IEA]; cytoskeletal adaptor activity [goid 8093] [pmid 9391086] [evidence NAS]; interleukin-5 receptor binding [goid 5137] [pmid 11498591] [evidence ISS]; syndecan binding [goid 45545] [pmid 9391086] [evidence NAS],8,59657151-59657200,8q12.1c,+,NM_001007067.1,6386,SDCBP,-1.7549883915324234,9.974790111794112,-15.539207337852249,2.0927813797413156e-30,1.040251152659682e-28,58.57003940224402
AURKB,ILMN_1684217,"Homo sapiens aurora kinase B (AURKB), mRNA.",,protein amino acid phosphorylation [goid 6468] [evidence IEA]; cell cycle [goid 7049] [evidence IEA],protein serine/threonine kinase activity [goid 4674] [evidence IEA]; transferase activity [goid 16740] [evidence IEA]; nucleotide binding [goid 166] [evidence IEA]; protein binding [goid 5515] [pmid 16179162] [evidence IPI]; ATP binding [goid 5524] [evidence IEA]; protein-tyrosine kinase activity [goid 4713] [evidence IEA],17,8049067-8049087:8049259-8049287,17p13.1c,-,NM_004217.1,9212,AURKB,2.383902315563801,6.740458253351729,15.536893026719342,2.117861961706235e-30,1.0500391939909922e-28,58.5581611305026
HBEGF,ILMN_2121408,"Homo sapiens heparin-binding EGF-like growth factor (HBEGF), mRNA.",integral to plasma membrane [goid 5887] [pmid 15389565] [evidence TAS]; membrane [goid 16020] [evidence IEA]; extracellular space [goid 5615] [pmid 15389565] [evidence TAS]; cell surface [goid 9986] [pmid 15289334] [evidence NAS],muscle development [goid 7517] [pmid 8347598] [evidence TAS]; signal transduction [goid 7165] [pmid 1840698] [evidence TAS],receptor activity [goid 4872] [evidence IEA]; heparin binding [goid 8201] [pmid 8300582] [evidence IMP]; growth factor activity [goid 8083] [evidence IEA]; epidermal growth factor receptor binding [goid 5154] [pmid 10749879] [evidence TAS],5,139692882-139692931,5q31.3a,-,NM_001945.1,1839,HBEGF,-2.4129371599292817,9.647542472625075,-15.52790370734125,2.2181779350129574e-30,1.0969846970489208e-28,58.51201730868374
ST14,ILMN_1699887,"Homo sapiens suppression of tumorigenicity 14 (colon carcinoma, matriptase, epithin) (ST14), mRNA.",integral to plasma membrane [goid 5887] [pmid 10831593] [evidence TAS]; plasma membrane [goid 5886] [pmid 10831593] [evidence TAS],,serine-type endopeptidase activity [goid 4252] [evidence IEA],11,129585022-129585071,11q24.3c,+,NM_021978.2,6768,ST14,1.88522837819969,9.336882751799868,15.525779065002942,2.2425768992874936e-30,1.10624331348397e-28,58.501109767317104
FLJ40629,ILMN_1751776,"Homo sapiens cytoskeleton associated protein 2-like (CKAP2L), mRNA.",,,,2,113212054-113212103,2q13d,-,NM_152515.2,150468,FLJ40629,1.8043854791940168,6.040016738327343,15.522794643190908,2.277305328178305e-30,1.1205377353422796e-28,58.48578738882064
AQP9,ILMN_1715068,"Homo sapiens aquaporin 9 (AQP9), mRNA.",integral to plasma membrane [goid 5887] [evidence ISS]; membrane [goid 16020] [evidence IEA],carboxylic acid transport [goid 46942] [pmid 9733774] [evidence TAS]; immune response [goid 6955] [evidence ISS]; response to mercury ion [goid 46689] [pmid 9733774] [evidence IDA]; purine transport [goid 6863] [pmid 9733774] [evidence IDA]; response to osmotic stress [goid 6970] [pmid 9733774] [evidence TAS]; amine transport [goid 15837] [pmid 9733774] [evidence IDA]; water transport [goid 6833] [pmid 9733774] [evidence IDA]; metabolism [goid 8152] [pmid 9733774] [evidence TAS]; water homeostasis [goid 30104] [pmid 9733774] [evidence NAS]; response to organic substance [goid 10033] [pmid 9733774] [evidence IDA]; pyrimidine transport [goid 15855] [pmid 9733774] [evidence IDA]; polyol transport [goid 15791] [pmid 9733774] [evidence IDA]; nutrient import [goid 9935] [pmid 9733774] [evidence TAS]; excretion [goid 7588] [pmid 9733774] [evidence TAS],polyol transporter activity [goid 15166] [pmid 9733774] [evidence TAS]; purine transporter activity [goid 5345] [pmid 9733774] [evidence IDA]; water channel activity [goid 15250] [pmid 9733774] [evidence IDA]; pyrimidine transporter activity [goid 5350] [pmid 9733774] [evidence IDA]; amine transporter activity [goid 5275] [pmid 9733774] [evidence TAS]; porin activity [goid 15288] [pmid 9733774] [evidence NAS]; carboxylic acid transporter activity [goid 46943] [pmid 9733774] [evidence TAS],15,56265152-56265201,15q22.1a,+,NM_020980.2,366,AQP9,-2.4298613676188987,8.585239990059733,-15.510743014876834,2.4231275021373544e-30,1.1892856266787495e-28,58.42390243415694
OCIAD2,ILMN_1700306,"Homo sapiens OCIA domain containing 2 (OCIAD2), transcript variant 1, mRNA.",,,,4,48582339-48582339:48589546-48589594,4p12a,-,NM_001014446.1,132299,OCIAD2,1.7539411202045212,10.462242432051227,15.507992520916606,2.4577013902883305e-30,1.2032239092906563e-28,58.40977633588966
MUSTN1,ILMN_1773814,"Homo sapiens musculoskeletal, embryonic nuclear protein 1 (MUSTN1), mRNA.",,,,3,52842264-52842313,3p21.1c,-,NM_205853.1,389125,MUSTN1,-1.5209422905187635,6.776187981274859,-15.500750261180183,2.5511255986896087e-30,1.245831636352557e-28,58.372577074600855
TMEM132A,ILMN_2317923,"Homo sapiens transmembrane protein 132A (TMEM132A), transcript variant 2, mRNA.",integral to membrane [goid 16021] [evidence IEA],,,11,60460878-60460927,11q12.2a,+,NM_178031.2,54972,TMEM132A,1.9527605145587792,7.592268301236372,15.464395572784856,3.076846386375083e-30,1.4988087959629623e-28,58.185753037883146
SCN4B,ILMN_1695947,"Homo sapiens sodium channel, voltage-gated, type IV, beta (SCN4B), mRNA.",membrane [goid 16020] [evidence IEA]; voltage-gated sodium channel complex [goid 1518] [pmid 12930796] [evidence IDA]; integral to membrane [goid 16021] [evidence IEA],sodium ion transport [goid 6814] [pmid 12930796] [evidence IDA]; synaptic transmission [goid 7268] [pmid 12930796] [evidence ISS]; ion transport [goid 6811] [evidence IEA],voltage-gated sodium channel activity [goid 5248] [pmid 12930796] [evidence IDA]; sodium ion binding [goid 31402] [evidence IEA],11,117509646-117509695,11q23.3d,-,NM_174934.1,6330,SCN4B,-2.315352574824571,6.983984869721445,-15.453207646852093,3.2595781280167245e-30,1.583862339760745e-28,58.12822855192982
TCEAL7,ILMN_1753525,"Homo sapiens transcription elongation factor A (SII)-like 7 (TCEAL7), mRNA.",nucleus [goid 5634] [evidence IEA]; nucleus [goid 5634] [evidence IEA],"transcription [goid 6350] [evidence IEA]; regulation of transcription, DNA-dependent [goid 6355] [evidence IEA]; transcription [goid 6350] [evidence IEA]; regulation of transcription, DNA-dependent [goid 6355] [evidence IEA]",,X,102473239-102473288,Xq22.1e,+,NM_152278.1,56849,TCEAL7,-1.5550844186430153,5.874493838495595,-15.449414796104147,3.323969062372938e-30,1.6111327656800176e-28,58.10872375079168
HOOK1,ILMN_1741406,"Homo sapiens hook homolog 1 (Drosophila) (HOOK1), mRNA.",cytoskeleton [goid 5856] [evidence IEA]; microtubule [goid 5874] [evidence IEA]; cytoplasm [goid 5737] [evidence IEA],microtubule cytoskeleton organization and biogenesis [goid 226] [evidence IEA]; spermatogenesis [goid 7283] [evidence IEA]; cell differentiation [goid 30154] [evidence IEA],microtubule binding [goid 8017] [evidence IEA],1,60111064-60111113,1p32.1c,+,NM_015888.3,51361,HOOK1,2.2531394014138364,8.68249524882227,15.443484004796364,3.427225987517704e-30,1.6570595128233863e-28,58.07822124548355
SEC22C,ILMN_1664051,"Homo sapiens SEC22 vesicle trafficking protein homolog C (S. cerevisiae) (SEC22C), transcript variant 2, mRNA.",integral to membrane [goid 16021] [pmid 9501016] [evidence TAS]; endoplasmic reticulum [goid 5783] [pmid 9501016] [evidence TAS]; integral to membrane [goid 16021] [pmid 9501016] [evidence TAS]; endoplasmic reticulum [goid 5783] [pmid 9501016] [evidence TAS],vesicle-mediated transport [goid 16192] [evidence IEA]; vesicle-mediated transport [goid 16192] [evidence IEA],,3,42574132-42574181,3p22.1a,-,NM_004206.2,9117,SEC22C,-1.3783271496745737,8.929989491431028,-15.429870195603883,3.676597753868455e-30,1.7732303770823478e-28,58.008189151279595
PPM1F,ILMN_2059535,"Homo sapiens protein phosphatase 1F (PP2C domain containing) (PPM1F), mRNA.",protein serine/threonine phosphatase complex [goid 8287] [evidence IEA],apoptosis [goid 6915] [evidence IEA]; protein amino acid dephosphorylation [goid 6470] [evidence IEA],hydrolase activity [goid 16787] [evidence IEA]; magnesium ion binding [goid 287] [evidence IEA]; manganese ion binding [goid 30145] [evidence IEA]; protein serine/threonine phosphatase activity [goid 4722] [evidence IEA],22,20603825-20603874,22q11.22a,-,NM_014634.2,9647,PPM1F,-1.5582719516202364,10.80265452064162,-15.4274386310904,3.723019399729773e-30,1.791186000092213e-28,57.99567847350727
NARF,ILMN_2334693,"Homo sapiens nuclear prelamin A recognition factor (NARF), transcript variant 3, mRNA.",nuclear lamina [goid 5652] [pmid 10514485] [evidence TAS]; lamin filament [goid 5638] [pmid 10514485] [evidence IDA],electron transport [goid 6118] [evidence IEA],protein binding [goid 5515] [pmid 10514485] [evidence IPI]; ferredoxin hydrogenase activity [goid 8901] [evidence IEA]; iron ion binding [goid 5506] [evidence IEA]; electron carrier activity [goid 9055] [evidence IEA]; lamin binding [goid 5521] [pmid 10514485] [evidence TAS],17,78039236-78039285,17q25.3g,+,NM_001038618.1,26502,NARF,1.360106741347618,9.98999409774686,15.416858271985978,3.9319637031090994e-30,1.8870520383024829e-28,57.941233434626966
DNASE1,ILMN_1719616,"Homo sapiens deoxyribonuclease I (DNASE1), mRNA.",extracellular region [goid 5576] [pmid 2349940] [evidence TAS],apoptosis [goid 6915] [evidence IEA]; DNA catabolism [goid 6308] [evidence IEA],hydrolase activity [goid 16787] [evidence IEA]; deoxyribonuclease activity [goid 4536] [evidence IEA]; deoxyribonuclease I activity [goid 4530] [evidence IEA]; endonuclease activity [goid 4519] [evidence IEA]; calcium ion binding [goid 5509] [evidence IEA]; actin binding [goid 3779] [evidence IEA]; protein binding [goid 5515] [pmid 12849983] [evidence IPI],16,3647803-3647818:3647908-3647941,16p13.3c,+,NM_005223.3,1773,DNASE1,1.3108563319432776,5.735500184143284,15.399681999321244,4.296543603807388e-30,2.056957054550048e-28,57.852819487198886
PHLDA2,ILMN_1671557,"Homo sapiens pleckstrin homology-like domain, family A, member 2 (PHLDA2), mRNA.",,,,11,2906093-2906142,11p15.4d,-,NM_003311.3,7262,PHLDA2,2.400563859456134,6.969395082299368,15.39817410519073,4.330127320182227e-30,2.067954187101733e-28,57.84505607266564
GSDML,ILMN_1666206,"Homo sapiens gasdermin-like (GSDML), mRNA.",,,,17,35314497-35314546,17q12c,-,NM_018530.1,55876,GSDML,1.946463530851883,7.497356528238501,15.395667373626631,4.386541520658864e-30,2.0897741205388256e-28,57.832149554583296
UBE2C,ILMN_1714730,"Homo sapiens ubiquitin-conjugating enzyme E2C (UBE2C), transcript variant 6, mRNA.",,ubiquitin cycle [goid 6512] [evidence IEA]; phosphoinositide-mediated signaling [goid 48015] [pmid 15504738] [evidence NAS]; protein ubiquitination [goid 16567] [pmid 9122200] [evidence IDA]; ubiquitin-dependent protein catabolism [goid 6511] [pmid 9122200] [evidence IDA]; cyclin catabolism [goid 8054] [pmid 9122200] [evidence IDA]; spindle organization and biogenesis [goid 7051] [pmid 15504738] [evidence NAS]; mitosis [goid 7067] [evidence IEA]; cell cycle [goid 7049] [pmid 15504738] [evidence NAS]; cell division [goid 51301] [evidence IEA],ligase activity [goid 16874] [evidence IEA]; ubiquitin-protein ligase activity [goid 4842] [pmid 9122200] [evidence IDA],20,43875503-43875510:43877900-43877923:43877924-43877941,20q13.12b,+,NM_181803.1,11065,UBE2C,2.327458461967016,7.353079323500098,15.36407345705788,5.1641779517570805e-30,2.454244082682603e-28,57.66941911505752
C13orf1,ILMN_2223350,"Homo sapiens chromosome 13 open reading frame 1 (C13orf1), mRNA.",,,,13,49385160-49385209,13q14.3a,-,NM_020456.1,57213,C13orf1,-1.4721938156606846,7.682394418052159,-15.34291336380381,5.761029724410798e-30,2.7312327051130022e-28,57.56036647282613
HYOU1,ILMN_1673649,"Homo sapiens hypoxia up-regulated 1 (HYOU1), mRNA.",endoplasmic reticulum [goid 5783] [pmid 9020069] [evidence TAS],protein folding [goid 6457] [evidence IEA]; response to stress [goid 6950] [pmid 9020069] [evidence TAS],ATP binding [goid 5524] [evidence IEA]; nucleotide binding [goid 166] [evidence IEA],11,118420565-118420614,11q23.3e,-,NM_006389.2,10525,HYOU1,1.4594642288526245,8.959002714931794,15.337566576056856,5.9225094646303866e-30,2.8009732261728906e-28,57.53280270682565
OLR1,ILMN_1723035,"Homo sapiens oxidised low density lipoprotein (lectin-like) receptor 1 (OLR1), mRNA.",membrane fraction [goid 5624] [pmid 9052782] [evidence TAS]; integral to plasma membrane [goid 5887] [pmid 9052782] [evidence TAS],cell adhesion [goid 7155] [evidence IEA]; inflammatory response [goid 6954] [evidence IEA]; circulation [goid 8015] [pmid 9052782] [evidence TAS],protein binding [goid 5515] [evidence IEA]; receptor activity [goid 4872] [evidence IEA]; sugar binding [goid 5529] [evidence IEA],12,10202439-10202488,12p13.2c,-,NM_002543.2,4973,OLR1,-2.3768573512151008,10.94675656823157,-15.322445733512277,6.40421120760849e-30,3.019955545405289e-28,57.45483414620821
AOX1,ILMN_1767113,"Homo sapiens aldehyde oxidase 1 (AOX1), mRNA.",,oxygen and reactive oxygen species metabolism [goid 6800] [pmid 7570184] [evidence TAS]; inflammatory response [goid 6954] [pmid 8248161] [evidence TAS]; electron transport [goid 6118] [evidence IEA],"oxidoreductase activity [goid 16491] [evidence IEA]; 2 iron, 2 sulfur cluster binding [goid 51537] [evidence IEA]; aldehyde oxidase activity [goid 4031] [pmid 7570184] [evidence TAS]; xanthine dehydrogenase activity [goid 4854] [pmid 8248161] [evidence TAS]; metal ion binding [goid 46872] [evidence IEA]; electron carrier activity [goid 9055] [evidence IEA]; iron ion binding [goid 5506] [evidence IEA]; molybdenum ion binding [goid 30151] [evidence IEA]",2,201243679-201243728,2q33.1e,+,NM_001159.3,316,AOX1,-2.4442562070946448,6.496013183776652,-15.322074081445765,6.416533722339182e-30,3.019955545405289e-28,57.45291744625544
FGFR4,ILMN_1730355,"Homo sapiens fibroblast growth factor receptor 4 (FGFR4), transcript variant 2, mRNA.",integral to membrane [goid 16021] [evidence IEA]; integral to plasma membrane [goid 5887] [pmid 10918587] [evidence TAS]; membrane [goid 16020] [evidence IEA]; integral to membrane [goid 16021] [evidence IEA]; integral to plasma membrane [goid 5887] [pmid 10918587] [evidence TAS]; membrane [goid 16020] [evidence IEA],fibroblast growth factor receptor signaling pathway [goid 8543] [pmid 10918587] [evidence TAS]; protein amino acid phosphorylation [goid 6468] [evidence IEA]; fibroblast growth factor receptor signaling pathway [goid 8543] [pmid 10918587] [evidence TAS]; protein amino acid phosphorylation [goid 6468] [evidence IEA],transferase activity [goid 16740] [evidence IEA]; protein-tyrosine kinase activity [goid 4713] [evidence IEA]; fibroblast growth factor receptor activity [goid 5007] [pmid 10918587] [evidence TAS]; nucleotide binding [goid 166] [evidence IEA]; ATP binding [goid 5524] [evidence IEA]; receptor activity [goid 4872] [evidence IEA]; transferase activity [goid 16740] [evidence IEA]; protein-tyrosine kinase activity [goid 4713] [evidence IEA]; fibroblast growth factor receptor activity [goid 5007] [pmid 10918587] [evidence TAS]; nucleotide binding [goid 166] [evidence IEA]; ATP binding [goid 5524] [evidence IEA]; receptor activity [goid 4872] [evidence IEA],5,176457351-176457400,5q35.2d,+,NM_022963.2,2264,FGFR4,-2.265812520646871,7.463698334652438,-15.311846234338988,6.76515516861622e-30,3.1763626135057116e-28,57.40016380674109
CEP55,ILMN_1747016,"Homo sapiens centrosomal protein 55kDa (CEP55), mRNA.",,mitosis [goid 7067] [evidence IEA]; cell cycle [goid 7049] [evidence IEA]; cell division [goid 51301] [evidence IEA],,10,95278458-95278507,10q23.33b,+,NM_018131.3,55165,CEP55,1.848805596182399,6.825998060638053,15.29984822195093,7.19843938760861e-30,3.3716728718161964e-28,57.33826481726368
WDR77,ILMN_1742889,"Homo sapiens WD repeat domain 77 (WDR77), mRNA.",,,receptor activity [goid 4872] [evidence IEA],1,111784725-111784774,1p13.2d,-,NM_024102.2,79084,WDR77,1.0609624437302916,7.148013172580886,15.298926125079257,7.232870307571663e-30,3.3796757300487738e-28,57.33350694917945
PRELP,ILMN_1707380,"Homo sapiens proline/arginine-rich end leucine-rich repeat protein (PRELP), transcript variant 1, mRNA.",extracellular matrix (sensu Metazoa) [goid 5578] [pmid 7592739] [evidence TAS],skeletal development [goid 1501] [pmid 7592739] [evidence TAS],extracellular matrix structural constituent [goid 5201] [pmid 7592739] [evidence TAS]; transferase activity [goid 16740] [evidence IEA],1,201726438-201726487,1q32.1e,+,NM_002725.3,5549,PRELP,-1.64651570179217,6.2674141326371995,-15.28110905456283,7.931604717372635e-30,3.697304256411622e-28,57.24155490564324
HCAP-G,ILMN_1751444,"Homo sapiens non-SMC condensin I complex, subunit G (NCAPG), mRNA.",nucleus [goid 5634] [pmid 10910072] [evidence NAS],mitosis [goid 7067] [evidence IEA]; mitotic chromosome condensation [goid 7076] [pmid 10910072] [evidence NAS]; cell cycle [goid 7049] [evidence IEA]; cell division [goid 51301] [evidence IEA],binding [goid 5488] [evidence IEA],4,17453041-17453090,4p15.32b,+,NM_022346.3,64151,HCAP-G,1.866385636653403,6.321897803312107,15.268477005677612,8.467703687918438e-30,3.9377853546322376e-28,57.17634047449283
SNX1,ILMN_2365479,"Homo sapiens sorting nexin 1 (SNX1), transcript variant 1, mRNA.",,intracellular signaling cascade [goid 7242] [evidence IEA]; endocytosis [goid 6897] [pmid 9819414] [evidence TAS]; intracellular protein transport [goid 6886] [evidence IEA]; intracellular signaling cascade [goid 7242] [evidence IEA]; endocytosis [goid 6897] [pmid 9819414] [evidence TAS]; intracellular protein transport [goid 6886] [evidence IEA],protein binding [goid 5515] [evidence IEA]; protein transporter activity [goid 8565] [evidence IEA]; phosphoinositide binding [goid 35091] [evidence IEA]; protein binding [goid 5515] [evidence IEA]; protein transporter activity [goid 8565] [evidence IEA]; phosphoinositide binding [goid 35091] [evidence IEA],15,62222858-62222907,15q22.31a,+,NM_003099.3,6642,SNX1,-1.562119252886835,7.0804474116045295,-15.248750322297546,9.378620682031126e-30,4.351010094985155e-28,57.07446313205632
CSTF2,ILMN_1653129,"Homo sapiens cleavage stimulation factor, 3' pre-RNA, subunit 2, 64kDa (CSTF2), mRNA.",nucleus [goid 5634] [pmid 1741396] [evidence TAS],mRNA cleavage [goid 6379] [pmid 1741396] [evidence TAS],RNA binding [goid 3723] [pmid 1741396] [evidence TAS]; nucleotide binding [goid 166] [evidence IEA],X,99982434-99982483,Xq22.1c,+,NM_001325.2,1478,CSTF2,1.2873561982738986,8.412915399719827,15.234038043163732,1.0121508823154492e-29,4.684503549148819e-28,56.998453839604124
AURKA,ILMN_1680955,"Homo sapiens aurora kinase A (AURKA), transcript variant 3, mRNA.",spindle [goid 5819] [pmid 9153231] [evidence TAS]; nucleus [goid 5634] [pmid 9153231] [evidence TAS]; spindle [goid 5819] [pmid 9153231] [evidence TAS]; nucleus [goid 5634] [pmid 9153231] [evidence TAS],regulation of protein stability [goid 31647] [pmid 15987997] [evidence IMP]; protein amino acid phosphorylation [goid 6468] [pmid 9153231] [evidence TAS]; cell cycle [goid 7049] [pmid 15504738] [evidence NAS]; mitosis [goid 7067] [pmid 9153231] [evidence TAS]; spindle organization and biogenesis [goid 7051] [pmid 15504738] [evidence NAS]; phosphoinositide-mediated signaling [goid 48015] [pmid 15504738] [evidence NAS]; regulation of protein stability [goid 31647] [pmid 15987997] [evidence IMP]; protein amino acid phosphorylation [goid 6468] [pmid 9153231] [evidence TAS]; cell cycle [goid 7049] [pmid 15504738] [evidence NAS]; mitosis [goid 7067] [pmid 9153231] [evidence TAS]; spindle organization and biogenesis [goid 7051] [pmid 15504738] [evidence NAS]; phosphoinositide-mediated signaling [goid 48015] [pmid 15504738] [evidence NAS],protein kinase activity [goid 4672] [evidence IEA]; protein binding [goid 5515] [pmid 15987997] [evidence IPI]; protein serine/threonine kinase activity [goid 4674] [evidence IEA]; ATP binding [goid 5524] [evidence IEA]; nucleotide binding [goid 166] [evidence IEA]; transferase activity [goid 16740] [evidence IEA]; protein kinase activity [goid 4672] [evidence IEA]; protein binding [goid 5515] [pmid 15987997] [evidence IPI]; protein serine/threonine kinase activity [goid 4674] [evidence IEA]; ATP binding [goid 5524] [evidence IEA]; nucleotide binding [goid 166] [evidence IEA]; transferase activity [goid 16740] [evidence IEA],20,54378045-54378094,20q13.2d-q13.31a,-,NM_198434.1,6790,AURKA,2.0470927500973124,7.736025669272912,15.226038605727316,1.0549950501955648e-29,4.871227145275018e-28,56.95711544260051
KIAA1912,ILMN_1669982,"PREDICTED: Homo sapiens KIAA1912 protein (KIAA1912), mRNA.",,,,,,2p16.1d-p16.1c,,XM_941554.1,114800,KIAA1912,-2.388105629393812,7.2686516771288545,-15.219363428797678,1.0921375202992822e-29,5.0308036839318e-28,56.92261486891053
HSD11B1,ILMN_1811370,"Homo sapiens hydroxysteroid (11-beta) dehydrogenase 1 (HSD11B1), transcript variant 1, mRNA.",integral to membrane [goid 16021] [evidence IEA]; membrane [goid 16020] [evidence IEA]; endoplasmic reticulum [goid 5783] [evidence IEA]; endoplasmic reticulum membrane [goid 5789] [pmid 10497258] [evidence IDA]; microsome [goid 5792] [evidence IEA],metabolism [goid 8152] [evidence IEA]; glucocorticoid metabolism [goid 8211] [pmid 10497258] [evidence NAS]; lipid metabolism [goid 6629] [evidence IEA],oxidoreductase activity [goid 16491] [evidence IEA]; 11-beta-hydroxysteroid dehydrogenase activity [goid 3845] [pmid 10497258] [evidence IDA],1,207944825-207944874,1q32.2b,+,NM_005525.2,3290,HSD11B1,-1.9326092488806932,6.653704044896097,-15.205166083165867,1.1755607697399849e-29,5.391360181638541e-28,56.849219404613336
SLC22A18AS,ILMN_1691048,"Homo sapiens solute carrier family 22 (organic cation transporter), member 18 antisense (SLC22A18AS), mRNA.",,,,11,2866156-2866205,11p15.4d,-,NM_007105.1,5003,SLC22A18AS,2.3729788567015646,7.034844156076081,15.205103125377573,1.1759446123666307e-29,5.391360181638541e-28,56.84889388377886
DKFZp762E1312,ILMN_1703906,"Homo sapiens hypothetical protein DKFZp762E1312 (DKFZp762E1312), mRNA.",,,,2,234414010-234414059,2q37.1e,-,NM_018410.2,55355,DKFZp762E1312,1.904649198834191,6.265717806188624,15.201937891539732,1.1954055913691958e-29,5.467717828128822e-28,56.83252758996433
CDC45L,ILMN_1670238,"Homo sapiens CDC45 cell division cycle 45-like (S. cerevisiae) (CDC45L), mRNA.",nucleus [goid 5634] [pmid 9660782] [evidence TAS],DNA replication checkpoint [goid 76] [pmid 9660782] [evidence TAS]; DNA replication initiation [goid 6270] [pmid 9660782] [evidence TAS]; cell cycle [goid 7049] [evidence IEA]; DNA replication [goid 6260] [evidence IEA],protein binding [goid 5515] [pmid 10518787] [evidence IPI],22,17886374-17886423,22q11.21c,+,NM_003504.3,8318,CDC45L,2.130077261086239,6.900531934480221,15.195234798017147,1.2376929485766223e-29,5.647879883610184e-28,56.79786457620044
SDHAP3,ILMN_2148679,"Homo sapiens succinate dehydrogenase complex, subunit A, flavoprotein pseudogene 3 (SDHAP3) on chromosome 5.",,,,,,5p15.33d,,NR_003263.1,728609,SDHAP3,2.0756012649589337,6.6050613708731,15.192302344430702,1.2566619984123259e-29,5.72104183155705e-28,56.78269869795845
LOC652846,ILMN_1799098,"PREDICTED: Homo sapiens similar to Annexin A8 (Annexin VIII) (Vascular anticoagulant-beta) (VAC-beta) (LOC652846), mRNA.",,,,,,,,XM_942545.1,652846,LOC652846,-2.7192653167079754,6.213481999565534,-15.182251732374414,1.3239189385714885e-29,6.013184269945327e-28,56.7307122644697
CYBRD1,ILMN_1712305,"Homo sapiens cytochrome b reductase 1 (CYBRD1), mRNA.",integral to membrane [goid 16021] [evidence IEA]; integral to membrane [goid 16021] [evidence IEA],electron transport [goid 6118] [evidence IEA]; electron transport [goid 6118] [evidence IEA],,2,172122282-172122331,2q31.1c,+,NM_024843.2,79901,CYBRD1,-1.9482072130636112,11.011544738749611,-15.179258235452963,1.3446410354611103e-29,6.093100133944124e-28,56.71522632088083
ZMYND19,ILMN_1757627,"Homo sapiens zinc finger, MYND-type containing 19 (ZMYND19), mRNA.",,,zinc ion binding [goid 8270] [evidence IEA]; metal ion binding [goid 46872] [evidence IEA],9,139596627-139596676,9q34.3f,-,NM_138462.2,116225,ZMYND19,1.1135386735267634,8.511470946320461,15.175882882996653,1.3683974270561143e-29,6.186362845983384e-28,56.6977637606082
SLCO2B1,ILMN_1761199,"Homo sapiens solute carrier organic anion transporter family, member 2B1 (SLCO2B1), mRNA.",membrane [goid 16020] [evidence IEA]; integral to membrane [goid 16021] [evidence IEA]; membrane [goid 16020] [evidence IEA]; integral to membrane [goid 16021] [evidence IEA],ion transport [goid 6811] [evidence IEA]; ion transport [goid 6811] [evidence IEA],transporter activity [goid 5215] [evidence IEA]; transporter activity [goid 5215] [evidence IEA],11,74594467-74594516,11q13.4c,+,NM_007256.2,11309,SLCO2B1,-1.6111185433192219,10.676604292681231,-15.169345921110546,1.4156111020361633e-29,6.384995908142278e-28,56.663940824562076
KLF2,ILMN_1735930,"Homo sapiens Kruppel-like factor 2 (lung) (KLF2), mRNA.",nucleus [goid 5634] [evidence NAS]; intracellular [goid 5622] [evidence IEA],"regulation of transcription, DNA-dependent [goid 6355] [evidence IEA]; transcription [goid 6350] [evidence IEA]",zinc ion binding [goid 8270] [evidence IEA]; metal ion binding [goid 46872] [evidence IEA]; transcriptional activator activity [goid 16563] [evidence NAS]; transcription factor activity [goid 3700] [evidence NAS],19,16299231-16299280,19p13.11f,+,NM_016270.2,10365,KLF2,-1.7196189516606157,12.43555692004749,-15.156375067613503,1.5141930522690698e-29,6.798168576834753e-28,56.59681409943502
CBX7,ILMN_1657361,"Homo sapiens chromobox homolog 7 (CBX7), mRNA.",nucleus [goid 5634] [evidence IEA]; chromatin [goid 785] [evidence IEA],"chromatin modification [goid 16568] [evidence IEA]; regulation of transcription, DNA-dependent [goid 6355] [evidence IEA]; transcription [goid 6350] [evidence IEA]; chromatin assembly or disassembly [goid 6333] [evidence IEA]",chromatin binding [goid 3682] [evidence IEA],22,37857028-37857077,22q13.1c,-,NM_175709.2,23492,CBX7,-1.505318403044818,9.378821059683915,-15.151817353589268,1.55044591817733e-29,6.94492844038742e-28,56.57322256644774
FAM65A,ILMN_1680037,"Homo sapiens family with sequence similarity 65, member A (FAM65A), mRNA.",,,binding [goid 5488] [evidence IEA]; DNA-directed RNA polymerase activity [goid 3899] [evidence IEA],16,66138095-66138144,16q22.1b,+,NM_024519.2,79567,FAM65A,-1.5471928483008384,10.643383814885821,-15.14292590443745,1.623698193102409e-29,7.256366810229458e-28,56.527192178699224
SBK1,ILMN_1728298,"Homo sapiens SH3-binding domain kinase 1 (SBK1), mRNA.",,protein amino acid phosphorylation [goid 6468] [evidence IEA]; protein amino acid phosphorylation [goid 6468] [evidence IEA],ATP binding [goid 5524] [evidence IEA]; transferase activity [goid 16740] [evidence IEA]; protein serine/threonine kinase activity [goid 4674] [evidence IEA]; nucleotide binding [goid 166] [evidence IEA]; ATP binding [goid 5524] [evidence IEA]; transferase activity [goid 16740] [evidence IEA]; protein serine/threonine kinase activity [goid 4674] [evidence IEA]; nucleotide binding [goid 166] [evidence IEA],16,28242520-28242569,16p11.2e,+,NM_001024401.2,388228,SBK1,2.0525280897646168,8.946532259012024,15.127652753416072,1.7577316557562982e-29,7.837391604670817e-28,56.44810359769403
SFN,ILMN_1806607,"Homo sapiens stratifin (SFN), mRNA.",cytoplasm [goid 5737] [pmid 10767298] [evidence TAS]; extracellular space [goid 5615] [pmid 8515476] [evidence TAS],signal transduction [goid 7165] [pmid 8515476] [evidence TAS]; cell proliferation [goid 8283] [pmid 10767298] [evidence TAS]; negative regulation of protein kinase activity [goid 6469] [pmid 8515476] [evidence TAS],protein kinase C inhibitor activity [goid 8426] [pmid 8515476] [evidence TAS]; protein domain specific binding [goid 19904] [evidence IEA],1,27063337-27063386,1p36.11a,+,NM_006142.3,2810,SFN,2.7943912133634887,9.139172931697372,15.122763530711607,1.8029437544347693e-29,8.020629921269744e-28,56.42278036335135
AGRN,ILMN_1770454,"Homo sapiens agrin (AGRN), mRNA.",basal lamina [goid 5605] [pmid 9405491] [evidence IDA]; basal lamina [goid 5605] [pmid 9405491] [evidence IDA],"receptor clustering [goid 43113] [pmid 15340048] [evidence IDA]; clustering of voltage-gated sodium channels [goid 45162] [pmid 9405491] [evidence TAS]; acetylcholine receptor signaling, muscarinic pathway [goid 7213] [pmid 9405491] [evidence TAS]; synapse organization and biogenesis [goid 50808] [pmid 9652404] [evidence TAS]; signal transduction [goid 7165] [pmid 9652404] [evidence TAS]; receptor clustering [goid 43113] [pmid 15340048] [evidence IDA]; clustering of voltage-gated sodium channels [goid 45162] [pmid 9405491] [evidence TAS]; acetylcholine receptor signaling, muscarinic pathway [goid 7213] [pmid 9405491] [evidence TAS]; synapse organization and biogenesis [goid 50808] [pmid 9652404] [evidence TAS]; signal transduction [goid 7165] [pmid 9652404] [evidence TAS]",laminin binding [goid 43236] [pmid 9652404] [evidence TAS]; structural constituent of cytoskeleton [goid 5200] [pmid 9652404] [evidence TAS]; laminin binding [goid 43236] [pmid 9652404] [evidence TAS]; structural constituent of cytoskeleton [goid 5200] [pmid 9652404] [evidence TAS],1,981059-981108,1p36.33b,+,NM_198576.2,375790,AGRN,1.8389896489739908,9.916231112058101,15.118421568583825,1.8440733284762066e-29,8.184913167507719e-28,56.400289378145644
BTK,ILMN_1662026,"Homo sapiens Bruton agammaglobulinemia tyrosine kinase (BTK), mRNA.",lipid raft [goid 45121] [pmid 15046600] [evidence IDA]; cytoplasm [goid 5737] [pmid 15046600] [evidence TAS],mesoderm development [goid 7498] [pmid 8013627] [evidence TAS]; calcium-mediated signaling [goid 19722] [pmid 15046600] [evidence TAS]; intracellular signaling cascade [goid 7242] [pmid 11913944] [evidence TAS]; induction of apoptosis by extracellular signals [goid 8624] [pmid 8688094] [evidence TAS]; protein amino acid phosphorylation [goid 6468] [pmid 11913944] [evidence TAS],transferase activity [goid 16740] [evidence IEA]; protein-tyrosine kinase activity [goid 4713] [pmid 11913944] [evidence TAS]; nucleotide binding [goid 166] [evidence IEA]; zinc ion binding [goid 8270] [evidence IEA]; metal ion binding [goid 46872] [evidence IEA]; ATP binding [goid 5524] [pmid 11913944] [evidence TAS]; protein binding [goid 5515] [pmid 11788586] [evidence IPI],X,100491221-100491270,Xq22.1c,-,NM_000061.1,695,BTK,-1.787017587038549,8.542085858790701,-15.093105260556015,2.103357431999056e-29,9.31452717329582e-28,56.26911135293352
SLIT3,ILMN_1811313,"Homo sapiens slit homolog 3 (Drosophila) (SLIT3), mRNA.",extracellular space [goid 5615] [pmid 9813312] [evidence TAS],cell differentiation [goid 30154] [evidence IEA]; central nervous system development [goid 7417] [pmid 10349621] [evidence TAS],transferase activity [goid 16740] [evidence IEA]; structural molecule activity [goid 5198] [evidence NAS]; calcium ion binding [goid 5509] [evidence NAS]; protein binding [goid 5515] [pmid 9813312] [evidence TAS],5,168026045-168026094,5q35.1a-q35.1b,-,NM_003062.1,6586,SLIT3,-2.290264528605176,7.648533435578524,-15.076823360524475,2.289154433517384e-29,1.0114325201153339e-27,56.18470806531757
HSPB8,ILMN_1791280,"Homo sapiens heat shock 22kDa protein 8 (HSPB8), mRNA.",intracellular [goid 5622] [pmid 11256614] [evidence IDA],protein folding [goid 6457] [evidence IEA]; response to unfolded protein [goid 6986] [evidence IEA],kinase activity [goid 16301] [evidence IEA]; transferase activity [goid 16740] [evidence IEA]; protein serine/threonine kinase activity [goid 4674] [pmid 10833516] [evidence NAS],12,118116751-118116800,12q24.23b,+,NM_014365.2,26353,HSPB8,-2.2929921950493526,8.928253018534072,-15.069459285377674,2.3785168425975792e-29,1.048538476878141e-27,56.14652398813012
TMPRSS4,ILMN_1687358,"Homo sapiens transmembrane protease, serine 4 (TMPRSS4), transcript variant 2, mRNA.",integral to membrane [goid 16021] [pmid 10825129] [evidence NAS]; membrane [goid 16020] [evidence IEA],,scavenger receptor activity [goid 5044] [evidence IEA]; peptidase activity [goid 8233] [evidence IEA]; serine-type endopeptidase activity [goid 4252] [pmid 10825129] [evidence NAS],11,117493943-117493992,11q23.3d,+,NM_183247.1,56649,TMPRSS4,2.383065784028724,6.4662765252333285,15.067840356768592,2.3986274199840764e-29,1.055017049173583e-27,56.13812874151726
CRTAP,ILMN_1665235,"Homo sapiens cartilage associated protein (CRTAP), mRNA.",extracellular matrix (sensu Metazoa) [goid 5578] [evidence IEA]; extracellular matrix (sensu Metazoa) [goid 5578] [evidence IEA],,binding [goid 5488] [evidence IEA]; binding [goid 5488] [evidence IEA],3,33140904-33140953,3p22.3c,+,NM_006371.3,10491,CRTAP,-1.647432719256182,8.43977441430845,-15.056723560381556,2.541411236374324e-29,1.1153017554223807e-27,56.08047274985622
DKFZP686A01247,ILMN_2139761,"Homo sapiens LIM and calponin homology domains 1 (LIMCH1), mRNA.",actin cytoskeleton [goid 15629] [pmid 11256614] [evidence IDA],actomyosin structure organization and biogenesis [goid 31032] [evidence IEA],zinc ion binding [goid 8270] [evidence IEA]; metal ion binding [goid 46872] [evidence IEA]; actin binding [goid 3779] [evidence IEA],4,41395534-41395583,4p13d,+,NM_014988.1,22998,DKFZP686A01247,-1.6661666336291958,11.622011258070344,-15.047717888448645,2.6633151270958134e-29,1.1661729269991444e-27,56.03375584021863
S100A8,ILMN_1729801,"Homo sapiens S100 calcium binding protein A8 (S100A8), mRNA.",extracellular space [goid 5615] [evidence NR ],inflammatory response [goid 6954] [pmid 3313057] [evidence TAS],calcium ion binding [goid 5509] [pmid 2149559] [evidence TAS],1,151629237-151629286,1q21.3c,-,NM_002964.3,6279,S100A8,-3.0891086349212333,10.728714116816256,-15.027249478676367,2.962673619705415e-29,1.291447326173602e-27,55.92754267334504
RASSF1,ILMN_1683239,"Homo sapiens Ras association (RalGDS/AF-6) domain family 1 (RASSF1), transcript variant C, mRNA.",microtubule [goid 5874] [evidence IEA]; nucleus [goid 5634] [pmid 14743218] [evidence IEP],cell cycle arrest [goid 7050] [pmid 12024041] [evidence IMP]; cell cycle [goid 7049] [evidence IEA]; intracellular signaling cascade [goid 7242] [evidence IEA]; Ras protein signal transduction [goid 7265] [pmid 15109305] [evidence IDA],metal ion binding [goid 46872] [evidence IEA]; protein binding [goid 5515] [pmid 15109305] [evidence IPI]; zinc ion binding [goid 8270] [pmid 11333291] [evidence TAS]; diacylglycerol binding [goid 19992] [evidence IEA],3,50349648-50349697,3p21.31b,-,NM_170713.1,11186,RASSF1,-1.0615898093448504,8.09530796130272,-15.020753962806545,3.0645641561209914e-29,1.3328801915628909e-27,55.893826958147386
TMEM47,ILMN_2129234,"Homo sapiens transmembrane protein 47 (TMEM47), mRNA.",plasma membrane [goid 5886] [pmid 11256614] [evidence IDA]; integral to membrane [goid 16021] [evidence IEA],,,X,34555202-34555251,Xp21.1c,-,NM_031442.2,83604,TMEM47,-1.9172120798525096,9.61185829663791,-15.002940139514083,3.362421511744971e-29,1.4559285145855723e-27,55.80133842707603
EVI2B,ILMN_1763452,"Homo sapiens ecotropic viral integration site 2B (EVI2B), mRNA.",integral to plasma membrane [goid 5887] [pmid 1903357] [evidence TAS],,,17,26655419-26655468,17q11.2d,-,NM_006495.2,2124,EVI2B,-2.228903940467438,9.017503034012222,-14.996314959821422,3.480470320731332e-29,1.503702088679601e-27,55.7669318979573
CACNA2D2,ILMN_1711049,"Homo sapiens calcium channel, voltage-dependent, alpha 2/delta subunit 2 (CACNA2D2), transcript variant 1, mRNA.",membrane [goid 16020] [evidence IEA]; membrane [goid 16020] [evidence IEA],,,3,50375436-50375485,3p21.31b,-,NM_001005505.1,9254,CACNA2D2,-2.0952767636875524,8.05443339883906,-14.993463758562156,3.5325460785562187e-29,1.5228243438200868e-27,55.75212327644522
DDX56,ILMN_1679405,"Homo sapiens DEAD (Asp-Glu-Ala-Asp) box polypeptide 56 (DDX56), mRNA.",nucleus [goid 5634] [evidence IEA]; nucleolus [goid 5730] [pmid 10749921] [evidence TAS],rRNA processing [goid 6364] [evidence IEA],hydrolase activity [goid 16787] [evidence IEA]; RNA binding [goid 3723] [evidence IEA]; nucleotide binding [goid 166] [evidence IEA]; ATP binding [goid 5524] [evidence IEA]; ATP-dependent RNA helicase activity [goid 4004] [pmid 10749921] [evidence TAS]; protein binding [goid 5515] [pmid 15231747] [evidence IPI],7,44572106-44572125:44572126-44572155,7p13d,-,NM_019082.2,54606,DDX56,1.1560350117102303,9.975383597226076,14.98292437390982,3.731926504457401e-29,1.6052226918179352e-27,55.69737587483336
TROAP,ILMN_1700337,"Homo sapiens trophinin associated protein (tastin) (TROAP), mRNA.",cytoplasm [goid 5737] [pmid 7758945] [evidence TAS],cell adhesion [goid 7155] [pmid 7758945] [evidence TAS],protein binding [goid 5515] [evidence IEA],12,48011638-48011667:48011668-48011687,12q13.12b,+,NM_005480.2,10024,TROAP,1.7070188384863503,5.945131699831406,14.977674858979634,3.8354120933734163e-29,1.6461014237749124e-27,55.670102436980244
PDK4,ILMN_1684982,"Homo sapiens pyruvate dehydrogenase kinase, isozyme 4 (PDK4), mRNA.",mitochondrion [goid 5739] [pmid 8798399] [evidence TAS],glucose metabolism [goid 6006] [pmid 8798399] [evidence TAS]; protein amino acid phosphorylation [goid 6468] [evidence IEA],[pyruvate dehydrogenase (lipoamide)] kinase activity [goid 4740] [pmid 8798399] [evidence TAS]; ATP binding [goid 5524] [evidence IEA],7,95051128-95051177,7q21.3b,-,NM_002612.2,5166,PDK4,-2.7134057223312373,9.140628611443002,-14.963647722549913,4.126292572034463e-29,1.7670507860679454e-27,55.597210737192995
C1QA,ILMN_1737918,"Homo sapiens complement component 1, q subcomponent, alpha polypeptide (C1QA), mRNA.",complement component C1q complex [goid 5602] [pmid 9461517] [evidence TAS]; cytoplasm [goid 5737] [evidence IEA],"immune response [goid 6955] [evidence IEA]; cell-cell signaling [goid 7267] [pmid 9461517] [evidence TAS]; phosphate transport [goid 6817] [evidence IEA]; complement activation, classical pathway [goid 6958] [evidence IEA]",,1,22838328-22838377,1p36.12a,+,NM_015991.1,712,C1QA,-2.049662674365049,9.983639184373992,-14.961545399073039,4.1717576400214693e-29,1.782603017890753e-27,55.58628420247921
TMOD1,ILMN_1736911,"Homo sapiens tropomodulin 1 (TMOD1), mRNA.",cytoskeleton [goid 5856] [evidence IEA],cytoskeleton organization and biogenesis [goid 7010] [evidence NR ],actin binding [goid 3779] [evidence IEA]; tropomyosin binding [goid 5523] [evidence IEA],9,99402093-99402142,9q22.33a-q22.33b,+,NM_003275.1,7111,TMOD1,-2.11982112823049,7.192388256501556,-14.959315021986361,4.2205420184249254e-29,1.799502433895179e-27,55.57469159776055
ECM2,ILMN_1746763,"Homo sapiens extracellular matrix protein 2, female organ and adipocyte specific (ECM2), mRNA.",extracellular matrix (sensu Metazoa) [goid 5578] [pmid 9790758] [evidence TAS]; extracellular matrix (sensu Metazoa) [goid 5578] [pmid 9790758] [evidence TAS],cell-matrix adhesion [goid 7160] [pmid 9790758] [evidence TAS]; cell-matrix adhesion [goid 7160] [pmid 9790758] [evidence TAS],transferase activity [goid 16740] [evidence IEA]; integrin binding [goid 5178] [pmid 9790758] [evidence TAS]; transferase activity [goid 16740] [evidence IEA]; integrin binding [goid 5178] [pmid 9790758] [evidence TAS],9,94303013-94303062,9q22.31a-q22.31b,-,NM_001393.2,1842,ECM2,-1.8088240601922045,7.291055580823233,-14.954159413617486,4.335512794840131e-29,1.8444861748353703e-27,55.54789273085025
RASAL1,ILMN_1793517,"Homo sapiens RAS protein activator like 1 (GAP1 like) (RASAL1), mRNA.",intracellular [goid 5622] [evidence IEA],regulation of small GTPase mediated signal transduction [goid 51056] [evidence IEA]; intracellular signaling cascade [goid 7242] [evidence IEA],zinc ion binding [goid 8270] [evidence IEA]; metal ion binding [goid 46872] [evidence IEA]; Ras GTPase activator activity [goid 5099] [pmid 9751798] [evidence TAS]; phospholipid binding [goid 5543] [pmid 9751798] [evidence TAS],12,112021796-112021845,12q24.13b,-,NM_004658.1,8437,RASAL1,1.5211348464899963,5.967110126821073,14.947244446756374,4.49467062914482e-29,1.908031747470301e-27,55.51194414717444
FLJ36748,ILMN_1694140,"Homo sapiens actin filament associated protein 1-like 1 (AFAP1L1), mRNA.",,,,5,148701168-148701217,5q33.1b,+,NM_152406.1,134265,FLJ36748,-1.7623382966641694,7.4181973124841045,-14.940061367194188,4.666215174617951e-29,1.9765478842919734e-27,55.47459619960699
SLC16A3,ILMN_2364022,"Homo sapiens solute carrier family 16, member 3 (monocarboxylic acid transporter 4) (SLC16A3), transcript variant 2, mRNA.",membrane fraction [goid 5624] [pmid 9425115] [evidence TAS]; integral to plasma membrane [goid 5887] [pmid 9425115] [evidence TAS]; membrane [goid 16020] [evidence IEA],organic anion transport [goid 15711] [evidence IEA]; transport [goid 6810] [evidence IEA]; monocarboxylic acid transport [goid 15718] [pmid 9425115] [evidence TAS],symporter activity [goid 15293] [evidence IEA]; monocarboxylate porter activity [goid 15355] [evidence IEA]; transporter activity [goid 5215] [evidence IEA],,,17q25.3g,,NM_004207.2,9123,SLC16A3,1.7478142679511652,11.151391482890642,14.90623130111283,5.566852160476204e-29,2.347837972876165e-27,55.29862328576279
PFC,ILMN_1658121,"Homo sapiens complement factor properdin (CFP), mRNA.",extracellular space [goid 5615] [pmid 8530058] [evidence TAS],"complement activation, alternative pathway [goid 6957] [evidence IEA]; innate immune response [goid 45087] [evidence IEA]",,X,47368761-47368783:47370401-47370427,Xp11.23f,-,NM_002621.1,5199,PFC,-1.1594121991824906,5.912370578242724,-14.904666316314193,5.61250329493186e-29,2.3619789784394662e-27,55.29047972956841
DOCK11,ILMN_1765860,"Homo sapiens dedicator of cytokinesis 11 (DOCK11), mRNA.",,,GTP binding [goid 5525] [evidence IEA]; guanyl-nucleotide exchange factor activity [goid 5085] [evidence IEA]; GTPase binding [goid 51020] [evidence IEA],X,117703748-117703797,Xq24a-q24b,+,NM_144658.2,139818,DOCK11,-1.5059895225194078,8.62669094875765,-14.900507024524432,5.735666571804879e-29,2.4034293150885605e-27,55.26883513993664
KIF11,ILMN_1794539,"Homo sapiens kinesin family member 11 (KIF11), mRNA.",microtubule [goid 5874] [evidence IEA]; spindle [goid 5819] [pmid 8548803] [evidence TAS]; kinesin complex [goid 5871] [pmid 8548803] [evidence TAS]; microtubule associated complex [goid 5875] [evidence IEA],microtubule-based movement [goid 7018] [evidence IEA]; cell cycle [goid 7049] [evidence IEA]; cell division [goid 51301] [evidence IEA]; mitotic spindle organization and biogenesis [goid 7052] [pmid 8548803] [evidence TAS],nucleotide binding [goid 166] [evidence IEA]; microtubule motor activity [goid 3777] [pmid 8548803] [evidence TAS]; ATP binding [goid 5524] [evidence IEA],10,94404566-94404615,10q23.33a,+,NM_004523.2,3832,KIF11,1.4935850138679863,6.08788396441142,14.899351600377427,5.770359635979293e-29,2.4127780580913416e-27,55.26282207999727
LIMK1,ILMN_1797362,"Homo sapiens LIM domain kinase 1 (LIMK1), transcript variant dLIMK, mRNA.",cytoplasm [goid 5737] [pmid 8537403] [evidence TAS],signal transduction [goid 7165] [pmid 10436159] [evidence TAS]; Rho protein signal transduction [goid 7266] [pmid 10436159] [evidence TAS]; protein amino acid phosphorylation [goid 6468] [pmid 8537403] [evidence TAS]; actin cytoskeleton organization and biogenesis [goid 30036] [pmid 10428028] [evidence TAS]; cell motility [goid 6928] [evidence NR ],metal ion binding [goid 46872] [evidence IEA]; nucleotide binding [goid 166] [evidence IEA]; protein binding [goid 5515] [pmid 15220930] [evidence IPI]; protein serine/threonine kinase activity [goid 4674] [pmid 8537403] [evidence TAS]; transferase activity [goid 16740] [evidence IEA]; zinc ion binding [goid 8270] [evidence IEA]; ATP binding [goid 5524] [evidence IEA]; protein-tyrosine kinase activity [goid 4713] [evidence IEA],7,73174332-73174381,7q11.23b,+,NM_016735.1,3984,LIMK1,1.4666861391499282,6.104895268815287,14.893856360317104,5.938267172174142e-29,2.4776688618803675e-27,55.234221756904255
DPT,ILMN_1708107,"Homo sapiens dermatopontin (DPT), mRNA.",extracellular matrix (sensu Metazoa) [goid 5578] [evidence IEA],cell adhesion [goid 7155] [evidence IEA],protein binding [goid 5515] [pmid 8104875] [evidence TAS],1,166931501-166931550,1q24.2b,-,NM_001937.3,1805,DPT,-2.6996495270817356,8.66241861888026,-14.880339867388427,6.37243759164775e-29,2.6531398819071882e-27,55.16386035594118
CHTF18,ILMN_1756705,"Homo sapiens CTF18, chromosome transmission fidelity factor 18 homolog (S. cerevisiae) (CHTF18), mRNA.",,,ATP binding [goid 5524] [evidence IEA]; nucleotide binding [goid 166] [evidence IEA]; nucleoside-triphosphatase activity [goid 17111] [evidence IEA]; helicase activity [goid 4386] [evidence IEA],16,787085-787093:787695-787735,16p13.3f,+,NM_022092.1,63922,CHTF18,1.9200103669088966,7.0756458791986265,14.86130253066984,7.0385541702298e-29,2.9242266099558133e-27,55.0647260488421
TPX2,ILMN_1796949,"Homo sapiens TPX2, microtubule-associated, homolog (Xenopus laevis) (TPX2), mRNA.",nucleus [goid 5634] [pmid 9207457] [evidence TAS]; spindle pole [goid 922] [pmid 14718566] [evidence IDA],cell proliferation [goid 8283] [pmid 10512675] [evidence TAS]; mitosis [goid 7067] [pmid 9207457] [evidence TAS],ATP binding [goid 5524] [pmid 10512675] [evidence TAS]; GTP binding [goid 5525] [pmid 10512675] [evidence TAS],20,29852491-29852540,20q11.21b,+,NM_012112.4,22974,TPX2,1.988359042903789,6.366668893453759,14.809817760194933,9.21169634497379e-29,3.818934112379028e-27,54.79642983941045
CCNB2,ILMN_1801939,"Homo sapiens cyclin B2 (CCNB2), mRNA.",nucleus [goid 5634] [evidence IEA]; microtubule cytoskeleton [goid 15630] [pmid 11256614] [evidence IDA],mitosis [goid 7067] [evidence IEA]; cell cycle [goid 7049] [evidence IEA]; cell division [goid 51301] [evidence IEA],protein binding [goid 5515] [pmid 15232106] [evidence IPI],15,57204299-57204348,15q22.2a,+,NM_004701.2,9133,CCNB2,2.265599238372289,7.498560635460115,14.795442949499185,9.93090142438477e-29,4.108356990533699e-27,54.72146913444551
WWC2,ILMN_2207170,"Homo sapiens WW and C2 domain containing 2 (WWC2), mRNA.",,,,4,184476781-184476830,4q35.1c,+,NM_024949.4,80014,WWC2,-1.4190853876148646,6.131769494982094,-14.79308953088275,1.0053906427456897e-28,4.1504314987075774e-27,54.70919458365957
MYH10,ILMN_1815154,"Homo sapiens myosin, heavy chain 10, non-muscle (MYH10), mRNA.",myosin [goid 16459] [pmid 7499478] [evidence NAS],regulation of cell shape [goid 8360] [evidence IEA]; cytokinesis [goid 910] [evidence NAS],nucleotide binding [goid 166] [evidence IEA]; calmodulin binding [goid 5516] [evidence IEA]; ATP binding [goid 5524] [pmid 7782316] [evidence NAS]; motor activity [goid 3774] [evidence IEA]; actin binding [goid 3779] [pmid 7782316] [evidence NAS]; protein binding [goid 5515] [pmid 7542763] [evidence IPI],17,8318410-8318459,17p13.1c,-,NM_005964.1,4628,MYH10,-1.5238932130142473,12.19944435250415,-14.792638948858569,1.0077630663640129e-28,4.151429883319829e-27,54.70684444856204
LMCD1,ILMN_1754969,"Homo sapiens LIM and cysteine-rich domains 1 (LMCD1), mRNA.",,,zinc ion binding [goid 8270] [evidence IEA]; metal ion binding [goid 46872] [evidence IEA],3,8584584-8584633,3p26.1a,+,NM_014583.2,29995,LMCD1,-1.7538805983465409,10.412563053429734,-14.774916625270508,1.1056717968232796e-28,4.545150835675444e-27,54.614391481466335
FER1L4,ILMN_2206722,Homo sapiens fer-1-like 4 (C. elegans) (FER1L4) on chromosome 20.,,,,20,33610027-33610076,20q11.22b,-,NR_001442.2,80307,FER1L4,2.8429971339476294,6.904357704689379,14.77298949241146,1.116878300804454e-28,4.581552356036797e-27,54.60433607604309
FCN3,ILMN_1780060,"Homo sapiens ficolin (collagen/fibrinogen domain containing) 3 (Hakata antigen) (FCN3), transcript variant 2, mRNA.",extracellular region [goid 5576] [pmid 14718574] [evidence NAS]; extracellular space [goid 5615] [pmid 9694814] [evidence TAS]; extracellular region [goid 5576] [pmid 14718574] [evidence NAS]; extracellular space [goid 5615] [pmid 9694814] [evidence TAS],,sugar binding [goid 5529] [pmid 9694814] [evidence TAS]; sugar binding [goid 5529] [pmid 9694814] [evidence TAS],1,27568218-27568267,1p36.11a,-,NM_173452.1,8547,FCN3,-3.8922526288888175,9.35047206419632,-14.75902879094464,1.2015400731726174e-28,4.918489144069002e-27,54.53147996204823
SC65,ILMN_1655663,"Homo sapiens synaptonemal complex protein SC65 (SC65), mRNA.",nucleus [goid 5634] [evidence IEA]; nucleolus [goid 5730] [pmid 8862517] [evidence TAS]; synaptonemal complex [goid 795] [pmid 8862517] [evidence TAS],synaptonemal complex formation [goid 7130] [pmid 8862517] [evidence TAS],binding [goid 5488] [evidence IEA],17,37211920-37211969,17q21.2b,-,NM_006455.2,10609,SC65,1.7292229241494095,8.508080027219997,14.748552285734718,1.2692790837924301e-28,5.184885313982285e-27,54.47679297349859
PAFAH1B3,ILMN_1748093,"Homo sapiens platelet-activating factor acetylhydrolase, isoform Ib, gamma subunit 29kDa (PAFAH1B3), mRNA.",soluble fraction [goid 5625] [evidence NR ]; cytoplasm [goid 5737] [evidence NR ],lipid catabolism [goid 16042] [evidence IEA],"hydrolase activity, acting on ester bonds [goid 16788] [evidence IEA]; protein binding [goid 5515] [pmid 16189514] [evidence IPI]; 1-alkyl-2-acetylglycerophosphocholine esterase activity [goid 3847] [evidence IEA]",19,47493038-47493069:47493070-47493087,19q13.2c,-,NM_002573.2,5050,PAFAH1B3,1.6078131409591006,10.480168843341653,14.74222193648053,1.3120547856981971e-28,5.348407426637944e-27,54.44374308678412
IRAK1,ILMN_2379130,"Homo sapiens interleukin-1 receptor-associated kinase 1 (IRAK1), transcript variant 3, mRNA.",interleukin-1 receptor complex [goid 45323] [pmid 10854325] [evidence NAS],transmembrane receptor protein serine/threonine kinase signaling pathway [goid 7178] [pmid 11397809] [evidence NAS]; signal transduction [goid 7165] [pmid 10854325] [evidence NAS]; positive regulation of transcription [goid 45941] [pmid 11397809] [evidence NAS]; activation of NF-kappaB-inducing kinase [goid 7250] [pmid 11397809] [evidence IDA]; protein amino acid phosphorylation [goid 6468] [evidence IEA],transcriptional activator activity [goid 16563] [pmid 11397809] [evidence NAS]; transferase activity [goid 16740] [evidence IEA]; protein homodimerization activity [goid 42803] [pmid 11397809] [evidence NAS]; protein kinase binding [goid 19901] [evidence ISS]; ATP binding [goid 5524] [evidence IEA]; protein serine/threonine kinase activity [goid 4674] [pmid 11397809] [evidence NAS]; protein kinase activity [goid 4672] [evidence IEA]; protein binding [goid 5515] [evidence IEA]; nucleotide binding [goid 166] [evidence IEA]; receptor activity [goid 4872] [evidence IEA]; magnesium ion binding [goid 287] [evidence IEA]; NF-kappaB-inducing kinase activity [goid 4704] [pmid 8599092] [evidence TAS],X,152929380-152929429,Xq28g,-,NM_001025243.1,3654,IRAK1,1.1021151010914654,10.497474842641623,14.734897469255287,1.3633573668221278e-28,5.545932837688759e-27,54.40549770603508
MAOB,ILMN_1727360,"Homo sapiens monoamine oxidase B (MAOB), nuclear gene encoding mitochondrial protein, mRNA.",integral to membrane [goid 16021] [evidence IEA],electron transport [goid 6118] [evidence IEA],electron transporter activity [goid 5489] [pmid 8602220] [evidence TAS]; amine oxidase activity [goid 8131] [evidence IEA]; oxidoreductase activity [goid 16491] [evidence IEA],X,43511097-43511146,Xp11.3c,-,NM_000898.3,4129,MAOB,-2.1959637628361808,7.5588371343141985,-14.727392554053424,1.4180136823422836e-28,5.7562492917582074e-27,54.366304162177386
FCER1G,ILMN_2123743,"Homo sapiens Fc fragment of IgE, high affinity I, receptor for; gamma polypeptide (FCER1G), mRNA.",plasma membrane [goid 5886] [pmid 1535625] [evidence TAS]; integral to plasma membrane [goid 5887] [pmid 1535625] [evidence TAS],immune response [goid 6955] [evidence NR ]; cell surface receptor linked signal transduction [goid 7166] [evidence IEA],IgE binding [goid 19863] [evidence IEA]; transmembrane receptor activity [goid 4888] [evidence IEA]; receptor signaling protein activity [goid 5057] [evidence NR ]; protein binding [goid 5515] [pmid 11788586] [evidence IPI],1,159455128-159455137:159455295-159455334,1q23.3a,+,NM_004106.1,2207,FCER1G,-1.8549877041770788,11.269978932219443,-14.72530023988004,1.4336398840123388e-28,5.807582773384703e-27,54.355376225038455
GIMAP8,ILMN_1747305,"Homo sapiens GTPase, IMAP family member 8 (GIMAP8), mRNA.",,,GTP binding [goid 5525] [evidence IEA],7,149807193-149807242,7q36.1c,+,NM_175571.2,155038,GIMAP8,-1.956986386488639,8.903036142062103,-14.715282134213382,1.5108882736021507e-28,6.107812865381308e-27,54.30304624865759
LOC642342,ILMN_1770818,"PREDICTED: Homo sapiens similar to Contactin-associated protein-like 3 precursor (Cell recognition molecule Caspr3) (LOC642342), mRNA.",,,,9,40022224-40022273,,+,XM_925876.1,642342,LOC642342,-1.5078804537858659,5.878314944284572,-14.714788383885757,1.5148017789097393e-28,6.1109550024961225e-27,54.300466847697656
MYADM,ILMN_2308849,"Homo sapiens myeloid-associated differentiation marker (MYADM), transcript variant 4, mRNA.",membrane [goid 16020] [evidence IEA]; integral to membrane [goid 16021] [evidence IEA],,,19,59071241-59071290,19q13.41b,+,NM_001020820.1,91663,MYADM,-1.6413879198356724,10.278651090943413,-14.70994622061904,1.5537245671033039e-28,6.255025452480966e-27,54.27516952904862
ANKRD29,ILMN_1749338,"Homo sapiens ankyrin repeat domain 29 (ANKRD29), mRNA.",,,,18,19434820-19434869,18q11.2b,-,NM_173505.2,147463,ANKRD29,-2.141367003381651,7.58888424060497,-14.695193929410951,1.6786077164449297e-28,6.726079739397186e-27,54.19808253198965
AMICA1,ILMN_1778723,"Homo sapiens adhesion molecule, interacts with CXADR antigen 1 (AMICA1), mRNA.",integral to membrane [goid 16021] [evidence IEA]; membrane [goid 16020] [evidence IEA],cell adhesion [goid 7155] [evidence IEA],protein binding [goid 5515] [evidence IEA],11,117570158-117570207,11q23.3d,-,NM_153206.1,120425,AMICA1,-1.863046708436979,9.495153631245419,-14.695180928579541,1.678722102995275e-28,6.726079739397186e-27,54.19801458691782
DACH1,ILMN_1666882,"Homo sapiens dachshund homolog 1 (Drosophila) (DACH1), transcript variant 1, mRNA.",nucleus [goid 5634] [evidence IEA]; nucleus [goid 5634] [evidence IEA],"regulation of transcription, DNA-dependent [goid 6355] [evidence IEA]; development [goid 7275] [evidence IEA]; transcription [goid 6350] [evidence IEA]; eye development (sensu Endopterygota) [goid 7456] [pmid 9651501] [evidence TAS]; regulation of transcription, DNA-dependent [goid 6355] [evidence IEA]; development [goid 7275] [evidence IEA]; transcription [goid 6350] [evidence IEA]; eye development (sensu Endopterygota) [goid 7456] [pmid 9651501] [evidence TAS]",DNA binding [goid 3677] [evidence IEA]; protein binding [goid 5515] [pmid 14525983] [evidence IPI]; DNA binding [goid 3677] [evidence IEA]; protein binding [goid 5515] [pmid 14525983] [evidence IPI],13,71032055-71032088:71044973-71044988,13q21.33d,-,NM_080759.3,1602,DACH1,-1.0990014524820442,6.034269094558371,-14.694912176684653,1.6810884439755862e-28,6.726079739397186e-27,54.196610029125175
CSNK1D,ILMN_1720708,"Homo sapiens casein kinase 1, delta (CSNK1D), transcript variant 2, mRNA.",,Wnt receptor signaling pathway [goid 16055] [evidence IEA]; DNA repair [goid 6281] [pmid 8786104] [evidence TAS]; protein amino acid phosphorylation [goid 6468] [pmid 8786104] [evidence TAS]; signal transduction [goid 7165] [pmid 8786104] [evidence TAS]; Wnt receptor signaling pathway [goid 16055] [evidence IEA]; DNA repair [goid 6281] [pmid 8786104] [evidence TAS]; protein amino acid phosphorylation [goid 6468] [pmid 8786104] [evidence TAS]; signal transduction [goid 7165] [pmid 8786104] [evidence TAS],transferase activity [goid 16740] [evidence IEA]; nucleotide binding [goid 166] [evidence IEA]; ATP binding [goid 5524] [evidence IEA]; protein serine/threonine kinase activity [goid 4674] [evidence IEA]; casein kinase I activity [goid 4681] [pmid 8786104] [evidence TAS]; transferase activity [goid 16740] [evidence IEA]; nucleotide binding [goid 166] [evidence IEA]; ATP binding [goid 5524] [evidence IEA]; protein serine/threonine kinase activity [goid 4674] [evidence IEA]; casein kinase I activity [goid 4681] [pmid 8786104] [evidence TAS],17,77795637-77795686,17q25.3g,-,NM_139062.1,1453,CSNK1D,1.0527874140806226,9.781651699229277,14.685865063653653,1.762731885652325e-28,7.03828499834745e-27,54.149323310829416
TYROBP,ILMN_1778977,"Homo sapiens TYRO protein tyrosine kinase binding protein (TYROBP), transcript variant 1, mRNA.",integral to plasma membrane [goid 5887] [pmid 9490415] [evidence TAS]; membrane [goid 16020] [evidence IEA],cellular defense response [goid 6968] [pmid 9490415] [evidence TAS]; intracellular signaling cascade [goid 7242] [pmid 9490415] [evidence TAS],receptor signaling protein activity [goid 5057] [pmid 9490415] [evidence TAS],19,41090225-41090274,19q13.12a,-,NM_003332.2,7305,TYROBP,-1.9544635575785883,12.303878276290956,-14.6836172837582,1.7836264526951483e-28,7.107149576843551e-27,54.1375734500963
XPR1,ILMN_1798030,"Homo sapiens xenotropic and polytropic retrovirus receptor (XPR1), mRNA.",plasma membrane [goid 5886] [pmid 9927670] [evidence TAS]; integral to plasma membrane [goid 5887] [pmid 9927670] [evidence TAS]; integral to membrane [goid 16021] [evidence IEA]; plasma membrane [goid 5886] [pmid 9927670] [evidence TAS]; integral to plasma membrane [goid 5887] [pmid 9927670] [evidence TAS]; integral to membrane [goid 16021] [evidence IEA],G-protein coupled receptor protein signaling pathway [goid 7186] [pmid 9990033] [evidence TAS]; G-protein coupled receptor protein signaling pathway [goid 7186] [pmid 9990033] [evidence TAS],receptor activity [goid 4872] [evidence IEA]; G-protein coupled receptor activity [goid 4930] [pmid 9990033] [evidence TAS]; receptor activity [goid 4872] [evidence IEA]; G-protein coupled receptor activity [goid 4930] [pmid 9990033] [evidence TAS],1,179121561-179121610,1q25.3a,+,NM_004736.2,9213,XPR1,1.8245225103690714,10.044565913019627,14.682921443259904,1.790145002301248e-28,7.118566402008126e-27,54.13393596181043
PPP1R15A,ILMN_1659936,"Homo sapiens protein phosphatase 1, regulatory (inhibitor) subunit 15A (PPP1R15A), mRNA.",,apoptosis [goid 6915] [pmid 9153226] [evidence TAS]; response to DNA damage stimulus [goid 6974] [pmid 9153226] [evidence TAS]; cell cycle arrest [goid 7050] [pmid 9153226] [evidence TAS],,19,54071014-54071042:54071043-54071063,19q13.33a,+,NM_014330.2,23645,PPP1R15A,-1.690537655916998,11.803463729708135,-14.668880787695107,1.9269084346803644e-28,7.646804653716273e-27,54.060527834641064
BZW2,ILMN_1676548,"Homo sapiens basic leucine zipper and W2 domains 2 (BZW2), mRNA.",,regulation of translational initiation [goid 6446] [evidence IEA],translation initiation factor activity [goid 3743] [evidence IEA],7,16712406-16712455,7p21.1b,+,NM_014038.1,28969,BZW2,1.1739098559341041,10.140643787778707,14.666726988766676,1.9487962486603464e-28,7.717946118932287e-27,54.049265378139694
JM11,ILMN_1714710,"Homo sapiens coiled-coil domain containing 120 (CCDC120), mRNA.",,,,X,48814301-48814350,Xp11.23c,+,NM_033626.2,90060,JM11,1.116547505969435,8.071007321443712,14.666289047021355,1.9532772406643288e-28,7.720001426844716e-27,54.04697527151811
RHOD,ILMN_2089167,"Homo sapiens ras homolog gene family, member D (RHOD), mRNA.",intracellular [goid 5622] [evidence IEA]; membrane [goid 16020] [evidence IEA],Rho protein signal transduction [goid 7266] [pmid 9116026] [evidence TAS],nucleotide binding [goid 166] [evidence IEA]; GTPase activity [goid 3924] [pmid 9116026] [evidence TAS]; GTP binding [goid 5525] [evidence IEA],11,66595830-66595879,11q13.1f,+,NM_014578.2,29984,RHOD,2.0138422016437003,8.339558369985644,14.664348442142876,1.9732581808322147e-28,7.783185354962693e-27,54.036827120416945
COLEC12,ILMN_1679049,"Homo sapiens collectin sub-family member 12 (COLEC12), transcript variant II, mRNA.",membrane [goid 16020] [pmid 11564734] [evidence TAS]; cytoplasm [goid 5737] [evidence IEA],"protein homooligomerization [goid 51260] [pmid 11564734] [evidence NAS]; innate immune response [goid 45087] [pmid 11564734] [evidence TAS]; oxidized low-density lipoprotein catabolism [goid 45194] [pmid 11564734] [evidence NAS]; antibacterial humoral response (sensu Vertebrata) [goid 19733] [pmid 11564734] [evidence IDA]; carbohydrate mediated signaling [goid 9756] [pmid 11564734] [evidence NAS]; phosphate transport [goid 6817] [evidence IEA]; antifungal humoral response (sensu Vertebrata) [goid 19734] [pmid 11564734] [evidence IDA]; symbiotic interaction between host and other organism [goid 44404] [pmid 11564734] [evidence NAS]; phagocytosis, recognition [goid 6910] [pmid 11564734] [evidence IDA]",low-density lipoprotein binding [goid 30169] [pmid 11564734] [evidence IDA]; sugar binding [goid 5529] [evidence IEA]; galactose binding [goid 5534] [pmid 11564734] [evidence NAS]; scavenger receptor activity [goid 5044] [pmid 11564734] [evidence TAS]; pattern recognition receptor activity [goid 8329] [pmid 11564734] [evidence IDA],18,323443-323492,18p11.32c,-,NM_030781.2,81035,COLEC12,-1.186667826679754,7.3735891195786945,-14.638652325292453,2.258016328587701e-28,8.870453258574869e-27,53.90241496476305
ESAM,ILMN_1668092,"Homo sapiens endothelial cell adhesion molecule (ESAM), mRNA.",integral to membrane [goid 16021] [evidence IEA]; membrane [goid 16020] [evidence IEA],cell adhesion [goid 7155] [evidence IEA],protein binding [goid 5515] [evidence IEA],11,124128359-124128408,11q24.2a,-,NM_138961.1,90952,ESAM,-2.028852517850039,9.93352822119921,-14.63203659635458,2.3377848207756675e-28,9.165339483463557e-27,53.86779789901771
S100A4,ILMN_1684306,"Homo sapiens S100 calcium binding protein A4 (S100A4), transcript variant 1, mRNA.",,,calcium ion binding [goid 5509] [pmid 8204608] [evidence TAS]; calcium ion binding [goid 5509] [pmid 8204608] [evidence TAS],1,151783859-151783894:151783895-151783908,1q21.3c,-,NM_002961.2,6275,S100A4,-2.238767551323411,12.870252616560636,-14.611190152981472,2.6081188756902213e-28,1.0204657890125294e-26,53.7586879191733
DPYSL2,ILMN_1672503,"Homo sapiens dihydropyrimidinase-like 2 (DPYSL2), mRNA.",,"nucleobase, nucleoside, nucleotide and nucleic acid metabolism [goid 6139] [pmid 8973361] [evidence TAS]; signal transduction [goid 7165] [pmid 8973361] [evidence TAS]",hydrolase activity [goid 16787] [evidence IEA]; dihydropyrimidinase activity [goid 4157] [pmid 8973361] [evidence TAS],8,26571233-26571282,8p21.2a,+,NM_001386.4,1808,DPYSL2,-1.386657617102541,12.726831373321904,-14.608300808339722,2.6479859974437823e-28,1.0339881194427274e-26,53.743561526541995
WNT3,ILMN_1803593,"Homo sapiens wingless-type MMTV integration site family, member 3 (WNT3), mRNA.",extracellular matrix (sensu Metazoa) [goid 5578] [evidence IEA],cell-cell signaling [goid 7267] [evidence NAS]; frizzled-2 signaling pathway [goid 7223] [evidence IEA]; morphogenesis [goid 9653] [evidence NAS],signal transducer activity [goid 4871] [evidence IEA]; extracellular matrix structural constituent [goid 5201] [evidence NAS],17,42196988-42197037,17q21.32a,-,NM_030753.3,7473,WNT3,1.7513258987498226,6.8821118679893,14.596753524693309,2.8135179493100136e-28,1.0964279448461123e-26,53.68310005571827
SFXN1,ILMN_2205935,"Homo sapiens sideroflexin 1 (SFXN1), mRNA.",membrane [goid 16020] [evidence IEA]; mitochondrion [goid 5739] [evidence IEA]; integral to membrane [goid 16021] [evidence IEA],cation transport [goid 6812] [evidence IEA]; iron ion transport [goid 6826] [evidence IEA],iron ion binding [goid 5506] [evidence IEA]; cation transporter activity [goid 8324] [evidence IEA],5,174887440-174887489,5q35.2c,+,NM_022754.4,94081,SFXN1,1.4660978740058157,6.8977456165720685,14.587706523180906,2.9504344616276424e-28,1.1474893310342238e-26,53.63572027017537
CRABP2,ILMN_1690170,"Homo sapiens cellular retinoic acid binding protein 2 (CRABP2), mRNA.",,"regulation of transcription, DNA-dependent [goid 6355] [pmid 1334086] [evidence TAS]; transport [goid 6810] [evidence IEA]; signal transduction [goid 7165] [pmid 1654334] [evidence TAS]; epidermis development [goid 8544] [pmid 1654334] [evidence TAS]",retinal binding [goid 16918] [evidence IEA]; lipid binding [goid 8289] [evidence IEA],1,154936143-154936192,1q23.1a,-,NM_001878.2,1382,CRABP2,3.6507726437705363,8.67003555664355,14.58115890820122,3.0536795899447802e-28,1.1852778249018732e-26,53.601424600986135
DUOX1,ILMN_1690289,"Homo sapiens dual oxidase 1 (DUOX1), transcript variant 1, mRNA.",membrane [goid 16020] [evidence IEA]; integral to membrane [goid 16021] [evidence IEA]; apical plasma membrane [goid 16324] [pmid 10806195] [evidence NAS],hydrogen peroxide biosynthesis [goid 50665] [pmid 10806195] [evidence NAS]; cytokine and chemokine mediated signaling pathway [goid 19221] [pmid 16111680] [evidence IDA]; hormone biosynthesis [goid 42446] [evidence IEA]; electron transport [goid 6118] [pmid 10601291] [evidence TAS]; hydrogen peroxide catabolism [goid 42744] [evidence IEA]; superoxide release [goid 42554] [pmid 10806195] [evidence NAS],NAD(P)H oxidase activity [goid 16174] [pmid 10806195] [evidence NAS]; oxidoreductase activity [goid 16491] [evidence IEA]; NADP binding [goid 50661] [pmid 10806195] [evidence NAS]; iron ion binding [goid 5506] [evidence IEA]; peroxidase activity [goid 4601] [evidence IEA]; FAD binding [goid 50660] [evidence IEA]; calcium ion binding [goid 5509] [evidence IEA],15,43244887-43244936,15q21.1a,+,NM_017434.3,53905,DUOX1,-2.299191223165983,8.012689894481872,-14.58029021456263,3.067647261128187e-28,1.188332144792897e-26,53.596874144481546
WISP2,ILMN_1812461,"Homo sapiens WNT1 inducible signaling pathway protein 2 (WISP2), mRNA.",extracellular region [goid 5576] [evidence IEA]; soluble fraction [goid 5625] [pmid 9843955] [evidence TAS],regulation of cell growth [goid 1558] [evidence IEA]; cell adhesion [goid 7155] [evidence IEA]; cell-cell signaling [goid 7267] [pmid 9843955] [evidence TAS]; signal transduction [goid 7165] [pmid 9843955] [evidence TAS],protein binding [goid 5515] [evidence IEA]; insulin-like growth factor binding [goid 5520] [evidence IEA],20,42789604-42789653,20q13.12a,+,NM_003881.2,8839,WISP2,-2.485549584678303,8.24794100886031,-14.578696363532927,3.09344168978696e-28,1.1959466532837087e-26,53.58852490854678
CLEC10A,ILMN_1653166,"Homo sapiens C-type lectin domain family 10, member A (CLEC10A), transcript variant 2, mRNA.",plasma membrane [goid 5886] [pmid 8598452] [evidence TAS]; integral to membrane [goid 16021] [evidence IEA]; plasma membrane [goid 5886] [pmid 8598452] [evidence TAS]; integral to membrane [goid 16021] [evidence IEA],endocytosis [goid 6897] [evidence IEA]; immune response [goid 6955] [evidence IEA]; endocytosis [goid 6897] [evidence IEA]; immune response [goid 6955] [evidence IEA],sugar binding [goid 5529] [pmid 8598452] [evidence TAS]; sugar binding [goid 5529] [pmid 8598452] [evidence TAS],17,6918736-6918785,17p13.1d,-,NM_006344.2,10462,CLEC10A,-1.4128947560365477,6.121904606001224,-14.570366843573963,3.231828949587694e-28,1.2469740016379449e-26,53.544887194352754
FMO3,ILMN_1808657,"Homo sapiens flavin containing monooxygenase 3 (FMO3), transcript variant 1, mRNA.",microsome [goid 5792] [pmid 9207220] [evidence TAS]; intrinsic to endoplasmic reticulum membrane [goid 31227] [evidence IEA]; endoplasmic reticulum [goid 5783] [evidence IEA]; membrane [goid 16020] [evidence IEA]; integral to membrane [goid 16021] [evidence IEA],electron transport [goid 6118] [evidence IEA],FAD binding [goid 50660] [evidence IEA]; monooxygenase activity [goid 4497] [evidence IEA]; dimethylaniline monooxygenase (N-oxide-forming) activity [goid 4499] [evidence IEA]; NADP binding [goid 50661] [evidence IEA],1,169353085-169353134,1q24.3a,+,NM_006894.4,2328,FMO3,-2.263453176746828,8.429717368577778,-14.569260418530792,3.250672845755372e-28,1.2517660158012535e-26,53.53909017306817
NUP155,ILMN_1768293,"Homo sapiens nucleoporin 155kDa (NUP155), transcript variant 2, mRNA.",nucleus [goid 5634] [evidence IEA]; nuclear pore [goid 5643] [evidence IEA],transport [goid 6810] [evidence IEA]; nucleocytoplasmic transport [goid 6913] [evidence IEA],structural constituent of nuclear pore [goid 17056] [evidence IEA]; nucleocytoplasmic transporter activity [goid 5487] [evidence IEA]; transporter activity [goid 5215] [pmid 10191094] [evidence TAS],5,37327831-37327880,5p13.2b,-,NM_004298.2,9631,NUP155,1.271279643578442,8.683995051605425,14.553342716284954,3.534305855793713e-28,1.3571422983054667e-26,53.455676560225164
PHKA1,ILMN_1812503,"Homo sapiens phosphorylase kinase, alpha 1 (muscle) (PHKA1), mRNA.",,generation of precursor metabolites and energy [goid 6091] [pmid 7874115] [evidence TAS]; glycogen catabolism [goid 5980] [evidence NR ]; carbohydrate metabolism [goid 5975] [evidence IEA]; muscle development [goid 7517] [evidence IEA],phosphorylase kinase activity [goid 4689] [pmid 8226841] [evidence TAS]; phosphorylase kinase regulator activity [goid 8607] [evidence NR ]; calmodulin binding [goid 5516] [evidence IEA],X,71717443-71717492,Xq13.1e,-,NM_002637.1,5255,PHKA1,1.3920545317988555,6.368745314925015,14.553130450095349,3.538251411543121e-28,1.3571422983054667e-26,53.45456404207982
SPP1,ILMN_1651354,"Homo sapiens secreted phosphoprotein 1 (osteopontin, bone sialoprotein I, early T-lymphocyte activation 1) (SPP1), transcript variant 2, mRNA.",extracellular region [goid 5576] [pmid 1107524] [evidence TAS]; extracellular space [goid 5615] [evidence IEA]; extracellular matrix (sensu Metazoa) [goid 5578] [pmid 1107524] [evidence TAS],cell-cell signaling [goid 7267] [pmid 1107524] [evidence TAS]; ossification [goid 1503] [pmid 10766759] [evidence TAS]; cell-matrix adhesion [goid 7160] [evidence NAS]; induction of positive chemotaxis [goid 50930] [pmid 1107524] [evidence TAS]; positive regulation of T cell proliferation [goid 42102] [pmid 1107524] [evidence TAS]; regulation of myeloid cell differentiation [goid 45637] [pmid 1107524] [evidence TAS]; cell adhesion [goid 7155] [evidence IEA]; negative regulation of bone mineralization [goid 30502] [pmid 1729712] [evidence NAS]; T-helper 1 type immune response [goid 42088] [pmid 1107524] [evidence TAS]; anti-apoptosis [goid 6916] [evidence ISS],cytokine activity [goid 5125] [evidence ISS]; growth factor activity [goid 8083] [pmid 1107524] [evidence TAS]; protein binding [goid 5515] [evidence IEA]; integrin binding [goid 5178] [evidence NAS],4,89122810-89122859,4q22.1b,+,NM_000582.2,6696,SPP1,3.900021883153615,8.827815579098592,14.548169882477989,3.631726939030092e-28,1.3902593203733074e-26,53.428563644444935
CTNNAL1,ILMN_1721901,"Homo sapiens catenin (cadherin-associated protein), alpha-like 1 (CTNNAL1), mRNA.",actin cytoskeleton [goid 15629] [evidence IEA]; actin cytoskeleton [goid 15629] [evidence IEA],cell adhesion [goid 7155] [evidence IEA]; apoptosis [goid 6915] [evidence NR ]; cell adhesion [goid 7155] [evidence IEA]; apoptosis [goid 6915] [evidence NR ],cadherin binding [goid 45296] [evidence IEA]; structural molecule activity [goid 5198] [evidence IEA]; cadherin binding [goid 45296] [evidence IEA]; structural molecule activity [goid 5198] [evidence IEA],9,110754381-110754430,9q31.3a,-,NM_003798.1,8727,CTNNAL1,-1.8139872872148892,8.91803044825618,-14.544251673006409,3.7073097543497813e-28,1.4164104032059898e-26,53.40802486707903
MLSTD1,ILMN_1694596,"Homo sapiens male sterility domain containing 1 (MLSTD1), mRNA.",,,,12,29366103-29366124:29376800-29376827,12p11.22a,+,NM_018099.3,55711,MLSTD1,-1.4052445538198484,6.310189156289135,-14.536576502778539,3.859971696401416e-28,1.4718502642736123e-26,53.36778792674838
ZSWIM4,ILMN_1735231,"Homo sapiens zinc finger, SWIM-type containing 4 (ZSWIM4), mRNA.",,,zinc ion binding [goid 8270] [evidence IEA]; metal ion binding [goid 46872] [evidence IEA],19,13803473-13803522,19p13.13a-p13.12c,+,NM_023072.1,65249,ZSWIM4,1.1601564861019344,8.034258381242227,14.525694912964129,4.087289398694451e-28,1.5554850377648707e-26,53.31073088974993
ATIC,ILMN_1673991,"Homo sapiens 5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/IMP cyclohydrolase (ATIC), mRNA.",,"purine nucleotide biosynthesis [goid 6164] [evidence IEA]; nucleobase, nucleoside, nucleotide and nucleic acid metabolism [goid 6139] [pmid 8567683] [evidence TAS]",transferase activity [goid 16740] [evidence IEA]; hydrolase activity [goid 16787] [evidence IEA]; IMP cyclohydrolase activity [goid 3937] [pmid 8567683] [evidence TAS]; phosphoribosylaminoimidazolecarboxamide formyltransferase activity [goid 4643] [pmid 8567683] [evidence TAS],2,215922199-215922217:215922504-215922534,2q35a,+,NM_004044.4,471,ATIC,1.0063351838839125,10.938812514433241,14.517527930060034,4.266685103532738e-28,1.6205917980962067e-26,53.267899669685335
PAICS,ILMN_1773760,"Homo sapiens phosphoribosylaminoimidazole carboxylase, phosphoribosylaminoimidazole succinocarboxamide synthetase (PAICS), mRNA.",phosphoribosylaminoimidazole carboxylase complex [goid 9320] [evidence IEA]; phosphoribosylaminoimidazole carboxylase complex [goid 9320] [evidence IEA]; phosphoribosylaminoimidazole carboxylase complex [goid 9320] [evidence IEA],purine nucleotide biosynthesis [goid 6164] [evidence IEA]; 'de novo' IMP biosynthesis [goid 6189] [evidence IEA]; purine base biosynthesis [goid 9113] [pmid 2253271] [evidence TAS]; purine nucleotide biosynthesis [goid 6164] [evidence IEA]; 'de novo' IMP biosynthesis [goid 6189] [evidence IEA]; purine base biosynthesis [goid 9113] [pmid 2253271] [evidence TAS]; 'de novo' IMP biosynthesis [goid 6189] [evidence IEA]; purine base biosynthesis [goid 9113] [pmid 2253271] [evidence TAS]; purine nucleotide biosynthesis [goid 6164] [evidence IEA],ligase activity [goid 16874] [evidence IEA]; lyase activity [goid 16829] [evidence IEA]; ATP binding [goid 5524] [evidence IEA]; phosphoribosylaminoimidazole carboxylase activity [goid 4638] [evidence IEA]; ligase activity [goid 16874] [evidence IEA]; lyase activity [goid 16829] [evidence IEA]; ATP binding [goid 5524] [evidence IEA]; phosphoribosylaminoimidazole carboxylase activity [goid 4638] [evidence IEA]; phosphoribosylaminoimidazole carboxylase activity [goid 4638] [evidence IEA]; lyase activity [goid 16829] [evidence IEA]; ligase activity [goid 16874] [evidence IEA],4,57021950-57021999,4q12e,+,NM_006452.2,10606,PAICS,1.3445409553481387,10.055201866086907,14.51656163386922,4.288427048493393e-28,1.625680954083536e-26,53.26283153309056
BCL9,ILMN_1704452,"Homo sapiens B-cell CLL/lymphoma 9 (BCL9), mRNA.",nucleus [goid 5634] [evidence IEA],Wnt receptor signaling pathway [goid 16055] [evidence IEA],protein binding [goid 5515] [pmid 11955446] [evidence IPI],1,145564526-145564575,1q21.1c,+,NM_004326.2,607,BCL9,1.063109666957267,8.641184044441891,14.509796177440624,4.443799086252062e-28,1.681309227099445e-26,53.227344610362046
RAMP3,ILMN_1761782,"Homo sapiens receptor (G protein-coupled) activity modifying protein 3 (RAMP3), mRNA.",integral to membrane [goid 16021] [evidence IEA]; lysosome [goid 5764] [pmid 10882736] [evidence TAS]; integral to plasma membrane [goid 5887] [pmid 9620797] [evidence TAS]; plasma membrane [goid 5886] [pmid 9620797] [evidence TAS]; plasma membrane [goid 5886] [pmid 9620797] [evidence TAS]; lysosome [goid 5764] [pmid 10882736] [evidence TAS]; integral to plasma membrane [goid 5887] [pmid 9620797] [evidence TAS],intracellular protein transport [goid 6886] [evidence IEA]; receptor mediated endocytosis [goid 6898] [pmid 10882736] [evidence TAS]; cell surface receptor linked signal transduction [goid 7166] [evidence NR ]; regulation of G-protein coupled receptor protein signaling pathway [goid 8277] [evidence IEA]; intracellular protein transport [goid 6886] [evidence IEA]; regulation of G-protein coupled receptor protein signaling pathway [goid 8277] [evidence IEA]; cell surface receptor linked signal transduction [goid 7166] [evidence NR ]; receptor mediated endocytosis [goid 6898] [pmid 10882736] [evidence TAS],protein transporter activity [goid 8565] [evidence IEA]; receptor activity [goid 4872] [evidence IEA]; protein transporter activity [goid 8565] [evidence IEA]; receptor activity [goid 4872] [evidence IEA],7,45190165-45190214,7p13c,+,NM_005856.2,10268,RAMP3,-2.6795756753689117,8.580548474292643,-14.504814538549251,4.561805992222191e-28,1.7226122046211123e-26,53.20121133264334
LAYN,ILMN_1716397,"Homo sapiens layilin (LAYN), mRNA.",ruffle [goid 1726] [evidence ISS]; focal adhesion [goid 5925] [evidence ISS]; cell surface [goid 9986] [evidence ISS],,hyaluronic acid binding [goid 5540] [pmid 11294894] [evidence IDA]; protein binding [goid 5515] [pmid 9786953] [evidence ISS]; sugar binding [goid 5529] [evidence IEA],11,110936530-110936579,11q23.1b,+,NM_178834.2,143903,LAYN,-1.3884604479740545,7.628048962094517,-14.503178411952973,4.601245358231117e-28,1.7341444062888455e-26,53.1926277830923
EPB41L2,ILMN_1805448,"Homo sapiens erythrocyte membrane protein band 4.1-like 2 (EPB41L2), mRNA.",plasma membrane [goid 5886] [pmid 9598318] [evidence TAS]; cytoskeleton [goid 5856] [evidence IEA]; membrane [goid 16020] [evidence IEA]; cytoplasm [goid 5737] [evidence IEA]; spectrin [goid 8091] [pmid 9598318] [evidence TAS]; plasma membrane [goid 5886] [pmid 9598318] [evidence TAS]; cytoskeleton [goid 5856] [evidence IEA]; membrane [goid 16020] [evidence IEA]; cytoplasm [goid 5737] [evidence IEA]; spectrin [goid 8091] [pmid 9598318] [evidence TAS],cortical actin cytoskeleton organization and biogenesis [goid 30866] [evidence IEA]; cortical actin cytoskeleton organization and biogenesis [goid 30866] [evidence IEA],structural constituent of cytoskeleton [goid 5200] [evidence NR ]; binding [goid 5488] [evidence IEA]; structural molecule activity [goid 5198] [evidence IEA]; actin binding [goid 3779] [evidence IEA]; structural constituent of cytoskeleton [goid 5200] [evidence NR ]; binding [goid 5488] [evidence IEA]; structural molecule activity [goid 5198] [evidence IEA]; actin binding [goid 3779] [evidence IEA],6,131202612-131202661,6q23.1e-q23.2a,-,NM_001431.1,2037,EPB41L2,-1.1546793094557959,6.703934694670623,-14.49602112375844,4.777837302536436e-28,1.7972231629328656e-26,53.15507551316336
RAG1AP1,ILMN_1776522,"Homo sapiens recombination activating gene 1 activating protein 1 (RAG1AP1), mRNA.",membrane [goid 16020] [evidence IEA]; nucleus [goid 5634] [pmid 8630032] [evidence IC ]; membrane [goid 16020] [evidence IEA]; nucleus [goid 5634] [pmid 8630032] [evidence IC ],"positive regulation of gene expression, epigenetic [goid 45815] [pmid 8630032] [evidence ISS]; positive regulation of gene expression, epigenetic [goid 45815] [pmid 8630032] [evidence ISS]",,1,153377450-153377499,1q22a,+,NM_018845.1,55974,RAG1AP1,1.4633590020663902,9.235500585733137,14.495539924556422,4.789951157460398e-28,1.7983082524685136e-26,53.15255060667783
NTAN1,ILMN_1801864,"PREDICTED: Homo sapiens N-terminal asparagine amidase, transcript variant 3 (NTAN1), mRNA.",,,,,,16p13.11b,,XM_942894.1,123803,NTAN1,-1.1902705178147333,9.098301553958908,-14.485416011513102,5.052084483742798e-28,1.893074349340931e-26,53.099423742965804
KIAA0284,ILMN_1664960,"Homo sapiens KIAA0284 (KIAA0284), mRNA.",,,,14,104433874-104433923,14q32.33c,+,NM_015005.1,283638,KIAA0284,1.2274957065662742,6.061178052913029,14.4817284551829,5.15110191741967e-28,1.9264725693075293e-26,53.08007006633581
TIMP1,ILMN_1711566,"Homo sapiens TIMP metallopeptidase inhibitor 1 (TIMP1), mRNA.",extracellular matrix (sensu Metazoa) [goid 5578] [evidence IEA]; extracellular region [goid 5576] [pmid 1653055] [evidence NAS],positive regulation of cell proliferation [goid 8284] [pmid 3839290] [evidence TAS]; development [goid 7275] [evidence NR ]; negative regulation of membrane protein ectodomain proteolysis [goid 51045] [pmid 12714508] [evidence IDA]; erythrocyte maturation [goid 43249] [evidence IEA],protein binding [goid 5515] [pmid 2251898] [evidence IPI]; enzyme inhibitor activity [goid 4857] [evidence IEA]; metalloendopeptidase inhibitor activity [goid 8191] [pmid 12714508] [evidence IDA],X,47331009-47331034:47331035-47331058,Xp11.23f,+,NM_003254.2,7076,TIMP1,1.629369571265821,13.669745717988713,14.479508504804663,5.211648477999338e-28,1.945382578425615e-26,53.068418258384185
WFDC2,ILMN_1685427,"Homo sapiens WAP four-disulfide core domain 2 (WFDC2), transcript variant 3, mRNA.",extracellular space [goid 5615] [pmid 1686187] [evidence TAS],spermatogenesis [goid 7283] [pmid 1686187] [evidence TAS],serine-type endopeptidase inhibitor activity [goid 4867] [evidence IEA],20,43533226-43533275,20q13.12b,+,NM_080733.1,10406,WFDC2,1.4674128626431182,6.115335508537804,14.474542427708744,5.349691551923718e-28,1.9930925409031292e-26,53.042351070282145
KIAA1522,ILMN_1700384,"Homo sapiens KIAA1522 (KIAA1522), mRNA.",,,,1,33012857-33012906,1p35.1b,+,NM_020888.1,57648,KIAA1522,1.2282012165081415,9.312266672154983,14.466614512539675,5.577712618812364e-28,2.0740788239992158e-26,53.00073177487009
CD302,ILMN_1716797,"Homo sapiens CD302 molecule (CD302), mRNA.",integral to membrane [goid 16021] [evidence IEA]; integral to membrane [goid 16021] [evidence IEA],,receptor activity [goid 4872] [evidence IEA]; sugar binding [goid 5529] [evidence IEA]; receptor activity [goid 4872] [evidence IEA]; sugar binding [goid 5529] [evidence IEA],2,160334548-160334597,2q24.2a,-,NM_014880.3,9936,CD302,-1.4325547817425317,7.1796305346577425,-14.447128815994425,6.1804872558955315e-28,2.2898479301854564e-26,52.89840992102928
PLEK2,ILMN_1811470,"Homo sapiens pleckstrin 2 (PLEK2), mRNA.",membrane [goid 16020] [evidence IEA]; cytoskeleton [goid 5856] [evidence IEA],intracellular signaling cascade [goid 7242] [evidence IEA]; actin cytoskeleton organization and biogenesis [goid 30036] [pmid 10419454] [evidence TAS],,14,66923812-66923861,14q23.3b,-,NM_016445.1,26499,PLEK2,2.103644217243981,6.931885272348396,14.447098539311781,6.181472985771363e-28,2.2898479301854564e-26,52.898250903964495
XPO5,ILMN_1759495,"Homo sapiens exportin 5 (XPO5), mRNA.",nucleus [goid 5634] [evidence IEA],protein transport [goid 15031] [evidence IEA],binding [goid 5488] [evidence IEA]; tRNA binding [goid 49] [evidence IEA]; protein binding [goid 5515] [pmid 12702765] [evidence IPI],6,43598330-43598379,6p21.1c,-,NM_020750.1,57510,XPO5,1.1381814973479294,7.9162495877339465,14.445506624913305,6.233524455827951e-28,2.3047480839052684e-26,52.88988983039756
CD34,ILMN_1694249,"Homo sapiens CD34 antigen (CD34), transcript variant 2, mRNA.",membrane [goid 16020] [evidence IEA]; integral to membrane [goid 16021] [evidence IEA]; plasma membrane [goid 5886] [pmid 9780190] [evidence TAS]; membrane [goid 16020] [evidence IEA]; integral to membrane [goid 16021] [evidence IEA]; plasma membrane [goid 5886] [pmid 9780190] [evidence TAS],cell adhesion [goid 7155] [evidence IEA]; cell adhesion [goid 7155] [evidence IEA],protein binding [goid 5515] [evidence IEA]; protein binding [goid 5515] [evidence IEA],1,206127912-206127961,1q32.2a,-,NM_001773.1,947,CD34,-1.1720119589893851,8.57768859215862,-14.444841084560538,6.255416098948662e-28,2.3084617933336116e-26,52.88639419351444
RNF125,ILMN_1747192,"Homo sapiens ring finger protein 125 (RNF125), mRNA.",ubiquitin ligase complex [goid 151] [evidence IEA]; nucleus [goid 5634] [evidence IEA],immune response [goid 6955] [evidence IEA]; protein ubiquitination [goid 16567] [evidence IEA],metal ion binding [goid 46872] [evidence IEA]; nucleic acid binding [goid 3676] [evidence IEA]; ubiquitin-protein ligase activity [goid 4842] [evidence IEA]; zinc ion binding [goid 8270] [evidence IEA]; ligase activity [goid 16874] [evidence IEA],18,27879682-27879693:27899863-27899900,18q12.1e,+,NM_017831.2,54941,RNF125,-1.644194992207975,6.5256408469992015,-14.434725337891294,6.597814868978254e-28,2.4302159304733701e-26,52.833257366251225
THBD,ILMN_1759787,"Homo sapiens thrombomodulin (THBD), mRNA.",membrane [goid 16020] [evidence IEA]; integral to plasma membrane [goid 5887] [pmid 2822087] [evidence TAS],blood coagulation [goid 7596] [pmid 9252393] [evidence TAS],calcium ion binding [goid 5509] [pmid 10336638] [evidence TAS]; transmembrane receptor activity [goid 4888] [evidence IEA]; sugar binding [goid 5529] [evidence IEA],20,22974506-22974555,20p11.21c,-,NM_000361.2,7056,THBD,-2.146474289015475,6.59344299946598,-14.427783479078778,6.843608059458538e-28,2.515994396953766e-26,52.79678652582883
LAMA4,ILMN_1795442,"Homo sapiens laminin, alpha 4 (LAMA4), mRNA.",laminin-1 [goid 5606] [evidence IEA]; basal lamina [goid 5605] [pmid 7959779] [evidence TAS]; laminin-1 [goid 5606] [evidence IEA]; basal lamina [goid 5605] [pmid 7959779] [evidence TAS],regulation of embryonic development [goid 45995] [evidence IEA]; regulation of cell adhesion [goid 30155] [evidence IEA]; regulation of cell migration [goid 30334] [evidence IEA]; regulation of embryonic development [goid 45995] [evidence IEA]; regulation of cell adhesion [goid 30155] [evidence IEA]; regulation of cell migration [goid 30334] [evidence IEA],extracellular matrix structural constituent [goid 5201] [pmid 7959779] [evidence TAS]; receptor binding [goid 5102] [evidence IEA]; extracellular matrix structural constituent [goid 5201] [pmid 7959779] [evidence TAS]; receptor binding [goid 5102] [evidence IEA],6,112537392-112537441,6q21i,-,NM_002290.2,3910,LAMA4,-1.6085965509103506,8.333158913133612,-14.39014774689405,8.345342981134453e-28,3.062316534602727e-26,52.59897171238689
ALDH1A2,ILMN_1748538,"Homo sapiens aldehyde dehydrogenase 1 family, member A2 (ALDH1A2), transcript variant 2, mRNA.",,metabolism [goid 8152] [evidence IEA]; vitamin A metabolism [goid 6776] [pmid 8663198] [evidence TAS]; metabolism [goid 8152] [evidence IEA]; vitamin A metabolism [goid 6776] [pmid 8663198] [evidence TAS],oxidoreductase activity [goid 16491] [evidence IEA]; electron carrier activity [goid 9055] [pmid 8797830] [evidence TAS]; retinal dehydrogenase activity [goid 1758] [evidence IEA]; oxidoreductase activity [goid 16491] [evidence IEA]; electron carrier activity [goid 9055] [pmid 8797830] [evidence TAS]; retinal dehydrogenase activity [goid 1758] [evidence IEA],15,56033099-56033148,15q22.1a,-,NM_170696.1,8854,ALDH1A2,-2.189698805791367,7.446182664528582,-14.369632645087401,9.298989715535682e-28,3.4058423798348266e-26,52.49108274176317
XDH,ILMN_1712632,"Homo sapiens xanthine dehydrogenase (XDH), mRNA.",,electron transport [goid 6118] [evidence IEA],"xanthine dehydrogenase activity [goid 4854] [pmid 8224915] [evidence TAS]; iron ion binding [goid 5506] [evidence IEA]; electron transporter activity [goid 5489] [evidence IEA]; metal ion binding [goid 46872] [evidence IEA]; 2 iron, 2 sulfur cluster binding [goid 51537] [evidence IEA]; xanthine oxidase activity [goid 4855] [evidence IEA]; oxidoreductase activity [goid 16491] [evidence IEA]; molybdenum ion binding [goid 30151] [evidence IEA]",2,31412008-31412057,2p23.1a,-,NM_000379.2,7498,XDH,1.8413939002739133,5.797090914427443,14.368364831846923,9.361391641054125e-28,3.422264842888173e-26,52.48441390472878
OSR1,ILMN_2197128,"Homo sapiens odd-skipped related 1 (Drosophila) (OSR1), mRNA.",intracellular [goid 5622] [evidence IEA]; nucleus [goid 5634] [evidence IEA],,nucleic acid binding [goid 3676] [evidence IEA]; metal ion binding [goid 46872] [evidence IEA]; zinc ion binding [goid 8270] [evidence IEA],2,19414793-19414842,2p24.1d,-,NM_145260.2,130497,OSR1,-2.1811286685361564,8.91915954835637,-14.365132894110008,9.522376065432065e-28,3.474597333987711e-26,52.46741281840966
COL10A1,ILMN_1672776,"Homo sapiens collagen, type X, alpha 1(Schmid metaphyseal chondrodysplasia) (COL10A1), mRNA.",cytoplasm [goid 5737] [evidence IEA]; collagen [goid 5581] [pmid 8554571] [evidence TAS],phosphate transport [goid 6817] [evidence IEA]; skeletal development [goid 1501] [pmid 8554571] [evidence TAS],calcium ion binding [goid 5509] [evidence IEA]; structural molecule activity [goid 5198] [evidence IEA],6,116547372-116547421,6q22.1d,-,NM_000493.2,1300,COL10A1,2.830004517172691,6.523161557561908,14.36398383358176,9.580278452919878e-28,3.4891911337410063e-26,52.461368115584385
SRL,ILMN_1736692,"PREDICTED: Homo sapiens sarcalumenin, transcript variant 4 (SRL), mRNA.",,,,,,16p13.3c-p13.3b,,XM_945656.1,6345,SRL,-1.4193774336622935,5.978436783735816,-14.35473405073153,1.0059443989893423e-27,3.656870636997637e-26,52.4127041903633
SLC7A7,ILMN_1810275,"Homo sapiens solute carrier family 7 (cationic amino acid transporter, y+ system), member 7 (SLC7A7), mRNA.",integral to plasma membrane [goid 5887] [pmid 9829974] [evidence TAS]; membrane [goid 16020] [evidence IEA],transport [goid 6810] [pmid 9829974] [evidence TAS]; amino acid transport [goid 6865] [evidence IEA]; amino acid metabolism [goid 6520] [pmid 9829974] [evidence TAS]; protein complex assembly [goid 6461] [pmid 9829974] [evidence TAS],basic amino acid permease activity [goid 5286] [pmid 9829974] [evidence TAS]; amino acid-polyamine transporter activity [goid 5279] [evidence IEA],14,22312594-22312643,14q11.2e-q11.2f,-,NM_003982.2,9056,SLC7A7,-1.6600790978181514,10.545912133169812,-14.354092317595006,1.0093566456628395e-27,3.6624421304917e-26,52.40932765375187
KIFC1,ILMN_2222008,"Homo sapiens kinesin family member C1 (KIFC1), mRNA.",microtubule associated complex [goid 5875] [evidence NAS]; microtubule [goid 5874] [evidence IEA],microtubule-based movement [goid 7018] [evidence IEA]; mitotic sister chromatid segregation [goid 70] [pmid 8276466] [evidence NAS],ATP binding [goid 5524] [pmid 8276466] [evidence NAS]; microtubule motor activity [goid 3777] [pmid 8276466] [evidence NAS]; nucleotide binding [goid 166] [evidence IEA],6,33482588-33482630:33485401-33485407,6p21.32a,+,NM_002263.2,3833,KIFC1,2.0477330146471413,6.831391889589727,14.340890568573956,1.0821895838648045e-27,3.919417108105152e-26,52.339856208082956
SEZ6L2,ILMN_1800873,"PREDICTED: Homo sapiens seizure related 6 homolog (mouse)-like 2 (SEZ6L2), mRNA.",,,,,,16p11.2d,,XM_939114.1,26470,SEZ6L2,1.170689195342896,7.238985385317134,14.3317690067522,1.1355720020967851e-27,4.105124389769176e-26,52.29184559414933
MGC34774,ILMN_1749234,"Homo sapiens ribosomal protein L13A-like (MGC34774), mRNA.",,,,7,77826605-77826654,7q21.11a,+,NM_203308.1,399670,MGC34774,-2.697072902080806,6.742466633020283,-14.328683668877071,1.1542202646737036e-27,4.164811455030947e-26,52.27560426122385
ZNF25,ILMN_1808765,"Homo sapiens zinc finger protein 25 (ZNF25), mRNA.",nucleus [goid 5634] [evidence IEA]; intracellular [goid 5622] [evidence IEA],"transcription [goid 6350] [evidence IEA]; regulation of transcription, DNA-dependent [goid 6355] [evidence IEA]",DNA binding [goid 3677] [evidence IEA]; zinc ion binding [goid 8270] [evidence IEA]; metal ion binding [goid 46872] [evidence IEA]; nucleic acid binding [goid 3676] [evidence IEA],10,38279101-38279150,10p11.21a,-,NM_145011.2,219749,ZNF25,-1.1281070749931583,8.80559605030072,-14.3241850905696,1.1819625715772872e-27,4.2570315540080303e-26,52.25192185603688
POLQ,ILMN_1740291,"Homo sapiens polymerase (DNA directed), theta (POLQ), mRNA.",nucleoplasm [goid 5654] [pmid 10395804] [evidence TAS],DNA replication [goid 6260] [evidence IEA]; DNA repair [goid 6281] [pmid 10395804] [evidence TAS],nucleotide binding [goid 166] [evidence IEA]; DNA-directed DNA polymerase activity [goid 3887] [pmid 10395804] [evidence TAS]; damaged DNA binding [goid 3684] [pmid 10395804] [evidence TAS]; transferase activity [goid 16740] [evidence IEA]; ATP binding [goid 5524] [evidence IEA],3,122633049-122633098,3q13.33c,-,NM_199420.2,10721,POLQ,1.6477747874582835,6.065916024567853,14.319366345945628,1.2124221736747085e-27,4.358680083773375e-26,52.226551695858575
FLJ11235,ILMN_1689831,"PREDICTED: Homo sapiens hypothetical protein FLJ11235 (FLJ11235), misc RNA.",,,,,,5q22.2a,,XR_000626.1,54508,FLJ11235,-1.620999722575216,7.228461313721791,-14.317558533693608,1.2240516257331028e-27,4.3923841486942004e-26,52.21703315926691
ANKS1A,ILMN_1813669,"Homo sapiens ankyrin repeat and sterile alpha motif domain containing 1A (ANKS1A), mRNA.",,,,6,35166819-35166868,6p21.31d,+,NM_015245.1,23294,ANKS1A,-1.0163763025135033,10.128628824247107,-14.315148471802845,1.2397295859458247e-27,4.440465254072499e-26,52.20434313106712
LOC654260,ILMN_1763310,"PREDICTED: Homo sapiens similar to beta-tubulin cofactor D isoform 1 (LOC654260), mRNA.",,,,,,,,XM_942439.1,654260,LOC654260,1.6361090423879778,7.170942593214116,14.30889478398449,1.281357612124397e-27,4.581147352705299e-26,52.17141200492755
SMAD6,ILMN_1767068,"Homo sapiens SMAD, mothers against DPP homolog 6 (Drosophila) (SMAD6), mRNA.",intracellular [goid 5622] [evidence IEA],"regulation of transcription, DNA-dependent [goid 6355] [evidence IEA]; transcription [goid 6350] [evidence IEA]","transforming growth factor beta receptor, inhibitory cytoplasmic mediator activity [goid 30617] [pmid 9436979] [evidence TAS]; signal transducer activity [goid 4871] [pmid 9436979] [evidence TAS]; receptor signaling protein serine/threonine kinase signaling protein activity [goid 5076] [evidence NR ]; protein binding [goid 5515] [pmid 9436979] [evidence TAS]",15,64861015-64861064,15q22.31c,+,NM_005585.2,4091,SMAD6,-2.7658947458863565,9.460987910235882,-14.29818235253976,1.3559518408224837e-27,4.838960003374743e-26,52.11499255504695
TMEM178,ILMN_1678403,"Homo sapiens transmembrane protein 178 (TMEM178), mRNA.",tight junction [goid 5923] [evidence IEA]; tight junction [goid 5923] [evidence IEA],,structural molecule activity [goid 5198] [evidence IEA]; structural molecule activity [goid 5198] [evidence IEA],2,39797960-39798009,2p22.1b,+,NM_152390.1,130733,TMEM178,-2.0065784105466236,6.778646479528556,-14.295480719300883,1.3754427111008077e-27,4.8995431857037e-26,52.10076196902452
SLIT2,ILMN_1676449,"Homo sapiens slit homolog 2 (Drosophila) (SLIT2), mRNA.",extracellular region [goid 5576] [pmid 10102268] [evidence IEP]; extracellular space [goid 5615] [evidence NR ]; integral to membrane [goid 16021] [evidence IEA],induction of negative chemotaxis [goid 50929] [pmid 10197527] [evidence IDA]; chemotaxis [goid 6935] [evidence IEA]; positive regulation of axonogenesis [goid 50772] [pmid 10197527] [evidence TAS]; ureteric bud development [goid 1657] [pmid 15130495] [evidence IMP]; mesoderm migration [goid 7509] [pmid 10102268] [evidence IMP]; glial cell migration [goid 8347] [pmid 10102268] [evidence IMP]; neuron recognition [goid 8038] [pmid 10432110] [evidence TAS]; cell differentiation [goid 30154] [evidence IEA]; motor axon guidance [goid 8045] [pmid 10102268] [evidence TAS]; G-protein coupled receptor protein signaling pathway [goid 7186] [evidence IEA],transferase activity [goid 16740] [evidence IEA]; receptor binding [goid 5102] [pmid 10102268] [evidence TAS]; calcium ion binding [goid 5509] [evidence IEA],4,20229660-20229709,4p15.31d,+,NM_004787.1,9353,SLIT2,-2.001279678972219,9.989024019501363,-14.284754323813239,1.4556426726032077e-27,5.166338338009745e-26,52.04425450932559
C1orf97,ILMN_1808769,"Homo sapiens chromosome 1 open reading frame 97 (C1orf97), mRNA.",,,,1,209672321-209672370,1q32.3a,+,NM_032705.3,84791,C1orf97,1.6376090665127307,7.9172705451846035,14.278375425810886,1.5055455035645534e-27,5.333737115810059e-26,52.010644521122444
C1orf178,ILMN_1655722,"Homo sapiens chromosome 1 open reading frame 178 (C1orf178), transcript variant d, mRNA.",,,,1,114231423-114231472,1p13.2b,-,NM_001029946.1,440603,C1orf178,1.8317785397197959,5.80511003866488,14.270678480879516,1.5680510233031862e-27,5.54509513413114e-26,51.970084404361636
AIF1,ILMN_1703538,"Homo sapiens allograft inflammatory factor 1 (AIF1), transcript variant 3, mRNA.",nucleus [goid 5634] [pmid 9614071] [evidence TAS]; nucleus [goid 5634] [pmid 9614071] [evidence TAS],response to stress [goid 6950] [pmid 9614071] [evidence TAS]; cell cycle arrest [goid 7050] [pmid 9614071] [evidence TAS]; inflammatory response [goid 6954] [pmid 8912632] [evidence TAS]; negative regulation of cell proliferation [goid 8285] [pmid 9614071] [evidence TAS]; response to stress [goid 6950] [pmid 9614071] [evidence TAS]; cell cycle arrest [goid 7050] [pmid 9614071] [evidence TAS]; inflammatory response [goid 6954] [pmid 8912632] [evidence TAS]; negative regulation of cell proliferation [goid 8285] [pmid 9614071] [evidence TAS],calcium ion binding [goid 5509] [evidence IEA]; calcium ion binding [goid 5509] [evidence IEA],6,31691054-31691085:31691086-31691103,6p21.33a,+,NM_001623.3,199,AIF1,-1.0694976955059197,8.365836411054161,-14.252120482960512,1.7296802823736226e-27,6.105583388052542e-26,51.87226609925039
LOC653626,ILMN_1811426,"PREDICTED: Homo sapiens similar to ARG99 protein (LOC653626), mRNA.",,,,12,29545629-29545678,,-,XM_928461.1,653626,LOC653626,-2.068581995275985,6.6621951786932865,-14.250444021564716,1.745080290387325e-27,6.148804603652264e-26,51.863427858770464
CD163,ILMN_1722622,"Homo sapiens CD163 molecule (CD163), transcript variant 2, mRNA.",integral to membrane [goid 16021] [evidence IEA]; membrane [goid 16020] [evidence IEA]; integral to membrane [goid 16021] [evidence IEA]; membrane [goid 16020] [evidence IEA],inflammatory response [goid 6954] [evidence IEA]; acute-phase response [goid 6953] [evidence IEA]; inflammatory response [goid 6954] [evidence IEA]; acute-phase response [goid 6953] [evidence IEA],scavenger receptor activity [goid 5044] [evidence IEA]; scavenger receptor activity [goid 5044] [evidence IEA],12,7526586-7526625:7526829-7526838,12p13.31c,-,NM_203416.1,9332,CD163,-1.928709130702991,9.32361634414774,-14.234616928563536,1.8974243058710863e-27,6.673522129945509e-26,51.77997422107482
MCM2,ILMN_1681503,"Homo sapiens MCM2 minichromosome maintenance deficient 2, mitotin (S. cerevisiae) (MCM2), mRNA.",chromatin [goid 785] [pmid 8798650] [evidence TAS]; nucleus [goid 5634] [pmid 8175912] [evidence TAS],"regulation of transcription, DNA-dependent [goid 6355] [evidence IEA]; cell cycle [goid 7049] [pmid 8175912] [evidence TAS]; transcription [goid 6350] [evidence IEA]; DNA replication initiation [goid 6270] [evidence IEA]; DNA replication [goid 6260] [pmid 8175912] [evidence TAS]",metal ion binding [goid 46872] [evidence IEA]; nucleotide binding [goid 166] [evidence IEA]; DNA-dependent ATPase activity [goid 8094] [evidence IEA]; protein binding [goid 5515] [pmid 15654075] [evidence IPI]; DNA binding [goid 3677] [pmid 8175912] [evidence TAS]; ATP binding [goid 5524] [evidence IEA],3,128823652-128823701,3q21.3b,+,NM_004526.2,4171,MCM2,1.7359073584018798,8.067424480164714,14.233160786677345,1.912093977378219e-27,6.713000207065693e-26,51.772294973199976
KIAA0406,ILMN_1741398,"Homo sapiens KIAA0406 (KIAA0406), mRNA.",,,binding [goid 5488] [evidence IEA],20,36045150-36045199,20q11.23c,-,NM_014657.1,9675,KIAA0406,1.1509208424541884,7.086180798840325,14.228389147075186,1.9609674704809743e-27,6.872203446460753e-26,51.74712932438561
OTUD1,ILMN_1723141,"PREDICTED: Homo sapiens OTU domain containing 1 (OTUD1), mRNA.",,,,10,23770773-23770822,10p12.2a,+,XM_166659.6,220213,OTUD1,-1.3463883822689295,6.767237742016036,-14.2246605267736,2.0000288791700663e-27,6.99651036097464e-26,51.727462988640745
PDZK3,ILMN_1717722,"Homo sapiens PDZ domain containing 3 (PDZK3), transcript variant 1, mRNA.",intercellular junction [goid 5911] [pmid 12671685] [evidence ISS]; endoplasmic reticulum [goid 5783] [pmid 12671685] [evidence ISS]; extracellular region [goid 5576] [pmid 12671685] [evidence ISS]; nucleus [goid 5634] [pmid 12671685] [evidence ISS]; intercellular junction [goid 5911] [pmid 12671685] [evidence ISS]; endoplasmic reticulum [goid 5783] [pmid 12671685] [evidence ISS]; extracellular region [goid 5576] [pmid 12671685] [evidence ISS]; nucleus [goid 5634] [pmid 12671685] [evidence ISS],cell adhesion [goid 7155] [evidence IEA]; cell adhesion [goid 7155] [evidence IEA],structural molecule activity [goid 5198] [evidence IEA]; protein binding [goid 5515] [pmid 12671685] [evidence ISS]; structural molecule activity [goid 5198] [evidence IEA]; protein binding [goid 5515] [pmid 12671685] [evidence ISS],5,32073096-32073145,5p13.3c,+,NM_178140.1,23037,PDZK3,-1.168583597658614,6.1598199587825855,-14.223326181900743,2.0141965428430396e-27,7.03344437944384e-26,51.720424748327574
MORC2,ILMN_2103591,"Homo sapiens MORC family CW-type zinc finger 2 (MORC2), mRNA.",,,zinc ion binding [goid 8270] [evidence IEA]; metal ion binding [goid 46872] [evidence IEA]; ATP binding [goid 5524] [evidence IEA],22,29654119-29654168,22q12.2c,-,NM_014941.1,22880,MORC2,1.09420985790638,8.097753530447912,14.221574022805607,2.0329535097785733e-27,7.086243137394544e-26,51.711182403706744
FPRL1,ILMN_1740875,"Homo sapiens formyl peptide receptor-like 1 (FPRL1), transcript variant 1, mRNA.",integral to membrane [goid 16021] [pmid 9054386] [evidence TAS]; plasma membrane [goid 5886] [pmid 9054386] [evidence TAS]; integral to membrane [goid 16021] [pmid 9054386] [evidence TAS]; plasma membrane [goid 5886] [pmid 9054386] [evidence TAS],inflammatory response [goid 6954] [pmid 9054386] [evidence TAS]; signal transduction [goid 7165] [evidence IEA]; G-protein coupled receptor protein signaling pathway [goid 7186] [pmid 9054386] [evidence TAS]; chemotaxis [goid 6935] [pmid 9054386] [evidence TAS]; cell adhesion [goid 7155] [pmid 9054386] [evidence TAS]; cell motility [goid 6928] [pmid 1374236] [evidence TAS]; inflammatory response [goid 6954] [pmid 9054386] [evidence TAS]; signal transduction [goid 7165] [evidence IEA]; G-protein coupled receptor protein signaling pathway [goid 7186] [pmid 9054386] [evidence TAS]; chemotaxis [goid 6935] [pmid 9054386] [evidence TAS]; cell adhesion [goid 7155] [pmid 9054386] [evidence TAS]; cell motility [goid 6928] [pmid 1374236] [evidence TAS],rhodopsin-like receptor activity [goid 1584] [evidence IEA]; receptor activity [goid 4872] [evidence IEA]; N-formyl peptide receptor activity [goid 4982] [pmid 1374236] [evidence TAS]; rhodopsin-like receptor activity [goid 1584] [evidence IEA]; receptor activity [goid 4872] [evidence IEA]; N-formyl peptide receptor activity [goid 4982] [pmid 1374236] [evidence TAS],19,56964814-56964863,19q13.33e,+,NM_001462.3,2358,FPRL1,-2.2151409726808726,5.970629901772726,-14.220634609344872,2.043082071734904e-27,7.10883110138475e-26,51.706227030106845
C7,ILMN_1687848,"Homo sapiens complement component 7 (C7), mRNA.",membrane [goid 16020] [evidence IEA]; integral to membrane [goid 16021] [evidence IEA]; membrane attack complex [goid 5579] [pmid 3335508] [evidence TAS],"complement activation, alternative pathway [goid 6957] [evidence IEA]; innate immune response [goid 45087] [evidence IEA]; cytolysis [goid 19835] [evidence IEA]; complement activation, classical pathway [goid 6958] [evidence IEA]",,5,41018553-41018602,5p13.1b,+,NM_000587.2,730,C7,-3.252318959957008,9.093472651198189,-14.213722624375752,2.119179492725022e-27,7.36046567125616e-26,51.66976385462725
RAB26,ILMN_1790317,"Homo sapiens RAB26, member RAS oncogene family (RAB26), mRNA.",membrane [goid 16020] [evidence IEA]; intracellular [goid 5622] [evidence IEA],"protein transport [goid 15031] [evidence IEA]; regulation of transcription, DNA-dependent [goid 6355] [evidence IEA]; small GTPase mediated signal transduction [goid 7264] [evidence IEA]",nucleotide binding [goid 166] [evidence IEA]; ATP binding [goid 5524] [evidence IEA]; GTP binding [goid 5525] [pmid 11043516] [evidence NAS]; transcription factor binding [goid 8134] [evidence IEA]; protein binding [goid 5515] [pmid 16696853] [evidence IPI],16,2143907-2143956,16p13.3d,+,NM_014353.4,25837,RAB26,1.531974057298437,6.092757945290621,14.192717201889435,2.3683474721726897e-27,8.196669714970667e-26,51.55892373383699
TIMELESS,ILMN_1735093,"Homo sapiens timeless homolog (Drosophila) (TIMELESS), mRNA.",nucleus [goid 5634] [pmid 9856465] [evidence IC ],"morphogenesis of an epithelium [goid 2009] [evidence ISS]; transcription [goid 6350] [evidence IEA]; regulation of transcription, DNA-dependent [goid 6355] [evidence IEA]; development [goid 7275] [evidence IEA]; circadian rhythm [goid 7623] [evidence ISS]; negative regulation of transcription [goid 16481] [pmid 9856465] [evidence IDA]",protein heterodimerization activity [goid 46982] [evidence ISS]; protein binding [goid 5515] [evidence ISS],12,55097382-55097431,12q13.2c,-,NM_003920.2,8914,TIMELESS,1.253865663755131,8.37025852147057,14.191415653828637,2.384720328322617e-27,8.238701347050745e-26,51.552054368758235
RAMP2,ILMN_1814464,"Homo sapiens receptor (G protein-coupled) activity modifying protein 2 (RAMP2), mRNA.",coated pit [goid 5905] [pmid 10882736] [evidence TAS]; lysosome [goid 5764] [pmid 10882736] [evidence TAS]; integral to plasma membrane [goid 5887] [pmid 9620797] [evidence TAS]; plasma membrane [goid 5886] [pmid 9620797] [evidence TAS]; lysosome [goid 5764] [pmid 10882736] [evidence TAS]; coated pit [goid 5905] [pmid 10882736] [evidence TAS]; integral to plasma membrane [goid 5887] [pmid 9620797] [evidence TAS],intracellular protein transport [goid 6886] [evidence IEA]; receptor mediated endocytosis [goid 6898] [pmid 10882736] [evidence TAS]; cell surface receptor linked signal transduction [goid 7166] [evidence NR ]; regulation of G-protein coupled receptor protein signaling pathway [goid 8277] [evidence IEA]; intracellular protein transport [goid 6886] [evidence IEA]; regulation of G-protein coupled receptor protein signaling pathway [goid 8277] [evidence IEA]; cell surface receptor linked signal transduction [goid 7166] [evidence NR ]; receptor mediated endocytosis [goid 6898] [pmid 10882736] [evidence TAS],protein transporter activity [goid 8565] [evidence IEA]; receptor activity [goid 4872] [evidence IEA]; protein transporter activity [goid 8565] [evidence IEA]; receptor activity [goid 4872] [evidence IEA],17,38168393-38168396:38168397-38168442,17q21.31a,+,NM_005854.2,10266,RAMP2,-1.9119906847871562,8.21971154626702,-14.1708507575441,2.659024316590557e-27,9.153902616389929e-26,51.44349389930729
CYB5A,ILMN_1714167,"Homo sapiens cytochrome b5 type A (microsomal) (CYB5A), transcript variant 1, mRNA.",integral to membrane [goid 16021] [evidence IEA]; membrane [goid 16020] [evidence IEA]; mitochondrion [goid 5739] [evidence NR ]; endoplasmic reticulum [goid 5783] [evidence IEA]; microsome [goid 5792] [evidence IEA],transport [goid 6810] [evidence IEA]; electron transport [goid 6118] [evidence IEA],cytochrome-c oxidase activity [goid 4129] [pmid 1712589] [evidence TAS]; metal ion binding [goid 46872] [evidence IEA]; iron ion binding [goid 5506] [evidence IEA],18,70071744-70071793,18q22.3c,-,NM_148923.2,1528,CYB5A,-1.6444458390268828,12.313025361736868,-14.165781489007102,2.7313721726236653e-27,9.386382148778152e-26,51.41672722511856
DLG7,ILMN_1749829,"Homo sapiens discs, large homolog 7 (Drosophila) (DLG7), mRNA.",nucleus [goid 5634] [pmid 12527899] [evidence IDA],M phase of mitotic cell cycle [goid 87] [pmid 12527899] [evidence IDA]; cell-cell signaling [goid 7267] [evidence IEA]; mitotic chromosome movement towards spindle pole [goid 7079] [pmid 12527899] [evidence NAS]; cell proliferation [goid 8283] [pmid 12527899] [evidence NAS]; positive regulation of mitotic metaphase/anaphase transition [goid 45842] [pmid 12527899] [evidence NAS]; cell cycle [goid 7049] [evidence IEA],phosphoprotein phosphatase activity [goid 4721] [pmid 15145941] [evidence IDA]; protein binding [goid 5515] [pmid 15145941] [evidence IPI],14,54684927-54684944:54687270-54687301,14q22.3a,-,NM_014750.3,9787,DLG7,1.5830520325853454,6.294190468321571,14.15914761951179,2.829042534347313e-27,9.704910877069964e-26,51.3816953492901
CLIC5,ILMN_1778964,"Homo sapiens chloride intracellular channel 5 (CLIC5), mRNA.",actin cytoskeleton [goid 15629] [pmid 10793131] [evidence TAS]; Golgi stack [goid 5795] [evidence IEA]; insoluble fraction [goid 5626] [pmid 10793131] [evidence TAS]; membrane [goid 16020] [evidence IEA],chloride transport [goid 6821] [evidence IEA]; ion transport [goid 6811] [evidence IEA]; pregnancy [goid 7565] [pmid 10793131] [evidence TAS],chloride transporter activity [goid 15108] [evidence NR ]; voltage-gated chloride channel activity [goid 5247] [evidence IEA],6,45977706-45977755,6p12.3f,-,NM_016929.1,53405,CLIC5,-2.9312097480791905,9.690727128681772,-14.14882538532716,2.988033536304126e-27,1.0209763161600183e-25,51.327177502561256
FLJ13236,ILMN_1749636,"Homo sapiens hypothetical protein FLJ13236 (FLJ13236), mRNA.",membrane [goid 16020] [evidence IEA]; integral to membrane [goid 16021] [evidence IEA],protein folding [goid 6457] [evidence IEA],heat shock protein binding [goid 31072] [evidence IEA],12,48031542-48031552:48031553-48031591,12q13.12b,+,NM_024902.2,79962,FLJ13236,2.107039979194334,6.309318310750452,14.148625678251067,2.9911964232019914e-27,1.0209763161600183e-25,51.32612262777555
VMD2,ILMN_1718982,"Homo sapiens vitelliform macular dystrophy 2 (Best disease, bestrophin) (VMD2), mRNA.",membrane fraction [goid 5624] [pmid 10737974] [evidence TAS]; integral to membrane [goid 16021] [pmid 10737974] [evidence TAS]; basolateral plasma membrane [goid 16323] [pmid 11050159] [evidence IDA],ion transport [goid 6811] [evidence IEA]; visual perception [goid 7601] [pmid 9662395] [evidence TAS]; sensory perception [goid 7600] [evidence IEA],ion channel activity [goid 5216] [evidence IEA]; calcium ion binding [goid 5509] [evidence IEA],11,61488158-61488170:61488171-61488207,11q12.3a,+,NM_004183.1,7439,VMD2,-1.139904637872796,6.463804152285437,-14.148579417121141,2.9919295690396226e-27,1.0209763161600183e-25,51.32587827083055
NCF1,ILMN_1697309,"Homo sapiens neutrophil cytosolic factor 1 (47kDa, chronic granulomatous disease, autosomal 1) (NCF1), mRNA.",cytosol [goid 5829] [pmid 2848318] [evidence TAS]; soluble fraction [goid 5625] [pmid 2848318] [evidence TAS],superoxide metabolism [goid 6801] [evidence NR ]; electron transport [goid 6118] [evidence IEA]; intracellular signaling cascade [goid 7242] [evidence IEA]; cellular defense response [goid 6968] [pmid 2848318] [evidence TAS],protein binding [goid 5515] [pmid 12681507] [evidence IPI]; GTPase activity [goid 3924] [pmid 2547247] [evidence TAS]; electron transporter activity [goid 5489] [pmid 2848318] [evidence TAS]; phosphoinositide binding [goid 35091] [evidence IEA]; GTP binding [goid 5525] [pmid 2848318] [evidence TAS],7,74222428-74222452:74222864-74222865:74225612-74225634,7q11.23d,-,NM_000265.1,4687,NCF1,-2.8891078845966387,6.913617794756068,-14.14269818909486,3.0866192887672184e-27,1.0514471475809308e-25,51.29481119545061
DOCK2,ILMN_1799725,"Homo sapiens dedicator of cytokinesis 2 (DOCK2), mRNA.",membrane [goid 16020] [evidence IEA]; cytoskeleton [goid 5856] [evidence IEA],lymphocyte chemotaxis [goid 48247] [pmid 11518968] [evidence ISS]; actin cytoskeleton organization and biogenesis [goid 30036] [pmid 12176041] [evidence TAS],Rac guanyl-nucleotide exchange factor activity [goid 30676] [pmid 10559471] [evidence IDA]; T cell receptor binding [goid 42608] [pmid 12176041] [evidence IDA]; protein binding [goid 5515] [pmid 12134158] [evidence IPI],5,169442689-169442738,5q35.1b-q35.1c,+,NM_004946.1,1794,DOCK2,-1.5013795016724707,9.906896894862358,-14.140707788281649,3.1193418671350057e-27,1.0607395511540242e-25,51.28429630821616
GOLPH2,ILMN_1737011,"Homo sapiens golgi phosphoprotein 2 (GOLPH2), transcript variant 2, mRNA.",Golgi apparatus [goid 5794] [pmid 10831838] [evidence TAS]; integral to plasma membrane [goid 5887] [pmid 10831838] [evidence TAS]; membrane [goid 16020] [evidence IEA],,,9,87904772-87904821,9q21.33b,-,NM_177937.1,51280,GOLPH2,1.2471309669918123,6.831525009393976,14.13717293375679,3.1783160936549238e-27,1.0789109596666585e-25,51.26562142571444
GPR109A,ILMN_1750497,"Homo sapiens G protein-coupled receptor 109A (GPR109A), mRNA.",membrane [goid 16020] [evidence IEA]; integral to membrane [goid 16021] [evidence IEA],G-protein coupled receptor protein signaling pathway [goid 7186] [evidence IEA]; signal transduction [goid 7165] [evidence IEA],"receptor activity [goid 4872] [evidence IEA]; purinergic nucleotide receptor activity, G-protein coupled [goid 45028] [evidence IEA]; rhodopsin-like receptor activity [goid 1584] [evidence IEA]",12,121752686-121752691:121752692-121752735,12q24.31c,-,NM_177551.3,338442,GPR109A,-1.7929577571883026,5.817320074120323,-14.125599933266857,3.379338230373839e-27,1.1431667607436503e-25,51.20447190056075
LDHA,ILMN_1807106,"Homo sapiens lactate dehydrogenase A (LDHA), mRNA.",cytosol [goid 5829] [pmid 2434947] [evidence TAS]; cytoplasm [goid 5737] [evidence IEA],tricarboxylic acid cycle intermediate metabolism [goid 6100] [evidence IEA]; anaerobic glycolysis [goid 19642] [evidence IEA],oxidoreductase activity [goid 16491] [evidence IEA]; L-lactate dehydrogenase activity [goid 4459] [pmid 2334430] [evidence TAS]; protein binding [goid 5515] [pmid 15231747] [evidence IPI],11,18385623-18385672,11p15.1c,+,NM_005566.1,3939,LDHA,1.1377847524999396,12.955043630623823,14.12019474730324,3.477549677741759e-27,1.1743510480207656e-25,51.17590744314894
ASPA,ILMN_1692824,"Homo sapiens aspartoacylase (Canavan disease) (ASPA), mRNA.",,metabolism [goid 8152] [evidence IEA]; aspartate catabolism [goid 6533] [pmid 8252036] [evidence TAS],"hydrolase activity, acting on ester bonds [goid 16788] [evidence IEA]; aspartoacylase activity [goid 19807] [evidence IEA]; aminoacylase activity [goid 4046] [pmid 8252036] [evidence TAS]",17,3348980-3349029,17p13.3a,+,NM_000049.2,443,ASPA,-1.0846874952478798,5.349914686181097,-14.115526507240379,3.5646732320913556e-27,1.201689583517302e-25,51.15123518261302
GRASP,ILMN_1705210,"Homo sapiens GRP1 (general receptor for phosphoinositides 1)-associated scaffold protein (GRASP), mRNA.",membrane [goid 16020] [evidence IEA]; nucleus [goid 5634] [evidence IEA],,protein binding [goid 5515] [evidence IEA],12,50695586-50695635,12q13.13c,+,NM_181711.1,160622,GRASP,-1.8671878181839512,7.837772654793892,-14.110640391026294,3.6582102365870885e-27,1.2310919941260696e-25,51.125409140371936
CHEK1,ILMN_1664630,"Homo sapiens CHK1 checkpoint homolog (S. pombe) (CHEK1), mRNA.",condensed nuclear chromosome [goid 794] [pmid 9382850] [evidence TAS]; nucleus [goid 5634] [evidence IEA],gametogenesis [goid 7276] [pmid 9382850] [evidence TAS]; cell cycle [goid 7049] [evidence IEA]; DNA damage checkpoint [goid 77] [pmid 9278511] [evidence TAS]; meiotic recombination [goid 7131] [pmid 9278511] [evidence TAS]; negative regulation of cell proliferation [goid 8285] [pmid 9278511] [evidence TAS]; protein amino acid phosphorylation [goid 6468] [evidence IEA]; DNA repair [goid 6281] [evidence IEA],nucleotide binding [goid 166] [evidence IEA]; transferase activity [goid 16740] [evidence IEA]; protein serine/threonine kinase activity [goid 4674] [evidence IEA]; ATP binding [goid 5524] [evidence IEA],11,125030428-125030477,11q24.2b,+,NM_001274.2,1111,CHEK1,1.4296970372832165,6.224474230239109,14.107786061593776,3.7139875155520474e-27,1.2477077024229593e-25,51.1103212274834
TMEM62,ILMN_1745807,"Homo sapiens transmembrane protein 62 (TMEM62), mRNA.",,,,15,41264348-41264397,15q15.2b,+,NM_024956.3,80021,TMEM62,1.2565775298786015,9.69001493333077,14.106812618427657,3.7332043629363236e-27,1.2507652633901164e-25,51.105175450050325
CES4,ILMN_2150095,Homo sapiens carboxylesterase 4-like (CES4) on chromosome 16.,,,,,,16q12.2c,,NR_003276.1,51716,CES4,-3.137454084887671,6.862053328875592,-14.106675106222243,3.735927037685644e-27,1.2507652633901164e-25,51.10444853093126
NDRG2,ILMN_1670535,"Homo sapiens NDRG family member 2 (NDRG2), transcript variant 1, mRNA.",cytosol [goid 5829] [pmid 11936845] [evidence NAS],cell differentiation [goid 30154] [pmid 11978393] [evidence ISS],,14,20555000-20555049,14q11.2c,-,NM_201535.1,57447,NDRG2,-1.5415460954824267,7.714386054897304,-14.09955596296949,3.879638694132511e-27,1.2966511141538934e-25,51.06681269142504
ELMO3,ILMN_1752665,"Homo sapiens engulfment and cell motility 3 (ced-12 homolog, C. elegans) (ELMO3), mRNA.",membrane [goid 16020] [evidence IEA]; cytoskeleton [goid 5856] [evidence IEA],apoptosis [goid 6915] [evidence IEA]; phagocytosis [goid 6909] [evidence IEA],,16,65794952-65794987:65795069-65795082,16q22.1a,+,NM_024712.2,79767,ELMO3,1.526494194213531,8.539176726737171,14.086203695155158,4.16430674083078e-27,1.3894095350186258e-25,50.996211715617235
ITGA11,ILMN_1651343,"Homo sapiens integrin, alpha 11 (ITGA11), transcript variant 2, mRNA.",membrane [goid 16020] [evidence IEA]; integrin complex [goid 8305] [pmid 10486209] [evidence TAS]; integral to membrane [goid 16021] [evidence IEA]; membrane [goid 16020] [evidence IEA]; integrin complex [goid 8305] [pmid 10486209] [evidence TAS]; integral to membrane [goid 16021] [evidence IEA],integrin-mediated signaling pathway [goid 7229] [evidence IEA]; cell-matrix adhesion [goid 7160] [pmid 10464311] [evidence TAS]; muscle development [goid 7517] [pmid 10464311] [evidence TAS]; cell adhesion [goid 7155] [pmid 10486209] [evidence TAS]; integrin-mediated signaling pathway [goid 7229] [evidence IEA]; cell-matrix adhesion [goid 7160] [pmid 10464311] [evidence TAS]; muscle development [goid 7517] [pmid 10464311] [evidence TAS]; cell adhesion [goid 7155] [pmid 10486209] [evidence TAS],calcium ion binding [goid 5509] [evidence IEA]; collagen binding [goid 5518] [pmid 10464311] [evidence TAS]; magnesium ion binding [goid 287] [evidence IEA]; receptor activity [goid 4872] [evidence IEA]; calcium ion binding [goid 5509] [evidence IEA]; collagen binding [goid 5518] [pmid 10464311] [evidence TAS]; magnesium ion binding [goid 287] [evidence IEA]; receptor activity [goid 4872] [evidence IEA],15,66381222-66381271,15q23a,-,NM_012211.3,22801,ITGA11,1.8911573591283055,6.1115761649638785,14.080524220230553,4.2916602766830046e-27,1.4294529998490314e-25,50.96617587653205
BST1,ILMN_1770161,"Homo sapiens bone marrow stromal cell antigen 1 (BST1), mRNA.",membrane [goid 16020] [evidence IEA]; extrinsic to membrane [goid 19898] [pmid 8202488] [evidence TAS],development [goid 7275] [pmid 8202488] [evidence TAS]; humoral immune response [goid 6959] [pmid 8202488] [evidence TAS],hydrolase activity [goid 16787] [evidence IEA]; NAD+ nucleosidase activity [goid 3953] [evidence IEA]; GPI anchor binding [goid 48503] [evidence IEA],4,15342563-15342566:15342567-15342612,4p15.32d,+,NM_004334.1,683,BST1,-1.1832598349112056,5.862179929539523,-14.05979785348077,4.790490492908541e-27,1.5901653706017532e-25,50.856538199386776
CIRBP,ILMN_1674661,"Homo sapiens cold inducible RNA binding protein (CIRBP), mRNA.",nucleus [goid 5634] [evidence IEA],response to cold [goid 9409] [pmid 9151692] [evidence TAS],RNA binding [goid 3723] [pmid 9151692] [evidence TAS]; nucleotide binding [goid 166] [evidence IEA],19,1223846-1223895,19p13.3i,+,NM_001280.1,1153,CIRBP,-1.133113724075658,12.714601904912534,-14.056267394407428,4.8810826762814e-27,1.61748122359427e-25,50.83785874645497
BEX1,ILMN_1702637,"Homo sapiens brain expressed, X-linked 1 (BEX1), mRNA.",nucleus [goid 5634] [evidence IEA]; nucleus [goid 5634] [evidence IEA],cell differentiation [goid 30154] [evidence IEA]; cell differentiation [goid 30154] [evidence IEA],,X,102205743-102205792,Xq22.1e,-,NM_018476.3,55859,BEX1,-1.6823216628519306,7.016480055121207,-14.052536528141681,4.978686390868397e-27,1.64702384254789e-25,50.81811764242116
CG018,ILMN_1799487,"Homo sapiens hypothetical gene CG018 (CG018), mRNA.",,,,13,31874187-31874236,13q13.1a,-,NM_052818.1,90634,CG018,-1.5182136073257153,7.627700580353814,-14.045597061752481,5.165470360337175e-27,1.7059184740876245e-25,50.78139532413197
PPP3CC,ILMN_1690546,"Homo sapiens protein phosphatase 3 (formerly 2B), catalytic subunit, gamma isoform (PPP3CC), mRNA.",calcineurin complex [goid 5955] [evidence NR ],,zinc ion binding [goid 8270] [evidence IEA]; metal ion binding [goid 46872] [evidence IEA]; calmodulin binding [goid 5516] [evidence IEA]; iron ion binding [goid 5506] [evidence IEA]; hydrolase activity [goid 16787] [evidence IEA]; phosphoprotein phosphatase activity [goid 4721] [evidence IEA],8,22454144-22454193,8p21.3a,+,NM_005605.3,5533,PPP3CC,-1.0715075067971789,8.480015999746238,-14.044201587669464,5.20387209849496e-27,1.7156928568388206e-25,50.774010183457136
NSUN5,ILMN_1751958,"Homo sapiens NOL1/NOP2/Sun domain family, member 5 (NSUN5), transcript variant 1, mRNA.",,,,7,72355419-72355462:72355533-72355538,7q11.23a,-,NM_148956.1,55695,NSUN5,1.057386487350934,7.578160501853494,14.028868759862895,5.645157874158137e-27,1.8580388712495153e-25,50.69285330135422
CCNA2,ILMN_1786125,"Homo sapiens cyclin A2 (CCNA2), mRNA.",nucleus [goid 5634] [evidence IEA],mitotic G2 checkpoint [goid 7095] [pmid 1312467] [evidence TAS]; mitosis [goid 7067] [evidence IEA]; cell cycle [goid 7049] [evidence IEA]; cell division [goid 51301] [evidence IEA],protein binding [goid 5515] [pmid 7630397] [evidence IPI],4,122958685-122958734,4q27c,-,NM_001237.2,890,CCNA2,1.6968385850450964,6.345784333250121,14.024671697217974,5.772368549979051e-27,1.8967049105622563e-25,50.67063424516908
PTGDS,ILMN_1664464,"Homo sapiens prostaglandin D2 synthase 21kDa (brain) (PTGDS), mRNA.",membrane [goid 16020] [evidence IEA]; Golgi apparatus [goid 5794] [evidence ISS]; nucleus [goid 5634] [evidence IEA]; rough endoplasmic reticulum [goid 5791] [pmid 9065498] [evidence IDA]; extracellular region [goid 5576] [pmid 7692978] [evidence IDA],"lipid metabolism [goid 6629] [evidence IEA]; regulation of circadian sleep/wake cycle, sleep [goid 45187] [evidence ISS]; prostaglandin biosynthesis [goid 1516] [evidence ISS]; transport [goid 6810] [evidence ISS]; fatty acid biosynthesis [goid 6633] [evidence IEA]",binding [goid 5488] [evidence IEA]; isomerase activity [goid 16853] [evidence IEA]; prostaglandin-D synthase activity [goid 4667] [evidence ISS]; transporter activity [goid 5215] [evidence ISS]; retinoid binding [goid 5501] [evidence ISS],9,138994544-138994557:138995106-138995128:138995852-138995864,9q34.3e,+,NM_000954.5,5730,PTGDS,-2.457137337272977,11.448804238865497,-14.017484838203904,5.9969147237755474e-27,1.967169754086979e-25,50.63258341627758
WNT2,ILMN_1694011,"Homo sapiens wingless-type MMTV integration site family member 2 (WNT2), mRNA.",extracellular region [goid 5576] [pmid 2971536] [evidence NAS],development [goid 7275] [evidence NAS]; frizzled-2 signaling pathway [goid 7223] [evidence IEA],extracellular matrix structural constituent [goid 5201] [evidence NAS]; signal transducer activity [goid 4871] [evidence IEA],7,116704775-116704824,7q31.2c,-,NM_003391.1,7472,WNT2,-1.5126155584070151,7.076641929226191,-14.007564792664356,6.3213282867130936e-27,2.0701022128841113e-25,50.58005359155835
SHMT2,ILMN_1661264,"Homo sapiens serine hydroxymethyltransferase 2 (mitochondrial) (SHMT2), mRNA.",mitochondrion [goid 5739] [pmid 8505317] [evidence TAS],one-carbon compound metabolism [goid 6730] [evidence IEA]; L-serine metabolism [goid 6563] [evidence IEA]; glycine metabolism [goid 6544] [evidence IEA],transferase activity [goid 16740] [evidence IEA]; glycine hydroxymethyltransferase activity [goid 4372] [evidence IEA],12,55914669-55914718,12q13.3b,+,NM_005412.4,6472,SHMT2,1.1237025311725777,11.110755874398581,14.00117386179733,6.53959939608952e-27,2.1379881582685283e-25,50.54620656951285
RGS17,ILMN_1725485,"Homo sapiens regulator of G-protein signalling 17 (RGS17), mRNA.",membrane [goid 16020] [evidence IEA],negative regulation of signal transduction [goid 9968] [evidence IEA],signal transducer activity [goid 4871] [evidence IEA],6,153373768-153373817,6q25.2a,-,NM_012419.4,26575,RGS17,2.7210456832993737,6.772121652060364,13.999982263389521,6.581125175666289e-27,2.1479602018066604e-25,50.53989531050434
PSAT1,ILMN_1692938,"Homo sapiens phosphoserine aminotransferase 1 (PSAT1), transcript variant 2, mRNA.",,metabolism [goid 8152] [evidence IEA]; amino acid biosynthesis [goid 8652] [evidence IEA]; L-serine biosynthesis [goid 6564] [pmid 10637769] [evidence NAS]; pyridoxine biosynthesis [goid 8615] [pmid 10637769] [evidence NAS],transferase activity [goid 16740] [evidence IEA]; phosphoserine transaminase activity [goid 4648] [pmid 10637769] [evidence NAS],9,80134501-80134550,9q21.2c,+,NM_021154.3,29968,PSAT1,2.1628161680484395,7.007832013026253,13.988300602456116,7.002494664308636e-27,2.281665694549394e-25,50.478016618951536
ENTPD5,ILMN_1745849,"Homo sapiens ectonucleoside triphosphate diphosphohydrolase 5 (ENTPD5), mRNA.",membrane [goid 16020] [evidence IEA]; integral to membrane [goid 16021] [evidence IEA]; endoplasmic reticulum [goid 5783] [evidence IEA],,hydrolase activity [goid 16787] [evidence IEA]; magnesium ion binding [goid 287] [evidence IEA]; nucleoside-diphosphatase activity [goid 17110] [evidence IEA]; calcium ion binding [goid 5509] [evidence IEA],14,73503185-73503234,14q24.3a,-,NM_001249.1,957,ENTPD5,1.5407956535361942,6.359229557489535,13.986923698162471,7.053912046963737e-27,2.294582240986451e-25,50.47072218843763
IBRDC2,ILMN_1752526,"Homo sapiens IBR domain containing 2 (IBRDC2), mRNA.",ubiquitin ligase complex [goid 151] [pmid 12853982] [evidence IC ]; integral to membrane [goid 16021] [evidence ISS]; membrane [goid 16020] [evidence IEA],protein ubiquitination during ubiquitin-dependent protein catabolism [goid 42787] [pmid 12853982] [evidence IDA]; electron transport [goid 6118] [evidence IEA]; ubiquitin cycle [goid 6512] [evidence IEA],metal ion binding [goid 46872] [evidence IEA]; protein binding [goid 5515] [pmid 12853982] [evidence IPI]; iron ion binding [goid 5506] [evidence IEA]; ubiquitin-protein ligase activity [goid 4842] [pmid 12853982] [evidence IDA]; electron transporter activity [goid 5489] [evidence IEA]; zinc ion binding [goid 8270] [evidence IEA]; ligase activity [goid 16874] [evidence IEA],6,18576211-18576260,6p22.3d,+,NM_182757.2,255488,IBRDC2,-1.717977381399308,8.93026806001197,-13.98386320475167,7.169560233355745e-27,2.328314685782278e-25,50.45450795444645
AGRP,ILMN_1714253,"Homo sapiens agouti related protein homolog (mouse) (AGRP), transcript variant 2, mRNA.",extracellular region [goid 5576] [evidence IEA],neuropeptide signaling pathway [goid 7218] [pmid 9311920] [evidence TAS]; feeding behavior [goid 7631] [pmid 9751529] [evidence TAS]; hormone-mediated signaling [goid 9755] [evidence IEA],neuropeptide hormone activity [goid 5184] [pmid 9311920] [evidence TAS]; receptor binding [goid 5102] [pmid 10318826] [evidence TAS],16,66074070-66074119,16q22.1b,-,NM_007316.1,181,AGRP,-1.6056607943124463,6.3140921291011916,-13.981429317627253,7.262887236862618e-27,2.354698133282331e-25,50.44161278974993
C16orf30,ILMN_1751559,"Homo sapiens chromosome 16 open reading frame 30 (C16orf30), mRNA.",integral to membrane [goid 16021] [evidence IEA],,,16,1545239-1545288,16p13.3e,+,NM_024600.1,79652,C16orf30,-1.7669266638283627,8.990217077671469,-13.971224873188032,7.667631333570692e-27,2.481790640110049e-25,50.38754169451004
KIAA0672,ILMN_2065022,"Homo sapiens KIAA0672 gene product (KIAA0672), mRNA.",intracellular [goid 5622] [evidence IEA]; cytoplasm [goid 5737] [evidence IEA],signal transduction [goid 7165] [evidence IEA],protein binding [goid 5515] [evidence IEA],17,12835495-12835544,17p12c,+,NM_014859.3,9912,KIAA0672,-1.8464706169174754,9.33221512517285,-13.967297495717315,7.829369591400042e-27,2.5299380843852376e-25,50.366728748624034
C16orf9,ILMN_1810055,"Homo sapiens integrin alpha FG-GAP repeat containing 3 (ITFG3), mRNA.",membrane [goid 16020] [evidence IEA]; integral to membrane [goid 16021] [evidence IEA],,,16,255781-255830,16p13.3f,+,NM_032039.1,83986,C16orf9,1.2348329517608239,10.507785753264264,13.966080624533076,7.880174432655446e-27,2.5379371705833284e-25,50.36027970138809
CEECAM1,ILMN_1750563,"Homo sapiens cerebral endothelial cell adhesion molecule 1 (CEECAM1), mRNA.",plasma membrane [goid 5886] [pmid 10608765] [evidence NAS]; integral to membrane [goid 16021] [evidence NR ]; membrane fraction [goid 5624] [evidence NR ],cell motility [goid 6928] [pmid 10608765] [evidence TAS]; lipopolysaccharide biosynthesis [goid 9103] [evidence IEA]; leukocyte adhesion [goid 7159] [pmid 10608765] [evidence TAS]; cell adhesion [goid 7155] [pmid 10608765] [evidence IDA],"procollagen-lysine 5-dioxygenase activity [goid 8475] [evidence IEA]; oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen [goid 16702] [evidence IEA]",9,130239121-130239170,9q34.11b,+,NM_016174.3,51148,CEECAM1,2.0458235247190952,7.52465379312264,13.962896226660204,8.014695290410747e-27,2.5770022728325646e-25,50.3434026950902
BYSL,ILMN_1682792,"Homo sapiens bystin-like (BYSL), mRNA.",cytoplasm [goid 5737] [pmid 9560222] [evidence TAS],pregnancy [goid 7565] [pmid 9560222] [evidence TAS]; cell adhesion [goid 7155] [pmid 9560222] [evidence TAS],protein binding [goid 5515] [evidence IEA],6,42008511-42008560,6p21.1f,+,NM_004053.3,705,BYSL,1.256980388555676,8.402697247351892,13.947488474529074,8.698848973862291e-27,2.7832031569081566e-25,50.26172947778682
MGC4172,ILMN_1756701,"Homo sapiens short-chain dehydrogenase/reductase (MGC4172), mRNA.",,metabolism [goid 8152] [evidence IEA],oxidoreductase activity [goid 16491] [evidence IEA],17,32031237-32031286,17q12b,+,NM_024308.2,79154,MGC4172,1.4400361422253,8.103128029491815,13.94638196138445,8.750179983879761e-27,2.7950369997688055e-25,50.25586322081099
LRRC45,ILMN_1742507,"PREDICTED: Homo sapiens leucine rich repeat containing 45 (LRRC45), mRNA.",,,,,,17q25.3g,,XM_938258.1,201255,LRRC45,1.4129363836224496,6.931718111384573,13.935035719302316,9.2943928532309e-27,2.9640138256170884e-25,50.19570363790152
NPNT,ILMN_1735762,"Homo sapiens nephronectin (NPNT), mRNA.",membrane [goid 16020] [evidence IEA],,calcium ion binding [goid 5509] [evidence IEA],4,107111934-107111983,4q24e,+,NM_001033047.1,255743,NPNT,-2.0929362862486034,7.79305205964575,-13.925231057060468,9.791948119351303e-27,3.117583482116996e-25,50.14370795812159
PIAS3,ILMN_1814966,"Homo sapiens protein inhibitor of activated STAT, 3 (PIAS3), mRNA.",nucleus [goid 5634] [evidence IEA],"regulation of transcription, DNA-dependent [goid 6355] [evidence IEA]; ubiquitin cycle [goid 6512] [evidence IEA]; transcription [goid 6350] [evidence IEA]",metal ion binding [goid 46872] [evidence IEA]; transcription corepressor activity [goid 3714] [evidence NR ]; zinc ion binding [goid 8270] [evidence IEA]; DNA binding [goid 3677] [evidence IEA],1,144297547-144297596,1q21.1b,+,NM_006099.2,10401,PIAS3,1.0733779351224513,7.536745318395559,13.92154521977333,9.985829774810264e-27,3.1741255001986625e-25,50.124159032235625
TSPAN4,ILMN_1718607,"Homo sapiens tetraspanin 4 (TSPAN4), transcript variant 3, mRNA.",plasma membrane [goid 5886] [pmid 9360996] [evidence TAS]; integral to plasma membrane [goid 5887] [pmid 9360996] [evidence TAS]; integral to membrane [goid 16021] [evidence IEA],protein complex assembly [goid 6461] [pmid 9360996] [evidence TAS],,11,857045-857094,11p15.5c,+,NM_001025235.1,7106,TSPAN4,-1.0122595525423872,8.856647636760025,-13.916188358058308,1.0274498468005067e-26,3.260563561059914e-25,50.095745052513735
SOCS2,ILMN_1798926,"Homo sapiens suppressor of cytokine signaling 2 (SOCS2), mRNA.",cytoplasm [goid 5737] [pmid 9727029] [evidence NAS]; cytoplasm [goid 5737] [pmid 9727029] [evidence NAS],JAK-STAT cascade [goid 7259] [pmid 9266833] [evidence TAS]; intracellular signaling cascade [goid 7242] [evidence IEA]; negative regulation of signal transduction [goid 9968] [evidence IEA]; anti-apoptosis [goid 6916] [pmid 9266833] [evidence TAS]; regulation of cell growth [goid 1558] [pmid 9727029] [evidence NAS]; JAK-STAT cascade [goid 7259] [pmid 9266833] [evidence TAS]; intracellular signaling cascade [goid 7242] [evidence IEA]; negative regulation of signal transduction [goid 9968] [evidence IEA]; anti-apoptosis [goid 6916] [pmid 9266833] [evidence TAS]; regulation of cell growth [goid 1558] [pmid 9727029] [evidence NAS],insulin-like growth factor receptor binding [goid 5159] [pmid 9727029] [evidence IPI]; JAK pathway signal transduction adaptor activity [goid 8269] [pmid 9266833] [evidence TAS]; SH3/SH2 adaptor activity [goid 5070] [pmid 9344848] [evidence TAS]; growth hormone receptor binding [goid 5131] [pmid 12135564] [evidence NAS]; prolactin receptor binding [goid 5148] [evidence NAS]; protein binding [goid 5515] [pmid 11781573] [evidence IPI]; insulin-like growth factor receptor binding [goid 5159] [pmid 9727029] [evidence IPI]; JAK pathway signal transduction adaptor activity [goid 8269] [pmid 9266833] [evidence TAS]; SH3/SH2 adaptor activity [goid 5070] [pmid 9344848] [evidence TAS]; growth hormone receptor binding [goid 5131] [pmid 12135564] [evidence NAS]; prolactin receptor binding [goid 5148] [evidence NAS]; protein binding [goid 5515] [pmid 11781573] [evidence IPI],12,92493453-92493502,12q22b,+,NM_003877.3,8835,SOCS2,-2.259981577953316,8.914914475601616,-13.905030585248518,1.0902932364356717e-26,3.4543680832437503e-25,50.03655308500782
MCM4,ILMN_1737205,"Homo sapiens MCM4 minichromosome maintenance deficient 4 (S. cerevisiae) (MCM4), transcript variant 1, mRNA.",nucleus [goid 5634] [pmid 8265339] [evidence NAS],"regulation of transcription, DNA-dependent [goid 6355] [evidence IEA]; transcription [goid 6350] [evidence IEA]; DNA replication initiation [goid 6270] [evidence IEA]; DNA replication [goid 6260] [pmid 9465298] [evidence NAS]",nucleotide binding [goid 166] [evidence IEA]; DNA-dependent ATPase activity [goid 8094] [evidence IEA]; protein binding [goid 5515] [pmid 15232106] [evidence IPI]; DNA binding [goid 3677] [evidence IEA]; ATP binding [goid 5524] [evidence NAS],8,49051904-49051953,8q11.21b,+,NM_005914.2,4173,MCM4,1.579406557763038,8.132992413016373,13.881590087706133,1.2351647457358796e-26,3.907010563419418e-25,49.912163211211315
PADI4,ILMN_1807529,"Homo sapiens peptidyl arginine deiminase, type IV (PADI4), mRNA.",nucleus [goid 5634] [evidence IEA],"chromatin modification [goid 16568] [evidence IEA]; transcription [goid 6350] [evidence IEA]; regulation of transcription, DNA-dependent [goid 6355] [evidence IEA]; protein modification [goid 6464] [pmid 10488123] [evidence TAS]",protein-arginine deiminase activity [goid 4668] [pmid 10488123] [evidence TAS]; hydrolase activity [goid 16787] [evidence IEA]; calcium ion binding [goid 5509] [evidence IEA],1,17562982-17563031,1p36.13d,+,NM_012387.1,23569,PADI4,-2.115725230526621,6.061012940153237,-13.879300782822094,1.2503100343660726e-26,3.9485074586098743e-25,49.90001197561166
SRD5A1,ILMN_1793241,"Homo sapiens steroid-5-alpha-reductase, alpha polypeptide 1 (3-oxo-5 alpha-steroid delta 4-dehydrogenase alpha 1) (SRD5A1), mRNA.",microsome [goid 5792] [evidence IEA]; integral to membrane [goid 16021] [evidence IEA]; endoplasmic reticulum [goid 5783] [evidence IEA],cell-cell signaling [goid 7267] [evidence NR ]; sex differentiation [goid 7548] [evidence IEA]; sex determination [goid 7530] [pmid 1686016] [evidence NAS],3-oxo-5-alpha-steroid 4-dehydrogenase activity [goid 3865] [evidence IEA]; electron transporter activity [goid 5489] [pmid 1686016] [evidence TAS]; oxidoreductase activity [goid 16491] [evidence IEA],5,6722048-6722097,5p15.31c,+,NM_001047.1,6715,SRD5A1,1.4888459054896295,6.927175589439793,13.87597156269312,1.2726682049369173e-26,4.012611646148193e-25,49.882340174813045
SOX18,ILMN_1812968,"Homo sapiens SRY (sex determining region Y)-box 18 (SOX18), mRNA.",nucleus [goid 5634] [evidence IEA],transcription [goid 6350] [evidence IEA]; regulation of transcription from RNA polymerase II promoter [goid 6357] [pmid 10807548] [evidence TAS],RNA polymerase II transcription factor activity [goid 3702] [pmid 10807548] [evidence TAS]; DNA binding [goid 3677] [evidence IEA],20,62149664-62149713,20q13.33e,-,NM_018419.2,54345,SOX18,-2.722916728531864,10.680727678026372,-13.871821307982122,1.3011028265846896e-26,4.091504559187859e-25,49.8603087982443
MSR1,ILMN_1694400,"Homo sapiens macrophage scavenger receptor 1 (MSR1), transcript variant SR-AI, mRNA.",membrane [goid 16020] [evidence IEA]; integral to plasma membrane [goid 5887] [pmid 8093617] [evidence TAS]; cytoplasm [goid 5737] [evidence IEA],phosphate transport [goid 6817] [evidence IEA]; receptor mediated endocytosis [goid 6898] [pmid 2251254] [evidence TAS],scavenger receptor activity [goid 5044] [pmid 2251254] [evidence TAS]; receptor activity [goid 4872] [evidence IEA]; lipid transporter activity [goid 5319] [evidence IEA],8,16022341-16022390,8p22c,-,NM_138715.1,4481,MSR1,-1.709920027626187,6.467732878161635,-13.87170770065886,1.3018900829851028e-26,4.091504559187859e-25,49.85970569800931
KIAA1754,ILMN_1805192,"Homo sapiens KIAA1754 (KIAA1754), mRNA.",,,,10,106062072-106062121,10q25.1a,-,NM_033397.2,85450,KIAA1754,-1.3068138883845712,9.509350677932499,-13.864838081875646,1.3503930040064668e-26,4.237102686484059e-25,49.82323513541251
TMEM16J,ILMN_1762629,"Homo sapiens transmembrane protein 16J (TMEM16J), mRNA.",,,,11,408229-408278,11p15.5d,-,NM_001012302.1,338440,TMEM16J,1.4452486695351654,6.853004400488775,13.856282891426499,1.4133398220813581e-26,4.427480133963869e-25,49.77780978153588
KNTC1,ILMN_1732516,"Homo sapiens kinetochore associated 1 (KNTC1), mRNA.",spindle pole [goid 922] [pmid 11146660] [evidence IDA]; nucleus [goid 5634] [pmid 11146660] [evidence NAS]; kinetochore microtubule [goid 5828] [pmid 11146660] [evidence IDA],"mitotic checkpoint [goid 7093] [pmid 11146660] [evidence IDA]; regulation of exit from mitosis [goid 7096] [pmid 11146660] [evidence NAS]; mitosis [goid 7067] [evidence IEA]; regulation of transcription, DNA-dependent [goid 6355] [evidence IEA]; cell cycle [goid 7049] [evidence IEA]; cell division [goid 51301] [evidence IEA]; protein complex assembly [goid 6461] [pmid 11146660] [evidence NAS]",sequence-specific DNA binding [goid 43565] [evidence IEA]; protein dimerization activity [goid 46983] [evidence IEA]; transcription factor activity [goid 3700] [evidence IEA],12,121675137-121675186,12q24.31c,+,NM_014708.3,9735,KNTC1,1.5617667861697226,7.839652589449098,13.850713524817643,1.4558915267571882e-26,4.548265546394061e-25,49.74823454560119
CYP4B1,ILMN_1659215,"Homo sapiens cytochrome P450, family 4, subfamily B, polypeptide 1 (CYP4B1), mRNA.",membrane [goid 16020] [evidence IEA]; microsome [goid 5792] [evidence IEA]; endoplasmic reticulum [goid 5783] [evidence IEA],electron transport [goid 6118] [evidence IEA],metal ion binding [goid 46872] [evidence IEA]; heme binding [goid 20037] [evidence IEA]; unspecific monooxygenase activity [goid 50381] [evidence IEA]; oxygen binding [goid 19825] [pmid 2574990] [evidence TAS]; monooxygenase activity [goid 4497] [evidence IEA]; iron ion binding [goid 5506] [evidence IEA],1,47056997-47057046,1p33d,+,NM_000779.2,1580,CYP4B1,-3.456058941858494,9.640399030640822,-13.84712694880663,1.4839721404911076e-26,4.6264315451950765e-25,49.72918707708118
SGPL1,ILMN_1761531,"Homo sapiens sphingosine-1-phosphate lyase 1 (SGPL1), mRNA.",integral to membrane [goid 16021] [evidence IEA]; membrane [goid 16020] [evidence IEA]; endoplasmic reticulum [goid 5783] [evidence IEA]; integral to endoplasmic reticulum membrane [goid 30176] [pmid 11018465] [evidence NAS],apoptosis [goid 6915] [pmid 14570870] [evidence IDA]; sphingolipid catabolism [goid 30149] [pmid 11018465] [evidence NAS]; ceramide metabolism [goid 6672] [pmid 14570870] [evidence IDA]; lipid metabolism [goid 6629] [evidence IEA]; carboxylic acid metabolism [goid 19752] [evidence IEA],sphinganine-1-phosphate aldolase activity [goid 8117] [pmid 11018465] [evidence NAS]; lyase activity [goid 16829] [evidence IEA]; carboxy-lyase activity [goid 16831] [evidence IEA],10,72309382-72309431,10q22.1c,+,NM_003901.2,8879,SGPL1,1.3896411269867137,7.620936942523952,13.838346348102998,1.5550340081466202e-26,4.835029180448621e-25,49.68255031206415
CPB2,ILMN_1744806,"Homo sapiens carboxypeptidase B2 (plasma, carboxypeptidase U) (CPB2), transcript variant 1, mRNA.",,,metal ion binding [goid 46872] [evidence IEA]; carboxypeptidase A activity [goid 4182] [evidence IEA]; zinc ion binding [goid 8270] [evidence IEA]; metallopeptidase activity [goid 8237] [evidence IEA]; carboxypeptidase activity [goid 4180] [evidence IEA]; metal ion binding [goid 46872] [evidence IEA]; carboxypeptidase A activity [goid 4182] [evidence IEA]; zinc ion binding [goid 8270] [evidence IEA]; metallopeptidase activity [goid 8237] [evidence IEA]; carboxypeptidase activity [goid 4180] [evidence IEA],13,45525386-45525435,13q14.12b,-,NM_001872.2,1361,CPB2,-3.025773533409433,6.984286879191454,-13.83824852289818,1.555844647750211e-26,4.835029180448621e-25,49.682030688735445
PYGO2,ILMN_1695334,"Homo sapiens pygopus homolog 2 (Drosophila) (PYGO2), mRNA.",nucleus [goid 5634] [evidence IEA],"regulation of transcription, DNA-dependent [goid 6355] [evidence IEA]; Wnt receptor signaling pathway [goid 16055] [evidence IEA]",metal ion binding [goid 46872] [evidence IEA]; zinc ion binding [goid 8270] [evidence IEA]; protein binding [goid 5515] [evidence IEA],1,153196432-153196481,1q21.3e,-,NM_138300.3,90780,PYGO2,1.6929225978355307,7.251435909281607,13.820042400966926,1.7143387597554236e-26,5.319090881183827e-25,49.585308829581315
C6orf105,ILMN_2078592,"Homo sapiens chromosome 6 open reading frame 105 (C6orf105), mRNA.",integral to membrane [goid 16021] [evidence IEA]; membrane [goid 16020] [evidence IEA],,,6,11831673-11831719:11843787-11843789,6p24.1c,-,NM_032744.1,84830,C6orf105,-2.243160184635614,6.5046980748029455,-13.819655237628837,1.7178795805695695e-26,5.321603120413047e-25,49.58325165227033
C17orf53,ILMN_1776490,"Homo sapiens chromosome 17 open reading frame 53 (C17orf53), mRNA.",,,,17,39595293-39595342,17q21.31c,+,NM_024032.2,78995,C17orf53,1.8196535817103197,6.900308463881217,13.802019282358684,1.887195297720779e-26,5.836825456522123e-25,49.48952902184158
PAK6,ILMN_1708223,"Homo sapiens p21(CDKN1A)-activated kinase 6 (PAK6), mRNA.",,protein amino acid phosphorylation [goid 6468] [evidence IEA],ATP binding [goid 5524] [evidence IEA]; transferase activity [goid 16740] [evidence IEA]; protein serine/threonine kinase activity [goid 4674] [evidence IEA]; nucleotide binding [goid 166] [evidence IEA],15,38356636-38356685,15q15.1a,+,NM_020168.3,56924,PAK6,1.5151621489395977,6.991300018410561,13.801592305034243,1.8914957917880126e-26,5.840855071789133e-25,49.4872595838147
KSP37,ILMN_1761945,"Homo sapiens fibroblast growth factor binding protein 2 (FGFBP2), mRNA.",,,growth factor binding [goid 19838] [evidence IEA],4,15573160-15573178:15573179-15573209,4p15.32d,-,NM_031950.2,83888,KSP37,-2.7045917594966404,6.374990696740097,-13.783355377435395,2.084655131812019e-26,6.416983450767329e-25,49.390312375642296
ARMCX1,ILMN_1788192,"Homo sapiens armadillo repeat containing, X-linked 1 (ARMCX1), mRNA.",membrane [goid 16020] [evidence IEA]; integral to membrane [goid 16021] [evidence IEA]; membrane [goid 16020] [evidence IEA]; integral to membrane [goid 16021] [evidence IEA],,binding [goid 5488] [evidence IEA]; binding [goid 5488] [evidence IEA],X,100695454-100695503,Xq22.1c,+,NM_016608.1,51309,ARMCX1,-1.6816150864422958,7.038139745661827,-13.782915061979372,2.0895557635573804e-26,6.421923352194883e-25,49.38797128823609
LRRC32,ILMN_2129161,"Homo sapiens leucine rich repeat containing 32 (LRRC32), mRNA.",integral to plasma membrane [goid 5887] [pmid 8180135] [evidence TAS]; membrane [goid 16020] [evidence IEA],,transferase activity [goid 16740] [evidence IEA],11,76046296-76046345,11q13.5b,-,NM_005512.1,2615,LRRC32,-1.888891118048866,10.092283448062142,-13.777176446225429,2.1544925662806308e-26,6.611068921886313e-25,49.35745835328741
LOC400986,ILMN_1811117,"Homo sapiens protein immuno-reactive with anti-PTH polyclonal antibodies (LOC400986), mRNA.",integral to membrane [goid 16021] [evidence NAS]; integral to membrane [goid 16021] [evidence NAS],"di-, tri-valent inorganic anion homeostasis [goid 30319] [pmid 8608414] [evidence NAS]; di-, tri-valent inorganic anion homeostasis [goid 30319] [pmid 8608414] [evidence NAS]",ion channel inhibitor activity [goid 8200] [pmid 8608414] [evidence NAS]; ion channel inhibitor activity [goid 8200] [pmid 8608414] [evidence NAS],2,95943639-95943655:95943750-95943778:95945455-95945458,2q11.2a,-,NM_001010914.1,400986,LOC400986,3.051643024864278,7.364400473532982,13.774232062647293,2.1885925334998236e-26,6.70514552126479e-25,49.34180152757227
TUBB3,ILMN_1791726,"Homo sapiens tubulin, beta 3 (TUBB3), mRNA.",microtubule [goid 5874] [evidence IEA]; membrane [goid 16020] [evidence IEA]; integral to membrane [goid 16021] [evidence IEA]; protein complex [goid 43234] [evidence IEA]; cytoskeleton [goid 5856] [evidence NR ]; cytoplasm [goid 5737] [evidence IEA],signal transduction [goid 7165] [evidence IEA]; microtubule-based movement [goid 7018] [evidence IEA]; G-protein coupled receptor protein signaling pathway [goid 7186] [evidence IEA]; protein polymerization [goid 51258] [evidence IEA],GTPase activity [goid 3924] [evidence IEA]; melanocyte stimulating hormone receptor activity [goid 4980] [evidence IEA]; rhodopsin-like receptor activity [goid 1584] [evidence IEA]; structural molecule activity [goid 5198] [evidence IEA]; GTP binding [goid 5525] [evidence IEA]; nucleotide binding [goid 166] [evidence IEA]; structural constituent of cytoskeleton [goid 5200] [evidence NR ]; receptor activity [goid 4872] [evidence IEA],16,88529862-88529911,16q24.3b,+,NM_006086.2,10381,TUBB3,3.101235177848113,8.411497778937669,13.764573464253804,2.3043001274246973e-26,7.048553843464713e-25,49.290436143682264
PTPNS1,ILMN_1758146,"Homo sapiens protein tyrosine phosphatase, non-receptor type substrate 1 (PTPNS1), mRNA.",plasma membrane [goid 5886] [pmid 9070220] [evidence TAS]; integral to membrane [goid 16021] [evidence IEA]; integral to membrane [goid 16021] [evidence IEA]; plasma membrane [goid 5886] [pmid 9070220] [evidence TAS],cell adhesion [goid 7155] [pmid 9070220] [evidence TAS]; cell adhesion [goid 7155] [pmid 9070220] [evidence TAS],,20,1868371-1868420,20p13d,+,NM_080792.1,140885,PTPNS1,-1.450376102008164,9.532919963609727,-13.763368375788561,2.3191609681291417e-26,7.08289207899629e-25,49.28402676522368
BOP1,ILMN_1715583,"Homo sapiens block of proliferation 1 (BOP1), mRNA.",nucleus [goid 5634] [evidence IEA],rRNA processing [goid 6364] [evidence IEA],,8,,8q24.3g,-,NM_015201.3,23246,BOP1,1.2011040411312006,10.568961723413395,13.757803962989357,2.389036702769488e-26,7.28487952323372e-25,49.25443018248599
RAB8B,ILMN_2173004,"Homo sapiens RAB8B, member RAS oncogene family (RAB8B), mRNA.",intracellular [goid 5622] [evidence IEA]; membrane [goid 16020] [evidence IEA],"small GTPase mediated signal transduction [goid 7264] [evidence IEA]; regulation of transcription, DNA-dependent [goid 6355] [evidence IEA]; protein transport [goid 15031] [evidence NAS]",transcription factor binding [goid 8134] [evidence IEA]; GTP binding [goid 5525] [evidence IEA]; ATP binding [goid 5524] [evidence IEA]; nucleotide binding [goid 166] [evidence IEA]; GTPase activity [goid 3924] [pmid 9030196] [evidence NAS],15,61346835-61346884,15q22.2b,+,NM_016530.2,51762,RAB8B,-1.3128315842557186,9.664305688729664,-13.75401054963948,2.4378799613476396e-26,7.422201726071681e-25,49.23425175759951
C10orf132,ILMN_1717887,"Homo sapiens chromosome 10 open reading frame 132 (C10orf132), mRNA.",,,,10,99617480-99617529,10q24.2a,+,NM_001010917.1,401647,C10orf132,1.752870825436716,5.766848574923421,13.745961863883338,2.5448569100665256e-26,7.73580918762032e-25,49.19143378200628
ADAMTS1,ILMN_1673566,"Homo sapiens ADAM metallopeptidase with thrombospondin type 1 motif, 1 (ADAMTS1), mRNA.",extracellular matrix (sensu Metazoa) [goid 5578] [evidence IEA],negative regulation of cell proliferation [goid 8285] [pmid 10438512] [evidence TAS]; integrin-mediated signaling pathway [goid 7229] [pmid 8995297] [evidence TAS],zinc ion binding [goid 8270] [evidence IEA]; metal ion binding [goid 46872] [evidence IEA]; integrin binding [goid 5178] [evidence NR ]; heparin binding [goid 8201] [evidence IEA]; metalloendopeptidase activity [goid 4222] [evidence IEA],21,27130839-27130888,21q21.3a,-,NM_006988.3,9510,ADAMTS1,-2.777240520529496,8.645237933478061,-13.730163867369908,2.7687215454446463e-26,8.390130530791435e-25,49.1073733297297
CDT1,ILMN_1651237,"Homo sapiens chromatin licensing and DNA replication factor 1 (CDT1), mRNA.",nucleus [goid 5634] [pmid 11125146] [evidence IDA]; replication fork [goid 5657] [evidence IPI],DNA replication checkpoint [goid 76] [pmid 14672932] [evidence IDA]; regulation of DNA replication initiation [goid 30174] [pmid 11125146] [evidence IDA]; DNA replication [goid 6260] [evidence IEA]; cell cycle [goid 7049] [evidence IEA],DNA binding [goid 3677] [evidence ISS]; protein binding [goid 5515] [pmid 14672932] [evidence IPI],16,87403077-87403126,16q24.3a,+,NM_030928.2,81620,CDT1,1.8892806172813552,6.493916125881824,13.728934660239565,2.786946949768261e-26,8.419384151120922e-25,49.100831821600266
GFRA2,ILMN_1656300,"Homo sapiens GDNF family receptor alpha 2 (GFRA2), mRNA.",membrane [goid 16020] [evidence IEA]; extrinsic to membrane [goid 19898] [pmid 10829012] [evidence TAS],transmembrane receptor protein tyrosine kinase signaling pathway [goid 7169] [pmid 9192898] [evidence TAS],receptor activity [goid 4872] [evidence IEA]; glial cell line-derived neurotrophic factor receptor activity [goid 16167] [pmid 10829012] [evidence TAS]; GPI anchor binding [goid 48503] [evidence IEA],8,,8p21.3b,-,NM_001495.4,2675,GFRA2,-1.2824123612746599,8.016321203682972,-13.728929946018757,2.7870170785080805e-26,8.419384151120922e-25,49.100806733527406
CD53,ILMN_1662843,"Homo sapiens CD53 antigen (CD53), mRNA.",plasma membrane [goid 5886] [pmid 8452817] [evidence TAS]; integral to plasma membrane [goid 5887] [evidence NR ]; plasma membrane [goid 5886] [pmid 8452817] [evidence TAS]; integral to plasma membrane [goid 5887] [evidence NR ],antimicrobial humoral response (sensu Vertebrata) [goid 19735] [evidence NR ]; signal transduction [goid 7165] [pmid 8404042] [evidence NAS]; signal transduction [goid 7165] [pmid 8404042] [evidence NAS]; antimicrobial humoral response (sensu Vertebrata) [goid 19735] [evidence NR ],,1,111243669-111243718,1p13.3a,+,NM_000560.2,963,CD53,-1.633259373815556,8.355180434860685,-13.720781756237932,2.91091452385836e-26,8.780057197736865e-25,49.057440802530984
FOXM1,ILMN_1716400,"Homo sapiens forkhead box M1 (FOXM1), transcript variant 1, mRNA.",nucleus [goid 5634] [evidence IEA],"regulation of transcription, DNA-dependent [goid 6355] [evidence IEA]; transcription [goid 6350] [evidence IEA]",sequence-specific DNA binding [goid 43565] [evidence IEA]; transcription factor activity [goid 3700] [evidence IEA]; protein binding [goid 5515] [pmid 10523841] [evidence IPI],12,2837460-2837509,12p13.33a,-,NM_202002.1,2305,FOXM1,1.7165014311122109,6.00682029697295,13.717262314797628,2.966124246914002e-26,8.932755942985985e-25,49.03870792902301
Pfs2,ILMN_1809590,"Homo sapiens GINS complex subunit 2 (Psf2 homolog) (GINS2), mRNA.",nucleus [goid 5634] [evidence IEA],DNA replication [goid 6260] [evidence IEA],,16,84268826-84268875,16q24.1b,-,NM_016095.1,51659,Pfs2,1.9997225105322256,7.608417169693997,13.700748830314437,3.2395353740199017e-26,9.726093491953434e-25,48.95079692181796
APIN,ILMN_1729851,"Homo sapiens APin protein (APIN), mRNA.",,,,4,71103111-71103160,4q13.3a,+,NM_017855.2,54959,APIN,-1.3699191315133286,5.956305225093699,-13.694273039380901,3.3535323683896135e-26,1.005285818431871e-24,48.91631575479891
RETN,ILMN_1675190,"Homo sapiens resistin (RETN), mRNA.",extracellular region [goid 5576] [evidence NAS],,hormone activity [goid 5179] [evidence NAS],19,7640707-7640756,19p13.2e,+,NM_020415.2,56729,RETN,-3.1720255205960344,7.280284249625895,-13.692211124519867,3.3906674874960406e-26,1.0148564668795753e-24,48.90533603580581
TLCD1,ILMN_1784655,"Homo sapiens TLC domain containing 1 (TLCD1), mRNA.",integral to membrane [goid 16021] [evidence IEA],,,17,24075691-24075740,17q11.2a,-,NM_138463.2,116238,TLCD1,1.8623320325727288,8.221586932902987,13.684859622129572,3.526457846134749e-26,1.0538808455818341e-24,48.86618609284407
KIF15,ILMN_1753063,"Homo sapiens kinesin family member 15 (KIF15), mRNA.",plus-end kinesin complex [goid 5873] [pmid 10878014] [evidence TAS]; centrosome [goid 5813] [pmid 10878014] [evidence TAS]; microtubule associated complex [goid 5875] [evidence IEA],cell proliferation [goid 8283] [pmid 10878014] [evidence TAS]; microtubule-based movement [goid 7018] [evidence IEA]; mitosis [goid 7067] [pmid 10878014] [evidence TAS],microtubule motor activity [goid 3777] [evidence IEA]; DNA binding [goid 3677] [pmid 10878014] [evidence TAS]; ATP binding [goid 5524] [evidence IEA],3,44868721-44868770,3p21.31k,+,NM_020242.1,56992,KIF15,1.3755333772871863,5.763696724264894,13.676123653056703,3.694932951444364e-26,1.1008527302583094e-24,48.81965694971552
GRTP1,ILMN_1745068,"Homo sapiens growth hormone regulated TBC protein 1 (GRTP1), mRNA.",,,,13,113027458-113027507,13q34d,-,NM_024719.2,79774,GRTP1,1.3758993713937633,6.657463874077349,13.672306883402927,3.7710526607868935e-26,1.1193977865638436e-24,48.799326085836185
C2orf11,ILMN_1801441,"Homo sapiens raftlin family member 2 (RFTN2), mRNA.",,,,2,198143958-198144007,2q33.1b,-,NM_144629.1,130132,C2orf11,-1.8037211361896794,7.14757536381163,-13.671855521965648,3.7801577806466976e-26,1.1193977865638436e-24,48.79692172342401
NEK2,ILMN_1653822,"Homo sapiens NIMA (never in mitosis gene a)-related kinase 2 (NEK2), mRNA.",centrosome [goid 5813] [pmid 9430639] [evidence TAS]; nucleus [goid 5634] [evidence IEA]; centrosome [goid 5813] [pmid 9430639] [evidence TAS]; nucleus [goid 5634] [evidence IEA],regulation of mitosis [goid 7088] [pmid 9430639] [evidence TAS]; meiosis [goid 7126] [evidence IEA]; cell cycle [goid 7049] [evidence IEA]; protein amino acid phosphorylation [goid 6468] [evidence IEA]; cell division [goid 51301] [evidence IEA]; regulation of mitosis [goid 7088] [pmid 9430639] [evidence TAS]; meiosis [goid 7126] [evidence IEA]; cell cycle [goid 7049] [evidence IEA]; protein amino acid phosphorylation [goid 6468] [evidence IEA]; cell division [goid 51301] [evidence IEA],transferase activity [goid 16740] [evidence IEA]; nucleotide binding [goid 166] [evidence IEA]; ATP binding [goid 5524] [evidence IEA]; magnesium ion binding [goid 287] [evidence IEA]; protein serine/threonine kinase activity [goid 4674] [pmid 9430639] [evidence TAS]; protein binding [goid 5515] [pmid 9647649] [evidence IPI]; transferase activity [goid 16740] [evidence IEA]; nucleotide binding [goid 166] [evidence IEA]; ATP binding [goid 5524] [evidence IEA]; magnesium ion binding [goid 287] [evidence IEA]; protein serine/threonine kinase activity [goid 4674] [pmid 9430639] [evidence TAS]; protein binding [goid 5515] [pmid 9647649] [evidence IPI],1,209903459-209903508,1q32.3a,-,NM_002497.2,4751,NEK2,1.3765079511285148,5.834194297800831,13.669778325789242,3.822345287254982e-26,1.1301729578476985e-24,48.78585644801464
NDN,ILMN_1692058,"Homo sapiens necdin homolog (mouse) (NDN), mRNA.",nucleus [goid 5634] [evidence IEA],"transcription [goid 6350] [evidence IEA]; negative regulation of cell proliferation [goid 8285] [pmid 9630521] [evidence TAS]; regulation of transcription, DNA-dependent [goid 6355] [evidence IEA]; regulation of cell growth [goid 1558] [evidence IEA]",DNA binding [goid 3677] [evidence IEA],15,21482033-21482082,15q11.2d,-,NM_002487.2,4692,NDN,-1.6474045009870508,10.744436828841105,-13.666466671293987,3.8905834163239833e-26,1.1486063313192851e-24,48.76821438347095
EPB41L3,ILMN_2109197,"Homo sapiens erythrocyte membrane protein band 4.1-like 3 (EPB41L3), mRNA.",plasma membrane [goid 5886] [pmid 9892180] [evidence NAS]; intercellular junction [goid 5911] [pmid 12234973] [evidence IDA]; cytoskeleton [goid 5856] [evidence IEA]; cytoplasm [goid 5737] [evidence IEA],cortical actin cytoskeleton organization and biogenesis [goid 30866] [evidence IEA],binding [goid 5488] [evidence IEA]; structural molecule activity [goid 5198] [evidence IEA]; actin binding [goid 3779] [evidence IEA],18,5382986-5383035,18p11.31c-p11.31b,-,NM_012307.2,23136,EPB41L3,-1.8448930346297852,8.386897844535497,-13.665098997263623,3.919120304210218e-26,1.1552807734876868e-24,48.760928133609376
KLF13,ILMN_1679929,"Homo sapiens Kruppel-like factor 13 (KLF13), mRNA.",nucleus [goid 5634] [evidence IEA]; intracellular [goid 5622] [evidence IEA],"transcription [goid 6350] [evidence IEA]; transcription from RNA polymerase II promoter [goid 6366] [pmid 10023774] [evidence TAS]; regulation of transcription, DNA-dependent [goid 6355] [evidence IEA]",RNA polymerase II transcription factor activity [goid 3702] [pmid 10023774] [evidence TAS]; DNA binding [goid 3677] [evidence IEA]; zinc ion binding [goid 8270] [evidence IEA]; metal ion binding [goid 46872] [evidence IEA],15,29456936-29456985,15q13.3a,+,NM_015995.2,51621,KLF13,-1.387131666963807,10.383858203264246,-13.654658776260197,4.143991949860763e-26,1.219723310317779e-24,48.70530260067939
GJA4,ILMN_1671106,"Homo sapiens gap junction protein, alpha 4, 37kDa (GJA4), mRNA.",integral to plasma membrane [goid 5887] [pmid 7680674] [evidence TAS]; membrane [goid 16020] [evidence IEA]; connexon complex [goid 5922] [evidence IEA]; integral to membrane [goid 16021] [evidence IEA],intercellular junction assembly [goid 7043] [pmid 7680674] [evidence TAS]; transport [goid 6810] [pmid 7680674] [evidence TAS]; cell communication [goid 7154] [evidence IEA],connexon channel activity [goid 15285] [pmid 7680674] [evidence TAS],1,35033688-35033737,1p34.3f,+,NM_002060.2,2701,GJA4,-1.7496057366096176,8.309775111626426,-13.654365473599935,4.150492944704486e-26,1.2197941934776305e-24,48.70373974248448
CD300LF,ILMN_2112357,"Homo sapiens CD300 molecule-like family member f (CD300LF), mRNA.",membrane [goid 16020] [evidence IEA]; integral to membrane [goid 16021] [evidence IEA],,receptor activity [goid 4872] [evidence IEA],17,70202077-70202126,17q25.1b,-,NM_139018.2,146722,CD300LF,-2.0734697999546556,8.319513552503922,-13.641833850507401,4.4380240531917245e-26,1.30233281139218e-24,48.63695803687602
ABCB9,ILMN_2343047,"Homo sapiens ATP-binding cassette, sub-family B (MDR/TAP), member 9 (ABCB9), transcript variant 2, mRNA.",lysosome [goid 5764] [evidence IEA]; integral to membrane [goid 16021] [pmid 10748049] [evidence NAS]; ATP-binding cassette (ABC) transporter complex [goid 43190] [pmid 10748049] [evidence NAS]; membrane [goid 16020] [evidence IEA]; endoplasmic reticulum [goid 5783] [evidence IEA]; lysosome [goid 5764] [evidence IEA]; integral to membrane [goid 16021] [pmid 10748049] [evidence NAS]; ATP-binding cassette (ABC) transporter complex [goid 43190] [pmid 10748049] [evidence NAS]; membrane [goid 16020] [evidence IEA]; endoplasmic reticulum [goid 5783] [evidence IEA],oligopeptide transport [goid 6857] [evidence IEA]; transport [goid 6810] [evidence IEA]; protein transport [goid 15031] [evidence IEA]; spermatogenesis [goid 7283] [pmid 10748049] [evidence TAS]; oligopeptide transport [goid 6857] [evidence IEA]; transport [goid 6810] [evidence IEA]; protein transport [goid 15031] [evidence IEA]; spermatogenesis [goid 7283] [pmid 10748049] [evidence TAS],"ATPase activity, coupled to transmembrane movement of substances [goid 42626] [evidence IEA]; ATPase activity [goid 16887] [evidence IEA]; transporter activity [goid 5215] [pmid 10748049] [evidence TAS]; nucleotide binding [goid 166] [evidence IEA]; ATP binding [goid 5524] [pmid 10748049] [evidence NAS]; oligopeptide transporter activity [goid 15198] [evidence IEA]; ATPase activity, coupled to transmembrane movement of substances [goid 42626] [evidence IEA]; ATPase activity [goid 16887] [evidence IEA]; transporter activity [goid 5215] [pmid 10748049] [evidence TAS]; nucleotide binding [goid 166] [evidence IEA]; ATP binding [goid 5524] [pmid 10748049] [evidence NAS]; oligopeptide transporter activity [goid 15198] [evidence IEA]",12,121979605-121979654,12q24.31d,-,NM_019624.2,23457,ABCB9,1.723934844745827,7.8878491518920395,13.636979458226627,4.5547016254953385e-26,1.3325579755672174e-24,48.611084955901546
GATA2,ILMN_2102670,"Homo sapiens GATA binding protein 2 (GATA2), mRNA.",nucleus [goid 5634] [pmid 1370462] [evidence TAS],"regulation of transcription, DNA-dependent [goid 6355] [evidence IEA]; positive regulation of phagocytosis [goid 50766] [evidence ISS]; transcription [goid 6350] [evidence IEA]; phagocytosis [goid 6909] [evidence IEA]; transcription from RNA polymerase II promoter [goid 6366] [pmid 1370462] [evidence TAS]",zinc ion binding [goid 8270] [evidence IEA]; metal ion binding [goid 46872] [evidence IEA]; sequence-specific DNA binding [goid 43565] [evidence IEA]; transcription factor activity [goid 3700] [pmid 8078582] [evidence TAS],3,129681589-129681638,3q21.3c,-,NM_032638.3,2624,GATA2,-2.164165017455761,7.1952134401663255,-13.635151740318427,4.59942480531619e-26,1.3416136576584724e-24,48.60134298876665
GAB2,ILMN_1665964,"Homo sapiens GRB2-associated binding protein 2 (GAB2), transcript variant 1, mRNA.",,,,11,77604355-77604404,11q14.1a,-,NM_080491.1,9846,GAB2,-1.328978674060787,8.845891371358409,-13.621787655344411,4.940105232684174e-26,1.4388333401920946e-24,48.530101713510255
NIP,ILMN_1710622,"Homo sapiens dual oxidase maturation factor 1 (DUOXA1), mRNA.",,,,15,43197005-43197054,15q21.1a,-,NM_144565.2,90527,NIP,-2.186383237558232,7.8985538097471215,-13.619892168479444,4.9904334331507773e-26,1.4513223200737746e-24,48.51999596775957
PTK6,ILMN_1764508,"Homo sapiens PTK6 protein tyrosine kinase 6 (PTK6), mRNA.",nucleus [goid 5634] [evidence IEA],protein amino acid phosphorylation [goid 6468] [pmid 8036022] [evidence TAS]; intracellular signaling cascade [goid 7242] [evidence IEA],ATP binding [goid 5524] [evidence IEA]; transferase activity [goid 16740] [evidence IEA]; nucleotide binding [goid 166] [evidence IEA]; non-membrane spanning protein tyrosine kinase activity [goid 4715] [pmid 8036022] [evidence TAS],20,61630757-61630806,20q13.33e,-,NM_005975.2,5753,PTK6,1.6699521888286224,7.119485732842091,13.619547401264706,4.999642685115877e-26,1.4518336470861828e-24,48.51815781486411
PODXL2,ILMN_1657347,"Homo sapiens podocalyxin-like 2 (PODXL2), mRNA.",integral to plasma membrane [goid 5887] [pmid 10722749] [evidence TAS],,glycosaminoglycan binding [goid 5539] [pmid 10722749] [evidence TAS],3,128874153-128874202,3q21.3b,+,NM_015720.1,50512,PODXL2,2.7334501553954684,8.056898754019812,13.619175075018138,5.0096072280423534e-26,1.4525624529524592e-24,48.516172717047816
LOC647954,ILMN_1687867,"PREDICTED: Homo sapiens similar to Keratin, type II cytoskeletal 8 (Cytokeratin-8) (CK-8) (Keraton-8) (K8) (LOC647954), mRNA.",,,,,,,,XM_938141.1,647954,LOC647954,1.7506812884555014,9.035024715992193,13.609969187535116,5.262421438082811e-26,1.523600025572713e-24,48.46708662578801
SELP,ILMN_1715417,"Homo sapiens selectin P (granule membrane protein 140kDa, antigen CD62) (SELP), mRNA.",platelet alpha granule membrane [goid 31092] [pmid 15297306] [evidence IDA]; membrane fraction [goid 5624] [pmid 15297306] [evidence IDA]; membrane [goid 16020] [evidence IEA]; soluble fraction [goid 5625] [pmid 1701178] [evidence TAS]; integral to plasma membrane [goid 5887] [pmid 1701178] [evidence TAS]; plasma membrane [goid 5886] [pmid 1701178] [evidence TAS],cell adhesion [goid 7155] [pmid 2466574] [evidence TAS],protein binding [goid 5515] [pmid 11237770] [evidence IPI]; sugar binding [goid 5529] [evidence IEA],1,167824803-167824852,1q24.2b,-,NM_003005.2,6403,SELP,-1.941910403747289,6.585264951627479,-13.602309253323764,5.482509623040515e-26,1.5849658754442793e-24,48.426237897339604
TACC3,ILMN_1724407,"Homo sapiens transforming, acidic coiled-coil containing protein 3 (TACC3), mRNA.",,,,4,1716348-1716357:1716473-1716512,4p16.3b,+,NM_006342.1,10460,TACC3,1.4673681352272343,7.419627372630388,13.600925116937846,5.52325316514534e-26,1.5943790803386216e-24,48.418856052756
MAL,ILMN_2320330,"Homo sapiens mal, T-cell differentiation protein (MAL), transcript variant a, mRNA.",lipid raft [goid 45121] [pmid 12153479] [evidence IDA]; insoluble fraction [goid 5626] [pmid 9003426] [evidence TAS]; membrane fraction [goid 5624] [pmid 9003426] [evidence TAS]; integral to plasma membrane [goid 5887] [pmid 9003426] [evidence TAS]; membrane [goid 16020] [evidence IEA]; endoplasmic reticulum [goid 5783] [pmid 8132541] [evidence IDA]; apical plasma membrane [goid 16324] [pmid 10739088] [evidence TAS]; endosome [goid 5768] [pmid 9003426] [evidence TAS],apical protein localization [goid 45176] [pmid 10739088] [evidence TAS]; induction of apoptosis [goid 6917] [pmid 10366425] [evidence NAS]; lipid raft polarization [goid 1766] [pmid 12153479] [evidence TAS]; signal transduction [goid 7165] [pmid 3494249] [evidence TAS]; cell differentiation [goid 30154] [pmid 10739088] [evidence TAS]; central nervous system development [goid 7417] [pmid 10739088] [evidence TAS]; myelination [goid 42552] [pmid 12153479] [evidence NAS],apoptotic protease activator activity [goid 16505] [pmid 10366425] [evidence NAS]; structural constituent of myelin sheath [goid 19911] [pmid 12153479] [evidence IDA]; channel or pore class transporter activity [goid 15267] [pmid 3494249] [evidence TAS]; lipid binding [goid 8289] [pmid 10739088] [evidence TAS],2,95082940-95082989,2q11.1c,+,NM_002371.2,4118,MAL,-2.208882295359386,8.87018260391999,-13.591290494765444,5.815400440546481e-26,1.6762289583439082e-24,48.367468226324874
SLC5A6,ILMN_1741054,"Homo sapiens solute carrier family 5 (sodium-dependent vitamin transporter), member 6 (SLC5A6), mRNA.",membrane fraction [goid 5624] [pmid 9516450] [evidence TAS]; integral to plasma membrane [goid 5887] [pmid 9516450] [evidence TAS]; membrane [goid 16020] [evidence IEA],ion transport [goid 6811] [evidence IEA]; sodium ion transport [goid 6814] [evidence IEA],symporter activity [goid 15293] [evidence IEA]; sodium ion binding [goid 31402] [evidence IEA]; transporter activity [goid 5215] [evidence IEA]; sodium-dependent multivitamin transporter activity [goid 8523] [pmid 9516450] [evidence TAS],2,27276165-27276214,2p23.3a,-,NM_021095.1,8884,SLC5A6,1.069626822726022,8.62218152260973,13.575469506972787,6.329148119536505e-26,1.8216167076686678e-24,48.283066695899095
TSC22D1,ILMN_1692177,"Homo sapiens TSC22 domain family, member 1 (TSC22D1), transcript variant 2, mRNA.",nucleus [goid 5634] [evidence IEA],"regulation of transcription, DNA-dependent [goid 6355] [evidence IEA]; transcription [goid 6350] [evidence IEA]; transcription from RNA polymerase II promoter [goid 6366] [pmid 9022669] [evidence TAS]",transcription factor activity [goid 3700] [evidence IEA],13,43908708-43908757,13q14.11e,-,NM_006022.2,8848,TSC22D1,-1.341297805790143,9.064955934055764,-13.570241181338647,6.508744841126008e-26,1.8705441479253727e-24,48.255169885551645
HSD17B6,ILMN_1779855,"Homo sapiens hydroxysteroid (17-beta) dehydrogenase 6 homolog (mouse) (HSD17B6), mRNA.",intracellular [goid 5622] [pmid 11513953] [evidence NAS],metabolism [goid 8152] [evidence IEA]; androgen catabolism [goid 6710] [pmid 9188497] [evidence TAS]; androgen biosynthesis [goid 6702] [pmid 9188497] [evidence NAS],oxidoreductase activity [goid 16491] [pmid 9188497] [evidence NAS]; electron carrier activity [goid 9055] [pmid 9188497] [evidence TAS],12,55467249-55467298,12q13.3a,+,NM_003725.2,8630,HSD17B6,-3.0348075065562696,9.532232196272272,-13.537011658126673,7.775994600080532e-26,2.2314470512896787e-24,48.077811057587084
AHDC1,ILMN_1680111,"Homo sapiens AT hook, DNA binding motif, containing 1 (AHDC1), mRNA.",,,,1,27733961-27734010,1p36.11a-p35.3b,-,NM_001029882.1,27245,AHDC1,1.7841610886614179,6.979953959511687,13.534323664204827,7.888735569052662e-26,2.2604707729851637e-24,48.06345998762969
LNK,ILMN_1752046,"Homo sapiens SH2B adaptor protein 3 (SH2B3), mRNA.",,intracellular signaling cascade [goid 7242] [evidence IEA],,12,110373463-110373512,12q24.12a,+,NM_005475.1,10019,LNK,-1.2676774563730255,9.728934564995885,-13.533770771759137,7.912127756161123e-26,2.263844483535969e-24,48.060508043679036
DBNDD1,ILMN_2374352,"Homo sapiens dysbindin (dystrobrevin binding protein 1) domain containing 1 (DBNDD1), transcript variant 1, mRNA.",cytoplasm [goid 5737] [evidence IEA],,protein binding [goid 5515] [evidence IEA],,,16q24.3b,,NM_001042610.1,79007,DBNDD1,1.4811765595748145,8.939426951141842,13.527819374607125,8.168372333060014e-26,2.3337351159776303e-24,48.02873130300443
TXNL5,ILMN_1659437,"Homo sapiens thioredoxin-like 5 (TXNL5), mRNA.",,,protein disulfide oxidoreductase activity [goid 15035] [evidence IEA]; electron carrier activity [goid 9055] [evidence IEA],17,6486367-6486368:6486995-6487042,17p13.2a,+,NM_032731.2,84817,TXNL5,1.325176756135404,12.317089462807782,13.518767876492284,8.574144995569234e-26,2.4425031467641304e-24,47.98039607335106
EZH2,ILMN_1652913,"Homo sapiens enhancer of zeste homolog 2 (Drosophila) (EZH2), transcript variant 1, mRNA.",nucleus [goid 5634] [evidence IEA],"establishment and/or maintenance of chromatin architecture [goid 6325] [pmid 8921387] [evidence TAS]; regulation of transcription, DNA-dependent [goid 6355] [pmid 8921387] [evidence TAS]; transcription [goid 6350] [evidence IEA]",DNA binding [goid 3677] [pmid 8954776] [evidence TAS],7,148160666-148160715,7q36.1a,-,NM_004456.3,2146,EZH2,1.1009742303266572,5.808933044266389,13.512595960902035,8.862362860855255e-26,2.5209217568432794e-24,47.947433820653096
C1orf135,ILMN_1787280,"Homo sapiens chromosome 1 open reading frame 135 (C1orf135), mRNA.",,,,1,26033122-26033171,1p36.11b,-,NM_024037.1,79000,C1orf135,1.2570167150429414,5.64321721567028,13.509074556295772,9.0311401246862e-26,2.5651860835205624e-24,47.92862563510648
GYPE,ILMN_1695187,"Homo sapiens glycophorin E (GYPE), transcript variant 1, mRNA.",integral to plasma membrane [goid 5887] [pmid 7622054] [evidence TAS]; plasma membrane [goid 5886] [pmid 2295603] [evidence TAS]; integral to plasma membrane [goid 5887] [pmid 7622054] [evidence TAS]; plasma membrane [goid 5886] [pmid 2295603] [evidence TAS],,,4,145016057-145016106,4q31.22a,-,NM_002102.2,2996,GYPE,-1.1938885678553168,5.520052384503059,-13.494714036696625,9.753472970479436e-26,2.766323447304102e-24,47.85191354015654
CDH3,ILMN_1704294,"Homo sapiens cadherin 3, type 1, P-cadherin (placental) (CDH3), mRNA.",integral to membrane [goid 16021] [evidence IEA]; membrane [goid 16020] [evidence IEA],cell adhesion [goid 7155] [pmid 2793940] [evidence TAS]; visual perception [goid 7601] [evidence IEA]; homophilic cell adhesion [goid 7156] [evidence IEA],protein binding [goid 5515] [evidence IEA]; calcium ion binding [goid 5509] [evidence IEA],16,67290098-67290147,16q22.1c,+,NM_001793.3,1001,CDH3,2.8683830831020973,8.361247090504627,13.490860887235371,9.956961752802012e-26,2.8199331359498144e-24,47.831327476827695
FLJ10815,ILMN_1784105,"Homo sapiens amino acid transporter (FLJ10815), mRNA.",,,,16,57257934-57257983,16q21a,-,NM_018231.1,55238,FLJ10815,1.4678989071605875,6.699542055272134,13.486566525940415,1.0188773405921356e-25,2.8813969494104154e-24,47.80838266521763
PTHR1,ILMN_1795166,"Homo sapiens parathyroid hormone receptor 1 (PTHR1), mRNA.",integral to membrane [goid 16021] [evidence IEA]; nucleus [goid 5634] [pmid 10709993] [evidence TAS]; integral to plasma membrane [goid 5887] [pmid 9745456] [evidence TAS]; membrane [goid 16020] [evidence IEA]; cytoplasm [goid 5737] [pmid 10709993] [evidence TAS],"skeletal development [goid 1501] [pmid 9745456] [evidence TAS]; G-protein signaling, coupled to cyclic nucleotide second messenger [goid 7187] [pmid 9927325] [evidence TAS]; signal transduction [goid 7165] [evidence IEA]",parathyroid hormone receptor activity [goid 4991] [pmid 9927325] [evidence TAS]; receptor activity [goid 4872] [evidence IEA]; G-protein coupled receptor activity [goid 4930] [evidence IEA],3,46920155-46920204,3p21.31h,+,NM_000316.2,5745,PTHR1,-1.7479900536133028,8.388998295674721,-13.485992894148087,1.0220145452447077e-25,2.8860802049410334e-24,47.80531762536732
GRB7,ILMN_1740762,"Homo sapiens growth factor receptor-bound protein 7 (GRB7), transcript variant 1, mRNA.",,epidermal growth factor receptor signaling pathway [goid 7173] [pmid 9710451] [evidence TAS]; signal transduction [goid 7165] [evidence IEA]; intracellular signaling cascade [goid 7242] [evidence IEA]; epidermal growth factor receptor signaling pathway [goid 7173] [pmid 9710451] [evidence TAS]; signal transduction [goid 7165] [evidence IEA]; intracellular signaling cascade [goid 7242] [evidence IEA],SH3/SH2 adaptor activity [goid 5070] [pmid 9710451] [evidence TAS]; SH3/SH2 adaptor activity [goid 5070] [pmid 9710451] [evidence TAS],17,35156822-35156871,17q12c,+,NM_005310.2,2886,GRB7,1.4879205607344286,7.826800369257032,13.482270650268363,1.0426083384795042e-25,2.939974453729832e-24,47.78542817764004
SGCE,ILMN_1674620,"Homo sapiens sarcoglycan, epsilon (SGCE), mRNA.",membrane [goid 16020] [evidence IEA]; integral to plasma membrane [goid 5887] [pmid 9475163] [evidence TAS]; cytoskeleton [goid 5856] [evidence IEA]; sarcoglycan complex [goid 16012] [pmid 9475163] [evidence TAS],cell-matrix adhesion [goid 7160] [pmid 9405466] [evidence TAS]; muscle development [goid 7517] [pmid 9405466] [evidence TAS],protein binding [goid 5515] [evidence IEA]; calcium ion binding [goid 5509] [evidence IEA],7,94066091-94066140,7q21.3b,-,NM_003919.1,8910,SGCE,-1.7470316023812682,9.940790977846255,-13.476749976123477,1.0739211921516138e-25,3.0238951487101436e-24,47.7559268043441
HYAL1,ILMN_1712620,"Homo sapiens hyaluronoglucosaminidase 1 (HYAL1), transcript variant 1, mRNA.",extracellular space [goid 5615] [pmid 9223416] [evidence TAS]; lysosome [goid 5764] [evidence NR ],carbohydrate metabolism [goid 5975] [evidence IEA],hyalurononglucosaminidase activity [goid 4415] [pmid 9223416] [evidence TAS],3,50315431-50315480,3p21.31b,-,NM_007312.3,3373,HYAL1,-1.6674864934592861,7.995171998882165,-13.473741310066261,1.0913814728001451e-25,3.068624530665343e-24,47.73984799794636
LOC647108,ILMN_1774206,"PREDICTED: Homo sapiens hypothetical protein LOC647108 (LOC647108), mRNA.",,,,16,31456416-31456465,,+,XM_934378.1,647108,LOC647108,-2.1330955722641685,7.102042275883076,-13.466891665424086,1.1322017042003612e-25,3.1771948573141443e-24,47.70323948034889
GFPT1,ILMN_2220184,"Homo sapiens glutamine-fructose-6-phosphate transaminase 1 (GFPT1), mRNA.",cytoplasm [goid 5737] [evidence IEA]; cytoplasm [goid 5737] [evidence IEA],metabolism [goid 8152] [evidence IEA]; energy reserve metabolism [goid 6112] [pmid 1460020] [evidence TAS]; carbohydrate metabolism [goid 5975] [evidence IEA]; carbohydrate biosynthesis [goid 16051] [evidence IEA]; fructose 6-phosphate metabolism [goid 6002] [pmid 8144040] [evidence TAS]; glutamine metabolism [goid 6541] [evidence IEA]; metabolism [goid 8152] [evidence IEA]; energy reserve metabolism [goid 6112] [pmid 1460020] [evidence TAS]; carbohydrate metabolism [goid 5975] [evidence IEA]; carbohydrate biosynthesis [goid 16051] [evidence IEA]; fructose 6-phosphate metabolism [goid 6002] [pmid 8144040] [evidence TAS]; glutamine metabolism [goid 6541] [evidence IEA],transferase activity [goid 16740] [evidence IEA]; glutamine-fructose-6-phosphate transaminase (isomerizing) activity [goid 4360] [pmid 8144040] [evidence TAS]; sugar binding [goid 5529] [evidence IEA]; transferase activity [goid 16740] [evidence IEA]; glutamine-fructose-6-phosphate transaminase (isomerizing) activity [goid 4360] [pmid 8144040] [evidence TAS]; sugar binding [goid 5529] [evidence IEA],2,69406509-69406558,2p14a,-,NM_002056.1,2673,GFPT1,1.3254750727876488,9.175731995342085,13.448516247856816,1.2494356526061141e-25,3.497881277446858e-24,47.60501068311221
GAS1,ILMN_1772910,"Homo sapiens growth arrest-specific 1 (GAS1), mRNA.",membrane [goid 16020] [evidence IEA]; anchored to plasma membrane [goid 46658] [evidence ISS],cell cycle arrest [goid 7050] [pmid 8127893] [evidence TAS]; negative regulation of cell proliferation [goid 8285] [pmid 8127893] [evidence TAS]; cell cycle [goid 7049] [evidence IEA]; negative regulation of S phase of mitotic cell cycle [goid 45749] [pmid 8127893] [evidence NAS],molecular function unknown [goid 5554] [evidence ND ],9,88749559-88749608,9q21.33c,-,NM_002048.1,2619,GAS1,-2.33672042521085,7.877941143319526,-13.446348243070851,1.2640471636437185e-25,3.533710040688358e-24,47.59341936193324
GABARAPL1,ILMN_2151281,"Homo sapiens GABA(A) receptor-associated protein like 1 (GABARAPL1), mRNA.",plasma membrane [goid 5886] [evidence ISS]; autophagic vacuole [goid 5776] [pmid 15292400] [evidence IDA]; microtubule [goid 5874] [evidence IEA]; intracellular [goid 5622] [pmid 11256614] [evidence IDA],protein targeting [goid 6605] [evidence ISS]; synaptic transmission [goid 7268] [evidence ISS],beta-tubulin binding [goid 48487] [evidence ISS]; GABA receptor binding [goid 50811] [evidence ISS]; protein binding [goid 5515] [pmid 9892355] [evidence IPI],12,10266658-10266707,12p13.2c,+,NM_031412.2,23710,GABARAPL1,-1.2541908586803547,10.520679604344823,-13.443531375910581,1.2832880714750613e-25,3.582359322735182e-24,47.57835827602284
QDPR,ILMN_1672443,"Homo sapiens quinoid dihydropteridine reductase (QDPR), mRNA.",cytoplasm [goid 5737] [pmid 11256614] [evidence IDA],metabolism [goid 8152] [evidence IEA]; dihydrobiopterin metabolism [goid 51066] [pmid 3033643] [evidence TAS]; tetrahydrobiopterin biosynthesis [goid 6729] [evidence IEA]; L-phenylalanine catabolism [goid 6559] [evidence IEA]; amino acid metabolism [goid 6520] [pmid 3033643] [evidence TAS],"electron carrier activity [goid 9055] [pmid 3033643] [evidence TAS]; 6,7-dihydropteridine reductase activity [goid 4155] [pmid 3033643] [evidence TAS]",4,17097488-17097537,4p15.32b,-,NM_000320.1,5860,QDPR,-1.1819013211778717,10.461234612091207,-13.43440441222352,1.347671936511613e-25,3.756707823022715e-24,47.529554048777754
DUSP1,ILMN_1781285,"Homo sapiens dual specificity phosphatase 1 (DUSP1), mRNA.",,response to oxidative stress [goid 6979] [pmid 1406996] [evidence TAS]; cell cycle [goid 7049] [evidence IEA]; protein amino acid dephosphorylation [goid 6470] [evidence IEA],MAP kinase phosphatase activity [goid 17017] [evidence IEA]; non-membrane spanning protein tyrosine phosphatase activity [goid 4726] [pmid 1406996] [evidence TAS]; hydrolase activity [goid 16787] [evidence IEA],5,172128082-172128131,5q35.1e,-,NM_004417.2,1843,DUSP1,-1.699800561640819,13.144014187631686,-13.42962217055898,1.382690624861532e-25,3.848818117918136e-24,47.5039793490295
C10orf32,ILMN_1772706,"Homo sapiens chromosome 10 open reading frame 32 (C10orf32), mRNA.",,,,10,104604121-104604170,10q24.32b,+,NM_144591.1,119032,C10orf32,-1.1878029739587852,9.058495165516423,-13.401983936734657,1.6037199044630571e-25,4.457700761549596e-24,47.3561364162799
LOC404266,ILMN_1683798,"PREDICTED: Homo sapiens hypothetical LOC404266 (LOC404266), misc RNA.",,,,,,,,XR_001389.1,404266,LOC404266,-1.5724399327933716,6.407942056593679,-13.390440719525067,1.7062211694786257e-25,4.729120837452493e-24,47.294370189022025
RAPGEF4,ILMN_1661802,"Homo sapiens Rap guanine nucleotide exchange factor (GEF) 4 (RAPGEF4), mRNA.",intracellular [goid 5622] [evidence IEA]; membrane fraction [goid 5624] [pmid 10777494] [evidence TAS]; cAMP-dependent protein kinase complex [goid 5952] [evidence IEA],exocytosis [goid 6887] [evidence IEA]; protein amino acid phosphorylation [goid 6468] [evidence IEA]; regulation of small GTPase mediated signal transduction [goid 51056] [evidence IEA]; G-protein coupled receptor protein signaling pathway [goid 7186] [pmid 9856955] [evidence TAS],protein binding [goid 5515] [pmid 11438518] [evidence IPI]; guanyl-nucleotide exchange factor activity [goid 5085] [pmid 9856955] [evidence TAS]; nucleotide binding [goid 166] [evidence IEA]; cAMP-dependent protein kinase regulator activity [goid 8603] [evidence IEA],2,173625165-173625214,2q31.1e,+,NM_007023.1,11069,RAPGEF4,-1.2307111777338555,6.226311078441739,-13.372987894758081,1.8738145091201044e-25,5.171568797479494e-24,47.2009612275388
FCER1A,ILMN_1688423,"Homo sapiens Fc fragment of IgE, high affinity I, receptor for; alpha polypeptide (FCER1A), mRNA.",plasma membrane [goid 5886] [pmid 1535625] [evidence TAS]; integral to plasma membrane [goid 5887] [pmid 2964640] [evidence TAS],immune response [goid 6955] [evidence NR ],receptor activity [goid 4872] [evidence IEA]; IgE binding [goid 19863] [evidence IEA]; receptor signaling protein activity [goid 5057] [evidence NR ],1,157544285-157544334,1q23.2a,+,NM_002001.2,2205,FCER1A,-2.702992780635764,8.6362237167863,-13.372091050314857,1.8828594197719867e-25,5.189181866231564e-24,47.196160554055794
ANXA3,ILMN_1694548,"Homo sapiens annexin A3 (ANXA3), mRNA.",cytoplasm [goid 5737] [pmid 16130169] [evidence TAS],signal transduction [goid 7165] [pmid 16130169] [evidence TAS],calcium-dependent phospholipid binding [goid 5544] [evidence IEA]; phospholipase A2 inhibitor activity [goid 19834] [evidence IEA]; calcium ion binding [goid 5509] [evidence IEA]; diphosphoinositol-polyphosphate diphosphatase activity [goid 8486] [evidence NR ],4,79750287-79750293:79750294-79750336,4q21.21a,+,NM_005139.1,306,ANXA3,-2.499805872127788,8.051439778046975,-13.371805069778837,1.8857528060220048e-25,5.189815455556323e-24,47.19462972912159
CCND2,ILMN_1667081,"Homo sapiens cyclin D2 (CCND2), mRNA.",nucleus [goid 5634] [evidence IEA],cell cycle [goid 7049] [evidence IEA]; cell division [goid 51301] [evidence IEA],protein binding [goid 5515] [pmid 11896535] [evidence IPI],12,4284268-4284317,12p13.32a,+,NM_001759.2,894,CCND2,-1.6290795879524662,10.415546233533103,-13.366494469035068,1.940300076172236e-25,5.332404370129198e-24,47.166201379957016
DLL1,ILMN_1743373,"Homo sapiens delta-like 1 (Drosophila) (DLL1), mRNA.",extracellular region [goid 5576] [pmid 11823422] [evidence NAS]; membrane [goid 16020] [evidence IEA]; integral to plasma membrane [goid 5887] [pmid 10079256] [evidence NAS],embryonic development (sensu Mammalia) [goid 1701] [pmid 10473134] [evidence ISS]; cell communication [goid 7154] [evidence IEA]; odontogenesis (sensu Vertebrata) [goid 42475] [pmid 9882480] [evidence ISS]; inner ear morphogenesis [goid 42472] [pmid 9858718] [evidence ISS]; regulation of cell adhesion [goid 30155] [pmid 11912004] [evidence TAS]; Notch signaling pathway [goid 7219] [pmid 10079256] [evidence NAS]; cell differentiation [goid 30154] [pmid 11912004] [evidence TAS]; auditory receptor cell fate commitment [goid 9912] [pmid 10473135] [evidence ISS]; hemopoiesis [goid 30097] [pmid 11581320] [evidence NAS]; cell fate determination [goid 1709] [pmid 11581320] [evidence NAS],calcium ion binding [goid 5509] [evidence IEA]; Notch binding [goid 5112] [pmid 11823422] [evidence IPI],6,170433567-170433616,6q27f,-,NM_005618.2,28514,DLL1,-1.787086785470608,7.886712882540826,-13.363077883402585,1.9762269217128936e-25,5.423490361912075e-24,47.14791070192151
STX2,ILMN_1747775,"Homo sapiens syntaxin 2 (STX2), transcript variant 1, mRNA.",membrane [goid 16020] [evidence IEA]; integral to membrane [goid 16021] [evidence IEA]; soluble fraction [goid 5625] [pmid 8466509] [evidence TAS]; microsome [goid 5792] [pmid 8466509] [evidence TAS]; membrane [goid 16020] [evidence IEA]; integral to membrane [goid 16021] [evidence IEA]; soluble fraction [goid 5625] [pmid 8466509] [evidence TAS]; microsome [goid 5792] [pmid 8466509] [evidence TAS],signal transduction [goid 7165] [pmid 1581962] [evidence TAS]; ectoderm development [goid 7398] [pmid 8466509] [evidence TAS]; signal transduction [goid 7165] [pmid 1581962] [evidence TAS]; ectoderm development [goid 7398] [pmid 8466509] [evidence TAS],,12,129840467-129840516,12q24.33b,-,NM_001980.2,2054,STX2,-1.1006693460665993,8.647179898986773,-13.359048795544664,2.0194528044273094e-25,5.5343231918799045e-24,47.12633974675029
ZFP36L2,ILMN_2150258,"Homo sapiens zinc finger protein 36, C3H type-like 2 (ZFP36L2), mRNA.",nucleus [goid 5634] [evidence IEA],cell proliferation [goid 8283] [pmid 7835719] [evidence TAS],transcription factor activity [goid 3700] [pmid 7835719] [evidence TAS]; nucleic acid binding [goid 3676] [evidence IEA]; metal ion binding [goid 46872] [evidence IEA]; zinc ion binding [goid 8270] [evidence IEA],2,43304551-43304600,2p21e,-,NM_006887.3,678,ZFP36L2,-1.8406787698897755,8.494070570420588,-13.351828773207231,2.099298533993308e-25,5.7370030764178975e-24,47.08768177036061
SMPDL3B,ILMN_1678095,"Homo sapiens sphingomyelin phosphodiesterase, acid-like 3B (SMPDL3B), transcript variant 1, mRNA.",,metabolism [goid 8152] [evidence IEA]; metabolism [goid 8152] [evidence IEA],"hydrolase activity, acting on glycosyl bonds [goid 16798] [evidence IEA]; hydrolase activity, acting on glycosyl bonds [goid 16798] [evidence IEA]",1,28155132-28155180:28157574-28157574,1p35.3b,+,NM_014474.2,27293,SMPDL3B,1.6531397631868883,7.344399652130927,13.3510205814798,2.108431062647707e-25,5.7538742915305655e-24,47.08335422110113
CA2,ILMN_1662795,"Homo sapiens carbonic anhydrase II (CA2), mRNA.",cytoplasm [goid 5737] [pmid 114507] [evidence IDA]; cytoplasm [goid 5737] [pmid 114507] [evidence IDA],one-carbon compound metabolism [goid 6730] [evidence IEA]; one-carbon compound metabolism [goid 6730] [evidence IEA],metal ion binding [goid 46872] [evidence IEA]; zinc ion binding [goid 8270] [pmid 3151020] [evidence IDA]; carbonate dehydratase activity [goid 4089] [pmid 1928091] [evidence TAS]; lyase activity [goid 16829] [evidence IEA]; metal ion binding [goid 46872] [evidence IEA]; zinc ion binding [goid 8270] [pmid 3151020] [evidence IDA]; carbonate dehydratase activity [goid 4089] [pmid 1928091] [evidence TAS]; lyase activity [goid 16829] [evidence IEA],8,86580426-86580475,8q21.2b,+,NM_000067.1,760,CA2,-2.508808328440576,9.410750348980276,-13.350760534705133,2.1113780438513492e-25,5.7538742915305655e-24,47.08196176123488
PRKCE,ILMN_1717799,"Homo sapiens protein kinase C, epsilon (PRKCE), mRNA.",membrane fraction [goid 5624] [pmid 7935319] [evidence TAS],induction of apoptosis [goid 6917] [pmid 10438519] [evidence TAS]; intracellular signaling cascade [goid 7242] [evidence IEA]; protein amino acid phosphorylation [goid 6468] [pmid 1382605] [evidence TAS],transferase activity [goid 16740] [evidence IEA]; protein kinase C activity [goid 4697] [pmid 1382605] [evidence TAS]; nucleotide binding [goid 166] [evidence IEA]; zinc ion binding [goid 8270] [evidence IEA]; metal ion binding [goid 46872] [evidence IEA]; ATP binding [goid 5524] [evidence IEA]; diacylglycerol binding [goid 19992] [evidence IEA]; signal transducer activity [goid 4871] [pmid 10438519] [evidence TAS],2,46267860-46267909,2p21b,+,NM_005400.2,5581,PRKCE,-1.626477020109668,7.431308741616601,-13.349513948301205,2.125562459423099e-25,5.784439179030597e-24,47.07528664747812
RARRES2,ILMN_1810844,"Homo sapiens retinoic acid receptor responder (tazarotene induced) 2 (RARRES2), mRNA.",,retinoid metabolism [goid 1523] [pmid 9204961] [evidence IDA],,7,149666666-149666715,7q36.1c,-,NM_002889.2,5919,RARRES2,-1.5545469573836623,11.844925769902883,-13.335695419861747,2.2893474550355515e-25,6.204163443861992e-24,47.00128375238589
PGM2L1,ILMN_1716265,"Homo sapiens phosphoglucomutase 2-like 1 (PGM2L1), mRNA.",,carbohydrate metabolism [goid 5975] [evidence IEA]; glucose metabolism [goid 6006] [evidence IEA],phosphoglucomutase activity [goid 4614] [evidence IEA]; isomerase activity [goid 16853] [evidence IEA],11,73719291-73719340,11q13.4c,-,NM_173582.3,283209,PGM2L1,1.4431140934181235,7.406557312488134,13.334986866673933,2.298078785987065e-25,6.219175714577495e-24,46.997488784399074
C7orf21,ILMN_1666050,"Homo sapiens transmembrane and ubiquitin-like domain containing 1 (TMUB1), mRNA.",membrane [goid 16020] [evidence IEA]; integral to membrane [goid 16021] [evidence IEA],protein modification [goid 6464] [evidence IEA],,7,150409212-150409261,7q36.1d,-,NM_031434.2,83590,C7orf21,1.0284499722116127,10.411041549458476,13.330577255650729,2.353173089456505e-25,6.350634023277007e-24,46.973870242300734
PSME4,ILMN_1763540,"Homo sapiens proteasome (prosome, macropain) activator subunit 4 (PSME4), mRNA.",,,binding [goid 5488] [evidence IEA],2,53945667-53945716,2p16.2a,-,NM_014614.1,23198,PSME4,1.2241050041278339,10.15769448291861,13.324785767801291,2.4275503773749347e-25,6.5422986311411625e-24,46.9428477210762
CAMP,ILMN_1688580,"Homo sapiens cathelicidin antimicrobial peptide (CAMP), mRNA.",extracellular region [goid 5576] [evidence IEA],,,3,48241909-48241918:48241919-48241958,3p21.31f,+,NM_004345.3,820,CAMP,-2.994562752533759,7.55400599757079,-13.309146188567292,2.6403966321829793e-25,7.086519060342335e-24,46.85905938861428
ANXA6,ILMN_1678612,"Homo sapiens annexin A6 (ANXA6), transcript variant 1, mRNA.",,,calcium-dependent phospholipid binding [goid 5544] [evidence IEA]; catalytic activity [goid 3824] [evidence IEA]; calcium ion binding [goid 5509] [evidence IEA],5,150460633-150460682,5q33.1d,-,NM_001155.3,309,ANXA6,-1.0816727654867488,6.741678150697535,-13.300185501208459,2.770679961756351e-25,7.42595585348315e-24,46.81104386250659
DCBLD1,ILMN_1695604,"Homo sapiens discoidin, CUB and LCCL domain containing 1 (DCBLD1), mRNA.",membrane [goid 16020] [evidence IEA]; integral to membrane [goid 16021] [evidence IEA],cell adhesion [goid 7155] [evidence IEA],,6,117971011-117971060,6q22.2b,+,NM_173674.1,285761,DCBLD1,1.5267217344231003,7.929016487954575,13.299546739229088,2.780209710886704e-25,7.441261842943327e-24,46.80762082781148
PTD015,ILMN_1779163,"Homo sapiens chromosome 11 open reading frame 67 (C11orf67), mRNA.",,,,11,77209896-77209935:77231173-77231182,11q14.1a,+,NM_024684.2,28971,PTD015,-1.4754103378594152,9.409700419584846,-13.296064628738888,2.832740657541062e-25,7.571461140217776e-24,46.788960105181864
ADCY4,ILMN_2148944,"Homo sapiens adenylate cyclase 4 (ADCY4), mRNA.",membrane [goid 16020] [evidence IEA]; integral to membrane [goid 16021] [evidence IEA],cAMP biosynthesis [goid 6171] [evidence IEA]; cyclic nucleotide biosynthesis [goid 9190] [evidence IEA]; intracellular signaling cascade [goid 7242] [evidence IEA],magnesium ion binding [goid 287] [evidence IEA]; adenylate cyclase activity [goid 4016] [evidence IEA],14,23857547-23857596,14q12a,-,NM_139247.2,196883,ADCY4,-1.712691519100801,8.56589422604713,-13.27902589812951,3.1044981450374307e-25,8.273224640193235e-24,46.69763481343282
ZBED2,ILMN_1651365,"Homo sapiens zinc finger, BED-type containing 2 (ZBED2), mRNA.",,,metal ion binding [goid 46872] [evidence IEA]; DNA binding [goid 3677] [evidence IEA],3,112794641-112794690,3q13.13d,-,NM_024508.3,79413,ZBED2,-2.7091152992903247,7.127336131847942,-13.278678168819374,3.110308338690463e-25,8.273224640193235e-24,46.69577078487972
CD69,ILMN_1651316,"Homo sapiens CD69 molecule (CD69), mRNA.",integral to plasma membrane [goid 5887] [pmid 8340758] [evidence TAS]; membrane [goid 16020] [evidence IEA],defense response [goid 6952] [evidence NR ]; cell surface receptor linked signal transduction [goid 7166] [evidence NR ],sugar binding [goid 5529] [evidence IEA]; transmembrane receptor activity [goid 4888] [pmid 8340758] [evidence TAS],12,9796974-9797023,12p13.31a,-,NM_001781.1,969,CD69,-2.2566923729473034,7.661366816532303,-13.278538158787972,3.1126508384120996e-25,8.273224640193235e-24,46.695020248024825
ABCB6,ILMN_2193980,"Homo sapiens ATP-binding cassette, sub-family B (MDR/TAP), member 6 (ABCB6), nuclear gene encoding mitochondrial protein, mRNA.",integral to membrane [goid 16021] [evidence IEA]; ATP-binding cassette (ABC) transporter complex [goid 43190] [pmid 11955620] [evidence NAS]; membrane [goid 16020] [evidence IEA]; mitochondrion [goid 5739] [pmid 10837493] [evidence IDA],transport [goid 6810] [pmid 10837493] [evidence IDA]; iron ion homeostasis [goid 6879] [pmid 11977179] [evidence NAS],"ATPase activity, coupled to transmembrane movement of substances [goid 42626] [evidence IEA]; ATPase activity [goid 16887] [evidence IEA]; nucleotide binding [goid 166] [evidence IEA]; ATP binding [goid 5524] [pmid 10837493] [evidence IDA]",2,219782844-219782893,2q35f,-,NM_005689.1,10058,ABCB6,1.5175020368429157,8.590925051447744,13.278306897428795,3.116523934258062e-25,8.273224640193235e-24,46.69378054640684
SAMD10,ILMN_1767801,"Homo sapiens sterile alpha motif domain containing 10 (SAMD10), mRNA.",,,,20,62076085-62076134,20q13.33e,-,NM_080621.3,140700,SAMD10,1.085865656913401,5.72179352598451,13.274971143640402,3.1729308076961972e-25,8.411504324892572e-24,46.67589839202566
JUP,ILMN_1733811,"Homo sapiens junction plakoglobin (JUP), transcript variant 2, mRNA.",membrane fraction [goid 5624] [pmid 1639850] [evidence TAS]; cytoskeleton [goid 5856] [pmid 1639850] [evidence TAS]; soluble fraction [goid 5625] [pmid 1639850] [evidence TAS]; cytoplasm [goid 5737] [pmid 1639850] [evidence TAS]; membrane fraction [goid 5624] [pmid 1639850] [evidence TAS]; cytoskeleton [goid 5856] [pmid 1639850] [evidence TAS]; soluble fraction [goid 5625] [pmid 1639850] [evidence TAS]; cytoplasm [goid 5737] [pmid 1639850] [evidence TAS],cell adhesion [goid 7155] [pmid 1639850] [evidence NAS]; cell adhesion [goid 7155] [pmid 1639850] [evidence NAS],structural molecule activity [goid 5198] [evidence IEA]; cytoskeletal protein binding [goid 8092] [pmid 1639850] [evidence TAS]; structural molecule activity [goid 5198] [evidence IEA]; cytoskeletal protein binding [goid 8092] [pmid 1639850] [evidence TAS],17,37164659-37164708,17q21.2b,-,NM_021991.1,3728,JUP,1.224221476867422,8.654635066019523,13.273575304631967,3.1968369477219786e-25,8.463365207386243e-24,46.66841537433409
GPR120,ILMN_1755942,"Homo sapiens G protein-coupled receptor 120 (GPR120), mRNA.",membrane [goid 16020] [evidence IEA]; integral to membrane [goid 16021] [evidence IEA],G-protein coupled receptor protein signaling pathway [goid 7186] [evidence IEA]; signal transduction [goid 7165] [evidence IEA],receptor activity [goid 4872] [evidence IEA]; rhodopsin-like receptor activity [goid 1584] [evidence IEA]; lipid binding [goid 8289] [evidence IEA],10,95337155-95337204,10q23.33b,+,NM_181745.2,338557,GPR120,-1.9290407928458384,6.209279259120045,-13.266776655659507,3.315883472243542e-25,8.76662000768866e-24,46.631965920316645
STK32A,ILMN_1756612,"Homo sapiens serine/threonine kinase 32A (STK32A), mRNA.",,protein amino acid phosphorylation [goid 6468] [evidence IEA],nucleotide binding [goid 166] [evidence IEA]; protein serine/threonine kinase activity [goid 4674] [evidence IEA]; magnesium ion binding [goid 287] [evidence IEA]; transferase activity [goid 16740] [evidence IEA]; ATP binding [goid 5524] [evidence IEA],5,146683786-146683827:146702762-146702769,5q32e,+,NM_145001.1,202374,STK32A,1.879866652519861,5.9492894996080175,13.258226913787086,3.471924005556903e-25,9.154321955111806e-24,46.586123045815235
L2HGDH,ILMN_1723211,"Homo sapiens L-2-hydroxyglutarate dehydrogenase (L2HGDH), mRNA.",,electron transport [goid 6118] [evidence IEA],2-hydroxyglutarate dehydrogenase activity [goid 47545] [evidence IEA]; oxidoreductase activity [goid 16491] [evidence IEA],14,49783034-49783083,14q22.1b,-,NM_024884.1,79944,L2HGDH,1.59356108989929,7.978160093784881,13.252816245185622,3.574457200552953e-25,9.41193223686139e-24,46.55710851518869
CDKN1C,ILMN_1718565,"Homo sapiens cyclin-dependent kinase inhibitor 1C (p57, Kip2) (CDKN1C), mRNA.",nucleus [goid 5634] [evidence IEA],G1 phase of mitotic cell cycle [goid 80] [pmid 7729684] [evidence TAS]; cell cycle [goid 7049] [evidence IEA]; cell cycle arrest [goid 7050] [pmid 7729684] [evidence TAS]; negative regulation of cell proliferation [goid 8285] [pmid 7729684] [evidence TAS],protein binding [goid 5515] [pmid 9106657] [evidence IPI]; cyclin-dependent protein kinase inhibitor activity [goid 4861] [pmid 7729684] [evidence TAS],11,2861687-2861721:2861805-2861809:2861810-2861819,11p15.4d,-,NM_000076.1,1028,CDKN1C,-1.420108305440297,8.248990047697824,-13.22819897912177,4.0806736594205355e-25,1.0730354420217158e-23,46.42506942371789
SH3BGRL,ILMN_1702835,"Homo sapiens SH3 domain binding glutamic acid-rich protein like (SH3BGRL), mRNA.",nucleus [goid 5634] [pmid 16130169] [evidence TAS]; cytoplasm [goid 5737] [pmid 16130169] [evidence TAS]; nucleus [goid 5634] [pmid 16130169] [evidence TAS]; cytoplasm [goid 5737] [pmid 16130169] [evidence TAS],,SH3/SH2 adaptor activity [goid 5070] [pmid 9642120] [evidence TAS]; SH3/SH2 adaptor activity [goid 5070] [pmid 9642120] [evidence TAS],X,80440189-80440238,Xq21.1c,+,NM_003022.1,6451,SH3BGRL,-1.2794356630248576,10.390385823566891,-13.220051781447376,4.263573197419701e-25,1.1196189184868311e-23,46.3813597477128
CYP27B1,ILMN_1740418,"Homo sapiens cytochrome P450, family 27, subfamily B, polypeptide 1 (CYP27B1), nuclear gene encoding mitochondrial protein, mRNA.",membrane [goid 16020] [evidence IEA]; mitochondrion [goid 5739] [evidence IEA],calcium ion homeostasis [goid 6874] [evidence NR ]; vitamin biosynthesis [goid 9110] [pmid 9333115] [evidence TAS]; lipid metabolism [goid 6629] [pmid 9344864] [evidence NAS]; electron transport [goid 6118] [evidence IEA],heme binding [goid 20037] [evidence IEA]; calcidiol 1-monooxygenase activity [goid 4498] [evidence IEA]; metal ion binding [goid 46872] [evidence IEA]; iron ion binding [goid 5506] [evidence IEA]; oxygen binding [goid 19825] [evidence NR ]; monooxygenase activity [goid 4497] [evidence IEA],12,56442565-56442614,12q14.1a,-,NM_000785.3,1594,CYP27B1,1.8024284313914407,6.374839868363164,13.215790536972335,4.362487186971781e-25,1.1440519897462336e-23,46.35849607375877
WFDC3,ILMN_1740415,"Homo sapiens WAP four-disulfide core domain 3 (WFDC3), transcript variant 4, mRNA.",,,serine-type endopeptidase inhibitor activity [goid 4867] [evidence IEA],20,43837497-43837546,20q13.12b,-,NM_181530.1,140686,WFDC3,2.8988754232132425,7.179705516523655,13.210099482298876,4.498189215662125e-25,1.1764727096265302e-23,46.327958499467385
OGN,ILMN_1790098,"Homo sapiens osteoglycin (osteoinductive factor, mimecan) (OGN), transcript variant 2, mRNA.",cellular component unknown [goid 8372] [pmid 10373482] [evidence ND ],biological process unknown [goid 4] [pmid 10373482] [evidence ND ],growth factor activity [goid 8083] [evidence IEA],9,94186594-94186643,9q22.31a,-,NM_024416.2,4969,OGN,-2.2274802344740925,5.95632600356128,-13.204041947362006,4.647284199155216e-25,1.2138382388812251e-23,46.29545159082402
CEACAM1,ILMN_1664330,"Homo sapiens carcinoembryonic antigen-related cell adhesion molecule 1 (biliary glycoprotein) (CEACAM1), transcript variant 1, mRNA.",integral to membrane [goid 16021] [evidence IEA]; membrane fraction [goid 5624] [pmid 2457922] [evidence TAS]; integral to plasma membrane [goid 5887] [pmid 15687237] [evidence NAS]; membrane [goid 16020] [evidence IEA],angiogenesis [goid 1525] [pmid 15687237] [evidence NAS]; pregnancy [goid 7565] [evidence TAS]; homophilic cell adhesion [goid 7156] [pmid 15687237] [evidence NAS]; cell migration [goid 16477] [pmid 15687237] [evidence NAS]; integrin-mediated signaling pathway [goid 7229] [pmid 15687237] [evidence NAS],,19,47707570-47707619,19q13.2c,-,NM_001712.3,634,CEACAM1,1.3615127311147353,8.473439685797732,13.201631661632362,4.707978187292271e-25,1.2280449127093696e-23,46.28251631789675
MC1R,ILMN_1653319,"Homo sapiens melanocortin 1 receptor (alpha melanocyte stimulating hormone receptor) (MC1R), mRNA.",integral to plasma membrane [goid 5887] [pmid 9571181] [evidence TAS]; membrane [goid 16020] [evidence IEA],"UV protection [goid 9650] [pmid 7581459] [evidence TAS]; G-protein signaling, coupled to cyclic nucleotide second messenger [goid 7187] [pmid 9571181] [evidence TAS]; development [goid 7275] [pmid 7581459] [evidence TAS]; signal transduction [goid 7165] [evidence IEA]",melanocyte stimulating hormone receptor activity [goid 4980] [evidence IEA]; receptor activity [goid 4872] [evidence IEA]; rhodopsin-like receptor activity [goid 1584] [evidence IEA],16,88514810-88514859,16q24.3b,+,NM_002386.2,4157,MC1R,1.706760847766338,7.744381476542849,13.18525600863841,5.14192691764317e-25,1.3383279364439914e-23,46.19462091485035
CCNB1,ILMN_1712803,"Homo sapiens cyclin B1 (CCNB1), mRNA.",nucleus [goid 5634] [evidence IEA],cell division [goid 51301] [evidence IEA]; mitosis [goid 7067] [evidence IEA]; G2/M transition of mitotic cell cycle [goid 86] [evidence NAS]; cell cycle [goid 7049] [evidence IEA],protein binding [goid 5515] [pmid 10373560] [evidence IPI],5,68509546-68509595,5q13.2a,+,NM_031966.2,891,CCNB1,1.589207862414515,5.965546545473417,13.18516276876075,5.144509234778288e-25,1.3383279364439914e-23,46.194120394042585
CLEC4A,ILMN_1709204,"Homo sapiens C-type lectin domain family 4, member A (CLEC4A), transcript variant 4, mRNA.",membrane [goid 16020] [evidence IEA]; integral to plasma membrane [goid 5887] [pmid 10438934] [evidence TAS]; membrane [goid 16020] [evidence IEA]; integral to plasma membrane [goid 5887] [pmid 10438934] [evidence TAS],cell adhesion [goid 7155] [pmid 10438934] [evidence TAS]; antimicrobial humoral response (sensu Vertebrata) [goid 19735] [pmid 10438934] [evidence TAS]; cell surface receptor linked signal transduction [goid 7166] [pmid 10438934] [evidence TAS]; immune response [goid 6955] [evidence IEA]; cell adhesion [goid 7155] [pmid 10438934] [evidence TAS]; antimicrobial humoral response (sensu Vertebrata) [goid 19735] [pmid 10438934] [evidence TAS]; cell surface receptor linked signal transduction [goid 7166] [pmid 10438934] [evidence TAS]; immune response [goid 6955] [evidence IEA],transmembrane receptor activity [goid 4888] [pmid 10438934] [evidence TAS]; sugar binding [goid 5529] [evidence IEA]; transmembrane receptor activity [goid 4888] [pmid 10438934] [evidence TAS]; sugar binding [goid 5529] [evidence IEA],12,8179527-8179576,12p13.31b,+,NM_194448.1,50856,CLEC4A,-1.5109603531798372,7.7408969662546365,-13.170256206396507,5.574532856846498e-25,1.4482636362087203e-23,46.11409165416342
ZFP36,ILMN_1720829,"Homo sapiens zinc finger protein 36, C3H type, homolog (mouse) (ZFP36), mRNA.",cytoplasm [goid 5737] [pmid 9703499] [evidence TAS]; cytosol [goid 5829] [pmid 10751406] [evidence IDA]; nucleus [goid 5634] [evidence IEA],mRNA catabolism [goid 6402] [pmid 11782475] [evidence IDA],protein binding [goid 5515] [pmid 15231747] [evidence IPI]; metal ion binding [goid 46872] [evidence IEA]; zinc ion binding [goid 8270] [evidence IEA]; DNA binding [goid 3677] [evidence IEA]; mRNA binding [goid 3729] [pmid 11782475] [evidence IDA]; single-stranded RNA binding [goid 3727] [pmid 9703499] [evidence TAS],19,44591555-44591604,19q13.2a,+,NM_003407.1,7538,ZFP36,-1.9969165574378565,12.626303895288435,-13.15638101647296,6.0071402573641235e-25,1.558576936281491e-23,46.03958427095933
STK39,ILMN_1791328,"Homo sapiens serine threonine kinase 39 (STE20/SPS1 homolog, yeast) (STK39), mRNA.",cytoplasm [goid 5737] [pmid 10980603] [evidence NAS]; nucleus [goid 5634] [pmid 10980603] [evidence NAS],response to stress [goid 6950] [pmid 10980603] [evidence NAS]; protein amino acid phosphorylation [goid 6468] [pmid 10980603] [evidence NAS],nucleotide binding [goid 166] [evidence IEA]; receptor signaling protein serine/threonine kinase activity [goid 4702] [pmid 10980603] [evidence NAS]; transferase activity [goid 16740] [evidence IEA]; ATP binding [goid 5524] [evidence NAS],2,168518970-168519019,2q24.3f,-,NM_013233.1,27347,STK39,1.429346692204163,9.436559350322462,13.15460915114903,6.064755787286159e-25,1.5714330653626437e-23,46.030068567819384
LOC344595,ILMN_1696701,"PREDICTED: Homo sapiens hypothetical LOC344595 (LOC344595), mRNA.",,,,3,108450314-108450363,3q13.12a,+,XM_298151.5,344595,LOC344595,-1.0961844458943677,6.023655294683049,-13.150305840973333,6.207003866018421e-25,1.6061549844537707e-23,46.00695685549184
GLDN,ILMN_1704376,"Homo sapiens gliomedin (GLDN), mRNA.",cytoplasm [goid 5737] [evidence IEA],phosphate transport [goid 6817] [evidence IEA],,15,49487325-49487374,15q21.2b,+,NM_181789.1,342035,GLDN,-2.437723199951594,8.33486226643665,-13.146991238499306,6.318846708127608e-25,1.6329274284862922e-23,45.98915418735445
HLX1,ILMN_1686862,"Homo sapiens H2.0-like homeobox (HLX), mRNA.",nucleus [goid 5634] [evidence IEA]; nucleus [goid 5634] [evidence IEA],"regulation of transcription, DNA-dependent [goid 6355] [evidence IEA]; development [goid 7275] [pmid 8094082] [evidence TAS]; transcription from RNA polymerase II promoter [goid 6366] [evidence NR ]; regulation of transcription, DNA-dependent [goid 6355] [evidence IEA]; development [goid 7275] [pmid 8094082] [evidence TAS]; transcription from RNA polymerase II promoter [goid 6366] [evidence NR ]",sequence-specific DNA binding [goid 43565] [evidence IEA]; transcription factor activity [goid 3700] [evidence IEA]; sequence-specific DNA binding [goid 43565] [evidence IEA]; transcription factor activity [goid 3700] [evidence IEA],1,219124373-219124422,1q41d,+,NM_021958.2,3142,HLX1,-1.3798057754606372,7.547476193490062,-13.131741477600439,6.860022018417483e-25,1.765753355731369e-23,45.907236921230535
KCNN4,ILMN_1709937,"Homo sapiens potassium intermediate/small conductance calcium-activated channel, subfamily N, member 4 (KCNN4), mRNA.",integral to membrane [goid 16021] [evidence IEA]; membrane fraction [goid 5624] [evidence NR ]; voltage-gated potassium channel complex [goid 8076] [pmid 9380751] [evidence TAS]; membrane [goid 16020] [evidence IEA],ion transport [goid 6811] [evidence IEA]; potassium ion transport [goid 6813] [pmid 9380751] [evidence TAS]; defense response [goid 6952] [pmid 9407042] [evidence TAS],calmodulin binding [goid 5516] [evidence IEA]; ion channel activity [goid 5216] [evidence IEA]; calcium-activated potassium channel activity [goid 15269] [pmid 9380751] [evidence TAS]; voltage-gated potassium channel activity [goid 5249] [evidence IEA],19,48962909-48962958,19q13.31b,-,NM_002250.2,3783,KCNN4,1.6936080888047362,6.774368725618158,13.128287524207137,6.988912769289896e-25,1.7965562705753778e-23,45.88868076752392
DES,ILMN_1698995,"Homo sapiens desmin (DES), mRNA.",intermediate filament [goid 5882] [pmid 9736733] [evidence TAS],muscle contraction [goid 6936] [pmid 9697706] [evidence TAS]; cytoskeleton organization and biogenesis [goid 7010] [pmid 9736733] [evidence TAS],structural molecule activity [goid 5198] [evidence IEA]; protein binding [goid 5515] [pmid 15731013] [evidence IPI]; structural constituent of cytoskeleton [goid 5200] [pmid 9736733] [evidence TAS],2,219999247-219999296,2q35f,+,NM_001927.3,1674,DES,-2.294514252445653,6.70780788159424,-13.1278801451614,7.004274106875775e-25,1.798132819136686e-23,45.88649208713834
TBX4,ILMN_1745827,"Homo sapiens T-box 4 (TBX4), mRNA.",nucleus [goid 5634] [evidence NAS],"regulation of transcription, DNA-dependent [goid 6355] [pmid 10945475] [evidence NAS]; development [goid 7275] [pmid 10945475] [evidence NAS]; transcription [goid 6350] [evidence IEA]",transcription factor activity [goid 3700] [pmid 10945475] [evidence TAS],17,56916188-56916237,17q23.2b,+,NM_018488.2,9496,TBX4,-1.6745433171278146,5.73975002560572,-13.112255440555662,7.619715236445069e-25,1.9495328738118798e-23,45.802537214676555
LOC89944,ILMN_2144401,"Homo sapiens hypothetical protein BC008326 (LOC89944), mRNA.",beta-galactosidase complex [goid 9341] [evidence IEA],carbohydrate metabolism [goid 5975] [evidence IEA],beta-galactosidase activity [goid 4565] [evidence IEA]; catalytic activity [goid 3824] [evidence IEA],11,133750797-133750846,11q25e,+,NM_138342.2,89944,LOC89944,2.294499066333631,7.2263457867369585,13.112150200706019,7.624039260172709e-25,1.9495328738118798e-23,45.80197167418577
GNG2,ILMN_1807925,"Homo sapiens guanine nucleotide binding protein (G protein), gamma 2 (GNG2), mRNA.",heterotrimeric G-protein complex [goid 5834] [evidence IEA],signal transduction [goid 7165] [evidence IEA]; G-protein coupled receptor protein signaling pathway [goid 7186] [evidence IEA],signal transducer activity [goid 4871] [evidence IEA],14,51505271-51505320,14q22.1d,+,NM_053064.2,54331,GNG2,-1.650494179568243,6.235249573582572,-13.106400713866313,7.864047840064098e-25,2.0056409969064e-23,45.77107363546193
EFCBP1,ILMN_1695941,"Homo sapiens EF-hand calcium binding protein 1 (EFCBP1), mRNA.",cytoplasm [goid 5737] [evidence IEA]; cytoplasm [goid 5737] [evidence IEA],antibiotic biosynthesis [goid 17000] [evidence IEA]; antibiotic biosynthesis [goid 17000] [evidence IEA],calcium ion binding [goid 5509] [evidence IEA]; oxidoreductase activity [goid 16491] [evidence IEA]; calcium ion binding [goid 5509] [evidence IEA]; oxidoreductase activity [goid 16491] [evidence IEA],8,92038407-92038456,8q21.3e,+,NM_022351.2,64168,EFCBP1,-1.6963251496884455,5.777934219908245,-13.099612189870466,8.157203367184785e-25,2.0776876811711833e-23,45.7345884619344
CHPT1,ILMN_1729112,"Homo sapiens choline phosphotransferase 1 (CHPT1), mRNA.",membrane [goid 16020] [pmid 10893425] [evidence NAS]; microsome [goid 5792] [pmid 10893425] [evidence NAS]; membrane [goid 16020] [pmid 10893425] [evidence NAS]; microsome [goid 5792] [pmid 10893425] [evidence NAS],CDP-choline pathway [goid 6657] [pmid 10893425] [evidence NAS]; regulation of cell growth [goid 1558] [pmid 10893425] [evidence NAS]; platelet activating factor biosynthesis [goid 6663] [pmid 10893425] [evidence IDA]; CDP-choline pathway [goid 6657] [pmid 10893425] [evidence NAS]; regulation of cell growth [goid 1558] [pmid 10893425] [evidence NAS]; platelet activating factor biosynthesis [goid 6663] [pmid 10893425] [evidence IDA],transferase activity [goid 16740] [evidence IEA]; diacylglycerol cholinephosphotransferase activity [goid 4142] [pmid 10893425] [evidence IEP]; diacylglycerol binding [goid 19992] [pmid 10893425] [evidence NAS]; transferase activity [goid 16740] [evidence IEA]; diacylglycerol cholinephosphotransferase activity [goid 4142] [pmid 10893425] [evidence IEP]; diacylglycerol binding [goid 19992] [pmid 10893425] [evidence NAS],12,100638149-100638163:100641077-100641111,12q23.2a,+,NM_020244.2,56994,CHPT1,-1.8058639017517164,8.49992259158898,-13.093669051135139,8.422834921592592e-25,2.1425448883450608e-23,45.70264391859105
ATP13A2,ILMN_1704164,"Homo sapiens ATPase type 13A2 (ATP13A2), mRNA.",integral to membrane [goid 16021] [evidence IEA]; membrane [goid 16020] [evidence IEA]; endoplasmic reticulum [goid 5783] [evidence IEA],metabolism [goid 8152] [evidence IEA]; cation transport [goid 6812] [evidence IEA],"ATPase activity, coupled to transmembrane movement of ions, phosphorylative mechanism [goid 15662] [evidence IEA]; ATPase activity [goid 16887] [evidence IEA]; hydrolase activity [goid 16787] [evidence IEA]; nucleotide binding [goid 166] [evidence IEA]; ATP binding [goid 5524] [evidence IEA]; hydrolase activity, acting on acid anhydrides, catalyzing transmembrane movement of substances [goid 16820] [evidence IEA]; magnesium ion binding [goid 287] [evidence IEA]",1,17185182-17185231,1p36.13e,-,NM_022089.1,23400,ATP13A2,1.26569776958151,7.972341541957785,13.089783043602475,8.601194679315432e-25,2.185062298910837e-23,45.68175504159897
TARSL1,ILMN_1778187,"Homo sapiens threonyl-tRNA synthetase 2, mitochondrial (putative) (TARS2), mRNA.",,threonyl-tRNA aminoacylation [goid 6435] [evidence IEA]; protein biosynthesis [goid 6412] [evidence IEA]; electron transport [goid 6118] [evidence IEA],ligase activity [goid 16874] [evidence IEA]; nucleotide binding [goid 166] [evidence IEA]; electron carrier activity [goid 9055] [evidence IEA]; ATP binding [goid 5524] [evidence IEA]; iron ion binding [goid 5506] [evidence IEA]; threonine-tRNA ligase activity [goid 4829] [evidence IEA],1,148746173-148746222,1q21.2b,+,NM_025150.3,80222,TARSL1,1.034652499642843,7.081598337928771,13.085585599817408,8.798105975854074e-25,2.2321757153582896e-23,45.659190760463716
MST1R,ILMN_1688154,"Homo sapiens macrophage stimulating 1 receptor (c-met-related tyrosine kinase) (MST1R), mRNA.",membrane [goid 16020] [evidence IEA]; integral to plasma membrane [goid 5887] [pmid 7939629] [evidence TAS],defense response [goid 6952] [pmid 9045873] [evidence TAS]; development [goid 7275] [evidence IEA]; positive regulation of cell proliferation [goid 8284] [pmid 10871856] [evidence TAS]; fertilization (sensu Metazoa) [goid 7338] [pmid 9045873] [evidence TAS]; protein amino acid phosphorylation [goid 6468] [evidence IEA]; cell motility [goid 6928] [pmid 9045873] [evidence TAS]; signal transduction [goid 7165] [pmid 7939629] [evidence TAS],macrophage colony stimulating factor receptor activity [goid 5011] [pmid 9045873] [evidence TAS]; receptor activity [goid 4872] [evidence IEA]; transferase activity [goid 16740] [evidence IEA]; ATP binding [goid 5524] [evidence IEA]; protein-tyrosine kinase activity [goid 4713] [evidence IEA]; nucleotide binding [goid 166] [evidence IEA],3,49899719-49899743:49899744-49899768,3p21.31c,-,NM_002447.1,4486,MST1R,1.5847141727799183,7.873179718221279,13.082396655076725,8.950722642987635e-25,2.2649978012807023e-23,45.64204698109296
NCF2,ILMN_1796642,"Homo sapiens neutrophil cytosolic factor 2 (65kDa, chronic granulomatous disease, autosomal 2) (NCF2), mRNA.",cytosol [goid 5829] [evidence NR ]; soluble fraction [goid 5625] [evidence NR ],cellular defense response [goid 6968] [pmid 1692159] [evidence TAS]; superoxide metabolism [goid 6801] [evidence NR ],electron carrier activity [goid 9055] [pmid 1692159] [evidence TAS]; binding [goid 5488] [evidence IEA]; protein binding [goid 5515] [pmid 11090627] [evidence IPI],1,181791603-181791652,1q25.3e,-,NM_000433.2,4688,NCF2,-1.727876228889432,7.043230758408573,-13.079607497407592,9.08638102918524e-25,2.2963441550411723e-23,45.62705181764147
C13orf21,ILMN_1696767,"Homo sapiens chromosome 13 open reading frame 21 (C13orf21), mRNA.",,,,13,43869663-43869712,13q14.11e,+,NM_001010897.1,387923,C13orf21,-1.5364474200002238,7.143361738793414,-13.078837503589044,9.124193628412331e-25,2.302913378881014e-23,45.62291204565523
RRBP1,ILMN_1803810,"Homo sapiens ribosome binding protein 1 homolog 180kDa (dog) (RRBP1), mRNA.",integral to membrane [goid 16021] [evidence IEA]; integral to endoplasmic reticulum membrane [goid 30176] [evidence NAS]; endoplasmic reticulum [goid 5783] [pmid 9628588] [evidence NAS]; ribosome [goid 5840] [pmid 9628588] [evidence TAS],signal transduction [goid 7165] [evidence NAS]; protein targeting [goid 6605] [evidence IEA]; protein biosynthesis [goid 6412] [pmid 9628588] [evidence TAS]; protein transport [goid 15031] [evidence IEA],ribosome receptor activity [goid 30376] [evidence NAS]; receptor activity [goid 4872] [pmid 9628588] [evidence TAS]; extracellular matrix structural constituent [goid 5201] [evidence NR ],20,17544091-17544140,20p12.1a,-,NM_004587.1,6238,RRBP1,1.6328782126499313,9.095318702046123,13.07736299281511,9.197044351164207e-25,2.318297660833565e-23,45.61498440249005
C8orf13,ILMN_1687213,"Homo sapiens chromosome 8 open reading frame 13 (C8orf13), mRNA.",,,,8,11316511-11316560,8p23.1b,-,NM_053279.1,83648,C8orf13,-2.2491932119958875,8.07714152148279,-13.07160565266137,9.48712387511727e-25,2.3883282778638245e-23,45.5840287158849
TSCOT,ILMN_1707585,"Homo sapiens solute carrier family 46, member 2 (SLC46A2), mRNA.",membrane [goid 16020] [evidence IEA]; integral to membrane [goid 16021] [pmid 10978518] [evidence NAS],transport [goid 6810] [evidence NAS]; tetracycline transport [goid 15904] [evidence IEA],symporter activity [goid 15293] [pmid 10978518] [evidence NAS]; tetracycline:hydrogen antiporter activity [goid 15520] [evidence IEA],9,114681119-114681168,9q32b,-,NM_033051.2,57864,TSCOT,-1.5827803940834544,8.517301052544084,-13.070137947303321,9.562529350721461e-25,2.404204959984615e-23,45.576136848150604
SPTBN2,ILMN_1667079,"Homo sapiens spectrin, beta, non-erythrocytic 2 (SPTBN2), mRNA.",membrane [goid 16020] [evidence IEA]; cytoskeleton [goid 5856] [evidence IEA]; spectrin [goid 8091] [pmid 9826670] [evidence IEP],vesicle-mediated transport [goid 16192] [pmid 9826670] [evidence IDA]; barbed-end actin filament capping [goid 51016] [evidence IEA],actin binding [goid 3779] [pmid 9826670] [evidence TAS]; structural constituent of cytoskeleton [goid 5200] [pmid 9826670] [evidence TAS],11,66209455-66209504,11q13.1e,-,NM_006946.1,6712,SPTBN2,1.391436388520047,5.938875239071009,13.067308583281982,9.709592111723424e-25,2.4348957824572832e-23,45.56092286143561
WDR46,ILMN_2212354,"Homo sapiens WD repeat domain 46 (WDR46), mRNA.",,,,6,33355001-33355030:33355031-33355050,6p21.32a,-,NM_005452.4,9277,WDR46,1.0344715201300367,9.577734858241227,13.065933991194623,9.781856120028963e-25,2.4498646079532695e-23,45.553531217514745
TMEM106C,ILMN_1692511,"Homo sapiens transmembrane protein 106C (TMEM106C), mRNA.",membrane [goid 16020] [evidence IEA]; integral to membrane [goid 16021] [evidence IEA],,,12,46648846-46648895,12q13.11c,+,NM_024056.2,79022,TMEM106C,1.107075617089869,10.404446996593258,13.041238072032447,1.1176037432321129e-24,2.7954440227057404e-23,45.4207083941846
PLXNB3,ILMN_1686313,"Homo sapiens plexin B3 (PLXNB3), mRNA.",membrane [goid 16020] [evidence IEA]; integral to membrane [goid 16021] [evidence IEA],development [goid 7275] [evidence IEA],receptor activity [goid 4872] [evidence IEA],X,152697649-152697688:152697689-152697698,Xq28f,+,NM_005393.1,5365,PLXNB3,1.3938529868100664,5.5925060348283235,13.030406847031381,1.1848781786752716e-24,2.9599168348061114e-23,45.36243986052698
LST1,ILMN_1688373,"Homo sapiens leukocyte specific transcript 1 (LST1), transcript variant 2, mRNA.",integral to membrane [goid 16021] [pmid 10706707] [evidence IDA]; Golgi apparatus [goid 5794] [pmid 11478849] [evidence NAS]; membrane [goid 16020] [evidence IEA]; cytoplasm [goid 5737] [pmid 11478849] [evidence IDA]; integral to membrane [goid 16021] [pmid 10706707] [evidence IDA]; Golgi apparatus [goid 5794] [pmid 11478849] [evidence NAS]; membrane [goid 16020] [evidence IEA]; cytoplasm [goid 5737] [pmid 11478849] [evidence IDA],regulation of cell shape [goid 8360] [evidence IEA]; immune response [goid 6955] [pmid 10944527] [evidence NAS]; negative regulation of lymphocyte proliferation [goid 50672] [pmid 10706707] [evidence IDA]; regulation of cell shape [goid 8360] [evidence IEA]; immune response [goid 6955] [pmid 10944527] [evidence NAS]; negative regulation of lymphocyte proliferation [goid 50672] [pmid 10706707] [evidence IDA],protein binding [goid 5515] [pmid 14667819] [evidence IPI]; protein binding [goid 5515] [pmid 14667819] [evidence IPI],6,31664410-31664459,6p21.33a,+,NM_205837.1,7940,LST1,-1.7176509749799385,8.65973778256003,-13.027921856845206,1.2008769112463701e-24,2.9922877904099494e-23,45.349070154060975
SLC29A2,ILMN_1730809,"Homo sapiens solute carrier family 29 (nucleoside transporters), member 2 (SLC29A2), mRNA.",nucleus [goid 5634] [evidence IEA]; integral to plasma membrane [goid 5887] [pmid 7639753] [evidence TAS]; membrane [goid 16020] [evidence IEA]; nucleolus [goid 5730] [pmid 7639753] [evidence TAS],"transport [goid 6810] [evidence IEA]; nucleoside transport [goid 15858] [pmid 9396714] [evidence TAS]; cell proliferation [goid 8283] [pmid 7639753] [evidence TAS]; nucleobase, nucleoside, nucleotide and nucleic acid metabolism [goid 6139] [pmid 9396714] [evidence TAS]",nucleoside transporter activity [goid 5337] [pmid 9396714] [evidence TAS],11,65886733-65886782,11q13.1e,-,NM_001532.2,3177,SLC29A2,1.3693278405981761,7.850443449789603,13.027917075115148,1.2009079045935748e-24,2.9922877904099494e-23,45.34904442701961
PDE7B,ILMN_1806533,"Homo sapiens phosphodiesterase 7B (PDE7B), mRNA.",,synaptic transmission [goid 7268] [pmid 10814504] [evidence TAS]; signal transduction [goid 7165] [pmid 10814504] [evidence TAS],"hydrolase activity [goid 16787] [evidence IEA]; 3',5'-cyclic-nucleotide phosphodiesterase activity [goid 4114] [evidence IEA]; catalytic activity [goid 3824] [evidence IEA]",6,136558046-136558095,6q23.3b,+,NM_018945.3,27115,PDE7B,-1.7661704634761461,7.2117740489461095,-13.027267841804195,1.205123442568649e-24,2.998956612828879e-23,45.345551354687174
CNFN,ILMN_1803838,"Homo sapiens cornifelin (CNFN), mRNA.",cornified envelope [goid 1533] [pmid 15147942] [evidence IDA],,,19,47583079-47583128,19q13.2c,-,NM_032488.2,84518,CNFN,1.9337299602506643,7.43396985918801,13.02548802524965,1.2167562200912579e-24,3.0240427230201736e-23,45.33597523794811
MRPL2,ILMN_1763264,"Homo sapiens mitochondrial ribosomal protein L2 (MRPL2), nuclear gene encoding mitochondrial protein, mRNA.",intracellular [goid 5622] [evidence IEA]; ribosome [goid 5840] [evidence IEA],protein biosynthesis [goid 6412] [evidence IEA],structural constituent of ribosome [goid 3735] [evidence IEA]; nucleic acid binding [goid 3676] [evidence IEA],6,43130105-43130154,6p21.1d,-,NM_015950.3,51069,MRPL2,1.3280561677543066,8.311209128393044,13.02029414196733,1.2513508313622809e-24,3.1060599935151646e-23,45.30802872548057
LOC149620,ILMN_1782691,"Homo sapiens similar to CHIA protein (LOC149620), mRNA.",,metabolism [goid 8152] [evidence IEA],hydrolase activity [goid 16787] [evidence IEA],1,111630063-111630112,1p13.2d,+,NM_001013621.1,149620,LOC149620,-4.0823132063600465,7.4690691655497305,-13.019193231027602,1.258809351916833e-24,3.120597992633523e-23,45.3021048383192
DEAF1,ILMN_1658902,"PREDICTED: Homo sapiens deformed epidermal autoregulatory factor 1 (Drosophila) (DEAF1), mRNA.",,,,,,11p15.5d,,XM_938667.1,10522,DEAF1,1.1564235872567066,7.305804780946516,13.017668941617114,1.2692098436401035e-24,3.142382948326228e-23,45.29390264492291
C1QTNF7,ILMN_1662935,"Homo sapiens C1q and tumor necrosis factor related protein 7 (C1QTNF7), mRNA.",cytoplasm [goid 5737] [evidence IEA],phosphate transport [goid 6817] [evidence IEA],,4,15055905-15055954,4p15.33a,+,NM_031911.3,114905,C1QTNF7,-1.5373219610599573,5.874613620947613,-13.009157764613386,1.3288870268228804e-24,3.2859598626451556e-23,45.248100831631476
RASGRP2,ILMN_1794594,"Homo sapiens RAS guanyl releasing protein 2 (calcium and DAG-regulated) (RASGRP2), transcript variant 1, mRNA.",intracellular [goid 5622] [evidence IEA]; cytosol [goid 5829] [pmid 10918068] [evidence IDA]; plasma membrane [goid 5886] [pmid 10918068] [evidence IDA]; intracellular [goid 5622] [evidence IEA]; cytosol [goid 5829] [pmid 10918068] [evidence IDA]; plasma membrane [goid 5886] [pmid 10918068] [evidence IDA]; intracellular [goid 5622] [evidence IEA]; cytosol [goid 5829] [pmid 10918068] [evidence IDA]; plasma membrane [goid 5886] [pmid 10918068] [evidence IDA],Ras protein signal transduction [goid 7265] [pmid 10918068] [evidence NAS]; regulation of cell growth [goid 1558] [pmid 10918068] [evidence NAS]; regulation of small GTPase mediated signal transduction [goid 51056] [evidence IEA]; Ras protein signal transduction [goid 7265] [pmid 10918068] [evidence NAS]; regulation of cell growth [goid 1558] [pmid 10918068] [evidence NAS]; regulation of small GTPase mediated signal transduction [goid 51056] [evidence IEA]; Ras protein signal transduction [goid 7265] [pmid 10918068] [evidence NAS]; regulation of cell growth [goid 1558] [pmid 10918068] [evidence NAS]; regulation of small GTPase mediated signal transduction [goid 51056] [evidence IEA],calcium ion binding [goid 5509] [pmid 10918068] [evidence NAS]; diacylglycerol binding [goid 19992] [pmid 10918068] [evidence NAS]; guanyl-nucleotide exchange factor activity [goid 5085] [evidence IEA]; Ras guanyl-nucleotide exchange factor activity [goid 5088] [pmid 10918068] [evidence IEP]; kinase activity [goid 16301] [evidence IEA]; calcium ion binding [goid 5509] [pmid 10918068] [evidence NAS]; diacylglycerol binding [goid 19992] [pmid 10918068] [evidence NAS]; guanyl-nucleotide exchange factor activity [goid 5085] [evidence IEA]; Ras guanyl-nucleotide exchange factor activity [goid 5088] [pmid 10918068] [evidence IEP]; kinase activity [goid 16301] [evidence IEA]; calcium ion binding [goid 5509] [pmid 10918068] [evidence NAS]; diacylglycerol binding [goid 19992] [pmid 10918068] [evidence NAS]; guanyl-nucleotide exchange factor activity [goid 5085] [evidence IEA]; Ras guanyl-nucleotide exchange factor activity [goid 5088] [pmid 10918068] [evidence IEP]; kinase activity [goid 16301] [evidence IEA],11,64251346-64251349:64251350-64251395,11q13.1b,-,NM_005825.2,10235,RASGRP2,-1.0357221049953242,6.270176699757481,-13.000731338812951,1.3907414017639493e-24,3.434549583443669e-23,45.20274973625087
PROS1,ILMN_1671928,"Homo sapiens protein S (alpha) (PROS1), mRNA.",extracellular region [goid 5576] [pmid 14718574] [evidence NAS],blood coagulation [goid 7596] [pmid 9657428] [evidence TAS],endopeptidase inhibitor activity [goid 4866] [pmid 8146182] [evidence TAS]; calcium ion binding [goid 5509] [evidence IEA],3,95074739-95074788,3q11.2a,-,NM_000313.1,5627,PROS1,-1.479194964175484,10.76328802337939,-12.989617471688694,1.476759798426818e-24,3.6423626167527276e-23,45.14292667804553
EFEMP2,ILMN_1653203,"Homo sapiens EGF-containing fibulin-like extracellular matrix protein 2 (EFEMP2), mRNA.",basement membrane [goid 5604] [pmid 10601734] [evidence TAS]; membrane [goid 16020] [evidence IEA],blood coagulation [goid 7596] [evidence IEA]; homophilic cell adhesion [goid 7156] [evidence IEA],calcium ion binding [goid 5509] [evidence IEA]; transmembrane receptor activity [goid 4888] [evidence IEA]; protein binding [goid 5515] [pmid 16189514] [evidence IPI]; extracellular matrix structural constituent [goid 5201] [pmid 10601734] [evidence TAS],11,65390547-65390596,11q13.1d,-,NM_016938.1,30008,EFEMP2,-1.4303377928736758,10.408634647937687,-12.987135051370084,1.496690581552062e-24,3.686854106389625e-23,45.12956319403988
HCK,ILMN_1791771,"Homo sapiens hemopoietic cell kinase (HCK), mRNA.",,intracellular signaling cascade [goid 7242] [evidence IEA]; protein amino acid phosphorylation [goid 6468] [pmid 3496523] [evidence TAS]; mesoderm development [goid 7498] [pmid 3453117] [evidence TAS],nucleotide binding [goid 166] [evidence IEA]; protein binding [goid 5515] [pmid 12029088] [evidence IPI]; transferase activity [goid 16740] [evidence IEA]; ATP binding [goid 5524] [evidence IEA]; protein-tyrosine kinase activity [goid 4713] [pmid 3496523] [evidence TAS],20,30153066-30153115,20q11.21b,+,NM_002110.2,3055,HCK,-1.4866994349647804,8.95260155997817,-12.975941464570772,1.589964920161191e-24,3.9116750592602027e-23,45.069299639162686
EGR2,ILMN_1743199,"Homo sapiens early growth response 2 (Krox-20 homolog, Drosophila) (EGR2), mRNA.",nucleus [goid 5634] [evidence IEA]; intracellular [goid 5622] [evidence IEA],"mechanosensory behavior [goid 7638] [evidence IEA]; peripheral nervous system development [goid 7422] [pmid 9537424] [evidence TAS]; transcription [goid 6350] [evidence IEA]; brain development [goid 7420] [pmid 9537424] [evidence TAS]; regulation of transcription, DNA-dependent [goid 6355] [evidence IEA]",transcription factor activity [goid 3700] [pmid 14532282] [evidence IDA]; zinc ion binding [goid 8270] [evidence IEA]; metal ion binding [goid 46872] [evidence IEA]; protein binding [goid 5515] [pmid 14532282] [evidence IPI],10,64242090-64242139,10q21.2b,-,NM_000399.2,1959,EGR2,-2.1754831880808077,8.86877565542335,-12.968900464119962,1.6516002657660717e-24,4.053076974616109e-23,45.03138783010359
ASF1B,ILMN_1695414,"Homo sapiens ASF1 anti-silencing function 1 homolog B (S. cerevisiae) (ASF1B), mRNA.",,,,19,14091475-14091524,19p13.12c,-,NM_018154.2,55723,ASF1B,1.7687473185678684,6.704461862228968,12.964323311967055,1.6929468099855273e-24,4.1493168040966036e-23,45.006740480731196
MGC4677,ILMN_1726153,"PREDICTED: Homo sapiens hypothetical protein MGC4677 (MGC4677), mRNA.",,,,,,2p11.2d,,XM_939115.1,112597,MGC4677,1.0618071988370845,8.541142711782152,12.96101915714463,1.7234375803630555e-24,4.2187413634892136e-23,44.98894708723905
MRPL12,ILMN_1699603,"Homo sapiens mitochondrial ribosomal protein L12 (MRPL12), nuclear gene encoding mitochondrial protein, mRNA.",mitochondrion [goid 5739] [evidence IEA]; ribosome [goid 5840] [evidence IEA]; mitochondrial large ribosomal subunit [goid 5762] [pmid 8626705] [evidence TAS]; intracellular [goid 5622] [evidence IEA],protein biosynthesis [goid 6412] [pmid 9169145] [evidence TAS],RNA binding [goid 3723] [pmid 8626705] [evidence TAS]; structural constituent of ribosome [goid 3735] [pmid 9169145] [evidence TAS],17,77284452-77284475:77284559-77284584,17q25.3f,+,NM_002949.2,6182,MRPL12,1.3888009758902466,9.397210716698972,12.949710127162433,1.8320261166611556e-24,4.473311890118122e-23,44.92804007904062
GAS7,ILMN_1745994,"Homo sapiens growth arrest-specific 7 (GAS7), transcript variant b, mRNA.",,cell differentiation [goid 30154] [evidence IEA]; cell cycle arrest [goid 7050] [pmid 9736752] [evidence TAS]; cell differentiation [goid 30154] [evidence IEA]; cell cycle arrest [goid 7050] [pmid 9736752] [evidence TAS],transcription factor activity [goid 3700] [pmid 9736752] [evidence TAS]; transcription factor activity [goid 3700] [pmid 9736752] [evidence TAS],17,9755047-9755096,17p13.1b,-,NM_201432.1,8522,GAS7,-1.3042592085137859,8.224597368374539,-12.945225115972047,1.876967242977516e-24,4.577309978650425e-23,44.903882557757356
STOM,ILMN_1696419,"Homo sapiens stomatin (STOM), transcript variant 1, mRNA.",membrane [goid 16020] [evidence IEA]; cytoskeleton [goid 5856] [pmid 7592848] [evidence TAS]; integral to plasma membrane [goid 5887] [pmid 7592848] [evidence TAS]; membrane [goid 16020] [evidence IEA]; cytoskeleton [goid 5856] [pmid 7592848] [evidence TAS]; integral to plasma membrane [goid 5887] [pmid 7592848] [evidence TAS],,,9,123150194-123150243,9q33.2a,-,NM_004099.4,2040,STOM,-1.6674858313512395,10.84048264703426,-12.940290391393365,1.927692858644036e-24,4.69513691883488e-23,44.877301045863625
PLA2G1B,ILMN_1721549,"Homo sapiens phospholipase A2, group IB (pancreas) (PLA2G1B), mRNA.",,signal transduction [goid 7165] [pmid 9886417] [evidence TAS]; phospholipid metabolism [goid 6644] [evidence IEA]; lipid catabolism [goid 16042] [evidence IEA]; actin filament organization [goid 7015] [pmid 9886417] [evidence TAS],calcium ion binding [goid 5509] [evidence IEA]; hydrolase activity [goid 16787] [evidence IEA]; phospholipase A2 activity [goid 4623] [pmid 9886417] [evidence TAS],12,119244480-119244503:119247120-119247145,12q24.31a,-,NM_000928.2,5319,PLA2G1B,-3.380747070010445,9.10721531773968,-12.932254512430248,2.013254565904086e-24,4.897411387845333e-23,44.83401095334918
C22orf18,ILMN_1668814,"Homo sapiens centromere protein M (CENPM), transcript variant 1, mRNA.","chromosome [goid 5694] [evidence IEA]; nucleus [goid 5634] [evidence IEA]; chromosome, pericentric region [goid 775] [evidence IEA]",,,22,40669560-40669609,22q13.2b,-,NM_024053.3,79019,C22orf18,1.5808515530564389,6.156034729306631,12.931211363712778,2.0246371518409678e-24,4.9189594642919276e-23,44.828391058803795
MGC35295,ILMN_1721088,"Homo sapiens hypothetical protein MGC35295 (MGC35295), mRNA.",integral to membrane [goid 16021] [evidence IEA],signal transduction [goid 7165] [evidence IEA],receptor activity [goid 4872] [evidence IEA],11,60300600-60300649,11q12.2a,+,NM_152717.1,219995,MGC35295,-2.752419411645591,7.421087137833787,-12.92538618968319,2.0893965580362136e-24,5.063668150912391e-23,44.79700685688092
SETD1A,ILMN_1714327,"Homo sapiens SET domain containing 1A (SETD1A), mRNA.",nucleus [goid 5634] [evidence IEA],chromatin modification [goid 16568] [evidence IEA],transferase activity [goid 16740] [evidence IEA]; histone-lysine N-methyltransferase activity [goid 18024] [evidence IEA]; RNA binding [goid 3723] [evidence IEA]; nucleotide binding [goid 166] [evidence IEA]; methyltransferase activity [goid 8168] [evidence IEA]; protein binding [goid 5515] [pmid 12670868] [evidence IPI],16,30903280-30903329,16p11.2c,+,NM_014712.1,9739,SETD1A,1.0418770899229344,9.054563088556561,12.924888351137312,2.0950265133835245e-24,5.071005169351301e-23,44.79432454466824
VEGFC,ILMN_1701204,"Homo sapiens vascular endothelial growth factor C (VEGFC), mRNA.",membrane [goid 16020] [evidence IEA],cell proliferation [goid 8283] [evidence IEA]; signal transduction [goid 7165] [pmid 8617204] [evidence TAS]; angiogenesis [goid 1525] [evidence IEA]; positive regulation of cell proliferation [goid 8284] [pmid 8617204] [evidence TAS]; substrate-bound cell migration [goid 6929] [pmid 8617204] [evidence TAS]; cell differentiation [goid 30154] [evidence IEA],growth factor activity [goid 8083] [evidence IEA],4,177842138-177842187,4q34.3a,-,NM_005429.2,7424,VEGFC,-1.774519200332378,7.090066314324968,-12.918805690807925,2.1650547690605433e-24,5.2340064733430134e-23,44.76155022198234
C1orf172,ILMN_1676322,"Homo sapiens chromosome 1 open reading frame 172 (C1orf172), mRNA.",,,,1,27148981-27149030,1p36.11a,-,NM_152365.1,126695,C1orf172,1.2151505952544692,6.7592159041238915,12.915581900413812,2.2031161452362734e-24,5.31941983766156e-23,44.744178843030966
GSN,ILMN_1787518,"Homo sapiens gelsolin (amyloidosis, Finnish type) (GSN), transcript variant 1, mRNA.",actin cytoskeleton [goid 15629] [pmid 1321812] [evidence TAS]; cytosol [goid 5829] [pmid 3020431] [evidence IDA]; extracellular region [goid 5576] [pmid 14718574] [evidence NAS],actin filament polymerization [goid 30041] [pmid 3020431] [evidence IDA]; actin filament severing [goid 51014] [pmid 3020431] [evidence IDA]; barbed-end actin filament capping [goid 51016] [pmid 1321812] [evidence TAS],actin binding [goid 3779] [evidence IEA]; calcium ion binding [goid 5509] [pmid 1321812] [evidence TAS]; protein binding [goid 5515] [pmid 10793131] [evidence IPI],9,123101929-123101960:123101961-123101978,9q33.2a,+,NM_000177.3,2934,GSN,-1.451050099110609,8.37044452000822,-12.911869597001596,2.247776894130357e-24,5.42053623541213e-23,44.72417417702782
PDE2A,ILMN_1681356,"Homo sapiens phosphodiesterase 2A, cGMP-stimulated (PDE2A), mRNA.",membrane [goid 16020] [evidence IEA],signal transduction [goid 7165] [evidence IEA],"hydrolase activity [goid 16787] [evidence IEA]; 3',5'-cyclic-nucleotide phosphodiesterase activity [goid 4114] [evidence IEA]; cGMP-stimulated cyclic-nucleotide phosphodiesterase activity [goid 4118] [pmid 9210593] [evidence TAS]; catalytic activity [goid 3824] [evidence IEA]",11,71965053-71965102,11q13.4a,-,NM_002599.1,5138,PDE2A,-1.552585720169402,6.494882362576324,-12.909444312151399,2.2774432821963665e-24,5.485288300815352e-23,44.711104388075356
C20orf94,ILMN_1715625,"Homo sapiens chromosome 20 open reading frame 94 (C20orf94), mRNA.",,,,20,10551897-10551946,20p12.2b-p12.2a,+,NM_001009608.1,128710,C20orf94,1.8482414440729809,7.145827824539958,12.907289398545027,2.3041316456185847e-24,5.542716680849152e-23,44.6994912633897
TNRC9,ILMN_1732808,"PREDICTED: Homo sapiens trinucleotide repeat containing 9, transcript variant 2 (TNRC9), mRNA.",,,,16,51029619-51029668,16q12.1d,-,XM_931515.1,27324,TNRC9,1.4072602491256436,5.633370284201081,12.903967632621937,2.3458868567942603e-24,5.636202885898416e-23,44.681589151620535
BTG2,ILMN_1770085,"Homo sapiens BTG family, member 2 (BTG2), mRNA.",,"regulation of transcription, DNA-dependent [goid 6355] [evidence IEA]; DNA repair [goid 6281] [pmid 8944033] [evidence TAS]; transcription [goid 6350] [evidence IEA]; negative regulation of cell proliferation [goid 8285] [pmid 8944033] [evidence TAS]",transcription factor activity [goid 3700] [evidence NR ],1,201544859-201544908,1q32.1e,+,NM_006763.2,7832,BTG2,-2.090970999868528,10.343024237819254,-12.898269483588425,2.419288203206783e-24,5.798257151228066e-23,44.65087805104143
KIF4A,ILMN_1799667,"Homo sapiens kinesin family member 4A (KIF4A), mRNA.",spindle microtubule [goid 5876] [pmid 7929562] [evidence TAS]; microtubule associated complex [goid 5875] [evidence IEA]; cytoplasm [goid 5737] [pmid 7929562] [evidence TAS]; nucleus [goid 5634] [evidence IEA],organelle organization and biogenesis [goid 6996] [pmid 7929562] [evidence TAS]; microtubule-based movement [goid 7018] [evidence IEA]; anterograde axon cargo transport [goid 8089] [pmid 7929562] [evidence TAS],nucleotide binding [goid 166] [evidence IEA]; microtubule motor activity [goid 3777] [pmid 7929562] [evidence TAS]; DNA binding [goid 3677] [evidence IEA]; ATP binding [goid 5524] [evidence IEA],X,69556993-69557042,Xq13.1b-q13.1c,+,NM_012310.2,24137,KIF4A,1.4657229521409603,5.604372897174162,12.895016486666233,2.46221999482488e-24,5.893901302108451e-23,44.633344441671106
TSTA3,ILMN_1697777,"Homo sapiens tissue specific transplantation antigen P35B (TSTA3), mRNA.",cytoplasm [goid 5737] [pmid 11698403] [evidence IC ],leukocyte adhesion [goid 7159] [pmid 11698403] [evidence NAS]; 'de novo' GDP-L-fucose biosynthesis [goid 42351] [pmid 11698403] [evidence TAS]; nucleotide-sugar metabolism [goid 9225] [pmid 9525924] [evidence TAS]; protein amino acid glycosylation [goid 6486] [evidence NR ],isomerase activity [goid 16853] [evidence IEA]; electron carrier activity [goid 9055] [pmid 8910301] [evidence TAS]; GDP-L-fucose synthase activity [goid 50577] [evidence IEA]; GDP-4-dehydro-D-rhamnose reductase activity [goid 42356] [pmid 11698403] [evidence TAS],8,144766164-144766213,8q24.3g,-,NM_003313.2,7264,TSTA3,1.4429426284858868,8.627824303999835,12.89062086411612,2.5214476356779986e-24,6.0282708197774e-23,44.609650881007475
MAN1C1,ILMN_1713807,"Homo sapiens mannosidase, alpha, class 1C, member 1 (MAN1C1), mRNA.",membrane [goid 16020] [evidence IEA]; integral to Golgi membrane [goid 30173] [pmid 10915796] [evidence TAS]; integral to membrane [goid 16021] [evidence IEA],metabolism [goid 8152] [evidence IEA],"calcium ion binding [goid 5509] [pmid 10915796] [evidence TAS]; hydrolase activity, acting on glycosyl bonds [goid 16798] [evidence IEA]; mannosyl-oligosaccharide 1,2-alpha-mannosidase activity [goid 4571] [pmid 10915796] [evidence TAS]",1,25983100-25983149,1p36.11b,+,NM_020379.1,57134,MAN1C1,-1.4292624248896022,7.918127782339012,-12.880974696544351,2.656477374603166e-24,6.335552220825299e-23,44.55765061934391
CDH1,ILMN_1770940,"Homo sapiens cadherin 1, type 1, E-cadherin (epithelial) (CDH1), mRNA.",membrane [goid 16020] [evidence IEA]; integral to membrane [goid 16021] [pmid 8033105] [evidence NAS],homophilic cell adhesion [goid 7156] [pmid 8033105] [evidence NAS]; cell adhesion [goid 7155] [evidence IEA],calcium ion binding [goid 5509] [evidence IEA]; protein binding [goid 5515] [evidence IEA],16,67426402-67426451,16q22.1d,+,NM_004360.2,999,CDH1,1.357197173311464,11.723202904818187,12.879909605385054,2.671824380749557e-24,6.364364065880822e-23,44.55190854828502
MARCKSL1,ILMN_1714433,"Homo sapiens MARCKS-like 1 (MARCKSL1), mRNA.",plasma membrane [goid 5886] [pmid 11256614] [evidence IDA],,calmodulin binding [goid 5516] [evidence IEA],1,32572371-32572420,1p35.1b,-,NM_023009.4,65108,MARCKSL1,1.5118640862285684,11.117139010433252,12.877507009009003,2.7067708388331486e-24,6.43973501766348e-23,44.53895548049185
SPAG4,ILMN_1684620,"Homo sapiens sperm associated antigen 4 (SPAG4), mRNA.",membrane [goid 16020] [evidence IEA]; integral to membrane [goid 16021] [evidence IEA]; cytoskeleton [goid 5856] [evidence IEA],spermatogenesis [goid 7283] [pmid 9691178] [evidence TAS],structural molecule activity [goid 5198] [pmid 9691178] [evidence TAS],20,33670934-33670983,20q11.22b,+,NM_003116.1,6676,SPAG4,1.8598475824904002,6.759550018687944,12.863544661367092,2.9191205272555212e-24,6.936471155313882e-23,44.46367237264479
CHST7,ILMN_1732831,"Homo sapiens carbohydrate (N-acetylglucosamine 6-O) sulfotransferase 7 (CHST7), mRNA.",intrinsic to Golgi membrane [goid 31228] [evidence ISS]; integral to membrane [goid 16021] [pmid 10913333] [evidence NAS]; membrane [goid 16020] [evidence IEA],N-acetylglucosamine metabolism [goid 6044] [pmid 10913333] [evidence IDA]; chondroitin sulfate biosynthesis [goid 30206] [pmid 10781596] [evidence IDA]; sulfur metabolism [goid 6790] [pmid 10913333] [evidence IDA]; polysaccharide metabolism [goid 5976] [pmid 10781596] [evidence TAS],N-acetylglucosamine 6-O-sulfotransferase activity [goid 1517] [pmid 10913333] [evidence IDA]; transferase activity [goid 16740] [evidence IEA]; chondroitin 6-sulfotransferase activity [goid 8459] [pmid 10781596] [evidence IDA],X,46342593-46342642,Xp11.3a,+,NM_019886.2,56548,CHST7,-1.1496921785961192,8.980317335804877,-12.85984702289982,2.9781023318940986e-24,7.06800535163904e-23,44.4437328653214
DSCR1,ILMN_1712112,"Homo sapiens Down syndrome critical region gene 1 (DSCR1), transcript variant 3, mRNA.",nucleus [goid 5634] [pmid 8595418] [evidence TAS],signal transduction [goid 7165] [pmid 8595418] [evidence TAS]; circulation [goid 8015] [pmid 8595418] [evidence TAS]; calcium-mediated signaling [goid 19722] [evidence IEA]; central nervous system development [goid 7417] [pmid 8595418] [evidence TAS],transcription factor activity [goid 3700] [pmid 8595418] [evidence TAS]; nucleotide binding [goid 166] [evidence IEA],21,34820937-34820986,21q22.12a,-,NM_203418.1,1827,DSCR1,-1.3651954535404327,7.022975818329912,-12.855918717272758,3.0420730406943874e-24,7.211045401208045e-23,44.42254841689927
KIAA1698,ILMN_1796968,"Homo sapiens integrator complex subunit 5 (INTS5), mRNA.",,,protein binding [goid 5515] [pmid 16239144] [evidence IPI],11,62171080-62171129,11q12.3a,-,NM_030628.1,80789,KIAA1698,1.1225613060531305,8.937138731077562,12.854446540067595,3.0664000940826554e-24,7.259879202089981e-23,44.41460902056654
MCM10,ILMN_2413898,"Homo sapiens minichromosome maintenance complex component 10 (MCM10), transcript variant 2, mRNA.",,,protein binding [goid 5515] [pmid 15232106] [evidence IPI]; protein binding [goid 5515] [pmid 15232106] [evidence IPI],10,13293016-13293065,10p13e,+,NM_018518.3,55388,MCM10,1.0475918437535094,5.549191862789293,12.850811682418193,3.127302984719313e-24,7.386989457590936e-23,44.395005708939756
COX4I2,ILMN_1815634,"Homo sapiens cytochrome c oxidase subunit IV isoform 2 (lung) (COX4I2), nuclear gene encoding mitochondrial protein, mRNA.",membrane [goid 16020] [evidence IEA]; mitochondrion [goid 5739] [evidence IEA]; respiratory chain complex IV (sensu Eukaryota) [goid 5751] [pmid 11311561] [evidence IC ],cellular respiration [goid 45333] [pmid 11911854] [evidence NAS]; electron transport [goid 6118] [pmid 11311561] [evidence NAS],oxidoreductase activity [goid 16491] [evidence IEA]; cytochrome-c oxidase activity [goid 4129] [pmid 11311561] [evidence IDA],20,29694869-29694918,20q11.21b,+,NM_032609.2,84701,COX4I2,-2.0613236728855124,8.077204588241619,-12.844840708041806,3.229991573348062e-24,7.61941716787978e-23,44.36280134338528
ATP10B,ILMN_1698804,"PREDICTED: Homo sapiens ATPase, Class V, type 10B (ATP10B), mRNA.",,,,5,159922890-159922939,5q34a,-,XM_927593.1,23120,ATP10B,2.866283730687961,6.455397348871459,12.844206234702966,3.2410999949603214e-24,7.636376469383539e-23,44.359379171601084
WFDC1,ILMN_1660808,"Homo sapiens WAP four-disulfide core domain 1 (WFDC1), mRNA.",extracellular space [goid 5615] [pmid 10967136] [evidence NAS],negative regulation of cell growth [goid 30308] [pmid 10967136] [evidence NAS],serine-type endopeptidase inhibitor activity [goid 4867] [evidence IEA],16,82920607-82920656,16q24.1a,+,NM_021197.2,58189,WFDC1,-2.1194726651151212,7.49050798462984,-12.836152401428405,3.385481249034145e-24,7.966920547998831e-23,44.31593656624505
FLJ25006,ILMN_2144162,"Homo sapiens hypothetical protein FLJ25006 (FLJ25006), mRNA.",,protein amino acid phosphorylation [goid 6468] [evidence IEA]; protein amino acid phosphorylation [goid 6468] [evidence IEA],ATP binding [goid 5524] [evidence IEA]; transferase activity [goid 16740] [evidence IEA]; protein serine/threonine kinase activity [goid 4674] [evidence IEA]; nucleotide binding [goid 166] [evidence IEA]; ATP binding [goid 5524] [evidence IEA]; transferase activity [goid 16740] [evidence IEA]; protein serine/threonine kinase activity [goid 4674] [evidence IEA]; nucleotide binding [goid 166] [evidence IEA],17,23959389-23959438,17q11.2a,-,NM_144610.1,124923,FLJ25006,1.2721073511909156,5.908782034269163,12.825970652040843,3.577275049450754e-24,8.408106675337508e-23,44.26100935398319
IL6,ILMN_1699651,"Homo sapiens interleukin 6 (interferon, beta 2) (IL6), mRNA.",extracellular region [goid 5576] [pmid 14718574] [evidence NAS]; extracellular space [goid 5615] [pmid 10925276] [evidence TAS],humoral immune response [goid 6959] [pmid 2829354] [evidence TAS]; negative regulation of cell proliferation [goid 8285] [pmid 3023045] [evidence TAS]; cell-cell signaling [goid 7267] [pmid 1883960] [evidence NAS]; acute-phase response [goid 6953] [evidence IEA]; cell surface receptor linked signal transduction [goid 7166] [pmid 10925276] [evidence TAS]; negative regulation of chemokine biosynthesis [goid 45079] [evidence ISS]; neutrophil apoptosis [goid 1781] [evidence ISS]; positive regulation of cell proliferation [goid 8284] [pmid 2829354] [evidence TAS],cytokine activity [goid 5125] [evidence IEA]; interleukin-6 receptor binding [goid 5138] [pmid 1883960] [evidence NAS],7,22737683-22737717:22737718-22737732,7p15.3c,+,NM_000600.1,3569,IL6,-3.5643321557669383,8.298601040516369,-12.822398806795444,3.6471080881342684e-24,8.561915794854966e-23,44.241738682659644
NAALADL1,ILMN_1770963,"Homo sapiens N-acetylated alpha-linked acidic dipeptidase-like 1 (NAALADL1), mRNA.",integral to membrane [goid 16021] [pmid 9388249] [evidence NAS],,metal ion binding [goid 46872] [evidence IEA]; glutamate carboxypeptidase II activity [goid 43275] [evidence IEA]; metallopeptidase activity [goid 8237] [evidence IEA]; carboxypeptidase activity [goid 4180] [evidence IEA]; dipeptidase activity [goid 16805] [evidence IEA],11,64568981-64569030,11q13.1c,-,NM_005468.2,10004,NAALADL1,-1.231926532349095,7.103648002410422,-12.822161274488218,3.6518002471344796e-24,8.562614658894745e-23,44.24045712634379
BUB1,ILMN_2202948,"Homo sapiens BUB1 budding uninhibited by benzimidazoles 1 homolog (yeast) (BUB1), mRNA.",spindle pole body [goid 5816] [pmid 9660858] [evidence TAS]; kinetochore [goid 776] [pmid 9660858] [evidence TAS]; nucleus [goid 5634] [evidence IEA],cell proliferation [goid 8283] [pmid 9790499] [evidence TAS]; mitosis [goid 7067] [evidence IEA]; mitotic spindle checkpoint [goid 7094] [pmid 9790499] [evidence TAS]; cell cycle [goid 7049] [evidence IEA]; protein amino acid phosphorylation [goid 6468] [evidence IEA]; cell division [goid 51301] [evidence IEA],transferase activity [goid 16740] [evidence IEA]; nucleotide binding [goid 166] [evidence IEA]; ATP binding [goid 5524] [evidence IEA]; protein serine/threonine kinase activity [goid 4674] [evidence IEA],2,111112194-111112208:111113791-111113825,2q13b,-,NM_004336.2,699,BUB1,1.652056131848191,6.239619244782531,12.81013360788545,3.8974753831461935e-24,9.127681230841776e-23,44.17555916014218
DOPEY2,ILMN_1741711,"Homo sapiens dopey family member 2 (DOPEY2), mRNA.",cellular component unknown [goid 8372] [evidence ND ],development [goid 7275] [pmid 10950924] [evidence NAS],molecular function unknown [goid 5554] [evidence ND ],21,36587619-36587668,21q22.12b,+,NM_005128.2,9980,DOPEY2,1.402866871149456,8.54168886021736,12.8059030301644,3.987771946122189e-24,9.316754960454539e-23,44.15272971905124
IPO4,ILMN_1798172,"Homo sapiens importin 4 (IPO4), mRNA.",nucleus [goid 5634] [evidence IEA]; nuclear pore [goid 5643] [pmid 11823430] [evidence NAS]; cytoplasm [goid 5737] [evidence IEA],protein transport [goid 15031] [pmid 11823430] [evidence NAS],binding [goid 5488] [evidence IEA]; protein transporter activity [goid 8565] [evidence IEA],14,23719762-23719804:23720559-23720565,14q12a,-,NM_024658.3,79711,IPO4,1.1811924924413253,7.658876249630468,12.798727877166424,4.1457376550369465e-24,9.674215354298791e-23,44.114007622074965
PRX,ILMN_1786648,"Homo sapiens periaxin (PRX), transcript variant 1, mRNA.",membrane [goid 16020] [evidence IEA]; nucleus [goid 5634] [evidence IEA]; membrane [goid 16020] [evidence IEA]; nucleus [goid 5634] [evidence IEA],mechanosensory behavior [goid 7638] [evidence IEA]; mechanosensory behavior [goid 7638] [evidence IEA],protein binding [goid 5515] [evidence IEA]; protein binding [goid 5515] [evidence IEA],19,45591839-45591888,19q13.2b,-,NM_020956.1,57716,PRX,-1.671665986282262,6.233274707944124,-12.784841401673782,4.469498118644857e-24,1.0404799383727008e-22,44.039056382814955
NOSTRIN,ILMN_1670099,"Homo sapiens nitric oxide synthase trafficker (NOSTRIN), transcript variant 1, mRNA.",intracellular [goid 5622] [evidence IEA],signal transduction [goid 7165] [evidence IEA],,2,169426732-169426781,2q24.3f,+,NM_052946.2,115677,NOSTRIN,-1.972688482754462,8.87252828650984,-12.773992112576378,4.739988745044917e-24,1.1008186018736615e-22,43.980488817533235
PLXNA3,ILMN_1719972,"Homo sapiens plexin A3 (PLXNA3), mRNA.",membrane [goid 16020] [pmid 8570614] [evidence TAS]; integral to membrane [goid 16021] [evidence IEA],development [goid 7275] [pmid 8570614] [evidence TAS],transmembrane receptor activity [goid 4888] [pmid 8570614] [evidence NAS]; receptor activity [goid 4872] [evidence IEA],X,153354914-153354963,Xq28g,+,NM_017514.2,55558,PLXNA3,1.3955960856815892,8.393646295858652,12.765633065518543,4.9595362942596775e-24,1.1504352939720217e-22,43.935358739194335
WDR74,ILMN_1789775,"Homo sapiens WD repeat domain 74 (WDR74), mRNA.",nucleus [goid 5634] [evidence IEA]; nucleus [goid 5634] [evidence IEA],,,11,62358339-62358379:62358475-62358483,11q12.3b,-,NM_018093.1,54663,WDR74,1.1732287237002552,8.950641058639711,12.762509393820777,5.044170194446207e-24,1.168676055157959e-22,43.91849295474435
FLJ38159,ILMN_1695972,"Homo sapiens coiled-coil domain containing 89 (CCDC89), mRNA.",,,,11,85073673-85073696:85073697-85073722,11q14.1e,-,NM_152723.1,220388,FLJ38159,-1.6171022020026937,6.748797104039674,-12.756834343128753,5.201654020084235e-24,1.20373193089479e-22,43.88784967435964
CAPN12,ILMN_1787514,"Homo sapiens calpain 12 (CAPN12), mRNA.",intracellular [goid 5622] [evidence IEA],,calpain activity [goid 4198] [evidence IEA]; calcium ion binding [goid 5509] [evidence IEA],19,43913136-43913185,19q13.2a,-,NM_144691.3,147968,CAPN12,2.2391129804735055,7.581833110537472,12.755292895368111,5.2452743552106204e-24,1.2123863678680775e-22,43.87952601570157
LYL1,ILMN_2216582,"Homo sapiens lymphoblastic leukemia derived sequence 1 (LYL1), mRNA.",nucleus [goid 5634] [evidence IEA],"regulation of transcription, DNA-dependent [goid 6355] [evidence IEA]",transcription regulator activity [goid 30528] [evidence IEA]; DNA binding [goid 3677] [pmid 2752424] [evidence TAS],19,,19p13.13b,-,NM_005583.3,4066,LYL1,-1.2789364571841073,10.323582161546053,-12.747995204122633,5.456816449571454e-24,1.2597875417049738e-22,43.84011702485232
NUSAP1,ILMN_1726720,"Homo sapiens nucleolar and spindle associated protein 1 (NUSAP1), transcript variant 1, mRNA.",nucleus [goid 5634] [evidence IEA],positive regulation of mitosis [goid 45840] [pmid 12963707] [evidence IDA]; mitotic chromosome condensation [goid 7076] [pmid 12963707] [evidence IDA]; establishment of mitotic spindle localization [goid 40001] [pmid 12963707] [evidence IDA],,15,39460433-39460482,15q15.1c,+,NM_016359.2,51203,NUSAP1,1.3241412280336409,7.171768073353355,12.747279015035371,5.47803237479406e-24,1.26318888547766e-22,43.83624926410396
EEF1A2,ILMN_2108735,"Homo sapiens eukaryotic translation elongation factor 1 alpha 2 (EEF1A2), mRNA.",nucleus [goid 5634] [evidence IEA]; cytoplasm [goid 5737] [evidence IEA],protein biosynthesis [goid 6412] [evidence IEA]; translational elongation [goid 6414] [evidence IEA],GTP binding [goid 5525] [evidence IEA]; nucleotide binding [goid 166] [evidence IEA]; translation elongation factor activity [goid 3746] [evidence IEA],20,61589812-61589861,20q13.33e,-,NM_001958.2,1917,EEF1A2,4.229603479118328,7.413109314326825,12.732262793243386,5.942409366792371e-24,1.368650667989945e-22,43.75514647729407
CD86,ILMN_1714602,"Homo sapiens CD86 antigen (CD28 antigen ligand 2, B7-2 antigen) (CD86), transcript variant 1, mRNA.",integral to membrane [goid 16021] [pmid 9915850] [evidence IC ]; plasma membrane [goid 5886] [pmid 7513726] [evidence NAS]; integral to membrane [goid 16021] [pmid 9915850] [evidence IC ]; plasma membrane [goid 5886] [pmid 7513726] [evidence NAS],immune response [goid 6955] [pmid 7694363] [evidence TAS]; positive regulation of tumor necrosis factor-beta biosynthesis [goid 43017] [pmid 9915850] [evidence NAS]; cell-cell signaling [goid 7267] [pmid 9915850] [evidence IC ]; positive regulation of transcription [goid 45941] [pmid 9915850] [evidence NAS]; positive regulation of interleukin-4 biosynthesis [goid 45404] [pmid 9915850] [evidence NAS]; positive regulation of cell proliferation [goid 8284] [pmid 7513726] [evidence TAS]; positive regulation of T-helper 2 cell differentiation [goid 45630] [pmid 9915850] [evidence NAS]; positive regulation of interleukin-2 biosynthesis [goid 45086] [pmid 9915850] [evidence NAS]; immune response [goid 6955] [pmid 7694363] [evidence TAS]; positive regulation of tumor necrosis factor-beta biosynthesis [goid 43017] [pmid 9915850] [evidence NAS]; cell-cell signaling [goid 7267] [pmid 9915850] [evidence IC ]; positive regulation of transcription [goid 45941] [pmid 9915850] [evidence NAS]; positive regulation of interleukin-4 biosynthesis [goid 45404] [pmid 9915850] [evidence NAS]; positive regulation of cell proliferation [goid 8284] [pmid 7513726] [evidence TAS]; positive regulation of T-helper 2 cell differentiation [goid 45630] [pmid 9915850] [evidence NAS]; positive regulation of interleukin-2 biosynthesis [goid 45086] [pmid 9915850] [evidence NAS],protein binding [goid 5515] [pmid 9915850] [evidence IPI]; transcriptional activator activity [goid 16563] [pmid 9915850] [evidence NAS]; coreceptor activity [goid 15026] [pmid 9915850] [evidence NAS]; protein binding [goid 5515] [pmid 9915850] [evidence IPI]; transcriptional activator activity [goid 16563] [pmid 9915850] [evidence NAS]; coreceptor activity [goid 15026] [pmid 9915850] [evidence NAS],3,123322566-123322615,3q13.33c,+,NM_175862.2,942,CD86,-1.311540992474999,8.092230083976487,-12.729603066343817,6.028683372169808e-24,1.3868818831963248e-22,43.74077966012334
MTA1,ILMN_1671911,"Homo sapiens metastasis associated 1 (MTA1), mRNA.",nucleus [goid 5634] [evidence IEA],"regulation of transcription, DNA-dependent [goid 6355] [evidence IEA]; signal transduction [goid 7165] [pmid 8083195] [evidence TAS]",metal ion binding [goid 46872] [evidence IEA]; zinc ion binding [goid 8270] [evidence IEA]; transcription factor activity [goid 3700] [evidence IEA],14,105007804-105007853,14q32.33c,+,NM_004689.2,9112,MTA1,1.1291745034984153,9.383982816222135,12.726213324665133,6.1404592467081754e-24,1.4109298162984527e-22,43.72246888850534
ANXA8L1,ILMN_2095610,"Homo sapiens annexin A8 (ANXA8), mRNA. XM_931361 XM_931369 XM_931374 XM_931375 XM_931378 XM_931383 XM_931388 XM_931391 XM_931399 XM_931404 XM_931411",,,calcium-dependent phospholipid binding [goid 5544] [evidence IEA]; calcium ion binding [goid 5509] [evidence IEA],10,47882230-47882279,,+,NM_001040084.1,653145,ANXA8L1,-2.007988715771104,5.848774483440563,-12.719488727173266,6.368387247552652e-24,1.4598591237478049e-22,43.68614152205568
CAD,ILMN_1810992,"Homo sapiens carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase (CAD), mRNA.",cytoplasm [goid 5737] [evidence IEA],'de novo' pyrimidine base biosynthesis [goid 6207] [evidence IEA]; pyrimidine nucleotide biosynthesis [goid 6221] [evidence IEA]; glutamine metabolism [goid 6541] [evidence IEA]; nitrogen compound metabolism [goid 6807] [evidence IEA]; biosynthesis [goid 9058] [evidence IEA]; amino acid metabolism [goid 6520] [evidence IEA]; arginine biosynthesis [goid 6526] [evidence IEA],transferase activity [goid 16740] [evidence IEA]; hydrolase activity [goid 16787] [evidence IEA]; dihydroorotase activity [goid 4151] [evidence IEA]; amino acid binding [goid 16597] [evidence IEA]; aspartate carbamoyltransferase activity [goid 4070] [evidence IEA]; ATP binding [goid 5524] [evidence IEA]; carbamoyl-phosphate synthase (glutamine-hydrolyzing) activity [goid 4088] [pmid 8619816] [evidence TAS]; ligase activity [goid 16874] [evidence IEA]; zinc ion binding [goid 8270] [evidence IEA]; metal ion binding [goid 46872] [evidence IEA],2,27319652-27319664:27319788-27319824,2p23.3a,+,NM_004341.3,790,CAD,1.2762611216494584,7.6085454460860165,12.717842893143379,6.425452243808146e-24,1.4712096001245799e-22,43.677249993153154
MGC15523,ILMN_1759743,"Homo sapiens hypothetical protein MGC15523 (MGC15523), mRNA.",membrane [goid 16020] [evidence IEA]; integral to membrane [goid 16021] [evidence IEA],transport [goid 6810] [evidence IEA]; amino acid transport [goid 6865] [evidence IEA],amino acid-polyamine transporter activity [goid 5279] [evidence IEA],17,76839642-76839691,17q25.3f,-,NM_138570.1,124565,MGC15523,1.010768013900142,8.283647484410547,12.704970627968601,6.889812550534467e-24,1.575680722384555e-22,43.60770196963524
TSEN54,ILMN_1657509,"Homo sapiens tRNA splicing endonuclease 54 homolog (S. cerevisiae) (TSEN54), mRNA.",nucleus [goid 5634] [evidence IEA],mRNA processing [goid 6397] [evidence IEA]; tRNA processing [goid 8033] [evidence IEA],,17,71032138-71032187,17q25.1c,+,NM_207346.1,283989,TSEN54,1.1432584879790975,8.045435371141073,12.700153687160396,7.072104565443971e-24,1.6129399105544526e-22,43.5816734774162
MUC20,ILMN_1653278,"Homo sapiens mucin 20, cell surface associated (MUC20), mRNA.",basal plasma membrane [goid 9925] [pmid 15314156] [evidence IDA],protein homooligomerization [goid 51260] [pmid 15314156] [evidence IDA],"glucan 1,4-alpha-glucosidase activity [goid 4339] [evidence IEA]",3,196945843-196945892,3q29e,+,NM_152673.1,200958,MUC20,2.440736006137035,8.838370410207855,12.70001131499153,7.077565427375196e-24,1.6129399105544526e-22,43.58090414116848
PLEKHG6,ILMN_1744614,"Homo sapiens pleckstrin homology domain containing, family G (with RhoGef domain) member 6 (PLEKHG6), mRNA.",intracellular [goid 5622] [evidence IEA],regulation of Rho protein signal transduction [goid 35023] [evidence IEA],Rho guanyl-nucleotide exchange factor activity [goid 5089] [evidence IEA],12,6307583-6307632,12p13.31d,+,NM_018173.1,55200,PLEKHG6,1.4859895253620925,6.079316301635391,12.695877988376381,7.237960337533779e-24,1.646191239056731e-22,43.558568298052705
MGC24665,ILMN_1790537,"Homo sapiens chromosome 16 open reading frame 75 (C16orf75), mRNA.",,,nucleic acid binding [goid 3676] [evidence IEA],16,11352686-11352735,16p13.13c,+,NM_152308.1,116028,MGC24665,1.3883708490809683,8.322143854535044,12.695816621095451,7.240368960080157e-24,1.646191239056731e-22,43.55823667034149
SALL4,ILMN_1695687,"Homo sapiens sal-like 4 (Drosophila) (SALL4), mRNA.",nucleus [goid 5634] [evidence IEA]; intracellular [goid 5622] [evidence IEA],"transcription [goid 6350] [evidence IEA]; regulation of transcription, DNA-dependent [goid 6355] [evidence IEA]",DNA binding [goid 3677] [evidence IEA]; zinc ion binding [goid 8270] [evidence IEA]; metal ion binding [goid 46872] [evidence IEA]; nucleic acid binding [goid 3676] [evidence IEA],20,49834172-49834210:49834211-49834221,20q13.2a,-,NM_020436.2,57167,SALL4,1.8559205159468926,5.885771958420022,12.694294585162881,7.300365556859852e-24,1.6578977025106553e-22,43.550011534053915
LOC654017,ILMN_1661138,"PREDICTED: Homo sapiens similar to Dingo protein isoform 1 (LOC654017), mRNA.",,,,,,,,XM_937953.1,654017,LOC654017,1.1909735517333928,8.543665116165721,12.677959889446097,7.976493304251355e-24,1.8051332408053155e-22,43.46172850586667
ALDH18A1,ILMN_2302716,"Homo sapiens aldehyde dehydrogenase 18 family, member A1 (ALDH18A1), nuclear gene encoding mitochondrial protein, transcript variant 1, mRNA.",membrane [goid 16020] [evidence IEA]; mitochondrion [goid 5739] [evidence IEA]; cytoplasm [goid 5737] [evidence IEA],proline biosynthesis [goid 6561] [pmid 8761662] [evidence TAS]; amino acid biosynthesis [goid 8652] [evidence IEA],oxidoreductase activity [goid 16491] [evidence IEA]; kinase activity [goid 16301] [evidence IEA]; transferase activity [goid 16740] [evidence IEA]; glutamate 5-kinase activity [goid 4349] [evidence IEA]; glutamate-5-semialdehyde dehydrogenase activity [goid 4350] [evidence IEA]; N-acetyl-gamma-glutamyl-phosphate reductase activity [goid 3942] [evidence NR ],10,97355874-97355923,10q23.33d,-,NM_002860.3,5832,ALDH18A1,1.1577926565162446,9.338511927492391,12.672869206720389,8.199775248192218e-24,1.8535106811023824e-22,43.43421160111971
PA2G4,ILMN_1728984,"Homo sapiens proliferation-associated 2G4, 38kDa (PA2G4), mRNA.",nucleus [goid 5634] [pmid 7556453] [evidence TAS],cell proliferation [goid 8283] [pmid 7556453] [evidence TAS]; cell cycle arrest [goid 7050] [pmid 7556453] [evidence TAS],methionyl aminopeptidase activity [goid 4239] [evidence IEA]; hydrolase activity [goid 16787] [evidence IEA]; cobalt ion binding [goid 50897] [evidence IEA],12,54793008-54793057,12q13.2c,+,NM_006191.1,5036,PA2G4,1.1514744668350847,9.904858255857595,12.66260825386605,8.669052710050069e-24,1.9573174050443289e-22,43.378742366741456
RPL15,ILMN_1762747,"Homo sapiens ribosomal protein L15 (RPL15), mRNA.",ribosome [goid 5840] [evidence IEA]; intracellular [goid 5622] [evidence IEA],protein biosynthesis [goid 6412] [evidence IEA],structural constituent of ribosome [goid 3735] [evidence IEA],3,23936823-23936872,3p24.2b,+,NM_002948.2,6138,RPL15,-1.0122371490751032,12.568698902193573,-12.652804963796223,9.14252690343509e-24,2.0618302860351008e-22,43.32574068670957
TNFAIP8L3,ILMN_1682099,"Homo sapiens tumor necrosis factor, alpha-induced protein 8-like 3 (TNFAIP8L3), mRNA.",,,,15,49136179-49136228,15q21.2b,-,NM_207381.2,388121,TNFAIP8L3,-1.3277330887289098,7.166479282143329,-12.649987806084818,9.283322534803313e-24,2.0911623074062725e-22,43.31050849622832
FAM13A1,ILMN_1752510,"Homo sapiens family with sequence similarity 13, member A1 (FAM13A1), transcript variant 1, mRNA.",intracellular [goid 5622] [evidence IEA],signal transduction [goid 7165] [evidence IEA],,4,89867383-89867432,4q22.1c,-,NM_014883.2,10144,FAM13A1,1.4096592261871805,8.311203716413916,12.642462161903486,9.67018826808318e-24,2.170779013866368e-22,43.26981526360028
LOC200810,ILMN_1782084,"Homo sapiens similar to beta-1,4-mannosyltransferase; beta-1,4 mannosyltransferase (LOC200810), mRNA.",,biosynthesis [goid 9058] [evidence IEA]; biosynthesis [goid 9058] [evidence IEA],"transferase activity, transferring glycosyl groups [goid 16757] [evidence IEA]; transferase activity, transferring glycosyl groups [goid 16757] [evidence IEA]",3,127133270-127133285:127134183-127134216,3q21.2c,-,NM_001015050.1,200810,LOC200810,2.368050580204933,7.563586438262066,12.638814246272043,9.863488486461648e-24,2.2116233965328563e-22,43.250088640865634
GSTM3,ILMN_1736184,"Homo sapiens glutathione S-transferase M3 (brain) (GSTM3), mRNA.",,establishment of blood-nerve barrier [goid 8065] [pmid 2345169] [evidence TAS]; metabolism [goid 8152] [evidence IEA],transferase activity [goid 16740] [evidence IEA]; glutathione transferase activity [goid 4364] [pmid 2345169] [evidence TAS],1,110078131-110078180,1p13.3b,-,NM_000849.3,2947,GSTM3,-2.110305964094378,8.47502266558779,-12.636380705859402,9.994588808948987e-24,2.238443252211161e-22,43.23692844024749
SNRK,ILMN_1794399,"Homo sapiens SNF related kinase (SNRK), mRNA.",nucleus [goid 5634] [evidence ISS]; nucleus [goid 5634] [evidence ISS],protein amino acid phosphorylation [goid 6468] [pmid 12234663] [evidence IDA]; protein amino acid phosphorylation [goid 6468] [pmid 12234663] [evidence IDA],transferase activity [goid 16740] [evidence IEA]; nucleotide binding [goid 166] [evidence IEA]; ATP binding [goid 5524] [pmid 12234663] [evidence IDA]; magnesium ion binding [goid 287] [pmid 12234663] [evidence IDA]; protein serine/threonine kinase activity [goid 4674] [pmid 12234663] [evidence IDA]; transferase activity [goid 16740] [evidence IEA]; nucleotide binding [goid 166] [evidence IEA]; ATP binding [goid 5524] [pmid 12234663] [evidence IDA]; magnesium ion binding [goid 287] [pmid 12234663] [evidence IDA]; protein serine/threonine kinase activity [goid 4674] [pmid 12234663] [evidence IDA],3,43367082-43367131,3p22.1a,+,NM_017719.3,54861,SNRK,-1.0929100354815233,9.615899277487806,-12.635093598073976,1.0064632926693852e-23,2.2515427391117073e-22,43.229967808806464
TFRC,ILMN_1674243,"Homo sapiens transferrin receptor (p90, CD71) (TFRC), mRNA.",extracellular region [goid 5576] [pmid 1871153] [evidence IDA]; cytoplasmic membrane-bound vesicle [goid 16023] [pmid 15229288] [evidence IDA]; integral to plasma membrane [goid 5887] [pmid 6090955] [evidence TAS]; membrane [goid 16020] [pmid 1871153] [evidence NAS]; endosome [goid 5768] [pmid 14612438] [evidence IDA],endocytosis [goid 6897] [evidence IEA]; iron ion transport [goid 6826] [evidence NR ]; iron ion homeostasis [goid 6879] [pmid 1871153] [evidence NAS],transferrin receptor activity [goid 4998] [pmid 1871153] [evidence NAS]; receptor activity [goid 4872] [evidence IEA]; peptidase activity [goid 8233] [evidence IEA],3,197260755-197260804,3q29f,-,NM_003234.1,7037,TFRC,-1.2054022686073154,11.991839788482649,-12.632901022883486,1.0185087224956435e-23,2.2758764286499555e-22,43.21811019365243
SLC5A3,ILMN_1787813,"Homo sapiens solute carrier family 5 (inositol transporters), member 3 (SLC5A3), mRNA.",membrane [goid 16020] [evidence IEA]; integral to plasma membrane [goid 5887] [pmid 1372904] [evidence TAS],ion transport [goid 6811] [evidence IEA]; sodium ion transport [goid 6814] [evidence IEA],symporter activity [goid 15293] [evidence IEA]; transporter activity [goid 5215] [evidence IEA]; myo-inositol:sodium symporter activity [goid 5367] [pmid 1372904] [evidence TAS]; sodium ion binding [goid 31402] [evidence IEA],21,34391192-34391241,21q22.11c,+,NM_006933.2,6526,SLC5A3,1.62656682363348,6.152521543040666,12.626097285352811,1.0568143228410688e-23,2.3587659886091896e-22,43.18131306038764
B3GALNT1,ILMN_2325347,"Homo sapiens beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group) (B3GALNT1), transcript variant 3, mRNA.",membrane [goid 16020] [evidence IEA]; integral to membrane [goid 16021] [evidence IEA],protein amino acid glycosylation [goid 6486] [pmid 9582303] [evidence TAS],"transferase activity, transferring glycosyl groups [goid 16757] [evidence IEA]; magnesium ion binding [goid 287] [evidence IEA]; galactosyltransferase activity [goid 8378] [evidence IEA]; galactosylgalactosylglucosylceramide beta-D-acetylgalactosaminyltransferase activity [goid 47273] [evidence IEA]",3,162284475-162284524,3q26.1a,-,NM_033168.2,8706,B3GALNT1,-1.6572985063444046,8.41147842223164,-12.625878303227317,1.0580709105643356e-23,2.358868614684906e-22,43.18012867379505
PRG4,ILMN_1780349,"Homo sapiens proteoglycan 4 (PRG4), mRNA.",extracellular space [goid 5615] [evidence NR ],cell proliferation [goid 8283] [pmid 10545950] [evidence TAS],,1,184549495-184549533:184549534-184549544,1q31.1a,+,NM_005807.2,10216,PRG4,-3.4386133342882443,8.432359730562606,-12.614027642476845,1.1283551175754112e-23,2.509817290634348e-22,43.11602854732296
BTNL9,ILMN_1772976,"Homo sapiens butyrophilin-like 9 (BTNL9), mRNA.",integral to membrane [goid 16021] [evidence IEA]; membrane [goid 16020] [evidence IEA],,,5,180420676-180420725,5q35.3g,+,NM_152547.2,153579,BTNL9,-2.0243952309179223,6.286636172451616,-12.596236004847404,1.2427590602552706e-23,2.761135722813449e-22,43.01977665407177
ADCK5,ILMN_1761309,"Homo sapiens aarF domain containing kinase 5 (ADCK5), mRNA.",,,kinase activity [goid 16301] [evidence IEA],8,145588894-145588915:145588992-145589019,8q24.3h,+,NM_174922.3,203054,ADCK5,1.1914046030133258,7.089060625636646,12.594406455633221,1.2551636420775744e-23,2.7855197683236375e-22,43.00987772512051
ROBO4,ILMN_1665449,"Homo sapiens roundabout homolog 4, magic roundabout (Drosophila) (ROBO4), mRNA.",integral to membrane [goid 16021] [pmid 14527427] [evidence TAS],angiogenesis [goid 1525] [pmid 15849270] [evidence IGI]; cell differentiation [goid 30154] [evidence IEA]; regulation of cell migration [goid 30334] [pmid 15894287] [evidence NAS],receptor activity [goid 4872] [pmid 14527427] [evidence TAS],11,124259599-124259648,11q24.2a,-,NM_019055.4,54538,ROBO4,-1.6795788723290972,6.676440328611371,-12.586153961868012,1.3126771995894593e-23,2.909842461205986e-22,42.965224247468015
ZNF341,ILMN_2043728,"Homo sapiens zinc finger protein 341 (ZNF341), mRNA.",nucleus [goid 5634] [evidence IEA]; intracellular [goid 5622] [evidence IEA],"transcription [goid 6350] [evidence IEA]; regulation of transcription, DNA-dependent [goid 6355] [evidence IEA]",nutrient reservoir activity [goid 45735] [evidence IEA]; DNA binding [goid 3677] [evidence IEA]; zinc ion binding [goid 8270] [evidence IEA]; metal ion binding [goid 46872] [evidence IEA]; nucleic acid binding [goid 3676] [evidence IEA],20,31843452-31843501,20q11.22a,+,NM_032819.3,84905,ZNF341,1.3123390351408002,7.595527557393319,12.584088776325933,1.3274785443607062e-23,2.9393090269168588e-22,42.95404903756017
SLFN13,ILMN_2215862,"Homo sapiens schlafen family member 13 (SLFN13), mRNA.",intracellular [goid 5622] [pmid 11256614] [evidence IDA],,,17,30786595-30786644,17q12a,-,NM_144682.3,146857,SLFN13,1.7608111186330024,6.838907502132183,12.577203649134562,1.3780439478807233e-23,3.044352190981394e-22,42.91679000824234
LCP1,ILMN_1662932,"Homo sapiens lymphocyte cytosolic protein 1 (L-plastin) (LCP1), mRNA.",cytosol [goid 5829] [pmid 2111166] [evidence IDA]; cytoplasm [goid 5737] [pmid 2378651] [evidence NAS],,calcium ion binding [goid 5509] [pmid 2378651] [evidence NAS]; actin binding [goid 3779] [pmid 2252891] [evidence NAS]; protein binding [goid 5515] [pmid 16115810] [evidence IPI],13,45598252-45598301,13q14.12b,-,NM_002298.2,3936,LCP1,-1.2810790170551947,12.279413836043252,-12.571270625293451,1.423162868942513e-23,3.140467553946191e-22,42.88468088375232
CDCA3,ILMN_1737728,"Homo sapiens cell division cycle associated 3 (CDCA3), mRNA.",,cell division [goid 51301] [evidence IEA],,12,6828529-6828578,12p13.31d,-,NM_031299.3,83461,CDCA3,1.5322797494590414,5.820551955755102,12.558830886972183,1.5226281950999063e-23,3.3523627549742006e-22,42.817350598885824
EPN3,ILMN_1726893,"Homo sapiens epsin 3 (EPN3), mRNA.",,,lipid binding [goid 8289] [evidence IEA],17,45974948-45974997,17q21.33b,+,NM_017957.1,55040,EPN3,1.2904204809664774,5.709490756218341,12.549965113594252,1.5977418115233812e-23,3.509808252258521e-22,42.769358480468206
ESPN,ILMN_1806710,"Homo sapiens espin (ESPN), mRNA.",actin cytoskeleton [goid 15629] [evidence IEA],cell adhesion [goid 7155] [evidence IEA],structural molecule activity [goid 5198] [evidence IEA],1,6443495-6443544,1p36.31a,+,NM_031475.1,83715,ESPN,1.937216195199058,6.227582960546665,12.547218742490212,1.6217549847218447e-23,3.5585468330298587e-22,42.75449084561576
PKMYT1,ILMN_1766658,"Homo sapiens protein kinase, membrane associated tyrosine/threonine 1 (PKMYT1), transcript variant 2, mRNA.",membrane fraction [goid 5624] [pmid 9001210] [evidence TAS]; Golgi apparatus [goid 5794] [pmid 9001210] [evidence TAS]; membrane [goid 16020] [evidence IEA]; endoplasmic reticulum [goid 5783] [pmid 9001210] [evidence TAS],regulation of mitosis [goid 7088] [pmid 9001210] [evidence TAS]; cell cycle [goid 7049] [evidence IEA]; protein amino acid phosphorylation [goid 6468] [evidence IEA],transferase activity [goid 16740] [evidence IEA]; nucleotide binding [goid 166] [evidence IEA]; ATP binding [goid 5524] [evidence IEA]; protein serine/threonine kinase activity [goid 4674] [evidence IEA]; protein binding [goid 5515] [pmid 10373560] [evidence IPI],16,2964384-2964419:2964552-2964565,16p13.3d,-,NM_182687.1,9088,PKMYT1,1.1147337584822132,5.54570258997947,12.544065250309089,1.649774319652753e-23,3.6118935526330214e-22,42.737418652583386
LRRC36,ILMN_1774389,"Homo sapiens leucine rich repeat containing 36 (LRRC36), mRNA.",,,,16,65976304-65976353,16q22.1b,+,NM_018296.4,55282,LRRC36,-2.1453858313045497,6.474720297029527,-12.53968266751835,1.6895218518192498e-23,3.694762433523915e-22,42.71369144276135
MAP3K8,ILMN_1741159,"Homo sapiens mitogen-activated protein kinase kinase kinase 8 (MAP3K8), mRNA.",cytosol [goid 5829] [pmid 8226782] [evidence TAS],protein amino acid phosphorylation [goid 6468] [pmid 2072910] [evidence TAS],ATP binding [goid 5524] [evidence IEA]; transferase activity [goid 16740] [evidence IEA]; protein serine/threonine kinase activity [goid 4674] [pmid 8226782] [evidence TAS]; nucleotide binding [goid 166] [evidence IEA]; protein kinase activity [goid 4672] [evidence IEA],10,30790328-30790377,10p11.23a,+,NM_005204.2,1326,MAP3K8,-1.7175327525429624,8.671374777938707,-12.539413463353524,1.691994435320771e-23,3.6960214767068636e-22,42.71223393786449
MS4A6A,ILMN_1721035,"Homo sapiens membrane-spanning 4-domains, subfamily A, member 6A (MS4A6A), transcript variant 3, mRNA.",membrane [goid 16020] [evidence IEA]; integral to membrane [goid 16021] [evidence IEA]; membrane [goid 16020] [evidence IEA]; integral to membrane [goid 16021] [evidence IEA],signal transduction [goid 7165] [evidence IEA]; signal transduction [goid 7165] [evidence IEA],receptor activity [goid 4872] [evidence IEA]; receptor activity [goid 4872] [evidence IEA],11,59697120-59697169,11q12.1d-q12.2a,-,NM_152851.1,64231,MS4A6A,-1.6436419438394392,10.062089602931385,-12.537835570288673,1.706560149172009e-23,3.7236645584117125e-22,42.70369093682565
OBFC2B,ILMN_1704672,"Homo sapiens oligonucleotide/oligosaccharide-binding fold containing 2B (OBFC2B), mRNA.",,,nucleic acid binding [goid 3676] [evidence IEA],12,54909410-54909459,12q13.2c,+,NM_024068.2,79035,OBFC2B,1.0432501930617057,8.710405049673529,12.529955934272925,1.781200527244132e-23,3.882180343775382e-22,42.66102681707391
PEAR1,ILMN_2407669,"Homo sapiens platelet endothelial aggregation receptor 1 (PEAR1), mRNA.",,,,,,1q23.1a,,NM_001080471.1,375033,PEAR1,-1.3706605945258747,6.362923929618213,-12.527663133637668,1.8035275452241396e-23,3.926450750691884e-22,42.64861176871995
DGCR5,ILMN_2221808,Homo sapiens DiGeorge syndrome critical region gene 5 (non-coding) (DGCR5) on chromosome 22.,,,,22,17361966-17362015,22q11.21b,+,NR_002733.1,26220,DGCR5,1.7489078585050786,6.0160551732953165,12.512767973177535,1.9555646752208202e-23,4.252698403647063e-22,42.56794954184257
GSTA4,ILMN_1771964,"Homo sapiens glutathione S-transferase A4 (GSTA4), mRNA.",,metabolism [goid 8152] [evidence IEA]; response to stress [goid 6950] [evidence NR ],transferase activity [goid 16740] [evidence IEA]; glutathione transferase activity [goid 4364] [pmid 11851347] [evidence IDA],6,52950929-52950978,6p12.1d,-,NM_001512.2,2941,GSTA4,-1.6140228950237177,9.123258306264997,-12.496390575250494,2.1376005194894006e-23,4.643383068255404e-22,42.47924465157543
REEP1,ILMN_1733746,"Homo sapiens receptor accessory protein 1 (REEP1), mRNA.",membrane [goid 16020] [evidence IEA]; mitochondrion [goid 5739] [evidence IEA]; integral to membrane [goid 16021] [evidence IEA],,,2,86294886-86294935,2p11.2f,-,NM_022912.1,65055,REEP1,-1.886400682343897,6.939866467761672,-12.490675769126671,2.205040371689308e-23,4.784544726321399e-22,42.44828766430029
CD37,ILMN_1786176,"Homo sapiens CD37 antigen (CD37), mRNA.",plasma membrane [goid 5886] [pmid 8436422] [evidence TAS]; integral to plasma membrane [goid 5887] [pmid 2466944] [evidence TAS]; integral to membrane [goid 16021] [evidence IEA]; integral to membrane [goid 16021] [evidence IEA]; integral to plasma membrane [goid 5887] [pmid 2466944] [evidence TAS]; plasma membrane [goid 5886] [pmid 8436422] [evidence TAS],,,19,54533817-54533866,19q13.33a,+,NM_001774.1,951,CD37,-1.6948573208244726,8.67355850537297,-12.484178570177196,2.2843072280651896e-23,4.9510262890823375e-22,42.4130900396723
SYNC1,ILMN_1771261,"Homo sapiens syncoilin, intermediate filament 1 (SYNC1), mRNA.",,,structural molecule activity [goid 5198] [evidence IEA],1,32918884-32918933,1p35.1b,-,NM_030786.1,81493,SYNC1,-1.5576420982764256,6.65760999697787,-12.475018303709355,2.4009393460045473e-23,5.1922645013206e-22,42.363461255896844
PKHD1,ILMN_1720034,"Homo sapiens polycystic kidney and hepatic disease 1 (autosomal recessive) (PKHD1), transcript variant 1, mRNA.",membrane [goid 16020] [evidence IEA]; integral to membrane [goid 16021] [evidence IEA],,receptor activity [goid 4872] [evidence IEA],6,51588533-51588582,6p12.2a,-,NM_138694.2,5314,PKHD1,-1.1733388128416085,6.723071876529432,-12.473830061106177,2.4164994860011646e-23,5.214404456578114e-22,42.357023182671156
SAC3D1,ILMN_1776674,"Homo sapiens SAC3 domain containing 1 (SAC3D1), mRNA.",,,,11,64568681-64568730,11q13.1c,+,NM_013299.2,29901,SAC3D1,1.218948079402118,8.927514426696932,12.473827796303441,2.4165292400770012e-23,5.214404456578114e-22,42.35701091155477
F13A1,ILMN_1717163,"Homo sapiens coagulation factor XIII, A1 polypeptide (F13A1), mRNA.",extracellular space [goid 5615] [evidence IEA],blood coagulation [goid 7596] [pmid 10801785] [evidence TAS]; peptide cross-linking [goid 18149] [evidence IEA],protein-glutamine gamma-glutamyltransferase activity [goid 3810] [pmid 2877456] [evidence TAS]; acyltransferase activity [goid 8415] [evidence IEA]; transferase activity [goid 16740] [evidence IEA]; calcium ion binding [goid 5509] [evidence IEA],6,6089880-6089929,6p25.1a,-,NM_000129.2,2162,F13A1,-2.202410965304158,7.812740612671651,-12.470502654748062,2.4606120028384646e-23,5.303653194171182e-22,42.338994348843684
NPLOC4,ILMN_1807600,"Homo sapiens nuclear protein localization 4 homolog (S. cerevisiae) (NPLOC4), mRNA.",nucleus [goid 5634] [evidence IEA]; endoplasmic reticulum [goid 5783] [pmid 11574150] [evidence ISS]; intracellular [goid 5622] [evidence IEA]; nuclear envelope-endoplasmic reticulum network [goid 42175] [pmid 11574150] [evidence ISS],ubiquitin cycle [goid 6512] [evidence IEA]; membrane fusion [goid 6944] [pmid 11574150] [evidence ISS]; Golgi organization and biogenesis [goid 7030] [pmid 11574150] [evidence ISS]; protein folding [goid 6457] [evidence IEA]; ER-associated protein catabolism [goid 30433] [pmid 11574150] [evidence ISS],zinc ion binding [goid 8270] [evidence IEA]; metal ion binding [goid 46872] [evidence IEA]; protein binding [goid 5515] [pmid 11574150] [evidence IPI],17,77134616-77134665,17q25.3f,-,NM_017921.1,55666,NPLOC4,1.036007687612928,9.24384469828138,12.46400313810846,2.5491195707308305e-23,5.482295235727398e-22,42.30377618161329
ACAT1,ILMN_1800008,"Homo sapiens acetyl-Coenzyme A acetyltransferase 1 (acetoacetyl Coenzyme A thiolase) (ACAT1), nuclear gene encoding mitochondrial protein, mRNA.",mitochondrion [goid 5739] [pmid 1715688] [evidence TAS],,acyltransferase activity [goid 8415] [evidence IEA]; transferase activity [goid 16740] [evidence IEA]; acetyl-CoA C-acetyltransferase activity [goid 3985] [pmid 1979337] [evidence TAS],11,107522294-107522296:107523207-107523253,11q22.3c,+,NM_000019.2,38,ACAT1,-1.0936437395749845,10.933992372409884,-12.463097941725971,2.561696685802852e-23,5.503270112774925e-22,42.298871097303916
LRRC8C,ILMN_2094396,"Homo sapiens leucine rich repeat containing 8 family, member C (LRRC8C), mRNA.",membrane [goid 16020] [evidence IEA]; integral to membrane [goid 16021] [evidence IEA],,transferase activity [goid 16740] [evidence IEA],1,89952665-89952714,1p22.2c,+,NM_032270.2,84230,LRRC8C,-1.2411144365262148,5.890095563297536,-12.461283151012934,2.5870996531891154e-23,5.551722108192722e-22,42.28903694776395
MOSC2,ILMN_1665775,"Homo sapiens MOCO sulphurase C-terminal domain containing 2 (MOSC2), mRNA.",mitochondrion [goid 5739] [evidence ISS],transport [goid 6810] [evidence IEA],,1,219021878-219021897:219023884-219023913,1q41d,+,NM_017898.3,54996,MOSC2,-1.6052430970633367,7.654367729839662,-12.456421081310893,2.656408781375781e-23,5.6941831798797685e-22,42.262688950826984
GYLTL1B,ILMN_1697916,"Homo sapiens glycosyltransferase-like 1B (GYLTL1B), mRNA.",integral to Golgi membrane [goid 30173] [evidence ISS],carbohydrate biosynthesis [goid 16051] [evidence IEA]; myelination [goid 42552] [evidence ISS]; synaptic transmission [goid 7268] [evidence ISS]; glycosphingolipid biosynthesis [goid 6688] [evidence ISS]; muscle maintenance [goid 46716] [evidence ISS]; glycoprotein biosynthesis [goid 9101] [evidence ISS],"transferase activity, transferring hexosyl groups [goid 16758] [evidence IEA]",11,45906880-45906929,11p11.2c,+,NM_152312.2,120071,GYLTL1B,1.1584815648072038,5.690478159658068,12.449055416798576,2.7649680415982537e-23,5.920373878081536e-22,42.22277103196837
RGS18,ILMN_2101278,"Homo sapiens regulator of G-protein signalling 18 (RGS18), mRNA.",,negative regulation of signal transduction [goid 9968] [evidence IEA],signal transducer activity [goid 4871] [evidence IEA],1,190421142-190421191,1q31.2a,+,NM_130782.2,64407,RGS18,-1.5071312095921243,6.740799397116545,-12.445653986389159,2.816590078742796e-23,6.023010320024572e-22,42.20433601739596
MS4A4A,ILMN_1741712,"Homo sapiens membrane-spanning 4-domains, subfamily A, member 4 (MS4A4A), transcript variant 2, mRNA.",membrane [goid 16020] [evidence IEA]; integral to membrane [goid 16021] [evidence IEA]; membrane [goid 16020] [evidence IEA]; integral to membrane [goid 16021] [evidence IEA],signal transduction [goid 7165] [evidence IEA]; signal transduction [goid 7165] [evidence IEA],receptor activity [goid 4872] [evidence IEA]; receptor activity [goid 4872] [evidence IEA],11,59832682-59832731,11q12.2a,+,NM_148975.1,51338,MS4A4A,-1.2764754408358598,6.5797136795417375,-12.445491237244399,2.819084122074626e-23,6.023010320024572e-22,42.20345393494719
Ells1,ILMN_1672605,"Homo sapiens hypothetical protein Ells1 (Ells1), mRNA.",,,,7,30168829-30168878,7p15.1b,+,NM_152793.1,222166,Ells1,-1.571375987940426,10.320806642837201,-12.444695686214468,2.831307401516771e-23,6.042499969173526e-22,42.19914211307926
ZHX3,ILMN_1774387,"Homo sapiens zinc fingers and homeoboxes 3 (ZHX3), mRNA.",nucleus [goid 5634] [pmid 12659632] [evidence IDA]; intracellular [goid 5622] [evidence IEA],"negative regulation of transcription, DNA-dependent [goid 45892] [pmid 12659632] [evidence IDA]; regulation of transcription, DNA-dependent [goid 6355] [evidence IEA]",sequence-specific DNA binding [goid 43565] [evidence IEA]; transcription factor activity [goid 3700] [pmid 12659632] [evidence IDA]; zinc ion binding [goid 8270] [evidence IEA]; metal ion binding [goid 46872] [evidence IEA]; nucleic acid binding [goid 3676] [evidence IEA]; protein binding [goid 5515] [pmid 12659632] [evidence IPI],20,39240659-39240708,20q12c,-,NM_015035.3,23051,ZHX3,-1.0903091738548119,7.738214484793481,-12.443570566497359,2.848685081403398e-23,6.072935318506041e-22,42.19304399095472
LYSMD2,ILMN_1724493,"Homo sapiens LysM, putative peptidoglycan-binding, domain containing 2 (LYSMD2), mRNA.",,cell wall catabolism [goid 16998] [evidence IEA],,15,49802846-49802895,15q21.2b,-,NM_153374.1,256586,LYSMD2,-1.087307166252545,9.758056225991158,-12.438055277954522,2.9354283467000695e-23,6.251018725185886e-22,42.16315016158429
KCNJ8,ILMN_1735779,"Homo sapiens potassium inwardly-rectifying channel, subfamily J, member 8 (KCNJ8), mRNA.",integral to membrane [goid 16021] [evidence IEA]; membrane fraction [goid 5624] [evidence NR ]; voltage-gated potassium channel complex [goid 8076] [pmid 7890693] [evidence TAS]; membrane [goid 16020] [evidence IEA],ion transport [goid 6811] [evidence IEA]; potassium ion transport [goid 6813] [pmid 7890693] [evidence TAS],voltage-gated ion channel activity [goid 5244] [evidence IEA]; ATP-activated inward rectifier potassium channel activity [goid 15272] [evidence IEA]; potassium ion binding [goid 30955] [evidence IEA],12,21809316-21809365,12p12.1e,-,NM_004982.2,3764,KCNJ8,-1.4468496218486226,8.920612968941322,-12.434156576867386,2.9983385347088215e-23,6.378015976943384e-22,42.142017422197455
MPP1,ILMN_1733675,"Homo sapiens membrane protein, palmitoylated 1, 55kDa (MPP1), mRNA.",membrane fraction [goid 5624] [pmid 1713685] [evidence TAS]; integral to plasma membrane [goid 5887] [pmid 1713685] [evidence TAS]; membrane [goid 16020] [evidence IEA]; intracellular [goid 5622] [pmid 11256614] [evidence IDA],signal transduction [goid 7165] [pmid 1713685] [evidence TAS],guanylate kinase activity [goid 4385] [pmid 1310897] [evidence TAS]; protein binding [goid 5515] [evidence IEA],X,153660447-153660496,Xq28g,-,NM_002436.2,4354,MPP1,-1.305480868646054,8.645254671447121,-12.432860378566074,3.0195521041521673e-23,6.416136613893672e-22,42.13499123486603
SOX4,ILMN_1815745,"Homo sapiens SRY (sex determining region Y)-box 4 (SOX4), mRNA.",nucleus [goid 5634] [evidence IEA],"regulation of transcription, DNA-dependent [goid 6355] [evidence IEA]; transcription [goid 6350] [evidence IEA]",transcription factor activity [goid 3700] [pmid 8268656] [evidence TAS],6,21706556-21706605,6p22.3b,+,NM_003107.2,6659,SOX4,1.365147027474885,9.641725788255076,12.428009936579356,3.100277576690394e-23,6.573330640023104e-22,42.108697985489975
PPAT,ILMN_1674302,"Homo sapiens phosphoribosyl pyrophosphate amidotransferase (PPAT), mRNA.",,purine nucleotide biosynthesis [goid 6164] [pmid 8106516] [evidence TAS]; metabolism [goid 8152] [evidence IEA]; purine base biosynthesis [goid 9113] [evidence IEA]; nucleoside metabolism [goid 9116] [evidence IEA]; glutamine metabolism [goid 6541] [evidence IEA],"transferase activity, transferring glycosyl groups [goid 16757] [evidence IEA]; 4 iron, 4 sulfur cluster binding [goid 51539] [evidence IEA]; iron ion binding [goid 5506] [evidence IEA]; amidophosphoribosyltransferase activity [goid 4044] [pmid 8106516] [evidence TAS]; magnesium ion binding [goid 287] [evidence IEA]",4,56954676-56954725,4q12e,-,NM_002703.3,5471,PPAT,1.2647275384609244,7.355008980151453,12.427108923899684,3.1155095309376344e-23,6.598446001121718e-22,42.10381362670268
SFTPC,ILMN_2206949,"Homo sapiens surfactant, pulmonary-associated protein C (SFTPC), mRNA.",extracellular space [goid 5615] [evidence NR ]; extracellular region [goid 5576] [evidence IEA],regulation of liquid surface tension [goid 50828] [evidence IEA]; respiratory gaseous exchange [goid 7585] [evidence IEA],,8,22077751-22077800,8p21.3a,+,NM_003018.2,6440,SFTPC,-3.595569616534874,13.139233007221907,-12.425324606392874,3.145895751444525e-23,6.655567721704296e-22,42.09414076040462
ICAM2,ILMN_1786823,"Homo sapiens intercellular adhesion molecule 2 (ICAM2), mRNA.",integral to plasma membrane [goid 5887] [pmid 2497351] [evidence TAS]; plasma membrane [goid 5886] [pmid 2497351] [evidence TAS],cell-cell adhesion [goid 16337] [evidence IEA],protein binding [goid 5515] [evidence IEA]; integrin binding [goid 5178] [pmid 2497351] [evidence TAS],17,59433952-59434001,17q23.3b,-,NM_000873.2,3384,ICAM2,-1.3530868382829944,10.728892138791181,-12.42277556111422,3.189820901402421e-23,6.738691748226208e-22,42.080321942143165
IKBKE,ILMN_1755024,"Homo sapiens inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase epsilon (IKBKE), mRNA.",cytoplasm [goid 5737] [evidence NAS],immune response [goid 6955] [pmid 10421793] [evidence NAS]; positive regulation of I-kappaB kinase/NF-kappaB cascade [goid 43123] [pmid 12761501] [evidence IEP]; protein amino acid phosphorylation [goid 6468] [pmid 10882136] [evidence IDA],nucleotide binding [goid 166] [evidence IEA]; signal transducer activity [goid 4871] [pmid 12761501] [evidence IEP]; transferase activity [goid 16740] [evidence IEA]; protein serine/threonine kinase activity [goid 4674] [evidence IEA]; NF-kappaB-inducing kinase activity [goid 4704] [pmid 10882136] [evidence IDA]; ATP binding [goid 5524] [evidence NAS],1,204736599-204736648,1q32.1h,+,NM_014002.2,9641,IKBKE,1.5247103686922507,7.28449317802572,12.422644096600294,3.1921028912562436e-23,6.738691748226208e-22,42.07960923966946
HOXA2,ILMN_1799836,"Homo sapiens homeobox A2 (HOXA2), mRNA.",nucleus [goid 5634] [evidence IEA]; nucleus [goid 5634] [evidence IEA],"regulation of transcription, DNA-dependent [goid 6355] [evidence IEA]; development [goid 7275] [evidence IEA]; regulation of transcription, DNA-dependent [goid 6355] [evidence IEA]; development [goid 7275] [evidence IEA]",sequence-specific DNA binding [goid 43565] [evidence IEA]; transcription factor activity [goid 3700] [evidence IEA]; sequence-specific DNA binding [goid 43565] [evidence IEA]; transcription factor activity [goid 3700] [evidence IEA],7,27106946-27106995,7p15.2a,-,NM_006735.3,3199,HOXA2,-1.2768130005870733,6.136093133981308,-12.417313072135846,3.286031374759e-23,6.921980685100444e-22,42.05070754111362
DENND2A,ILMN_1666503,"Homo sapiens DENN/MADD domain containing 2A (DENND2A), mRNA.",,,,7,139864739-139864788,7q34c,-,NM_015689.2,27147,DENND2A,-1.5468247502013437,9.073856382321813,-12.409711725361609,3.424771567483634e-23,7.185175517194829e-22,42.009494575761224
ZNF408,ILMN_1739618,"Homo sapiens zinc finger protein 408 (ZNF408), mRNA.",nucleus [goid 5634] [evidence IEA]; intracellular [goid 5622] [evidence IEA],"regulation of transcription, DNA-dependent [goid 6355] [evidence IEA]; transcription [goid 6350] [evidence IEA]",zinc ion binding [goid 8270] [evidence IEA]; metal ion binding [goid 46872] [evidence IEA]; DNA binding [goid 3677] [evidence IEA],11,46683788-46683837,11p11.2b,+,NM_024741.1,79797,ZNF408,1.0382414257746309,6.943922020382531,12.409660483425736,3.425726484718499e-23,7.185175517194829e-22,42.009216740777084
AVPI1,ILMN_1671731,"Homo sapiens arginine vasopressin-induced 1 (AVPI1), mRNA.",,,,10,99427209-99427258,10q24.2a,-,NM_021732.1,60370,AVPI1,-1.2228534966306235,11.298213045405216,-12.407490607969327,3.466408935212081e-23,7.262685817484667e-22,41.99745148296153
FGF11,ILMN_1719938,"Homo sapiens fibroblast growth factor 11 (FGF11), mRNA.",extracellular space [goid 5615] [evidence NR ],cell-cell signaling [goid 7267] [pmid 8790420] [evidence TAS]; signal transduction [goid 7165] [pmid 8790420] [evidence TAS],growth factor activity [goid 8083] [pmid 8790420] [evidence TAS],17,7288858-7288907,17p13.1d,+,NM_004112.2,2256,FGF11,1.683170008915809,5.9195374568208345,12.406653121344435,3.482239938924389e-23,7.288017745428756e-22,41.992910481816075
STAC,ILMN_1774127,"Homo sapiens SH3 and cysteine rich domain (STAC), mRNA.",soluble fraction [goid 5625] [pmid 8954993] [evidence TAS],intracellular signaling cascade [goid 7242] [evidence IEA],zinc ion binding [goid 8270] [evidence IEA]; metal ion binding [goid 46872] [evidence IEA]; diacylglycerol binding [goid 19992] [evidence IEA],3,36564237-36564286,3p22.3a-p22.2b,+,NM_003149.1,6769,STAC,-1.3548388634325903,6.4372055694702786,-12.404173090663681,3.529546159589658e-23,7.379099454893185e-22,41.979463073258266
SFTPA2,ILMN_2205012,"Homo sapiens surfactant, pulmonary-associated protein A2 (SFTPA2), mRNA.",cytoplasm [goid 5737] [evidence IEA],regulation of liquid surface tension [goid 50828] [evidence IEA]; respiratory gaseous exchange [goid 7585] [evidence IEA]; phosphate transport [goid 6817] [evidence IEA],calcium ion binding [goid 5509] [evidence IEA]; sugar binding [goid 5529] [evidence IEA],10,81306454-81306503,10q22.3f,-,NM_006926.1,6436,SFTPA2,-3.9850353967389154,10.89431708934773,-12.398662670059256,3.6369746251721894e-23,7.582971444108495e-22,41.94958276394039
CDC42EP2,ILMN_1652777,"Homo sapiens CDC42 effector protein (Rho GTPase binding) 2 (CDC42EP2), mRNA.",cytoskeleton [goid 5856] [evidence IEA]; membrane [goid 16020] [pmid 11035016] [evidence IDA]; cytoplasm [goid 5737] [pmid 11035016] [evidence IDA],regulation of cell shape [goid 8360] [pmid 11035016] [evidence IDA]; positive regulation of actin filament polymerization [goid 30838] [pmid 11035016] [evidence IDA]; positive regulation of pseudopodium formation [goid 31274] [pmid 11035016] [evidence IDA]; actin filament organization [goid 7015] [pmid 11035016] [evidence NAS]; positive regulation of protein complex assembly [goid 31334] [pmid 11584266] [evidence TAS],GTP-Rho binding [goid 17049] [pmid 11035016] [evidence IPI]; protein binding [goid 5515] [pmid 11584266] [evidence IPI],11,64846266-64846315,11q13.1c,+,NM_006779.2,10435,CDC42EP2,-1.5506625837847885,7.490376204821822,-12.398573656504198,3.638736618035126e-23,7.582971444108495e-22,41.94910007245576
TMEM54,ILMN_2059689,"Homo sapiens transmembrane protein 54 (TMEM54), mRNA.",membrane [goid 16020] [evidence IEA]; integral to membrane [goid 16021] [evidence IEA],glycolysis [goid 6096] [evidence IEA],pyruvate kinase activity [goid 4743] [evidence IEA],1,33132955-33132992:33132993-33133004,1p35.1b,-,NM_033504.2,113452,TMEM54,1.4217531669383252,9.954649865402486,12.392961279018449,3.7515764674222176e-23,7.805872341820564e-22,41.91866504277232
GIMAP1,ILMN_1757186,"Homo sapiens GTPase, IMAP family member 1 (GIMAP1), mRNA.",membrane [goid 16020] [evidence IEA]; integral to membrane [goid 16021] [evidence IEA]; endoplasmic reticulum [goid 5783] [evidence IEA],,GTP binding [goid 5525] [evidence IEA],7,150048984-150049033,7q36.1c,+,NM_130759.2,170575,GIMAP1,-1.7489825786301303,6.70949706718227,-12.392856838388779,3.7537092041497913e-23,7.805872341820564e-22,41.91809866040432
GALNT6,ILMN_1677574,"Homo sapiens UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 6 (GalNAc-T6) (GALNT6), mRNA.",integral to membrane [goid 16021] [evidence IEA]; Golgi stack [goid 5795] [evidence IEA]; membrane [goid 16020] [evidence IEA],,"manganese ion binding [goid 30145] [evidence IEA]; transferase activity, transferring glycosyl groups [goid 16757] [evidence IEA]; polypeptide N-acetylgalactosaminyltransferase activity [goid 4653] [pmid 10464263] [evidence TAS]; sugar binding [goid 5529] [evidence IEA]; calcium ion binding [goid 5509] [evidence IEA]",12,50033971-50034020,12q13.13c,-,NM_007210.2,11226,GALNT6,1.8130868712073847,7.3270414666407,12.384866698737875,3.920526640305957e-23,8.1440790603796985e-22,41.87476618250694
S100A3,ILMN_1712545,"Homo sapiens S100 calcium binding protein A3 (S100A3), mRNA.",,,zinc ion binding [goid 8270] [evidence IEA]; calcium ion binding [goid 5509] [evidence IEA],1,151786449-151786498,1q21.3c,-,NM_002960.1,6274,S100A3,-2.7778670420947993,8.196695001176511,-12.376291550690565,4.107832055154364e-23,8.524079616047155e-22,41.828256929034396
KIAA1893,ILMN_1653263,"Homo sapiens G protein-regulated inducer of neurite outgrowth 1 (KIAA1893), mRNA.",,,,5,175955597-175955646,5q35.2d,-,NM_052899.1,114787,KIAA1893,1.1032720271348087,5.445649997748075,12.372808427988975,4.1864505396129033e-23,8.67797752812313e-22,41.809364208262856
LASS6,ILMN_1767662,"Homo sapiens LAG1 homolog, ceramide synthase 6 (LASS6), mRNA.",nucleus [goid 5634] [evidence IEA]; integral to membrane [goid 16021] [evidence IEA],"regulation of transcription, DNA-dependent [goid 6355] [evidence IEA]",sequence-specific DNA binding [goid 43565] [evidence IEA]; transcription factor activity [goid 3700] [evidence IEA],2,169339205-169339254,2q24.3f,+,NM_203463.1,253782,LASS6,1.127116338422379,10.598948377127845,12.361817797119002,4.444545285863751e-23,9.203184367168457e-22,41.74974560254041
ECT2,ILMN_1717173,"Homo sapiens epithelial cell transforming sequence 2 oncogene (ECT2), mRNA.",intracellular [goid 5622] [evidence IEA],positive regulation of I-kappaB kinase/NF-kappaB cascade [goid 43123] [pmid 12761501] [evidence IMP]; regulation of Rho protein signal transduction [goid 35023] [evidence IEA]; intracellular signaling cascade [goid 7242] [evidence IEA],Rho guanyl-nucleotide exchange factor activity [goid 5089] [evidence IEA]; signal transducer activity [goid 4871] [pmid 12761501] [evidence IMP]; GTPase activator activity [goid 5096] [evidence IEA]; protein binding [goid 5515] [pmid 16129829] [evidence IPI],3,174021849-174021898,3q26.31b,+,NM_018098.4,1894,ECT2,1.670057206040723,7.991607035624968,12.360456819460566,4.477595407118711e-23,9.261777760903193e-22,41.742362504020065
ARFGAP1,ILMN_1675709,"Homo sapiens ADP-ribosylation factor GTPase activating protein 1 (ARFGAP1), transcript variant 2, mRNA.",,regulation of GTPase activity [goid 43087] [evidence IEA]; protein transport [goid 15031] [evidence IEA]; regulation of GTPase activity [goid 43087] [evidence IEA]; protein transport [goid 15031] [evidence IEA],zinc ion binding [goid 8270] [evidence IEA]; metal ion binding [goid 46872] [evidence IEA]; GTPase activator activity [goid 5096] [evidence IEA]; zinc ion binding [goid 8270] [evidence IEA]; metal ion binding [goid 46872] [evidence IEA]; GTPase activator activity [goid 5096] [evidence IEA],20,61391358-61391407,20q13.33d,+,NM_175609.1,55738,ARFGAP1,1.4830268032283245,8.419696005998459,12.324535127396238,5.444844421006326e-23,1.1214883038404678e-21,41.54745450353695
ADM2,ILMN_1702933,"Homo sapiens adrenomedullin 2 (ADM2), mRNA.",,,hormone activity [goid 5179] [evidence IEA],22,49271611-49271660,22q13.33b,+,NM_024866.3,79924,ADM2,1.0470376790326972,7.860880500999561,12.318333078607594,5.631891237805047e-23,1.15878987084088e-21,41.513795320114454
RBP1,ILMN_1656837,"Homo sapiens retinol binding protein 1, cellular (RBP1), mRNA.",,transport [goid 6810] [evidence IEA]; vitamin A metabolism [goid 6776] [pmid 3472205] [evidence TAS],retinal binding [goid 16918] [evidence IEA]; retinol binding [goid 19841] [evidence IEA]; lipid binding [goid 8289] [evidence IEA],3,140719991-140720040,3q23a,-,NM_002899.2,5947,RBP1,-1.2443855583012216,9.559893964689545,-12.30983458026441,5.898697165956692e-23,1.212406268762301e-21,41.46766955125602
LOC652888,ILMN_1703060,"PREDICTED: Homo sapiens similar to synaptotagmin XV isoform b (LOC652888), mRNA.",,,,,,,,XM_942613.1,652888,LOC652888,-1.2353733494986958,5.516633324297738,-12.307882360664017,5.961753644228989e-23,1.2240755506617688e-21,41.45707326945228
KIF26B,ILMN_2055330,"Homo sapiens kinesin family member 26B (KIF26B), mRNA.",microtubule [goid 5874] [evidence IEA]; microtubule associated complex [goid 5875] [evidence IEA],microtubule-based movement [goid 7018] [evidence IEA],nucleotide binding [goid 166] [evidence IEA]; microtubule motor activity [goid 3777] [evidence IEA]; ATP binding [goid 5524] [evidence IEA],,,1q44b-q44c,,NM_018012.2,55083,KIF26B,1.3928837888013303,5.56267902120545,12.301585023133683,6.169797078156978e-23,1.265457853346197e-21,41.42289105285292
CST1,ILMN_1753449,"Homo sapiens cystatin SN (CST1), mRNA.",,,cysteine protease inhibitor activity [goid 4869] [pmid 3446578] [evidence TAS],20,23676424-23676452:23676453-23676473,20p11.21b,-,NM_001898.2,1469,CST1,3.9705950016783786,7.008657355398896,12.300437277406711,6.208491255274833e-23,1.2720552272242915e-21,41.41666080206786
SPINK1,ILMN_1787266,"Homo sapiens serine peptidase inhibitor, Kazal type 1 (SPINK1), mRNA.",,,serine-type endopeptidase inhibitor activity [goid 4867] [evidence IEA]; protein binding [goid 5515] [pmid 14507909] [evidence IPI],5,147189361-147189386:147191279-147191302,5q32e,-,NM_003122.2,6690,SPINK1,4.531810925122083,8.017067115041682,12.2967041313763,6.336037160383883e-23,1.29682441250084e-21,41.39639584543506
FLJ22662,ILMN_1707286,"Homo sapiens hypothetical protein FLJ22662 (FLJ22662), mRNA.",,,,12,14548081-14548130,12p13.1a,-,NM_024829.4,79887,FLJ22662,-1.816769153291915,10.289977415859116,-12.290248456559095,6.562827382293738e-23,1.3418330697166158e-21,41.36135012761566
GAPDH,ILMN_1343295,"Homo sapiens glyceraldehyde-3-phosphate dehydrogenase (GAPDH), mRNA.",cytoplasm [goid 5737] [evidence NAS]; cytoplasm [goid 5737] [evidence NAS]; cytoplasm [goid 5737] [evidence NAS],glucose metabolism [goid 6006] [evidence IEA]; glycolysis [goid 6096] [evidence NAS]; glucose metabolism [goid 6006] [evidence IEA]; glycolysis [goid 6096] [evidence NAS]; glucose metabolism [goid 6006] [evidence IEA]; glycolysis [goid 6096] [evidence NAS],glyceraldehyde-3-phosphate dehydrogenase (phosphorylating) activity [goid 4365] [pmid 3170585] [evidence NAS]; oxidoreductase activity [goid 16491] [evidence IEA]; NAD binding [goid 51287] [evidence IEA]; glyceraldehyde-3-phosphate dehydrogenase (phosphorylating) activity [goid 4365] [pmid 3170585] [evidence NAS]; oxidoreductase activity [goid 16491] [evidence IEA]; NAD binding [goid 51287] [evidence IEA]; glyceraldehyde-3-phosphate dehydrogenase (phosphorylating) activity [goid 4365] [pmid 3170585] [evidence NAS]; oxidoreductase activity [goid 16491] [evidence IEA]; NAD binding [goid 51287] [evidence IEA],12,6517340-6517389,12p13.31d,+,NM_002046.2,2597,GAPDH,1.013374007361664,12.604532394956845,12.285831777437064,6.722655623085814e-23,1.373070700375546e-21,41.337372112690716
OSCAR,ILMN_1741917,"Homo sapiens osteoclast-associated receptor (OSCAR), transcript variant 3, mRNA.",,,receptor activity [goid 4872] [evidence IEA],19,59290134-59290183,19q13.42a,-,NM_130771.2,126014,OSCAR,-1.6174576149617739,8.698738360901777,-12.276896097289677,7.058041920216253e-23,1.4400622703184678e-21,41.28885729144819
TPSAB1,ILMN_1676256,"Homo sapiens tryptase alpha/beta 1 (TPSAB1), mRNA.",,defense response [goid 6952] [pmid 2677049] [evidence TAS]; defense response [goid 6952] [pmid 2677049] [evidence TAS],tryptase activity [goid 30019] [pmid 2187193] [evidence NAS]; serine-type endopeptidase activity [goid 4252] [evidence IEA]; peptidase activity [goid 8233] [evidence IEA]; tryptase activity [goid 30019] [pmid 2187193] [evidence NAS]; serine-type endopeptidase activity [goid 4252] [evidence IEA]; peptidase activity [goid 8233] [evidence IEA],16,1232163-1232212,16p13.3e,+,NM_003294.3,7177,TPSAB1,-2.147808183792309,10.706067781251303,-12.266880384259526,7.45393391827687e-23,1.519245840979339e-21,41.23447339797396
GLIPR1,ILMN_1769245,"Homo sapiens GLI pathogenesis-related 1 (glioma) (GLIPR1), mRNA.",membrane [goid 16020] [evidence IEA]; integral to membrane [goid 16021] [evidence IEA]; extracellular region [goid 5576] [evidence IEA],,,12,74175624-74175673,12q21.2a,+,NM_006851.1,11010,GLIPR1,-1.8440894328935764,8.015768754009512,-12.26173871700952,7.665735313240133e-23,1.5607821586048485e-21,41.20655274878781
PGC,ILMN_1795484,"Homo sapiens progastricsin (pepsinogen C) (PGC), mRNA.",extracellular space [goid 5615] [pmid 3335549] [evidence TAS],digestion [goid 7586] [pmid 3335549] [evidence TAS],peptidase activity [goid 8233] [evidence IEA]; pepsin A activity [goid 4194] [evidence IEA],6,41812566-41812567:41812568-41812615,6p21.1f,-,NM_002630.1,5225,PGC,-3.9444083454450745,11.487455854546516,-12.254116363874973,7.990870885338435e-23,1.6252830814281774e-21,41.1651586550722
IDH2,ILMN_1751753,"Homo sapiens isocitrate dehydrogenase 2 (NADP+), mitochondrial (IDH2), mRNA.",mitochondrion [goid 5739] [pmid 8707889] [evidence IDA],tricarboxylic acid cycle [goid 6099] [evidence IEA]; metabolism [goid 8152] [pmid 8707889] [evidence NAS]; carbohydrate metabolism [goid 5975] [pmid 8954790] [evidence NAS]; main pathways of carbohydrate metabolism [goid 6092] [evidence IEA]; glyoxylate cycle [goid 6097] [evidence IEA],oxidoreductase activity [goid 16491] [evidence IEA]; isocitrate dehydrogenase (NADP+) activity [goid 4450] [pmid 8707889] [evidence NAS],15,88428515-88428564,15q26.1b,-,NM_002168.2,3418,IDH2,1.1534367962727057,10.363645812782607,12.252807108209513,8.048092430119762e-23,1.635214608976888e-21,41.15804826947646
ABHD6,ILMN_1706344,"Homo sapiens abhydrolase domain containing 6 (ABHD6), mRNA.",,aromatic compound metabolism [goid 6725] [evidence IEA],hydrolase activity [goid 16787] [evidence IEA],3,58255167-58255216,3p14.3a,+,NM_020676.4,57406,ABHD6,-1.082461788465542,7.65853765369522,-12.251365780210364,8.111561126848648e-23,1.6463934224650615e-21,41.1502205100442
ALDH1A1,ILMN_1709348,"Homo sapiens aldehyde dehydrogenase 1 family, member A1 (ALDH1A1), mRNA.",cytoplasm [goid 5737] [pmid 2987944] [evidence TAS],metabolism [goid 8152] [evidence IEA]; aldehyde metabolism [goid 6081] [pmid 1709013] [evidence TAS],oxidoreductase activity [goid 16491] [evidence IEA]; Ras GTPase activator activity [goid 5099] [pmid 1709013] [evidence TAS]; retinal dehydrogenase activity [goid 1758] [evidence IEA]; aldehyde dehydrogenase (NAD) activity [goid 4029] [pmid 1709013] [evidence TAS]; androgen binding [goid 5497] [pmid 1709013] [evidence TAS],9,74710736-74710768:74714338-74714354,9q21.13a,-,NM_000689.3,216,ALDH1A1,-2.1331888991346073,9.815318737631783,-12.250771470684446,8.137877271022357e-23,1.6500160106750326e-21,41.14699282059178
LYZ,ILMN_1815205,"Homo sapiens lysozyme (renal amyloidosis) (LYZ), mRNA.",extracellular region [goid 5576] [evidence IEA]; extracellular region [goid 5576] [evidence IEA],metabolism [goid 8152] [evidence IEA]; cell wall catabolism [goid 16998] [evidence IEA]; cytolysis [goid 19835] [evidence IEA]; metabolism [goid 8152] [evidence IEA]; cell wall catabolism [goid 16998] [evidence IEA]; cytolysis [goid 19835] [evidence IEA],"hydrolase activity, acting on glycosyl bonds [goid 16798] [evidence IEA]; lysozyme activity [goid 3796] [evidence IEA]; hydrolase activity, acting on glycosyl bonds [goid 16798] [evidence IEA]; lysozyme activity [goid 3796] [evidence IEA]",12,68032310-68032345:68033200-68033213,12q15c,+,NM_000239.1,4069,LYZ,-2.639461293473957,9.682060722903902,-12.244151333806128,8.436865912832339e-23,1.708860003238442e-21,41.111037629190434
MYL9,ILMN_1675062,"Homo sapiens myosin, light chain 9, regulatory (MYL9), transcript variant 1, mRNA.",myosin [goid 16459] [evidence IEA]; muscle myosin [goid 5859] [pmid 2526655] [evidence TAS]; myosin [goid 16459] [evidence IEA]; muscle myosin [goid 5859] [pmid 2526655] [evidence TAS],regulation of muscle contraction [goid 6937] [pmid 2526655] [evidence TAS]; regulation of muscle contraction [goid 6937] [pmid 2526655] [evidence TAS],structural constituent of muscle [goid 8307] [pmid 2526655] [evidence TAS]; motor activity [goid 3774] [evidence IEA]; calcium ion binding [goid 5509] [evidence IEA]; structural constituent of muscle [goid 8307] [pmid 2526655] [evidence TAS]; motor activity [goid 3774] [evidence IEA]; calcium ion binding [goid 5509] [evidence IEA],20,34611451-34611500,20q11.23a,+,NM_006097.3,10398,MYL9,-1.4938695559753548,8.659236216580828,-12.243854310168404,8.450535566480198e-23,1.7098513552737968e-21,41.10942438329545
KCTD13,ILMN_1786843,"Homo sapiens potassium channel tetramerisation domain containing 13 (KCTD13), mRNA.",nucleus [goid 5634] [evidence IEA]; voltage-gated potassium channel complex [goid 8076] [evidence IEA]; membrane [goid 16020] [evidence IEA],potassium ion transport [goid 6813] [evidence IEA]; protein homooligomerization [goid 51260] [pmid 15726626] [evidence ISS]; DNA replication [goid 6260] [pmid 15726626] [evidence ISS]; actin cytoskeleton organization and biogenesis [goid 30036] [pmid 15726626] [evidence ISS]; regulation of transcription [goid 45449] [pmid 15726626] [evidence ISS]; protein heterooligomerization [goid 51291] [pmid 15726626] [evidence ISS]; DNA repair [goid 6281] [pmid 15726626] [evidence ISS],protein binding [goid 5515] [pmid 15726626] [evidence ISS]; voltage-gated potassium channel activity [goid 5249] [evidence IEA],16,29825334-29825383,16p11.2d,-,NM_178863.2,253980,KCTD13,1.3807856261767437,8.004540024017142,12.230781293238831,9.07468663071782e-23,1.834235155596854e-21,41.03841526741092
NCF1C,ILMN_2112988,Homo sapiens neutrophil cytosolic factor 1C pseudogene (NCF1C) on chromosome 7.,,,,,,,,NR_003187.1,654817,NCF1C,-1.681208645693446,8.044640318762672,-12.227364358571924,9.2453029993535406e-23,1.8652643293182066e-21,41.01985388716701
E2F2,ILMN_1777233,"Homo sapiens E2F transcription factor 2 (E2F2), mRNA.",transcription factor complex [goid 5667] [evidence IEA]; nucleus [goid 5634] [evidence IEA],"transcription [goid 6350] [evidence IEA]; transcription initiation from RNA polymerase II promoter [goid 6367] [pmid 8246996] [evidence TAS]; regulation of transcription, DNA-dependent [goid 6355] [evidence IEA]; cell cycle [goid 7049] [evidence IEA]",RNA polymerase II transcription factor activity [goid 3702] [pmid 8246996] [evidence TAS]; transcription factor activity [goid 3700] [pmid 8246995] [evidence NAS]; protein binding [goid 5515] [pmid 8246996] [evidence TAS],1,23705554-23705603,1p36.12a,-,NM_004091.2,1870,E2F2,1.7574290979454483,7.463639342680709,12.227323829944602,9.247345866673788e-23,1.8652643293182066e-21,41.019633724910996
C20orf20,ILMN_1790136,"Homo sapiens chromosome 20 open reading frame 20 (C20orf20), mRNA.",nucleus [goid 5634] [evidence IEA],"regulation of transcription, DNA-dependent [goid 6355] [evidence IEA]; regulation of cell growth [goid 1558] [evidence IEA]; transcription [goid 6350] [evidence IEA]; chromatin modification [goid 16568] [evidence IEA]",,20,60902321-60902370,20q13.33d,+,NM_018270.3,55257,C20orf20,1.0564287004889827,10.283890753365815,12.226991376441683,9.264120444547585e-23,1.8667154794416724e-21,41.017827745974024
C3orf10,ILMN_1764500,"Homo sapiens chromosome 3 open reading frame 10 (C3orf10), mRNA.",,,,3,10143726-10143775,3p25.3b,+,NM_018462.4,55845,C3orf10,-1.0851380706408094,10.381110680995157,-12.217274243268589,9.768118744283403e-23,1.9621834405398158e-21,40.9650390039825
TRIM46,ILMN_1770865,"Homo sapiens tripartite motif-containing 46 (TRIM46), mRNA.",intracellular [goid 5622] [evidence IEA],,zinc ion binding [goid 8270] [evidence IEA]; metal ion binding [goid 46872] [evidence IEA]; protein binding [goid 5515] [evidence IEA],1,153423851-153423900,1q22a,+,NM_025058.3,80128,TRIM46,1.3279085473376746,5.737316450038055,12.213852854782978,9.952040138273015e-23,1.9970700524639515e-21,40.94645097092603
KDELR2,ILMN_1724293,"Homo sapiens KDEL (Lys-Asp-Glu-Leu) endoplasmic reticulum protein retention receptor 2 (KDELR2), mRNA.",endoplasmic reticulum [goid 5783] [pmid 1316805] [evidence TAS]; membrane [goid 16020] [evidence IEA]; Golgi apparatus [goid 5794] [pmid 1316805] [evidence TAS]; integral to membrane [goid 16021] [pmid 1325562] [evidence TAS],protein transport [goid 15031] [evidence IEA]; protein retention in ER [goid 6621] [evidence IEA]; intracellular protein transport [goid 6886] [pmid 1325562] [evidence TAS],receptor activity [goid 4872] [evidence IEA]; ER retention sequence binding [goid 46923] [evidence IEA]; KDEL sequence binding [goid 5046] [pmid 1316805] [evidence TAS],7,6469227-6469276,7p22.1b,-,NM_006854.2,11014,KDELR2,1.2269540970463755,10.4442274420513,12.212645238145857,1.0017782321221998e-22,2.0081943264301505e-21,40.93988997252512
FOLR3,ILMN_1730454,"Homo sapiens folate receptor 3 (gamma) (FOLR3), mRNA.",membrane fraction [goid 5624] [pmid 8110752] [evidence TAS]; extrinsic to membrane [goid 19898] [pmid 8110752] [evidence TAS],folic acid transport [goid 15884] [pmid 8110752] [evidence TAS],folic acid binding [goid 5542] [pmid 8110752] [evidence TAS]; receptor activity [goid 4872] [evidence IEA],11,71528496-71528523:71528524-71528545,11q13.4a,+,NM_000804.2,2352,FOLR3,-3.4402966281278946,7.041366681966223,-12.20793466042788,1.027840996834762e-22,2.058322900650086e-21,40.91429659985847
SKIV2L,ILMN_1666512,"Homo sapiens superkiller viralicidic activity 2-like (S. cerevisiae) (SKIV2L), mRNA.",,regulation of translation [goid 6445] [pmid 7610041] [evidence TAS],ATP-dependent helicase activity [goid 8026] [evidence IEA]; hydrolase activity [goid 16787] [evidence IEA]; RNA binding [goid 3723] [evidence IEA]; nucleotide binding [goid 166] [evidence IEA]; ATP binding [goid 5524] [evidence IEA]; nucleic acid binding [goid 3676] [evidence IEA]; ATP-dependent RNA helicase activity [goid 4004] [pmid 7610041] [evidence TAS]; protein binding [goid 5515] [pmid 15231747] [evidence IPI],6,32045380-32045429,6p21.32b,+,NM_006929.4,6499,SKIV2L,1.0482867721297637,9.912829533953033,12.204488105532754,1.0473395372250204e-22,2.095216723083113e-21,40.89557013727478
MGC14376,ILMN_2390310,"Homo sapiens hypothetical protein MGC14376 (MGC14376), transcript variant 2, mRNA.",,,,17,1561813-1561862,17p13.3d,-,NM_001001870.1,84981,MGC14376,-1.7191286490251194,8.677406708251604,-12.179260024766371,1.2018138804579153e-22,2.3944113968018895e-21,40.75847728461798
SPSB1,ILMN_1714170,"Homo sapiens splA/ryanodine receptor domain and SOCS box containing 1 (SPSB1), mRNA.",,intracellular signaling cascade [goid 7242] [evidence IEA],,1,9351943-9351992,1p36.22d,+,NM_025106.2,80176,SPSB1,1.4173283645798662,9.117388865871161,12.174592038562926,1.2328052161690869e-22,2.453647562518351e-21,40.73310717487967
CLEC7A,ILMN_1700610,"Homo sapiens C-type lectin domain family 7, member A (CLEC7A), transcript variant 8, mRNA.",integral to membrane [goid 16021] [pmid 11567029] [evidence TAS],"reduction of virulence [goid 46803] [pmid 11567029] [evidence NAS]; antibacterial humoral response (sensu Vertebrata) [goid 19733] [pmid 11567029] [evidence NAS]; carbohydrate mediated signaling [goid 9756] [pmid 11567029] [evidence TAS]; antifungal humoral response (sensu Vertebrata) [goid 19734] [pmid 11567029] [evidence NAS]; cell recognition [goid 8037] [pmid 11567029] [evidence IDA]; phagocytosis, recognition [goid 6910] [pmid 11567029] [evidence IDA]",sugar binding [goid 5529] [pmid 11567029] [evidence IDA]; MHC protein binding [goid 42287] [pmid 11567029] [evidence NAS]; pattern recognition receptor activity [goid 8329] [pmid 11567029] [evidence IDA],12,10174011-10174060,12p13.2c,-,NM_197953.1,64581,CLEC7A,-1.1056156247692899,5.819473184913837,-12.171788871742484,1.251799252444357e-22,2.488909023865132e-21,40.7178716591342
JAZF1,ILMN_1682727,"Homo sapiens juxtaposed with another zinc finger gene 1 (JAZF1), mRNA.",nucleus [goid 5634] [evidence IEA],"regulation of transcription, DNA-dependent [goid 6355] [evidence IEA]; transcription [goid 6350] [evidence IEA]",metal ion binding [goid 46872] [evidence IEA]; nucleic acid binding [goid 3676] [evidence IEA]; zinc ion binding [goid 8270] [evidence IEA],7,27837063-27837112,7p15.2a-p15.1d,-,NM_175061.2,221895,JAZF1,-1.3156183956090564,7.4991676087679515,-12.165758056041827,1.2936634171546937e-22,2.5669075033868848e-21,40.68509214806536
ABCA3,ILMN_1758523,"Homo sapiens ATP-binding cassette, sub-family A (ABC1), member 3 (ABCA3), mRNA.",membrane fraction [goid 5624] [pmid 9027511] [evidence TAS]; integral to membrane [goid 16021] [pmid 9027511] [evidence TAS]; lamellar body [goid 42599] [pmid 11718719] [evidence IDA]; plasma membrane [goid 5886] [pmid 11718719] [evidence IDA],transport [goid 6810] [pmid 15531465] [evidence IDA]; response to drug [goid 42493] [pmid 8706931] [evidence TAS],"nucleotide binding [goid 166] [evidence IEA]; ATPase activity, coupled to transmembrane movement of substances [goid 42626] [pmid 9027511] [evidence TAS]; ATPase activity [goid 16887] [evidence IEA]; transporter activity [goid 5215] [pmid 9027511] [evidence TAS]; ATP binding [goid 5524] [pmid 9027511] [evidence TAS]",16,2265911-2265960,16p13.3d,-,NM_001089.1,21,ABCA3,-1.7715539694743132,11.391224429546437,-12.153521133042226,1.3829689245894144e-22,2.7413173444175726e-21,40.61857461906484
FAM43A,ILMN_1706015,"Homo sapiens family with sequence similarity 43, member A (FAM43A), mRNA.",,,,3,195890991-195891040,3q29d,+,NM_153690.4,131583,FAM43A,-1.5121330569435845,8.921686856588797,-12.15181649193792,1.3958901910423655e-22,2.7641179240305377e-21,40.60930791468119
FLJ10159,ILMN_1666502,"Homo sapiens hypothetical protein FLJ10159 (FLJ10159), mRNA.",,,,6,108087919-108087968,6q21d,+,NM_018013.2,55084,FLJ10159,-1.1976758059043755,6.393921730296168,-12.15103835222806,1.4018286681510037e-22,2.773059045575869e-21,40.60507777229711
ENPP2,ILMN_1780799,"Homo sapiens ectonucleotide pyrophosphatase/phosphodiesterase 2 (autotaxin) (ENPP2), mRNA.",integral to plasma membrane [goid 5887] [pmid 1733949] [evidence TAS]; plasma membrane [goid 5886] [pmid 8579579] [evidence TAS],chemotaxis [goid 6935] [pmid 7982964] [evidence NAS]; G-protein coupled receptor protein signaling pathway [goid 7186] [pmid 1733949] [evidence TAS]; phosphate metabolism [goid 6796] [pmid 8579579] [evidence TAS]; nucleotide metabolism [goid 9117] [evidence IEA]; cell motility [goid 6928] [pmid 1733949] [evidence TAS],nucleic acid binding [goid 3676] [evidence IEA]; transcription factor binding [goid 8134] [pmid 8586446] [evidence TAS]; hydrolase activity [goid 16787] [pmid 7982964] [evidence TAS]; nucleotide diphosphatase activity [goid 4551] [pmid 8579579] [evidence TAS]; endonuclease activity [goid 4519] [evidence IEA]; phosphodiesterase I activity [goid 4528] [pmid 7982964] [evidence TAS],8,120638968-120639017,8q24.12b,-,NM_006209.2,5168,ENPP2,-1.9672470352542923,9.517311564142728,-12.147303814759354,1.4306834234990068e-22,2.827268408405492e-21,40.58477555820809
CLIC3,ILMN_1796423,"Homo sapiens chloride intracellular channel 3 (CLIC3), mRNA.",cytoplasm [goid 5737] [pmid 9880541] [evidence IDA]; membrane [goid 16020] [evidence IEA]; nucleus [goid 5634] [pmid 9880541] [evidence IDA],signal transduction [goid 7165] [pmid 9880541] [evidence TAS]; chloride transport [goid 6821] [pmid 9880541] [evidence IMP]; ion transport [goid 6811] [evidence IEA],protein binding [goid 5515] [pmid 9880541] [evidence IPI]; voltage-gated chloride channel activity [goid 5247] [evidence IEA],9,139008985-139009034,9q34.3e,-,NM_004669.2,9022,CLIC3,-1.9129216125903632,10.816977628528711,-12.130462162812233,1.568383248575143e-22,3.096245957293481e-21,40.493209838360706
HMGB3,ILMN_1733519,"Homo sapiens high-mobility group box 3 (HMGB3), mRNA.",chromosome [goid 5694] [evidence IEA]; nucleus [goid 5634] [evidence IEA]; chromatin [goid 785] [evidence IEA],"regulation of transcription, DNA-dependent [goid 6355] [evidence IEA]; development [goid 7275] [pmid 9598312] [evidence TAS]",DNA bending activity [goid 8301] [pmid 9598312] [evidence TAS]; DNA binding [goid 3677] [evidence IEA],X,149909484-149909533,Xq28c-q28d,+,NM_005342.2,3149,HMGB3,2.576693575706237,8.823888584125879,12.125303061489044,1.6131647796310508e-22,3.181428717723788e-21,40.46515766185068
CASP1,ILMN_2326509,"Homo sapiens caspase 1, apoptosis-related cysteine peptidase (interleukin 1, beta, convertase) (CASP1), transcript variant delta, mRNA.",intracellular [goid 5622] [evidence IEA]; intracellular [goid 5622] [evidence IEA],positive regulation of I-kappaB kinase/NF-kappaB cascade [goid 43123] [pmid 12761501] [evidence IEP]; regulation of apoptosis [goid 42981] [evidence IEA]; signal transduction [goid 7165] [pmid 1373520] [evidence TAS]; positive regulation of I-kappaB kinase/NF-kappaB cascade [goid 43123] [pmid 12761501] [evidence IEP]; regulation of apoptosis [goid 42981] [evidence IEA]; signal transduction [goid 7165] [pmid 1373520] [evidence TAS],cysteine-type peptidase activity [goid 8234] [evidence IEA]; caspase activity [goid 30693] [pmid 10353249] [evidence TAS]; signal transducer activity [goid 4871] [pmid 12761501] [evidence IEP]; caspase activator activity [goid 8656] [pmid 10799503] [evidence TAS]; protein binding [goid 5515] [pmid 12888622] [evidence IPI]; cysteine-type peptidase activity [goid 8234] [evidence IEA]; caspase activity [goid 30693] [pmid 10353249] [evidence TAS]; signal transducer activity [goid 4871] [pmid 12761501] [evidence IEP]; caspase activator activity [goid 8656] [pmid 10799503] [evidence TAS]; protein binding [goid 5515] [pmid 12888622] [evidence IPI],11,104402250-104402293:104402779-104402784,11q22.3b,-,NM_033294.2,834,CASP1,-1.3560720035935319,9.830744477357293,-12.122601256137681,1.637125515265692e-22,3.2254186718859462e-21,40.450466291750644
FGFRL1,ILMN_1795865,"Homo sapiens fibroblast growth factor receptor-like 1 (FGFRL1), transcript variant 2, mRNA.",membrane [goid 16020] [evidence IEA]; integral to membrane [goid 16021] [evidence IEA]; membrane [goid 16020] [evidence IEA]; integral to membrane [goid 16021] [evidence IEA],,receptor activity [goid 4872] [evidence IEA]; receptor activity [goid 4872] [evidence IEA],4,1010460-1010509,4p16.3c,+,NM_001004358.1,53834,FGFRL1,1.212631911876942,7.76618677706703,12.107211466948522,1.7805690024498837e-22,3.5044835366399985e-21,40.3667756408262
SELI,ILMN_1696133,"Homo sapiens selenoprotein I (SELI), mRNA.",integral to membrane [goid 16021] [evidence IEA],phospholipid biosynthesis [goid 8654] [evidence IEA],transferase activity [goid 16740] [evidence IEA],2,26471813-26471862,2p23.3b,+,NM_033505.1,85465,SELI,1.1436019077884145,7.32875457925676,12.08818697728612,1.9754139194979397e-22,3.876227615449885e-21,40.26330306240923
MAPK8IP3,ILMN_1811574,"Homo sapiens mitogen-activated protein kinase 8 interacting protein 3 (MAPK8IP3), transcript variant 2, mRNA.",cytoplasm [goid 5737] [evidence ISS],regulation of JNK cascade [goid 46328] [evidence ISS]; vesicle-mediated transport [goid 16192] [evidence ISS],kinesin binding [goid 19894] [evidence ISS]; MAP-kinase scaffold activity [goid 5078] [evidence ISS]; protein kinase binding [goid 19901] [evidence ISS],16,1760148-1760197,16p13.3e,+,NM_033392.3,23162,MAPK8IP3,1.078025496790107,7.028307877558723,12.083666285592614,2.0247715828524984e-22,3.969081920712367e-21,40.23871279501135
CMTM2,ILMN_1799030,"Homo sapiens CKLF-like MARVEL transmembrane domain containing 2 (CMTM2), mRNA.",membrane [goid 16020] [evidence IEA]; integral to membrane [goid 16021] [evidence IEA]; extracellular space [goid 5615] [evidence IEA],chemotaxis [goid 6935] [evidence IEA],cytokine activity [goid 5125] [evidence IEA],16,65179379-65179428,16q21e,+,NM_144673.2,146225,CMTM2,-2.106369655996299,5.86962605650725,-12.061223333094993,2.288716314947856e-22,4.470127677184804e-21,40.11661984017199
SLC6A4,ILMN_1683694,"Homo sapiens solute carrier family 6 (neurotransmitter transporter, serotonin), member 4 (SLC6A4), mRNA.",membrane [goid 16020] [evidence IEA]; integral to plasma membrane [goid 5887] [pmid 7681602] [evidence TAS],serotonin transport [goid 6837] [pmid 7681602] [evidence TAS]; neurotransmitter uptake [goid 1504] [pmid 7681602] [evidence TAS]; monoamine transport [goid 15844] [pmid 16024787] [evidence IDA],serotonin transporter activity [goid 15222] [pmid 7681602] [evidence TAS]; symporter activity [goid 15293] [evidence IEA]; serotonin:sodium symporter activity [goid 5335] [evidence IEA]; protein binding [goid 5515] [pmid 11343649] [evidence IPI]; monoamine transporter activity [goid 8504] [pmid 16024787] [evidence IDA],17,25549322-25549371,17q11.2c,-,NM_001045.2,6532,SLC6A4,-3.5476276535016122,6.586599351605084,-12.06003076187022,2.3036689255584502e-22,4.493192093544184e-21,40.11013139787679
RHOT2,ILMN_1669310,"Homo sapiens ras homolog gene family, member T2 (RHOT2), mRNA.",integral to membrane [goid 16021] [evidence IEA]; outer membrane [goid 19867] [evidence IEA]; membrane [goid 16020] [evidence IEA]; mitochondrion [goid 5739] [evidence IEA],apoptosis [goid 6915] [pmid 12482879] [evidence IMP]; cell homeostasis [goid 19725] [pmid 12482879] [evidence IMP]; small GTPase mediated signal transduction [goid 7264] [evidence IEA],hydrolase activity [goid 16787] [evidence IEA]; nucleotide binding [goid 166] [evidence IEA]; GTP binding [goid 5525] [evidence IEA]; calcium ion binding [goid 5509] [evidence IEA],16,663941-663990,16p13.3f,+,NM_138769.1,89941,RHOT2,1.1981537375647058,9.593159611972627,12.059788991545693,2.306712182423533e-22,4.4946286874522535e-21,40.10881598569254
ZNF669,ILMN_1770172,"Homo sapiens zinc finger protein 669 (ZNF669), mRNA.",nucleus [goid 5634] [evidence IEA]; intracellular [goid 5622] [evidence IEA]; nucleus [goid 5634] [evidence IEA]; intracellular [goid 5622] [evidence IEA],"transcription [goid 6350] [evidence IEA]; regulation of transcription, DNA-dependent [goid 6355] [evidence IEA]; transcription [goid 6350] [evidence IEA]; regulation of transcription, DNA-dependent [goid 6355] [evidence IEA]",DNA binding [goid 3677] [evidence IEA]; zinc ion binding [goid 8270] [evidence IEA]; metal ion binding [goid 46872] [evidence IEA]; nucleic acid binding [goid 3676] [evidence IEA]; DNA binding [goid 3677] [evidence IEA]; zinc ion binding [goid 8270] [evidence IEA]; metal ion binding [goid 46872] [evidence IEA]; nucleic acid binding [goid 3676] [evidence IEA],1,245330375-245330424,1q44d,-,NM_024804.1,79862,ZNF669,1.4970435631979129,7.733181766422063,12.055163094239752,2.3657220840933606e-22,4.605004476379533e-21,40.08364708997632
CRR9,ILMN_1752802,"Homo sapiens CLPTM1-like (CLPTM1L), mRNA.",integral to membrane [goid 16021] [evidence IEA],,,5,1371249-1371298,5p15.33d,-,NM_030782.2,81037,CRR9,1.1484291916544613,11.626065426372312,12.044906387423566,2.502010914881377e-22,4.8654373928606416e-21,40.02783806033734
UHMK1,ILMN_2096012,"Homo sapiens U2AF homology motif (UHM) kinase 1 (UHMK1), mRNA.",cytoplasm [goid 5737] [evidence ISS]; nucleus [goid 5634] [evidence ISS],cell cycle arrest [goid 7050] [pmid 12093740] [evidence IMP]; regulation of protein export from nucleus [goid 46825] [pmid 12093740] [evidence IDA]; peptidyl-serine phosphorylation [goid 18105] [evidence ISS],protein binding [goid 5515] [pmid 12093740] [evidence IPI]; protein serine/threonine kinase activity [goid 4674] [evidence ISS]; ATP binding [goid 5524] [evidence ISS]; nucleotide binding [goid 166] [evidence IEA]; RNA binding [goid 3723] [evidence ISS]; transferase activity [goid 16740] [pmid 12093740] [evidence IC ],1,160760315-160760364,1q23.3b,+,NM_175866.2,127933,UHMK1,1.6568284092046799,6.587159421647852,12.043797916103859,2.5172031268241607e-22,4.89009999263896e-21,40.021806321025586
ALDH2,ILMN_1793859,"Homo sapiens aldehyde dehydrogenase 2 family (mitochondrial) (ALDH2), nuclear gene encoding mitochondrial protein, mRNA.",mitochondrion [goid 5739] [evidence IEA],metabolism [goid 8152] [evidence IEA]; carbohydrate metabolism [goid 5975] [pmid 8903321] [evidence TAS]; alcohol metabolism [goid 6066] [pmid 1306115] [evidence TAS],electron carrier activity [goid 9055] [pmid 8903321] [evidence TAS]; aldehyde dehydrogenase (NAD) activity [goid 4029] [pmid 1306115] [evidence TAS]; aldehyde dehydrogenase [NAD(P)+] activity [goid 4030] [pmid 8903321] [evidence TAS],12,110731770-110731819,12q24.12b,+,NM_000690.2,217,ALDH2,-1.2484561401968453,11.592837779883034,-12.022007763301398,2.835341981939611e-22,5.492742351684206e-21,39.90322357477169
MXD3,ILMN_1711904,"Homo sapiens MAX dimerization protein 3 (MXD3), mRNA.",nucleus [goid 5634] [evidence IEA],regulation of transcription [goid 45449] [evidence IEA],transcription regulator activity [goid 30528] [evidence IEA],5,176667071-176667120,5q35.3a,-,NM_031300.2,83463,MXD3,1.124418918134829,6.9775153678299136,12.019286099087322,2.877809779175698e-22,5.568433321473533e-21,39.88841062153501
LOC652773,ILMN_1687526,"PREDICTED: Homo sapiens similar to Shwachman-Bodian-Diamond syndrome (predicted) (LOC652773), mRNA.",,,,,,,,XM_942415.1,652773,LOC652773,-1.8857103632764822,6.29267985205386,-12.013287627980917,2.973670850926338e-22,5.748211957371002e-21,39.85576207267839
HKDC1,ILMN_1752502,"Homo sapiens hexokinase domain containing 1 (HKDC1), mRNA.",,glycolysis [goid 6096] [evidence IEA],kinase activity [goid 16301] [evidence IEA]; ATP binding [goid 5524] [evidence IEA]; transferase activity [goid 16740] [evidence IEA]; nucleotide binding [goid 166] [evidence IEA]; hexokinase activity [goid 4396] [evidence IEA],10,70697054-70697103,10q21.3e,+,NM_025130.2,80201,HKDC1,2.050782545964865,7.2817342294980705,12.011526777708758,3.0024134478267068e-22,5.79802041931649e-21,39.84617777881811
FLJ14082,ILMN_1814967,"PREDICTED: Homo sapiens hypothetical protein FLJ14082 (FLJ14082), mRNA.",,,,2,95561545-95561594,2q11.1c,+,XM_496575.2,80092,FLJ14082,1.3122251851170814,5.855840219672814,12.004942128681321,3.1123835385723957e-22,6.0044349751567455e-21,39.8103363151619
UNC5CL,ILMN_1745491,"Homo sapiens unc-5 homolog C (C. elegans)-like (UNC5CL), mRNA.",,signal transduction [goid 7165] [evidence IEA],protein binding [goid 5515] [evidence IEA],6,41102842-41102891,6p21.1h,-,NM_173561.1,222643,UNC5CL,1.4192627455847795,5.527377997785754,11.995117975353372,3.2840022526676143e-22,6.323002360990955e-21,39.75685791488785
MGC13170,ILMN_1759184,"Homo sapiens chromosome 19 open reading frame 48 (C19orf48), mRNA.",,,,19,55992778-55992827,19q13.33c,-,NM_199249.1,84798,MGC13170,1.0650012938963194,9.65232473724729,11.993330775392595,3.3162270833176385e-22,6.37874478957988e-21,39.74712870269794
STARD8,ILMN_1799600,"Homo sapiens START domain containing 8 (STARD8), mRNA.",intracellular [goid 5622] [evidence IEA],signal transduction [goid 7165] [evidence IEA],GTPase activator activity [goid 5096] [evidence IEA],X,67862329-67862378,Xq13.1a,+,NM_014725.2,9754,STARD8,-1.493588978804346,7.921998263997626,-11.991211260303688,3.354854662975179e-22,6.446680779888695e-21,39.735590234210484
ARHGAP15,ILMN_2208413,"Homo sapiens Rho GTPase activating protein 15 (ARHGAP15), mRNA.",intracellular [goid 5622] [evidence IEA],signal transduction [goid 7165] [evidence IEA],GTPase activator activity [goid 5096] [evidence IEA],2,144242060-144242109,2q22.2a,+,NM_018460.2,55843,ARHGAP15,-1.272684151657547,8.61566014377927,-11.990144194027142,3.374471888234886e-22,6.477988644557316e-21,39.72978113416446
BEXL1,ILMN_1804798,"PREDICTED: Homo sapiens brain expressed X-linked-like 1 (BEXL1), mRNA.",,,,,,Xq22.1e,,XM_936467.1,56271,BEXL1,-1.5092402730473538,9.899449072106776,-11.985324774379434,3.4645146287150154e-22,6.644297986270873e-21,39.703543606553445
PUSL1,ILMN_1780315,"Homo sapiens pseudouridylate synthase-like 1 (PUSL1), mRNA.",,tRNA processing [goid 8033] [evidence IEA],pseudouridylate synthase activity [goid 4730] [evidence IEA]; isomerase activity [goid 16853] [evidence IEA],1,1236597-1236622:1236623-1236646,1p36.33a,+,NM_153339.1,126789,PUSL1,1.143156788313732,7.559296535698076,11.972961470252926,3.7066624669089956e-22,7.101702868015908e-21,39.63623140140983
LHX6,ILMN_1683752,"Homo sapiens LIM homeobox 6 (LHX6), transcript variant 1, mRNA.",nucleus [goid 5634] [evidence IEA],"regulation of transcription, DNA-dependent [goid 6355] [evidence IEA]; brain development [goid 7420] [pmid 10393337] [evidence TAS]",transcription factor activity [goid 3700] [pmid 10393337] [evidence TAS]; sequence-specific DNA binding [goid 43565] [evidence IEA]; metal ion binding [goid 46872] [evidence IEA]; zinc ion binding [goid 8270] [evidence IEA],9,124011739-124011788,9q33.2b,-,NM_014368.2,26468,LHX6,-1.1057789846373192,7.31009164965055,-11.97229438744834,3.720199722154369e-22,7.120637680371108e-21,39.63259926215859
CLDN11,ILMN_1754103,"Homo sapiens claudin 11 (oligodendrocyte transmembrane protein) (CLDN11), mRNA.",membrane [goid 16020] [evidence IEA]; integral to membrane [goid 16021] [evidence ISS]; tight junction [goid 5923] [evidence ISS],calcium-independent cell-cell adhesion [goid 16338] [evidence ISS],structural molecule activity [goid 5198] [evidence IEA],3,171634465-171634514,3q26.2c,+,NM_005602.4,5010,CLDN11,-1.8081628659006963,7.655206859781937,-11.966157969672553,3.84707376076173e-22,7.35625438944478e-21,39.599186693566054
PKM2,ILMN_1672650,"Homo sapiens pyruvate kinase, muscle (PKM2), transcript variant 1, mRNA.",cytosol [goid 5829] [pmid 2813362] [evidence NAS]; cytoplasm [goid 5737] [pmid 11256614] [evidence IDA],glycolysis [goid 6096] [evidence NAS],transferase activity [goid 16740] [evidence IEA]; magnesium ion binding [goid 287] [evidence IEA]; pyruvate kinase activity [goid 4743] [pmid 2854097] [evidence TAS]; protein binding [goid 5515] [pmid 15231747] [evidence IPI],15,70281933-70281982,15q23b,-,NM_002654.3,5315,PKM2,1.3553405473229745,9.259736516286514,11.953097815219158,4.131714391476278e-22,7.885059247592094e-21,39.52806902599561
BTG1,ILMN_1775743,"Homo sapiens B-cell translocation gene 1, anti-proliferative (BTG1), mRNA.",nucleus [goid 5634] [pmid 11420681] [evidence IMP]; cytoplasm [goid 5737] [pmid 11420681] [evidence IMP],positive regulation of angiogenesis [goid 45766] [pmid 15033446] [evidence IMP]; negative regulation of cell growth [goid 30308] [pmid 15033446] [evidence NAS]; negative regulation of cell proliferation [goid 8285] [pmid 1373383] [evidence IDA]; regulation of transcription [goid 45449] [pmid 11420681] [evidence NAS]; positive regulation of myoblast differentiation [goid 45663] [pmid 15033446] [evidence NAS]; positive regulation of endothelial cell differentiation [goid 45603] [pmid 15033446] [evidence IMP]; regulation of apoptosis [goid 42981] [pmid 9690562] [evidence IMP]; positive regulation of enzyme activity [goid 43085] [evidence ISS]; cell migration [goid 16477] [pmid 15033446] [evidence NAS],transcription cofactor activity [goid 3712] [pmid 11420681] [evidence NAS]; kinase binding [goid 19900] [pmid 9820826] [evidence NAS],12,91061324-91061373,12q21.33d,-,NM_001731.1,694,BTG1,-1.0636706560660585,12.370466302871293,-11.945039304125926,4.317773654126516e-22,8.22402929136414e-21,39.48418348943489
RPP40,ILMN_1810423,"Homo sapiens ribonuclease P 40kDa subunit (RPP40), mRNA.",nucleolar ribonuclease P complex [goid 5655] [pmid 9630247] [evidence TAS]; nucleus [goid 5634] [pmid 9630247] [evidence TAS],tRNA processing [goid 8033] [evidence IEA],ribonuclease P activity [goid 4526] [pmid 9630247] [evidence TAS]; hydrolase activity [goid 16787] [evidence IEA]; protein binding [goid 5515] [pmid 15096576] [evidence IPI],6,4940314-4940363,6p25.1c,-,NM_006638.2,10799,RPP40,1.1382865570405887,8.910488664996475,11.936065260832539,4.534864948176363e-22,8.620667660021116e-21,39.435308722025326
LMO7,ILMN_1770479,"Homo sapiens LIM domain 7 (LMO7), mRNA.",ubiquitin ligase complex [goid 151] [pmid 10531035] [evidence NAS]; cytoplasm [goid 5737] [pmid 9826547] [evidence TAS]; nucleus [goid 5634] [pmid 9826547] [evidence TAS],protein ubiquitination [goid 16567] [pmid 10531035] [evidence NAS]; smooth muscle contraction [goid 6939] [evidence IEA],metal ion binding [goid 46872] [evidence IEA]; actin binding [goid 3779] [evidence IEA]; protein binding [goid 5515] [evidence IEA]; ubiquitin-protein ligase activity [goid 4842] [pmid 10531035] [evidence NAS]; zinc ion binding [goid 8270] [evidence IEA],13,75331915-75331964,13q22.2a-q22.2b,+,NM_005358.3,4008,LMO7,-1.6408688477125084,8.542571928437708,-11.934698030267311,4.568886037880185e-22,8.668426918022922e-21,39.42786215004934
ZSCAN1,ILMN_1716999,"Homo sapiens zinc finger and SCAN domain containing 1 (ZSCAN1), mRNA.",nucleus [goid 5634] [evidence IEA],"regulation of transcription, DNA-dependent [goid 6355] [evidence IEA]; transcription [goid 6350] [evidence IEA]",metal ion binding [goid 46872] [evidence IEA]; zinc ion binding [goid 8270] [evidence IEA]; transcription factor activity [goid 3700] [evidence IEA],19,63257592-63257641,19q13.43c,+,NM_182572.2,284312,ZSCAN1,-1.2190844373425076,5.555728593662833,-11.928540599839254,4.725298760313951e-22,8.956463652209858e-21,39.394324915217204
NOL3,ILMN_1813925,"Homo sapiens nucleolar protein 3 (apoptosis repressor with CARD domain) (NOL3), mRNA.",nucleus [goid 5634] [evidence IEA]; nucleolus [goid 5730] [pmid 10196175] [evidence TAS]; cytosol [goid 5829] [pmid 10196175] [evidence TAS]; intracellular [goid 5622] [evidence IEA]; nucleus [goid 5634] [evidence IEA]; nucleolus [goid 5730] [pmid 10196175] [evidence TAS]; cytosol [goid 5829] [pmid 10196175] [evidence TAS]; intracellular [goid 5622] [evidence IEA],"RNA splicing [goid 8380] [pmid 10196175] [evidence TAS]; anti-apoptosis [goid 6916] [pmid 9560245] [evidence TAS]; regulation of apoptosis [goid 42981] [evidence IEA]; nuclear mRNA splicing, via spliceosome [goid 398] [evidence IEA]; RNA splicing [goid 8380] [pmid 10196175] [evidence TAS]; anti-apoptosis [goid 6916] [pmid 9560245] [evidence TAS]; regulation of apoptosis [goid 42981] [evidence IEA]; nuclear mRNA splicing, via spliceosome [goid 398] [evidence IEA]",RNA binding [goid 3723] [pmid 10196175] [evidence TAS]; RNA binding [goid 3723] [pmid 10196175] [evidence TAS],16,65766308-65766348:65766451-65766458:65766459-65766459,16q22.1a,+,NM_003946.3,8996,NOL3,1.0415797652002272,8.026338867614914,11.916736651839889,5.040299324798963e-22,9.534974013952211e-21,39.33002859052905
LOC441193,ILMN_1788439,"Homo sapiens similar to zinc finger protein 469 (LOC441193), mRNA.",,,,7,5426395-5426444,7p22.1c,-,NM_001013722.1,441193,LOC441193,1.8694554798075549,6.312559824569245,11.90641402140988,5.332962085838585e-22,1.0059319094149547e-20,39.27379610375484
ZNF366,ILMN_1733535,"Homo sapiens zinc finger protein 366 (ZNF366), mRNA.",nucleus [goid 5634] [evidence IEA]; intracellular [goid 5622] [evidence IEA],"regulation of transcription, DNA-dependent [goid 6355] [evidence IEA]; transcription [goid 6350] [evidence IEA]",zinc ion binding [goid 8270] [evidence IEA]; metal ion binding [goid 46872] [evidence IEA]; DNA binding [goid 3677] [evidence IEA],5,71775161-71775210,5q13.2c,-,NM_152625.1,167465,ZNF366,-1.0892442581193942,6.175213314335168,-11.905824894796162,5.350169041601551e-22,1.0082015839033485e-20,39.2705867011377
PTGES,ILMN_1713829,"Homo sapiens prostaglandin E synthase (PTGES), mRNA.",membrane fraction [goid 5624] [pmid 10377395] [evidence TAS]; membrane [goid 16020] [evidence IEA]; integral to membrane [goid 16021] [evidence IEA],prostaglandin metabolism [goid 6693] [pmid 10377395] [evidence TAS]; antimicrobial humoral response (sensu Vertebrata) [goid 19735] [evidence NR ]; signal transduction [goid 7165] [pmid 10377395] [evidence NAS],prostaglandin-E synthase activity [goid 50220] [evidence IEA]; isomerase activity [goid 16853] [evidence IEA],9,131540755-131540804,9q34.11d,-,NM_004878.3,9536,PTGES,1.7705675147271531,7.556768145038577,11.891928455328953,5.772575385853256e-22,1.0846541117970173e-20,39.19487836692194
DDX27,ILMN_1676759,"Homo sapiens DEAD (Asp-Glu-Ala-Asp) box polypeptide 27 (DDX27), mRNA.",nucleus [goid 5634] [evidence IEA],,ATP binding [goid 5524] [evidence IEA]; ATP-dependent helicase activity [goid 8026] [evidence IEA]; hydrolase activity [goid 16787] [evidence IEA]; nucleic acid binding [goid 3676] [evidence IEA]; nucleotide binding [goid 166] [evidence IEA],20,47289227-47289276,20q13.13c,+,NM_017895.6,55661,DDX27,1.292521909254022,8.682003162255953,11.891382023658702,5.7898510531075015e-22,1.0868520979749485e-20,39.19190121888878
ANGPTL7,ILMN_1813361,"Homo sapiens angiopoietin-like 7 (ANGPTL7), mRNA.",soluble fraction [goid 5625] [evidence NR ]; cytoplasm [goid 5737] [evidence NR ],response to oxidative stress [goid 6979] [pmid 8026862] [evidence TAS],,1,11178290-11178339,1p36.22b,+,NM_021146.2,10218,ANGPTL7,-1.1158205143496405,5.515593344349944,-11.890212940903416,5.826986197733506e-22,1.0927702219714859e-20,39.185531610833536
SLC15A3,ILMN_2085862,"Homo sapiens solute carrier family 15, member 3 (SLC15A3), mRNA.",membrane [goid 16020] [evidence IEA],oligopeptide transport [goid 6857] [evidence IEA],transporter activity [goid 5215] [evidence IEA],11,60461216-60461265,11q12.2a,-,NM_016582.1,51296,SLC15A3,-1.3537386799078437,11.470791550132052,-11.886383102475653,5.950317409305926e-22,1.1137553767562533e-20,39.16466478893759
H2AFX,ILMN_1785756,"Homo sapiens H2A histone family, member X (H2AFX), mRNA.",chromosome [goid 5694] [evidence IEA]; nucleus [goid 5634] [pmid 15604234] [evidence IDA]; nucleosome [goid 786] [evidence NAS]; chromosome [goid 5694] [evidence IEA]; nucleus [goid 5634] [pmid 15604234] [evidence IDA]; nucleosome [goid 786] [evidence NAS],chromosome organization and biogenesis (sensu Eukaryota) [goid 7001] [evidence NAS]; DNA recombination [goid 6310] [evidence IEA]; nucleosome assembly [goid 6334] [pmid 2587254] [evidence NAS]; meiosis [goid 7126] [evidence IEA]; DNA repair [goid 6281] [evidence IEA]; cell cycle [goid 7049] [evidence IEA]; chromosome organization and biogenesis (sensu Eukaryota) [goid 7001] [evidence NAS]; DNA recombination [goid 6310] [evidence IEA]; nucleosome assembly [goid 6334] [pmid 2587254] [evidence NAS]; meiosis [goid 7126] [evidence IEA]; DNA repair [goid 6281] [evidence IEA]; cell cycle [goid 7049] [evidence IEA],DNA binding [goid 3677] [pmid 2587254] [evidence NAS]; protein binding [goid 5515] [pmid 12607005] [evidence IPI]; DNA binding [goid 3677] [pmid 2587254] [evidence NAS]; protein binding [goid 5515] [pmid 12607005] [evidence IPI],11,118470028-118470077,11q23.3e,-,NM_002105.2,3014,H2AFX,1.0011155164440435,7.976230475110061,11.879981356441053,6.162336285694153e-22,1.152333229623326e-20,39.12978358713248
SH3GL2,ILMN_1661491,"Homo sapiens SH3-domain GRB2-like 2 (SH3GL2), mRNA.",cytoplasm [goid 5737] [evidence IEA],central nervous system development [goid 7417] [pmid 9169142] [evidence TAS]; signal transduction [goid 7165] [pmid 9169142] [evidence TAS],acyltransferase activity [goid 8415] [evidence IEA]; transferase activity [goid 16740] [evidence IEA]; lipid binding [goid 8289] [evidence IEA],9,17786995-17787044,9p22.2a,+,NM_003026.1,6456,SH3GL2,-1.937484329542304,6.352728791260615,-11.87423400558497,6.359120359633516e-22,1.187990989525015e-20,39.09846652799518
SPIRE2,ILMN_1703284,"Homo sapiens spire homolog 2 (Drosophila) (SPIRE2), mRNA.",,,zinc ion binding [goid 8270] [evidence IEA],16,88465064-88465113,16q24.3b,+,NM_032451.1,84501,SPIRE2,1.688809867690936,7.682507722936753,11.871843533765132,6.4428098103345695e-22,1.2024726930495125e-20,39.08544054795543
POMT2,ILMN_1678805,"Homo sapiens protein-O-mannosyltransferase 2 (POMT2), mRNA.",integral to membrane [goid 16021] [evidence IEA]; membrane [goid 16020] [evidence IEA]; endoplasmic reticulum [goid 5783] [evidence IEA],,"transferase activity, transferring glycosyl groups [goid 16757] [evidence IEA]; mannosyltransferase activity [goid 30] [evidence IEA]; magnesium ion binding [goid 287] [evidence IEA]; dolichyl-phosphate-mannose-protein mannosyltransferase activity [goid 4169] [evidence IEA]",14,76811245-76811294,14q24.3c,-,NM_013382.3,29954,POMT2,1.2300886626128635,7.578535810179644,11.871134020612553,6.4678612173141725e-22,1.2059930700417862e-20,39.08157427628624
CDK6,ILMN_1802615,"Homo sapiens cyclin-dependent kinase 6 (CDK6), mRNA.",,cell proliferation [goid 8283] [pmid 8114739] [evidence TAS]; cell cycle [goid 7049] [evidence IEA]; cell division [goid 51301] [evidence IEA]; protein amino acid phosphorylation [goid 6468] [evidence IEA]; G1 phase of mitotic cell cycle [goid 80] [pmid 8114739] [evidence TAS],nucleotide binding [goid 166] [evidence IEA]; protein binding [goid 5515] [pmid 15232106] [evidence IPI]; transferase activity [goid 16740] [evidence IEA]; protein serine/threonine kinase activity [goid 4674] [evidence IEA]; ATP binding [goid 5524] [evidence IEA],7,92072593-92072642,7q21.2b,-,NM_001259.5,1021,CDK6,-1.3268386196805224,8.193690005496284,-11.864436492510315,6.709196675229395e-22,1.2486026477253558e-20,39.04507714749002
TARP,ILMN_1723944,"Homo sapiens TCR gamma alternate reading frame protein (TARP), nuclear gene encoding mitochondrial protein, transcript variant 1, mRNA.",,,,7,38271612-38271615:38271616-38271661,7p14.1e,-,NM_001003799.1,445347,TARP,-1.2903877984622376,5.835982370226602,-11.856922864004117,6.990689728454067e-22,1.299747990066102e-20,39.004130603073335
FGD3,ILMN_1772686,"Homo sapiens FYVE, RhoGEF and PH domain containing 3 (FGD3), mRNA.",intracellular [goid 5622] [evidence IEA]; cytoplasm [goid 5737] [evidence ISS]; Golgi apparatus [goid 5794] [evidence ISS]; cytoskeleton [goid 5856] [evidence IEA]; ruffle [goid 1726] [evidence ISS]; lamellipodium [goid 30027] [evidence ISS],cytoskeleton organization and biogenesis [goid 7010] [evidence ISS]; actin cytoskeleton organization and biogenesis [goid 30036] [evidence ISS]; regulation of Rho protein signal transduction [goid 35023] [evidence IEA]; regulation of cell shape [goid 8360] [evidence ISS]; filopodium formation [goid 46847] [evidence ISS]; regulation of Cdc42 GTPase activity [goid 43088] [evidence ISS],metal ion binding [goid 46872] [evidence IEA]; zinc ion binding [goid 8270] [evidence IEA]; Rho guanyl-nucleotide exchange factor activity [goid 5089] [evidence IEA]; small GTPase binding [goid 31267] [evidence ISS]; protein binding [goid 5515] [evidence ISS],9,94838248-94838297,9q22.31b,+,NM_033086.1,89846,FGD3,-1.2904386786314124,9.818772803516332,-11.85310135266894,7.138367397837816e-22,1.3259398355278343e-20,38.98330386554009
IFI30,ILMN_1807277,"Homo sapiens interferon, gamma-inducible protein 30 (IFI30), mRNA.",lysosome [goid 5764] [pmid 3136170] [evidence TAS]; extracellular region [goid 5576] [pmid 3136170] [evidence TAS],immune response [goid 6955] [evidence IEA],oxidoreductase activity [goid 16491] [evidence IEA],19,18149528-18149574:18149659-18149661,19p13.11c,+,NM_006332.3,10437,IFI30,-1.5176301153805039,10.552593639724519,-11.839791909120562,7.677515725744693e-22,1.4233719687548557e-20,38.91076448670095
KCNT2,ILMN_2053345,"Homo sapiens potassium channel, subfamily T, member 2 (KCNT2), mRNA.",membrane [goid 16020] [evidence IEA]; membrane [goid 16020] [evidence IEA],potassium ion transport [goid 6813] [evidence IEA]; potassium ion transport [goid 6813] [evidence IEA],ion channel activity [goid 5216] [evidence IEA]; calcium-activated potassium channel activity [goid 15269] [evidence IEA]; ion channel activity [goid 5216] [evidence IEA]; calcium-activated potassium channel activity [goid 15269] [evidence IEA],1,194461589-194461638,1q31.3b-q31.3c,-,NM_198503.2,343450,KCNT2,-1.6725589112848986,6.0392285876626985,-11.829549033045888,8.120055831174965e-22,1.5025573397003247e-20,38.854933689971254
TPPP,ILMN_1718687,"Homo sapiens brain-specific protein p25 alpha (TPPP), mRNA.",,,,5,714007-714056,5p15.33e,-,NM_007030.1,11076,TPPP,-1.6274541124581834,6.273738778434709,-11.829023212508952,8.143450897177709e-22,1.5054567431831848e-20,38.85206748865661
COL11A1,ILMN_1731446,"Homo sapiens collagen, type XI, alpha 1 (COL11A1), transcript variant A, mRNA.",cytoplasm [goid 5737] [evidence IEA]; collagen [goid 5581] [evidence IEA]; collagen type XI [goid 5592] [pmid 3182841] [evidence TAS],cartilage condensation [goid 1502] [pmid 3182841] [evidence TAS]; visual perception [goid 7601] [pmid 8872475] [evidence TAS]; extracellular matrix organization and biogenesis [goid 30198] [pmid 10486316] [evidence NAS]; cell adhesion [goid 7155] [evidence IEA]; phosphate transport [goid 6817] [evidence IEA]; cell-cell adhesion [goid 16337] [pmid 10486316] [evidence NAS],"protein binding, bridging [goid 30674] [pmid 10486316] [evidence NAS]; extracellular matrix structural constituent [goid 5201] [pmid 10486316] [evidence NAS]",1,103264392-103264441,1p21.1d-p21.1c,-,NM_001854.2,1301,COL11A1,1.3195892949870567,5.63377341869308,11.824799468520897,8.333841365943796e-22,1.5391933555963494e-20,38.8290438318517
LOC650128,ILMN_1660323,"PREDICTED: Homo sapiens similar to CG1486-PA, isoform A, transcript variant 2 (LOC650128), mRNA.",,,,,,,,XM_945831.1,650128,LOC650128,1.4221057500162297,6.449043243847012,11.821745225012073,8.474286479251786e-22,1.563650303486942e-20,38.812394686362815
FAM26B,ILMN_1766200,"Homo sapiens family with sequence similarity 26, member B (FAM26B), mRNA.",membrane [goid 16020] [evidence IEA]; integral to membrane [goid 16021] [evidence IEA],,,10,105196743-105196792,10q24.33a,-,NM_015916.3,51063,FAM26B,-1.13136610545632,7.2022502107646185,-11.819452445659822,8.581272125318707e-22,1.5818929740949384e-20,38.799896153722926
MGC15619,ILMN_1815168,"Homo sapiens hypothetical protein MGC15619 (MGC15619), mRNA.",membrane [goid 16020] [evidence IEA]; integral to membrane [goid 16021] [pmid 16554753] [evidence IDA]; membrane [goid 16020] [evidence IEA],ion transport [goid 6811] [evidence IEA]; response to pH [goid 9268] [pmid 16556803] [evidence ISS]; response to zinc ion [goid 10043] [pmid 16556803] [evidence ISS]; proton transport [goid 15992] [pmid 16556803] [evidence ISS]; cation transport [goid 6812] [evidence IEA],ion channel activity [goid 5216] [evidence IEA]; voltage-gated proton channel activity [goid 30171] [pmid 16556803] [evidence ISS]; cation channel activity [goid 5261] [evidence IEA]; voltage-gated ion channel activity [goid 5244] [evidence IEA],12,109571013-109571062,12q24.11d,-,NM_032369.1,84329,MGC15619,-1.1398948200455177,6.47686062130052,-11.816067104263487,8.741716944040087e-22,1.6099466413480256e-20,38.78144140153775
FRMD3,ILMN_1698725,"Homo sapiens FERM domain containing 3 (FRMD3), mRNA.",membrane [goid 16020] [evidence IEA]; cytoskeleton [goid 5856] [evidence IEA]; cytoplasm [goid 5737] [evidence IEA],,cytoskeletal protein binding [goid 8092] [evidence IEA]; binding [goid 5488] [evidence IEA],9,85052548-85052597,9q21.32b-q21.32c,-,NM_174938.3,257019,FRMD3,-1.6808949756519427,6.762582033975701,-11.815450226729208,8.77127518682961e-22,1.6138649387665244e-20,38.778078524273276
SPON1,ILMN_1791890,"Homo sapiens spondin 1, extracellular matrix protein (SPON1), mRNA.",extracellular matrix (sensu Metazoa) [goid 5578] [evidence IEA],cell adhesion [goid 7155] [evidence IEA]; development [goid 7275] [evidence IEA],protein binding [goid 5515] [evidence IEA],11,14245674-14245723,11p15.2b,+,NM_006108.1,10418,SPON1,-1.6697520774517862,9.828668232731996,-11.813033673343524,8.888033741957854e-22,1.6322651975687918e-20,38.76490465846381
FBXO7,ILMN_1667112,"Homo sapiens F-box protein 7 (FBXO7), transcript variant 1, mRNA.",ubiquitin ligase complex [goid 151] [pmid 10531035] [evidence TAS]; ubiquitin ligase complex [goid 151] [pmid 10531035] [evidence TAS],ubiquitin-dependent protein catabolism [goid 6511] [pmid 10531035] [evidence TAS]; regulation of protein stability [goid 31647] [pmid 15145941] [evidence IDA]; ubiquitin-dependent protein catabolism [goid 6511] [pmid 10531035] [evidence TAS]; regulation of protein stability [goid 31647] [pmid 15145941] [evidence IDA],ubiquitin-protein ligase activity [goid 4842] [pmid 10531035] [evidence TAS]; protein binding [goid 5515] [pmid 15145941] [evidence IPI]; ubiquitin-protein ligase activity [goid 4842] [pmid 10531035] [evidence TAS]; protein binding [goid 5515] [pmid 15145941] [evidence IPI],22,31201076-31201111:31204968-31204981,22q12.3a,+,NM_012179.3,25793,FBXO7,-1.0109361302078845,7.566314663053306,-11.808400630453981,9.116254996229324e-22,1.6710275503436347e-20,38.73964693281074
GFOD1,ILMN_1778240,"Homo sapiens glucose-fructose oxidoreductase domain containing 1 (GFOD1), mRNA.",,electron transport [goid 6118] [evidence IEA]; metabolism [goid 8152] [evidence IEA],oxidoreductase activity [goid 16491] [evidence IEA],6,13471893-13471942,6p24.1a-p23b,-,NM_018988.1,54438,GFOD1,-1.5052637312213966,8.759383571205358,-11.800528227742099,9.517584377892808e-22,1.7417206348267017e-20,38.69672741950249
GPR162,ILMN_1730816,"Homo sapiens G protein-coupled receptor 162 (GPR162), transcript variant A-1, mRNA.",membrane [goid 16020] [evidence IEA]; integral to membrane [goid 16021] [evidence IEA],G-protein coupled receptor protein signaling pathway [goid 7186] [evidence IEA]; signal transduction [goid 7165] [evidence IEA],receptor activity [goid 4872] [evidence IEA]; rhodopsin-like receptor activity [goid 1584] [evidence IEA],12,6806759-6806808,12p13.31d,+,NM_014449.1,27239,GPR162,-1.6541819842894547,9.160743052645703,-11.80048575024476,9.51979715725141e-22,1.7417206348267017e-20,38.69649583006747
RNU33,ILMN_1682354,"Homo sapiens small nucleolar RNA, C/D box 33 (SNORD33) on chromosome 19.",,,,19,54685717-54685766,19q13.33b,+,NR_000020.1,26818,RNU33,1.4289453500307365,6.544553024151069,11.797367451292725,9.683653721293277e-22,1.7683785638181772e-20,38.679494516392396
PDE4B,ILMN_1782922,"Homo sapiens phosphodiesterase 4B, cAMP-specific (phosphodiesterase E4 dunce homolog, Drosophila) (PDE4B), mRNA.",soluble fraction [goid 5625] [pmid 9371714] [evidence TAS]; insoluble fraction [goid 5626] [pmid 9371714] [evidence TAS],signal transduction [goid 7165] [evidence IEA],"3',5'-cyclic-nucleotide phosphodiesterase activity [goid 4114] [evidence IEA]; hydrolase activity [goid 16787] [evidence IEA]",1,66611705-66611754,1p31.3b,+,NM_002600.2,5142,PDE4B,-1.4446956086211786,7.320760117293563,-11.794282362110513,9.848544520330537e-22,1.7968060859423268e-20,38.66267389361747
DENR,ILMN_1760954,"Homo sapiens density-regulated protein (DENR), mRNA.",cellular component unknown [goid 8372] [evidence ND ],translational initiation [goid 6413] [evidence IEA],translation initiation factor activity [goid 3743] [evidence IEA],12,121821401-121821450,12q24.31d,+,NM_003677.3,8562,DENR,1.4690872564694164,10.015001245839741,11.79238212975722,9.951503774152003e-22,1.8121967386855306e-20,38.65231320155963
CPVL,ILMN_1682928,"Homo sapiens carboxypeptidase, vitellogenic-like (CPVL), transcript variant 1, mRNA.",,,serine carboxypeptidase activity [goid 4185] [evidence IEA]; peptidase activity [goid 8233] [evidence IEA],7,29036794-29036843,7p15.1c,-,NM_031311.2,54504,CPVL,-1.5309743177462831,10.07829200060024,-11.786697342408926,1.0266000328959168e-21,1.8677219085879495e-20,38.621317036004825
IRF3,ILMN_1765649,"Homo sapiens interferon regulatory factor 3 (IRF3), mRNA.",nucleus [goid 5634] [evidence IEA],"regulation of transcription, DNA-dependent [goid 6355] [evidence IEA]; transcription [goid 6350] [evidence IEA]; response to virus [goid 9615] [evidence IEA]; transcription from RNA polymerase II promoter [goid 6366] [pmid 8524823] [evidence TAS]",RNA polymerase II transcription factor activity [goid 3702] [pmid 8524823] [evidence TAS]; transcription cofactor activity [goid 3712] [pmid 8524823] [evidence TAS]; transcription factor activity [goid 3700] [evidence IEA],19,54854799-54854848,19q13.33b,-,NM_001571.2,3661,IRF3,1.163264185870311,8.857434543698066,11.785544352448674,1.0330990630815947e-21,1.877792466804559e-20,38.61503023398396
SLC9A9,ILMN_1758315,"Homo sapiens solute carrier family 9 (sodium/hydrogen exchanger), member 9 (SLC9A9), mRNA.",membrane [goid 16020] [evidence IEA]; integral to membrane [goid 16021] [evidence IEA],ion transport [goid 6811] [evidence IEA]; regulation of pH [goid 6885] [evidence IEA]; sodium ion transport [goid 6814] [evidence IEA],sodium:hydrogen antiporter activity [goid 15385] [evidence IEA]; solute:hydrogen antiporter activity [goid 15299] [evidence IEA]; sodium ion binding [goid 31402] [evidence IEA]; antiporter activity [goid 15297] [evidence IEA],3,144467024-144467073,3q24a,-,NM_173653.1,285195,SLC9A9,-1.2686109756265047,7.236698886472596,-11.783331761008164,1.0456863442042331e-21,1.8989001320428223e-20,38.60296569739259
CCNDBP1,ILMN_1658743,"Homo sapiens cyclin D-type binding-protein 1 (CCNDBP1), transcript variant 1, mRNA.",nucleus [goid 5634] [pmid 12437976] [evidence IDA],,,15,41265312-41265361,15q15.2b,+,NM_012142.2,23582,CCNDBP1,-1.124130496234951,8.718999444301607,-11.781916563206542,1.0538177220056722e-21,1.911884386711408e-20,38.59524898854887
MEIS1,ILMN_1705685,"Homo sapiens Meis homeobox 1 (MEIS1), mRNA.",nucleus [goid 5634] [evidence IEA],"regulation of transcription, DNA-dependent [goid 6355] [evidence IEA]; development [goid 7275] [evidence IEA]",RNA polymerase II transcription factor activity [goid 3702] [pmid 7565694] [evidence TAS]; sequence-specific DNA binding [goid 43565] [evidence IEA]; transcription factor activity [goid 3700] [evidence IEA],2,66652810-66652859,2p14b,+,NM_002398.2,4211,MEIS1,-1.2002415567219673,8.245007018292561,-11.779888996657329,1.065578091105097e-21,1.9314222423425875e-20,38.58419305686972
ARHGEF19,ILMN_1808999,"Homo sapiens Rho guanine nucleotide exchange factor (GEF) 19 (ARHGEF19), mRNA.",,,,1,16397350-16397399,1p36.13f,-,NM_153213.2,128272,ARHGEF19,1.376837128510088,8.977081103778081,11.765613780434114,1.1521828904436594e-21,2.0825866067063734e-20,38.5063486003424
RAB25,ILMN_1791826,"Homo sapiens RAB25, member RAS oncogene family (RAB25), mRNA.",,"regulation of transcription, DNA-dependent [goid 6355] [evidence IEA]; intracellular protein transport [goid 6886] [evidence IEA]; small GTPase mediated signal transduction [goid 7264] [evidence IEA]; two-component signal transduction system (phosphorelay) [goid 160] [evidence IEA]",nucleotide binding [goid 166] [evidence IEA]; GTP binding [goid 5525] [evidence IEA]; DNA binding [goid 3677] [evidence IEA],1,154306744-154306793,1q22c,+,NM_020387.1,57111,RAB25,1.1198914039545969,11.343471257163056,11.761895654865528,1.1758746913943319e-21,2.1234400706041297e-20,38.48607195010207
IRF8,ILMN_1666594,"Homo sapiens interferon regulatory factor 8 (IRF8), mRNA.",nucleus [goid 5634] [evidence IEA],"immune response [goid 6955] [pmid 8861914] [evidence TAS]; regulation of transcription, DNA-dependent [goid 6355] [evidence IEA]; transcription [goid 6350] [evidence IEA]; negative regulation of transcription from RNA polymerase II promoter [goid 122] [pmid 1460054] [evidence TAS]","RNA polymerase II transcription factor activity, enhancer binding [goid 3705] [pmid 1460054] [evidence TAS]",16,84513378-84513427,16q24.1b,+,NM_002163.2,3394,IRF8,-1.3135445073986425,9.966953832196593,-11.753864046480022,1.228730286541841e-21,2.2168342253025717e-20,38.44227011855327
NUP210,ILMN_1784467,"Homo sapiens nucleoporin 210kDa (NUP210), mRNA.",,,protein binding [goid 5515] [pmid 15231747] [evidence IPI],3,13333037-13333086,3p25.1c,-,NM_024923.2,23225,NUP210,1.3382238343323634,7.671790056818776,11.749503163823157,1.2584189473495967e-21,2.268297242285559e-20,38.41848624422906
UNQ5783,ILMN_1682761,"Homo sapiens chromosome 17 open reading frame 87 (C17orf87), mRNA.",,,,17,5054544-5054593,17p13.2b,-,NM_207103.1,388325,UNQ5783,-1.4322464529848622,7.241688551935243,-11.744505563862587,1.293326712839e-21,2.3290638631855746e-20,38.39122889945756
KLRD1,ILMN_1797988,"Homo sapiens killer cell lectin-like receptor subfamily D, member 1 (KLRD1), transcript variant 1, mRNA.",plasma membrane [goid 5886] [pmid 7589107] [evidence TAS]; integral to membrane [goid 16021] [evidence IEA],cell surface receptor linked signal transduction [goid 7166] [pmid 7589107] [evidence TAS]; antimicrobial humoral response (sensu Vertebrata) [goid 19735] [pmid 7589107] [evidence TAS],receptor activity [goid 4872] [evidence IEA]; sugar binding [goid 5529] [evidence IEA]; transmembrane receptor activity [goid 4888] [pmid 7589107] [evidence TAS],12,10353263-10353312,12p13.2c,+,NM_002262.2,3824,KLRD1,-1.3729342017747372,5.880022985225756,-11.7436758171797,1.299215561312935e-21,2.3357964155217383e-20,38.38670329928007
IL1B,ILMN_1775501,"Homo sapiens interleukin 1, beta (IL1B), mRNA.",extracellular region [goid 5576] [pmid 1919436] [evidence NAS]; extracellular space [goid 5615] [pmid 3493774] [evidence TAS],apoptosis [goid 6915] [pmid 9218611] [evidence TAS]; antimicrobial humoral response (sensu Vertebrata) [goid 19735] [evidence NR ]; cell-cell signaling [goid 7267] [pmid 2989698] [evidence TAS]; negative regulation of cell proliferation [goid 8285] [pmid 3493774] [evidence TAS]; fever [goid 1660] [evidence IEA]; cell proliferation [goid 8283] [evidence IEA]; signal transduction [goid 7165] [pmid 10786823] [evidence TAS],interleukin-1 receptor binding [goid 5149] [pmid 1919436] [evidence NAS]; signal transducer activity [goid 4871] [pmid 10786823] [evidence TAS],2,113304123-113304172,2q13d,-,NM_000576.2,3553,IL1B,-2.3990055033961664,7.672793597082113,-11.7436410598367,1.2994628249553834e-21,2.3357964155217383e-20,38.386513725399176
CRIM1,ILMN_2146418,"Homo sapiens cysteine rich transmembrane BMP regulator 1 (chordin-like) (CRIM1), mRNA.",integral to membrane [goid 16021] [pmid 10642437] [evidence TAS]; extracellular region [goid 5576] [evidence IEA]; membrane fraction [goid 5624] [evidence NR ]; membrane [goid 16020] [evidence IEA],regulation of cell growth [goid 1558] [evidence IEA],insulin-like growth factor receptor activity [goid 5010] [pmid 10642437] [evidence TAS]; serine-type endopeptidase inhibitor activity [goid 4867] [evidence IEA]; insulin-like growth factor binding [goid 5520] [evidence IEA]; cysteine-type endopeptidase activity [goid 4197] [evidence IEA],2,36630135-36630184,2p22.2b,+,NM_016441.1,51232,CRIM1,-1.7228203790012255,7.03372935003235,-11.743014963856508,1.30392494843613e-21,2.3416569235279258e-20,38.38309885819584
DAPK2,ILMN_1791847,"Homo sapiens death-associated protein kinase 2 (DAPK2), mRNA.",cytoplasm [goid 5737] [pmid 10376525] [evidence IEP],induction of apoptosis [goid 6917] [pmid 10376525] [evidence IMP]; apoptosis [goid 6915] [evidence IEA]; protein amino acid phosphorylation [goid 6468] [pmid 10376525] [evidence IDA]; protein kinase cascade [goid 7243] [pmid 10376525] [evidence IDA],nucleotide binding [goid 166] [evidence IEA]; calcium- and calmodulin-dependent protein kinase activity [goid 4685] [pmid 10376525] [evidence IDA]; calmodulin binding [goid 5516] [pmid 10376525] [evidence IDA]; transferase activity [goid 16740] [evidence IEA]; ATP binding [goid 5524] [pmid 10376525] [evidence IDA],15,61986611-61986660,15q22.31a,-,NM_014326.3,23604,DAPK2,-1.6717869363453115,7.181651845762204,-11.739570703420794,1.3287476360206376e-21,2.384037540318796e-20,38.36431283425684
TSC22D3,ILMN_1695382,"Homo sapiens TSC22 domain family, member 3 (TSC22D3), transcript variant 3, mRNA.",,"regulation of transcription, DNA-dependent [goid 6355] [pmid 8982256] [evidence TAS]",transcription factor activity [goid 3700] [pmid 8982256] [evidence TAS],X,106846216-106846265,Xq22.3b,-,NM_001015881.1,1831,TSC22D3,-1.0776726006885191,8.140135874767214,-11.736991448067194,1.3476456272635063e-21,2.4157198755500848e-20,38.35024451985284
C1QB,ILMN_1796409,"Homo sapiens complement component 1, q subcomponent, beta polypeptide (C1QB), mRNA.",complement component C1q complex [goid 5602] [pmid 1706597] [evidence TAS]; cytoplasm [goid 5737] [evidence IEA],"immune response [goid 6955] [evidence IEA]; phosphate transport [goid 6817] [evidence IEA]; complement activation, classical pathway [goid 6958] [evidence IEA]",,1,22860377-22860426,1p36.12a,+,NM_000491.2,713,C1QB,-1.5789734911794184,12.5745770110678,-11.734514193350181,1.3660496109483855e-21,2.446459252695707e-20,38.336732328532655
NMU,ILMN_2162253,"Homo sapiens neuromedin U (NMU), mRNA.",,digestion [goid 7586] [pmid 7619205] [evidence TAS]; neuropeptide signaling pathway [goid 7218] [evidence IEA]; regulation of smooth muscle contraction [goid 6940] [pmid 7619205] [evidence TAS]; signal transduction [goid 7165] [pmid 7619205] [evidence TAS],receptor binding [goid 5102] [pmid 10811630] [evidence TAS],4,56166204-56166253,4q12d,-,NM_006681.1,10874,NMU,2.4416480745290015,6.092170598498653,11.731747736225255,1.3868997558367565e-21,2.4815189846170066e-20,38.32164241621042
MMP15,ILMN_1718646,"Homo sapiens matrix metallopeptidase 15 (membrane-inserted) (MMP15), mRNA.",extracellular matrix (sensu Metazoa) [goid 5578] [evidence IEA]; integral to plasma membrane [goid 5887] [pmid 7649159] [evidence TAS],peptidoglycan metabolism [goid 270] [evidence IEA]; protein modification [goid 6464] [pmid 7559440] [evidence TAS],enzyme activator activity [goid 8047] [pmid 7559440] [evidence TAS]; metalloendopeptidase activity [goid 4222] [pmid 7649159] [evidence TAS]; calcium ion binding [goid 5509] [evidence IEA]; zinc ion binding [goid 8270] [pmid 7649159] [evidence TAS],16,56637889-56637938,16q13d,+,NM_002428.2,4324,MMP15,1.6850484187713102,7.935028885776509,11.729996939298324,1.4002594558968967e-21,2.500830018162331e-20,38.3120923776831
MGRN1,ILMN_1745697,"Homo sapiens mahogunin, ring finger 1 (MGRN1), mRNA.",,ubiquitin cycle [goid 6512] [evidence IEA],zinc ion binding [goid 8270] [evidence IEA]; metal ion binding [goid 46872] [evidence IEA]; ligase activity [goid 16874] [evidence IEA]; protein binding [goid 5515] [evidence IEA],16,4680651-4680700,16p13.3b,+,NM_015246.1,23295,MGRN1,1.600797531462499,8.877064926283762,11.720191747652077,1.4774966978230085e-21,2.636357431967154e-20,38.25860612458667
SPARC,ILMN_1796734,"Homo sapiens secreted protein, acidic, cysteine-rich (osteonectin) (SPARC), mRNA.",extracellular region [goid 5576] [pmid 14718574] [evidence NAS]; basement membrane [goid 5604] [evidence IEA],transmembrane receptor protein tyrosine kinase signaling pathway [goid 7169] [pmid 15609325] [evidence NAS]; ossification [goid 1503] [pmid 7034958] [evidence TAS],copper ion binding [goid 5507] [evidence IEA]; calcium ion binding [goid 5509] [pmid 7034958] [evidence TAS]; collagen binding [goid 5518] [pmid 7034958] [evidence TAS],5,151021513-151021562,5q33.1d,-,NM_003118.2,6678,SPARC,-1.4274222800045386,11.933057298794552,-11.718598971972716,1.4904400176502107e-21,2.6570195557103712e-20,38.24991737776825
EIF4E3,ILMN_1796146,"Homo sapiens eukaryotic translation initiation factor 4E family member 3 (EIF4E3), mRNA.",cytoplasm [goid 5737] [evidence IEA]; cytoplasm [goid 5737] [evidence IEA],translational initiation [goid 6413] [evidence IEA]; translational initiation [goid 6413] [evidence IEA],RNA binding [goid 3723] [evidence IEA]; translation initiation factor activity [goid 3743] [evidence IEA]; RNA binding [goid 3723] [evidence IEA]; translation initiation factor activity [goid 3743] [evidence IEA],3,71815183-71815232,3p13d,-,NM_173359.3,317649,EIF4E3,-1.2304626548122561,8.250770749472306,-11.716409867345575,1.5084147298054987e-21,2.684151690434716e-20,38.23797544903913
SEC14L1,ILMN_1732575,"Homo sapiens SEC14-like 1 (S. cerevisiae) (SEC14L1), mRNA.",Golgi apparatus [goid 5794] [pmid 8697811] [evidence TAS]; membrane [goid 16020] [pmid 8697811] [evidence TAS]; intracellular [goid 5622] [evidence IEA],transport [goid 6810] [evidence IEA],transporter activity [goid 5215] [evidence IEA]; binding [goid 5488] [pmid 8697811] [evidence TAS],17,72724294-72724343,17q25.2b,+,NM_003003.1,6397,SEC14L1,-1.0176524824896207,7.819424459024879,-11.704495987343693,1.6101136655938385e-21,2.859896515414398e-20,38.1729802444631
PCSK9,ILMN_1668850,"Homo sapiens proprotein convertase subtilisin/kexin type 9 (PCSK9), mRNA.",,cholesterol metabolism [goid 8203] [evidence IEA]; lipid metabolism [goid 6629] [evidence IEA]; steroid metabolism [goid 8202] [evidence IEA]; negative regulation of enzyme activity [goid 43086] [evidence IEA],peptidase activity [goid 8233] [evidence IEA]; subtilase activity [goid 4289] [pmid 12730697] [evidence NAS]; calcium ion binding [goid 5509] [evidence IEA],1,55302870-55302919,1p32.3a,+,NM_174936.2,255738,PCSK9,-1.5374890926613851,6.450353100294802,-11.703061839344162,1.6228099228474788e-21,2.879822527020321e-20,38.165156025016444
CYP27A1,ILMN_1704985,"Homo sapiens cytochrome P450, family 27, subfamily A, polypeptide 1 (CYP27A1), nuclear gene encoding mitochondrial protein, mRNA.",membrane [goid 16020] [evidence IEA]; mitochondrion [goid 5739] [evidence IEA],electron transport [goid 6118] [evidence IEA],metal ion binding [goid 46872] [evidence IEA]; steroid hydroxylase activity [goid 8395] [pmid 9790667] [evidence TAS]; iron ion binding [goid 5506] [evidence IEA]; heme binding [goid 20037] [evidence IEA],2,219387910-219387959,2q35e,+,NM_000784.2,1593,CYP27A1,-1.6163010412230037,10.735699378006695,-11.697264555398672,1.6751621207813833e-21,2.967321265765932e-20,38.133527289763634
BMP6,ILMN_1747650,"Homo sapiens bone morphogenetic protein 6 (BMP6), mRNA.",extracellular space [goid 5615] [evidence IEA],growth [goid 40007] [evidence IEA]; cartilage development [goid 51216] [evidence IEA]; cell differentiation [goid 30154] [evidence IEA]; ossification [goid 1503] [evidence IEA],cytokine activity [goid 5125] [evidence IEA]; growth factor activity [goid 8083] [evidence IEA],6,7826459-7826508,6p24.3c,+,NM_001718.2,654,BMP6,-1.8736894948794784,6.67238500133945,-11.691505837664689,1.7288402701744292e-21,3.0596233119299504e-20,38.10210778931043
GUSBL2,ILMN_1657288,"Homo sapiens glucuronidase, beta-like 2 (GUSBL2), transcript variant 3, mRNA.",,carbohydrate metabolism [goid 5975] [evidence IEA],"hydrolase activity, hydrolyzing O-glycosyl compounds [goid 4553] [evidence IEA]",6,58395604-58395653,6p11.2a,-,NM_206910.1,375513,GUSBL2,1.6053289016229986,7.1449887468674245,11.688315432287423,1.75931659630409e-21,3.1107335643362244e-20,38.08470047158608
FLJ11000,ILMN_1736863,"Homo sapiens hypothetical protein FLJ11000 (FLJ11000), mRNA.",,,,7,134500907-134500956,7q33b,+,NM_018295.1,55281,FLJ11000,-1.1107541887737788,9.588416074778259,-11.685420737848627,1.7874333648800304e-21,3.1575828753116406e-20,38.0689062880265
RHPN1,ILMN_1742003,"Homo sapiens rhophilin, Rho GTPase binding protein 1 (RHPN1), mRNA.",intracellular [goid 5622] [evidence IEA],signal transduction [goid 7165] [evidence IEA],protein binding [goid 5515] [evidence IEA],8,144535784-144535833,8q24.3f,+,NM_052924.1,114822,RHPN1,1.1132640178335071,7.105107152001223,11.681822389514293,1.823012981383218e-21,3.217518835348913e-20,38.04927238417218
XRCC3,ILMN_1696266,"Homo sapiens X-ray repair complementing defective repair in Chinese hamster cells 3 (XRCC3), mRNA.",nucleus [goid 5634] [evidence IEA],DNA recombination [goid 6310] [pmid 9660962] [evidence TAS]; DNA repair [goid 6281] [pmid 9660962] [evidence TAS],DNA binding [goid 3677] [evidence IEA]; nucleotide binding [goid 166] [evidence IEA]; ATP binding [goid 5524] [evidence IEA]; DNA-dependent ATPase activity [goid 8094] [evidence IEA],14,103233872-103233921,14q32.33a,-,NM_005432.2,7517,XRCC3,1.1321887802605364,6.4043500292967535,11.680699048080516,1.834264907217852e-21,3.234448119198176e-20,38.04314293053181
ZAK,ILMN_1672390,"Homo sapiens sterile alpha motif and leucine zipper containing kinase AZK (ZAK), transcript variant 1, mRNA.",cytoplasm [goid 5737] [evidence ISS]; cytoplasm [goid 5737] [evidence ISS],cell cycle [goid 7049] [evidence IEA]; cell cycle checkpoint [goid 75] [pmid 15342622] [evidence IDA]; protein amino acid phosphorylation [goid 6468] [pmid 11836244] [evidence IDA]; positive regulation of apoptosis [goid 43065] [pmid 10924358] [evidence IDA]; protein kinase cascade [goid 7243] [pmid 11836244] [evidence IDA]; cell cycle [goid 7049] [evidence IEA]; cell cycle checkpoint [goid 75] [pmid 15342622] [evidence IDA]; protein amino acid phosphorylation [goid 6468] [pmid 11836244] [evidence IDA]; positive regulation of apoptosis [goid 43065] [pmid 10924358] [evidence IDA]; protein kinase cascade [goid 7243] [pmid 11836244] [evidence IDA],nucleotide binding [goid 166] [evidence IEA]; magnesium ion binding [goid 287] [pmid 11836244] [evidence IDA]; transferase activity [goid 16740] [evidence IEA]; protein serine/threonine kinase activity [goid 4674] [pmid 11836244] [evidence IDA]; ATP binding [goid 5524] [pmid 11836244] [evidence IDA]; protein-tyrosine kinase activity [goid 4713] [evidence IEA]; nucleotide binding [goid 166] [evidence IEA]; magnesium ion binding [goid 287] [pmid 11836244] [evidence IDA]; transferase activity [goid 16740] [evidence IEA]; protein serine/threonine kinase activity [goid 4674] [pmid 11836244] [evidence IDA]; ATP binding [goid 5524] [pmid 11836244] [evidence IDA]; protein-tyrosine kinase activity [goid 4713] [evidence IEA],2,173840775-173840824,2q31.1e,+,NM_016653.1,51776,ZAK,-1.0711032387309203,7.123767912593181,-11.671804673046115,1.9258456162767315e-21,3.3898014302757106e-20,37.99460969894113
PRR11,ILMN_1782403,"Homo sapiens proline rich 11 (PRR11), mRNA.",,,,17,54629932-54629932:54633706-54633754,17q22d,+,NM_018304.1,55771,PRR11,1.3160124301172633,5.993520830076281,11.666135764088693,1.98659024518466e-21,3.4935659681789803e-20,37.963675193179135
BAT2,ILMN_1760563,"Homo sapiens HLA-B associated transcript 2 (BAT2), transcript variant 1, mRNA.",nucleus [goid 5634] [evidence IEA]; nucleus [goid 5634] [evidence IEA],,protein binding [goid 5515] [pmid 16713569] [evidence IPI]; protein binding [goid 5515] [pmid 16713569] [evidence IPI],6,31713066-31713080:31713202-31713236,6p21.33a,+,NM_080686.1,7916,BAT2,1.1920931287606749,8.65013217418961,11.661988717128718,2.0322391969901557e-21,3.5706204466504226e-20,37.94104459711087
MOBKL2B,ILMN_1717046,"Homo sapiens MOB1, Mps One Binder kinase activator-like 2B (yeast) (MOBKL2B), mRNA.",,,metal ion binding [goid 46872] [evidence IEA]; zinc ion binding [goid 8270] [evidence IEA],9,27315805-27315854,9p21.2a,-,NM_024761.3,79817,MOBKL2B,-1.3894053888303537,6.593379382146877,-11.658923640348448,2.0666519482088057e-21,3.627812000977349e-20,37.924317978545176
RAVER1,ILMN_1740395,"Homo sapiens RAVER1 (RAVER1), mRNA.",,,nucleotide binding [goid 166] [evidence IEA]; nucleic acid binding [goid 3676] [evidence IEA],19,10288082-10288131,19p13.2c,-,NM_133452.1,125950,RAVER1,1.066678127086793,8.555941964846166,11.658343272950532,2.073233348419871e-21,3.636089270383545e-20,37.92115078415025
FAM64A,ILMN_1728972,"Homo sapiens family with sequence similarity 64, member A (FAM64A), mRNA.",,,,17,6294796-6294845,17p13.2a,+,NM_019013.1,54478,FAM64A,1.3661090867415098,5.763506076073641,11.656131852720224,2.0985038849026438e-21,3.677099658033095e-20,37.90908246608153
PPAP2A,ILMN_1676296,"Homo sapiens phosphatidic acid phosphatase type 2A (PPAP2A), transcript variant 2, mRNA.",plasma membrane [goid 5886] [pmid 9705349] [evidence TAS]; membrane fraction [goid 5624] [pmid 9468526] [evidence IDA]; integral to plasma membrane [goid 5887] [pmid 9705349] [evidence NAS]; plasma membrane [goid 5886] [pmid 9705349] [evidence TAS]; membrane fraction [goid 5624] [pmid 9468526] [evidence IDA]; integral to plasma membrane [goid 5887] [pmid 9705349] [evidence NAS],regulation of lipid metabolism [goid 19216] [pmid 9468526] [evidence NAS]; germ cell migration [goid 8354] [pmid 9305923] [evidence TAS]; negative regulation of cell proliferation [goid 8285] [pmid 9468526] [evidence NAS]; androgen receptor signaling pathway [goid 30521] [pmid 9468526] [evidence NAS]; protein kinase C activation [goid 7205] [pmid 9468526] [evidence TAS]; phospholipid dephosphorylation [goid 46839] [pmid 9468526] [evidence TAS]; regulation of lipid metabolism [goid 19216] [pmid 9468526] [evidence NAS]; germ cell migration [goid 8354] [pmid 9305923] [evidence TAS]; negative regulation of cell proliferation [goid 8285] [pmid 9468526] [evidence NAS]; androgen receptor signaling pathway [goid 30521] [pmid 9468526] [evidence NAS]; protein kinase C activation [goid 7205] [pmid 9468526] [evidence TAS]; phospholipid dephosphorylation [goid 46839] [pmid 9468526] [evidence TAS],hydrolase activity [goid 16787] [evidence IEA]; phosphatidate phosphatase activity [goid 8195] [pmid 9570154] [evidence NAS]; hydrolase activity [goid 16787] [evidence IEA]; phosphatidate phosphatase activity [goid 8195] [pmid 9570154] [evidence NAS],5,54822546-54822595,5q11.2e,-,NM_176895.1,8611,PPAP2A,-1.1415537866025476,7.986790233524597,-11.6558419968408,2.1018389327540963e-21,3.679634465832306e-20,37.90750063193571
PRNP,ILMN_1737988,"Homo sapiens prion protein (p27-30) (Creutzfeldt-Jakob disease, Gerstmann-Strausler-Scheinker syndrome, fatal familial insomnia) (PRNP), transcript variant 2, mRNA.",Golgi apparatus [goid 5794] [evidence ISS]; endoplasmic reticulum [goid 5783] [evidence ISS]; extrinsic to membrane [goid 19898] [pmid 16004966] [evidence TAS]; lipid raft [goid 45121] [evidence ISS]; plasma membrane [goid 5886] [evidence ISS]; lipid raft [goid 45121] [evidence ISS]; Golgi apparatus [goid 5794] [evidence ISS]; endoplasmic reticulum [goid 5783] [evidence ISS]; extrinsic to membrane [goid 19898] [pmid 16004966] [evidence TAS]; cytoplasm [goid 5737] [pmid 16004966] [evidence TAS],metabolism [goid 8152] [pmid 3755672] [evidence TAS]; copper ion homeostasis [goid 6878] [pmid 16004966] [evidence NAS]; response to oxidative stress [goid 6979] [evidence ISS]; metabolism [goid 8152] [pmid 3755672] [evidence TAS]; copper ion homeostasis [goid 6878] [pmid 16004966] [evidence NAS]; response to oxidative stress [goid 6979] [evidence ISS],microtubule binding [goid 8017] [pmid 16004966] [evidence IDA]; copper ion binding [goid 5507] [pmid 16294306] [evidence TAS]; microtubule binding [goid 8017] [pmid 16004966] [evidence IDA]; GPI anchor binding [goid 48503] [evidence IEA]; copper ion binding [goid 5507] [pmid 16294306] [evidence TAS],20,4630022-4630071,20p13a,+,NM_183079.2,5621,PRNP,-1.164159964874461,10.872912481405272,-11.65483646128089,2.1134496996686274e-21,3.6966398023378103e-20,37.902013088069644
NEK6,ILMN_1660871,"Homo sapiens NIMA (never in mitosis gene a)-related kinase 6 (NEK6), mRNA.",nucleus [goid 5634] [pmid 12054534] [evidence IDA]; cytoplasm [goid 5737] [pmid 12054534] [evidence IDA],apoptosis [goid 6915] [evidence IEA]; cell cycle [goid 7049] [evidence IEA]; cell division [goid 51301] [evidence IEA]; chromosome segregation [goid 7059] [pmid 14563848] [evidence IDA]; positive regulation of I-kappaB kinase/NF-kappaB cascade [goid 43123] [pmid 12761501] [evidence IMP]; mitosis [goid 7067] [evidence IEA]; regulation of mitotic metaphase/anaphase transition [goid 30071] [pmid 14563848] [evidence IDA]; protein amino acid phosphorylation [goid 6468] [pmid 14563848] [evidence IDA],transferase activity [goid 16740] [evidence IEA]; protein-tyrosine kinase activity [goid 4713] [evidence IEA]; ATP binding [goid 5524] [pmid 14563848] [evidence IDA]; protein serine/threonine kinase activity [goid 4674] [pmid 14563848] [evidence IDA]; signal transducer activity [goid 4871] [pmid 12761501] [evidence IMP]; protein kinase activity [goid 4672] [evidence IEA]; nucleotide binding [goid 166] [evidence IEA]; magnesium ion binding [goid 287] [pmid 14563848] [evidence IDA],9,126154389-126154438,9q33.3a,+,NM_014397.3,10783,NEK6,1.3347299553242689,8.586747831715257,11.653934605235191,2.123917913756148e-21,3.711617986505699e-20,37.897091328992055
FGL2,ILMN_1693009,"Homo sapiens fibrinogen-like 2 (FGL2), mRNA.",fibrinogen complex [goid 5577] [pmid 7642106] [evidence TAS],,,7,76663704-76663753,7q11.23g,-,NM_006682.1,10875,FGL2,-1.6214583898251735,9.121161767186313,-11.65175544613018,2.1494270920984158e-21,3.7528303664460247e-20,37.88519874582931
C6orf81,ILMN_1712616,"Homo sapiens chromosome 6 open reading frame 81 (C6orf81), mRNA.",,,binding [goid 5488] [evidence IEA],6,35824467-35824516,6p21.31b,+,NM_145028.3,221481,C6orf81,1.0263557165734856,6.337610708387524,11.644972415811951,2.2308092956922675e-21,3.887953410247212e-20,37.84817989136303
KLF6,ILMN_1700727,"Homo sapiens Kruppel-like factor 6 (KLF6), transcript variant 1, mRNA.",nucleus [goid 5634] [pmid 9689109] [evidence TAS]; nucleus [goid 5634] [pmid 9689109] [evidence TAS],"regulation of transcription, DNA-dependent [goid 6355] [evidence NAS]; transcription [goid 6350] [evidence IEA]; B cell differentiation [goid 30183] [pmid 9000136] [evidence NAS]; cell growth [goid 16049] [pmid 9000136] [evidence NAS]; regulation of transcription, DNA-dependent [goid 6355] [evidence NAS]; transcription [goid 6350] [evidence IEA]; B cell differentiation [goid 30183] [pmid 9000136] [evidence NAS]; cell growth [goid 16049] [pmid 9000136] [evidence NAS]",DNA binding [goid 3677] [evidence IEA]; zinc ion binding [goid 8270] [evidence IEA]; transcriptional activator activity [goid 16563] [pmid 9689109] [evidence TAS]; metal ion binding [goid 46872] [evidence IEA]; DNA binding [goid 3677] [evidence IEA]; zinc ion binding [goid 8270] [evidence IEA]; transcriptional activator activity [goid 16563] [pmid 9689109] [evidence TAS]; metal ion binding [goid 46872] [evidence IEA],10,3808441-3808490,10p15.1e,-,NM_001008490.1,1316,KLF6,-1.2409745771460816,9.864018265199281,-11.641268380701364,2.276545024736922e-21,3.960578554196332e-20,37.82796421663477
LPHN2,ILMN_1697548,"Homo sapiens latrophilin 2 (LPHN2), mRNA.",integral to membrane [goid 16021] [pmid 15203201] [evidence TAS]; membrane [goid 16020] [evidence IEA],G-protein coupled receptor protein signaling pathway [goid 7186] [evidence IEA]; neuropeptide signaling pathway [goid 7218] [evidence IEA]; signal transduction [goid 7165] [evidence IEA],latrotoxin receptor activity [goid 16524] [pmid 10030676] [evidence NAS]; receptor activity [goid 4872] [evidence IEA]; G-protein coupled receptor activity [goid 4930] [pmid 15203201] [evidence TAS]; sugar binding [goid 5529] [evidence IEA],1,82230373-82230422,1p31.1b,+,NM_012302.2,23266,LPHN2,-1.6204187367734946,8.469711248133732,-11.639579386276559,2.2977104619404364e-21,3.9938348216689923e-20,37.81874596640753
TMEM63A,ILMN_1719649,"Homo sapiens transmembrane protein 63A (TMEM63A), mRNA.",membrane [goid 16020] [evidence IEA]; integral to membrane [goid 16021] [evidence IEA],,nucleotide binding [goid 166] [evidence IEA],1,224100110-224100159,1q42.12c,-,NM_014698.1,9725,TMEM63A,1.4485621128321418,8.595893217927316,11.635196956747235,2.353551769309274e-21,4.087251000444849e-20,37.794826955568524
HOXA4,ILMN_1677018,"Homo sapiens homeo box A4 (HOXA4), mRNA.",nucleus [goid 5634] [evidence IEA],"regulation of transcription, DNA-dependent [goid 6355] [evidence IEA]; morphogenesis [goid 9653] [pmid 1675427] [evidence TAS]",transcription factor activity [goid 3700] [evidence IEA],7,27135116-27135165,7p15.2a,-,NM_002141.2,3201,HOXA4,-1.5159654801280098,6.414702769602841,-11.634840267900271,2.3581560883684167e-21,4.091600301145023e-20,37.792880143491786
KIFC2,ILMN_1803018,"Homo sapiens kinesin family member C2 (KIFC2), mRNA.",microtubule associated complex [goid 5875] [evidence IEA]; microtubule [goid 5874] [evidence IEA],microtubule-based movement [goid 7018] [evidence IEA],ATP binding [goid 5524] [evidence IEA]; microtubule motor activity [goid 3777] [evidence IEA]; nucleotide binding [goid 166] [evidence IEA],8,145670113-145670162,8q24.3h,+,NM_145754.2,90990,KIFC2,1.5469632810668168,7.618372785678009,11.628433955264885,2.4424047700602926e-21,4.234008624966619e-20,37.75791369853634
PCDHB4,ILMN_1722673,"Homo sapiens protocadherin beta 4 (PCDHB4), mRNA.",integral to plasma membrane [goid 5887] [pmid 10380929] [evidence TAS]; membrane [goid 16020] [evidence IEA],calcium-dependent cell-cell adhesion [goid 16339] [pmid 11322959] [evidence NAS]; synaptogenesis [goid 7416] [pmid 12231349] [evidence TAS]; synaptic transmission [goid 7268] [pmid 12231349] [evidence TAS]; cell adhesion [goid 7155] [pmid 10380929] [evidence TAS]; homophilic cell adhesion [goid 7156] [evidence IEA],calcium ion binding [goid 5509] [evidence IEA]; protein binding [goid 5515] [pmid 11322959] [evidence NAS],5,140484978-140485027,5q31.3b,+,NM_018938.2,56131,PCDHB4,-1.2510007703325048,6.1791191547584114,-11.626351884787251,2.4704295923491828e-21,4.278784053948785e-20,37.74654921127778
LOC644743,ILMN_1671971,"PREDICTED: Homo sapiens hypothetical protein LOC644743 (LOC644743), mRNA.",,,,1,44341805-44341854,1p34.1e,-,XM_932346.1,644743,LOC644743,1.5162478549293237,11.417130558272088,11.624766219003126,2.4919885451719553e-21,4.3122910126710077e-20,37.73789413620712
PTGIS,ILMN_1667692,"Homo sapiens prostaglandin I2 (prostacyclin) synthase (PTGIS), mRNA.",integral to membrane [goid 16021] [evidence IEA]; membrane [goid 16020] [evidence IEA]; endoplasmic reticulum [goid 5783] [evidence IEA],fatty acid biosynthesis [goid 6633] [evidence IEA]; prostaglandin biosynthesis [goid 1516] [evidence IEA]; lipid metabolism [goid 6629] [pmid 8812456] [evidence NAS]; electron transport [goid 6118] [evidence IEA],heme binding [goid 20037] [evidence IEA]; prostaglandin-I synthase activity [goid 8116] [pmid 8812456] [evidence TAS]; isomerase activity [goid 16853] [evidence IEA]; metal ion binding [goid 46872] [evidence IEA]; iron ion binding [goid 5506] [evidence IEA]; monooxygenase activity [goid 4497] [evidence IEA],20,47554109-47554158,20q13.13d,-,NM_000961.3,5740,PTGIS,-1.780482670123428,8.458860821010168,-11.619971501472847,2.5583310056884232e-21,4.4192446494538056e-20,37.71172252429067
BCL9L,ILMN_1743966,"Homo sapiens B-cell CLL/lymphoma 9-like (BCL9L), mRNA.",intracellular [goid 5622] [evidence IEA]; ribosome [goid 5840] [evidence IEA],protein biosynthesis [goid 6412] [evidence IEA],structural constituent of ribosome [goid 3735] [evidence IEA],11,118272330-118272379,11q23.3e,-,NM_182557.1,283149,BCL9L,1.2761954243241016,7.215830398851954,11.619392093987441,2.5664668560977174e-21,4.429371717543315e-20,37.70855982074295
FRK,ILMN_1727605,"Homo sapiens fyn-related kinase (FRK), mRNA.",nucleus [goid 5634] [pmid 7696183] [evidence TAS]; intracellular [goid 5622] [pmid 7510261] [evidence TAS],negative regulation of cell proliferation [goid 8285] [pmid 7664264] [evidence TAS]; intracellular signaling cascade [goid 7242] [evidence IEA]; protein amino acid phosphorylation [goid 6468] [pmid 7696183] [evidence TAS],transferase activity [goid 16740] [evidence IEA]; non-membrane spanning protein tyrosine kinase activity [goid 4715] [pmid 7510261] [evidence TAS]; nucleotide binding [goid 166] [evidence IEA]; ATP binding [goid 5524] [evidence IEA],6,116369422-116369471,6q22.1d,-,NM_002031.2,2444,FRK,1.2337035103226706,5.742111475981699,11.618160119613256,2.5838520383657312e-21,4.455429820137723e-20,37.7018350359375
SLA,ILMN_1667371,"Homo sapiens Src-like-adaptor (SLA), mRNA.",,intracellular signaling cascade [goid 7242] [evidence IEA],SH3/SH2 adaptor activity [goid 5070] [pmid 7543898] [evidence TAS],8,134118388-134118437,8q24.22c,-,NM_006748.1,6503,SLA,-1.0362332444814806,7.479200308133868,-11.616096591484562,2.613236364995409e-21,4.502114108924451e-20,37.69057106948876
GNG7,ILMN_1728107,"Homo sapiens guanine nucleotide binding protein (G protein), gamma 7 (GNG7), mRNA.",membrane [goid 16020] [evidence IEA]; heterotrimeric G-protein complex [goid 5834] [evidence IEA],signal transduction [goid 7165] [evidence IEA]; regulation of G-protein coupled receptor protein signaling pathway [goid 8277] [pmid 9600093] [evidence TAS],signal transducer activity [goid 4871] [evidence IEA],19,2462391-2462440,19p13.3g,-,NM_052847.1,2788,GNG7,-1.153524275515207,7.710361664398239,-11.59335228046997,2.96014508742601e-21,5.077326322930969e-20,37.56641003656233
MRGPRF,ILMN_2075603,"Homo sapiens MAS-related GPR, member F (MRGPRF), mRNA.",integral to membrane [goid 16021] [evidence IEA]; membrane [goid 16020] [evidence IEA],signal transduction [goid 7165] [evidence IEA]; G-protein coupled receptor protein signaling pathway [goid 7186] [evidence IEA],rhodopsin-like receptor activity [goid 1584] [evidence IEA]; receptor activity [goid 4872] [evidence IEA],11,68528756-68528805,11q13.2c,-,NM_145015.2,219928,MRGPRF,-1.374248915503336,6.860070895174478,-11.590621602863289,3.004781482685416e-21,5.144830157304511e-20,37.551502185980105
LOC255783,ILMN_1703316,"PREDICTED: Homo sapiens hypothetical protein LOC255783, transcript variant 2 (LOC255783), misc RNA.",,,,,,19q13.32b,,XR_001409.1,255783,LOC255783,-1.1806207277548548,10.62158698002587,-11.589767711987344,3.0188772486707262e-21,5.164426970179903e-20,37.54684040956413
ETS1,ILMN_1687538,"Homo sapiens v-ets erythroblastosis virus E26 oncogene homolog 1 (avian) (ETS1), mRNA.",nucleus [goid 5634] [evidence IEA],"immune response [goid 6955] [pmid 2187191] [evidence TAS]; regulation of transcription, DNA-dependent [goid 6355] [evidence IEA]; negative regulation of cell proliferation [goid 8285] [pmid 2187191] [evidence TAS]; transcription [goid 6350] [evidence IEA]; transcription from RNA polymerase II promoter [goid 6366] [pmid 7753825] [evidence TAS]",RNA polymerase II transcription factor activity [goid 3702] [pmid 7753825] [evidence TAS]; transcription factor activity [goid 3700] [evidence IEA],11,127834393-127834442,11q24.3a,-,NM_005238.2,2113,ETS1,-1.2240265789817144,10.627171704256355,-11.565117948785183,3.455615058572409e-21,5.885721976947849e-20,37.41225647478035
CHAF1B,ILMN_1674231,"Homo sapiens chromatin assembly factor 1, subunit B (p60) (CHAF1B), mRNA.",heterotrimeric G-protein complex [goid 5834] [evidence IEA]; cytoplasm [goid 5737] [pmid 9614144] [evidence NAS]; chromatin assembly complex [goid 5678] [pmid 7600578] [evidence TAS]; nucleus [goid 5634] [pmid 9614144] [evidence NAS],"regulation of transcription, DNA-dependent [goid 6355] [evidence IEA]; G-protein coupled receptor protein signaling pathway [goid 7186] [evidence IEA]; cell cycle [goid 7049] [evidence IEA]; transcription [goid 6350] [evidence IEA]; DNA replication-dependent nucleosome assembly [goid 6335] [pmid 7600578] [evidence TAS]; protein complex assembly [goid 6461] [pmid 7600578] [evidence TAS]; DNA replication [goid 6260] [evidence IEA]; DNA repair [goid 6281] [evidence IEA]",signal transducer activity [goid 4871] [evidence IEA]; unfolded protein binding [goid 51082] [pmid 7600578] [evidence TAS]; histone binding [goid 42393] [pmid 7600578] [evidence NAS]; chromatin binding [goid 3682] [pmid 7600578] [evidence TAS],21,36710816-36710865,21q22.12b-q22.13a,+,NM_005441.2,8208,CHAF1B,1.3402348257780083,6.566199556878258,11.553704452180803,3.678737705816907e-21,6.238486005034155e-20,37.34993425553289
GLT25D2,ILMN_1736742,"Homo sapiens glycosyltransferase 25 domain containing 2 (GLT25D2), mRNA.",,lipopolysaccharide biosynthesis [goid 9103] [evidence IEA],transferase activity [goid 16740] [evidence IEA],1,182171897-182171946,1q25.3e,-,NM_015101.1,23127,GLT25D2,-1.7172673137939602,6.335758966353469,-11.551228593027405,3.7290108896258856e-21,6.318241494292206e-20,37.33641456663276
CDKN3,ILMN_1666305,"Homo sapiens cyclin-dependent kinase inhibitor 3 (CDK2-associated dual specificity phosphatase) (CDKN3), mRNA.",,G1/S transition of mitotic cell cycle [goid 82] [pmid 8127873] [evidence TAS]; negative regulation of cell proliferation [goid 8285] [pmid 8242750] [evidence TAS]; cell cycle [goid 7049] [evidence IEA]; protein amino acid dephosphorylation [goid 6470] [evidence IEA]; cell cycle arrest [goid 7050] [pmid 8242750] [evidence TAS],hydrolase activity [goid 16787] [evidence IEA]; protein tyrosine phosphatase activity [goid 4725] [evidence IEA]; protein tyrosine/serine/threonine phosphatase activity [goid 8138] [pmid 8242750] [evidence TAS],14,53948082-53948131,14q22.2b,+,NM_005192.2,1033,CDKN3,1.522190848242757,6.177094029308855,11.538511911976478,3.998273558295935e-21,6.756839573581639e-20,37.26697092981289
PFKP,ILMN_1805737,"Homo sapiens phosphofructokinase, platelet (PFKP), mRNA.",6-phosphofructokinase complex [goid 5945] [evidence NAS]; cytoplasm [goid 5737] [evidence IEA],glycolysis [goid 6096] [evidence NAS],kinase activity [goid 16301] [evidence IEA]; transferase activity [goid 16740] [evidence IEA]; nucleotide binding [goid 166] [evidence IEA]; ATP binding [goid 5524] [evidence IEA]; magnesium ion binding [goid 287] [evidence IEA]; 6-phosphofructokinase activity [goid 3872] [pmid 1834056] [evidence TAS],10,3168718-3168767,10p15.2b,+,NM_002627.3,5214,PFKP,1.540124336067377,10.226373699450487,11.530334221655494,4.1816253116080315e-21,7.048353736737239e-20,37.22231144319337
FCGR3B,ILMN_1728639,"Homo sapiens Fc fragment of IgG, low affinity IIIb, receptor (CD16b) (FCGR3B), mRNA.",membrane [goid 16020] [evidence IEA]; membrane [goid 16020] [evidence IEA],immune response [goid 6955] [pmid 2139735] [evidence TAS]; immune response [goid 6955] [pmid 2139735] [evidence TAS],GPI anchor binding [goid 48503] [evidence IEA]; IgG binding [goid 19864] [evidence IEA]; receptor activity [goid 4872] [evidence IEA]; GPI anchor binding [goid 48503] [evidence IEA]; IgG binding [goid 19864] [evidence IEA]; receptor activity [goid 4872] [evidence IEA],1,159860148-159860197,1q23.3b,-,NM_000570.2,2215,FCGR3B,-1.6756075849954133,6.573838500106235,-11.529795492124927,4.193995554877505e-21,7.063094501883161e-20,37.21936929918779
GPR65,ILMN_1734740,"Homo sapiens G protein-coupled receptor 65 (GPR65), mRNA.",integral to plasma membrane [goid 5887] [pmid 9655242] [evidence TAS]; membrane [goid 16020] [evidence IEA]; integral to plasma membrane [goid 5887] [pmid 9655242] [evidence TAS]; membrane [goid 16020] [evidence IEA],immune response [goid 6955] [pmid 9655242] [evidence TAS]; apoptosis [goid 6915] [pmid 9655242] [evidence TAS]; G-protein coupled receptor protein signaling pathway [goid 7186] [pmid 9655242] [evidence TAS]; development [goid 7275] [pmid 9655242] [evidence TAS]; signal transduction [goid 7165] [evidence IEA]; immune response [goid 6955] [pmid 9655242] [evidence TAS]; apoptosis [goid 6915] [pmid 9655242] [evidence TAS]; G-protein coupled receptor protein signaling pathway [goid 7186] [pmid 9655242] [evidence TAS]; development [goid 7275] [pmid 9655242] [evidence TAS]; signal transduction [goid 7165] [evidence IEA],receptor activity [goid 4872] [evidence IEA]; rhodopsin-like receptor activity [goid 1584] [evidence IEA]; receptor activity [goid 4872] [evidence IEA]; rhodopsin-like receptor activity [goid 1584] [evidence IEA],14,87547553-87547602,14q31.3c,+,NM_003608.2,8477,GPR65,-1.2698181286302894,6.725608272411101,-11.51783799647945,4.478193281011347e-21,7.52869681453892e-20,37.154064110328996
NPM3,ILMN_2110252,"Homo sapiens nucleophosmin/nucleoplasmin, 3 (NPM3), mRNA.",nucleus [goid 5634] [evidence IEA],protein folding [goid 6457] [evidence IEA],nucleic acid binding [goid 3676] [evidence IEA],10,103531194-103531243,10q24.32a,-,NM_006993.1,10360,NPM3,1.3191204591883263,8.974786584849422,11.51386919851832,4.576720024605672e-21,7.687706006848407e-20,37.132387840044736
PRICKLE2,ILMN_1683148,"Homo sapiens prickle-like 2 (Drosophila) (PRICKLE2), mRNA.",membrane [goid 16020] [evidence IEA]; nucleus [goid 5634] [evidence IEA],,metal ion binding [goid 46872] [evidence IEA]; zinc ion binding [goid 8270] [evidence IEA],3,64054830-64054879,3p14.1d,-,NM_198859.1,166336,PRICKLE2,-1.1605061452965337,9.285656666165705,-11.507000351250223,4.752397093249753e-21,7.962206136025058e-20,37.094871399992726
MYH4,ILMN_1729251,"Homo sapiens myosin, heavy polypeptide 4, skeletal muscle (MYH4), mRNA.",striated muscle thick filament [goid 5863] [evidence IEA]; muscle myosin [goid 5859] [evidence NR ]; myosin [goid 16459] [evidence IEA],actin filament-based movement [goid 30048] [pmid 10388558] [evidence NAS]; striated muscle contraction [goid 6941] [evidence IEA]; muscle development [goid 7517] [evidence IEA],"actin binding [goid 3779] [evidence IEA]; nucleotide binding [goid 166] [evidence IEA]; calmodulin binding [goid 5516] [evidence IEA]; microfilament motor activity [goid 146] [pmid 10388558] [evidence NAS]; ATP binding [goid 5524] [evidence IEA]; ATPase activity, coupled [goid 42623] [evidence NR ]",17,10287517-10287566,17p13.1a,-,NM_017533.1,4622,MYH4,-1.442616211915503,6.282913422057702,-11.50639965917637,4.768077660059638e-21,7.981614536620451e-20,37.09159046199209
MYO7A,ILMN_1811719,"Homo sapiens myosin VIIA (MYO7A), mRNA.",cytoskeleton [goid 5856] [evidence IEA]; myosin [goid 16459] [evidence IEA],actin filament-based movement [goid 30048] [pmid 12466270] [evidence NAS]; visual perception [goid 7601] [pmid 7870171] [evidence TAS]; sensory perception [goid 7600] [evidence IEA],"actin binding [goid 3779] [evidence IEA]; nucleotide binding [goid 166] [evidence IEA]; calmodulin binding [goid 5516] [evidence IEA]; microfilament motor activity [goid 146] [pmid 12466270] [evidence NAS]; ATP binding [goid 5524] [evidence IEA]; ATPase activity, coupled [goid 42623] [evidence NR ]",11,76603587-76603636,11q13.5c,+,NM_000260.1,4647,MYO7A,1.3432728759729917,6.390205515018362,11.505045078901777,4.8036282039377526e-21,8.034222794311341e-20,37.084191802352734
C9orf150,ILMN_1701361,"Homo sapiens chromosome 9 open reading frame 150 (C9orf150), mRNA.",,,,9,12812625-12812674,9p23b,+,NM_203403.1,286343,C9orf150,-1.47605054894896,6.749774278888542,-11.49429170241686,5.095426238747419e-21,8.5149554255569e-20,37.025455504408114
PROK2,ILMN_1775257,"Homo sapiens prokineticin 2 (PROK2), mRNA.",extracellular region [goid 5576] [pmid 12466223] [evidence TAS],angiogenesis [goid 1525] [pmid 12604792] [evidence IDA]; spermatogenesis [goid 7283] [pmid 10580115] [evidence IMP]; chemotaxis [goid 6935] [pmid 12604792] [evidence IDA]; anti-apoptosis [goid 6916] [pmid 12604792] [evidence IDA]; cell proliferation [goid 8283] [pmid 12604792] [evidence IDA]; rhythmic process [goid 48511] [evidence IEA]; neuropeptide signaling pathway [goid 7218] [evidence IEA]; positive regulation of smooth muscle contraction [goid 45987] [pmid 11259612] [evidence IDA]; inflammatory response [goid 6954] [pmid 11259612] [evidence NAS],G-protein-coupled receptor binding [goid 1664] [pmid 12728244] [evidence TAS],3,71903840-71903889,3p13d,-,NM_021935.2,60675,PROK2,-2.1763587331771124,6.148743903732695,-11.49403901837571,5.102492227113667e-21,8.519456816221919e-20,37.024075273786444
CNTFR,ILMN_1809456,"Homo sapiens ciliary neurotrophic factor receptor (CNTFR), transcript variant 1, mRNA.",membrane [goid 16020] [evidence IEA]; extrinsic to membrane [goid 19898] [pmid 1648265] [evidence TAS]; membrane [goid 16020] [evidence IEA]; extrinsic to membrane [goid 19898] [pmid 1648265] [evidence TAS],signal transduction [goid 7165] [pmid 1648265] [evidence NAS]; signal transduction [goid 7165] [pmid 1648265] [evidence NAS],ciliary neurotrophic factor receptor activity [goid 4897] [pmid 7585948] [evidence TAS]; cytokine binding [goid 19955] [pmid 15272019] [evidence IPI]; GPI anchor binding [goid 48503] [evidence IEA]; receptor activity [goid 4872] [evidence IEA]; hematopoietin/interferon-class (D200-domain) cytokine receptor activity [goid 4896] [evidence IEA]; ciliary neurotrophic factor receptor activity [goid 4897] [pmid 7585948] [evidence TAS]; cytokine binding [goid 19955] [pmid 15272019] [evidence IPI]; GPI anchor binding [goid 48503] [evidence IEA]; receptor activity [goid 4872] [evidence IEA]; hematopoietin/interferon-class (D200-domain) cytokine receptor activity [goid 4896] [evidence IEA],9,34541533-34541582,9p13.3c,-,NM_147164.1,1271,CNTFR,-1.2376080188487304,5.730257541342655,-11.490574098891296,5.200379610205079e-21,8.668040778857652e-20,37.00514874108623
KCNA5,ILMN_1790508,"Homo sapiens potassium voltage-gated channel, shaker-related subfamily, member 5 (KCNA5), mRNA.",membrane [goid 16020] [evidence IEA]; voltage-gated potassium channel complex [goid 8076] [pmid 1986382] [evidence TAS]; membrane fraction [goid 5624] [evidence NR ]; integral to membrane [goid 16021] [evidence IEA],potassium ion transport [goid 6813] [pmid 1986382] [evidence TAS]; ion transport [goid 6811] [evidence IEA],protein binding [goid 5515] [evidence IEA]; delayed rectifier potassium channel activity [goid 5251] [pmid 1986382] [evidence TAS]; potassium ion binding [goid 30955] [evidence IEA],12,5025988-5026037,12p13.32a,+,NM_002234.2,3741,KCNA5,-1.5697140373994367,6.326170921313674,-11.484294102107235,5.38261199852448e-21,8.941193076832863e-20,36.97084448975524
EPHA1,ILMN_1664265,"Homo sapiens EPH receptor A1 (EPHA1), mRNA.",integral to plasma membrane [goid 5887] [pmid 2825356] [evidence TAS]; membrane [goid 16020] [evidence IEA],transmembrane receptor protein tyrosine kinase signaling pathway [goid 7169] [evidence IEA]; protein amino acid phosphorylation [goid 6468] [evidence IEA]; signal transduction [goid 7165] [pmid 2825356] [evidence TAS],transferase activity [goid 16740] [evidence IEA]; nucleotide binding [goid 166] [evidence IEA]; ATP binding [goid 5524] [evidence IEA]; receptor activity [goid 4872] [evidence IEA]; ephrin receptor activity [goid 5003] [evidence IEA],7,142798521-142798570,7q34f-q35a,-,NM_005232.3,2041,EPHA1,1.14070085132977,7.8936017748116685,11.48406164287081,5.3894788167734434e-21,8.944973998707882e-20,36.969574669094136
MMP9,ILMN_1796316,"Homo sapiens matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase) (MMP9), mRNA.",extracellular matrix (sensu Metazoa) [goid 5578] [evidence IEA]; extracellular space [goid 5615] [pmid 2251898] [evidence IDA],peptidoglycan metabolism [goid 270] [evidence IEA]; macrophage differentiation [goid 30225] [pmid 2251898] [evidence TAS]; collagen catabolism [goid 30574] [evidence IEA],zinc ion binding [goid 8270] [pmid 2251898] [evidence TAS]; gelatinase B activity [goid 4229] [pmid 16192646] [evidence IDA]; collagenase activity [goid 8133] [pmid 2551898] [evidence IDA]; collagen binding [goid 5518] [pmid 2251898] [evidence TAS]; calcium ion binding [goid 5509] [evidence IEA],20,44078320-44078369,20q13.12b,+,NM_004994.2,4318,MMP9,2.7635303428588864,9.1881895909001,11.462421498647942,6.0686850848310645e-21,1.005513000662698e-19,36.85135789160191
SEPT10,ILMN_1691864,"Homo sapiens septin 10 (SEPT10), transcript variant 1, mRNA.",nucleus [goid 5634] [evidence IEA]; nucleus [goid 5634] [evidence IEA]; nucleus [goid 5634] [evidence IEA],cell cycle [goid 7049] [evidence IEA]; cell division [goid 51301] [evidence IEA]; cell cycle [goid 7049] [evidence IEA]; cell division [goid 51301] [evidence IEA]; cell cycle [goid 7049] [evidence IEA]; cell division [goid 51301] [evidence IEA],GTP binding [goid 5525] [evidence IEA]; nucleotide binding [goid 166] [evidence IEA]; GTP binding [goid 5525] [evidence IEA]; nucleotide binding [goid 166] [evidence IEA]; GTP binding [goid 5525] [evidence IEA]; nucleotide binding [goid 166] [evidence IEA],2,109659184-109659190:109660916-109660958,2q13a,-,NM_144710.2,151011,SEPT10,-1.385222444798634,6.817190632417549,-11.461864827545963,6.087243878769648e-21,1.0077310703298776e-19,36.84831671870324
SLC43A2,ILMN_1787127,"Homo sapiens solute carrier family 43, member 2 (SLC43A2), mRNA.",,,,17,1424557-1424606,17p13.3e,-,NM_152346.1,124935,SLC43A2,-1.1134077263882372,9.003138270884138,-11.45851252874444,6.2002131987725155e-21,1.0255615804591042e-19,36.830002464521534
PLA2G5,ILMN_1807171,"Homo sapiens phospholipase A2, group V (PLA2G5), mRNA.",extracellular region [goid 5576] [pmid 8300559] [evidence TAS],lipid catabolism [goid 16042] [evidence IEA]; phospholipid metabolism [goid 6644] [pmid 8300559] [evidence TAS],calcium ion binding [goid 5509] [evidence IEA]; hydrolase activity [goid 16787] [evidence IEA]; calcium-dependent phospholipase A2 activity [goid 47498] [pmid 8300559] [evidence TAS],1,20289860-20289909,1p36.13a,+,NM_000929.1,5322,PLA2G5,-1.0509994817766328,5.660398188476538,-11.457184838488283,6.245533156478382e-21,1.0321816247157022e-19,36.822748955486304
ZNF537,ILMN_1743933,"Homo sapiens zinc finger protein 537 (ZNF537), mRNA.",nucleus [goid 5634] [evidence IEA],"regulation of transcription, DNA-dependent [goid 6355] [evidence IEA]; development [goid 7275] [evidence IEA]",metal ion binding [goid 46872] [evidence IEA]; zinc ion binding [goid 8270] [evidence IEA]; transcription factor activity [goid 3700] [evidence IEA]; sequence-specific DNA binding [goid 43565] [evidence IEA],19,36457754-36457803,19q12d,-,NM_020856.1,57616,ZNF537,-1.2107902114649347,7.917503472674439,-11.456547692882927,6.2673993625063116e-21,1.0349175981223345e-19,36.819268050888795
TSPAN32,ILMN_1718621,"Homo sapiens tetraspanin 32 (TSPAN32), transcript variant 1, mRNA.",membrane [goid 16020] [evidence IEA]; integral to membrane [goid 16021] [evidence NAS]; membrane [goid 16020] [evidence IEA]; integral to membrane [goid 16021] [evidence NAS],cell-cell signaling [goid 7267] [pmid 10950922] [evidence TAS]; cell-cell signaling [goid 7267] [pmid 10950922] [evidence TAS],,11,2295848-2295897,11p15.5a,+,NM_139022.2,10077,TSPAN32,-1.0417854334931205,6.353530634851035,-11.456389945522156,6.2728249206868955e-21,1.0349364401319574e-19,36.81840623131219
TNPO3,ILMN_1683811,"Homo sapiens transportin 3 (TNPO3), mRNA.",nucleus [goid 5634] [evidence IEA],protein transport [goid 15031] [evidence IEA],binding [goid 5488] [evidence IEA]; receptor activity [goid 4872] [pmid 10366588] [evidence TAS],7,128382581-128382630,7q32.1a,-,NM_012470.2,23534,TNPO3,1.204795344237521,9.259645612348667,11.454538356753877,6.3368609728727375e-21,1.0437340325986923e-19,36.808290416452294
ANKRD38,ILMN_1776936,"Homo sapiens ankyrin repeat domain 38 (ANKRD38), mRNA.",,,,1,62475456-62475505,1p31.3d,-,NM_181712.2,163782,ANKRD38,-1.6768393152017795,7.811630878250554,-11.451057944908719,6.459005229421673e-21,1.06295368999393e-19,36.78927558498307
GCN5L2,ILMN_1782247,"Homo sapiens GCN5 general control of amino-acid synthesis 5-like 2 (yeast) (GCN5L2), mRNA.",nucleus [goid 5634] [evidence IEA],protein amino acid acetylation [goid 6473] [pmid 8552087] [evidence TAS]; regulation of transcription from RNA polymerase II promoter [goid 6357] [pmid 8552087] [evidence TAS]; transcription [goid 6350] [evidence IEA]; chromatin remodeling [goid 6338] [pmid 8552087] [evidence TAS],protein binding [goid 5515] [pmid 12887892] [evidence IPI]; histone acetyltransferase activity [goid 4402] [evidence IEA]; N-acetyltransferase activity [goid 8080] [evidence IEA]; histone deacetylase binding [goid 42826] [pmid 12887892] [evidence IPI]; transferase activity [goid 16740] [evidence IEA]; transcription coactivator activity [goid 3713] [pmid 8552087] [evidence TAS],17,37518751-37518800,17q21.2b,-,NM_021078.1,2648,GCN5L2,1.1193539175204155,9.970332025950663,11.443501016536521,6.732389162818963e-21,1.106075909254026e-19,36.74798809560806
LENG4,ILMN_1722218,"Homo sapiens leukocyte receptor cluster (LRC) member 4 (LENG4), mRNA.",,,receptor activity [goid 4872] [evidence IEA],19,59369210-59369259,19q13.42a,-,NM_024298.2,79143,LENG4,1.0571628269807984,9.541702468044877,11.443000283903178,6.750907863730185e-21,1.108183990941724e-19,36.745252277090614
PHLDB2,ILMN_1719792,"Homo sapiens pleckstrin homology-like domain, family B, member 2 (PHLDB2), mRNA.",,,,3,113176934-113176983,3q13.2a,+,NM_145753.1,90102,PHLDB2,-1.3042419002660797,6.324238383592882,-11.436708730698227,6.987981493631705e-21,1.146134843463079e-19,36.71087700533994
TBC1D3B,ILMN_2153679,"Homo sapiens TBC1 domain family, member 3B (TBC1D3B), mRNA.",,,,17,31517652-31517701,17q12b,-,NM_001001417.4,414059,TBC1D3B,1.5774705023968965,7.138586529681408,11.435089283294065,7.050341398043034e-21,1.1553902619080616e-19,36.7020286391136
FEN1,ILMN_1755834,"Homo sapiens flap structure-specific endonuclease 1 (FEN1), mRNA.",nucleus [goid 5634] [evidence IEA],UV protection [goid 9650] [pmid 8007985] [evidence TAS]; double-strand break repair [goid 6302] [pmid 8131753] [evidence TAS]; phosphoinositide-mediated signaling [goid 48015] [pmid 15504738] [evidence NAS]; DNA replication [goid 6260] [pmid 15504738] [evidence NAS],exonuclease activity [goid 4527] [pmid 9778254] [evidence TAS]; hydrolase activity [goid 16787] [evidence IEA]; double-stranded DNA specific exodeoxyribonuclease activity [goid 8309] [pmid 8131753] [evidence TAS]; damaged DNA binding [goid 3684] [pmid 8007985] [evidence TAS]; endonuclease activity [goid 4519] [pmid 8131753] [evidence TAS]; double-stranded DNA binding [goid 3690] [pmid 8131753] [evidence TAS],11,61320359-61320408,11q12.2b,+,NM_004111.4,2237,FEN1,1.0141389726027938,8.140893617241636,11.415683033052415,7.8423996131094e-21,1.2804534490789528e-19,36.59599131456775
EIF1B,ILMN_1679324,"Homo sapiens eukaryotic translation initiation factor 1B (EIF1B), mRNA.",,protein biosynthesis [goid 6412] [evidence IEA]; regulation of translational initiation [goid 6446] [pmid 7904817] [evidence TAS],translation initiation factor activity [goid 3743] [evidence IEA],3,40328048-40328066:40328465-40328495,3p22.1c,+,NM_005875.2,10289,EIF1B,-1.4102466184720885,9.584548512904837,-11.411404045478363,8.028696769759715e-21,1.3091142808265109e-19,36.57260932962972
RBMS3,ILMN_1665040,"Homo sapiens RNA binding motif, single stranded interacting protein (RBMS3), transcript variant 2, mRNA.",,,RNA binding [goid 3723] [evidence IEA]; nucleotide binding [goid 166] [evidence IEA]; RNA binding [goid 3723] [evidence IEA]; nucleotide binding [goid 166] [evidence IEA],3,29952642-29952691,3p24.1b-p24.1a,+,NM_014483.2,27303,RBMS3,-1.4749557239291073,6.4682265058872765,-11.40469954813423,8.329543004177813e-21,1.3558992935372153e-19,36.53597256088784
TBC1D3G,ILMN_2068991,"Homo sapiens TBC1 domain family, member 3G (TBC1D3G), mRNA.",,,,17,31871671-31871720,17q12b,-,NM_001040282.1,654341,TBC1D3G,1.2791269710077868,6.856109126958422,11.400895695093517,8.5052211248849e-21,1.383340848233575e-19,36.515185900620374
GIMAP7,ILMN_1776678,"Homo sapiens GTPase, IMAP family member 7 (GIMAP7), mRNA.",,,GTP binding [goid 5525] [evidence IEA]; nucleotide binding [goid 166] [evidence IEA]; GTP binding [goid 5525] [evidence IEA]; nucleotide binding [goid 166] [evidence IEA],7,149848443-149848492,7q36.1c,+,NM_153236.3,168537,GIMAP7,-1.1381621919723335,7.177703719387035,-11.40016945561181,8.53918121599073e-21,1.387705971589486e-19,36.51121722915907
MCM8,ILMN_1798581,"Homo sapiens minichromosome maintenance complex component 8 (MCM8), transcript variant 1, mRNA.",nucleus [goid 5634] [evidence IEA]; nucleus [goid 5634] [evidence IEA],"DNA replication initiation [goid 6270] [evidence IEA]; transcription [goid 6350] [evidence IEA]; DNA replication [goid 6260] [evidence IEA]; regulation of transcription, DNA-dependent [goid 6355] [evidence IEA]; cell cycle [goid 7049] [evidence IEA]; DNA replication initiation [goid 6270] [evidence IEA]; transcription [goid 6350] [evidence IEA]; DNA replication [goid 6260] [evidence IEA]; regulation of transcription, DNA-dependent [goid 6355] [evidence IEA]; cell cycle [goid 7049] [evidence IEA]",DNA-dependent ATPase activity [goid 8094] [evidence IEA]; nucleoside-triphosphatase activity [goid 17111] [evidence IEA]; nucleotide binding [goid 166] [evidence IEA]; DNA binding [goid 3677] [evidence IEA]; ATP binding [goid 5524] [evidence IEA]; DNA-dependent ATPase activity [goid 8094] [evidence IEA]; nucleoside-triphosphatase activity [goid 17111] [evidence IEA]; nucleotide binding [goid 166] [evidence IEA]; DNA binding [goid 3677] [evidence IEA]; ATP binding [goid 5524] [evidence IEA],20,5923495-5923544,20p12.3c,+,NM_032485.4,84515,MCM8,1.2044329720937021,9.354670623103036,11.393931936982057,8.836503179157392e-21,1.4336325099573838e-19,36.47713062592497
GPD1,ILMN_1764175,"Homo sapiens glycerol-3-phosphate dehydrogenase 1 (soluble) (GPD1), mRNA.",glycerol-3-phosphate dehydrogenase complex [goid 9331] [evidence IEA]; cytoplasm [goid 5737] [evidence IEA],glycerol-3-phosphate catabolism [goid 46168] [evidence IEA]; carbohydrate metabolism [goid 5975] [evidence IEA],glycerol-3-phosphate dehydrogenase (NAD+) activity [goid 4367] [pmid 7772607] [evidence TAS]; NAD binding [goid 51287] [evidence IEA],12,48791043-48791092,12q13.13a,+,NM_005276.2,2819,GPD1,-1.6844854672157634,5.844469073325247,-11.390897447709037,8.984872039436248e-21,1.4540716917642466e-19,36.4605475082012
RHBDD3,ILMN_1815264,"Homo sapiens rhomboid domain containing 3 (RHBDD3), mRNA.",membrane [goid 16020] [evidence IEA]; integral to membrane [goid 16021] [evidence IEA],,,22,27986094-27986143,22q12.2a,-,NM_012265.1,25807,RHBDD3,1.1658524835619444,7.300771078685935,11.387955005702265,9.131121153691218e-21,1.476513657092725e-19,36.444467211298374
ELF3,ILMN_1769201,"Homo sapiens E74-like factor 3 (ets domain transcription factor, epithelial-specific ) (ELF3), mRNA.",nucleus [goid 5634] [pmid 9234700] [evidence NAS],"morphogenesis [goid 9653] [evidence NR ]; regulation of transcription, DNA-dependent [goid 6355] [evidence IEA]; transcription [goid 6350] [evidence IEA]; epidermis development [goid 8544] [pmid 9234700] [evidence NAS]; transcription from RNA polymerase II promoter [goid 6366] [pmid 9234700] [evidence TAS]",transcription coactivator activity [goid 3713] [pmid 9234700] [evidence TAS]; sequence-specific DNA binding [goid 43565] [evidence IEA]; transcription factor activity [goid 3700] [pmid 10821850] [evidence TAS],1,200251463-200251512,1q32.1c,+,NM_004433.3,1999,ELF3,1.511527633289571,10.719533335440337,11.374538028965729,9.82878358165362e-21,1.585379537156629e-19,36.371141564169605
BCMO1,ILMN_1814686,"Homo sapiens beta-carotene 15,15'-monooxygenase 1 (BCMO1), mRNA.",,,"oxidoreductase activity [goid 16491] [evidence IEA]; beta-carotene 15,15'-monooxygenase activity [goid 3834] [evidence IEA]; iron ion binding [goid 5506] [evidence IEA]",16,79882169-79882218,16q23.2b,+,NM_017429.2,53630,BCMO1,1.7384403043236416,5.954887443596622,11.361280981703116,1.0570521184317181e-20,1.7022033493919033e-19,36.298685920903516
TFAP2C,ILMN_1683891,"Homo sapiens transcription factor AP-2 gamma (activating enhancer binding protein 2 gamma) (TFAP2C), mRNA.",nucleus [goid 5634] [evidence IEA],cell-cell signaling [goid 7267] [pmid 9113991] [evidence TAS]; transcription [goid 6350] [evidence IEA]; regulation of transcription from RNA polymerase II promoter [goid 6357] [pmid 9113991] [evidence TAS],transcription factor activity [goid 3700] [pmid 9113991] [evidence TAS],20,54647265-54647314,20q13.31a,+,NM_003222.3,7022,TFAP2C,1.282707175128528,7.965528057492861,11.353114908310395,1.1055039844134336e-20,1.7787568238064207e-19,36.25405275386769
SYT11,ILMN_1717934,"Homo sapiens synaptotagmin XI (SYT11), mRNA.",synapse [goid 45202] [evidence IEA]; membrane [goid 16020] [evidence IEA]; integral to membrane [goid 16021] [evidence IEA]; synaptic vesicle [goid 8021] [evidence IEA],transport [goid 6810] [evidence IEA],transporter activity [goid 5215] [evidence IEA]; calcium ion binding [goid 5509] [evidence IEA],1,154121345-154121394,1q22c,+,NM_152280.2,23208,SYT11,-1.0819117404143963,9.667920861564928,-11.350384806819594,1.1221933912696566e-20,1.8041203159149554e-19,36.23913055766594
FAM83E,ILMN_1658301,"Homo sapiens family with sequence similarity 83, member E (FAM83E), mRNA.",,,,19,53796039-53796088,19q13.32c-q13.33a,-,NM_017708.1,54854,FAM83E,1.6357924168500562,7.7067642980875695,11.345825242453314,1.150630680364693e-20,1.8483131745182227e-19,36.21420851596017
COL1A1,ILMN_1701308,"Homo sapiens collagen, type I, alpha 1 (COL1A1), mRNA.",collagen [goid 5581] [evidence IEA]; collagen type I [goid 5584] [evidence NR ]; cytoplasm [goid 5737] [evidence IEA],epidermis development [goid 8544] [pmid 1303238] [evidence TAS]; skeletal development [goid 1501] [pmid 1874719] [evidence TAS]; phosphate transport [goid 6817] [evidence IEA],extracellular matrix structural constituent [goid 5201] [evidence IEA]; structural constituent of bone [goid 8147] [evidence NR ],17,45616596-45616645,17q21.33a,-,NM_000088.2,1277,COL1A1,2.7263856782169906,11.184693637754007,11.344522680929424,1.1588862177162089e-20,1.860041017479434e-19,36.20708878532494
E2F3,ILMN_1669502,"Homo sapiens E2F transcription factor 3 (E2F3), mRNA.",transcription factor complex [goid 5667] [evidence IEA]; nucleus [goid 5634] [evidence IEA],"transcription [goid 6350] [evidence IEA]; transcription initiation from RNA polymerase II promoter [goid 6367] [pmid 8246996] [evidence TAS]; regulation of transcription, DNA-dependent [goid 6355] [evidence IEA]; cell cycle [goid 7049] [evidence IEA]",transcription factor activity [goid 3700] [pmid 8246996] [evidence TAS]; protein binding [goid 5515] [pmid 8246996] [evidence TAS],6,20601815-20601864,6p22.3c,+,NM_001949.2,1871,E2F3,1.1451984283879302,9.013924761638815,11.34363275619046,1.1645605561241437e-20,1.866653347020106e-19,36.20222448390862
RNASE4,ILMN_1696974,"Homo sapiens ribonuclease, RNase A family, 4 (RNASE4), transcript variant 1, mRNA.",cellular component unknown [goid 8372] [pmid 7742370] [evidence ND ],mRNA cleavage [goid 6379] [pmid 7742370] [evidence NAS],pancreatic ribonuclease activity [goid 4522] [pmid 7742370] [evidence NAS]; nucleic acid binding [goid 3676] [evidence IEA]; endonuclease activity [goid 4519] [evidence IEA]; hydrolase activity [goid 16787] [evidence IEA],14,20231551-20231600,14q11.2b,+,NM_194430.1,6038,RNASE4,-1.5180693370790515,8.981850786470575,-11.33985872184006,1.1889352220102195e-20,1.903566376406666e-19,36.181595538210374
KIAA0963,ILMN_1808811,"Homo sapiens strawberry notch homolog 2 (Drosophila) (SBNO2), mRNA.",,,,19,1058865-1058914,19p13.3i,-,NM_014963.1,22904,KIAA0963,1.278693793165127,8.170902972652366,11.33466122896097,1.2233413451897713e-20,1.9570448367013706e-19,36.15318544191475
ETS2,ILMN_1720158,"Homo sapiens v-ets erythroblastosis virus E26 oncogene homolog 2 (avian) (ETS2), mRNA.",nucleus [goid 5634] [evidence IEA],"regulation of transcription, DNA-dependent [goid 6355] [evidence IEA]; skeletal development [goid 1501] [pmid 8596630] [evidence TAS]",transcription factor activity [goid 3700] [pmid 8596630] [evidence NAS],21,39118265-39118314,21q22.2a,+,NM_005239.4,2114,ETS2,-1.335617368869137,10.512846474756136,-11.331294747445849,1.2461566106947559e-20,1.9886455003593217e-19,36.13478355946101
LOC653617,ILMN_1675482,"PREDICTED: Homo sapiens similar to breakpoint cluster region isoform 1 (LOC653617), mRNA.",,,,22,19975109-19975135:19975855-19975877,,-,XM_928425.1,653617,LOC653617,1.1169961650613436,7.797821723658124,11.32344111929437,1.3010514997830402e-20,2.0728526960975092e-19,36.09185308327352
HS6ST2,ILMN_1739429,"Homo sapiens heparan sulfate 6-O-sulfotransferase 2 (HS6ST2), mRNA.",membrane [goid 16020] [evidence IEA]; integral to membrane [goid 16021] [evidence IEA],,transferase activity [goid 16740] [evidence IEA],X,131587967-131588016,Xq26.2a-q26.2b,-,NM_147175.2,90161,HS6ST2,2.0267037860033277,6.202718346456879,11.322664892039263,1.3066068577486714e-20,2.0786652322744007e-19,36.087609903852886
ASNS,ILMN_1796417,"Homo sapiens asparagine synthetase (ASNS), transcript variant 1, mRNA.",soluble fraction [goid 5625] [pmid 2564390] [evidence IDA],metabolism [goid 8152] [evidence IEA]; amino acid biosynthesis [goid 8652] [evidence IEA]; glutamine metabolism [goid 6541] [evidence IEA]; asparagine biosynthesis [goid 6529] [evidence NAS],ligase activity [goid 16874] [evidence IEA]; asparagine synthase (glutamine-hydrolyzing) activity [goid 4066] [pmid 2886907] [evidence IDA],7,97319516-97319565,7q21.3d,-,NM_133436.1,440,ASNS,1.0611293685352141,8.102734551397818,11.322633306241425,1.3068334152097208e-20,2.0786652322744007e-19,36.0874372425459
BPHL,ILMN_1657746,"Homo sapiens biphenyl hydrolase-like (serine hydrolase; breast epithelial mucin-associated antigen) (BPHL), mRNA.",mitochondrion [goid 5739] [evidence ISS],response to toxin [goid 9636] [pmid 7759552] [evidence TAS]; aromatic compound metabolism [goid 6725] [evidence IEA]; amino acid and derivative metabolism [goid 6519] [pmid 7759552] [evidence TAS],hydrolase activity [goid 16787] [evidence IEA]; serine esterase activity [goid 4759] [evidence IEA],6,3097823-3097872,6p25.2b,+,NM_004332.1,670,BPHL,1.0357340751978867,9.608417626970521,11.321353208575454,1.3160484144175658e-20,2.0916152818047528e-19,36.08043967087219
SCARA3,ILMN_1654966,"Homo sapiens scavenger receptor class A, member 3 (SCARA3), transcript variant 2, mRNA.",membrane [goid 16020] [evidence IEA]; integral to membrane [goid 16021] [evidence IEA]; cytoplasm [goid 5737] [evidence IEA]; membrane [goid 16020] [evidence IEA]; integral to membrane [goid 16021] [evidence IEA]; cytoplasm [goid 5737] [evidence IEA],phosphate transport [goid 6817] [evidence IEA]; phosphate transport [goid 6817] [evidence IEA],,8,27590114-27590163,8p21.1e,+,NM_182826.1,51435,SCARA3,-1.2474273560974751,6.517820958825947,-11.314258633906565,1.3683116012248286e-20,2.1729055867861273e-19,36.04165702340712
H3F3B,ILMN_1695706,"Homo sapiens H3 histone, family 3B (H3.3B) (H3F3B), mRNA.",,,,17,71284232-71284281,17q25.1d,-,NM_005324.3,3021,H3F3B,-1.1077320503048593,11.126501103044172,-11.303862404776831,1.44867223253013e-20,2.294908817142243e-19,35.984823964062315
KLF9,ILMN_1778523,"Homo sapiens Kruppel-like factor 9 (KLF9), mRNA.",nucleus [goid 5634] [evidence IEA],transcription [goid 6350] [evidence IEA]; regulation of transcription from RNA polymerase II promoter [goid 6357] [pmid 1356762] [evidence TAS],metal ion binding [goid 46872] [evidence IEA]; zinc ion binding [goid 8270] [evidence IEA]; transcription factor activity [goid 3700] [pmid 8051167] [evidence TAS],9,72189657-72189706,9q21.11c,-,NM_001206.2,687,KLF9,-1.5683761646758771,11.178943897388624,-11.295079037178448,1.5202360436111695e-20,2.404366827091204e-19,35.9368062544565
GYG2,ILMN_1684017,"Homo sapiens glycogenin 2 (GYG2), mRNA.",soluble fraction [goid 5625] [pmid 9346895] [evidence TAS],carbohydrate biosynthesis [goid 16051] [evidence IEA]; glycogen biosynthesis [goid 5978] [pmid 9346895] [evidence TAS],"transferase activity [goid 16740] [evidence IEA]; transferase activity, transferring hexosyl groups [goid 16758] [evidence IEA]; glycogenin glucosyltransferase activity [goid 8466] [pmid 9346895] [evidence TAS]",X,2810548-2810597,Xp22.33c,+,NM_003918.1,8908,GYG2,1.3304400038637336,6.2401275158036675,11.292538097724133,1.5415909971720717e-20,2.4361638750930913e-19,35.922914933939296
LRRC33,ILMN_1746148,"Homo sapiens leucine rich repeat containing 33 (LRRC33), mRNA.",membrane [goid 16020] [evidence IEA]; integral to membrane [goid 16021] [evidence IEA],,transferase activity [goid 16740] [evidence IEA],3,197872952-197872990:197872991-197873001,3q29g,+,NM_198565.1,375387,LRRC33,-1.2237814468690837,7.700725792632523,-11.292369541946169,1.5430181716295818e-20,2.43644319888188e-19,35.921993434753055
TMEM16F,ILMN_1674941,"Homo sapiens transmembrane protein 16F (TMEM16F), mRNA.",membrane [goid 16020] [evidence IEA]; integral to membrane [goid 16021] [evidence IEA],,,12,44111807-44111856,12q12h,+,NM_001025356.1,196527,TMEM16F,-1.2934814909037886,9.427291037351662,-11.291474335903484,1.5506201388759045e-20,2.446464243400567e-19,35.917099308848826
SIX1,ILMN_1812702,"Homo sapiens sine oculis homeobox homolog 1 (Drosophila) (SIX1), mRNA.",nucleus [goid 5634] [evidence IEA],"muscle development [goid 7517] [pmid 8617500] [evidence TAS]; development [goid 7275] [evidence IEA]; regulation of transcription, DNA-dependent [goid 6355] [evidence IEA]",protein binding [goid 5515] [pmid 16189514] [evidence IPI]; transcription factor activity [goid 3700] [evidence IEA]; sequence-specific DNA binding [goid 43565] [evidence IEA],14,60182827-60182876,14q23.1c,-,NM_005982.1,6495,SIX1,1.61024932801336,6.048247139673659,11.287239126110856,1.587096228816231e-20,2.50198786557316e-19,35.893945043545
CLDN9,ILMN_1740276,"Homo sapiens claudin 9 (CLDN9), mRNA.",membrane [goid 16020] [evidence IEA]; integral to membrane [goid 16021] [evidence ISS]; tight junction [goid 5923] [evidence ISS],calcium-independent cell-cell adhesion [goid 16338] [evidence ISS],structural molecule activity [goid 5198] [evidence IEA],16,3004266-3004315,16p13.3d,+,NM_020982.2,9080,CLDN9,1.5292511218657046,6.24687493596456,11.281602499854161,1.63697757593303e-20,2.576454609616728e-19,35.863128576489274
BTN3A3,ILMN_1700067,"Homo sapiens butyrophilin, subfamily 3, member A3 (BTN3A3), transcript variant 1, mRNA.",membrane [goid 16020] [evidence IEA]; integral to membrane [goid 16021] [evidence IEA],,,6,26551781-26551781:26551782-26551830,6p22.1d,+,NM_006994.3,10384,BTN3A3,-1.3703176985041141,7.735718262481226,-11.280594466904505,1.646062151691805e-20,2.588661906837354e-19,35.857617412095415
KIAA1794,ILMN_1655642,"Homo sapiens KIAA1794 (KIAA1794), mRNA.",,,,15,87661081-87661130,15q26.1a,+,NM_018193.1,55215,KIAA1794,1.1128245540184958,5.909852726455902,11.272968878437228,1.7164399183149553e-20,2.6928205964868684e-19,35.815925821107534
RERG,ILMN_1746359,"Homo sapiens RAS-like, estrogen-regulated, growth inhibitor (RERG), mRNA.",nucleus [goid 5634] [pmid 11533059] [evidence IDA]; cytosol [goid 5829] [pmid 11533059] [evidence IEP]; intracellular [goid 5622] [evidence IEA],response to hormone stimulus [goid 9725] [pmid 11533059] [evidence IDA]; negative regulation of cell growth [goid 30308] [pmid 11533059] [evidence IDA]; negative regulation of cell proliferation [goid 8285] [pmid 11533059] [evidence IDA]; small GTPase mediated signal transduction [goid 7264] [pmid 11533059] [evidence NAS],GDP binding [goid 19003] [pmid 11533059] [evidence TAS]; GTPase activity [goid 3924] [pmid 11533059] [evidence IDA]; nucleotide binding [goid 166] [evidence IEA]; estrogen receptor binding [goid 30331] [pmid 11533059] [evidence NAS]; GTP binding [goid 5525] [evidence IEA],12,15152396-15152445,12p12.3e,-,NM_032918.1,85004,RERG,-1.7734674087517055,7.6147579097298586,-11.26624333737933,1.7810061186288527e-20,2.7918667917524695e-19,35.779154184406245
HEY1,ILMN_1788203,"Homo sapiens hairy/enhancer-of-split related with YRPW motif 1 (HEY1), mRNA.",nucleus [goid 5634] [evidence IEA],"regulation of transcription, DNA-dependent [goid 6355] [evidence IEA]",transcription regulator activity [goid 30528] [evidence IEA]; transcription factor activity [goid 3700] [pmid 10415358] [evidence TAS]; DNA binding [goid 3677] [evidence IEA],8,80838956-80839005,8q21.13a,-,NM_012258.2,23462,HEY1,-1.5242168670797405,7.855665181289613,-11.263574727578195,1.8072937224972197e-20,2.8307972815802516e-19,35.76456343234778
PRSS22,ILMN_1776925,"Homo sapiens protease, serine, 22 (PRSS22), mRNA.",,,serine-type endopeptidase activity [goid 4252] [evidence IEA]; peptidase activity [goid 8233] [evidence IEA],16,2842952-2843001,16p13.3d,-,NM_022119.3,64063,PRSS22,1.2369939039745548,5.925565690789604,11.259655239184223,1.846608930781691e-20,2.890054218175201e-19,35.74313320631294
SLC1A4,ILMN_1656904,"Homo sapiens solute carrier family 1 (glutamate/neutral amino acid transporter), member 4 (SLC1A4), mRNA.",membrane fraction [goid 5624] [pmid 8910405] [evidence TAS]; integral to plasma membrane [goid 5887] [pmid 8910405] [evidence TAS]; membrane [goid 16020] [evidence IEA],transport [goid 6810] [evidence IEA]; neutral amino acid transport [goid 15804] [pmid 8910405] [evidence TAS]; dicarboxylic acid transport [goid 6835] [evidence IEA],symporter activity [goid 15293] [evidence IEA]; sodium:dicarboxylate symporter activity [goid 17153] [evidence IEA]; neutral amino acid transporter activity [goid 15175] [pmid 8910405] [evidence TAS],2,65104245-65104294,2p14c,+,NM_003038.2,6509,SLC1A4,1.2113102705288883,7.049671498058086,11.253288464437631,1.9123047793403674e-20,2.985677774474925e-19,35.70832158705882
LRRC20,ILMN_1690523,"Homo sapiens leucine rich repeat containing 20 (LRRC20), transcript variant 1, mRNA.",,,transferase activity [goid 16740] [evidence IEA]; transferase activity [goid 16740] [evidence IEA],10,71728811-71728860,10q22.1a-q22.1b,-,NM_207119.1,55222,LRRC20,1.218353339824894,8.290685114362885,11.251417917320511,1.9320469853378633e-20,3.014086109632367e-19,35.69809385742787
WFS1,ILMN_1759023,"Homo sapiens Wolfram syndrome 1 (wolframin) (WFS1), mRNA.",integral to membrane [goid 16021] [pmid 9771706] [evidence TAS]; membrane fraction [goid 5624] [pmid 9771706] [evidence TAS]; membrane [goid 16020] [evidence IEA]; endoplasmic reticulum [goid 5783] [evidence IEA],visual perception [goid 7601] [pmid 9771706] [evidence TAS]; generation of precursor metabolites and energy [goid 6091] [pmid 9771706] [evidence TAS],,4,6355789-6355838,4p16.1f,+,NM_006005.2,7466,WFS1,-1.2488651721961688,11.45506674489643,-11.248398944432239,1.9643411141908674e-20,3.0595672749807396e-19,35.6815866640164
BRAF,ILMN_1652472,"Homo sapiens v-raf murine sarcoma viral oncogene homolog B1 (BRAF), mRNA.",,anti-apoptosis [goid 6916] [pmid 9207797] [evidence TAS]; intracellular signaling cascade [goid 7242] [evidence IEA]; protein amino acid phosphorylation [goid 6468] [pmid 2284096] [evidence TAS],metal ion binding [goid 46872] [evidence IEA]; nucleotide binding [goid 166] [evidence IEA]; transferase activity [goid 16740] [evidence IEA]; protein serine/threonine kinase activity [goid 4674] [evidence IEA]; zinc ion binding [goid 8270] [evidence IEA]; diacylglycerol binding [goid 19992] [evidence IEA]; receptor signaling protein activity [goid 5057] [evidence IEA]; ATP binding [goid 5524] [evidence IEA],7,140086150-140086199,7q34d,-,NM_004333.2,673,BRAF,1.0191703297338934,5.831838761780422,11.241381357272147,2.0415113887382064e-20,3.17722439373514e-19,35.64321515867436
FLJ20152,ILMN_1811330,"Homo sapiens hypothetical protein FLJ20152 (FLJ20152), mRNA.",,,,5,16526588-16526637,5p15.1b,-,NM_019000.2,54463,FLJ20152,-1.4246381669801336,6.854867648297184,-11.232486609903427,2.1436993176901147e-20,3.3309394900471996e-19,35.59457829504573
NR2C2,ILMN_1724479,"Homo sapiens nuclear receptor subfamily 2, group C, member 2 (NR2C2), mRNA.",nucleus [goid 5634] [evidence IEA],"regulation of transcription, DNA-dependent [goid 6355] [pmid 9006963] [evidence TAS]; transcription [goid 6350] [evidence IEA]",metal ion binding [goid 46872] [evidence IEA]; transcription coactivator activity [goid 3713] [pmid 9006963] [evidence TAS]; steroid hormone receptor activity [goid 3707] [evidence IEA]; transcription factor activity [goid 3700] [pmid 9006963] [evidence TAS],3,15059518-15059519:15059520-15059567,3p24.3e,+,NM_003298.2,7182,NR2C2,1.2241085683653736,6.3461108039220235,11.231591584735074,2.1542611745501648e-20,3.3420206199132134e-19,35.58968418399546
WDR51A,ILMN_1780667,"Homo sapiens WD repeat domain 51A (WDR51A), mRNA.",,,,3,52084332-52084381,3p21.1e,-,NM_015426.2,25886,WDR51A,1.3872609944000462,8.081826623452018,11.224131825178763,2.2443414066929137e-20,3.478997001544266e-19,35.54889274964389
SNURF,ILMN_1656537,"Homo sapiens SNRPN upstream reading frame (SNURF), transcript variant 1, mRNA.",nucleus [goid 5634] [pmid 10318933] [evidence NAS],,,15,22770551-22770600,15q11.2e,+,NM_005678.3,8926,SNURF,-1.002908833624141,7.909466257732544,-11.219626541027228,2.3005607079159868e-20,3.5604785856825263e-19,35.524256520574994
ZNF651,ILMN_1699440,"Homo sapiens zinc finger protein 651 (ZNF651), mRNA.",nucleus [goid 5634] [evidence IEA],"regulation of transcription, DNA-dependent [goid 6355] [evidence IEA]; transcription [goid 6350] [evidence IEA]",metal ion binding [goid 46872] [evidence IEA]; nucleic acid binding [goid 3676] [evidence IEA]; zinc ion binding [goid 8270] [evidence IEA]; protein binding [goid 5515] [evidence IEA]; DNA binding [goid 3677] [evidence IEA],3,42683889-42683938,3p22.1a,+,NM_145166.2,92999,ZNF651,-1.0827766832752674,6.83497907401479,-11.21482236564538,2.3620632096988947e-20,3.6527620349986477e-19,35.49798549920234
FOXO1A,ILMN_1738816,"Homo sapiens forkhead box O1A (rhabdomyosarcoma) (FOXO1A), mRNA.",nucleus [goid 5634] [evidence IEA],anti-apoptosis [goid 6916] [pmid 10871843] [evidence TAS]; transcription [goid 6350] [evidence IEA]; regulation of transcription from RNA polymerase II promoter [goid 6357] [pmid 10871843] [evidence TAS],transcription factor activity [goid 3700] [pmid 10871843] [evidence TAS]; sequence-specific DNA binding [goid 43565] [evidence IEA],13,40028101-40028150,13q14.11a,-,NM_002015.2,2308,FOXO1A,-1.1241672025973042,9.44606173248993,-11.211841808824959,2.4010442422798225e-20,3.710098894593366e-19,35.48168651562712
TRAF2,ILMN_1691487,"Homo sapiens TNF receptor-associated factor 2 (TRAF2), mRNA.",,regulation of apoptosis [goid 42981] [evidence IEA]; signal transduction [goid 7165] [pmid 8702708] [evidence TAS]; protein complex assembly [goid 6461] [pmid 8702708] [evidence TAS],zinc ion binding [goid 8270] [evidence IEA]; metal ion binding [goid 46872] [evidence IEA]; receptor activity [goid 4872] [evidence IEA]; signal transducer activity [goid 4871] [pmid 8702708] [evidence NAS]; protein binding [goid 5515] [pmid 11777919] [evidence IPI],9,138940540-138940589,9q34.3e,+,NM_021138.3,7186,TRAF2,1.166288368355243,7.602404197163303,11.20788372301796,2.4538067008680083e-20,3.788623103519266e-19,35.46004175718746
HES6,ILMN_1694268,"Homo sapiens hairy and enhancer of split 6 (Drosophila) (HES6), mRNA.",nucleus [goid 5634] [evidence IEA]; transcription factor complex [goid 5667] [pmid 10851137] [evidence ISS],"cell differentiation [goid 30154] [evidence IEA]; regulation of transcription, DNA-dependent [goid 6355] [evidence NAS]",transcription cofactor activity [goid 3712] [pmid 10851137] [evidence ISS]; transcription factor activity [goid 3700] [pmid 10851137] [evidence TAS],2,238811723-238811772,2q37.3c,-,NM_018645.3,55502,HES6,1.651532782130852,8.695653944080842,11.192118650991464,2.675728500644286e-20,4.121467971150507e-19,35.37382815040277
KIAA0256,ILMN_1784333,"Homo sapiens KIAA0256 gene product (KIAA0256), mRNA.",,,,15,47068447-47068496,15q21.1d,-,NM_014701.2,9728,KIAA0256,-1.3023673832472742,9.773205899441095,-11.19185699664434,2.6795763867570724e-20,4.1241347469163947e-19,35.37239722287911
CNN1,ILMN_1810054,"Homo sapiens calponin 1, basic, smooth muscle (CNN1), mRNA.",,actomyosin structure organization and biogenesis [goid 31032] [evidence IEA]; regulation of smooth muscle contraction [goid 6940] [pmid 14550641] [evidence TAS],calmodulin binding [goid 5516] [evidence IEA]; actin binding [goid 3779] [evidence IEA],19,11521806-11521855,19p13.2a,+,NM_001299.4,1264,CNN1,-1.8982722090901598,7.586551039238178,-11.179652963000335,2.8653378808424814e-20,4.399614547534732e-19,35.30565502191828
MMP25,ILMN_1717207,"Homo sapiens matrix metallopeptidase 25 (MMP25), transcript variant 2, mRNA.",extracellular matrix (sensu Metazoa) [goid 5578] [pmid 10628838] [evidence NAS]; membrane [goid 16020] [pmid 11034316] [evidence NAS]; cell surface [goid 9986] [pmid 12493773] [evidence IEP],peptidoglycan metabolism [goid 270] [evidence IEA]; inflammatory response [goid 6954] [pmid 10628838] [evidence NAS],metalloendopeptidase activity [goid 4222] [evidence IEA]; zinc ion binding [goid 8270] [evidence IEA]; calcium ion binding [goid 5509] [evidence IEA],16,3050524-3050573,16p13.3d,+,NM_022718.2,64386,MMP25,-1.6737628271991376,6.942545473415986,-11.175480784554464,2.9317560761565956e-20,4.498052531016635e-19,35.28283743940831
GCAT,ILMN_1724437,"Homo sapiens glycine C-acetyltransferase (2-amino-3-ketobutyrate coenzyme A ligase) (GCAT), nuclear gene encoding mitochondrial protein, mRNA.",mitochondrion [goid 5739] [evidence NAS],biosynthesis [goid 9058] [evidence IEA]; amino acid metabolism [goid 6520] [pmid 10712613] [evidence NAS],"acyltransferase activity [goid 8415] [evidence IEA]; ligase activity [goid 16874] [evidence IEA]; glycine C-acetyltransferase activity [goid 8890] [pmid 10712613] [evidence NAS]; transferase activity, transferring nitrogenous groups [goid 16769] [evidence IEA]",22,36542575-36542624,22q13.1a,+,NM_014291.2,23464,GCAT,1.4699814686564334,8.239723524815618,11.173087739169109,2.970544663248979e-20,4.553515215523051e-19,35.26974979522551
ALDH3B2,ILMN_1763666,"Homo sapiens aldehyde dehydrogenase 3 family, member B2 (ALDH3B2), transcript variant 1, mRNA.",,metabolism [goid 8152] [evidence IEA]; lipid metabolism [goid 6629] [pmid 8890755] [evidence TAS]; aldehyde metabolism [goid 6081] [evidence IEA]; alcohol metabolism [goid 6066] [pmid 8890755] [evidence TAS]; metabolism [goid 8152] [evidence IEA]; lipid metabolism [goid 6629] [pmid 8890755] [evidence TAS]; aldehyde metabolism [goid 6081] [evidence IEA]; alcohol metabolism [goid 6066] [pmid 8890755] [evidence TAS],oxidoreductase activity [goid 16491] [evidence IEA]; aldehyde dehydrogenase [NAD(P)+] activity [goid 4030] [evidence IEA]; oxidoreductase activity [goid 16491] [evidence IEA]; aldehyde dehydrogenase [NAD(P)+] activity [goid 4030] [evidence IEA],11,67186363-67186412,11q13.2a,-,NM_000695.3,222,ALDH3B2,1.5392051648205953,6.031035884146582,11.171812455930157,2.991424899009599e-20,4.5787835158839e-19,35.262775195366594
PPAN,ILMN_1798459,"Homo sapiens peter pan homolog (Drosophila) (PPAN), mRNA.",nucleus [goid 5634] [pmid 15302935] [evidence IDA],RNA splicing [goid 8380] [pmid 10944437] [evidence TAS],,19,10082538-10082542:10082621-10082665,19p13.2c,+,NM_020230.4,56342,PPAN,1.0550681188773634,7.581454758582539,11.168980480622396,3.038319573910967e-20,4.646911844399936e-19,35.24728687067468
ABCG2,ILMN_1789641,"Homo sapiens ATP-binding cassette, sub-family G (WHITE), member 2 (ABCG2), mRNA.",integral to membrane [goid 16021] [pmid 9850061] [evidence TAS]; membrane [goid 16020] [evidence IEA],transport [goid 6810] [pmid 9850061] [evidence TAS]; response to drug [goid 42493] [pmid 9861027] [evidence TAS],nucleotide binding [goid 166] [evidence IEA]; ATPase activity [goid 16887] [evidence IEA]; transporter activity [goid 5215] [pmid 9861027] [evidence TAS]; xenobiotic-transporting ATPase activity [goid 8559] [pmid 9861027] [evidence TAS]; ATP binding [goid 5524] [pmid 9850061] [evidence TAS],4,89230773-89230822,4q22.1b,-,NM_004827.2,9429,ABCG2,-1.316188880702331,5.45970513134364,-11.151370616030217,3.346888353477517e-20,5.098836557272042e-19,35.15097443229861
C8orf72,ILMN_1679217,"Homo sapiens chromosome 8 open reading frame 72 (C8orf72), mRNA.",,,,8,59223712-59223761,8q12.1c,+,NM_147189.1,90362,C8orf72,-1.0362644153825276,6.390707635500057,-11.149883287072946,3.3743437067780584e-20,5.136647431763318e-19,35.142839690228314
ENC1,ILMN_1779147,"Homo sapiens ectodermal-neural cortex (with BTB-like domain) (ENC1), mRNA.",nucleus [goid 5634] [pmid 9566959] [evidence TAS]; cytoskeleton [goid 5856] [evidence IEA],development [goid 7275] [pmid 9566959] [evidence TAS],actin binding [goid 3779] [evidence IEA]; protein binding [goid 5515] [evidence IEA],5,73959244-73959293,5q13.3a,-,NM_003633.1,8507,ENC1,1.2965424485621782,9.392088582176692,11.144791540250809,3.470052527342587e-20,5.274100896666951e-19,35.11499085445723
AK3L1,ILMN_1764090,"Homo sapiens adenylate kinase 3-like 1 (AK3L1), nuclear gene encoding mitochondrial protein, transcript variant 5, mRNA.",mitochondrion [goid 5739] [evidence IEA],"nucleobase, nucleoside, nucleotide and nucleic acid metabolism [goid 6139] [evidence IEA]",kinase activity [goid 16301] [evidence IEA]; ATP binding [goid 5524] [evidence IEA]; transferase activity [goid 16740] [evidence IEA]; GTP binding [goid 5525] [evidence IEA]; adenylate kinase activity [goid 4017] [evidence IEA]; nucleotide binding [goid 166] [evidence IEA],1,65465168-65465217,1p31.3b,+,NM_001005353.1,205,AK3L1,1.6644874076789273,6.789317945395782,11.143927696147077,3.486557502232537e-20,5.295056346921355e-19,35.11026610537261
AK1,ILMN_1779965,"Homo sapiens adenylate kinase 1 (AK1), mRNA.",cytoplasm [goid 5737] [evidence IEA]; cytosol [goid 5829] [evidence NR ],"nucleobase, nucleoside, nucleotide and nucleic acid metabolism [goid 6139] [evidence IEA]; ATP metabolism [goid 46034] [evidence IEA]",ATP binding [goid 5524] [evidence IEA]; nucleotide binding [goid 166] [evidence IEA]; adenylate kinase activity [goid 4017] [pmid 2542324] [evidence TAS]; transferase activity [goid 16740] [evidence IEA]; kinase activity [goid 16301] [evidence IEA],9,129668725-129668774,9q34.11a,-,NM_000476.1,203,AK1,-1.4606770315656927,9.38445511814483,-11.142237987250569,3.519069245822135e-20,5.33611394979333e-19,35.101024304661486
ID1,ILMN_1664861,"Homo sapiens inhibitor of DNA binding 1, dominant negative helix-loop-helix protein (ID1), transcript variant 2, mRNA.",nucleus [goid 5634] [pmid 15138269] [evidence IC ]; nucleus [goid 5634] [pmid 15138269] [evidence IC ],negative regulation of transcription factor activity [goid 43433] [pmid 15138269] [evidence IDA]; development [goid 7275] [evidence IEA]; negative regulation of transcription [goid 16481] [pmid 15138269] [evidence IDA]; regulation of transcription from RNA polymerase II promoter [goid 6357] [evidence NR ]; negative regulation of transcription factor activity [goid 43433] [pmid 15138269] [evidence IDA]; development [goid 7275] [evidence IEA]; negative regulation of transcription [goid 16481] [pmid 15138269] [evidence IDA]; regulation of transcription from RNA polymerase II promoter [goid 6357] [evidence NR ],transcriptional repressor activity [goid 16564] [pmid 15138269] [evidence IDA]; protein binding [goid 5515] [pmid 15138269] [evidence IPI]; transcriptional repressor activity [goid 16564] [pmid 15138269] [evidence IDA]; protein binding [goid 5515] [pmid 15138269] [evidence IPI],20,29657653-29657702,20q11.21b,+,NM_181353.1,3397,ID1,-1.7810100662464876,9.28581705388572,-11.13846393059399,3.592785653887682e-20,5.443656956920799e-19,35.08038210593213
PPP1R16B,ILMN_1727098,"Homo sapiens protein phosphatase 1, regulatory (inhibitor) subunit 16B (PPP1R16B), mRNA.",plasma membrane [goid 5886] [pmid 12055102] [evidence NAS],signal transduction [goid 7165] [pmid 12055102] [evidence NAS],protein phosphatase binding [goid 19903] [pmid 12055102] [evidence NAS],20,36984885-36984934,20q11.23c,+,NM_015568.2,26051,PPP1R16B,-1.4304592015835675,8.00649305501742,-11.135589895943365,3.649957102983624e-20,5.5259840055661155e-19,35.06466245305388
GPR110,ILMN_1744299,"Homo sapiens G protein-coupled receptor 110 (GPR110), transcript variant 1, mRNA.",membrane [goid 16020] [evidence IEA]; integral to membrane [goid 16021] [pmid 15203201] [evidence TAS]; membrane [goid 16020] [evidence IEA]; integral to membrane [goid 16021] [pmid 15203201] [evidence TAS],neuropeptide signaling pathway [goid 7218] [evidence IEA]; signal transduction [goid 7165] [evidence IEA]; neuropeptide signaling pathway [goid 7218] [evidence IEA]; signal transduction [goid 7165] [evidence IEA],receptor activity [goid 4872] [evidence IEA]; G-protein coupled receptor activity [goid 4930] [pmid 15203201] [evidence TAS]; receptor activity [goid 4872] [evidence IEA]; G-protein coupled receptor activity [goid 4930] [pmid 15203201] [evidence TAS],6,47084690-47084739,6p12.3e,-,NM_153840.2,266977,GPR110,1.6933875495818933,6.095485302438574,11.132743503139185,3.707475862484636e-20,5.608708632027417e-19,35.04909388426681
MGC2408,ILMN_1762883,"Homo sapiens hypothetical protein MGC2408 (MGC2408), mRNA.",,,methyltransferase activity [goid 8168] [evidence IEA]; transferase activity [goid 16740] [evidence IEA],3,185459123-185459172,3q27.1b,+,NM_032331.2,84291,MGC2408,1.303853070921444,7.227590593424712,11.128859563226342,3.7874268761367095e-20,5.725214327503785e-19,35.0278502047756
NTN4,ILMN_1757019,"Homo sapiens netrin 4 (NTN4), mRNA.",basement membrane [goid 5604] [evidence IEA]; basement membrane [goid 5604] [evidence IEA],,structural molecule activity [goid 5198] [evidence IEA],12,94576365-94576414,12q22d,-,NM_021229.3,59277,NTN4,-1.2330658980085891,7.39282763084506,-11.123827072134581,3.893592117632848e-20,5.8811350707035685e-19,35.000324105511396
H1F0,ILMN_1757467,"Homo sapiens H1 histone family, member 0 (H1F0), mRNA.",nucleosome [goid 786] [evidence IEA]; chromosome [goid 5694] [evidence IEA]; nucleus [goid 5634] [evidence IEA],nucleosome assembly [goid 6334] [evidence IEA]; chromosome organization and biogenesis (sensu Eukaryota) [goid 7001] [evidence IEA],DNA binding [goid 3677] [evidence IEA],22,36533168-36533217,22q13.1a,+,NM_005318.2,3005,H1F0,1.0671304016781509,11.585192303016699,11.118354419730077,4.012425463236907e-20,6.05124691572532e-19,34.97039011332889
C1orf115,ILMN_1674817,"Homo sapiens chromosome 1 open reading frame 115 (C1orf115), mRNA.",,,,1,218938891-218938940,1q41d,+,NM_024709.2,79762,C1orf115,-1.623622171848817,9.466324631411922,-11.113542806499618,4.1198992438272624e-20,6.208525658621361e-19,34.94407153613227
MGC10911,ILMN_1802627,"Homo sapiens chromosome 7 open reading frame 48 (C7orf48), mRNA.",,,,7,1573637-1573686,7p22.3b-p22.3a,-,NM_032302.2,84262,MGC10911,1.0546892758260524,8.269351779712984,11.103515050279771,4.353228960495171e-20,6.555074675057837e-19,34.88922080881934
LRRK2,ILMN_1776649,"PREDICTED: Homo sapiens leucine-rich repeat kinase 2, transcript variant 2 (LRRK2), mRNA.",,,,12,39045111-39045119:39047075-39047115,12q12c,+,XM_930820.1,120892,LRRK2,-1.5460681710207238,6.4725224720705095,-11.099989769114378,4.4383601745814815e-20,6.678104092796924e-19,34.86993763279159
MTP18,ILMN_1657898,"Homo sapiens mitochondrial protein 18 kDa (MTP18), nuclear gene encoding mitochondrial protein, transcript variant 1, mRNA.",mitochondrion [goid 5739] [evidence IEA]; mitochondrion [goid 5739] [evidence IEA],apoptosis [goid 6915] [evidence IEA]; apoptosis [goid 6915] [evidence IEA],,22,29153339-29153388,22q12.2b,+,NM_016498.3,51537,MTP18,1.16526682766552,7.754411473356438,11.098874082047324,4.4656481223052696e-20,6.7139779061047975e-19,34.86383483077115
C16orf34,ILMN_1706118,"Homo sapiens hematological and neurological expressed 1-like (HN1L), mRNA.",nucleus [goid 5634] [evidence IEA],,DNA binding [goid 3677] [evidence IEA],16,1691736-1691785,16p13.3e,+,NM_144570.2,90861,C16orf34,1.18158014957229,8.005098521170712,11.096525893874905,4.5236307977305356e-20,6.795909490653777e-19,34.85099020914995
C1orf198,ILMN_1657683,"Homo sapiens chromosome 1 open reading frame 198 (C1orf198), mRNA.",,,,1,229039792-229039841,1q42.2a,-,NM_032800.1,84886,C1orf198,-1.2287699380419568,10.640706554615946,-11.09600572176633,4.536576728599682e-20,6.810107670012697e-19,34.848144852264305
EDG6,ILMN_1784737,"Homo sapiens endothelial differentiation, G-protein-coupled receptor 6 (EDG6), mRNA.",integral to plasma membrane [goid 5887] [pmid 9790765] [evidence TAS],immune response [goid 6955] [pmid 9790765] [evidence TAS]; phospholipase C activation [goid 7202] [pmid 10679247] [evidence TAS]; signal transduction [goid 7165] [evidence IEA]; G-protein coupled receptor protein signaling pathway [goid 7186] [pmid 9790765] [evidence TAS],lipid binding [goid 8289] [pmid 10679247] [evidence TAS]; receptor activity [goid 4872] [evidence IEA]; lysosphingolipid and lysophosphatidic acid receptor activity [goid 1619] [evidence IEA],19,3130929-3130945:3130946-3130978,19p13.3f,+,NM_003775.1,8698,EDG6,-1.4695963640517045,7.8586429211223985,-11.095555620928463,4.547808652334456e-20,6.821712978501684e-19,34.84568278489425
PLEK,ILMN_1795762,"Homo sapiens pleckstrin (PLEK), mRNA.",,intracellular signaling cascade [goid 7242] [evidence IEA],calcium ion binding [goid 5509] [pmid 2897630] [evidence TAS],2,68477871-68477920,2p14a,+,NM_002664.1,5341,PLEK,-1.5399755792031513,9.719355889394237,-11.087809781007778,4.745518563962703e-20,7.10733506678042e-19,34.803312421592075
SMCX,ILMN_1798224,"Homo sapiens Smcy homolog, X-linked (mouse) (SMCX), mRNA.",nucleus [goid 5634] [evidence IEA],"regulation of transcription, DNA-dependent [goid 6355] [evidence IEA]",metal ion binding [goid 46872] [evidence IEA]; zinc ion binding [goid 8270] [evidence IEA]; protein binding [goid 5515] [evidence IEA]; DNA binding [goid 3677] [evidence IEA],X,53238603-53238652,Xp11.22a,-,NM_004187.1,8242,SMCX,1.2167997165382776,6.1837591404023495,11.086257209884655,4.786170276288555e-20,7.162713351265936e-19,34.79481965555233
AP1G2,ILMN_1754179,"Homo sapiens adaptor-related protein complex 1, gamma 2 subunit (AP1G2), transcript variant 1, mRNA.",AP-1 adaptor complex [goid 30121] [pmid 9733768] [evidence TAS]; transport vesicle [goid 30133] [pmid 9733768] [evidence IDA]; coated pit [goid 5905] [evidence IEA]; Golgi apparatus [goid 5794] [pmid 9762922] [evidence TAS]; membrane [goid 16020] [pmid 9733768] [evidence IDA],intracellular protein transport [goid 6886] [evidence IEA]; endocytosis [goid 6897] [evidence IEA]; protein complex assembly [goid 6461] [evidence IEA],protein binding [goid 5515] [evidence ISS],14,23099000-23099049,14q11.2g,-,NM_003917.2,8906,AP1G2,1.0781510349631578,9.134483634028607,11.079050430529108,4.979478883747382e-20,7.446289029149481e-19,34.75539730167656
CD59,ILMN_1724789,"Homo sapiens CD59 molecule, complement regulatory protein (CD59), transcript variant 3, mRNA.",plasma membrane [goid 5886] [pmid 1381503] [evidence NAS]; membrane fraction [goid 5624] [pmid 1381503] [evidence TAS],immune response [goid 6955] [evidence NR ]; cell surface receptor linked signal transduction [goid 7166] [pmid 7691713] [evidence TAS]; blood coagulation [goid 7596] [pmid 1381503] [evidence TAS],GPI anchor binding [goid 48503] [evidence IEA]; protein binding [goid 5515] [pmid 12577067] [evidence IPI],11,33681376-33681425,11p13d-p13c,-,NM_203329.1,966,CD59,-1.0118518103107004,7.602385096381408,-11.071794180349087,5.182007525472415e-20,7.743206797072853e-19,34.71570379211117
APCDD1,ILMN_1656951,"Homo sapiens adenomatosis polyposis coli down-regulated 1 (APCDD1), mRNA.",membrane [goid 16020] [evidence IEA]; integral to membrane [goid 16021] [evidence IEA],,,18,10478228-10478277,18p11.22a,+,NM_153000.3,147495,APCDD1,-1.3447162397341135,7.91622616441448,-11.068786861835061,5.268341359865979e-20,7.860155543414135e-19,34.69925284978645
XKRX,ILMN_1769071,"Homo sapiens XK, Kell blood group complex subunit-related, X-linked (XKRX), mRNA.",membrane [goid 16020] [evidence IEA]; integral to membrane [goid 16021] [evidence IEA],,,X,100055351-100055400,Xq22.1c,-,NM_212559.1,402415,XKRX,2.1954444081023974,6.621247926804594,11.067915041665957,5.2936375078518185e-20,7.89185362207289e-19,34.694483712896954
SHANK3,ILMN_2317580,"Homo sapiens SH3 and multiple ankyrin repeat domains 3 (SHANK3), mRNA.",,,,,,22q13.33b,,NM_001080420.1,85358,SHANK3,-1.372053084172526,9.510404410451567,-11.064467446308084,5.3948667121896435e-20,8.030479594118808e-19,34.675624183892225
MYH11,ILMN_1660086,"Homo sapiens myosin, heavy polypeptide 11, smooth muscle (MYH11), transcript variant SM1, mRNA.",striated muscle thick filament [goid 5863] [evidence IEA]; muscle myosin [goid 5859] [pmid 7684189] [evidence TAS]; myosin [goid 16459] [evidence IEA],striated muscle contraction [goid 6941] [evidence IEA],actin binding [goid 3779] [evidence IEA]; nucleotide binding [goid 166] [evidence IEA]; calmodulin binding [goid 5516] [evidence IEA]; ATP binding [goid 5524] [evidence IEA]; motor activity [goid 3774] [evidence IEA],16,15704616-15704665,16p13.11a,-,NM_002474.1,4629,MYH11,-1.964932243817561,9.33260504937528,-11.063191869569279,5.432809431747394e-20,8.080785631877708e-19,34.668646312406054
EMILIN2,ILMN_1697268,"Homo sapiens elastin microfibril interfacer 2 (EMILIN2), mRNA.",extracellular region [goid 5576] [pmid 11278945] [evidence IDA]; extracellular matrix (sensu Metazoa) [goid 5578] [evidence IEA],cell adhesion [goid 7155] [evidence IEA],extracellular matrix constituent conferring elasticity [goid 30023] [pmid 11278945] [evidence NAS]; protein binding [goid 5515] [pmid 11278945] [evidence IPI],18,2903925-2903974,18p11.32a-p11.31e,+,NM_032048.2,84034,EMILIN2,-1.248702346363574,9.939182366718887,-11.049621607673096,5.853372530850973e-20,8.686440499895752e-19,34.59441106368341
GLT8D2,ILMN_1802654,"Homo sapiens glycosyltransferase 8 domain containing 2 (GLT8D2), mRNA.",,carbohydrate biosynthesis [goid 16051] [evidence IEA],"transferase activity, transferring hexosyl groups [goid 16758] [evidence IEA]",12,102907345-102907394,12q23.3a,-,NM_031302.2,83468,GLT8D2,-1.5234638079101428,7.87800740239614,-11.048992134770783,5.873652609168401e-20,8.709902670444923e-19,34.59096753131351
ZFPM2,ILMN_1814077,"Homo sapiens zinc finger protein, multitype 2 (ZFPM2), mRNA.",nucleus [goid 5634] [evidence IEA],transcription [goid 6350] [evidence IEA]; regulation of transcription from RNA polymerase II promoter [goid 6357] [pmid 10438528] [evidence TAS],metal ion binding [goid 46872] [evidence IEA]; transcription corepressor activity [goid 3714] [pmid 10438528] [evidence TAS]; zinc ion binding [goid 8270] [pmid 10438528] [evidence TAS]; RNA polymerase II transcription factor activity [goid 3702] [pmid 10438528] [evidence TAS]; DNA binding [goid 3677] [evidence IEA],8,106884536-106884585,8q23.1a,+,NM_012082.2,23414,ZFPM2,-1.0840693901740606,5.583318651656535,-11.044614500488784,6.016647106160591e-20,8.915161130307158e-19,34.56701957906881
C1orf155,ILMN_1742779,"Homo sapiens centromere protein L (CENPL), mRNA.","chromosome [goid 5694] [evidence IEA]; nucleus [goid 5634] [evidence IEA]; chromosome, pericentric region [goid 775] [evidence IEA]",,,1,172036047-172036096,1q25.1a,-,NM_033319.1,91687,C1orf155,1.1504695231155404,6.8274167198165285,11.043997684614764,6.037073279783657e-20,8.938630156275422e-19,34.56364525955297
SAMD1,ILMN_1658821,"Homo sapiens sterile alpha motif domain containing 1 (SAMD1), mRNA.",,,,19,,19p13.12c,-,NM_138352.1,90378,SAMD1,1.1698299673183117,6.828431997560553,11.042383675397536,6.090850909737249e-20,9.011406983768435e-19,34.55481573237653
KIAA0562,ILMN_2228453,"Homo sapiens KIAA0562 (KIAA0562), mRNA.",,,binding [goid 5488] [evidence IEA],,,1p36.32b,,NM_014704.2,9731,KIAA0562,1.1787394762381753,7.773601032880849,11.040015499149828,6.170625555967563e-20,9.122506749471014e-19,34.541860451560254
MYO6,ILMN_1727080,"Homo sapiens myosin VI (MYO6), mRNA.",unconventional myosin [goid 16461] [pmid 9259267] [evidence TAS],actin filament-based movement [goid 30048] [pmid 10519557] [evidence NAS]; striated muscle contraction [goid 6941] [evidence NAS],"actin binding [goid 3779] [pmid 10519557] [evidence TAS]; nucleotide binding [goid 166] [evidence IEA]; calmodulin binding [goid 5516] [evidence IEA]; structural constituent of muscle [goid 8307] [evidence NAS]; microfilament motor activity [goid 146] [pmid 10519557] [evidence NAS]; ATP binding [goid 5524] [evidence NAS]; ATPase activity, coupled [goid 42623] [evidence NR ]; motor activity [goid 3774] [evidence IEA]",6,76681376-76681425,6q14.1a,+,NM_004999.2,4646,MYO6,1.1005613442033866,7.913401060158924,11.03783271253418,6.245080618161572e-20,9.225579669816393e-19,34.52991931554945
C20orf59,ILMN_1785405,"Homo sapiens chromosome 20 open reading frame 59 (C20orf59), mRNA.",integral to membrane [goid 16021] [evidence IEA]; membrane [goid 16020] [evidence IEA],transport [goid 6810] [evidence IEA],transporter activity [goid 5215] [evidence IEA],20,61070035-61070084,20q13.33d,+,NM_022082.2,63910,C20orf59,1.4569532855372307,5.975999511461042,11.03662892296671,6.286525825804976e-20,9.279769372409846e-19,34.52333385606653
CBX4,ILMN_1724145,"Homo sapiens chromobox homolog 4 (Pc class homolog, Drosophila) (CBX4), mRNA.",chromatin [goid 785] [evidence IEA]; nucleus [goid 5634] [pmid 9315667] [evidence TAS],"chromatin modification [goid 16568] [evidence IEA]; chromosome organization and biogenesis (sensu Eukaryota) [goid 7001] [pmid 9315667] [evidence TAS]; transcription [goid 6350] [evidence IEA]; chromatin assembly or disassembly [goid 6333] [evidence IEA]; anti-apoptosis [goid 6916] [pmid 9315667] [evidence TAS]; regulation of transcription, DNA-dependent [goid 6355] [evidence IEA]",transcription corepressor activity [goid 3714] [pmid 9315667] [evidence TAS]; chromatin binding [goid 3682] [evidence IEA],17,75421935-75421984,17q25.3d,-,NM_003655.2,8535,CBX4,1.0512856390069407,8.330841583769663,11.036150348932106,6.303078969151765e-20,9.297160765626204e-19,34.52071576226023
RAD54L,ILMN_1658027,"Homo sapiens RAD54-like (S. cerevisiae) (RAD54L), mRNA.",nucleus [goid 5634] [pmid 8805304] [evidence TAS],DNA recombination [goid 6310] [pmid 8805304] [evidence TAS]; meiosis [goid 7126] [pmid 8805304] [evidence TAS]; DNA repair [goid 6281] [pmid 8805304] [evidence TAS],nucleotide binding [goid 166] [evidence IEA]; helicase activity [goid 4386] [evidence IEA]; hydrolase activity [goid 16787] [evidence IEA]; ATP binding [goid 5524] [evidence IEA]; DNA binding [goid 3677] [evidence IEA],1,46516548-46516597,1p34.1a-p33d,+,NM_003579.2,8438,RAD54L,1.0832203818137875,6.198925715585524,11.034618556490761,6.356355045943927e-20,9.368651896385583e-19,34.51233590416819
AADAC,ILMN_1760414,"Homo sapiens arylacetamide deacetylase (esterase) (AADAC), mRNA.",membrane [goid 16020] [evidence IEA]; integral to membrane [goid 16021] [evidence IEA]; endoplasmic reticulum [goid 5783] [evidence IEA]; endoplasmic reticulum membrane [goid 5789] [pmid 15152005] [evidence IDA]; microsome [goid 5792] [pmid 8063807] [evidence TAS],metabolism [goid 8152] [evidence IEA],deacetylase activity [goid 19213] [pmid 9665742] [evidence IDA]; lipase activity [goid 16298] [pmid 11481320] [evidence TAS],3,153028383-153028432,3q25.1c,+,NM_001086.2,13,AADAC,-2.587208236869797,6.816774891687821,-11.026309815772727,6.653282846698199e-20,9.76934561174939e-19,34.46688158347936
B3GAT3,ILMN_2210581,"Homo sapiens beta-1,3-glucuronyltransferase 3 (glucuronosyltransferase I) (B3GAT3), mRNA.",integral to membrane [goid 16021] [pmid 10842173] [evidence NAS]; membrane [goid 16020] [evidence IEA]; Golgi membrane [goid 139] [evidence NAS],glycosaminoglycan biosynthesis [goid 6024] [pmid 10842173] [evidence NAS],transferase activity [goid 16740] [evidence IEA]; manganese ion binding [goid 30145] [evidence NAS]; metal ion binding [goid 46872] [evidence IEA]; galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity [goid 15018] [pmid 10842173] [evidence NAS],11,62139628-62139677,11q12.3a,-,NM_012200.2,26229,B3GAT3,1.1711108397189678,8.003998281826394,11.02378483678533,6.746237615728431e-20,9.898376501691904e-19,34.45306816393493
PCNXL3,ILMN_1783350,"PREDICTED: Homo sapiens pecanex-like 3 (Drosophila), transcript variant 4 (PCNXL3), mRNA.",,,,,,11q13.1d,,XM_941490.1,399909,PCNXL3,1.2300497048026067,8.808316982707998,11.016940374854,7.004796809822589e-20,1.0270012478509643e-18,34.415623869741644
PACS1,ILMN_1716488,"Homo sapiens phosphofurin acidic cluster sorting protein 1 (PACS1), mRNA.",Golgi stack [goid 5795] [evidence IEA],,protein binding [goid 5515] [pmid 10707087] [evidence IPI],11,65768449-65768498,11q13.1d-q13.1e,+,NM_018026.2,55690,PACS1,1.4585249851109587,7.8201426653453945,11.013387562072056,7.142894344754263e-20,1.045674652949187e-18,34.39618720247437
DENND3,ILMN_1692742,"Homo sapiens DENN/MADD domain containing 3 (DENND3), mRNA.",,,,8,142274765-142274814,8q24.3c,+,NM_014957.2,22898,DENND3,-1.162441222225783,8.075333460743746,-11.011926628261028,7.20046796543049e-20,1.0533116989970953e-18,34.38819472359755
FLJ46380,ILMN_1727916,"Homo sapiens FLJ46380 protein (FLJ46380), mRNA.",ubiquitin ligase complex [goid 151] [evidence IEA],protein ubiquitination [goid 16567] [evidence IEA],ubiquitin-protein ligase activity [goid 4842] [evidence IEA]; zinc ion binding [goid 8270] [evidence IEA],1,6190669-6190718,1p36.31b,+,NM_207396.1,388591,FLJ46380,1.0830231535537465,5.736206608213766,11.010120920601487,7.272270636810291e-20,1.0622203400168554e-18,34.37831603381085
C1orf112,ILMN_1727540,"Homo sapiens chromosome 1 open reading frame 112 (C1orf112), mRNA.",,,binding [goid 5488] [evidence IEA],1,168088633-168088682,1q24.2c,+,NM_018186.2,55732,C1orf112,1.187773596901808,7.058807756793691,11.001676613911151,7.617677005107675e-20,1.111838475239873e-18,34.33211849730462
PHACTR1,ILMN_1736982,"Homo sapiens phosphatase and actin regulator 1 (PHACTR1), mRNA.",,,protein phosphatase inhibitor activity [goid 4864] [evidence IEA]; actin binding [goid 3779] [evidence IEA],6,13391737-13391773:13394357-13394369,6p24.1a,+,NM_030948.1,221692,PHACTR1,-1.267929569231013,6.947055032743782,-10.993158651509928,7.982726356717694e-20,1.1642471785976366e-18,34.2855175047544
THBS2,ILMN_1678842,"Homo sapiens thrombospondin 2 (THBS2), mRNA.",extracellular region [goid 5576] [evidence IEA]; extracellular matrix (sensu Metazoa) [goid 5578] [evidence NR ],cell adhesion [goid 7155] [evidence IEA],structural molecule activity [goid 5198] [evidence IEA]; heparin binding [goid 8201] [pmid 1459996] [evidence TAS]; calcium ion binding [goid 5509] [evidence IEA]; protein binding [goid 5515] [evidence IEA],6,169358052-169358101,6q27e,-,NM_003247.2,7058,THBS2,1.9709505345482246,9.821711056438104,10.990640741153547,8.093949237291405e-20,1.1795856461377937e-18,34.271742156227525
NAG8,ILMN_1655961,"Homo sapiens nasopharyngeal carcinoma associated gene protein-8 (NAG8), mRNA.",,,,7,127427193-127427242,7q32.1a,+,NM_014411.2,27099,NAG8,2.4097298560062965,7.8190365020992925,10.979685520446234,8.596200450141724e-20,1.250910872076262e-18,34.21180628725418
BEAN,ILMN_1733066,"PREDICTED: Homo sapiens brain expressed, associated with Nedd4 (BEAN), mRNA.",,,,16,65073833-65073882,,+,XM_375359.2,146227,BEAN,1.650070567482353,5.6995406806491555,10.978749404273332,8.640536808982708e-20,1.2564243262912541e-18,34.206684774346215
LOC441155,ILMN_1767514,"PREDICTED: Homo sapiens similar to Zinc finger CCCH-type domain containing protein 11A, transcript variant 3 (LOC441155), mRNA.",,,,6,66069519-66069568,6q12c,+,XM_930970.1,441155,LOC441155,1.4657500407355935,6.996674093776188,10.97810084872722,8.671387787852614e-20,1.2599701047450275e-18,34.203136509174456
PITX1,ILMN_1674386,"Homo sapiens paired-like homeodomain transcription factor 1 (PITX1), mRNA.",nucleus [goid 5634] [evidence IEA],"regulation of transcription, DNA-dependent [goid 6355] [evidence IEA]; skeletal development [goid 1501] [pmid 9070926] [evidence TAS]; morphogenesis [goid 9653] [pmid 9070926] [evidence TAS]",transcription factor activity [goid 3700] [evidence IEA]; sequence-specific DNA binding [goid 43565] [evidence IEA],5,134391393-134391442,5q31.1e,-,NM_002653.3,5307,PITX1,3.3472859412873,7.2799477349878465,10.969371593420133,9.097511252916008e-20,1.320901689739705e-18,34.15537828119852
SLC29A4,ILMN_1801377,"Homo sapiens solute carrier family 29 (nucleoside transporters), member 4 (SLC29A4), mRNA.",membrane [goid 16020] [evidence IEA],transport [goid 6810] [evidence IEA],nucleoside transporter activity [goid 5337] [evidence IEA],7,5310144-5310193,7p22.1c,+,NM_153247.1,222962,SLC29A4,1.6261335530743004,6.892153178094801,10.967824018108821,9.175214287689822e-20,1.330201267824674e-18,34.14691136902386
GBP4,ILMN_1771385,"Homo sapiens guanylate binding protein 4 (GBP4), mRNA.",,immune response [goid 6955] [evidence IEA],GTPase activity [goid 3924] [evidence IEA]; GTP binding [goid 5525] [evidence IEA],1,89420346-89420395,1p22.2c,-,NM_052941.2,115361,GBP4,-1.7433731724220092,9.539808559792393,-10.96588014686655,9.273756538093805e-20,1.3434880754257083e-18,34.13627627100313
FLJ10925,ILMN_1770030,"Homo sapiens chromosome 7 open reading frame 43 (C7orf43), mRNA.",cytoplasm [goid 5737] [pmid 11256614] [evidence IDA],,catalytic activity [goid 3824] [evidence IEA],7,99590213-99590262,7q22.1c,-,NM_018275.3,55262,FLJ10925,1.015827786358944,7.537306116768426,10.96451777475622,9.343450735464769e-20,1.3525790310589228e-18,34.12882259625625
C20orf42,ILMN_1696585,"Homo sapiens chromosome 20 open reading frame 42 (C20orf42), mRNA.",cytoskeleton [goid 5856] [evidence IEA],,binding [goid 5488] [evidence IEA],20,6004160-6004209,20p12.3c,-,NM_017671.3,55612,C20orf42,1.7140236212331983,6.172896774690148,10.960436581670063,9.555381777155098e-20,1.3822317292343512e-18,34.10649392142777
CCL21,ILMN_1677505,"Homo sapiens chemokine (C-C motif) ligand 21 (CCL21), mRNA.",extracellular region [goid 5576] [evidence IEA]; extracellular space [goid 5615] [evidence IEA],immune response [goid 6955] [evidence IEA]; cell-cell signaling [goid 7267] [pmid 9235955] [evidence TAS]; chemotaxis [goid 6935] [pmid 10861057] [evidence TAS]; signal transduction [goid 7165] [pmid 10201891] [evidence NAS]; inflammatory response [goid 6954] [pmid 9235955] [evidence TAS],chemokine activity [goid 8009] [pmid 10861057] [evidence TAS],9,34699244-34699293,9p13.3c,-,NM_002989.2,6366,CCL21,-2.0398181523975545,9.720222505905767,-10.949691409328075,1.0136647113844913e-19,1.4652267730954608e-18,34.047705461798024
MGC15476,ILMN_1733851,"Homo sapiens dapper, antagonist of beta-catenin, homolog 3 (Xenopus laevis) (DACT3), mRNA.",,,,19,51842736-51842785,19q13.32b,-,NM_145056.1,147906,MGC15476,-1.2601476742790556,9.181453811551739,-10.948229757717835,1.0218402308530953e-19,1.4737643892059632e-18,34.03970850365088
TGFA,ILMN_1805175,"Homo sapiens transforming growth factor, alpha (TGFA), mRNA.",extracellular space [goid 5615] [evidence NR ]; soluble fraction [goid 5625] [evidence NR ]; integral to plasma membrane [goid 5887] [evidence NR ]; plasma membrane [goid 5886] [pmid 10918572] [evidence NAS],cell proliferation [goid 8283] [pmid 10861448] [evidence TAS]; cell-cell signaling [goid 7267] [evidence NR ],signal transducer activity [goid 4871] [pmid 10918572] [evidence TAS]; growth factor activity [goid 8083] [evidence IEA]; protein binding [goid 5515] [pmid 10918572] [evidence TAS]; epidermal growth factor receptor activating ligand activity [goid 5155] [evidence NR ]; protein-tyrosine kinase activity [goid 4713] [pmid 10918572] [evidence TAS],2,70528444-70528493,2p13.3c,-,NM_003236.1,7039,TGFA,1.5513966554479541,7.383756099294569,10.947329117570668,1.0269106301093444e-19,1.4799817771953088e-18,34.03478093510457
CGI-38,ILMN_1695036,"Homo sapiens tubulin polymerization-promoting protein family member 3 (TPPP3), mRNA.",,,,16,65984371-65984420,16q22.1b,-,NM_016140.2,51673,CGI-38,-1.4870230936754716,7.170907747823831,-10.942712719447437,1.0532977228689339e-19,1.5168888492314247e-18,34.00952371309883
FUT6,ILMN_1761275,"Homo sapiens fucosyltransferase 6 (alpha (1,3) fucosyltransferase) (FUT6), mRNA.",integral to membrane [goid 16021] [evidence IEA]; Golgi stack [goid 5795] [evidence IEA]; extracellular region [goid 5576] [evidence NR ]; membrane [goid 16020] [evidence IEA],protein amino acid glycosylation [goid 6486] [pmid 11698403] [evidence TAS]; L-fucose catabolism [goid 42355] [pmid 11698403] [evidence NAS],"transferase activity, transferring glycosyl groups [goid 16757] [evidence IEA]; alpha(1,3)-fucosyltransferase activity [goid 46920] [pmid 11698403] [evidence TAS]; 3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase activity [goid 17060] [evidence IEA]",19,5782314-5782363,19p13.3b,-,NM_000150.1,2528,FUT6,1.5604604889742566,6.470204631540088,10.94063094921617,1.0654178744881862e-19,1.5320787663765541e-18,33.998133909196895
TGM1,ILMN_1721134,"Homo sapiens transglutaminase 1 (K polypeptide epidermal type I, protein-glutamine-gamma-glutamyltransferase) (TGM1), mRNA.",intrinsic to membrane [goid 31224] [pmid 8824274] [evidence IDA]; cornified envelope [goid 1533] [pmid 8824274] [evidence TAS],peptide cross-linking [goid 18149] [evidence IEA]; cell envelope organization and biogenesis [goid 43163] [pmid 14645372] [evidence TAS]; keratinization [goid 31424] [evidence IEA]; keratinocyte differentiation [goid 30216] [pmid 8824274] [evidence IDA],protein binding [goid 5515] [pmid 10066784] [evidence IPI]; acyltransferase activity [goid 8415] [evidence IEA]; transferase activity [goid 16740] [evidence IEA]; calcium ion binding [goid 5509] [evidence IEA]; protein-glutamine gamma-glutamyltransferase activity [goid 3810] [pmid 7961731] [evidence IDA],14,23788297-23788346,14q12a,-,NM_000359.1,7051,TGM1,-1.2271789477413408,5.980059235722199,-10.928689349294727,1.1376872812550416e-19,1.6335915014925928e-18,33.932798566809076
NRIP3,ILMN_1759563,"Homo sapiens nuclear receptor interacting protein 3 (NRIP3), mRNA.",,,,11,8960988-8961037,11p15.4a,-,NM_020645.1,56675,NRIP3,1.9507406458033651,7.380360548330365,10.926973186899609,1.1484687674115234e-19,1.6478581688522486e-18,33.92340898933998
LOC144501,ILMN_1705814,"Homo sapiens hypothetical protein LOC144501 (LOC144501), mRNA.",intermediate filament [goid 5882] [evidence IEA]; intermediate filament [goid 5882] [evidence IEA],,structural molecule activity [goid 5198] [evidence IEA]; structural molecule activity [goid 5198] [evidence IEA],12,50849804-50849853,12q13.13d,-,NM_182507.1,144501,LOC144501,1.526614801737618,6.747995385199042,10.916653371559624,1.2154907697430196e-19,1.7401791071596427e-18,33.866946347641495
LOC642560,ILMN_1787823,"PREDICTED: Homo sapiens similar to phosphodiesterase 4D interacting protein isoform 1 (LOC642560), mRNA.",,,,1,149636-149685,,-,XM_926046.1,642560,LOC642560,1.2516929858382326,6.5033136784730345,10.906227658453172,1.287174161844402e-19,1.83606065472461e-18,33.809903984411065
TCF3,ILMN_1664434,"Homo sapiens transcription factor 3 (E2A immunoglobulin enhancer binding factors E12/E47) (TCF3), mRNA.",nucleus [goid 5634] [pmid 2493990] [evidence NAS],"regulation of transcription, DNA-dependent [goid 6355] [pmid 2493990] [evidence NAS]",transcription factor activity [goid 3700] [pmid 2493990] [evidence NAS],19,1560558-1560607,19p13.3h,-,NM_003200.1,6929,TCF3,1.1081557861622002,8.162156195797447,10.904764127520826,1.2975697687734217e-19,1.849535255636439e-18,33.80189652212796
SLC11A1,ILMN_1735737,"Homo sapiens solute carrier family 11 (proton-coupled divalent metal ion transporters), member 1 (SLC11A1), transcript variant 1, mRNA.",membrane fraction [goid 5624] [pmid 8537108] [evidence TAS]; membrane [goid 16020] [evidence IEA]; integral to plasma membrane [goid 5887] [pmid 8537108] [evidence TAS],"ion transport [goid 6811] [evidence IEA]; transport [goid 6810] [evidence IEA]; response to pest, pathogen or parasite [goid 9613] [pmid 8490962] [evidence TAS]; iron ion transport [goid 6826] [evidence IEA]",iron ion binding [goid 5506] [evidence IEA]; transporter activity [goid 5215] [pmid 8537108] [evidence TAS],2,218968524-218968573,2q35e,+,NM_000578.2,6556,SLC11A1,-1.1346766956524492,7.188186746984329,-10.90351639521416,1.3064988292575804e-19,1.8609012929885933e-18,33.79506976141339
OPLAH,ILMN_1711030,"Homo sapiens 5-oxoprolinase (ATP-hydrolysing) (OPLAH), mRNA.",,,catalytic activity [goid 3824] [evidence IEA]; hydrolase activity [goid 16787] [evidence IEA]; 5-oxoprolinase (ATP-hydrolyzing) activity [goid 17168] [evidence IEA]; catalytic activity [goid 3824] [evidence IEA]; hydrolase activity [goid 16787] [evidence IEA]; 5-oxoprolinase (ATP-hydrolyzing) activity [goid 17168] [evidence IEA],8,145178201-145178214:145178215-145178250,8q24.3g,-,NM_017570.1,26873,OPLAH,1.0410899139014766,7.56404687494962,10.900656112432587,1.3272002956577108e-19,1.8890064105836738e-18,33.779420183838766
TMEM79,ILMN_2090802,"Homo sapiens transmembrane protein 79 (TMEM79), mRNA.",,,,1,154528742-154528791,1q22d,+,NM_032323.1,84283,TMEM79,1.1815723338217214,8.580759239549597,10.899031399542524,1.33910503649589e-19,1.9045592435125852e-18,33.770530820036
GPR37,ILMN_2218935,"Homo sapiens G protein-coupled receptor 37 (endothelin receptor type B-like) (GPR37), mRNA.",integral to plasma membrane [goid 5887] [pmid 9144577] [evidence TAS]; membrane [goid 16020] [evidence IEA],G-protein coupled receptor protein signaling pathway [goid 7186] [pmid 9144577] [evidence TAS]; signal transduction [goid 7165] [evidence IEA],"receptor activity [goid 4872] [evidence IEA]; G-protein coupled receptor activity, unknown ligand [goid 16526] [evidence IEA]; rhodopsin-like receptor activity [goid 1584] [evidence IEA]",7,124173852-124173901,7q31.33a,-,NM_005302.2,2861,GPR37,2.0422564051344123,6.27962212977599,10.898132656793734,1.345736207560109e-19,1.912594456915297e-18,33.76561348641654
GPA33,ILMN_1729170,"Homo sapiens glycoprotein A33 (transmembrane) (GPA33), mRNA.",integral to plasma membrane [goid 5887] [pmid 9012807] [evidence TAS],,receptor activity [goid 4872] [pmid 9012807] [evidence TAS],1,165289017-165289066,1q24.1c,-,NM_005814.1,10223,GPA33,-1.9688839113921484,6.844679754711247,-10.895568947792436,1.3648329902544272e-19,1.9378142208255485e-18,33.75158653493276
PRKCDBP,ILMN_1793476,"Homo sapiens protein kinase C, delta binding protein (PRKCDBP), mRNA.",,,kinase activity [goid 16301] [evidence IEA],11,6296938-6296968:6296969-6296987,11p15.4c,-,NM_145040.2,112464,PRKCDBP,-1.31456917390466,10.633759314138615,-10.895484006930577,1.365470323424931e-19,1.9378142208255485e-18,33.75112179344131
POU2F1,ILMN_1794333,"Homo sapiens POU class 2 homeobox 1 (POU2F1), mRNA.",nucleus [goid 5634] [pmid 11891224] [evidence IDA],"regulation of transcription, DNA-dependent [goid 6355] [evidence IEA]; negative regulation of transcription [goid 16481] [pmid 11891224] [evidence IDA]",sequence-specific DNA binding [goid 43565] [evidence IEA]; transcription factor activity [goid 3700] [pmid 2341156] [evidence TAS]; protein binding [goid 5515] [pmid 12670868] [evidence IPI],1,165651657-165651671:165651672-165651706,1q24.1c-q24.2a,+,NM_002697.2,5451,POU2F1,1.2853962187039638,7.014782358270596,10.892040481992991,1.391560190884919e-19,1.9734024977723906e-18,33.73228103883431
CXCL2,ILMN_1682636,"Homo sapiens chemokine (C-X-C motif) ligand 2 (CXCL2), mRNA.",soluble fraction [goid 5625] [pmid 2643119] [evidence TAS]; extracellular space [goid 5615] [pmid 9873037] [evidence TAS]; extracellular region [goid 5576] [evidence IEA],chemotaxis [goid 6935] [pmid 2643119] [evidence TAS]; inflammatory response [goid 6954] [pmid 2643119] [evidence TAS]; G-protein coupled receptor protein signaling pathway [goid 7186] [evidence NR ],chemokine activity [goid 8009] [pmid 9873037] [evidence TAS],4,75181931-75181980,4q13.3d,-,NM_002089.1,2920,CXCL2,-2.5929395069033854,9.245921044832503,-10.890998200792406,1.3995549030174253e-19,1.9832965298396023e-18,33.726578341738836
SLPI,ILMN_2114720,"Homo sapiens secretory leukocyte peptidase inhibitor (SLPI), mRNA.",,,serine-type endopeptidase inhibitor activity [goid 4867] [evidence IEA],20,43315182-43315206:43315630-43315654,20q13.12b,-,NM_003064.2,6590,SLPI,-2.3692177915836865,12.006744421246507,-10.884520601405875,1.4502810214733062e-19,2.053686461003443e-18,33.69113701245287
EIF4G3,ILMN_1775692,"Homo sapiens eukaryotic translation initiation factor 4 gamma, 3 (EIF4G3), mRNA.",eukaryotic translation initiation factor 4F complex [goid 16281] [pmid 9418880] [evidence TAS],regulation of translational initiation [goid 6446] [pmid 9418880] [evidence TAS],RNA cap binding [goid 339] [pmid 9418880] [evidence TAS]; RNA binding [goid 3723] [evidence IEA]; protein binding [goid 5515] [pmid 15361857] [evidence IPI]; translation initiation factor activity [goid 3743] [evidence IEA],1,21006430-21006479,1p36.12b,-,NM_003760.2,8672,EIF4G3,1.010289140636825,9.162446899509993,10.883414590801962,1.4591241899820477e-19,2.0647084126216558e-18,33.685085614834726
RSNL2,ILMN_1759792,"Homo sapiens CAP-GLY domain containing linker protein family, member 4 (CLIP4), mRNA.",,,,2,29258931-29258980,2p23.2a,+,NM_024692.3,79745,RSNL2,-1.2281920380423337,7.574962846981025,-10.872513348965809,1.5492238593434616e-19,2.187436731833866e-18,33.62544075808972
TAOK1,ILMN_1758087,"Homo sapiens TAO kinase 1 (TAOK1), mRNA.",,protein amino acid phosphorylation [goid 6468] [evidence IEA],ATP binding [goid 5524] [evidence IEA]; transferase activity [goid 16740] [evidence IEA]; protein serine/threonine kinase activity [goid 4674] [evidence IEA]; nucleotide binding [goid 166] [evidence IEA],17,24895361-24895410,17q11.2b,+,NM_020791.1,57551,TAOK1,1.6164042286889995,7.612824606677579,10.856786092692653,1.6891051276174847e-19,2.3809551020110802e-18,33.53939074853045
DCLRE1C,ILMN_1678464,"Homo sapiens DNA cross-link repair 1C (PSO2 homolog, S. cerevisiae) (DCLRE1C), transcript variant c, mRNA.",nucleus [goid 5634] [evidence IEA]; nucleus [goid 5634] [evidence IEA],immune response [goid 6955] [evidence IEA]; DNA repair [goid 6281] [evidence IEA]; DNA recombination [goid 6310] [evidence IEA]; immune response [goid 6955] [evidence IEA]; DNA repair [goid 6281] [evidence IEA]; DNA recombination [goid 6310] [evidence IEA],exonuclease activity [goid 4527] [evidence IEA]; hydrolase activity [goid 16787] [evidence IEA]; magnesium ion binding [goid 287] [evidence IEA]; endonuclease activity [goid 4519] [evidence IEA]; exonuclease activity [goid 4527] [evidence IEA]; hydrolase activity [goid 16787] [evidence IEA]; magnesium ion binding [goid 287] [evidence IEA]; endonuclease activity [goid 4519] [evidence IEA],10,15024208-15024257,10p13c,-,NM_001033858.1,64421,DCLRE1C,1.376029464749406,8.067847637144117,10.845460124665394,1.7976008992076004e-19,2.5271467186912043e-18,33.477421874610584
TRPV2,ILMN_2049536,"Homo sapiens transient receptor potential cation channel, subfamily V, member 2 (TRPV2), mRNA.",integral to plasma membrane [goid 5887] [pmid 10201375] [evidence TAS]; membrane [goid 16020] [evidence IEA],ion transport [goid 6811] [evidence IEA]; sensory perception [goid 7600] [pmid 10201375] [evidence TAS]; calcium ion transport [goid 6816] [evidence IEA],ion channel activity [goid 5216] [pmid 10201375] [evidence TAS]; calcium ion binding [goid 5509] [evidence IEA]; calcium channel activity [goid 5262] [evidence IEA],17,16280844-16280893,17p11.2i,+,NM_016113.3,51393,TRPV2,-1.3467292989424617,9.403749147698404,-10.840849850499042,1.8437358671540786e-19,2.588270415813921e-18,33.452197239188486
SCN2B,ILMN_1676998,"Homo sapiens sodium channel, voltage-gated, type II, beta (SCN2B), mRNA.",membrane fraction [goid 5624] [evidence NR ]; membrane [goid 16020] [evidence IEA]; integral to membrane [goid 16021] [evidence IEA]; voltage-gated sodium channel complex [goid 1518] [pmid 9295116] [evidence TAS],ion transport [goid 6811] [evidence IEA]; synaptic transmission [goid 7268] [pmid 9295116] [evidence TAS]; sodium ion transport [goid 6814] [pmid 9295116] [evidence TAS],voltage-gated sodium channel activity [goid 5248] [pmid 9295116] [evidence TAS]; sodium ion binding [goid 31402] [evidence IEA],11,117539114-117539163,11q23.3d,-,NM_004588.3,6327,SCN2B,-1.2972355958946666,5.762166309518131,-10.840327215737467,1.8490400426389705e-19,2.5938477487991605e-18,33.44933769808577
LRRC49,ILMN_1763941,"Homo sapiens leucine rich repeat containing 49 (LRRC49), mRNA.",microtubule [goid 5874] [evidence IEA]; cytoskeleton [goid 5856] [evidence IEA],,transferase activity [goid 16740] [evidence IEA],15,69129254-69129303,15q23b,+,NM_017691.2,54839,LRRC49,-1.2242962254426333,6.871425596564199,-10.83751483985749,1.8778457415685724e-19,2.632361458594506e-18,33.43395008213873
C9orf28,ILMN_1652525,"Homo sapiens family with sequence similarity 125, member B (FAM125B), transcript variant 1, mRNA.",,,,9,128308937-128308986,9q33.3b,+,NM_033446.1,89853,C9orf28,-1.1585056929033382,9.311943716181052,-10.834135306213604,1.9130548919092345e-19,2.677864552360017e-18,33.41545932994131
C3orf63,ILMN_1661409,"Homo sapiens chromosome 3 open reading frame 63 (C3orf63), mRNA.",,,,3,56630278-56630327,3p14.3b,-,NM_015224.1,23272,C3orf63,-1.0056605798464187,7.0486502467477266,-10.833355355578362,1.9212740150806225e-19,2.687438922027705e-18,33.41119191583674
P2RY14,ILMN_2342835,"Homo sapiens purinergic receptor P2Y, G-protein coupled, 14 (P2RY14), transcript variant 2, mRNA.",integral to membrane [goid 16021] [pmid 10753868] [evidence NAS]; membrane [goid 16020] [evidence IEA]; integral to membrane [goid 16021] [pmid 10753868] [evidence NAS]; membrane [goid 16020] [evidence IEA],G-protein coupled receptor protein signaling pathway [goid 7186] [pmid 10753868] [evidence NAS]; signal transduction [goid 7165] [evidence IEA]; G-protein coupled receptor protein signaling pathway [goid 7186] [pmid 10753868] [evidence NAS]; signal transduction [goid 7165] [evidence IEA],"purinergic nucleotide receptor activity, G-protein coupled [goid 45028] [evidence IEA]; UDP-activated nucleotide receptor activity [goid 45029] [pmid 10753868] [evidence NAS]; receptor activity [goid 4872] [evidence IEA]; rhodopsin-like receptor activity [goid 1584] [evidence IEA]; purinergic nucleotide receptor activity, G-protein coupled [goid 45028] [evidence IEA]; UDP-activated nucleotide receptor activity [goid 45029] [pmid 10753868] [evidence NAS]; receptor activity [goid 4872] [evidence IEA]; rhodopsin-like receptor activity [goid 1584] [evidence IEA]",,,3q25.1b-q25.1c,,NM_014879.3,9934,P2RY14,-1.1421189219493826,5.39779795821027,-10.823614604038466,2.0269464661967403e-19,2.8311865156877048e-18,33.357896517458194
EMR1,ILMN_1780601,"Homo sapiens egf-like module containing, mucin-like, hormone receptor-like 1 (EMR1), mRNA.",integral to plasma membrane [goid 5887] [pmid 7601460] [evidence TAS]; membrane [goid 16020] [evidence IEA],neuropeptide signaling pathway [goid 7218] [evidence IEA]; cell adhesion [goid 7155] [pmid 7601460] [evidence TAS]; signal transduction [goid 7165] [evidence IEA],receptor activity [goid 4872] [evidence IEA]; G-protein coupled receptor activity [goid 4930] [pmid 7601460] [evidence TAS]; calcium ion binding [goid 5509] [evidence IEA],19,6891122-6891171,19p13.3a,+,NM_001974.3,2015,EMR1,-1.5061428128123646,5.743126441249281,-10.821709056388167,2.0482888185547255e-19,2.856901047211083e-18,33.34747054677671
HSPB3,ILMN_1720710,"Homo sapiens heat shock 27kDa protein 3 (HSPB3), mRNA.",,protein folding [goid 6457] [evidence IEA]; response to unfolded protein [goid 6986] [pmid 9858786] [evidence TAS],,5,53787838-53787887,5q11.2d,+,NM_006308.1,8988,HSPB3,-1.5378965903302673,6.138927500709787,-10.819701710738434,2.0710144496030259e-19,2.886531942096921e-18,33.336487606414934
LRDD,ILMN_2400352,"Homo sapiens leucine-rich repeats and death domain containing (LRDD), transcript variant 2, mRNA.",nucleus [goid 5634] [evidence IEA]; nucleus [goid 5634] [evidence IEA],apoptosis [goid 6915] [evidence IEA]; signal transduction [goid 7165] [evidence IEA]; apoptosis [goid 6915] [evidence IEA]; signal transduction [goid 7165] [evidence IEA],transferase activity [goid 16740] [evidence IEA]; protein binding [goid 5515] [pmid 15073321] [evidence IPI]; transferase activity [goid 16740] [evidence IEA]; protein binding [goid 5515] [pmid 15073321] [evidence IPI],11,789511-789560,11p15.5c,-,NM_018494.3,55367,LRDD,1.3451140850682046,7.351402846861328,10.81891228259315,2.0800206838520249e-19,2.897012367752445e-18,33.332168350829626
STX7,ILMN_1792518,"Homo sapiens syntaxin 7 (STX7), mRNA.",integral to plasma membrane [goid 5887] [evidence NR ]; membrane [goid 16020] [evidence IEA]; endosome [goid 5768] [evidence NR ]; integral to plasma membrane [goid 5887] [evidence NR ]; membrane [goid 16020] [evidence IEA]; endosome [goid 5768] [evidence NR ],intracellular protein transport [goid 6886] [evidence IEA]; intracellular protein transport [goid 6886] [evidence IEA],protein transporter activity [goid 8565] [evidence IEA]; protein transporter activity [goid 8565] [evidence IEA],6,132823658-132823682:132826825-132826849,6q23.2b,-,NM_003569.1,8417,STX7,-1.0795228817419504,8.03516173139588,-10.813640905254093,2.1411718562512137e-19,2.980052401361064e-18,33.30332670692226
XAGE1,ILMN_1691494,"Homo sapiens X antigen family, member 1D (XAGE1D), transcript variant 3, mRNA.",,,,X,52547661-52547710,Xp11.22b,-,NM_133430.1,9503,XAGE1,2.5101332706247153,6.44386367189833,10.806317675524882,2.2291211706195304e-19,3.0980332389102388e-18,33.26325870896971
FOSB,ILMN_1751607,"Homo sapiens FBJ murine osteosarcoma viral oncogene homolog B (FOSB), mRNA.",nucleus [goid 5634] [evidence IEA],"behavior [goid 7610] [pmid 8706134] [evidence TAS]; regulation of transcription, DNA-dependent [goid 6355] [evidence IEA]; negative regulation of transcription from RNA polymerase II promoter [goid 122] [pmid 1900040] [evidence TAS]; development [goid 7275] [pmid 8706134] [evidence TAS]",sequence-specific DNA binding [goid 43565] [evidence IEA]; protein dimerization activity [goid 46983] [evidence IEA]; transcription factor activity [goid 3700] [evidence IEA]; transcription factor binding [goid 8134] [pmid 1900040] [evidence TAS],19,50670217-50670266,19q13.32a,+,NM_006732.1,2354,FOSB,-3.2624626027814223,11.670173402222595,-10.805761119486059,2.2359510983704207e-19,3.105310559639889e-18,33.26021359716269
PAPSS2,ILMN_2410929,"Homo sapiens 3'-phosphoadenosine 5'-phosphosulfate synthase 2 (PAPSS2), transcript variant 1, mRNA.",intracellular [goid 5622] [evidence ISS],"skeletal development [goid 1501] [evidence ISS]; sulfate assimilation [goid 103] [evidence IEA]; nucleobase, nucleoside, nucleotide and nucleic acid metabolism [goid 6139] [evidence NR ]",sulfate adenylyltransferase (ATP) activity [goid 4781] [evidence ISS]; adenylylsulfate kinase activity [goid 4020] [evidence IEA]; nucleotide binding [goid 166] [evidence IEA]; ATP binding [goid 5524] [evidence ISS]; nucleotidyltransferase activity [goid 16779] [evidence ISS],10,89496772-89496821,10q23.2b,+,NM_004670.3,9060,PAPSS2,-1.2768655097789932,10.551216782011323,-10.80445098191845,2.252111541208462e-19,3.125526594048923e-18,33.25304538119896
LY86,ILMN_1807825,"Homo sapiens lymphocyte antigen 86 (LY86), mRNA.",plasma membrane [goid 5886] [pmid 9763566] [evidence TAS],cell proliferation [goid 8283] [pmid 9763566] [evidence TAS]; humoral immune response [goid 6959] [pmid 9763566] [evidence TAS]; apoptosis [goid 6915] [pmid 9763566] [evidence TAS]; signal transduction [goid 7165] [evidence NR ]; inflammatory response [goid 6954] [evidence IEA],signal transducer activity [goid 4871] [evidence NR ],6,6600007-6600056,6p25.1a,+,NM_004271.3,9450,LY86,-1.5766477010496835,9.750942393470677,-10.80135639446756,2.2907483793146967e-19,3.176884852024688e-18,33.23611383796616
COMT,ILMN_1730084,"Homo sapiens catechol-O-methyltransferase (COMT), transcript variant MB-COMT, mRNA.",integral to membrane [goid 16021] [evidence IEA]; membrane [goid 16020] [evidence IEA]; soluble fraction [goid 5625] [pmid 1707278] [evidence TAS]; microsome [goid 5792] [pmid 1707278] [evidence TAS]; integral to membrane [goid 16021] [evidence IEA]; membrane [goid 16020] [evidence IEA]; soluble fraction [goid 5625] [pmid 1707278] [evidence TAS]; microsome [goid 5792] [pmid 1707278] [evidence TAS],catecholamine metabolism [goid 6584] [evidence IEA]; neurotransmitter catabolism [goid 42135] [evidence IEA]; catecholamine metabolism [goid 6584] [evidence IEA]; neurotransmitter catabolism [goid 42135] [evidence IEA],transferase activity [goid 16740] [evidence IEA]; catechol O-methyltransferase activity [goid 16206] [evidence IEA]; magnesium ion binding [goid 287] [evidence IEA]; protein binding [goid 5515] [pmid 15231747] [evidence IPI]; transferase activity [goid 16740] [evidence IEA]; catechol O-methyltransferase activity [goid 16206] [evidence IEA]; magnesium ion binding [goid 287] [evidence IEA]; protein binding [goid 5515] [pmid 15231747] [evidence IPI],22,18336317-18336366,22q11.21c,+,NM_000754.2,1312,COMT,-1.1522303962688945,9.775553124634412,-10.7982886534732,2.3297043214144594e-19,3.2263176050291927e-18,33.21932920346015
STON1,ILMN_1668592,"Homo sapiens stonin 1 (STON1), mRNA.",,,,2,48679254-48679303,2p16.3d,+,NM_006873.2,11037,STON1,-1.5369470199342992,6.97240901618767,-10.79797622780517,2.333708668463498e-19,3.2279384355296978e-18,33.21761981970933
VIPR1,ILMN_2199389,"Homo sapiens vasoactive intestinal peptide receptor 1 (VIPR1), mRNA.",integral to plasma membrane [goid 5887] [pmid 8179610] [evidence TAS]; membrane [goid 16020] [evidence IEA],"immune response [goid 6955] [pmid 8390245] [evidence TAS]; synaptic transmission [goid 7268] [pmid 8390245] [evidence TAS]; G-protein signaling, coupled to cyclic nucleotide second messenger [goid 7187] [pmid 8390245] [evidence TAS]; muscle contraction [goid 6936] [pmid 8390245] [evidence TAS]; digestion [goid 7586] [pmid 8390245] [evidence TAS]; signal transduction [goid 7165] [evidence IEA]; positive regulation of cell proliferation [goid 8284] [pmid 8389448] [evidence TAS]",receptor activity [goid 4872] [evidence IEA]; G-protein coupled receptor activity [goid 4930] [evidence IEA]; vasoactive intestinal polypeptide receptor activity [goid 4999] [pmid 8179610] [evidence TAS],3,42553981-42554030,3p22.1a,+,NM_004624.2,7433,VIPR1,-2.0308749656451734,10.337093059072856,-10.79793886800806,2.3341879680068486e-19,3.2279384355296978e-18,33.217415411968716
POLM,ILMN_1716973,"Homo sapiens polymerase (DNA directed), mu (POLM), mRNA.",nucleus [goid 5634] [evidence IEA]; intracellular [goid 5622] [evidence IEA],DNA replication [goid 6260] [evidence IEA],transferase activity [goid 16740] [evidence IEA]; DNA-directed DNA polymerase activity [goid 3887] [evidence IEA]; DNA binding [goid 3677] [evidence IEA]; DNA nucleotidylexotransferase activity [goid 3912] [evidence IEA]; magnesium ion binding [goid 287] [evidence IEA],7,44078607-44078656,7p13d,-,NM_013284.1,27434,POLM,1.0165923585735568,7.8513303046671465,10.794459364372385,2.379261819344442e-19,3.2879373439664155e-18,33.198377918857084
CD9,ILMN_1695423,"Homo sapiens CD9 molecule (CD9), mRNA.",plasma membrane [goid 5886] [pmid 6198179] [evidence NAS]; integral to plasma membrane [goid 5887] [pmid 2037603] [evidence NAS]; integral to membrane [goid 16021] [evidence IEA],cell motility [goid 6928] [pmid 8478605] [evidence IDA]; paranodal junction assembly [goid 30913] [evidence ISS]; fusion of sperm to egg plasma membrane [goid 7342] [pmid 14575715] [evidence IDA]; cell adhesion [goid 7155] [pmid 7511626] [evidence IDA]; platelet activation [goid 30168] [pmid 2037603] [evidence NAS],protein binding [goid 5515] [pmid 11504738] [evidence IPI],12,6214685-6214734,12p13.31e,+,NM_001769.2,928,CD9,-1.2416464805972804,10.312909384847918,-10.791828100814227,2.413924615162566e-19,3.33111339422398e-18,33.18398144413486
DAB2,ILMN_1764228,"Homo sapiens disabled homolog 2, mitogen-responsive phosphoprotein (Drosophila) (DAB2), mRNA.",,cell proliferation [goid 8283] [pmid 9620555] [evidence TAS],,5,39408932-39408981,5p13.1c,-,NM_001343.1,1601,DAB2,-1.0555518930535488,10.61301412813878,-10.789095825035742,2.4504526869937013e-19,3.3791274314276203e-18,33.16903232048816
C9orf123,ILMN_1769409,"Homo sapiens chromosome 9 open reading frame 123 (C9orf123), mRNA.",membrane [goid 16020] [evidence IEA]; integral to membrane [goid 16021] [evidence IEA],,,9,7786655-7786704,9p24.1a,-,NM_033428.1,90871,C9orf123,-1.0488425104151293,8.014731259017225,-10.788275244384476,2.461530676753836e-19,3.3920031991901336e-18,33.16454267490347
GALNTL4,ILMN_1673773,"Homo sapiens UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase-like 4 (GALNTL4), mRNA.",membrane [goid 16020] [evidence IEA]; integral to membrane [goid 16021] [evidence IEA],,"transferase activity, transferring glycosyl groups [goid 16757] [evidence IEA]; polypeptide N-acetylgalactosaminyltransferase activity [goid 4653] [evidence IEA]; sugar binding [goid 5529] [evidence IEA]; calcium ion binding [goid 5509] [evidence IEA]; manganese ion binding [goid 30145] [evidence IEA]",11,11249312-11249361,11p15.3d-p15.3c,-,NM_198516.1,374378,GALNTL4,-1.2463944249604655,9.521685957707197,-10.78492210611834,2.507321584339155e-19,3.452661559777275e-18,33.14619665999049
SFTPD,ILMN_1768575,"Homo sapiens surfactant, pulmonary-associated protein D (SFTPD), mRNA.",lysosome [goid 5764] [pmid 10485905] [evidence TAS]; extracellular region [goid 5576] [pmid 9751757] [evidence TAS]; endocytic vesicle [goid 30139] [pmid 10485905] [evidence TAS]; cytoplasm [goid 5737] [evidence IEA],oxygen and reactive oxygen species metabolism [goid 6800] [pmid 10485905] [evidence TAS]; surfactant homeostasis [goid 43129] [pmid 9751757] [evidence IMP]; regulation of cytokine production [goid 1817] [pmid 9751757] [evidence NAS]; phosphate transport [goid 6817] [evidence IEA]; positive regulation of phagocytosis [goid 50766] [pmid 10485905] [evidence TAS]; negative regulation of interleukin-2 biosynthesis [goid 45085] [pmid 10485905] [evidence TAS]; macrophage chemotaxis [goid 48246] [pmid 10485905] [evidence TAS]; respiratory gaseous exchange [goid 7585] [evidence IEA]; regulation of liquid surface tension [goid 50828] [evidence IEA]; antimicrobial humoral response (sensu Vertebrata) [goid 19735] [evidence NR ]; innate immune response [goid 45087] [pmid 10485905] [evidence TAS]; alveolus development [goid 48286] [pmid 9751757] [evidence IMP]; receptor mediated endocytosis [goid 6898] [pmid 10485905] [evidence TAS],sugar binding [goid 5529] [pmid 10485905] [evidence TAS]; bacterial binding [goid 8367] [pmid 9751757] [evidence TAS]; calcium ion binding [goid 5509] [evidence IEA],10,81687578-81687587:81687588-81687627,10q22.3f,-,NM_003019.4,6441,SFTPD,-2.3357938400985088,13.573718840038802,-10.781497051466939,2.554974219278399e-19,3.5133149373775304e-18,33.12745720605768
LOC653764,ILMN_1677946,"PREDICTED: Homo sapiens similar to muscle RAS oncogene homolog (LOC653764), mRNA.",,,,3,139605911-139605956:139606331-139606334,,+,XM_929539.1,653764,LOC653764,-1.0788410292248498,5.696373375937371,-10.773424402857058,2.670902610998127e-19,3.662388274123751e-18,33.08328959427063
INT1,ILMN_1793854,"PREDICTED: Homo sapiens integrator complex subunit 1, transcript variant 5 (INT1), mRNA.",,,,7,1476711-1476738:1476739-1476760,7p22.3b,-,XM_931339.1,26173,INT1,1.2482096500411792,8.801240442003179,10.77197130942402,2.6923218437081943e-19,3.6891625263469876e-18,33.07533935792324
C1orf188,ILMN_1789058,"Homo sapiens chromosome 1 open reading frame 188 (C1orf188), mRNA.",,,,1,6202992-6203041,1p36.31b-p36.31a,+,NM_173795.2,148646,C1orf188,1.2787132462129538,6.484918079564733,10.768927528110696,2.7377469258386535e-19,3.7487701229772426e-18,33.05868609786031
LOC340243,ILMN_1727049,"PREDICTED: Homo sapiens similar to solute carrier family 29 (nucleoside transporters), member 4 (LOC340243), mRNA.",,,,,,,,XM_935493.1,340243,LOC340243,1.7177422030401681,6.4857782474688666,10.759947557520052,2.8762786043132974e-19,3.927420364754352e-18,33.00955473559155
MAP4,ILMN_1708064,"Homo sapiens microtubule-associated protein 4 (MAP4), transcript variant 1, mRNA.",microtubule associated complex [goid 5875] [pmid 1905296] [evidence TAS]; microtubule [goid 5874] [evidence IEA],negative regulation of microtubule depolymerization [goid 7026] [evidence IEA],structural molecule activity [goid 5198] [pmid 1905296] [evidence TAS],3,47931376-47931425,3p21.31f,-,NM_002375.3,4134,MAP4,1.3500422113947481,6.480474725761178,10.757930761000607,2.9083428682533863e-19,3.9656445617856705e-18,32.99852045267098
SLC41A2,ILMN_1747197,"Homo sapiens solute carrier family 41, member 2 (SLC41A2), mRNA.",,cation transport [goid 6812] [evidence IEA],cation transporter activity [goid 8324] [evidence IEA],12,103723196-103723245,12q23.3b,-,NM_032148.2,84102,SLC41A2,1.2836558758595578,6.203747086161746,10.754531944240107,2.9631902164832163e-19,4.034987703679213e-18,32.97992491167425
OSTbeta,ILMN_1750312,"Homo sapiens organic solute transporter beta (OSTbeta), mRNA.",plasma membrane [goid 5886] [pmid 12719432] [evidence IDA],,,15,63130924-63130973,15q22.31b,+,NM_178859.2,123264,OSTbeta,-1.29158930236457,5.569450442680038,-10.754522767225483,2.9633396992378515e-19,4.034987703679213e-18,32.979874702639655
CCNE1,ILMN_1795852,"Homo sapiens cyclin E1 (CCNE1), transcript variant 1, mRNA.",nucleus [goid 5634] [evidence NAS]; nucleus [goid 5634] [evidence NAS]; nucleus [goid 5634] [evidence NAS],"G1/S transition of mitotic cell cycle [goid 82] [pmid 8207080] [evidence NAS]; positive regulation of transcription, DNA-dependent [goid 45893] [pmid 15572661] [evidence NAS]; androgen receptor signaling pathway [goid 30521] [pmid 15572661] [evidence NAS]; cell cycle [goid 7049] [evidence IEA]; cell division [goid 51301] [evidence IEA]; G1/S transition of mitotic cell cycle [goid 82] [pmid 8207080] [evidence NAS]; positive regulation of transcription, DNA-dependent [goid 45893] [pmid 15572661] [evidence NAS]; androgen receptor signaling pathway [goid 30521] [pmid 15572661] [evidence NAS]; cell cycle [goid 7049] [evidence IEA]; cell division [goid 51301] [evidence IEA]; G1/S transition of mitotic cell cycle [goid 82] [pmid 8207080] [evidence NAS]; positive regulation of transcription, DNA-dependent [goid 45893] [pmid 15572661] [evidence NAS]; androgen receptor signaling pathway [goid 30521] [pmid 15572661] [evidence NAS]; cell cycle [goid 7049] [evidence IEA]; cell division [goid 51301] [evidence IEA]",transcription coactivator activity [goid 3713] [pmid 15572661] [evidence NAS]; androgen receptor binding [goid 50681] [pmid 15572661] [evidence NAS]; protein binding [goid 5515] [pmid 9891079] [evidence IPI]; transcription coactivator activity [goid 3713] [pmid 15572661] [evidence NAS]; androgen receptor binding [goid 50681] [pmid 15572661] [evidence NAS]; protein binding [goid 5515] [pmid 9891079] [evidence IPI]; transcription coactivator activity [goid 3713] [pmid 15572661] [evidence NAS]; androgen receptor binding [goid 50681] [pmid 15572661] [evidence NAS]; protein binding [goid 5515] [pmid 9891079] [evidence IPI],19,35006560-35006609,19q12c,+,NM_001238.1,898,CCNE1,1.4664626859338528,6.071924966326473,10.753199371633894,2.984975401207332e-19,4.061609336070172e-18,32.97263418052007
LOC650580,ILMN_1736701,"PREDICTED: Homo sapiens hypothetical protein LOC650580 (LOC650580), mRNA.",,,,,,,,XM_942530.1,650580,LOC650580,1.261796806363594,5.880399932516948,10.75172030027256,3.0093431803911615e-19,4.0919087138814924e-18,32.96454193955617
ILKAP,ILMN_1684647,"Homo sapiens integrin-linked kinase-associated serine/threonine phosphatase 2C (ILKAP), mRNA.",protein serine/threonine phosphatase complex [goid 8287] [evidence IEA],protein amino acid dephosphorylation [goid 6470] [evidence IEA]; integrin-mediated signaling pathway [goid 7229] [evidence IEA],kinase activity [goid 16301] [evidence IEA]; hydrolase activity [goid 16787] [evidence IEA]; magnesium ion binding [goid 287] [evidence IEA]; protein serine/threonine phosphatase activity [goid 4722] [evidence IEA],2,238743860-238743909,2q37.3c,-,NM_030768.2,80895,ILKAP,1.114315725124511,8.511604850340117,10.751247402836551,3.017176083425563e-19,4.0996984648219734e-18,32.961954642648685
REV3L,ILMN_2199947,"Homo sapiens REV3-like, catalytic subunit of DNA polymerase zeta (yeast) (REV3L), mRNA.",nucleus [goid 5634] [evidence IEA]; zeta DNA polymerase complex [goid 16035] [evidence NR ],DNA-dependent DNA replication [goid 6261] [pmid 9618506] [evidence TAS]; DNA repair [goid 6281] [evidence IEA]; DNA replication [goid 6260] [evidence IEA],zeta DNA polymerase activity [goid 3894] [pmid 9618506] [evidence TAS]; metal ion binding [goid 46872] [evidence IEA]; zinc ion binding [goid 8270] [evidence IEA]; DNA binding [goid 3677] [evidence IEA]; nucleotide binding [goid 166] [evidence IEA]; 3'-5' exonuclease activity [goid 8408] [evidence IEA]; DNA-directed DNA polymerase activity [goid 3887] [evidence IEA]; transferase activity [goid 16740] [evidence IEA],6,111735413-111735462,6q21h,-,NM_002912.1,5980,REV3L,-1.087033055648626,5.818858845721196,-10.749204145084184,3.051254908008331e-19,4.1402299361101905e-18,32.95077566766128
SAMD4B,ILMN_1753467,"Homo sapiens sterile alpha motif domain containing 4B (SAMD4B), mRNA.",,,,19,44567062-44567111,19q13.2a,+,NM_018028.2,55095,SAMD4B,1.2807967394096655,7.851150567391383,10.747321835750432,3.0829898704491285e-19,4.177472713887432e-18,32.94047728409119
CTSG,ILMN_1680424,"Homo sapiens cathepsin G (CTSG), mRNA.",insoluble fraction [goid 5626] [evidence NR ],immune response [goid 6955] [pmid 2569462] [evidence TAS],cathepsin G activity [goid 4261] [pmid 2569462] [evidence TAS]; peptidase activity [goid 8233] [evidence IEA],14,24112612-24112661,14q12a,-,NM_001911.2,1511,CTSG,-2.845659248355214,8.371362088665254,-10.743407566166157,3.1500436752726373e-19,4.2653649070665276e-18,32.919061812258
IPO13,ILMN_1651229,"Homo sapiens importin 13 (IPO13), mRNA.",nucleus [goid 5634] [evidence IEA]; nuclear pore [goid 5643] [evidence IEA]; cytoplasm [goid 5737] [evidence IEA],protein transport [goid 15031] [evidence IEA],protein transporter activity [goid 8565] [evidence IEA]; protein binding [goid 5515] [pmid 16189514] [evidence IPI],1,44205856-44205905,1p34.1f,+,NM_014652.2,9670,IPO13,1.1227056227233358,8.374293003175534,10.736489288667165,3.272144608115148e-19,4.40924880284396e-18,32.88121122267289
RBM12B,ILMN_1805778,"Homo sapiens RNA binding motif protein 12B (RBM12B), mRNA.",,,nucleotide binding [goid 166] [evidence IEA]; nucleic acid binding [goid 3676] [evidence IEA],8,94813465-94813514,8q22.1b,-,NM_203390.1,389677,RBM12B,1.1064957028221913,7.604300102603067,10.734745261394332,3.303664859003476e-19,4.4440310376215746e-18,32.87166951561382
BDP1,ILMN_1687149,"Homo sapiens B double prime 1, subunit of RNA polymerase III transcription initiation factor IIIB (BDP1), mRNA.",nucleus [goid 5634] [evidence IEA],regulation of transcription [goid 45449] [evidence IEA],DNA binding [goid 3677] [evidence IEA],5,70876655-70876704,5q13.2b,+,NM_018429.1,55814,BDP1,1.1451254921716965,5.906993423363331,10.734682816062298,3.304799062619277e-19,4.4440310376215746e-18,32.87132787272343
DKK2,ILMN_1695506,"Homo sapiens dickkopf homolog 2 (Xenopus laevis) (DKK2), mRNA.",extracellular region [goid 5576] [evidence IEA]; extracellular space [goid 5615] [pmid 10570958] [evidence TAS]; extracellular region [goid 5576] [evidence IEA]; extracellular space [goid 5615] [pmid 10570958] [evidence TAS],Wnt receptor signaling pathway [goid 16055] [evidence IEA]; development [goid 7275] [evidence IEA]; negative regulation of Wnt receptor signaling pathway [goid 30178] [evidence IEA]; Wnt receptor signaling pathway [goid 16055] [evidence IEA]; development [goid 7275] [evidence IEA]; negative regulation of Wnt receptor signaling pathway [goid 30178] [evidence IEA],,4,108063211-108063260,4q25a,-,NM_014421.2,27123,DKK2,-1.1797197150819283,5.496050987312402,-10.731586041554923,3.3615374386635045e-19,4.517210827059199e-18,32.85438522487301
FLJ33641,ILMN_1675191,"Homo sapiens chromosome 5 open reading frame 29 (C5orf29), mRNA.",,,,5,57827608-57827657,5q11.2g,+,NM_152687.1,202309,FLJ33641,-1.2135002211296442,6.4982443657709075,-10.728395997316428,3.421003425846765e-19,4.593952567375893e-18,32.836932350055555
RDX,ILMN_1708611,"Homo sapiens radixin (RDX), mRNA.",plasma membrane [goid 5886] [evidence NR ]; actin cytoskeleton [goid 15629] [evidence NR ]; cytoplasm [goid 5737] [evidence IEA],cytoskeletal anchoring [goid 7016] [evidence NR ]; barbed-end actin filament capping [goid 51016] [evidence IEA],binding [goid 5488] [evidence IEA]; structural molecule activity [goid 5198] [evidence IEA]; actin binding [goid 3779] [evidence IEA],11,109605912-109605961,11q22.3d,-,NM_002906.3,5962,RDX,-1.0561885295018545,8.937674743343035,-10.722388721499607,3.5358563403891e-19,4.741649056605754e-18,32.8040664393199
BNC2,ILMN_1656373,"Homo sapiens basonuclin 2 (BNC2), mRNA.",nucleus [goid 5634] [evidence IEA],,metal ion binding [goid 46872] [evidence IEA]; nucleic acid binding [goid 3676] [evidence IEA]; zinc ion binding [goid 8270] [evidence IEA],9,16406696-16406745,9p22.3a-p22.2b,-,NM_017637.4,54796,BNC2,-1.2656833688041447,6.791053571031263,-10.72209389015113,3.5415914388374193e-19,4.7460735340954e-18,32.80245341753464
TACSTD1,ILMN_2160209,"Homo sapiens tumor-associated calcium signal transducer 1 (TACSTD1), mRNA.",plasma membrane [goid 5886] [pmid 1729376] [evidence TAS]; integral to membrane [goid 16021] [evidence IEA]; plasma membrane [goid 5886] [pmid 1729376] [evidence TAS]; integral to membrane [goid 16021] [evidence IEA],,,2,47465832-47465853:47467215-47467242,2p21a,+,NM_002354.1,4072,TACSTD1,1.1438696658907972,9.904511516544696,10.721345942552128,3.556182381428355e-19,4.762351457191169e-18,32.798361399966986
LAPTM4B,ILMN_1680196,"Homo sapiens lysosomal associated protein transmembrane 4 beta (LAPTM4B), mRNA.",membrane [goid 16020] [evidence IEA]; integral to membrane [goid 16021] [evidence IEA]; membrane [goid 16020] [evidence IEA]; integral to membrane [goid 16021] [evidence IEA],transport [goid 6810] [evidence IEA]; transport [goid 6810] [evidence IEA],,8,98933500-98933549,8q22.1e,+,NM_018407.4,55353,LAPTM4B,1.1392411581317532,11.93965844327117,10.716292768467003,3.6563470371207957e-19,4.886414404547236e-18,32.77071560232102
F2RL1,ILMN_1673113,"Homo sapiens coagulation factor II (thrombin) receptor-like 1 (F2RL1), mRNA.",integral to plasma membrane [goid 5887] [pmid 8615752] [evidence TAS]; plasma membrane [goid 5886] [pmid 8615752] [evidence TAS]; Golgi apparatus [goid 5794] [pmid 8615752] [evidence TAS],signal transduction [goid 7165] [evidence IEA]; G-protein coupled receptor protein signaling pathway [goid 7186] [pmid 7556175] [evidence TAS]; blood coagulation [goid 7596] [evidence IEA],receptor binding [goid 5102] [pmid 8615752] [evidence TAS]; receptor activity [goid 4872] [pmid 8615752] [evidence TAS]; thrombin receptor activity [goid 15057] [evidence IEA]; rhodopsin-like receptor activity [goid 1584] [evidence IEA],5,76166279-76166328,5q13.3d,+,NM_005242.3,2150,F2RL1,1.3960492797312618,7.730281689133931,10.710376244366637,3.7772162711525445e-19,5.044486569116335e-18,32.7383466477449
SFRP1,ILMN_2149164,"Homo sapiens secreted frizzled-related protein 1 (SFRP1), mRNA.",,cell differentiation [goid 30154] [evidence IEA]; Wnt receptor signaling pathway [goid 16055] [evidence IEA],,8,41239120-41239169,8p11.21b,-,NM_003012.3,6422,SFRP1,-2.173653545259433,6.630947135452426,-10.705944991264982,3.8703524792133873e-19,5.165330003936497e-18,32.714103677966115
KCNQ3,ILMN_1775004,"Homo sapiens potassium voltage-gated channel, KQT-like subfamily, member 3 (KCNQ3), mRNA.",integral to membrane [goid 16021] [evidence IEA]; membrane fraction [goid 5624] [evidence NR ]; voltage-gated potassium channel complex [goid 8076] [pmid 9677360] [evidence TAS]; membrane [goid 16020] [evidence IEA],ion transport [goid 6811] [evidence IEA]; potassium ion transport [goid 6813] [pmid 9677360] [evidence TAS]; synaptic transmission [goid 7268] [pmid 9425900] [evidence TAS],potassium ion binding [goid 30955] [evidence IEA]; ion channel activity [goid 5216] [evidence IEA]; voltage-gated potassium channel activity [goid 5249] [pmid 9677360] [evidence TAS],8,133210591-133210640,8q24.22b,-,NM_004519.2,3786,KCNQ3,1.001575331316106,6.3478773839308715,10.688189943936496,4.26713900713011e-19,5.687086426397414e-18,32.61696889983148
CXXC5,ILMN_1745256,"Homo sapiens CXXC finger 5 (CXXC5), mRNA.",,positive regulation of I-kappaB kinase/NF-kappaB cascade [goid 43123] [pmid 12761501] [evidence IMP],zinc ion binding [goid 8270] [evidence IEA]; signal transducer activity [goid 4871] [pmid 12761501] [evidence IMP]; DNA binding [goid 3677] [evidence IEA],5,139043454-139043503,5q31.3a,+,NM_016463.5,51523,CXXC5,1.046891852554717,10.711330334454251,10.6859506469338,4.3199886448469947e-19,5.749657018090416e-18,32.60471826534084
LOC152485,ILMN_1727574,"Homo sapiens hypothetical protein LOC152485 (LOC152485), mRNA.",nucleus [goid 5634] [evidence IEA],,metal ion binding [goid 46872] [evidence IEA]; nucleic acid binding [goid 3676] [evidence IEA]; zinc ion binding [goid 8270] [evidence IEA],4,146901403-146901452,4q31.22b,-,NM_178835.2,152485,LOC152485,1.3676220890958408,8.80202943169341,10.682832679062933,4.3946676893616625e-19,5.841070936371896e-18,32.587660708695495
RNF122,ILMN_1691119,"Homo sapiens ring finger protein 122 (RNF122), mRNA.",membrane [goid 16020] [evidence IEA]; integral to membrane [goid 16021] [evidence IEA]; endoplasmic reticulum [goid 5783] [evidence IEA],,zinc ion binding [goid 8270] [evidence IEA]; metal ion binding [goid 46872] [evidence IEA]; protein binding [goid 5515] [evidence IEA],8,33524873-33524922,8p12c,-,NM_024787.2,79845,RNF122,-1.1481842788852035,6.828820978935978,-10.681655517524105,4.423196594556623e-19,5.874981979886557e-18,32.581220797603855
RAB28,ILMN_2293992,"Homo sapiens RAB28, member RAS oncogene family (RAB28), transcript variant 1, mRNA.",membrane [goid 16020] [evidence IEA],small GTPase mediated signal transduction [goid 7264] [evidence IEA],GTP binding [goid 5525] [evidence IEA]; GTPase activity [goid 3924] [pmid 8647132] [evidence TAS]; nucleotide binding [goid 166] [evidence IEA],4,12979199-12979248,4p15.33c,-,NM_001017979.1,9364,RAB28,-1.064112301156686,6.794096685418431,-10.679455757684236,4.477005818719503e-19,5.934316896445546e-18,32.56918657672941
C9orf42,ILMN_1723353,"Homo sapiens family with sequence similarity 122A (FAM122A), mRNA.",,,,9,70587743-70587792,9q21.11a,+,NM_138333.3,116224,C9orf42,-1.086821552592033,7.000697591114409,-10.677139771356943,4.534365601482983e-19,6.006261981298159e-18,32.556516559228044
GRHL2,ILMN_2060145,"Homo sapiens grainyhead-like 2 (Drosophila) (GRHL2), mRNA.",nucleus [goid 5634] [evidence IEA],"transcription [goid 6350] [evidence IEA]; regulation of transcription, DNA-dependent [goid 6355] [evidence IEA]",DNA binding [goid 3677] [evidence IEA],8,102750453-102750502,8q22.3a-q22.3b,+,NM_024915.1,79977,GRHL2,1.173738276232319,7.108549972507039,10.674910900105735,4.590261604460432e-19,6.076171695849968e-18,32.544323162871414
COMP,ILMN_1677636,"Homo sapiens cartilage oligomeric matrix protein (COMP), mRNA.",extracellular region [goid 5576] [evidence IEA]; extracellular matrix (sensu Metazoa) [goid 5578] [pmid 7713493] [evidence TAS],skeletal development [goid 1501] [pmid 7670472] [evidence TAS]; cell adhesion [goid 7155] [evidence IEA],extracellular matrix structural constituent [goid 5201] [pmid 7713493] [evidence TAS]; calcium ion binding [goid 5509] [pmid 7670472] [evidence TAS]; protein binding [goid 5515] [evidence IEA],19,18754711-18754724:18754725-18754760,19p13.11b,-,NM_000095.2,1311,COMP,3.4494097983684986,8.140353312781379,10.667899409138455,4.770629396559625e-19,6.306357787785909e-18,32.505965959289014
DKFZP564J0863,ILMN_1751086,"Homo sapiens DKFZP564J0863 protein (DKFZP564J0863), mRNA.",,immune response [goid 6955] [evidence IEA],GTP binding [goid 5525] [evidence IEA]; GTPase activity [goid 3924] [evidence IEA],11,63153293-63153342,11q13.1a,-,NM_015459.3,25923,DKFZP564J0863,1.0529735570865562,9.15556843727011,10.667553829173238,4.779700313916989e-19,6.3140651265540695e-18,32.50407543369424
UBB,ILMN_1762436,"Homo sapiens ubiquitin B (UBB), mRNA.",,protein modification [goid 6464] [evidence IEA]; protein modification [goid 6464] [evidence IEA],,17,16225155-16225204,17p11.2i,+,NM_018955.2,7314,UBB,-1.0236063152554635,13.740450739574928,-10.667188085380843,4.789319284664077e-19,6.32248551908398e-18,32.50207460126352
ST6GALNAC5,ILMN_1773959,"Homo sapiens ST6 (alpha-N-acetyl-neuraminyl-2,3-beta-galactosyl-1, 3)-N-acetylgalactosaminide alpha-2,6-sialyltransferase 5 (ST6GALNAC5), mRNA.",integral to Golgi membrane [goid 30173] [evidence IEA]; membrane [goid 16020] [evidence IEA]; integral to membrane [goid 16021] [evidence IEA],protein amino acid glycosylation [goid 6486] [evidence IEA],sialyltransferase activity [goid 8373] [evidence IEA],1,77301926-77301975,1p31.1f,+,NM_030965.1,81849,ST6GALNAC5,-1.3946313938037855,6.483682407819173,-10.666220158686874,4.814869014146147e-19,6.3519108152090496e-18,32.49677948195002
C20orf54,ILMN_1740923,"Homo sapiens chromosome 20 open reading frame 54 (C20orf54), mRNA.",membrane [goid 16020] [evidence IEA]; integral to membrane [goid 16021] [evidence IEA],,,20,688957-689006,20p13f,-,NM_033409.2,113278,C20orf54,1.1849697574031959,6.192111036803833,10.655283498697179,5.113202249996806e-19,6.7272617043340835e-18,32.43695021347283
CHRDL1,ILMN_1678233,"Homo sapiens chordin-like 1 (CHRDL1), mRNA.",,ossification [goid 1503] [evidence IEA]; cell differentiation [goid 30154] [evidence IEA]; ossification [goid 1503] [evidence IEA]; cell differentiation [goid 30154] [evidence IEA],,X,109805406-109805455,Xq22.3d,-,NM_145234.2,91851,CHRDL1,-1.2669409265336098,5.394373863311733,-10.64825038009446,5.314747844208687e-19,6.982998094700356e-18,32.39847595938533
EPHB3,ILMN_1741346,"Homo sapiens EPH receptor B3 (EPHB3), mRNA.",membrane [goid 16020] [evidence IEA]; integral to plasma membrane [goid 5887] [pmid 8397371] [evidence TAS],signal transduction [goid 7165] [pmid 8397371] [evidence TAS]; transmembrane receptor protein tyrosine kinase signaling pathway [goid 7169] [evidence IEA]; protein amino acid phosphorylation [goid 6468] [evidence IEA],nucleotide binding [goid 166] [evidence IEA]; receptor activity [goid 4872] [evidence IEA]; transferase activity [goid 16740] [evidence IEA]; ATP binding [goid 5524] [evidence IEA]; ephrin receptor activity [goid 5003] [evidence IEA],3,185782572-185782621,3q27.1b,+,NM_004443.3,2049,EPHB3,1.1129884665053407,6.7328911000721545,10.647475362044661,5.337437572519373e-19,7.008084305966305e-18,32.39423629897986
NOS1AP,ILMN_1710315,"Homo sapiens nitric oxide synthase 1 (neuronal) adaptor protein (NOS1AP), mRNA.",cytoplasm [goid 5737] [pmid 9459447] [evidence ISS],neurotransmitter secretion [goid 7269] [pmid 9459447] [evidence ISS]; regulation of nitric-oxide synthase activity [goid 50999] [pmid 9459447] [evidence ISS],nitric-oxide synthase binding [goid 50998] [pmid 9459447] [evidence ISS]; PDZ domain binding [goid 30165] [pmid 9459447] [evidence ISS]; protein binding [goid 5515] [pmid 9459447] [evidence ISS],1,160604747-160604796,1q23.3b,+,NM_014697.1,9722,NOS1AP,1.1393887655803905,5.65045378744126,10.645200666681653,5.404593283659841e-19,7.091481490377912e-18,32.3817928348787
NGEF,ILMN_1809613,"Homo sapiens neuronal guanine nucleotide exchange factor (NGEF), mRNA.",,,,2,233451784-233451833,2q37.1c-q37.1d,-,NM_019850.1,25791,NGEF,1.400626154476205,5.766930767184806,10.643421509487343,5.457707533725088e-19,7.156354730459848e-18,32.37206019231906
SPINT1,ILMN_1724946,"Homo sapiens serine peptidase inhibitor, Kunitz type 1 (SPINT1), transcript variant 1, mRNA.",membrane fraction [goid 5624] [pmid 9045658] [evidence TAS]; extracellular region [goid 5576] [pmid 9045658] [evidence TAS],,serine-type endopeptidase inhibitor activity [goid 4867] [pmid 9045658] [evidence TAS],15,38936918-38936967,15q15.1b,+,NM_181642.2,6692,SPINT1,1.1638558251248723,7.8246392722418765,10.635158715279317,5.711304373279626e-19,7.473792190285661e-18,32.326860098736184
SLC4A2,ILMN_2078389,"Homo sapiens solute carrier family 4, anion exchanger, member 2 (erythrocyte membrane protein band 3-like 1) (SLC4A2), mRNA.",membrane fraction [goid 5624] [pmid 3015590] [evidence TAS]; membrane [goid 16020] [evidence IEA]; integral to membrane [goid 16021] [evidence IEA],anion transport [goid 6820] [pmid 3015590] [evidence TAS],antiporter activity [goid 15297] [evidence IEA]; anion transporter activity [goid 8509] [pmid 3015590] [evidence TAS]; inorganic anion exchanger activity [goid 5452] [evidence IEA],7,150403753-150403795:150404033-150404039,7q36.1d,+,NM_003040.2,6522,SLC4A2,1.0747916380052978,8.96826308125173,10.633441701665088,5.765462700234327e-19,7.539600047923883e-18,32.31746758088704
PODXL,ILMN_1711311,"Homo sapiens podocalyxin-like (PODXL), transcript variant 2, mRNA.",membrane [goid 16020] [evidence IEA]; integral to plasma membrane [goid 5887] [pmid 9188463] [evidence TAS],,,7,130835864-130835913,7q32.3b,-,NM_005397.2,5420,PODXL,-1.113530499284673,9.007137175292767,-10.63240784073744,5.7983202801891105e-19,7.577482941615346e-18,32.31181210362324
PLAC8,ILMN_1653026,"Homo sapiens placenta-specific 8 (PLAC8), mRNA.",,,,4,84248065-84248098:84248099-84248114,4q21.22a,-,NM_016619.1,51316,PLAC8,-2.1938841010186305,9.167358960570203,-10.63048991108485,5.859771469744249e-19,7.652657311525917e-18,32.30132057990702
CXCR7,ILMN_2371458,"Homo sapiens chemokine (C-X-C motif) receptor 7 (CXCR7), transcript variant 1, mRNA.",integral to membrane [goid 16021] [evidence NAS]; membrane [goid 16020] [evidence IEA],signal transduction [goid 7165] [evidence IEA]; G-protein coupled receptor protein signaling pathway [goid 7186] [evidence IEA],"rhodopsin-like receptor activity [goid 1584] [evidence IEA]; G-protein coupled receptor activity, unknown ligand [goid 16526] [pmid 1315461] [evidence NAS]; receptor activity [goid 4872] [evidence IEA]",,,2q37.3a,,NM_001047841.1,57007,CXCR7,-1.8022951378230392,8.190355669374037,-10.62796104449935,5.941793765759319e-19,7.75457813300873e-18,32.28748714856495
LOC440345,ILMN_1656868,"PREDICTED: Homo sapiens hypothetical protein LOC440345, transcript variant 11 (LOC440345), mRNA.",,,,16,21753690-21753739,16p12.1c,-,XM_933731.1,440345,LOC440345,1.719680218722833,8.797069808640671,10.627552439986951,5.955153917280267e-19,7.766812187296252e-18,32.2852520025469
XPNPEP3,ILMN_1659000,"Homo sapiens X-prolyl aminopeptidase (aminopeptidase P) 3, putative (XPNPEP3), mRNA.",,,peptidase activity [goid 8233] [evidence IEA]; metalloexopeptidase activity [goid 8235] [evidence IEA]; peptidase activity [goid 8233] [evidence IEA]; metalloexopeptidase activity [goid 8235] [evidence IEA],22,39653117-39653166,22q13.2a,+,NM_022098.2,63929,XPNPEP3,1.174298165550475,10.26705683510073,10.62737808918897,5.960863808000208e-19,7.769058949758131e-18,32.28429827038117
HCN3,ILMN_1787256,"Homo sapiens hyperpolarization activated cyclic nucleotide-gated potassium channel 3 (HCN3), mRNA.",integral to membrane [goid 16021] [evidence IEA]; membrane [goid 16020] [evidence IEA],ion transport [goid 6811] [evidence IEA]; potassium ion transport [goid 6813] [evidence IEA]; sodium ion transport [goid 6814] [evidence IEA],sodium ion binding [goid 31402] [evidence IEA]; nucleotide binding [goid 166] [evidence IEA]; potassium ion binding [goid 30955] [evidence IEA]; sodium channel activity [goid 5272] [evidence IEA]; voltage-gated potassium channel activity [goid 5249] [evidence IEA],1,153526081-153526130,1q22a,+,NM_020897.1,57657,HCN3,1.174332853488476,6.537823258030978,10.626212492250048,5.999177331191295e-19,7.813768068065667e-18,32.2779222409943
BIK,ILMN_1770505,"Homo sapiens BCL2-interacting killer (apoptosis-inducing) (BIK), mRNA.",membrane [goid 16020] [evidence IEA]; integral to membrane [goid 16021] [evidence IEA],apoptotic program [goid 8632] [pmid 7478623] [evidence TAS]; regulation of apoptosis [goid 42981] [evidence IEA]; induction of apoptosis [goid 6917] [pmid 10381623] [evidence TAS],protein binding [goid 5515] [pmid 15694340] [evidence IPI],22,41855291-41855340,22q13.2c,+,NM_001197.3,638,BIK,1.4594322140242264,6.239943022084097,10.62195864380807,6.14110349063605e-19,7.987944026371391e-18,32.254653035028205
IFT57,ILMN_1811636,"Homo sapiens intraflagellar transport 57 homolog (Chlamydomonas) (IFT57), mRNA.",flagellum [goid 19861] [evidence IEA],regulation of apoptosis [goid 42981] [pmid 11788820] [evidence IDA]; caspase activation [goid 6919] [pmid 11788820] [evidence IDA],protein binding [goid 5515] [pmid 11788820] [evidence IDA],3,109362379-109362428,3q13.12b,-,NM_018010.2,55081,IFT57,-1.5380433172712031,9.307262699573473,-10.621333376319841,6.162246137055314e-19,8.010097797233009e-18,32.251232742482976
MIA3,ILMN_2312906,"Homo sapiens melanoma inhibitory activity family, member 3 (MIA3), mRNA.",,glycolysis [goid 6096] [evidence IEA],phosphoglycerate kinase activity [goid 4618] [evidence IEA],,,1q41e,,NM_198551.2,375056,MIA3,1.076227254504201,6.412360208473571,10.615869585239658,6.350121705677707e-19,8.248808095675341e-18,32.22134529865302
ChGn,ILMN_2055523,"Homo sapiens chondroitin beta1,4 N-acetylgalactosaminyltransferase (ChGn), mRNA.",membrane [goid 16020] [evidence IEA]; integral to membrane [goid 16021] [evidence IEA]; integral to Golgi membrane [goid 30173] [pmid 11788602] [evidence ISS]; soluble fraction [goid 5625] [pmid 11514575] [evidence IDA]; intracellular [goid 5622] [evidence ISS],"morphogenesis [goid 9653] [pmid 11514575] [evidence NAS]; chondroitin sulfate biosynthesis [goid 30206] [pmid 11514575] [evidence IDA]; UDP-glucuronate metabolism [goid 46398] [pmid 11514575] [evidence IDA]; heparan sulfate proteoglycan biosynthesis, polysaccharide chain biosynthesis [goid 15014] [pmid 11514575] [evidence NAS]; cell proliferation [goid 8283] [pmid 11514575] [evidence NAS]; UDP-N-acetylgalactosamine metabolism [goid 19276] [pmid 11514575] [evidence IDA]; dermatan sulfate proteoglycan biosynthesis, polysaccharide chain biosynthesis [goid 50652] [pmid 11788602] [evidence ISS]; extracellular matrix organization and biogenesis [goid 30198] [pmid 11514575] [evidence NAS]; heparin biosynthesis [goid 30210] [pmid 11514575] [evidence NAS]; cell recognition [goid 8037] [pmid 11514575] [evidence NAS]; chondroitin sulfate proteoglycan biosynthesis, polysaccharide chain biosynthesis [goid 50653] [pmid 11788602] [evidence ISS]",transferase activity [goid 16740] [evidence IEA]; glucuronosyltransferase activity [goid 15020] [pmid 11514575] [evidence IDA]; protein binding [goid 5515] [pmid 11788602] [evidence ISS]; metal ion binding [goid 46872] [evidence ISS]; peptidoglycan glycosyltransferase activity [goid 8955] [pmid 11514575] [evidence IDA]; glucuronylgalactosylproteoglycan 4-beta-N-acetylgalactosaminyltransferase activity [goid 47237] [evidence ISS],8,19306323-19306372,8p21.3c,-,NM_018371.3,55790,ChGn,-1.3204703694289623,6.249670260624763,-10.615521705063951,6.362275872902931e-19,8.259090298701772e-18,32.21944237331164
FLJ20054,ILMN_1789436,"Homo sapiens hypothetical protein FLJ20054 (FLJ20054), mRNA.",,,,1,195745406-195745455,1q31.3c,-,NM_019049.1,54530,FLJ20054,1.1055861514241645,9.536628802849947,10.61429701919316,6.405249068594547e-19,8.309339420876482e-18,32.21274327948811
TBC1D2,ILMN_1769876,"Homo sapiens TBC1 domain family, member 2 (TBC1D2), mRNA.",,,GTPase activator activity [goid 5096] [evidence IEA],9,100001298-100001347,9q22.33b,-,NM_018421.2,55357,TBC1D2,-1.0886157932898062,9.401205390985243,-10.612567223292734,6.466441036805345e-19,8.383140625559025e-18,32.20328123763611
WASPIP,ILMN_1668417,"Homo sapiens Wiskott-Aldrich syndrome protein interacting protein (WASPIP), mRNA.",actin cytoskeleton [goid 15629] [pmid 9405671] [evidence TAS],protein complex assembly [goid 6461] [pmid 9405671] [evidence TAS]; actin polymerization and/or depolymerization [goid 8154] [pmid 9405671] [evidence TAS],actin binding [goid 3779] [pmid 9405671] [evidence TAS]; profilin binding [goid 5522] [pmid 9405671] [evidence TAS],2,175133267-175133316,2q31.1g,-,NM_003387.3,7456,WASPIP,-1.1624509946823274,7.7357837048625715,-10.610567793665544,6.5378999769723645e-19,8.4588964841505e-18,32.19234433349026
C16orf7,ILMN_1693630,"Homo sapiens chromosome 16 open reading frame 7 (C16orf7), mRNA.",,ATP synthesis coupled proton transport [goid 15986] [pmid 10231027] [evidence TAS],transporter activity [goid 5215] [pmid 10231027] [evidence TAS],16,88301132-88301181,16q24.3b,-,NM_004913.1,9605,C16orf7,1.0317387714882766,8.5348963222534,10.607691842382405,6.642072312260265e-19,8.582279774827007e-18,32.17661292747855
LOC401115,ILMN_1668629,"PREDICTED: Homo sapiens hypothetical gene supported by BC038466; BC062790 (LOC401115), mRNA.",,,,,,4p16.3b,,XM_937968.1,401115,LOC401115,1.2127277199879334,12.047759646283925,10.604494314167269,6.759842165538338e-19,8.722882423544008e-18,32.159122616051654
IL4I1,ILMN_1659960,"Homo sapiens interleukin 4 induced 1 (IL4I1), transcript variant 1, mRNA.",,electron transport [goid 6118] [evidence IEA],oxidoreductase activity [goid 16491] [evidence IEA],19,55085015-55085064,19q13.33b,-,NM_152899.1,259307,IL4I1,1.7090970480722651,6.545625244046034,10.604002973468303,6.778123131109031e-19,8.734902725506579e-18,32.15643501907067
C1orf176,ILMN_1783996,"Homo sapiens chromosome 1 open reading frame 176 (C1orf176), mRNA.",,,,1,40754073-40754122,1p34.2c,+,NM_022774.1,64789,C1orf176,1.3587556176271924,9.262068625406593,10.602157597398204,6.847225272247252e-19,8.81229751847673e-18,32.14634097557966
TMEM92,ILMN_2092223,"Homo sapiens transmembrane protein 92 (TMEM92), mRNA.",,,,17,45713595-45713644,17q21.33a,+,NM_153229.1,162461,TMEM92,1.0983296148433963,5.586702653006142,10.601337117353687,6.8781748276628085e-19,8.846286238746523e-18,32.141853035722036
RAB3IP,ILMN_1803197,"Homo sapiens RAB3A interacting protein (rabin3) (RAB3IP), transcript variant beta 1, mRNA.",cytosol [goid 5829] [pmid 12007189] [evidence IDA]; nucleus [goid 5634] [pmid 12007189] [evidence IDA],protein transport [goid 15031] [evidence IEA],GTPase activator activity [goid 5096] [evidence IEA]; protein binding [goid 5515] [pmid 12007189] [evidence IPI],12,68495484-68495533,12q15c,+,NM_175624.1,117177,RAB3IP,1.0626287856316008,9.255444446863926,10.600311865254039,6.917045301961664e-19,8.890410798728432e-18,32.136245025697235
ENG,ILMN_1760778,"Homo sapiens endoglin (Osler-Rendu-Weber syndrome 1) (ENG), mRNA.",integral to membrane [goid 16021] [evidence IEA]; integral to plasma membrane [goid 5887] [pmid 7894484] [evidence TAS]; membrane [goid 16020] [evidence IEA],transport [goid 6810] [evidence IEA]; circulation [goid 8015] [pmid 7894484] [evidence TAS]; cell adhesion [goid 7155] [evidence IEA],protein binding [goid 5515] [pmid 8194490] [evidence TAS],9,129617495-129617544,9q34.11a,-,NM_000118.1,2022,ENG,-1.270842396891437,10.583982416673754,-10.595329609103995,7.109087705321497e-19,9.13121779421156e-18,32.1089928464811
ProSAPiP1,ILMN_1736154,"Homo sapiens ProSAPiP1 protein (ProSAPiP1), mRNA.",membrane [goid 16020] [evidence IEA]; cytoplasm [goid 5737] [evidence IEA],,structural molecule activity [goid 5198] [evidence IEA],20,3091550-3091599,20p13c,-,NM_014731.2,9762,ProSAPiP1,1.4704316857459379,7.904696049312994,10.595162042724354,7.115638436857659e-19,9.133610997508004e-18,32.10807628935464
DKFZp761I2123,ILMN_1760718,"Homo sapiens hypothetical protein DKFZp761I2123 (DKFZp761I2123), transcript variant 1, mRNA.",nucleus [goid 5634] [evidence IEA],,metal ion binding [goid 46872] [evidence IEA]; zinc ion binding [goid 8270] [evidence IEA],7,44775812-44775861,7p13c,+,NM_031449.3,83637,DKFZp761I2123,1.1464812943550253,8.71530729687811,10.591811977913759,7.247877531640089e-19,9.295572443579904e-18,32.08975212783729
CBX5,ILMN_1813028,"Homo sapiens chromobox homolog 5 (HP1 alpha homolog, Drosophila) (CBX5), mRNA.",nucleus [goid 5634] [evidence IEA]; chromatin [goid 785] [evidence IEA]; nuclear heterochromatin [goid 5720] [pmid 8663349] [evidence TAS],chromatin assembly or disassembly [goid 6333] [evidence IEA],chromatin binding [goid 3682] [evidence IEA]; protein binding [goid 5515] [pmid 15502821] [evidence IPI],12,52937613-52937662,12q13.13f,-,NM_012117.1,23468,CBX5,1.0308077043520028,8.024865192783578,10.591297254480741,7.268412142917884e-19,9.311309046992439e-18,32.086936709664485
PBK,ILMN_1673673,"Homo sapiens PDZ binding kinase (PBK), mRNA.",cellular component unknown [goid 8372] [evidence ND ],mitosis [goid 7067] [pmid 10779557] [evidence NAS]; protein amino acid phosphorylation [goid 6468] [evidence NAS],nucleotide binding [goid 166] [evidence IEA]; protein binding [goid 5515] [pmid 12620389] [evidence IPI]; transferase activity [goid 16740] [evidence IEA]; protein serine/threonine kinase activity [goid 4674] [pmid 10779557] [evidence TAS]; ATP binding [goid 5524] [evidence NAS]; protein-tyrosine kinase activity [goid 4713] [evidence IEA],8,27723197-27723246,8p21.1e,-,NM_018492.2,55872,PBK,1.288407122805066,5.713562396876101,10.58403352964064,7.564474090727241e-19,9.671507720329416e-18,32.04720617533538
ACTG2,ILMN_1795325,"Homo sapiens actin, gamma 2, smooth muscle, enteric (ACTG2), mRNA.",cytoskeleton [goid 5856] [evidence IEA]; actin filament [goid 5884] [evidence IEA],,ATP binding [goid 5524] [evidence IEA]; nucleotide binding [goid 166] [evidence IEA]; protein binding [goid 5515] [evidence IEA]; structural constituent of cytoskeleton [goid 5200] [evidence IEA],2,74000212-74000261,2p13.1b,+,NM_001615.3,72,ACTG2,-2.0136666703512542,10.95203799388587,-10.571648522832003,8.097343401392751e-19,1.0339235660297362e-17,31.97946526403243
TTLL12,ILMN_1663113,"Homo sapiens tubulin tyrosine ligase-like family, member 12 (TTLL12), mRNA.",,protein modification [goid 6464] [evidence IEA],ligase activity [goid 16874] [evidence IEA]; tubulin-tyrosine ligase activity [goid 4835] [evidence IEA],22,41892701-41892750,22q13.2c,-,NM_015140.2,23170,TTLL12,1.087393698905581,8.993354943066919,10.571169554445605,8.118688469375055e-19,1.0359701691275241e-17,31.9768455447329
LOC400987,ILMN_1654313,"PREDICTED: Homo sapiens similar to ankyrin repeat domain 36 (LOC400987), mRNA.",,,,,,2q11.2a,,XM_376101.3,400987,LOC400987,1.4593837249689523,5.815647007466388,10.566965171232145,8.308486119004802e-19,1.0588021715422405e-17,31.95384979110015
PPAP2C,ILMN_1675523,"Homo sapiens phosphatidic acid phosphatase type 2C (PPAP2C), transcript variant 3, mRNA.",membrane [goid 16020] [pmid 9607309] [evidence TAS]; integral to membrane [goid 16021] [evidence IEA]; membrane [goid 16020] [pmid 9607309] [evidence TAS]; integral to membrane [goid 16021] [evidence IEA],,hydrolase activity [goid 16787] [evidence IEA]; phosphoprotein phosphatase activity [goid 4721] [pmid 9607309] [evidence TAS]; phosphatidate phosphatase activity [goid 8195] [evidence IEA]; hydrolase activity [goid 16787] [evidence IEA]; phosphoprotein phosphatase activity [goid 4721] [pmid 9607309] [evidence TAS]; phosphatidate phosphatase activity [goid 8195] [evidence IEA],19,242051-242066:242067-242100,19p13.3j,-,NM_177543.1,8612,PPAP2C,1.2674337150475434,6.787901172697841,10.559977761775082,8.633780052336776e-19,1.0966701715761544e-17,31.91563290040185
TMEM8,ILMN_1741371,"Homo sapiens transmembrane protein 8 (five membrane-spanning domains) (TMEM8), mRNA.",integral to plasma membrane [goid 5887] [pmid 11006113] [evidence NAS]; membrane [goid 16020] [evidence IEA],cell adhesion [goid 7155] [evidence IEA],protein binding [goid 5515] [evidence IEA],16,362151-362200,16p13.3f,-,NM_021259.1,58986,TMEM8,1.123743523627958,9.533818521314911,10.557018509403118,8.775355591124703e-19,1.1132018469600575e-17,31.89944779397892
GJB2,ILMN_1769388,"Homo sapiens gap junction protein, beta 2, 26kDa (connexin 26) (GJB2), mRNA.",integral to membrane [goid 16021] [evidence IEA]; connexon complex [goid 5922] [pmid 1324944] [evidence TAS]; plasma membrane [goid 5886] [pmid 1324944] [evidence TAS],cell-cell signaling [goid 7267] [pmid 1324944] [evidence TAS]; transport [goid 6810] [pmid 1324944] [evidence TAS],connexon channel activity [goid 15285] [pmid 1324944] [evidence TAS],13,19659909-19659958,13q12.11a,-,NM_004004.3,2706,GJB2,2.1040278540439017,6.327595266409113,10.555170445270887,8.864944934100873e-19,1.1238350815937249e-17,31.88934019861264
THOP1,ILMN_1726659,"Homo sapiens thimet oligopeptidase 1 (THOP1), mRNA.",,,zinc ion binding [goid 8270] [evidence IEA]; metal ion binding [goid 46872] [evidence IEA]; metalloendopeptidase activity [goid 4222] [pmid 7639763] [evidence TAS]; protein binding [goid 5515] [pmid 15231747] [evidence IPI],19,2764369-2764418,19p13.3g-p13.3f,+,NM_003249.3,7064,THOP1,1.0075459691735187,8.696270746274537,10.550727232218177,9.08410022101068e-19,1.1501214607302996e-17,31.865039189100568
GADD45B,ILMN_1718977,"Homo sapiens growth arrest and DNA-damage-inducible, beta (GADD45B), mRNA.",,activation of MAPKKK activity [goid 185] [pmid 9827804] [evidence TAS]; apoptosis [goid 6915] [pmid 9827804] [evidence TAS]; cell differentiation [goid 30154] [evidence IEA]; response to stress [goid 6950] [pmid 9827804] [evidence TAS],,19,2429064-2429113,19p13.3g,+,NM_015675.1,4616,GADD45B,-1.6517062723815883,9.304531683109369,-10.547051973347532,9.269464472360015e-19,1.1719784037853851e-17,31.844938526674465
P2RY5,ILMN_1786429,"Homo sapiens purinergic receptor P2Y, G-protein coupled, 5 (P2RY5), mRNA.",integral to membrane [goid 16021] [evidence NAS],signal transduction [goid 7165] [evidence IEA]; G-protein coupled receptor protein signaling pathway [goid 7186] [evidence NAS],"rhodopsin-like receptor activity [goid 1584] [evidence IEA]; purinergic nucleotide receptor activity, G-protein coupled [goid 45028] [evidence IEA]; receptor activity [goid 4872] [evidence IEA]",13,47884066-47884115,13q14.2b,-,NM_005767.3,10161,P2RY5,-1.2205645406246006,8.100552861355528,-10.546947686670546,9.274779053821216e-19,1.1719784037853851e-17,31.84436816670598
SCHIP1,ILMN_1794598,"Homo sapiens schwannomin interacting protein 1 (SCHIP1), mRNA.",cytoplasm [goid 5737] [pmid 10669747] [evidence TAS],,,3,161092629-161092673:161097206-161097210,3q25.33a-q25.33b,+,NM_014575.1,29970,SCHIP1,-1.0229931239551648,7.7975523215974345,-10.54459690140963,9.395389649404026e-19,1.1864495613651163e-17,31.831511401624734
PPP1R3C,ILMN_1736670,"Homo sapiens protein phosphatase 1, regulatory (inhibitor) subunit 3C (PPP1R3C), mRNA.",,,protein phosphatase type 1 activity [goid 163] [pmid 8985175] [evidence TAS]; phosphoprotein phosphatase activity [goid 4721] [evidence IEA]; hydrolase activity [goid 16787] [evidence IEA],10,93378527-93378576,10q23.32a,-,NM_005398.3,5507,PPP1R3C,-1.7207904686871185,8.699676788018092,-10.536994884008301,9.796260889737549e-19,1.23547018405525e-17,31.78993550423557
VDR,ILMN_2319952,"Homo sapiens vitamin D (1,25- dihydroxyvitamin D3) receptor (VDR), transcript variant 1, mRNA.",nucleus [goid 5634] [evidence IEA],"signal transduction [goid 7165] [pmid 2849209] [evidence TAS]; negative regulation of transcription [goid 16481] [pmid 11891224] [evidence IDA]; regulation of transcription, DNA-dependent [goid 6355] [evidence IEA]; transcription [goid 6350] [evidence IEA]",protein binding [goid 5515] [pmid 10866662] [evidence IPI]; steroid hormone receptor activity [goid 3707] [evidence IEA]; vitamin D3 receptor activity [goid 8434] [pmid 9070272] [evidence TAS]; metal ion binding [goid 46872] [evidence IEA]; zinc ion binding [goid 8270] [evidence IEA]; transcription factor activity [goid 3700] [evidence IEA]; sequence-specific DNA binding [goid 43565] [evidence IEA],12,46522051-46522100,12q13.11c,-,NM_000376.2,7421,VDR,1.2919606588315942,6.729562608854808,10.535250107555857,9.890653440704758e-19,1.2457620057668533e-17,31.780393340221675
TAF13,ILMN_2061318,"Homo sapiens TAF13 RNA polymerase II, TATA box binding protein (TBP)-associated factor, 18kDa (TAF13), mRNA.",nucleus [goid 5634] [evidence IEA]; transcription factor TFIID complex [goid 5669] [pmid 7729427] [evidence TAS]; nucleus [goid 5634] [evidence IEA]; transcription factor TFIID complex [goid 5669] [pmid 7729427] [evidence TAS],"transcription initiation [goid 6352] [evidence IEA]; transcription [goid 6350] [evidence IEA]; regulation of transcription, DNA-dependent [goid 6355] [evidence IEA]; transcription initiation [goid 6352] [evidence IEA]; transcription [goid 6350] [evidence IEA]; regulation of transcription, DNA-dependent [goid 6355] [evidence IEA]",transcription factor activity [goid 3700] [pmid 9695952] [evidence TAS]; general RNA polymerase II transcription factor activity [goid 16251] [pmid 7729427] [evidence TAS]; protein binding [goid 5515] [pmid 7729427] [evidence TAS]; transcription factor activity [goid 3700] [pmid 9695952] [evidence TAS]; general RNA polymerase II transcription factor activity [goid 16251] [pmid 7729427] [evidence TAS]; protein binding [goid 5515] [pmid 7729427] [evidence TAS],1,109419200-109419210:109420066-109420092:109420093-109420104,1p13.3b,-,NM_005645.3,6884,TAF13,1.1458520730442583,6.2086468167017745,10.528621587932172,1.0257620386988877e-18,1.2886507623499566e-17,31.74414246911987
TUB,ILMN_1755352,"Homo sapiens tubby homolog (mouse) (TUB), transcript variant 2, mRNA.",nucleus [goid 5634] [pmid 11000483] [evidence TAS]; cytoplasm [goid 5737] [pmid 11000483] [evidence TAS]; nucleus [goid 5634] [pmid 11000483] [evidence TAS]; cytoplasm [goid 5737] [pmid 11000483] [evidence TAS],,,11,8083980-8084029,11p15.4b,+,NM_177972.1,7275,TUB,-1.108480265203788,6.057976280984115,-10.519441896279304,1.0788408078697755e-18,1.3544596096225886e-17,31.693940584972946
CMKOR1,ILMN_1798360,"Homo sapiens chemokine orphan receptor 1 (CMKOR1), mRNA.",integral to membrane [goid 16021] [evidence NAS],signal transduction [goid 7165] [evidence IEA]; G-protein coupled receptor protein signaling pathway [goid 7186] [evidence IEA],"rhodopsin-like receptor activity [goid 1584] [evidence IEA]; G-protein coupled receptor activity, unknown ligand [goid 16526] [pmid 1315461] [evidence NAS]; receptor activity [goid 4872] [evidence IEA]",2,237155523-237155572,2q37.3a,+,NM_020311.1,57007,CMKOR1,-1.7122821545661484,10.052423322164847,-10.514586080026893,1.1080195668248338e-18,1.3893025263566206e-17,31.66738565790406
PDLIM3,ILMN_1695299,"Homo sapiens PDZ and LIM domain 3 (PDLIM3), mRNA.",,,zinc ion binding [goid 8270] [evidence IEA]; metal ion binding [goid 46872] [evidence IEA]; protein binding [goid 5515] [evidence IEA]; zinc ion binding [goid 8270] [evidence IEA]; metal ion binding [goid 46872] [evidence IEA]; protein binding [goid 5515] [evidence IEA],4,186660434-186660441:186660442-186660483,4q35.1f,-,NM_014476.1,27295,PDLIM3,-1.6417070565237513,9.256173980082988,-10.511791630475063,1.1251677911829525e-18,1.4098967467009536e-17,31.652103871709674
SLC25A13,ILMN_1668012,"Homo sapiens solute carrier family 25, member 13 (citrin) (SLC25A13), mRNA.",mitochondrion [goid 5739] [pmid 10642534] [evidence TAS]; integral to plasma membrane [goid 5887] [pmid 10642534] [evidence TAS]; mitochondrial inner membrane [goid 5743] [evidence IEA],transport [goid 6810] [pmid 10642534] [evidence TAS],calcium ion binding [goid 5509] [pmid 10642534] [evidence TAS]; carrier activity [goid 5386] [pmid 10642534] [evidence TAS]; binding [goid 5488] [evidence IEA],7,95587736-95587785,7q21.3c,-,NM_014251.1,10165,SLC25A13,1.110517645636965,8.236019520451931,10.509278835965524,1.140814053918352e-18,1.4276661426203655e-17,31.63836246168483
EPHB2,ILMN_1785061,"Homo sapiens EPH receptor B2 (EPHB2), transcript variant 1, mRNA.",integral to membrane [goid 16021] [evidence TAS]; synapse [goid 45202] [evidence ISS]; membrane [goid 16020] [evidence IEA],transmembrane receptor protein tyrosine kinase signaling pathway [goid 7169] [evidence IEA]; protein amino acid phosphorylation [goid 6468] [evidence TAS],transmembrane-ephrin receptor activity [goid 5005] [pmid 8589679] [evidence TAS]; nucleotide binding [goid 166] [evidence IEA]; protein binding [goid 5515] [evidence ISS]; receptor activity [goid 4872] [evidence IEA]; transferase activity [goid 16740] [evidence IEA]; ATP binding [goid 5524] [evidence IEA]; ephrin receptor activity [goid 5003] [evidence IEA]; protein-tyrosine kinase activity [goid 4713] [evidence ISS],1,23114084-23114133,1p36.12a,+,NM_017449.2,2048,EPHB2,1.047329707563784,5.814312806714355,10.501376909181882,1.191448019252771e-18,1.4891189644092524e-17,31.595150864257032
GGTL3,ILMN_1737036,"Homo sapiens gamma-glutamyltransferase-like 3 (GGTL3), transcript variant 2, mRNA.",integral to membrane [goid 16021] [evidence IEA]; integral to membrane [goid 16021] [evidence IEA],glutathione biosynthesis [goid 6750] [evidence IEA]; glutathione biosynthesis [goid 6750] [evidence IEA],acyltransferase activity [goid 8415] [evidence IEA]; transferase activity [goid 16740] [evidence IEA]; gamma-glutamyltransferase activity [goid 3840] [evidence IEA]; acyltransferase activity [goid 8415] [evidence IEA]; transferase activity [goid 16740] [evidence IEA]; gamma-glutamyltransferase activity [goid 3840] [evidence IEA],20,32912946-32912995,20q11.22b,-,NM_178025.1,2686,GGTL3,1.03221690549341,5.976191406311517,10.484749676011289,1.3054488074437842e-18,1.628467990591686e-17,31.50422857581412
ZNF692,ILMN_1800750,"Homo sapiens zinc finger protein 692 (ZNF692), mRNA.",nucleus [goid 5634] [evidence IEA]; intracellular [goid 5622] [evidence IEA],"transcription [goid 6350] [evidence IEA]; regulation of transcription, DNA-dependent [goid 6355] [evidence IEA]",DNA binding [goid 3677] [evidence IEA]; zinc ion binding [goid 8270] [evidence IEA]; metal ion binding [goid 46872] [evidence IEA]; nucleic acid binding [goid 3676] [evidence IEA],1,247111025-247111031:247111032-247111074,1q44f,-,NM_017865.2,55657,ZNF692,1.297563886187647,8.073587985656681,10.48330814902804,1.3158316256285695e-18,1.6403697521031786e-17,31.496346141856055
FAT3,ILMN_1780591,"PREDICTED: Homo sapiens FAT tumor suppressor homolog 3 (Drosophila) (FAT3), mRNA.",,,,11,92268980-92269029,11q14.3d,+,XM_926199.1,120114,FAT3,-1.2275968821068544,5.914155516524509,-10.481256625442917,1.3307505306736393e-18,1.6568481846757738e-17,31.485128242098288
C18orf34,ILMN_1673320,"Homo sapiens chromosome 18 open reading frame 34 (C18orf34), mRNA.",,,,18,28771615-28771664,18q12.1e-q12.1f,-,NM_198995.1,374864,C18orf34,-2.3436582263021055,6.14379182220165,-10.48044206585515,1.3367208868634288e-18,1.662157401438029e-17,31.48067418457799
HLA-DQA1,ILMN_1808405,"PREDICTED: Homo sapiens major histocompatibility complex, class II, DQ alpha 1, transcript variant 2 (HLA-DQA1), mRNA.",,,,,,6p21.32b,,XM_936120.1,3117,HLA-DQA1,-1.7852162635002067,12.409943040148132,-10.4783928260179,1.3518595749013931e-18,1.6788389940697034e-17,31.469468880048108
C6orf32,ILMN_1726597,"Homo sapiens chromosome 6 open reading frame 32 (C6orf32), mRNA.",,,binding [goid 5488] [evidence IEA],6,24947735-24947784,6p22.2b,-,NM_015864.2,9750,C6orf32,-1.6045625345845336,7.890060721389523,-10.471508097277727,1.4039865822986778e-18,1.7413544593309828e-17,31.431823547667523
KLRB1,ILMN_2079655,"Homo sapiens killer cell lectin-like receptor subfamily B, member 1 (KLRB1), mRNA.",plasma membrane [goid 5886] [pmid 8077657] [evidence TAS],cell surface receptor linked signal transduction [goid 7166] [pmid 8077657] [evidence TAS]; antimicrobial humoral response (sensu Vertebrata) [goid 19735] [pmid 8077657] [evidence TAS],sugar binding [goid 5529] [pmid 8077657] [evidence TAS]; transmembrane receptor activity [goid 4888] [pmid 8077657] [evidence TAS],12,9642375-9642424,12p13.31a,-,NM_002258.2,3820,KLRB1,-1.5283744222852995,8.755257720530725,-10.465957877225447,1.447468621535495e-18,1.793002294381381e-17,31.40147588599986
LXN,ILMN_1723962,"Homo sapiens latexin (LXN), mRNA.",,,metalloendopeptidase inhibitor activity [goid 8191] [evidence IEA]; enzyme inhibitor activity [goid 4857] [evidence IEA],3,159867177-159867226,3q25.32b,-,NM_020169.2,56925,LXN,-1.2094894768175521,9.294517358165338,-10.459178468857546,1.5024108890515776e-18,1.8598777746613716e-17,31.364408029675207
MGC40579,ILMN_1673892,"Homo sapiens hypothetical protein MGC40579 (MGC40579), mRNA.",,glycerol metabolism [goid 6071] [evidence IEA]; carbohydrate metabolism [goid 5975] [evidence IEA],transferase activity [goid 16740] [evidence IEA]; kinase activity [goid 16301] [evidence IEA]; ATP binding [goid 5524] [evidence IEA],3,143367285-143367302:143371857-143371888,3q23c-q23d,-,NM_152776.1,256356,MGC40579,1.2630218036238388,6.773278016631829,10.456792168100067,1.522242164454422e-18,1.8820360770554833e-17,31.35136063477768
NDST1,ILMN_1807283,"Homo sapiens N-deacetylase/N-sulfotransferase (heparan glucosaminyl) 1 (NDST1), mRNA.",integral to membrane [goid 16021] [evidence IEA]; Golgi stack [goid 5795] [evidence IEA]; intracellular [goid 5622] [evidence IEA]; ribosome [goid 5840] [evidence IEA],protein biosynthesis [goid 6412] [evidence IEA]; heparan sulfate proteoglycan biosynthesis [goid 15012] [pmid 9915799] [evidence TAS]; protein amino acid sulfation [goid 6477] [evidence NR ]; protein amino acid deacetylation [goid 6476] [evidence NR ],structural constituent of ribosome [goid 3735] [evidence IEA]; transferase activity [goid 16740] [evidence IEA]; [heparan sulfate]-glucosamine N-sulfotransferase activity [goid 15016] [evidence IEA],5,149917621-149917670,5q33.1c,+,NM_001543.3,3340,NDST1,-1.6137031763901968,7.222365583005931,-10.44167324145993,1.6541125562531155e-18,2.042483089898096e-17,31.268698649149695
FRAS1,ILMN_1671318,"Homo sapiens Fraser syndrome 1 (FRAS1), transcript variant 2, mRNA.",extracellular matrix (sensu Metazoa) [goid 5578] [evidence IEA]; integral to membrane [goid 16021] [evidence IEA],cell communication [goid 7154] [evidence IEA],calcium ion binding [goid 5509] [evidence IEA],4,79586695-79586744,4q21.1c-q21.21a,+,NM_206841.1,80144,FRAS1,-1.2854593621228512,7.125522499154919,-10.43874855685565,1.6809107800788873e-18,2.0716348228865983e-17,31.25270861175314
MRAS,ILMN_1748881,"Homo sapiens muscle RAS oncogene homolog (MRAS), mRNA.",intracellular [goid 5622] [evidence IEA]; plasma membrane [goid 5886] [pmid 9395237] [evidence TAS],Ras protein signal transduction [goid 7265] [pmid 10446149] [evidence TAS]; development [goid 7275] [pmid 10446149] [evidence TAS]; actin cytoskeleton organization and biogenesis [goid 30036] [pmid 9395237] [evidence TAS]; muscle development [goid 7517] [pmid 9395237] [evidence TAS],GTP binding [goid 5525] [evidence IEA]; GTP-dependent protein binding [goid 30742] [pmid 10934204] [evidence IPI]; nucleotide binding [goid 166] [evidence IEA]; GTPase activity [goid 3924] [pmid 10446149] [evidence TAS],3,139606278-139606327,3q22.3c,+,NM_012219.2,22808,MRAS,-1.0731783502323387,6.470102780376193,-10.437236587982735,1.6949343274995752e-18,2.0875976846605072e-17,31.24444233993854
LOC283932,ILMN_1710954,"Homo sapiens hypothetical protein LOC283932 (LOC283932), mRNA.",,,,16,30838591-30838640,,-,NM_175901.3,283932,LOC283932,1.393132882303128,6.519997811311242,10.435101029556451,1.7149411450915577e-18,2.1095724881381943e-17,31.232766844854037
DNAJC3,ILMN_1659843,"Homo sapiens DnaJ (Hsp40) homolog, subfamily C, member 3 (DNAJC3), mRNA.",cytoplasm [goid 5737] [pmid 8666242] [evidence TAS],regulation of translation [goid 6445] [pmid 7511204] [evidence TAS]; response to virus [goid 9615] [evidence IEA]; defense response [goid 6952] [evidence NR ]; protein folding [goid 6457] [evidence IEA]; response to unfolded protein [goid 6986] [evidence IEA],binding [goid 5488] [evidence IEA]; heat shock protein binding [goid 31072] [evidence IEA]; protein kinase inhibitor activity [goid 4860] [pmid 7511204] [evidence TAS],13,95241143-95241192,13q32.1b,+,NM_006260.2,5611,DNAJC3,1.1347258989165816,6.158811612251713,10.434231957091766,1.7231504041651604e-18,2.116997832607702e-17,31.228015491054325
PLA2G3,ILMN_1746769,"Homo sapiens phospholipase A2, group III (PLA2G3), mRNA.",extracellular space [goid 5615] [pmid 10713052] [evidence TAS]; extracellular region [goid 5576] [evidence IEA],phospholipid metabolism [goid 6644] [pmid 10713052] [evidence TAS]; lipid catabolism [goid 16042] [evidence IEA],calcium ion binding [goid 5509] [evidence IEA]; calcium-dependent phospholipase A2 activity [goid 47498] [pmid 10713052] [evidence TAS]; hydrolase activity [goid 16787] [evidence IEA],22,29860905-29860954,22q12.2c,-,NM_015715.2,50487,PLA2G3,-1.5601063155156396,6.623270475119359,-10.42993631686025,1.7643075453060688e-18,2.1661961260421393e-17,31.204530791194816
SDC2,ILMN_1784553,"Homo sapiens syndecan 2 (SDC2), mRNA.",integral to membrane [goid 16021] [evidence IEA]; membrane [goid 16020] [evidence IEA]; integral to plasma membrane [goid 5887] [evidence NAS],,cytoskeletal protein binding [goid 8092] [evidence IEA],8,97692961-97693010,8q22.1d,+,NM_002998.3,6383,SDC2,-1.3203941660037133,6.936030935531491,-10.418982330709827,1.873761605318944e-18,2.297686902431694e-17,31.14464600142455
PDGFRA,ILMN_1681949,"Homo sapiens platelet-derived growth factor receptor, alpha polypeptide (PDGFRA), mRNA.",membrane [goid 16020] [evidence IEA]; integral to plasma membrane [goid 5887] [pmid 8586421] [evidence TAS],cell proliferation [goid 8283] [pmid 10806482] [evidence TAS]; transmembrane receptor protein tyrosine kinase signaling pathway [goid 7169] [evidence IEA]; cell surface receptor linked signal transduction [goid 7166] [pmid 10806482] [evidence TAS]; protein amino acid phosphorylation [goid 6468] [evidence IEA],nucleotide binding [goid 166] [evidence IEA]; receptor activity [goid 4872] [evidence IEA]; transferase activity [goid 16740] [evidence IEA]; ATP binding [goid 5524] [evidence IEA]; vascular endothelial growth factor receptor activity [goid 5021] [evidence IEA]; platelet-derived growth factor alpha-receptor activity [goid 5018] [pmid 10806482] [evidence TAS],4,54858477-54858526,4q12c,+,NM_006206.3,5156,PDGFRA,-1.153914543241532,8.983688381718027,-10.4177216496896,1.886786294207477e-18,2.3122032039391628e-17,31.137754097952655
CHRNA5,ILMN_1770044,"Homo sapiens cholinergic receptor, nicotinic, alpha 5 (CHRNA5), mRNA.",nicotinic acetylcholine-gated receptor-channel complex [goid 5892] [pmid 1542648] [evidence IC ]; integral to membrane [goid 16021] [evidence IEA]; postsynaptic membrane [goid 45211] [evidence IEA],ion transport [goid 6811] [evidence IEA]; synaptic transmission [goid 7268] [pmid 9009220] [evidence TAS]; signal transduction [goid 7165] [pmid 9009220] [evidence NAS],acetylcholine receptor activity [goid 15464] [pmid 1542648] [evidence IDA]; nicotinic acetylcholine-activated cation-selective channel activity [goid 4889] [pmid 1542648] [evidence NAS]; ion channel activity [goid 5216] [evidence IEA]; extracellular ligand-gated ion channel activity [goid 5230] [evidence IEA],15,76669832-76669881,15q25.1a,+,NM_000745.2,1138,CHRNA5,1.5013836715074271,8.711458456226257,10.41146586197674,1.952768747185935e-18,2.3915587076629758e-17,31.10355540594968
NKD2,ILMN_1731206,"Homo sapiens naked cuticle homolog 2 (Drosophila) (NKD2), mRNA.",,,calcium ion binding [goid 5509] [evidence IEA],5,1091714-1091763,5p15.33d,+,NM_033120.2,85409,NKD2,-1.2412300995880177,10.387281373079224,-10.410149638405676,1.9669425257774275e-18,2.407404215752084e-17,31.0963600781493
RGS2,ILMN_2197365,"Homo sapiens regulator of G-protein signalling 2, 24kDa (RGS2), mRNA.",,negative regulation of signal transduction [goid 9968] [evidence IEA]; cell cycle [goid 7049] [evidence IEA]; transmembrane receptor protein tyrosine kinase signaling pathway [goid 7169] [pmid 15609325] [evidence NAS]; regulation of G-protein coupled receptor protein signaling pathway [goid 8277] [pmid 10747990] [evidence TAS],GTPase activator activity [goid 5096] [pmid 10747990] [evidence TAS]; signal transducer activity [goid 4871] [evidence IEA]; calmodulin binding [goid 5516] [pmid 10747990] [evidence TAS],1,191047925-191047974,1q31.2b,+,NM_002923.1,5997,RGS2,-1.6268328643420933,11.359817801163418,-10.409990750051252,1.9686604588019066e-18,2.407994290003462e-17,31.095491494401816
DGAT1,ILMN_1704091,"Homo sapiens diacylglycerol O-acyltransferase homolog 1 (mouse) (DGAT1), mRNA.",endoplasmic reticulum [goid 5783] [evidence IEA]; integral to membrane [goid 16021] [evidence IEA]; membrane [goid 16020] [evidence IEA],triacylglycerol metabolism [goid 6641] [pmid 9756920] [evidence TAS]; fat body development [goid 7503] [evidence NR ],diacylglycerol O-acyltransferase activity [goid 4144] [pmid 9789033] [evidence TAS]; transferase activity [goid 16740] [evidence IEA]; acyltransferase activity [goid 8415] [pmid 9756920] [evidence TAS],8,145510844-145510893,8q24.3h,-,NM_012079.2,8694,DGAT1,1.0046797794472688,8.831489820988292,10.408460848158452,1.9852790011338458e-18,2.4252765728584944e-17,31.087128116231586
SLC35F2,ILMN_1790577,"Homo sapiens solute carrier family 35, member F2 (SLC35F2), mRNA.",,,,11,107167398-107167447,11q22.3c,-,NM_017515.3,54733,SLC35F2,1.3944357657946425,8.248845190803092,10.402191612841214,2.0548558295070047e-18,2.5071299835907317e-17,31.052857189212244
VEPH1,ILMN_1684336,"Homo sapiens ventricular zone expressed PH domain homolog 1 (zebrafish) (VEPH1), mRNA.",,,,3,158461765-158461814,3q25.32a,-,NM_024621.1,79674,VEPH1,-1.5274051315961437,6.0792719408421485,-10.399147836081807,2.08950973025183e-18,2.5462224574081867e-17,31.036218626796472
VPS24,ILMN_1683827,"Homo sapiens vacuolar protein sorting 24 homolog (S. cerevisiae) (VPS24), transcript variant 1, mRNA.",membrane [goid 16020] [evidence IEA]; membrane [goid 16020] [evidence IEA],protein transport [goid 15031] [evidence IEA]; protein transport [goid 15031] [evidence IEA],,2,86584529-86584578,2p11.2e,-,NM_016079.2,51652,VPS24,-1.5980831236448285,9.447268980614327,-10.39488039630208,2.1390809930328484e-18,2.6049995718278155e-17,31.012891361040094
PLCXD3,ILMN_1798841,"Homo sapiens phosphatidylinositol-specific phospholipase C, X domain containing 3 (PLCXD3), mRNA.",,intracellular signaling cascade [goid 7242] [evidence IEA],phospholipase C activity [goid 4629] [evidence IEA],5,41343016-41343065,5p13.1a,-,NM_001005473.1,345557,PLCXD3,-1.412809365170764,5.982580964875688,-10.391514175757033,2.179011434930379e-18,2.651969881924949e-17,30.99449075667778
BRF1,ILMN_1703686,"Homo sapiens BRF1 homolog, subunit of RNA polymerase III transcription initiation factor IIIB (S. cerevisiae) (BRF1), transcript variant 2, mRNA.",transcription factor TFIIIB complex [goid 126] [pmid 10921893] [evidence NAS]; nucleus [goid 5634] [evidence IEA]; transcription factor complex [goid 5667] [evidence IEA]; transcription factor TFIIIB complex [goid 126] [pmid 10921893] [evidence NAS]; nucleus [goid 5634] [evidence IEA]; transcription factor complex [goid 5667] [evidence IEA],"positive regulation of transcription [goid 45941] [evidence IEA]; tRNA transcription [goid 9304] [pmid 8943358] [evidence TAS]; rRNA transcription [goid 9303] [pmid 7624363] [evidence TAS]; transcription initiation [goid 6352] [evidence IEA]; transcription initiation from RNA polymerase III promoter [goid 6384] [pmid 7624363] [evidence TAS]; regulation of transcription, DNA-dependent [goid 6355] [evidence IEA]; positive regulation of transcription [goid 45941] [evidence IEA]; tRNA transcription [goid 9304] [pmid 8943358] [evidence TAS]; rRNA transcription [goid 9303] [pmid 7624363] [evidence TAS]; transcription initiation [goid 6352] [evidence IEA]; transcription initiation from RNA polymerase III promoter [goid 6384] [pmid 7624363] [evidence TAS]; regulation of transcription, DNA-dependent [goid 6355] [evidence IEA]",metal ion binding [goid 46872] [evidence IEA]; zinc ion binding [goid 8270] [evidence IEA]; RNA polymerase III transcription factor activity [goid 3709] [pmid 8943358] [evidence TAS]; protein binding [goid 5515] [pmid 7624363] [evidence TAS]; transcription regulator activity [goid 30528] [evidence IEA]; transcription factor activity [goid 3700] [pmid 10921893] [evidence NAS]; transcriptional activator activity [goid 16563] [evidence IEA]; RNA polymerase II transcription factor activity [goid 3702] [evidence IEA]; metal ion binding [goid 46872] [evidence IEA]; zinc ion binding [goid 8270] [evidence IEA]; RNA polymerase III transcription factor activity [goid 3709] [pmid 8943358] [evidence TAS]; protein binding [goid 5515] [pmid 7624363] [evidence TAS]; transcription regulator activity [goid 30528] [evidence IEA]; transcription factor activity [goid 3700] [pmid 10921893] [evidence NAS]; transcriptional activator activity [goid 16563] [evidence IEA]; RNA polymerase II transcription factor activity [goid 3702] [evidence IEA],14,104746939-104746988,14q32.33c,-,NM_145696.1,2972,BRF1,1.079121678460024,7.259208130658594,10.390906942311014,2.186293412208625e-18,2.659171481703187e-17,30.99117149430184
LOC440157,ILMN_1803559,"Homo sapiens hypothetical gene supported by AK096951; BC066547 (LOC440157), mRNA.",,,,14,18757335-18757384,14q11.1d,+,NM_001013701.1,440157,LOC440157,1.588949175313238,7.244962117865435,10.369771335432482,2.4554950324359134e-18,2.977306826821019e-17,30.875645313541664
MMP23B,ILMN_2193325,"Homo sapiens matrix metallopeptidase 23B (MMP23B), mRNA.",extracellular matrix (sensu Metazoa) [goid 5578] [pmid 9740677] [evidence NAS]; intracellular [goid 5622] [pmid 9988691] [evidence NAS]; extracellular matrix (sensu Metazoa) [goid 5578] [pmid 9740677] [evidence NAS]; intracellular [goid 5622] [pmid 9988691] [evidence NAS],reproduction [goid 3] [pmid 9988691] [evidence IEP]; reproduction [goid 3] [pmid 9988691] [evidence IEP],zinc ion binding [goid 8270] [pmid 9988691] [evidence NAS]; metalloendopeptidase activity [goid 4222] [pmid 9988691] [evidence IDA]; zinc ion binding [goid 8270] [pmid 9988691] [evidence NAS]; metalloendopeptidase activity [goid 4222] [pmid 9988691] [evidence IDA],1,1559849-1559864:1559865-1559893,1p36.33a,+,NM_006983.1,8510,MMP23B,-1.276462483021465,10.01398823102329,-10.356531724005977,2.640752735336807e-18,3.1939830569855795e-17,30.80328371741553
CCNE2,ILMN_2412384,"Homo sapiens cyclin E2 (CCNE2), transcript variant 2, mRNA.",nucleus [goid 5634] [evidence IEA],cell division [goid 51301] [evidence IEA]; cell cycle [goid 7049] [evidence IEA]; cell cycle checkpoint [goid 75] [pmid 9858585] [evidence TAS],protein binding [goid 5515] [pmid 15232106] [evidence IPI],8,95962279-95962328,8q22.1c,-,NM_057735.1,9134,CCNE2,1.2636193328639118,6.074569118523419,10.34687745753451,2.7845896490312674e-18,3.3616932658844023e-17,30.75052069991165
AQP1,ILMN_1681103,"Homo sapiens aquaporin 1 (Colton blood group) (AQP1), mRNA.",integral to membrane [goid 16021] [evidence IEA]; outer membrane [goid 19867] [evidence IEA]; integral to plasma membrane [goid 5887] [pmid 1722319] [evidence TAS]; membrane [goid 16020] [evidence IEA],transport [goid 6810] [evidence IEA]; excretion [goid 7588] [pmid 1722319] [evidence TAS]; water transport [goid 6833] [pmid 7521540] [evidence TAS],transporter activity [goid 5215] [evidence IEA]; porin activity [goid 15288] [evidence IEA]; water transporter activity [goid 5372] [pmid 7521540] [evidence TAS],7,30930996-30931045,7p15.1a,+,NM_198098.1,358,AQP1,-1.908473235736417,7.9437087652335,-10.343682195637706,2.8338992197965204e-18,3.416988013473713e-17,30.733058300988194
MMRN2,ILMN_1715788,"Homo sapiens multimerin 2 (MMRN2), mRNA.",extracellular matrix (sensu Metazoa) [goid 5578] [evidence IEA],,,10,88685778-88685827,10q23.2a,-,NM_024756.1,79812,MMRN2,-1.2062534271206697,5.721295100072736,-10.342415472012375,2.853688103861957e-18,3.438720637213991e-17,30.726135612464436
FLJ37078,ILMN_1717265,"Homo sapiens hypothetical protein FLJ37078 (FLJ37078), mRNA.",,,,7,75754207-75754256,7q11.23e,+,NM_153043.3,222183,FLJ37078,1.0708894333952603,5.634065300999969,10.34229908547109,2.8555132186878735e-18,3.4387932673753534e-17,30.725499558042056
PITPNM1,ILMN_1653220,"Homo sapiens phosphatidylinositol transfer protein, membrane-associated 1 (PITPNM1), mRNA.",membrane fraction [goid 5624] [pmid 9245688] [evidence TAS]; membrane [goid 16020] [evidence IEA]; endoplasmic reticulum [goid 5783] [evidence IEA]; intracellular [goid 5622] [evidence IEA],protein transport [goid 15031] [evidence IEA]; brain development [goid 7420] [pmid 9245688] [evidence TAS]; phototransduction [goid 7602] [pmid 9680295] [evidence TAS]; lipid metabolism [goid 6629] [pmid 9680295] [evidence NAS],phosphatidylinositol transporter activity [goid 8526] [pmid 9245688] [evidence TAS]; calcium ion binding [goid 5509] [evidence IEA],11,67015922-67015971,11q13.1f,-,NM_004910.1,9600,PITPNM1,1.04116297740884,9.922116653239001,10.33223711045674,3.0177912371406646e-18,3.623022936271463e-17,30.67051201521021
ABCD1,ILMN_1772189,"Homo sapiens ATP-binding cassette, sub-family D (ALD), member 1 (ABCD1), mRNA.",integral to membrane [goid 16021] [evidence IEA]; integral to peroxisomal membrane [goid 5779] [pmid 8441467] [evidence NAS]; membrane [goid 16020] [evidence IEA]; peroxisome [goid 5777] [evidence IEA],transport [goid 6810] [evidence IEA]; peroxisomal membrane transport [goid 15919] [pmid 8441467] [evidence NAS]; peroxisome organization and biogenesis [goid 7031] [pmid 8441467] [evidence NAS],"ATPase activity, coupled to transmembrane movement of substances [goid 42626] [pmid 8441467] [evidence NAS]; ATPase activity [goid 16887] [evidence IEA]; transporter activity [goid 5215] [pmid 8441467] [evidence NAS]; nucleotide binding [goid 166] [evidence IEA]; ATP binding [goid 5524] [evidence IEA]",X,152663031-152663080,Xq28f,+,NM_000033.2,215,ABCD1,1.2163236820517769,6.97551431679172,10.330993234804598,3.0384820102629482e-18,3.6456171163776817e-17,30.663714559888728
FOLR2,ILMN_1745963,"Homo sapiens folate receptor 2 (fetal) (FOLR2), mRNA.",membrane [goid 16020] [evidence IEA]; membrane fraction [goid 5624] [pmid 2605182] [evidence TAS],folic acid transport [goid 15884] [pmid 2605182] [evidence TAS],GPI anchor binding [goid 48503] [evidence IEA]; receptor activity [goid 4872] [evidence IEA]; folic acid binding [goid 5542] [pmid 2605182] [evidence TAS],11,71610373-71610422,11q13.4a,+,NM_000803.2,2350,FOLR2,-1.5988039850679305,8.460807261694065,-10.323428632850208,3.1674008538755352e-18,3.795621502937565e-17,30.622376865185377
PENK,ILMN_1726711,"Homo sapiens proenkephalin (PENK), mRNA.",soluble fraction [goid 5625] [evidence NR ],neuropeptide signaling pathway [goid 7218] [evidence IEA]; cell-cell signaling [goid 7267] [evidence NR ]; signal transduction [goid 7165] [pmid 7057924] [evidence TAS],opioid peptide activity [goid 1515] [evidence IEA]; neuropeptide hormone activity [goid 5184] [pmid 7057924] [evidence TAS],8,57516311-57516360,8q12.1b,-,NM_006211.2,5179,PENK,-1.790242871628255,6.425379137862922,-10.32085265163543,3.2125379212881318e-18,3.8473448922126153e-17,30.608300446846204
OSBP2,ILMN_1781966,"Homo sapiens oxysterol binding protein 2 (OSBP2), transcript variant 1, mRNA.",membrane [goid 16020] [evidence IEA],lipid transport [goid 6869] [evidence IEA]; steroid metabolism [goid 8202] [evidence IEA],,22,29633500-29633549,22q12.2b-q12.2c,+,NM_030758.3,23762,OSBP2,1.067663464285336,6.4056312785413825,10.318336727456371,3.257243077323329e-18,3.898487798626847e-17,30.594552380990397
CCL2,ILMN_1720048,"Homo sapiens chemokine (C-C motif) ligand 2 (CCL2), mRNA.",extracellular region [goid 5576] [evidence IEA]; membrane [goid 16020] [evidence IEA]; extracellular space [goid 5615] [pmid 10942204] [evidence TAS],"cell-cell signaling [goid 7267] [evidence NR ]; G-protein signaling, coupled to cyclic nucleotide second messenger [goid 7187] [pmid 10770925] [evidence TAS]; chemotaxis [goid 6935] [pmid 10623817] [evidence TAS]; calcium ion homeostasis [goid 6874] [pmid 9670957] [evidence TAS]; JAK-STAT cascade [goid 7259] [pmid 9670957] [evidence TAS]; humoral immune response [goid 6959] [pmid 9548499] [evidence TAS]; cell adhesion [goid 7155] [pmid 10198043] [evidence TAS]; anti-apoptosis [goid 6916] [pmid 12753088] [evidence IDA]; viral genome replication [goid 19079] [pmid 10985244] [evidence TAS]; protein amino acid phosphorylation [goid 6468] [pmid 9670957] [evidence TAS]; inflammatory response [goid 6954] [evidence IEA]",signal transducer activity [goid 4871] [pmid 10770925] [evidence TAS]; protein kinase activity [goid 4672] [pmid 9973507] [evidence TAS]; chemokine activity [goid 8009] [pmid 10623817] [evidence TAS],17,29607909-29607958,17q12a,+,NM_002982.3,6347,CCL2,-1.9042381239143662,10.715784050556627,-10.31583604908031,3.3022933689103687e-18,3.942733658937044e-17,30.58088779343412
ROR1,ILMN_1655904,"Homo sapiens receptor tyrosine kinase-like orphan receptor 1 (ROR1), mRNA.",integral to plasma membrane [goid 5887] [pmid 1334494] [evidence TAS]; plasma membrane [goid 5886] [pmid 8875995] [evidence TAS]; cytoplasm [goid 5737] [pmid 8875995] [evidence TAS],transmembrane receptor protein tyrosine kinase signaling pathway [goid 7169] [pmid 1334494] [evidence TAS]; protein amino acid phosphorylation [goid 6468] [evidence IEA],receptor activity [goid 4872] [evidence IEA]; ATP binding [goid 5524] [evidence IEA]; transmembrane receptor protein tyrosine kinase activity [goid 4714] [pmid 8875995] [evidence TAS]; nucleotide binding [goid 166] [evidence IEA]; transferase activity [goid 16740] [evidence IEA]; kinase activity [goid 16301] [evidence IEA],1,64416902-64416951,1p31.3c,+,NM_005012.1,4919,ROR1,-1.2289572923496213,6.956525332601162,-10.315835406766825,3.302305019956508e-18,3.942733658937044e-17,30.58088428362866
MARCH6,ILMN_1757106,"Homo sapiens membrane-associated ring finger (C3HC4) 6 (MARCH6), mRNA.",ubiquitin ligase complex [goid 151] [evidence IEA],protein ubiquitination [goid 16567] [evidence IEA],ubiquitin-protein ligase activity [goid 4842] [evidence IEA]; metal ion binding [goid 46872] [evidence IEA]; zinc ion binding [goid 8270] [evidence IEA],5,10488390-10488439,5p15.2c,+,NM_005885.2,10299,MARCH6,1.6702719356369595,10.780207744241881,10.30868725065369,3.4345444128907232e-18,4.0955996257757495e-17,30.54182517648253
LOC400509,ILMN_1670371,"PREDICTED: Homo sapiens similar to FLJ12363 protein (LOC400509), mRNA.",,,,,,16p11.2d,,XM_942431.1,400509,LOC400509,1.1085712557964271,6.897753100065708,10.30193312711335,3.564352982920782e-18,4.245196691455467e-17,30.50492043843644
SLC7A5,ILMN_1720373,"Homo sapiens solute carrier family 7 (cationic amino acid transporter, y+ system), member 5 (SLC7A5), mRNA.",plasma membrane [goid 5886] [pmid 9751058] [evidence NAS]; integral to membrane [goid 16021] [evidence ISS]; membrane [goid 16020] [evidence IEA],transport [goid 6810] [pmid 9751058] [evidence TAS]; neutral amino acid transport [goid 15804] [evidence ISS]; amino acid transport [goid 6865] [evidence IEA]; amino acid metabolism [goid 6520] [pmid 9751058] [evidence TAS],peptide antigen binding [goid 42605] [evidence ISS]; neutral amino acid transporter activity [goid 15175] [pmid 9751058] [evidence TAS]; amino acid permease activity [goid 15359] [evidence IEA],16,86421232-86421281,16q24.2b,-,NM_003486.5,8140,SLC7A5,1.8622181934778297,9.13189685401168,10.299159903091489,3.619061409258876e-18,4.3050922807942127e-17,30.489767823761337
SIX4,ILMN_1743402,"Homo sapiens sine oculis homeobox homolog 4 (Drosophila) (SIX4), mRNA.",nucleus [goid 5634] [evidence IEA],"regulation of transcription, DNA-dependent [goid 6355] [evidence IEA]; morphogenesis [goid 9653] [pmid 10640827] [evidence TAS]",transcription factor activity [goid 3700] [evidence IEA],14,60246172-60246221,14q23.1c,-,NM_017420.2,51804,SIX4,1.8586854295511355,7.8635936990424895,10.297176885240654,3.6586949302982054e-18,4.346931141271984e-17,30.478932947198896
SLC25A10,ILMN_1804090,"Homo sapiens solute carrier family 25 (mitochondrial carrier; dicarboxylate transporter), member 10 (SLC25A10), mRNA.",integral to membrane [goid 16021] [evidence IEA]; membrane [goid 16020] [evidence IEA]; mitochondrion [goid 5739] [evidence IEA],mitochondrial transport [goid 6839] [evidence IEA]; transport [goid 6810] [evidence IEA]; gluconeogenesis [goid 6094] [pmid 9733776] [evidence TAS]; dicarboxylic acid transport [goid 6835] [pmid 9733776] [evidence TAS],dicarboxylic acid transporter activity [goid 5310] [pmid 9733776] [evidence TAS]; binding [goid 5488] [evidence IEA],17,77298387-77298436,17q25.3f,+,NM_012140.3,1468,SLC25A10,1.3488816806295105,7.753280000425174,10.292824109364028,3.747219092806332e-18,4.441275183900935e-17,30.455150498271397
RAB15,ILMN_1731699,"Homo sapiens RAB15, member RAS onocogene family (RAB15), mRNA.",membrane [goid 16020] [evidence IEA],small GTPase mediated signal transduction [goid 7264] [evidence IEA]; protein transport [goid 15031] [evidence IEA],GTP binding [goid 5525] [evidence IEA]; nucleotide binding [goid 166] [evidence IEA],14,64482581-64482630,14q23.3a,-,NM_198686.1,376267,RAB15,1.3225436519009346,6.974516548370695,10.27856427568559,4.052495352102879e-18,4.791436403866784e-17,30.377242210791795
CRTC1,ILMN_1699843,"Homo sapiens CREB regulated transcription coactivator 1 (CRTC1), transcript variant 1, mRNA.",nucleus [goid 5634] [pmid 14506290] [evidence IDA],"transcription [goid 6350] [evidence IEA]; positive regulation of transcription from RNA polymerase II promoter [goid 45944] [pmid 14536081] [evidence IDA]; regulation of transcription, DNA-dependent [goid 6355] [evidence IEA]",protein binding [goid 5515] [pmid 14506290] [evidence IPI]; cAMP response element binding protein binding [goid 8140] [pmid 14536081] [evidence IDA],19,18749276-18749325,19p13.11b,+,NM_015321.1,23373,CRTC1,1.2213246096244044,6.123400024137987,10.278159147845146,4.061522218712661e-18,4.796288511007042e-17,30.375028889383923
C6orf125,ILMN_1790461,"Homo sapiens chromosome 6 open reading frame 125 (C6orf125), mRNA.",,,,6,33776229-33776268:33777101-33777110,6p21.31f,-,NM_032340.1,84300,C6orf125,1.0079487119622677,10.575475174727156,10.274718544705262,4.138998525051666e-18,4.878910239602645e-17,30.356232149987267
ATR,ILMN_2376771,"Homo sapiens ataxia telangiectasia and Rad3 related (ATR), mRNA.",nucleus [goid 5634] [evidence IEA]; chromosome [goid 5694] [evidence IEA]; nucleus [goid 5634] [evidence IEA]; chromosome [goid 5694] [evidence IEA],cell cycle [goid 7049] [pmid 9590286] [evidence TAS]; cell cycle checkpoint [goid 75] [pmid 8610130] [evidence TAS]; DNA repair [goid 6281] [pmid 8610130] [evidence TAS]; development [goid 7275] [pmid 9590286] [evidence TAS]; cell cycle [goid 7049] [pmid 9590286] [evidence TAS]; cell cycle checkpoint [goid 75] [pmid 8610130] [evidence TAS]; DNA repair [goid 6281] [pmid 8610130] [evidence TAS]; development [goid 7275] [pmid 9590286] [evidence TAS],"phosphotransferase activity, alcohol group as acceptor [goid 16773] [evidence IEA]; protein serine/threonine kinase activity [goid 4674] [evidence IEA]; binding [goid 5488] [evidence IEA]; DNA binding [goid 3677] [evidence IEA]; manganese ion binding [goid 30145] [evidence IEA]; transferase activity [goid 16740] [evidence IEA]; phosphotransferase activity, alcohol group as acceptor [goid 16773] [evidence IEA]; protein serine/threonine kinase activity [goid 4674] [evidence IEA]; binding [goid 5488] [evidence IEA]; DNA binding [goid 3677] [evidence IEA]; manganese ion binding [goid 30145] [evidence IEA]; transferase activity [goid 16740] [evidence IEA]",3,143769659-143769686:143780178-143780199,3q23d,-,NM_001184.2,545,ATR,-1.3832033137934747,5.992281031625573,-10.267461988556358,4.307279438228612e-18,5.0711383597513304e-17,30.316589195307163
EMP1,ILMN_1801616,"Homo sapiens epithelial membrane protein 1 (EMP1), mRNA.",integral to membrane [goid 16021] [pmid 8884260] [evidence TAS]; membrane fraction [goid 5624] [pmid 8996089] [evidence TAS]; membrane [goid 16020] [evidence IEA],cell growth [goid 16049] [evidence IEA]; cell death [goid 8219] [evidence NR ]; development [goid 7275] [pmid 8996089] [evidence TAS]; cell proliferation [goid 8283] [pmid 8996089] [evidence TAS]; epidermis development [goid 8544] [pmid 7499420] [evidence TAS],,12,13260606-13260655,12p13.1b,+,NM_001423.1,2012,EMP1,-1.2800647724580898,11.32770057480622,-10.264554256021185,4.376613566165715e-18,5.1465489038466483e-17,30.30070453433746
C17orf28,ILMN_1654013,"Homo sapiens chromosome 17 open reading frame 28 (C17orf28), mRNA.",integral to membrane [goid 16021] [evidence IEA],,,17,70458476-70458525,17q25.1c,-,NM_030630.1,283987,C17orf28,1.0194600161039507,7.8937266555573515,10.264163253568482,4.386021590967574e-18,5.1545012484923505e-17,30.298568545059506
LOC653879,ILMN_1713182,"PREDICTED: Homo sapiens similar to Complement C3 precursor (LOC653879), mRNA.",,,,,,,,XM_936226.1,653879,LOC653879,-1.5289849512684643,9.891866560145383,-10.261670585717571,4.446475297862363e-18,5.222397298303083e-17,30.28495157222309
ANKRD1,ILMN_1716264,"Homo sapiens ankyrin repeat domain 1 (cardiac muscle) (ANKRD1), mRNA.",nucleus [goid 5634] [pmid 7730328] [evidence TAS],defense response [goid 6952] [pmid 7730328] [evidence TAS]; signal transduction [goid 7165] [pmid 7730328] [evidence TAS],DNA binding [goid 3677] [pmid 7730328] [evidence TAS],10,92661948-92661997,10q23.31d,-,NM_014391.2,27063,ANKRD1,-2.545849655943508,6.58496019391731,-10.259254236651103,4.5058727246335534e-18,5.2889716891255893e-17,30.271751692410465
FLJ41603,ILMN_1795300,"Homo sapiens FLJ41603 protein (FLJ41603), mRNA.",,,,5,148994542-148994591,5q33.1b,+,NM_001001669.1,389337,FLJ41603,-1.3831291165425252,7.058554063893142,-10.247645771837297,4.802468228830453e-18,5.630330531814763e-17,30.20834016735768
KIAA0241,ILMN_1722292,"Homo sapiens KIAA0241 (KIAA0241), mRNA.",membrane [goid 16020] [evidence IEA]; integral to membrane [goid 16021] [evidence IEA],,,7,32590042-32590044:32590045-32590091,7p14.3c,+,NM_015060.1,23080,KIAA0241,1.1640004356954359,6.57525256764798,10.245134637665425,4.8691510046405454e-18,5.705075605858149e-17,30.19462357770266
ITGB4,ILMN_2253707,"Homo sapiens integrin, beta 4 (ITGB4), transcript variant 2, mRNA.",integral to membrane [goid 16021] [evidence IEA]; integrin complex [goid 8305] [pmid 7545057] [evidence TAS]; membrane [goid 16020] [evidence IEA]; integral to membrane [goid 16021] [evidence IEA]; integrin complex [goid 8305] [pmid 7545057] [evidence TAS]; membrane [goid 16020] [evidence IEA],cell adhesion [goid 7155] [pmid 2311577] [evidence NAS]; cell-matrix adhesion [goid 7160] [evidence IEA]; development [goid 7275] [evidence IEA]; cell communication [goid 7154] [evidence IEA]; integrin-mediated signaling pathway [goid 7229] [evidence IEA]; cell adhesion [goid 7155] [pmid 2311577] [evidence NAS]; cell-matrix adhesion [goid 7160] [evidence IEA]; development [goid 7275] [evidence IEA]; cell communication [goid 7154] [evidence IEA]; integrin-mediated signaling pathway [goid 7229] [evidence IEA],receptor activity [goid 4872] [evidence IEA]; protein binding [goid 5515] [pmid 11375975] [evidence IPI]; receptor activity [goid 4872] [evidence IEA]; protein binding [goid 5515] [pmid 11375975] [evidence IPI],17,71262801-71262850,17q25.1c-q25.1d,+,NM_001005619.1,3691,ITGB4,1.1293442414590213,7.203614622837621,10.241336640374008,4.971768188235251e-18,5.821809083399271e-17,30.173878115288634
FOXA3,ILMN_1792733,"Homo sapiens forkhead box A3 (FOXA3), mRNA.",nucleus [goid 5634] [pmid 7739897] [evidence TAS],"regulation of transcription, DNA-dependent [goid 6355] [evidence IEA]; transcription [goid 6350] [evidence IEA]",sequence-specific DNA binding [goid 43565] [evidence IEA]; specific RNA polymerase II transcription factor activity [goid 3704] [evidence NR ]; transcription factor activity [goid 3700] [pmid 7739897] [evidence TAS],19,51068733-51068782,19q13.32a,+,NM_004497.2,3171,FOXA3,2.002976572488709,6.629996754755563,10.240186640489846,5.00326390507313e-18,5.85517100242342e-17,30.167596661732222
DPP9,ILMN_1673069,"Homo sapiens dipeptidyl-peptidase 9 (DPP9), mRNA.",membrane [goid 16020] [evidence IEA],,dipeptidyl-peptidase IV activity [goid 4274] [evidence IEA]; serine-type endopeptidase activity [goid 4252] [evidence IEA]; aminopeptidase activity [goid 4177] [evidence IEA],19,4626532-4626581,19p13.3d,-,NM_139159.3,91039,DPP9,1.3592389646710945,9.934829748339173,10.239089288836448,5.033503577427519e-18,5.887023841907275e-17,30.161602818325076
ZNF365,ILMN_1658094,"Homo sapiens zinc finger protein 365 (ZNF365), transcript variant A, mRNA.",intracellular [goid 5622] [evidence IEA],,protein binding [goid 5515] [pmid 16682949] [evidence IPI]; nucleic acid binding [goid 3676] [evidence IEA]; zinc ion binding [goid 8270] [evidence IEA],10,63831868-63831917,10q21.2b,+,NM_014951.1,22891,ZNF365,-1.262109017180597,6.211322246468693,-10.230829581792705,5.267054024802394e-18,6.149104114635988e-17,30.116488693038054
CENTD3,ILMN_1812618,"Homo sapiens centaurin, delta 3 (CENTD3), mRNA.",lamellipodium [goid 30027] [evidence ISS]; ruffle [goid 1726] [evidence ISS]; cytoplasm [goid 5737] [pmid 11804589] [evidence IC ]; intracellular [goid 5622] [evidence IEA],vesicle-mediated transport [goid 16192] [pmid 15569923] [evidence TAS]; negative regulation of Rho protein signal transduction [goid 35024] [evidence ISS]; signal transduction [goid 7165] [evidence IEA]; regulation of cell shape [goid 8360] [evidence ISS]; regulation of GTPase activity [goid 43087] [evidence IEA]; negative regulation of cell migration [goid 30336] [evidence ISS]; cytoskeleton organization and biogenesis [goid 7010] [pmid 15569923] [evidence TAS],"ARF GTPase activator activity [goid 8060] [evidence ISS]; phosphatidylinositol-3,4-bisphosphate binding [goid 43325] [pmid 11804589] [evidence IDA]; phosphatidylinositol-3,4,5-triphosphate binding [goid 5547] [pmid 11804589] [evidence IDA]; Rho GTPase activator activity [goid 5100] [evidence ISS]; zinc ion binding [goid 8270] [evidence IEA]; metal ion binding [goid 46872] [evidence IEA]; Rac GTPase activator activity [goid 30675] [evidence ISS]",5,141013211-141013260,5q31.3c,-,NM_022481.5,64411,CENTD3,-1.1608036090929712,9.918109936014929,-10.228541827071986,5.333636123885071e-18,6.223107776880276e-17,30.103993467220736
RASGRF1,ILMN_1748083,"Homo sapiens Ras protein-specific guanine nucleotide-releasing factor 1 (RASGRF1), transcript variant 2, mRNA.",plasma membrane [goid 5886] [pmid 10918068] [evidence NAS]; synaptosome [goid 19717] [pmid 10918068] [evidence NAS]; intracellular [goid 5622] [evidence IEA],long-term memory [goid 7616] [pmid 10918068] [evidence NAS]; regulation of Rho protein signal transduction [goid 35023] [evidence IEA],Ras guanyl-nucleotide exchange factor activity [goid 5088] [pmid 7684828] [evidence TAS]; Rho guanyl-nucleotide exchange factor activity [goid 5089] [evidence IEA],15,77052715-77052764,15q25.1a,-,NM_153815.1,5923,RASGRF1,-1.3373250215318517,5.953426869157852,-10.221346601239166,5.548575227261569e-18,6.470017253332835e-17,30.064695775304646
KCNMB3,ILMN_1712197,"Homo sapiens potassium large conductance calcium-activated channel, subfamily M beta member 3 (KCNMB3), transcript variant 1, mRNA.",voltage-gated potassium channel complex [goid 8076] [pmid 10692449] [evidence IDA]; membrane [goid 16020] [evidence NAS],ion transport [goid 6811] [evidence IEA]; detection of calcium ion [goid 5513] [pmid 10692449] [evidence IDA]; potassium ion transport [goid 6813] [pmid 10692449] [evidence IDA]; regulation of action potential [goid 1508] [pmid 10692449] [evidence IDA]; generation of action potential [goid 19228] [pmid 10692449] [evidence IDA],ion channel activity [goid 5216] [evidence IEA]; calcium-activated potassium channel activity [goid 15269] [pmid 10692449] [evidence IDA]; potassium channel regulator activity [goid 15459] [pmid 10792058] [evidence NAS]; protein binding [goid 5515] [pmid 10692449] [evidence IDA],3,180443530-180443579,3q26.32c,-,NM_171828.1,27094,KCNMB3,1.0919858604334332,6.467078584697779,10.219149277348391,5.615923914835262e-18,6.54463382060796e-17,30.05269512748703
NOTCH1,ILMN_1729161,"Homo sapiens Notch homolog 1, translocation-associated (Drosophila) (NOTCH1), mRNA.",integral to membrane [goid 16021] [evidence NAS]; membrane [goid 16020] [evidence IEA]; nucleus [goid 5634] [pmid 10713164] [evidence TAS],"immune response [goid 6955] [pmid 1831692] [evidence NAS]; regulation of transcription, DNA-dependent [goid 6355] [evidence IEA]; transcription [goid 6350] [evidence IEA]; negative regulation of myoblast differentiation [goid 45662] [pmid 10713164] [evidence IMP]; Notch signaling pathway [goid 7219] [pmid 10713164] [evidence TAS]; regulation of development [goid 50793] [evidence IEA]; cell differentiation [goid 30154] [evidence IEA]",protein binding [goid 5515] [pmid 10713164] [evidence IPI]; receptor activity [goid 4872] [evidence IEA]; calcium ion binding [goid 5509] [evidence IEA],9,138508852-138508901,9q34.3d,-,NM_017617.2,4851,NOTCH1,-1.0601641440860536,10.247028675051476,-10.216490486348738,5.698509750460658e-18,6.632942800939422e-17,30.038174393645075
SH3D19,ILMN_1653133,"Homo sapiens SH3 domain protein D19 (SH3D19), mRNA.",,,,4,152261295-152261344,4q31.3b,-,NM_001009555.2,152503,SH3D19,-1.0236439254932872,9.277126329980478,-10.213049006094513,5.8072114596303035e-18,6.739339802912236e-17,30.019379418263288
LOC649841,ILMN_1697377,"PREDICTED: Homo sapiens similar to protein immuno-reactive with anti-PTH polyclonal antibodies (LOC649841), mRNA.",,,,,,,,XM_938906.1,649841,LOC649841,2.7410445564274717,7.840899361945581,10.212637555859844,5.8203453049576825e-18,6.750561206375027e-17,30.017132388659615
ZMYND15,ILMN_1778136,"Homo sapiens zinc finger, MYND-type containing 15 (ZMYND15), mRNA.",,,zinc ion binding [goid 8270] [evidence IEA]; metal ion binding [goid 46872] [evidence IEA],17,4596022-4596034:4596035-4596071,17p13.2c,+,NM_032265.1,84225,ZMYND15,-1.057793769672811,8.360445898348937,-10.209540405701787,5.920166227053882e-18,6.858171161364143e-17,30.0002182778767
C10orf38,ILMN_1749868,"Homo sapiens chromosome 10 open reading frame 38 (C10orf38), mRNA.",,,,10,15293996-15294045,10p13c-p13b,-,NM_001010924.1,221061,C10orf38,-1.3077317268174262,9.139463288422084,-10.208438288193966,5.9560985223558375e-18,6.893598507199436e-17,29.994199486001992
ARSE,ILMN_1727462,"Homo sapiens arylsulfatase E (chondrodysplasia punctata 1) (ARSE), mRNA.",,metabolism [goid 8152] [evidence IEA]; skeletal development [goid 1501] [pmid 7720070] [evidence TAS],hydrolase activity [goid 16787] [evidence IEA]; calcium ion binding [goid 5509] [evidence IEA]; arylsulfatase activity [goid 4065] [pmid 9192838] [evidence TAS],X,2862991-2863040,Xp22.33c-p22.33b,-,NM_000047.1,415,ARSE,1.7496500404347612,6.298351448269785,10.20289904741399,6.140020906136354e-18,7.083381134166185e-17,29.96394965547154
NIPSNAP1,ILMN_1805916,"Homo sapiens nipsnap homolog 1 (C. elegans) (NIPSNAP1), mRNA.",mitochondrion [goid 5739] [evidence ISS],,,22,28280956-28281005,22q12.2a,-,NM_003634.1,8508,NIPSNAP1,1.0035241193774649,9.131515583263871,10.189153404651584,6.621310916057626e-18,7.620569592403002e-17,29.88888903726176
SNRPN,ILMN_1660000,"Homo sapiens small nuclear ribonucleoprotein polypeptide N (SNRPN), transcript variant 1, mRNA.",ribonucleoprotein complex [goid 30529] [evidence IEA]; nucleus [goid 5634] [evidence IEA],mRNA metabolism [goid 16071] [evidence IEA],RNA binding [goid 3723] [evidence IEA],15,22751231-22751280,15q11.2e,+,NM_003097.3,6638,SNRPN,-1.3038594059125117,9.639408195388935,-10.178011186900859,7.038969559581755e-18,8.082163928606393e-17,29.8280496121389
EMR3,ILMN_1755873,"Homo sapiens egf-like module containing, mucin-like, hormone receptor-like 3 (EMR3), transcript variant 1, mRNA.",membrane [goid 16020] [evidence IEA]; integral to membrane [goid 16021] [pmid 15203201] [evidence TAS],signal transduction [goid 7165] [evidence IEA]; neuropeptide signaling pathway [goid 7218] [evidence IEA],calcium ion binding [goid 5509] [evidence IEA]; receptor activity [goid 4872] [evidence IEA]; G-protein coupled receptor activity [goid 4930] [pmid 15203201] [evidence TAS],19,14591257-14591283:14597304-14597326,19p13.12b,-,NM_032571.2,84658,EMR3,-1.0084942930171064,5.499900082535229,-10.176144016714792,7.111490310941183e-18,8.160623598862718e-17,29.817854792917235
CSF3R,ILMN_2323172,"Homo sapiens colony stimulating factor 3 receptor (granulocyte) (CSF3R), transcript variant 1, mRNA.",integral to plasma membrane [goid 5887] [pmid 7542747] [evidence TAS]; membrane [goid 16020] [evidence IEA],cell adhesion [goid 7155] [evidence IEA]; defense response [goid 6952] [pmid 7542747] [evidence TAS]; signal transduction [goid 7165] [pmid 1371413] [evidence NAS],receptor activity [goid 4872] [pmid 7542747] [evidence TAS]; hematopoietin/interferon-class (D200-domain) cytokine receptor activity [goid 4896] [evidence IEA]; protein binding [goid 5515] [evidence IEA],1,36704923-36704972,1p34.3d,-,NM_000760.2,1441,CSF3R,-1.4738297529804933,8.106810179606065,-10.174652183164348,7.169969121922153e-18,8.222886894682352e-17,29.809709412849482
LOC652726,ILMN_1667932,"PREDICTED: Homo sapiens similar to ankyrin repeat domain 36 (LOC652726), mRNA.",,,,,,,,XM_942351.1,652726,LOC652726,1.775706193751656,6.714144773380732,10.172411953650633,7.258688175971217e-18,8.319737594635244e-17,29.79747795210996
RAD9A,ILMN_1684183,"Homo sapiens RAD9 homolog A (S. pombe) (RAD9A), mRNA.",nucleus [goid 5634] [pmid 12628935] [evidence IDA],DNA replication checkpoint [goid 76] [pmid 8943031] [evidence TAS]; DNA damage checkpoint [goid 77] [pmid 8943031] [evidence TAS]; DNA repair [goid 6281] [pmid 8943031] [evidence TAS],hydrolase activity [goid 16787] [evidence IEA]; histone deacetylase binding [goid 42826] [pmid 10846170] [evidence IPI]; 3'-5' exonuclease activity [goid 8408] [pmid 10713044] [evidence IDA]; protein kinase binding [goid 19901] [pmid 12628935] [evidence IPI]; SH3 domain binding [goid 17124] [pmid 11971963] [evidence IPI]; exodeoxyribonuclease III activity [goid 8853] [evidence IEA]; protein binding [goid 5515] [pmid 15897895] [evidence IPI],11,66922099-66922148,11q13.1f,+,NM_004584.2,5883,RAD9A,1.1360680102667295,7.884730296649266,10.17180466277732,7.282926904530083e-18,8.342612036141603e-17,29.794162226300944
BCORL1,ILMN_1767015,"Homo sapiens BCL6 co-repressor-like 1 (BCORL1), mRNA.",,,,X,129019070-129019119,Xq25h,+,NM_021946.2,63035,BCORL1,1.138656138943138,6.429918329395669,10.16776224283698,7.446345185601976e-18,8.514790841634654e-17,29.772091491129718
TBX15,ILMN_1721580,"Homo sapiens T-box 15 (TBX15), mRNA.",nucleus [goid 5634] [evidence IEA],"regulation of transcription, DNA-dependent [goid 6355] [evidence IEA]; transcription [goid 6350] [evidence IEA]",transcription factor activity [goid 3700] [evidence IEA],1,119227617-119227666,1p12b,-,NM_152380.2,6913,TBX15,1.3045423535541385,5.7193555794277495,10.160238723078557,7.760306341775624e-18,8.86859642636352e-17,29.731016242035732
PFAAP5,ILMN_1797893,"Homo sapiens phosphonoformate immuno-associated protein 5 (PFAAP5), mRNA.",,,,13,31989252-31989301,13q13.1a-q13.1b,-,NM_014887.1,10443,PFAAP5,-1.0241762548315112,8.802547702618519,-10.15892566088947,7.816441292442233e-18,8.927512226449993e-17,29.72384768164026
SUSD2,ILMN_1693270,"Homo sapiens sushi domain containing 2 (SUSD2), mRNA.",,,,22,22915000-22915049,22q11.23b,+,NM_019601.3,56241,SUSD2,-1.8256251732856263,12.712445188744367,-10.158067456294901,7.853349584406232e-18,8.964412223324864e-17,29.71916241400245
FAM46B,ILMN_1808011,"Homo sapiens family with sequence similarity 46, member B (FAM46B), mRNA.",,,,1,27204252-27204301,1p36.11a,-,NM_052943.2,115572,FAM46B,-1.4102829101641197,7.56428982649259,-10.1524729251531,8.098254432662396e-18,9.22235462422132e-17,29.688620372581237
ATG12,ILMN_1673898,"Homo sapiens ATG12 autophagy related 12 homolog (S. cerevisiae) (ATG12), mRNA.",cytoplasm [goid 5737] [pmid 9852036] [evidence TAS],autophagic vacuole formation [goid 45] [evidence IEA]; apoptosis [goid 6915] [pmid 9852036] [evidence TAS]; ubiquitin cycle [goid 6512] [evidence IEA]; autophagy [goid 6914] [pmid 9852036] [evidence TAS],protein binding [goid 5515] [pmid 11825910] [evidence IPI],5,115194222-115194271,5q22.3b-q23.1a,-,NM_004707.2,9140,ATG12,1.0893597588799686,9.050228498097967,10.1479744091008,8.300703357898843e-18,9.447383465459051e-17,29.664062589271968
B3GNT1,ILMN_1711102,"Homo sapiens UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 1 (B3GNT1), transcript variant 1, mRNA.",membrane [goid 16020] [evidence IEA]; integral to membrane [goid 16021] [evidence NAS]; Golgi stack [goid 5795] [evidence IEA],protein amino acid glycosylation [goid 6486] [evidence IEA],"manganese ion binding [goid 30145] [evidence IEA]; transferase activity, transferring glycosyl groups [goid 16757] [evidence IEA]; galactosyltransferase activity [goid 8378] [evidence IEA]",2,62303799-62303848,2p15c,+,NM_006577.3,10678,B3GNT1,-1.642679721321998,6.942709466518458,-10.146422692731148,8.371702500141337e-18,9.522628325467247e-17,29.655591807399706
KIAA0460,ILMN_1705733,"Homo sapiens KIAA0460 (KIAA0460), mRNA.",,,,1,148712270-148712319,1q21.2b,+,NM_015203.2,23248,KIAA0460,1.142728111893847,7.385254534326831,10.144965793932629,8.438915365245842e-18,9.58788722401255e-17,29.64763871216387
CYGB,ILMN_1758128,"Homo sapiens cytoglobin (CYGB), mRNA.",cytoplasm [goid 5737] [evidence NAS],transport [goid 6810] [evidence IEA]; oxygen transport [goid 15671] [pmid 11919282] [evidence NAS],heme binding [goid 20037] [evidence IEA]; metal ion binding [goid 46872] [evidence IEA]; oxygen transporter activity [goid 5344] [pmid 11919282] [evidence NAS]; iron ion binding [goid 5506] [evidence IEA]; oxygen binding [goid 19825] [evidence IEA],17,72035154-72035203,17q25.1d,-,NM_134268.3,114757,CYGB,-1.0452339006543347,9.454886390320235,-10.143947765349608,8.486201010737033e-18,9.635992231597383e-17,29.64208142068024
LIFR,ILMN_1709094,"Homo sapiens leukemia inhibitory factor receptor (LIFR), mRNA.",membrane [goid 16020] [evidence IEA]; integral to plasma membrane [goid 5887] [pmid 1915266] [evidence TAS],cell surface receptor linked signal transduction [goid 7166] [pmid 1915266] [evidence TAS],receptor activity [goid 4872] [evidence IEA]; leukemia inhibitory factor receptor activity [goid 4923] [pmid 1915266] [evidence TAS],5,38511336-38511385,5p13.1c,-,NM_002310.3,3977,LIFR,-1.6541915159277183,7.072355712562559,-10.141058166210556,8.62186472892236e-18,9.778639944298729e-17,29.626307664818444
IER5L,ILMN_1755620,"Homo sapiens immediate early response 5-like (IER5L), mRNA.",,,,9,130979040-130979083:130979084-130979089,9q34.11c,-,NM_203434.1,389792,IER5L,1.325658192995216,7.569777210864963,10.132421331400787,9.04040842916451e-18,1.0235465324943085e-16,29.579162708418057
LOC652616,ILMN_1652680,"PREDICTED: Homo sapiens similar to neutrophil cytosolic factor 1 (LOC652616), mRNA.",,,,,,,,XM_942152.1,652616,LOC652616,-1.1740744214167442,5.477006164618381,-10.12953433030232,9.18479193163763e-18,1.0392896096861743e-16,29.56340436494337
C8orf51,ILMN_1688772,"Homo sapiens chromosome 8 open reading frame 51 (C8orf51), mRNA.",,,,8,144520263-144520312,8q24.3f,-,NM_024035.1,78998,C8orf51,1.0181922393064236,6.461441084387725,10.128270965776357,9.248697246605001e-18,1.0459133247248894e-16,29.556508541646995
LEFTY2,ILMN_1781256,"Homo sapiens left-right determination factor 2 (LEFTY2), mRNA.",extracellular space [goid 5615] [evidence IEA],oocyte axis determination [goid 7309] [pmid 10053005] [evidence TAS]; cell growth [goid 16049] [evidence IEA]; cell-cell signaling [goid 7267] [evidence NR ]; development [goid 7275] [pmid 10053005] [evidence TAS]; transforming growth factor beta receptor signaling pathway [goid 7179] [pmid 9153275] [evidence TAS],cytokine activity [goid 5125] [evidence IEA]; growth factor activity [goid 8083] [evidence IEA]; transforming growth factor beta receptor binding [goid 5160] [evidence IEA],1,224191049-224191098,1q42.12c,-,NM_003240.2,7044,LEFTY2,-1.6412156901743264,6.3590287432499295,-10.122640879294384,9.538930221561126e-18,1.0768601122081027e-16,29.52577856585918
KIAA0415,ILMN_2083559,"Homo sapiens KIAA0415 (KIAA0415), mRNA.",,,,7,4797531-4797542:4797543-4797580,7p22.1d,+,NM_014855.1,9907,KIAA0415,1.109022723575305,6.969027438290477,10.12086227070292,9.63249595012039e-18,1.0855360531410978e-16,29.516070864091535
PHACTR2,ILMN_1790533,"Homo sapiens phosphatase and actin regulator 2 (PHACTR2), mRNA.",,,actin binding [goid 3779] [evidence IEA]; protein phosphatase inhibitor activity [goid 4864] [evidence IEA],6,144188366-144188415,6q24.2b,+,NM_014721.1,9749,PHACTR2,-1.4992673730137547,9.237369908247205,-10.118497954711417,9.75829443280184e-18,1.0984423282677286e-16,29.503166538415694
PRRG1,ILMN_1781791,"Homo sapiens proline rich Gla (G-carboxyglutamic acid) 1 (PRRG1), mRNA.",integral to plasma membrane [goid 5887] [pmid 9256434] [evidence TAS]; membrane [goid 16020] [evidence IEA]; extracellular region [goid 5576] [evidence IEA],,calcium ion binding [goid 5509] [evidence IEA],X,37201128-37201177,Xp21.1a,+,NM_000950.1,5638,PRRG1,-1.2569957470770685,7.2318572198507765,-10.114159169853265,9.993433647076817e-18,1.124261285296142e-16,29.47948620762517
PTPRH,ILMN_1741465,"Homo sapiens protein tyrosine phosphatase, receptor type, H (PTPRH), mRNA.",membrane [goid 16020] [evidence IEA]; integral to plasma membrane [goid 5887] [pmid 8294459] [evidence TAS]; integral to membrane [goid 16021] [evidence IEA],protein amino acid dephosphorylation [goid 6470] [pmid 8294459] [evidence TAS],receptor activity [goid 4872] [evidence IEA]; transmembrane receptor protein tyrosine phosphatase activity [goid 5001] [pmid 8294459] [evidence TAS]; protein tyrosine phosphatase activity [goid 4725] [evidence IEA]; hydrolase activity [goid 16787] [evidence IEA],19,60384744-60384793,19q13.42b,-,NM_002842.2,5794,PTPRH,1.5202390843609805,5.893961832622325,10.112630392159096,1.0077626912623928e-17,1.1330788251152755e-16,29.47114257703119
RAB32,ILMN_2115434,"Homo sapiens RAB32, member RAS oncogene family (RAB32), mRNA.",mitochondrion [goid 5739] [evidence IEA],protein transport [goid 15031] [evidence IEA]; small GTPase mediated signal transduction [goid 7264] [evidence IEA],nucleotide binding [goid 166] [evidence IEA]; GTP binding [goid 5525] [evidence IEA],6,146917424-146917434:146917435-146917473,6q24.3b,+,NM_006834.2,10981,RAB32,-1.0702915897070255,9.674900931890244,-10.111025019657733,1.016680126133445e-17,1.1417874500121139e-16,29.46238101039253
CD83,ILMN_1780582,"Homo sapiens CD83 antigen (activated B lymphocytes, immunoglobulin superfamily) (CD83), mRNA.",integral to plasma membrane [goid 5887] [pmid 8422464] [evidence TAS]; plasma membrane [goid 5886] [pmid 9310491] [evidence TAS],humoral immune response [goid 6959] [pmid 8422464] [evidence TAS]; signal transduction [goid 7165] [pmid 9310491] [evidence TAS]; defense response [goid 6952] [pmid 1378080] [evidence TAS],,6,14244566-14244615,6p23b,+,NM_004233.2,9308,CD83,-1.3794861523580266,9.574537553969012,-10.104862873770621,1.051647402389553e-17,1.177663772158646e-16,29.42875107604655
IGSF4C,ILMN_1812096,"Homo sapiens immunoglobulin superfamily, member 4C (IGSF4C), mRNA.",membrane [goid 16020] [evidence IEA]; integral to membrane [goid 16021] [evidence IEA],,receptor activity [goid 4872] [evidence IEA],19,48818486-48818535,19q13.31a,-,NM_145296.1,199731,IGSF4C,1.2576250788465133,6.596350115096268,10.10317274987985,1.061446281417085e-17,1.1872721465793284e-16,29.419527475368294
HSH2D,ILMN_1788017,"Homo sapiens hematopoietic SH2 domain containing (HSH2D), mRNA.",nucleus [goid 5634] [evidence IEA],intracellular signaling cascade [goid 7242] [evidence IEA],,19,16129952-16130001,19p13.11f,+,NM_032855.2,84941,HSH2D,1.3073612437042108,7.790215945495156,10.100209992916431,1.0788441326031418e-17,1.2039678077761866e-16,29.40335893646149
NQO1,ILMN_1720282,"Homo sapiens NAD(P)H dehydrogenase, quinone 1 (NQO1), transcript variant 1, mRNA.",cytoplasm [goid 5737] [pmid 2843525] [evidence TAS],"nitric oxide biosynthesis [goid 6809] [pmid 9579781] [evidence TAS]; response to toxin [goid 9636] [pmid 10393963] [evidence TAS]; xenobiotic metabolism [goid 6805] [pmid 10393963] [evidence TAS]; synaptic transmission, cholinergic [goid 7271] [pmid 9579781] [evidence TAS]; electron transport [goid 6118] [evidence IEA]",oxidoreductase activity [goid 16491] [evidence IEA]; cytochrome-b5 reductase activity [goid 4128] [pmid 9579781] [evidence TAS]; NAD(P)H dehydrogenase (quinone) activity [goid 3955] [pmid 10393963] [evidence TAS],16,68300911-68300960,16q22.1e,-,NM_000903.2,1728,NQO1,1.2298445472665716,8.004947674561603,10.098137271457826,1.0911846088284588e-17,1.2163462301500298e-16,29.392047757578087
NIPSNAP3A,ILMN_1700159,"Homo sapiens nipsnap homolog 3A (C. elegans) (NIPSNAP3A), mRNA.",,,,9,106556744-106556793,9q31.1d,+,NM_015469.1,25934,NIPSNAP3A,-1.3868452219730845,6.820372013144271,-10.097852025569253,1.0928938949833514e-17,1.2175550339480046e-16,29.39049113742674
MBTD1,ILMN_2101650,"Homo sapiens mbt domain containing 1 (MBTD1), mRNA.",nucleus [goid 5634] [evidence IEA]; nucleus [goid 5634] [evidence IEA],regulation of transcription [goid 45449] [evidence IEA]; regulation of transcription [goid 45449] [evidence IEA],zinc ion binding [goid 8270] [evidence IEA]; zinc ion binding [goid 8270] [evidence IEA],17,46623964-46624013,17q21.33b,-,NM_017643.1,54799,MBTD1,2.550580494368581,8.437056324926516,10.097074718616334,1.0975653585786169e-17,1.2209504500155125e-16,29.386249298725847
LOC648434,ILMN_1735179,"PREDICTED: Homo sapiens hypothetical protein LOC648434 (LOC648434), mRNA.",,,,,,,,XM_937486.1,648434,LOC648434,1.0975784418018453,5.822004701195432,10.08899608302239,1.1473132321036089e-17,1.2738118705150323e-16,29.3421648167493
IL7R,ILMN_1691341,"PREDICTED: Homo sapiens interleukin 7 receptor (IL7R), mRNA.",,,,,,5p13.2c,,XM_937367.1,3575,IL7R,-1.690716035580147,9.918896839782477,-10.088783463700384,1.1486525150852535e-17,1.2745725658562736e-16,29.341004604610983
LAMA3,ILMN_1688892,"Homo sapiens laminin, alpha 3 (LAMA3), transcript variant 1, mRNA.",basement membrane [goid 5604] [pmid 8586427] [evidence TAS]; laminin-1 [goid 5606] [evidence IEA],regulation of cell migration [goid 30334] [evidence IEA]; regulation of cell adhesion [goid 30155] [evidence IEA]; epidermis development [goid 8544] [pmid 8586427] [evidence TAS]; regulation of embryonic development [goid 45995] [evidence IEA],structural molecule activity [goid 5198] [pmid 8586427] [evidence NAS]; receptor binding [goid 5102] [evidence IEA],18,19787015-19787064,18q11.2b-q11.2c,+,NM_198129.1,3909,LAMA3,-1.1907225077738834,7.289969522162197,-10.085814655392829,1.167516919381354e-17,1.294031124809197e-16,29.32480472456631
TMEM37,ILMN_1670672,"Homo sapiens transmembrane protein 37 (TMEM37), mRNA.",,,,2,119911220-119911269,2q14.2b,+,NM_183240.1,140738,TMEM37,-1.587157149474466,7.462477571377821,-10.083847899981386,1.180184184446876e-17,1.3073273924927446e-16,29.314072934530376
IL8RB,ILMN_1680397,"Homo sapiens interleukin 8 receptor, beta (IL8RB), mRNA.",integral to plasma membrane [goid 5887] [pmid 10438939] [evidence TAS]; membrane [goid 16020] [pmid 10725748] [evidence IDA]; cell surface [goid 9986] [pmid 10878382] [evidence IDA]; intracellular [goid 5622] [pmid 10878382] [evidence IDA],"neutrophil activation [goid 42119] [pmid 10878382] [evidence IDA]; G-protein signaling, coupled to IP3 second messenger (phospholipase C activating) [goid 7200] [pmid 10438939] [evidence IDA]; chemotaxis [goid 6935] [pmid 10725748] [evidence IDA]; cellular defense response [goid 6968] [pmid 10725748] [evidence IDA]; neutrophil chemotaxis [goid 30593] [pmid 10820279] [evidence IDA]; positive regulation of cell proliferation [goid 8284] [pmid 10438939] [evidence IDA]",receptor activity [goid 4872] [evidence IEA]; rhodopsin-like receptor activity [goid 1584] [evidence IEA]; interleukin-8 receptor activity [goid 4918] [pmid 10820279] [evidence IDA],2,218708265-218708314,2q35e,+,NM_001557.2,3579,IL8RB,-1.7730237758795235,5.922226039086242,-10.07421646777857,1.244227707389427e-17,1.3759237728991478e-16,29.261520340332336
LOC402560,ILMN_1769288,"PREDICTED: Homo sapiens hypothetical LOC402560 (LOC402560), mRNA.",,,,,,,,XM_944321.1,402560,LOC402560,-1.15195371384908,6.45166272356529,-10.070553716251952,1.269484025604125e-17,1.4030570753769926e-16,29.24153602128391
C7orf24,ILMN_1745005,"Homo sapiens chromosome 7 open reading frame 24 (C7orf24), mRNA.",,,,7,30502993-30503042,7p15.1b,-,NM_024051.2,79017,C7orf24,1.3079079601299117,8.449510877273891,10.069675809765368,1.275613279229565e-17,1.409032015067351e-16,29.236746161514734
KIAA1688,ILMN_1784436,"Homo sapiens KIAA1688 protein (KIAA1688), mRNA.",nucleus [goid 5634] [evidence IEA]; cytoskeleton [goid 5856] [evidence IEA]; intracellular [goid 5622] [evidence IEA],signal transduction [goid 7165] [evidence IEA],,8,145725377-145725426,8q24.3h,-,NM_025251.1,80728,KIAA1688,1.5428785712358133,8.56616855543839,10.06617242228729,1.3003685466544734e-17,1.434749780949174e-16,29.217631985102134
HHEX,ILMN_1762712,"Homo sapiens hematopoietically expressed homeobox (HHEX), mRNA.",nucleus [goid 5634] [evidence IEA],"regulation of transcription, DNA-dependent [goid 6355] [evidence IEA]; development [goid 7275] [pmid 1360645] [evidence TAS]; antimicrobial humoral response (sensu Vertebrata) [goid 19735] [pmid 8096636] [evidence TAS]",transcription factor activity [goid 3700] [pmid 10871399] [evidence TAS],10,94445134-94445183,10q23.33a,+,NM_002729.2,3087,HHEX,-1.5092503832534225,7.605947763144909,-10.062446840847818,1.3272205612521875e-17,1.4627201717193934e-16,29.19730609010109
MMP12,ILMN_1768035,"Homo sapiens matrix metallopeptidase 12 (macrophage elastase) (MMP12), mRNA.",extracellular matrix (sensu Metazoa) [goid 5578] [evidence IEA],peptidoglycan metabolism [goid 270] [evidence IEA]; cell motility [goid 6928] [evidence NR ],zinc ion binding [goid 8270] [pmid 8226919] [evidence TAS]; calcium ion binding [goid 5509] [evidence IEA]; macrophage elastase activity [goid 4234] [pmid 8226919] [evidence TAS],11,102242277-102242326,11q22.2b,-,NM_002426.2,4321,MMP12,1.7679050337831672,5.885330064788326,10.057099649611201,1.3667310850619822e-17,1.5045624402504365e-16,29.16813407462993
FLJ35880,ILMN_1768919,"Homo sapiens hypothetical protein FLJ35880 (FLJ35880), mRNA.",,,,3,131686024-131686073,3q22.1a,+,NM_153264.2,256076,FLJ35880,-1.3312446604850452,6.542207792563084,-10.056434943878038,1.3717240089776043e-17,1.509206228962655e-16,29.164507803883023
UNQ830,ILMN_1774265,"Homo sapiens ASCL830 (UNQ830), mRNA.",,,,2,233449250-233449299,2q37.1c,+,NM_206895.1,389084,UNQ830,1.1597558737839773,5.999689382196227,10.052828775712582,1.3991309297333734e-17,1.5376235852145955e-16,29.14483484426562
GGCX,ILMN_1758232,"Homo sapiens gamma-glutamyl carboxylase (GGCX), mRNA.",membrane fraction [goid 5624] [pmid 1749935] [evidence TAS]; integral to membrane [goid 16021] [pmid 1749935] [evidence TAS],protein modification [goid 6464] [pmid 1749935] [evidence TAS]; blood coagulation [goid 7596] [pmid 9845520] [evidence TAS]; peptidyl-glutamic acid carboxylation [goid 17187] [evidence IEA],gamma-glutamyl carboxylase activity [goid 8488] [pmid 1749935] [evidence TAS]; ligase activity [goid 16874] [evidence IEA],2,85629904-85629953,2p11.2f,-,NM_000821.3,2677,GGCX,1.10857853280325,8.284680132419284,10.052557185795521,1.40121702904441e-17,1.539048129139252e-16,29.14335324440368
SEMA5A,ILMN_1656927,"Homo sapiens sema domain, seven thrombospondin repeats (type 1 and type 1-like), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 5A (SEMA5A), mRNA.",membrane [goid 16020] [evidence IEA]; integral to membrane [goid 16021] [evidence IEA],cell-cell signaling [goid 7267] [pmid 9464278] [evidence TAS]; cell differentiation [goid 30154] [evidence IEA]; cell adhesion [goid 7155] [pmid 9049630] [evidence TAS],receptor activity [goid 4872] [evidence IEA],5,9092140-9092189,5p15.2d,-,NM_003966.1,9037,SEMA5A,-1.6236767485175836,7.2752996063995115,-10.050003833216286,1.4209820342108812e-17,1.5589997148985936e-16,29.129424134339022
ADFP,ILMN_1801077,"Homo sapiens adipose differentiation-related protein (ADFP), mRNA.",membrane [goid 16020] [evidence IEA]; extracellular region [goid 5576] [pmid 9003395] [evidence TAS]; endoplasmic reticulum [goid 5783] [pmid 9003395] [evidence TAS]; lipid particle [goid 5811] [pmid 9003395] [evidence TAS],,,9,19106260-19106309,9p22.1b,-,NM_001122.2,123,ADFP,-1.221946267731946,10.162276103102844,-10.049089707943685,1.428125592053753e-17,1.5659553832958569e-16,29.124437442710533
CTGF,ILMN_1699829,"Homo sapiens connective tissue growth factor (CTGF), mRNA.",extracellular space [goid 5615] [evidence NR ]; extracellular matrix (sensu Metazoa) [goid 5578] [pmid 10809757] [evidence TAS]; soluble fraction [goid 5625] [evidence NR ]; plasma membrane [goid 5886] [pmid 10809757] [evidence TAS]; plasma membrane [goid 5886] [pmid 10809757] [evidence TAS]; extracellular region [goid 5576] [evidence IEA]; extracellular matrix (sensu Metazoa) [goid 5578] [pmid 10809757] [evidence TAS]; extracellular space [goid 5615] [evidence NR ]; soluble fraction [goid 5625] [evidence NR ],epidermis development [goid 8544] [pmid 10809757] [evidence TAS]; cell adhesion [goid 7155] [evidence IEA]; response to wounding [goid 9611] [pmid 10809757] [evidence TAS]; regulation of cell growth [goid 1558] [evidence IEA]; DNA replication [goid 6260] [evidence IEA]; cell motility [goid 6928] [evidence NR ]; cell motility [goid 6928] [evidence NR ]; response to wounding [goid 9611] [pmid 10809757] [evidence TAS]; cell adhesion [goid 7155] [evidence IEA]; DNA replication [goid 6260] [evidence IEA]; regulation of cell growth [goid 1558] [evidence IEA]; epidermis development [goid 8544] [pmid 10809757] [evidence TAS],insulin-like growth factor binding [goid 5520] [pmid 9371786] [evidence TAS]; protein binding [goid 5515] [evidence IEA]; heparin binding [goid 8201] [evidence IEA]; insulin-like growth factor binding [goid 5520] [pmid 9371786] [evidence TAS]; heparin binding [goid 8201] [evidence IEA]; protein binding [goid 5515] [evidence IEA],6,132311203-132311252,6q23.2b,-,NM_001901.2,1490,CTGF,-1.3143122644361043,12.777956681854532,-10.048746739542931,1.430815010078106e-17,1.5680219612695104e-16,29.122566507259418
LILRB5,ILMN_1732919,"Homo sapiens leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 5 (LILRB5), mRNA.",membrane [goid 16020] [evidence IEA]; integral to membrane [goid 16021] [evidence IEA]; integral to membrane [goid 16021] [evidence IEA],immune response [goid 6955] [evidence IEA]; cell surface receptor linked signal transduction [goid 7166] [pmid 9548455] [evidence TAS]; cell surface receptor linked signal transduction [goid 7166] [pmid 9548455] [evidence TAS]; immune response [goid 6955] [evidence IEA],transmembrane receptor activity [goid 4888] [pmid 9548455] [evidence TAS]; transmembrane receptor activity [goid 4888] [pmid 9548455] [evidence TAS],19,59446415-59446461:59446462-59446464,19q13.42a,-,NM_006840.2,10990,LILRB5,-1.166144403108123,6.516978866895118,-10.047437086660846,1.4411313969188565e-17,1.577553104997973e-16,29.11542223274608
TRIM2,ILMN_1745079,"Homo sapiens tripartite motif-containing 2 (TRIM2), mRNA.",cytoplasm [goid 5737] [pmid 11331580] [evidence IEP]; intracellular [goid 5622] [evidence IEA],,metal ion binding [goid 46872] [evidence IEA]; zinc ion binding [goid 8270] [pmid 11331580] [evidence NAS]; protein binding [goid 5515] [evidence IEA]; myosin binding [goid 17022] [pmid 11432975] [evidence ISS],4,154479738-154479787,4q31.3d,+,NM_015271.2,23321,TRIM2,1.4378447473438083,9.480027119863905,10.045781793624306,1.4542768216434327e-17,1.59104906623932e-16,29.106392563344247
EGFL7,ILMN_1669898,"Homo sapiens EGF-like-domain, multiple 7 (EGFL7), transcript variant 1, mRNA.",extracellular region [goid 5576] [evidence ISS]; extracellular region [goid 5576] [evidence ISS],angiogenesis [goid 1525] [evidence IEA]; vasculogenesis [goid 1570] [evidence ISS]; blood vessel development [goid 1568] [evidence ISS]; regulation of cell migration [goid 30334] [evidence ISS]; angiogenesis [goid 1525] [evidence IEA]; vasculogenesis [goid 1570] [evidence ISS]; blood vessel development [goid 1568] [evidence ISS]; regulation of cell migration [goid 30334] [evidence ISS],calcium ion binding [goid 5509] [evidence ISS]; calcium ion binding [goid 5509] [evidence ISS],9,138686361-138686361:138686537-138686559:138686560-138686585,9q34.3d,+,NM_016215.3,51162,EGFL7,-1.1790298720856773,7.116608859789951,-10.045105074371085,1.4596853820276637e-17,1.5951749674037594e-16,29.102701074332064
SYT12,ILMN_1815610,"Homo sapiens synaptotagmin XII (SYT12), mRNA.",synapse [goid 45202] [evidence IEA]; membrane [goid 16020] [evidence IEA]; integral to membrane [goid 16021] [evidence IEA]; synaptic vesicle [goid 8021] [evidence IEA],transport [goid 6810] [evidence IEA],transporter activity [goid 5215] [evidence IEA],11,66574654-66574703,11q13.1f,+,NM_177963.2,91683,SYT12,1.713655332558771,5.908575855586705,10.043053937457348,1.4762017836102076e-17,1.6123201655630546e-16,29.09151228466966
PTTG3,ILMN_2049021,Homo sapiens pituitary tumor-transforming 3 (PTTG3) on chromosome 8.,,,,8,67842374-67842423,8q13.1b,-,NR_002734.1,26255,PTTG3,1.4160176268676947,8.15529734557821,10.033077573542375,1.5592355308323874e-17,1.69825066060755e-16,29.03709455822548
PDE8B,ILMN_2301722,"Homo sapiens phosphodiesterase 8B (PDE8B), transcript variant 3, mRNA.",,"regulation of transcription, DNA-dependent [goid 6355] [evidence IEA]; two-component signal transduction system (phosphorelay) [goid 160] [evidence IEA]; cyclic nucleotide metabolism [goid 9187] [pmid 9784418] [evidence NAS]; regulation of transcription, DNA-dependent [goid 6355] [evidence IEA]; two-component signal transduction system (phosphorelay) [goid 160] [evidence IEA]; cyclic nucleotide metabolism [goid 9187] [pmid 9784418] [evidence NAS]","hydrolase activity [goid 16787] [evidence IEA]; manganese ion binding [goid 30145] [evidence IEA]; magnesium ion binding [goid 287] [evidence IEA]; 3',5'-cyclic-nucleotide phosphodiesterase activity [goid 4114] [pmid 9784418] [evidence NAS]; hydrolase activity [goid 16787] [evidence IEA]; manganese ion binding [goid 30145] [evidence IEA]; magnesium ion binding [goid 287] [evidence IEA]; 3',5'-cyclic-nucleotide phosphodiesterase activity [goid 4114] [pmid 9784418] [evidence NAS]",5,76758755-76758804,5q14.1a,+,NM_001029851.1,8622,PDE8B,-1.0571363858157596,6.625424389739863,-10.031728021507405,1.57082046316195e-17,1.7099126661849494e-16,29.029733530302035
VGF,ILMN_1757497,"Homo sapiens VGF nerve growth factor inducible (VGF), mRNA.",,,growth factor activity [goid 8083] [evidence NAS],7,100592625-100592674,7q22.1d,-,NM_003378.2,7425,VGF,1.258316083998725,5.649954519421375,10.027707093138797,1.6058494078514966e-17,1.7451185561620976e-16,29.007802150228155
C18orf45,ILMN_1690442,"Homo sapiens chromosome 18 open reading frame 45 (C18orf45), mRNA.",,,,18,19130737-19130786,18q11.2b,-,NM_032933.3,85019,C18orf45,1.282216485888246,7.834304782297327,10.027203406653552,1.6102919857158167e-17,1.748970977796694e-16,29.005054938407053
CTSL,ILMN_1694757,"Homo sapiens cathepsin L (CTSL), transcript variant 1, mRNA.",extracellular region [goid 5576] [pmid 14718574] [evidence NAS]; lysosome [goid 5764] [evidence NAS],,cysteine-type endopeptidase activity [goid 4197] [evidence IEA]; cathepsin L activity [goid 4217] [pmid 8419312] [evidence TAS],9,89531002-89531051,9q21.33c,+,NM_001912.2,1514,CTSL,-1.2898514667122791,6.936394142073244,-10.026903476372844,1.6129432375348345e-17,1.7508745951736074e-16,29.00341906091064
ZNF322A,ILMN_1749342,"Homo sapiens zinc finger protein 322A (ZNF322A), mRNA.",intracellular [goid 5622] [evidence IEA]; nucleus [goid 5634] [evidence IEA]; intracellular [goid 5622] [evidence IEA]; nucleus [goid 5634] [evidence IEA],"transcription [goid 6350] [evidence IEA]; regulation of transcription, DNA-dependent [goid 6355] [evidence IEA]; transcription [goid 6350] [evidence IEA]; regulation of transcription, DNA-dependent [goid 6355] [evidence IEA]",DNA binding [goid 3677] [evidence IEA]; metal ion binding [goid 46872] [evidence IEA]; zinc ion binding [goid 8270] [evidence IEA]; DNA binding [goid 3677] [evidence IEA]; metal ion binding [goid 46872] [evidence IEA]; zinc ion binding [goid 8270] [evidence IEA],6,26766818-26766853:26767648-26767661,6p22.1d,-,NM_024639.2,79692,ZNF322A,1.035524787102494,6.345630988820594,10.021184876395552,1.6643355040175057e-17,1.8056557514354732e-16,28.97222946234201
SLC1A1,ILMN_1658917,"Homo sapiens solute carrier family 1 (neuronal/epithelial high affinity glutamate transporter, system Xag), member 1 (SLC1A1), mRNA.",membrane fraction [goid 5624] [pmid 7521911] [evidence TAS]; integral to plasma membrane [goid 5887] [pmid 7521911] [evidence TAS]; membrane [goid 16020] [evidence IEA],transport [goid 6810] [evidence IEA]; synaptic transmission [goid 7268] [pmid 7521911] [evidence TAS]; dicarboxylic acid transport [goid 6835] [evidence IEA],symporter activity [goid 15293] [evidence IEA]; sodium:dicarboxylate symporter activity [goid 17153] [evidence IEA]; L-glutamate transporter activity [goid 5313] [pmid 7521911] [evidence TAS],9,4577281-4577330,9p24.2a,+,NM_004170.4,6505,SLC1A1,-1.6823101362605142,6.972713494907101,-10.0168707463718,1.7041854994565264e-17,1.845806251078956e-16,28.948700873297657
MATN3,ILMN_1663171,"Homo sapiens matrilin 3 (MATN3), mRNA.",extracellular matrix (sensu Metazoa) [goid 5578] [pmid 9350998] [evidence TAS],skeletal development [goid 1501] [pmid 9350998] [evidence TAS]; extracellular matrix organization and biogenesis [goid 30198] [evidence IEA],calcium ion binding [goid 5509] [evidence IEA]; collagen binding [goid 5518] [evidence IEA]; extracellular matrix structural constituent [goid 5201] [pmid 9350998] [evidence TAS],2,20060396-20060445,2p24.1d,-,NM_002381.3,4148,MATN3,-1.719423168752284,6.250549907783817,-10.015883390120715,1.7134389913471168e-17,1.8547977081332538e-16,28.94331610169286
NOTCH4,ILMN_1711157,"Homo sapiens Notch homolog 4 (Drosophila) (NOTCH4), mRNA.",integral to plasma membrane [goid 5887] [pmid 11823422] [evidence TAS]; nucleus [goid 5634] [pmid 8681805] [evidence TAS]; membrane [goid 16020] [evidence IEA]; integral to membrane [goid 16021] [evidence IEA]; cell surface [goid 9986] [pmid 11823422] [evidence IDA],"mammary gland development [goid 30879] [pmid 9576833] [evidence IDA]; regulation of development [goid 50793] [evidence IEA]; Notch signaling pathway [goid 7219] [evidence ISS]; hemopoiesis [goid 30097] [pmid 11532344] [evidence TAS]; cell fate determination [goid 1709] [pmid 11823422] [evidence TAS]; patterning of blood vessels [goid 1569] [evidence ISS]; positive regulation of transcription, DNA-dependent [goid 45893] [pmid 11823422] [evidence TAS]; transcription [goid 6350] [evidence IEA]; embryonic development [goid 9790] [evidence ISS]; cell differentiation [goid 30154] [pmid 11823422] [evidence NAS]; negative regulation of endothelial cell differentiation [goid 45602] [evidence ISS]",protein heterodimerization activity [goid 46982] [pmid 8681805] [evidence TAS]; protein binding [goid 5515] [pmid 7671825] [evidence IPI]; receptor activity [goid 4872] [pmid 11823422] [evidence TAS]; calcium ion binding [goid 5509] [pmid 11823422] [evidence TAS],6,32270714-32270763,6p21.32b,-,NM_004557.3,4855,NOTCH4,-1.3442831722735802,8.497335828019311,-10.015154231120377,1.7203048615351376e-17,1.861196014825772e-16,28.93933949493538
SBDSP,ILMN_1765725,Homo sapiens Shwachman-Bodian-Diamond syndrome pseudogene (SBDSP) on chromosome 7.,,,,7,71938143-71938192,7q11.23a,+,NR_001588.1,155370,SBDSP,-1.609666525900245,7.768563381714745,-10.011133967229954,1.7586566666517025e-17,1.9005782112983043e-16,28.917414644521887
FBXL20,ILMN_1754489,"Homo sapiens F-box and leucine-rich repeat protein 20 (FBXL20), mRNA.",,ubiquitin cycle [goid 6512] [evidence IEA],transferase activity [goid 16740] [evidence IEA],17,34670485-34670534,17q12c,-,NM_032875.1,84961,FBXL20,1.054506078376198,8.180670751320738,10.004169128954132,1.827130735488029e-17,1.970178694595681e-16,28.879433001039427
OLFML2A,ILMN_1761425,"Homo sapiens olfactomedin-like 2A (OLFML2A), mRNA.",membrane [goid 16020] [evidence IEA],,latrotoxin receptor activity [goid 16524] [evidence IEA],9,126616630-126616679,9q33.3a,+,NM_182487.1,169611,OLFML2A,-1.5332443570678986,9.01265593734353,-10.00407087523251,1.8281155144105674e-17,1.970178694595681e-16,28.878897205349528
CENPA,ILMN_1801257,"Homo sapiens centromere protein A, 17kDa (CENPA), mRNA.","nucleosome [goid 786] [evidence IEA]; chromosome, pericentric region [goid 775] [pmid 11084331] [evidence IDA]; chromosome [goid 5694] [evidence IEA]; nucleus [goid 5634] [pmid 7962047] [evidence TAS]",nucleosome assembly [goid 6334] [evidence IEA]; chromosome organization and biogenesis (sensu Eukaryota) [goid 7001] [pmid 7962047] [evidence TAS],chromatin binding [goid 3682] [pmid 7962047] [evidence TAS]; DNA binding [goid 3677] [evidence IEA],2,26870611-26870660,2p23.3a,+,NM_001809.2,1058,CENPA,1.014479224046383,6.222783811611445,10.002909527818563,1.8397957277803002e-17,1.980575677115975e-16,28.872564196070112
PRRG4,ILMN_1661809,"Homo sapiens proline rich Gla (G-carboxyglutamic acid) 4 (transmembrane) (PRRG4), mRNA.",membrane [goid 16020] [evidence IEA]; extracellular region [goid 5576] [evidence IEA]; integral to membrane [goid 16021] [pmid 11171957] [evidence NAS]; membrane [goid 16020] [evidence IEA]; extracellular region [goid 5576] [evidence IEA]; integral to membrane [goid 16021] [pmid 11171957] [evidence NAS],,calcium ion binding [goid 5509] [evidence IEA]; calcium ion binding [goid 5509] [evidence IEA],11,32831507-32831556,11p13d,+,NM_024081.4,79056,PRRG4,1.1563138937253195,7.844191267080023,10.000899186164004,1.860191130828016e-17,2.0014259626827106e-16,28.861601630793867
UPK3B,ILMN_1701565,"Homo sapiens uroplakin 3B (UPK3B), transcript variant 1, mRNA.",membrane [goid 16020] [evidence IEA]; integral to membrane [goid 16021] [evidence IEA]; endoplasmic reticulum [goid 5783] [evidence IEA],,,7,75978012-75978061,7q11.23f,+,NM_030570.2,80761,UPK3B,-2.0659565253321555,6.097274044399697,-10.000727829826866,1.8619399916684802e-17,2.0022020274646984e-16,28.860667218375323
DNAJC12,ILMN_1725773,"Homo sapiens DnaJ (Hsp40) homolog, subfamily C, member 12 (DNAJC12), transcript variant 2, mRNA.",,protein folding [goid 6457] [evidence IEA]; protein folding [goid 6457] [evidence IEA],heat shock protein binding [goid 31072] [evidence IEA]; unfolded protein binding [goid 51082] [evidence IEA]; heat shock protein binding [goid 31072] [evidence IEA]; unfolded protein binding [goid 51082] [evidence IEA],10,69241237-69241260:69241261-69241286,10q21.3d,-,NM_201262.1,56521,DNAJC12,1.9407196862565845,6.814136212286344,9.998401937418425,1.8858410830789832e-17,2.0267850801872027e-16,28.847984171671353
CENPM,ILMN_2368718,"Homo sapiens centromere protein M (CENPM), transcript variant 2, mRNA.","chromosome [goid 5694] [evidence IEA]; nucleus [goid 5634] [evidence IEA]; chromosome, pericentric region [goid 775] [evidence IEA]; chromosome [goid 5694] [evidence IEA]; nucleus [goid 5634] [evidence IEA]; chromosome, pericentric region [goid 775] [evidence IEA]",,,22,40664776-40664825,22q13.2b,-,NM_001002876.1,79019,CENPM,1.1664890951523192,6.722860772436481,9.97823761389137,2.1063247979464932e-17,2.257521379977306e-16,28.738038774440927
FLJ43855,ILMN_1704446,"Homo sapiens similar to sodium- and chloride-dependent creatine transporter (FLJ43855), mRNA.",membrane [goid 16020] [evidence IEA]; integral to plasma membrane [goid 5887] [evidence IEA]; membrane [goid 16020] [evidence IEA]; integral to plasma membrane [goid 5887] [evidence IEA],neurotransmitter transport [goid 6836] [evidence IEA]; neurotransmitter transport [goid 6836] [evidence IEA],symporter activity [goid 15293] [evidence IEA]; neurotransmitter:sodium symporter activity [goid 5328] [evidence IEA]; symporter activity [goid 15293] [evidence IEA]; neurotransmitter:sodium symporter activity [goid 5328] [evidence IEA],16,32796401-32796450,16p11.2b,-,NM_198857.1,386757,FLJ43855,1.6142913214987074,7.941453612139582,9.97162728148489,2.184067369922039e-17,2.339557597742217e-16,28.702000185634756
ZNF500,ILMN_1700238,"Homo sapiens zinc finger protein 500 (ZNF500), mRNA.",nucleus [goid 5634] [evidence IEA]; intracellular [goid 5622] [evidence IEA],"transcription [goid 6350] [evidence IEA]; regulation of transcription, DNA-dependent [goid 6355] [evidence IEA]",transcription factor activity [goid 3700] [evidence IEA]; zinc ion binding [goid 8270] [evidence IEA]; metal ion binding [goid 46872] [evidence IEA]; nucleic acid binding [goid 3676] [evidence IEA],16,4741136-4741185,16p13.3b,-,NM_021646.1,26048,ZNF500,1.0027900532779066,7.919532581521829,9.964992056080577,2.2649846292085596e-17,2.4235708676622066e-16,28.66582792847471
GOLGA8A,ILMN_1712469,"Homo sapiens golgi autoantigen, golgin subfamily a, 8A (GOLGA8A), mRNA.",,,,15,32467354-32467403,15q14a,-,NM_181077.2,23015,GOLGA8A,2.031915075855231,7.4374072963148095,9.951236520053875,2.4423976678978866e-17,2.607677729259744e-16,28.59084554852718
JAM3,ILMN_1769575,"Homo sapiens junctional adhesion molecule 3 (JAM3), mRNA.",membrane [goid 16020] [evidence IEA]; integral to membrane [goid 16021] [evidence IEA],,,11,133526711-133526760,11q25d,+,NM_032801.3,83700,JAM3,-1.0223325461562105,9.988359546088555,-9.947576833630688,2.4918926305998893e-17,2.656155793612628e-16,28.57089785918107
LOC196752,ILMN_1803743,"Homo sapiens similar to CG32542-PA (LOC196752), mRNA.",,,,10,75217925-75217974,10q22.2a,+,NM_001010864.1,196752,LOC196752,1.4852533114307045,7.432482209929151,9.946759071289422,2.503088560038853e-17,2.665173802861041e-16,28.56644060619998
LOC643313,ILMN_1731907,"PREDICTED: Homo sapiens similar to hypothetical protein LOC284701, transcript variant 1 (LOC643313), mRNA.",,,,1,684306-684355,,-,XM_933030.1,643313,LOC643313,1.3002777360732942,5.942795551689896,9.945473790191263,2.5207868687968507e-17,2.6810879988267814e-16,28.559435184633845
BAI3,ILMN_1671076,"Homo sapiens brain-specific angiogenesis inhibitor 3 (BAI3), mRNA.",membrane [goid 16020] [evidence IEA]; integral to membrane [goid 16021] [pmid 15203201] [evidence TAS]; cell surface [goid 9986] [evidence IEA],neuropeptide signaling pathway [goid 7218] [evidence IEA]; signal transduction [goid 7165] [evidence IEA],receptor activity [goid 4872] [evidence IEA]; G-protein coupled receptor activity [goid 4930] [pmid 15203201] [evidence TAS]; brain-specific angiogenesis inhibitor activity [goid 16527] [evidence IEA],6,70155664-70155713,6q12g-q13a,+,NM_001704.1,577,BAI3,-1.0005477406155103,5.3656998914717295,-9.94375937598727,2.5445890114498153e-17,2.704927271582087e-16,28.550090897750454
C9orf125,ILMN_1809323,"Homo sapiens chromosome 9 open reading frame 125 (C9orf125), mRNA.",membrane [goid 16020] [evidence IEA]; integral to membrane [goid 16021] [evidence IEA],,,9,103277705-103277754,9q31.1b,-,NM_032342.1,84302,C9orf125,-1.4222343001612021,6.167583053179282,-9.939839941334151,2.5998511489792555e-17,2.7621646476478073e-16,28.528728843654267
METTL7A,ILMN_1656285,"Homo sapiens methyltransferase like 7A (METTL7A), mRNA.",nucleus [goid 5634] [evidence IEA],,transferase activity [goid 16740] [evidence IEA]; S-adenosylmethionine-dependent methyltransferase activity [goid 8757] [evidence IEA],12,49612362-49612411,12q13.13b,+,NM_014033.2,25840,METTL7A,-1.8215397277946144,8.723518395352569,-9.931888880633153,2.7156663815008665e-17,2.880498608793924e-16,28.485395548473495
TRIM38,ILMN_1697971,"Homo sapiens tripartite motif-containing 38 (TRIM38), mRNA.",intracellular [goid 5622] [evidence IEA],positive regulation of I-kappaB kinase/NF-kappaB cascade [goid 43123] [pmid 12761501] [evidence IMP],zinc ion binding [goid 8270] [evidence IEA]; metal ion binding [goid 46872] [evidence IEA]; signal transducer activity [goid 4871] [pmid 12761501] [evidence IMP]; protein binding [goid 5515] [evidence IEA],6,26093123-26093172,6p22.2a,+,NM_006355.2,10475,TRIM38,1.176254134821896,8.096744750036589,9.917282196117556,2.942019111868411e-17,3.1188924045025017e-16,28.40579716784502
SNCAIP,ILMN_1807969,"Homo sapiens synuclein, alpha interacting protein (synphilin) (SNCAIP), mRNA.",presynaptic membrane [goid 42734] [pmid 11956199] [evidence NAS]; cell soma [goid 43025] [pmid 11956199] [evidence NAS]; cytoplasm [goid 5737] [pmid 14506261] [evidence IDA],dopamine metabolism [goid 42417] [pmid 14506261] [evidence IDA]; regulation of neurotransmitter secretion [goid 46928] [pmid 14506261] [evidence IDA],protein binding [goid 5515] [pmid 12364339] [evidence IPI],5,121827524-121827573,5q23.2a,+,NM_005460.2,9627,SNCAIP,-1.371466021193612,6.943334590609253,-9.916457934958707,2.9553397024684963e-17,3.1313101741489205e-16,28.401305713519772
ETNK2,ILMN_1800130,"Homo sapiens ethanolamine kinase 2 (ETNK2), mRNA.",,,kinase activity [goid 16301] [evidence IEA]; transferase activity [goid 16740] [evidence IEA]; choline kinase activity [goid 4103] [evidence NAS]; ethanolamine kinase activity [goid 4305] [evidence IEA],1,202367083-202367132,1q32.1e-q32.1f,-,NM_018208.1,55224,ETNK2,1.2086582756526258,6.272279530811099,9.907786944794665,3.099170558706072e-17,3.2819205617602076e-16,28.35405896377633
PALLD,ILMN_1698732,"Homo sapiens palladin, cytoskeletal associated protein (PALLD), mRNA.",actin filament [goid 5884] [pmid 11598191] [evidence IDA]; nucleus [goid 5634] [pmid 11598191] [evidence IDA],cytoskeleton organization and biogenesis [goid 7010] [pmid 11598191] [evidence NAS]; protein amino acid phosphorylation [goid 6468] [evidence IEA],muscle alpha-actinin binding [goid 51371] [pmid 16125169] [evidence TAS]; vascular endothelial growth factor receptor activity [goid 5021] [evidence IEA]; protein binding [goid 5515] [pmid 11598191] [evidence IPI]; ATP binding [goid 5524] [evidence IEA],4,170085818-170085867,4q32.3e,+,NM_016081.2,23022,PALLD,-1.1079355311610168,10.855195675244627,-9.906621197503911,3.119033225209011e-17,3.29936820809976e-16,28.347707292908634
TRIM22,ILMN_1779252,"Homo sapiens tripartite motif-containing 22 (TRIM22), mRNA.",ubiquitin ligase complex [goid 151] [evidence IEA]; nucleus [goid 5634] [pmid 7797467] [evidence TAS],"immune response [goid 6955] [pmid 7797467] [evidence TAS]; regulation of transcription, DNA-dependent [goid 6355] [pmid 7797467] [evidence TAS]; response to virus [goid 9615] [pmid 7797467] [evidence TAS]; protein ubiquitination [goid 16567] [evidence IEA]",metal ion binding [goid 46872] [evidence IEA]; transcription corepressor activity [goid 3714] [pmid 7797467] [evidence TAS]; ubiquitin-protein ligase activity [goid 4842] [evidence IEA]; zinc ion binding [goid 8270] [evidence IEA]; transcription factor activity [goid 3700] [pmid 7797467] [evidence TAS],11,5687843-5687892,11p15.4c,+,NM_006074.2,10346,TRIM22,-1.1373869185090406,9.044351487852268,-9.9044905400335,3.15566565500347e-17,3.3344981175565413e-16,28.336098405913777
LMBRD1,ILMN_1652128,"Homo sapiens LMBR1 domain containing 1 (LMBRD1), mRNA.",,,,6,70442883-70442884:70443063-70443110,6q13a,-,NM_018368.2,55788,LMBRD1,-1.1057725899376738,10.632410973606119,-9.903436099783049,3.1739532718097653e-17,3.3520043090088495e-16,28.330353373142696
DDX51,ILMN_1682323,"Homo sapiens DEAD (Asp-Glu-Ala-Asp) box polypeptide 51 (DDX51), mRNA.",,,nucleotide binding [goid 166] [evidence IEA]; RNA binding [goid 3723] [evidence IEA]; hydrolase activity [goid 16787] [evidence IEA]; ATP binding [goid 5524] [evidence IEA]; ATP-dependent helicase activity [goid 8026] [evidence IEA],12,131189475-131189524,12q24.33c,-,NM_175066.2,317781,DDX51,1.3099701808293123,10.390509940447942,9.900438459343325,3.226522790899409e-17,3.4056769545327726e-16,28.314021278177268
SCAMP5,ILMN_1753345,"Homo sapiens secretory carrier membrane protein 5 (SCAMP5), mRNA.",membrane [goid 16020] [evidence IEA]; integral to membrane [goid 16021] [evidence IEA],protein transport [goid 15031] [evidence IEA],,15,73100541-73100590,15q24.1b-q24.2a,+,NM_138967.2,192683,SCAMP5,1.0814317381055805,7.198368729460159,9.884874561576117,3.513769026083912e-17,3.6928689036270237e-16,28.22923160209697
SUPT5H,ILMN_1703866,"Homo sapiens suppressor of Ty 5 homolog (S. cerevisiae) (SUPT5H), mRNA.",nucleus [goid 5634] [evidence IEA],"positive regulation of transcription from RNA polymerase II promoter [goid 45944] [pmid 9450929] [evidence IDA]; transcription [goid 6350] [evidence IEA]; regulation of transcription, DNA-dependent [goid 6355] [evidence IEA]; negative regulation of transcription from RNA polymerase II promoter [goid 122] [pmid 9450929] [evidence IDA]; RNA elongation from RNA polymerase II promoter [goid 6368] [pmid 9450929] [evidence IDA]",protein heterodimerization activity [goid 46982] [pmid 9450929] [evidence IPI]; positive transcription elongation factor activity [goid 8159] [pmid 9450929] [evidence IDA]; protein binding [goid 5515] [pmid 16169070] [evidence IPI]; negative transcription elongation factor activity [goid 8148] [pmid 9450929] [evidence IDA],19,44658768-44658817,19q13.2a,+,NM_003169.2,6829,SUPT5H,1.0992985176437529,10.23906436097264,9.882240243906939,3.5648546372581756e-17,3.744538685012159e-16,28.21488148557621
SERPINH1,ILMN_1751028,"Homo sapiens serpin peptidase inhibitor, clade H (heat shock protein 47), member 1, (collagen binding protein 1) (SERPINH1), mRNA.",endoplasmic reticulum [goid 5783] [pmid 7656593] [evidence TAS]; ER-Golgi intermediate compartment [goid 5793] [pmid 15308636] [evidence IDA],protein folding [goid 6457] [evidence IEA]; response to unfolded protein [goid 6986] [pmid 10023073] [evidence TAS],serine-type endopeptidase inhibitor activity [goid 4867] [pmid 1309665] [evidence TAS]; collagen binding [goid 5518] [pmid 7656593] [evidence NAS],11,74961166-74961215,11q13.5a,+,NM_001235.2,871,SERPINH1,1.0564776675685632,10.852557177951239,9.882033465564449,3.568895807675054e-17,3.7467637291243765e-16,28.213755101601176
C8B,ILMN_1731293,"Homo sapiens complement component 8, beta polypeptide (C8B), mRNA.",extracellular space [goid 5615] [evidence IEA]; membrane attack complex [goid 5579] [evidence IEA]; integral to membrane [goid 16021] [evidence IEA]; membrane [goid 16020] [pmid 2820472] [evidence TAS],"immune response [goid 6955] [pmid 8098723] [evidence TAS]; cytolysis [goid 19835] [evidence IEA]; complement activation, classical pathway [goid 6958] [evidence IEA]; response to pathogenic bacteria [goid 9618] [pmid 8098723] [evidence TAS]; complement activation, alternative pathway [goid 6957] [evidence IEA]",,1,57170103-57170139:57171596-57171608,1p32.2b,-,NM_000066.2,732,C8B,-2.2346616812214464,6.1013554000041195,-9.881737498885247,3.574687990295096e-17,3.7508236667151293e-16,28.21214288572612
COL4A5,ILMN_1742534,"Homo sapiens collagen, type IV, alpha 5 (Alport syndrome) (COL4A5), transcript variant 3, mRNA.",collagen type IV [goid 5587] [pmid 2349482] [evidence TAS]; cytoplasm [goid 5737] [evidence IEA]; collagen [goid 5581] [evidence IEA],phosphate transport [goid 6817] [evidence IEA],extracellular matrix structural constituent [goid 5201] [evidence IEA],X,107827209-107827258,Xq22.3c,+,NM_033381.1,1287,COL4A5,-1.1458842647263712,7.147075548620076,-9.878968813106418,3.629328925739328e-17,3.80405993103985e-16,28.197061276054075
LEMD1,ILMN_1785444,"Homo sapiens LEM domain containing 1 (LEMD1), mRNA.",,,,1,203617473-203617485:203617486-203617522,1q32.1g,-,NM_001001552.3,93273,LEMD1,1.8232198327018327,6.174486685172782,9.878752942704153,3.633624083879743e-17,3.806514262064344e-16,28.195885401646027
LOC654342,ILMN_1717060,"PREDICTED: Homo sapiens similar to lymphocyte-specific protein 1 isoform 1 (LOC654342), mRNA.",,,,2,91188289-91188338,2p11.1d,-,XM_946374.1,654342,LOC654342,1.2097786301287439,5.930471917483283,9.874784465937323,3.7134951350859695e-17,3.8839212403193834e-16,28.174269021007586
SOLH,ILMN_1763739,"Homo sapiens small optic lobes homolog (Drosophila) (SOLH), mRNA.",intracellular [goid 5622] [evidence IEA],,zinc ion binding [goid 8270] [evidence IEA]; calpain activity [goid 4198] [pmid 9722942] [evidence TAS]; transcription factor activity [goid 3700] [pmid 9722942] [evidence TAS],16,544305-544354,16p13.3f,+,NM_005632.2,6650,SOLH,1.3642489554065316,6.9881312374370745,9.871818424059537,3.774333435039125e-17,3.9433183368223784e-16,28.158113463247037
CLDN4,ILMN_2132458,"Homo sapiens claudin 4 (CLDN4), mRNA.",plasma membrane [goid 5886] [pmid 9892664] [evidence TAS]; integral to plasma membrane [goid 5887] [pmid 9334247] [evidence TAS]; tight junction [goid 5923] [evidence ISS],pathogenesis [goid 9405] [pmid 9334247] [evidence TAS]; calcium-independent cell-cell adhesion [goid 16338] [evidence ISS],transmembrane receptor activity [goid 4888] [pmid 9334247] [evidence TAS]; structural molecule activity [goid 5198] [evidence IEA],7,72884625-72884674,7q11.23b,+,NM_001305.3,1364,CLDN4,1.0333460888869777,6.368875332335415,9.864366890723648,3.9316034440897535e-17,4.10322941125275e-16,28.11752818917716
AIM2,ILMN_1681301,"Homo sapiens absent in melanoma 2 (AIM2), mRNA.",,immune response [goid 6955] [pmid 9242382] [evidence TAS]; immune response [goid 6955] [pmid 9242382] [evidence TAS],,1,157302354-157302403,1q23.1g-q23.2a,-,NM_004833.1,9447,AIM2,1.1557129389578238,5.945619383539528,9.86299415480764,3.961281828649127e-17,4.1319901729779574e-16,28.110051811300107
LEPREL1,ILMN_1657373,"Homo sapiens leprecan-like 1 (LEPREL1), mRNA.",endoplasmic reticulum [goid 5783] [evidence IEA],protein metabolism [goid 19538] [evidence IEA],"oxidoreductase activity [goid 16491] [evidence IEA]; oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen [goid 16702] [evidence IEA]; metal ion binding [goid 46872] [evidence IEA]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, 2-oxoglutarate as one donor, and incorporation of one atom each of oxygen into both donors [goid 16706] [evidence IEA]; binding [goid 5488] [evidence IEA]; iron ion binding [goid 5506] [evidence IEA]; L-ascorbic acid binding [goid 31418] [evidence IEA]",3,191157361-191157410,3q28b-q28c,-,NM_018192.2,55214,LEPREL1,-1.8366009085556243,10.782838999237285,-9.857674120033707,4.0784289896895323e-17,4.248403604575253e-16,28.081078072296133
IL3RA,ILMN_1747344,"Homo sapiens interleukin 3 receptor, alpha (low affinity) (IL3RA), mRNA.",integral to membrane [goid 16021] [evidence IEA]; membrane [goid 16020] [evidence IEA],development [goid 7275] [evidence NR ]; protein amino acid phosphorylation [goid 6468] [evidence NR ],interleukin-3 receptor activity [goid 4912] [pmid 1833064] [evidence TAS]; receptor activity [goid 4872] [evidence IEA]; receptor signaling protein activity [goid 5057] [evidence NR ]; hematopoietin/interferon-class (D200-domain) cytokine receptor activity [goid 4896] [evidence IEA],X,1461338-1461358:1461359-1461387,"Xp22.33e-p22.33d,Yp11.32a",+,NM_002183.2,3563,IL3RA,-1.184550030655676,6.73788938321337,-9.851545039454935,4.2176857893450325e-17,4.3853579298499444e-16,28.047700016507545
LOC285908,ILMN_1733103,"Homo sapiens hypothetical protein LOC285908 (LOC285908), mRNA.",,,,7,65478742-65478791,7q11.21e,-,NM_181722.2,285908,LOC285908,1.1024523188129312,6.892262749588919,9.839441008812779,4.506796925489222e-17,4.678472993775039e-16,27.981789219499515
BARD1,ILMN_2074258,"Homo sapiens BRCA1 associated RING domain 1 (BARD1), mRNA.",BRCA1-BARD1 complex [goid 31436] [pmid 15265711] [evidence IDA]; ubiquitin ligase complex [goid 151] [pmid 14976165] [evidence NAS]; nucleus [goid 5634] [pmid 15632137] [evidence IMP]; cytoplasm [goid 5737] [pmid 15265711] [evidence IDA]; intracellular [goid 5622] [evidence IEA],positive regulation of apoptosis [goid 43065] [pmid 15782130] [evidence IMP]; positive regulation of protein catabolism [goid 45732] [pmid 15905410] [evidence NAS]; regulation of phosphorylation [goid 42325] [pmid 15782130] [evidence IMP]; negative regulation of protein export from nucleus [goid 46826] [pmid 15265711] [evidence IDA]; negative regulation of mRNA 3'-end processing [goid 31441] [pmid 15905410] [evidence NAS]; protein ubiquitination [goid 16567] [pmid 15905410] [evidence NAS]; negative regulation of apoptosis [goid 43066] [pmid 15265711] [evidence IMP]; tissue homeostasis [goid 1894] [pmid 15782130] [evidence TAS]; response to DNA damage stimulus [goid 6974] [pmid 15905410] [evidence NAS]; cell cycle arrest [goid 7050] [pmid 15632137] [evidence NAS],RNA binding [goid 3723] [pmid 12419249] [evidence IDA]; protein homodimerization activity [goid 42803] [pmid 15265711] [evidence IPI]; protein heterodimerization activity [goid 46982] [pmid 15265711] [evidence IPI]; protein binding [goid 5515] [pmid 15782130] [evidence IPI]; ubiquitin-protein ligase activity [goid 4842] [pmid 15905410] [evidence NAS]; zinc ion binding [goid 8270] [evidence IEA]; metal ion binding [goid 46872] [evidence IEA]; kinase binding [goid 19900] [pmid 15782130] [evidence NAS],2,215301702-215301751,2q35a,-,NM_000465.1,580,BARD1,1.2218291485798503,8.11546209159642,9.83922362026612,4.5121663153911595e-17,4.681552750553607e-16,27.980605533363683
DECR2,ILMN_1783337,"Homo sapiens 2,4-dienoyl CoA reductase 2, peroxisomal (DECR2), mRNA.",peroxisome [goid 5777] [evidence IEA],metabolism [goid 8152] [evidence IEA],"oxidoreductase activity [goid 16491] [evidence IEA]; 2,4-dienoyl-CoA reductase (NADPH) activity [goid 8670] [evidence IEA]",16,402244-402293,16p13.3f,+,NM_020664.3,26063,DECR2,1.0155177134514464,9.217677739636544,9.834061588669995,4.641559521716641e-17,4.810680174502593e-16,27.952498898641156
IGFBP7,ILMN_2062468,"Homo sapiens insulin-like growth factor binding protein 7 (IGFBP7), mRNA.",extracellular region [goid 5576] [evidence IEA],regulation of cell growth [goid 1558] [evidence IEA]; negative regulation of cell proliferation [goid 8285] [pmid 8939990] [evidence TAS],insulin-like growth factor binding [goid 5520] [evidence IEA],4,57594170-57594219,4q12e,-,NM_001553.1,3490,IGFBP7,-1.4109795481392648,12.41528376784889,-9.828951760298633,4.773292458567814e-17,4.944582857798716e-16,27.924677942302612
TNFRSF1B,ILMN_1764788,"Homo sapiens tumor necrosis factor receptor superfamily, member 1B (TNFRSF1B), mRNA.",membrane [goid 16020] [evidence IEA]; integral to membrane [goid 16021] [evidence IEA],apoptosis [goid 6915] [evidence IEA]; cytokine and chemokine mediated signaling pathway [goid 19221] [evidence IEA],receptor activity [goid 4872] [evidence IEA]; tumor necrosis factor receptor activity [goid 5031] [pmid 8702885] [evidence TAS]; protein binding [goid 5515] [pmid 11244088] [evidence IPI],1,12191715-12191764,1p36.22a,+,NM_001066.2,7133,TNFRSF1B,-1.0422228566588227,8.492787271082618,-9.82774997146737,4.804813273680289e-17,4.974590150778981e-16,27.918134895134468
MAP1LC3C,ILMN_1711331,"Homo sapiens microtubule-associated protein 1 light chain 3 gamma (MAP1LC3C), mRNA.",membrane [goid 16020] [evidence IEA]; microtubule [goid 5874] [evidence IEA],ubiquitin cycle [goid 6512] [evidence IEA]; autophagy [goid 6914] [evidence IEA],,1,240225931-240225980,1q43e,-,NM_001004343.1,440738,MAP1LC3C,-1.4234952115490769,6.479614776009788,-9.820260509661146,5.0059860208053954e-17,5.177369300180103e-16,27.877360894785912
FCGBP,ILMN_1718984,"PREDICTED: Homo sapiens Fc fragment of IgG binding protein (FCGBP), mRNA.",,,,,,19q13.2b,,XM_940656.1,8857,FCGBP,1.8838350586407842,8.41775605682539,9.813387098624853,5.198002768577894e-17,5.373107901630784e-16,27.83994353371774
TNF,ILMN_1728106,"Homo sapiens tumor necrosis factor (TNF superfamily, member 2) (TNF), mRNA.",integral to membrane [goid 16021] [evidence IEA]; membrane [goid 16020] [evidence IEA]; extracellular space [goid 5615] [evidence IEA]; soluble fraction [goid 5625] [pmid 3856324] [evidence TAS],"immune response [goid 6955] [evidence IEA]; apoptosis [goid 6915] [pmid 3856324] [evidence TAS]; response to wounding [goid 9611] [evidence NR ]; leukocyte adhesion [goid 7159] [pmid 10820279] [evidence TAS]; cell-cell signaling [goid 7267] [evidence NR ]; response to virus [goid 9615] [pmid 10490959] [evidence TAS]; anti-apoptosis [goid 6916] [pmid 10748004] [evidence TAS]; activation of NF-kappaB transcription factor [goid 51092] [pmid 15790681] [evidence IDA]; regulation of transcription, DNA-dependent [goid 6355] [pmid 2537468] [evidence TAS]; signal transduction [goid 7165] [pmid 10820279] [evidence TAS]",tumor necrosis factor receptor binding [goid 5164] [pmid 3001529] [evidence TAS]; protein binding [goid 5515] [pmid 2848815] [evidence IPI],6,31653868-31653917,6p21.33a,+,NM_000594.2,7124,TNF,-1.4367625825990737,6.311020177589457,-9.812715433453372,5.2171564432835264e-17,5.3871909537562e-16,27.836287275741658
LOC402116,ILMN_1696469,"PREDICTED: Homo sapiens similar to plakophilin 4 (LOC402116), mRNA.",,,,2,209752790-209752839,2q34a,+,XM_929112.1,402116,LOC402116,1.477954756746735,7.416552208492193,9.807067059873601,5.38104277566182e-17,5.550535652925916e-16,27.805540948668597
ENO2,ILMN_1765796,"Homo sapiens enolase 2 (gamma, neuronal) (ENO2), mRNA.",phosphopyruvate hydratase complex [goid 15] [evidence IEA],glycolysis [goid 6096] [evidence IEA],phosphopyruvate hydratase activity [goid 4634] [pmid 2045099] [evidence TAS]; magnesium ion binding [goid 287] [evidence IEA]; lyase activity [goid 16829] [evidence IEA],12,6902932-6902981,12p13.31d,+,NM_001975.2,2026,ENO2,1.2023397668674392,9.263890113294476,9.806409449329832,5.4004541922611223e-17,5.567611107735872e-16,27.80196143173941
CHN1,ILMN_1678493,"Homo sapiens chimerin (chimaerin) 1 (CHN1), transcript variant 1, mRNA.",,intracellular signaling cascade [goid 7242] [evidence IEA]; intracellular signaling cascade [goid 7242] [evidence IEA],metal ion binding [goid 46872] [evidence IEA]; SH3/SH2 adaptor activity [goid 5070] [pmid 8336731] [evidence TAS]; diacylglycerol binding [goid 19992] [evidence IEA]; GTPase activator activity [goid 5096] [evidence IEA]; metal ion binding [goid 46872] [evidence IEA]; SH3/SH2 adaptor activity [goid 5070] [pmid 8336731] [evidence TAS]; diacylglycerol binding [goid 19992] [evidence IEA]; GTPase activator activity [goid 5096] [evidence IEA],2,175372736-175372785,2q31.1g,-,NM_001822.3,1123,CHN1,-1.2720148516459453,9.039353200792554,-9.798278407774937,5.6463228018015e-17,5.808796187597795e-16,27.757704431856776
LOC442578,ILMN_1791375,"Homo sapiens similar to Cohesin subunit SA-3 (Stromal antigen 3) (Stromalin 3) (SCC3 homolog 3) (LOC442578), mRNA.",,,binding [goid 5488] [evidence IEA],7,72107119-72107168,7q11.23a,-,NM_001013739.1,442578,LOC442578,1.8529982215374439,9.99448746953562,9.791527489618298,5.858927998287951e-17,6.02116097292409e-16,27.72096226149659
LOC284757,ILMN_1657398,"Homo sapiens hypothetical protein LOC284757 (LOC284757), mRNA.",,,,20,58332875-58332924,20q13.33a,+,NM_001004305.1,284757,LOC284757,1.8874012483866247,6.495263026706334,9.78874937704681,5.948722731198027e-17,6.110219421053956e-16,27.705843019980694
PDE4D,ILMN_1791483,"Homo sapiens phosphodiesterase 4D, cAMP-specific (phosphodiesterase E3 dunce homolog, Drosophila) (PDE4D), mRNA.",soluble fraction [goid 5625] [pmid 9371713] [evidence TAS]; insoluble fraction [goid 5626] [pmid 9371713] [evidence TAS],signal transduction [goid 7165] [evidence IEA],"metal ion binding [goid 46872] [evidence IEA]; 3',5'-cyclic-nucleotide phosphodiesterase activity [goid 4114] [pmid 10913353] [evidence NAS]; hydrolase activity [goid 16787] [evidence IEA]",5,58302551-58302600,5q11.2h-q12.1a,-,NM_006203.3,5144,PDE4D,-1.7211527776564273,7.7442319477694745,-9.781253680628657,6.197914059719175e-17,6.356123971243585e-16,27.66505162982641
DSP,ILMN_1655614,"Homo sapiens desmoplakin (DSP), transcript variant 2, mRNA.",cell-cell adherens junction [goid 5913] [evidence NR ]; intermediate filament [goid 5882] [evidence NR ]; cornified envelope [goid 1533] [pmid 10908733] [evidence IDA]; cell-cell adherens junction [goid 5913] [evidence NR ]; intermediate filament [goid 5882] [evidence NR ]; cornified envelope [goid 1533] [pmid 10908733] [evidence IDA],keratinocyte differentiation [goid 30216] [pmid 10908733] [evidence IDA]; peptide cross-linking [goid 18149] [pmid 10908733] [evidence IDA]; epidermis development [goid 8544] [pmid 9887343] [evidence TAS]; keratinocyte differentiation [goid 30216] [pmid 10908733] [evidence IDA]; peptide cross-linking [goid 18149] [pmid 10908733] [evidence IDA]; epidermis development [goid 8544] [pmid 9887343] [evidence TAS],"structural constituent of cytoskeleton [goid 5200] [pmid 9887343] [evidence TAS]; protein binding, bridging [goid 30674] [pmid 10908733] [evidence IDA]; structural constituent of cytoskeleton [goid 5200] [pmid 9887343] [evidence TAS]; protein binding, bridging [goid 30674] [pmid 10908733] [evidence IDA]",6,7531020-7531069,6p24.3c,+,NM_001008844.1,1832,DSP,1.1697237152363753,6.566450038940121,9.778853412293877,6.279892223884129e-17,6.436806942787073e-16,27.651990118523248
ABCB1,ILMN_1812070,"Homo sapiens ATP-binding cassette, sub-family B (MDR/TAP), member 1 (ABCB1), mRNA.",integral to membrane [goid 16021] [pmid 3768958] [evidence TAS]; membrane fraction [goid 5624] [pmid 3022150] [evidence TAS]; membrane [goid 16020] [evidence IEA]; cell surface [goid 9986] [pmid 12493773] [evidence IEP]; integral to membrane [goid 16021] [pmid 3768958] [evidence TAS]; membrane fraction [goid 5624] [pmid 3022150] [evidence TAS]; membrane [goid 16020] [evidence IEA]; cell surface [goid 9986] [pmid 12493773] [evidence IEP],response to drug [goid 42493] [pmid 3022150] [evidence TAS]; transport [goid 6810] [pmid 3022150] [evidence TAS]; response to drug [goid 42493] [pmid 3022150] [evidence TAS]; transport [goid 6810] [pmid 3022150] [evidence TAS],xenobiotic-transporting ATPase activity [goid 8559] [evidence IEA]; ATPase activity [goid 16887] [evidence IEA]; hydrolase activity [goid 16787] [evidence IEA]; transporter activity [goid 5215] [pmid 3022150] [evidence TAS]; nucleotide binding [goid 166] [evidence IEA]; ATP binding [goid 5524] [pmid 3768958] [evidence TAS]; xenobiotic-transporting ATPase activity [goid 8559] [evidence IEA]; ATPase activity [goid 16887] [evidence IEA]; hydrolase activity [goid 16787] [evidence IEA]; transporter activity [goid 5215] [pmid 3022150] [evidence TAS]; nucleotide binding [goid 166] [evidence IEA]; ATP binding [goid 5524] [pmid 3768958] [evidence TAS],7,86971478-86971494:86971495-86971527,7q21.12a-q21.12b,-,NM_000927.3,5243,ABCB1,-1.6420552706638967,6.094938500491313,-9.778073813417036,6.306750651780679e-17,6.460937773393614e-16,27.647747856799636
PTPRO,ILMN_1720113,"Homo sapiens protein tyrosine phosphatase, receptor type, O (PTPRO), transcript variant 6, mRNA.",membrane [goid 16020] [evidence IEA]; integral to plasma membrane [goid 5887] [pmid 7665166] [evidence TAS]; integral to membrane [goid 16021] [pmid 10498613] [evidence TAS],protein amino acid dephosphorylation [goid 6470] [pmid 10498613] [evidence TAS],receptor activity [goid 4872] [evidence IEA]; transmembrane receptor protein tyrosine phosphatase activity [goid 5001] [pmid 7665166] [evidence TAS]; protein tyrosine phosphatase activity [goid 4725] [pmid 10498613] [evidence TAS]; hydrolase activity [goid 16787] [evidence IEA],12,15641552-15641601,12p12.3e,+,NM_030670.1,5800,PTPRO,-1.0798954322383372,7.0085560474757855,-9.772971581344407,6.485384399700421e-17,6.63347585449673e-16,27.619984449213153
SLCO2A1,ILMN_1705231,"Homo sapiens solute carrier organic anion transporter family, member 2A1 (SLCO2A1), mRNA.",membrane fraction [goid 5624] [pmid 8787677] [evidence TAS]; integral to plasma membrane [goid 5887] [pmid 8787677] [evidence TAS]; membrane [goid 16020] [evidence IEA],lipid transport [goid 6869] [pmid 8787677] [evidence TAS],lipid transporter activity [goid 5319] [pmid 8787677] [evidence TAS],3,135134380-135134429,3q22.1e,-,NM_005630.1,6578,SLCO2A1,-1.4457660037081528,11.029421338539027,-9.771942085985811,6.522035814997759e-17,6.667464210662714e-16,27.614382713141875
IGFBP6,ILMN_1669362,"Homo sapiens insulin-like growth factor binding protein 6 (IGFBP6), mRNA.",extracellular region [goid 5576] [evidence IEA]; extracellular space [goid 5615] [evidence NR ],regulation of cell growth [goid 1558] [evidence IEA]; signal transduction [goid 7165] [pmid 10087296] [evidence NAS]; negative regulation of cell proliferation [goid 8285] [pmid 7539002] [evidence TAS],insulin-like growth factor binding [goid 5520] [evidence IEA],12,51781127-51781176,12q13.13e,+,NM_002178.2,3489,IGFBP6,-2.0779346086378645,9.839859529697103,-9.77134567785289,6.543363265991665e-17,6.685759477600818e-16,27.6111375390257
EVI2A,ILMN_1733579,"Homo sapiens ecotropic viral integration site 2A (EVI2A), transcript variant 2, mRNA.",membrane [goid 16020] [evidence IEA]; integral to membrane [goid 16021] [evidence IEA]; membrane [goid 16020] [evidence IEA]; integral to membrane [goid 16021] [evidence IEA],,transmembrane receptor activity [goid 4888] [pmid 2117566] [evidence NAS]; transmembrane receptor activity [goid 4888] [pmid 2117566] [evidence NAS],17,26669289-26669338,17q11.2d,-,NM_014210.2,2123,EVI2A,-1.0580803459859558,6.549066364812772,-9.770842656956791,6.561405321790756e-17,6.700680434753295e-16,27.60840051948011
MX2,ILMN_2231928,"Homo sapiens myxovirus (influenza virus) resistance 2 (mouse) (MX2), mRNA.",nucleus [goid 5634] [pmid 8798556] [evidence TAS]; cytoplasm [goid 5737] [pmid 8798556] [evidence TAS],immune response [goid 6955] [evidence IEA]; response to virus [goid 9615] [evidence IEA],GTP binding [goid 5525] [evidence IEA]; GTPase activity [goid 3924] [pmid 8798556] [evidence TAS]; nucleotide binding [goid 166] [evidence IEA],21,41702511-41702560,21q22.3a,+,NM_002463.1,4600,MX2,1.5174398718664097,9.217791580879776,9.762821772890305,6.855895993910901e-17,6.990430844654836e-16,27.56475958011119
ATP1A2,ILMN_1777411,"Homo sapiens ATPase, Na+/K+ transporting, alpha 2 (+) polypeptide (ATP1A2), mRNA.",integral to membrane [goid 16021] [evidence IEA]; sodium:potassium-exchanging ATPase complex [goid 5890] [evidence ISS]; membrane [goid 16020] [evidence IEA],ATP hydrolysis coupled proton transport [goid 15991] [evidence ISS]; metabolism [goid 8152] [evidence IEA]; potassium ion transport [goid 6813] [evidence ISS]; sperm motility [goid 30317] [evidence ISS]; sodium ion transport [goid 6814] [evidence ISS]; hydrogen ion homeostasis [goid 30641] [evidence ISS]; monovalent inorganic cation transport [goid 15672] [evidence IEA],"ATP binding [goid 5524] [evidence IEA]; ATPase activity, coupled to transmembrane movement of ions, phosphorylative mechanism [goid 15662] [evidence IEA]; sodium ion binding [goid 31402] [evidence IEA]; hydrolase activity, acting on acid anhydrides, catalyzing transmembrane movement of substances [goid 16820] [evidence IEA]; potassium ion binding [goid 30955] [evidence IEA]; nucleotide binding [goid 166] [evidence IEA]; magnesium ion binding [goid 287] [evidence IEA]; monovalent inorganic cation transporter activity [goid 15077] [evidence IEA]; hydrolase activity [goid 16787] [evidence IEA]; sodium:potassium-exchanging ATPase activity [goid 5391] [evidence ISS]",1,158379422-158379471,1q23.2c,+,NM_000702.2,477,ATP1A2,-1.0694430706347422,5.362779663798828,-9.753382386177485,7.219412271349864e-17,7.353384637075384e-16,27.513405570739568
SLC20A1,ILMN_1672662,"Homo sapiens solute carrier family 20 (phosphate transporter), member 1 (SLC20A1), mRNA.",integral to membrane [goid 16021] [evidence IEA]; membrane [goid 16020] [evidence IEA],transport [goid 6810] [evidence IEA]; positive regulation of I-kappaB kinase/NF-kappaB cascade [goid 43123] [evidence ISS]; phosphate transport [goid 6817] [evidence IEA],symporter activity [goid 15293] [evidence IEA]; inorganic phosphate transporter activity [goid 5315] [evidence IEA]; receptor activity [goid 4872] [evidence IEA],2,113137447-113137496,2q13d,+,NM_005415.3,6574,SLC20A1,1.009735244534257,10.494756518577487,9.751872976084629,7.27929902137299e-17,7.410508956711219e-16,27.505194273537324
PRKD1,ILMN_1785891,"Homo sapiens protein kinase D1 (PRKD1), mRNA.",Golgi apparatus [goid 5794] [evidence NR ]; cytosol [goid 5829] [pmid 10856238] [evidence TAS]; integral to plasma membrane [goid 5887] [pmid 8119958] [evidence TAS]; plasma membrane [goid 5886] [pmid 10856238] [evidence TAS],cell proliferation [goid 8283] [pmid 8119958] [evidence TAS]; intracellular signaling cascade [goid 7242] [evidence IEA]; protein amino acid phosphorylation [goid 6468] [pmid 8119958] [evidence TAS],metal ion binding [goid 46872] [evidence IEA]; nucleotide binding [goid 166] [evidence IEA]; atypical protein kinase C activity [goid 4700] [pmid 8119958] [evidence TAS]; protein binding [goid 5515] [pmid 12893243] [evidence IPI]; transferase activity [goid 16740] [evidence IEA]; protein serine/threonine kinase activity [goid 4674] [evidence IEA]; zinc ion binding [goid 8270] [evidence IEA]; diacylglycerol binding [goid 19992] [evidence IEA]; ATP binding [goid 5524] [evidence IEA]; protein-tyrosine kinase activity [goid 4713] [evidence IEA],14,29115520-29115569,14q12d,-,NM_002742.1,5587,PRKD1,-1.2878086004841922,7.8772169574408535,-9.751019219926775,7.313391626324261e-17,7.437444459234249e-16,27.500549840306658
HBG2,ILMN_2084825,"Homo sapiens hemoglobin, gamma G (HBG2), mRNA.",hemoglobin complex [goid 5833] [evidence IEA],transport [goid 6810] [evidence IEA]; oxygen transport [goid 15671] [evidence IEA],heme binding [goid 20037] [evidence IEA]; metal ion binding [goid 46872] [evidence IEA]; oxygen transporter activity [goid 5344] [evidence IEA]; binding [goid 5488] [evidence IEA]; iron ion binding [goid 5506] [evidence IEA]; oxygen binding [goid 19825] [evidence IEA],11,5231114-5231163,11p15.4c,-,NM_000184.2,3048,HBG2,-2.8105809800503545,6.458291395992417,-9.74999835826275,7.354366482111098e-17,7.475212879704473e-16,27.494996410526003
SSFA2,ILMN_1742260,"Homo sapiens sperm specific antigen 2 (SSFA2), mRNA.",plasma membrane [goid 5886] [pmid 1555770] [evidence NAS],,,2,182495136-182495185,2q31.3b,+,NM_006751.3,6744,SSFA2,-1.3845779160627556,7.0609242021438154,-9.740223199860315,7.758507687059017e-17,7.8736730355388e-16,27.441823276486648
PLK4,ILMN_1789123,"Homo sapiens polo-like kinase 4 (Drosophila) (PLK4), mRNA.",,protein amino acid phosphorylation [goid 6468] [pmid 10607900] [evidence TAS],nucleotide binding [goid 166] [evidence IEA]; protein binding [goid 5515] [pmid 16189514] [evidence IPI]; transferase activity [goid 16740] [evidence IEA]; protein serine/threonine kinase activity [goid 4674] [pmid 10607900] [evidence TAS]; ATP binding [goid 5524] [evidence IEA]; protein-tyrosine kinase activity [goid 4713] [evidence IEA],4,129037441-129037490,4q28.1e,+,NM_014264.2,10733,PLK4,1.0557449611649803,6.622686524275497,9.738151464618863,7.846967912412937e-17,7.959300873158047e-16,27.43055456861018
MBOAT2,ILMN_2347424,"Homo sapiens membrane bound O-acyltransferase domain containing 2 (MBOAT2), mRNA.",,,,2,8914407-8914456,2p25.1e,-,NM_138799.2,129642,MBOAT2,1.6848307538413323,8.070925518103774,9.73722314943737,7.886931651697225e-17,7.991516548794613e-16,27.42550530496114
FAT,ILMN_1754795,"Homo sapiens FAT tumor suppressor homolog 1 (Drosophila) (FAT), mRNA.",integral to plasma membrane [goid 5887] [pmid 8586420] [evidence TAS]; membrane [goid 16020] [evidence IEA],morphogenesis [goid 9653] [pmid 8586420] [evidence TAS]; cell-cell signaling [goid 7267] [pmid 8586420] [evidence TAS]; cell adhesion [goid 7155] [pmid 8586420] [evidence TAS]; homophilic cell adhesion [goid 7156] [evidence IEA],calcium ion binding [goid 5509] [evidence IEA]; protein binding [goid 5515] [evidence IEA],4,187746056-187746105,4q35.2a,-,NM_005245.3,2195,FAT,1.1390181451158625,9.805643789486025,9.73304551910121,8.069307049904816e-17,8.172060699968573e-16,27.402783114465546
LOC146439,ILMN_1803889,"PREDICTED: Homo sapiens hypothetical LOC146439 (LOC146439), mRNA.",,,,,,16p13.3d,,XM_940000.1,146439,LOC146439,1.2381525874173818,7.312677326418664,9.725720910559614,8.399283838434121e-17,8.492996657596721e-16,27.362947039803476
WDR24,ILMN_1761442,"Homo sapiens WD repeat domain 24 (WDR24), mRNA.",,,,16,674837-674886,16p13.3f,-,NM_032259.1,84219,WDR24,1.0345685743862756,7.375125365592029,9.718586730849987,8.733625372351432e-17,8.808213787798533e-16,27.32414981591798
VWA2,ILMN_1716674,"Homo sapiens von Willebrand factor A domain containing 2 (VWA2), mRNA.",,,,10,116039309-116039358,10q25.3a,+,NM_198496.1,340706,VWA2,1.489263919346775,5.920459652215454,9.71680747007281,8.819059465769591e-17,8.885179611712538e-16,27.314474298568197
CCDC5,ILMN_1745946,"Homo sapiens coiled-coil domain containing 5 (spindle associated) (CCDC5), mRNA.",microtubule [goid 5874] [evidence IEA],mitosis [goid 7067] [evidence IEA]; cell cycle [goid 7049] [evidence IEA]; cell division [goid 51301] [evidence IEA],,18,41938351-41938375:41938376-41938400,18q21.1a,+,NM_138443.2,115106,CCDC5,-1.0270337542626446,6.411455755041727,-9.715787674627018,8.868402176364179e-17,8.925662004465703e-16,27.308928798406466
HABP2,ILMN_1737041,"Homo sapiens hyaluronan binding protein 2 (HABP2), mRNA.",extracellular region [goid 5576] [pmid 14718574] [evidence NAS]; extracellular space [goid 5615] [pmid 8827452] [evidence TAS],cell adhesion [goid 7155] [pmid 8827452] [evidence TAS],serine-type endopeptidase activity [goid 4252] [evidence IEA]; peptidase activity [goid 8233] [evidence IEA]; glycosaminoglycan binding [goid 5539] [pmid 8827452] [evidence TAS],10,115339090-115339139,10q25.3a,+,NM_004132.2,3026,HABP2,2.373204430197874,6.492764117294379,9.712106343237641,9.048827148153097e-17,9.08379170436698e-16,27.288910788879978
ZNF444,ILMN_1727300,"Homo sapiens zinc finger protein 444 (ZNF444), mRNA.",nucleus [goid 5634] [evidence IEA]; intracellular [goid 5622] [evidence IEA],"regulation of transcription, DNA-dependent [goid 6355] [evidence IEA]; transcription [goid 6350] [evidence IEA]",zinc ion binding [goid 8270] [evidence IEA]; metal ion binding [goid 46872] [evidence IEA]; transcription factor activity [goid 3700] [evidence IEA],19,61363824-61363873,19q13.42c,+,NM_018337.2,55311,ZNF444,1.073287161669822,8.25958686223711,9.711196282901554,9.093991922106512e-17,9.124430103102232e-16,27.283962275618837
LOC653219,ILMN_1672582,"PREDICTED: Homo sapiens similar to G antigen, family D, 2 isoform 1a, transcript variant 1 (LOC653219), mRNA.",,,,X,52256017-52256066,,+,XM_927237.1,653219,LOC653219,2.030192973461739,6.374601916387108,9.705688663410905,9.372167966971246e-17,9.393862800228124e-16,27.25401533547417
KISS1R,ILMN_1673521,"Homo sapiens KISS1 receptor (KISS1R), mRNA.",integral to membrane [goid 16021] [pmid 11387329] [evidence IEP]; membrane [goid 16020] [evidence IEA],behavior [goid 7610] [pmid 11387329] [evidence NAS]; G-protein coupled receptor protein signaling pathway [goid 7186] [pmid 11387329] [evidence NAS]; signal transduction [goid 7165] [evidence IEA],neuropeptide receptor activity [goid 8188] [pmid 11387329] [evidence IDA]; receptor activity [goid 4872] [evidence IEA]; rhodopsin-like receptor activity [goid 1584] [evidence IEA]; protein binding [goid 5515] [pmid 11387329] [evidence IPI],19,871774-871823,19p13.3i,+,NM_032551.3,84634,KISS1R,2.0916295092812307,5.987068780428795,9.705272561395205,9.39352611690089e-17,9.410429634334901e-16,27.251752913973082
RP2,ILMN_1659255,"Homo sapiens retinitis pigmentosa 2 (X-linked recessive) (RP2), mRNA.",,beta-tubulin folding [goid 7025] [pmid 9697692] [evidence TAS]; UTP biosynthesis [goid 6228] [evidence IEA]; visual perception [goid 7601] [pmid 9697692] [evidence TAS]; GTP biosynthesis [goid 6183] [evidence IEA]; CTP biosynthesis [goid 6241] [evidence IEA],ATP binding [goid 5524] [evidence IEA]; unfolded protein binding [goid 51082] [pmid 9697692] [evidence TAS],X,46625612-46625661,Xp11.3a,+,NM_006915.1,6102,RP2,-1.437451291741918,7.053176623906149,-9.704594797893133,9.42841918869181e-17,9.44053175188386e-16,27.248067815190463
PTTG1,ILMN_1753196,"Homo sapiens pituitary tumor-transforming 1 (PTTG1), mRNA.",cytoplasm [goid 5737] [pmid 9811450] [evidence TAS]; nucleus [goid 5634] [pmid 9811450] [evidence TAS]; cytoplasm [goid 5737] [pmid 9811450] [evidence TAS]; nucleus [goid 5634] [pmid 9811450] [evidence TAS],cell division [goid 51301] [evidence IEA]; cell cycle [goid 7049] [evidence IEA]; DNA repair [goid 6281] [evidence IEA]; chromosome organization and biogenesis [goid 51276] [evidence IEA]; mitosis [goid 7067] [evidence IEA]; DNA metabolism [goid 6259] [evidence IEA]; transcription from RNA polymerase II promoter [goid 6366] [pmid 9811450] [evidence TAS]; spermatogenesis [goid 7283] [pmid 9915854] [evidence TAS]; chromosome segregation [goid 7059] [evidence IEA]; cell division [goid 51301] [evidence IEA]; cell cycle [goid 7049] [evidence IEA]; DNA repair [goid 6281] [evidence IEA]; chromosome organization and biogenesis [goid 51276] [evidence IEA]; mitosis [goid 7067] [evidence IEA]; DNA metabolism [goid 6259] [evidence IEA]; transcription from RNA polymerase II promoter [goid 6366] [pmid 9811450] [evidence TAS]; spermatogenesis [goid 7283] [pmid 9915854] [evidence TAS]; chromosome segregation [goid 7059] [evidence IEA],protein binding [goid 5515] [pmid 12194817] [evidence IPI]; cysteine protease inhibitor activity [goid 4869] [pmid 12194817] [evidence NAS]; transcription factor activity [goid 3700] [pmid 9811450] [evidence TAS]; protein binding [goid 5515] [pmid 12194817] [evidence IPI]; cysteine protease inhibitor activity [goid 4869] [pmid 12194817] [evidence NAS]; transcription factor activity [goid 3700] [pmid 9811450] [evidence TAS],5,159781951-159781988:159782294-159782305,5q33.3d,+,NM_004219.2,9232,PTTG1,1.2793365509704078,8.725011349889218,9.700906683962447,9.620573097168284e-17,9.618105017871936e-16,27.228015509583475
REEP6,ILMN_1697460,"Homo sapiens receptor accessory protein 6 (REEP6), mRNA.",membrane [goid 16020] [evidence IEA]; integral to membrane [goid 16021] [evidence IEA],,,19,1448755-1448804,19p13.3h,+,NM_138393.1,92840,REEP6,1.6796919541431583,7.72955126787795,9.696012287314085,9.881624393531469e-17,9.868962137773484e-16,27.201405960403147
JAK1,ILMN_1793384,"Homo sapiens Janus kinase 1 (a protein tyrosine kinase) (JAK1), mRNA.",cytoskeleton [goid 5856] [evidence IEA],intracellular signaling cascade [goid 7242] [pmid 8232552] [evidence TAS]; protein amino acid phosphorylation [goid 6468] [pmid 1848670] [evidence TAS],nucleotide binding [goid 166] [evidence IEA]; Janus kinase activity [goid 4718] [evidence IEA]; transferase activity [goid 16740] [evidence IEA]; ATP binding [goid 5524] [evidence IEA]; protein-tyrosine kinase activity [goid 4713] [pmid 1848670] [evidence TAS],1,65074399-65074448,1p31.3b,-,NM_002227.1,3716,JAK1,-1.3197719022522056,8.43696346296234,-9.695897972391501,9.887805344294329e-17,9.87007618512167e-16,27.200784478310037
RNF146,ILMN_1685679,"Homo sapiens ring finger protein 146 (RNF146), mRNA.",,,zinc ion binding [goid 8270] [evidence IEA]; metal ion binding [goid 46872] [evidence IEA]; protein binding [goid 5515] [evidence IEA]; zinc ion binding [goid 8270] [evidence IEA]; metal ion binding [goid 46872] [evidence IEA]; protein binding [goid 5515] [evidence IEA],6,127650337-127650386,6q22.33a,+,NM_030963.2,81847,RNF146,-1.222782778232368,7.063242701220502,-9.691240376303512,1.014294823710234e-16,1.0104056564414064e-15,27.17546379540578
HCLS1,ILMN_1727402,"Homo sapiens hematopoietic cell-specific Lyn substrate 1 (HCLS1), mRNA.","DNA-directed RNA polymerase II, core complex [goid 5665] [pmid 2587259] [evidence TAS]; nucleus [goid 5634] [evidence ISS]; cytoplasm [goid 5737] [evidence ISS]","response to hormone stimulus [goid 9725] [evidence ISS]; positive regulation of tyrosine phosphorylation of STAT protein [goid 42531] [evidence ISS]; intracellular signaling cascade [goid 7242] [pmid 8978766] [evidence TAS]; erythrocyte differentiation [goid 30218] [evidence ISS]; regulation of transcription, DNA-dependent [goid 6355] [pmid 2587259] [evidence TAS]; positive regulation of cell proliferation [goid 8284] [evidence ISS]",transcription factor activity [goid 3700] [pmid 2587259] [evidence TAS]; protein binding [goid 5515] [evidence ISS],3,122833112-122833161,3q13.33c,-,NM_005335.3,3059,HCLS1,-1.1109695930565575,10.951346802413072,-9.687111384235864,1.0374623806762314e-16,1.0324287276545642e-15,27.15301798504419
CHI3L2,ILMN_2326273,"Homo sapiens chitinase 3-like 2 (CHI3L2), transcript variant 1, mRNA.",extracellular space [goid 5615] [pmid 8702629] [evidence TAS],chitin catabolism [goid 6032] [evidence IEA]; carbohydrate metabolism [goid 5975] [evidence IEA],hydrolase activity [goid 16787] [evidence IEA]; chitinase activity [goid 4568] [evidence IEA]; catalytic activity [goid 3824] [evidence IEA],1,111586462-111586509:111586510-111586511,1p13.3a,+,NM_004000.2,1117,CHI3L2,-2.1605233959148267,8.394231492561115,-9.683141069683396,1.0602375779774091e-16,1.0545548344507308e-15,27.131435797305446
N4BP2,ILMN_1782273,"Homo sapiens Nedd4 binding protein 2 (N4BP2), mRNA.",,,ATP binding [goid 5524] [pmid 12730195] [evidence IDA]; hydrolase activity [goid 16787] [evidence IEA]; endonuclease activity [goid 4519] [pmid 12730195] [evidence IDA]; nucleotide binding [goid 166] [evidence IEA]; ATP binding [goid 5524] [pmid 12730195] [evidence IDA]; hydrolase activity [goid 16787] [evidence IEA]; endonuclease activity [goid 4519] [pmid 12730195] [evidence IDA]; nucleotide binding [goid 166] [evidence IEA],4,39832625-39832674,4p14b,+,NM_018177.2,55728,N4BP2,1.5061758099789913,8.922562943139043,9.676514117965937,1.099369261845569e-16,1.0906929769379284e-15,27.095414682298827
PSIP1,ILMN_1788701,"Homo sapiens PC4 and SFRS1 interacting protein 1 (PSIP1), transcript variant 2, mRNA.",nucleus [goid 5634] [evidence IEA],"regulation of transcription, DNA-dependent [goid 6355] [evidence IEA]; transcription [goid 6350] [evidence IEA]",DNA binding [goid 3677] [evidence IEA],9,15454347-15454396,9p22.3b,-,NM_033222.2,11168,PSIP1,-1.083530156311907,8.18504503713616,-9.664768546705838,1.1723010593820045e-16,1.1595069107643837e-15,27.03157804926131
VNN2,ILMN_1678939,"Homo sapiens vanin 2 (VNN2), transcript variant 1, mRNA.",membrane [goid 16020] [evidence IEA]; membrane [goid 16020] [evidence IEA],nitrogen compound metabolism [goid 6807] [evidence IEA]; cell motility [goid 6928] [pmid 9790769] [evidence TAS]; nitrogen compound metabolism [goid 6807] [evidence IEA]; cell motility [goid 6928] [pmid 9790769] [evidence TAS],"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides [goid 16811] [evidence IEA]; GPI anchor binding [goid 48503] [evidence IEA]; hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides [goid 16811] [evidence IEA]; GPI anchor binding [goid 48503] [evidence IEA]",6,133106828-133106877,6q23.2b,-,NM_004665.2,8875,VNN2,-1.662241466228548,6.796999393923471,-9.66338994169112,1.1811718920118904e-16,1.1676881946144945e-15,27.02408598460504
CYBB,ILMN_1682312,"Homo sapiens cytochrome b-245, beta polypeptide (chronic granulomatous disease) (CYBB), mRNA.",integral to plasma membrane [goid 5887] [pmid 15233623] [evidence IDA]; membrane [goid 16020] [evidence IEA],ion transport [goid 6811] [evidence IEA]; antimicrobial humoral response (sensu Vertebrata) [goid 19735] [pmid 7719350] [evidence TAS]; inflammatory response [goid 6954] [pmid 7719350] [evidence TAS]; electron transport [goid 6118] [evidence IEA],oxidoreductase activity [goid 16491] [evidence IEA]; voltage-gated ion channel activity [goid 5244] [evidence IEA]; metal ion binding [goid 46872] [evidence IEA]; iron ion binding [goid 5506] [evidence IEA]; FAD binding [goid 50660] [evidence IEA],X,37557345-37557394,Xp11.4e,+,NM_000397.2,1536,CYBB,-1.3669832025327686,9.43634150919889,-9.659793295778169,1.2046317052208226e-16,1.1902763071109397e-15,27.004540505368272
PREX1,ILMN_1777342,"Homo sapiens phosphatidylinositol 3,4,5-trisphosphate-dependent RAC exchanger 1 (PREX1), mRNA.",cytosol [goid 5829] [pmid 11955434] [evidence IDA]; plasma membrane [goid 5886] [evidence TAS],actin filament polymerization [goid 30041] [evidence TAS]; superoxide metabolism [goid 6801] [evidence TAS]; neutrophil activation [goid 42119] [evidence TAS]; intracellular signaling cascade [goid 7242] [evidence IEA],Rho GTPase activator activity [goid 5100] [evidence TAS]; phospholipid binding [goid 5543] [pmid 11955434] [evidence IDA]; enzyme binding [goid 19899] [evidence TAS]; Rho guanyl-nucleotide exchange factor activity [goid 5089] [evidence TAS],20,46674552-46674601,20q13.13b,-,NM_020820.2,57580,PREX1,-1.0090658273143767,7.10674864160037,-9.657194601999084,1.2218710508071578e-16,1.2059053689790731e-15,26.990418788863256
BCYRN1,ILMN_1678757,"Homo sapiens brain cytoplasmic RNA 1, Bc1 analog (mouse) (BCYRN1) on chromosome 2.",,,,2,47416014-47416063,2p21a,+,NR_001568.1,618,BCYRN1,1.8801869206247002,10.62605954447214,9.657129521724327,1.2223059295528198e-16,1.2059053689790731e-15,26.990065137973364
VASH1,ILMN_1796216,"Homo sapiens vasohibin 1 (VASH1), mRNA.",,cell cycle arrest [goid 7050] [evidence IEA]; cell cycle [goid 7049] [evidence IEA],,14,76318923-76318972,14q24.3c,+,NM_014909.2,22846,VASH1,-1.0121956100771534,9.05114864419523,-9.653925840549041,1.2439056065588882e-16,1.2259737351441547e-15,26.97265644944868
SLC39A8,ILMN_1695316,"Homo sapiens solute carrier family 39 (zinc transporter), member 8 (SLC39A8), mRNA.",membrane [goid 16020] [evidence IEA],metal ion transport [goid 30001] [evidence IEA],metal ion transporter activity [goid 46873] [evidence IEA],4,103402447-103402496,4q24a,-,NM_022154.5,64116,SLC39A8,-2.0258286772332994,9.3116671719654,-9.650141954226982,1.2699083146108892e-16,1.250968832669018e-15,26.952095820556654
PIGX,ILMN_1769508,"Homo sapiens phosphatidylinositol glycan anchor biosynthesis, class X (PIGX), mRNA.",membrane [goid 16020] [evidence IEA]; integral to membrane [goid 16021] [evidence IEA]; endoplasmic reticulum [goid 5783] [evidence IEA],GPI anchor biosynthesis [goid 6506] [evidence IEA],,3,197945714-197945763,3q29g,+,NM_017861.1,54965,PIGX,1.4715323312603452,7.785895521196606,9.648561223477179,1.2809310386941617e-16,1.2611895547729025e-15,26.943506832286868
ABLIM3,ILMN_1656940,"Homo sapiens actin binding LIM protein family, member 3 (ABLIM3), mRNA.",cytoplasm [goid 5737] [evidence NAS],cytoskeleton organization and biogenesis [goid 7010] [evidence IEA],actin binding [goid 3779] [evidence IEA]; metal ion binding [goid 46872] [evidence IEA]; zinc ion binding [goid 8270] [evidence NAS],5,148619956-148620005,5q33.1b,+,NM_014945.1,22885,ABLIM3,-1.3594294502529864,6.722632806787273,-9.645617879893344,1.301710582941446e-16,1.2810015509401049e-15,26.927514453899736
NEK8,ILMN_1755138,"Homo sapiens NIMA (never in mitosis gene a)- related kinase 8 (NEK8), mRNA.",,protein amino acid phosphorylation [goid 6468] [evidence IEA],ATP binding [goid 5524] [evidence IEA]; transferase activity [goid 16740] [evidence IEA]; magnesium ion binding [goid 287] [evidence IEA]; protein serine/threonine kinase activity [goid 4674] [evidence IEA]; protein-tyrosine kinase activity [goid 4713] [evidence IEA]; nucleotide binding [goid 166] [evidence IEA],17,24093831-24093880,17q11.2a,+,NM_178170.2,284086,NEK8,1.4909007107887353,7.5429673633531005,9.6449052640903,1.3067919206952606e-16,1.2853528811078825e-15,26.92364261016962
FLJ10178,ILMN_1703279,"Homo sapiens chromosome X open reading frame 57 (CXorf57), mRNA.",,,nucleic acid binding [goid 3676] [evidence IEA],X,105808986-105809035,Xq22.3b,+,NM_018015.3,55086,FLJ10178,-1.394776365735356,6.799176589162437,-9.641915142013989,1.3283298195682126e-16,1.3052196941143025e-15,26.90739679823876
C3,ILMN_1762260,"Homo sapiens complement component 3 (C3), mRNA.",extracellular space [goid 5615] [evidence IEA],"signal transduction [goid 7165] [pmid 10085065] [evidence TAS]; innate immune response [goid 45087] [evidence IEA]; G-protein coupled receptor protein signaling pathway [goid 7186] [pmid 9164946] [evidence TAS]; complement activation, classical pathway [goid 6958] [evidence IEA]; complement activation, alternative pathway [goid 6957] [evidence IEA]; inflammatory response [goid 6954] [evidence IEA]",receptor binding [goid 5102] [pmid 9164946] [evidence TAS]; endopeptidase inhibitor activity [goid 4866] [evidence IEA],19,6636154-6636157:6637135-6637180,19p13.3a,-,NM_000064.1,718,C3,-1.5521214806247832,8.487594785265646,-9.633248727133457,1.3927764578862395e-16,1.3637311196941395e-15,26.86031416081435
PTPLA,ILMN_1725791,"Homo sapiens protein tyrosine phosphatase-like (proline instead of catalytic arginine), member a (PTPLA), mRNA.",,signal transduction [goid 7165] [pmid 10644438] [evidence NAS]; protein amino acid dephosphorylation [goid 6470] [pmid 10644438] [evidence TAS]; development [goid 7275] [pmid 10644438] [evidence TAS],protein tyrosine phosphatase activity [goid 4725] [pmid 10644438] [evidence TAS],10,17681354-17681403,10p12.33c,-,NM_014241.2,9200,PTPLA,-1.6936916002011246,8.142585377677605,-9.628036777823958,1.433027501221489e-16,1.4010306503412302e-15,26.83200127445402
GREM1,ILMN_1752965,"Homo sapiens gremlin 1, cysteine knot superfamily, homolog (Xenopus laevis) (GREM1), mRNA.",extracellular space [goid 5615] [pmid 9660951] [evidence TAS],development [goid 7275] [pmid 9660951] [evidence TAS],cytokine activity [goid 5125] [evidence IEA]; protein binding [goid 5515] [pmid 16545136] [evidence IPI],15,30813620-30813669,15q13.3c-q13.3d,+,NM_013372.5,26585,GREM1,1.211979498623637,5.7456848342306355,9.627847510181395,1.4345108294902155e-16,1.4017775081553085e-15,26.8309731498893
ZNF579,ILMN_1761722,"Homo sapiens zinc finger protein 579 (ZNF579), mRNA.",nucleus [goid 5634] [evidence IEA],,metal ion binding [goid 46872] [evidence IEA]; nucleic acid binding [goid 3676] [evidence IEA]; zinc ion binding [goid 8270] [evidence IEA],19,60780843-60780892,19q13.42c,-,NM_152600.1,163033,ZNF579,1.0043734837463285,6.875495445788926,9.62593431092526,1.4495912574295956e-16,1.4158037920308608e-15,26.820580558075445
MYOM2,ILMN_1716733,"Homo sapiens myomesin (M-protein) 2, 165kDa (MYOM2), mRNA.",striated muscle thick filament [goid 5863] [evidence IEA],striated muscle contraction [goid 6941] [evidence IEA],structural constituent of muscle [goid 8307] [pmid 7505783] [evidence TAS],8,2080589-2080638,8p23.3a,+,NM_003970.1,9172,MYOM2,-1.654463462849522,7.489826073620428,-9.622805793403007,1.4745928517017225e-16,1.4373407561484772e-15,26.803586833482616
SFMBT2,ILMN_1660125,"Homo sapiens Scm-like with four mbt domains 2 (SFMBT2), mRNA.",nucleus [goid 5634] [evidence IEA],regulation of transcription [goid 45449] [evidence IEA],,10,7244266-7244315,10p14e,-,NM_001029880.1,57713,SFMBT2,1.3676274824036723,6.174404050859089,9.620473659883979,1.4935096916217864e-16,1.4550518170625253e-15,26.790919402692975
CA9,ILMN_1725139,"Homo sapiens carbonic anhydrase IX (CA9), mRNA.",integral to membrane [goid 16021] [pmid 8661007] [evidence TAS]; nucleus [goid 5634] [evidence IEA]; membrane [goid 16020] [evidence IEA],one-carbon compound metabolism [goid 6730] [evidence IEA],carbonate dehydratase activity [goid 4089] [pmid 8661007] [evidence TAS]; lyase activity [goid 16829] [evidence IEA]; zinc ion binding [goid 8270] [evidence IEA]; metal ion binding [goid 46872] [evidence IEA],9,35670757-35670806,9p13.3a,+,NM_001216.1,768,CA9,2.2319872666730927,6.431773156792109,9.613713644198082,1.5497223447871867e-16,1.5075556609175403e-15,26.75420317937346
BC002942,ILMN_1716056,"Homo sapiens transmembrane protein 112B (TMEM112B), mRNA.",,,,22,49288446-49288495,22q13.33b,-,NM_033200.1,91289,BC002942,1.0244245074245342,9.89636378491385,9.609338055620366,1.5872280872087366e-16,1.5432704231168778e-15,26.730439360287814
HBLD2,ILMN_1715931,"Homo sapiens iron-sulfur cluster assembly 1 homolog (S. cerevisiae) (ISCA1), mRNA.",mitochondrion [goid 5739] [evidence IEA],,metal ion binding [goid 46872] [evidence IEA]; iron ion binding [goid 5506] [evidence IEA],9,88069929-88069978,9q21.33b,-,NM_030940.3,81689,HBLD2,-1.0015483340082545,7.473298214011716,-9.599420659802806,1.6756233252265427e-16,1.625972136057728e-15,26.676582883283363
SILV,ILMN_1665994,"Homo sapiens silver homolog (mouse) (SILV), mRNA.",plasma membrane [goid 5886] [pmid 8179825] [evidence TAS]; extracellular region [goid 5576] [evidence NR ]; integral to membrane [goid 16021] [evidence IEA]; extracellular space [goid 5615] [evidence NR ],melanin biosynthesis from tyrosine [goid 6583] [evidence IEA],,12,54634297-54634346,12q13.2c,-,NM_006928.3,6490,SILV,1.005813467067294,5.875950410193704,9.597792787102927,1.6905950682399306e-16,1.6388679057042312e-15,26.667743363018506
OMD,ILMN_1749846,"Homo sapiens osteomodulin (OMD), mRNA.",extracellular matrix (sensu Metazoa) [goid 5578] [evidence IEA],cell adhesion [goid 7155] [evidence IEA],transferase activity [goid 16740] [evidence IEA]; protein binding [goid 5515] [evidence IEA],9,94216694-94216743,9q22.31a,-,NM_005014.1,4958,OMD,-1.3790797602574312,6.206204038930784,-9.585719725418802,1.8058792329170738e-16,1.7445491746846397e-15,26.602191147754272
SCGB1A1,ILMN_1655347,"Homo sapiens secretoglobin, family 1A, member 1 (uteroglobin) (SCGB1A1), mRNA.",,signal transduction [goid 7165] [pmid 10587371] [evidence NAS]; embryo implantation [goid 7566] [pmid 10587371] [evidence TAS],phospholipase A2 inhibitor activity [goid 19834] [evidence IEA]; steroid binding [goid 5496] [evidence IEA]; cytokine activity [goid 5125] [evidence NR ],11,61947151-61947200,11q12.3a,+,NM_003357.3,7356,SCGB1A1,-4.313152845104259,11.797142934612726,-9.582618543720267,1.8367375851790953e-16,1.7734802699313515e-15,26.58535454289272
PLEKHH2,ILMN_1806752,"Homo sapiens pleckstrin homology domain containing, family H (with MyTH4 domain) member 2 (PLEKHH2), mRNA.",cytoskeleton [goid 5856] [evidence IEA],cell adhesion [goid 7155] [evidence IEA],protein binding [goid 5515] [evidence IEA],2,43848299-43848348,2p21d,+,NM_172069.1,130271,PLEKHH2,-1.2897716137429036,7.49287632311362,-9.576768983879274,1.8963832326995535e-16,1.8292587766906337e-15,26.553598588100808
LILRB2,ILMN_2312340,"Homo sapiens leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 2 (LILRB2), transcript variant 2, mRNA.",membrane fraction [goid 5624] [pmid 9079806] [evidence TAS]; integral to plasma membrane [goid 5887] [pmid 9079806] [evidence TAS]; membrane [goid 16020] [evidence IEA],cellular defense response [goid 6968] [pmid 9382880] [evidence TAS]; cell surface receptor linked signal transduction [goid 7166] [pmid 9079806] [evidence TAS]; antimicrobial humoral response (sensu Vertebrata) [goid 19735] [pmid 9382880] [evidence TAS]; cell-cell signaling [goid 7267] [pmid 9382880] [evidence TAS],receptor activity [goid 4872] [pmid 9382880] [evidence TAS],,,19q13.42a,,NM_001080978.1,10288,LILRB2,-1.291228579896246,7.128554473362279,-9.574917324866336,1.9156636791265697e-16,1.8469424437298964e-15,26.543546850537556
HBG1,ILMN_1796678,"Homo sapiens hemoglobin, gamma A (HBG1), mRNA.",hemoglobin complex [goid 5833] [evidence IEA],transport [goid 6810] [evidence IEA]; oxygen transport [goid 15671] [evidence IEA],heme binding [goid 20037] [evidence IEA]; metal ion binding [goid 46872] [evidence IEA]; oxygen transporter activity [goid 5344] [evidence IEA]; iron ion binding [goid 5506] [evidence IEA]; oxygen binding [goid 19825] [evidence IEA],11,5226196-5226245,11p15.4c,-,NM_000559.2,3047,HBG1,-2.6377684780525064,6.511818952023211,-9.57079999521306,1.9592394398074987e-16,1.8861551622850354e-15,26.521196786922385
LOC644354,ILMN_1738648,"PREDICTED: Homo sapiens similar to Apoptosis-related protein 2 (APR-2) (LOC644354), mRNA.",,,,17,41774285-41774334,17q21.31d,-,XM_930138.1,644354,LOC644354,1.5874993832698765,6.371349057790244,9.570140576593888,1.96630971191949e-16,1.8920269005803092e-15,26.51761738313559
TBC1D24,ILMN_2060212,"Homo sapiens TBC1 domain family, member 24 (TBC1D24), mRNA. XM_945422",,,,16,2493115-2493164,16p13.3d,+,NM_020705.1,57465,TBC1D24,1.178441877495457,6.607048039497022,9.569109999891317,1.9774105574102664e-16,1.9017692354955102e-15,26.512023350765116
FAM105A,ILMN_1695711,"Homo sapiens family with sequence similarity 105, member A (FAM105A), mRNA.",,,,5,14663400-14663423:14663424-14663449,5p15.2a,+,NM_019018.1,54491,FAM105A,-1.3462622147715217,6.759163761597465,-9.565102562244684,2.0211742548530934e-16,1.9428998695516786e-15,26.490271460902367
CPNE4,ILMN_1814770,"Homo sapiens copine IV (CPNE4), mRNA.",,,,3,132736522-132736571,3q22.1b-q22.1c,-,NM_130808.1,131034,CPNE4,1.2081194262406107,5.479516575484975,9.559755538358017,2.0810758415115922e-16,1.9975252596972107e-15,26.46125025450746
HLA-DPA1,ILMN_1772218,"Homo sapiens major histocompatibility complex, class II, DP alpha 1 (HLA-DPA1), mRNA.",integral to plasma membrane [goid 5887] [pmid 2461352] [evidence NAS]; membrane [goid 16020] [evidence IEA],immune response [goid 6955] [pmid 2461352] [evidence NAS],MHC class II receptor activity [goid 45012] [pmid 2461352] [evidence NAS],6,33144417-33144466,6p21.32a,-,NM_033554.2,3113,HLA-DPA1,-1.1255369267293567,13.43995428095664,-9.555513154644785,2.1298601409637202e-16,2.0426477606430173e-15,26.438225998285727
GNAQ,ILMN_1659923,"Homo sapiens guanine nucleotide binding protein (G protein), q polypeptide (GNAQ), mRNA.",heterotrimeric G-protein complex [goid 5834] [evidence NR ]; plasma membrane [goid 5886] [pmid 10633085] [evidence TAS]; cytoplasm [goid 5737] [pmid 9175863] [evidence TAS],phospholipase C activation [goid 7202] [pmid 8825633] [evidence TAS]; blood coagulation [goid 7596] [pmid 9238049] [evidence TAS]; protein amino acid ADP-ribosylation [goid 6471] [evidence IEA]; G-protein coupled receptor protein signaling pathway [goid 7186] [evidence IEA]; signal transduction [goid 7165] [evidence IEA],GTPase activity [goid 3924] [pmid 9238049] [evidence TAS]; nucleotide binding [goid 166] [evidence IEA]; signal transducer activity [goid 4871] [evidence IEA]; GTP binding [goid 5525] [evidence IEA],9,79525637-79525686,9q21.2a-q21.2b,-,NM_002072.2,2776,GNAQ,-1.6882233864211669,7.125623665658513,-9.555485460845173,2.1301823195414992e-16,2.0426477606430173e-15,26.438075702830435
FAM108A2,ILMN_2239772,"Homo sapiens family with sequence similarity 108, member A3 (FAM108A3), mRNA.",,,,,,1q21.1c,,NM_001080422.1,653401,FAM108A2,-1.0303738995649718,7.721666850259874,-9.543556112552167,2.2735850733741176e-16,2.174806340436656e-15,26.373339795296626
CLDN3,ILMN_1723042,"Homo sapiens claudin 3 (CLDN3), mRNA.",integral to plasma membrane [goid 5887] [pmid 9334247] [evidence TAS]; membrane [goid 16020] [evidence IEA]; tight junction [goid 5923] [evidence ISS],calcium-independent cell-cell adhesion [goid 16338] [evidence ISS],structural molecule activity [goid 5198] [evidence IEA]; transmembrane receptor activity [goid 4888] [pmid 9334247] [evidence TAS],7,72821281-72821330,7q11.23b,-,NM_001306.2,1365,CLDN3,1.927527207264271,9.290693305603133,9.533579939050506,2.400877489027989e-16,2.2909450476841513e-15,26.319210999050373
LOC51252,ILMN_1804993,"Homo sapiens hypothetical protein LOC51252 (LOC51252), mRNA.",,,,2,96905440-96905489,2q11.2a,-,NM_016490.3,51252,LOC51252,1.4973200717626778,5.995111532180399,9.533276886895546,2.404853656166123e-16,2.2936159319822275e-15,26.317566811150936
LDLR,ILMN_2053415,"Homo sapiens low density lipoprotein receptor (familial hypercholesterolemia) (LDLR), mRNA.",plasma membrane [goid 5886] [pmid 2777800] [evidence TAS]; coated pit [goid 5905] [evidence IEA]; integral to plasma membrane [goid 5887] [pmid 6327078] [evidence TAS],endocytosis [goid 6897] [pmid 12671190] [evidence TAS]; cholesterol metabolism [goid 8203] [evidence IEA]; lipid transport [goid 6869] [evidence IEA]; lipid metabolism [goid 6629] [pmid 10827173] [evidence TAS]; steroid metabolism [goid 8202] [evidence IEA],transmembrane receptor activity [goid 4888] [pmid 6091915] [evidence TAS]; lipid transporter activity [goid 5319] [evidence IEA]; low-density lipoprotein receptor activity [goid 5041] [pmid 2777800] [evidence TAS]; lipoprotein binding [goid 8034] [pmid 6091915] [evidence TAS]; calcium ion binding [goid 5509] [evidence IEA],19,11105336-11105385,19p13.2b,+,NM_000527.2,3949,LDLR,-1.21206205124399,12.029194041429232,-9.533068512047471,2.4075914302257553e-16,2.295103670154053e-15,26.316436292179358
ARHGEF10,ILMN_2132809,"Homo sapiens Rho guanine nucleotide exchange factor (GEF) 10 (ARHGEF10), mRNA.",intracellular [goid 5622] [evidence IEA],regulation of Rho protein signal transduction [goid 35023] [evidence IEA],Rho guanyl-nucleotide exchange factor activity [goid 5089] [evidence IEA],8,1893956-1894005,8p23.3a,+,NM_014629.2,9639,ARHGEF10,-1.0392990252898748,9.690203265561852,-9.532690291660293,2.4125687014300236e-16,2.2976324097920004e-15,26.314384299730985
AXUD1,ILMN_1703123,"Homo sapiens AXIN1 up-regulated 1 (AXUD1), mRNA.",nucleus [goid 5634] [evidence IEA],apoptosis [goid 6915] [evidence IEA],,3,39158376-39158425,3p22.2a,-,NM_033027.2,64651,AXUD1,-1.5308648437984402,12.034384653338215,-9.532653116771826,2.4130584660705514e-16,2.2976324097920004e-15,26.314182612098296
KIRREL,ILMN_1742781,"Homo sapiens kin of IRRE like (Drosophila) (KIRREL), mRNA.",integral to membrane [goid 16021] [evidence IEA]; membrane [goid 16020] [evidence IEA],cell adhesion [goid 7155] [evidence IEA],protein binding [goid 5515] [evidence IEA],1,156332331-156332380,1q23.1e,+,NM_018240.3,55243,KIRREL,1.176315247611626,6.225833581279023,9.532598238372982,2.4137816488807925e-16,2.2976324097920004e-15,26.31388487650683
MOV10,ILMN_1725700,"Homo sapiens Mov10, Moloney leukemia virus 10, homolog (mouse) (MOV10), mRNA.",,development [goid 7275] [evidence IEA],helicase activity [goid 4386] [evidence IEA]; nucleotide binding [goid 166] [evidence IEA]; hydrolase activity [goid 16787] [evidence IEA]; ATP binding [goid 5524] [evidence IEA],1,113044647-113044652:113044653-113044696,1p13.2c,+,NM_020963.1,4343,MOV10,1.0368112768696314,8.749971514268534,9.526503438843061,2.495458984266913e-16,2.3730609228131184e-15,26.28081972513044
KDELR3,ILMN_1713901,"Homo sapiens KDEL (Lys-Asp-Glu-Leu) endoplasmic reticulum protein retention receptor 3 (KDELR3), transcript variant 2, mRNA.",membrane [goid 16020] [evidence IEA]; integral to membrane [goid 16021] [evidence IEA]; endoplasmic reticulum [goid 5783] [evidence IEA]; membrane [goid 16020] [evidence IEA]; integral to membrane [goid 16021] [evidence IEA]; endoplasmic reticulum [goid 5783] [evidence IEA],protein retention in ER [goid 6621] [evidence IEA]; protein transport [goid 15031] [evidence IEA]; protein retention in ER [goid 6621] [evidence IEA]; protein transport [goid 15031] [evidence IEA],ER retention sequence binding [goid 46923] [evidence IEA]; receptor activity [goid 4872] [evidence IEA]; ER retention sequence binding [goid 46923] [evidence IEA]; receptor activity [goid 4872] [evidence IEA],22,37207271-37207320,22q13.1b,+,NM_016657.1,11015,KDELR3,1.2203749355022318,7.660852455879071,9.520596295375547,2.577252113156655e-16,2.4472591337649815e-15,26.248775269578967
DEPDC6,ILMN_1756685,"Homo sapiens DEP domain containing 6 (DEPDC6), mRNA.",intracellular [goid 5622] [pmid 11256614] [evidence IDA]; intracellular [goid 5622] [pmid 11256614] [evidence IDA],intracellular signaling cascade [goid 7242] [evidence IEA]; intracellular signaling cascade [goid 7242] [evidence IEA],protein binding [goid 5515] [evidence IEA]; protein binding [goid 5515] [evidence IEA],8,121131437-121131486,8q24.12c,+,NM_022783.1,64798,DEPDC6,1.4328073116468953,7.526110420887239,9.514667984861639,2.662027663635498e-16,2.5216144397636205e-15,26.216618610918704
ADC,ILMN_1659599,"Homo sapiens arginine decarboxylase (ADC), mRNA.",,polyamine biosynthesis [goid 6596] [evidence IEA]; spermatogenesis [goid 7283] [pmid 11587527] [evidence NAS],arginine decarboxylase activity [goid 8792] [evidence IEA]; lyase activity [goid 16829] [evidence IEA],1,33358486-33358535,1p35.1a,+,NM_052998.2,113451,ADC,1.0918506989535475,6.671801054124196,9.513285221013566,2.6821982084162735e-16,2.539486496160889e-15,26.209118528578355
YBX2,ILMN_1755354,"Homo sapiens Y box binding protein 2 (YBX2), mRNA.",cytoplasm [goid 5737] [pmid 10100484] [evidence TAS]; nucleus [goid 5634] [pmid 10100484] [evidence TAS],"regulation of transcription, DNA-dependent [goid 6355] [evidence IEA]; spermatogenesis [goid 7283] [pmid 10100484] [evidence TAS]; transcription from RNA polymerase II promoter [goid 6366] [pmid 10100484] [evidence TAS]; translational attenuation [goid 9386] [pmid 10100484] [evidence TAS]",DNA binding [goid 3677] [evidence IEA]; RNA binding [goid 3723] [evidence IEA],17,7132333-7132382,17p13.1d,-,NM_015982.1,51087,YBX2,1.3484924850518265,5.823051089821808,9.510504987726254,2.7232165283701267e-16,2.5761033613737026e-15,26.194039036512503
LAMC3,ILMN_1688642,"Homo sapiens laminin, gamma 3 (LAMC3), mRNA.",extracellular matrix (sensu Metazoa) [goid 5578] [evidence IEA]; basement membrane [goid 5604] [evidence IEA]; membrane [goid 16020] [pmid 10225960] [evidence TAS],cell adhesion [goid 7155] [evidence IEA],structural molecule activity [goid 5198] [pmid 10225960] [evidence TAS]; protein binding [goid 5515] [evidence IEA],9,132957211-132957260,9q34.13a,+,NM_006059.2,10319,LAMC3,-1.7307327661386047,8.995345561973604,-9.508399720589468,2.7546925875154716e-16,2.604327271603055e-15,26.182620828749652
SNX30,ILMN_1738491,"PREDICTED: Homo sapiens sorting nexin family member 30, transcript variant 2 (SNX30), mRNA.",,,,9,114676426-114676475,9q32b,+,XM_933299.1,401548,SNX30,-1.197424291011476,9.158738853155345,-9.506073089813604,2.7899007001060955e-16,2.6350564780207114e-15,26.170002414108584
C1R,ILMN_1677198,"Homo sapiens complement component 1, r subcomponent (C1R), mRNA.",extracellular region [goid 5576] [pmid 14718574] [evidence NAS]; extracellular region [goid 5576] [pmid 14718574] [evidence NAS],"innate immune response [goid 45087] [evidence IEA]; complement activation, classical pathway [goid 6958] [evidence IEA]; innate immune response [goid 45087] [evidence IEA]; complement activation, classical pathway [goid 6958] [evidence IEA]",complement component C1r activity [goid 3815] [pmid 2834284] [evidence TAS]; complement component C1s activity [goid 3816] [evidence IEA]; calcium ion binding [goid 5509] [evidence IEA]; complement component C1r activity [goid 3815] [pmid 2834284] [evidence TAS]; complement component C1s activity [goid 3816] [evidence IEA]; calcium ion binding [goid 5509] [evidence IEA],12,,12p13.31d,-,NM_001733.4,715,C1R,-1.343952535777233,7.586884066722014,-9.505840197397008,2.7934496088210837e-16,2.6371301176297872e-15,26.168739351376264
DKFZp564K142,ILMN_1721349,"Homo sapiens implantation-associated protein (DKFZp564K142), mRNA.",endoplasmic reticulum [goid 5783] [evidence IEA]; integral to membrane [goid 16021] [evidence IEA]; membrane [goid 16020] [evidence IEA],,,X,76970258-76970307,Xq21.1a,-,NM_032121.3,84061,DKFZp564K142,1.9726628848326584,12.59148568861065,9.474622256901664,3.3123171347131136e-16,3.1103855118016874e-15,25.999470278390152
LOC653509,ILMN_1678533,"PREDICTED: Homo sapiens similar to surfactant, pulmonary-associated protein A1, transcript variant 1 (LOC653509), mRNA.",,,,10,81044828-81044877,10q22.3e,+,XM_930304.1,653509,LOC653509,-1.3390549104886666,9.577642365493677,-9.473901933711625,3.3253613424906992e-16,3.1211303351845507e-15,25.995565448380464
RAC3,ILMN_1693340,"Homo sapiens ras-related C3 botulinum toxin substrate 3 (rho family, small GTP binding protein Rac3) (RAC3), mRNA.",endomembrane system [goid 12505] [pmid 11956649] [evidence IDA]; intracellular [goid 5622] [evidence IEA],cell projection biogenesis [goid 30031] [pmid 11956649] [evidence IDA]; actin cytoskeleton organization and biogenesis [goid 30036] [pmid 11956649] [evidence IDA]; small GTPase mediated signal transduction [goid 7264] [evidence IEA],GTPase activity [goid 3924] [pmid 11956649] [evidence IDA]; nucleotide binding [goid 166] [evidence IEA]; GTP binding [goid 5525] [evidence IEA]; protein binding [goid 5515] [pmid 11956649] [evidence IPI],17,77585144-77585193,17q25.3g,+,NM_005052.2,5881,RAC3,1.204053657930901,6.555050302032897,9.471171024471852,3.375282079988569e-16,3.164936060085528e-15,25.980761715616257
SLC2A6,ILMN_1778321,"Homo sapiens solute carrier family 2 (facilitated glucose transporter), member 6 (SLC2A6), mRNA.",membrane [goid 16020] [pmid 10970791] [evidence NAS]; integral to membrane [goid 16021] [evidence IEA],carbohydrate transport [goid 8643] [evidence IEA],glucose transporter activity [goid 5355] [pmid 10970791] [evidence NAS]; transporter activity [goid 5215] [evidence IEA]; sugar porter activity [goid 5351] [evidence IEA],9,135326072-135326121,9q34.2a,-,NM_017585.2,11182,SLC2A6,-1.2778406037118648,8.091248985219057,-9.46849712176843,3.424885084543092e-16,3.209903120361815e-15,25.966267567998802
SERINC1,ILMN_1741613,"Homo sapiens serine incorporator 1 (SERINC1), mRNA.",plasma membrane [goid 5886] [evidence ISS]; integral to membrane [goid 16021] [evidence IEA]; endoplasmic reticulum membrane [goid 5789] [evidence ISS],positive regulation of transferase activity [goid 51347] [evidence ISS]; sphingolipid metabolism [goid 6665] [evidence ISS]; phosphatidylserine metabolism [goid 6658] [evidence ISS]; L-serine transport [goid 15825] [evidence ISS],L-serine transporter activity [goid 15194] [evidence ISS]; protein binding [goid 5515] [evidence ISS],6,122806526-122806575,6q22.31c,-,NM_020755.2,57515,SERINC1,-1.048522473298446,9.68997500331604,-9.457413105770886,3.638377741119847e-16,3.3985517874266644e-15,25.906191565755616
PPP1R14D,ILMN_1788267,"Homo sapiens protein phosphatase 1, regulatory (inhibitor) subunit 14D (PPP1R14D), mRNA.",,,protein phosphatase inhibitor activity [goid 4864] [evidence IEA],15,38895204-38895251:38895452-38895453,15q15.1b,-,NM_017726.6,54866,PPP1R14D,1.6537899543394223,6.77987629798579,9.45578317229059,3.670872816480206e-16,3.4272619467712898e-15,25.89735804849533
FAM82C,ILMN_1727309,"Homo sapiens family with sequence similarity 82, member C (FAM82C), mRNA.",,,binding [goid 5488] [evidence IEA],15,38815706-38815755,15q15.1b,-,NM_018145.1,55177,FAM82C,-1.0138522616239243,9.876520939938406,-9.442886204305443,3.938413475017463e-16,3.67001370448184e-15,25.827469624387138
ITLN1,ILMN_2165993,"Homo sapiens intelectin 1 (galactofuranose binding) (ITLN1), mRNA.",membrane [goid 16020] [evidence IEA],,sugar binding [goid 5529] [evidence IEA]; GPI anchor binding [goid 48503] [evidence IEA],1,159113227-159113230:159115725-159115770,1q23.3a,-,NM_017625.2,55600,ITLN1,-4.148339103407614,7.958599215826148,-9.4314084340424,4.192827822702564e-16,3.897993186919602e-15,25.765282978997877
ACHE,ILMN_1735471,"Homo sapiens acetylcholinesterase (YT blood group) (ACHE), transcript variant E4-E5, mRNA.",basal lamina [goid 5605] [evidence NAS]; synapse [goid 45202] [evidence IEA]; extracellular region [goid 5576] [pmid 11283752] [evidence TAS]; membrane [goid 16020] [evidence IEA]; basal lamina [goid 5605] [evidence NAS]; synapse [goid 45202] [evidence IEA]; extracellular region [goid 5576] [pmid 11283752] [evidence TAS]; membrane [goid 16020] [evidence IEA],cell proliferation [goid 8283] [pmid 11283752] [evidence TAS]; cell adhesion [goid 7155] [pmid 11283752] [evidence TAS]; response to wounding [goid 9611] [pmid 11283752] [evidence TAS]; positive regulation of protein secretion [goid 50714] [pmid 11283752] [evidence TAS]; acetylcholine catabolism in synaptic cleft [goid 1507] [pmid 1517212] [evidence NAS]; synaptogenesis [goid 7416] [pmid 11283752] [evidence TAS]; muscle development [goid 7517] [pmid 11283752] [evidence TAS]; neurotransmitter catabolism [goid 42135] [evidence IEA]; amyloid precursor protein metabolism [goid 42982] [pmid 12769797] [evidence TAS]; DNA replication [goid 6260] [pmid 11283752] [evidence TAS]; cell proliferation [goid 8283] [pmid 11283752] [evidence TAS]; cell adhesion [goid 7155] [pmid 11283752] [evidence TAS]; response to wounding [goid 9611] [pmid 11283752] [evidence TAS]; positive regulation of protein secretion [goid 50714] [pmid 11283752] [evidence TAS]; acetylcholine catabolism in synaptic cleft [goid 1507] [pmid 1517212] [evidence NAS]; synaptogenesis [goid 7416] [pmid 11283752] [evidence TAS]; muscle development [goid 7517] [pmid 11283752] [evidence TAS]; neurotransmitter catabolism [goid 42135] [evidence IEA]; amyloid precursor protein metabolism [goid 42982] [pmid 12769797] [evidence TAS]; DNA replication [goid 6260] [pmid 11283752] [evidence TAS],serine esterase activity [goid 4759] [evidence IEA]; acetylcholinesterase activity [goid 3990] [pmid 1517212] [evidence IMP]; hydrolase activity [goid 16787] [evidence IEA]; acetylcholine binding [goid 42166] [pmid 1517212] [evidence NAS]; beta-amyloid binding [goid 1540] [pmid 11283752] [evidence TAS]; cholinesterase activity [goid 4104] [evidence IEA]; protein homodimerization activity [goid 42803] [pmid 1517212] [evidence NAS]; serine esterase activity [goid 4759] [evidence IEA]; acetylcholinesterase activity [goid 3990] [pmid 1517212] [evidence IMP]; hydrolase activity [goid 16787] [evidence IEA]; acetylcholine binding [goid 42166] [pmid 1517212] [evidence NAS]; beta-amyloid binding [goid 1540] [pmid 11283752] [evidence TAS]; cholinesterase activity [goid 4104] [evidence IEA]; protein homodimerization activity [goid 42803] [pmid 1517212] [evidence NAS],7,100325559-100325608,7q22.1c,-,NM_015831.1,43,ACHE,1.0164353010655072,5.568560861403951,9.431397914055346,4.193068370430324e-16,3.897993186919602e-15,25.76522598648889
DHRS8,ILMN_1675117,"Homo sapiens hydroxysteroid (17-beta) dehydrogenase 11 (HSD17B11), mRNA.",,steroid biosynthesis [goid 6694] [evidence IEA]; metabolism [goid 8152] [evidence IEA]; steroid biosynthesis [goid 6694] [evidence IEA]; metabolism [goid 8152] [evidence IEA],oxidoreductase activity [goid 16491] [evidence IEA]; oxidoreductase activity [goid 16491] [evidence IEA],4,88514916-88514965,4q22.1a,-,NM_016245.2,51170,DHRS8,-1.065199706517861,7.787462836991708,-9.430542932936376,4.212664280112325e-16,3.914342560705229e-15,25.7605941171954
ABCA2,ILMN_1747627,"Homo sapiens ATP-binding cassette, sub-family A (ABC1), member 2 (ABCA2), transcript variant 1, mRNA.",integral to membrane [goid 16021] [evidence NAS]; ATP-binding cassette (ABC) transporter complex [goid 43190] [pmid 11178988] [evidence NAS]; lysosomal membrane [goid 5765] [pmid 11309290] [evidence IDA],transport [goid 6810] [pmid 11178988] [evidence NAS]; lipid metabolism [goid 6629] [pmid 11178988] [evidence NAS]; cholesterol metabolism [goid 8203] [pmid 15238223] [evidence IDA],"nucleotide binding [goid 166] [evidence IEA]; ATPase activity, coupled to transmembrane movement of substances [goid 42626] [pmid 7766993] [evidence NAS]; ATPase activity [goid 16887] [evidence IEA]; ATP binding [goid 5524] [evidence IEA]",9,139021747-139021796,9q34.3e,-,NM_001606.3,20,ABCA2,1.0914922423968045,6.714860551101627,9.430256412376322,4.2192516622007177e-16,3.918594787320352e-15,25.7590419022191
LOC440731,ILMN_1683250,"PREDICTED: Homo sapiens hypothetical LOC440731, transcript variant 2 (LOC440731), mRNA.",,,,1,229725573-229725573:229729707-229729755,1q42.2a,-,XM_933693.1,440731,LOC440731,1.322274297860762,6.579819519391124,9.429428257798296,4.238349561305999e-16,3.9344564650808664e-15,25.754555441432817
FAM119A,ILMN_1762888,"Homo sapiens family with sequence similarity 119, member A (FAM119A), mRNA.",,,,2,208185875-208185924,2q33.3c,-,NM_145280.3,151194,FAM119A,1.1223006444744428,9.235036584786412,9.4215453459847,4.4245085236537686e-16,4.0955605027740465e-15,25.71185318112639
KIAA0690,ILMN_1767253,"Homo sapiens ribosomal RNA processing 12 homolog (S. cerevisiae) (RRP12), mRNA.",nucleus [goid 5634] [evidence IEA]; membrane [goid 16020] [evidence IEA]; integral to membrane [goid 16021] [evidence IEA],,binding [goid 5488] [evidence IEA],10,99106694-99106743,10q24.1b,-,NM_015179.2,23223,KIAA0690,1.049005506677414,8.370873358379713,9.420903299000193,4.440025278472833e-16,4.107972105937472e-15,25.708375391860738
PANX2,ILMN_1694810,"Homo sapiens pannexin 2 (PANX2), mRNA.",gap junction [goid 5921] [evidence IEA]; membrane [goid 16020] [evidence IEA]; integral to membrane [goid 16021] [evidence IEA],,,22,48960774-48960823,22q13.33b,+,NM_052839.2,56666,PANX2,1.4509729364105715,7.823701978878314,9.420348418087764,4.453479159643916e-16,4.117906180957457e-15,25.705369783898863
OASL,ILMN_1674811,"Homo sapiens 2'-5'-oligoadenylate synthetase-like (OASL), transcript variant 1, mRNA.",nucleolus [goid 5730] [pmid 9826176] [evidence TAS]; cytoplasm [goid 5737] [pmid 9826176] [evidence TAS]; nucleolus [goid 5730] [pmid 9826176] [evidence TAS]; cytoplasm [goid 5737] [pmid 9826176] [evidence TAS],immune response [goid 6955] [evidence IEA]; protein modification [goid 6464] [evidence IEA]; immune response [goid 6955] [evidence IEA]; protein modification [goid 6464] [evidence IEA],ATP binding [goid 5524] [evidence IEA]; transferase activity [goid 16740] [evidence IEA]; thyroid hormone receptor binding [goid 46966] [pmid 7776974] [evidence TAS]; DNA binding [goid 3677] [pmid 9826176] [evidence TAS]; double-stranded RNA binding [goid 3725] [pmid 9826176] [evidence TAS]; ATP binding [goid 5524] [evidence IEA]; transferase activity [goid 16740] [evidence IEA]; thyroid hormone receptor binding [goid 46966] [pmid 7776974] [evidence TAS]; DNA binding [goid 3677] [pmid 9826176] [evidence TAS]; double-stranded RNA binding [goid 3725] [pmid 9826176] [evidence TAS],12,119942793-119942842,12q24.31a,-,NM_003733.2,8638,OASL,-1.2797484805572052,6.73643988759044,-9.420286248410713,4.454989083632702e-16,4.117906180957457e-15,25.705033032704822
SSTR1,ILMN_1673998,"Homo sapiens somatostatin receptor 1 (SSTR1), mRNA.",plasma membrane [goid 5886] [pmid 1346068] [evidence TAS]; integral to plasma membrane [goid 5887] [pmid 1346068] [evidence TAS],"negative regulation of cell proliferation [goid 8285] [pmid 9886848] [evidence TAS]; cell-cell signaling [goid 7267] [pmid 1346068] [evidence TAS]; G-protein signaling, coupled to cyclic nucleotide second messenger [goid 7187] [pmid 8405411] [evidence TAS]; digestion [goid 7586] [pmid 1346068] [evidence TAS]; response to nutrient [goid 7584] [pmid 1346068] [evidence TAS]",receptor activity [goid 4872] [evidence IEA]; rhodopsin-like receptor activity [goid 1584] [evidence IEA]; somatostatin receptor activity [goid 4994] [pmid 1346068] [evidence IDA],14,37751342-37751391,14q21.1a,+,NM_001049.2,6751,SSTR1,-1.126528399737305,5.582325745142164,-9.419095931939962,4.483997167602197e-16,4.142754139911276e-15,25.69858556929641
MYO3B,ILMN_1727490,"Homo sapiens myosin IIIB (MYO3B), mRNA.",cytoskeleton [goid 5856] [evidence IEA]; myosin [goid 16459] [evidence IEA]; cytoskeleton [goid 5856] [evidence IEA]; myosin [goid 16459] [evidence IEA],protein amino acid phosphorylation [goid 6468] [evidence IEA]; visual perception [goid 7601] [evidence IEA]; protein amino acid phosphorylation [goid 6468] [evidence IEA]; visual perception [goid 7601] [evidence IEA],actin binding [goid 3779] [evidence IEA]; motor activity [goid 3774] [evidence IEA]; protein serine/threonine kinase activity [goid 4674] [evidence IEA]; ATP binding [goid 5524] [evidence IEA]; nucleotide binding [goid 166] [evidence IEA]; transferase activity [goid 16740] [evidence IEA]; actin binding [goid 3779] [evidence IEA]; motor activity [goid 3774] [evidence IEA]; protein serine/threonine kinase activity [goid 4674] [evidence IEA]; ATP binding [goid 5524] [evidence IEA]; nucleotide binding [goid 166] [evidence IEA]; transferase activity [goid 16740] [evidence IEA],2,171218732-171218781,2q31.1b,+,NM_138995.1,140469,MYO3B,1.3587856030186085,6.82980301050992,9.418717037059789,4.493270335226786e-16,4.1493541460613235e-15,25.69653327303875
SCG5,ILMN_2065773,"Homo sapiens secretogranin V (7B2 protein) (SCG5), mRNA.",secretory granule [goid 30141] [evidence ISS],neuropeptide signaling pathway [goid 7218] [evidence IEA]; regulation of hormone secretion [goid 46883] [evidence ISS]; peptide hormone processing [goid 16486] [evidence ISS]; protein folding [goid 6457] [evidence IEA]; transport [goid 6810] [evidence IEA]; intracellular protein transport [goid 6886] [evidence ISS],GTP binding [goid 5525] [pmid 3134253] [evidence TAS]; unfolded protein binding [goid 51082] [pmid 7913882] [evidence IDA]; enzyme inhibitor activity [goid 4857] [evidence ISS]; enzyme activator activity [goid 8047] [evidence NR ],15,30776515-30776564,15q13.3c,+,NM_003020.1,6447,SCG5,2.3929284665407202,7.524178047239005,9.417812787453022,4.515478548198749e-16,4.1678872340906024e-15,25.69163542338273
C14orf153,ILMN_1662895,"Homo sapiens chromosome 14 open reading frame 153 (C14orf153), mRNA.",,,,14,103127703-103127752,14q32.33a,+,NM_032374.2,84334,C14orf153,1.4714417112997378,9.308749654613724,9.41286344422933,4.638987694574459e-16,4.2778360259717615e-15,25.664828589517516
LOC648075,ILMN_1794510,"PREDICTED: Homo sapiens hypothetical protein LOC648075, transcript variant 1 (LOC648075), mRNA.",,,,,,,,XM_943636.1,648075,LOC648075,1.5053948412251312,6.557570355018174,9.405083565848754,4.839978811950421e-16,4.452643397113029e-15,25.622694956284885
KIF12,ILMN_2105960,"Homo sapiens kinesin family member 12 (KIF12), mRNA.",microtubule associated complex [goid 5875] [evidence IEA]; microtubule [goid 5874] [evidence IEA],microtubule-based movement [goid 7018] [evidence IEA],ATP binding [goid 5524] [evidence IEA]; microtubule motor activity [goid 3777] [evidence IEA]; nucleotide binding [goid 166] [evidence IEA],9,115893872-115893921,9q32d,-,NM_138424.1,113220,KIF12,1.4028667417785838,5.886663762376584,9.40103541233804,4.947974175618625e-16,4.545557605465767e-15,25.600773267560545
C1S,ILMN_1677603,"Homo sapiens complement component 1, s subcomponent (C1S), transcript variant 2, mRNA.",integral to membrane [goid 16021] [evidence IEA]; extracellular region [goid 5576] [evidence IEA],"complement activation, classical pathway [goid 6958] [evidence IEA]; innate immune response [goid 45087] [evidence IEA]; G-protein coupled receptor protein signaling pathway [goid 7186] [evidence IEA]",rhodopsin-like receptor activity [goid 1584] [evidence IEA]; complement component C1s activity [goid 3816] [pmid 9856483] [evidence TAS]; calcium ion binding [goid 5509] [evidence IEA],12,7039320-7039369,12p13.31d,+,NM_201442.1,716,C1S,-1.1863797618320113,8.848228291600046,-9.397864849168926,5.034233303871364e-16,4.620444461890416e-15,25.583604880336953
BMP5,ILMN_1660552,"Homo sapiens bone morphogenetic protein 5 (BMP5), mRNA.",extracellular space [goid 5615] [evidence IEA],ossification [goid 1503] [evidence IEA]; cell differentiation [goid 30154] [evidence IEA]; growth [goid 40007] [evidence IEA]; cartilage development [goid 51216] [evidence IEA],cytokine activity [goid 5125] [evidence NAS]; growth factor activity [goid 8083] [evidence IEA],6,55731840-55731872:55733214-55733230,6p12.1b,-,NM_021073.2,653,BMP5,-1.35276347036607,6.853357107798115,-9.38698196352209,5.341887984163948e-16,4.895893103077823e-15,25.524681140097034
DNTTIP1,ILMN_1691117,"Homo sapiens deoxynucleotidyltransferase, terminal, interacting protein 1 (DNTTIP1), mRNA.",nucleus [goid 5634] [evidence IEA],,,20,43873184-43873233,20q13.12b,+,NM_052951.2,116092,DNTTIP1,1.1185692479095906,9.868741799396004,9.379339591363603,5.56907614573039e-16,5.096921028631126e-15,25.483308589766292
CYTL1,ILMN_2201596,"Homo sapiens cytokine-like 1 (CYTL1), mRNA.",extracellular space [goid 5615] [pmid 10857752] [evidence TAS]; soluble fraction [goid 5625] [pmid 10857752] [evidence TAS],signal transduction [goid 7165] [pmid 10857752] [evidence TAS],receptor binding [goid 5102] [pmid 10857752] [evidence TAS],4,5067685-5067734,4p16.2a,-,NM_018659.2,54360,CYTL1,-1.6372927367914825,5.718588987925693,-9.370956047004334,5.829396653054982e-16,5.32766387358238e-15,25.437929306860145
MGC15912,ILMN_1657701,"Homo sapiens hypothetical protein MGC15912 (MGC15912), mRNA.",,,,11,66153907-66153956,11q13.1e,+,NM_032886.1,84972,MGC15912,1.7693092543476787,8.654835839067603,9.361695542021213,6.131077491137026e-16,5.585041837999297e-15,25.38781005255097
COL9A2,ILMN_1685122,"Homo sapiens collagen, type IX, alpha 2 (COL9A2), mRNA.",collagen type IX [goid 5594] [pmid 10364514] [evidence TAS]; extracellular matrix (sensu Metazoa) [goid 5578] [evidence IEA]; cytoplasm [goid 5737] [evidence IEA],skeletal development [goid 1501] [pmid 10364514] [evidence TAS]; phosphate transport [goid 6817] [evidence IEA],structural molecule activity [goid 5198] [evidence IEA],1,40538963-40539012,1p34.2d,-,NM_001852.3,1298,COL9A2,1.7027354719421561,7.587024810186931,9.359870422775407,6.19234673138867e-16,5.638218507528423e-15,25.377933093418218
C20orf102,ILMN_1715927,"Homo sapiens chromosome 20 open reading frame 102 (C20orf102), mRNA.",,,,20,36006935-36006984,20q11.23b,+,NM_080607.1,128434,C20orf102,2.253946314805402,7.559292759144937,9.356728190014719,6.29926567720115e-16,5.7302143660254155e-15,25.360929006847538
TRK1,ILMN_1776125,Homo sapiens tRNA lysine 1 (TRK1) on chromosome 17.,,,,11,,,-,NR_001449.1,7206,TRK1,-1.5516144850392566,6.374930059555028,-9.352023728998025,6.462793442655975e-16,5.8707473300770006e-15,25.335472558331777
HCST,ILMN_1699931,"Homo sapiens hematopoietic cell signal transducer (HCST), transcript variant 1, mRNA.",integral to membrane [goid 16021] [evidence IEA]; integral to membrane [goid 16021] [evidence IEA],,,19,41086896-41086902:41086903-41086945,19q13.12a,+,NM_014266.3,10870,HCST,-1.0935526326822345,9.95183260284256,-9.350818067051327,6.505379701042843e-16,5.90591430834332e-15,25.32894887163098
GUCY1B2,ILMN_1652166,"Homo sapiens guanylate cyclase 1, soluble, beta 2 (GUCY1B2), mRNA.",,intracellular signaling cascade [goid 7242] [evidence IEA]; cGMP biosynthesis [goid 6182] [evidence IEA],metal ion binding [goid 46872] [evidence IEA]; iron ion binding [goid 5506] [evidence IEA]; guanylate cyclase activity [goid 4383] [evidence IEA],13,50466844-50466893,13q14.3b,-,NM_004129.2,2974,GUCY1B2,1.6119516862665018,5.954940651272614,9.349711475664794,6.54471289525666e-16,5.936858974118995e-15,25.322961353632426
GZMH,ILMN_1731233,"Homo sapiens granzyme H (cathepsin G-like 2, protein h-CCPX) (GZMH), mRNA.",cytoplasm [goid 5737] [evidence NAS],apoptosis [goid 6915] [pmid 2402757] [evidence NAS]; cytolysis [goid 19835] [evidence IEA],peptidase activity [goid 8233] [evidence IEA]; chymotrypsin activity [goid 4263] [evidence IEA]; trypsin activity [goid 4295] [evidence IEA],14,24145611-24145648:24145649-24145660,14q12a,-,NM_033423.2,2999,GZMH,-1.5266338957349985,8.710829955130276,-9.345324756691284,6.702984293764912e-16,6.071950207531813e-15,25.299226840377575
TSPAN12,ILMN_1768115,"Homo sapiens tetraspanin 12 (TSPAN12), mRNA.",membrane fraction [goid 5624] [pmid 10719184] [evidence TAS]; membrane [goid 16020] [evidence IEA]; integral to membrane [goid 16021] [pmid 10719184] [evidence TAS],,,7,120215952-120216001,7q31.31d,-,NM_012338.3,23554,TSPAN12,-1.4518435724504606,7.137270058715087,-9.34093247934002,6.865280889418455e-16,6.216077980033393e-15,25.275463921862244
KCNK12,ILMN_1711988,"Homo sapiens potassium channel, subfamily K, member 12 (KCNK12), mRNA.",membrane [goid 16020] [evidence IEA]; integral to membrane [goid 16021] [evidence IEA],ion transport [goid 6811] [evidence IEA]; potassium ion transport [goid 6813] [evidence IEA],potassium ion binding [goid 30955] [evidence IEA]; potassium channel activity [goid 5267] [evidence IEA]; voltage-gated ion channel activity [goid 5244] [evidence IEA],2,47601456-47601505,2p16.3d,-,NM_022055.1,56660,KCNK12,1.8417296887964651,6.378857074100774,9.334453266944728,7.11187263310224e-16,6.427404371799496e-15,25.24041341344645
CLC,ILMN_1654875,"Homo sapiens Charcot-Leyden crystal protein (CLC), mRNA.",,development [goid 7275] [pmid 8400237] [evidence TAS]; antimicrobial humoral response (sensu Vertebrata) [goid 19735] [pmid 8400237] [evidence TAS]; lipid catabolism [goid 16042] [evidence IEA]; phospholipid metabolism [goid 6644] [evidence NR ],hydrolase activity [goid 16787] [evidence IEA]; serine esterase activity [goid 4759] [evidence IEA]; sugar binding [goid 5529] [evidence IEA]; lysophospholipase activity [goid 4622] [evidence IEA],19,44916827-44916876,19q13.2b,-,NM_001828.4,1178,CLC,-1.9341983783023116,5.970191148785922,-9.33349647636133,7.149028088360314e-16,6.4579885165368905e-15,25.235237786336388
MMP23A,ILMN_1790052,"Homo sapiens matrix metallopeptidase 23A (MMP23A), mRNA.",extracellular matrix (sensu Metazoa) [goid 5578] [pmid 9740677] [evidence NAS]; intracellular [goid 5622] [evidence ISS],,metalloendopeptidase activity [goid 4222] [pmid 9740677] [evidence NAS]; zinc ion binding [goid 8270] [evidence ISS],1,1559525-1559570:1559690-1559693,1p36.33a,+,NM_004659.1,8511,MMP23A,-1.104378190054236,7.343385291351564,-9.331293398519895,7.235318936391706e-16,6.526860623870018e-15,25.2233208438295
GALNT3,ILMN_1671039,"Homo sapiens UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 3 (GalNAc-T3) (GALNT3), mRNA.",membrane fraction [goid 5624] [pmid 8663203] [evidence TAS]; integral to membrane [goid 16021] [pmid 8663203] [evidence TAS]; Golgi stack [goid 5795] [evidence IEA],carbohydrate metabolism [goid 5975] [pmid 9592121] [evidence NAS],"manganese ion binding [goid 30145] [evidence IEA]; transferase activity, transferring glycosyl groups [goid 16757] [evidence IEA]; polypeptide N-acetylgalactosaminyltransferase activity [goid 4653] [pmid 9592121] [evidence TAS]; sugar binding [goid 5529] [evidence IEA]; calcium ion binding [goid 5509] [evidence IEA]",2,166311884-166311933,2q24.3c,-,NM_004482.2,2591,GALNT3,2.1582503691849997,8.762359397738546,9.325831091804707,7.453775593766725e-16,6.714600898961842e-15,25.193775834478718
STEAP3,ILMN_2383349,"Homo sapiens STEAP family member 3 (STEAP3), transcript variant 2, mRNA.",integral to membrane [goid 16021] [evidence IEA]; multivesicular body [goid 5771] [pmid 15319436] [evidence IDA]; integral to membrane [goid 16021] [evidence IEA]; multivesicular body [goid 5771] [pmid 15319436] [evidence IDA],protein secretion [goid 9306] [pmid 15319436] [evidence IDA]; electron transport [goid 6118] [evidence IEA]; protein secretion [goid 9306] [pmid 15319436] [evidence IDA]; electron transport [goid 6118] [evidence IEA],oxidoreductase activity [goid 16491] [evidence IEA]; iron ion binding [goid 5506] [evidence IEA]; FAD binding [goid 50660] [evidence IEA]; oxidoreductase activity [goid 16491] [evidence IEA]; iron ion binding [goid 5506] [evidence IEA]; FAD binding [goid 50660] [evidence IEA],2,119739480-119739529,2q14.2b,+,NM_018234.2,55240,STEAP3,1.1245998949271954,9.329900815921533,9.321189880641247,7.644555189884287e-16,6.880099670895858e-15,25.168674099831268
CDCA7,ILMN_1737184,"Homo sapiens cell division cycle associated 7 (CDCA7), transcript variant 2, mRNA.",,,metal ion binding [goid 46872] [evidence IEA]; oxidoreductase activity [goid 16491] [evidence IEA]; copper ion binding [goid 5507] [evidence IEA],2,173941629-173941678,2q31.1e,+,NM_145810.1,83879,CDCA7,2.075734143676341,8.110046870563307,9.319985510370074,7.69485236506859e-16,6.9189754653143274e-15,25.162160639860485
ANXA2,ILMN_1711899,"Homo sapiens annexin A2 (ANXA2), transcript variant 2, mRNA.",plasma membrane [goid 5886] [pmid 10809787] [evidence TAS]; soluble fraction [goid 5625] [pmid 7961821] [evidence TAS]; plasma membrane [goid 5886] [pmid 10809787] [evidence TAS]; soluble fraction [goid 5625] [pmid 7961821] [evidence TAS],skeletal development [goid 1501] [pmid 7961821] [evidence TAS]; skeletal development [goid 1501] [pmid 7961821] [evidence TAS],calcium-dependent phospholipid binding [goid 5544] [evidence IEA]; calcium ion binding [goid 5509] [evidence IEA]; phospholipase inhibitor activity [goid 4859] [pmid 3013422] [evidence TAS]; cytoskeletal protein binding [goid 8092] [evidence IEA]; calcium-dependent phospholipid binding [goid 5544] [evidence IEA]; calcium ion binding [goid 5509] [evidence IEA]; phospholipase inhibitor activity [goid 4859] [pmid 3013422] [evidence TAS]; cytoskeletal protein binding [goid 8092] [evidence IEA],15,58476750-58476799,15q22.2a,-,NM_001002857.1,302,ANXA2,-1.012494662342247,10.962081484366184,-9.319886766069645,7.698990756331284e-16,6.919503454202724e-15,25.161626617870656
FLJ23191,ILMN_1689176,"Homo sapiens hypothetical protein FLJ23191 (FLJ23191), mRNA.",integral to membrane [goid 16021] [evidence IEA],,,4,122176576-122176625,4q27b,-,NM_024574.2,79625,FLJ23191,-1.4254775903670271,10.103963179579345,-9.319765993066529,7.7040553924212875e-16,6.920863039249829e-15,25.160973462968737
FKBP14,ILMN_1665243,"Homo sapiens FK506 binding protein 14, 22 kDa (FKBP14), mRNA.",endoplasmic reticulum [goid 5783] [evidence IEA]; endoplasmic reticulum [goid 5783] [evidence IEA],protein folding [goid 6457] [evidence IEA]; protein folding [goid 6457] [evidence IEA],peptidyl-prolyl cis-trans isomerase activity [goid 3755] [evidence IEA]; calcium ion binding [goid 5509] [evidence IEA]; isomerase activity [goid 16853] [evidence IEA]; peptidyl-prolyl cis-trans isomerase activity [goid 3755] [evidence IEA]; calcium ion binding [goid 5509] [evidence IEA]; isomerase activity [goid 16853] [evidence IEA],7,30019936-30019985,7p15.1b,-,NM_017946.2,55033,FKBP14,1.358045932100202,9.97888953564733,9.318978618540493,7.737155620884213e-16,6.947395266033589e-15,25.156715278570655
TEX14,ILMN_1685490,"Homo sapiens testis expressed 14 (TEX14), transcript variant 2, mRNA.",,protein amino acid phosphorylation [goid 6468] [evidence IEA],ATP binding [goid 5524] [evidence IEA]; protein-tyrosine kinase activity [goid 4713] [evidence IEA]; nucleotide binding [goid 166] [evidence IEA],17,53989237-53989286,17q22d,-,NM_031272.3,56155,TEX14,-1.0487686530984597,5.383299115467688,-9.315396179255407,7.8895566641899e-16,7.077716924573674e-15,25.137341852595167
ANKS3,ILMN_1751636,"Homo sapiens ankyrin repeat and sterile alpha motif domain containing 3 (ANKS3), mRNA.",,,,16,4686831-4686880,16p13.3b,-,NM_133450.1,124401,ANKS3,1.1971705411611042,6.665954837249137,9.31266594709977,8.007710959055402e-16,7.180407180726852e-15,25.12257782970463
FOXD2,ILMN_1789400,"Homo sapiens forkhead box D2 (FOXD2), mRNA.",nucleus [goid 5634] [evidence IEA],"regulation of transcription, DNA-dependent [goid 6355] [evidence IEA]; transcription [goid 6350] [evidence IEA]",transcription factor activity [goid 3700] [pmid 9403061] [evidence TAS],1,47678781-47678830,1p33d,+,NM_004474.2,2306,FOXD2,1.3755255831460236,6.862378097402719,9.311628329326922,8.053076561541392e-16,7.217764342301473e-15,25.11696697393931
NUP188,ILMN_1715416,"Homo sapiens nucleoporin 188kDa (NUP188), mRNA.",integral to membrane [goid 16021] [evidence IEA]; outer membrane [goid 19867] [evidence IEA],,porin activity [goid 15288] [evidence IEA],9,130808945-130808994,9q34.11c,+,NM_015354.1,23511,NUP188,1.0238283567104398,8.473903866514874,9.307991477815541,8.214116229266217e-16,7.351954741720359e-15,25.097301673833467
FLJ10986,ILMN_1737604,"Homo sapiens hypothetical protein FLJ10986 (FLJ10986), mRNA.",,carbohydrate metabolism [goid 5975] [evidence IEA],,1,59912323-59912372,1p32.1d-p32.1c,+,NM_018291.2,55277,FLJ10986,-1.260570161962752,10.027822154067819,-9.30347087033815,8.418772789289433e-16,7.52131076567192e-15,25.072859343806375
LOC286208,ILMN_1657011,"PREDICTED: Homo sapiens hypothetical protein LOC286208, transcript variant 1 (LOC286208), mRNA.",,,,9,129913314-129913363,,-,XM_379668.3,286208,LOC286208,1.4321998801710851,7.155701604127832,9.296459395038525,8.746301127794877e-16,7.810342689050559e-15,25.034952837264957
SRPX2,ILMN_1676213,"Homo sapiens sushi-repeat-containing protein, X-linked 2 (SRPX2), mRNA.",,,,X,99812607-99812640:99812641-99812656,Xq22.1b,+,NM_014467.1,27286,SRPX2,1.8068943505593094,7.947905505352615,9.294330827850857,8.84822536941642e-16,7.897740326297707e-15,25.02344592653024
TM4SF11,ILMN_1787673,"Homo sapiens transmembrane 4 superfamily member 11 (plasmolipin) (TM4SF11), mRNA.",,,,16,55847999-55848048,16q13c,-,NM_015993.1,51090,TM4SF11,-1.4309845029349137,9.595900925721063,-9.293615059452632,8.882764648756124e-16,7.924939065064702e-15,25.019576615748893
GLULD1,ILMN_1742620,"Homo sapiens glutamate-ammonia ligase (glutamine synthetase) domain containing 1 (GLULD1), mRNA.",,nitrogen compound metabolism [goid 6807] [evidence IEA]; glutamine biosynthesis [goid 6542] [evidence IEA]; nitrogen compound metabolism [goid 6807] [evidence IEA]; glutamine biosynthesis [goid 6542] [evidence IEA],glutamate-ammonia ligase activity [goid 4356] [evidence IEA]; glutamate-ammonia ligase activity [goid 4356] [evidence IEA],6,64047981-64048030,6q12a,-,NM_016571.1,51557,GLULD1,1.8565389905200043,5.906153922947709,9.279391132818464,9.597715728792631e-16,8.54323850961738e-15,24.94269432396896
NEXN,ILMN_1783276,"Homo sapiens nexilin (F actin binding protein) (NEXN), mRNA.",cellular component unknown [goid 8372] [evidence ND ],biological process unknown [goid 4] [evidence ND ],molecular function unknown [goid 5554] [evidence ND ],1,78181250-78181299,1p31.1e,+,NM_144573.1,91624,NEXN,-1.268553016502194,7.532582188990907,-9.277745629967473,9.684043714102203e-16,8.612213225435027e-15,24.93380133919388
IGF2BP3,ILMN_1807423,"Homo sapiens insulin-like growth factor 2 mRNA binding protein 3 (IGF2BP3), mRNA.",cytoplasm [goid 5737] [pmid 9891060] [evidence TAS],"morphogenesis [goid 9653] [pmid 9891060] [evidence TAS]; regulation of translation [goid 6445] [evidence IEA]; transcription [goid 6350] [evidence IEA]; regulation of transcription, DNA-dependent [goid 6355] [evidence IEA]; RNA processing [goid 6396] [pmid 9891060] [evidence TAS]",RNA binding [goid 3723] [pmid 9891060] [evidence TAS]; nucleotide binding [goid 166] [evidence IEA],7,23316661-23316710,7p15.3b,-,NM_006547.2,10643,IGF2BP3,1.9597308953258024,6.760874190420325,9.27557169233709,9.799283374295774e-16,8.706750412592482e-15,24.922052850936755
SGK,ILMN_1702487,"Homo sapiens serum/glucocorticoid regulated kinase (SGK), mRNA.",nucleus [goid 5634] [evidence IEA],apoptosis [goid 6915] [evidence IEA]; sodium ion transport [goid 6814] [pmid 10884438] [evidence TAS]; response to stress [goid 6950] [pmid 9114008] [evidence TAS]; protein amino acid phosphorylation [goid 6468] [pmid 9114008] [evidence TAS],transferase activity [goid 16740] [evidence IEA]; nucleotide binding [goid 166] [evidence IEA]; ATP binding [goid 5524] [evidence IEA]; protein serine/threonine kinase activity [goid 4674] [pmid 9114008] [evidence TAS],6,134532365-134532414,6q23.2d,-,NM_005627.2,6446,SGK,-1.1143027440556246,11.830461943571429,-9.273425622140048,9.914387076080154e-16,8.805006024495069e-15,24.910455388678688
RGS5,ILMN_1651554,"Homo sapiens regulator of G-protein signalling 5 (RGS5), mRNA.",,regulation of G-protein coupled receptor protein signaling pathway [goid 8277] [pmid 10471929] [evidence TAS]; negative regulation of signal transduction [goid 9968] [evidence IEA],signal transducer activity [goid 4871] [evidence IEA]; GTPase activator activity [goid 5096] [pmid 10471929] [evidence TAS],1,161379402-161379451,1q23.3c,-,NM_003617.2,8490,RGS5,-1.723826367003788,8.058426411323733,-9.271111645108391,1.004000747538943e-15,8.908449255827095e-15,24.897951022498557
RDH13,ILMN_1660723,"Homo sapiens retinol dehydrogenase 13 (all-trans/9-cis) (RDH13), mRNA.",,metabolism [goid 8152] [evidence IEA],oxidoreductase activity [goid 16491] [evidence IEA],19,60247666-60247715,19q13.42b,-,NM_138412.2,112724,RDH13,1.2265396183279424,8.474696851354437,9.270457908851247,1.0075783977990737e-15,8.936124297275809e-15,24.89441842399209
LOC642678,ILMN_1796206,"PREDICTED: Homo sapiens similar to myeloid/lymphoid or mixed-lineage leukemia 3 isoform 2 (LOC642678), mRNA.",,,,2,91249727-91249749:91250257-91250283,2p11.1d,-,XM_926130.1,642678,LOC642678,1.542879616801721,7.286633737021193,9.260690005159697,1.062573754872612e-15,9.406746757697793e-15,24.841640224962536
PACSIN3,ILMN_1682957,"Homo sapiens protein kinase C and casein kinase substrate in neurons 3 (PACSIN3), mRNA.",cytoplasm [goid 5737] [evidence ISS],endocytosis [goid 6897] [evidence IEA]; negative regulation of endocytosis [goid 45806] [evidence ISS],enzyme binding [goid 19899] [pmid 10531379] [evidence IPI]; cytoskeletal protein binding [goid 8092] [evidence ISS],11,47155817-47155866,11p11.2b,-,NM_016223.3,29763,PACSIN3,1.0105231254518356,8.364729309439733,9.259454901864448,1.0697375105380587e-15,9.465865301014566e-15,24.834967308402728
MYOC,ILMN_2052331,"Homo sapiens myocilin, trabecular meshwork inducible glucocorticoid response (MYOC), mRNA.",membrane [goid 16020] [evidence IEA]; endoplasmic reticulum [goid 5783] [evidence IEA]; cilium [goid 5929] [evidence NR ]; membrane [goid 16020] [evidence IEA]; endoplasmic reticulum [goid 5783] [evidence IEA]; cilium [goid 5929] [evidence NR ],morphogenesis [goid 9653] [pmid 9169133] [evidence TAS]; visual perception [goid 7601] [evidence NR ]; morphogenesis [goid 9653] [pmid 9169133] [evidence TAS]; visual perception [goid 7601] [evidence NR ],latrotoxin receptor activity [goid 16524] [evidence IEA]; structural molecule activity [goid 5198] [pmid 9169133] [evidence TAS]; latrotoxin receptor activity [goid 16524] [evidence IEA]; structural molecule activity [goid 5198] [pmid 9169133] [evidence TAS],1,169871551-169871600,1q24.3b,-,NM_000261.1,4653,MYOC,-1.2259357828562383,5.479418685220707,-9.259133725390544,1.0716082521771102e-15,9.478114749737172e-15,24.833232105145026
PTP4A2,ILMN_1670972,"PREDICTED: Homo sapiens protein tyrosine phosphatase type IVA, member 2, transcript variant 14 (PTP4A2), mRNA.",,,,,,1p35.2a,,XM_944928.1,8073,PTP4A2,1.1679039669539222,9.215330393243342,9.257394183428689,1.0817973120792244e-15,9.559555839393963e-15,24.823834139115267
LOC92017,ILMN_1670539,"Homo sapiens similar to RIKEN cDNA 4933437K13 (LOC92017), mRNA.",,intracellular signaling cascade [goid 7242] [evidence IEA],,16,12528603-12528652,16p13.13a-p13.12b,+,NM_001009607.1,92017,LOC92017,1.8547927728336209,6.915588531199457,9.246911950884286,1.1452728360025391e-15,1.0106721562277841e-14,24.7672092802931
DPRXP4,ILMN_1739532,Homo sapiens divergent-paired related homeobox pseudogene 4 (DPRXP4) on chromosome 17.,,,,17,26326864-26326913,17q11.2c,+,NR_002221.1,503645,DPRXP4,1.0126274798029309,5.5690610517172745,9.246475377811388,1.147995610638351e-15,1.012616318392407e-14,24.764851141311095
FOXF2,ILMN_1674934,"Homo sapiens forkhead box F2 (FOXF2), mRNA.",transcription factor complex [goid 5667] [pmid 9722567] [evidence TAS]; nucleus [goid 5634] [pmid 9722567] [evidence TAS],"regulation of transcription, DNA-dependent [goid 6355] [evidence IEA]; transcription [goid 6350] [evidence IEA]; transcription from RNA polymerase II promoter [goid 6366] [evidence NR ]",transcription coactivator activity [goid 3713] [evidence NR ]; RNA polymerase II transcription factor activity [goid 3702] [evidence NR ]; transcription factor activity [goid 3700] [pmid 9722567] [evidence NAS],6,1340322-1340371,6p25.3a,+,NM_001452.1,2295,FOXF2,-1.224852915007502,7.637335680085919,-9.244813427020462,1.1584198849272653e-15,1.0204254727761195e-14,24.755874316942307
ANK2,ILMN_1776363,"Homo sapiens ankyrin 2, neuronal (ANK2), transcript variant 2, mRNA.",membrane [goid 16020] [evidence NR ]; actin cytoskeleton [goid 15629] [evidence NR ],metabolism [goid 8152] [evidence IEA]; signal transduction [goid 7165] [evidence IEA],oxidoreductase activity [goid 16491] [evidence IEA]; protein binding [goid 5515] [evidence IEA]; structural constituent of cytoskeleton [goid 5200] [evidence NR ],4,114523964-114524013,4q26a,+,NM_020977.2,287,ANK2,-1.1035837476529586,5.949055473337811,-9.240970756384678,1.1828851596836515e-15,1.0410351100467908e-14,24.735119590332506
FLJ14166,ILMN_1763745,"Homo sapiens hypothetical protein FLJ14166 (FLJ14166), mRNA.",nucleus [goid 5634] [evidence IEA],cytokinesis [goid 910] [evidence IEA],,5,159612823-159612872,5q33.3d,-,NM_024565.4,79616,FLJ14166,1.0876677709606941,6.666351156032194,9.240328005776226,1.1870273891158656e-15,1.0437377561788196e-14,24.73164815205728
IPP,ILMN_1789106,"Homo sapiens intracisternal A particle-promoted polypeptide (IPP), mRNA.",actin cytoskeleton [goid 15629] [pmid 10072760] [evidence TAS],,protein binding [goid 5515] [evidence IEA]; actin binding [goid 3779] [pmid 10072760] [evidence TAS],1,45937209-45937258,1p34.1b,-,NM_005897.1,3652,IPP,1.277864968375786,8.04576587462447,9.23024847008557,1.2539098546561917e-15,1.0990748321176739e-14,24.67721456946568
WFDC10B,ILMN_1661076,"Homo sapiens WAP four-disulfide core domain 10B (WFDC10B), transcript variant 2, mRNA.",,,,20,43767021-43767044:43767045-43767070,20q13.12b,-,NM_172131.2,280664,WFDC10B,1.0365662743717614,5.783164754903405,9.222006596359662,1.3113812979428091e-15,1.148416386086096e-14,24.632712243999027
SPI1,ILMN_1696463,"Homo sapiens spleen focus forming virus (SFFV) proviral integration oncogene spi1 (SPI1), mRNA.",nucleus [goid 5634] [evidence IEA],"regulation of transcription, DNA-dependent [goid 6355] [evidence IEA]; transcription [goid 6350] [evidence IEA]; negative regulation of transcription from RNA polymerase II promoter [goid 122] [pmid 10867017] [evidence TAS]",RNA binding [goid 3723] [evidence IEA]; protein binding [goid 5515] [pmid 10207087] [evidence IPI]; transcription factor activity [goid 3700] [pmid 10867017] [evidence TAS]; sequence-specific DNA binding [goid 43565] [evidence IEA],11,47333039-47333088,11p11.2b,-,NM_003120.1,6688,SPI1,-1.1588034247677736,8.412029325899091,-9.221549974458496,1.3146410731719653e-15,1.1502371491134147e-14,24.630246884460508
TMEM16H,ILMN_1709124,"Homo sapiens transmembrane protein 16H (TMEM16H), mRNA.",membrane [goid 16020] [evidence IEA]; integral to membrane [goid 16021] [evidence IEA],,,19,17295236-17295285,19p13.11e,-,NM_020959.1,57719,TMEM16H,1.041257081760464,6.8850251197810906,9.221003947091498,1.318549713737341e-15,1.15313919085153e-14,24.627298839532624
AGMAT,ILMN_1707169,"Homo sapiens agmatine ureohydrolase (agmatinase) (AGMAT), mRNA.",mitochondrion [goid 5739] [evidence IEA],arginine catabolism [goid 6527] [evidence IEA]; putrescine biosynthesis [goid 9446] [evidence IEA]; spermidine biosynthesis [goid 8295] [evidence IEA],hydrolase activity [goid 16787] [evidence IEA]; arginase activity [goid 4053] [evidence IEA]; manganese ion binding [goid 30145] [evidence IEA]; metal ion binding [goid 46872] [evidence IEA]; agmatinase activity [goid 8783] [evidence IEA],1,15771847-15771896,1p36.21a,-,NM_024758.3,79814,AGMAT,1.0764653730731508,5.610528309364984,9.214655171410321,1.3648559058835465e-15,1.190430498036746e-14,24.593023384780405
RNU101A,ILMN_1716441,"Homo sapiens small nucleolar RNA, C/D box 4A (SNORD4A) on chromosome 17.",,,,17,24073749-24073798,17q11.2a,+,NR_000010.1,26773,RNU101A,1.1124277377511795,6.144639730481931,9.21317277733055,1.375899509106129e-15,1.199525813643531e-14,24.585020863929135
FLJ13265,ILMN_1807525,"Homo sapiens cyclin N-terminal domain containing 2 (CNTD2), mRNA.",,,,19,45420261-45420310,19q13.2b,-,NM_024877.1,79935,FLJ13265,1.1301602203787189,5.558000506520888,9.21199243850646,1.3847565285705216e-15,1.2056291760141471e-14,24.578649101468994
SNAI2,ILMN_1655740,"Homo sapiens snail homolog 2 (Drosophila) (SNAI2), mRNA.",nucleus [goid 5634] [pmid 10866665] [evidence TAS],"regulation of transcription, DNA-dependent [goid 6355] [evidence IEA]; ectoderm and mesoderm interaction [goid 7499] [pmid 9182671] [evidence TAS]; transcription [goid 6350] [evidence IEA]; negative regulation of transcription from RNA polymerase II promoter [goid 122] [pmid 10866665] [evidence TAS]; development [goid 7275] [evidence IEA]",metal ion binding [goid 46872] [evidence IEA]; zinc ion binding [goid 8270] [evidence IEA]; DNA binding [goid 3677] [evidence IEA],8,49993911-49993918:49993919-49993960,8q11.21c,-,NM_003068.3,6591,SNAI2,-1.3335192557223952,6.774348457770605,-9.205414793185785,1.4351651435183572e-15,1.2478443918543146e-14,24.543143785672907
WDR34,ILMN_1685928,"Homo sapiens WD repeat domain 34 (WDR34), mRNA.",,,,9,130436048-130436082:130436326-130436340,9q34.11b,-,NM_052844.3,89891,WDR34,1.077408456544818,8.987494275877614,9.191250515333332,1.550012856777386e-15,1.3459002011723426e-14,24.466700942930306
MAP7D2,ILMN_2080080,"Homo sapiens MAP7 domain containing 2 (MAP7D2), mRNA.",,,,X,19935651-19935700,Xp22.12b,-,NM_152780.2,256714,MAP7D2,1.4953502839893114,5.56042544689972,9.178822200084053,1.658306901969397e-15,1.438011125272528e-14,24.399642952482015
TMEM55A,ILMN_1752117,"Homo sapiens transmembrane protein 55A (TMEM55A), mRNA.",membrane [goid 16020] [evidence IEA]; integral to membrane [goid 16021] [evidence IEA],,hydrolase activity [goid 16787] [evidence IEA],8,92075933-92075982,8q21.3e,-,NM_018710.1,55529,TMEM55A,-1.0512112120798829,6.740058982256454,-9.176022624901071,1.6837236826402794e-15,1.4587530438526386e-14,24.38453970470272
A2M,ILMN_1745607,"Homo sapiens alpha-2-macroglobulin (A2M), mRNA.",extracellular region [goid 5576] [pmid 14718574] [evidence NAS],intracellular protein transport [goid 6886] [evidence NR ]; protein homooligomerization [goid 51260] [evidence NAS],serine-type endopeptidase inhibitor activity [goid 4867] [evidence IEA]; tumor necrosis factor binding [goid 43120] [pmid 9714181] [evidence IDA]; interleukin-8 binding [goid 19959] [pmid 10880251] [evidence IPI]; interleukin-1 binding [goid 19966] [pmid 9714181] [evidence IDA]; wide-spectrum protease inhibitor activity [goid 17114] [evidence IEA]; protein carrier activity [goid 8320] [evidence NR ]; enzyme binding [goid 19899] [pmid 11435418] [evidence IPI],12,9111650-9111685:9111686-9111699,12p13.31a,-,NM_000014.4,2,A2M,-1.2553702784480478,12.17903207222903,-9.170904495974272,1.7311984149274419e-15,1.497886372773588e-14,24.35693023613769
LMOD1,ILMN_1680948,"Homo sapiens leiomodin 1 (smooth muscle) (LMOD1), mRNA.",membrane fraction [goid 5624] [pmid 2026759] [evidence TAS]; cytoskeleton [goid 5856] [evidence IEA],,tropomyosin binding [goid 5523] [evidence IEA],1,200132489-200132538,1q32.1c,-,NM_012134.1,25802,LMOD1,-1.3094741176564364,6.80768197456268,-9.168628916999818,1.7527325934367417e-15,1.5156046225148814e-14,24.344655579451686
DNASE2B,ILMN_1789130,"Homo sapiens deoxyribonuclease II beta (DNASE2B), transcript variant 1, mRNA.",lysosome [goid 5764] [evidence IEA]; lysosome [goid 5764] [evidence IEA],DNA metabolism [goid 6259] [evidence IEA]; DNA metabolism [goid 6259] [evidence IEA],deoxyribonuclease II activity [goid 4531] [evidence IEA]; endonuclease activity [goid 4519] [evidence IEA]; hydrolase activity [goid 16787] [evidence IEA]; deoxyribonuclease II activity [goid 4531] [evidence IEA]; endonuclease activity [goid 4519] [evidence IEA]; hydrolase activity [goid 16787] [evidence IEA],1,84652854-84652903,1p31.1a,+,NM_021233.2,58511,DNASE2B,-1.1102606127485055,5.836831037465524,-9.165303669631616,1.784681099514384e-15,1.542106927895245e-14,24.32671984843057
DTWD2,ILMN_1794882,"Homo sapiens DTW domain containing 2 (DTWD2), mRNA.",,,,5,118204603-118204652,5q23.1c,-,NM_173666.1,285605,DTWD2,1.0419301209636505,8.349719071726447,9.15840057165467,1.8528707675136796e-15,1.5967796065901834e-14,24.289489399073926
ATAD2,ILMN_2048700,"Homo sapiens ATPase family, AAA domain containing 2 (ATAD2), mRNA.",,,nucleoside-triphosphatase activity [goid 17111] [evidence IEA]; nucleotide binding [goid 166] [evidence IEA]; ATP binding [goid 5524] [evidence IEA],8,124407324-124407373,8q24.13b-q24.13c,-,NM_014109.2,29028,ATAD2,1.1743045042078224,6.530043306767363,9.154898391027402,1.88845272539608e-15,1.6252871622942853e-14,24.27060291791411
LOC613037,ILMN_2070052,Homo sapiens nuclear pore complex interacting protein pseudogene (LOC613037) on chromosome 16.,,,,16,30142001-30142050,16p11.2d,-,NR_002555.2,613037,LOC613037,1.5096965703439054,11.635244020304821,9.149707462344804,1.942449193360494e-15,1.6695466489911437e-14,24.242611649968794
MATN2,ILMN_1694840,"Homo sapiens matrilin 2 (MATN2), transcript variant 2, mRNA.",extracellular matrix (sensu Metazoa) [goid 5578] [pmid 11124542] [evidence NAS],,calcium ion binding [goid 5509] [evidence IEA],8,99117381-99117430,8q22.1e-q22.2a,+,NM_030583.2,4147,MATN2,-1.369651249444801,7.444142646775599,-9.146349366092647,1.9781975551206217e-15,1.698773881072072e-14,24.224505082464614
VLDLR,ILMN_2361862,"Homo sapiens very low density lipoprotein receptor (VLDLR), transcript variant 2, mRNA.",membrane fraction [goid 5624] [pmid 15082773] [evidence IDA]; membrane [goid 16020] [evidence IEA]; plasma membrane [goid 5886] [pmid 10380922] [evidence TAS]; integral to membrane [goid 16021] [evidence IEA]; coated pit [goid 5905] [evidence IEA],memory [goid 7613] [pmid 7550352] [evidence TAS]; lipid transport [goid 6869] [evidence IEA]; signal transduction [goid 7165] [pmid 10380922] [evidence TAS]; steroid metabolism [goid 8202] [evidence IEA]; endocytosis [goid 6897] [evidence IEA]; cholesterol metabolism [goid 8203] [evidence IEA]; lipid metabolism [goid 6629] [evidence IEA],low-density lipoprotein receptor activity [goid 5041] [pmid 10380922] [evidence TAS]; lipid transporter activity [goid 5319] [evidence IEA]; receptor activity [goid 4872] [evidence IEA]; calcium ion binding [goid 5509] [evidence IEA],9,2643893-2643942,9p24.2b,+,NM_001018056.1,7436,VLDLR,-1.1551347536847345,7.86743742613305,-9.142540046945545,2.0195439927982554e-15,1.7312280994137268e-14,24.203966932640675
EVPL,ILMN_1727288,"Homo sapiens envoplakin (EVPL), mRNA.",plasmodesma [goid 9506] [pmid 8707850] [evidence TAS]; cytoskeleton [goid 5856] [evidence IEA],keratinization [goid 31424] [evidence IEA]; epidermis development [goid 8544] [pmid 8707850] [evidence TAS],structural molecule activity [goid 5198] [pmid 8707850] [evidence TAS],17,71514544-71514593,17q25.1d,-,NM_001988.1,2125,EVPL,1.0266392960077422,9.596824489287316,9.140784110365056,2.0388919738036076e-15,1.7470452994530913e-14,24.194500198208353
CEACAM5,ILMN_1670959,"Homo sapiens carcinoembryonic antigen-related cell adhesion molecule 5 (CEACAM5), mRNA.",membrane [goid 16020] [evidence IEA]; integral to plasma membrane [goid 5887] [pmid 3814146] [evidence TAS],,,19,46916801-46916850,19q13.2c,+,NM_004363.1,1048,CEACAM5,3.5016327324637393,8.144047032825407,9.138710217832873,2.0619815305579796e-15,1.7652772461740876e-14,24.18331967723389
FLJ46309,ILMN_2194852,"Homo sapiens hypothetical protein LOC649598 (FLJ46309), mRNA.",,,,9,35175670-35175719,9p13.3b,+,NM_001039797.1,649598,FLJ46309,1.5209636386524874,13.217994169328867,9.138269258601344,2.0669244289162456e-15,1.7687317741516492e-14,24.180942486690117
NGFRAP1L1,ILMN_1806473,"Homo sapiens NGFRAP1-like 1 (NGFRAP1L1), mRNA.",,,,X,101295722-101295771,Xq22.1d,-,NM_001012978.1,340542,NGFRAP1L1,-1.5129713966162628,7.1303276837474705,-9.1358636079929,2.0940991244321405e-15,1.7896281333140462e-14,24.16797408350531
FLJ35773,ILMN_1670611,"Homo sapiens hypothetical protein FLJ35773 (FLJ35773), mRNA.",,,,17,8641427-8641476,17p13.1c,-,NM_152599.2,162387,FLJ35773,1.2590550697285368,6.104263401219341,9.134910518427262,2.104963657313313e-15,1.7981243692569006e-14,24.162836321709687
CYP26B1,ILMN_1812297,"Homo sapiens cytochrome P450, family 26, subfamily B, polypeptide 1 (CYP26B1), mRNA.",membrane [goid 16020] [evidence IEA]; endoplasmic reticulum [goid 5783] [evidence NAS]; microsome [goid 5792] [evidence NAS],electron transport [goid 6118] [evidence NAS],heme binding [goid 20037] [evidence IEA]; metal ion binding [goid 46872] [evidence IEA]; iron ion binding [goid 5506] [evidence IEA]; monooxygenase activity [goid 4497] [evidence NAS],2,72210302-72210351,2p13.3a,-,NM_019885.2,56603,CYP26B1,-1.7005364659846212,7.214503841412683,-9.13318774085344,2.1247448604715674e-15,1.8142267136848596e-14,24.15354968343416
ATF3,ILMN_1791346,"Homo sapiens activating transcription factor 3 (ATF3), transcript variant 2, mRNA.",nucleus [goid 5634] [evidence IEA],"regulation of transcription, DNA-dependent [goid 6355] [evidence IEA]; transcription [goid 6350] [evidence IEA]",transcription corepressor activity [goid 3714] [pmid 7515060] [evidence TAS]; DNA binding [goid 3677] [evidence IEA]; protein dimerization activity [goid 46983] [evidence IEA]; sequence-specific DNA binding [goid 43565] [evidence IEA]; transcription factor activity [goid 3700] [pmid 7515060] [evidence TAS],1,210859111-210859160,1q32.3c,+,NM_004024.3,467,ATF3,-1.059240366105901,7.409277159739548,-9.131221945385825,2.1475429000243968e-15,1.832889768154856e-14,24.142953424422085
FLJ44124,ILMN_2230162,"Homo sapiens hypothetical protein LOC641737 (FLJ44124), mRNA.",,,,7,852625-852674,7p22.3c,+,NM_001039755.1,641737,FLJ44124,1.6840014973233934,12.361726283773702,9.119328283977268,2.2907732800305267e-15,1.950861772788235e-14,24.078851227137026
UNQ3045,ILMN_2054121,"Homo sapiens chromosome 6 open reading frame 126 (C6orf126), mRNA.",,,,6,35855184-35855233,6p21.31b,+,NM_207409.1,389383,UNQ3045,1.5086396634235655,5.589541566519084,9.118417466142542,2.3021265987848746e-15,1.9579631941214874e-14,24.073942870381106
ACOT2,ILMN_1716237,"Homo sapiens acyl-CoA thioesterase 2 (ACOT2), mRNA.",peroxisome [goid 5777] [pmid 10944470] [evidence NAS],acyl-CoA metabolism [goid 6637] [evidence NAS]; lipid metabolism [goid 6629] [evidence IEA],palmitoyl-CoA hydrolase activity [goid 16290] [evidence IEA]; hydrolase activity [goid 16787] [evidence IEA]; acyl-CoA thioesterase activity [goid 16291] [pmid 10944470] [evidence NAS]; serine esterase activity [goid 4759] [evidence IEA],14,73105757-73105806,14q24.3a,+,NM_006821.3,10965,ACOT2,-1.6848427286014571,7.286253557101385,-9.11579061867142,2.3351853157700174e-15,1.984347399815909e-14,24.05978738313071
MGC42105,ILMN_1652072,"Homo sapiens hypothetical protein MGC42105 (MGC42105), mRNA.",,protein amino acid phosphorylation [goid 6468] [pmid 15733851] [evidence IDA],ATP binding [goid 5524] [pmid 15733851] [evidence IDA]; transferase activity [goid 16740] [evidence IEA]; magnesium ion binding [goid 287] [pmid 15733851] [evidence IDA]; protein serine/threonine kinase activity [goid 4674] [pmid 15733851] [evidence IDA]; nucleotide binding [goid 166] [evidence IEA],5,43316459-43316508,5p12c,+,NM_153361.2,167359,MGC42105,-1.5706512211313424,5.936514857956694,-9.109568164776077,2.4153949620837373e-15,2.0498245137718477e-14,24.026258817393195
SLC30A7,ILMN_1789999,"Homo sapiens solute carrier family 30 (zinc transporter), member 7 (SLC30A7), mRNA.",Golgi apparatus [goid 5794] [pmid 11256614] [evidence IDA]; membrane [goid 16020] [evidence IEA],cation transport [goid 6812] [evidence IEA],cation transporter activity [goid 8324] [evidence IEA],1,101217499-101217548,1p21.2a,+,NM_133496.3,148867,SLC30A7,1.0183457390059463,10.261695545642567,9.10786326728514,2.4378470799579735e-15,2.067977812493736e-14,24.01707298284828
C1QC,ILMN_1785902,"Homo sapiens complement component 1, q subcomponent, C chain (C1QC), mRNA.",extracellular region [goid 5576] [pmid 9777412] [evidence NAS]; cytoplasm [goid 5737] [evidence IEA],"innate immune response [goid 45087] [evidence IEA]; phosphate transport [goid 6817] [evidence IEA]; complement activation, classical pathway [goid 6958] [evidence IEA]",,1,22846804-22846853,1p36.12a,+,NM_172369.2,714,C1QC,-1.1734241426333032,11.947610111351148,-9.106934277032929,2.450168570406102e-15,2.0766217744394475e-14,24.012067793221412
TUFT1,ILMN_1781374,"Homo sapiens tuftelin 1 (TUFT1), mRNA.",extracellular region [goid 5576] [pmid 12489194] [evidence NAS],bone mineralization [goid 30282] [pmid 12489194] [evidence NAS]; odontogenesis [goid 42476] [pmid 12489194] [evidence NAS],structural constituent of tooth enamel [goid 30345] [pmid 12489194] [evidence NAS],1,149822458-149822507,1q21.3a,+,NM_020127.1,7286,TUFT1,1.012615756049879,9.28252735275036,9.105751857174505,2.4659412099368096e-15,2.0890810641573363e-14,24.005697311216913
CTHRC1,ILMN_1725090,"Homo sapiens collagen triple helix repeat containing 1 (CTHRC1), mRNA.",extracellular matrix (sensu Metazoa) [goid 5578] [evidence IEA]; cytoplasm [goid 5737] [evidence IEA]; extracellular matrix (sensu Metazoa) [goid 5578] [evidence IEA]; cytoplasm [goid 5737] [evidence IEA],phosphate transport [goid 6817] [evidence IEA]; phosphate transport [goid 6817] [evidence IEA],structural molecule activity [goid 5198] [evidence IEA]; structural molecule activity [goid 5198] [evidence IEA],8,104463866-104463915,8q22.3c,+,NM_138455.2,115908,CTHRC1,2.031118675121106,8.570998568866452,9.099736079935763,2.5477684997725172e-15,2.1574649812284876e-14,23.973288562521496
PRO0628,ILMN_2213834,Homo sapiens PRO0628 protein (PRO0628) on chromosome 20.,,,,20,39100622-39100671,20q12b-q12c,+,NR_002764.1,29053,PRO0628,2.413234661666431,8.367901936655583,9.09834970944086,2.567006592006646e-15,2.172811617951759e-14,23.965820312534515
CD58,ILMN_1785268,"Homo sapiens CD58 molecule (CD58), mRNA.",integral to plasma membrane [goid 5887] [pmid 7544493] [evidence NAS]; membrane [goid 16020] [evidence IEA]; integral to plasma membrane [goid 5887] [pmid 7544493] [evidence NAS]; membrane [goid 16020] [evidence IEA],cell-cell adhesion [goid 16337] [pmid 7544493] [evidence NAS]; antimicrobial humoral response (sensu Vertebrata) [goid 19735] [evidence NR ]; cell-cell adhesion [goid 16337] [pmid 7544493] [evidence NAS]; antimicrobial humoral response (sensu Vertebrata) [goid 19735] [evidence NR ],GPI anchor binding [goid 48503] [evidence IEA]; protein binding [goid 5515] [pmid 7544493] [evidence IPI]; GPI anchor binding [goid 48503] [evidence IEA]; protein binding [goid 5515] [pmid 7544493] [evidence IPI],1,116880330-116880373:116888456-116888461,1p13.1b,-,NM_001779.1,965,CD58,-1.0239377019715485,8.383955475949126,-9.097431925078821,2.5798218999180715e-15,2.182710799822129e-14,23.960876402816012
LOC349114,ILMN_1809173,"Homo sapiens hypothetical protein LOC349114 (LOC349114), mRNA.",,,,7,39798297-39798346,7p14.1d,+,NM_198284.1,349114,LOC349114,1.1082071870023054,7.802292126473713,9.091763042647955,2.660403919917074e-15,2.246986145625669e-14,23.9303412810722
SLC36A4,ILMN_2082324,"Homo sapiens solute carrier family 36 (proton/amino acid symporter), member 4 (SLC36A4), mRNA.",,,,11,92520896-92520945,11q21a,-,NM_152313.2,120103,SLC36A4,1.3373909154811097,7.407386743573262,9.089727515695706,2.689946655589386e-15,2.269970142232966e-14,23.9193778465371
FLJ39653,ILMN_1666633,"Homo sapiens hypothetical protein FLJ39653 (FLJ39653), mRNA.",,,,4,15838953-15839002,4p15.32d,+,NM_152684.1,202020,FLJ39653,1.7423531521509101,7.118254148306326,9.08846488781304,2.7084359766502112e-15,2.2845833335510546e-14,23.912577497073702
SGCA,ILMN_1741007,"Homo sapiens sarcoglycan, alpha (50kDa dystrophin-associated glycoprotein) (SGCA), mRNA.",integral to membrane [goid 16021] [evidence IEA]; sarcoglycan complex [goid 16012] [evidence IEA]; cytoskeleton [goid 5856] [evidence IEA]; membrane [goid 16020] [evidence IEA]; dystrophin-associated glycoprotein complex [goid 16010] [pmid 7937874] [evidence TAS],muscle development [goid 7517] [pmid 7663524] [evidence TAS]; muscle contraction [goid 6936] [pmid 8069911] [evidence TAS],calcium ion binding [goid 5509] [evidence IEA]; protein binding [goid 5515] [evidence IEA],17,45607808-45607809:45608072-45608119,17q21.33a,+,NM_000023.1,6442,SGCA,-1.4177016176952195,7.439598610955986,-9.082789819633343,2.7931157046937728e-15,2.352897957399751e-14,23.882014382710707
BLZF1,ILMN_2106656,"Homo sapiens basic leucine zipper nuclear factor 1 (JEM-1) (BLZF1), mRNA.",nucleus [goid 5634] [pmid 9129147] [evidence NAS]; cytoplasm [goid 5737] [pmid 11056056] [evidence NAS]; nucleus [goid 5634] [pmid 9129147] [evidence NAS]; cytoplasm [goid 5737] [pmid 11056056] [evidence NAS],protein transport [goid 15031] [evidence IEA]; regulation of transcription from RNA polymerase II promoter [goid 6357] [pmid 9129147] [evidence TAS]; cell proliferation [goid 8283] [pmid 9129147] [evidence TAS]; regulation of cell growth [goid 1558] [pmid 9129147] [evidence NAS]; protein transport [goid 15031] [evidence IEA]; regulation of transcription from RNA polymerase II promoter [goid 6357] [pmid 9129147] [evidence TAS]; cell proliferation [goid 8283] [pmid 9129147] [evidence TAS]; regulation of cell growth [goid 1558] [pmid 9129147] [evidence NAS],transcription factor activity [goid 3700] [pmid 9129147] [evidence NAS]; transcription factor activity [goid 3700] [pmid 9129147] [evidence NAS],1,167632109-167632158,1q24.2b,+,NM_003666.2,8548,BLZF1,2.09078635982374,11.036282532705458,9.082267222695293,2.8010450180392714e-15,2.357596638293529e-14,23.87920010382056
CDK5R1,ILMN_1730928,"Homo sapiens cyclin-dependent kinase 5, regulatory subunit 1 (p35) (CDK5R1), mRNA.",cyclin-dependent protein kinase 5 activator complex [goid 16533] [evidence IEA]; membrane fraction [goid 5624] [evidence ISS]; nucleus [goid 5634] [evidence ISS]; contractile fiber [goid 43292] [evidence ISS]; membrane [goid 16020] [evidence ISS]; neuromuscular junction [goid 31594] [evidence ISS]; dendritic spine [goid 43197] [evidence ISS]; growth cone [goid 30426] [evidence ISS]; axon [goid 30424] [evidence ISS]; cell soma [goid 43025] [evidence ISS]; cytoplasm [goid 5737] [evidence ISS]; cyclin-dependent protein kinase 5 activator complex [goid 16533] [evidence IEA]; membrane fraction [goid 5624] [evidence ISS]; nucleus [goid 5634] [evidence ISS]; contractile fiber [goid 43292] [evidence ISS]; membrane [goid 16020] [evidence ISS]; neuromuscular junction [goid 31594] [evidence ISS]; dendritic spine [goid 43197] [evidence ISS]; growth cone [goid 30426] [evidence ISS]; axon [goid 30424] [evidence ISS]; cell soma [goid 43025] [evidence ISS]; cytoplasm [goid 5737] [evidence ISS],"brain development [goid 7420] [pmid 10915792] [evidence NAS]; cell proliferation [goid 8283] [pmid 8090221] [evidence TAS]; neuron adhesion [goid 7158] [evidence ISS]; positive regulation of neuron apoptosis [goid 43525] [evidence ISS]; regulation of neuron differentiation [goid 45664] [pmid 10721722] [evidence NAS]; axonal fasciculation [goid 7413] [evidence ISS]; acetylcholine receptor signaling, muscarinic pathway [goid 7213] [evidence ISS]; embryonic development [goid 9790] [evidence ISS]; axon guidance [goid 7411] [evidence ISS]; neuron migration [goid 1764] [evidence ISS]; brain development [goid 7420] [pmid 10915792] [evidence NAS]; cell proliferation [goid 8283] [pmid 8090221] [evidence TAS]; neuron adhesion [goid 7158] [evidence ISS]; positive regulation of neuron apoptosis [goid 43525] [evidence ISS]; regulation of neuron differentiation [goid 45664] [pmid 10721722] [evidence NAS]; axonal fasciculation [goid 7413] [evidence ISS]; acetylcholine receptor signaling, muscarinic pathway [goid 7213] [evidence ISS]; embryonic development [goid 9790] [evidence ISS]; axon guidance [goid 7411] [evidence ISS]; neuron migration [goid 1764] [evidence ISS]",cadherin binding [goid 45296] [evidence ISS]; protein kinase activity [goid 4672] [pmid 7592934] [evidence TAS]; protein binding [goid 5515] [pmid 12223541] [evidence IPI]; cyclin-dependent protein kinase 5 activator activity [goid 16534] [evidence IEA]; calcium ion binding [goid 5509] [evidence ISS]; cadherin binding [goid 45296] [evidence ISS]; protein kinase activity [goid 4672] [pmid 7592934] [evidence TAS]; protein binding [goid 5515] [pmid 12223541] [evidence IPI]; cyclin-dependent protein kinase 5 activator activity [goid 16534] [evidence IEA]; calcium ion binding [goid 5509] [evidence ISS],17,27841663-27841712,17q11.2e,+,NM_003885.2,8851,CDK5R1,1.0358822628332804,6.267478539508275,9.073191491318502,2.9423843094317278e-15,2.472161226953228e-14,23.830330242846117
ALPL,ILMN_1701603,"Homo sapiens alkaline phosphatase, liver/bone/kidney (ALPL), mRNA.",membrane [goid 16020] [evidence IEA]; integral to membrane [goid 16021] [evidence IEA],metabolism [goid 8152] [evidence IEA]; ossification [goid 1503] [evidence IEA],alkaline phosphatase activity [goid 4035] [evidence IEA]; magnesium ion binding [goid 287] [evidence IEA]; hydrolase activity [goid 16787] [evidence IEA],1,21777336-21777385,1p36.12b,+,NM_000478.2,249,ALPL,-1.9772639951036357,11.568963829975344,-9.067635417401856,3.032396039850237e-15,2.5446269094092105e-14,23.800416892273564
FA2H,ILMN_1791531,"Homo sapiens fatty acid 2-hydroxylase (FA2H), mRNA.",,,,16,73304694-73304743,16q23.1a,-,NM_024306.2,79152,FA2H,1.3256663168563607,5.6395603109673775,9.067431144984182,3.035757176997854e-15,2.546350778898114e-14,23.799317172300874
PLA2G2D,ILMN_1788811,"Homo sapiens phospholipase A2, group IID (PLA2G2D), mRNA.",extracellular region [goid 5576] [pmid 10455175] [evidence TAS],lipid catabolism [goid 16042] [evidence IEA]; phospholipid metabolism [goid 6644] [pmid 10455175] [evidence TAS]; inflammatory response [goid 6954] [pmid 10455175] [evidence TAS],phospholipase A2 activity [goid 4623] [pmid 10455175] [evidence TAS]; calcium ion binding [goid 5509] [evidence IEA]; hydrolase activity [goid 16787] [evidence IEA],1,20311609-20311658,1p36.12b,-,NM_012400.2,26279,PLA2G2D,1.1347108263004868,7.200193612201789,9.065232180927069,3.0721753394424952e-15,2.5757890055523675e-14,23.787479121323617
LOC644297,ILMN_1722284,"PREDICTED: Homo sapiens similar to Apoptosis-related protein 2 (APR-2) (LOC644297), mRNA.",,,,17,41991780-41991829,17q21.32a,-,XM_927470.1,644297,LOC644297,1.310657003401599,6.1859389399215985,9.054287893383327,3.2600092422524137e-15,2.7238970877053294e-14,23.7285685797113
FLJ46109,ILMN_2246548,Homo sapiens glutathione S-transferase theta pseudogene (FLJ46109) on chromosome 22. XM_941198 XM_945014 XM_945016,,,,,,22q11.23b,,NR_003082.1,653399,FLJ46109,2.2441644476266998,8.745540035442598,9.054102271647302,3.2632918099362737e-15,2.7243033811743055e-14,23.727569531820617
PIP5KL1,ILMN_2103774,"Homo sapiens phosphatidylinositol-4-phosphate 5-kinase-like 1 (PIP5KL1), mRNA.",,,kinase activity [goid 16301] [evidence IEA]; 1-phosphatidylinositol-4-phosphate 5-kinase activity [goid 16308] [evidence IEA],9,129723816-129723865,9q34.11a,-,NM_173492.1,138429,PIP5KL1,1.032871738381468,5.950454431568435,9.053836654220055,3.2679947664377112e-15,2.7270611573464155e-14,23.726139939884007
PSG1,ILMN_1798000,"Homo sapiens pregnancy specific beta-1-glycoprotein 1 (PSG1), mRNA.",integral to membrane [goid 16021] [evidence IEA]; extracellular space [goid 5615] [evidence NR ],pregnancy [goid 7565] [pmid 1572651] [evidence TAS],,19,48063432-48063481,19q13.31a,-,NM_006905.2,5669,PSG1,2.1849479338198847,6.028281602810814,9.052122869517097,3.2985014442739573e-15,2.751339924729369e-14,23.71691628139302
APLN,ILMN_1689353,"Homo sapiens apelin, AGTRL1 ligand (APLN), mRNA.",,immune response [goid 6955] [pmid 10525157] [evidence TAS]; signal transduction [goid 7165] [pmid 9792798] [evidence TAS]; lactation [goid 7595] [pmid 10525157] [evidence TAS],hormone activity [goid 5179] [evidence IEA],X,128607421-128607470,Xq25g,-,NM_017413.3,8862,APLN,-1.6642050713006693,6.611922552537668,-9.048642699661542,3.361327326799444e-15,2.8025444143212312e-14,23.698186837909912
HIST1H2BD,ILMN_1651496,"Homo sapiens histone cluster 1, H2bd (HIST1H2BD), transcript variant 2, mRNA.",chromosome [goid 5694] [evidence IEA]; nucleus [goid 5634] [evidence IEA]; nucleosome [goid 786] [evidence ISS]; chromosome [goid 5694] [evidence IEA]; nucleus [goid 5634] [evidence IEA]; nucleosome [goid 786] [evidence ISS],nucleosome assembly [goid 6334] [evidence ISS]; chromosome organization and biogenesis (sensu Eukaryota) [goid 7001] [evidence IEA]; nucleosome assembly [goid 6334] [evidence ISS]; chromosome organization and biogenesis (sensu Eukaryota) [goid 7001] [evidence IEA],DNA binding [goid 3677] [evidence ISS]; DNA binding [goid 3677] [evidence ISS],6,26279283-26279332,6p22.1d,+,NM_138720.1,3017,HIST1H2BD,1.0922422397017444,7.372102160886759,9.047539281559946,3.3814947642574547e-15,2.8169485028455112e-14,23.692248777205663
KCNK1,ILMN_1718863,"Homo sapiens potassium channel, subfamily K, member 1 (KCNK1), mRNA.",integral to membrane [goid 16021] [evidence IEA]; membrane fraction [goid 5624] [evidence NR ]; voltage-gated potassium channel complex [goid 8076] [pmid 8605869] [evidence TAS]; membrane [goid 16020] [evidence IEA]; integral to membrane [goid 16021] [evidence IEA]; membrane fraction [goid 5624] [evidence NR ]; voltage-gated potassium channel complex [goid 8076] [pmid 8605869] [evidence TAS]; membrane [goid 16020] [evidence IEA],ion transport [goid 6811] [evidence IEA]; potassium ion transport [goid 6813] [pmid 8605869] [evidence TAS]; ion transport [goid 6811] [evidence IEA]; potassium ion transport [goid 6813] [pmid 8605869] [evidence TAS],voltage-gated ion channel activity [goid 5244] [evidence IEA]; potassium ion binding [goid 30955] [evidence IEA]; potassium channel activity [goid 5267] [evidence IEA]; ion channel activity [goid 5216] [evidence IEA]; inward rectifier potassium channel activity [goid 5242] [pmid 8605869] [evidence TAS]; voltage-gated ion channel activity [goid 5244] [evidence IEA]; potassium ion binding [goid 30955] [evidence IEA]; potassium channel activity [goid 5267] [evidence IEA]; ion channel activity [goid 5216] [evidence IEA]; inward rectifier potassium channel activity [goid 5242] [pmid 8605869] [evidence TAS],1,231874087-231874136,1q42.2c,+,NM_002245.2,3775,KCNK1,1.4839626782780693,7.831723257063219,9.046906467871487,3.393115221208507e-15,2.8254209438140067e-14,23.688843340246674
RGS22,ILMN_1669983,"Homo sapiens regulator of G-protein signalling 22 (RGS22), mRNA.",,,signal transducer activity [goid 4871] [evidence IEA],8,101044363-101044382:101046739-101046768,8q22.2b,-,NM_015668.2,26166,RGS22,-1.3236816966393512,5.740907782738972,-9.042178369121823,3.4812069789236744e-15,2.895659434865906e-14,23.66340081722161
APOB48R,ILMN_1697925,"Homo sapiens apolipoprotein B48 receptor (APOB48R), mRNA.",integral to plasma membrane [goid 5887] [evidence NR ]; nucleus [goid 5634] [evidence IEA],lipid metabolism [goid 6629] [pmid 10852956] [evidence TAS],receptor activity [goid 4872] [evidence IEA]; DNA binding [goid 3677] [evidence IEA]; lipoprotein binding [goid 8034] [pmid 10852956] [evidence TAS],16,28417416-28417465,16p11.2e,+,NM_018690.1,55911,APOB48R,-1.0885155226125747,6.5734812853735916,-9.042140345099035,3.4819245860358315e-15,2.895659434865906e-14,23.66319621472914
ITGAM,ILMN_1685009,"Homo sapiens integrin, alpha M (complement component receptor 3, alpha; also known as CD11b (p170), macrophage antigen alpha polypeptide) (ITGAM), mRNA.",integral to membrane [goid 16021] [evidence IEA]; integrin complex [goid 8305] [pmid 2563162] [evidence TAS],cell-matrix adhesion [goid 7160] [evidence IEA]; cell adhesion [goid 7155] [pmid 2563162] [evidence TAS]; integrin-mediated signaling pathway [goid 7229] [evidence IEA],magnesium ion binding [goid 287] [evidence IEA]; protein binding [goid 5515] [evidence IEA]; receptor activity [goid 4872] [evidence IEA]; calcium ion binding [goid 5509] [evidence IEA],16,31251381-31251430,16p11.2c,+,NM_000632.2,3684,ITGAM,-1.2753873525090764,8.53413071578354,-9.041484130293158,3.494332232030708e-15,2.90349951134833e-14,23.659665229890077
PCDHB9,ILMN_2047885,"Homo sapiens protocadherin beta 9 (PCDHB9), mRNA.",integral to membrane [goid 16021] [pmid 11322959] [evidence NAS]; membrane [goid 16020] [evidence IEA]; integral to membrane [goid 16021] [pmid 11322959] [evidence NAS]; membrane [goid 16020] [evidence IEA],calcium-dependent cell-cell adhesion [goid 16339] [pmid 11322959] [evidence NAS]; synaptogenesis [goid 7416] [pmid 12231349] [evidence TAS]; synaptic transmission [goid 7268] [pmid 12231349] [evidence TAS]; cell adhesion [goid 7155] [evidence IEA]; homophilic cell adhesion [goid 7156] [evidence IEA]; calcium-dependent cell-cell adhesion [goid 16339] [pmid 11322959] [evidence NAS]; synaptogenesis [goid 7416] [pmid 12231349] [evidence TAS]; synaptic transmission [goid 7268] [pmid 12231349] [evidence TAS]; cell adhesion [goid 7155] [evidence IEA]; homophilic cell adhesion [goid 7156] [evidence IEA],calcium ion binding [goid 5509] [evidence IEA]; protein binding [goid 5515] [pmid 11322959] [evidence NAS]; calcium ion binding [goid 5509] [evidence IEA]; protein binding [goid 5515] [pmid 11322959] [evidence NAS],5,140550934-140550983,5q31.3b,+,NM_019119.3,56127,PCDHB9,2.303961765271458,8.75609135770644,9.029935635064145,3.720045003160091e-15,3.087098674896694e-14,23.597532305016497
LOC643977,ILMN_1745599,"PREDICTED: Homo sapiens hypothetical protein LOC643977, transcript variant 1 (LOC643977), mRNA.",,,,5,43028024-43028073,,-,XM_932991.1,643977,LOC643977,1.5895150209701407,7.110124160809464,9.02370964494855,3.847699921513019e-15,3.188959292670403e-14,23.56404141596894
FLRT3,ILMN_1805665,"Homo sapiens fibronectin leucine rich transmembrane protein 3 (FLRT3), transcript variant 1, mRNA.",integral to plasma membrane [goid 5887] [pmid 10644439] [evidence NAS]; membrane [goid 16020] [evidence IEA]; extracellular matrix (sensu Metazoa) [goid 5578] [pmid 10644439] [evidence NAS],cell adhesion [goid 7155] [evidence IEA],"transferase activity [goid 16740] [evidence IEA]; receptor signaling protein activity [goid 5057] [pmid 10644439] [evidence NAS]; protein binding, bridging [goid 30674] [pmid 10644439] [evidence NAS]",20,14252872-14252921,20p12.1d-p12.1c,-,NM_013281.2,23767,FLRT3,-1.439662372016917,10.559382593222267,-9.022944717205155,3.863681815544073e-15,3.1994832203942315e-14,23.559927003832595
LAMA2,ILMN_1788019,"Homo sapiens laminin, alpha 2 (merosin, congenital muscular dystrophy) (LAMA2), mRNA.",basement membrane [goid 5604] [pmid 2185464] [evidence TAS]; laminin-1 [goid 5606] [evidence IEA]; extracellular matrix [goid 31012] [evidence IEA],regulation of cell migration [goid 30334] [evidence IEA]; regulation of cell adhesion [goid 30155] [evidence IEA]; regulation of embryonic development [goid 45995] [evidence IEA]; muscle development [goid 7517] [pmid 7550355] [evidence TAS],structural molecule activity [goid 5198] [pmid 2185464] [evidence TAS]; receptor binding [goid 5102] [evidence IEA],6,129870374-129870423,6q22.33d-q22.33e,+,NM_000426.2,3908,LAMA2,-1.109626734230682,7.388790470210024,-9.002138464937588,4.32470554540304e-15,3.5630819260963315e-14,23.448038523676388
HRASLS,ILMN_1655867,"Homo sapiens HRAS-like suppressor (HRASLS), mRNA.",,,,3,194463691-194463718:194471087-194471108,3q29b,+,NM_020386.2,57110,HRASLS,1.1603003484641379,5.592581593180428,9.001902791356262,4.330229895695351e-15,3.566125507930005e-14,23.44677143087295
QKI,ILMN_1690476,"PREDICTED: Homo sapiens quaking homolog, KH domain RNA binding (mouse), transcript variant 5 (QKI), mRNA.",,,,,,6q26c,,XM_942223.1,9444,QKI,-1.0814646303252617,6.121641119291678,-9.000936451855067,4.35295518951896e-15,3.583326230155342e-14,23.441575996550412
PDCL,ILMN_1694041,"Homo sapiens phosducin-like (PDCL), mRNA.",cellular component unknown [goid 8372] [evidence ND ],sensory perception [goid 7600] [evidence IEA]; signal transduction [goid 7165] [pmid 10524200] [evidence NAS]; electron transport [goid 6118] [evidence IEA]; visual perception [goid 7601] [evidence IEA],electron transporter activity [goid 5489] [evidence IEA]; regulator of G-protein signaling activity [goid 16299] [pmid 10524200] [evidence NAS],9,124621585-124621634,9q33.2b,-,NM_005388.2,5082,PDCL,-1.130037981081479,6.50742568022178,-8.99760142153855,4.432301521105596e-15,3.647102835250952e-14,23.423646314764877
LOC441066,ILMN_1714808,"PREDICTED: Homo sapiens similar to Beta-glucuronidase precursor (LOC441066), mRNA.",,,,5,98889676-98889710:98896232-98896246,5q21.1b,+,XM_496741.2,441066,LOC441066,1.3209416229214046,6.315975599314137,8.996674198133526,4.45461677987456e-15,3.663917600500456e-14,23.418661626504118
BAIAP2L2,ILMN_1771652,"Homo sapiens BAI1-associated protein 2-like 2 (BAIAP2L2), mRNA.",,,,22,36810882-36810931,22q13.1b,-,NM_025045.3,80115,BAIAP2L2,1.9836599770551588,6.819339837727706,8.988715888864997,4.65081060177351e-15,3.815578767801185e-14,23.375882261183214
EIF2AK4,ILMN_1755114,"Homo sapiens eukaryotic translation initiation factor 2 alpha kinase 4 (EIF2AK4), mRNA.",cytosolic ribosome (sensu Eukaryota) [goid 5830] [evidence ISS],regulation of translational initiation [goid 6446] [evidence ISS]; protein amino acid phosphorylation [goid 6468] [evidence ISS]; tRNA aminoacylation for protein translation [goid 6418] [evidence IEA],nucleotide binding [goid 166] [evidence IEA]; transferase activity [goid 16740] [evidence IEA]; eukaryotic translation initiation factor 2alpha kinase activity [goid 4694] [evidence ISS]; ATP binding [goid 5524] [evidence IEA]; protein-tyrosine kinase activity [goid 4713] [evidence IEA],15,38114867-38114916,15q15.1a,+,NM_001013703.2,440275,EIF2AK4,1.6089504894996836,9.875563944758037,8.988640291203469,4.652714987064724e-15,3.815578767801185e-14,23.375475924940154
LAPTM5,ILMN_1772359,"Homo sapiens lysosomal associated multispanning membrane protein 5 (LAPTM5), mRNA.",lysosome [goid 5764] [pmid 8661146] [evidence TAS]; integral to plasma membrane [goid 5887] [pmid 8661146] [evidence TAS]; membrane [goid 16020] [evidence IEA],transport [goid 6810] [evidence IEA],,1,30978154-30978203,1p35.2b,-,NM_006762.1,7805,LAPTM5,-1.0084511310753381,11.483487746517127,-8.986761663511627,4.7002900228901265e-15,3.849733127196894e-14,23.365378536515372
CCL3,ILMN_1671509,"Homo sapiens chemokine (C-C motif) ligand 3 (CCL3), mRNA.",extracellular space [goid 5615] [evidence IEA]; soluble fraction [goid 5625] [pmid 10706735] [evidence TAS],cell-cell signaling [goid 7267] [pmid 10679098] [evidence TAS]; chemotaxis [goid 6935] [pmid 10679098] [evidence TAS]; signal transduction [goid 7165] [pmid 10706735] [evidence TAS]; G-protein coupled receptor protein signaling pathway [goid 7186] [pmid 10734056] [evidence TAS]; cytoskeleton organization and biogenesis [goid 7010] [pmid 10072545] [evidence TAS]; exocytosis [goid 6887] [pmid 10734056] [evidence TAS]; calcium ion homeostasis [goid 6874] [pmid 10734056] [evidence TAS]; sensory perception [goid 7600] [evidence IEA]; regulation of viral genome replication [goid 45069] [pmid 10841574] [evidence TAS]; inflammatory response [goid 6954] [pmid 10679098] [evidence TAS]; antimicrobial humoral response (sensu Vertebrata) [goid 19735] [pmid 9973507] [evidence TAS]; cell motility [goid 6928] [pmid 10660125] [evidence TAS],signal transducer activity [goid 4871] [pmid 10857861] [evidence TAS]; chemokine activity [goid 8009] [pmid 10660125] [evidence TAS],17,31440747-31440756:31441445-31441484,17q12b,-,NM_002983.1,6348,CCL3,-1.925323232315474,7.5644102995750035,-8.974730165849161,5.016686533518783e-15,4.101978057306483e-14,23.300720159938365
INSIG1,ILMN_1686989,"Homo sapiens insulin induced gene 1 (INSIG1), transcript variant 2, mRNA.",membrane [goid 16020] [evidence IEA]; integral to membrane [goid 16021] [evidence IEA],metabolism [goid 8152] [pmid 9268630] [evidence TAS]; cell proliferation [goid 8283] [pmid 9268630] [evidence TAS],,7,154726472-154726521,7q36.3a,+,NM_198336.1,3638,INSIG1,-1.0952069606454193,8.074912257603858,-8.973680469997452,5.0452773165425326e-15,4.123625357081847e-14,23.295079772832334
APOBEC3G,ILMN_1802106,"Homo sapiens apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3G (APOBEC3G), mRNA.",nucleus [goid 5634] [evidence IEA]; nucleus [goid 5634] [evidence IEA],response to virus [goid 9615] [evidence IEA]; RNA metabolism [goid 16070] [pmid 11863358] [evidence NAS]; negative regulation of retroviral genome replication [goid 45869] [pmid 15031497] [evidence NAS]; innate immune response [goid 45087] [pmid 15031497] [evidence NAS]; response to virus [goid 9615] [evidence IEA]; RNA metabolism [goid 16070] [pmid 11863358] [evidence NAS]; negative regulation of retroviral genome replication [goid 45869] [pmid 15031497] [evidence NAS]; innate immune response [goid 45087] [pmid 15031497] [evidence NAS],hydrolase activity [goid 16787] [evidence IEA]; RNA binding [goid 3723] [pmid 11863358] [evidence IDA]; protein homodimerization activity [goid 42803] [pmid 11863358] [evidence NAS]; metal ion binding [goid 46872] [evidence IEA]; zinc ion binding [goid 8270] [pmid 11863358] [evidence IDA]; cytidine deaminase activity [goid 4126] [pmid 15031497] [evidence NAS]; protein binding [goid 5515] [pmid 12859895] [evidence IPI]; hydrolase activity [goid 16787] [evidence IEA]; RNA binding [goid 3723] [pmid 11863358] [evidence IDA]; protein homodimerization activity [goid 42803] [pmid 11863358] [evidence NAS]; metal ion binding [goid 46872] [evidence IEA]; zinc ion binding [goid 8270] [pmid 11863358] [evidence IDA]; cytidine deaminase activity [goid 4126] [pmid 15031497] [evidence NAS]; protein binding [goid 5515] [pmid 12859895] [evidence IPI],22,37812266-37812315,22q13.1c,+,NM_021822.1,60489,APOBEC3G,-1.2021531772836251,7.651446896783052,-8.973337885875967,5.054643450271638e-15,4.1295483282407904e-14,23.293238974173228
KCNK3,ILMN_1768483,"Homo sapiens potassium channel, subfamily K, member 3 (KCNK3), mRNA.",integral to plasma membrane [goid 5887] [pmid 9312005] [evidence TAS]; membrane [goid 16020] [evidence IEA],ion transport [goid 6811] [evidence IEA]; potassium ion transport [goid 6813] [pmid 9312005] [evidence TAS]; synaptic transmission [goid 7268] [pmid 9312005] [evidence TAS],voltage-gated ion channel activity [goid 5244] [evidence IEA]; potassium ion binding [goid 30955] [evidence IEA]; potassium channel activity [goid 5267] [pmid 9312005] [evidence TAS],2,26805870-26805919,2p23.3a,+,NM_002246.1,3777,KCNK3,-1.5748210655155903,7.883297027497018,-8.970180921164316,5.1417734419972626e-15,4.195454586152289e-14,23.27627636104202
MAP3K9,ILMN_1735553,"Homo sapiens mitogen-activated protein kinase kinase kinase 9 (MAP3K9), mRNA.",cellular component unknown [goid 8372] [evidence ND ],,nucleotide binding [goid 166] [evidence IEA]; protein serine/threonine kinase activity [goid 4674] [pmid 15610029] [evidence IDA]; transferase activity [goid 16740] [evidence IEA]; MAP kinase kinase activity [goid 4708] [pmid 8477742] [evidence NAS]; ATP binding [goid 5524] [evidence NAS]; JUN kinase kinase kinase activity [goid 4706] [evidence ISS]; protein homodimerization activity [goid 42803] [pmid 8195146] [evidence ISS]; protein-tyrosine kinase activity [goid 4713] [evidence IEA],14,70265162-70265211,14q24.2a,-,NM_033141.2,4293,MAP3K9,1.0181957841789524,6.374047739134076,8.967874351612146,5.206377854413475e-15,4.2446139118513205e-14,23.26388370129929
PDE3B,ILMN_2131381,"Homo sapiens phosphodiesterase 3B, cGMP-inhibited (PDE3B), mRNA.",membrane [goid 16020] [evidence IEA],signal transduction [goid 7165] [evidence IEA],"hydrolase activity [goid 16787] [evidence IEA]; cGMP-inhibited cyclic-nucleotide phosphodiesterase activity [goid 4119] [pmid 8884271] [evidence TAS]; 3',5'-cyclic-nucleotide phosphodiesterase activity [goid 4114] [evidence IEA]; catalytic activity [goid 3824] [evidence IEA]",11,14848310-14848359,11p15.2b,+,NM_000922.2,5140,PDE3B,-1.0946777227136133,6.351346786088512,-8.965219792803719,5.281730784422797e-15,4.3024466695015973e-14,23.249622125142686
ZNF577,ILMN_1667322,"Homo sapiens zinc finger protein 577 (ZNF577), mRNA.",nucleus [goid 5634] [evidence IEA]; intracellular [goid 5622] [evidence IEA]; nucleus [goid 5634] [evidence IEA]; intracellular [goid 5622] [evidence IEA],"regulation of transcription, DNA-dependent [goid 6355] [evidence IEA]; transcription [goid 6350] [evidence IEA]; regulation of transcription, DNA-dependent [goid 6355] [evidence IEA]; transcription [goid 6350] [evidence IEA]",zinc ion binding [goid 8270] [evidence IEA]; metal ion binding [goid 46872] [evidence IEA]; DNA binding [goid 3677] [evidence IEA]; zinc ion binding [goid 8270] [evidence IEA]; metal ion binding [goid 46872] [evidence IEA]; DNA binding [goid 3677] [evidence IEA],19,57066814-57066863,19q13.33e,-,NM_032679.1,84765,ZNF577,1.3530854455350072,8.091891027813576,8.96340526580642,5.33386272551421e-15,4.339470363534212e-14,23.2398740685608
FCHO1,ILMN_1654571,"Homo sapiens FCH domain only 1 (FCHO1), mRNA.",,,,19,17759616-17759655:17760093-17760102,19p13.11d,+,NM_015122.1,23149,FCHO1,1.177641770099764,6.617515847752495,8.949577373962924,5.74835353009842e-15,4.66888989303742e-14,23.165599815052264
CST7,ILMN_1679826,"Homo sapiens cystatin F (leukocystatin) (CST7), mRNA.",,immune response [goid 6955] [pmid 9632704] [evidence TAS],cysteine protease inhibitor activity [goid 4869] [pmid 9733783] [evidence TAS],20,24888342-24888348:24888349-24888391,20p11.21a,+,NM_003650.2,8530,CST7,-1.2720724311195042,8.195382465422696,-8.946353741104808,5.849505991003524e-15,4.747089722394988e-14,23.14828775465903
C14orf82,ILMN_1690443,"PREDICTED: Homo sapiens chromosome 14 open reading frame 82 (C14orf82), mRNA.",,,,,,14q22.1c,,XM_944991.1,145438,C14orf82,2.237362276497482,7.95020966129726,8.943799906100615,5.93089880358867e-15,4.809137044857479e-14,23.13457359856763
FAAH,ILMN_1810915,"Homo sapiens fatty acid amide hydrolase (FAAH), mRNA.",insoluble fraction [goid 5626] [pmid 10431820] [evidence TAS]; integral to membrane [goid 16021] [evidence IEA]; membrane fraction [goid 5624] [pmid 9122178] [evidence TAS]; membrane [goid 16020] [evidence IEA],fatty acid metabolism [goid 6631] [pmid 9122178] [evidence TAS],hydrolase activity [goid 16787] [evidence IEA]; receptor binding [goid 5102] [evidence NR ]; amidase activity [goid 4040] [pmid 10431820] [evidence TAS],1,46651775-46651824,1p33d,+,NM_001441.1,2166,FAAH,1.0512643112238358,8.276007490401524,8.940804899205974,6.027790959028883e-15,4.8836385379076005e-14,23.118491298453883
PTPN21,ILMN_1719664,"Homo sapiens protein tyrosine phosphatase, non-receptor type 21 (PTPN21), mRNA.",cytoskeleton [goid 5856] [pmid 7519780] [evidence TAS],protein amino acid dephosphorylation [goid 6470] [pmid 7519780] [evidence TAS],structural molecule activity [goid 5198] [evidence IEA]; hydrolase activity [goid 16787] [evidence IEA]; binding [goid 5488] [evidence IEA]; protein tyrosine phosphatase activity [goid 4725] [pmid 7519780] [evidence TAS],14,88004056-88004105,14q31.3d,-,NM_007039.2,11099,PTPN21,-1.0393972649495478,6.128650225465538,-8.939379401248983,6.074459987964403e-15,4.9194036934948626e-14,23.110837161025675
LOC399942,ILMN_1765701,"PREDICTED: Homo sapiens similar to Tubulin alpha-2 chain (Alpha-tubulin 2), transcript variant 5 (LOC399942), mRNA.",,,,11,89655450-89655477:89655607-89655628,11q14.3b,+,XM_934471.1,399942,LOC399942,-2.260710041727643,7.680574783384012,-8.93712472201948,6.149011534344997e-15,4.9777104173956074e-14,23.09873125833645
MPP6,ILMN_1679995,"Homo sapiens membrane protein, palmitoylated 6 (MAGUK p55 subfamily member 6) (MPP6), mRNA.",membrane [goid 16020] [pmid 11311936] [evidence NAS],protein complex assembly [goid 6461] [pmid 11311936] [evidence NAS],protein binding [goid 5515] [pmid 11311936] [evidence IPI],7,24686627-24686664:24693582-24693593,7p15.3a,+,NM_016447.2,51678,MPP6,1.0145261718815606,6.088977274280451,8.931596684390227,6.335678014035206e-15,5.122435108028049e-14,23.069052422099016
GIMAP2,ILMN_1689371,"Homo sapiens GTPase, IMAP family member 2 (GIMAP2), mRNA.",membrane [goid 16020] [evidence IEA]; integral to membrane [goid 16021] [evidence IEA]; membrane [goid 16020] [evidence IEA]; integral to membrane [goid 16021] [evidence IEA],,GTP binding [goid 5525] [evidence IEA]; nucleotide binding [goid 166] [evidence IEA]; GTP binding [goid 5525] [evidence IEA]; nucleotide binding [goid 166] [evidence IEA],7,150021053-150021102,7q36.1c,+,NM_015660.2,26157,GIMAP2,-1.138957430155478,6.090192061495224,-8.929352361501547,6.413064394490103e-15,5.180703139578759e-14,23.05700415341863
TBX2,ILMN_1792256,"Homo sapiens T-box 2 (TBX2), mRNA.",nucleus [goid 5634] [evidence IEA],"regulation of transcription, DNA-dependent [goid 6355] [evidence IEA]; development [goid 7275] [evidence IEA]; transcription [goid 6350] [evidence IEA]",transcription factor activity [goid 3700] [evidence IEA],17,56841035-56841084,17q23.2b,+,NM_005994.3,6909,TBX2,-1.3185756293301285,9.922076533964589,-8.92508695149164,6.562745033435676e-15,5.295034657411766e-14,23.034107638874424
HK3,ILMN_1670302,"Homo sapiens hexokinase 3 (white cell) (HK3), nuclear gene encoding mitochondrial protein, mRNA.",membrane [goid 16020] [evidence NAS],glycolysis [goid 6096] [evidence NAS],kinase activity [goid 16301] [evidence IEA]; ATP binding [goid 5524] [evidence NAS]; transferase activity [goid 16740] [evidence IEA]; nucleotide binding [goid 166] [evidence IEA]; hexokinase activity [goid 4396] [evidence NAS],5,176240673-176240679:176240680-176240722,5q35.2d,-,NM_002115.1,3101,HK3,-1.3947869824693218,8.074352122581523,-8.922473171452655,6.6561819503146155e-15,5.363759524478092e-14,23.0200780447485
SSTR2,ILMN_2152257,"Homo sapiens somatostatin receptor 2 (SSTR2), mRNA.",integral to plasma membrane [goid 5887] [pmid 7914078] [evidence TAS]; plasma membrane [goid 5886] [pmid 7914078] [evidence TAS],"response to nutrient [goid 7584] [pmid 1346068] [evidence TAS]; signal transduction [goid 7165] [evidence IEA]; digestion [goid 7586] [pmid 1346068] [evidence TAS]; G-protein signaling, coupled to cyclic nucleotide second messenger [goid 7187] [pmid 7914078] [evidence TAS]; negative regulation of cell proliferation [goid 8285] [pmid 9892014] [evidence TAS]; cell-cell signaling [goid 7267] [pmid 1346068] [evidence TAS]",protein binding [goid 5515] [pmid 10551867] [evidence IPI]; somatostatin receptor activity [goid 4994] [pmid 7914078] [evidence TAS]; rhodopsin-like receptor activity [goid 1584] [evidence IEA]; receptor activity [goid 4872] [evidence IEA]; PDZ domain binding [goid 30165] [pmid 10551867] [evidence IPI],17,68679500-68679549,17q25.1a,+,NM_001050.2,6752,SSTR2,2.3130418378421167,9.328627418338781,8.920921899576236,6.712262083558314e-15,5.4044804420716423e-14,23.011751894161222
LOC646897,ILMN_1693225,"PREDICTED: Homo sapiens hypothetical protein LOC646897 (LOC646897), mRNA.",,,,15,76230663-76230712,,+,XM_929859.1,646897,LOC646897,1.5869717409478783,6.733837193747978,8.904755092038176,7.325476187555587e-15,5.888486118585834e-14,22.92499653551171
LOC648059,ILMN_1768392,"PREDICTED: Homo sapiens hypothetical protein LOC648059 (LOC648059), mRNA.",,,,,,,,XM_937109.1,648059,LOC648059,1.9311193737770491,7.486639775199946,8.900914348471293,7.479178135411161e-15,5.994725872829554e-14,22.904390630310644
CLCF1,ILMN_1661197,"Homo sapiens cardiotrophin-like cytokine factor 1 (CLCF1), mRNA.",extracellular space [goid 5615] [evidence IEA],cytokine and chemokine mediated signaling pathway [goid 19221] [pmid 10500198] [evidence NAS]; positive regulation of tyrosine phosphorylation of Stat3 protein [goid 42517] [pmid 14632778] [evidence TAS]; negative regulation of apoptosis [goid 43066] [pmid 14632778] [evidence TAS]; JAK-STAT cascade [goid 7259] [evidence ISS],cytokine activity [goid 5125] [pmid 10500198] [evidence NAS]; growth factor activity [goid 8083] [pmid 14632778] [evidence TAS],11,66888452-66888501,11q13.1f,-,NM_013246.2,23529,CLCF1,1.152557528325831,7.744222647336857,8.89435816481963,7.749008216964899e-15,6.203345320770791e-14,22.869220214983134
PDIA6,ILMN_1680626,"Homo sapiens protein disulfide isomerase family A, member 6 (PDIA6), mRNA.",endoplasmic reticulum [goid 5783] [pmid 16130169] [evidence TAS]; ER-Golgi intermediate compartment [goid 5793] [pmid 15308636] [evidence IDA],protein folding [goid 6457] [pmid 7590364] [evidence TAS],electron carrier activity [goid 9055] [evidence IEA]; protein disulfide oxidoreductase activity [goid 15035] [evidence IEA]; isomerase activity [goid 16853] [evidence IEA]; protein disulfide isomerase activity [goid 3756] [pmid 7590364] [evidence TAS],2,10844978-10845016:10846274-10846284,2p25.1c,-,NM_005742.2,10130,PDIA6,1.2040555633532186,9.197213188945499,8.883381170285638,8.222668632687082e-15,6.571726755861682e-14,22.810346001547767
LMTK3,ILMN_1668194,"PREDICTED: Homo sapiens lemur tyrosine kinase 3 (LMTK3), mRNA.",,,,,,19q13.32c,,XM_936372.1,114783,LMTK3,1.231722834671496,9.036958236265939,8.877907789129113,8.469514553741728e-15,6.763462749166294e-14,22.780995368474343
SLC2A3,ILMN_1775708,"Homo sapiens solute carrier family 2 (facilitated glucose transporter), member 3 (SLC2A3), mRNA.",integral to membrane [goid 16021] [evidence IEA]; membrane fraction [goid 5624] [evidence NR ]; membrane [goid 16020] [evidence IEA],carbohydrate metabolism [goid 5975] [pmid 1695905] [evidence NAS]; glucose transport [goid 15758] [pmid 1695905] [evidence TAS]; carbohydrate transport [goid 8643] [evidence IEA],transporter activity [goid 5215] [evidence IEA]; sugar porter activity [goid 5351] [evidence IEA]; glucose transporter activity [goid 5355] [pmid 1695905] [evidence TAS],12,7963180-7963229,12p13.31c,-,NM_006931.1,6515,SLC2A3,-1.2209106050193892,11.503485732296857,-8.872892974418745,8.702154158882238e-15,6.94354929507864e-14,22.75410693526077
KRT4,ILMN_1744765,"Homo sapiens keratin 4 (KRT4), mRNA.",intermediate filament [goid 5882] [pmid 2452170] [evidence NAS],cytoskeleton organization and biogenesis [goid 7010] [pmid 2452170] [evidence NAS],structural molecule activity [goid 5198] [evidence NAS],12,51486884-51486933,12q13.13d,-,NM_002272.1,3851,KRT4,-1.8670082192283557,6.328462487088746,-8.870569641061458,8.812081978806359e-15,7.028383845969787e-14,22.741650716476723
TMEM118,ILMN_1738093,"Homo sapiens transmembrane protein 118 (TMEM118), mRNA.",,,,12,115774987-115775036,12q24.22a,+,NM_032814.1,84900,TMEM118,1.15642954470888,7.243362610860401,8.869303644564281,8.87256339524337e-15,7.070834264062047e-14,22.73486353270873
LOC399900,ILMN_1701314,"Homo sapiens hypothetical gene supported by AK093779 (LOC399900), mRNA.",,,,11,61493398-61493447,11q12.3a,+,NM_001013667.1,399900,LOC399900,1.348849913104873,14.363326822509135,8.867294935888896,8.969376717108292e-15,7.145065630942563e-14,22.724094963924482
ZNF69,ILMN_2176882,"Homo sapiens zinc finger protein 69 (ZNF69), mRNA.",nucleus [goid 5634] [evidence NAS]; intracellular [goid 5622] [evidence IEA],"transcription [goid 6350] [evidence IEA]; regulation of transcription, DNA-dependent [goid 6355] [evidence NAS]",transcription factor activity [goid 3700] [evidence NAS]; zinc ion binding [goid 8270] [evidence IEA]; metal ion binding [goid 46872] [evidence IEA]; nucleic acid binding [goid 3676] [evidence IEA],19,11885842-11885891,19p13.2a,+,NM_021915.1,7620,ZNF69,1.9345745419716796,12.10330016024628,8.867107601015414,8.978459132203407e-15,7.149377858233893e-14,22.72309069765605
DUSP19,ILMN_1722492,"Homo sapiens dual specificity phosphatase 19 (DUSP19), mRNA.",,protein amino acid dephosphorylation [goid 6470] [evidence IEA],hydrolase activity [goid 16787] [evidence IEA]; protein tyrosine phosphatase activity [goid 4725] [evidence IEA]; protein tyrosine/serine/threonine phosphatase activity [goid 8138] [evidence IEA],2,183672674-183672723,2q32.1a,+,NM_080876.2,142679,DUSP19,1.7763350283544739,12.917037664183264,8.860072633771926,9.326244452972542e-15,7.414193111634843e-14,22.68538067637705
TMEM86B,ILMN_2049417,"Homo sapiens transmembrane protein 86B (TMEM86B), mRNA.",membrane [goid 16020] [evidence IEA]; integral to membrane [goid 16021] [evidence IEA],,,19,60429973-60430022,19q13.42b,-,NM_173804.3,255043,TMEM86B,1.1298605063901856,7.05151088465407,8.855976383034054,9.5348982111675e-15,7.56155847149364e-14,22.66342603694945
ARL16,ILMN_1679917,"PREDICTED: Homo sapiens ADP-ribosylation factor-like 16 (ARL16), mRNA.",,,,17,77258972-77259021,17q25.3f,-,XM_290777.4,339231,ARL16,1.0968366343778033,10.486849271859253,8.854130352230277,9.63044474146482e-15,7.628016901928537e-14,22.653532551539996
ITPR1,ILMN_1789505,"Homo sapiens inositol 1,4,5-triphosphate receptor, type 1 (ITPR1), mRNA.",endoplasmic reticulum membrane [goid 5789] [evidence NAS]; endoplasmic reticulum [goid 5783] [pmid 8648241] [evidence NAS]; membrane [goid 16020] [evidence IEA]; integral to plasma membrane [goid 5887] [pmid 8132516] [evidence TAS],calcium ion transport [goid 6816] [pmid 7852357] [evidence NAS]; signal transduction [goid 7165] [pmid 8648241] [evidence NAS]; ion transport [goid 6811] [evidence IEA],"protein binding [goid 5515] [pmid 15652484] [evidence IPI]; calcium channel activity [goid 5262] [evidence IEA]; calcium ion binding [goid 5509] [evidence IEA]; inositol 1,4,5-triphosphate-sensitive calcium-release channel activity [goid 5220] [evidence IEA]; inositol-1,4,5-triphosphate receptor activity [goid 8095] [pmid 8648241] [evidence TAS]; ion channel activity [goid 5216] [evidence IEA]; calcium ion transporter activity [goid 15085] [pmid 7500840] [evidence TAS]",3,4863464-4863513,3p26.2a,+,NM_002222.1,3708,ITPR1,-1.1583493949602497,8.073222243750914,-8.853531344266278,9.661652584737694e-15,7.649626193157821e-14,22.650322360669062
GNG10,ILMN_1757074,"Homo sapiens guanine nucleotide binding protein (G protein), gamma 10 (GNG10), mRNA.",heterotrimeric G-protein complex [goid 5834] [evidence IEA],signal transduction [goid 7165] [pmid 7665596] [evidence TAS]; protein folding [goid 6457] [evidence IEA]; G-protein coupled receptor protein signaling pathway [goid 7186] [evidence IEA],signal transducer activity [goid 4871] [evidence IEA]; heat shock protein binding [goid 31072] [evidence IEA]; GTPase activity [goid 3924] [pmid 7665596] [evidence TAS]; unfolded protein binding [goid 51082] [evidence IEA],9,113463766-113463815,9q31.3b,+,NM_001017998.1,2790,GNG10,-1.6548192128743686,8.660841403490943,-8.850489894287934,9.821670947165419e-15,7.766853019704472e-14,22.634023363767696
GABPA,ILMN_1750029,"Homo sapiens GA binding protein transcription factor, alpha subunit 60kDa (GABPA), mRNA.",nucleus [goid 5634] [pmid 9016666] [evidence TAS]; nucleus [goid 5634] [pmid 9016666] [evidence TAS],"transcription [goid 6350] [evidence IEA]; transcription from RNA polymerase II promoter [goid 6366] [pmid 8441384] [evidence TAS]; regulation of transcription, DNA-dependent [goid 6355] [evidence IEA]; transcription [goid 6350] [evidence IEA]; transcription from RNA polymerase II promoter [goid 6366] [pmid 8441384] [evidence TAS]; regulation of transcription, DNA-dependent [goid 6355] [evidence IEA]",RNA polymerase II transcription factor activity [goid 3702] [pmid 8441384] [evidence TAS]; transcription coactivator activity [goid 3713] [pmid 8441384] [evidence TAS]; sequence-specific DNA binding [goid 43565] [evidence IEA]; transcription factor activity [goid 3700] [pmid 8441384] [evidence TAS]; protein binding [goid 5515] [pmid 10675337] [evidence IPI]; RNA polymerase II transcription factor activity [goid 3702] [pmid 8441384] [evidence TAS]; transcription coactivator activity [goid 3713] [pmid 8441384] [evidence TAS]; sequence-specific DNA binding [goid 43565] [evidence IEA]; transcription factor activity [goid 3700] [pmid 8441384] [evidence TAS]; protein binding [goid 5515] [pmid 10675337] [evidence IPI],21,26065252-26065301,21q21.3a,+,NM_002040.2,2551,GABPA,-1.1459925354790785,6.756056382931117,-8.84495434183959,1.0119715739373978e-14,7.986337026395382e-14,22.60436149324869
DKFZp762I137,ILMN_1713706,"Homo sapiens zinc finger protein 786 (ZNF786), mRNA.",intracellular [goid 5622] [evidence IEA]; nucleus [goid 5634] [pmid 11256614] [evidence IDA],"regulation of transcription, DNA-dependent [goid 6355] [evidence IEA]",nucleic acid binding [goid 3676] [evidence IEA]; zinc ion binding [goid 8270] [evidence IEA],7,148397711-148397760,7q36.1a,-,NM_152411.1,136051,DKFZp762I137,1.8641147865852314,10.86880770977717,8.843622235938629,1.019277358091067e-14,8.040736567775078e-14,22.597224059244386
RBP7,ILMN_1716465,"Homo sapiens retinol binding protein 7, cellular (RBP7), mRNA.",,transport [goid 6810] [evidence IEA],retinal binding [goid 16918] [evidence IEA]; retinol binding [goid 19841] [evidence IEA]; lipid binding [goid 8289] [evidence IEA],1,9998450-9998477:9998478-9998499,1p36.22d,+,NM_052960.1,116362,RBP7,-1.3885293282454105,6.87025537240329,-8.837699995069958,1.0523984845511215e-14,8.275215686633818e-14,22.565495293137563
LOC642852,ILMN_1688246,"PREDICTED: Homo sapiens hypothetical protein LOC642852 (LOC642852), mRNA.",,,,21,45532437-45532486,21q22.3e,+,XM_926249.1,642852,LOC642852,1.0070161811557057,6.001601865632172,8.835904614219706,1.0626496432286661e-14,8.349083991254257e-14,22.555877286390817
UGCGL1,ILMN_1755462,"Homo sapiens UDP-glucose ceramide glucosyltransferase-like 1 (UGCGL1), transcript variant 1, mRNA.",endoplasmic reticulum [goid 5783] [pmid 10694380] [evidence IDA]; ER-Golgi intermediate compartment [goid 5793] [evidence ISS]; endoplasmic reticulum [goid 5783] [pmid 10694380] [evidence IDA]; ER-Golgi intermediate compartment [goid 5793] [evidence ISS],posttranslational protein folding [goid 51084] [pmid 10694380] [evidence TAS]; protein amino acid glycosylation [goid 6486] [evidence IEA]; posttranslational protein folding [goid 51084] [pmid 10694380] [evidence TAS]; protein amino acid glycosylation [goid 6486] [evidence IEA],"transferase activity, transferring glycosyl groups [goid 16757] [evidence IEA]; unfolded protein binding [goid 51082] [pmid 10694380] [evidence IDA]; UDP-glucose:glycoprotein glucosyltransferase activity [goid 3980] [pmid 10694380] [evidence IDA]; transferase activity, transferring glycosyl groups [goid 16757] [evidence IEA]; unfolded protein binding [goid 51082] [pmid 10694380] [evidence IDA]; UDP-glucose:glycoprotein glucosyltransferase activity [goid 3980] [pmid 10694380] [evidence IDA]",2,128664910-128664959,2q14.3e,+,NM_020120.2,56886,UGCGL1,1.1672928862427225,7.5493027335366,8.83248523947876,1.0824493011888688e-14,8.490951945919931e-14,22.537560510784793
LOC112714,ILMN_1652464,"Homo sapiens tubulin, alpha 3e (TUBA3E), mRNA.",microtubule [goid 5874] [evidence IEA]; protein complex [goid 43234] [evidence IEA],microtubule-based movement [goid 7018] [evidence IEA]; protein polymerization [goid 51258] [evidence IEA],GTP binding [goid 5525] [evidence IEA]; structural molecule activity [goid 5198] [evidence IEA]; GTPase activity [goid 3924] [evidence IEA]; nucleotide binding [goid 166] [evidence IEA],2,130667866-130667915,2q21.1b,-,NM_207312.1,112714,LOC112714,-1.2902421377897975,6.2412371532371225,-8.82901767823802,1.1029032819557377e-14,8.640961177686992e-14,22.518987092115665
KLF10,ILMN_1659122,"Homo sapiens Kruppel-like factor 10 (KLF10), transcript variant 1, mRNA.",nucleus [goid 5634] [pmid 9748269] [evidence TAS]; intracellular [goid 5622] [evidence IEA]; nucleus [goid 5634] [pmid 9748269] [evidence TAS]; intracellular [goid 5622] [evidence IEA],"skeletal development [goid 1501] [pmid 10816551] [evidence TAS]; transcription [goid 6350] [evidence IEA]; cell-cell signaling [goid 7267] [pmid 8532536] [evidence TAS]; negative regulation of cell proliferation [goid 8285] [pmid 9748269] [evidence TAS]; cell proliferation [goid 8283] [pmid 10816551] [evidence TAS]; regulation of transcription, DNA-dependent [goid 6355] [evidence IEA]; negative regulation of transcription from RNA polymerase II promoter [goid 122] [pmid 9748269] [evidence TAS]; transforming growth factor beta receptor signaling pathway [goid 7179] [pmid 10816551] [evidence TAS]; skeletal development [goid 1501] [pmid 10816551] [evidence TAS]; transcription [goid 6350] [evidence IEA]; cell-cell signaling [goid 7267] [pmid 8532536] [evidence TAS]; negative regulation of cell proliferation [goid 8285] [pmid 9748269] [evidence TAS]; cell proliferation [goid 8283] [pmid 10816551] [evidence TAS]; regulation of transcription, DNA-dependent [goid 6355] [evidence IEA]; negative regulation of transcription from RNA polymerase II promoter [goid 122] [pmid 9748269] [evidence TAS]; transforming growth factor beta receptor signaling pathway [goid 7179] [pmid 10816551] [evidence TAS]",transcription factor activity [goid 3700] [pmid 10816551] [evidence TAS]; zinc ion binding [goid 8270] [evidence IEA]; metal ion binding [goid 46872] [evidence IEA]; nucleic acid binding [goid 3676] [evidence IEA]; transcription factor activity [goid 3700] [pmid 10816551] [evidence TAS]; zinc ion binding [goid 8270] [evidence IEA]; metal ion binding [goid 46872] [evidence IEA]; nucleic acid binding [goid 3676] [evidence IEA],8,103736971-103737005:103737006-103737020,8q22.3b,-,NM_005655.1,7071,KLF10,-1.0504192064231903,6.149449184523903,-8.826700474067922,1.1167858389479254e-14,8.746210639831321e-14,22.506576203587315
LOC441268,ILMN_1675258,"Homo sapiens hypothetical gene supported by BC044942 (LOC441268), mRNA.",,,,7,97394601-97394650,7q21.3d,-,NM_001013725.1,441268,LOC441268,1.6035706221921746,7.294813585437457,8.823387672821305,1.1369359402906313e-14,8.889725841317397e-14,22.488834082315112
PRAM1,ILMN_1711493,"Homo sapiens PML-RARA regulated adaptor molecule 1 (PRAM1), mRNA.",,,,19,8461072-8461072:8461073-8461110:8461222-8461232,19p13.2d,-,NM_032152.3,84106,PRAM1,-1.3442250531233295,7.011881778911546,-8.82316662889218,1.1382932556381249e-14,8.896768586485706e-14,22.487650302586793
DLX3,ILMN_1789357,"Homo sapiens distal-less homeobox 3 (DLX3), mRNA.",nucleus [goid 5634] [evidence IEA],"regulation of transcription, DNA-dependent [goid 6355] [evidence IEA]; skeletal development [goid 1501] [evidence NR ]; development [goid 7275] [evidence IEA]",transcription factor activity [goid 3700] [pmid 9467018] [evidence TAS]; sequence-specific DNA binding [goid 43565] [evidence IEA],17,45422494-45422543,17q21.33a,-,NM_005220.2,1747,DLX3,1.1010657705175397,6.183791276304189,8.8180713877332,1.1700318147975241e-14,9.141166764767344e-14,22.46036491421615
NKG7,ILMN_1682993,"Homo sapiens natural killer cell group 7 sequence (NKG7), mRNA.",integral to plasma membrane [goid 5887] [pmid 8458737] [evidence TAS]; membrane [goid 16020] [evidence IEA],,,19,56566846-56566895,19q13.33d,-,NM_005601.3,4818,NKG7,-1.546918835634166,9.347345491545768,-8.81723047766076,1.175353986765825e-14,9.179067107066974e-14,22.455862091370424
LMOD3,ILMN_1785703,"Homo sapiens leiomodin 3 (fetal) (LMOD3), mRNA.",actin cytoskeleton [goid 15629] [pmid 11256614] [evidence IDA]; cytoskeleton [goid 5856] [evidence IEA],,tropomyosin binding [goid 5523] [evidence IEA],3,69239594-69239643,3p14.1b,-,NM_198271.2,56203,LMOD3,2.3297417108912697,10.856105974943835,8.816234199688337,1.1816907096332952e-14,9.219356296273483e-14,22.450527434279124
SELENBP1,ILMN_1680652,"Homo sapiens selenium binding protein 1 (SELENBP1), mRNA.",,,selenium binding [goid 8430] [pmid 9027582] [evidence TAS],1,149603638-149603642:149603643-149603687,1q21.3a,-,NM_003944.2,8991,SELENBP1,-1.2825755973988393,11.131102556818458,-8.816101597833702,1.1825366720709395e-14,9.220378973710386e-14,22.449817415483352
UST,ILMN_1700024,"Homo sapiens uronyl-2-sulfotransferase (UST), mRNA.",membrane [goid 16020] [evidence IEA]; integral to membrane [goid 16021] [pmid 10187838] [evidence TAS],protein amino acid sulfation [goid 6477] [pmid 10187838] [evidence TAS],transferase activity [goid 16740] [evidence IEA]; sulfotransferase activity [goid 8146] [pmid 10187838] [evidence TAS],6,149439344-149439393,6q25.1a,+,NM_005715.1,10090,UST,-1.258774652491601,7.233989166905593,-8.814768774998239,1.1910732825790385e-14,9.279513359077395e-14,22.442680916205294
LOC729603,ILMN_2180519,Homo sapiens calcium binding protein P22 pseudogene (LOC729603) on chromosome 6.,,,,,,6q25.3f,,NR_003288.1,729603,LOC729603,1.103619034940289,14.342521133104349,8.807717638252543,1.2372670588364137e-14,9.623513709530313e-14,22.404929846597955
HOXC9,ILMN_1718898,"Homo sapiens homeobox C9 (HOXC9), mRNA.",nucleus [goid 5634] [evidence IEA],"regulation of transcription, DNA-dependent [goid 6355] [evidence IEA]; development [goid 7275] [evidence IEA]",transcriptional activator activity [goid 16563] [evidence IEA]; sequence-specific DNA binding [goid 43565] [evidence IEA]; transcription factor activity [goid 3700] [evidence IEA],12,52683077-52683126,12q13.13f,+,NM_006897.1,3225,HOXC9,1.360722640731593,5.557614388581373,8.80477011332965,1.2571019720237464e-14,9.762707024664288e-14,22.389150951511
TAGLN,ILMN_1778668,"Homo sapiens transgelin (TAGLN), transcript variant 2, mRNA.",,muscle development [goid 7517] [pmid 9615232] [evidence TAS]; muscle development [goid 7517] [pmid 9615232] [evidence TAS],actin binding [goid 3779] [evidence IEA]; actin binding [goid 3779] [evidence IEA],11,116580580-116580629,11q23.3b,+,NM_003186.3,6876,TAGLN,-1.2631323427743286,11.855562476288036,-8.80216374274446,1.2749048237047709e-14,9.893078649895443e-14,22.375199260426704
C6orf205,ILMN_1700978,"Homo sapiens chromosome 6 open reading frame 205 (C6orf205), mRNA.",,,,6,31065450-31065499,6p21.33a,+,NM_001010909.1,394263,C6orf205,2.046443554657608,6.976334738316973,8.795190160728325,1.3237824589390645e-14,1.0260103903113632e-13,22.33787446360995
ZNF331,ILMN_1711199,"Homo sapiens zinc finger protein 331 (ZNF331), mRNA.",nucleus [goid 5634] [evidence NAS]; intracellular [goid 5622] [evidence IEA]; nucleus [goid 5634] [evidence NAS]; intracellular [goid 5622] [evidence IEA]; nucleus [goid 5634] [evidence NAS],"regulation of transcription, DNA-dependent [goid 6355] [evidence NAS]; transcription [goid 6350] [evidence IEA]; regulation of transcription, DNA-dependent [goid 6355] [evidence NAS]; transcription [goid 6350] [evidence IEA]; regulation of transcription, DNA-dependent [goid 6355] [evidence NAS]; transcription [goid 6350] [evidence IEA]",metal ion binding [goid 46872] [evidence IEA]; zinc ion binding [goid 8270] [pmid 10502321] [evidence NAS]; DNA binding [goid 3677] [evidence NAS]; metal ion binding [goid 46872] [evidence IEA]; zinc ion binding [goid 8270] [pmid 10502321] [evidence NAS]; DNA binding [goid 3677] [evidence NAS]; metal ion binding [goid 46872] [evidence IEA]; zinc ion binding [goid 8270] [pmid 10502321] [evidence NAS]; DNA binding [goid 3677] [evidence NAS],19,58775163-58775212,19q13.41b,+,NM_018555.4,55422,ZNF331,-1.0116160887948613,6.573052368804213,-8.787884623646367,1.3769895084295602e-14,1.0664006586546097e-13,22.298779557882707
C16orf60,ILMN_1720526,"Homo sapiens centromere protein N (CENPN), mRNA.",,,,16,79611335-79611382:79613861-79613862,16q23.2b,+,NM_018455.3,55839,C16orf60,1.1133399691157395,7.467984214244877,8.773280713707027,1.4898200645279512e-14,1.15103663589719e-13,22.22064850626159
PCDHB19P,ILMN_1690237,Homo sapiens protocadherin beta 19 pseudogene (PCDHB19P) on chromosome 5.,,,,5,140604365-140604414,5q31.3b,+,NR_001282.1,84054,PCDHB19P,1.9437954915664424,8.520914612269113,8.771115361366745,1.5073158962467022e-14,1.163631150489976e-13,22.209066180355705
HTR3A,ILMN_1662070,"Homo sapiens 5-hydroxytryptamine (serotonin) receptor 3A (HTR3A), transcript variant 2, mRNA.",integral to membrane [goid 16021] [evidence IEA]; postsynaptic membrane [goid 45211] [evidence IEA]; integral to plasma membrane [goid 5887] [pmid 7565620] [evidence TAS]; integral to membrane [goid 16021] [evidence IEA]; postsynaptic membrane [goid 45211] [evidence IEA]; integral to plasma membrane [goid 5887] [pmid 7565620] [evidence TAS],ion transport [goid 6811] [evidence IEA]; synaptic transmission [goid 7268] [pmid 7565620] [evidence TAS]; digestion [goid 7586] [pmid 7565620] [evidence TAS]; ion transport [goid 6811] [evidence IEA]; synaptic transmission [goid 7268] [pmid 7565620] [evidence TAS]; digestion [goid 7586] [pmid 7565620] [evidence TAS],serotonin-activated cation-selective channel activity [goid 5232] [pmid 7565620] [evidence TAS]; ion channel activity [goid 5216] [evidence IEA]; extracellular ligand-gated ion channel activity [goid 5230] [evidence NAS]; serotonin receptor activity [goid 4993] [evidence NAS]; neurotransmitter receptor activity [goid 30594] [evidence IEA]; serotonin-activated cation-selective channel activity [goid 5232] [pmid 7565620] [evidence TAS]; ion channel activity [goid 5216] [evidence IEA]; extracellular ligand-gated ion channel activity [goid 5230] [evidence NAS]; serotonin receptor activity [goid 4993] [evidence NAS]; neurotransmitter receptor activity [goid 30594] [evidence IEA],11,113365898-113365947,11q23.2a,+,NM_000869.2,3359,HTR3A,1.0399176670870833,5.447251206018457,8.770648871155903,1.5111118001098873e-14,1.1660995415897485e-13,22.206571034208025
ZNF533,ILMN_1657087,"Homo sapiens zinc finger protein 533 (ZNF533), mRNA.",nucleus [goid 5634] [evidence IEA]; intracellular [goid 5622] [evidence IEA],,zinc ion binding [goid 8270] [evidence IEA]; metal ion binding [goid 46872] [evidence IEA]; nucleic acid binding [goid 3676] [evidence IEA],2,180015130-180015179,2q31.2c-q31.3a,-,NM_152520.3,151126,ZNF533,-2.203159780255703,8.46906855846376,-8.768091630290185,1.5320902512190526e-14,1.179951721146373e-13,22.19289345396506
LCOR,ILMN_2062381,"Homo sapiens ligand dependent nuclear receptor corepressor (LCOR), mRNA.",nucleus [goid 5634] [evidence IEA],"transcription [goid 6350] [evidence IEA]; regulation of transcription, DNA-dependent [goid 6355] [evidence IEA]",DNA binding [goid 3677] [evidence IEA],10,98708585-98708634,10q24.1a-q24.1b,+,NM_032440.1,84458,LCOR,1.479415370928069,8.562947744624745,8.765201783482455,1.556146549984538e-14,1.196587037349989e-13,22.177437923176402
ACACB,ILMN_1763852,"Homo sapiens acetyl-Coenzyme A carboxylase beta (ACACB), mRNA.",,fatty acid biosynthesis [goid 6633] [evidence IEA]; metabolism [goid 8152] [evidence IEA],acetyl-CoA carboxylase activity [goid 3989] [evidence IEA]; nucleotide binding [goid 166] [evidence IEA]; biotin binding [goid 9374] [evidence IEA]; biotin carboxylase activity [goid 4075] [evidence IEA]; ATP binding [goid 5524] [evidence IEA]; ligase activity [goid 16874] [evidence IEA],12,108190342-108190391,12q24.11a-q24.11b,+,NM_001093.2,32,ACACB,-1.085790638295764,8.922455863971072,-8.760604175816582,1.5951966506826244e-14,1.2237168007303518e-13,22.15285114011
ABCA4,ILMN_1794965,"Homo sapiens ATP-binding cassette, sub-family A (ABC1), member 4 (ABCA4), mRNA.",membrane fraction [goid 5624] [pmid 9054934] [evidence TAS]; integral to plasma membrane [goid 5887] [evidence IEA],"visual perception [goid 7601] [pmid 9425888] [evidence TAS]; transport [goid 6810] [pmid 9054934] [evidence TAS]; phototransduction, visible light [goid 7603] [pmid 9202155] [evidence TAS]; sensory perception [goid 7600] [evidence IEA]","nucleotide binding [goid 166] [evidence IEA]; ATPase activity, coupled to transmembrane movement of substances [goid 42626] [pmid 9054934] [evidence TAS]; ATPase activity [goid 16887] [evidence IEA]; transporter activity [goid 5215] [pmid 9054934] [evidence TAS]; ATP binding [goid 5524] [pmid 9054934] [evidence TAS]",1,94231064-94231113,1p22.1a,-,NM_000350.1,24,ABCA4,2.121265109557328,6.932915376466242,8.749465524162083,1.693897429002238e-14,1.2963704400671097e-13,22.09329596592169
SEMA3G,ILMN_1676067,"Homo sapiens sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3G (SEMA3G), mRNA.",membrane [goid 16020] [evidence IEA],development [goid 7275] [evidence IEA],receptor activity [goid 4872] [evidence IEA],3,52442679-52442728,3p21.1d,-,NM_020163.1,56920,SEMA3G,-1.185555418804336,5.73575333405214,-8.74887223267725,1.6993220058683596e-14,1.3000113578462893e-13,22.090124259692704
MAN2A1,ILMN_2147435,"Homo sapiens mannosidase, alpha, class 2A, member 1 (MAN2A1), mRNA.",integral to membrane [goid 16021] [evidence IEA]; membrane fraction [goid 5624] [evidence NR ]; Golgi apparatus [goid 5794] [evidence NR ]; membrane [goid 16020] [evidence IEA]; integral to membrane [goid 16021] [evidence IEA]; membrane fraction [goid 5624] [evidence NR ]; Golgi apparatus [goid 5794] [evidence NR ]; membrane [goid 16020] [evidence IEA],metabolism [goid 8152] [evidence IEA]; glycoprotein biosynthesis [goid 9101] [evidence NR ]; carbohydrate metabolism [goid 5975] [evidence IEA]; mannose metabolism [goid 6013] [evidence IEA]; metabolism [goid 8152] [evidence IEA]; glycoprotein biosynthesis [goid 9101] [evidence NR ]; carbohydrate metabolism [goid 5975] [evidence IEA]; mannose metabolism [goid 6013] [evidence IEA],"alpha-mannosidase activity [goid 4559] [evidence IEA]; mannosyl-oligosaccharide 1,3-1,6-alpha-mannosidase activity [goid 4572] [pmid 8524845] [evidence TAS]; hydrolase activity, acting on glycosyl bonds [goid 16798] [evidence IEA]; alpha-mannosidase activity [goid 4559] [evidence IEA]; mannosyl-oligosaccharide 1,3-1,6-alpha-mannosidase activity [goid 4572] [pmid 8524845] [evidence TAS]; hydrolase activity, acting on glycosyl bonds [goid 16798] [evidence IEA]",5,109230556-109230598:109230599-109230605,5q21.3e,+,NM_002372.2,4124,MAN2A1,1.0276134051930566,8.9601961111989,8.747471540515441,1.712197536876878e-14,1.308833621265044e-13,22.082636412628528
BMPR2,ILMN_1789095,"Homo sapiens bone morphogenetic protein receptor, type II (serine/threonine kinase) (BMPR2), mRNA.",integral to plasma membrane [goid 5887] [pmid 7791754] [evidence TAS]; membrane [goid 16020] [evidence IEA],transmembrane receptor protein serine/threonine kinase signaling pathway [goid 7178] [pmid 7644468] [evidence TAS]; skeletal development [goid 1501] [evidence NR ]; protein amino acid phosphorylation [goid 6468] [evidence IEA],transferase activity [goid 16740] [evidence IEA]; manganese ion binding [goid 30145] [evidence IEA]; nucleotide binding [goid 166] [evidence IEA]; ATP binding [goid 5524] [evidence IEA]; receptor activity [goid 4872] [evidence IEA]; magnesium ion binding [goid 287] [evidence IEA]; protein serine/threonine kinase activity [goid 4674] [evidence IEA]; transforming growth factor beta receptor activity [goid 5024] [evidence IEA]; protein binding [goid 5515] [pmid 15188402] [evidence IPI],2,203140150-203140199,2q33.1g,+,NM_001204.5,659,BMPR2,-1.0316360767306545,9.343843325789972,-8.745987798498652,1.7259424657291645e-14,1.3183061130824292e-13,22.07470487558082
NUCKS1,ILMN_1680692,"Homo sapiens nuclear casein kinase and cyclin-dependent kinase substrate 1 (NUCKS1), mRNA.",nucleus [goid 5634] [evidence IEA],,kinase activity [goid 16301] [evidence IEA],1,203954016-203954030:203954031-203954065,1q32.1g,-,NM_022731.2,64710,NUCKS1,1.3502029646429756,7.7361443038912965,8.741423112812802,1.7689211489475638e-14,1.3495469298059233e-13,22.050305557070182
BCL6B,ILMN_1651285,"Homo sapiens B-cell CLL/lymphoma 6, member B (zinc finger protein) (BCL6B), mRNA.",nucleus [goid 5634] [evidence IEA],,metal ion binding [goid 46872] [evidence IEA]; nucleic acid binding [goid 3676] [evidence IEA]; zinc ion binding [goid 8270] [evidence IEA]; protein binding [goid 5515] [evidence IEA],17,6873650-6873685,17p13.1d,+,NM_181844.2,255877,BCL6B,-1.1812014532635136,6.8545868811682125,-8.740552021356464,1.7772431857274032e-14,1.3552638970260563e-13,22.04564967853083
LOC389432,ILMN_1755215,"Homo sapiens sterile alpha motif domain containing 5 (SAMD5), mRNA.",,,,6,147932558-147932607,6q24.3b,+,NM_001030060.1,389432,LOC389432,-1.3558566417971498,6.3069682713139255,-8.735555778445436,1.825733883037565e-14,1.39071245938182e-13,22.01894728829784
SLC6A8,ILMN_1806349,"Homo sapiens solute carrier family 6 (neurotransmitter transporter, creatine), member 8 (SLC6A8), mRNA.",membrane [goid 16020] [evidence IEA]; integral to plasma membrane [goid 5887] [evidence IEA],ion transport [goid 6811] [evidence IEA]; sodium ion transport [goid 6814] [evidence IEA]; neurotransmitter transport [goid 6836] [evidence IEA]; neurotransmitter uptake [goid 1504] [evidence NR ]; muscle contraction [goid 6936] [pmid 8661155] [evidence TAS],symporter activity [goid 15293] [evidence IEA]; neurotransmitter:sodium symporter activity [goid 5328] [evidence IEA]; sodium ion binding [goid 31402] [evidence IEA]; creatine:sodium symporter activity [goid 5309] [pmid 7953292] [evidence TAS],X,152614922-152614971,Xq28f,+,NM_005629.1,6535,SLC6A8,1.2691431069512067,6.889955788995008,8.73142816973148,1.8667863406422616e-14,1.420317526255934e-13,21.996889785227523
AGR2,ILMN_1814151,"Homo sapiens anterior gradient homolog 2 (Xenopus laevis) (AGR2), mRNA.",,,,7,16798155-16798204,7p21.1b,-,NM_006408.2,10551,AGR2,1.6109475017190995,8.143778131694358,8.726500123711126,1.9170053759341738e-14,1.4579566647180865e-13,21.97055777350416
RND3,ILMN_1759513,"Homo sapiens Rho family GTPase 3 (RND3), mRNA.",intracellular [goid 5622] [evidence IEA],small GTPase mediated signal transduction [goid 7264] [evidence IEA],GTP binding [goid 5525] [evidence IEA]; nucleotide binding [goid 166] [evidence IEA],2,151033301-151033350,2q23.3a,-,NM_005168.3,390,RND3,-1.1890181258533215,8.958357701301985,-8.721934012516968,1.964735994776268e-14,1.493092077153494e-13,21.94616255398205
JOSD2,ILMN_2169025,"Homo sapiens Josephin domain containing 2 (JOSD2), mRNA.",,,,19,55701261-55701310,19q13.33c,-,NM_138334.1,126119,JOSD2,1.17803726454747,7.538152805714839,8.711740893839835,2.0755997388500105e-14,1.5742725150444708e-13,21.89171408616849
CYP3A7,ILMN_1685043,"Homo sapiens cytochrome P450, family 3, subfamily A, polypeptide 7 (CYP3A7), mRNA.",membrane fraction [goid 5624] [evidence ISS]; membrane [goid 16020] [evidence IEA]; endoplasmic reticulum [goid 5783] [evidence IEA]; microsome [goid 5792] [evidence IEA],xenobiotic metabolism [goid 6805] [evidence ISS]; electron transport [goid 6118] [evidence IEA],"heme binding [goid 20037] [evidence IEA]; metal ion binding [goid 46872] [evidence IEA]; unspecific monooxygenase activity [goid 50381] [evidence IEA]; iron ion binding [goid 5506] [evidence IEA]; oxygen binding [goid 19825] [pmid 2722762] [evidence TAS]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [goid 16712] [evidence IEA]",7,99141045-99141058:99141059-99141094,7q22.1b,-,NM_000765.2,1551,CYP3A7,-1.106345177256066,5.340478091600156,-8.710037269307351,2.0947271796266625e-14,1.58692686994656e-13,21.882615204172055
DKFZp547E087,ILMN_1752832,"PREDICTED: Homo sapiens hypothetical gene LOC283846, transcript variant 2 (DKFZp547E087), mRNA.",,,,18,11629363-11629412,,-,XM_931802.1,283846,DKFZp547E087,1.7957460061785673,6.867228563279593,8.709620832243218,2.0994293609410613e-14,1.589871010413392e-13,21.880391115942867
IFIT3,ILMN_1664543,"Homo sapiens interferon-induced protein with tetratricopeptide repeats 3 (IFIT3), mRNA.",,immune response [goid 6955] [evidence IEA],binding [goid 5488] [evidence IEA],10,91082306-91082355,10q23.31b,+,NM_001031683.1,3437,IFIT3,-1.3268062962171667,7.371192551246951,-8.703831586888663,2.165897607639695e-14,1.6382963852818115e-13,21.849474579056157
HSD17B7,ILMN_1671661,"Homo sapiens hydroxysteroid (17-beta) dehydrogenase 7 (HSD17B7), mRNA.",membrane [goid 16020] [evidence IEA]; integral to membrane [goid 16021] [evidence IEA],metabolism [goid 8152] [evidence IEA]; steroid biosynthesis [goid 6694] [evidence IEA],oxidoreductase activity [goid 16491] [evidence IEA]; 3-keto-steroid reductase activity [goid 50576] [evidence IEA]; estradiol 17-beta-dehydrogenase activity [goid 4303] [pmid 10544267] [evidence TAS],1,161048944-161048993,1q23.3c,+,NM_016371.2,51478,HSD17B7,1.9255522065233972,12.82419799329453,8.702672212534862,2.1794585105795744e-14,1.6479142056128447e-13,21.843283665725682
COL5A2,ILMN_1729117,"Homo sapiens collagen, type V, alpha 2 (COL5A2), mRNA.",collagen type V [goid 5588] [pmid 9425231] [evidence TAS]; cytoplasm [goid 5737] [evidence IEA]; collagen [goid 5581] [evidence IEA],phosphate transport [goid 6817] [evidence IEA],extracellular matrix structural constituent [goid 5201] [evidence IEA],2,189605701-189605750,2q32.2a,-,NM_000393.2,1290,COL5A2,1.5534538540015532,10.103030438570052,8.700392963951392,2.2063652732235357e-14,1.665673279688516e-13,21.831113290657093
CNGB1,ILMN_1702383,"Homo sapiens cyclic nucleotide gated channel beta 1 (CNGB1), mRNA.",membrane fraction [goid 5624] [evidence NR ]; membrane [goid 16020] [evidence IEA]; integral to plasma membrane [goid 5887] [evidence NR ]; intracellular cyclic nucleotide activated cation channel complex [goid 17071] [evidence NAS],ion transport [goid 6811] [evidence IEA]; potassium ion transport [goid 6813] [evidence IEA]; visual perception [goid 7601] [pmid 7682292] [evidence TAS],ligand-gated ion channel activity [goid 15276] [pmid 7682292] [evidence TAS]; nucleotide binding [goid 166] [evidence IEA]; intracellular cAMP activated cation channel activity [goid 5222] [evidence NAS]; potassium channel activity [goid 5267] [evidence IEA]; ion channel activity [goid 5216] [evidence IEA]; receptor activity [goid 4872] [evidence IEA],16,,16q13d,-,NM_001297.1,1258,CNGB1,1.391545950953792,6.176764739183534,8.699104875388736,2.2217173148595028e-14,1.67531586223055e-13,21.824235665446743
NUBPL,ILMN_2048811,"Homo sapiens nucleotide binding protein-like (NUBPL), mRNA.",,,ATP binding [goid 5524] [evidence IEA]; nucleotide binding [goid 166] [evidence IEA],14,31399175-31399224,14q12e,+,NM_025152.1,80224,NUBPL,1.795729588187962,11.47660998432901,8.697956040060754,2.2354993885804285e-14,1.685056308955112e-13,21.818101757718285
DPY19L1,ILMN_1791296,"PREDICTED: Homo sapiens dpy-19-like 1 (C. elegans) (DPY19L1), mRNA.",,,,,,7p14.3a,,XM_938743.1,23333,DPY19L1,1.0713440680505872,10.114334635788993,8.691699229299504,2.312067671260774e-14,1.7394068947689647e-13,21.784698262654196
LOC285382,ILMN_1660519,"Homo sapiens hypothetical gene supported by AK091454 (LOC285382), mRNA.",,,,3,186279006-186279055,3q27.2a,-,NM_001025266.1,285382,LOC285382,-1.017558155991062,6.105539031604069,-8.690811813891697,2.3231369033148524e-14,1.7463859012766164e-13,21.779961008847405
TMPRSS6,ILMN_1725014,"Homo sapiens transmembrane protease, serine 6 (TMPRSS6), mRNA.",integral to membrane [goid 16021] [pmid 12149247] [evidence IDA]; membrane [goid 16020] [evidence IEA],angiogenesis [goid 1525] [pmid 12149247] [evidence NAS]; extracellular matrix organization and biogenesis [goid 30198] [pmid 12149247] [evidence NAS]; fibrinolysis [goid 42730] [pmid 12149247] [evidence IDA]; intracellular signaling cascade [goid 7242] [pmid 12149247] [evidence NAS],serine-type endopeptidase activity [goid 4252] [pmid 12149247] [evidence IDA]; peptidase activity [goid 8233] [evidence IEA],22,35791704-35791753,22q12.3d,-,NM_153609.2,164656,TMPRSS6,1.7013204822417451,5.990564482480661,8.690654390546715,2.3251060369635873e-14,1.7471920991220785e-13,21.779120653277467
TNFSF15,ILMN_1759501,"Homo sapiens tumor necrosis factor (ligand) superfamily, member 15 (TNFSF15), mRNA.",plasma membrane [goid 5886] [pmid 11911831] [evidence IDA]; integral to plasma membrane [goid 5887] [pmid 9872942] [evidence TAS]; membrane [goid 16020] [evidence IEA]; extracellular space [goid 5615] [evidence IEA]; soluble fraction [goid 5625] [evidence NR ]; plasma membrane [goid 5886] [pmid 11911831] [evidence IDA]; integral to plasma membrane [goid 5887] [pmid 9872942] [evidence TAS]; membrane [goid 16020] [evidence IEA]; extracellular space [goid 5615] [evidence IEA]; soluble fraction [goid 5625] [evidence NR ],immune response [goid 6955] [evidence IEA]; negative regulation of endothelial cell proliferation [goid 1937] [pmid 12345] [evidence IDA]; cytokine metabolism [goid 42107] [pmid 11911831] [evidence IDA]; activation of NF-kappaB-inducing kinase [goid 7250] [pmid 11911831] [evidence IDA]; caspase activation [goid 6919] [pmid 11911831] [evidence IDA]; signal transduction [goid 7165] [pmid 9872942] [evidence NAS]; immune response [goid 6955] [evidence IEA]; negative regulation of endothelial cell proliferation [goid 1937] [pmid 12345] [evidence IDA]; cytokine metabolism [goid 42107] [pmid 11911831] [evidence IDA]; activation of NF-kappaB-inducing kinase [goid 7250] [pmid 11911831] [evidence IDA]; caspase activation [goid 6919] [pmid 11911831] [evidence IDA]; signal transduction [goid 7165] [pmid 9872942] [evidence NAS],tumor necrosis factor receptor binding [goid 5164] [evidence IEA]; tumor necrosis factor receptor binding [goid 5164] [evidence IEA],9,116592418-116592467,9q32e,-,NM_005118.2,9966,TNFSF15,1.1473561093304694,7.442227782370358,8.682276002768116,2.4323408226310754e-14,1.8242556169733065e-13,21.734400075435023
PPP1R9A,ILMN_1741674,"PREDICTED: Homo sapiens protein phosphatase 1, regulatory (inhibitor) subunit 9A, transcript variant 3 (PPP1R9A), mRNA.",,,,7,94757970-94758019,7q21.3b,+,XM_934519.1,55607,PPP1R9A,1.0843631117411325,6.855054127625737,8.68137831425284,2.444118457697823e-14,1.8323835378315538e-13,21.729609127569883
CYCSL1,ILMN_1663751,"Homo sapiens cytochrome c, somatic-like 1 (CYCSL1) on chromosome 6.",,,,6,34295306-34295355,6p21.31e,+,NR_001561.1,157317,CYCSL1,1.0497229861112185,8.692465060796325,8.670365181885723,2.5933162370880356e-14,1.941251128684609e-13,21.67084116214044
MAFB,ILMN_1764709,"Homo sapiens v-maf musculoaponeurotic fibrosarcoma oncogene homolog B (avian) (MAFB), mRNA.",nucleus [goid 5634] [pmid 8001130] [evidence TAS],"regulation of transcription, DNA-dependent [goid 6355] [evidence IEA]; transcription [goid 6350] [evidence IEA]; sensory organ development [goid 7423] [pmid 8001130] [evidence TAS]",DNA binding [goid 3677] [evidence IEA],20,38748223-38748272,20q12b,-,NM_005461.3,9935,MAFB,-1.0132463212418195,10.057459616899239,-8.670149458223172,2.5963274959862206e-14,1.9420131001647414e-13,21.669690188909687
ABP1,ILMN_1731433,"Homo sapiens amiloride binding protein 1 (amine oxidase (copper-containing)) (ABP1), mRNA.",peroxisome [goid 5777] [pmid 1356107] [evidence NAS],metabolism [goid 8152] [evidence NR ],oxidoreductase activity [goid 16491] [evidence IEA]; amine oxidase activity [goid 8131] [pmid 8144586] [evidence IDA]; heparin binding [goid 8201] [evidence IEA]; drug binding [goid 8144] [evidence NR ]; calcium ion binding [goid 5509] [evidence IEA]; copper ion binding [goid 5507] [evidence IEA],7,150189216-150189230:150189231-150189265,7q36.1c,+,NM_001091.2,26,ABP1,2.143875185215138,6.588683973849078,8.66914439975109,2.6104029380611914e-14,1.9517920663132123e-13,21.66432787825512
RAC2,ILMN_1709795,"Homo sapiens ras-related C3 botulinum toxin substrate 2 (rho family, small GTP binding protein Rac2) (RAC2), mRNA.",intracellular [goid 5622] [evidence IEA],small GTPase mediated signal transduction [goid 7264] [evidence IEA]; signal transduction [goid 7165] [pmid 2674130] [evidence TAS],GTP binding [goid 5525] [evidence IEA]; GTPase activity [goid 3924] [pmid 2674130] [evidence TAS]; nucleotide binding [goid 166] [evidence IEA]; protein binding [goid 5515] [pmid 11090627] [evidence IPI],22,35951411-35951460,22q13.1a,-,NM_002872.3,5880,RAC2,-1.0764438461710952,11.161647731117974,-8.66714043891449,2.6386947802592868e-14,1.9706771864067537e-13,21.653636514430055
C10orf73,ILMN_1738047,"PREDICTED: Homo sapiens chromosome 10 open reading frame 73 (C10orf73), mRNA.",,,,,,10q11.22d,,XM_937528.1,170370,C10orf73,-1.1874182248498393,7.032395305385749,-8.663996463507843,2.6836977642356735e-14,2.0019851047523775e-13,21.63686414942908
NUPR1,ILMN_2404688,"Homo sapiens nuclear protein 1 (NUPR1), transcript variant 1, mRNA.",nucleus [goid 5634] [pmid 10092851] [evidence IDA],cell growth [goid 16049] [pmid 10092851] [evidence IDA]; induction of apoptosis [goid 6917] [evidence NAS],,,,16p11.2e,,NM_001042483.1,26471,NUPR1,-1.1864032241042697,10.182436421008724,-8.660521707754755,2.7343250561159264e-14,2.038191419985418e-13,21.61832872800256
CLIC4,ILMN_2063584,"Homo sapiens chloride intracellular channel 4 (CLIC4), mRNA.",microvillus [goid 5902] [pmid 10793131] [evidence IDA]; membrane [goid 16020] [evidence IEA]; actin cytoskeleton [goid 15629] [pmid 12163372] [evidence TAS]; soluble fraction [goid 5625] [pmid 10793131] [evidence IDA]; cytoplasm [goid 5737] [pmid 10793131] [evidence IDA]; intracellular [goid 5622] [pmid 11256614] [evidence IDA]; microvillus [goid 5902] [pmid 10793131] [evidence IDA]; membrane [goid 16020] [evidence IEA]; actin cytoskeleton [goid 15629] [pmid 12163372] [evidence TAS]; soluble fraction [goid 5625] [pmid 10793131] [evidence IDA]; cytoplasm [goid 5737] [pmid 10793131] [evidence IDA]; intracellular [goid 5622] [pmid 11256614] [evidence IDA],ion transport [goid 6811] [evidence IEA]; cell differentiation [goid 30154] [pmid 12163372] [evidence TAS]; chloride transport [goid 6821] [pmid 10793131] [evidence NAS]; negative regulation of cell migration [goid 30336] [pmid 12163372] [evidence IDA]; ion transport [goid 6811] [evidence IEA]; cell differentiation [goid 30154] [pmid 12163372] [evidence TAS]; chloride transport [goid 6821] [pmid 10793131] [evidence NAS]; negative regulation of cell migration [goid 30336] [pmid 12163372] [evidence IDA],voltage-gated chloride channel activity [goid 5247] [evidence IEA]; protein binding [goid 5515] [pmid 10793131] [evidence IPI]; voltage-gated chloride channel activity [goid 5247] [evidence IEA]; protein binding [goid 5515] [pmid 10793131] [evidence IPI],1,25043065-25043114,1p36.11c,+,NM_013943.1,25932,CLIC4,-1.0946092612845337,8.74738371172924,-8.65938947376994,2.751026277637763e-14,2.0498564825916564e-13,21.612289400437508
CXCR4,ILMN_1801584,"Homo sapiens chemokine (C-X-C motif) receptor 4 (CXCR4), transcript variant 2, mRNA.",integral to membrane [goid 16021] [evidence IEA]; membrane [goid 16020] [evidence IEA],G-protein coupled receptor protein signaling pathway [goid 7186] [evidence IEA]; signal transduction [goid 7165] [evidence IEA],C-C chemokine receptor activity [goid 16493] [evidence IEA]; receptor activity [goid 4872] [evidence IEA]; rhodopsin-like receptor activity [goid 1584] [evidence IEA]; C-X-C chemokine receptor activity [goid 16494] [pmid 9468539] [evidence NAS],2,136592116-136592165,2q21.3b,-,NM_003467.2,7852,CXCR4,-1.5666746506780331,8.938898461952952,-8.65906965060278,2.7557622570883816e-14,2.0518161092612577e-13,21.610583498019942
CFB,ILMN_1774287,"Homo sapiens complement factor B (CFB), mRNA.",extracellular region [goid 5576] [evidence IEA],"innate immune response [goid 45087] [evidence IEA]; complement activation, alternative pathway [goid 6957] [pmid 8225386] [evidence NAS]; complement activation [goid 6956] [evidence IEA]",peptidase activity [goid 8233] [evidence IEA]; complement binding [goid 1848] [pmid 11367526] [evidence TAS]; alternative-complement-pathway C3/C5 convertase activity [goid 3812] [evidence IEA]; serine-type endopeptidase activity [goid 4252] [evidence IEA],6,32027200-32027229:32027311-32027330,6p21.32b,+,NM_001710.4,629,CFB,1.6803702662857365,11.003326689671622,8.652102752555852,2.860967369983603e-14,2.125274464511266e-13,21.57342631080068
RAB11FIP4,ILMN_1681467,"Homo sapiens RAB11 family interacting protein 4 (class II) (RAB11FIP4), mRNA.",,,calcium ion binding [goid 5509] [evidence IEA],17,26889135-26889184,17q11.2d,+,NM_032932.3,84440,RAB11FIP4,1.0464342633258887,6.466659778624574,8.649359153793926,2.9034866848318966e-14,2.155216687769505e-13,21.558795467089706
XRCC2,ILMN_1651569,"Homo sapiens X-ray repair complementing defective repair in Chinese hamster cells 2 (XRCC2), mRNA.",nucleus [goid 5634] [evidence IEA]; nucleus [goid 5634] [evidence IEA],meiosis [goid 7126] [pmid 9628903] [evidence TAS]; DNA repair [goid 6281] [pmid 9628903] [evidence TAS]; DNA recombination [goid 6310] [evidence IEA]; meiosis [goid 7126] [pmid 9628903] [evidence TAS]; DNA repair [goid 6281] [pmid 9628903] [evidence TAS]; DNA recombination [goid 6310] [evidence IEA],DNA-dependent ATPase activity [goid 8094] [evidence IEA]; ATP binding [goid 5524] [evidence IEA]; DNA binding [goid 3677] [evidence IEA]; DNA-dependent ATPase activity [goid 8094] [evidence IEA]; ATP binding [goid 5524] [evidence IEA]; DNA binding [goid 3677] [evidence IEA],7,151974964-151975013,7q36.1e,-,NM_005431.1,7516,XRCC2,1.1976720828720149,8.576087772383335,8.649272198159904,2.9048445293423354e-14,2.1554034902602972e-13,21.558331774077637
PAQR4,ILMN_1660793,"Homo sapiens progestin and adipoQ receptor family member IV (PAQR4), mRNA.",membrane [goid 16020] [evidence IEA]; integral to membrane [goid 16021] [evidence IEA],,receptor activity [goid 4872] [evidence IEA],16,2963395-2963444,16p13.3d,+,NM_152341.2,124222,PAQR4,1.004015476749295,9.532916913301843,8.64843307496853,2.917980281446865e-14,2.1643260671485405e-13,21.55385718325457
AXIN2,ILMN_1724480,"Homo sapiens axin 2 (conductin, axil) (AXIN2), mRNA.",nucleus [goid 5634] [pmid 12072559] [evidence IDA]; intracellular [goid 5622] [evidence IEA],development [goid 7275] [evidence IEA]; frizzled signaling pathway [goid 7222] [evidence IEA]; signal transduction [goid 7165] [pmid 10049590] [evidence TAS],signal transducer activity [goid 4871] [evidence IEA],17,60955365-60955414,17q24.1a,-,NM_004655.2,8313,AXIN2,-1.193594995822874,9.620624448397642,-8.64685591557362,2.942829603172032e-14,2.1794387996125826e-13,21.54544730787962
FLI1,ILMN_1665738,"Homo sapiens Friend leukemia virus integration 1 (FLI1), mRNA.",nucleus [goid 5634] [evidence IEA],"regulation of transcription, DNA-dependent [goid 6355] [evidence IEA]; transcription [goid 6350] [evidence IEA]; hemostasis [goid 7599] [pmid 10891501] [evidence TAS]",sequence-specific DNA binding [goid 43565] [evidence IEA]; transcription factor activity [goid 3700] [pmid 10891501] [evidence TAS],11,128187303-128187352,11q24.3a,+,NM_002017.2,2313,FLI1,-1.0864586235137992,5.603291052503853,-8.64156994045237,3.027660639475591e-14,2.2388602489632595e-13,21.517263458374227
LOC643011,ILMN_1719072,"PREDICTED: Homo sapiens hypothetical protein LOC643011 (LOC643011), mRNA.",,,,13,95124628-95124677,,-,XM_931238.1,643011,LOC643011,1.1573448208584471,6.8562240806005725,8.637073032482645,3.1017421546466195e-14,2.2910328234757157e-13,21.49328982851213
FCMD,ILMN_2357386,"Homo sapiens Fukuyama type congenital muscular dystrophy (fukutin) (FCMD), mRNA.",membrane [goid 16020] [evidence IEA]; integral to membrane [goid 16021] [evidence IEA]; extracellular space [goid 5615] [pmid 9690476] [evidence TAS]; extracellular space [goid 5615] [pmid 9690476] [evidence TAS]; integral to membrane [goid 16021] [evidence IEA]; Golgi stack [goid 5795] [evidence IEA],muscle development [goid 7517] [pmid 9690476] [evidence TAS]; muscle development [goid 7517] [pmid 9690476] [evidence TAS],transferase activity [goid 16740] [evidence IEA]; transferase activity [goid 16740] [evidence IEA],9,,9q31.2a,+,NM_006731.1,2218,FCMD,1.1018052441366848,13.905228058190511,8.633755744022295,3.1575448728429227e-14,2.330483403308498e-13,21.47560671782955
EIF2C2,ILMN_1695719,"Homo sapiens eukaryotic translation initiation factor 2C, 2 (EIF2C2), mRNA.",,protein biosynthesis [goid 6412] [pmid 10534406] [evidence NAS],protein binding [goid 5515] [pmid 14749716] [evidence IPI]; translation initiation factor activity [goid 3743] [pmid 10534406] [evidence NAS],8,141610650-141610699,8q24.3c,-,NM_012154.2,27161,EIF2C2,1.0284412497942181,10.346827424866667,8.631425932792945,3.1973328612552e-14,2.357515477429339e-13,21.463188363941107
C18orf56,ILMN_1796074,"Homo sapiens chromosome 18 open reading frame 56 (C18orf56), mRNA.",,,,18,639651-639700,18p11.32c,-,NM_001012716.1,494514,C18orf56,1.3001436874847494,6.348203056332126,8.627027268525548,3.2738180209774195e-14,2.412645391026665e-13,21.439744685624557
P8,ILMN_1810560,"Homo sapiens p8 protein (candidate of metastasis 1) (P8), mRNA.",nucleus [goid 5634] [pmid 10092851] [evidence IDA],induction of apoptosis [goid 6917] [evidence NAS]; cell growth [goid 16049] [pmid 10092851] [evidence IDA],molecular function unknown [goid 5554] [evidence ND ],16,28456834-28456840:28456841-28456883,16p11.2e,-,NM_012385.1,26471,P8,-1.2324970685784553,9.845155610339836,-8.625299133905587,3.304363274195554e-14,2.433315132188222e-13,21.430534942442566
MGC16121,ILMN_1673409,"PREDICTED: Homo sapiens hypothetical protein MGC16121 (MGC16121), mRNA.",,,,X,133506231-133506244:133506245-133506280,Xq26.3a,-,XM_927600.1,84848,MGC16121,1.1936288817227059,5.905574223345762,8.614043473986458,3.51037111292658e-14,2.581116269259412e-13,21.37056046028118
DNAJB4,ILMN_1813019,"Homo sapiens DnaJ (Hsp40) homolog, subfamily B, member 4 (DNAJB4), mRNA.",,response to heat [goid 9408] [pmid 9546042] [evidence TAS]; protein folding [goid 6457] [evidence IEA]; response to unfolded protein [goid 6986] [pmid 9546042] [evidence TAS]; response to heat [goid 9408] [pmid 9546042] [evidence TAS]; protein folding [goid 6457] [evidence IEA]; response to unfolded protein [goid 6986] [pmid 9546042] [evidence TAS],heat shock protein binding [goid 31072] [evidence IEA]; unfolded protein binding [goid 51082] [pmid 9546042] [evidence TAS]; heat shock protein binding [goid 31072] [evidence IEA]; unfolded protein binding [goid 51082] [pmid 9546042] [evidence TAS],1,78254973-78255022,1p31.1e,+,NM_007034.3,11080,DNAJB4,-1.0737296135536596,5.589585122385365,-8.608573264424464,3.615058166332102e-14,2.6490939590440395e-13,21.341419537477204
HDC,ILMN_1792323,"Homo sapiens histidine decarboxylase (HDC), mRNA.",,histidine metabolism [goid 6547] [pmid 1487235] [evidence TAS]; amino acid metabolism [goid 6520] [evidence IEA]; catecholamine biosynthesis [goid 42423] [evidence IEA],lyase activity [goid 16829] [evidence IEA]; histidine decarboxylase activity [goid 4398] [pmid 1487235] [evidence TAS],15,48321494-48321543,15q21.2a,-,NM_002112.1,3067,HDC,-1.5007689674458558,7.991762846109764,-8.60781124757221,3.629885932063266e-14,2.6585720728748936e-13,21.337360454414203
S100A12,ILMN_1748915,"Homo sapiens S100 calcium binding protein A12 (S100A12), mRNA.",insoluble fraction [goid 5626] [pmid 7626002] [evidence TAS]; cytosol [goid 5829] [pmid 7626002] [evidence TAS],xenobiotic metabolism [goid 6805] [pmid 11522286] [evidence IDA]; inflammatory response [goid 6954] [pmid 8619876] [evidence TAS],zinc ion binding [goid 8270] [pmid 11522286] [evidence TAS]; calcium ion binding [goid 5509] [pmid 7626002] [evidence TAS],1,151612983-151613032,1q21.3c,-,NM_005621.1,6283,S100A12,-1.3301114167976742,5.45556241484683,-8.606937513463139,3.646962081875539e-14,2.669461163236096e-13,21.332706381343694
CKMT1B,ILMN_1763491,"Homo sapiens creatine kinase, mitochondrial 1B (CKMT1B), nuclear gene encoding mitochondrial protein, mRNA.",mitochondrion [goid 5739] [pmid 2914937] [evidence TAS],,kinase activity [goid 16301] [evidence IEA]; creatine kinase activity [goid 4111] [pmid 2914937] [evidence TAS],15,41678337-41678386,15q15.3a,+,NM_020990.3,1159,CKMT1B,1.3110584052697254,5.743735056221811,8.605781252781743,3.669682895988549e-14,2.6840754965591923e-13,21.3265475554842
USP49,ILMN_1680279,"Homo sapiens ubiquitin specific peptidase 49 (USP49), mRNA.",,ubiquitin-dependent protein catabolism [goid 6511] [evidence IEA],zinc ion binding [goid 8270] [evidence IEA]; metal ion binding [goid 46872] [evidence IEA]; peptidase activity [goid 8233] [evidence IEA]; ubiquitin thiolesterase activity [goid 4221] [evidence IEA]; cysteine-type endopeptidase activity [goid 4197] [evidence IEA],6,41873670-41873719,6p21.1f,-,NM_018561.3,25862,USP49,1.9527125359252135,11.996951505710147,8.604887752076904,3.6873368832690886e-14,2.6959759538648476e-13,21.32178845138505
LOC647673,ILMN_1757702,"PREDICTED: Homo sapiens similar to Translationally-controlled tumor protein (TCTP) (p23) (Histamine-releasing factor) (HRF) (Fortilin) (LOC647673), mRNA.",,,,,,,,XM_936731.1,647673,LOC647673,-1.3930260645899057,9.226919796304585,-8.6037520841560209,3.709897740733401e-14,2.711453768874356e-13,21.315739641796583
WDR66,ILMN_1800341,"Homo sapiens WD repeat domain 66 (WDR66), mRNA.",,,calcium ion binding [goid 5509] [evidence IEA],12,120923859-120923887:120925941-120925961,12q24.31b-q24.31c,+,NM_144668.3,144406,WDR66,2.5108526606286397,7.2986943411115766,8.60309340529307,3.723045777301712e-14,2.7200430060263915e-13,21.312231461651983
ALPP,ILMN_1693789,"Homo sapiens alkaline phosphatase, placental (Regan isozyme) (ALPP), mRNA.",membrane [goid 16020] [evidence IEA]; integral to membrane [goid 16021] [evidence IEA],metabolism [goid 8152] [evidence IEA],alkaline phosphatase activity [goid 4035] [pmid 3042787] [evidence NAS]; magnesium ion binding [goid 287] [evidence IEA]; zinc ion binding [goid 8270] [evidence IEA]; hydrolase activity [goid 16787] [evidence IEA],2,232955647-232955696,2q37.1c,+,NM_001632.2,250,ALPP,1.8347594747730653,12.687252752311446,8.598261210275211,3.820931292820781e-14,2.785291666315485e-13,21.286496663980813
TNNI3,ILMN_1768637,"Homo sapiens troponin I type 3 (cardiac) (TNNI3), mRNA.",troponin complex [goid 5861] [pmid 12809519] [evidence TAS],negative regulation of angiogenesis [goid 16525] [pmid 12809519] [evidence TAS]; regulation of muscle contraction [goid 6937] [pmid 12809519] [evidence TAS],protein binding [goid 5515] [pmid 12809519] [evidence IPI]; actin binding [goid 3779] [pmid 12809519] [evidence TAS]; calcium channel inhibitor activity [goid 19855] [pmid 12809519] [evidence IPI],19,60355059-60355097:60357210-60357220,19q13.42b,-,NM_000363.3,7137,TNNI3,1.2012700665161624,5.839712012270838,8.595327562165439,3.881603513702301e-14,2.828460899943506e-13,21.27087457181069
ZNF641,ILMN_1731666,"Homo sapiens zinc finger protein 641 (ZNF641), mRNA.",nucleus [goid 5634] [evidence IEA]; intracellular [goid 5622] [evidence IEA],"regulation of transcription, DNA-dependent [goid 6355] [evidence IEA]",zinc ion binding [goid 8270] [evidence IEA]; metal ion binding [goid 46872] [evidence IEA]; nucleic acid binding [goid 3676] [evidence IEA],12,47022350-47022399,12q13.11c,-,NM_152320.1,121274,ZNF641,1.1780083512206714,7.588039667777986,8.593052761944712,3.9293091180474103e-14,2.8610832647665843e-13,21.258761783954437
SULT1C1,ILMN_1766079,"Homo sapiens sulfotransferase family, cytosolic, 1C, member 2 (SULT1C2), transcript variant 1, mRNA.",cytoplasm [goid 5737] [pmid 9169148] [evidence TAS]; cytoplasm [goid 5737] [pmid 9169148] [evidence TAS],amine metabolism [goid 9308] [pmid 9169148] [evidence TAS]; amine metabolism [goid 9308] [pmid 9169148] [evidence TAS],transferase activity [goid 16740] [evidence IEA]; sulfotransferase activity [goid 8146] [pmid 9169148] [evidence TAS]; transferase activity [goid 16740] [evidence IEA]; sulfotransferase activity [goid 8146] [pmid 9169148] [evidence TAS],2,108283737-108283786,2q12.3c,+,NM_001056.3,6819,SULT1C1,1.2342000469078194,5.888760734185779,8.583373361808402,4.13891094871309e-14,3.0058397255189924e-13,21.207229489242827
FLJ20130,ILMN_1756550,"Homo sapiens nucleoporin 62kDa C-terminal like (NUP62CL), mRNA.",integral to membrane [goid 16021] [evidence IEA]; nuclear pore [goid 5643] [evidence IEA]; outer membrane [goid 19867] [evidence IEA],,structural constituent of nuclear pore [goid 17056] [evidence IEA]; porin activity [goid 15288] [evidence IEA],X,106253395-106253444,Xq22.3b,-,NM_017681.1,54830,FLJ20130,1.393274239132733,6.807659783537216,8.582056853373464,4.16826605701615e-14,3.0260307049537886e-13,21.200221550482205
CCDC47,ILMN_1804522,"Homo sapiens coiled-coil domain containing 47 (CCDC47), mRNA.",,,,17,59176735-59176784,17q23.3b,-,NM_020198.1,57003,CCDC47,1.1410325270815562,6.8721950433744405,8.577861704058925,4.2631977338265444e-14,3.0926436278335897e-13,21.177891911316703
UGT8,ILMN_1758816,"Homo sapiens UDP glycosyltransferase 8 (UDP-galactose ceramide galactosyltransferase) (UGT8), mRNA.",microsome [goid 5792] [evidence IEA]; integral to membrane [goid 16021] [evidence IEA]; endoplasmic reticulum [goid 5783] [evidence IEA],metabolism [goid 8152] [evidence IEA]; peripheral nervous system development [goid 7422] [pmid 8661025] [evidence TAS]; glycosphingolipid biosynthesis [goid 6688] [evidence NR ]; central nervous system development [goid 7417] [pmid 8661025] [evidence TAS],"2-hydroxyacylsphingosine 1-beta-galactosyltransferase activity [goid 3851] [evidence IEA]; transferase activity, transferring hexosyl groups [goid 16758] [evidence IEA]",4,115816633-115816682,4q26b,+,NM_003360.2,7368,UGT8,1.1238115833006015,5.813414113412498,8.577606823907317,4.269034254619965e-14,3.09572506331485e-13,21.176535335302816
TRIM51,ILMN_1753648,"Homo sapiens SPRY domain containing 5 (SPRYD5), mRNA.",,,,11,55415610-55415659,11q11c,+,NM_032681.1,84767,TRIM51,1.0644361769070674,6.295252424400021,8.565989239667221,4.543682648106817e-14,3.2887688112318477e-13,21.11471178800391
MCHR2,ILMN_2383150,"Homo sapiens melanin-concentrating hormone receptor 2 (MCHR2), mRNA.",membrane [goid 16020] [evidence IEA]; integral to membrane [goid 16021] [evidence IEA]; membrane [goid 16020] [evidence IEA]; integral to membrane [goid 16021] [evidence IEA],G-protein coupled receptor protein signaling pathway [goid 7186] [evidence IEA]; signal transduction [goid 7165] [evidence IEA]; signal transduction [goid 7165] [evidence IEA]; G-protein coupled receptor protein signaling pathway [goid 7186] [evidence IEA],receptor activity [goid 4872] [evidence IEA]; rhodopsin-like receptor activity [goid 1584] [evidence IEA]; rhodopsin-like receptor activity [goid 1584] [evidence IEA]; receptor activity [goid 4872] [evidence IEA],6,,6q16.3a,-,NM_032503.1,84539,MCHR2,1.2174611011074763,6.322169607278392,8.559871186740938,4.6953165252227403e-14,3.39222256188228e-13,21.08216213718608
IL18,ILMN_1778457,"Homo sapiens interleukin 18 (interferon-gamma-inducing factor) (IL18), mRNA.",extracellular space [goid 5615] [evidence IEA],granulocyte macrophage colony-stimulating factor biosynthesis [goid 42253] [pmid 10653850] [evidence TAS]; interferon-gamma biosynthesis [goid 42095] [pmid 10227975] [evidence TAS]; interleukin-2 biosynthesis [goid 42094] [pmid 10653850] [evidence TAS]; immune response [goid 6955] [pmid 8999896] [evidence TAS]; interleukin-13 biosynthesis [goid 42231] [pmid 10227975] [evidence TAS]; induction of apoptosis via death domain receptors [goid 8625] [pmid 11714750] [evidence ISS]; cell-cell signaling [goid 7267] [pmid 9792649] [evidence TAS]; T-helper 2 type immune response [goid 42092] [pmid 11905033] [evidence TAS]; angiogenesis [goid 1525] [pmid 11466388] [evidence IDA]; positive regulation of activated T cell proliferation [goid 42104] [pmid 10000000] [evidence IDA]; regulation of cell adhesion [goid 30155] [pmid 11477102] [evidence IDA]; sleep [goid 30431] [pmid 11506998] [evidence ISS]; chemokine biosynthesis [goid 42033] [pmid 11598150] [evidence TAS],signal transducer activity [goid 4871] [pmid 8999896] [evidence TAS]; interleukin-1 receptor binding [goid 5149] [evidence IEA],11,111519243-111519292,11q23.1c,-,NM_001562.2,3606,IL18,1.0153610175979555,14.0625129311763,8.558448937903922,4.731281935897482e-14,3.4156735280089824e-13,21.074596179844697
TMSL8,ILMN_1681737,"Homo sapiens thymosin-like 8 (TMSL8), mRNA.",cytoskeleton [goid 5856] [evidence IEA]; cytoplasm [goid 5737] [evidence NAS],cytoskeleton organization and biogenesis [goid 7010] [evidence IEA],actin binding [goid 3779] [evidence IEA],X,101655524-101655573,Xq22.1e,-,NM_021992.2,11013,TMSL8,-2.148614195420759,6.709824763065547,-8.548390888856385,4.9935746308492446e-14,3.6010289297593465e-13,21.021098665772765
ARRDC4,ILMN_1660544,"Homo sapiens arrestin domain containing 4 (ARRDC4), mRNA.",,,,15,96317363-96317412,15q26.3a,+,NM_183376.1,91947,ARRDC4,-1.088981272146797,6.622959956476596,-8.544837449191633,5.089659847317425e-14,3.6676043685273677e-13,21.002201903456342
SLC4A11,ILMN_1735156,"Homo sapiens solute carrier family 4, sodium bicarbonate transporter-like, member 11 (SLC4A11), mRNA.",membrane [goid 16020] [evidence IEA]; integral to membrane [goid 16021] [evidence IEA],anion transport [goid 6820] [evidence IEA],inorganic anion exchanger activity [goid 5452] [evidence IEA],20,3156309-3156358,20p13c,-,NM_032034.1,83959,SLC4A11,1.4527455822149884,6.429091060047803,8.54230006469367,5.1593949144822335e-14,3.713735127768242e-13,20.98870953481927
ZNF486,ILMN_1805668,"PREDICTED: Homo sapiens zinc finger protein 486 (ZNF486), mRNA.",,,,19,20171476-20171525,19p12d,+,XM_371152.2,90649,ZNF486,1.4627725021909157,13.630493030308827,8.53772211390822,5.2876252703615785e-14,3.801822080922338e-13,20.964368991828792
ENTPD4,ILMN_1806304,"Homo sapiens ectonucleoside triphosphate diphosphohydrolase 4 (ENTPD4), mRNA.",membrane [goid 16020] [evidence IEA]; integral to Golgi membrane [goid 30173] [pmid 9556635] [evidence IDA]; integral to membrane [goid 16021] [evidence IEA]; lysosome [goid 5764] [evidence IEA]; vacuole [goid 5773] [evidence IEA],UDP catabolism [goid 6256] [pmid 9556635] [evidence IDA],calcium ion binding [goid 5509] [evidence IEA]; uridine-diphosphatase activity [goid 45134] [pmid 9556635] [evidence IDA]; magnesium ion binding [goid 287] [evidence IEA]; hydrolase activity [goid 16787] [evidence IEA],8,23346502-23346551,8p21.3a,-,NM_004901.1,9583,ENTPD4,1.011090007801707,7.75826687032126,8.534416328928899,5.382189353034726e-14,3.8669601601726267e-13,20.946794359218114
LOC441087,ILMN_1742163,"Homo sapiens hypothetical gene supported by AK125735 (LOC441087), mRNA.",,,,5,75064202-75064251,5q13.3c,+,NM_001013716.1,441087,LOC441087,1.250683402490008,14.291350268535949,8.528073146382164,5.568378921891548e-14,3.9957485016658304e-13,20.91307645451497
COL17A1,ILMN_1651282,"Homo sapiens collagen, type XVII, alpha 1 (COL17A1), transcript variant short, mRNA.",intercellular junction [goid 5911] [pmid 9012408] [evidence TAS]; microsome [goid 5792] [evidence IEA]; extracellular matrix (sensu Metazoa) [goid 5578] [evidence IEA]; membrane [goid 16020] [evidence IEA]; cytoplasm [goid 5737] [evidence IEA]; integral to plasma membrane [goid 5887] [pmid 9012408] [evidence TAS],electron transport [goid 6118] [evidence IEA]; cell-matrix adhesion [goid 7160] [pmid 9012408] [evidence TAS]; epidermis development [goid 8544] [pmid 9012408] [evidence TAS]; phosphate transport [goid 6817] [evidence IEA],monooxygenase activity [goid 4497] [evidence IEA]; structural molecule activity [goid 5198] [evidence IEA]; iron ion binding [goid 5506] [evidence IEA]; heme binding [goid 20037] [evidence IEA],10,105781170-105781219,10q25.1a,-,NM_130778.1,1308,COL17A1,1.8554039818575276,6.73549056756727,8.52803074577711,5.569644819360736e-14,3.9957485016658304e-13,20.912851089355158
SELE,ILMN_1739393,"Homo sapiens selectin E (endothelial adhesion molecule 1) (SELE), mRNA.",plasma membrane [goid 5886] [pmid 2466335] [evidence TAS]; membrane [goid 16020] [evidence IEA]; integral to membrane [goid 16021] [evidence IEA]; plasma membrane [goid 5886] [pmid 2466335] [evidence TAS]; membrane [goid 16020] [evidence IEA]; integral to membrane [goid 16021] [evidence IEA],cell adhesion [goid 7155] [evidence IEA]; inflammatory response [goid 6954] [pmid 2466335] [evidence TAS]; cell adhesion [goid 7155] [evidence IEA]; inflammatory response [goid 6954] [pmid 2466335] [evidence TAS],sugar binding [goid 5529] [evidence IEA]; protein binding [goid 5515] [evidence IEA]; sugar binding [goid 5529] [evidence IEA]; protein binding [goid 5515] [evidence IEA],1,167958962-167959011,1q24.2c,-,NM_000450.1,6401,SELE,-1.0677656575159,5.759073503379353,-8.521312824630229,5.773873600968278e-14,4.1255565498667733e-13,20.87714776884936
HSPB7,ILMN_2200836,"Homo sapiens heat shock 27kDa protein family, member 7 (cardiovascular) (HSPB7), mRNA.",,protein folding [goid 6457] [evidence IEA]; response to unfolded protein [goid 6986] [pmid 10593960] [evidence TAS],protein C-terminus binding [goid 8022] [pmid 10593960] [evidence TAS],1,16213331-16213380,1p36.13f,-,NM_014424.3,27129,HSPB7,-1.1766620445668625,6.589003619270018,-8.52007776781784,5.812223120285273e-14,4.14839441387394e-13,20.870584619112343
MMP28,ILMN_1752952,"Homo sapiens matrix metallopeptidase 28 (MMP28), transcript variant 3, mRNA.",extracellular matrix (sensu Metazoa) [goid 5578] [pmid 11121398] [evidence NAS]; extracellular matrix (sensu Metazoa) [goid 5578] [pmid 11121398] [evidence NAS],peptidoglycan metabolism [goid 270] [evidence IEA]; peptidoglycan metabolism [goid 270] [evidence IEA],zinc ion binding [goid 8270] [evidence IEA]; metalloendopeptidase activity [goid 4222] [pmid 11255011] [evidence TAS]; calcium ion binding [goid 5509] [evidence IEA]; zinc ion binding [goid 8270] [evidence IEA]; metalloendopeptidase activity [goid 4222] [pmid 11255011] [evidence TAS]; calcium ion binding [goid 5509] [evidence IEA],17,31130376-31130425,17q12b,-,NM_001032278.1,79148,MMP28,-1.370020927703031,7.623031524609821,-8.518245527058475,5.869583175660898e-14,4.1878003726749397e-13,20.860848424586106
NLRP8,ILMN_2075794,"Homo sapiens NLR family, pyrin domain containing 8 (NLRP8), mRNA.",,,transferase activity [goid 16740] [evidence IEA],19,61191460-61191509,19q13.42c,+,NM_176811.2,126205,NLRP8,2.0352846858039175,13.09804385804249,8.517150383946145,5.90413632759311e-14,4.2109112863525525e-13,20.855029272056655
LOC338758,ILMN_1795835,"PREDICTED: Homo sapiens hypothetical protein LOC338758 (LOC338758), mRNA.",,,,12,88628314-88628363,12q21.33b,+,XM_931359.1,338758,LOC338758,-1.262427831205473,8.688652887542093,-8.510676204642609,6.112580368738114e-14,4.3532027954993474e-13,20.820631732247072
LOC652334,ILMN_1724017,"PREDICTED: Homo sapiens similar to protein immuno-reactive with anti-PTH polyclonal antibodies (LOC652334), mRNA.",,,,,,,,XM_941763.1,652334,LOC652334,1.232952325298636,6.201585326271364,8.507871935090828,6.205125270342418e-14,4.4142703867331877e-13,20.805734497510432
DEFA1,ILMN_1679357,"Homo sapiens defensin, alpha 1 (DEFA1), mRNA.",extracellular region [goid 5576] [evidence IEA]; extracellular region [goid 5576] [evidence IEA],response to virus [goid 9615] [evidence IEA]; xenobiotic metabolism [goid 6805] [evidence IEA]; response to virus [goid 9615] [evidence IEA]; xenobiotic metabolism [goid 6805] [evidence IEA],,8,6823476-6823525,8p23.1f,-,NM_004084.2,1667,DEFA1,-2.2177801870490894,5.874646940461779,-8.507683339234624,6.211399011967212e-14,4.417120793729238e-13,20.804732654412607
SFTPB,ILMN_1727017,"Homo sapiens surfactant, pulmonary-associated protein B (SFTPB), transcript variant 2, mRNA.",extracellular space [goid 5615] [evidence NR ]; lysosome [goid 5764] [evidence IEA],regulation of liquid surface tension [goid 50828] [evidence IEA]; sphingolipid metabolism [goid 6665] [evidence IEA]; respiratory gaseous exchange [goid 7585] [pmid 10378403] [evidence TAS]; lipid metabolism [goid 6629] [evidence IEA],,2,85738216-85738265,2p11.2f,-,NM_198843.1,6439,SFTPB,-1.585579148515892,10.492351774254693,-8.50502741855464,6.300422990167204e-14,4.4755283253156385e-13,20.79062466208983
SLC35E1,ILMN_1752333,"Homo sapiens solute carrier family 35, member E1 (SLC35E1), mRNA.",membrane [goid 16020] [evidence IEA]; integral to membrane [goid 16021] [evidence IEA]; membrane [goid 16020] [evidence IEA]; integral to membrane [goid 16021] [evidence IEA],transport [goid 6810] [evidence IEA]; transport [goid 6810] [evidence IEA],,19,16524097-16524146,19p13.11f,-,NM_024881.3,79939,SLC35E1,1.1065626298747677,11.02160818221487,8.502492373548346,6.386579442831158e-14,4.5304159345859227e-13,20.77715973797618
RNUXA,ILMN_1728074,"Homo sapiens RNA U, small nuclear RNA export adaptor (phosphorylation regulated) (RNUXA), mRNA.",nucleus [goid 5634] [evidence IEA]; nucleus [goid 5634] [evidence IEA],protein transport [goid 15031] [evidence IEA]; protein transport [goid 15031] [evidence IEA],RNA binding [goid 3723] [evidence IEA]; RNA binding [goid 3723] [evidence IEA],5,125988351-125988400,5q23.2e,+,NM_032177.2,51808,RNUXA,1.0911867021211865,8.636412664320398,8.502483061040216,6.386898091002898e-14,4.5304159345859227e-13,20.777110276250994
CABYR,ILMN_2412139,"Homo sapiens calcium binding tyrosine-(Y)-phosphorylation regulated (fibrousheathin 2) (CABYR), transcript variant 2, mRNA.",nucleus [goid 5634] [evidence IEA]; cytoskeleton [goid 5856] [evidence IEA],signal transduction [goid 7165] [evidence IEA],cAMP-dependent protein kinase regulator activity [goid 8603] [evidence IEA]; structural molecule activity [goid 5198] [evidence IEA]; calcium ion binding [goid 5509] [evidence IEA],18,19993964-19994013,18q11.2c,+,NM_153768.1,26256,CABYR,1.5365495856696159,6.203978453350434,8.50141970057465,6.423387580653612e-14,4.552917679484744e-13,20.771462512698317
TDRD1,ILMN_1809750,"Homo sapiens tudor domain containing 1 (TDRD1), mRNA.",,,nucleic acid binding [goid 3676] [evidence IEA],10,115981532-115981581,10q25.3a,+,NM_198795.1,56165,TDRD1,2.0117942960371877,9.667515571658827,8.500855812286877,6.442821657735394e-14,4.565032000035424e-13,20.768467635236068
VSIG2,ILMN_1666536,"Homo sapiens V-set and immunoglobulin domain containing 2 (VSIG2), mRNA.",membrane [goid 16020] [evidence IEA]; integral to membrane [goid 16021] [evidence IEA],,,11,124123562-124123611,11q24.2a,-,NM_014312.3,23584,VSIG2,-2.076369922204517,9.88987795302857,-8.500650705641778,6.449905041017454e-14,4.568389666456745e-13,20.767378301432206
MAOA,ILMN_1663640,"Homo sapiens monoamine oxidase A (MAOA), nuclear gene encoding mitochondrial protein, mRNA.",integral to membrane [goid 16021] [evidence IEA]; membrane [goid 16020] [evidence NR ]; mitochondrion [goid 5739] [evidence IEA],catecholamine metabolism [goid 6584] [evidence IEA]; electron transport [goid 6118] [evidence IEA]; behavior [goid 7610] [pmid 8211186] [evidence TAS]; neurotransmitter catabolism [goid 42135] [evidence IEA],amine oxidase activity [goid 8131] [evidence IEA]; oxidoreductase activity [goid 16491] [evidence IEA],X,43490870-43490919,Xp11.3c,+,NM_000240.2,4128,MAOA,-1.0325982752893488,12.168107765556966,-8.494814993119856,6.654721912840374e-14,4.698089002597634e-13,20.736387136081404
TYMS,ILMN_1806040,"Homo sapiens thymidylate synthetase (TYMS), mRNA.",,"dTMP biosynthesis [goid 6231] [evidence IEA]; deoxyribonucleoside monophosphate biosynthesis [goid 9157] [pmid 2987839] [evidence TAS]; phosphoinositide-mediated signaling [goid 48015] [pmid 15504738] [evidence NAS]; DNA replication [goid 6260] [pmid 15504738] [evidence NAS]; nucleobase, nucleoside, nucleotide and nucleic acid metabolism [goid 6139] [pmid 2987839] [evidence TAS]; DNA repair [goid 6281] [pmid 15504738] [evidence NAS]; nucleotide biosynthesis [goid 9165] [evidence IEA]",transferase activity [goid 16740] [evidence IEA]; thymidylate synthase activity [goid 4799] [evidence IEA]; methyltransferase activity [goid 8168] [evidence IEA],18,663033-663082,18p11.32c,+,NM_001071.1,7298,TYMS,1.2285827632743018,8.094908392699876,8.493702737303698,6.694487062242786e-14,4.723007928651001e-13,20.730480967765157
LOC644931,ILMN_1731922,"PREDICTED: Homo sapiens hypothetical LOC644931 (LOC644931), mRNA.",,,,17,17526414-17526463,17p11.2g,-,XM_932522.1,644931,LOC644931,1.3515295472175008,7.719082287540561,8.483278734699093,7.078848502163107e-14,4.972291386613127e-13,20.675137775530064
GNL3L,ILMN_1708414,"Homo sapiens guanine nucleotide binding protein-like 3 (nucleolar)-like (GNL3L), mRNA.",,,GTP binding [goid 5525] [evidence IEA],X,54605704-54605753,Xp11.22a,+,NM_019067.3,54552,GNL3L,1.2539543709209617,10.485572608565436,8.482826891258282,7.095996912496248e-14,4.982540534774393e-13,20.672739217839975
LOC653388,ILMN_1770498,"PREDICTED: Homo sapiens similar to SMA4 (LOC653388), mRNA.",,,,5,69847861-69847910,,-,XM_931940.1,653388,LOC653388,1.5838261571933625,6.983454732543095,8.482235194934725,7.118515562872911e-14,4.996551719833526e-13,20.669598314541606
LOC642947,ILMN_2049343,"Homo sapiens hypothetical protein LOC642947 (LOC642947), mRNA.",,,,9,79000381-79000430,9q21.13c,+,NM_001039895.1,642947,LOC642947,1.0437769387062534,14.268307250952356,8.481455824389093,7.148285238629699e-14,5.015640542841184e-13,20.665461260905875
FLJ32130,ILMN_1676459,"Homo sapiens hypothetical protein FLJ32130 (FLJ32130), mRNA.",nucleus [goid 5634] [evidence IEA],"regulation of transcription, DNA-dependent [goid 6355] [evidence IEA]",zinc ion binding [goid 8270] [evidence IEA]; DNA binding [goid 3677] [evidence IEA],16,30499600-30499649,16p11.2c,-,NM_152458.4,146540,FLJ32130,1.2474033882084452,6.11832073071275,8.48027480688996,7.193632933075142e-14,5.043826473586511e-13,20.659192361657617
ANKRD36,ILMN_2280568,"Homo sapiens ankyrin repeat domain 36 (ANKRD36), mRNA.",,,catalytic activity [goid 3824] [evidence IEA]; catalytic activity [goid 3824] [evidence IEA],2,97143180-97143203:97143204-97143229,2q11.2b,+,NM_198555.3,375248,ANKRD36,1.1566245976831402,5.95816394539689,8.479514167921812,7.222990743110323e-14,5.06076859509186e-13,20.655154964868103
B3Gn-T6,ILMN_1680081,"Homo sapiens beta-1,3-N-acetylglucosaminyltransferase protein (B3Gn-T6), mRNA.",membrane [goid 16020] [pmid 11821425] [evidence NAS],"protein amino acid glycosylation [goid 6486] [evidence IEA]; O-glycan processing, core 3 [goid 16269] [pmid 11821425] [evidence NAS]","beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,3-N-acetylglucosaminyltransferase activity [goid 47223] [pmid 11821425] [evidence NAS]; transferase activity, transferring glycosyl groups [goid 16757] [evidence IEA]; galactosyltransferase activity [goid 8378] [pmid 11821425] [evidence IDA]",11,76430231-76430280,11q13.5c,+,NM_138706.2,192134,B3Gn-T6,1.8148606911916012,5.813273174578888,8.477985721411496,7.282344029050426e-14,5.100520251834923e-13,20.647042387745735
ALDOB,ILMN_1747716,"Homo sapiens aldolase B, fructose-bisphosphate (ALDOB), mRNA.",cytoplasm [goid 5737] [pmid 3383242] [evidence TAS],glycolysis [goid 6096] [pmid 3383242] [evidence TAS]; fructose metabolism [goid 6000] [pmid 3383242] [evidence TAS],lyase activity [goid 16829] [evidence IEA]; fructose-bisphosphate aldolase activity [goid 4332] [pmid 3383242] [evidence TAS],9,103223911-103223911:103223912-103223960,9q31.1b,-,NM_000035.2,229,ALDOB,1.1813355809259152,6.2517092395874885,8.473117312949016,7.474650247983445e-14,5.227694188153533e-13,20.621204579312852
EFNB2,ILMN_1703852,"Homo sapiens ephrin-B2 (EFNB2), mRNA.",plasma membrane [goid 5886] [pmid 8660976] [evidence TAS]; integral to plasma membrane [goid 5887] [pmid 8660976] [evidence TAS]; membrane [goid 16020] [evidence IEA],morphogenesis [goid 9653] [pmid 9630219] [evidence TAS]; cell differentiation [goid 30154] [evidence IEA]; cell-cell signaling [goid 7267] [pmid 8559144] [evidence TAS],ephrin receptor binding [goid 46875] [pmid 8559144] [evidence TAS],13,105940388-105940437,13q33.3a,-,NM_004093.2,1948,EFNB2,-1.1365015762456991,10.191571640064678,-8.46063777344779,7.99099484369115e-14,5.568831707057298e-13,20.55498924898083
BMP8B,ILMN_2123415,"Homo sapiens bone morphogenetic protein 8b (osteogenic protein 2) (BMP8B), mRNA.",extracellular region [goid 5576] [evidence IEA]; extracellular space [goid 5615] [evidence IEA],ossification [goid 1503] [evidence IEA]; cell differentiation [goid 30154] [evidence IEA]; growth [goid 40007] [evidence IEA]; cartilage development [goid 51216] [evidence IEA],cytokine activity [goid 5125] [evidence IEA]; growth factor activity [goid 8083] [evidence IEA],1,39996519-39996568,1p34.2d,-,NM_001720.3,656,BMP8B,1.2802925555991038,6.374015854087112,8.452755856663883,8.335243187084017e-14,5.798365351671977e-13,20.51318083803295
CTSW,ILMN_1794364,"Homo sapiens cathepsin W (lymphopain) (CTSW), mRNA.",,immune response [goid 6955] [pmid 9823953] [evidence TAS],cysteine-type endopeptidase activity [goid 4197] [evidence IEA],11,65407706-65407755,11q13.1d,+,NM_001335.2,1521,CTSW,-1.0373426985575147,7.320398847529818,-8.44996359004471,8.460704661732585e-14,5.87724885325702e-13,20.498371992281104
PPBP,ILMN_1767281,"Homo sapiens pro-platelet basic protein (chemokine (C-X-C motif) ligand 7) (PPBP), mRNA.",extracellular region [goid 5576] [evidence IEA]; extracellular space [goid 5615] [evidence IEA],immune response [goid 6955] [evidence IEA]; chemotaxis [goid 6935] [evidence IEA]; cell proliferation [goid 8283] [evidence IEA]; glucose transport [goid 15758] [pmid 4005226] [evidence TAS],glucose transporter activity [goid 5355] [pmid 4005226] [evidence TAS]; growth factor activity [goid 8083] [evidence IEA]; chemokine activity [goid 8009] [evidence IEA],4,75071933-75071955:75072098-75072124,4q13.3d,-,NM_002704.2,5473,PPBP,-1.4142640043377295,5.508765436443204,-8.447058411553238,8.593234324301821e-14,5.965057741682258e-13,20.482965597274116
ROPN1L,ILMN_1696466,"Homo sapiens ropporin 1-like (ROPN1L), mRNA.",,,,5,10514353-10514402,5p15.2c,+,NM_031916.2,83853,ROPN1L,-2.4024918773710304,7.2394862341613475,-8.444777305469271,8.698740806724981e-14,6.036145463640892e-13,20.470869625496153
HSD3B7,ILMN_1653042,"Homo sapiens hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 7 (HSD3B7), mRNA.",integral to membrane [goid 16021] [evidence IEA]; membrane [goid 16020] [evidence IEA]; endoplasmic reticulum [goid 5783] [evidence IEA],steroid biosynthesis [goid 6694] [evidence IEA]; bile acid biosynthesis [goid 6699] [pmid 11067870] [evidence TAS]; C21-steroid hormone biosynthesis [goid 6700] [evidence IEA],oxidoreductase activity [goid 16491] [evidence IEA]; steroid delta-isomerase activity [goid 4769] [evidence IEA]; 3-beta-hydroxy-delta5-steroid dehydrogenase activity [goid 3854] [pmid 11067870] [evidence NAS],16,30907561-30907610,16p11.2c,+,NM_025193.2,80270,HSD3B7,1.0724349771647619,8.260328156411129,8.435540959248517,9.139282022258769e-14,6.330569150505229e-13,20.421900520641366
MGC34647,ILMN_1713686,"Homo sapiens chromosome 16 open reading frame 77 (C16orf77), mRNA.",,,,16,69251743-69251792,16q22.1f,+,NM_152456.1,146433,MGC34647,-1.0458398044879909,6.140011304605521,-8.433010457588738,9.263805287419837e-14,6.407711963982092e-13,20.40848666966877
SESN2,ILMN_1751598,"Homo sapiens sestrin 2 (SESN2), mRNA.",nucleus [goid 5634] [evidence IEA]; cytoplasm [goid 5737] [pmid 11256614] [evidence IDA],cell cycle arrest [goid 7050] [evidence IEA],,1,28481249-28481298,1p35.3b,+,NM_031459.3,83667,SESN2,1.0051541134551192,6.1964518071724575,8.423445195621651,9.74994314280956e-14,6.720114684741573e-13,20.357791544609707
CHRNE,ILMN_1703346,"Homo sapiens cholinergic receptor, nicotinic, epsilon (CHRNE), mRNA.",nicotinic acetylcholine-gated receptor-channel complex [goid 5892] [pmid 7531341] [evidence TAS]; postsynaptic membrane [goid 45211] [evidence IEA],"ion transport [goid 6811] [evidence IEA]; muscle contraction [goid 6936] [pmid 8872460] [evidence TAS]; synaptic transmission, cholinergic [goid 7271] [pmid 8872460] [evidence TAS]; signal transduction [goid 7165] [pmid 8872460] [evidence TAS]",cation transporter activity [goid 8324] [pmid 8872460] [evidence TAS]; acetylcholine receptor activity [goid 15464] [pmid 8872460] [evidence TAS]; nicotinic acetylcholine-activated cation-selective channel activity [goid 4889] [pmid 7531341] [evidence TAS]; ion channel activity [goid 5216] [evidence IEA]; extracellular ligand-gated ion channel activity [goid 5230] [evidence IEA],17,4742189-4742238,17p13.2b,-,NM_000080.2,1145,CHRNE,-1.0280511867818758,6.090326480277118,-8.420484228404156,9.905512511997523e-14,6.820102872659779e-13,20.34210156359068
PPARGC1A,ILMN_1750062,"Homo sapiens peroxisome proliferative activated receptor, gamma, coactivator 1, alpha (PPARGC1A), mRNA.","nucleus [goid 5634] [pmid 12588810] [evidence TAS]; DNA-directed RNA polymerase II, core complex [goid 5665] [pmid 12588810] [evidence TAS]","cellular respiration [goid 45333] [pmid 11551810] [evidence TAS]; thermoregulation [goid 1659] [pmid 1258810] [evidence TAS]; response to starvation [goid 42594] [pmid 11854298] [evidence NAS]; protein stabilization [goid 50821] [pmid 14636573] [evidence TAS]; gluconeogenesis [goid 6094] [pmid 11854298] [evidence NAS]; brown fat cell differentiation [goid 50873] [pmid 12588810] [evidence TAS]; cell glucose homeostasis [goid 1678] [pmid 11854298] [evidence NAS]; positive regulation of transcription, DNA-dependent [goid 45893] [pmid 15572661] [evidence NAS]; androgen receptor signaling pathway [goid 30521] [pmid 15572661] [evidence NAS]; transcription initiation from RNA polymerase II promoter [goid 6367] [pmid 14636573] [evidence TAS]; positive regulation of histone acetylation [goid 35066] [pmid 14636573] [evidence TAS]; transcription [goid 6350] [evidence IEA]; positive regulation of fatty acid oxidation [goid 46321] [pmid 12588810] [evidence TAS]; positive regulation of gluconeogenesis [goid 45722] [pmid 12588810] [evidence TAS]; mRNA processing [goid 6397] [pmid 12588810] [evidence TAS]; digestion [goid 7586] [pmid 10585775] [evidence TAS]; mitochondrion organization and biogenesis [goid 7005] [pmid 11854298] [evidence NAS]; protein complex assembly [goid 6461] [pmid 14636573] [evidence TAS]; RNA splicing [goid 8380] [pmid 12588810] [evidence TAS]; fatty acid oxidation [goid 19395] [pmid 11854298] [evidence NAS]",nucleotide binding [goid 166] [evidence IEA]; DNA binding [goid 3677] [pmid 10713165] [evidence TAS]; RNA binding [goid 3723] [pmid 12588810] [evidence TAS]; androgen receptor binding [goid 50681] [pmid 15572661] [evidence NAS]; transcription factor binding [goid 8134] [pmid 12588810] [evidence TAS]; ligand-dependent nuclear receptor transcription coactivator activity [goid 30374] [pmid 12588810] [evidence TAS]; RNA polymerase II transcription mediator activity [goid 16455] [pmid 14636573] [evidence TAS],4,23402860-23402909,4p15.2d,-,NM_013261.2,10891,PPARGC1A,-1.5571535675742192,7.0331459342775755,-8.416010938378172,1.0145235616757723e-13,6.975296965156113e-13,20.31840049428976
ZKSCAN1,ILMN_2139052,"Homo sapiens zinc finger with KRAB and SCAN domains 1 (ZKSCAN1), mRNA.",nucleus [goid 5634] [pmid 7557990] [evidence NAS]; intracellular [goid 5622] [evidence IEA],"regulation of transcription, DNA-dependent [goid 6355] [pmid 7557990] [evidence NAS]; transcription [goid 6350] [evidence IEA]",zinc ion binding [goid 8270] [evidence IEA]; metal ion binding [goid 46872] [evidence IEA]; transcription factor activity [goid 3700] [pmid 7557990] [evidence NAS],7,99473261-99473310,7q22.1b,+,NM_003439.1,7586,ZKSCAN1,1.1511647183165037,6.095407147217717,8.413697542052365,1.0271465811946752e-13,7.053256608277865e-13,20.306144541367818
LOC158301,ILMN_1767263,"PREDICTED: Homo sapiens hypothetical protein LOC158301 (LOC158301), mRNA.",,,,9,132447529-132447578,9q34.11e,+,XM_925839.1,158301,LOC158301,2.0668281509967503,7.895441489461081,8.41303789015493,1.0307745103719591e-13,7.07454784593083e-13,20.30264998036477
UBE2S,ILMN_1808591,"Homo sapiens ubiquitin-conjugating enzyme E2S (UBE2S), mRNA.",,ubiquitin cycle [goid 6512] [evidence IEA]; ubiquitin cycle [goid 6512] [evidence IEA],ubiquitin-protein ligase activity [goid 4842] [evidence IEA]; ubiquitin-like activating enzyme activity [goid 8642] [evidence IEA]; ligase activity [goid 16874] [evidence IEA]; ligase activity [goid 16874] [evidence IEA]; ubiquitin-protein ligase activity [goid 4842] [evidence IEA],19,60604568-60604615:60604616-60604617,19q13.42b,-,NM_014501.2,27338,UBE2S,1.0473236202419276,9.54479580129044,8.39972780352363,1.1067624959371207e-13,7.561454149135623e-13,20.232153400290727
IL18R1,ILMN_1781700,"Homo sapiens interleukin 18 receptor 1 (IL18R1), mRNA.",integral to membrane [goid 16021] [evidence IEA]; plasma membrane [goid 5886] [pmid 9325300] [evidence TAS],immune response [goid 6955] [pmid 9325300] [evidence TAS]; signal transduction [goid 7165] [pmid 9325300] [evidence TAS],interleukin-1 receptor activity [goid 4908] [evidence IEA]; transmembrane receptor activity [goid 4888] [evidence IEA]; receptor activity [goid 4872] [evidence IEA],2,102381204-102381253,2q12.1a,+,NM_003855.2,8809,IL18R1,-1.3996940535843132,6.955214527545201,-8.397641434302633,1.1191687571802548e-13,7.643534256451898e-13,20.221105541224006
NAP1L5,ILMN_1773307,"Homo sapiens nucleosome assembly protein 1-like 5 (NAP1L5), mRNA.",nucleus [goid 5634] [evidence IEA],nucleosome assembly [goid 6334] [evidence IEA],,4,89836359-89836408,4q22.1b,-,NM_153757.1,266812,NAP1L5,-1.1176473416851218,6.852747681852424,-8.39744772178733,1.1203276332735363e-13,7.648768021841224e-13,20.220079819023297
KPNA2,ILMN_1708160,"Homo sapiens karyopherin alpha 2 (RAG cohort 1, importin alpha 1) (KPNA2), mRNA. XM_001133262 XM_001133265 XM_001133267 XM_001133271",nucleus [goid 5634] [pmid 9020106] [evidence TAS]; nucleoplasm [goid 5654] [pmid 7565597] [evidence TAS]; cytoplasm [goid 5737] [pmid 7754385] [evidence TAS],intracellular protein transport [goid 6886] [evidence IEA]; M phase specific microtubule process [goid 72] [pmid 7565597] [evidence TAS]; regulation of DNA recombination [goid 18] [pmid 8016130] [evidence TAS]; DNA metabolism [goid 6259] [pmid 9168958] [evidence TAS]; G2 phase of mitotic cell cycle [goid 85] [pmid 7565597] [evidence TAS],protein transporter activity [goid 8565] [evidence IEA]; nuclear localization sequence binding [goid 8139] [pmid 9020106] [evidence TAS]; protein binding [goid 5515] [pmid 9497340] [evidence IPI],17,63473387-63473432,17q24.2b,+,NM_002266.2,3838,KPNA2,1.0608025277709716,5.981626944698994,8.392711806373748,1.1490344016173507e-13,7.83926306565619e-13,20.19500465443496
LOC643367,ILMN_1682288,"PREDICTED: Homo sapiens region containing SMA4; hypothetical protein LOC153561, transcript variant 1 (LOC643367), mRNA.",,,,5,69848056-69848065:69849904-69849943,5q13.2a,-,XM_928286.1,643367,LOC643367,1.1729926915494415,7.493415143036087,8.387551192564041,1.1811491791250869e-13,8.052726296449377e-13,20.167684924038635
ALDH3B1,ILMN_1727965,"Homo sapiens aldehyde dehydrogenase 3 family, member B1 (ALDH3B1), transcript variant 1, mRNA.",,metabolism [goid 8152] [evidence IEA]; lipid metabolism [goid 6629] [pmid 7828891] [evidence TAS]; aldehyde metabolism [goid 6081] [evidence IEA]; alcohol metabolism [goid 6066] [pmid 7828891] [evidence TAS],oxidoreductase activity [goid 16491] [evidence IEA]; aldehyde dehydrogenase [NAD(P)+] activity [goid 4030] [evidence IEA],11,67542575-67542624,11q13.2a,+,NM_000694.2,221,ALDH3B1,-1.0523942020928079,8.03954854934219,-8.38157388910631,1.2194638492565347e-13,8.3023246340893e-13,20.136047056639942
C10orf107,ILMN_1770399,"Homo sapiens chromosome 10 open reading frame 107 (C10orf107), mRNA.",,,,10,63195865-63195914,10q21.2b,+,NM_173554.1,219621,C10orf107,-1.6896036356174289,6.481538507486689,-8.377588603840781,1.2456941160245358e-13,8.472024380711372e-13,20.114956128514834
SNX10,ILMN_2170949,"Homo sapiens sorting nexin 10 (SNX10), mRNA.",,protein transport [goid 15031] [evidence IEA]; intracellular signaling cascade [goid 7242] [evidence IEA],phosphoinositide binding [goid 35091] [evidence IEA]; protein binding [goid 5515] [evidence IEA],7,26379889-26379938,7p15.2b,+,NM_013322.2,29887,SNX10,-1.492053764936074,7.522432343478167,-8.371356458146098,1.2878422459595577e-13,8.740371355807029e-13,20.08197949058738
SLC2A5,ILMN_1671337,"Homo sapiens solute carrier family 2 (facilitated glucose/fructose transporter), member 5 (SLC2A5), mRNA.",plasma membrane [goid 5886] [pmid 1634504] [evidence TAS]; integral to membrane [goid 16021] [evidence IEA]; membrane [goid 16020] [evidence IEA],fructose transport [goid 15755] [pmid 1634504] [evidence TAS]; carbohydrate metabolism [goid 5975] [pmid 1634504] [evidence TAS]; glucose transport [goid 15758] [pmid 1695905] [evidence TAS]; carbohydrate transport [goid 8643] [evidence IEA],fructose transporter activity [goid 5353] [pmid 1634504] [evidence TAS]; transporter activity [goid 5215] [evidence IEA]; sugar porter activity [goid 5351] [evidence IEA]; glucose transporter activity [goid 5355] [pmid 1695905] [evidence TAS],1,9019938-9019987,1p36.23a,-,NM_003039.1,6518,SLC2A5,1.492336630533405,6.6843839995094445,8.370825761833302,1.2914962338636813e-13,8.762118425081417e-13,20.0791716653052
SLC16A9,ILMN_1732410,"Homo sapiens solute carrier family 16, member 9 (monocarboxylic acid transporter 9) (SLC16A9), mRNA.",membrane [goid 16020] [evidence IEA]; integral to membrane [goid 16021] [evidence IEA],transport [goid 6810] [evidence IEA],transporter activity [goid 5215] [evidence IEA],10,61080823-61080872,10q21.1f,-,NM_194298.1,220963,SLC16A9,1.7672396830567774,7.348513913301419,8.36707002988493,1.3176519098895382e-13,8.933349848363832e-13,20.059302017531706
TLR7,ILMN_1677827,"Homo sapiens toll-like receptor 7 (TLR7), mRNA.",integral to membrane [goid 16021] [evidence IEA]; membrane [goid 16020] [evidence IEA],positive regulation of interleukin-8 biosynthesis [goid 45416] [pmid 16188996] [evidence IMP]; defense response to virus [goid 51607] [pmid 16188996] [evidence IMP]; positive regulation of interferon-gamma biosynthesis [goid 45078] [pmid 16286015] [evidence IDA]; positive regulation of interferon-beta biosynthesis [goid 45359] [pmid 16286015] [evidence IDA]; inflammatory response [goid 6954] [evidence IEA],single-stranded RNA binding [goid 3727] [evidence ISS]; transferase activity [goid 16740] [evidence IEA]; transmembrane receptor activity [goid 4888] [evidence IEA]; double-stranded RNA binding [goid 3725] [pmid 16111635] [evidence IDA],X,12818206-12818255,Xp22.2,+,NM_016562.3,51284,TLR7,-1.0827587704926636,7.0671791333793985,-8.363137127312598,1.3456063832113728e-13,9.116530033683449e-13,20.038497497819474
LCN2,ILMN_1692223,"Homo sapiens lipocalin 2 (oncogene 24p3) (LCN2), mRNA.",soluble fraction [goid 5625] [evidence NR ]; cytoplasm [goid 5737] [evidence NR ],transport [goid 6810] [evidence IEA],transporter activity [goid 5215] [evidence IEA]; binding [goid 5488] [evidence IEA],9,129954359-129954384:129955200-129955219:129955220-129955223,9q34.11b,+,NM_005564.2,3934,LCN2,2.1939827756585437,10.791066616618535,8.36146815697332,1.3576467410342696e-13,9.191711865549945e-13,20.029669629470373
RASL11A,ILMN_1651902,"Homo sapiens RAS-like, family 11, member A (RASL11A), mRNA.",membrane [goid 16020] [evidence IEA],small GTPase mediated signal transduction [goid 7264] [evidence IEA],GTP binding [goid 5525] [evidence IEA]; nucleotide binding [goid 166] [evidence IEA],13,26745521-26745570,13q12.2a,+,NM_206827.1,387496,RASL11A,-1.3163982217555645,6.8191300589641575,-8.359395853424997,1.3727460951141583e-13,9.290711241159907e-13,20.018708995649632
HLF,ILMN_1722829,"Homo sapiens hepatic leukemia factor (HLF), mRNA.",nucleus [goid 5634] [pmid 1386162] [evidence TAS],"regulation of transcription, DNA-dependent [goid 6355] [evidence IEA]; transcription [goid 6350] [evidence IEA]; transcription from RNA polymerase II promoter [goid 6366] [pmid 8639829] [evidence TAS]; rhythmic process [goid 48511] [evidence IEA]; development [goid 7275] [pmid 1386162] [evidence TAS]",double-stranded DNA binding [goid 3690] [pmid 1386162] [evidence TAS],17,50755617-50755666,17q22b,+,NM_002126.3,3131,HLF,-1.3470495063813104,6.978556410214236,-8.359114004364926,1.3748125861080154e-13,9.301466402887042e-13,20.017218319888954
LOC647389,ILMN_1784554,"PREDICTED: Homo sapiens hypothetical protein LOC647389 (LOC647389), mRNA.",,,,,,,,XM_936461.1,647389,LOC647389,2.0055140482545575,9.978357002581767,8.357698468131547,1.3852380579314907e-13,9.368748198123947e-13,20.00973186414119
LOC643591,ILMN_1780806,"PREDICTED: Homo sapiens hypothetical protein LOC643591 (LOC643591), mRNA.",,,,2,97568247-97568293:97572420-97572422,,-,XM_931666.1,643591,LOC643591,1.057857853552,7.565043339825168,8.353380131697492,1.4175311432803215e-13,9.573862851583039e-13,19.986895159308524
C8orf44,ILMN_1792242,"Homo sapiens chromosome 8 open reading frame 44 (C8orf44), mRNA.",,,,8,67755449-67755498,8q13.1b,+,NM_019607.1,56260,C8orf44,1.2201382584640728,6.390915730905638,8.353046654791761,1.4200558534009662e-13,9.587591234760162e-13,19.98513175615283
LOC642033,ILMN_1673753,"PREDICTED: Homo sapiens similar to ATP-binding cassette, sub-family F, member 1 isoform b (LOC642033), mRNA.",,,,,,,,XM_936103.1,642033,LOC642033,1.1807245810094003,7.384178033917023,8.350165718790649,1.4420541223116547e-13,9.7192751896377e-13,19.96989831805955
LOC388743,ILMN_1753766,"PREDICTED: Homo sapiens similar to calpain 8, transcript variant 5 (LOC388743), mRNA.",,,,,,1q41e,,XM_943925.1,388743,LOC388743,1.419284200477117,7.346182631082374,8.34998863895108,1.4434172745931235e-13,9.725098753612382e-13,19.968962022537664
GPR4,ILMN_2074477,"Homo sapiens G protein-coupled receptor 4 (GPR4), mRNA.",integral to plasma membrane [goid 5887] [pmid 8595909] [evidence TAS]; membrane [goid 16020] [evidence IEA],G-protein coupled receptor protein signaling pathway [goid 7186] [pmid 7498459] [evidence TAS]; signal transduction [goid 7165] [evidence IEA],"receptor activity [goid 4872] [evidence IEA]; G-protein coupled receptor activity, unknown ligand [goid 16526] [evidence IEA]; rhodopsin-like receptor activity [goid 1584] [evidence IEA]",19,50785018-50785067,19q13.32a,-,NM_005282.1,2828,GPR4,-1.2081052140273894,7.426726168366598,-8.337438162620836,1.5433672542700196e-13,1.0355547847607206e-12,19.902615450078233
HSD17B1,ILMN_1773623,"Homo sapiens hydroxysteroid (17-beta) dehydrogenase 1 (HSD17B1), mRNA.",cytoplasm [goid 5737] [pmid 8547176] [evidence TAS],estrogen biosynthesis [goid 6703] [evidence IEA]; metabolism [goid 8152] [evidence IEA],oxidoreductase activity [goid 16491] [evidence IEA]; estradiol 17-beta-dehydrogenase activity [goid 4303] [pmid 2330005] [evidence NAS],17,37960564-37960613,17q21.31a,+,NM_000413.1,3292,HSD17B1,1.3326787028858815,6.115176305965294,8.331415704466894,1.5937443837113104e-13,1.0686204169516477e-12,19.87078763669035
WBSCR18,ILMN_1771824,"Homo sapiens Williams Beuren syndrome chromosome region 18 (WBSCR18), mRNA.",,protein folding [goid 6457] [evidence IEA],heat shock protein binding [goid 31072] [evidence IEA]; unfolded protein binding [goid 51082] [evidence IEA],7,72733445-72733494,7q11.23b,-,NM_032317.2,84277,WBSCR18,1.0279935988561064,7.51590753648086,8.320183211712576,1.6921128033734657e-13,1.1337970417376885e-12,19.811441542645852
SLC2A14,ILMN_1668865,"Homo sapiens solute carrier family 2 (facilitated glucose transporter), member 14 (SLC2A14), mRNA.",integral to membrane [goid 16021] [evidence IEA]; membrane [goid 16020] [evidence IEA],spermatogenesis [goid 7283] [evidence IEA]; cell differentiation [goid 30154] [evidence IEA]; carbohydrate transport [goid 8643] [evidence IEA],transporter activity [goid 5215] [evidence IEA]; sugar porter activity [goid 5351] [evidence IEA]; glucose transporter activity [goid 5355] [evidence IEA],12,7858049-7858098,12p13.31c,-,NM_153449.2,144195,SLC2A14,-1.063490817208069,5.689974697098337,-8.317845590525899,1.7133315152054695e-13,1.146831486560583e-12,19.799093510155934
NEDD4L,ILMN_1733627,"Homo sapiens neural precursor cell expressed, developmentally down-regulated 4-like (NEDD4L), mRNA.",intracellular [goid 5622] [pmid 11244092] [evidence IC ],positive regulation of endocytosis [goid 45807] [pmid 11244092] [evidence NAS]; response to metal ion [goid 10038] [pmid 11244092] [evidence IDA]; excretion [goid 7588] [pmid 11244092] [evidence NAS]; sodium ion transport [goid 6814] [pmid 11244092] [evidence NAS]; sodium ion homeostasis [goid 6883] [pmid 11244092] [evidence NAS]; protein ubiquitination [goid 16567] [pmid 11244092] [evidence NAS]; regulation of protein catabolism [goid 42176] [pmid 11244092] [evidence NAS]; water homeostasis [goid 30104] [pmid 11244092] [evidence NAS],protein binding [goid 5515] [pmid 11244092] [evidence IPI]; sodium channel regulator activity [goid 17080] [pmid 11244092] [evidence IDA]; ubiquitin-protein ligase activity [goid 4842] [pmid 11244092] [evidence NAS]; ligase activity [goid 16874] [evidence IEA],18,54216019-54216068,18q21.31b,+,NM_015277.2,23327,NEDD4L,-1.1733317355553137,9.808812049059476,-8.316646702395333,1.7243163454644662e-13,1.1537879117917283e-12,19.79276096707132
FLJ13841,ILMN_1700583,"Homo sapiens hypothetical protein LOC79755 (FLJ13841), mRNA.",nucleus [goid 5634] [evidence IEA],,nucleic acid binding [goid 3676] [evidence IEA]; zinc ion binding [goid 8270] [evidence IEA],17,78381220-78381269,17q25.3h,-,NM_024702.1,79755,FLJ13841,1.7688480497586543,7.437591892996882,8.31409344436231,1.747944610918668e-13,1.1691967299605303e-12,19.779275420178326
RBP4,ILMN_1814719,"Homo sapiens retinol binding protein 4, plasma (RBP4), mRNA.",extracellular region [goid 5576] [pmid 14718574] [evidence NAS]; extracellular space [goid 5615] [pmid 6316270] [evidence TAS],visual perception [goid 7601] [evidence IEA]; transport [goid 6810] [evidence IEA],retinal binding [goid 16918] [evidence IEA]; transporter activity [goid 5215] [evidence IEA]; binding [goid 5488] [evidence IEA]; retinol binding [goid 19841] [evidence IEA],10,95343601-95343650,10q23.33b,-,NM_006744.3,5950,RBP4,-1.276146493884906,5.984518467521575,-8.30878443202519,1.798111003978469e-13,1.2006920120808934e-12,19.75123827542577
NNAT,ILMN_1691413,"Homo sapiens neuronatin (NNAT), transcript variant 1, mRNA.",,brain development [goid 7420] [pmid 8813377] [evidence TAS]; development [goid 7275] [evidence IEA]; protein-lipoylation [goid 9249] [pmid 8813377] [evidence TAS]; brain development [goid 7420] [pmid 8813377] [evidence TAS]; development [goid 7275] [evidence IEA]; protein-lipoylation [goid 9249] [pmid 8813377] [evidence TAS],auxiliary transport protein activity [goid 15457] [pmid 8813377] [evidence TAS]; auxiliary transport protein activity [goid 15457] [pmid 8813377] [evidence TAS],20,35585280-35585329,20q11.23b,+,NM_005386.2,4826,NNAT,-1.0671279713415247,6.070475024504534,-8.295706903098534,1.9278764768899041e-13,1.2833848019200472e-12,19.68219531190495
CX3CR1,ILMN_1745788,"Homo sapiens chemokine (C-X3-C motif) receptor 1 (CX3CR1), mRNA.",plasma membrane [goid 5886] [pmid 9390561] [evidence TAS]; integral to plasma membrane [goid 5887] [pmid 9390561] [evidence TAS]; plasma membrane [goid 5886] [pmid 9390561] [evidence TAS]; integral to plasma membrane [goid 5887] [pmid 9390561] [evidence TAS],cell adhesion [goid 7155] [pmid 10754298] [evidence TAS]; chemotaxis [goid 6935] [pmid 10754298] [evidence TAS]; cellular defense response [goid 6968] [pmid 10754298] [evidence TAS]; G-protein coupled receptor protein signaling pathway [goid 7186] [pmid 10754298] [evidence TAS]; signal transduction [goid 7165] [evidence IEA]; cell adhesion [goid 7155] [pmid 10754298] [evidence TAS]; chemotaxis [goid 6935] [pmid 10754298] [evidence TAS]; cellular defense response [goid 6968] [pmid 10754298] [evidence TAS]; G-protein coupled receptor protein signaling pathway [goid 7186] [pmid 10754298] [evidence TAS]; signal transduction [goid 7165] [evidence IEA],rhodopsin-like receptor activity [goid 1584] [evidence IEA]; C-X-C chemokine receptor activity [goid 16494] [evidence IEA]; coreceptor activity [goid 15026] [evidence NR ]; protein binding [goid 5515] [pmid 9931005] [evidence IPI]; rhodopsin-like receptor activity [goid 1584] [evidence IEA]; C-X-C chemokine receptor activity [goid 16494] [evidence IEA]; coreceptor activity [goid 15026] [evidence NR ]; protein binding [goid 5515] [pmid 9931005] [evidence IPI],3,39280494-39280543,3p22.2a,-,NM_001337.3,1524,CX3CR1,-1.241748309487983,6.599100130417864,-8.289896696873877,1.9884786517057887e-13,1.3214702090207127e-12,19.651529466316287
RHPN2,ILMN_1753143,"Homo sapiens rhophilin, Rho GTPase binding protein 2 (RHPN2), mRNA.",intracellular [goid 5622] [evidence IEA],signal transduction [goid 7165] [evidence IEA],protein binding [goid 5515] [evidence IEA],19,38161365-38161414,19q13.11a-q13.11b,-,NM_033103.3,85415,RHPN2,1.1597186471941114,9.98655987728235,8.28640390742875,2.0258174157861068e-13,1.3449080867663472e-12,19.633097513718727
LSDP5,ILMN_1791467,"Homo sapiens lipid storage droplet protein 5 (LSDP5), mRNA.",,,,19,4479825-4479874,19p13.3d,-,NM_001013706.2,440503,LSDP5,1.0146973983610925,6.643111932083659,8.283298060680254,2.059604916769394e-13,1.365942879620546e-12,19.61670924268571
PAPSS1,ILMN_1781819,"Homo sapiens 3'-phosphoadenosine 5'-phosphosulfate synthase 1 (PAPSS1), mRNA.",intracellular [goid 5622] [evidence ISS],"skeletal development [goid 1501] [evidence ISS]; sulfate assimilation [goid 103] [evidence IEA]; nucleobase, nucleoside, nucleotide and nucleic acid metabolism [goid 6139] [evidence NR ]",sulfate adenylyltransferase (ATP) activity [goid 4781] [evidence ISS]; adenylylsulfate kinase activity [goid 4020] [evidence IEA]; nucleotide binding [goid 166] [evidence IEA]; ATP binding [goid 5524] [evidence ISS]; nucleotidyltransferase activity [goid 16779] [evidence ISS],4,108754882-108754931,4q25a,-,NM_005443.4,9061,PAPSS1,-1.0236868051910761,9.091387759058003,-8.281974385834639,2.0741745225015362e-13,1.3751374811480923e-12,19.60972525240704
FAM40B,ILMN_2161286,"Homo sapiens family with sequence similarity 40, member B (FAM40B), mRNA.",,,,7,128915140-128915189,7q32.1a,+,NM_020704.1,57464,FAM40B,1.9784179087887939,9.353698799825782,8.280523246529583,2.0902649251056786e-13,1.3848627019953807e-12,19.602069073066918
LOC644151,ILMN_1695397,"PREDICTED: Homo sapiens similar to calpain 8 (LOC644151), mRNA.",,,,1,221784057-221784106,1q41e,-,XM_927359.1,644151,LOC644151,2.0163618024370376,9.441216744553966,8.275289211208346,2.1493387141550378e-13,1.4215840069691416e-12,19.57445738025822
EFCAB1,ILMN_1699562,"Homo sapiens EF-hand calcium binding domain 1 (EFCAB1), mRNA.",,,calcium ion binding [goid 5509] [evidence IEA],8,49798702-49798751,8q11.21c,-,NM_024593.2,79645,EFCAB1,-2.5880927235516067,6.967362518192202,-8.275029946772099,2.1523076700300845e-13,1.4230646403303766e-12,19.57308977430137
IL17RD,ILMN_2407851,"Homo sapiens interleukin 17 receptor D (IL17RD), transcript variant 1, mRNA.",membrane [goid 16020] [evidence IEA]; integral to membrane [goid 16021] [evidence IEA]; membrane [goid 16020] [evidence IEA]; integral to membrane [goid 16021] [evidence IEA],,receptor activity [goid 4872] [evidence IEA]; receptor activity [goid 4872] [evidence IEA],,,3p14.3b,,NM_001080973.1,54756,IL17RD,2.04656974049424,11.258122784367881,8.274613600423447,2.1570839789945075e-13,1.4257388511094973e-12,19.57089359358066
A4GALT,ILMN_1735045,"Homo sapiens alpha 1,4-galactosyltransferase (globotriaosylceramide synthase) (A4GALT), mRNA.",integral to membrane [goid 16021] [evidence IEA]; membrane fraction [goid 5624] [pmid 10748143] [evidence IDA]; integral to Golgi membrane [goid 30173] [pmid 10748143] [evidence NAS]; membrane [goid 16020] [evidence IEA]; Golgi stack [goid 5795] [evidence IEA],lipid biosynthesis [goid 8610] [evidence IEA]; glycosphingolipid biosynthesis [goid 6688] [pmid 10748143] [evidence NAS]; plasma membrane organization and biogenesis [goid 7009] [pmid 10747952] [evidence IDA],"transferase activity, transferring glycosyl groups [goid 16757] [evidence IEA]; galactosyltransferase activity [goid 8378] [pmid 10747952] [evidence IDA]; lactosylceramide 4-alpha-galactosyltransferase activity [goid 50512] [evidence IEA]",22,41418120-41418169,22q13.2b,-,NM_017436.4,53947,A4GALT,-1.0715960992851459,7.901122603798075,-8.270432185528241,2.2056414237043577e-13,1.4573388654079147e-12,19.548838727857447
LOC388969,ILMN_1679771,"Homo sapiens hypothetical LOC388969 (LOC388969), mRNA.",,,,2,85690987-85691036,2p11.2f,-,NM_001013649.1,388969,LOC388969,1.2666443512245236,7.695256158035353,8.270328355217764,2.2068609029807482e-13,1.4576503286298264e-12,19.548291112889853
MFSD2,ILMN_1789638,"Homo sapiens major facilitator superfamily domain containing 2 (MFSD2), mRNA.",,,sugar porter activity [goid 5351] [evidence IEA],1,40207775-40207824,1p34.2d,+,NM_032793.2,84879,MFSD2,-1.2521362734746617,7.79205304989288,-8.268831677486034,2.2245139477688495e-13,1.4683148466218168e-12,19.540397637879245
FLJ23754,ILMN_1716546,"Homo sapiens hypothetical protein FLJ23754 (FLJ23754), mRNA.",,,,17,77663496-77663545,,-,NM_152675.1,201252,FLJ23754,1.2555189015553614,6.33004824189826,8.262027800624551,2.30655126419496e-13,1.519376314497593e-12,19.504518819608816
NR4A2,ILMN_1782305,"Homo sapiens nuclear receptor subfamily 4, group A, member 2 (NR4A2), transcript variant 1, mRNA.",nucleus [goid 5634] [pmid 7877627] [evidence TAS]; nucleus [goid 5634] [pmid 7877627] [evidence TAS],"transcription [goid 6350] [evidence IEA]; antimicrobial humoral response (sensu Vertebrata) [goid 19735] [pmid 7877627] [evidence TAS]; regulation of transcription, DNA-dependent [goid 6355] [evidence IEA]; signal transduction [goid 7165] [pmid 7877627] [evidence NAS]; transcription [goid 6350] [evidence IEA]; antimicrobial humoral response (sensu Vertebrata) [goid 19735] [pmid 7877627] [evidence TAS]; regulation of transcription, DNA-dependent [goid 6355] [evidence IEA]; signal transduction [goid 7165] [pmid 7877627] [evidence NAS]",sequence-specific DNA binding [goid 43565] [evidence IEA]; transcription factor activity [goid 3700] [evidence IEA]; zinc ion binding [goid 8270] [evidence IEA]; metal ion binding [goid 46872] [evidence IEA]; steroid hormone receptor activity [goid 3707] [evidence IEA]; sequence-specific DNA binding [goid 43565] [evidence IEA]; transcription factor activity [goid 3700] [evidence IEA]; zinc ion binding [goid 8270] [evidence IEA]; metal ion binding [goid 46872] [evidence IEA]; steroid hormone receptor activity [goid 3707] [evidence IEA],2,156889936-156889985,2q24.1c,-,NM_006186.2,4929,NR4A2,-2.03583088534804,8.563183219298487,-8.259750217352895,2.3346797397964425e-13,1.5368660381734351e-12,19.49251022761884
DKFZp761B107,ILMN_1792276,"Homo sapiens hypothetical protein DKFZp761B107 (DKFZp761B107), mRNA.",,,,4,24437765-24437814,4p15.2c,-,NM_173463.2,91050,DKFZp761B107,1.3128048803182777,6.18328975903232,8.257573122383569,2.3618859740561993e-13,1.5542501926540035e-12,19.481032291307226
CKMT1A,ILMN_1732066,"Homo sapiens creatine kinase, mitochondrial 1A (CKMT1A), nuclear gene encoding mitochondrial protein, mRNA.",,,,15,41777634-41777638:41778131-41778175,15q15.3a,+,NM_001015001.1,548596,CKMT1A,1.7090362301716269,6.7171339017555045,8.248302010327347,2.4813173486589763e-13,1.630089970958198e-12,19.432162846904017
LOC647834,ILMN_1693740,"PREDICTED: Homo sapiens hypothetical protein LOC647834 (LOC647834), mRNA.",,,,,,,,XM_943048.1,647834,LOC647834,1.2269814317784107,7.050797076092567,8.247939158858719,2.4861118157856863e-13,1.6326892056145635e-12,19.4302505018437
TSPAN5,ILMN_1799028,"Homo sapiens tetraspanin 5 (TSPAN5), mRNA.",membrane [goid 16020] [evidence IEA]; integral to membrane [goid 16021] [evidence IEA],electron transport [goid 6118] [evidence IEA],cytochrome-c oxidase activity [goid 4129] [evidence IEA],4,99616396-99616445,4q23a,-,NM_005723.2,10098,TSPAN5,1.2458928160801017,7.956130487786619,8.23217228905364,2.7035865191266215e-13,1.7665789176788135e-12,19.347175921255978
LOC388135,ILMN_2141118,"Homo sapiens similar to RIKEN cDNA 6030419C18 gene (LOC388135), mRNA.",,,,15,71819378-71819427,15q24.1b,-,NM_001039614.1,388135,LOC388135,-1.1070525696918443,6.027245738743374,-8.23094239350329,2.7213253339795416e-13,1.7751500733340261e-12,19.340697492968985
HOXC8,ILMN_1718285,"Homo sapiens homeobox C8 (HOXC8), mRNA.",nucleus [goid 5634] [evidence NAS],"regulation of transcription, DNA-dependent [goid 6355] [evidence NAS]; development [goid 7275] [evidence NAS]",transcription factor activity [goid 3700] [evidence NAS],12,52692510-52692559,12q13.13f,+,NM_022658.3,3224,HOXC8,1.2584124034754263,5.754653326197264,8.226354049908231,2.7885303886624636e-13,1.8153863890106282e-12,19.316530885229433
CD55,ILMN_1800540,"Homo sapiens CD55 molecule, decay accelerating factor for complement (Cromer blood group) (CD55), mRNA.",integral to plasma membrane [goid 5887] [pmid 2433596] [evidence TAS]; membrane [goid 16020] [evidence IEA]; soluble fraction [goid 5625] [pmid 2433596] [evidence TAS],"innate immune response [goid 45087] [evidence IEA]; complement activation, classical pathway [goid 6958] [evidence IEA]",GPI anchor binding [goid 48503] [evidence IEA],1,205600102-205600151,1q32.2a,+,NM_000574.2,1604,CD55,-1.084003645717532,11.75951046407036,-8.21599826846592,2.9463373949820226e-13,1.91492275320963e-12,19.262000908706383
CP,ILMN_1813206,"Homo sapiens ceruloplasmin (ferroxidase) (CP), mRNA.",extracellular space [goid 5615] [pmid 7708681] [evidence TAS],ion transport [goid 6811] [evidence IEA]; iron ion homeostasis [goid 6879] [pmid 9445478] [evidence TAS]; copper ion transport [goid 6825] [evidence IEA]; copper ion homeostasis [goid 6878] [evidence NR ],metal ion binding [goid 46872] [evidence IEA]; ferroxidase activity [goid 4322] [pmid 7708681] [evidence TAS]; copper ion binding [goid 5507] [evidence IEA]; oxidoreductase activity [goid 16491] [evidence IEA]; copper ion transporter activity [goid 5375] [evidence IEA],3,150387020-150387069,3q24f-q25.1a,-,NM_000096.1,1356,CP,1.7390214505579422,6.361834103685386,8.21440768783857,2.9713498567606217e-13,1.9305352437139286e-12,19.253627118637922
FLJ14054,ILMN_1769556,"Homo sapiens hypothetical protein FLJ14054 (FLJ14054), mRNA.",,,,5,32827158-32827207,5p13.3b,+,NM_024563.2,79614,FLJ14054,-1.4699066809104027,6.745791212522065,-8.210021869620048,3.04141748170408e-13,1.973392643127693e-12,19.230539782143147
ANKRD30B,ILMN_1730678,"Homo sapiens ankyrin repeat domain 30B (ANKRD30B), mRNA.",cellular component unknown [goid 8372] [evidence ND ]; cellular component unknown [goid 8372] [evidence ND ],biological process unknown [goid 4] [evidence ND ]; biological process unknown [goid 4] [evidence ND ],molecular function unknown [goid 5554] [evidence ND ]; molecular function unknown [goid 5554] [evidence ND ],18,14806601-14806650,18p11.21a,+,NM_001029862.1,374860,ANKRD30B,1.3730423855335214,12.427343654803682,8.20132954533377,3.1851764965986095e-13,2.063270080991486e-12,19.184792594643163
C2,ILMN_1710740,"Homo sapiens complement component 2 (C2), mRNA.",extracellular region [goid 5576] [evidence IEA]; complement component C2 complex [goid 5603] [pmid 6199794] [evidence TAS],"innate immune response [goid 45087] [evidence IEA]; complement activation, classical pathway [goid 6958] [pmid 8621452] [evidence TAS]",serine-type endopeptidase activity [goid 4252] [evidence IEA]; peptidase activity [goid 8233] [evidence IEA]; classical-complement-pathway C3/C5 convertase activity [goid 3813] [evidence IEA],6,32021146-32021195,6p21.32b,+,NM_000063.3,717,C2,-1.1747320639111916,9.818518352087949,-8.197652834073628,3.2479989831394644e-13,2.1018684884248575e-12,19.165446284609388
FLNC,ILMN_1715748,"Homo sapiens filamin C, gamma (actin binding protein 280) (FLNC), mRNA.",actin cytoskeleton [goid 15629] [evidence NR ],,actin binding [goid 3779] [evidence IEA]; protein binding [goid 5515] [pmid 11038172] [evidence IPI],7,128286512-128286561,7q32.1a,+,NM_001458.2,2318,FLNC,-1.497211755710281,8.777371134258043,-8.19478934488481,3.297778311518777e-13,2.131250759533777e-12,19.150380681468913
C8orf45,ILMN_2113738,"Homo sapiens chromosome 8 open reading frame 45 (C8orf45), mRNA.",,,nucleic acid binding [goid 3676] [evidence IEA]; nucleic acid binding [goid 3676] [evidence IEA],8,67976486-67976535,8q13.1b,+,NM_173518.2,157777,C8orf45,1.7296678810182922,12.269642266531507,8.19453939190731,3.3021593598475305e-13,2.1333745068510984e-12,19.149065678958117
ZADH1,ILMN_2105253,"Homo sapiens zinc binding alcohol dehydrogenase, domain containing 1 (ZADH1), mRNA.",cytoplasm [goid 5737] [evidence NAS]; cytoplasm [goid 5737] [evidence NAS],,zinc ion binding [goid 8270] [evidence NAS]; oxidoreductase activity [goid 16491] [evidence NAS]; zinc ion binding [goid 8270] [evidence NAS]; oxidoreductase activity [goid 16491] [evidence NAS],14,73421462-73421511,14q24.3a,+,NM_152444.1,145482,ZADH1,1.4517299585565375,7.671849409494073,8.191472055600112,3.356395614119441e-13,2.1655420046727582e-12,19.13292932387456
IGSF9B,ILMN_1660204,"PREDICTED: Homo sapiens immunoglobulin superfamily, member 9B (IGSF9B), mRNA.",,,,,,11q25d,,XM_940668.1,22997,IGSF9B,1.5051164412862432,6.155896050244779,8.191183646826742,3.3615405485193774e-13,2.1681435811949706e-12,19.131412175707908
FLJ90231,ILMN_1789048,"Homo sapiens hypothetical protein FLJ90231 (FLJ90231), mRNA.",beta-galactosidase complex [goid 9341] [evidence IEA],carbohydrate metabolism [goid 5975] [evidence IEA],beta-galactosidase activity [goid 4565] [evidence IEA]; hydrolase activity [goid 16787] [evidence IEA],11,133694344-133694393,,+,NM_173581.1,283176,FLJ90231,1.2750279693541202,5.3962718180834095,8.191065481832949,3.3636507617700445e-13,2.1687867337223467e-12,19.130790583740843
FAM55C,ILMN_1814924,"Homo sapiens family with sequence similarity 55, member C (FAM55C), mRNA.",,,,3,103024820-103024869,3q12.3a,+,NM_145037.1,91775,FAM55C,-1.0165841160797031,6.281379415323921,-8.1868674688436,3.439480361170306e-13,2.215480159914162e-12,19.10870907439587
LOC646163,ILMN_1660439,"PREDICTED: Homo sapiens similar to 60S ribosomal protein L3 (L4) (LOC646163), mRNA.",,,,10,121819491-121819540,10q26.12a,-,XM_929125.1,646163,LOC646163,-1.322056153337975,10.299597821447868,-8.182872164335457,3.5132261046989724e-13,2.2599937487639313e-12,19.087696714672017
SPATA18,ILMN_1667948,"Homo sapiens spermatogenesis associated 18 homolog (rat) (SPATA18), mRNA.",,,,4,52657892-52657941,4q12a,+,NM_145263.1,132671,SPATA18,-1.7017567427354097,7.524179408624871,-8.178503866012015,3.595656562428847e-13,2.3107311384870083e-12,19.064725931005704
RPL21,ILMN_2290808,"Homo sapiens ribosomal protein L21 (RPL21), mRNA.",ribosome [goid 5840] [evidence IEA]; cytosolic large ribosomal subunit (sensu Eukaryota) [goid 5842] [pmid 7772601] [evidence TAS]; intracellular [goid 5622] [evidence IEA],protein biosynthesis [goid 6412] [pmid 7772601] [evidence TAS],RNA binding [goid 3723] [pmid 7772601] [evidence TAS]; structural constituent of ribosome [goid 3735] [pmid 7772601] [evidence TAS],13,26723694-26723722:26725902-26725913:26725914-26725922,13q12.2a,+,NM_000982.3,6144,RPL21,-1.088225768260397,11.044956207369099,-8.177576427240085,3.613403404219404e-13,2.3213704362418426e-12,19.059849413195533
LOC123688,ILMN_1708351,"Homo sapiens similar to RIKEN cDNA C630028N24 gene (LOC123688), mRNA.",,,,15,76607527-76607576,15q25.1a,+,NM_001013619.1,123688,LOC123688,1.2468397854341235,6.999558306678954,8.170160818103806,3.7584711140683206e-13,2.410592812956591e-12,19.020863304384044
GPRC5A,ILMN_1682599,"Homo sapiens G protein-coupled receptor, family C, group 5, member A (GPRC5A), mRNA.",integral to plasma membrane [goid 5887] [pmid 9857033] [evidence TAS]; membrane [goid 16020] [evidence IEA],G-protein coupled receptor protein signaling pathway [goid 7186] [evidence IEA]; signal transduction [goid 7165] [pmid 9857033] [evidence TAS],"receptor activity [goid 4872] [evidence IEA]; metabotropic glutamate, GABA-B-like receptor activity [goid 8067] [evidence IEA]",12,12957521-12957570,12p13.1b,+,NM_003979.3,9052,GPRC5A,-1.2356128201941292,9.802097144256313,-8.16754474946113,3.81101755167133e-13,2.4402785735890853e-12,19.007112183721745
LOC653743,ILMN_1660794,"PREDICTED: Homo sapiens similar to hypothetical protein DKFZp566J091 (LOC653743), mRNA.",,,,2,30334076-30334125,,+,XM_929369.1,653743,LOC653743,-1.5213123675246942,6.80018106830784,-8.163919449157648,3.8850448089321315e-13,2.4868626183325422e-12,18.98805815872064
PCSK1N,ILMN_1755582,"Homo sapiens proprotein convertase subtilisin/kexin type 1 inhibitor (PCSK1N), mRNA.",extracellular space [goid 5615] [pmid 10632593] [evidence TAS]; soluble fraction [goid 5625] [pmid 10632593] [evidence TAS],,endopeptidase inhibitor activity [goid 4866] [pmid 10632593] [evidence TAS]; receptor binding [goid 5102] [pmid 10632593] [evidence TAS],X,48574769-48574809:48575223-48575231,Xp11.23c,-,NM_013271.2,27344,PCSK1N,1.878500106006996,7.676293527358141,8.16362171494026,3.8911875737869673e-13,2.489976678989788e-12,18.986493417907383
SHE,ILMN_1712865,"Homo sapiens Src homology 2 domain containing E (SHE), mRNA.",,intracellular signaling cascade [goid 7242] [evidence IEA]; intracellular signaling cascade [goid 7242] [evidence IEA],,1,152719176-152719225,1q21.3e,-,NM_001010846.1,126669,SHE,-1.3317511275113834,7.523625757727191,-8.156322420109147,4.04484179748798e-13,2.5823637753621654e-12,18.948136991400354
HAMP,ILMN_1729188,"Homo sapiens hepcidin antimicrobial peptide (HAMP), mRNA.",extracellular region [goid 5576] [pmid 11034317] [evidence NAS],immune response [goid 6955] [pmid 11113131] [evidence TAS]; xenobiotic metabolism [goid 6805] [evidence IEA]; iron ion homeostasis [goid 6879] [evidence IEA],hormone activity [goid 5179] [evidence IEA],19,40467698-40467747,19q13.12a,+,NM_021175.2,57817,HAMP,1.6207678380621333,6.510962946372791,8.152877217233764,4.119445913249705e-13,2.6282712383651113e-12,18.930036428955084
C6orf168,ILMN_1715096,"Homo sapiens chromosome 6 open reading frame 168 (C6orf168), mRNA.",,,,6,99835701-99835750,6q16.2a-q16.3a,-,NM_032511.1,84553,C6orf168,1.0434303901000623,6.308662946114239,8.142993840708137,4.341141747477008e-13,2.766998591743196e-12,18.878122600663918
DMRT2,ILMN_1751785,"Homo sapiens doublesex and mab-3 related transcription factor 2 (DMRT2), transcript variant 2, mRNA.",nucleus [goid 5634] [evidence IEA],"sex determination [goid 7530] [pmid 10332030] [evidence TAS]; regulation of transcription, DNA-dependent [goid 6355] [evidence IEA]; male gonad development [goid 8584] [pmid 10332030] [evidence TAS]; sex differentiation [goid 7548] [evidence IEA]; transcription [goid 6350] [evidence IEA]",metal ion binding [goid 46872] [evidence IEA]; zinc ion binding [goid 8270] [evidence IEA]; transcription factor activity [goid 3700] [pmid 10332030] [evidence TAS],9,1047232-1047273:1047274-1047281,9p24.3b,+,NM_181872.1,10655,DMRT2,-1.129427838630905,5.685376693941871,-8.14236777015064,4.3555781095392377e-13,2.7752923304242002e-12,18.87483467263457
PAQR5,ILMN_1806434,"Homo sapiens progestin and adipoQ receptor family member V (PAQR5), mRNA.",,,,15,67485623-67485672,15q23a,+,NM_017705.2,54852,PAQR5,-1.0271838690699635,6.468369650158057,-8.141608496597879,4.3731500040328255e-13,2.7855778956711214e-12,18.87084729929113
C21orf24,ILMN_2211724,"Homo sapiens chromosome 21 open reading frame 24 (C21orf24), mRNA.",,,,21,39043113-39043162,21q22.2a,-,NM_001001789.1,400866,C21orf24,1.2870368414617932,14.194381108802444,8.12107401962632,4.876051822816558e-13,3.089751862360346e-12,18.763048999419787
RASEF,ILMN_1779517,"Homo sapiens RAS and EF-hand domain containing (RASEF), mRNA.",,small GTPase mediated signal transduction [goid 7264] [evidence IEA]; protein transport [goid 15031] [evidence IEA],GTP binding [goid 5525] [evidence IEA]; calcium ion binding [goid 5509] [evidence IEA],9,84787248-84787297,9q21.32b,-,NM_152573.2,158158,RASEF,1.73848336958459,8.146601293897815,8.118419552202905,4.945123135859015e-13,3.131482752753101e-12,18.749119667797743
GATA5,ILMN_1760153,"Homo sapiens GATA binding protein 5 (GATA5), mRNA.",nucleus [goid 5634] [evidence IEA],"metabolism [goid 8152] [evidence IEA]; transcription [goid 6350] [evidence IEA]; positive regulation of transcription [goid 45941] [evidence IEA]; regulation of transcription, DNA-dependent [goid 6355] [evidence IEA]",transcriptional activator activity [goid 16563] [evidence IEA]; transferase activity [goid 16740] [evidence IEA]; sequence-specific DNA binding [goid 43565] [evidence IEA]; transcription factor activity [goid 3700] [evidence IEA]; zinc ion binding [goid 8270] [evidence IEA]; metal ion binding [goid 46872] [evidence IEA],20,60472061-60472110,20q13.33c,-,NM_080473.3,140628,GATA5,-1.0276773746603185,5.996816402772865,-8.093023497103943,5.657121484191009e-13,3.5661278589279137e-12,18.615919368946674
PZP,ILMN_1708183,"Homo sapiens pregnancy-zone protein (PZP), mRNA.",extracellular region [goid 5576] [pmid 14718574] [evidence NAS],pregnancy [goid 7565] [pmid 2692707] [evidence TAS],wide-spectrum protease inhibitor activity [goid 17114] [evidence IEA]; serine-type endopeptidase inhibitor activity [goid 4867] [evidence IEA]; endopeptidase inhibitor activity [goid 4866] [evidence IEA],12,9192843-9192857:9193424-9193458,12p13.31a,-,NM_002864.1,5858,PZP,-1.4411087505492368,5.9608128651038514,-8.091385596088855,5.706390926884867e-13,3.593698358447047e-12,18.607332806980438
NFE2L3,ILMN_2049766,"Homo sapiens nuclear factor (erythroid-derived 2)-like 3 (NFE2L3), mRNA.",nucleus [goid 5634] [evidence IEA],"transcription from RNA polymerase II promoter [goid 6366] [pmid 10037736] [evidence TAS]; transcription [goid 6350] [evidence IEA]; regulation of transcription, DNA-dependent [goid 6355] [evidence IEA]",transcription factor activity [goid 3700] [pmid 10037736] [evidence TAS]; sequence-specific DNA binding [goid 43565] [evidence IEA]; protein dimerization activity [goid 46983] [evidence IEA]; transcription coactivator activity [goid 3713] [pmid 10037736] [evidence TAS],7,26192199-26192248,7p15.2b,+,NM_004289.5,9603,NFE2L3,1.1306991383463005,8.505140331816945,8.090335439344413,5.73820466553431e-13,3.61256600671845e-12,18.601827708754524
LOC653829,ILMN_1743476,"PREDICTED: Homo sapiens similar to Williams Beuren syndrome chromosome region 19, transcript variant 6 (LOC653829), mRNA.",,,,,,,,XM_935802.1,653829,LOC653829,1.9386056500194284,8.141802606139745,8.090116323352254,5.744864820772811e-13,3.6155907956317254e-12,18.600679091758547
ZBTB16,ILMN_1750496,"Homo sapiens zinc finger and BTB domain containing 16 (ZBTB16), transcript variant 1, mRNA.",nuclear speck [goid 16607] [pmid 8541544] [evidence IDA]; transcriptional repressor complex [goid 17053] [pmid 12802276] [evidence IDA]; nucleus [goid 5634] [pmid 9294197] [evidence IDA]; intracellular [goid 5622] [evidence IEA]; nuclear speck [goid 16607] [pmid 8541544] [evidence IDA]; transcriptional repressor complex [goid 17053] [pmid 12802276] [evidence IDA]; nucleus [goid 5634] [pmid 9294197] [evidence IDA]; intracellular [goid 5622] [evidence IEA],"mesonephros development [goid 1823] [pmid 8541544] [evidence ISS]; apoptosis [goid 6915] [pmid 9294197] [evidence NAS]; transcription [goid 6350] [evidence IEA]; negative regulation of transcription, DNA-dependent [goid 45892] [pmid 12802276] [evidence IDA]; central nervous system development [goid 7417] [pmid 8541544] [evidence ISS]; negative regulation of myeloid cell differentiation [goid 45638] [pmid 8541544] [evidence ISS]; mesonephros development [goid 1823] [pmid 8541544] [evidence ISS]; apoptosis [goid 6915] [pmid 9294197] [evidence NAS]; transcription [goid 6350] [evidence IEA]; negative regulation of transcription, DNA-dependent [goid 45892] [pmid 12802276] [evidence IDA]; central nervous system development [goid 7417] [pmid 8541544] [evidence ISS]; negative regulation of myeloid cell differentiation [goid 45638] [pmid 8541544] [evidence ISS]",protein homodimerization activity [goid 42803] [pmid 8622986] [evidence IDA]; DNA binding [goid 3677] [pmid 9294197] [evidence NAS]; zinc ion binding [goid 8270] [evidence IEA]; metal ion binding [goid 46872] [evidence IEA]; specific transcriptional repressor activity [goid 16566] [pmid 12802276] [evidence IDA]; protein homodimerization activity [goid 42803] [pmid 8622986] [evidence IDA]; DNA binding [goid 3677] [pmid 9294197] [evidence NAS]; zinc ion binding [goid 8270] [evidence IEA]; metal ion binding [goid 46872] [evidence IEA]; specific transcriptional repressor activity [goid 16566] [pmid 12802276] [evidence IDA],11,113435646-113435695,11q23.2a,+,NM_006006.4,7704,ZBTB16,-1.715611235686005,7.455122624468828,-8.089873205329166,5.752263523168497e-13,3.6190782934755622e-12,18.59940466537372
KIAA0367,ILMN_1810628,"Homo sapiens KIAA0367 (KIAA0367), mRNA.",,induction of apoptosis [goid 6917] [pmid 16288218] [evidence IMP]; G1 phase [goid 51318] [pmid 16288218] [evidence IEP],,9,78416421-78416470,9q21.13c,-,NM_015225.1,23273,KIAA0367,-1.255659388984716,7.103523695207488,-8.088491715380755,5.794485950647188e-13,3.643290053190076e-12,18.592163094295003
DKFZP586H2123,ILMN_1658356,"Homo sapiens regeneration associated muscle protease (DKFZP586H2123), transcript variant 2, mRNA.",,,serine-type endopeptidase activity [goid 4252] [evidence IEA]; peptidase activity [goid 8233] [evidence IEA],11,35410028-35410077,11p13b-p13a,-,NM_001001991.1,25891,DKFZP586H2123,-1.4302638245521404,8.500225855833985,-8.081206354033494,6.022296139941072e-13,3.77799228225215e-12,18.553980167203463
ZNF600,ILMN_1678457,"Homo sapiens zinc finger protein 600 (ZNF600), mRNA.",nucleus [goid 5634] [evidence IEA]; intracellular [goid 5622] [evidence IEA],"transcription [goid 6350] [evidence IEA]; regulation of transcription, DNA-dependent [goid 6355] [evidence IEA]",DNA binding [goid 3677] [evidence IEA]; zinc ion binding [goid 8270] [evidence IEA]; metal ion binding [goid 46872] [evidence IEA]; nucleic acid binding [goid 3676] [evidence IEA],19,57959336-57959385,19q13.41a,-,NM_198457.1,162966,ZNF600,1.5741646535894631,7.704391984905305,8.080960598592252,6.030134067090658e-13,3.781691737922802e-12,18.55269232398102
KRT19,ILMN_1730777,"Homo sapiens keratin 19 (KRT19), mRNA.",intermediate filament [goid 5882] [pmid 2448790] [evidence TAS]; costamere [goid 43034] [pmid 16000376] [evidence IDA],,structural constituent of cytoskeleton [goid 5200] [pmid 2448790] [evidence TAS]; protein binding [goid 5515] [pmid 16000376] [evidence IPI]; structural molecule activity [goid 5198] [evidence IEA]; structural constituent of muscle [goid 8307] [pmid 16000376] [evidence IDA],17,36933718-36933767,17q21.2b,-,NM_002276.3,3880,KRT19,1.0748604520253622,12.71946710652312,8.072545218024331,6.304732927829085e-13,3.941216589629442e-12,18.50859965133832
ASPHD2,ILMN_2167426,"Homo sapiens aspartate beta-hydroxylase domain containing 2 (ASPHD2), mRNA.",integral to endoplasmic reticulum membrane [goid 30176] [evidence IEA],peptidyl-amino acid modification [goid 18193] [evidence IEA],peptide-aspartate beta-dioxygenase activity [goid 4597] [evidence IEA],22,25169156-25169172:25169173-25169205,22q12.1a,+,NM_020437.3,57168,ASPHD2,1.078719203148908,6.362928597295214,8.072006820035153,6.322718226764654e-13,3.951191938694974e-12,18.505779148655854
NFIL3,ILMN_1707312,"Homo sapiens nuclear factor, interleukin 3 regulated (NFIL3), mRNA.",nucleus [goid 5634] [pmid 7565758] [evidence TAS],"regulation of transcription, DNA-dependent [goid 6355] [evidence IEA]; immune response [goid 6955] [pmid 7565758] [evidence TAS]; transcription from RNA polymerase II promoter [goid 6366] [pmid 7565758] [evidence TAS]",protein dimerization activity [goid 46983] [evidence IEA]; sequence-specific DNA binding [goid 43565] [evidence IEA]; transcription corepressor activity [goid 3714] [pmid 1620116] [evidence TAS]; transcription factor activity [goid 3700] [pmid 7565758] [evidence TAS],9,93211451-93211500,9q22.31a,-,NM_005384.2,4783,NFIL3,-1.1851140628187267,8.49687426726189,-8.068780039951866,6.431583054447989e-13,4.017935101504299e-12,18.488876174104917
SEMA3B,ILMN_1653501,"Homo sapiens sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3B (SEMA3B), transcript variant 2, mRNA.",membrane [goid 16020] [evidence IEA]; endoplasmic reticulum [goid 5783] [pmid 8633026] [evidence TAS]; membrane [goid 16020] [evidence IEA]; endoplasmic reticulum [goid 5783] [pmid 8633026] [evidence TAS],development [goid 7275] [evidence IEA]; axon guidance [goid 7411] [pmid 8633026] [evidence TAS]; cell-cell signaling [goid 7267] [pmid 8633026] [evidence TAS]; development [goid 7275] [evidence IEA]; axon guidance [goid 7411] [pmid 8633026] [evidence TAS]; cell-cell signaling [goid 7267] [pmid 8633026] [evidence TAS],receptor activity [goid 4872] [evidence IEA]; receptor activity [goid 4872] [evidence IEA],3,50289448-50289497,3p21.31b,+,NM_001005914.1,7869,SEMA3B,-1.06224082061523,7.577234672599736,-8.062614593813423,6.644798619423509e-13,4.143164835182946e-12,18.456584912053184
CATSPER2,ILMN_2286014,"Homo sapiens cation channel, sperm associated 2 (CATSPER2), transcript variant 4, mRNA.",membrane [goid 16020] [evidence IEA],ion transport [goid 6811] [evidence IEA],ion channel activity [goid 5216] [evidence IEA],15,41718990-41719039,15q15.3a,-,NM_172097.1,117155,CATSPER2,1.0408442041532542,9.609062675641622,8.049934515635828,7.105634608349531e-13,4.423427806507687e-12,18.39019610127469
RNASE6,ILMN_1780533,"Homo sapiens ribonuclease, RNase A family, k6 (RNASE6), mRNA.",extracellular region [goid 5576] [pmid 8836175] [evidence TAS],RNA catabolism [goid 6401] [pmid 8836175] [evidence TAS]; defense response [goid 6952] [pmid 8836175] [evidence TAS],ribonuclease activity [goid 4540] [pmid 8836175] [evidence TAS]; pancreatic ribonuclease activity [goid 4522] [evidence IEA]; nucleic acid binding [goid 3676] [evidence IEA]; endonuclease activity [goid 4519] [evidence IEA]; hydrolase activity [goid 16787] [evidence IEA],14,20320082-20320131,14q11.2b,+,NM_005615.2,6039,RNASE6,-1.1402080772773964,8.393877831047696,-8.048799906184707,7.148386394494788e-13,4.447200156345177e-12,18.384257135627454
C14orf85,ILMN_2134381,Homo sapiens chromosome 14 open reading frame 85 (C14orf85) on chromosome 14.,,,,14,92608098-92608147,14q32.12b,+,NR_002808.1,319085,C14orf85,1.496162312833368,13.147401263882042,8.045533801456722,7.272884575240258e-13,4.521766303400014e-12,18.36716250008016
FAM100A,ILMN_1733863,"Homo sapiens family with sequence similarity 100, member A (FAM100A), mRNA.",,,,16,4599170-4599219,16p13.3b,-,NM_145253.1,124402,FAM100A,1.0455270539567225,8.063122589101676,8.038631653018125,7.543114860479526e-13,4.683798376559705e-12,18.331043663190187
CD47,ILMN_1771333,"Homo sapiens CD47 antigen (Rh-related antigen, integrin-associated signal transducer) (CD47), transcript variant 4, mRNA.",integral to plasma membrane [goid 5887] [pmid 7998989] [evidence TAS]; plasma membrane [goid 5886] [pmid 10429193] [evidence TAS],cell-matrix adhesion [goid 7160] [evidence NR ]; cell adhesion [goid 7155] [evidence IEA]; integrin-mediated signaling pathway [goid 7229] [pmid 8294396] [evidence TAS],protein binding [goid 5515] [evidence IEA],3,109245076-109245125,3q13.12b,-,NM_001025080.1,961,CD47,-1.0268140325283497,9.095469534794631,-8.038267629976955,7.557640723292698e-13,4.689828964756632e-12,18.32913898827007
ZNF223,ILMN_1815578,"Homo sapiens zinc finger protein 223 (ZNF223), mRNA.",nucleus [goid 5634] [evidence NAS],"regulation of transcription, DNA-dependent [goid 6355] [evidence IEA]",DNA binding [goid 3677] [pmid 10449920] [evidence NAS],19,49263889-49263938,19q13.31b,+,NM_013361.2,7766,ZNF223,1.7822105197005982,10.119017802399314,8.036995048488633,7.608640204422458e-13,4.719847391373792e-12,18.322480668820045
IFIT2,ILMN_1739428,"Homo sapiens interferon-induced protein with tetratricopeptide repeats 2 (IFIT2), mRNA.",,immune response [goid 6955] [evidence IEA],binding [goid 5488] [evidence IEA],10,91058378-91058427,10q23.31b,+,NM_001547.3,3433,IFIT2,-1.1133124851642258,9.31275513888213,-8.022374287847962,8.219690194897897e-13,5.0764077162467676e-12,18.246005092650297
KLHL9,ILMN_1664466,"Homo sapiens kelch-like 9 (Drosophila) (KLHL9), mRNA.",,,protein binding [goid 5515] [evidence IEA],9,21321362-21321411,9p21.3c,-,NM_018847.1,55958,KLHL9,-1.0011196910288351,9.15964703423199,-8.021258843763691,8.268262249864077e-13,5.103170413006067e-12,18.240172317526667
SOCS3,ILMN_1781001,"Homo sapiens suppressor of cytokine signaling 3 (SOCS3), mRNA.",,anti-apoptosis [goid 6916] [pmid 9266833] [evidence TAS]; JAK-STAT cascade [goid 7259] [pmid 9266833] [evidence TAS]; regulation of cell growth [goid 1558] [evidence IEA]; intracellular signaling cascade [goid 7242] [evidence IEA]; negative regulation of signal transduction [goid 9968] [evidence IEA],protein kinase inhibitor activity [goid 4860] [pmid 9266833] [evidence TAS],17,73865148-73865197,17q25.3b,-,NM_003955.3,9021,SOCS3,-1.5014925033130933,7.650224487709542,-8.014593903992736,8.564488075911564e-13,5.27263981545456e-12,18.205325634764232
SCEL,ILMN_1710325,"Homo sapiens sciellin (SCEL), transcript variant 1, mRNA.",cornified envelope [goid 1533] [pmid 9813070] [evidence TAS]; cytoplasm [goid 5737] [pmid 11112355] [evidence ISS]; cornified envelope [goid 1533] [pmid 9813070] [evidence TAS]; cytoplasm [goid 5737] [pmid 11112355] [evidence ISS],keratinocyte differentiation [goid 30216] [pmid 14632196] [evidence IDA]; embryonic development [goid 9790] [pmid 11112355] [evidence ISS]; epidermis development [goid 8544] [pmid 11112355] [evidence ISS]; keratinocyte differentiation [goid 30216] [pmid 14632196] [evidence IDA]; embryonic development [goid 9790] [pmid 11112355] [evidence ISS]; epidermis development [goid 8544] [pmid 11112355] [evidence ISS],zinc ion binding [goid 8270] [evidence IEA]; metal ion binding [goid 46872] [evidence IEA]; protein binding [goid 5515] [pmid 14632196] [evidence IPI]; zinc ion binding [goid 8270] [evidence IEA]; metal ion binding [goid 46872] [evidence IEA]; protein binding [goid 5515] [pmid 14632196] [evidence IPI],13,77106532-77106581,13q22.3b,+,NM_003843.2,8796,SCEL,-1.1344751908387911,7.0002968516561905,-8.014186141131114,8.582949768557328e-13,5.282336583712557e-12,18.20319398307421
COL7A1,ILMN_1751161,"Homo sapiens collagen, type VII, alpha 1 (epidermolysis bullosa, dystrophic, dominant and recessive) (COL7A1), mRNA.",basement membrane [goid 5604] [pmid 9375848] [evidence TAS]; collagen type VII [goid 5590] [pmid 9375848] [evidence TAS]; cytoplasm [goid 5737] [evidence IEA],cell adhesion [goid 7155] [evidence IEA]; phosphate transport [goid 6817] [evidence IEA]; epidermis development [goid 8544] [pmid 8170945] [evidence TAS],serine-type endopeptidase inhibitor activity [goid 4867] [evidence IEA]; structural molecule activity [goid 5198] [evidence IEA]; protein binding [goid 5515] [evidence IEA],3,48576675-48576724,3p21.31e,-,NM_000094.2,1294,COL7A1,1.5556970693157872,7.136504123976683,8.014028312673153,8.590106150543231e-13,5.2850716243553795e-12,18.202368915816013
OLFM1,ILMN_1714709,"Homo sapiens olfactomedin 1 (OLFM1), transcript variant 2, mRNA.",endoplasmic reticulum [goid 5783] [evidence IEA]; membrane [goid 16020] [evidence IEA],development [goid 7275] [evidence IEA],latrotoxin receptor activity [goid 16524] [evidence IEA],9,137129482-137129531,9q34.3a-q34.3b,+,NM_006334.2,10439,OLFM1,-1.2637858665156214,8.24932570241794,-8.003760149893388,9.068660197889479e-13,5.565443904122095e-12,18.148701208783308
IRF1,ILMN_1708375,"Homo sapiens interferon regulatory factor 1 (IRF1), mRNA.",nucleus [goid 5634] [evidence IEA],"immune response [goid 6955] [evidence IEA]; transcription [goid 6350] [evidence IEA]; transcription from RNA polymerase II promoter [goid 6366] [pmid 2475256] [evidence TAS]; regulation of transcription, DNA-dependent [goid 6355] [evidence IEA]; cell cycle [goid 7049] [evidence IEA]",transcription factor activity [goid 3700] [evidence IEA],5,131846773-131846822,5q31.1b,-,NM_002198.1,3659,IRF1,-1.1136241625188976,10.671658993006059,-8.003429519086986,9.084501902608703e-13,5.573410565879427e-12,18.146973469060185
LOC645466,ILMN_1712204,"PREDICTED: Homo sapiens hypothetical protein LOC645466 (LOC645466), mRNA.",,,,1,78085373-78085380:78085381-78085422,1p31.1e,+,XM_930477.1,645466,LOC645466,1.132194832206796,6.597832462308509,7.997523858288841,9.37214008017844e-13,5.744452641153725e-12,18.116116506324484
SLC44A4,ILMN_1719250,"Homo sapiens solute carrier family 44, member 4 (SLC44A4), transcript variant 2, mRNA.",integral to membrane [goid 16021] [evidence IEA]; membrane [goid 16020] [evidence IEA]; integral to membrane [goid 16021] [evidence IEA]; membrane [goid 16020] [evidence IEA],,,6,31939298-31939347,6p21.32b,-,NM_032794.1,80736,SLC44A4,1.100889468176712,11.071782762386455,7.99532048611268,9.481758832008036e-13,5.809813548480396e-12,18.10460566665026
DOCK9,ILMN_1773413,"Homo sapiens dedicator of cytokinesis 9 (DOCK9), mRNA.",,,GTPase binding [goid 51020] [evidence IEA]; guanyl-nucleotide exchange factor activity [goid 5085] [evidence IEA]; GTP binding [goid 5525] [evidence IEA],13,98244898-98244947,13q32.3a,-,NM_015296.1,23348,DOCK9,-1.091894713361067,7.671472206306479,-7.991859013504902,9.656546650998645e-13,5.915052231836171e-12,18.086524178395404
AKAP8L,ILMN_1768962,"Homo sapiens A kinase (PRKA) anchor protein 8-like (AKAP8L), mRNA.",chromosome [goid 5694] [evidence IEA]; nucleus [goid 5634] [pmid 10761695] [evidence TAS]; intracellular [goid 5622] [evidence IEA],,zinc ion binding [goid 8270] [evidence IEA]; metal ion binding [goid 46872] [evidence IEA]; DEAD/H-box RNA helicase binding [goid 17151] [pmid 10748171] [evidence TAS]; DNA binding [goid 3677] [evidence IEA],19,15352218-15352241:15352328-15352353,19p13.12a,-,NM_014371.2,26993,AKAP8L,1.0205593733463294,8.641078493346347,7.974067830338354,1.060670632286589e-12,6.462528852440333e-12,17.993626397749065
IL1F7,ILMN_1697710,"Homo sapiens interleukin 1 family, member 7 (zeta) (IL1F7), transcript variant 1, mRNA.",extracellular region [goid 5576] [pmid 10744718] [evidence TAS]; extracellular space [goid 5615] [evidence IEA],immune response [goid 6955] [pmid 10744718] [evidence NAS],interleukin-1 receptor antagonist activity [goid 5152] [evidence IEA],2,113391688-113391737,2q13d,+,NM_014439.3,27178,IL1F7,1.9353560743696203,6.559732187643347,7.969048406884352,1.0891188872246188e-12,6.627570742527076e-12,17.967428401828023
EGR1,ILMN_1762899,"Homo sapiens early growth response 1 (EGR1), mRNA.",nucleus [goid 5634] [evidence IEA]; intracellular [goid 5622] [evidence IEA],"regulation of transcription, DNA-dependent [goid 6355] [evidence IEA]; transcription [goid 6350] [evidence IEA]",zinc ion binding [goid 8270] [evidence IEA]; metal ion binding [goid 46872] [evidence IEA]; transcription factor activity [goid 3700] [pmid 3127059] [evidence TAS],5,137832431-137832480,5q31.2c,+,NM_001964.2,1958,EGR1,-1.2512396371394878,12.049259983384575,-7.96709982331282,1.1003658744395398e-12,6.691831792588774e-12,17.957259451326237
ANG,ILMN_1760727,"Homo sapiens angiogenin, ribonuclease, RNase A family, 5 (ANG), mRNA.",basal lamina [goid 5605] [pmid 15166501] [evidence IDA]; extracellular space [goid 5615] [pmid 16490744] [evidence IDA]; nucleolus [goid 5730] [evidence ISS]; nucleus [goid 5634] [pmid 15735021] [evidence IDA],actin filament polymerization [goid 30041] [evidence ISS]; cell communication [goid 7154] [pmid 10103013] [evidence NAS]; negative regulation of smooth muscle cell proliferation [goid 48662] [pmid 10103013] [evidence IDA]; positive regulation of protein secretion [goid 50714] [pmid 2646638] [evidence IDA]; cell differentiation [goid 30154] [evidence IEA]; rRNA transcription [goid 9303] [pmid 15735021] [evidence IMP]; ribosome biogenesis [goid 7046] [pmid 15735021] [evidence IMP]; diacylglycerol biosynthesis [goid 6651] [pmid 2457905] [evidence IDA]; ovarian follicle development [goid 1541] [pmid 12770725] [evidence NAS]; phospholipase C activation [goid 7202] [pmid 2457905] [evidence IMP]; angiogenesis [goid 1525] [pmid 16567967] [evidence TAS]; response to hypoxia [goid 1666] [pmid 16490744] [evidence IDA]; homeostasis [goid 42592] [pmid 15166501] [evidence NAS]; positive regulation of endothelial cell proliferation [goid 1938] [pmid 9707554] [evidence IDA]; calcium-dependent phospholipase A2 activation [goid 43006] [pmid 2646638] [evidence IMP]; negative regulation of protein biosynthesis [goid 17148] [evidence IEA],actin binding [goid 3779] [pmid 11782452] [evidence IDA]; heparin binding [goid 8201] [pmid 10103013] [evidence IDA]; rRNA binding [goid 19843] [pmid 2457905] [evidence TAS]; copper ion binding [goid 5507] [pmid 9245697] [evidence IDA]; receptor binding [goid 5102] [pmid 9122172] [evidence IDA]; endonuclease activity [goid 4519] [pmid 10103013] [evidence TAS]; DNA binding [goid 3677] [pmid 10649442] [evidence IC ]; ribonuclease activity [goid 4540] [pmid 2730651] [evidence IDA]; hydrolase activity [goid 16787] [evidence IEA]; pancreatic ribonuclease activity [goid 4522] [evidence IEA],14,20232018-20232067,14q11.2b,+,NM_001145.2,283,ANG,-1.052537530211593,10.693953754644289,-7.965566624474314,1.109296357928134e-12,6.744037296171511e-12,17.94925876973535
NELF,ILMN_1665095,"Homo sapiens nasal embryonic LHRH factor (NELF), mRNA.",,,,9,139462516-139462565,9q34.3f,-,NM_015537.3,26012,NELF,1.0258128130844737,7.792125339737015,7.96016772532926,1.1413205668666757e-12,6.923608731443704e-12,17.921089427193145
RAD51AP1,ILMN_1670353,"Homo sapiens RAD51 associated protein 1 (RAD51AP1), mRNA.",nucleus [goid 5634] [pmid 9396801] [evidence IC ],DNA repair [goid 6281] [pmid 9396801] [evidence NAS]; double-strand break repair via homologous recombination [goid 724] [pmid 9396801] [evidence NAS],protein binding [goid 5515] [pmid 9396801] [evidence IPI]; double-stranded DNA binding [goid 3690] [pmid 9396801] [evidence IDA]; DNA binding [goid 3677] [evidence IEA]; RNA binding [goid 3723] [pmid 9396801] [evidence IDA]; single-stranded DNA binding [goid 3697] [pmid 9396801] [evidence IDA],12,4539054-4539103,12p13.32a,+,NM_006479.2,10635,RAD51AP1,1.0390916963903356,6.441788441439581,7.955053373146702,1.1725034676587552e-12,7.097306637878485e-12,17.894410062086685
MT1E,ILMN_1718968,"Homo sapiens metallothionein 1E (functional) (MT1E), mRNA.",cytoplasm [goid 5737] [evidence NAS],biological process unknown [goid 4] [evidence ND ],metal ion binding [goid 46872] [evidence IEA]; cadmium ion binding [goid 46870] [evidence NAS]; zinc ion binding [goid 8270] [evidence NAS]; copper ion binding [goid 5507] [evidence NAS],16,55218122-55218171,16q13b,+,NM_175617.2,4493,MT1E,-1.5124315990183685,9.383628278319208,-7.951840818501299,1.1925221304695647e-12,7.2050523138603e-12,17.877654206663088
LOC90586,ILMN_2219618,Homo sapiens AOC3 pseudogene (LOC90586) on chromosome 17.,,,,17,38274563-38274612,17q21.31a,+,NR_002773.1,90586,LOC90586,1.8011002931354394,12.388150016544405,7.95001621045222,1.2040427665451012e-12,7.270149769485992e-12,17.868138435488177
LOH3CR2A,ILMN_2052135,"Homo sapiens loss of heterozygosity, 3, chromosomal region 2, gene A (LOH3CR2A), mRNA.",,,,3,8590113-8590162,3p26.1a,+,NM_013343.1,29931,LOH3CR2A,-1.3559903392232364,6.581709006803437,-7.9434972375131325,1.246114295736668e-12,7.511071008056105e-12,17.834145833045433
FLJ11783,ILMN_1679003,"Homo sapiens hypothetical protein FLJ11783 (FLJ11783), mRNA.",,,,11,117814732-117814781,11q23.3d,+,NM_024891.1,79951,FLJ11783,1.113371558898204,6.119500487940102,7.9390584223329315,1.275593572737007e-12,7.680760434110192e-12,17.81100487877255
WBSCR19,ILMN_1718311,"PREDICTED: Homo sapiens Williams Beuren syndrome chromosome region 19, transcript variant 4 (WBSCR19), mRNA.",,,,,,7p13d,,XM_943679.1,285955,WBSCR19,1.1970782919793077,6.006714577606284,7.934937951710721,1.3035782138700518e-12,7.839574536190729e-12,17.789527081680394
EDNRA,ILMN_1796629,"Homo sapiens endothelin receptor type A (EDNRA), mRNA.",integral to plasma membrane [goid 5887] [pmid 1326535] [evidence TAS]; membrane [goid 16020] [evidence NAS],cell proliferation [goid 8283] [pmid 9284755] [evidence NAS]; signal transduction [goid 7165] [pmid 1326535] [evidence TAS]; phospholipase C activation [goid 7202] [pmid 8702836] [evidence TAS]; respiratory gaseous exchange [goid 7585] [evidence ISS]; adenylate cyclase activation [goid 7190] [pmid 8702836] [evidence TAS]; smooth muscle contraction [goid 6939] [pmid 9284755] [evidence NAS]; G-protein coupled receptor protein signaling pathway [goid 7186] [pmid 8611157] [evidence NAS]; glucose transport [goid 15758] [evidence ISS],rhodopsin-like receptor activity [goid 1584] [evidence IEA]; phosphoinositide phospholipase C activity [goid 4435] [pmid 8702836] [evidence TAS]; protein binding [goid 5515] [evidence ISS]; endothelin-A receptor activity [goid 1599] [pmid 8611157] [evidence NAS]; receptor activity [goid 4872] [evidence IEA],4,148685486-148685535,4q31.23a,+,NM_001957.1,1909,EDNRA,-1.0014694732887879,9.566803023898611,-7.933225291727991,1.3153885827246466e-12,7.905724633044073e-12,17.780600906692893
MLR2,ILMN_1689817,"Homo sapiens ligand-dependent corepressor (MLR2), mRNA.",nucleus [goid 5634] [evidence IEA],,DNA binding [goid 3677] [evidence IEA],10,98708150-98708199,10q24.1a-q24.1b,+,NM_032440.1,84458,MLR2,1.0561511442821185,8.017691779624508,7.933225197440721,1.3153892358393064e-12,7.905724633044073e-12,17.780600415295325
CGN,ILMN_1746801,"Homo sapiens cingulin (CGN), mRNA.",myosin [goid 16459] [evidence IEA]; tight junction [goid 5923] [pmid 12529927] [evidence NAS],,motor activity [goid 3774] [evidence IEA]; actin binding [goid 3779] [evidence ISS]; protein binding [goid 5515] [pmid 11042084] [evidence IPI],1,149777638-149777687,1q21.3a,+,NM_020770.1,57530,CGN,1.057532307887426,10.771258015413757,7.9261889848001505,1.3650360594755839e-12,8.188955547685268e-12,17.743934709343645
ARL17P1,ILMN_1698680,"Homo sapiens ADP-ribosylation factor-like 17 pseudogene 1 (ARL17P1), mRNA.",Golgi stack [goid 5795] [evidence IEA],protein transport [goid 15031] [evidence IEA],nucleotide binding [goid 166] [evidence IEA]; GTP binding [goid 5525] [evidence IEA],17,41949510-41949559,17q21.32a,-,NM_016632.1,51326,ARL17P1,1.054333038213108,6.185189434216833,7.905731893408817,1.5202010521123569e-12,9.069539957259421e-12,17.637389484327002
C8orf1,ILMN_1757732,"Homo sapiens oxidative stress induced growth inhibitor family member 2 (OSGIN2), mRNA.",,germ cell development [goid 7281] [evidence NAS]; meiosis [goid 7126] [evidence NAS],,8,91007391-91007440,8q21.3d,+,NM_004337.1,734,C8orf1,-1.049594960492045,7.807364451569992,-7.903954039263603,1.5344859057087374e-12,9.151961393552113e-12,17.628134014063143
FUT8,ILMN_1741422,"Homo sapiens fucosyltransferase 8 (alpha (1,6) fucosyltransferase) (FUT8), transcript variant 2, mRNA.",integral to membrane [goid 16021] [evidence IEA]; Golgi apparatus [goid 5794] [pmid 11698403] [evidence NAS]; membrane [goid 16020] [evidence IEA],oligosaccharide biosynthesis [goid 9312] [pmid 9133635] [evidence TAS]; N-glycan processing [goid 6491] [pmid 11698403] [evidence TAS]; L-fucose catabolism [goid 42355] [pmid 11698403] [evidence NAS]; embryonic development (sensu Mammalia) [goid 1701] [pmid 11698403] [evidence NAS],"transferase activity, transferring glycosyl groups [goid 16757] [evidence IEA]; glycoprotein 6-alpha-L-fucosyltransferase activity [goid 8424] [pmid 11698403] [evidence TAS]",14,65279249-65279298,14q23.3a,+,NM_178154.1,2530,FUT8,1.0460331409322867,7.953600094054282,7.901091067836214,1.5577702739412523e-12,9.276636243198442e-12,17.613230796966533
NLRP3,ILMN_2310896,"Homo sapiens NLR family, pyrin domain containing 3 (NLRP3), transcript variant 1, mRNA.",cytoplasm [goid 5737] [pmid 15967716] [evidence TAS],detection of biotic stimulus [goid 9595] [pmid 15967716] [evidence TAS]; inflammatory response [goid 6954] [pmid 12093792] [evidence IMP]; defense response [goid 6952] [pmid 15967716] [evidence TAS]; protein oligomerization [goid 51259] [pmid 15967716] [evidence TAS]; positive regulation of interleukin-1 beta secretion [goid 50718] [pmid 15030775] [evidence IDA]; signal transduction [goid 7165] [pmid 11786556] [evidence NAS]; induction of apoptosis [goid 6917] [pmid 12032915] [evidence NAS]; apoptosis [goid 6915] [evidence IEA],peptidoglycan binding [goid 42834] [pmid 15967716] [evidence TAS]; protein binding [goid 5515] [pmid 15030775] [evidence IPI]; transferase activity [goid 16740] [evidence IEA],1,245678577-245678626,1q44e,+,NM_004895.3,114548,NLRP3,-1.1808202210015528,6.875331421310776,-7.8972982232449,1.5891584537460081e-12,9.449115798364653e-12,17.593489687709674
MSX1,ILMN_1777397,"Homo sapiens msh homeo box homolog 1 (Drosophila) (MSX1), mRNA.",nucleus [goid 5634] [evidence IEA],"regulation of transcription, DNA-dependent [goid 6355] [evidence IEA]; skeletal development [goid 1501] [pmid 8696335] [evidence TAS]; development [goid 7275] [evidence IEA]",transcription factor activity [goid 3700] [evidence IEA],4,4916048-4916097,4p16.2a,+,NM_002448.1,4487,MSX1,-1.2860049083100584,7.414103436386096,-7.88910514514662,1.6591215122770473e-12,9.847085795527953e-12,17.550856129193246
SLC25A37,ILMN_1715969,"Homo sapiens solute carrier family 25, member 37 (SLC25A37), transcript variant 1, mRNA.",membrane [goid 16020] [evidence IEA]; integral to membrane [goid 16021] [evidence IEA]; mitochondrial inner membrane [goid 5743] [evidence IEA],transport [goid 6810] [evidence IEA],binding [goid 5488] [evidence IEA],8,23485399-23485448,8p21.2d,+,NM_016612.1,51312,SLC25A37,1.3115813326380152,9.36860909322945,7.879863279935926,1.7417176435567116e-12,1.0318445814746891e-11,17.50278158213883
NAPSB,ILMN_1723043,"PREDICTED: Homo sapiens napsin B aspartic peptidase pseudogene, transcript variant 3 (NAPSB), misc RNA.",,,,,,19q13.33c,,XR_001413.1,256236,NAPSB,-1.1640872578508823,7.973799769454282,-7.8709113330790865,1.825612936644158e-12,1.0799049201733885e-11,17.456231871561624
LOC649970,ILMN_1715476,"PREDICTED: Homo sapiens similar to creatine kinase, mitochondrial 1B precursor (LOC649970), mRNA.",,,,,,,,XM_939056.1,649970,LOC649970,1.7801252826603235,7.566865254795413,7.868222964758263,1.8515824341813763e-12,1.0942700555057361e-11,17.44225570552125
LRP5L,ILMN_1718633,"Homo sapiens low density lipoprotein receptor-related protein 5-like (LRP5L), mRNA.",,,,22,24077507-24077556,22q11.23c,-,NM_182492.1,91355,LRP5L,1.011721931714816,8.291509505200539,7.86690556938671,1.864442011300851e-12,1.101201957871994e-11,17.435407435778615
DKFZp434K191,ILMN_1652533,"Homo sapiens hypothetical protein DKFZp434K191 (DKFZp434K191), mRNA.",,,,22,17227437-17227477,22q11.21b,+,NM_001029950.1,29797,DKFZp434K191,1.62925116929385,9.204662907622597,7.859589138558951,1.937491279475469e-12,1.1419243067325928e-11,17.397380671305267
APXL2,ILMN_1738322,"Homo sapiens shroom family member 1 (SHROOM1), mRNA.",,,,5,132186256-132186305,5q31.1c,-,NM_133456.1,134549,APXL2,1.0443717893941695,6.7465932373584865,7.854975240528994,1.9850117996691904e-12,1.1692247556394855e-11,17.373405884431108
MESP1,ILMN_1806603,"Homo sapiens mesoderm posterior 1 homolog (mouse) (MESP1), mRNA.",nucleus [goid 5634] [evidence IEA],regulation of transcription [goid 45449] [evidence IEA],transcription regulator activity [goid 30528] [evidence IEA],15,88094155-88094204,15q26.1b,-,NM_018670.1,55897,MESP1,1.4637245445027345,7.76157951830395,7.852862132415381,2.0071602991090597e-12,1.1815564479800614e-11,17.362427205707363
LOC653086,ILMN_1814039,"PREDICTED: Homo sapiens similar to RAN-binding protein 2-like 1 isoform 2, transcript variant 10 (LOC653086), mRNA.",,,,2,112851351-112851400,,-,XM_930995.1,653086,LOC653086,1.427414618688502,12.217894746253034,7.852238686648054,2.013741692324362e-12,1.1850726932932707e-11,17.359188263105825
FLJ40919,ILMN_1797475,"Homo sapiens hypothetical protein FLJ40919 (FLJ40919), mRNA.",,,,13,42263444-42263493,13q14.11c,+,NM_182508.1,144809,FLJ40919,-2.5780116113024336,6.815110891860677,-7.843747797202325,2.1055381924941862e-12,1.2364801591545877e-11,17.31508422178655
LOC653610,ILMN_1695435,"PREDICTED: Homo sapiens similar to Histone H2A.o (H2A/o) (H2A.2) (H2a-615) (LOC653610), mRNA.",,,,1,148089810-148089859,,+,XM_928387.1,653610,LOC653610,1.286846514810458,6.36824007591958,7.837519535742007,2.1755036643648147e-12,1.2752613989214324e-11,17.282742470856597
SCGB3A2,ILMN_1670306,"Homo sapiens secretoglobin, family 3A, member 2 (SCGB3A2), mRNA.",,,,5,147241328-147241377,5q33.1a,+,NM_054023.2,117156,SCGB3A2,-2.300948272310448,11.543554534129296,-7.836056150768052,2.1922747687730423e-12,1.2843197194691139e-11,17.275144669207332
FAM63A,ILMN_1689552,"Homo sapiens family with sequence similarity 63, member A (FAM63A), mRNA.",,,protein binding [goid 5515] [pmid 15231747] [evidence IPI],1,149235922-149235971,1q21.2d,-,NM_018379.2,55793,FAM63A,1.6232991976952729,10.50961170573498,7.833267621663232,2.224588861116035e-12,1.3012943247927331e-11,17.260668046443083
LOC390466,ILMN_1665781,"PREDICTED: Homo sapiens similar to SMT3 suppressor of mif two 3 homolog 2 (LOC390466), mRNA.",,,,14,34459695-34459744,,+,XM_372521.1,390466,LOC390466,-1.0898716425889496,8.962408679791842,-7.831230285341437,2.2484965510000016e-12,1.314095839719107e-11,17.25009226559834
ZNF281,ILMN_1683127,"Homo sapiens zinc finger protein 281 (ZNF281), mRNA.","DNA-directed RNA polymerase II, core complex [goid 5665] [pmid 10448078] [evidence TAS]; nucleus [goid 5634] [evidence IEA]; intracellular [goid 5622] [evidence IEA]","transcription [goid 6350] [evidence IEA]; regulation of transcription, DNA-dependent [goid 6355] [evidence IEA]; negative regulation of transcription from RNA polymerase II promoter [goid 122] [pmid 10448078] [evidence TAS]",DNA binding [goid 3677] [evidence IEA]; zinc ion binding [goid 8270] [evidence IEA]; metal ion binding [goid 46872] [evidence IEA]; nucleic acid binding [goid 3676] [evidence IEA]; specific RNA polymerase II transcription factor activity [goid 3704] [pmid 10448078] [evidence TAS],1,198642187-198642236,1q32.1b,-,NM_012482.3,23528,ZNF281,1.0541398503962451,8.917957218204656,7.818592500953262,2.4026032007544825e-12,1.4020582020575349e-11,17.184509235997886
KIAA0514,ILMN_1723505,"PREDICTED: Homo sapiens KIAA0514 (KIAA0514), mRNA.",,,,,,10q11.22a,,XM_941898.1,9721,KIAA0514,-1.1225923944464204,7.147294389094774,-7.816360245268266,2.4308932831839778e-12,1.4168719485360794e-11,17.172928578914355
KRT16,ILMN_1736760,"Homo sapiens keratin 16 (focal non-epidermolytic palmoplantar keratoderma) (KRT16), mRNA.",intermediate filament [goid 5882] [pmid 2451124] [evidence NAS]; intermediate filament [goid 5882] [pmid 2451124] [evidence NAS],cell proliferation [goid 8283] [pmid 8595410] [evidence TAS]; epidermis development [goid 8544] [pmid 7539673] [evidence TAS]; cytoskeleton organization and biogenesis [goid 7010] [pmid 2451124] [evidence NAS]; cell proliferation [goid 8283] [pmid 8595410] [evidence TAS]; epidermis development [goid 8544] [pmid 7539673] [evidence TAS]; cytoskeleton organization and biogenesis [goid 7010] [pmid 2451124] [evidence NAS],structural molecule activity [goid 5198] [evidence IEA]; protein binding [goid 5515] [pmid 15731013] [evidence IPI]; structural constituent of cytoskeleton [goid 5200] [pmid 2451124] [evidence NAS]; structural molecule activity [goid 5198] [evidence IEA]; protein binding [goid 5515] [pmid 15731013] [evidence IPI]; structural constituent of cytoskeleton [goid 5200] [pmid 2451124] [evidence NAS],17,37020692-37020741,17q21.2b,-,NM_005557.2,3868,KRT16,1.0776734711719538,5.942988033271292,7.815483711152222,2.442092092536721e-12,1.4225460216166819e-11,17.168381520066983
PCP4,ILMN_1682326,"Homo sapiens Purkinje cell protein 4 (PCP4), mRNA.",,central nervous system development [goid 7417] [pmid 8914602] [evidence TAS],,21,40222892-40222906:40222907-40222941,21q22.2b,+,NM_006198.2,5121,PCP4,2.332414214227719,6.456259863217384,7.814663251213616,2.4526208928939206e-12,1.4282521846395113e-11,17.164125495732158
PLCH1,ILMN_2043060,"Homo sapiens phospholipase C, eta 1 (PLCH1), mRNA.",,lipid metabolism [goid 6629] [evidence IEA]; intracellular signaling cascade [goid 7242] [evidence IEA],phosphoinositide phospholipase C activity [goid 4435] [evidence IEA]; calcium ion binding [goid 5509] [evidence IEA],3,156680640-156680689,3q25.31a,-,NM_014996.1,23007,PLCH1,1.0920446764109304,6.69173245109855,7.811125706604025,2.4985360225067186e-12,1.4541210991201737e-11,17.145776596279088
CCL5,ILMN_1773352,"Homo sapiens chemokine (C-C motif) ligand 5 (CCL5), mRNA.",extracellular space [goid 5615] [evidence IEA]; extracellular region [goid 5576] [evidence IEA]; extracellular space [goid 5615] [evidence IEA]; extracellular region [goid 5576] [evidence IEA],exocytosis [goid 6887] [pmid 10734056] [evidence TAS]; inflammatory response [goid 6954] [pmid 10415069] [evidence TAS]; signal transduction [goid 7165] [pmid 10770925] [evidence TAS]; cellular defense response [goid 6968] [pmid 10640778] [evidence TAS]; calcium ion homeostasis [goid 6874] [pmid 10713092] [evidence TAS]; chemotaxis [goid 6935] [pmid 10713092] [evidence TAS]; cell-cell signaling [goid 7267] [pmid 10734056] [evidence TAS]; response to virus [goid 9615] [pmid 10640778] [evidence TAS]; cell adhesion [goid 7155] [pmid 10910894] [evidence TAS]; response to oxidative stress [goid 6979] [pmid 10713092] [evidence TAS]; cell motility [goid 6928] [pmid 9558100] [evidence TAS]; exocytosis [goid 6887] [pmid 10734056] [evidence TAS]; inflammatory response [goid 6954] [pmid 10415069] [evidence TAS]; signal transduction [goid 7165] [pmid 10770925] [evidence TAS]; cellular defense response [goid 6968] [pmid 10640778] [evidence TAS]; calcium ion homeostasis [goid 6874] [pmid 10713092] [evidence TAS]; chemotaxis [goid 6935] [pmid 10713092] [evidence TAS]; cell-cell signaling [goid 7267] [pmid 10734056] [evidence TAS]; response to virus [goid 9615] [pmid 10640778] [evidence TAS]; cell adhesion [goid 7155] [pmid 10910894] [evidence TAS]; response to oxidative stress [goid 6979] [pmid 10713092] [evidence TAS]; cell motility [goid 6928] [pmid 9558100] [evidence TAS],chemokine activity [goid 8009] [pmid 10770925] [evidence TAS]; signal transducer activity [goid 4871] [pmid 10770925] [evidence TAS]; chemoattractant activity [goid 42056] [pmid 15001559] [evidence IDA]; chemokine activity [goid 8009] [pmid 10770925] [evidence TAS]; signal transducer activity [goid 4871] [pmid 10770925] [evidence TAS]; chemoattractant activity [goid 42056] [pmid 15001559] [evidence IDA],17,31223411-31223460,17q12b,-,NM_002985.2,6352,CCL5,-1.0336412272240771,11.253315771659437,-7.808976125908222,2.52685204795625e-12,1.468845827996048e-11,17.134628225927838
MTMR12,ILMN_1802831,"Homo sapiens myotubularin related protein 12 (MTMR12), mRNA.",,phospholipid dephosphorylation [goid 46839] [evidence IEA],inositol or phosphatidylinositol phosphatase activity [goid 4437] [evidence IEA],5,32263512-32263561,5p13.3c,-,NM_019061.2,54545,MTMR12,-1.2832017805104385,6.909863433187382,-7.808044940432018,2.5392170720010544e-12,1.474994804366689e-11,17.129799122988643
FLJ46266,ILMN_1766038,"Homo sapiens FLJ46266 protein (FLJ46266), mRNA.",,,,11,110912756-110912805,11q23.1b,+,NM_207430.1,399949,FLJ46266,-2.52617103409798,6.842603043647848,-7.795506008108586,2.7116886021562774e-12,1.571134475557986e-11,17.064790513042563
MGC4728,ILMN_1685365,"Homo sapiens zinc finger protein 773 (ZNF773), mRNA.",nucleus [goid 5634] [evidence IEA]; intracellular [goid 5622] [evidence IEA],"regulation of transcription, DNA-dependent [goid 6355] [evidence IEA]",zinc ion binding [goid 8270] [evidence IEA]; metal ion binding [goid 46872] [evidence IEA]; nucleic acid binding [goid 3676] [evidence IEA],19,62710919-62710968,19q13.43b,+,NM_198542.1,374928,MGC4728,1.1328689214222134,8.972924768335401,7.793456029682763,2.7409714551896357e-12,1.586214101703892e-11,17.05416550267024
C1orf87,ILMN_1669805,"Homo sapiens chromosome 1 open reading frame 87 (C1orf87), mRNA.",,,calcium ion binding [goid 5509] [evidence IEA]; calcium ion binding [goid 5509] [evidence IEA],1,60229061-60229093:60235869-60235885,1p32.1b,-,NM_152377.1,127795,C1orf87,-1.601380889078233,5.868467042114446,-7.786920238668436,2.8364439504516905e-12,1.6370885774452367e-11,17.02029658520002
VMO1,ILMN_1735910,"Homo sapiens vitelline membrane outer layer 1 homolog (chicken) (VMO1), mRNA.",,,,17,4635486-4635535,17p13.2c,-,NM_182566.1,284013,VMO1,-1.21684432947424,7.522469376999427,-7.780555307872231,2.9325919753846382e-12,1.6895787888932488e-11,16.987321874471693
NFIA,ILMN_1758049,"Homo sapiens nuclear factor I/A (NFIA), mRNA.",nucleus [goid 5634] [pmid 7590749] [evidence NAS]; intracellular [goid 5622] [evidence IEA],"transcription [goid 6350] [evidence IEA]; DNA replication [goid 6260] [evidence IEA]; regulation of transcription, DNA-dependent [goid 6355] [pmid 7590749] [evidence NAS]; viral genome replication [goid 19079] [pmid 7590749] [evidence NAS]; electron transport [goid 6118] [evidence IEA]",heme binding [goid 20037] [evidence IEA]; transcription factor activity [goid 3700] [pmid 7590749] [evidence NAS]; electron carrier activity [goid 9055] [evidence IEA]; iron ion binding [goid 5506] [evidence IEA],1,61694189-61694238,1p31.3d,+,NM_005595.1,4774,NFIA,-1.1780249899955537,8.431195938623057,-7.778556406496401,2.9634496197500596e-12,1.7063479858401274e-11,16.976967988357803
SLC5A8,ILMN_1811221,"Homo sapiens solute carrier family 5 (iodide transporter), member 8 (SLC5A8), mRNA.",membrane [goid 16020] [evidence IEA]; integral to membrane [goid 16021] [evidence IEA],ion transport [goid 6811] [evidence IEA]; sodium ion transport [goid 6814] [evidence IEA],transporter activity [goid 5215] [evidence IEA],12,100073632-100073681,12q23.2a,-,NM_145913.2,160728,SLC5A8,1.8954218148262711,8.976616858622112,7.768737700397813,3.1197677218133966e-12,1.791590747407428e-11,16.926121661459156
LOC642477,ILMN_1769704,"PREDICTED: Homo sapiens hypothetical protein LOC642477, transcript variant 1 (LOC642477), mRNA.",,,,14,18957521-18957570,14q11.1d,-,XM_925855.1,642477,LOC642477,1.1544329597375755,5.858048848731493,7.758904631805571,3.284515007159698e-12,1.883424806195018e-11,16.87522182996167
RHBDL2,ILMN_2053536,"Homo sapiens rhomboid, veinlet-like 2 (Drosophila) (RHBDL2), mRNA.",membrane [goid 16020] [evidence IEA]; integral to membrane [goid 16021] [evidence IEA]; membrane [goid 16020] [evidence IEA]; integral to membrane [goid 16021] [evidence IEA],,serine-type endopeptidase activity [goid 4252] [evidence IEA]; peptidase activity [goid 8233] [evidence IEA]; serine-type endopeptidase activity [goid 4252] [evidence IEA]; peptidase activity [goid 8233] [evidence IEA],1,39124491-39124540,1p34.3a,-,NM_017821.3,54933,RHBDL2,1.4511787689526008,8.755741106855455,7.758765935481988,3.2868994968901916e-12,1.8842376197971577e-11,16.87450403304793
ZNF557,ILMN_2346137,"Homo sapiens zinc finger protein 557 (ZNF557), transcript variant 2, mRNA.",nucleus [goid 5634] [evidence IEA]; intracellular [goid 5622] [evidence IEA],"regulation of transcription, DNA-dependent [goid 6355] [evidence IEA]; transcription [goid 6350] [evidence IEA]",zinc ion binding [goid 8270] [evidence IEA]; metal ion binding [goid 46872] [evidence IEA]; DNA binding [goid 3677] [evidence IEA],,,19p13.2e,,NM_001044387.1,79230,ZNF557,1.640928680475394,9.354327422141179,7.758065834359402,3.2989620034767874e-12,1.8905963128748586e-11,16.87088085418417
PRF1,ILMN_1740633,"Homo sapiens perforin 1 (pore forming protein) (PRF1), mRNA.",cytosol [goid 5829] [evidence NR ]; membrane [goid 16020] [evidence IEA]; integral to membrane [goid 16021] [evidence IEA],cellular defense response [goid 6968] [pmid 10779745] [evidence TAS]; virus-infected cell apoptosis [goid 6926] [evidence NR ]; pathogenesis [goid 9405] [pmid 1505959] [evidence TAS]; hemolysis of host red blood cells [goid 19836] [evidence NR ]; cytolysis [goid 19835] [evidence IEA],calcium ion binding [goid 5509] [evidence IEA],10,72027389-72027438,10q22.1b,-,NM_005041.3,5551,PRF1,-1.376296467529472,7.976320155669452,-7.737391706841939,3.675676359815262e-12,2.0966204294789337e-11,16.76393574771655
FLJ12078,ILMN_1775444,"PREDICTED: Homo sapiens hypothetical protein FLJ12078 (FLJ12078), misc RNA.",,,,,,,,XR_001261.1,80042,FLJ12078,1.2564629102812779,6.838493957968916,7.736957863693473,3.684022809827987e-12,2.1007662993707442e-11,16.761692522272597
FLJ90805,ILMN_1789112,"Homo sapiens hypothetical protein FLJ90805 (FLJ90805), mRNA.",,,,19,47520974-47521023,19q13.2c,+,NM_173633.1,284339,FLJ90805,1.250480559176765,6.051789993091528,7.736209396955346,3.6984663614995885e-12,2.1083855194212837e-11,16.75782260389007
LRRFIP1,ILMN_2214997,"Homo sapiens leucine rich repeat (in FLII) interacting protein 1 (LRRFIP1), mRNA.",nucleus [goid 5634] [evidence IEA],"regulation of transcription, DNA-dependent [goid 6355] [evidence IEA]; transcription [goid 6350] [evidence IEA]",DNA binding [goid 3677] [evidence IEA],2,238338330-238338379,2q37.3b,+,NM_004735.2,9208,LRRFIP1,1.7339875779068432,12.001784604334157,7.734799443340864,3.725827810535202e-12,2.1227413710022925e-11,16.750532826640843
EGFL6,ILMN_1716309,"Homo sapiens EGF-like-domain, multiple 6 (EGFL6), mRNA.",membrane [goid 16020] [evidence IEA]; extracellular space [goid 5615] [pmid 10610727] [evidence TAS]; membrane [goid 16020] [evidence IEA]; extracellular space [goid 5615] [pmid 10610727] [evidence TAS],cell cycle [goid 7049] [pmid 10610727] [evidence TAS]; cell cycle [goid 7049] [pmid 10610727] [evidence TAS],integrin binding [goid 5178] [pmid 10610727] [evidence TAS]; calcium ion binding [goid 5509] [evidence IEA]; integrin binding [goid 5178] [pmid 10610727] [evidence TAS]; calcium ion binding [goid 5509] [evidence IEA],X,13555228-13555277,Xp22.2,+,NM_015507.2,25975,EGFL6,-1.0523295625586346,7.691685422405393,-7.734500573948696,3.7316534042673675e-12,2.1254389530005746e-11,16.748987660662227
RNASE1,ILMN_1795183,"Homo sapiens ribonuclease, RNase A family, 1 (pancreatic) (RNASE1), transcript variant 3, mRNA.",extracellular region [goid 5576] [evidence NR ],,pancreatic ribonuclease activity [goid 4522] [pmid 8049276] [evidence TAS]; RNA binding [goid 3723] [evidence NR ]; hydrolase activity [goid 16787] [evidence IEA]; endonuclease activity [goid 4519] [evidence IEA],14,20339551-20339596:20339597-20339600,14q11.2b,-,NM_198232.1,6035,RNASE1,-1.1277296163195398,12.31974651094761,-7.733367303980168,3.753825477758398e-12,2.1368182715197893e-11,16.743128790371106
FOS,ILMN_1669523,"Homo sapiens v-fos FBJ murine osteosarcoma viral oncogene homolog (FOS), mRNA.",nucleus [goid 5634] [pmid 9443941] [evidence TAS],DNA methylation [goid 6306] [pmid 9888853] [evidence TAS]; inflammatory response [goid 6954] [pmid 9443941] [evidence TAS]; regulation of transcription from RNA polymerase II promoter [goid 6357] [pmid 10918580] [evidence TAS],protein dimerization activity [goid 46983] [evidence IEA]; sequence-specific DNA binding [goid 43565] [evidence IEA]; specific RNA polymerase II transcription factor activity [goid 3704] [pmid 10918580] [evidence TAS]; transcription factor activity [goid 3700] [evidence IEA],14,74818114-74818163,14q24.3b,+,NM_005252.2,2353,FOS,-1.7046105001267389,12.006723696887294,-7.719456719742755,4.036872176527223e-12,2.2879131576391198e-11,16.67123573465878
TMC5,ILMN_1730117,"Homo sapiens transmembrane channel-like 5 (TMC5), mRNA.",integral to membrane [goid 16021] [evidence IEA],,,16,19417350-19417399,16p12.3a,+,NM_024780.3,79838,TMC5,1.3041347882951992,7.631102974071673,7.715179766104327,4.128082445116201e-12,2.3366560420521835e-11,16.64914004214746
CHD8,ILMN_1806122,"Homo sapiens chromodomain helicase DNA binding protein 8 (CHD8), mRNA.",chromatin [goid 785] [evidence IEA]; nucleus [goid 5634] [evidence NAS],"regulation of transcription, DNA-dependent [goid 6355] [evidence NAS]; chromatin modification [goid 16568] [evidence IEA]; chromatin assembly or disassembly [goid 6333] [evidence IEA]",nucleotide binding [goid 166] [evidence IEA]; hydrolase activity [goid 16787] [evidence IEA]; DNA binding [goid 3677] [evidence IEA]; helicase activity [goid 4386] [evidence IEA]; transcription regulator activity [goid 30528] [evidence NAS]; ATP binding [goid 5524] [evidence IEA]; chromatin binding [goid 3682] [evidence IEA],14,20923549-20923598,14q11.2c,-,NM_020920.1,57680,CHD8,1.0483826049888396,9.897579001481773,7.71244628976869,4.1874448689343974e-12,2.3670543449720548e-11,16.63502041497412
DNHD3,ILMN_1714296,"Homo sapiens dynein, axonemal, heavy chain 2 (DNAH2), mRNA.",dynein complex [goid 30286] [evidence IEA],microtubule-based movement [goid 7018] [evidence IEA]; transport [goid 6810] [evidence IEA],ATP binding [goid 5524] [evidence IEA]; ATPase activity [goid 16887] [evidence IEA]; microtubule motor activity [goid 3777] [evidence IEA]; nucleotide binding [goid 166] [evidence IEA],17,7677666-7677715,17p13.1d,+,NM_020877.2,146754,DNHD3,1.9527253378392881,7.966328700068175,7.708995511037955,4.263596076581501e-12,2.4073071443694743e-11,16.617197963409602
C7orf10,ILMN_1763011,"Homo sapiens chromosome 7 open reading frame 10 (C7orf10), mRNA.",,metabolism [goid 8152] [evidence IEA],transferase activity [goid 16740] [evidence IEA],7,40866633-40866682,7p14.1c,+,NM_024728.1,79783,C7orf10,1.1209115744911786,6.9410236606205995,7.703422175857654,4.389500299661984e-12,2.4755257116907022e-11,16.58841859137798
FBP1,ILMN_1728799,"Homo sapiens fructose-1,6-bisphosphatase 1 (FBP1), mRNA.",,fructose metabolism [goid 6000] [pmid 7558035] [evidence TAS]; gluconeogenesis [goid 6094] [evidence IEA]; carbohydrate metabolism [goid 5975] [evidence IEA],"fructose-bisphosphatase activity [goid 42132] [evidence IEA]; hydrolase activity [goid 16787] [evidence IEA]; zinc ion binding [goid 8270] [evidence IEA]; phosphoric ester hydrolase activity [goid 42578] [evidence IEA]; fructose-2,6-bisphosphate 2-phosphatase activity [goid 4331] [pmid 8387495] [evidence TAS]",9,96405486-96405535,9q22.32a,-,NM_000507.2,2203,FBP1,-1.0176921591767112,12.073639741020072,-7.7025035399392845,4.4106040276724466e-12,2.4867077395601163e-11,16.583675637335993
CD1C,ILMN_1654210,"Homo sapiens CD1C antigen, c polypeptide (CD1C), mRNA.",integral to plasma membrane [goid 5887] [pmid 1702817] [evidence TAS]; plasma membrane [goid 5886] [pmid 2701945] [evidence TAS],antimicrobial humoral response (sensu Vertebrata) [goid 19735] [pmid 9601940] [evidence TAS],,1,156529893-156529942,1q23.1e,+,NM_001765.1,911,CD1C,-1.073256826676996,7.33946221705837,-7.69883440527473,4.495903692621946e-12,2.5326014296252854e-11,16.56473362076811
MAP3K13,ILMN_1673896,"Homo sapiens mitogen-activated protein kinase kinase kinase 13 (MAP3K13), mRNA.",membrane fraction [goid 5624] [pmid 9353328] [evidence IDA]; membrane [goid 16020] [evidence IEA]; IkappaB kinase complex [goid 8385] [pmid 12492477] [evidence IPI],JNK cascade [goid 7254] [pmid 11726277] [evidence IPI]; activation of MAPKK activity [goid 186] [pmid 11726277] [evidence IDA]; activation of NF-kappaB transcription factor [goid 51092] [pmid 12492477] [evidence IDA],transferase activity [goid 16740] [evidence IEA]; protein-tyrosine kinase activity [goid 4713] [evidence IEA]; protein homodimerization activity [goid 42803] [pmid 11163770] [evidence IDA]; protein kinase binding [goid 19901] [pmid 9353328] [evidence ISS]; ATP binding [goid 5524] [evidence IEA]; protein serine/threonine kinase activity [goid 4674] [pmid 9353328] [evidence IDA]; protein binding [goid 5515] [pmid 12492477] [evidence IPI]; MAP kinase kinase kinase activity [goid 4709] [pmid 11726277] [evidence IDA]; nucleotide binding [goid 166] [evidence IEA]; magnesium ion binding [goid 287] [evidence IEA],3,186683021-186683070,3q27.2a,+,NM_004721.3,9175,MAP3K13,1.0624865106262327,6.7536784483230985,7.694663294899108,4.5948631603356814e-12,2.5868508719774847e-11,16.543203782454338
IHPK2,ILMN_1683328,"Homo sapiens inositol hexaphosphate kinase 2 (IHPK2), transcript variant 4, mRNA.",nucleus [goid 5634] [evidence ISS],positive regulation of apoptosis [goid 43065] [pmid 11337497] [evidence IMP]; negative regulation of cell growth [goid 30308] [pmid 11337497] [evidence IMP],transferase activity [goid 16740] [evidence IEA]; polyphosphate kinase activity [goid 8976] [pmid 10574768] [evidence TAS]; inositol hexakisphosphate kinase activity [goid 50517] [pmid 11337497] [evidence NAS],3,48706676-48706677:48707527-48707574,3p21.31e,-,NM_001005911.1,51447,IHPK2,-1.1295533761861805,7.007365936598801,-7.6829094087976815,4.885503489601668e-12,2.744926052332425e-11,16.482555171297502
SNORA33,ILMN_2096747,"Homo sapiens small nucleolar RNA, H/ACA box 33 (SNORA33) on chromosome 6.",,,,6,133180116-133180165,6q23.2b,+,NR_002436.1,594839,SNORA33,1.016523397126984,6.372472358254066,7.6807966041454225,4.939648698140495e-12,2.773747979344886e-11,16.471656639679647
BATF,ILMN_1668822,"Homo sapiens basic leucine zipper transcription factor, ATF-like (BATF), mRNA.",nucleus [goid 5634] [evidence IEA],"antimicrobial humoral response (sensu Vertebrata) [goid 19735] [pmid 8630063] [evidence TAS]; transcription [goid 6350] [evidence IEA]; regulation of transcription, DNA-dependent [goid 6355] [evidence IEA]",RNA polymerase II transcription factor activity [goid 3702] [pmid 8570175] [evidence TAS]; sequence-specific DNA binding [goid 43565] [evidence IEA]; protein dimerization activity [goid 46983] [evidence IEA]; transcription factor activity [goid 3700] [pmid 8630063] [evidence TAS],14,75082963-75083012,14q24.3b,+,NM_006399.2,10538,BATF,1.1944538427820586,8.138579783975286,7.674744749397738,5.0980585273762824e-12,2.8585804433360246e-11,16.440444760214316
DRD4,ILMN_2112915,"Homo sapiens dopamine receptor D4 (DRD4), mRNA.",plasma membrane [goid 5886] [pmid 1319557] [evidence TAS]; integral to membrane [goid 16021] [evidence IEA]; integral to plasma membrane [goid 5887] [pmid 1319557] [evidence TAS]; membrane [goid 16020] [pmid 8746407] [evidence NAS],synaptic transmission [goid 7268] [pmid 8413587] [evidence TAS]; G-protein coupled receptor protein signaling pathway [goid 7186] [evidence IEA]; signal transduction [goid 7165] [evidence IEA]; dopamine receptor signaling pathway [goid 7212] [pmid 8746407] [evidence NAS],receptor activity [goid 4872] [evidence IEA]; dopamine receptor activity [goid 4952] [pmid 8746407] [evidence NAS]; rhodopsin-like receptor activity [goid 1584] [evidence IEA],11,630535-630584,11p15.5d,+,NM_000797.2,1815,DRD4,1.0830137464416882,6.364127567852453,7.6727070653789635,5.152522119758574e-12,2.8882880754745634e-11,16.429937448174307
LOC644940,ILMN_1750748,"PREDICTED: Homo sapiens similar to Keratin, type I cytoskeletal 16 (Cytokeratin-16) (CK-16) (Keratin-16) (K16) (LOC644940), mRNA.",,,,17,20345444-20345493,,-,XM_930405.1,644940,LOC644940,2.436474939288301,8.517003326762762,7.668805515546942,5.258419616782798e-12,2.9442616733624374e-11,16.40982172833174
MBD4,ILMN_2055310,"Homo sapiens methyl-CpG binding domain protein 4 (MBD4), mRNA.",nucleus [goid 5634] [pmid 9774669] [evidence TAS],base-excision repair [goid 6284] [evidence IEA],hydrolase activity [goid 16787] [evidence IEA]; satellite DNA binding [goid 3696] [pmid 9774669] [evidence TAS]; endodeoxyribonuclease activity [goid 4520] [pmid 10097147] [evidence TAS]; DNA binding [goid 3677] [evidence IEA]; protein binding [goid 5515] [pmid 14667819] [evidence IPI],3,130632633-130632682,3q21.3d,-,NM_003925.1,8930,MBD4,1.6884943866146536,11.994763568534218,7.667357704423773,5.298263746264407e-12,2.965718733006664e-11,16.402357936866192
C1GALT1,ILMN_1662578,"Homo sapiens core 1 synthase, glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase, 1 (C1GALT1), mRNA.",,,"transferase activity, transferring glycosyl groups [goid 16757] [evidence IEA]; glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase activity [goid 16263] [evidence IEA]",7,7250130-7250179,7p21.3e,+,NM_020156.1,56913,C1GALT1,1.242936956699375,6.665035032882333,7.6525993729281385,5.721903854103032e-12,3.190022792480617e-11,16.326302482108893
CEP27,ILMN_1738482,"Homo sapiens centrosomal protein 27kDa (CEP27), mRNA.",centrosome [goid 5813] [pmid 14654843] [evidence IDA],,,15,40646836-40646885,15q15.1d,+,NM_018097.1,55142,CEP27,1.5190386307578017,10.183001294571664,7.6465812219661355,5.904152270157199e-12,3.2878653039157766e-11,16.295302787059093
LOC653774,ILMN_1793367,"PREDICTED: Homo sapiens similar to phosphodiesterase 4C, cAMP-specific (phosphodiesterase E1 dunce homolog, Drosophila) (LOC653774), mRNA.",,,,19,18223890-18223939,,-,XM_933803.1,653774,LOC653774,1.2245647677917377,5.727763738601951,7.626588306672768,6.551952507387808e-12,3.633033426478413e-11,16.192377984877428
LOC388654,ILMN_1659550,"PREDICTED: Homo sapiens similar to laminin receptor 1 (ribosomal protein SA) (LOC388654), mRNA.",,,,4,81301307-81301356,,+,XM_371273.3,388654,LOC388654,-1.076415012518673,12.274330109670117,-7.620950921605984,6.747032550926934e-12,3.738013342474021e-11,16.163372936708612
LOC91461,ILMN_1734445,"Homo sapiens hypothetical protein BC007901 (LOC91461), mRNA.",,protein amino acid phosphorylation [goid 6468] [evidence IEA],ATP binding [goid 5524] [evidence IEA]; protein-tyrosine kinase activity [goid 4713] [evidence IEA]; nucleotide binding [goid 166] [evidence IEA],2,42138814-42138863,2p21f,+,NM_138370.1,91461,LOC91461,-1.1284654272581713,7.297348455189439,-7.61717028700252,6.8810774687168675e-12,3.810110670018419e-11,16.143925201252554
FLJ40113,ILMN_1740620,"Homo sapiens golgi autoantigen, golgin subfamily a-like (FLJ40113), mRNA.",,,,15,82856078-82856121:82856122-82856127,15q25.2b,-,NM_198079.1,374650,FLJ40113,1.233475830941683,6.947520680382578,7.61285489163632,7.037314239348652e-12,3.8921960815699255e-11,16.121730666320573
COL3A1,ILMN_1773079,"Homo sapiens collagen, type III, alpha 1 (Ehlers-Danlos syndrome type IV, autosomal dominant) (COL3A1), mRNA.",collagen type III [goid 5586] [pmid 1672129] [evidence TAS]; cytoplasm [goid 5737] [evidence IEA]; collagen [goid 5581] [evidence IEA],phosphate transport [goid 6817] [evidence IEA]; circulation [goid 8015] [pmid 2243125] [evidence TAS],extracellular matrix structural constituent [goid 5201] [evidence IEA],2,189585339-189585388,2q32.2a,+,NM_000090.2,1281,COL3A1,1.5043999138309374,11.623599708375586,7.612241138692333,7.0598188688407104e-12,3.90353492222932e-11,16.11857441949841
LOC440704,ILMN_1673421,"PREDICTED: Homo sapiens hypothetical gene supported by BC042042 (LOC440704), mRNA.",,,,,,,,XM_944716.1,440704,LOC440704,1.4403355668877165,11.447010913384329,7.6103003296957645,7.131453903273617e-12,3.9409069570415894e-11,16.108594312027652
FLJ90166,ILMN_1689431,"Homo sapiens adenomatosis polyposis coli down-regulated 1-like (APCDD1L), mRNA.",,,,20,56467866-56467915,20q13.32a,-,NM_153360.1,164284,FLJ90166,1.0411694652200536,5.594921244711468,7.600306033681961,7.511918013581479e-12,4.1429301583536686e-11,16.057215052485844
LOC90639,ILMN_1656656,"Homo sapiens hypothetical protein LOC90639 (LOC90639), mRNA.",,,,7,972327-972376,7p22.3c,-,NM_001031617.1,90639,LOC90639,1.1676729580338296,9.171418166374597,7.5992647398383335,7.552698221552571e-12,4.164242355601354e-11,16.051863242076937
MT2A,ILMN_1686664,"Homo sapiens metallothionein 2A (MT2A), mRNA.",,copper ion homeostasis [goid 6878] [pmid 6719135] [evidence TAS],zinc ion binding [goid 8270] [evidence IEA]; metal ion binding [goid 46872] [evidence IEA]; copper ion binding [goid 5507] [evidence NR ],16,55200021-55200068:55200069-55200070,16q13b,+,NM_005953.2,4502,MT2A,-1.285889041727227,12.795434823901337,-7.597545533518512,7.620508697369914e-12,4.2004416398374196e-11,16.04302779976225
TEKT1,ILMN_1654570,"Homo sapiens tektin 1 (TEKT1), mRNA.",microtubule [goid 5874] [evidence IEA],microtubule cytoskeleton organization and biogenesis [goid 226] [evidence IEA],structural molecule activity [goid 5198] [evidence IEA],17,6644051-6644069:6644070-6644100,17p13.2a,-,NM_053285.1,83659,TEKT1,-2.503278536352754,7.238273292842996,-7.596893222903337,7.646395474158525e-12,4.212327277748907e-11,16.0396755881232
MMP1,ILMN_1726448,"Homo sapiens matrix metallopeptidase 1 (interstitial collagenase) (MMP1), mRNA.",extracellular space [goid 5615] [evidence NR ]; extracellular matrix (sensu Metazoa) [goid 5578] [evidence IEA],peptidoglycan metabolism [goid 270] [evidence IEA]; collagen catabolism [goid 30574] [evidence IEA],zinc ion binding [goid 8270] [pmid 2167156] [evidence TAS]; interstitial collagenase activity [goid 4232] [evidence IEA]; calcium ion binding [goid 5509] [evidence IEA],11,102165974-102166023,11q22.2b,-,NM_002421.2,4312,MMP1,1.5714300844148825,6.074488530471376,7.595912207667433,7.6854911458091e-12,4.232668032111089e-11,16.034634356274097
ATHL1,ILMN_1794707,"Homo sapiens ATH1, acid trehalase-like 1 (yeast) (ATHL1), mRNA.",,,,11,285278-285327,11p15.5d,+,NM_025092.1,80162,ATHL1,1.8543821666538225,9.100948390396182,7.586797172314211,8.058359340229114e-12,4.434259580467785e-11,15.987804824933757
G6PD,ILMN_1697559,"Homo sapiens glucose-6-phosphate dehydrogenase (G6PD), nuclear gene encoding mitochondrial protein, mRNA.",cellular component unknown [goid 8372] [evidence ND ],glucose metabolism [goid 6006] [evidence IEA]; glucose 6-phosphate utilization [goid 6010] [pmid 2836867] [evidence TAS]; pentose-phosphate shunt [goid 6098] [evidence NAS]; carbohydrate metabolism [goid 5975] [evidence IEA],glucose-6-phosphate 1-dehydrogenase activity [goid 4345] [pmid 8466644] [evidence NAS]; oxidoreductase activity [goid 16491] [evidence IEA],X,153413077-153413126,Xq28g,-,NM_000402.2,2539,G6PD,1.017218527544994,9.068210155491112,7.582837477227988,8.225877904606582e-12,4.518782942522111e-11,15.967467487333629
CXCL5,ILMN_1752562,"Homo sapiens chemokine (C-X-C motif) ligand 5 (CXCL5), mRNA.",extracellular space [goid 5615] [evidence IEA],cell-cell signaling [goid 7267] [pmid 7929219] [evidence TAS]; chemotaxis [goid 6935] [pmid 10820279] [evidence TAS]; positive regulation of cell proliferation [goid 8284] [pmid 10463948] [evidence TAS]; signal transduction [goid 7165] [pmid 10820279] [evidence TAS]; inflammatory response [goid 6954] [evidence NR ],chemokine activity [goid 8009] [pmid 10820279] [evidence TAS],4,75080983-75081032,4q13.3d,-,NM_002994.3,6374,CXCL5,-1.5784677892809587,6.066655268152684,-7.581640597681766,8.277189570813537e-12,4.5456888046026433e-11,15.961320932377564
SCIN,ILMN_1813561,"Homo sapiens scinderin (SCIN), mRNA.",cytoskeleton [goid 5856] [evidence IEA]; cell cortex [goid 5938] [evidence ISS]; cytoplasm [goid 5737] [evidence ISS],calcium ion-dependent exocytosis [goid 17156] [evidence ISS]; positive regulation of apoptosis [goid 43065] [pmid 11568009] [evidence IMP]; barbed-end actin filament capping [goid 51016] [evidence IEA]; positive regulation of secretion [goid 51047] [evidence ISS]; negative regulation of cell proliferation [goid 8285] [pmid 11568009] [evidence IMP]; actin nucleation [goid 45010] [evidence ISS]; actin filament severing [goid 51014] [pmid 11568009] [evidence IMP]; positive regulation of megakaryocyte differentiation [goid 45654] [pmid 11568009] [evidence IMP],"actin filament binding [goid 51015] [evidence ISS]; phosphatidylserine binding [goid 1786] [evidence ISS]; phosphatidylinositol binding [goid 5545] [pmid 11568009] [evidence TAS]; phosphatidylinositol-4,5-bisphosphate binding [goid 5546] [evidence ISS]; calcium ion binding [goid 5509] [pmid 11568009] [evidence TAS]",7,12658795-12658844,7p21.3a,+,NM_033128.1,85477,SCIN,1.6056591736297197,8.417684660143317,7.581551198336116,8.281034947036416e-12,4.5465191868978464e-11,15.960861836995502
KIT,ILMN_1790160,"Homo sapiens v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog (KIT), mRNA.",membrane [goid 16020] [evidence IEA]; integral to membrane [goid 16021] [evidence IEA]; membrane [goid 16020] [evidence IEA]; integral to membrane [goid 16021] [evidence IEA],signal transduction [goid 7165] [pmid 9990072] [evidence TAS]; protein amino acid dephosphorylation [goid 6470] [evidence NR ]; protein amino acid phosphorylation [goid 6468] [evidence IEA]; transmembrane receptor protein tyrosine kinase signaling pathway [goid 7169] [evidence IEA]; signal transduction [goid 7165] [pmid 9990072] [evidence TAS]; protein amino acid dephosphorylation [goid 6470] [evidence NR ]; protein amino acid phosphorylation [goid 6468] [evidence IEA]; transmembrane receptor protein tyrosine kinase signaling pathway [goid 7169] [evidence IEA],receptor activity [goid 4872] [evidence IEA]; ATP binding [goid 5524] [evidence IEA]; nucleotide binding [goid 166] [evidence IEA]; vascular endothelial growth factor receptor activity [goid 5021] [evidence IEA]; transferase activity [goid 16740] [evidence IEA]; receptor signaling protein tyrosine kinase activity [goid 4716] [pmid 9438854] [evidence TAS]; receptor activity [goid 4872] [evidence IEA]; ATP binding [goid 5524] [evidence IEA]; nucleotide binding [goid 166] [evidence IEA]; vascular endothelial growth factor receptor activity [goid 5021] [evidence IEA]; transferase activity [goid 16740] [evidence IEA]; receptor signaling protein tyrosine kinase activity [goid 4716] [pmid 9438854] [evidence TAS],4,55301107-55301156,4q12c,+,NM_000222.1,3815,KIT,-1.2342014687419418,9.263175867097646,-7.574339765064574,8.597132083640352e-12,4.714751439620947e-11,15.923834901315
HNRPU,ILMN_1743677,"Homo sapiens heterogeneous nuclear ribonucleoprotein U (scaffold attachment factor A) (HNRPU), transcript variant 1, mRNA.",heterogeneous nuclear ribonucleoprotein complex [goid 30530] [pmid 7509195] [evidence TAS]; ribonucleoprotein complex [goid 30529] [evidence IEA],RNA processing [goid 6396] [pmid 1628625] [evidence TAS],nucleotide binding [goid 166] [evidence IEA]; RNA binding [goid 3723] [pmid 1628625] [evidence TAS]; ATP binding [goid 5524] [evidence IEA]; DNA binding [goid 3677] [pmid 1628625] [evidence TAS],1,243080265-243080314,1q44b,-,NM_031844.2,3192,HNRPU,1.1386788185359151,9.913135347509602,7.570889494627835,8.752571485923522e-12,4.7972955106390946e-11,15.906123888149388
ACE2,ILMN_1667018,"Homo sapiens angiotensin I converting enzyme (peptidyl-dipeptidase A) 2 (ACE2), mRNA.",integral to membrane [goid 16021] [evidence IEA]; extracellular region [goid 5576] [pmid 10969042] [evidence IDA]; membrane [goid 16020] [evidence IEA],,peptidyl-dipeptidase A activity [goid 4246] [evidence IEA]; viral receptor activity [goid 1618] [pmid 14647384] [evidence NAS]; zinc ion binding [goid 8270] [evidence IEA]; metal ion binding [goid 46872] [evidence IEA]; carboxypeptidase activity [goid 4180] [pmid 10969042] [evidence IDA]; protein binding [goid 5515] [pmid 14647384] [evidence NAS],X,15489259-15489308,Xp22.2,-,NM_021804.1,59272,ACE2,1.3906060943140863,6.228839675944134,7.5659693093295965,8.97906613093054e-12,4.9172879022254517e-11,15.880872318750246
FLJ14213,ILMN_1697491,"Homo sapiens hypothetical protein FLJ14213 (FLJ14213), mRNA.",,,,11,36443132-36443181,11p13a-p12d,+,NM_024841.2,79899,FLJ14213,-1.0295025576583354,8.015334393882176,-7.5641138578281915,9.065980917596858e-12,4.962096578072325e-11,15.871351178940102
HLA-DPB1,ILMN_1749070,"Homo sapiens major histocompatibility complex, class II, DP beta 1 (HLA-DPB1), mRNA.",membrane [goid 16020] [evidence IEA]; integral to membrane [goid 16021] [evidence IEA],immune response [goid 6955] [evidence IEA]; pathogenesis [goid 9405] [pmid 8105536] [evidence TAS],MHC class II receptor activity [goid 45012] [pmid 8105536] [evidence TAS],6,33162730-33162779,6p21.32a,+,NM_002121.4,3115,HLA-DPB1,-1.129078195132518,8.818615797109965,-7.551850590550203,9.66178817369571e-12,5.2714394196133514e-11,15.808443407918002
ARPC1B,ILMN_2085760,"Homo sapiens actin related protein 2/3 complex, subunit 1B, 41kDa (ARPC1B), mRNA.",Arp2/3 protein complex [goid 5885] [pmid 9230079] [evidence TAS]; membrane [goid 16020] [evidence IEA],cell motility [goid 6928] [pmid 9230079] [evidence TAS]; cell adhesion [goid 7155] [evidence IEA],structural constituent of cytoskeleton [goid 5200] [pmid 9230079] [evidence TAS],7,98821298-98821337:98822244-98822253,7q22.1b,+,NM_005720.2,10095,ARPC1B,-1.2272605733372224,9.325735731994268,-7.549521102019766,9.779278347868823e-12,5.333032146885643e-11,15.796497688200699
FLJ23878,ILMN_1777637,"Homo sapiens schlafen-like 1 (SLFNL1), mRNA.",,,,1,41253923-41253972,1p34.2c,-,NM_144990.2,200172,FLJ23878,-1.103561952042976,6.1477869886434,-7.54758821511162,9.877840370794383e-12,5.385274751676792e-11,15.786586737167113
HMOX1,ILMN_1800512,"Homo sapiens heme oxygenase (decycling) 1 (HMOX1), mRNA.",microsome [goid 5792] [evidence IEA]; endoplasmic reticulum [goid 5783] [pmid 3345742] [evidence TAS]; membrane fraction [goid 5624] [pmid 3345742] [evidence TAS],heme oxidation [goid 6788] [evidence IEA]; positive regulation of I-kappaB kinase/NF-kappaB cascade [goid 43123] [pmid 12761501] [evidence IMP],oxidoreductase activity [goid 16491] [evidence IEA]; heme oxygenase (decyclizing) activity [goid 4392] [pmid 9884342] [evidence TAS]; signal transducer activity [goid 4871] [pmid 12761501] [evidence IMP]; iron ion binding [goid 5506] [evidence IEA]; metal ion binding [goid 46872] [evidence IEA],22,34119915-34119964,22q12.3c,+,NM_002133.1,3162,HMOX1,-1.092984436058603,8.488451613065806,-7.537480954768767,1.040950165457547e-11,5.657716589662567e-11,15.73477585249255
LOC648852,ILMN_1677691,"PREDICTED: Homo sapiens hypothetical protein LOC648852 (LOC648852), mRNA.",,,,,,,,XM_940430.1,648852,LOC648852,2.146296407597344,11.320025523399218,7.533917125716192,1.0603655176117193e-11,5.7600284668704636e-11,15.716513096695468
GZMA,ILMN_1779324,"Homo sapiens granzyme A (granzyme 1, cytotoxic T-lymphocyte-associated serine esterase 3) (GZMA), mRNA.",nucleus [goid 5634] [pmid 11909973] [evidence TAS]; immunological synapse [goid 1772] [pmid 12524539] [evidence TAS],cytolysis [goid 19835] [evidence IEA]; immune response [goid 6955] [pmid 12524539] [evidence TAS]; cleavage of lamin [goid 6922] [pmid 11331782] [evidence IDA]; apoptosis [goid 6915] [pmid 12524539] [evidence TAS],protein homodimerization activity [goid 42803] [pmid 12819770] [evidence IDA]; granzyme A activity [goid 4277] [pmid 12819770] [evidence IDA]; peptidase activity [goid 8233] [evidence IEA],5,54441606-54441655,5q11.2d,+,NM_006144.2,3001,GZMA,-1.194343800047415,8.806958145814031,-7.53273940638058,1.0668602244753506e-11,5.7920789840908905e-11,15.710478569569997
CCL4L1,ILMN_1716276,"Homo sapiens chemokine (C-C motif) ligand 4-like 1 (CCL4L1), mRNA.",,,,17,31563350-31563399,17q12b,+,NM_001001435.2,9560,CCL4L1,-1.4394482036759975,8.052874654198403,-7.531376417372817,1.0744258909978266e-11,5.829904897268909e-11,15.703495151499101
MUC16,ILMN_2125346,"Homo sapiens mucin 16, cell surface associated (MUC16), mRNA.",extrinsic to membrane [goid 19898] [pmid 12766047] [evidence IDA],cell adhesion [goid 7155] [pmid 14676194] [evidence NAS],protein binding [goid 5515] [pmid 14676194] [evidence IPI],19,8820577-8820607:8820608-8820626,19p13.2d,-,NM_024690.2,94025,MUC16,2.2108985354040867,6.932790130844506,7.528683864378222,1.0895284168320248e-11,5.906917418467447e-11,15.689700878595634
LOC644037,ILMN_1732074,"PREDICTED: Homo sapiens similar to Heterogeneous nuclear ribonucleoprotein A1 (Helix-destabilizing protein) (Single-strand binding protein) (hnRNP core protein A1) (HDP-1) (Topoisomerase-inhibitor suppressed), transcript variant 2 (LOC644037), mRNA.",,,,5,79691601-79691650,5q14.1e,-,XM_933604.1,644037,LOC644037,-1.2156934112321096,12.142853060776842,-7.526443331400867,1.102255905508998e-11,5.969276353208123e-11,15.678223682305294
C14orf124,ILMN_1771629,"Homo sapiens chromosome 14 open reading frame 124 (C14orf124), mRNA.",,nucleotide-sugar metabolism [goid 9225] [evidence IEA],catalytic activity [goid 3824] [evidence IEA]; NAD binding [goid 51287] [evidence IEA],14,23981413-23981462,14q12a,-,NM_020195.1,56948,C14orf124,-1.083527249304046,6.616259890843225,-7.519111575950677,1.1449439972700298e-11,6.19013146137806e-11,15.640674968052377
OR11L1,ILMN_1785650,"Homo sapiens olfactory receptor, family 11, subfamily L, member 1 (OR11L1), mRNA.",,,,1,246071016-246071065,1q44e,-,NM_001001959.1,391189,OR11L1,-1.0627616562051667,7.7353350789110475,-7.517918632565997,1.1520431547607578e-11,6.226785262278326e-11,15.63456667208942
C9orf130,ILMN_1738678,"PREDICTED: Homo sapiens chromosome 9 open reading frame 130 (C9orf130), mRNA.",,,,,,,,XM_939697.1,286354,C9orf130,1.6339111819030663,8.926955272984094,7.517090831029481,1.1569950060212513e-11,6.251815777128142e-11,15.630328233967642
C9orf24,ILMN_1763695,"Homo sapiens chromosome 9 open reading frame 24 (C9orf24), transcript variant 2, mRNA.",,,,9,34369170-34369179:34369644-34369683,9p13.3c,-,NM_147168.1,84688,C9orf24,-2.999429120883752,8.522934145864584,-7.516492688089492,1.1605861861084868e-11,6.267744411397967e-11,15.627265776654092
C6,ILMN_1688242,"Homo sapiens complement component 6 (C6), mRNA.",membrane [goid 16020] [evidence IEA]; integral to membrane [goid 16021] [evidence IEA]; membrane attack complex [goid 5579] [evidence IEA]; extracellular space [goid 5615] [evidence NR ],"innate immune response [goid 45087] [evidence IEA]; cytolysis [goid 19835] [evidence IEA]; complement activation, classical pathway [goid 6958] [evidence IEA]",,5,41178489-41178538,5p13.1a,-,NM_000065.1,729,C6,-2.0414147064127457,7.012574013897591,-7.509689700857868,1.2022165803472799e-11,6.478205217938814e-11,15.59244094114549
RICS,ILMN_1722726,"Homo sapiens Rho GTPase-activating protein (RICS), mRNA.",intracellular [goid 5622] [evidence IEA],signal transduction [goid 7165] [evidence IEA],GTPase activator activity [goid 5096] [evidence IEA],11,128343563-128343612,11q24.3a-q24.3b,-,NM_014715.2,9743,RICS,1.0002388153272177,8.561604857523097,7.50323658032048,1.2430733241913877e-11,6.683577185946244e-11,15.559417417246188
C6orf141,ILMN_1761762,"Homo sapiens chromosome 6 open reading frame 141 (C6orf141), mRNA.",,,,6,49630741-49630790,6p12.3b,+,NM_153344.1,135398,C6orf141,1.191860095790557,6.023293371515026,7.500206923039588,1.2627270985565399e-11,6.785504003136839e-11,15.543916772467522
CHMP5,ILMN_1732534,"Homo sapiens chromatin modifying protein 5 (CHMP5), mRNA.",,protein transport [goid 15031] [evidence IEA]; protein transport [goid 15031] [evidence IEA],,9,33268139-33268188,9p13.3e,+,NM_016410.2,51510,CHMP5,-1.0215951569042137,9.205792938007566,-7.491348086997993,1.3219807109488129e-11,7.080482175051572e-11,15.49860505715366
LOC644591,ILMN_1710362,"PREDICTED: Homo sapiens similar to peptidylprolyl isomerase A (cyclophilin A)-like 4 (LOC644591), mRNA.",,,,1,142556030-142556079,1q21.1a,-,XM_927706.1,644591,LOC644591,1.0690318434051953,6.516601098636838,7.490609068038273,1.3270465761201352e-11,7.105661592663048e-11,15.494825939713778
LOC644250,ILMN_1654320,"PREDICTED: Homo sapiens hypothetical protein LOC644250 (LOC644250), mRNA.",,,,13,47980580-47980629,,-,XM_929199.1,644250,LOC644250,1.6015181181725247,10.81772751785595,7.486979381352705,1.3522083467392459e-11,7.238400998959947e-11,15.476266759893836
C11orf9,ILMN_1811437,"Homo sapiens chromosome 11 open reading frame 9 (C11orf9), mRNA.",,,,11,61312296-61312345,11q12.2b,+,NM_013279.1,745,C11orf9,-1.4064030080905496,6.9188972362613494,-7.486080446048578,1.3585126975351798e-11,7.268154835659795e-11,15.471670853026787
LOC643882,ILMN_1746919,"PREDICTED: Homo sapiens hypothetical protein LOC643882 (LOC643882), mRNA.",,,,12,8382616-8382665,,+,XM_931879.1,643882,LOC643882,1.8780101872182335,8.35045471998294,7.472819661804636,1.4549703419477282e-11,7.767149893931914e-11,15.403896546121285
SUSD4,ILMN_2360307,"Homo sapiens sushi domain containing 4 (SUSD4), transcript variant 2, mRNA.",,,,1,221504747-221504783:221508467-221508479,1q41e,-,NM_001037175.1,55061,SUSD4,1.2296550476562098,6.201166051892223,7.472217778302006,1.4595059341607603e-11,7.789228465385487e-11,15.400821411376974
C20orf85,ILMN_1661618,"Homo sapiens chromosome 20 open reading frame 85 (C20orf85), mRNA.",,,,20,56169276-56169284:56169285-56169325,20q13.32a,+,NM_178456.2,128602,C20orf85,-2.648547119496647,7.285359031451784,-7.470548382693357,1.472159434370783e-11,7.847275203049843e-11,15.392292623717363
ST6GALNAC2,ILMN_1658706,"Homo sapiens ST6 (alpha-N-acetyl-neuraminyl-2,3-beta-galactosyl-1, 3)-N-acetylgalactosaminide alpha-2,6-sialyltransferase 2 (ST6GALNAC2), mRNA.",integral to Golgi membrane [goid 30173] [evidence IEA]; membrane [goid 16020] [evidence IEA]; integral to membrane [goid 16021] [evidence IEA],protein amino acid glycosylation [goid 6486] [evidence IEA],sialyltransferase activity [goid 8373] [evidence IEA],17,72073145-72073194,17q25.1d,-,NM_006456.1,10610,ST6GALNAC2,-1.0933056128743521,7.220793792251176,-7.454445468641131,1.599938133372148e-11,8.513051482456664e-11,15.31005950848818
SELL,ILMN_1724422,"Homo sapiens selectin L (lymphocyte adhesion molecule 1) (SELL), mRNA.",integral to plasma membrane [goid 5887] [pmid 1692315] [evidence TAS]; plasma membrane [goid 5886] [pmid 10882119] [evidence TAS],cell adhesion [goid 7155] [pmid 10747985] [evidence TAS]; cell motility [goid 6928] [evidence NR ],protein binding [goid 5515] [evidence IEA]; sugar binding [goid 5529] [evidence IEA],1,167926921-167926970,1q24.2c,-,NM_000655.2,6402,SELL,-1.352509715480081,6.914756689573587,-7.4504885360659925,1.6329838911365805e-11,8.684140589191123e-11,15.289862338585166
KIAA0492,ILMN_1745841,"PREDICTED: Homo sapiens KIAA0492 protein (KIAA0492), mRNA.",,,,,,1q25.1a,,XM_944290.1,57238,KIAA0492,1.5928895992328043,6.762264413428856,7.446195912451371,1.6695986463250803e-11,8.871592479859337e-11,15.267956098921278
LOC650611,ILMN_1656509,"PREDICTED: Homo sapiens similar to Keratin, type I cytoskeletal 16 (Cytokeratin-16) (CK-16) (Keratin-16) (K16), transcript variant 1 (LOC650611), mRNA.",,,,,,,,XM_940706.1,650611,LOC650611,1.3059362166867077,6.636815470828045,7.440592410263307,1.7186219708094812e-11,9.129593539046549e-11,15.23936701945755
CFH,ILMN_1657803,"Homo sapiens complement factor H (CFH), transcript variant 2, mRNA.",extracellular space [goid 5615] [pmid 9312129] [evidence TAS]; extracellular space [goid 5615] [pmid 9312129] [evidence TAS]; extracellular space [goid 5615] [pmid 9312129] [evidence TAS],"innate immune response [goid 45087] [evidence IEA]; complement activation, alternative pathway [goid 6957] [evidence IEA]; innate immune response [goid 45087] [evidence IEA]; complement activation, alternative pathway [goid 6957] [evidence IEA]; innate immune response [goid 45087] [evidence IEA]; complement activation, alternative pathway [goid 6957] [evidence IEA]",,1,194937229-194937278,1q31.3c,+,NM_001014975.1,3075,CFH,-1.0196553955616592,8.207076298340848,-7.420330332000741,1.9080975241030156e-11,1.0086619711651453e-10,15.136055082602741
FAM73A,ILMN_2123557,"Homo sapiens family with sequence similarity 73, member A (FAM73A), mRNA.",,,,1,78116356-78116405,1p31.1e,+,NM_198549.1,374986,FAM73A,1.1227948138736759,8.321686351812954,7.415483462307321,1.956407697627997e-11,1.0330786988694178e-10,15.111357156529373
TESC,ILMN_1750181,"Homo sapiens tescalcin (TESC), mRNA.",,,calcium ion binding [goid 5509] [evidence IEA]; protein binding [goid 5515] [pmid 16189514] [evidence IPI],12,115961343-115961392,12q24.22a-q24.22b,-,NM_017899.1,54997,TESC,1.5111390468682622,9.635698839774548,7.413519499081035,1.9763265138952723e-11,1.0427490420592847e-10,15.101351175538763
FLJ25778,ILMN_1685855,"PREDICTED: Homo sapiens hypothetical protein FLJ25778 (FLJ25778), mRNA.",,,,,,7q34b,,XM_939098.1,254048,FLJ25778,1.1943327302007747,7.44603040895067,7.406676195951229,2.0473158241608224e-11,1.0784522528730367e-10,15.0664935547508
RPL39L,ILMN_1712413,"Homo sapiens ribosomal protein L39-like (RPL39L), mRNA.",ribosome [goid 5840] [evidence IEA]; cytosolic large ribosomal subunit (sensu Eukaryota) [goid 5842] [pmid 12490704] [evidence NAS]; intracellular [goid 5622] [evidence IEA]; ribosome [goid 5840] [evidence IEA]; cytosolic large ribosomal subunit (sensu Eukaryota) [goid 5842] [pmid 12490704] [evidence NAS]; intracellular [goid 5622] [evidence IEA],protein biosynthesis [goid 6412] [evidence IEA]; spermatogenesis [goid 7283] [pmid 12490704] [evidence IEP]; protein biosynthesis [goid 6412] [evidence IEA]; spermatogenesis [goid 7283] [pmid 12490704] [evidence IEP],structural constituent of ribosome [goid 3735] [evidence IEA]; structural constituent of ribosome [goid 3735] [evidence IEA],3,188339722-188339771,3q27.3b,-,NM_052969.1,116832,RPL39L,1.0837966741279406,8.187613390593963,7.401736148637783,2.1001269041950017e-11,1.1050762281458172e-10,15.041337845843085
ET,ILMN_1756152,"Homo sapiens major facilitator superfamily domain containing 11 (MFSD11), mRNA.",,,,17,72286774-72286823,17q25.2a,+,NM_024311.2,79157,ET,1.187578753910186,10.406926321284443,7.401369134326008,2.1041038910642856e-11,1.1065712366366424e-10,15.03946918120343
LOC654204,ILMN_1788540,"PREDICTED: Homo sapiens similar to pleckstrin homology-like domain, family B, member 1 (LOC654204), mRNA.",,,,,,,,XM_940949.1,654204,LOC654204,1.0037074833683617,6.98409479751078,7.400006687075725,2.1189328429059837e-11,1.1137687198279767e-10,15.03253253661282
MYEOV,ILMN_2198413,"Homo sapiens myeloma overexpressed gene (in a subset of t(11;14) positive multiple myelomas) (MYEOV), mRNA.",,,,11,68820979-68821028,11q13.2c,+,NM_138768.2,26579,MYEOV,1.6080262263417353,5.834530727226356,7.398844906872845,2.1316595167192646e-11,1.1198540221966802e-10,15.026617920964604
SLC7A10,ILMN_1681087,"Homo sapiens solute carrier family 7, (neutral amino acid transporter, y+ system) member 10 (SLC7A10), mRNA.",integral to plasma membrane [goid 5887] [pmid 10863037] [evidence NAS]; membrane [goid 16020] [pmid 10734121] [evidence TAS],neutral amino acid transport [goid 15804] [pmid 10863037] [evidence IDA]; transport [goid 6810] [evidence IEA]; amino acid transport [goid 6865] [evidence IEA],L-serine transporter activity [goid 15194] [pmid 10863037] [evidence TAS]; amino acid-polyamine transporter activity [goid 5279] [evidence IEA],19,38391632-38391636:38391637-38391681,19q13.11b,-,NM_019849.1,56301,SLC7A10,1.306836419519148,5.676733011471384,7.391447011299822,2.2144954989205714e-11,1.1602432050676884e-10,14.988963288407671
ACP5,ILMN_2078599,"Homo sapiens acid phosphatase 5, tartrate resistant (ACP5), mRNA.",lysosome [goid 5764] [evidence IEA]; integral to membrane [goid 16021] [pmid 2338077] [evidence TAS],,metal ion binding [goid 46872] [evidence IEA]; iron ion binding [goid 5506] [evidence IEA]; hydrolase activity [goid 16787] [evidence IEA]; acid phosphatase activity [goid 3993] [pmid 8359686] [evidence TAS],19,11546718-11546767,19p13.2a,-,NM_001611.2,54,ACP5,-1.5167621771282533,8.89415298240351,-7.386415054018093,2.272654693121782e-11,1.188877110569847e-10,14.963358995144102
C9orf9,ILMN_1813837,"Homo sapiens chromosome 9 open reading frame 9 (C9orf9), mRNA.",,,,9,134753552-134753601,9q34.13b,+,NM_018956.3,11092,C9orf9,-1.213088824199831,7.382093426122798,-7.385961409828799,2.2779716981154217e-11,1.1912581464782338e-10,14.961051016518002
EBF,ILMN_1778681,"Homo sapiens early B-cell factor 1 (EBF1), mRNA.",nucleus [goid 5634] [evidence IEA],"regulation of transcription, DNA-dependent [goid 6355] [evidence IEA]; development [goid 7275] [evidence IEA]",zinc ion binding [goid 8270] [evidence IEA]; metal ion binding [goid 46872] [evidence IEA]; transcription regulator activity [goid 30528] [evidence IEA]; DNA binding [goid 3677] [evidence IEA]; protein binding [goid 5515] [pmid 14594818] [evidence IDA],5,158058476-158058525,5q33.3c,-,NM_024007.2,1879,EBF,-1.0024756284944845,7.104312507665299,-7.374258545732291,2.4194803260135045e-11,1.26153529976915e-10,14.901529144045142
TUBB2B,ILMN_1680874,"Homo sapiens tubulin, beta 2B (TUBB2B), mRNA.",microtubule [goid 5874] [evidence IEA]; protein complex [goid 43234] [evidence IEA]; cytoplasm [goid 5737] [evidence IEA],microtubule-based movement [goid 7018] [evidence IEA]; protein polymerization [goid 51258] [evidence IEA],GTP binding [goid 5525] [evidence IEA]; structural molecule activity [goid 5198] [evidence IEA]; GTPase activity [goid 3924] [evidence IEA]; nucleotide binding [goid 166] [evidence IEA],6,3169836-3169885,6p25.2b,-,NM_178012.3,347733,TUBB2B,1.9807809848212763,7.489832148140209,7.370912267103388,2.461521039879987e-11,1.2813982757697447e-10,14.884516073264596
G0S2,ILMN_1691846,"Homo sapiens G0/G1switch 2 (G0S2), mRNA.",,cell cycle [goid 7049] [evidence IEA],,1,207915967-207916016,1q32.2b,+,NM_015714.2,50486,G0S2,-1.4264908191588654,7.306318964990406,-7.365727206611752,2.5280973719951863e-11,1.3153531987537038e-10,14.858159964545404
ANKRD44,ILMN_1755049,"Homo sapiens ankyrin repeat domain 44 (ANKRD44), mRNA.",,,,2,197568143-197568192,2q33.1a,-,NM_153697.1,91526,ANKRD44,1.0652859495036706,6.519577884298101,7.363769938672093,2.5536900684980992e-11,1.3276054158133794e-10,14.848212792274538
CD247,ILMN_1676924,"Homo sapiens CD247 molecule (CD247), transcript variant 1, mRNA.",plasma membrane [goid 5886] [pmid 11390434] [evidence IDA]; integral to membrane [goid 16021] [evidence IEA]; membrane [goid 16020] [evidence IEA]; cytoplasm [goid 5737] [pmid 11390434] [evidence IDA]; plasma membrane [goid 5886] [pmid 11390434] [evidence IDA]; integral to membrane [goid 16021] [evidence IEA]; membrane [goid 16020] [evidence IEA]; cytoplasm [goid 5737] [pmid 11390434] [evidence IDA],cell surface receptor linked signal transduction [goid 7166] [evidence IEA]; cell surface receptor linked signal transduction [goid 7166] [evidence IEA],protein homodimerization activity [goid 42803] [pmid 12110186] [evidence NAS]; transmembrane receptor activity [goid 4888] [evidence IEA]; receptor signaling protein activity [goid 5057] [evidence NR ]; protein binding [goid 5515] [pmid 11891219] [evidence IPI]; protein homodimerization activity [goid 42803] [pmid 12110186] [evidence NAS]; transmembrane receptor activity [goid 4888] [evidence IEA]; receptor signaling protein activity [goid 5057] [evidence NR ]; protein binding [goid 5515] [pmid 11891219] [evidence IPI],1,165666606-165666655,1q24.2a,-,NM_198053.1,919,CD247,-1.0107631489877331,9.308984622499947,-7.361414430857944,2.584830672191145e-11,1.343078017270519e-10,14.83624299826668
KIAA0408,ILMN_1661519,"Homo sapiens KIAA0408 (KIAA0408), mRNA.",,,,6,127803433-127803482,6q22.33a,-,NM_014702.3,9729,KIAA0408,1.4397824271346495,7.750650731796172,7.36053369132201,2.5965707556335286e-11,1.3488184796992618e-10,14.83176778073176
CACHD1,ILMN_1738854,"Homo sapiens cache domain containing 1 (CACHD1), mRNA.",membrane [goid 16020] [evidence IEA],,,1,64930924-64930973,1p31.3c-p31.3b,+,NM_020925.1,57685,CACHD1,-1.105164628176774,7.338329339343617,-7.358381759981317,2.6254783299501793e-11,1.363108053799074e-10,14.820834215376276
TNFRSF12A,ILMN_1689004,"Homo sapiens tumor necrosis factor receptor superfamily, member 12A (TNFRSF12A), mRNA.",integral to membrane [goid 16021] [evidence IEA]; membrane [goid 16020] [evidence IEA],angiogenesis [goid 1525] [evidence IEA]; cell motility [goid 6928] [pmid 10551889] [evidence TAS]; apoptosis [goid 6915] [evidence IEA]; cell adhesion [goid 7155] [evidence IEA]; cell differentiation [goid 30154] [evidence IEA],receptor activity [goid 4872] [evidence IEA]; protein binding [goid 5515] [evidence IEA],16,3012033-3012082,16p13.3d,+,NM_016639.1,51330,TNFRSF12A,1.1832353347122062,9.959306257219739,7.351953919228233,2.7137382420374577e-11,1.407431185682722e-10,14.788182630775605
LOC441124,ILMN_1778111,"PREDICTED: Homo sapiens hypothetical LOC441124 (LOC441124), mRNA.",,,,1,222205319-222205368,1q42.11a,-,XM_499022.2,441124,LOC441124,1.3731751194642001,8.104719470827463,7.3514840168693985,2.7203045520113682e-11,1.4100915816371027e-10,14.78579607874396
LOC440160,ILMN_1715693,"PREDICTED: Homo sapiens hypothetical LOC440160 (LOC440160), mRNA.",,,,,,,,XM_498571.2,440160,LOC440160,1.2866177200480298,6.435385465226677,7.343202299710308,2.8386496875098783e-11,1.469086033496148e-10,14.743744026187812
WDRPUH,ILMN_1802539,"Homo sapiens WD40-repeat protein upregulated in HCC (WDRPUH), mRNA.",cytoskeleton [goid 5856] [evidence IEA],,,17,9487118-9487167,17p13.1b,+,NM_145054.2,146845,WDRPUH,-1.8792308555338,6.1657588352623325,-7.333560566981468,2.982869048956037e-11,1.5382883017193322e-10,14.69480855748164
HIST2H2AC,ILMN_1768973,"Homo sapiens histone cluster 2, H2ac (HIST2H2AC), mRNA.",chromosome [goid 5694] [evidence IEA]; nucleus [goid 5634] [evidence IEA]; nucleosome [goid 786] [evidence NAS],nucleosome assembly [goid 6334] [evidence NAS]; chromosome organization and biogenesis (sensu Eukaryota) [goid 7001] [evidence NAS],DNA binding [goid 3677] [evidence NAS],1,148125457-148125506,1q21.2a,+,NM_003517.2,8338,HIST2H2AC,1.126765439081602,10.109793127074466,7.330641619125645,3.02794500478222e-11,1.5591836262732968e-10,14.679998535447012
GJB1,ILMN_1799535,"Homo sapiens gap junction protein, beta 1, 32kDa (GJB1), mRNA.",integral to membrane [goid 16021] [evidence IEA]; connexon complex [goid 5922] [pmid 2875078] [evidence TAS],cell-cell signaling [goid 7267] [pmid 8266101] [evidence TAS]; transport [goid 6810] [pmid 2875078] [evidence TAS],connexon channel activity [goid 15285] [pmid 2875078] [evidence TAS],X,70361613-70361662,Xq13.1c,+,NM_000166.2,2705,GJB1,1.0772232180002277,5.978380693926074,7.328450932840414,3.062217515748566e-11,1.5764150143820556e-10,14.668884986459663
CXCL13,ILMN_1718552,"Homo sapiens chemokine (C-X-C motif) ligand 13 (B-cell chemoattractant) (CXCL13), mRNA.",extracellular space [goid 5615] [evidence IEA]; soluble fraction [goid 5625] [pmid 9486651] [evidence TAS],sensory perception [goid 7600] [evidence IEA]; cell-cell signaling [goid 7267] [pmid 9486651] [evidence TAS]; chemotaxis [goid 6935] [pmid 9486651] [evidence TAS]; inflammatory response [goid 6954] [evidence IEA],chemokine activity [goid 8009] [pmid 9486651] [evidence TAS],4,78751655-78751704,4q21.1c,+,NM_006419.1,10563,CXCL13,1.6386635819050115,6.533723982837244,7.324305527069945,3.128126138804253e-11,1.6086444395513554e-10,14.647858383726774
RAMP1,ILMN_1764754,"Homo sapiens receptor (G protein-coupled) activity modifying protein 1 (RAMP1), mRNA.",plasma membrane [goid 5886] [pmid 9620797] [evidence TAS]; integral to plasma membrane [goid 5887] [pmid 9620797] [evidence TAS],intracellular protein transport [goid 6886] [evidence IEA]; regulation of G-protein coupled receptor protein signaling pathway [goid 8277] [pmid 9620797] [evidence TAS]; transport [goid 6810] [evidence IEA],receptor activity [goid 4872] [evidence IEA]; protein transporter activity [goid 8565] [pmid 9620797] [evidence TAS],2,238485302-238485351,2q37.3b,+,NM_005855.2,10267,RAMP1,1.2854109958377036,8.04522300935141,7.314448986062928,3.2905351167578214e-11,1.689043117756221e-10,14.597881360421322
LOC388886,ILMN_1737255,"Homo sapiens similar to hypothetical protein LOC192734 (LOC388886), mRNA.",,,,22,23311759-23311808,22q11.23b,-,NM_207644.1,388886,LOC388886,1.0640906967030093,7.946854298660557,7.310071253619757,3.365321541896832e-11,1.7256129011542044e-10,14.575692457967634
RNF39,ILMN_1730223,"Homo sapiens ring finger protein 39 (RNF39), transcript variant 1, mRNA.",ubiquitin ligase complex [goid 151] [evidence IEA],protein ubiquitination [goid 16567] [evidence IEA],ubiquitin-protein ligase activity [goid 4842] [evidence IEA]; metal ion binding [goid 46872] [evidence IEA]; zinc ion binding [goid 8270] [evidence IEA],6,30146148-30146197,6p21.33b,-,NM_025236.2,80352,RNF39,1.1505362743166545,6.737181896228295,7.306033626405011,3.4357895417507677e-11,1.7603565401265765e-10,14.555231855267628
DEFA3,ILMN_1725661,"Homo sapiens defensin, alpha 3, neutrophil-specific (DEFA3), mRNA.",extracellular region [goid 5576] [evidence IEA]; extracellular region [goid 5576] [evidence IEA],xenobiotic metabolism [goid 6805] [evidence IEA]; response to virus [goid 9615] [evidence IEA]; xenobiotic metabolism [goid 6805] [evidence IEA]; response to virus [goid 9615] [evidence IEA],,8,6863176-6863225,8p23.1f,-,NM_005217.2,1668,DEFA3,-1.768336294570684,5.716077956479507,-7.303224367728534,3.4856795313513854e-11,1.784979386816866e-10,14.540998509572944
DSG2,ILMN_1704196,"Homo sapiens desmoglein 2 (DSG2), mRNA.",intercellular junction [goid 5911] [pmid 8143788] [evidence TAS]; membrane [goid 16020] [evidence IEA]; cytoskeleton [goid 5856] [evidence IEA]; integral to membrane [goid 16021] [evidence IEA],homophilic cell adhesion [goid 7156] [evidence IEA]; cell adhesion [goid 7155] [evidence IEA],calcium ion binding [goid 5509] [evidence IEA]; protein binding [goid 5515] [evidence IEA],18,27380565-27380614,18q12.1d,+,NM_001943.1,1829,DSG2,1.083139315859598,7.608949522088207,7.3004997501022775,3.5347518028644885e-11,1.808207899155016e-10,14.52719598410954
HEY2,ILMN_1682034,"Homo sapiens hairy/enhancer-of-split related with YRPW motif 2 (HEY2), mRNA.",nucleus [goid 5634] [evidence IEA],"regulation of transcription, DNA-dependent [goid 6355] [evidence IEA]",transcription regulator activity [goid 30528] [evidence IEA]; transcription factor activity [goid 3700] [pmid 10415358] [evidence TAS]; DNA binding [goid 3677] [evidence IEA],6,126122702-126122751,6q22.31e,+,NM_012259.1,23493,HEY2,-1.0277132951322079,6.948523228232828,-7.297403776928664,3.59134360064906e-11,1.8366753296232788e-10,14.511514592447973
LOC653490,ILMN_1731063,"PREDICTED: Homo sapiens similar to suppression of tumorigenicity 5 (LOC653490), mRNA.",,,,11,8728844-8728848:8789370-8789414,,-,XM_932255.1,653490,LOC653490,1.0710297692829114,6.4293826812775805,7.294465741761721,3.64587819532331e-11,1.8630982595298896e-10,14.496635503941935
HLA-DRB3,ILMN_1717261,"Homo sapiens major histocompatibility complex, class II, DR beta 3 (HLA-DRB3), mRNA.",integral to plasma membrane [goid 5887] [evidence NR ]; membrane [goid 16020] [evidence NAS]; integral to membrane [goid 16021] [evidence IEA],immune response [goid 6955] [evidence NAS]; signal transduction [goid 7165] [pmid 8775462] [evidence NAS],MHC class II receptor activity [goid 45012] [evidence NAS],,,,,NM_022555.3,3125,HLA-DRB3,-1.2531980155487688,11.886591217416889,-7.291540644483859,3.7009875124466315e-11,1.890268458191943e-10,14.481824195890002
FLJ37396,ILMN_1771618,"Homo sapiens hypothetical protein FLJ37396 (FLJ37396), mRNA.",,,,6,109698391-109698410:109698621-109698650,6q21f,+,NM_173671.1,285754,FLJ37396,1.2309472326906032,6.599583650122307,7.289922044412059,3.7318360492666844e-11,1.9045265955987778e-10,14.473629340991
FLJ90586,ILMN_1683470,"Homo sapiens transmembrane protein 139 (TMEM139), mRNA.",,,,7,142695101-142695150,7q34f,+,NM_153345.1,135932,FLJ90586,-1.3106089289366931,6.907654322165302,-7.286952816462106,3.789089615748025e-11,1.9317219037899076e-10,14.45859815294099
SULF1,ILMN_1702363,"Homo sapiens sulfatase 1 (SULF1), mRNA.",endoplasmic reticulum [goid 5783] [evidence IEA]; extracellular space [goid 5615] [pmid 12368295] [evidence NAS]; cell surface [goid 9986] [pmid 12368295] [evidence IDA],metabolism [goid 8152] [evidence IEA]; apoptosis [goid 6915] [evidence IEA]; heparan sulfate proteoglycan metabolism [goid 30201] [pmid 12368295] [evidence NAS],hydrolase activity [goid 16787] [evidence IEA]; arylsulfatase activity [goid 4065] [pmid 12368295] [evidence IDA],8,70735259-70735308,8q13.2c-q13.3a,+,NM_015170.1,23213,SULF1,1.4183986404373297,8.98179307182442,7.286040237313926,3.806860443262613e-11,1.9397666249208161e-10,14.453978851310055
GRAMD2,ILMN_1661443,"Homo sapiens GRAM domain containing 2 (GRAMD2), mRNA.",,,,15,70239566-70239615,15q23b,-,NM_001012642.1,196996,GRAMD2,-1.1403504042849288,8.364430962726274,-7.283047202616802,3.865725860906148e-11,1.96667541513724e-10,14.438830225781544
GNLY,ILMN_1708779,"Homo sapiens granulysin (GNLY), transcript variant NKG5, mRNA.",extracellular space [goid 5615] [pmid 2212946] [evidence TAS],cellular defense response [goid 6968] [pmid 9756476] [evidence TAS]; xenobiotic metabolism [goid 6805] [evidence IEA],,2,85775009-85775052:85775053-85775058,2p11.2f,+,NM_006433.2,10578,GNLY,-1.161562478922816,7.087031506558443,-7.273291730819348,4.0639215332709834e-11,2.061585812959779e-10,14.389471395773679
LOC441294,ILMN_2231608,"Homo sapiens similar to CTAGE6 (LOC441294), mRNA.",,,,7,142981292-142981341,7q35a,+,NM_001008747.1,441294,LOC441294,1.0476219969270772,6.353330333614334,7.2618982463396025,4.308168199758622e-11,2.1786830358758563e-10,14.331856882815657
IRS2,ILMN_2083469,"Homo sapiens insulin receptor substrate 2 (IRS2), mRNA.",,positive regulation of cell proliferation [goid 8284] [evidence NR ]; signal transduction [goid 7165] [pmid 7675087] [evidence TAS]; glucose metabolism [goid 6006] [pmid 9495343] [evidence TAS],insulin receptor binding [goid 5158] [evidence IEA]; signal transducer activity [goid 4871] [pmid 9495343] [evidence TAS]; receptor activity [goid 4872] [evidence IEA],13,109204764-109204813,13q34a,-,NM_003749.2,8660,IRS2,-1.0249985944360613,8.970975607314694,-7.253632338445196,4.4944159510864225e-11,2.2699246969133993e-10,14.290079555979762
GP9,ILMN_1743290,"Homo sapiens glycoprotein IX (platelet) (GP9), mRNA.",plasma membrane [goid 5886] [pmid 10429193] [evidence TAS]; integral to plasma membrane [goid 5887] [pmid 2771955] [evidence TAS],blood coagulation [goid 7596] [pmid 9432024] [evidence TAS]; cell adhesion [goid 7155] [pmid 2771955] [evidence NAS],transferase activity [goid 16740] [evidence IEA]; protein binding [goid 5515] [evidence IEA],3,130263874-130263923,3q21.3c,+,NM_000174.2,2815,GP9,-1.1522340707827095,5.555886888997706,-7.253110435052441,4.506439598856866e-11,2.2748180203037836e-10,14.287442379354818
NOV,ILMN_1787186,"Homo sapiens nephroblastoma overexpressed gene (NOV), mRNA.",extracellular region [goid 5576] [evidence IEA],regulation of cell growth [goid 1558] [evidence IEA],growth factor activity [goid 8083] [evidence IEA]; insulin-like growth factor binding [goid 5520] [evidence IEA],8,120505381-120505430,8q24.12b,+,NM_002514.2,4856,NOV,-1.286461456623135,7.212168477758046,-7.232766321529712,5.000799565789804e-11,2.515751229470102e-10,14.18470060295639
RAXL1,ILMN_1653412,"Homo sapiens retina and anterior neural fold homeobox like 1 (RAXL1), mRNA.",nucleus [goid 5634] [evidence IEA],"regulation of transcription, DNA-dependent [goid 6355] [evidence IEA]",sequence-specific DNA binding [goid 43565] [evidence IEA]; transcription factor activity [goid 3700] [evidence IEA],19,3720269-3720318,19p13.3e,-,NM_032753.2,84839,RAXL1,1.4930018406989518,9.799223488682612,7.229301648102303,5.0901864629175866e-11,2.5588824362731985e-10,14.167214428320793
NES,ILMN_1738147,"Homo sapiens nestin (NES), mRNA.",intermediate filament [goid 5882] [pmid 9917366] [evidence NAS],central nervous system development [goid 7417] [pmid 9917366] [evidence NAS],structural molecule activity [goid 5198] [evidence IEA],1,154905342-154905391,1q23.1a,-,NM_006617.1,10763,NES,-1.0701636276769602,8.956668337654625,-7.223478564773778,5.24399747833154e-11,2.6348450455206305e-10,14.13783269166137
GJA1,ILMN_1727087,"Homo sapiens gap junction protein, alpha 1, 43kDa (connexin 43) (GJA1), mRNA.",membrane [goid 16020] [evidence IEA]; connexon complex [goid 5922] [pmid 1850831] [evidence TAS]; integral to plasma membrane [goid 5887] [pmid 15709751] [evidence TAS],cell-cell signaling [goid 7267] [pmid 7715640] [evidence TAS]; transport [goid 6810] [pmid 1696265] [evidence TAS]; gap junction assembly [goid 16264] [pmid 15709751] [evidence TAS]; heart development [goid 7507] [pmid 7715640] [evidence TAS]; positive regulation of I-kappaB kinase/NF-kappaB cascade [goid 43123] [pmid 12761501] [evidence IMP]; muscle contraction [goid 6936] [pmid 7715640] [evidence TAS],connexon channel activity [goid 15285] [pmid 1850831] [evidence TAS]; signal transducer activity [goid 4871] [pmid 12761501] [evidence IMP]; protein binding [goid 5515] [evidence ISS]; ion transporter activity [goid 15075] [pmid 1696265] [evidence TAS],6,121812181-121812230,6q22.31c,+,NM_000165.2,2697,GJA1,-1.253066701098783,9.545805905610994,-7.213020180908006,5.5318901097006354e-11,2.774488514479199e-10,14.085085532579239
SLN,ILMN_1778595,"Homo sapiens sarcolipin (SLN), mRNA.",sarcoplasmic reticulum [goid 16529] [evidence IEA]; membrane [goid 16020] [evidence IEA]; smooth endoplasmic reticulum [goid 5790] [evidence NR ]; integral to membrane [goid 16021] [pmid 9367679] [evidence TAS],transport [goid 6810] [pmid 9367679] [evidence TAS],enzyme regulator activity [goid 30234] [evidence IEA],11,107083412-107083461,11q22.3c,-,NM_003063.1,6588,SLN,-1.5992983463444936,6.387628756138503,-7.209189189313812,5.641218875079107e-11,2.8264116683187557e-10,14.065771254838058
EDG8,ILMN_2073184,"Homo sapiens endothelial differentiation, sphingolipid G-protein-coupled receptor, 8 (EDG8), mRNA.",membrane [goid 16020] [evidence IEA]; integral to membrane [goid 16021] [evidence IEA],G-protein coupled receptor protein signaling pathway [goid 7186] [evidence IEA]; signal transduction [goid 7165] [evidence IEA],receptor activity [goid 4872] [evidence IEA]; lysosphingolipid and lysophosphatidic acid receptor activity [goid 1619] [evidence IEA],19,10484758-10484807,19p13.2b,-,NM_030760.3,53637,EDG8,-1.0625375850933079,5.787260049270275,-7.208664356317024,5.656362247641962e-11,2.83327039576616e-10,14.063125574802779
LOC653157,ILMN_1665332,"PREDICTED: Homo sapiens similar to Iduronate 2-sulfatase precursor (Alpha-L-iduronate sulfate sulfatase) (Idursulfase) (LOC653157), mRNA.",,,,X,148415560-148415609,,+,XM_926258.1,653157,LOC653157,1.1197110251089972,6.249906966174553,7.204442451078273,5.7796533090894676e-11,2.8913105193224204e-10,14.041845706715051
FLJ10213,ILMN_2186877,"Homo sapiens hypothetical protein FLJ10213 (FLJ10213), mRNA.",,,,3,73194965-73195014,3p13b,+,NM_018029.3,55096,FLJ10213,1.5155177919885254,7.4896712674885855,7.203300725462154,5.813449491478374e-11,2.906724745739187e-10,14.036091848487509
LOC644852,ILMN_1727165,"PREDICTED: Homo sapiens hypothetical protein LOC644852, transcript variant 2 (LOC644852), mRNA.",,,,1,245748660-245748709,1q44e,+,XM_934218.1,644852,LOC644852,1.0229094896648965,7.1091910235995,7.1943959752365,6.083841641308866e-11,3.036466556887891e-10,13.991227554692077
SCNN1G,ILMN_1814215,"Homo sapiens sodium channel, nonvoltage-gated 1, gamma (SCNN1G), mRNA.",membrane [goid 16020] [evidence IEA]; integral to plasma membrane [goid 5887] [pmid 8640238] [evidence TAS]; membrane [goid 16020] [evidence IEA]; integral to plasma membrane [goid 5887] [pmid 8640238] [evidence TAS],excretion [goid 7588] [pmid 8640238] [evidence TAS]; sodium ion transport [goid 6814] [pmid 8521520] [evidence TAS]; ion transport [goid 6811] [evidence IEA]; excretion [goid 7588] [pmid 8640238] [evidence TAS]; sodium ion transport [goid 6814] [pmid 8521520] [evidence TAS]; ion transport [goid 6811] [evidence IEA],protein binding [goid 5515] [pmid 11244092] [evidence IPI]; ion channel activity [goid 5216] [evidence IEA]; sodium ion binding [goid 31402] [evidence IEA]; amiloride-sensitive sodium channel activity [goid 15280] [pmid 8640238] [evidence TAS]; protein binding [goid 5515] [pmid 11244092] [evidence IPI]; ion channel activity [goid 5216] [evidence IEA]; sodium ion binding [goid 31402] [evidence IEA]; amiloride-sensitive sodium channel activity [goid 15280] [pmid 8640238] [evidence TAS],16,23135217-23135266,16p12.1c,+,NM_001039.2,6340,SCNN1G,-1.1961029476460574,7.493885683875658,-7.193759405958134,6.103641187038289e-11,3.045568464262255e-10,13.988021195183208
SLC6A3,ILMN_2105797,"Homo sapiens solute carrier family 6 (neurotransmitter transporter, dopamine), member 3 (SLC6A3), mRNA.",cytoplasm [goid 5737] [pmid 10823899] [evidence TAS]; integral to plasma membrane [goid 5887] [evidence IEA]; plasma membrane [goid 5886] [pmid 11343649] [evidence IDA],monoamine transport [goid 15844] [pmid 16024787] [evidence IDA],protein binding [goid 5515] [pmid 11343649] [evidence IPI]; dopamine:sodium symporter activity [goid 5330] [evidence IEA]; monoamine transporter activity [goid 8504] [pmid 16024787] [evidence IDA]; symporter activity [goid 15293] [evidence IEA],5,1446076-1446125,5p15.33d,-,NM_001044.2,6531,SLC6A3,1.5546589040745653,6.054596310471718,7.175248113959724,6.708163822070088e-11,3.3412211675111364e-10,13.894829654977066
FLJ10246,ILMN_1712211,"PREDICTED: Homo sapiens FLJ10246 (FLJ10246), misc RNA.",,,,,,,,XR_001525.1,55104,FLJ10246,1.1747908950076287,6.28785723145032,7.1723599144877825,6.807685526415756e-11,3.387327693621323e-10,13.880298081809713
LOC644642,ILMN_1812250,"PREDICTED: Homo sapiens hypothetical protein LOC644642 (LOC644642), mRNA.",,,,1,142987262-142987311,,-,XM_932279.1,644642,LOC644642,1.4474208982413348,7.9587063321465665,7.166756123336126,7.004969531831308e-11,3.4801588813802404e-10,13.852109963840281
RAPGEFL1,ILMN_1758613,"Homo sapiens Rap guanine nucleotide exchange factor (GEF)-like 1 (RAPGEFL1), mRNA.",membrane fraction [goid 5624] [pmid 9582122] [evidence TAS],G-protein coupled receptor protein signaling pathway [goid 7186] [pmid 9582122] [evidence TAS]; small GTPase mediated signal transduction [goid 7264] [evidence IEA],guanyl-nucleotide exchange factor activity [goid 5085] [pmid 9582122] [evidence TAS],17,35605294-35605343,17q21.1d-q21.2a,+,NM_016339.1,51195,RAPGEFL1,1.175742444562852,7.507164235924592,7.165537458023798,7.048616877951007e-11,3.4991668755891816e-10,13.845980999725064
ITGA2,ILMN_1665792,"Homo sapiens integrin, alpha 2 (CD49B, alpha 2 subunit of VLA-2 receptor) (ITGA2), mRNA.",integral to membrane [goid 16021] [evidence IEA]; integrin complex [goid 8305] [pmid 2545729] [evidence TAS]; plasma membrane [goid 5886] [pmid 2545729] [evidence TAS],cell-matrix adhesion [goid 7160] [pmid 2545729] [evidence TAS]; blood coagulation [goid 7596] [pmid 2933589] [evidence TAS]; cell adhesion [goid 7155] [pmid 10942362] [evidence TAS]; integrin-mediated signaling pathway [goid 7229] [evidence IEA],magnesium ion binding [goid 287] [evidence IEA]; collagen binding [goid 5518] [pmid 9391074] [evidence TAS]; receptor activity [goid 4872] [evidence IEA]; calcium ion binding [goid 5509] [evidence IEA],5,52423650-52423699,5q11.2b,+,NM_002203.2,3673,ITGA2,1.3190188736258595,8.717082102618582,7.156771924636648,7.370594540258008e-11,3.651564572004253e-10,13.801909134983259
OLFML3,ILMN_1727532,"Homo sapiens olfactomedin-like 3 (OLFML3), mRNA.",,,,1,114326107-114326156,1p13.2b,+,NM_020190.2,56944,OLFML3,-1.008910914774992,9.505894205597018,-7.15455634271365,7.454257060380494e-11,3.690198140790496e-10,13.790772880154353
GNG12,ILMN_1673380,"Homo sapiens guanine nucleotide binding protein (G protein), gamma 12 (GNG12), mRNA.",heterotrimeric G-protein complex [goid 5834] [evidence IEA]; membrane [goid 16020] [evidence IEA],signal transduction [goid 7165] [pmid 10819326] [evidence TAS]; G-protein coupled receptor protein signaling pathway [goid 7186] [evidence IEA],signal transducer activity [goid 4871] [evidence IEA],1,67941908-67941957,1p31.3a,-,NM_018841.3,55970,GNG12,-1.2493699604928494,6.885869751884006,-7.153669207816878,7.488019118009496e-11,3.705029266490986e-10,13.786314226621741
COL22A1,ILMN_1784532,"Homo sapiens collagen, type XXII, alpha 1 (COL22A1), mRNA.",cytoplasm [goid 5737] [evidence IEA],phosphate transport [goid 6817] [evidence IEA],,8,139669749-139669798,8q24.23c,-,NM_152888.1,169044,COL22A1,1.0040319838244471,5.662672566853521,7.153562368600602,7.49209534245407e-11,3.7061050456389327e-10,13.785777277907709
ATOH8,ILMN_1654065,"Homo sapiens atonal homolog 8 (Drosophila) (ATOH8), mRNA.",nucleus [goid 5634] [evidence IEA],regulation of transcription [goid 45449] [evidence IEA],transcription regulator activity [goid 30528] [evidence IEA],2,85868440-85868489,2p11.2f,+,NM_032827.3,84913,ATOH8,-1.5286217775314723,8.707615937183384,-7.152353013884341,7.53838916911845e-11,3.7271127368757424e-10,13.779699567721615
MGC3020,ILMN_1656420,"Homo sapiens hypothetical protein MGC3020 (MGC3020), mRNA.",,,,16,31625980-31626029,,+,NM_024048.2,79014,MGC3020,1.2940260894070672,7.963278263349367,7.151992350642669,7.55225001907694e-11,3.7330185596578944e-10,13.77788710417573
LOC441763,ILMN_1703337,"PREDICTED: Homo sapiens hypothetical LOC441763 (LOC441763), mRNA.",,,,16,33871429-33871478,,+,XM_930284.1,441763,LOC441763,1.4244822703855018,10.367745679292753,7.150644207416962,7.604285057772368e-11,3.7558807186487856e-10,13.771112516491229
LOC653261,ILMN_1694280,"PREDICTED: Homo sapiens similar to Acidic mammalian chitinase precursor (AMCase) (TSA1902) (LOC653261), mRNA.",,,,1,111625779-111625828,,+,XM_926640.1,653261,LOC653261,-1.971401066483197,5.963444675475475,-7.150209667731832,7.621132751154645e-11,3.763248141313945e-10,13.768929008327934
FNDC6,ILMN_1765668,"Homo sapiens interleukin 20 receptor beta (IL20RB), mRNA.",,,,3,138212311-138212360,,+,NM_144717.2,53833,FNDC6,1.3201965240708242,5.938676146834627,7.140554858524282,8.005142468580118e-11,3.9418802375608693e-10,13.720428374109026
SPINK5L3,ILMN_1697543,"PREDICTED: Homo sapiens serine PI Kazal type 5-like 3 (SPINK5L3), mRNA.",,,,5,147641902-147641951,5q33.1a,+,XM_376433.2,153218,SPINK5L3,1.2820433575428378,5.568288411304961,7.1320588198149295,8.358869317947014e-11,4.1077570910516415e-10,13.677770349084216
GCHFR,ILMN_1694780,"Homo sapiens GTP cyclohydrolase I feedback regulator (GCHFR), mRNA.",,nitric oxide biosynthesis [goid 6809] [pmid 8702680] [evidence TAS]; neurotransmitter metabolism [goid 42133] [pmid 8702680] [evidence TAS],,15,38846896-38846945,15q15.1b,+,NM_005258.2,2644,GCHFR,-1.042080710261473,10.625045441144847,-7.12976048403356,8.457189396465886e-11,4.1539787091035487e-10,13.666234041291617
RUNDC2A,ILMN_1775357,"Homo sapiens RUN domain containing 2A (RUNDC2A), mRNA.",,"regulation of transcription, DNA-dependent [goid 6355] [evidence IEA]",transcription factor activity [goid 3700] [evidence IEA],16,12054236-12054285,16p13.13a,+,NM_032167.1,84127,RUNDC2A,1.0014826547239197,5.9095515371982765,7.12667732929644,8.590883194060899e-11,4.217519754000419e-10,13.650760729193149
WNT10A,ILMN_1658426,"Homo sapiens wingless-type MMTV integration site family, member 10A (WNT10A), mRNA.",extracellular region [goid 5576] [evidence IEA],development [goid 7275] [evidence IEA]; frizzled-2 signaling pathway [goid 7223] [evidence IEA],signal transducer activity [goid 4871] [evidence IEA],2,219466511-219466560,2q35e,+,NM_025216.2,80326,WNT10A,1.0063256773823017,6.16193547668142,7.126239549686939,8.610035334107886e-11,4.2258573925715907e-10,13.64856387783897
CKM,ILMN_1757521,"Homo sapiens creatine kinase, muscle (CKM), mRNA.",cytoplasm [goid 5737] [evidence NAS],,creatine kinase activity [goid 4111] [pmid 3778496] [evidence TAS],19,50501675-50501724,19q13.32a,-,NM_001824.2,1158,CKM,1.1835316117994603,5.426626996224927,7.125283732228489,8.651997783386747e-11,4.243246332979883e-10,13.643767613153251
C22orf15,ILMN_1802771,"Homo sapiens chromosome 22 open reading frame 15 (C22orf15), mRNA.",,,,22,22437931-22437980,22q11.23a,+,NM_182520.1,150248,C22orf15,-1.7377533971058412,6.276990320327595,-7.1143990289431,9.144377109054103e-11,4.479089692557044e-10,13.589166633853957
BPNT1,ILMN_1712718,"Homo sapiens 3'(2'), 5'-bisphosphate nucleotidase 1 (BPNT1), mRNA.",,"nucleobase, nucleoside, nucleotide and nucleic acid metabolism [goid 6139] [pmid 10224133] [evidence TAS]","magnesium ion binding [goid 287] [evidence IEA]; inositol or phosphatidylinositol phosphatase activity [goid 4437] [evidence IEA]; 3'(2'),5'-bisphosphate nucleotidase activity [goid 8441] [pmid 10224133] [evidence TAS]; hydrolase activity [goid 16787] [evidence IEA]",1,218298840-218298889,1q41d,-,NM_006085.3,10380,BPNT1,1.081545487644382,9.253405068644522,7.114254798663698,9.151084272532052e-11,4.4801225389519354e-10,13.588443355308648
LUM,ILMN_1790529,"Homo sapiens lumican (LUM), mRNA.",extracellular region [goid 5576] [pmid 14718574] [evidence NAS]; extracellular matrix (sensu Metazoa) [goid 5578] [pmid 7665616] [evidence TAS]; fibrillar collagen [goid 5583] [pmid 10734230] [evidence IDA]; extracellular region [goid 5576] [pmid 14718574] [evidence NAS]; extracellular matrix (sensu Metazoa) [goid 5578] [pmid 7665616] [evidence TAS]; fibrillar collagen [goid 5583] [pmid 10734230] [evidence IDA],collagen fibril organization [goid 30199] [pmid 10892350] [evidence NAS]; visual perception [goid 7601] [pmid 10802664] [evidence TAS]; collagen fibril organization [goid 30199] [pmid 10892350] [evidence NAS]; visual perception [goid 7601] [pmid 10802664] [evidence TAS],extracellular matrix structural constituent [goid 5201] [pmid 10892350] [evidence NAS]; transferase activity [goid 16740] [evidence IEA]; collagen binding [goid 5518] [pmid 10892350] [evidence IDA]; extracellular matrix structural constituent [goid 5201] [pmid 10892350] [evidence NAS]; transferase activity [goid 16740] [evidence IEA]; collagen binding [goid 5518] [pmid 10892350] [evidence IDA],12,90022113-90022162,12q21.33c,-,NM_002345.3,4060,LUM,-1.141428137681281,10.15204017401747,-7.099714616884407,9.852846408102326e-11,4.804372178725571e-10,13.5155582168656
LOC646962,ILMN_2189675,"Homo sapiens hypothetical protein LOC646962 (LGLL338), mRNA.",,,,9,35896885-35896934,9p13.3a,+,NM_001039792.1,646962,LOC646962,-1.1439322602108275,6.474961769388659,-7.093058460247129,1.0191621973015976e-10,4.957158116430762e-10,13.482213115815792
TM4SF4,ILMN_1792404,"Homo sapiens transmembrane 4 L six family member 4 (TM4SF4), mRNA.",membrane fraction [goid 5624] [pmid 7665614] [evidence TAS]; integral to plasma membrane [goid 5887] [pmid 7665614] [evidence TAS]; membrane [goid 16020] [evidence IEA],negative regulation of cell proliferation [goid 8285] [pmid 7665614] [evidence TAS],,3,150703657-150703706,3q25.1a,+,NM_004617.2,7104,TM4SF4,2.2278039305782302,6.5705049922963905,7.077402204425505,1.1034596998886294e-10,5.340514717419261e-10,13.403830347172974
FLJ46082,ILMN_1663665,"Homo sapiens FLJ46082 protein (FLJ46082), mRNA.",,,,9,134438353-134438402,9q34.13b,+,NM_207417.1,389799,FLJ46082,-1.7994942107730383,6.013131229728681,-7.067960079405775,1.157596824463734e-10,5.580349857663497e-10,13.35659243077161
LOC648526,ILMN_1711087,"PREDICTED: Homo sapiens similar to epiplakin 1 (LOC648526), mRNA.",,,,,,,,XM_937579.1,648526,LOC648526,1.0807449994444687,7.894384556462175,7.054232390484334,1.2410256243746182e-10,5.963350010096038e-10,13.287960050736217
NINJ2,ILMN_1731745,"Homo sapiens ninjurin 2 (NINJ2), mRNA.",integral to plasma membrane [goid 5887] [pmid 10627596] [evidence TAS]; membrane [goid 16020] [evidence IEA],tissue regeneration [goid 42246] [evidence IEA]; neuron adhesion [goid 7158] [pmid 10627596] [evidence TAS]; cell adhesion [goid 7155] [evidence IEA],protein binding [goid 5515] [evidence IEA],12,543798-543847,12p13.33d,-,NM_016533.4,4815,NINJ2,-1.085293277801922,10.986306707864303,-7.044870423983616,1.3013071880819633e-10,6.239165984197109e-10,13.241185568414267
SNF1LK,ILMN_1717639,"Homo sapiens SNF1-like kinase (SNF1LK), mRNA.",cytoplasm [goid 5737] [evidence ISS],regulation of cell differentiation [goid 45595] [evidence ISS]; cell cycle [goid 7049] [evidence IEA]; protein amino acid phosphorylation [goid 6468] [evidence ISS]; protein kinase cascade [goid 7243] [evidence ISS],nucleotide binding [goid 166] [evidence IEA]; magnesium ion binding [goid 287] [evidence ISS]; transferase activity [goid 16740] [evidence IEA]; protein serine/threonine kinase activity [goid 4674] [evidence ISS]; ATP binding [goid 5524] [evidence ISS]; protein-tyrosine kinase activity [goid 4713] [evidence IEA],21,43659254-43659303,21q22.3c,-,NM_173354.2,150094,SNF1LK,-1.188439225362485,9.496661008707367,-7.042122096653912,1.3195474494334264e-10,6.323507637041395e-10,13.22745913087818
IL1RL1,ILMN_2242900,"Homo sapiens interleukin 1 receptor-like 1 (IL1RL1), transcript variant 2, mRNA.",integral to membrane [goid 16021] [evidence IEA]; membrane [goid 16020] [evidence IEA]; integral to membrane [goid 16021] [evidence IEA]; membrane [goid 16020] [evidence IEA],immune response [goid 6955] [pmid 10527832] [evidence NAS]; signal transduction [goid 7165] [pmid 1482686] [evidence TAS]; immune response [goid 6955] [pmid 10527832] [evidence NAS]; signal transduction [goid 7165] [pmid 1482686] [evidence TAS],interleukin-1 receptor activity [goid 4908] [evidence IEA]; transmembrane receptor activity [goid 4888] [evidence IEA]; receptor signaling protein activity [goid 5057] [pmid 1482686] [evidence TAS]; protein binding [goid 5515] [pmid 8621446] [evidence IPI]; interleukin-1 receptor activity [goid 4908] [evidence IEA]; transmembrane receptor activity [goid 4888] [evidence IEA]; receptor signaling protein activity [goid 5057] [pmid 1482686] [evidence TAS]; protein binding [goid 5515] [pmid 8621446] [evidence IPI],2,102327480-102327529,2q12.1a,+,NM_003856.2,9173,IL1RL1,-1.9918792609022136,6.322673581399984,-7.041915897735387,1.3209261205944964e-10,6.32855801814206e-10,13.226429365021477
IL1A,ILMN_1658483,"Homo sapiens interleukin 1, alpha (IL1A), mRNA.",extracellular region [goid 5576] [evidence IEA]; extracellular space [goid 5615] [pmid 1924307] [evidence TAS]; cytoplasm [goid 5737] [evidence NR ],apoptosis [goid 6915] [pmid 1924307] [evidence TAS]; cell-cell signaling [goid 7267] [evidence NR ]; negative regulation of cell proliferation [goid 8285] [pmid 3493774] [evidence TAS]; chemotaxis [goid 6935] [evidence NR ]; fever [goid 1660] [evidence IEA]; anti-apoptosis [goid 6916] [pmid 10748004] [evidence TAS]; cell proliferation [goid 8283] [pmid 6209582] [evidence TAS],interleukin-1 receptor binding [goid 5149] [evidence IEA]; signal transducer activity [goid 4871] [pmid 10861041] [evidence TAS],2,113248305-113248354,2q13d,-,NM_000575.3,3552,IL1A,-1.1493180292336254,5.864582384133612,-7.035796484689822,1.3624964430360247e-10,6.514906304921949e-10,13.195874387881691
STRA6,ILMN_1807652,"Homo sapiens stimulated by retinoic acid gene 6 homolog (mouse) (STRA6), mRNA.",,,,15,72259138-72259187,15q24.1b,-,NM_022369.2,64220,STRA6,1.250052212160103,5.527265403428612,7.031304768176766,1.3938307929465193e-10,6.65330548764403e-10,13.173453630839507
MYRIP,ILMN_1668125,"Homo sapiens myosin VIIA and Rab interacting protein (MYRIP), mRNA.",,intracellular protein transport [goid 6886] [evidence IEA],zinc ion binding [goid 8270] [evidence IEA]; metal ion binding [goid 46872] [evidence IEA]; Rab GTPase binding [goid 17137] [evidence IEA]; actin binding [goid 3779] [evidence IEA]; protein binding [goid 5515] [evidence IEA],3,40276483-40276532,3p22.1c,+,NM_015460.2,25924,MYRIP,-1.1514386076558614,5.432072987034073,-7.025259938644256,1.4371277666852764e-10,6.849910600259935e-10,13.143289670792885
IGFBP3,ILMN_1746085,"Homo sapiens insulin-like growth factor binding protein 3 (IGFBP3), transcript variant 1, mRNA.",extracellular region [goid 5576] [pmid 14718574] [evidence NAS],positive regulation of apoptosis [goid 43065] [pmid 11971816] [evidence IMP]; negative regulation of signal transduction [goid 9968] [pmid 11940579] [evidence NAS]; positive regulation of myoblast differentiation [goid 45663] [pmid 12599210] [evidence IDA]; regulation of cell growth [goid 1558] [evidence IEA],protein tyrosine phosphatase activator activity [goid 8160] [pmid 11940579] [evidence IDA]; insulin-like growth factor binding [goid 5520] [pmid 12599210] [evidence NAS]; metal ion binding [goid 46872] [pmid 14576163] [evidence NAS],7,45918727-45918776,7p13b,-,NM_001013398.1,3486,IGFBP3,1.4191060392804058,10.493196720691099,7.020967580076163,1.4686777344320976e-10,6.99344712986545e-10,13.121877095412096
C15orf48,ILMN_1654696,"Homo sapiens chromosome 15 open reading frame 48 (C15orf48), transcript variant 2, mRNA.",nucleus [goid 5634] [pmid 12209954] [evidence IDA]; nucleus [goid 5634] [pmid 12209954] [evidence IDA],,,15,43510201-43510250,15q21.1a,+,NM_032413.2,84419,C15orf48,1.0719363467024126,6.771286466519209,7.014362489388101,1.51857030903393e-10,7.216912797933202e-10,13.088937910226576
C15orf26,ILMN_1686373,"Homo sapiens chromosome 15 open reading frame 26 (C15orf26), mRNA.",,,,15,79228403-79228452,15q25.1b,+,NM_173528.1,161502,C15orf26,-1.3308773918953083,5.760370372721748,-7.013525065730193,1.5250145116182647e-10,7.245771216503752e-10,13.08476264272807
KRT15,ILMN_1770612,"Homo sapiens keratin 15 (KRT15), mRNA.",intermediate filament [goid 5882] [pmid 2580298] [evidence TAS],epidermis development [goid 8544] [pmid 2452170] [evidence TAS],protein binding [goid 5515] [pmid 16189514] [evidence IPI]; structural constituent of cytoskeleton [goid 5200] [pmid 2580298] [evidence TAS],17,36923743-36923792,17q21.2b,-,NM_002275.2,3866,KRT15,1.785522936191307,7.144746436709365,6.999285692980343,1.6388244406450067e-10,7.760022898169612e-10,13.013798831276418
CAMK2N1,ILMN_1794863,"Homo sapiens calcium/calmodulin-dependent protein kinase II inhibitor 1 (CAMK2N1), mRNA.",ruffle [goid 1726] [pmid 11919189] [evidence IDA]; cytosol [goid 5829] [pmid 11919189] [evidence IDA]; lamellipodium [goid 30027] [pmid 11919189] [evidence IDA],cell migration [goid 16477] [pmid 11919189] [evidence TAS]; cell adhesion [goid 7155] [pmid 11919189] [evidence TAS],kinase activity [goid 16301] [evidence IEA]; protein binding [goid 5515] [pmid 11919189] [evidence TAS],1,20682709-20682728:20682729-20682758,1p36.12b,-,NM_018584.4,55450,CAMK2N1,-1.4615044141521647,10.85923977779748,-6.9989675086301375,1.6414612674037126e-10,7.770620212672824e-10,13.012213799053093
LOC442609,ILMN_1699383,"PREDICTED: Homo sapiens similar to Williams Beuren syndrome chromosome region 19, transcript variant 8 (LOC442609), mRNA.",,,,,,7q22.1f,,XM_935827.1,442609,LOC442609,1.7709706880370062,8.518708162070796,6.991154018679512,1.7075458351322994e-10,8.063870721656049e-10,12.973300354618285
TUBB1,ILMN_1710280,"Homo sapiens tubulin, beta 1 (TUBB1), mRNA.",microtubule [goid 5874] [evidence IEA]; protein complex [goid 43234] [evidence IEA],microtubule-based movement [goid 7018] [evidence IEA]; protein polymerization [goid 51258] [evidence IEA],GTP binding [goid 5525] [evidence IEA]; structural molecule activity [goid 5198] [evidence IEA]; GTPase activity [goid 3924] [evidence IEA]; nucleotide binding [goid 166] [evidence IEA],20,57034856-57034905,20q13.32b,+,NM_030773.2,81027,TUBB1,-1.0829864281787405,5.5106304249744475,-6.987677975732392,1.737784793131885e-10,8.198725591809874e-10,12.955994454599615
FLJ38717,ILMN_1771320,"Homo sapiens FLJ38717 protein (FLJ38717), mRNA.",,,,6,42861220-42861269,6p21.1e,+,NM_001004322.1,401261,FLJ38717,1.480004677964362,8.340753709428826,6.986852498741205,1.745043302044486e-10,8.230977666506127e-10,12.951885243308656
MGC5457,ILMN_1733412,"PREDICTED: Homo sapiens hypothetical protein MGC5457 (MGC5457), misc RNA.",,,,,,,,XR_001379.1,84719,MGC5457,1.0878225645612298,6.358107536419993,6.985771381424504,1.7545950612590978e-10,8.268025337033499e-10,12.946503763927872
ISG15,ILMN_2054019,"Homo sapiens ISG15 ubiquitin-like modifier (ISG15), mRNA.",cytoplasm [goid 5737] [evidence NAS]; extracellular space [goid 5615] [evidence NAS],response to virus [goid 9615] [evidence IEA]; cell-cell signaling [goid 7267] [evidence NAS]; immune response [goid 6955] [evidence IEA]; ubiquitin cycle [goid 6512] [pmid 16112642] [evidence IDA],protein binding [goid 5515] [evidence NAS],1,939540-939589,1p36.33b,+,NM_005101.1,9636,ISG15,1.2096466400444417,10.4526320894604,6.981070947960249,1.796728577286838e-10,8.4563421083174e-10,12.92311043815182
CYP24A1,ILMN_1685663,"Homo sapiens cytochrome P450, family 24, subfamily A, polypeptide 1 (CYP24A1), nuclear gene encoding mitochondrial protein, mRNA.",mitochondrion [goid 5739] [evidence IEA],electron transport [goid 6118] [pmid 7632726] [evidence NAS],electron transporter activity [goid 5489] [pmid 8506296] [evidence TAS]; metal ion binding [goid 46872] [evidence IEA]; heme binding [goid 20037] [evidence IEA]; oxygen binding [goid 19825] [pmid 8506296] [evidence TAS]; monooxygenase activity [goid 4497] [pmid 8506296] [evidence TAS]; iron ion binding [goid 5506] [evidence IEA],20,52203887-52203936,20q13.2c,-,NM_000782.3,1591,CYP24A1,1.5012483038022157,5.596972421137473,6.975378324645252,1.8490976714006374e-10,8.690223860887945e-10,12.894787922445655
CLEC2B,ILMN_1784608,"Homo sapiens C-type lectin domain family 2, member B (CLEC2B), mRNA.",integral to plasma membrane [goid 5887] [pmid 9038101] [evidence TAS],antimicrobial humoral response (sensu Vertebrata) [goid 19735] [pmid 9038101] [evidence TAS],sugar binding [goid 5529] [pmid 9038101] [evidence TAS],12,9896429-9896478,12p13.31a,-,NM_005127.2,9976,CLEC2B,-1.0684566683672871,6.904207704436166,-6.9679477335917746,1.91973257990073e-10,9.004812065326366e-10,12.857833004050995
MYBPH,ILMN_1705297,"Homo sapiens myosin binding protein H (MYBPH), mRNA.",cytoskeleton [goid 5856] [evidence NR ]; striated muscle thick filament [goid 5863] [evidence IEA],cell adhesion [goid 7155] [evidence IEA]; regulation of striated muscle contraction [goid 6942] [pmid 8486381] [evidence TAS],structural constituent of muscle [goid 8307] [pmid 8486381] [evidence TAS]; protein binding [goid 5515] [evidence IEA],1,201403623-201403672,1q32.1e,-,NM_004997.2,4608,MYBPH,1.4993760273098031,6.005811733117574,6.962708396188403,1.9711353689463983e-10,9.23703046270336e-10,12.831785853715804
KLK11,ILMN_1695924,"Homo sapiens kallikrein-related peptidase 11 (KLK11), transcript variant 1, mRNA.",,,serine-type endopeptidase activity [goid 4252] [evidence IEA]; peptidase activity [goid 8233] [evidence IEA],19,56217339-56217388,19q13.33d,-,NM_006853.2,11012,KLK11,-1.0797709666744852,7.719965751854281,-6.961403375701753,1.9841491748808894e-10,9.293544873210128e-10,12.825299273965712
JUNB,ILMN_2086077,"Homo sapiens jun B proto-oncogene (JUNB), mRNA.",chromatin [goid 785] [pmid 2513129] [evidence TAS]; nucleus [goid 5634] [evidence IEA],transcription [goid 6350] [evidence IEA]; regulation of transcription from RNA polymerase II promoter [goid 6357] [pmid 2513129] [evidence TAS],RNA polymerase II transcription factor activity [goid 3702] [pmid 2513129] [evidence TAS]; transcription coactivator activity [goid 3713] [pmid 2513129] [evidence TAS]; sequence-specific DNA binding [goid 43565] [evidence IEA]; protein dimerization activity [goid 46983] [evidence IEA]; transcription corepressor activity [goid 3714] [pmid 2513129] [evidence TAS]; transcription factor activity [goid 3700] [evidence IEA],19,12764585-12764629:12764630-12764634,19p13.13c,+,NM_002229.2,3726,JUNB,-1.1185193332309336,10.294984044988764,-6.957091900317474,2.0277507792494162e-10,9.49092575874967e-10,12.80387278922159
NOX4,ILMN_1735996,"Homo sapiens NADPH oxidase 4 (NOX4), mRNA.",nucleus [goid 5634] [evidence IEA]; membrane [goid 16020] [evidence IEA]; integral to membrane [goid 16021] [pmid 10869423] [evidence TAS]; endoplasmic reticulum [goid 5783] [evidence IEA],oxygen and reactive oxygen species metabolism [goid 6800] [pmid 10869423] [evidence IDA]; cell aging [goid 7569] [pmid 10869423] [evidence ISS]; electron transport [goid 6118] [pmid 10869423] [evidence IDA]; negative regulation of cell proliferation [goid 8285] [pmid 10869423] [evidence ISS]; inflammatory response [goid 6954] [pmid 10869423] [evidence TAS]; superoxide release [goid 42554] [pmid 10869423] [evidence ISS],heme binding [goid 20037] [pmid 10869423] [evidence TAS]; electron carrier activity [goid 9055] [pmid 10869423] [evidence TAS]; NAD(P)H oxidase activity [goid 16174] [pmid 10869423] [evidence TAS]; oxygen sensor activity [goid 19826] [pmid 10869423] [evidence TAS]; nucleotide binding [goid 166] [pmid 10869423] [evidence TAS]; iron ion binding [goid 5506] [evidence IEA]; FAD binding [goid 50660] [pmid 10869423] [evidence TAS],11,88699220-88699269,11q14.3a,-,NM_016931.2,50507,NOX4,1.0627398944985522,7.298563623024373,6.957001959445632,2.0286703622376434e-10,9.49294956969272e-10,12.803425874639604
IL18RAP,ILMN_1721762,"Homo sapiens interleukin 18 receptor accessory protein (IL18RAP), mRNA.",membrane [goid 16020] [evidence IEA]; integral to membrane [goid 16021] [evidence IEA],cell surface receptor linked signal transduction [goid 7166] [pmid 9792649] [evidence TAS]; inflammatory response [goid 6954] [pmid 9792649] [evidence TAS],receptor activity [goid 4872] [evidence IEA]; transmembrane receptor activity [goid 4888] [evidence IEA],2,102435293-102435342,2q12.1a,+,NM_003853.2,8807,IL18RAP,-1.2328948901874224,6.969941035387079,-6.95674317990308,2.0313185046956375e-10,9.503059078990274e-10,12.802140017242184
JUN,ILMN_1806023,"Homo sapiens jun oncogene (JUN), mRNA.",nucleus [goid 5634] [evidence IEA]; nuclear chromosome [goid 228] [pmid 10918580] [evidence TAS],"regulation of transcription, DNA-dependent [goid 6355] [evidence IEA]; transcription [goid 6350] [evidence IEA]",RNA polymerase II transcription factor activity [goid 3702] [pmid 9443941] [evidence TAS]; protein dimerization activity [goid 46983] [evidence IEA]; sequence-specific DNA binding [goid 43565] [evidence IEA]; transcription factor activity [goid 3700] [pmid 10973489] [evidence TAS],1,59019838-59019887,1p32.1f,-,NM_002228.3,3725,JUN,-1.0717930089267949,11.661235953385324,-6.956630251558766,2.0324751941216695e-10,9.506187987868635e-10,12.801578890507194
TMEM71,ILMN_1674402,"Homo sapiens transmembrane protein 71 (TMEM71), mRNA.",integral to membrane [goid 16021] [evidence IEA],,,8,133791561-133791610,8q24.22b,-,NM_144649.1,137835,TMEM71,-1.1133013381630708,7.010635468430072,-6.951232344353028,2.088530646814682e-10,9.747310096571036e-10,12.774761827708286
CXCL14,ILMN_1748323,"Homo sapiens chemokine (C-X-C motif) ligand 14 (CXCL14), mRNA.",extracellular region [goid 5576] [evidence IEA]; Golgi apparatus [goid 5794] [pmid 11256614] [evidence IDA]; extracellular space [goid 5615] [evidence IEA],cell-cell signaling [goid 7267] [pmid 10049774] [evidence TAS]; chemotaxis [goid 6935] [pmid 10049774] [evidence TAS]; inflammatory response [goid 6954] [evidence NR ]; signal transduction [goid 7165] [pmid 10049774] [evidence TAS],chemokine activity [goid 8009] [pmid 10049774] [evidence TAS],5,134934392-134934441,5q31.1f,-,NM_004887.3,9547,CXCL14,2.1776001575943438,8.078518248241839,6.944738222823173,2.1579992961615202e-10,1.0059477580312733e-9,12.742510312640693
RSHL3,ILMN_1689212,"Homo sapiens radial spokehead-like 3 (RSHL3), mRNA.",,,,6,117060572-117060621,6q22.1d,+,NM_001010892.1,345895,RSHL3,-1.5283603096880922,6.4946045179148415,-6.941269138340243,2.196040048398379e-10,1.0224573558672024e-9,12.725287125190562
CCL3L3,ILMN_1747355,"Homo sapiens chemokine (C-C motif) ligand 3-like 3 (CCL3L3), mRNA.",extracellular region [goid 5576] [evidence IEA],immune response [goid 6955] [evidence IEA],chemokine activity [goid 8009] [evidence IEA],17,31547400-31547424:31548110-31548134,17q12b,-,NM_001001437.3,414062,CCL3L3,-1.3914223000947672,8.286458023067187,-6.91575036355733,2.497007972941912e-10,1.1548587788457907e-9,12.598704154997254
PPARGC1B,ILMN_2195703,"Homo sapiens peroxisome proliferator-activated receptor gamma, coactivator 1 beta (PPARGC1B), mRNA.",nucleus [goid 5634] [evidence ISS],"estrogen receptor signaling pathway [goid 30520] [evidence ISS]; regulation of transcription, DNA-dependent [goid 6355] [evidence IEA]; transcription [goid 6350] [evidence IEA]; positive regulation of transcription from RNA polymerase II promoter [goid 45944] [evidence ISS]",ligand-dependent nuclear receptor transcription coactivator activity [goid 30374] [evidence ISS]; AF-2 domain binding [goid 50682] [evidence ISS]; nucleotide binding [goid 166] [evidence IEA]; RNA binding [goid 3723] [evidence ISS],5,149202104-149202133:149205516-149205535,5q33.1b-q33.1c,+,NM_133263.2,133522,PPARGC1B,-1.1452650219209808,6.627410063023916,-6.9051169358092865,2.634142253274927e-10,1.2153981009960208e-9,12.546016596981445
FLJ23514,ILMN_1794534,"Homo sapiens coiled-coil domain containing 81 (CCDC81), mRNA.",,,DNA binding [goid 3677] [evidence IEA],11,85811608-85811657,11q14.2a,+,NM_021827.2,60494,FLJ23514,-1.1272586168514964,5.76522374839258,-6.90186001520478,2.67761600129447e-10,1.2339959268028085e-9,12.529885784351745
CT45-4,ILMN_1672783,"Homo sapiens cancer/testis antigen CT45-4 (CT45-4), mRNA.",,,,X,134756415-134756464,Xq26.3b,-,NM_001017436.1,441520,CT45-4,-1.6271926838119617,6.287733220090335,-6.8945271737284,2.77810924762785e-10,1.2790987403125864e-9,12.493579703416241
DDIT4L,ILMN_1696537,"Homo sapiens DNA-damage-inducible transcript 4-like (DDIT4L), mRNA.",,,,4,101326239-101326288,4q23b,-,NM_145244.2,115265,DDIT4L,1.5234816306024852,7.200514285424548,6.89053895406966,2.834322336426159e-10,1.303748128547302e-9,12.473840300119647
CCDC3,ILMN_1671295,"Homo sapiens coiled-coil domain containing 3 (CCDC3), mRNA.",endoplasmic reticulum [goid 5783] [pmid 11256614] [evidence IDA],,,10,12978864-12978913,10p13e,-,NM_031455.2,83643,CCDC3,-1.008433942343042,8.419017697198777,-6.884043978769686,2.9282839413958844e-10,1.345698410332519e-9,12.441704343124648
KIR2DL4,ILMN_1739756,"Homo sapiens killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 4 (KIR2DL4), mRNA.",integral to plasma membrane [goid 5887] [pmid 8946682] [evidence TAS],signal transduction [goid 7165] [pmid 8946682] [evidence TAS]; cellular defense response [goid 6968] [pmid 8946682] [evidence TAS],transmembrane receptor activity [goid 4888] [pmid 8946682] [evidence TAS]; receptor activity [goid 4872] [evidence IEA],19,67964-68013,,+,NM_002255.3,3805,KIR2DL4,-1.2944103082572473,6.4287559040034,-6.8807218824672685,2.9775278857002036e-10,1.3667168634362417e-9,12.42527222885479
ST6GALNAC1,ILMN_1772951,"Homo sapiens ST6 (alpha-N-acetyl-neuraminyl-2,3-beta-galactosyl-1, 3)-N-acetylgalactosaminide alpha-2,6-sialyltransferase 1 (ST6GALNAC1), mRNA.",Golgi apparatus [goid 5794] [evidence IEA]; membrane [goid 16020] [evidence IEA]; integral to membrane [goid 16021] [evidence IEA]; Golgi stack [goid 5795] [evidence IEA],protein amino acid glycosylation [goid 6486] [pmid 10536037] [evidence NAS],"sialyltransferase activity [goid 8373] [evidence IEA]; alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity [goid 1665] [evidence IEA]",17,72132881-72132930,17q25.1d,-,NM_018414.2,55808,ST6GALNAC1,1.6717165828148994,7.599590390534284,6.879895150338944,2.9899093424811216e-10,1.3720768614753804e-9,12.421183484461856
FASN,ILMN_1784871,"Homo sapiens fatty acid synthase (FASN), mRNA.",,fatty acid biosynthesis [goid 6633] [evidence IEA],"transferase activity [goid 16740] [evidence IEA]; protein kinase binding [goid 19901] [pmid 11034606] [evidence IPI]; [acyl-carrier protein] S-acetyltransferase activity [goid 4313] [evidence IEA]; phosphopantetheine binding [goid 31177] [evidence IEA]; [acyl-carrier protein] S-malonyltransferase activity [goid 4314] [evidence IEA]; 3-oxoacyl-[acyl-carrier protein] reductase activity [goid 4316] [evidence IEA]; cofactor binding [goid 48037] [evidence IEA]; 3-oxoacyl-[acyl-carrier protein] synthase activity [goid 4315] [evidence IEA]; protein binding [goid 5515] [pmid 11034606] [evidence IPI]; oxidoreductase activity [goid 16491] [evidence IEA]; hydrolase activity, acting on ester bonds [goid 16788] [evidence IEA]; lyase activity [goid 16829] [evidence IEA]; oleoyl-[acyl-carrier protein] hydrolase activity [goid 4320] [evidence IEA]; enoyl-[acyl-carrier protein] reductase (NADPH, B-specific) activity [goid 4319] [evidence IEA]; catalytic activity [goid 3824] [evidence IEA]",17,77629503-77629552,17q25.3g,-,NM_004104.4,2194,FASN,-1.0034880535211546,11.753027102887891,-6.868772184825422,3.161524497608767e-10,1.4467427157328987e-9,12.366193465736476
C9orf18,ILMN_1748642,"Homo sapiens chromosome 9 open reading frame 18 (C9orf18), mRNA.",,,,9,123971800-123971849,9q33.2b,+,NM_198469.1,254956,C9orf18,-1.750116195551187,5.919438287659674,-6.867910546603935,3.175217942749232e-10,1.4523267984617085e-9,12.361935270402686
C20orf127,ILMN_1662640,"Homo sapiens chromosome 20 open reading frame 127 (C20orf127), mRNA.",,,metal ion binding [goid 46872] [evidence IEA],20,33269618-33269649:33269650-33269667,20q11.22b,+,NM_080757.1,140851,C20orf127,-1.4261309390725874,9.151852664914035,-6.864959373949148,3.2225647900100753e-10,1.472945693956048e-9,12.347352387455174
CEACAM6,ILMN_1712522,"Homo sapiens carcinoembryonic antigen-related cell adhesion molecule 6 (non-specific cross reacting antigen) (CEACAM6), mRNA.",integral to plasma membrane [goid 5887] [pmid 3220478] [evidence TAS]; membrane [goid 16020] [evidence IEA],cell-cell signaling [goid 7267] [pmid 3220478] [evidence TAS]; signal transduction [goid 7165] [pmid 3220478] [evidence TAS],GPI anchor binding [goid 48503] [evidence IEA],19,46967587-46967636,19q13.2c,+,NM_002483.3,4680,CEACAM6,1.259095623659638,13.585343364806755,6.862895699193129,3.2560871341865053e-10,1.4879188041656675e-9,12.337156576686798
CH25H,ILMN_1741021,"Homo sapiens cholesterol 25-hydroxylase (CH25H), mRNA.",membrane fraction [goid 5624] [evidence NR ],metabolism [goid 8152] [evidence IEA]; lipid metabolism [goid 6629] [pmid 9852097] [evidence TAS],steroid hydroxylase activity [goid 8395] [pmid 9852097] [evidence TAS]; catalytic activity [goid 3824] [evidence IEA],10,90956152-90956201,10q23.31b,-,NM_003956.2,9023,CH25H,-1.762754235973369,8.730163309726468,-6.861106513852036,3.2854295007663156e-10,1.4995688410033182e-9,12.32831797923097
GGT1,ILMN_1686531,"Homo sapiens gamma-glutamyltransferase 1 (GGT1), transcript variant 4, mRNA.",membrane [goid 16020] [evidence NAS]; integral to membrane [goid 16021] [evidence IEA],amino acid metabolism [goid 6520] [pmid 2904146] [evidence TAS]; glutathione biosynthesis [goid 6750] [evidence IEA],acyltransferase activity [goid 8415] [evidence IEA]; transferase activity [goid 16740] [evidence IEA]; gamma-glutamyltransferase activity [goid 3840] [evidence IEA],22,23353408-23353457,22q11.23b,+,NM_001032364.1,2678,GGT1,-1.0397155658693888,8.085692667156255,-6.855710948880515,3.375507820969991e-10,1.5388809052784341e-9,12.30166983686535
TRIP13,ILMN_1796589,"Homo sapiens thyroid hormone receptor interactor 13 (TRIP13), mRNA.",nucleus [goid 5634] [pmid 7776974] [evidence TAS],transcription from RNA polymerase II promoter [goid 6366] [pmid 7776974] [evidence TAS],ATP binding [goid 5524] [evidence IEA]; transcription cofactor activity [goid 3712] [pmid 7776974] [evidence TAS]; nucleotide binding [goid 166] [evidence IEA]; nucleoside-triphosphatase activity [goid 17111] [evidence IEA],5,970891-970940,5p15.33d,+,NM_004237.2,9319,TRIP13,1.504875136331135,7.418471480878665,6.839211740051372,3.6663819704063716e-10,1.6683664804616569e-9,12.220238142326302
CD48,ILMN_2061043,"Homo sapiens CD48 molecule (CD48), mRNA.",plasma membrane [goid 5886] [pmid 2828034] [evidence TAS]; integral to plasma membrane [goid 5887] [pmid 1693656] [evidence TAS],defense response [goid 6952] [pmid 2828034] [evidence TAS],GPI anchor binding [goid 48503] [evidence IEA]; protein binding [goid 5515] [pmid 12356317] [evidence IPI],1,158915342-158915391,1q23.3a,-,NM_001778.2,962,CD48,-1.163478102056077,8.455558753980492,-6.838112887726123,3.6866112764004034e-10,1.6771800308349722e-9,12.214817783749812
C4BPA,ILMN_1810752,"Homo sapiens complement component 4 binding protein, alpha (C4BPA), mRNA.",extracellular region [goid 5576] [pmid 14718574] [evidence NAS]; extracellular space [goid 5615] [evidence NR ],"innate immune response [goid 45087] [evidence IEA]; complement activation, classical pathway [goid 6958] [evidence IEA]",,1,205384554-205384603,1q32.2a,+,NM_000715.3,722,C4BPA,-1.7274699418402424,11.354100397895632,-6.830415996304886,3.8314331192995334e-10,1.7398152954917596e-9,12.17686157358704
ATG4B,ILMN_2411915,"Homo sapiens ATG4 autophagy related 4 homolog B (S. cerevisiae) (ATG4B), transcript variant 2, mRNA.",microtubule associated complex [goid 5875] [pmid 12446702] [evidence ISS]; cytosol [goid 5829] [pmid 12446702] [evidence ISS]; cytoplasm [goid 5737] [pmid 12446702] [evidence ISS],ubiquitin cycle [goid 6512] [evidence IEA]; autophagic vacuole formation [goid 45] [pmid 12446702] [evidence ISS]; protein transport [goid 15031] [evidence IEA]; protein targeting to membrane [goid 6612] [pmid 12446702] [evidence ISS]; autophagy [goid 6914] [pmid 12446702] [evidence IGI],cysteine-type peptidase activity [goid 8234] [pmid 15169837] [evidence IDA]; protein binding [goid 5515] [pmid 15187094] [evidence IPI],2,242225803-242225812:242239098-242239137,2q37.3g,+,NM_178326.2,23192,ATG4B,-1.408894245030579,7.616221911711625,-6.827893880485423,3.8801005435680403e-10,1.7606837236009143e-9,12.164428129077617
PKIB,ILMN_2337263,"Homo sapiens protein kinase (cAMP-dependent, catalytic) inhibitor beta (PKIB), transcript variant 3, mRNA.",,negative regulation of protein kinase activity [goid 6469] [evidence IEA],kinase activity [goid 16301] [evidence IEA]; cAMP-dependent protein kinase inhibitor activity [goid 4862] [evidence IEA],6,123080714-123080763,6q22.31c,+,NM_032471.4,5570,PKIB,1.2824731871382609,6.734530346937823,6.823721561445682,3.9619555435505905e-10,1.79448404849101e-9,12.143863950786443
CRIPAK,ILMN_2140700,"Homo sapiens cysteine-rich PAK1 inhibitor (CRIPAK), mRNA.",nucleus [goid 5634] [evidence IEA],,,4,1379469-1379518,4p16.3c,+,NM_175918.2,285464,CRIPAK,1.0181094450958001,7.985756945219777,6.818305651028987,4.070758087512254e-10,1.8424790089471841e-9,12.117178625983794
D4S234E,ILMN_1772627,"Homo sapiens DNA segment on chromosome 4 (unique) 234 expressed sequence (D4S234E), mRNA.",integral to membrane [goid 16021] [evidence IEA]; Golgi stack [goid 5795] [evidence IEA]; cytoplasm [goid 5737] [pmid 9013775] [evidence TAS]; nucleus [goid 5634] [pmid 9013775] [evidence TAS],dopamine receptor signaling pathway [goid 7212] [evidence IEA],dopamine receptor binding [goid 50780] [evidence IEA],4,4471438-4471487,4p16.2b,+,NM_014392.2,27065,D4S234E,-1.046258702291179,6.249990776149087,-6.812477877739262,4.1911341974625144e-10,1.8943226591871284e-9,12.088474285761027
HOXB7,ILMN_1702125,"Homo sapiens homeo box B7 (HOXB7), mRNA.",nucleus [goid 5634] [pmid 1678287] [evidence NAS],"regulation of transcription, DNA-dependent [goid 6355] [pmid 1678287] [evidence NAS]; development [goid 7275] [pmid 2885844] [evidence NAS]",transcription factor activity [goid 3700] [pmid 1678287] [evidence NAS],17,44039775-44039824,17q21.32c,-,NM_004502.2,3217,HOXB7,1.2604560482433067,7.857650193521374,6.812087187799315,4.199328795664994e-10,1.897146338593378e-9,12.08655034953561
C14orf152,ILMN_1762696,"Homo sapiens chromosome 14 open reading frame 152 (C14orf152), mRNA.",,,,14,93465587-93465636,14q32.13a,+,NM_138344.2,90050,C14orf152,-1.5470029814566253,6.125683134102159,-6.8081813701618215,4.282127479607919e-10,1.9309709312696203e-9,12.067318963988573
LOC643431,ILMN_1813131,"PREDICTED: Homo sapiens similar to Keratin, type II cytoskeletal 8 (Cytokeratin-8) (CK-8) (Keraton-8) (K8) (LOC643431), mRNA.",,,,5,122765483-122765532,,-,XM_928128.1,643431,LOC643431,1.048319919598642,6.018419656352447,6.802207829649727,4.4118898292233176e-10,1.9871861609435127e-9,12.037915895745975
ADH5,ILMN_1738604,"Homo sapiens alcohol dehydrogenase 5 (class III), chi polypeptide (ADH5), mRNA.",,ethanol oxidation [goid 6069] [pmid 8460164] [evidence TAS],metal ion binding [goid 46872] [evidence IEA]; formaldehyde dehydrogenase (glutathione) activity [goid 4327] [pmid 8460164] [evidence TAS]; fatty acid binding [goid 5504] [pmid 8460164] [evidence TAS]; electron transporter activity [goid 5489] [pmid 8460164] [evidence TAS]; alcohol dehydrogenase activity [goid 4022] [evidence IEA]; zinc ion binding [goid 8270] [evidence IEA]; oxidoreductase activity [goid 16491] [evidence IEA],4,100212201-100212250,4q23a,-,NM_000671.3,128,ADH5,-1.0220127468215647,6.127857656686389,-6.801362063082832,4.4305736001398147e-10,1.995140434451682e-9,12.033753761286704
PLA1A,ILMN_1792506,"Homo sapiens phospholipase A1 member A (PLA1A), mRNA.",,phosphatidylserine metabolism [goid 6658] [pmid 10196188] [evidence TAS]; lipid metabolism [goid 6629] [pmid 10196188] [evidence TAS],phospholipase A1 activity [goid 8970] [pmid 10196188] [evidence TAS]; catalytic activity [goid 3824] [evidence IEA],3,120830993-120831005:120831006-120831042,3q13.33a,+,NM_015900.1,51365,PLA1A,-1.2108045740174784,6.99873522122321,-6.792492306280133,4.6312863002430477e-10,2.0811949621825596e-9,11.990118124400823
TUBA4,ILMN_1677635,"Homo sapiens tubulin, alpha 4 (TUBA4), mRNA.",microtubule [goid 5874] [evidence IEA],microtubule-based movement [goid 7018] [evidence IEA],nucleotide binding [goid 166] [evidence IEA]; structural molecule activity [goid 5198] [evidence IEA]; GTP binding [goid 5525] [evidence IEA],2,219844848-219844897,2q35f,+,NM_025019.1,80086,TUBA4,-1.590206507258543,5.777736405197076,-6.789961018518482,4.690196588163474e-10,2.1059583645753628e-9,11.977669789511737
LCN6,ILMN_1792800,"Homo sapiens lipocalin 6 (LCN6), mRNA.",,fertilization (sensu Metazoa) [goid 7338] [evidence IEA]; transport [goid 6810] [evidence IEA]; lipid metabolism [goid 6629] [evidence IEA],binding [goid 5488] [evidence IEA]; transporter activity [goid 5215] [evidence IEA],9,138758381-138758415:138758612-138758626,9q34.3e,-,NM_198946.2,158062,LCN6,-1.2203445945411753,5.539549721345796,-6.760605602037568,5.429897587067098e-10,2.4210882032952495e-9,11.83345546090349
TNNT1,ILMN_2115991,"Homo sapiens troponin T type 1 (skeletal, slow) (TNNT1), mRNA.",,regulation of muscle contraction [goid 6937] [pmid 8135831] [evidence TAS],tropomyosin binding [goid 5523] [pmid 8135831] [evidence TAS]; protein binding [goid 5515] [pmid 15967462] [evidence IPI],19,60337379-60337384:60340283-60340326,19q13.42b,-,NM_003283.3,7138,TNNT1,1.1814275432281507,6.040065715191008,6.745988425893185,5.84008446843997e-10,2.5986308716043115e-9,11.761748800334342
KCNK17,ILMN_1717702,"Homo sapiens potassium channel, subfamily K, member 17 (KCNK17), mRNA.",membrane [goid 16020] [evidence NAS]; integral to membrane [goid 16021] [evidence IEA],ion transport [goid 6811] [evidence IEA]; potassium ion transport [goid 6813] [pmid 11248242] [evidence IDA],potassium ion binding [goid 30955] [evidence IEA]; potassium channel activity [goid 5267] [pmid 11248242] [evidence IDA]; voltage-gated ion channel activity [goid 5244] [evidence IEA],6,39374978-39375027,6p21.2a,-,NM_031460.2,89822,KCNK17,-1.150065224679092,7.0115330452212525,-6.7454956817728755,5.854432516357883e-10,2.6038260118975886e-9,11.759332773973458
FXYD3,ILMN_1665372,"Homo sapiens FXYD domain containing ion transport regulator 3 (FXYD3), transcript variant 2, mRNA.",integral to plasma membrane [goid 5887] [pmid 7836447] [evidence TAS]; membrane [goid 16020] [evidence IEA],ion transport [goid 6811] [evidence IEA]; chloride transport [goid 6821] [pmid 7836447] [evidence TAS],ion channel activity [goid 5216] [evidence IEA]; chloride channel activity [goid 5254] [pmid 7836447] [evidence TAS],19,40301943-40301992,19q13.11c-q13.12a,+,NM_021910.1,5349,FXYD3,-1.0098095793176878,6.433253251206467,-6.743799231961261,5.90409770272513e-10,2.625315922811483e-9,11.751015329749624
C6orf72,ILMN_2220403,"Homo sapiens chromosome 6 open reading frame 72 (C6orf72), mRNA.",integral to membrane [goid 16021] [evidence IEA]; membrane [goid 16020] [evidence IEA],,,6,149942706-149942755,6q25.1a,+,NM_138785.1,116254,C6orf72,-1.0986578175736526,7.202015272644464,-6.724395439385372,6.502633181326049e-10,2.879631989503138e-9,11.655947715738456
LOC653600,ILMN_1693262,"PREDICTED: Homo sapiens similar to Neutrophil defensin 1 precursor (HNP-1) (HP-1) (HP1) (Defensin, alpha 1) (LOC653600), mRNA.",,,,8,6842670-6842695:6843166-6843174:6843175-6843189,,-,XM_928349.1,653600,LOC653600,-1.167461995915156,5.428668235764296,-6.723367677746135,6.535955538865432e-10,2.8930734592183767e-9,11.650915675518242
GZMB,ILMN_2109489,"Homo sapiens granzyme B (granzyme 2, cytotoxic T-lymphocyte-associated serine esterase 1) (GZMB), mRNA.",cytoplasm [goid 5737] [evidence NR ]; immunological synapse [goid 1772] [pmid 12524539] [evidence TAS]; nucleus [goid 5634] [pmid 11909973] [evidence TAS],apoptosis [goid 6915] [pmid 12524539] [evidence TAS]; cleavage of lamin [goid 6922] [pmid 11331782] [evidence IDA]; cytolysis [goid 19835] [evidence IEA],peptidase activity [goid 8233] [evidence IEA]; granzyme B activity [goid 4278] [pmid 12524539] [evidence TAS]; serine-type endopeptidase activity [goid 4252] [evidence IEA],14,24170064-24170113,14q12a,-,NM_004131.3,3002,GZMB,-1.197640861776346,8.980168900237196,-6.720186991667368,6.640152944551814e-10,2.9378605841188033e-9,11.635344847674013
SBDS,ILMN_1679045,"Homo sapiens Shwachman-Bodian-Diamond syndrome (SBDS), mRNA.",,,,7,66090474-66090523,7q11.21e,-,NM_016038.2,51119,SBDS,-1.2015654753877936,9.00741218030983,-6.716979554634697,6.746887956297265e-10,2.9823754952008213e-9,11.619646402493785
DMBT1,ILMN_1681612,"Homo sapiens deleted in malignant brain tumors 1 (DMBT1), transcript variant 3, mRNA.",cytoplasm [goid 5737] [evidence ISS]; phagocytic vesicle membrane [goid 30670] [evidence ISS]; membrane [goid 16020] [evidence IEA]; extracellular region [goid 5576] [evidence ISS]; cytoplasm [goid 5737] [evidence ISS]; phagocytic vesicle membrane [goid 30670] [evidence ISS]; membrane [goid 16020] [evidence IEA]; extracellular region [goid 5576] [evidence ISS],induction of bacterial agglutination [goid 43152] [evidence ISS]; cell cycle [goid 7049] [evidence IEA]; epithelial cell differentiation [goid 30855] [evidence ISS]; innate immune response [goid 45087] [evidence ISS]; induction of bacterial agglutination [goid 43152] [evidence ISS]; cell cycle [goid 7049] [evidence IEA]; epithelial cell differentiation [goid 30855] [evidence ISS]; innate immune response [goid 45087] [evidence ISS],calcium-dependent protein binding [goid 48306] [evidence ISS]; scavenger receptor activity [goid 5044] [evidence ISS]; pattern recognition receptor activity [goid 8329] [evidence ISS]; calcium-dependent protein binding [goid 48306] [evidence ISS]; scavenger receptor activity [goid 5044] [evidence ISS]; pattern recognition receptor activity [goid 8329] [evidence ISS],10,124364789-124364812:124366734-124366759,10q26.13b,+,NM_017579.1,1755,DMBT1,-1.0512700070279504,8.18112195620705,-6.715374822773582,6.800923419553706e-10,3.004897796598729e-9,11.611793480212647
HS3ST1,ILMN_2228035,"Homo sapiens heparan sulfate (glucosamine) 3-O-sulfotransferase 1 (HS3ST1), mRNA.",Golgi lumen [goid 5796] [pmid 9346953] [evidence TAS]; integral to membrane [goid 16021] [pmid 9988767] [evidence TAS],,transferase activity [goid 16740] [evidence IEA]; heparin-glucosamine 3-O-sulfotransferase activity [goid 8467] [evidence IEA],4,11009243-11009292,4p15.33e,-,NM_005114.2,9957,HS3ST1,1.2114458242077815,7.090535409707027,6.71137745070499,6.937390822459026e-10,3.0617227672845784e-9,11.592235581847849
LRRC31,ILMN_1803528,"Homo sapiens leucine rich repeat containing 31 (LRRC31), mRNA.",,,,3,171040055-171040104,3q26.2b,-,NM_024727.1,79782,LRRC31,1.33767459287363,7.134431722481397,6.706143944254067,7.120154651970328e-10,3.1416714989502226e-9,11.566637562943573
C6orf97,ILMN_1772588,"Homo sapiens chromosome 6 open reading frame 97 (C6orf97), mRNA.",,,,6,151983417-151983466,6q25.1c,+,NM_025059.2,80129,C6orf97,-1.2308025463529253,5.936365881100868,-6.705549096671961,7.141226461430377e-10,3.1497279068423807e-9,11.563728624342431
MT1X,ILMN_1775170,"Homo sapiens metallothionein 1X (MT1X), mRNA.",,response to metal ion [goid 10038] [pmid 9074634] [evidence TAS],zinc ion binding [goid 8270] [evidence IEA]; metal ion binding [goid 46872] [pmid 9074634] [evidence TAS]; copper ion binding [goid 5507] [evidence IEA]; cadmium ion binding [goid 46870] [evidence IEA],16,55273897-55273946,16q13b,+,NM_005952.2,4501,MT1X,-1.414313372305612,11.608565987852023,-6.703432209127177,7.216715640221948e-10,3.1813960237494268e-9,11.55337750837344
FLJ32771,ILMN_1732739,"Homo sapiens chromosome 11 open reading frame 66 (C11orf66), mRNA.",,,,11,61011263-61011288:61013830-61013853,11q12.2b,+,NM_145017.1,220004,FLJ32771,-1.1279262132224908,5.821500079357914,-6.692158466855538,7.632214452325855e-10,3.3577263175337386e-9,11.498276159746716
FBXL16,ILMN_1697561,"Homo sapiens F-box and leucine-rich repeat protein 16 (FBXL16), mRNA.",,ubiquitin cycle [goid 6512] [evidence IEA],transferase activity [goid 16740] [evidence IEA],16,682825-682874,16p13.3f,-,NM_153350.2,146330,FBXL16,1.2714117578442368,6.389751936883608,6.6888900140252066,7.757031903576534e-10,3.41186832147153e-9,11.482309142777456
CYR61,ILMN_2188264,"Homo sapiens cysteine-rich, angiogenic inducer, 61 (CYR61), mRNA.",extracellular region [goid 5576] [evidence IEA],chemotaxis [goid 6935] [evidence IEA]; cell adhesion [goid 7155] [evidence IEA]; regulation of cell growth [goid 1558] [evidence IEA]; cell proliferation [goid 8283] [pmid 9135077] [evidence TAS]; morphogenesis [goid 9653] [pmid 9135077] [evidence TAS],insulin-like growth factor binding [goid 5520] [evidence IEA]; heparin binding [goid 8201] [evidence IEA],1,85821467-85821516,1p22.3e,+,NM_001554.3,3491,CYR61,-1.2847961467241902,11.406620671600711,-6.685276845730275,7.897360342117968e-10,3.468110576203935e-9,11.464662222626114
ZIC2,ILMN_1696339,"Homo sapiens Zic family member 2 (odd-paired homolog, Drosophila) (ZIC2), mRNA.",nucleus [goid 5634] [evidence IEA]; voltage-gated potassium channel complex [goid 8076] [evidence IEA]; intracellular [goid 5622] [evidence IEA],potassium ion transport [goid 6813] [evidence IEA]; cell differentiation [goid 30154] [evidence IEA]; brain development [goid 7420] [pmid 9771712] [evidence TAS],DNA binding [goid 3677] [evidence IEA]; zinc ion binding [goid 8270] [evidence IEA]; metal ion binding [goid 46872] [evidence IEA]; voltage-gated potassium channel activity [goid 5249] [evidence IEA],13,99436571-99436620,13q32.3b,+,NM_007129.2,7546,ZIC2,1.2437147181184196,5.576394512424221,6.679484744850585,8.127562126538669e-10,3.565988471866831e-9,11.436382262447292
RHOBTB3,ILMN_1744949,"Homo sapiens Rho-related BTB domain containing 3 (RHOBTB3), mRNA.",,biological process unknown [goid 4] [evidence ND ],GTPase activity [goid 3924] [pmid 12426103] [evidence NAS]; protein binding [goid 5515] [evidence IEA],5,95156219-95156268,5q15c-q15d,+,NM_014899.2,22836,RHOBTB3,1.001377031167797,10.438724144681494,6.672498278498356,8.414063489005624e-10,3.683397597916751e-9,11.40228556980541
PTPLAD2,ILMN_1690114,"Homo sapiens protein tyrosine phosphatase-like A domain containing 2 (PTPLAD2), mRNA.",,,,9,20993986-20994035,9p21.3d,-,NM_001010915.1,401494,PTPLAD2,1.4112804117700133,10.569934262533629,6.6697101056644215,8.531165030714185e-10,3.731307533635598e-9,11.388682708798562
LOC650230,ILMN_1703102,"PREDICTED: Homo sapiens similar to heat shock 70kD protein binding protein (LOC650230), mRNA.",,,,,,,,XM_941946.1,650230,LOC650230,-1.0394412518976495,7.549664244908666,-6.669430277596386,8.543006122963855e-10,3.7356479871173855e-9,11.387317633690756
IGSF4,ILMN_1680132,"Homo sapiens cell adhesion molecule 1 (CADM1), mRNA.",basolateral plasma membrane [goid 16323] [pmid 12826663] [evidence ISS]; plasma membrane [goid 5886] [pmid 15811952] [evidence IDA]; intercellular junction [goid 5911] [pmid 12826663] [evidence ISS],cell recognition [goid 8037] [pmid 15811952] [evidence IDA]; heterophilic cell adhesion [goid 7157] [pmid 12826663] [evidence ISS]; homophilic cell adhesion [goid 7156] [pmid 12826663] [evidence ISS]; cell adhesion [goid 7155] [evidence IEA]; calcium-independent cell-cell adhesion [goid 16338] [pmid 12202822] [evidence ISS]; positive regulation of cytokine secretion [goid 50715] [pmid 15811952] [evidence IDA],protein C-terminus binding [goid 8022] [pmid 12826663] [evidence ISS]; receptor binding [goid 5102] [pmid 15811952] [evidence IPI]; protein binding [goid 5515] [evidence IEA]; PDZ domain binding [goid 30165] [pmid 12826663] [evidence ISS]; protein homodimerization activity [goid 42803] [pmid 12826663] [evidence ISS],11,114550295-114550344,11q23.2c,-,NM_014333.2,23705,IGSF4,-1.1201591415565808,10.768772819119755,-6.664689779902198,8.74608706595396e-10,3.8150326053304886e-9,11.364196186344952
C19orf4,ILMN_1730945,"Homo sapiens chromosome 19 open reading frame 4 (C19orf4), mRNA.",integral to membrane [goid 16021] [pmid 10527841] [evidence TAS]; membrane [goid 16020] [evidence IEA]; membrane fraction [goid 5624] [pmid 10527841] [evidence TAS],,,19,18592697-18592746,19p13.11b,+,NM_012109.1,25789,C19orf4,1.5817012406306379,6.5315335172713285,6.66050000776739,8.929538703774846e-10,3.890699052841075e-9,11.343767081986297
SYT13,ILMN_1658499,"Homo sapiens synaptotagmin XIII (SYT13), mRNA.",membrane [goid 16020] [evidence IEA]; integral to membrane [goid 16021] [evidence IEA]; transport vesicle [goid 30133] [pmid 11256614] [evidence IDA],,,11,45218650-45218699,11p11.2d,-,NM_020826.1,57586,SYT13,1.5367723545164171,5.755799478021638,6.659524956377858,8.972773926952702e-10,3.906761047033096e-9,11.339013621458928
EGLN3,ILMN_1667626,"Homo sapiens egl nine homolog 3 (C. elegans) (EGLN3), mRNA.",nucleus [goid 5634] [evidence IEA],protein metabolism [goid 19538] [evidence IEA]; apoptosis [goid 6915] [evidence IEA],"L-ascorbic acid binding [goid 31418] [evidence IEA]; iron ion binding [goid 5506] [evidence IEA]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, 2-oxoglutarate as one donor, and incorporation of one atom each of oxygen into both donors [goid 16706] [evidence IEA]; metal ion binding [goid 46872] [evidence IEA]; oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen [goid 16702] [evidence IEA]; oxidoreductase activity [goid 16491] [evidence IEA]",14,33463218-33463267,14q13.1c,-,NM_022073.2,112399,EGLN3,1.0160822344250686,5.907563846515074,6.659487866861917,8.974422605347774e-10,3.906761047033096e-9,11.338832813084174
TMEM46,ILMN_1760412,"Homo sapiens transmembrane protein 46 (TMEM46), mRNA.",membrane [goid 16020] [evidence IEA]; integral to membrane [goid 16021] [evidence IEA],,,13,25517063-25517112,13q12.13b,-,NM_001007538.1,387914,TMEM46,-1.8462112557219612,8.188482530527716,-6.655023872547878,9.175053140203314e-10,3.984308233493684e-9,11.317074550483486
EXPH5,ILMN_1712066,"Homo sapiens exophilin 5 (EXPH5), mRNA.",,intracellular protein transport [goid 6886] [evidence IEA],zinc ion binding [goid 8270] [evidence IEA]; Rab GTPase binding [goid 17137] [evidence IEA]; protein binding [goid 5515] [evidence IEA],11,107885192-107885241,11q22.3c,-,NM_015065.1,23086,EXPH5,1.096082435763769,8.132076053644601,6.650016175812159,9.405393508037906e-10,4.073440598002191e-9,11.292674099403403
C15orf28,ILMN_1686662,"PREDICTED: Homo sapiens chromosome 15 open reading frame 28 (C15orf28), misc RNA.",,,,,,15q23a,,XR_001373.1,80035,C15orf28,1.1072610991905822,6.773130882735103,6.6466135969024025,9.565151002746817e-10,4.139870441770806e-9,11.276099507522964
LOC648024,ILMN_1665736,"PREDICTED: Homo sapiens similar to eukaryotic translation initiation factor 4A, isoform 1, transcript variant 2 (LOC648024), mRNA.",,,,,,,,XM_943353.1,648024,LOC648024,-1.1308529684223583,9.486398588327054,-6.6375282168126475,1.000497247799829e-9,4.31776054781388e-9,11.231861923479446
LOC653158,ILMN_1659490,"PREDICTED: Homo sapiens similar to hypothetical protein MGC40405, transcript variant 1 (LOC653158), mRNA.",,,,5,60710651-60710700,,+,XM_926814.1,653158,LOC653158,1.4540628797598751,8.315163679494967,6.625314868531723,1.0627819965680871e-9,4.571370243516375e-9,11.172437613095681
C14orf78,ILMN_1657111,"PREDICTED: Homo sapiens chromosome 14 open reading frame 78, transcript variant 1 (C14orf78), mRNA.",,,,14,104474690-104474739,14q32.33c,-,XM_290629.6,113146,C14orf78,1.3404373120169844,9.689528145030966,6.607788966487938,1.1588994166786334e-9,4.960710706059572e-9,11.087252804530735
TXNL6,ILMN_1742917,"Homo sapiens thioredoxin-like 6 (TXNL6), mRNA.",,electron transport [goid 6118] [evidence IEA],electron carrier activity [goid 9055] [evidence IEA]; protein disulfide oxidoreductase activity [goid 15035] [evidence IEA],19,17427256-17427305,19p13.11d,-,NM_138454.1,115861,TXNL6,1.0650890055500897,6.048615204564935,6.591564299961732,1.255503784347755e-9,5.344874642345642e-9,11.008485441162037
SIGLECP16,ILMN_2229261,"Homo sapiens sialic acid binding Ig-like lectin, pseudogene 16 (SIGLECP16) on chromosome 19.",,,,19,55170774-55170823,19q13.33b,+,NR_002825.1,400709,SIGLECP16,-1.074353174700593,5.692961439857238,-6.587265343174697,1.2824054967366566e-9,5.4486853693662795e-9,10.987629918283034
LOC645968,ILMN_1695370,"PREDICTED: Homo sapiens similar to 40S ribosomal protein S3a (V-fos transformation effector protein) (LOC645968), mRNA.",,,,7,94163044-94163065:94163066-94163093,7q21.3b,-,XM_928934.1,645968,LOC645968,-1.2416980979326047,7.443386875350695,-6.569735276898821,1.3981191434857466e-9,5.920963162534182e-9,10.902651728703198
LOC196549,ILMN_1677910,"Homo sapiens similar to hypothetical protein FLJ20897 (LOC196549), mRNA.",,,,13,31425162-31425211,13q13.1a,+,NM_145293.2,196549,LOC196549,1.3871326653375347,6.487702237956799,6.5632491302246905,1.443495375599979e-9,6.099871479845064e-9,10.871236397300482
CLDN10,ILMN_1685194,"Homo sapiens claudin 10 (CLDN10), transcript variant 2, mRNA.",integral to membrane [goid 16021] [evidence IEA]; integral to plasma membrane [goid 5887] [evidence NR ]; membrane [goid 16020] [evidence IEA]; tight junction [goid 5923] [evidence ISS]; integral to membrane [goid 16021] [evidence IEA]; integral to plasma membrane [goid 5887] [evidence NR ]; membrane [goid 16020] [evidence IEA]; tight junction [goid 5923] [evidence ISS],cell adhesion [goid 7155] [pmid 10508613] [evidence TAS]; calcium-independent cell-cell adhesion [goid 16338] [evidence ISS]; cell adhesion [goid 7155] [pmid 10508613] [evidence TAS]; calcium-independent cell-cell adhesion [goid 16338] [evidence ISS],structural molecule activity [goid 5198] [evidence IEA]; structural molecule activity [goid 5198] [evidence IEA],13,95003169-95003218,13q32.1b,+,NM_006984.3,9071,CLDN10,1.7754240870746987,6.410047467749862,6.560470822358563,1.4633737897080456e-9,6.17974791972604e-9,10.857784226422343
FLJ23834,ILMN_1809817,"Homo sapiens hypothetical protein FLJ23834 (FLJ23834), mRNA.",membrane [goid 16020] [evidence IEA],homophilic cell adhesion [goid 7156] [evidence IEA],calcium ion binding [goid 5509] [evidence IEA],7,105460957-105461006,7q22.2b-q22.2c,+,NM_152750.2,222256,FLJ23834,-1.9439537414758599,6.854953136618435,-6.542253849581245,1.6005731716716986e-9,6.72572099418224e-9,10.769646213152235
EBI2,ILMN_1798706,"Homo sapiens Epstein-Barr virus induced gene 2 (lymphocyte-specific G protein-coupled receptor) (EBI2), mRNA.",integral to plasma membrane [goid 5887] [pmid 8383238] [evidence TAS],immune response [goid 6955] [pmid 8383238] [evidence TAS]; signal transduction [goid 7165] [evidence IEA]; G-protein coupled receptor protein signaling pathway [goid 7186] [pmid 8383238] [evidence TAS],"rhodopsin-like receptor activity [goid 1584] [evidence IEA]; purinergic nucleotide receptor activity, G-protein coupled [goid 45028] [evidence IEA]; receptor activity [goid 4872] [evidence IEA]",13,98745378-98745427,13q32.3a,-,NM_004951.3,1880,EBI2,-1.0904036796652417,8.362782760154728,-6.530124453291949,1.698885192989074e-9,7.1188769861058295e-9,10.711025059926161
LOC644945,ILMN_1738546,"PREDICTED: Homo sapiens similar to Keratin, type I cytoskeletal 16 (Cytokeratin-16) (CK-16) (Keratin-16) (K16) (LOC644945), mRNA.",,,,17,20346821-20346868:20346983-20346984,17p11.2c,-,XM_930406.1,644945,LOC644945,1.4024607524306951,6.037199338427039,6.522667240657121,1.7622606476931824e-9,7.3733409319952026e-9,10.675009881653516
VTCN1,ILMN_1753101,"Homo sapiens V-set domain containing T cell activation inhibitor 1 (VTCN1), mRNA.",,,receptor activity [goid 4872] [evidence IEA],1,117487817-117487866,1p13.1a,-,NM_024626.1,79679,VTCN1,1.5182354608100388,6.257969741498295,6.521986864219831,1.7681576529840457e-9,7.396425905623472e-9,10.671724916492895
GPX2,ILMN_2133205,"Homo sapiens glutathione peroxidase 2 (gastrointestinal) (GPX2), mRNA.",cytoplasm [goid 5737] [pmid 8428933] [evidence TAS],response to oxidative stress [goid 6979] [evidence IEA],electron carrier activity [goid 9055] [pmid 8428933] [evidence TAS]; glutathione peroxidase activity [goid 4602] [pmid 8428933] [evidence TAS]; selenium binding [goid 8430] [evidence IEA],14,64475906-64475955,14q23.3a,-,NM_002083.2,2877,GPX2,2.2235918427402677,7.024323847870088,6.513963925319557,1.839180089445144e-9,7.685272151584523e-9,10.633001087403049
PLA2G4C,ILMN_1810191,"Homo sapiens phospholipase A2, group IVC (cytosolic, calcium-independent) (PLA2G4C), mRNA.",membrane [goid 16020] [pmid 10085124] [evidence TAS]; cytosol [goid 5829] [pmid 10085124] [evidence TAS],glycerophospholipid catabolism [goid 46475] [pmid 10085124] [evidence IDA]; intracellular signaling cascade [goid 7242] [pmid 10085124] [evidence NAS]; arachidonic acid metabolism [goid 19369] [pmid 10085124] [evidence NAS]; lipid catabolism [goid 16042] [evidence IEA]; inflammatory response [goid 6954] [pmid 10085124] [evidence NAS]; parturition [goid 7567] [pmid 10085124] [evidence NAS],hydrolase activity [goid 16787] [evidence IEA]; phospholipid binding [goid 5543] [pmid 10085124] [evidence NAS]; calcium-independent phospholipase A2 activity [goid 47499] [pmid 10085124] [evidence IDA],19,53243026-53243075,19q13.32c,-,NM_003706.1,8605,PLA2G4C,-1.0289231989300358,8.749085358835831,-6.503201611242917,1.9388893347460793e-9,8.088045105443665e-9,10.58109065521764
LOC642817,ILMN_1695034,"PREDICTED: Homo sapiens similar to Heterogeneous nuclear ribonucleoprotein A1 (Helix-destabilizing protein) (Single-strand binding protein) (hnRNP core protein A1) (HDP-1) (Topoisomerase-inhibitor suppressed) (LOC642817), mRNA.",,,,6,5555355-5555404,6p25.1b,-,XM_926703.1,642817,LOC642817,-1.0461678480806977,11.348398862084863,-6.500585745580259,1.9639189424213957e-9,8.183695593045528e-9,10.568479550941355
C4BPB,ILMN_1694588,"Homo sapiens complement component 4 binding protein, beta (C4BPB), transcript variant 1, mRNA.",extracellular region [goid 5576] [pmid 14718574] [evidence NAS],"innate immune response [goid 45087] [evidence IEA]; blood coagulation [goid 7596] [pmid 8325877] [evidence TAS]; complement activation, classical pathway [goid 6958] [evidence IEA]",,1,205338179-205338228,1q32.2a,+,NM_000716.3,725,C4BPB,1.073614003186072,6.167696722111221,6.49017038280218,2.0667770590685027e-9,8.58843058134992e-9,10.518290889414452
FHL2,ILMN_1668411,"Homo sapiens four and a half LIM domains 2 (FHL2), transcript variant 1, mRNA.",nucleus [goid 5634] [pmid 9150430] [evidence TAS],"androgen receptor signaling pathway [goid 30521] [pmid 15572661] [evidence NAS]; positive regulation of transcription, DNA-dependent [goid 45893] [pmid 15572661] [evidence NAS]",zinc ion binding [goid 8270] [evidence IEA]; metal ion binding [goid 46872] [evidence IEA]; transcription coactivator activity [goid 3713] [pmid 15572661] [evidence NAS]; androgen receptor binding [goid 50681] [pmid 15572661] [evidence NAS],2,105346294-105346343,2q12.2a,-,NM_001450.3,2274,FHL2,1.279811282660532,10.126472970867113,6.478010313872726,2.193602387819772e-9,9.070955544708883e-9,10.459743393077897
LOC647725,ILMN_1806703,"PREDICTED: Homo sapiens hypothetical protein LOC647725 (LOC647725), mRNA.",,,,,,,,XM_936787.1,647725,LOC647725,-1.2717960964243833,5.756882791595585,-6.477083771603561,2.2035747371288963e-9,9.106395281645078e-9,10.455284482232074
RPS23,ILMN_1772459,"Homo sapiens ribosomal protein S23 (RPS23), mRNA.",intracellular [goid 5622] [evidence IEA]; cytosolic small ribosomal subunit (sensu Eukaryota) [goid 5843] [pmid 15883184] [evidence IDA],translation [goid 43037] [evidence ISS],translation regulator activity [goid 45182] [evidence ISS]; structural constituent of ribosome [goid 3735] [pmid 15883184] [evidence IDA],5,81605044-81605093,5q14.2a,-,NM_001025.4,6228,RPS23,-1.0023543207882781,11.153516496982007,-6.465402638191715,2.333199624265627e-9,9.621220132051927e-9,10.39909606618873
LOC641849,ILMN_1745900,"PREDICTED: Homo sapiens similar to 40S ribosomal protein S3a (V-fos transformation effector protein) (LOC641849), mRNA.",,,,,,,,XM_935589.1,641849,LOC641849,-1.2101658726554065,6.880300200761534,-6.465021919040027,2.337548616067696e-9,9.633488744517566e-9,10.397265551779231
MFAP5,ILMN_1733415,"Homo sapiens microfibrillar associated protein 5 (MFAP5), mRNA.",microfibril [goid 1527] [evidence IEA]; extracellular space [goid 5615] [evidence NR ]; extracellular matrix (sensu Metazoa) [goid 5578] [evidence IEA],,extracellular matrix structural constituent [goid 5201] [pmid 8557636] [evidence TAS],12,8689900-8689949,12p13.31b,-,NM_003480.2,8076,MFAP5,-1.8429623954384988,7.164867415589459,-6.461428709067753,2.378989970260913e-9,9.795988920231169e-9,10.379991779720442
DYNLRB2,ILMN_1697317,"Homo sapiens dynein, light chain, roadblock-type 2 (DYNLRB2), mRNA.",microtubule [goid 5874] [evidence IEA]; cytoplasmic dynein complex [goid 5868] [pmid 11750132] [evidence NAS],microtubule-based movement [goid 7018] [pmid 11750132] [evidence NAS],microtubule motor activity [goid 3777] [pmid 11750132] [evidence NAS]; protein binding [goid 5515] [pmid 12077152] [evidence NAS],16,79141961-79142010,16q23.2a,+,NM_130897.1,83657,DYNLRB2,-1.4414204074041619,8.16682939177399,-6.455802783506175,2.445334724538837e-9,1.0058549104420358e-8,10.352955291847447
CHST6,ILMN_1670881,"Homo sapiens carbohydrate (N-acetylglucosamine 6-O) sulfotransferase 6 (CHST6), mRNA.",integral to membrane [goid 16021] [evidence IEA]; Golgi stack [goid 5795] [evidence IEA]; intrinsic to Golgi membrane [goid 31228] [evidence ISS],N-acetylglucosamine metabolism [goid 6044] [pmid 11352640] [evidence IDA]; keratan sulfate biosynthesis [goid 18146] [pmid 11278593] [evidence IDA]; sulfur metabolism [goid 6790] [pmid 11352640] [evidence IDA]; carbohydrate metabolism [goid 5975] [evidence IEA],transferase activity [goid 16740] [evidence IEA]; N-acetylglucosamine 6-O-sulfotransferase activity [goid 1517] [pmid 11352640] [evidence IDA],16,74064683-74064732,16q23.1a,-,NM_021615.3,4166,CHST6,1.067174408948615,6.011449898498956,6.454552335482318,2.4603268773898776e-9,1.0113812068764085e-8,10.346947551330246
ERN2,ILMN_1678899,"Homo sapiens endoplasmic reticulum to nucleus signalling 2 (ERN2), mRNA.",endoplasmic reticulum [goid 5783] [evidence IEA]; integral to membrane [goid 16021] [evidence IEA]; membrane [goid 16020] [evidence IEA],"rRNA catabolism [goid 16075] [pmid 11175748] [evidence IDA]; mRNA processing [goid 6397] [evidence IEA]; protein amino acid phosphorylation [goid 6468] [pmid 11175748] [evidence IDA]; transcription [goid 6350] [evidence IEA]; electron transport [goid 6118] [evidence IEA]; negative regulation of transcription [goid 16481] [pmid 11175748] [evidence IMP]; regulation of transcription, DNA-dependent [goid 6355] [evidence IEA]; induction of apoptosis [goid 6917] [pmid 11175748] [evidence IMP]; apoptosis [goid 6915] [evidence IEA]","magnesium ion binding [goid 287] [pmid 11175748] [evidence IDA]; nucleotide binding [goid 166] [evidence IEA]; endonuclease activity [goid 4519] [pmid 11175748] [evidence IDA]; protein serine/threonine kinase activity [goid 4674] [pmid 11175748] [evidence IDA]; ATP binding [goid 5524] [pmid 11175748] [evidence IDA]; endoribonuclease activity, producing 5'-phosphomonoesters [goid 16891] [evidence IEA]; hydrolase activity [goid 16787] [evidence IEA]; transferase activity [goid 16740] [evidence IEA]",16,23609234-23609283,16p12.1c,-,NM_033266.2,10595,ERN2,1.202765780088603,5.982191230492679,6.447776909672157,2.5431501660674944e-9,1.0430073876199774e-8,10.314404925128905
AKR1B10,ILMN_1672148,"Homo sapiens aldo-keto reductase family 1, member B10 (aldose reductase) (AKR1B10), mRNA.",,digestion [goid 7586] [pmid 9565553] [evidence TAS]; steroid metabolism [goid 8202] [pmid 9565553] [evidence TAS]; aldehyde metabolism [goid 6081] [pmid 9565553] [evidence TAS],oxidoreductase activity [goid 16491] [evidence IEA]; aldo-keto reductase activity [goid 4033] [pmid 9565553] [evidence TAS],7,133874286-133874309:133876339-133876364,7q33b,+,NM_020299.3,57016,AKR1B10,1.727887663122913,5.87605878516891,6.431885165357047,2.748351708148412e-9,1.1222052186352012e-8,10.238140745055855
SLC22A4,ILMN_1685057,"Homo sapiens solute carrier family 22 (organic cation transporter), member 4 (SLC22A4), mRNA.",integral to plasma membrane [goid 5887] [pmid 9426230] [evidence TAS]; nucleus [goid 5634] [evidence IEA]; nucleosome [goid 786] [evidence IEA]; plasma membrane [goid 5886] [pmid 9426230] [evidence TAS],ion transport [goid 6811] [evidence IEA]; organic cation transport [goid 15695] [pmid 9426230] [evidence TAS]; sodium ion transport [goid 6814] [evidence IEA]; fluid secretion [goid 7589] [pmid 9426230] [evidence TAS]; nucleosome assembly [goid 6334] [evidence IEA],sodium ion binding [goid 31402] [evidence IEA]; DNA binding [goid 3677] [evidence IEA]; ATP binding [goid 5524] [evidence IEA]; symporter activity [goid 15293] [evidence IEA]; nucleotide binding [goid 166] [pmid 9426230] [evidence TAS]; organic cation porter activity [goid 8513] [pmid 9426230] [evidence TAS]; ion transporter activity [goid 15075] [evidence IEA],5,131699588-131699592:131704157-131704201,5q31.1b,+,NM_003059.2,6583,SLC22A4,-1.1042731327281858,6.12064841974984,-6.400036680571813,3.2099634995964263e-9,1.299255064180232e-8,10.085574215599731
GFRA3,ILMN_1810716,"Homo sapiens GDNF family receptor alpha 3 (GFRA3), mRNA.",membrane [goid 16020] [evidence IEA]; extrinsic to membrane [goid 19898] [pmid 9490034] [evidence TAS],peripheral nervous system development [goid 7422] [pmid 9576965] [evidence TAS]; signal transduction [goid 7165] [pmid 9576965] [evidence TAS],receptor activity [goid 4872] [evidence IEA]; GPI anchor binding [goid 48503] [evidence IEA]; receptor binding [goid 5102] [pmid 9407096] [evidence TAS],5,137616255-137616304,5q31.2c,-,NM_001496.3,2676,GFRA3,1.74134416834554,6.572981467152239,6.3978424177795,3.2444433476661205e-9,1.3123931623266422e-8,10.075076372756605
C1orf158,ILMN_1733298,"Homo sapiens chromosome 1 open reading frame 158 (C1orf158), mRNA.",,,,1,12743506-12743555,1p36.21d,+,NM_152290.1,93190,C1orf158,-1.4598104540940966,5.901100672811563,-6.397688796288297,3.246870928342769e-9,1.3131025329754848e-8,10.074341478799862
LOC647436,ILMN_1772998,"PREDICTED: Homo sapiens similar to ribosomal protein L5, transcript variant 1 (LOC647436), mRNA.",,,,,,,,XM_937113.1,647436,LOC647436,-1.1736664107344827,6.868215534171444,-6.391416300848052,3.3475349611009725e-9,1.3523922987525979e-8,10.044342467768551
RPIB9,ILMN_1808157,"Homo sapiens Rap2-binding protein 9 (RPIB9), mRNA.",,,,7,87297603-87297652,7q21.12a-q21.12b,+,NM_138290.1,154661,RPIB9,-1.316957360309952,6.109948799458507,-6.386691006992958,3.425394519375734e-9,1.3812875043467751e-8,10.021752609043954
THY1,ILMN_1779875,"Homo sapiens Thy-1 cell surface antigen (THY1), mRNA.",lipid raft [goid 45121] [pmid 15093746] [evidence NAS]; external side of plasma membrane [goid 9897] [evidence ISS]; integral to plasma membrane [goid 5887] [pmid 2864289] [evidence TAS]; plasma membrane [goid 5886] [evidence ISS]; growth cone [goid 30426] [evidence ISS]; endoplasmic reticulum [goid 5783] [pmid 11256614] [evidence IDA]; cytosol [goid 5829] [evidence ISS],positive regulation of release of sequestered calcium ion into cytosol [goid 51281] [evidence ISS]; negative regulation of axonogenesis [goid 50771] [evidence ISS]; T cell receptor signaling pathway [goid 50852] [evidence ISS]; cell-cell adhesion [goid 16337] [evidence ISS]; positive regulation of GTPase activity [goid 43547] [evidence ISS]; positive regulation of T cell activation [goid 50870] [evidence ISS]; negative regulation of protein kinase activity [goid 6469] [evidence ISS]; positive regulation of peptidyl-tyrosine phosphorylation [goid 50731] [evidence ISS]; focal adhesion formation [goid 48041] [evidence ISS]; angiogenesis [goid 1525] [evidence ISS]; negative regulation of T cell receptor signaling pathway [goid 50860] [evidence ISS]; retinal cone cell development [goid 46549] [evidence ISS]; negative regulation of apoptosis [goid 43066] [evidence ISS]; negative regulation of fibroblast proliferation [goid 48147] [evidence ISS]; mast cell activation [goid 45576] [evidence ISS]; negative regulation of cell migration [goid 30336] [evidence ISS]; cytoskeleton organization and biogenesis [goid 7010] [evidence ISS],Rho GTPase activator activity [goid 5100] [evidence ISS]; protein binding [goid 5515] [pmid 7513706] [evidence IPI]; integrin binding [goid 5178] [pmid 15004192] [evidence IPI]; GPI anchor binding [goid 48503] [evidence ISS],11,118794230-118794279,11q23.3f,-,NM_006288.2,7070,THY1,1.3113480668346718,9.828037509602197,6.367564053873841,3.759204288161773e-9,1.50716245997597e-8,9.930397162670651
CTAGE6,ILMN_1806463,"PREDICTED: Homo sapiens CTAGE family, member 6 (CTAGE6), mRNA.",,,,7,143083292-143083341,7q35a,-,XM_498461.2,340307,CTAGE6,1.0363919718744086,6.62709630210093,6.3672270398740975,3.765364511338291e-9,1.5090112608685023e-8,9.928788695149958
TFCP2L1,ILMN_1736527,"Homo sapiens transcription factor CP2-like 1 (TFCP2L1), mRNA.",nucleus [goid 5634] [evidence IEA],transcription [goid 6350] [evidence IEA]; steroid biosynthesis [goid 6694] [pmid 10644752] [evidence TAS]; pregnancy [goid 7565] [pmid 10644752] [evidence TAS]; regulation of transcription from RNA polymerase II promoter [goid 6357] [pmid 10644752] [evidence TAS],transcription corepressor activity [goid 3714] [pmid 10644752] [evidence TAS]; transcription factor activity [goid 3700] [pmid 10644752] [evidence TAS],2,121695121-121695170,2q14.2e,-,NM_014553.1,29842,TFCP2L1,1.2181623140838012,7.613460265001968,6.361900722009293,3.864054880968003e-9,1.5453840179733482e-8,9.903373305264537
CABP4,ILMN_1688864,"Homo sapiens calcium binding protein 4 (CABP4), mRNA.",flagellum (sensu Bacteria) [goid 9288] [evidence IEA],ciliary or flagellar motility [goid 1539] [evidence IEA]; signal transduction [goid 7165] [pmid 10625670] [evidence NAS],calcium ion binding [goid 5509] [pmid 10625670] [evidence NAS],11,66983024-66983073,11q13.1f,+,NM_145200.2,57010,CABP4,1.020238710272138,5.7321504722242596,6.358550602213728,3.9274299806453765e-9,1.5694416155224603e-8,9.887393008816307
LOC387934,ILMN_1779852,"PREDICTED: Homo sapiens similar to Fatty acid-binding protein, epidermal (E-FABP) (Psoriasis-associated fatty acid-binding protein homolog) (PA-FABP) (LOC387934), mRNA.",,,,,,13q22.1a,,XM_937508.1,387934,LOC387934,-1.145575693061006,6.821286759117885,-6.3507953722381565,4.078094347418006e-9,1.6269792866388175e-08,9.850415902221787
MST1,ILMN_1707464,"Homo sapiens macrophage stimulating 1 (hepatocyte growth factor-like) (MST1), mRNA.",,blood coagulation [goid 7596] [evidence IEA],serine-type endopeptidase activity [goid 4252] [evidence IEA]; calcium ion binding [goid 5509] [evidence IEA],3,49696456-49696464:49696465-49696505,3p21.31c,-,NM_020998.2,4485,MST1,1.2309826572696014,9.694585870497342,6.350075379694166,4.092367547795851e-9,1.6323394405077205e-8,9.846984087221998
APOLD1,ILMN_1723522,"Homo sapiens apolipoprotein L domain containing 1 (APOLD1), mRNA.",,,,12,12835338-12835387,12p13.1b,+,NM_030817.1,81575,APOLD1,-1.4919474112329159,8.431274467234603,-6.327971163832401,4.555340888758982e-9,1.8077559514759425e-8,9.74171858669801
CAPSL,ILMN_1763843,"Homo sapiens calcyphosine-like (CAPSL), mRNA.",,,calcium ion binding [goid 5509] [evidence IEA]; calcium ion binding [goid 5509] [evidence IEA]; calcium ion binding [goid 5509] [evidence IEA],5,35945776-35945825,5p13.2c,-,NM_144647.2,133690,CAPSL,-1.0030878276276507,5.739462650885027,-6.306570393501641,5.052611151395466e-9,1.9977704603275295e-8,9.639976132967949
CCL3L1,ILMN_1773245,"Homo sapiens chemokine (C-C motif) ligand 3-like 1 (CCL3L1), mRNA.",extracellular region [goid 5576] [evidence NAS]; extracellular space [goid 5615] [evidence IEA]; extracellular region [goid 5576] [evidence NAS]; extracellular space [goid 5615] [evidence IEA],inflammatory response [goid 6954] [pmid 1694014] [evidence TAS]; negative regulation of cell proliferation [goid 8285] [pmid 2271120] [evidence TAS]; chemotaxis [goid 6935] [evidence NAS]; inflammatory response [goid 6954] [pmid 1694014] [evidence TAS]; negative regulation of cell proliferation [goid 8285] [pmid 2271120] [evidence TAS]; chemotaxis [goid 6935] [evidence NAS],chemokine activity [goid 8009] [evidence NAS]; chemokine activity [goid 8009] [evidence NAS],17,31649793-31649842,17q12b,-,NM_021006.4,6349,CCL3L1,-1.082405208459007,6.3517731837332905,-6.3001356040535965,5.212324565315114e-9,2.0575799058988047e-8,9.609417659058487
LOC163233,ILMN_1773236,"PREDICTED: Homo sapiens similar to Zinc finger protein 93 (Zinc finger protein HTF34) (LOC163233), mRNA.",,,,,,,,XM_938234.1,163233,LOC163233,1.012386867026314,6.031511792082111,6.287428494960646,5.542464156500326e-9,2.1795139069507334e-8,9.549117927433073
TOP1P2,ILMN_2043109,Homo sapiens topoisomerase (DNA) I pseudogene 2 (TOP1P2) on chromosome 22.,,,,22,23491609-23491658,22q11.23c,+,NR_001283.1,7152,TOP1P2,1.0108871074943924,7.347235241354343,6.285691727392337,5.589157577088087e-9,2.1961027503440487e-8,9.540881069470469
LOC115749,ILMN_1770616,"PREDICTED: Homo sapiens hypothetical protein LOC115749 (LOC115749), mRNA.",,,,12,62947271-62947320,12q14.2b,-,XM_056680.7,115749,LOC115749,1.1467207916876188,5.5130008087292035,6.283007650386175,5.662082781632681e-9,2.2234115880716e-8,9.528153703064202
CYP1A2,ILMN_1683607,"Homo sapiens cytochrome P450, family 1, subfamily A, polypeptide 2 (CYP1A2), mRNA.",membrane [goid 16020] [evidence IEA]; endoplasmic reticulum [goid 5783] [pmid 2813353] [evidence NAS]; microsome [goid 5792] [evidence IEA],electron transport [goid 6118] [evidence IEA],heme binding [goid 20037] [evidence IEA]; metal ion binding [goid 46872] [evidence IEA]; electron carrier activity [goid 9055] [pmid 2813353] [evidence TAS]; unspecific monooxygenase activity [goid 50381] [evidence IEA]; iron ion binding [goid 5506] [evidence IEA]; oxygen binding [goid 19825] [pmid 2813353] [evidence TAS],15,72835909-72835958,15q24.1b,+,NM_000761.3,1544,CYP1A2,-1.0972089161179612,5.41837013755347,-6.2805451647330965,5.729811310181998e-9,2.2481951949032668e-8,9.516479469543548
TM7SF4,ILMN_1793730,"Homo sapiens transmembrane 7 superfamily member 4 (TM7SF4), mRNA.",membrane [goid 16020] [evidence IEA]; integral to membrane [goid 16021] [pmid 11169400] [evidence NAS]; cell surface [goid 9986] [pmid 11169400] [evidence IDA],osteoclast differentiation [goid 30316] [evidence ISS],,8,105437739-105437788,8q22.3d,+,NM_030788.2,81501,TM7SF4,-1.176090172025436,6.3945038372016585,-6.259730518325295,6.335106227418335e-9,2.4752264856877135e-8,9.41789233419789
TNFAIP3,ILMN_1702691,"Homo sapiens tumor necrosis factor, alpha-induced protein 3 (TNFAIP3), mRNA.",nucleus [goid 5634] [pmid 11463333] [evidence IDA],ubiquitin cycle [goid 6512] [evidence IEA]; apoptosis [goid 6915] [evidence IEA]; anti-apoptosis [goid 6916] [evidence NAS]; negative regulation of I-kappaB kinase/NF-kappaB cascade [goid 43124] [pmid 11463333] [evidence IDA],cysteine-type peptidase activity [goid 8234] [evidence IEA]; DNA binding [goid 3677] [evidence IEA]; zinc ion binding [goid 8270] [evidence IEA]; metal ion binding [goid 46872] [evidence IEA]; protein binding [goid 5515] [pmid 11463333] [evidence IPI],6,138245727-138245776,6q23.3d,+,NM_006290.2,7128,TNFAIP3,-1.021757861033068,9.232979910800323,-6.2419000402926805,6.90337951045046e-9,2.6870225681407755e-8,9.333570390496362
CPXM2,ILMN_1741688,"Homo sapiens carboxypeptidase X (M14 family), member 2 (CPXM2), mRNA.",,cell adhesion [goid 7155] [evidence IEA],carboxypeptidase A activity [goid 4182] [evidence IEA],10,125495392-125495441,10q26.13c,-,NM_198148.1,119587,CPXM2,-1.2013269590426248,8.487602690808634,-6.239867700385438,6.971255988894848e-9,2.711817187934041e-8,9.323966971976368
ECM1,ILMN_1658333,"Homo sapiens extracellular matrix protein 1 (ECM1), transcript variant 1, mRNA.",extracellular region [goid 5576] [evidence IEA]; extracellular space [goid 5615] [evidence IEA]; extracellular matrix (sensu Metazoa) [goid 5578] [pmid 9367673] [evidence TAS],positive regulation of I-kappaB kinase/NF-kappaB cascade [goid 43123] [pmid 12761501] [evidence IMP]; transport [goid 6810] [evidence IEA],carrier activity [goid 5386] [evidence IEA]; signal transducer activity [goid 4871] [pmid 12761501] [evidence IMP],1,148750879-148750928,1q21.2b,+,NM_004425.2,1893,ECM1,1.1680010064681055,7.585091961396188,6.22963970434321,7.32295475712093e-9,2.8412539514635864e-8,9.275660605986516
PNMA3,ILMN_1783805,"Homo sapiens paraneoplastic antigen MA3 (PNMA3), mRNA.",,,nucleic acid binding [goid 3676] [evidence IEA],X,151979356-151979405,Xq28f,+,NM_013364.2,29944,PNMA3,1.0388637185117942,6.372242483205048,6.212455896024484,7.95356718313597e-9,3.0730766718898346e-8,9.194592673704449
KYNU,ILMN_1737514,"Homo sapiens kynureninase (L-kynurenine hydrolase) (KYNU), transcript variant 1, mRNA.",cytoplasm [goid 5737] [evidence IEA]; cytoplasm [goid 5737] [evidence IEA],NAD biosynthesis [goid 9435] [evidence IEA]; metabolism [goid 8152] [evidence IEA]; tryptophan catabolism [goid 6569] [evidence IEA]; NAD biosynthesis [goid 9435] [evidence IEA]; metabolism [goid 8152] [evidence IEA]; tryptophan catabolism [goid 6569] [evidence IEA],pyridoxal phosphate binding [goid 30170] [evidence IEA]; hydrolase activity [goid 16787] [evidence IEA]; kynureninase activity [goid 30429] [evidence IEA]; peptidase activity [goid 8233] [pmid 9180257] [evidence TAS]; transaminase activity [goid 8483] [evidence IEA]; pyridoxal phosphate binding [goid 30170] [evidence IEA]; hydrolase activity [goid 16787] [evidence IEA]; kynureninase activity [goid 30429] [evidence IEA]; peptidase activity [goid 8233] [pmid 9180257] [evidence TAS]; transaminase activity [goid 8483] [evidence IEA],2,143459996-143460045,2q22.2a,+,NM_003937.2,8942,KYNU,-1.1756125536850952,7.922049856029164,-6.203494743708698,8.303332016191428e-9,3.198703525810399e-8,9.152361855358684
MUC13,ILMN_1651568,"Homo sapiens mucin 13, cell surface associated (MUC13), mRNA.",membrane [goid 16020] [evidence IEA]; integral to membrane [goid 16021] [evidence IEA],,,3,126107260-126107309,3q21.2a,-,NM_033049.2,56667,MUC13,1.509221585095423,5.746079368638807,6.201818771751449,8.37040782781893e-9,3.22135880950132e-8,9.144467023279805
KIF1A,ILMN_1759330,"Homo sapiens kinesin family member 1A (KIF1A), mRNA.",microtubule associated complex [goid 5875] [evidence IEA]; microtubule [goid 5874] [evidence IEA],microtubule-based movement [goid 7018] [evidence IEA]; anterograde axon cargo transport [goid 8089] [pmid 7539720] [evidence TAS],ATP binding [goid 5524] [evidence IEA]; microtubule motor activity [goid 3777] [evidence IEA]; nucleotide binding [goid 166] [evidence IEA],2,241301894-241301943,2q37.3f,-,NM_004321.4,547,KIF1A,1.5483609320110245,5.867517165085256,6.1991984336047325,8.47634940113573e-9,3.260842410288839e-8,9.132125839347065
S100A9,ILMN_1750974,"Homo sapiens S100 calcium binding protein A9 (calgranulin B) (S100A9), mRNA.",extracellular space [goid 5615] [evidence NR ],cell-cell signaling [goid 7267] [pmid 3313057] [evidence TAS]; inflammatory response [goid 6954] [pmid 3313057] [evidence TAS],calcium ion binding [goid 5509] [pmid 2149559] [evidence TAS]; signal transducer activity [goid 4871] [pmid 3313057] [evidence TAS],1,151599776-151599825,1q21.3c,+,NM_002965.2,6280,S100A9,-1.3878922000215859,11.758354505978216,-6.196728775400688,8.577406602364774e-9,3.2951649772688806e-8,9.120496757437113
CRLF1,ILMN_1681515,"Homo sapiens cytokine receptor-like factor 1 (CRLF1), mRNA.",extracellular space [goid 5615] [pmid 9686600] [evidence TAS],antimicrobial humoral response (sensu Vertebrata) [goid 19735] [pmid 9686600] [evidence TAS],cytokine binding [goid 19955] [pmid 15034937] [evidence IPI]; receptor activity [goid 4872] [pmid 9686600] [evidence TAS],19,18565266-18565315,19p13.11c-p13.11b,-,NM_004750.2,9244,CRLF1,1.8297538730664096,7.0416032177160375,6.193607669541568,8.706818573645078e-9,3.3389561091807584e-8,9.105803532847986
LOC646100,ILMN_1676407,"PREDICTED: Homo sapiens hypothetical protein LOC646100 (LOC646100), mRNA.",,,,7,97357845-97357894,,+,XM_929061.1,646100,LOC646100,1.0796927549963469,6.180559724497937,6.189507033716486,8.879770292901477e-9,3.3999277688580325e-8,9.0865047226866409
MRC1L1,ILMN_1683806,"Homo sapiens mannose receptor, C type 1-like 1 (MRC1L1), mRNA.",,,receptor activity [goid 4872] [evidence IEA]; sugar binding [goid 5529] [evidence IEA],10,17931703-17931752,10p12.33c,+,NM_001009567.1,414308,MRC1L1,-1.0235948873327398,5.339535934265234,-6.185870090971595,9.035991545137171e-9,3.457025235754914e-8,9.069393656285097
PLD5,ILMN_1706051,"Homo sapiens phospholipase D family, member 5 (PLD5), mRNA.",membrane [goid 16020] [evidence IEA],metabolism [goid 8152] [evidence IEA],catalytic activity [goid 3824] [evidence IEA],1,240318912-240318961,1q43e-q43f,-,NM_152666.1,200150,PLD5,1.007068912163211,5.538134074096641,6.180383189863672,9.276808230492165e-9,3.547068453122838e-8,9.04358865474483
ARMC4,ILMN_1776395,"Homo sapiens armadillo repeat containing 4 (ARMC4), mRNA.",,,binding [goid 5488] [evidence IEA],10,28141508-28141557,10p12.1a-p11.23c,-,NM_018076.2,55130,ARMC4,-1.1327012731577746,5.790579102416706,-6.173992896597826,9.56524432299043e-9,3.650191649695819e-8,9.013549770023996
CCL22,ILMN_2160476,"Homo sapiens chemokine (C-C motif) ligand 22 (CCL22), mRNA.",extracellular region [goid 5576] [evidence IEA]; extracellular space [goid 5615] [pmid 9743322] [evidence TAS],antimicrobial humoral response (sensu Vertebrata) [goid 19735] [pmid 9151897] [evidence TAS]; cell-cell signaling [goid 7267] [pmid 9151897] [evidence TAS]; response to virus [goid 9615] [pmid 9381181] [evidence TAS]; chemotaxis [goid 6935] [pmid 10861057] [evidence TAS]; signal transduction [goid 7165] [pmid 9743322] [evidence TAS]; inflammatory response [goid 6954] [pmid 9151897] [evidence TAS],chemokine activity [goid 8009] [pmid 10861057] [evidence TAS],16,55957285-55957334,16q13c,+,NM_002990.3,6367,CCL22,1.1897413791638911,7.163731731742119,6.1508076759396655,1.0687785347640983e-8,4.061858738029736e-8,8.90469697063558
CACNA1I,ILMN_2300664,"Homo sapiens calcium channel, voltage-dependent, T type, alpha 1I subunit (CACNA1I), transcript variant 2, mRNA.",integral to membrane [goid 16021] [evidence IEA]; membrane [goid 16020] [evidence IEA]; voltage-gated calcium channel complex [goid 5891] [evidence NAS],ion transport [goid 6811] [evidence IEA]; calcium ion transport [goid 6816] [evidence NAS]; signal transduction [goid 7165] [pmid 10454147] [evidence TAS],low voltage-gated calcium channel activity [goid 8332] [evidence NAS]; calcium ion binding [goid 5509] [evidence IEA],22,38415607-38415656,22q13.1d,+,NM_001003406.1,8911,CACNA1I,1.0525130189718652,5.705002731037954,6.147197832846959,1.0873848850243018e-8,4.1277409866936535e-8,8.887768018858512
IGF2BP2,ILMN_1702447,"Homo sapiens insulin-like growth factor 2 mRNA binding protein 2 (IGF2BP2), transcript variant 1, mRNA.",cytoplasm [goid 5737] [pmid 10190901] [evidence TAS],morphogenesis [goid 9653] [pmid 9891060] [evidence TAS]; translational attenuation [goid 9386] [pmid 9891060] [evidence TAS],nucleotide binding [goid 166] [evidence IEA]; catalytic activity [goid 3824] [evidence IEA]; nucleic acid binding [goid 3676] [evidence IEA]; RNA binding [goid 3723] [pmid 9891060] [evidence TAS],3,186844539-186844588,3q27.2b,-,NM_006548.4,10644,IGF2BP2,1.063356305207206,8.520194476485742,6.139588961909093,1.127653695510985e-8,4.2706185144862084e-8,8.852101778901417
IGJ,ILMN_2105441,"Homo sapiens immunoglobulin J polypeptide, linker protein for immunoglobulin alpha and mu polypeptides (IGJ), mRNA.",extracellular region [goid 5576] [pmid 14718574] [evidence NAS],immune response [goid 6955] [pmid 2984306] [evidence NAS],antigen binding [goid 3823] [pmid 2984306] [evidence NAS],4,71740977-71741026,4q13.3b,-,NM_144646.2,3512,IGJ,-1.7358104753265646,10.461662650727783,-6.131164957462282,1.1739490947313223e-8,4.43904484976515e-8,8.812641287515518
KRTHB1,ILMN_1801442,"Homo sapiens keratin 81 (KRT81), mRNA.",intermediate filament [goid 5882] [evidence IEA],,structural molecule activity [goid 5198] [evidence IEA],12,50966078-50966127,12q13.13d,-,NM_002281.2,3887,KRTHB1,1.272132234430699,5.727547924710434,6.121847436537963,1.2273344981543256e-8,4.631921885829369e-8,8.769028008398177
HSPA2,ILMN_1766499,"Homo sapiens heat shock 70kDa protein 2 (HSPA2), mRNA.",cell surface [goid 9986] [pmid 12493773] [evidence IEP]; cell surface [goid 9986] [pmid 12493773] [evidence IEP],male meiosis [goid 7140] [pmid 8622925] [evidence TAS]; response to unfolded protein [goid 6986] [pmid 7829106] [evidence TAS]; protein folding [goid 6457] [evidence IEA]; male meiosis [goid 7140] [pmid 8622925] [evidence TAS]; response to unfolded protein [goid 6986] [pmid 7829106] [evidence TAS]; protein folding [goid 6457] [evidence IEA],unfolded protein binding [goid 51082] [pmid 3037489] [evidence TAS]; ATP binding [goid 5524] [evidence IEA]; nucleotide binding [goid 166] [evidence IEA]; unfolded protein binding [goid 51082] [pmid 3037489] [evidence TAS]; ATP binding [goid 5524] [evidence IEA]; nucleotide binding [goid 166] [evidence IEA],14,64079042-64079091,14q23.3a,+,NM_021979.2,3306,HSPA2,-1.019446344166516,7.173371599679094,-6.113265375449239,1.2786150518569073e-8,4.817056126340262e-8,8.728887729333266
FLJ22167,ILMN_2394523,"Homo sapiens hypothetical protein FLJ22167 (FLJ22167), transcript variant 3, mRNA.",,,,,,,,NM_001077419.1,79583,FLJ22167,-1.0600879149917537,6.789393918210305,-6.0927833640401445,1.4096727328210336e-8,5.2995317767736526e-8,8.633207195304905
EDN1,ILMN_1682775,"Homo sapiens endothelin 1 (EDN1), mRNA.",extracellular region [goid 5576] [evidence IEA]; extracellular space [goid 5615] [pmid 2670930] [evidence TAS]; soluble fraction [goid 5625] [pmid 2670930] [evidence TAS],regulation of vasoconstriction [goid 19229] [evidence IEA]; pathogenesis [goid 9405] [evidence IEA]; cell-cell signaling [goid 7267] [evidence NR ]; signal transduction [goid 7165] [pmid 2670930] [evidence TAS]; positive regulation of cell proliferation [goid 8284] [pmid 8144511] [evidence TAS],hormone activity [goid 5179] [pmid 2670930] [evidence TAS],6,12404601-12404650,6p24.1b,+,NM_001955.2,1906,EDN1,-1.1343268059242213,9.781189838087975,-6.075813987025529,1.528190623153351e-8,5.728509867668919e-8,8.554062899625734
TCN1,ILMN_1768469,"Homo sapiens transcobalamin I (vitamin B12 binding protein, R binder family) (TCN1), mRNA.",,ion transport [goid 6811] [evidence IEA]; cobalt ion transport [goid 6824] [evidence IEA]; cobalamin transport [goid 15889] [pmid 2777761] [evidence TAS],cobalt ion binding [goid 50897] [evidence IEA]; binding [goid 5488] [evidence IEA]; cobalt ion transporter activity [goid 15087] [evidence IEA],11,59377062-59377085:59377252-59377277,11q12.1d,-,NM_001062.2,6947,TCN1,2.0581875232247953,6.127268772143166,6.074583463841222,1.537156227438978e-8,5.756580644176146e-8,8.548328302312555
IL2RB,ILMN_1684349,"Homo sapiens interleukin 2 receptor, beta (IL2RB), mRNA.",plasma membrane [goid 5886] [pmid 2467293] [evidence TAS]; external side of plasma membrane [goid 9897] [evidence ISS]; integral to plasma membrane [goid 5887] [pmid 8514792] [evidence TAS],positive regulation of survival gene product activity [goid 45885] [pmid 7736574] [evidence IDA]; cytokine and chemokine mediated signaling pathway [goid 19221] [pmid 7736574] [evidence IDA]; signal transduction [goid 7165] [pmid 2785715] [evidence TAS]; protein complex assembly [goid 6461] [pmid 2467293] [evidence TAS],interleukin-2 receptor activity [goid 4911] [pmid 2467293] [evidence TAS]; receptor activity [goid 4872] [evidence IEA]; hematopoietin/interferon-class (D200-domain) cytokine receptor activity [goid 4896] [evidence IEA],22,35852138-35852187,22q12.3d,-,NM_000878.2,3560,IL2RB,-1.0412378401127,8.066065515541585,-6.0711151746183765,1.562705510694263e-8,5.850012848391492e-8,8.532168343084109
COCH,ILMN_1711514,"Homo sapiens coagulation factor C homolog, cochlin (Limulus polyphemus) (COCH), mRNA.",,,,14,30428867-30428916,14q12e,+,NM_004086.1,1690,COCH,1.1971844612802593,6.0397160805717265,6.065234353535216,1.606984441483876e-8,6.003085092468046e-8,8.504778645011442
RBP2,ILMN_2219681,"Homo sapiens retinol binding protein 2, cellular (RBP2), mRNA.",,transport [goid 6810] [evidence IEA]; vitamin A metabolism [goid 6776] [pmid 2992469] [evidence TAS]; epidermis development [goid 8544] [pmid 1654334] [evidence TAS],retinal binding [goid 16918] [evidence IEA]; retinol binding [goid 19841] [evidence IEA]; lipid binding [goid 8289] [evidence IEA],3,140656263-140656312,3q23a,-,NM_004164.2,5948,RBP2,-1.0185948167912562,5.927196715975618,-6.0630848488281774,1.6234748584131664e-8,6.058879068412287e-8,8.494770892665752
PLSCR1,ILMN_1745242,"Homo sapiens phospholipid scramblase 1 (PLSCR1), mRNA.",plasma membrane [goid 5886] [pmid 9218461] [evidence TAS]; integral to membrane [goid 16021] [evidence IEA],phospholipid scrambling [goid 17121] [pmid 9218461] [evidence TAS]; response to virus [goid 9615] [evidence IEA]; platelet activation [goid 30168] [pmid 9218461] [evidence NAS],calcium ion binding [goid 5509] [pmid 9218461] [evidence NAS]; phospholipid scramblase activity [goid 17128] [pmid 9218461] [evidence TAS]; protein binding [goid 5515] [pmid 16189514] [evidence IPI],3,147729187-147729236,3q24d,-,NM_021105.1,5359,PLSCR1,-1.085162679674185,6.977982428494065,-6.053493937938521,1.6991042942570594e-8,6.337489887748623e-8,8.450139898446452
LOC284422,ILMN_1774375,"PREDICTED: Homo sapiens similar to HSPC323 (LOC284422), mRNA.",,,,,,19p13.3f,,XM_939969.1,284422,LOC284422,1.2338620450443871,5.732941692465874,6.01867890494333,2.0038928003972103e-8,7.424367651293815e-8,8.288443277061234
PAEP,ILMN_1748004,"Homo sapiens progestagen-associated endometrial protein (placental protein 14, pregnancy-associated endometrial alpha-2-globulin, alpha uterine protein) (PAEP), transcript variant 2, mRNA.",,development [goid 7275] [pmid 3194393] [evidence TAS]; transport [goid 6810] [evidence IEA],binding [goid 5488] [evidence IEA]; transporter activity [goid 5215] [evidence IEA],9,137597462-137597468:137598220-137598262,9q34.3b,+,NM_002571.2,5047,PAEP,1.6118529167231888,5.755023649836618,6.017232305982802,2.017657615848555e-8,7.469895239370909e-8,8.28173532700253
MAG,ILMN_1803773,"Homo sapiens myelin associated glycoprotein (MAG), transcript variant 1, mRNA.",membrane [goid 16020] [evidence IEA]; integral to membrane [goid 16021] [evidence IEA],cell adhesion [goid 7155] [evidence IEA],sugar binding [goid 5529] [evidence IEA]; protein binding [goid 5515] [evidence IEA],19,40496458-40496507,19q13.12a,+,NM_002361.2,4099,MAG,-1.0185787023062245,5.517387778271046,-6.013773553370887,2.0509465442615642e-8,7.583053778925347e-8,8.265700398179106
INPP4B,ILMN_2198878,"Homo sapiens inositol polyphosphate-4-phosphatase, type II, 105kDa (INPP4B), mRNA.",,signal transduction [goid 7165] [pmid 9295334] [evidence TAS],"phosphatidylinositol-3,4-bisphosphate 4-phosphatase activity [goid 16316] [pmid 9295334] [evidence TAS]; hydrolase activity [goid 16787] [evidence IEA]",4,143222645-143222694,4q31.21b,-,NM_003866.1,8821,INPP4B,1.0236777539778714,7.09172531012415,6.010919926862111,2.0788173636379962e-8,7.68172886980587e-8,8.252474553888451
WDR72,ILMN_1763196,"Homo sapiens WD repeat domain 72 (WDR72), mRNA.",,,,15,51594718-51594767,15q21.3a,-,NM_182758.1,256764,WDR72,1.4565340376966027,6.270802801271168,6.008176353707345,2.1059641887467567e-8,7.774670749854216e-8,8.2397619308314
LOC649143,ILMN_1707951,"PREDICTED: Homo sapiens similar to HLA class II histocompatibility antigen, DRB1-9 beta chain precursor (MHC class I antigen DRB1*9) (DR-9) (DR9), transcript variant 2 (LOC649143), mRNA.",,,,,,,,XM_944822.1,649143,LOC649143,-1.066912404611994,8.476952766131259,-6.007258073400691,2.1151278901809444e-8,7.805542981093884e-8,8.235507676912807
MTE,ILMN_2136089,"Homo sapiens metallothionein E (MTE), mRNA.",,,metal ion binding [goid 46872] [evidence IEA],,,,,NM_175621.2,644314,MTE,-1.1349582352794325,9.5798182589277,-5.995287064029534,2.2382354422239673e-8,8.231788899912043e-8,8.180079535556484
FBXO2,ILMN_1803211,"Homo sapiens F-box protein 2 (FBXO2), mRNA.",,protein catabolism [goid 30163] [evidence IEA]; ubiquitin cycle [goid 6512] [evidence IEA],ubiquitin-protein ligase activity [goid 4842] [pmid 10531035] [evidence TAS]; protein binding [goid 5515] [evidence IEA]; ubiquitin conjugating enzyme activity [goid 4840] [pmid 10531035] [evidence TAS],1,11631219-11631268,1p36.22b,-,NM_012168.4,26232,FBXO2,1.1452393626203223,7.566006893304124,5.957913284965534,2.669667063042892e-8,9.723077144559019e-8,8.007412785267395
CD19,ILMN_1782704,"Homo sapiens CD19 antigen (CD19), mRNA.",integral to membrane [goid 16021] [evidence IEA]; integral to plasma membrane [goid 5887] [pmid 2472450] [evidence TAS]; plasma membrane [goid 5886] [pmid 2472450] [evidence TAS],cell surface receptor linked signal transduction [goid 7166] [pmid 1714482] [evidence TAS]; cellular defense response [goid 6968] [pmid 1373518] [evidence TAS],receptor signaling protein activity [goid 5057] [pmid 1373518] [evidence TAS]; protein binding [goid 5515] [pmid 8647200] [evidence IPI],16,28857792-28857800:28857963-28858003,16p11.2e,+,NM_001770.3,930,CD19,1.1408964968580362,6.4706278900177825,5.944634596418265,2.8418346066468374e-8,1.0321183096088281e-7,7.946205198409648
HP,ILMN_1812433,"Homo sapiens haptoglobin (HP), mRNA.",extracellular region [goid 5576] [pmid 14718574] [evidence NAS],defense response [goid 6952] [pmid 7036344] [evidence TAS]; iron ion homeostasis [goid 6879] [evidence NAS],serine-type endopeptidase activity [goid 4252] [evidence IEA]; hemoglobin binding [goid 30492] [evidence IEA],16,70652001-70652050,16q22.3a,+,NM_005143.2,3240,HP,-1.9304223416707016,8.587699970584083,-5.942484055637336,2.870725773336345e-8,1.0420285337827624e-7,7.93629930502257
LOC389394,ILMN_1671615,"PREDICTED: Homo sapiens similar to TRP (transient receptor potential) channel family member (trp-4) (LOC389394), mRNA.",,,,,,,,XM_941689.1,389394,LOC389394,-1.1566197610278808,5.525610938017365,-5.931338334869446,3.025147215480676e-8,1.0960392988776678e-7,7.88499058327642
NYD-SP14,ILMN_1694979,"Homo sapiens tetratricopeptide repeat domain 29 (TTC29), mRNA.",,,binding [goid 5488] [evidence IEA],4,147944089-147944138,4q31.23a,-,NM_031956.1,83894,NYD-SP14,-1.2404857413119696,5.738978812109478,-5.925808774667749,3.104757519279739e-8,1.1236292768047125e-7,7.859554921857989
TEP1,ILMN_1770682,"Homo sapiens telomerase-associated protein 1 (TEP1), mRNA.","chromosome [goid 5694] [evidence IEA]; chromosome, telomeric region [goid 781] [evidence IEA]; nuclear matrix [goid 16363] [pmid 7876352] [evidence IDA]; telomerase holoenzyme complex [goid 5697] [pmid 12135483] [evidence IDA]; nucleus [goid 5634] [evidence IEA]; soluble fraction [goid 5625] [evidence ISS]; cytoplasm [goid 5737] [pmid 7876352] [evidence IDA]",,telomerase activity [goid 3720] [pmid 12135483] [evidence IDA]; RNA binding [goid 3723] [evidence ISS]; nucleotide binding [goid 166] [evidence IEA]; ATP binding [goid 5524] [evidence IEA],14,19906082-19906131,14q11.2b,-,NM_007110.3,7011,TEP1,1.0984887511433046,7.382027329442356,5.923312143551013,3.141372978088226e-8,1.1351938515958657e-7,7.84807477854535
NR5A2,ILMN_1811303,"Homo sapiens nuclear receptor subfamily 5, group A, member 2 (NR5A2), transcript variant 1, mRNA.",nucleus [goid 5634] [pmid 9786908] [evidence TAS]; nucleus [goid 5634] [pmid 9786908] [evidence TAS],"morphogenesis [goid 9653] [pmid 9786908] [evidence TAS]; transcription from RNA polymerase II promoter [goid 6366] [pmid 9786908] [evidence TAS]; regulation of transcription, DNA-dependent [goid 6355] [evidence IEA]; homeostasis [goid 42592] [pmid 16289203] [evidence NAS]; transcription [goid 6350] [evidence IEA]; embryonic development [goid 9790] [pmid 16289203] [evidence TAS]; morphogenesis [goid 9653] [pmid 9786908] [evidence TAS]; transcription from RNA polymerase II promoter [goid 6366] [pmid 9786908] [evidence TAS]; regulation of transcription, DNA-dependent [goid 6355] [evidence IEA]; homeostasis [goid 42592] [pmid 16289203] [evidence NAS]; transcription [goid 6350] [evidence IEA]; embryonic development [goid 9790] [pmid 16289203] [evidence TAS]","transcription factor activity [goid 3700] [evidence IEA]; ligand-dependent nuclear receptor activity [goid 4879] [evidence IEA]; RNA polymerase II transcription factor activity, enhancer binding [goid 3705] [pmid 9786908] [evidence TAS]; protein binding [goid 5515] [pmid 12040021] [evidence IPI]; sequence-specific DNA binding [goid 43565] [pmid 16289203] [evidence IDA]; lipid binding [goid 8289] [evidence IEA]; zinc ion binding [goid 8270] [evidence IEA]; metal ion binding [goid 46872] [evidence IEA]; receptor activity [goid 4872] [evidence IEA]; steroid hormone receptor activity [goid 3707] [evidence IEA]; transcription factor activity [goid 3700] [evidence IEA]; ligand-dependent nuclear receptor activity [goid 4879] [evidence IEA]; RNA polymerase II transcription factor activity, enhancer binding [goid 3705] [pmid 9786908] [evidence TAS]; protein binding [goid 5515] [pmid 12040021] [evidence IPI]; sequence-specific DNA binding [goid 43565] [pmid 16289203] [evidence IDA]; lipid binding [goid 8289] [evidence IEA]; zinc ion binding [goid 8270] [evidence IEA]; metal ion binding [goid 46872] [evidence IEA]; receptor activity [goid 4872] [evidence IEA]; steroid hormone receptor activity [goid 3707] [evidence IEA]",1,198412730-198412779,1q32.1a,+,NM_205860.1,2494,NR5A2,-1.0118580303558051,6.5376931920532675,-5.902144039083743,3.469353740438309e-8,1.2479298067646384e-7,7.750844197861661
PTGER1,ILMN_1744929,"Homo sapiens prostaglandin E receptor 1 (subtype EP1), 42kDa (PTGER1), mRNA.",integral to plasma membrane [goid 5887] [pmid 8253813] [evidence TAS]; membrane [goid 16020] [evidence IEA],G-protein coupled receptor protein signaling pathway [goid 7186] [pmid 8253813] [evidence TAS]; signal transduction [goid 7165] [evidence IEA],prostaglandin E receptor activity [goid 4957] [pmid 8253813] [evidence TAS]; receptor activity [goid 4872] [evidence IEA]; rhodopsin-like receptor activity [goid 1584] [evidence IEA],19,14444337-14444371:14444372-14444386,19p13.12c,-,NM_000955.2,5731,PTGER1,-1.1781597454210386,7.724195867614625,-5.896236083621167,3.566745287927588e-8,1.281542171035756e-7,7.723741292703845
AGTRL1,ILMN_1700183,"Homo sapiens angiotensin II receptor-like 1 (AGTRL1), mRNA.",integral to membrane [goid 16021] [evidence IEA]; membrane [goid 16020] [evidence IEA]; integral to plasma membrane [goid 5887] [pmid 8294032] [evidence TAS]; plasma membrane [goid 5886] [pmid 9792798] [evidence TAS],signal transduction [goid 7165] [evidence IEA]; G-protein coupled receptor protein signaling pathway [goid 7186] [pmid 9792798] [evidence TAS],receptor activity [goid 4872] [pmid 9792798] [evidence TAS]; rhodopsin-like receptor activity [goid 1584] [evidence IEA],11,56757745-56757794,11q12.1a,-,NM_005161.2,187,AGTRL1,-1.3145567840233996,8.404290203255094,-5.894222323225445,3.6005513616279995e-8,1.2932118577202133e-7,7.7145064992023995
C20orf103,ILMN_1713561,"Homo sapiens chromosome 20 open reading frame 103 (C20orf103), mRNA.",membrane [goid 16020] [evidence IEA]; integral to membrane [goid 16021] [evidence IEA],,,20,9458993-9459042,20p12.2b,+,NM_012261.2,24141,C20orf103,1.180987433122766,7.422524443103505,5.874874706871406,3.941807396028664e-8,1.407478781594622e-7,7.625869301828902
C6orf165,ILMN_1757837,"Homo sapiens chromosome 6 open reading frame 165 (C6orf165), transcript variant 1, mRNA.",,,,6,88230585-88230634,6q15a,+,NM_001031743.1,154313,C6orf165,-1.1343438569515474,6.033784946527012,-5.863142896027046,4.1639956428904305e-8,1.4835519309146102e-7,7.572200247785953
TM4SF18,ILMN_1739170,"Homo sapiens transmembrane 4 L six family member 18 (TM4SF18), mRNA.",integral to membrane [goid 16021] [evidence IEA]; membrane [goid 16020] [evidence IEA]; integral to membrane [goid 16021] [evidence IEA]; membrane [goid 16020] [evidence IEA],,,3,150522768-150522817,3q25.1a,-,NM_138786.1,116441,TM4SF18,-1.255917792375719,7.350631962608344,-5.8484612395804865,4.459431748914017e-8,1.58014234638279e-7,7.505119840621803
DKFZp666G057,ILMN_2184884,"Homo sapiens hypothetical protein DKFZp666G057 (DKFZp666G057), mRNA.",,,,15,80363867-80363916,15q25.2a,+,NM_001008226.1,283726,DKFZp666G057,-1.2221965610290368,5.526703601483347,-5.842177218291288,4.592084348645502e-8,1.6259633569572526e-7,7.476436535295929
LOC644063,ILMN_1701753,"PREDICTED: Homo sapiens similar to heterogeneous nuclear ribonucleoprotein K isoform a, transcript variant 2 (LOC644063), mRNA.",,,,3,97550966-97551015,3q11.2b,+,XM_931572.1,644063,LOC644063,-1.4202457545683993,8.355219505565257,-5.829999764047876,4.8602616307224394e-8,1.716552435646669e-7,7.420901296237024
LOC401551,ILMN_2077008,"Homo sapiens WD repeat domain 38 (WDR38), mRNA.",,,,,,,,NM_001045476.1,401551,LOC401551,-1.4570399440704884,6.777365814452715,-5.814750655413169,5.217837153682664e-8,1.835853321406766e-7,7.351448381456138
MS4A8B,ILMN_1808249,"Homo sapiens membrane-spanning 4-domains, subfamily A, member 8B (MS4A8B), mRNA.",membrane [goid 16020] [evidence IEA]; integral to membrane [goid 16021] [evidence IEA],signal transduction [goid 7165] [evidence IEA],receptor activity [goid 4872] [evidence IEA],11,60239514-60239563,11q12.2a,+,NM_031457.1,83661,MS4A8B,-2.0344164662944095,7.116339498482529,-5.813517568918551,5.247854788672787e-8,1.8454150975868842e-7,7.345836635000938
MDAC1,ILMN_1815773,"Homo sapiens transmembrane protein 190 (TMEM190), mRNA.",,,,19,60580873-60580898:60580982-60581005,19q13.42b,+,NM_139172.1,147744,MDAC1,-1.7576826625568227,5.981616469585439,-5.807067603362225,5.407652229516644e-8,1.8992087904133347e-7,7.316493787764691
DPP4,ILMN_1692535,"Homo sapiens dipeptidyl-peptidase 4 (CD26, adenosine deaminase complexing protein 2) (DPP4), mRNA.",membrane [goid 16020] [evidence IEA]; integral to membrane [goid 16021] [evidence IEA],immune response [goid 6955] [pmid 9710254] [evidence TAS],prolyl oligopeptidase activity [goid 4287] [evidence IEA]; aminopeptidase activity [goid 4177] [evidence IEA]; dipeptidyl-peptidase IV activity [goid 4274] [pmid 9710254] [evidence TAS],2,162557231-162557280,2q24.2d,-,NM_001935.3,1803,DPP4,1.2769922303674885,7.676431123580454,5.800443532058127,5.576731172398116e-8,1.9557704624581946e-7,7.286377760273591
CST5,ILMN_1688022,"Homo sapiens cystatin D (CST5), mRNA.",,,cysteine protease inhibitor activity [goid 4869] [pmid 1939105] [evidence TAS],20,23804797-23804824:23804825-23804846,20p11.21b,-,NM_001900.4,1473,CST5,-1.0273592315508306,6.166333967882182,-5.772391868156014,6.35209671809831e-8,2.2133512974274957e-7,7.159055089967938
SPAG6,ILMN_1772458,"Homo sapiens sperm associated antigen 6 (SPAG6), transcript variant 1, mRNA.",flagellum [goid 19861] [evidence IEA]; cytoskeleton [goid 5856] [evidence IEA]; axoneme [goid 5930] [pmid 10493827] [evidence TAS]; microtubule [goid 5874] [evidence IEA],,binding [goid 5488] [evidence IEA],10,22739969-22740018,10p12.31a,+,NM_012443.2,9576,SPAG6,-1.4537403555984385,6.236773287531008,-5.751314854824149,7.003339874939058e-8,2.4259569326788895e-7,7.063617260349001
HPGD,ILMN_2166457,"Homo sapiens hydroxyprostaglandin dehydrogenase 15-(NAD) (HPGD), mRNA.",cytosol [goid 5829] [pmid 15581601] [evidence TAS],prostaglandin metabolism [goid 6693] [pmid 15581601] [evidence TAS]; metabolism [goid 8152] [evidence IEA]; pregnancy [goid 7565] [pmid 15531523] [evidence IDA]; lipid metabolism [goid 6629] [evidence IEA]; fatty acid metabolism [goid 6631] [evidence IEA]; parturition [goid 7567] [pmid 15531523] [evidence IDA]; transforming growth factor beta receptor signaling pathway [goid 7179] [pmid 15574495] [evidence IDA],oxidoreductase activity [goid 16491] [evidence IEA]; protein homodimerization activity [goid 42803] [pmid 2025296] [evidence TAS]; NAD binding [goid 51287] [pmid 15581601] [evidence IDA]; prostaglandin E receptor activity [goid 4957] [pmid 10198228] [evidence IDA]; 15-hydroxyprostaglandin dehydrogenase (NAD+) activity [goid 16404] [pmid 15581601] [evidence IDA],4,175648475-175648524,4q34.1d,-,NM_000860.3,3248,HPGD,-1.569268401522633,9.676617672961157,-5.750250504683681,7.037908538544747e-8,2.4374981847412793e-7,7.058803037365176
LRRC50,ILMN_1776967,"Homo sapiens leucine rich repeat containing 50 (LRRC50), mRNA.",,,transferase activity [goid 16740] [evidence IEA],16,82767369-82767406:82768836-82768847,16q24.1a,+,NM_178452.3,123872,LRRC50,-1.2073428381418845,6.256667684928963,-5.744778402532806,7.218293995926493e-8,2.497309277532452e-7,7.034059788759984
ITGA10,ILMN_1700144,"Homo sapiens integrin, alpha 10 (ITGA10), mRNA.",integral to membrane [goid 16021] [evidence IEA]; integrin complex [goid 8305] [pmid 9685391] [evidence TAS],cell-matrix adhesion [goid 7160] [pmid 9685391] [evidence TAS]; integrin-mediated signaling pathway [goid 7229] [evidence IEA],magnesium ion binding [goid 287] [evidence IEA]; collagen binding [goid 5518] [pmid 9685391] [evidence TAS]; receptor activity [goid 4872] [evidence IEA]; calcium ion binding [goid 5509] [evidence IEA],1,144255050-144255099,1q21.1b,+,NM_003637.3,8515,ITGA10,-1.0544679669724433,7.3408171948242975,-5.741750250313231,7.320056452669384e-8,2.5298208581103746e-7,7.020373079962481
FLJ10847,ILMN_1670325,"Homo sapiens solute carrier family 47, member 1 (SLC47A1), mRNA.",membrane [goid 16020] [evidence IEA],multidrug transport [goid 6855] [evidence IEA],drug transporter activity [goid 15238] [evidence IEA]; antiporter activity [goid 15297] [evidence IEA],17,19422831-19422880,17p11.2d,+,NM_018242.2,55244,FLJ10847,-1.0189384746952364,8.070889667264698,-5.721214868553674,8.048250043217706e-8,2.770184633317382e-7,6.927664481619657
GZMK,ILMN_1710734,"Homo sapiens granzyme K (granzyme 3; tryptase II) (GZMK), mRNA.",cytoplasm [goid 5737] [evidence NR ],,serine-type endopeptidase activity [goid 4252] [evidence IEA],5,54365361-54365410,5q11.2d,+,NM_002104.2,3003,GZMK,-1.1060903663777708,8.260189682617145,-5.70116972931778,8.827379565191464e-8,3.0234046550844734e-7,6.837350875605064
HSD17B13,ILMN_1683844,"Homo sapiens hydroxysteroid (17-beta) dehydrogenase 13 (HSD17B13), mRNA.",,metabolism [goid 8152] [evidence IEA],oxidoreductase activity [goid 16491] [evidence IEA],4,88444840-88444889,4q22.1a,-,NM_178135.2,345275,HSD17B13,-1.3236077435612827,5.746631622207437,-5.697878258078757,8.962194387189882e-8,3.0647307412143705e-7,6.822538348280472
PPP1R14C,ILMN_1664855,"Homo sapiens protein phosphatase 1, regulatory (inhibitor) subunit 14C (PPP1R14C), mRNA.",membrane [goid 16020] [evidence IEA],,protein phosphatase inhibitor activity [goid 4864] [evidence IEA],6,150612837-150612886,6q25.1b,+,NM_030949.1,81706,PPP1R14C,-1.0648980684871567,8.492532135922383,-5.6886203394833625,9.352302655698404e-8,3.1919708748692136e-7,6.780901312434707
LOC641805,ILMN_1780772,"PREDICTED: Homo sapiens similar to PMS1 protein homolog 2 (DNA mismatch repair protein PMS2) (LOC641805), mRNA.",,,,,,,,XM_935564.1,641805,LOC641805,-1.0436106348864627,5.320763068268152,-5.6775812987179854,9.839257668956775e-8,3.3493699454860715e-7,6.731304307048421
SERPINA3,ILMN_1788874,"Homo sapiens serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 3 (SERPINA3), mRNA.",extracellular region [goid 5576] [pmid 14718574] [evidence NAS]; intracellular [goid 5622] [pmid 9880565] [evidence NAS],regulation of lipid metabolism [goid 19216] [pmid 11835318] [evidence NAS]; acute-phase response [goid 6953] [evidence IEA]; inflammatory response [goid 6954] [pmid 12475184] [evidence NAS],DNA binding [goid 3677] [pmid 9880565] [evidence IC ]; chymotrypsin inhibitor activity [goid 30569] [pmid 9880565] [evidence NAS]; protein binding [goid 5515] [pmid 14687906] [evidence IPI],14,94160006-94160055,14q32.13b,+,NM_001085.4,12,SERPINA3,-1.334702960125668,10.652372171825284,-5.638678667835333,1.1761662147644707e-7,3.9723527396451746e-7,6.55696043567271
ISL1,ILMN_1763390,"Homo sapiens ISL1 transcription factor, LIM/homeodomain, (islet-1) (ISL1), mRNA.",nucleus [goid 5634] [evidence IEA],"regulation of transcription, DNA-dependent [goid 6355] [evidence IEA]; development [goid 7275] [evidence IEA]",metal ion binding [goid 46872] [evidence IEA]; zinc ion binding [goid 8270] [evidence IEA]; transcription factor activity [goid 3700] [evidence IEA]; sequence-specific DNA binding [goid 43565] [evidence IEA],5,50725929-50725978,5q11.2a,+,NM_002202.1,3670,ISL1,1.1656711202830952,5.641944934773317,5.621806466006066,1.2705644811542942e-7,4.2735972579477683e-7,6.4815617123545435
C1orf173,ILMN_1751569,"Homo sapiens chromosome 1 open reading frame 173 (C1orf173), mRNA.",,,,1,74806841-74806890,1p31.1h,-,NM_001002912.2,127254,C1orf173,-1.0853053778440387,5.819978057000794,-5.6156707395154735,1.3067014703001212e-7,4.3830397914955863e-7,6.454174705109945
LDLRAD1,ILMN_1731343,"Homo sapiens low density lipoprotein receptor class A domain containing 1 (LDLRAD1), mRNA.",,,,1,54247327-54247376,1p32.3b,-,NM_001010978.2,388633,LDLRAD1,-1.4224568643038147,6.167946716325374,-5.6044584760495875,1.3753558866589507e-7,4.6038154014000435e-7,6.404173214802362
DNAI1,ILMN_1745880,"Homo sapiens dynein, axonemal, intermediate polypeptide 1 (DNAI1), mRNA.",cytoskeleton [goid 5856] [pmid 10577904] [evidence TAS]; microtubule [goid 5874] [evidence IEA]; dynein complex [goid 30286] [evidence IEA]; cilium [goid 5929] [pmid 10577904] [evidence TAS],,motor activity [goid 3774] [pmid 10577904] [evidence TAS],9,34510899-34510948,9p13.3c,+,NM_012144.2,27019,DNAI1,-1.2856112760094751,6.181979193309028,-5.59303225217385,1.448952175231326e-7,4.836873930851873e-7,6.353277296172439
CCL18,ILMN_1654411,"Homo sapiens chemokine (C-C motif) ligand 18 (pulmonary and activation-regulated) (CCL18), mRNA.",extracellular region [goid 5576] [evidence IEA]; extracellular space [goid 5615] [evidence IEA],antimicrobial humoral response (sensu Vertebrata) [goid 19735] [pmid 9233607] [evidence TAS]; cell-cell signaling [goid 7267] [pmid 9233607] [evidence TAS]; chemotaxis [goid 6935] [pmid 9192897] [evidence TAS]; inflammatory response [goid 6954] [evidence IEA]; signal transduction [goid 7165] [pmid 9233607] [evidence TAS]; response to biotic stimulus [goid 9607] [pmid 9233607] [evidence TAS],chemokine activity [goid 8009] [pmid 9192897] [evidence TAS],17,31422539-31422588,17q12b,+,NM_002988.2,6362,CCL18,-1.4475343582858011,7.47335603595405,-5.581822711625424,1.524895051810833e-7,5.073869549954591e-7,6.303405332068679
CHST9,ILMN_1700547,"Homo sapiens carbohydrate (N-acetylgalactosamine 4-0) sulfotransferase 9 (CHST9), mRNA.",intrinsic to Golgi membrane [goid 31228] [evidence ISS]; integral to membrane [goid 16021] [pmid 11139592] [evidence NAS]; Golgi stack [goid 5795] [evidence IEA],sulfur metabolism [goid 6790] [pmid 11445554] [evidence IDA]; carbohydrate metabolism [goid 5975] [evidence IEA],transferase activity [goid 16740] [evidence IEA]; N-acetylgalactosamine 4-O-sulfotransferase activity [goid 1537] [pmid 11445554] [evidence IDA],18,22749905-22749954,18q11.2e,-,NM_031422.1,83539,CHST9,-1.4265399505837006,5.980829785202409,-5.569150172693027,1.6154481274465405e-7,5.359612934325871e-7,6.247094734734756
CCNA1,ILMN_2157099,"Homo sapiens cyclin A1 (CCNA1), mRNA.",microtubule cytoskeleton [goid 15630] [pmid 11256614] [evidence IDA]; nucleus [goid 5634] [evidence IEA]; cytosol [goid 5829] [pmid 9041194] [evidence TAS],male meiosis I [goid 7141] [pmid 9843212] [evidence TAS]; spermatogenesis [goid 7283] [pmid 9843212] [evidence TAS]; mitosis [goid 7067] [evidence IEA]; meiosis [goid 7126] [evidence IEA]; cell cycle [goid 7049] [evidence IEA]; cell division [goid 51301] [evidence IEA],protein binding [goid 5515] [pmid 15232106] [evidence IPI],13,35912278-35912320:35913255-35913261,13q13.3b,+,NM_003914.2,8900,CCNA1,-1.027889788153587,5.682920765924568,-5.548383884081841,1.775340381936393e-7,5.858172284848537e-7,6.154981509293388
NME5,ILMN_1784783,"Homo sapiens non-metastatic cells 5, protein expressed in (nucleoside-diphosphate kinase) (NME5), mRNA.",cellular component unknown [goid 8372] [evidence ND ],CTP biosynthesis [goid 6241] [evidence IEA]; UTP biosynthesis [goid 6228] [evidence IEA]; GTP biosynthesis [goid 6183] [evidence IEA]; response to reactive oxygen species [goid 302] [evidence ISS]; nucleoside metabolism [goid 9116] [pmid 9742940] [evidence TAS]; anti-apoptosis [goid 6916] [evidence ISS]; spermatogenesis [goid 7283] [pmid 9742940] [evidence TAS]; cell differentiation [goid 30154] [evidence IEA],ATP binding [goid 5524] [evidence IEA],5,137478823-137478872,5q31.2c,-,NM_003551.2,8382,NME5,-1.0060727406455543,6.714705541987431,-5.543010268146324,1.819176427144245e-7,5.990646050854423e-7,6.1311786085415045
ANPEP,ILMN_1763837,"Homo sapiens alanyl (membrane) aminopeptidase (aminopeptidase N, aminopeptidase M, microsomal aminopeptidase, CD13, p150) (ANPEP), mRNA.",ER-Golgi intermediate compartment [goid 5793] [pmid 15308636] [evidence IDA]; integral to plasma membrane [goid 5887] [pmid 2564851] [evidence TAS],angiogenesis [goid 1525] [evidence IEA]; cell differentiation [goid 30154] [evidence IEA],metallopeptidase activity [goid 8237] [pmid 2564851] [evidence TAS]; aminopeptidase activity [goid 4177] [pmid 10734069] [evidence TAS]; zinc ion binding [goid 8270] [evidence IEA]; metal ion binding [goid 46872] [evidence IEA]; receptor activity [goid 4872] [pmid 1350662] [evidence TAS]; membrane alanyl aminopeptidase activity [goid 4179] [evidence IEA],15,88129409-88129458,15q26.1b,-,NM_001150.1,290,ANPEP,-1.187939545343757,8.17968477835692,-5.517601494175874,2.041219297145644e-7,6.68568801561319e-7,6.018812284120968
PRSS3,ILMN_1685699,"Homo sapiens protease, serine, 3 (mesotrypsin) (PRSS3), mRNA.",extracellular space [goid 5615] [pmid 6698368] [evidence IDA],digestion [goid 7586] [pmid 14507909] [evidence TAS],serine-type endopeptidase activity [goid 4252] [evidence IEA]; trypsin activity [goid 4295] [pmid 14507909] [evidence IDA]; peptidase activity [goid 8233] [evidence IEA]; calcium ion binding [goid 5509] [pmid 6698368] [evidence IDA]; protein binding [goid 5515] [pmid 14507909] [evidence IPI],9,33788069-33788080:33788484-33788521,9p13.3d,+,NM_002771.2,5646,PRSS3,1.2862370475075933,5.647708058702889,5.515768658647552,2.0582241809318475e-7,6.736855058870662e-7,6.010718640726199
CCDC60,ILMN_1722446,"Homo sapiens coiled-coil domain containing 60 (CCDC60), mRNA.",,,,12,118462957-118463006,12q24.23b-q24.23c,+,NM_178499.2,160777,CCDC60,-1.0615910628050997,5.807171658440937,-5.5152747028784805,2.0628307218224032e-7,6.75079889397204e-7,6.008537646675038
GDF15,ILMN_2188862,"Homo sapiens growth differentiation factor 15 (GDF15), mRNA.",extracellular space [goid 5615] [evidence IEA]; extracellular region [goid 5576] [pmid 9326641] [evidence TAS],transforming growth factor beta receptor signaling pathway [goid 7179] [pmid 9348093] [evidence TAS]; signal transduction [goid 7165] [pmid 9326641] [evidence TAS]; cell-cell signaling [goid 7267] [pmid 9326641] [evidence TAS],growth factor activity [goid 8083] [evidence IEA]; cytokine activity [goid 5125] [pmid 9326641] [evidence TAS],19,18360697-18360745:18360746-18360746,19p13.11c,+,NM_004864.1,9518,GDF15,1.2752397998494533,10.31038882103896,5.482949529152051,2.387261327666084e-7,7.762981804000943e-7,5.866062097554381
SLC1A7,ILMN_1704629,"Homo sapiens solute carrier family 1 (glutamate transporter), member 7 (SLC1A7), mRNA.",membrane [goid 16020] [evidence IEA]; integral to membrane [goid 16021] [evidence NAS],transport [goid 6810] [evidence IEA]; dicarboxylic acid transport [goid 6835] [pmid 9108121] [evidence TAS],symporter activity [goid 15293] [evidence IEA]; sodium:dicarboxylate symporter activity [goid 17153] [evidence IEA]; L-glutamate transporter activity [goid 5313] [pmid 9108121] [evidence TAS],1,53325531-53325580,1p32.3c,-,NM_006671.3,6512,SLC1A7,1.5958134136179254,6.697945558430909,5.466220389232751,2.574251546691333e-7,8.345971944639039e-7,5.792522878513187
KIAA1199,ILMN_1813704,"Homo sapiens KIAA1199 (KIAA1199), mRNA.",,,,15,79030856-79030905,15q25.1b,+,NM_018689.1,57214,KIAA1199,1.2759999544747034,8.49690176275852,5.452069429592958,2.7435465724272155e-7,8.859463865386857e-7,5.730421815462777
ZMYND10,ILMN_2125763,"Homo sapiens zinc finger, MYND-type containing 10 (ZMYND10), mRNA.",cytoplasm [goid 5737] [pmid 11256614] [evidence IDA],,zinc ion binding [goid 8270] [evidence IEA]; metal ion binding [goid 46872] [evidence IEA]; protein binding [goid 5515] [pmid 16189514] [evidence IPI],3,50353767-50353816,3p21.31b,-,NM_015896.2,51364,ZMYND10,-1.4626336823898285,6.547574174224001,-5.434686304869549,2.966459470425546e-7,9.538195178422733e-7,5.654268524919149
LOC145837,ILMN_1688228,"PREDICTED: Homo sapiens hypothetical protein LOC145837, transcript variant 2 (LOC145837), mRNA.",,,,15,67650682-67650731,15q23a,+,XM_934770.1,145837,LOC145837,1.3453428201583302,6.228288707349815,5.417915306269115,3.1982610341687825e-7,1.023958531889233e-6,5.580935449720363
LRRC46,ILMN_1768818,"Homo sapiens leucine rich repeat containing 46 (LRRC46), mRNA.",,,transferase activity [goid 16740] [evidence IEA],17,43269334-43269383,17q21.32b,+,NM_033413.2,90506,LRRC46,-1.122450730000307,6.237630047642896,-5.388251634650346,3.6523581945233056e-7,1.1601923609437007e-6,5.451562841714083
WBSCR27,ILMN_1719170,"Homo sapiens Williams Beuren syndrome chromosome region 27 (WBSCR27), mRNA.",,,,7,72886999-72887008:72887009-72887048,7q11.23b,-,NM_152559.2,155368,WBSCR27,1.1653871619175398,7.837906186990595,5.365758200818497,4.0381235831549425e-7,1.2768194692659516e-6,5.353749097133744
MGC24103,ILMN_1811779,"PREDICTED: Homo sapiens hypothetical protein MGC24103 (MGC24103), misc RNA.",,,,9,16516491-16516540,,-,XR_001080.1,158295,MGC24103,1.322020353879629,7.328599096273036,5.3425327045019255,4.4781584054814344e-7,1.4095767365483807e-6,5.253013632184369
JSRP1,ILMN_1739726,"Homo sapiens junctional sarcoplasmic reticulum protein 1 (JSRP1), mRNA.",,,,19,,19p13.3g,-,NM_144616.2,126306,JSRP1,1.5426624411608163,8.157434510988619,5.337068756283264,4.5882965428245537e-7,1.4424485017253376e-6,5.229353770067495
LOC649598,ILMN_1661303,"PREDICTED: Homo sapiens hypothetical protein LOC649598 (LOC649598), mRNA.",,,,,,9p13.3b,,XM_941608.1,649598,LOC649598,1.2021706500012739,6.744959923619697,5.33621149590179,4.605814950555822e-7,1.4472553509366263e-6,5.225643026032729
OSM,ILMN_1780546,"Homo sapiens oncostatin M (OSM), mRNA.",extracellular space [goid 5615] [pmid 2779549] [evidence TAS],development [goid 7275] [pmid 1717982] [evidence TAS]; negative regulation of cell proliferation [goid 8285] [pmid 1717982] [evidence TAS]; regulation of cell growth [goid 1558] [evidence IEA]; cell proliferation [goid 8283] [pmid 1542793] [evidence TAS]; immune response [goid 6955] [evidence IEA]; cell-cell signaling [goid 7267] [evidence NR ],oncostatin-M receptor binding [goid 5147] [pmid 9920829] [evidence TAS]; cytokine activity [goid 5125] [pmid 2779549] [evidence TAS],22,28988989-28989038,22q12.2b,-,NM_020530.3,5008,OSM,-1.3206516710669538,6.959465193677854,-5.320646058829601,4.935499369438021e-7,1.547854582544662e-6,5.158329923917425
LOC349136,ILMN_1700248,"Homo sapiens WD repeat domain 86 (WDR86), mRNA.",,electron transport [goid 6118] [evidence IEA],,7,150709154-150709203,7q36.1d,-,NM_198285.1,349136,LOC349136,1.0360363268111854,7.476865251582512,5.279090691056083,5.932655029198014e-7,1.8442530830236649e-6,4.979216068025294
CCL13,ILMN_1783593,"Homo sapiens chemokine (C-C motif) ligand 13 (CCL13), mRNA.",extracellular region [goid 5576] [evidence IEA]; membrane [goid 16020] [evidence IEA]; extracellular space [goid 5615] [pmid 9195948] [evidence TAS],cell-cell signaling [goid 7267] [pmid 9195948] [evidence TAS]; chemotaxis [goid 6935] [pmid 9195948] [evidence TAS]; calcium ion homeostasis [goid 6874] [pmid 9195948] [evidence TAS]; signal transduction [goid 7165] [pmid 9558100] [evidence TAS]; inflammatory response [goid 6954] [pmid 9195948] [evidence TAS],chemokine receptor activity [goid 4950] [evidence NR ]; signal transducer activity [goid 4871] [pmid 9558100] [evidence NAS]; chemokine activity [goid 8009] [pmid 9558100] [evidence TAS],17,29709538-29709587,17q12a,+,NM_005408.2,6357,CCL13,-1.1382295111016596,8.71958028621168,-5.258094053763498,6.508724039704405e-7,2.0101836727475086e-6,4.889045935794239
TFAP2D,ILMN_1659378,"Homo sapiens transcription factor AP-2 delta (activating enhancer binding protein 2 delta) (TFAP2D), mRNA.",nucleus [goid 5634] [evidence IEA],"regulation of transcription, DNA-dependent [goid 6355] [evidence IEA]",transcription factor activity [goid 3700] [evidence IEA],6,50848453-50848502,6p12.3a,+,NM_172238.1,83741,TFAP2D,1.0993762629226573,5.438145806186167,5.237986564411454,7.111378513694101e-7,2.184193101187414e-6,4.802903757617025
GRP,ILMN_1777199,"Homo sapiens gastrin-releasing peptide (GRP), transcript variant 1, mRNA.",extracellular space [goid 5615] [pmid 8756537] [evidence IDA]; soluble fraction [goid 5625] [evidence NR ],neuropeptide signaling pathway [goid 7218] [pmid 8756537] [evidence IDA]; signal transduction [goid 7165] [pmid 3027901] [evidence NAS],neuropeptide hormone activity [goid 5184] [pmid 8756537] [evidence IDA]; growth factor activity [goid 8083] [evidence NR ],18,55043872-55043921,18q21.32a,+,NM_002091.3,2922,GRP,-1.2505174362272848,6.702009405364215,-5.233174641294273,7.26348188895775e-7,2.2284513400463196e-6,4.7823195900529205
PLA2G2A,ILMN_1740586,"Homo sapiens phospholipase A2, group IIA (platelets, synovial fluid) (PLA2G2A), mRNA.",extracellular region [goid 5576] [pmid 9272153] [evidence TAS]; membrane [goid 16020] [evidence IEA]; endoplasmic reticulum [goid 5783] [pmid 11256614] [evidence IDA],lipid catabolism [goid 16042] [evidence IEA]; phospholipid metabolism [goid 6644] [evidence IEA],calcium-dependent phospholipase A2 activity [goid 47498] [pmid 9272153] [evidence TAS]; hydrolase activity [goid 16787] [evidence IEA]; calcium ion binding [goid 5509] [evidence IEA],1,20174643-20174692,1p36.13a,-,NM_000300.2,5320,PLA2G2A,-1.4372110148581028,6.082251909193822,-5.214701632732184,7.877440119745911e-7,2.4058294785775718e-6,4.703406697210183
SOX9,ILMN_1805466,"Homo sapiens SRY (sex determining region Y)-box 9 (campomelic dysplasia, autosomal sex-reversal) (SOX9), mRNA.",nucleus [goid 5634] [pmid 10805756] [evidence TAS],cartilage condensation [goid 1502] [evidence NR ]; skeletal development [goid 1501] [evidence NR ]; transcription [goid 6350] [evidence IEA]; regulation of transcription from RNA polymerase II promoter [goid 6357] [pmid 10805756] [evidence TAS],specific RNA polymerase II transcription factor activity [goid 3704] [pmid 10805756] [evidence TAS]; DNA binding [goid 3677] [evidence IEA],17,67633576-67633625,17q24.3c,+,NM_000346.2,6662,SOX9,1.0595293686324876,7.582426338040176,5.208503464254782,8.094561553173187e-7,2.469044017901997e-6,4.676968557787705
POU2AF1,ILMN_1811049,"Homo sapiens POU domain, class 2, associating factor 1 (POU2AF1), mRNA.",nucleus [goid 5634] [evidence IEA],"regulation of transcription, DNA-dependent [goid 6355] [evidence IEA]; humoral immune response [goid 6959] [pmid 7859290] [evidence TAS]; transcription [goid 6350] [evidence IEA]; transcription from RNA polymerase II promoter [goid 6366] [pmid 7859290] [evidence TAS]",transcription coactivator activity [goid 3713] [pmid 7859290] [evidence TAS],11,110728486-110728535,11q23.1b,-,NM_006235.1,5450,POU2AF1,1.007365479714597,6.57238513365501,5.208088516208304,8.109303774732357e-7,2.4727665735627543e-6,4.6751993110907835
DACT2,ILMN_1691790,"Homo sapiens dapper, antagonist of beta-catenin, homolog 2 (Xenopus laevis) (DACT2), mRNA.",,,,6,168450633-168450682,6q27d,-,NM_214462.1,168002,DACT2,-1.0625792233983704,6.592585504059308,-5.1879418865714415,8.857444788820551e-7,2.6913627295762077e-6,4.589405098659445
C6orf206,ILMN_1659985,"Homo sapiens chromosome 6 open reading frame 206 (C6orf206), mRNA.",,,,6,43732353-43732402,6p21.1c,+,NM_152732.2,221421,C6orf206,-1.2472358279328812,6.100206834316019,-5.182583588765773,9.067495042265805e-7,2.752455848240368e-6,4.566622076484058
LOC642829,ILMN_1793950,"PREDICTED: Homo sapiens prostate-specific P704P (P704P), mRNA.",,,,14,19058193-19058242,14q11.1d,-,XM_926231.1,641455,LOC642829,-1.0033916235713596,7.162008150937644,-5.181993299823862,9.090929744291993e-7,2.7578509429788177e-6,4.564113125882758
C9orf117,ILMN_1686841,"Homo sapiens chromosome 9 open reading frame 117 (C9orf117), mRNA.",,,,9,129518030-129518079,9q34.11a,+,NM_001012502.2,286207,C9orf117,-1.3547102676340383,6.655404304688674,-5.124590872217957,1.1675311789219025e-6,3.4923771908647942e-6,4.320995966297965
LOC653216,ILMN_2190541,"Homo sapiens XAGE-2 protein (LOC653216), mRNA.",,,,,,,,NM_001079538.1,653216,LOC653216,-1.2175024396869683,6.45633546454963,-5.121822577648471,1.181656403720127e-6,3.5313765378047047e-6,4.309314872669375
FLJ23152,ILMN_1696243,"PREDICTED: Homo sapiens hypothetical gene supported by AK026805 (FLJ23152), mRNA.",,,,6,17239415-17239464,6p22.3e,+,XM_376469.2,401236,FLJ23152,-1.5517807041031215,7.563165386217805,-5.114083362651562,1.2220348193899116e-6,3.644780109568717e-6,4.276679844027071
LOC387882,ILMN_1716382,"Homo sapiens hypothetical protein (LOC387882), mRNA.",,,,12,104288777-104288826,12q23.3b,+,NM_207376.1,387882,LOC387882,-1.173233158030608,8.243142674030564,-5.099972776250613,1.2991417415270407e-6,3.866469655361904e-6,4.2172589040232635
SCGB3A1,ILMN_1679666,"Homo sapiens secretoglobin, family 3A, member 1 (SCGB3A1), mRNA.",extracellular region [goid 5576] [pmid 11481438] [evidence NAS]; extracellular space [goid 5615] [evidence IEA],regulation of cell proliferation [goid 42127] [pmid 11481438] [evidence NAS]; negative regulation of cell growth [goid 30308] [pmid 11481438] [evidence NAS],cytokine activity [goid 5125] [pmid 11481438] [evidence NAS],5,179950251-179950300,5q35.3f,-,NM_052863.2,92304,SCGB3A1,-1.6203235950784887,12.524786317314685,-5.083704308134945,1.3939289125148935e-6,4.131534052381001e-6,4.148881414715784
LOC440585,ILMN_1777170,"PREDICTED: Homo sapiens hypothetical LOC440585, transcript variant 3 (LOC440585), mRNA.",,,,,,1p34.2a,,XM_942137.1,440585,LOC440585,-1.9016153838936045,8.92261863121036,-5.083666983952001,1.3941539364274883e-6,4.1315725401200935e-6,4.148724699702178
C20orf133,ILMN_1725633,"Homo sapiens MACRO domain containing 2 (MACROD2), transcript variant 2, mRNA.",,,,20,15125509-15125558,20p12.1d-p12.1b,+,NM_001033087.1,140733,C20orf133,-1.3511633256661142,6.619743605202936,-5.072257057161171,1.4646273772351728e-6,4.3298838484945145e-6,4.1008518912006275
NELL2,ILMN_1725417,"Homo sapiens NEL-like 2 (chicken) (NELL2), mRNA.",extracellular region [goid 5576] [evidence NAS],cell adhesion [goid 7155] [evidence NAS],structural molecule activity [goid 5198] [evidence NAS]; calcium ion binding [goid 5509] [evidence NAS]; protein binding [goid 5515] [pmid 16713569] [evidence IPI],12,43188674-43188723,12q12g,-,NM_006159.1,4753,NELL2,-1.0623031191056516,6.8731856831775975,-5.063285889346387,1.5224619348433448e-6,4.488602027602144e-6,4.063260013987555
CXCL1,ILMN_1787897,"Homo sapiens chemokine (C-X-C motif) ligand 1 (melanoma growth stimulating activity, alpha) (CXCL1), mRNA.",extracellular region [goid 5576] [evidence IEA]; extracellular space [goid 5615] [pmid 10881932] [evidence TAS],negative regulation of cell proliferation [goid 8285] [pmid 9551928] [evidence TAS]; chemotaxis [goid 6935] [pmid 10820279] [evidence TAS]; intracellular signaling cascade [goid 7242] [pmid 9551928] [evidence TAS]; actin cytoskeleton organization and biogenesis [goid 30036] [pmid 9725262] [evidence TAS]; cell proliferation [goid 8283] [pmid 8380167] [evidence TAS]; G-protein coupled receptor protein signaling pathway [goid 7186] [pmid 10820279] [evidence TAS]; inflammatory response [goid 6954] [pmid 9725262] [evidence TAS],enzyme activator activity [goid 8047] [pmid 9079638] [evidence TAS]; growth factor activity [goid 8083] [evidence IEA]; chemokine activity [goid 8009] [pmid 10820279] [evidence TAS],4,74955506-74955555,4q13.3d,+,NM_001511.1,2919,CXCL1,-1.0676407578994285,6.6263532078682745,-5.053617517174281,1.5872799379932183e-6,4.670514888522781e-6,4.022794655643701
HHLA2,ILMN_1737076,"Homo sapiens HERV-H LTR-associating 2 (HHLA2), mRNA.",membrane [goid 16020] [evidence IEA]; integral to membrane [goid 16021] [evidence IEA],,,3,109579373-109579422,3q13.13a,+,NM_007072.2,11148,HHLA2,1.0442583709626856,5.81817209420526,5.012328120549211,1.895632150315535e-6,5.519484824999731e-6,3.8505481400826715
HAS1,ILMN_1754716,"Homo sapiens hyaluronan synthase 1 (HAS1), mRNA.",integral to plasma membrane [goid 5887] [pmid 9169154] [evidence TAS]; membrane [goid 16020] [evidence IEA]; extracellular matrix (sensu Metazoa) [goid 5578] [evidence NR ],substrate-bound cell migration [goid 6929] [evidence NR ]; cell adhesion [goid 7155] [pmid 8798544] [evidence TAS]; glycosaminoglycan biosynthesis [goid 6024] [pmid 8798544] [evidence TAS],"transferase activity, transferring glycosyl groups [goid 16757] [evidence IEA]; hyaluronan synthase activity [goid 50501] [evidence IEA]",19,56908379-56908428,19q13.33e,-,NM_001523.1,3036,HAS1,-1.1716723561163276,5.551897156296653,-4.999968701153515,1.9987624763451317e-6,5.800698071430576e-6,3.7991669615921095
CDH17,ILMN_1814015,"Homo sapiens cadherin 17, LI cadherin (liver-intestine) (CDH17), mRNA.",membrane fraction [goid 5624] [evidence NR ]; membrane [goid 16020] [evidence IEA]; integral to plasma membrane [goid 5887] [evidence NR ],transport [goid 6810] [pmid 8153632] [evidence NAS]; cell adhesion [goid 7155] [pmid 8153632] [evidence TAS]; homophilic cell adhesion [goid 7156] [evidence IEA],protein binding [goid 5515] [evidence IEA]; calcium ion binding [goid 5509] [evidence IEA]; transporter activity [goid 5215] [pmid 8153632] [evidence TAS],8,95208696-95208745,8q22.1b,-,NM_004063.2,1015,CDH17,1.087567744300368,5.426635568219181,4.983465664419719,2.1450121205814523e-6,6.196525006601868e-6,3.7306886862045916
HLA-DRB6,ILMN_2066060,"Homo sapiens major histocompatibility complex, class II, DR beta 6 (pseudogene) (HLA-DRB6) on chromosome 6.",,,,6,32628571-32628620,6p21.32b,-,NR_001298.1,3128,HLA-DRB6,-1.0976519713414241,11.408180326887928,-4.972423069810264,2.2486278693433653e-6,6.475689334046035e-6,3.684950776897554
CCDC17,ILMN_1787441,"Homo sapiens coiled-coil domain containing 17 (CCDC17), mRNA.",,,,1,45858518-45858567,1p34.1b,-,NM_152500.1,149483,CCDC17,-1.1169759450884946,6.354327746950462,-4.960442863363547,2.366544985057017e-6,6.799193310798581e-6,3.635404481207641
IL8,ILMN_1666733,"Homo sapiens interleukin 8 (IL8), mRNA.",extracellular space [goid 5615] [pmid 10823949] [evidence TAS],G-protein coupled receptor protein signaling pathway [goid 7186] [pmid 8381837] [evidence TAS]; neutrophil chemotaxis [goid 30593] [pmid 11564821] [evidence IGI]; sensory perception [goid 7600] [evidence IEA]; induction of positive chemotaxis [goid 50930] [pmid 11564821] [evidence IGI]; negative regulation of cell proliferation [goid 8285] [pmid 9551928] [evidence TAS]; intracellular signaling cascade [goid 7242] [pmid 10734056] [evidence TAS]; regulation of retroviral genome replication [goid 45091] [pmid 11483765] [evidence IDA]; chemotaxis [goid 6935] [pmid 10620615] [evidence TAS]; cell-cell signaling [goid 7267] [pmid 10881932] [evidence IC ]; cell cycle arrest [goid 7050] [pmid 11564821] [evidence IDA]; neutrophil activation [goid 42119] [pmid 11483765] [evidence TAS]; calcium-mediated signaling [goid 19722] [pmid 11877327] [evidence TAS]; angiogenesis [goid 1525] [pmid 11483765] [evidence TAS]; regulation of cell adhesion [goid 30155] [pmid 2007144] [evidence IDA]; cell motility [goid 6928] [pmid 10820279] [evidence TAS],chemokine activity [goid 8009] [pmid 10881932] [evidence TAS]; protein binding [goid 5515] [pmid 10880251] [evidence IPI]; interleukin-8 receptor binding [goid 5153] [pmid 1840701] [evidence IPI],4,74827512-74827561,4q13.3d,+,NM_000584.2,3576,IL8,-1.3529021787530322,9.508681611107274,-4.926191803883675,2.7377975962241245e-6,7.805968124440602e-6,3.4941865741487765
LOC653994,ILMN_1737586,"PREDICTED: Homo sapiens similar to Eukaryotic translation initiation factor 4H (eIF-4H) (Williams-Beuren syndrome chromosome region 1 protein homolog), transcript variant 2 (LOC653994), mRNA.",,,,,,,,XM_944429.1,653994,LOC653994,-1.3736239793844582,7.0121484857618706,-4.912207250382094,2.9051346778249955e-6,8.25770228992269e-6,3.4367135139224922
MUC5AC,ILMN_1748303,"PREDICTED: Homo sapiens mucin 5, subtypes A and C, tracheobronchial/gastric (MUC5AC), mRNA.",,,,11,1178751-1178800,11p15.5c,+,XM_495860.2,4586,MUC5AC,1.637048588238435,6.397455022439481,4.858060088946519,3.6518625121762867e-6,1.0250149963952023e-5,3.2152054007291815
CLDN2,ILMN_1795190,"Homo sapiens claudin 2 (CLDN2), mRNA.",tight junction [goid 5923] [evidence ISS]; membrane [goid 16020] [evidence IEA]; integral to membrane [goid 16021] [evidence ISS],calcium-independent cell-cell adhesion [goid 16338] [evidence ISS],structural molecule activity [goid 5198] [evidence IEA],X,106060454-106060503,Xq22.3b,+,NM_020384.2,9075,CLDN2,1.513338337879123,6.4635061960070095,4.849393165017904,3.7875222338362416e-6,1.06110525846584e-5,3.179902231532526
AGR3,ILMN_1728787,"Homo sapiens anterior gradient homolog 3 (Xenopus laevis) (AGR3), mRNA.",,,,7,16884704-16884753,7p21.1b,-,NM_176813.3,155465,AGR3,-1.0952738183519184,8.541091268998573,-4.758811202702586,5.5321357750455295e-6,1.5154458818608484e-5,2.813472826627261
VSIG1,ILMN_1806198,"Homo sapiens V-set and immunoglobulin domain containing 1 (VSIG1), mRNA.",membrane [goid 16020] [evidence IEA],,,X,107208870-107208919,Xq22.3c,+,NM_182607.3,340547,VSIG1,1.161857969931165,5.7860907124763585,4.704974067820775,6.9149898751859225e-6,1.8698109591728795e-5,2.597909954220202
CAPS,ILMN_1757660,"Homo sapiens calcyphosine (CAPS), transcript variant 2, mRNA.",,intracellular signaling cascade [goid 7242] [pmid 2540953] [evidence TAS],calcium ion binding [goid 5509] [pmid 2540953] [evidence TAS],19,5866751-5866800,19p13.3b,+,NM_080590.1,828,CAPS,-1.4214826443382744,8.77273058619015,-4.7018888083426615,7.0036452034677984e-6,1.8929895614542498e-5,2.5856074352986544
FBXO15,ILMN_1755281,"Homo sapiens F-box protein 15 (FBXO15), mRNA.",,ubiquitin cycle [goid 6512] [evidence IEA],,18,69891752-69891801,18q22.3c,-,NM_152676.1,201456,FBXO15,-1.0979363425884996,7.27011548027717,-4.69829570013286,7.1082814455589246e-6,1.9204778697547928e-5,2.571286835791402
CCL8,ILMN_1772964,"Homo sapiens chemokine (C-C motif) ligand 8 (CCL8), mRNA.",extracellular region [goid 5576] [evidence IEA]; membrane [goid 16020] [evidence IEA]; extracellular space [goid 5615] [evidence IEA],response to virus [goid 9615] [pmid 9468473] [evidence TAS]; cell-cell signaling [goid 7267] [pmid 10734056] [evidence TAS]; chemotaxis [goid 6935] [pmid 9468473] [evidence TAS]; inflammatory response [goid 6954] [evidence IEA]; signal transduction [goid 7165] [pmid 9119400] [evidence TAS]; calcium ion transport [goid 6816] [pmid 10734056] [evidence TAS]; exocytosis [goid 6887] [pmid 10734056] [evidence TAS],signal transducer activity [goid 4871] [pmid 10734056] [evidence TAS]; heparin binding [goid 8201] [evidence IEA]; chemokine activity [goid 8009] [pmid 9468473] [evidence TAS],17,29672323-29672372,17q12a,+,NM_005623.2,6355,CCL8,-1.1263258971333183,8.743847752516315,-4.690776316192339,7.3321778594816646e-6,1.9774046448719753e-5,2.541342084073441
DNHD2,ILMN_1801341,"Homo sapiens dynein heavy chain domain 2 (DNHD2), mRNA.",dynein complex [goid 30286] [evidence IEA],microtubule-based movement [goid 7018] [evidence IEA],microtubule motor activity [goid 3777] [evidence IEA],3,,3p14.3b,-,NM_178504.3,201625,DNHD2,-1.0056146991605006,5.896028120398477,-4.682702323575086,7.58018876753407e-6,2.038928466805651e-5,2.509225375944582
GSTA2,ILMN_1655613,"Homo sapiens glutathione S-transferase A2 (GSTA2), mRNA.",,metabolism [goid 8152] [evidence IEA]; metabolism [goid 8152] [evidence IEA],transferase activity [goid 16740] [evidence IEA]; glutathione transferase activity [goid 4364] [pmid 3138230] [evidence TAS]; transferase activity [goid 16740] [evidence IEA]; glutathione transferase activity [goid 4364] [pmid 3138230] [evidence TAS],6,52729056-52729066:52730618-52730656,6p12.1d,-,NM_000846.3,2939,GSTA2,-1.379260609838119,6.706976777046821,-4.681573988408281,7.615488505450821e-6,2.048140697428699e-5,2.5047401164173477
TFF1,ILMN_1722489,"Homo sapiens trefoil factor 1 (TFF1), mRNA.",,carbohydrate metabolism [goid 5975] [pmid 2303034] [evidence TAS]; defense response [goid 6952] [evidence NR ]; digestion [goid 7586] [pmid 9043862] [evidence NAS],growth factor activity [goid 8083] [evidence IEA],21,42656492-42656541,21q22.3b,-,NM_003225.2,7031,TFF1,1.5310636266004014,5.712063458933588,4.6799596281133145,7.666270313175561e-6,2.06009208457076e-5,2.498324145059862
MSLN,ILMN_2353161,"Homo sapiens mesothelin (MSLN), transcript variant 2, mRNA.",membrane [goid 16020] [pmid 8552591] [evidence NAS],cell adhesion [goid 7155] [pmid 8552591] [evidence NAS],peptide antigen binding [goid 42605] [pmid 14676194] [evidence IPI]; GPI anchor binding [goid 48503] [evidence IEA]; protein binding [goid 5515] [evidence IEA],16,758810-758859,16p13.3f,+,NM_013404.3,10232,MSLN,-1.5248248193325669,11.724211365003326,-4.675186638475666,7.818335754820397e-6,2.099218302090057e-5,2.4793637025591346
TNNC2,ILMN_1693428,"Homo sapiens troponin C type 2 (fast) (TNNC2), mRNA.",troponin complex [goid 5861] [evidence NR ],regulation of muscle contraction [goid 6937] [pmid 2373703] [evidence TAS],calcium ion binding [goid 5509] [evidence IEA],20,43886352-43886401,20q13.12b,-,NM_003279.2,7125,TNNC2,1.046584684808666,6.450125169081349,4.583398195600545,1.137913073247089e-5,2.98857477183172e-5,2.1173481212514558
FGB,ILMN_1678049,"Homo sapiens fibrinogen beta chain (FGB), mRNA.",soluble fraction [goid 5625] [pmid 6688356] [evidence TAS]; fibrinogen complex [goid 5577] [pmid 6688356] [evidence TAS],blood coagulation [goid 7596] [evidence IEA]; positive regulation of cell proliferation [goid 8284] [evidence NR ],,4,155711083-155711132,4q32.1a,+,NM_005141.2,2244,FGB,1.087445938567006,5.540293912323581,4.574276039982477,1.1808595613454602e-5,3.094277642928495e-5,2.0816432985033186
S100P,ILMN_1801216,"Homo sapiens S100 calcium binding protein P (S100P), mRNA.",nucleus [goid 5634] [pmid 15632002] [evidence IDA]; cytoplasm [goid 5737] [pmid 15632002] [evidence TAS],,magnesium ion binding [goid 287] [pmid 15632002] [evidence TAS]; calcium ion binding [goid 5509] [pmid 1633809] [evidence TAS]; calcium-dependent protein binding [goid 48306] [pmid 15632002] [evidence IPI],4,6749666-6749670:6749671-6749715,4p16.1f,+,NM_005980.2,6286,S100P,1.703320758526793,9.36756574344593,4.530784321567329,1.4080924391862358e-5,3.648980074151324e-5,1.912099784046677
HMGCS2,ILMN_1815203,"Homo sapiens 3-hydroxy-3-methylglutaryl-Coenzyme A synthase 2 (mitochondrial) (HMGCS2), mRNA.",mitochondrion [goid 5739] [pmid 7851882] [evidence TAS],cholesterol biosynthesis [goid 6695] [evidence IEA]; acetyl-CoA metabolism [goid 6084] [evidence IEA],hydroxymethylglutaryl-CoA synthase activity [goid 4421] [evidence IEA]; transferase activity [goid 16740] [evidence IEA],1,120092776-120092825,1p12a,-,NM_005518.2,3158,HMGCS2,-1.337349450212808,6.6070989709085195,-4.4951298966802025,1.6253576024135673e-5,4.179766778808019e-5,1.7739604578564991
DEFB1,ILMN_1686573,"Homo sapiens defensin, beta 1 (DEFB1), mRNA.",extracellular region [goid 5576] [evidence IEA],innate immune response [goid 45087] [pmid 12517831] [evidence NAS],,8,6722756-6722789:6722790-6722805,8p23.1f,-,NM_005218.3,1672,DEFB1,-1.2717183762281898,7.23143932487379,-4.4415304370648645,2.0139403507559368e-5,5.1269437855342864e-5,1.567753819610096
CHGB,ILMN_1765966,"Homo sapiens chromogranin B (secretogranin 1) (CHGB), mRNA.",extracellular space [goid 5615] [evidence NR ],,hormone activity [goid 5179] [pmid 3608978] [evidence TAS],20,5853679-5853695:5853696-5853728,20p12.3c,+,NM_001819.1,1114,CHGB,1.0183597471141708,5.719804189987219,4.414846671543507,2.239391240204078e-5,5.666087302347287e-5,1.4657554828350365
HLA-DRB4,ILMN_1752592,"Homo sapiens major histocompatibility complex, class II, DR beta 4 (HLA-DRB4), mRNA.",integral to membrane [goid 16021] [evidence IEA]; integral to plasma membrane [goid 5887] [evidence NR ]; membrane [goid 16020] [evidence IEA]; integral to membrane [goid 16021] [evidence IEA]; integral to plasma membrane [goid 5887] [evidence NR ]; membrane [goid 16020] [evidence IEA],immune response [goid 6955] [evidence IEA]; pathogenesis [goid 9405] [pmid 10425186] [evidence TAS]; signal transduction [goid 7165] [pmid 8775462] [evidence NAS]; immune response [goid 6955] [evidence IEA]; pathogenesis [goid 9405] [pmid 10425186] [evidence TAS]; signal transduction [goid 7165] [pmid 8775462] [evidence NAS],MHC class II receptor activity [goid 45012] [pmid 10425186] [evidence TAS]; MHC class II receptor activity [goid 45012] [pmid 10425186] [evidence TAS],,,,,NM_021983.4,3126,HLA-DRB4,-1.3823637005648148,10.830852662525754,-4.410973516298925,2.274072546156724e-5,5.750850559618918e-5,1.4509870211761546
TSGA2,ILMN_1684571,"Homo sapiens testis specific A2 homolog (mouse) (TSGA2), mRNA.",,meiosis [goid 7126] [evidence IEA],,21,42766047-42766049:42769077-42769123,21q22.3b,-,NM_080860.2,89765,TSGA2,-1.3205739845821256,7.451613345690748,-4.373111727798554,2.6415089544029076e-5,6.628435541087013e-5,1.3071102292331664
LOC138255,ILMN_1699537,"Homo sapiens chromosome 9 open reading frame 135 (C9orf135), mRNA.",,,,9,71662659-71662708,9q21.11b,+,NM_001010940.1,138255,LOC138255,-1.3238080809773152,6.673838411389391,-4.332802083816319,3.095356344765261e-5,7.685145053230263e-5,1.1549171559535347
MT1G,ILMN_1715401,"Homo sapiens metallothionein 1G (MT1G), mRNA.",,,zinc ion binding [goid 8270] [evidence IEA]; metal ion binding [goid 46872] [evidence IEA]; copper ion binding [goid 5507] [evidence IEA]; cadmium ion binding [goid 46870] [evidence IEA],16,55258248-55258291:55258292-55258297,16q13b,-,NM_005950.1,4495,MT1G,-1.277207744499444,9.330592352238781,-4.294522295328058,3.595190692445025e-5,8.855048747603501e-5,1.01133693051088
C10orf81,ILMN_1757099,"Homo sapiens chromosome 10 open reading frame 81 (C10orf81), mRNA.",,,protein binding [goid 5515] [evidence IEA],10,115532029-115532078,10q25.3a,+,NM_024889.3,79949,C10orf81,1.1731982414785218,6.831001017057058,4.206519740858411,5.055447521430585e-5,1.222151302172146e-4,0.684802929875187
LOC389816,ILMN_1680757,"PREDICTED: Homo sapiens similar to CDNA sequence BC004853 (LOC389816), mRNA.",,,,,,9q34.3e,,XM_939320.1,389816,LOC389816,1.1593332950103301,7.811609428934816,4.161870052602701,5.999355001421758e-5,1.437499166290002e-4,0.5210430136393631
ANXA10,ILMN_1699421,"Homo sapiens annexin A10 (ANXA10), mRNA.",,,calcium-dependent phospholipid binding [goid 5544] [evidence IEA]; calcium ion binding [goid 5509] [pmid 10458909] [evidence TAS],4,169345121-169345160:169345161-169345170,4q32.3e,+,NM_007193.3,11199,ANXA10,1.069544328481939,5.430846272149757,4.133436832704959,6.68616138121142e-5,1.5901361468681133e-4,0.41743825096875486
GSTA1,ILMN_1701831,"Homo sapiens glutathione S-transferase A1 (GSTA1), mRNA.",cytoplasm [goid 5737] [evidence NAS]; cytoplasm [goid 5737] [evidence NAS],glutathione metabolism [goid 6749] [pmid 11851347] [evidence IDA]; metabolism [goid 8152] [pmid 3800996] [evidence IC ]; glutathione metabolism [goid 6749] [pmid 11851347] [evidence IDA]; metabolism [goid 8152] [pmid 3800996] [evidence IC ],transferase activity [goid 16740] [evidence IEA]; glutathione transferase activity [goid 4364] [pmid 1731620] [evidence NAS]; transferase activity [goid 16740] [evidence IEA]; glutathione transferase activity [goid 4364] [pmid 1731620] [evidence NAS],6,52770382-52770394:52771938-52771974,6p12.1d,-,NM_145740.2,2938,GSTA1,-1.2563521367180206,7.285796465520931,-4.034170517416537,9.723985239265853e-5,2.2604611356131607e-4,0.05992103814887173
LOC652358,ILMN_1782937,"PREDICTED: Homo sapiens similar to Glutathione S-transferase A1 (GTH1) (HA subunit 1) (GST-epsilon) (GSTA1-1) (GST class-alpha) (LOC652358), mRNA.",,,,,,,,XM_941789.1,652358,LOC652358,-1.309618080149951,7.365965810386925,-3.992048263456428,1.1378266711224563e-4,2.621562337332513e-4,-0.08979586649274918
HOXD1,ILMN_1717381,"Homo sapiens homeobox D1 (HOXD1), mRNA.",nucleus [goid 5634] [evidence IEA],"regulation of transcription, DNA-dependent [goid 6355] [evidence IEA]; development [goid 7275] [evidence IEA]",sequence-specific DNA binding [goid 43565] [evidence IEA]; transcription factor activity [goid 3700] [evidence IEA],2,176763634-176763683,2q31.1h,+,NM_024501.1,3231,HOXD1,1.0124759554128193,8.668724085140978,3.9047351481893573,1.5703010727905446e-4,3.551632780420634e-4,-0.39630206015708236
C9orf116,ILMN_1723709,"Homo sapiens chromosome 9 open reading frame 116 (C9orf116), mRNA.",,,,9,137527008-137527057,9q34.3b,-,NM_144654.1,138162,C9orf116,-1.0022579916548473,7.873233936754764,-3.815016517437623,2.1755510168978916e-4,4.820401587929886e-4,-0.7057866464163629
WDR69,ILMN_1775042,"Homo sapiens WD repeat domain 69 (WDR69), mRNA.",,,,2,228496910-228496928:228496929-228496959,2q36.3c,+,NM_178821.1,164781,WDR69,-1.004515524327565,6.335962139448484,-3.716385795703318,3.094817849591863e-4,6.70847989757453e-4,-1.0395077045291377
HLA-DQB1,ILMN_1661266,"Homo sapiens major histocompatibility complex, class II, DQ beta 1 (HLA-DQB1), mRNA.",integral to membrane [goid 16021] [evidence IEA]; membrane [goid 16020] [evidence NAS],immune response [goid 6955] [evidence NAS],MHC class II receptor activity [goid 45012] [evidence NAS],6,32736001-32736004:32737102-32737147,6p21.32b,-,NM_002123.2,3119,HLA-DQB1,-1.1166709214148955,10.565403082578802,-3.5573259750617208,5.390965225795877e-4,0.0011319284205240589,-1.563027721753949
CT45-3,ILMN_1757689,"Homo sapiens cancer/testis antigen CT45-3 (CT45-3), mRNA.",,,,X,134718990-134718992:134718993-134719039,Xq26.3b,+,NM_001017435.1,441519,CT45-3,-1.021350664955368,5.615496510389369,-3.5129620342551964,6.274689411652076e-4,0.0013052452566034024,-1.7057565079376618
CCL20,ILMN_1657234,"Homo sapiens chemokine (C-C motif) ligand 20 (CCL20), mRNA.",extracellular space [goid 5615] [pmid 9038201] [evidence TAS]; extracellular region [goid 5576] [evidence IEA],inflammatory response [goid 6954] [pmid 9129037] [evidence TAS]; signal transduction [goid 7165] [pmid 9038201] [evidence TAS]; chemotaxis [goid 6935] [pmid 10438902] [evidence TAS]; cell-cell signaling [goid 7267] [pmid 9038201] [evidence TAS]; antimicrobial humoral response (sensu Vertebrata) [goid 19735] [pmid 9038201] [evidence TAS],chemokine activity [goid 8009] [pmid 10438902] [evidence TAS],2,228390096-228390145,2q36.3c,+,NM_004591.1,6364,CCL20,1.0220352613756498,7.736772070540689,3.431125036619963,8.273558936767656e-4,0.0016944533937662159,-1.965218419641796
TFF2,ILMN_1663919,"Homo sapiens trefoil factor 2 (spasmolytic protein 1) (TFF2), mRNA.",,defense response [goid 6952] [evidence NR ]; digestion [goid 7586] [pmid 9043862] [evidence TAS],,21,42640779-42640810:42643059-42643076,21q22.3b,-,NM_005423.3,7032,TFF2,1.008200125515918,5.377020370281596,3.284061840308301,0.0013443807723949007,0.0026659128180454546,-2.418811931851285
KRT17,ILMN_1666845,"Homo sapiens keratin 17 (KRT17), mRNA.",intermediate filament [goid 5882] [pmid 1281771] [evidence TAS],epidermis development [goid 8544] [pmid 7539673] [evidence TAS],structural molecule activity [goid 5198] [evidence IEA]; protein binding [goid 5515] [pmid 16189514] [evidence IPI]; structural constituent of cytoskeleton [goid 5200] [pmid 1281771] [evidence TAS],17,37029235-37029284,17q21.2b,-,NM_000422.1,3872,KRT17,1.105549776477508,8.379224463919892,3.2636447045318495,0.001436411971846745,0.0028362877251148994,-2.4804808204750373
PLUNC,ILMN_1774250,"Homo sapiens palate, lung and nasal epithelium carcinoma associated (PLUNC), transcript variant 1, mRNA.",extracellular region [goid 5576] [pmid 11425234] [evidence IDA],innate immune response [goid 45087] [pmid 11971875] [evidence NAS],lipid binding [goid 8289] [evidence IEA],20,31291794-31291843,20q11.21c,+,NM_016583.2,51297,PLUNC,1.1684354586806167,6.2698199351551605,2.961874867488069,0.003693202166699165,0.006858100087499593,-3.353924209677049
